Citrus Sinensis ID: 046265
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 639 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LP24 | 1120 | Probable leucine-rich rep | yes | no | 0.948 | 0.541 | 0.345 | 1e-101 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.960 | 0.587 | 0.345 | 1e-100 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.934 | 0.523 | 0.313 | 6e-80 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.921 | 0.518 | 0.307 | 4e-79 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.967 | 0.561 | 0.314 | 1e-78 | |
| C0LGW6 | 966 | LRR receptor-like serine/ | no | no | 0.968 | 0.640 | 0.303 | 1e-74 | |
| Q6XAT2 | 967 | LRR receptor-like serine/ | no | no | 0.979 | 0.647 | 0.299 | 1e-72 | |
| Q9SYQ8 | 980 | Receptor protein kinase C | no | no | 0.915 | 0.596 | 0.303 | 6e-70 | |
| C0LGR3 | 1091 | Probable LRR receptor-lik | no | no | 0.931 | 0.545 | 0.290 | 2e-69 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.923 | 0.471 | 0.293 | 5e-69 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 369 bits (946), Expect = e-101, Method: Compositional matrix adjust.
Identities = 255/739 (34%), Positives = 366/739 (49%), Gaps = 133/739 (17%)
Query: 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVG 75
N L IPP++GNI ++ L++ NN+L+G IP + L +L LY+ N L G +P E+G
Sbjct: 304 NYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELG 363
Query: 76 QLSSLKQLVLYCNGLSGWLPSSFGNLNNLAI---------GSMPNSLSNLTSLSLFHLDL 126
+ S+ L L N L+G +PSSFGNL NL G +P L N+ S+ +LDL
Sbjct: 364 NMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESM--INLDL 421
Query: 127 SENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP------------------------I 162
S+N+L+GS+P G+ + L L+L N L G+IPP
Sbjct: 422 SQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPET 481
Query: 163 LGKVQSLLSLGFDLNLLNGVLPPSISNLSNL---------------EGLYLYSSL----- 202
+ K + L ++ D N L G +P S+ + +L E +Y L
Sbjct: 482 VCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDF 541
Query: 203 --------------------------------VSAEIGNLLQLIELEIDNKQLFGQIPKS 230
+ EI N+ QL+EL++ LFG++P++
Sbjct: 542 SHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEA 601
Query: 231 LRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG-------------SLNF 277
+ N T+L+ + L N L+G + NL LDLS NNF +N
Sbjct: 602 IGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNL 661
Query: 278 SMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRV 337
S N SIP ++ KL QL +LD S N + GE+P +L +L+SL+ L+ N + G +P
Sbjct: 662 SRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTT 720
Query: 338 LGSISDLEYLDLSTNY-------NNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSV 390
+ L +D+S N FRK LE+ + L ++R +P
Sbjct: 721 FEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEE-----NIGLCSNIPKQRLKPCRE 775
Query: 391 IWKAWRS-------LISRMHGLSCIDISYNELRGLIRNSTGIHYNLVDALQGNKGLCGDV 443
+ K ++ L+ + L + I N IR + D G
Sbjct: 776 LKKPKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPETGEN------ 829
Query: 444 KLFSILTFEGKILYEEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPD 503
SI + +GK Y+++I +TN FD + IGT G + VY+A L I+AVK+ H +
Sbjct: 830 --MSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDE 886
Query: 504 M----VVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAA 559
VV+Q F NE+KALTE+RHRNVVK +GF H R +FL+YEY+ +GSL +L+ND
Sbjct: 887 EISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEE 946
Query: 560 IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619
+WT R+NV+K VA+ LSYMHHD PIVHRDISS N+LL DY A +SDFG +K L
Sbjct: 947 AKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLL 1006
Query: 620 KPDSSNWSEFVGTFGYVAP 638
K DSSNWS GT+GYVAP
Sbjct: 1007 KTDSSNWSAVAGTYGYVAP 1025
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 367 bits (942), Expect = e-100, Method: Compositional matrix adjust.
Identities = 250/723 (34%), Positives = 361/723 (49%), Gaps = 109/723 (15%)
Query: 10 QVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGS 69
++ + N L IP GN+ N+ L+M NQLSG IP EI +T L L ++ NKL G
Sbjct: 242 ELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGP 301
Query: 70 VPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLN---------NLAIGSMPNSLSNLTSLS 120
+P +G + +L L LY N L+G +P G + N G +P+S LT+L
Sbjct: 302 IPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALE 361
Query: 121 LFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN 180
L L +NQLSG IP + + + L VL L N+ G +P + + L +L D N
Sbjct: 362 W--LFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFE 419
Query: 181 GVLPPSISNLSNL---------------EGLYLYSSL----------------------- 202
G +P S+ + +L E +Y +L
Sbjct: 420 GPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQK 479
Query: 203 --------------VSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLT 248
+ EI N+ QL +L++ + ++ G++P+S+ N ++ + L N L+
Sbjct: 480 LVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLS 539
Query: 249 GNIYEVFGIYPNLTFLDLSQNNFYGS-------------LNFSMNNITRSIPPKIGKLYQ 295
G I + NL +LDLS N F +N S N++ ++IP + KL Q
Sbjct: 540 GKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQ 599
Query: 296 LHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNY-- 353
L LD S N + GE+ + +L++L L+ N + G +P + L ++D+S N
Sbjct: 600 LQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQ 659
Query: 354 -----NNEFRKEFPVELEK------LVQLTE--LDLVITFWEERYRPKSVIWKAWRSLIS 400
N FR P E V T+ IT ++ ++ +++I +I
Sbjct: 660 GPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIG 719
Query: 401 RMHGLS-CIDISYNELRGLIRNSTGIHYNLVDALQGNKGLCGDVKLFSILTFEGKILYEE 459
+ LS C I R T D+ G + L SI +F+GK+ Y+E
Sbjct: 720 AIIILSVCAGIFI-----CFRKRTKQIEEHTDSESGGETL-------SIFSFDGKVRYQE 767
Query: 460 VIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMV----VQQAFSNEIK 515
+I+AT FD KY IGT G VYKA+LP+ I+AVKK + + +Q F NEI+
Sbjct: 768 IIKATGEFDPKYLIGTGGHGKVYKAKLPN-AIMAVKKLNETTDSSISNPSTKQEFLNEIR 826
Query: 516 ALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSV 575
ALTE+RHRNVVK +GF H R +FL+YEY+ RGSL +L ND + W R+NV+K V
Sbjct: 827 ALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGV 886
Query: 576 ANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGY 635
A+ LSYMHHD P IVHRDISS N+LLG DY+A +SDFG +K LKPDSSNWS GT+GY
Sbjct: 887 AHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGY 946
Query: 636 VAP 638
VAP
Sbjct: 947 VAP 949
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 298 bits (764), Expect = 6e-80, Method: Compositional matrix adjust.
Identities = 226/720 (31%), Positives = 337/720 (46%), Gaps = 123/720 (17%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81
IP +GN S L L + N LSG IP+EI LT L+ L++ N L G +P E+G S+LK
Sbjct: 266 IPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLK 325
Query: 82 QLVLYCNGLSGWLPSSFGNL---------NNLAIGSMPNSLSNLTSLSLFHLDLSENQLS 132
+ L N LSG +PSS G L +N GS+P ++SN + SL L L +NQ+S
Sbjct: 326 MIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCS--SLVQLQLDKNQIS 383
Query: 133 GSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSN 192
G IP LG L+ L + N L GSIPP L L +L N L G +P + L N
Sbjct: 384 GLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRN 443
Query: 193 LEGLYLYSSLVSA----EIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLT 248
L L L S+ +S EIGN L+ L + ++ G+IP + + +N + N L
Sbjct: 444 LTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLH 503
Query: 249 GNIYEVFGIYPNLTFLDLSQNNFYGS-------------LNFSMNNITRSIPPKIGKLYQ 295
G + + G L +DLS N+ GS L+ S N + IP +G+L
Sbjct: 504 GKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVS 563
Query: 296 LHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLE-YLDLSTNYN 354
L+KL S N G +P LG L L N++ G +P LG I +LE L+LS+
Sbjct: 564 LNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSS--- 620
Query: 355 NEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNE 414
N + P ++ L +L+ LDL E P ++ + L ++ISYN
Sbjct: 621 NRLTGKIPSKIASLNKLSILDLSHNMLEGDLAP-----------LANIENLVSLNISYNS 669
Query: 415 LRGLIRNSTGIHYNLVDALQGNKGLCGDVKLFSILTF-EGKILYEE-------------- 459
G + ++ L+GNK LC + LT+ +G L ++
Sbjct: 670 FSGYLPDNKLFRQLSPQDLEGNKKLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLA 729
Query: 460 ----------------VIRATNNFDAK---------------------------YC---- 472
VIRA N D + C
Sbjct: 730 LLITLTVVLMILGAVAVIRARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEP 789
Query: 473 --IGTAGQASVYKAELPSWEIVAVKKFHSPHPDMV----------VQQAFSNEIKALTEL 520
IG VY+A++ + E++AVKK P MV V+ +FS E+K L +
Sbjct: 790 NVIGKGCSGVVYRADVDNGEVIAVKKL---WPAMVNGGHDEKTKNVRDSFSAEVKTLGTI 846
Query: 521 RHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLS 580
RH+N+V+F G ++ L+Y+Y+ GSL +L ++ W +R ++ A L+
Sbjct: 847 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL-HERRGSSLDWDLRYRILLGAAQGLA 905
Query: 581 YMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL-KPDSSNWSEFV-GTFGYVAP 638
Y+HHD PPIVHRDI + N+L+GLD++ +++DFG++K + + D S V G++GY+AP
Sbjct: 906 YLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAP 965
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (758), Expect = 4e-79, Method: Compositional matrix adjust.
Identities = 228/742 (30%), Positives = 345/742 (46%), Gaps = 153/742 (20%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
S L IP ++GN S L L + +N LSG +P+E+ L +L+ + + N L G +P E+
Sbjct: 260 STMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEI 319
Query: 75 GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLA---------IGSMPNSLSNLTSLSLFHLD 125
G + SL + L N SG +P SFGNL+NL GS+P+ LSN T L F +D
Sbjct: 320 GFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQID 379
Query: 126 LSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPP 185
NQ+SG IP +G L L + N L G+IP L Q+L +L N L G LP
Sbjct: 380 --ANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPA 437
Query: 186 SISNLSNLEGLYLYSSLVSA----EIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVH 241
+ L NL L L S+ +S EIGN L+ L + N ++ G+IPK + +L+ +
Sbjct: 438 GLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLD 497
Query: 242 LEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDF 301
L +N+L+G + L L+LS N G L S++++T+ L LD
Sbjct: 498 LSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTK-----------LQVLDV 546
Query: 302 SLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEF 361
S N + G++P LG+L SLN L+ N G +P LG ++L+ LDLS+ N
Sbjct: 547 SSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSS---NNISGTI 603
Query: 362 PVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSL-------ISRMHGLSCIDISYNE 414
P E+L + +LD+ + +W SL IS ++ LS +DIS+N
Sbjct: 604 P---EELFDIQDLDIALNL-------------SWNSLDGFIPERISALNRLSVLDISHNM 647
Query: 415 LRGLIRNSTGIHYNLVD------------------------ALQGNKGLCGD-------- 442
L G + +G+ NLV ++GN GLC
Sbjct: 648 LSGDLSALSGLE-NLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRSCFVS 706
Query: 443 --------------------------VKLFSILTFEGKILYEEVIRATN----------- 465
+ ++L I +++IR N
Sbjct: 707 NSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENLWTW 766
Query: 466 --------NFDAKY---C------IGTAGQASVYKAELPSWEIVAVKK--------FHSP 500
NF ++ C IG VYKAE+P+ E++AVKK +
Sbjct: 767 QFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNLNEK 826
Query: 501 HPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAI 560
V+ +FS E+K L +RH+N+V+F G ++ L+Y+Y+ GSL +L + +
Sbjct: 827 TKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGV 886
Query: 561 DEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620
W VR +I A L+Y+HHD PPIVHRDI + N+L+G D++ ++ DFG++K +
Sbjct: 887 CSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVD 946
Query: 621 ----PDSSNWSEFVGTFGYVAP 638
SSN G++GY+AP
Sbjct: 947 DGDFARSSN--TIAGSYGYIAP 966
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 295 bits (754), Expect = 1e-78, Method: Compositional matrix adjust.
Identities = 230/732 (31%), Positives = 330/732 (45%), Gaps = 114/732 (15%)
Query: 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVG 75
N L IPP +GNIS L+ L + N +G IP+EI LT +K LY+ N+L G +PRE+G
Sbjct: 245 NRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIG 304
Query: 76 QLSSLKQLVLYCNGLSGWLPSSFGNL---------NNLAIGSMPNSLSNLTSLS------ 120
L ++ N L+G++P FG++ N+ +G +P L LT L
Sbjct: 305 NLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSI 364
Query: 121 ----------------LFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILG 164
L L L +NQL G IP +G SN +VL + NSL G IP
Sbjct: 365 NRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFC 424
Query: 165 KVQSL--LSLG---------FDL-------------NLLNGVLPPSISNLSNLEGLYLY- 199
+ Q+L LSLG DL N L G LP + NL NL L L+
Sbjct: 425 RFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQ 484
Query: 200 ---SSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFG 256
S +SA++G L L L + N G+IP + N T + ++ N LTG+I + G
Sbjct: 485 NWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELG 544
Query: 257 IYPNLTFLDLSQNNFYGS-------------LNFSMNNITRSIPPKIGKLYQLHKLDFSL 303
+ LDLS N F G L S N +T IP G L +L +L
Sbjct: 545 SCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGG 604
Query: 304 NHIVGELPIELGNLKSLNYRA-LNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFP 362
N + +P+ELG L SL ++ N + G++P LG++ LE L L+ +N+ E P
Sbjct: 605 NLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLN---DNKLSGEIP 661
Query: 363 VELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRNS 422
+ L+ L ++ +V + S + HGL + + + L+ +S
Sbjct: 662 ASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLC--NSQRSHCQPLVPHS 719
Query: 423 TGIHYNLVDALQGNK------------------GLCGDVK----LFSILTFEGK------ 454
L++ Q K GLC +K F L + K
Sbjct: 720 DSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDS 779
Query: 455 -------ILYEEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQ 507
Y+ ++ AT NF +G +VYKAE+ E++AVKK +S
Sbjct: 780 YYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSD 839
Query: 508 QAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTV 567
+F EI L ++RHRN+VK YGF +H + LLYEY+ +GSL L W
Sbjct: 840 NSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNA 899
Query: 568 RMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD-SSNW 626
R + A L Y+HHD P IVHRDI S N+LL + AHV DFG++K + S +
Sbjct: 900 RYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSM 959
Query: 627 SEFVGTFGYVAP 638
S G++GY+AP
Sbjct: 960 SAVAGSYGYIAP 971
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 281 bits (719), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 219/722 (30%), Positives = 338/722 (46%), Gaps = 103/722 (14%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPRE 73
+ N L IP +IGN ++L +LD+ N L G IP I L L+ L + N+L G VP
Sbjct: 103 QGNKLAGQIPDEIGNCASLVYLDLSENLLYGDIPFSISKLKQLETLNLKNNQLTGPVPAT 162
Query: 74 VGQLSSLKQLVLYCNGLSG-------W-----------------LPSSFGNL-------- 101
+ Q+ +LK+L L N L+G W L S L
Sbjct: 163 LTQIPNLKRLDLAGNHLTGEISRLLYWNEVLQYLGLRGNMLTGTLSSDMCQLTGLWYFDV 222
Query: 102 --NNLAIGSMPNSLSNLTS---------------------LSLFHLDLSENQLSGSIPHF 138
NNL G++P S+ N TS L + L L N+L+G IP
Sbjct: 223 RGNNLT-GTIPESIGNCTSFQILDISYNQITGEIPYNIGFLQVATLSLQGNRLTGRIPEV 281
Query: 139 LGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYL 198
+G + LAVL L DN L G IPPILG + L N+L G +P + N+S L L L
Sbjct: 282 IGLMQALAVLDLSDNELVGPIPPILGNLSFTGKLYLHGNMLTGPIPSELGNMSRLSYLQL 341
Query: 199 YSS----LVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEV 254
+ + E+G L QL EL + N +L G IP ++ + +LN ++ N L+G+I
Sbjct: 342 NDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNISSCAALNQFNVHGNLLSGSIPLA 401
Query: 255 FGIYPNLTFLDLSQNNFYGS-------------LNFSMNNITRSIPPKIGKLYQLHKLDF 301
F +LT+L+LS NNF G L+ S NN + SIP +G L L L+
Sbjct: 402 FRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNL 461
Query: 302 SLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEF 361
S NH+ G+LP E GNL+S+ ++ N + G +P LG + +L NN+ +
Sbjct: 462 SRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTELGQLQNLNS---LILNNNKLHGKI 518
Query: 362 PVELEKLVQLTELDLVITFWE---------ERYRPKSVIWKAW--------------RSL 398
P +L L L++ R+ P S + + +S
Sbjct: 519 PDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPASFVGNPYLCGNWVGSICGPLPKSR 578
Query: 399 ISRMHGLSCIDISYNELRGLIRNSTGIHYNLVDALQGNKGLCGDVKLFSILTFEGKI-LY 457
+ L CI + L +I + LQG+ + IL + I +
Sbjct: 579 VFSRGALICIVLGVITLLCMIFLAVYKSMQQKKILQGSSKQAEGLTKLVILHMDMAIHTF 638
Query: 458 EEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKAL 517
++++R T N + K+ IG ++VYK L S +A+K+ ++ +P + + F E++ +
Sbjct: 639 DDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYPHNL--REFETELETI 696
Query: 518 TELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVAN 577
+RHRN+V +G++ P + L Y+Y+ GSL +L + W R+ + A
Sbjct: 697 GSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHGSLKKVKLDWETRLKIAVGAAQ 756
Query: 578 TLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFV-GTFGYV 636
L+Y+HHD P I+HRDI S N+LL +++AH+SDFGI+K + ++ S +V GT GY+
Sbjct: 757 GLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAKSIPASKTHASTYVLGTIGYI 816
Query: 637 AP 638
P
Sbjct: 817 DP 818
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 274 bits (701), Expect = 1e-72, Method: Compositional matrix adjust.
Identities = 214/714 (29%), Positives = 340/714 (47%), Gaps = 88/714 (12%)
Query: 2 SCLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYI 61
+C++ + V +N LF IP I + L+FL++ NNQL+G IP + + +LK L +
Sbjct: 119 NCVSLAY--VDFSTNLLFGDIPFSISKLKQLEFLNLKNNQLTGPIPATLTQIPNLKTLDL 176
Query: 62 NVNKLRGSVPR------------------------EVGQLSSLKQLVLYCNGLSGWLPSS 97
N+L G +PR ++ QL+ L + N L+G +P S
Sbjct: 177 ARNQLTGEIPRLLYWNEVLQYLGLRGNMLTGTLSPDMCQLTGLWYFDVRGNNLTGTIPES 236
Query: 98 FGNLNNLAI---------GSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVL 148
GN + I G +P N+ L + L L N+L+G IP +G + LAVL
Sbjct: 237 IGNCTSFEILDVSYNQITGVIP---YNIGFLQVATLSLQGNKLTGRIPEVIGLMQALAVL 293
Query: 149 HLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSS----LVS 204
L DN L G IPPILG + L N L G +PP + N+S L L L + +
Sbjct: 294 DLSDNELTGPIPPILGNLSFTGKLYLHGNKLTGQIPPELGNMSRLSYLQLNDNELVGKIP 353
Query: 205 AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFL 264
E+G L QL EL + N L G IP ++ + +LN ++ N L+G + F +LT+L
Sbjct: 354 PELGKLEQLFELNLANNNLVGLIPSNISSCAALNQFNVHGNFLSGAVPLEFRNLGSLTYL 413
Query: 265 DLSQNNFYG-------------SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELP 311
+LS N+F G +L+ S NN + SIP +G L L L+ S NH+ G LP
Sbjct: 414 NLSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTLP 473
Query: 312 IELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQL 371
E GNL+S+ ++ N + G +P LG L+ ++ NN+ + P +L L
Sbjct: 474 AEFGNLRSIQIIDVSFNFLAGVIPTELG---QLQNINSLILNNNKIHGKIPDQLTNCFSL 530
Query: 372 TELDLVITFWE---------ERYRPKS-----VIWKAW----------RSLISRMHGLSC 407
L++ R+ P S + W +S + + C
Sbjct: 531 ANLNISFNNLSGIIPPMKNFTRFSPASFFGNPFLCGNWVGSICGPSLPKSQVFTRVAVIC 590
Query: 408 IDISYNELRGLIRNSTGIHYNLVDALQG-NKGLCGDVKLFSILTFEGKI-LYEEVIRATN 465
+ + + L +I + L+G +K G KL IL + I +++++R T
Sbjct: 591 MVLGFITLICMIFIAVYKSKQQKPVLKGSSKQPEGSTKLV-ILHMDMAIHTFDDIMRVTE 649
Query: 466 NFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNV 525
N D KY IG ++VYK + +A+K+ ++ +P + F E++ + +RHRN+
Sbjct: 650 NLDEKYIIGYGASSTVYKCTSKTSRPIAIKRIYNQYPSNF--REFETELETIGSIRHRNI 707
Query: 526 VKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHD 585
V +G++ P + L Y+Y+ GSL +L + W R+ + A L+Y+HHD
Sbjct: 708 VSLHGYALSPFGNLLFYDYMENGSLWDLLHGPGKKVKLDWETRLKIAVGAAQGLAYLHHD 767
Query: 586 YFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFV-GTFGYVAP 638
P I+HRDI S N+LL +++A +SDFGI+K + + S +V GT GY+ P
Sbjct: 768 CTPRIIHRDIKSSNILLDGNFEARLSDFGIAKSIPATKTYASTYVLGTIGYIDP 821
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 265 bits (678), Expect = 6e-70, Method: Compositional matrix adjust.
Identities = 205/675 (30%), Positives = 313/675 (46%), Gaps = 90/675 (13%)
Query: 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVG 75
N+ +PP+ G ++ L+ LDM + L+G IP + L HL L++++N L G +P E+
Sbjct: 227 NSYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSLSNLKHLHTLFLHINNLTGHIPPELS 286
Query: 76 QLSSLKQLVLYCNGLSGWLPSSFGNLNNLAI---------GSMPNSLSNLTSLSLFH--- 123
L SLK L L N L+G +P SF NL N+ + G +P ++ L L +F
Sbjct: 287 GLVSLKSLDLSINQLTGEIPQSFINLGNITLINLFRNNLYGQIPEAIGELPKLEVFEVWE 346
Query: 124 -------------------LDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILG 164
LD+S+N L+G IP L L +L L +N FG IP LG
Sbjct: 347 NNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLCRGEKLEMLILSNNFFFGPIPEELG 406
Query: 165 KVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEI-----GNLLQLIELEID 219
K +SL + NLLNG +P + NL + + L + S E+ G++L I L
Sbjct: 407 KCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELTDNFFSGELPVTMSGDVLDQIYL--S 464
Query: 220 NKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNI-YEVFGIYPNLTFLDLSQNNFYGSLNFS 278
N G+IP ++ NF +L + L++N GNI E+F + +N S
Sbjct: 465 NNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREIFEL------------KHLSRINTS 512
Query: 279 MNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVL 338
NNIT IP I + L +D S N I GE+P + N+K+L ++GN++ GS+P +
Sbjct: 513 ANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQLTGSIPTGI 572
Query: 339 GSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSL 398
G+++ L LDLS N+ P+ + LV F E + + + R
Sbjct: 573 GNMTSLTTLDLSF---NDLSGRVPLGGQFLV----------FNETSFAGNTYLCLPHRVS 619
Query: 399 ISRMHGLSC-------------IDISYNELRGLIRNSTGIHYNLVDALQGNKGLCGDVKL 445
G + + + GLI S I ++ + K L +
Sbjct: 620 CPTRPGQTSDHNHTALFSPSRIVITVIAAITGLILISVAIRQ--MNKKKNQKSLAWKLTA 677
Query: 446 FSILTFEGKILYEEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMV 505
F L F+ E+V+ + IG G VY+ +P+ VA+K+
Sbjct: 678 FQKLDFKS----EDVLEC---LKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTGR- 729
Query: 506 VQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSW 565
F+ EI+ L +RHR++V+ G+ + + LLYEY+ GSL +L W
Sbjct: 730 SDHGFTAEIQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKG-GHLQW 788
Query: 566 TVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL--KPDS 623
R V A L Y+HHD P I+HRD+ S N+LL D++AHV+DFG++KFL S
Sbjct: 789 ETRHRVAVEAAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAAS 848
Query: 624 SNWSEFVGTFGYVAP 638
S G++GY+AP
Sbjct: 849 ECMSSIAGSYGYIAP 863
|
Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGR3|Y4265_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g26540 OS=Arabidopsis thaliana GN=At4g26540 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 263 bits (673), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 215/739 (29%), Positives = 333/739 (45%), Gaps = 144/739 (19%)
Query: 17 TLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQ 76
+L +P IGN+ ++ + + + LSG IP EI T L++LY+ N + GS+P +G
Sbjct: 225 SLSGKLPASIGNLKRVQTIAIYTSLLSGPIPDEIGYCTELQNLYLYQNSISGSIPTTIGG 284
Query: 77 LSSLKQLVLYCNGLSGWLPSSFGNL---------NNLAIGSMPNSLSNLTSLSLFHLDLS 127
L L+ L+L+ N L G +P+ GN NL G++P S L +L L LS
Sbjct: 285 LKKLQSLLLWQNNLVGKIPTELGNCPELWLIDFSENLLTGTIPRSFGKLENLQ--ELQLS 342
Query: 128 ENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSI 187
NQ+SG+IP L + + L L + +N + G IP ++ ++SL N L G +P S+
Sbjct: 343 VNQISGTIPEELTNCTKLTHLEIDNNLITGEIPSLMSNLRSLTMFFAWQNKLTGNIPQSL 402
Query: 188 SNLSNLEGLYL-YSSL---------------------------VSAEIGNLLQLIELEID 219
S L+ + L Y+SL + +IGN L L ++
Sbjct: 403 SQCRELQAIDLSYNSLSGSIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTNLYRLRLN 462
Query: 220 NKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSL---- 275
+L G IP + N +LN V + +N L G+I +L FLDL N+ GSL
Sbjct: 463 GNRLAGSIPSEIGNLKNLNFVDISENRLVGSIPPAISGCESLEFLDLHTNSLSGSLLGTT 522
Query: 276 --------NFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNG 327
+FS N ++ ++PP IG L +L KL+ + N + GE+P E+ +SL L
Sbjct: 523 LPKSLKFIDFSDNALSSTLPPGIGLLTELTKLNLAKNRLSGEIPREISTCRSLQLLNLGE 582
Query: 328 NKVYGSLPRVLGSISDLEY-LDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYR 386
N G +P LG I L L+LS N F E P L L LD+
Sbjct: 583 NDFSGEIPDELGQIPSLAISLNLSC---NRFVGEIPSRFSDLKNLGVLDVSHNQLTGNL- 638
Query: 387 PKSVIWKAWRSLISRMHGLSCIDISYNEL---------------------RGL------- 418
++++ + L ++ISYN+ RGL
Sbjct: 639 ----------NVLTDLQNLVSLNISYNDFSGDLPNTPFFRRLPLSDLASNRGLYISNAIS 688
Query: 419 ------IRNSTGIH------------------YNLVDALQGNKGLCG------DVKLFSI 448
RNS+ + Y LV A K L G +V L+
Sbjct: 689 TRPDPTTRNSSVVRLTILILVVVTAVLVLMAVYTLVRARAAGKQLLGEEIDSWEVTLYQK 748
Query: 449 LTFEGKILYEEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQ 508
L F +++++ N + IGT VY+ +PS E +AVKK S
Sbjct: 749 LDFS----IDDIVK---NLTSANVIGTGSSGVVYRITIPSGESLAVKKMWSKEE----SG 797
Query: 509 AFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVR 568
AF++EIK L +RHRN+V+ G+ + L Y+YL GSL+ L W R
Sbjct: 798 AFNSEIKTLGSIRHRNIVRLLGWCSNRNLKLLFYDYLPNGSLSSRLHGAGKGGCVDWEAR 857
Query: 569 MNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK--PDS--- 623
+V+ VA+ L+Y+HHD P I+H D+ + NVLLG ++ +++DFG+++ + P++
Sbjct: 858 YDVVLGVAHALAYLHHDCLPTIIHGDVKAMNVLLGPHFEPYLADFGLARTISGYPNTGID 917
Query: 624 ----SNWSEFVGTFGYVAP 638
+N G++GY+AP
Sbjct: 918 LAKPTNRPPMAGSYGYMAP 936
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 5e-69, Method: Compositional matrix adjust.
Identities = 207/706 (29%), Positives = 327/706 (46%), Gaps = 116/706 (16%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81
+P +IGN + L+ +D N+LSG IP I L L L++ N+L G++P +G +
Sbjct: 449 MPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMT 508
Query: 82 QLVLYCNGLSGWLPSSFGNL---------NNLAIGSMPNSLSNLTSL------------- 119
+ L N LSG +PSSFG L NN G++P+SL NL +L
Sbjct: 509 VIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGS 568
Query: 120 --------SLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLS 171
S D++EN G IP LG +NL L LG N G IP GK+ L
Sbjct: 569 ISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSL 628
Query: 172 LGFDLNLLNGVLPPSISNLSNLEGLYL----YSSLVSAEIGNLLQLIELEIDNKQLFGQI 227
L N L+G++P + L + L S ++ +G L L EL++ + + G +
Sbjct: 629 LDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSL 688
Query: 228 PKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIP 287
P + + T++ + L+ N L G+I + G L L+L +N G L P
Sbjct: 689 PTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPL-----------P 737
Query: 288 PKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYR-ALNGNKVYGSLPRVLGSISDLEY 346
IGKL +L +L S N + GE+P+E+G L+ L L+ N G +P + ++ LE
Sbjct: 738 STIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLES 797
Query: 347 LDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKA------------ 394
LDLS +N+ E P ++ + L L+L E + + + W+A
Sbjct: 798 LDLS---HNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCGS 854
Query: 395 ------------WRSL-------ISRMHGLSCIDIS--------------YNELRGLIRN 421
RSL IS + L+ I + + ++RG
Sbjct: 855 PLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSA 914
Query: 422 STGIHYNLVDALQGNKGLCGDVKLFSILTFEGKILYEEVIRATNNFDAKYCIGTAGQASV 481
+ + L N G D+K +++++ AT+ + ++ IG+ G V
Sbjct: 915 FSSNSSSSQAPLFSNGGAKSDIK------------WDDIMEATHYLNEEFMIGSGGSGKV 962
Query: 482 YKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ--SF 539
YKAEL + E +AVKK D++ ++F+ E+K L +RHR++VK G+ +
Sbjct: 963 YKAELKNGETIAVKKILWKD-DLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNL 1021
Query: 540 LLYEYLGRGSLAIIL---SNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDIS 596
L+YEY+ GS+ L N + W R+ + +A + Y+H+D PPIVHRDI
Sbjct: 1022 LIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIK 1081
Query: 597 SKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE----FVGTFGYVAP 638
S NVLL + +AH+ DFG++K L + +E F G++GY+AP
Sbjct: 1082 SSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAP 1127
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 639 | ||||||
| 147767326 | 1032 | hypothetical protein VITISV_008862 [Viti | 0.981 | 0.607 | 0.401 | 1e-133 | |
| 359491509 | 1032 | PREDICTED: probable LRR receptor-like se | 0.981 | 0.607 | 0.398 | 1e-132 | |
| 225456159 | 1038 | PREDICTED: probable LRR receptor-like se | 0.973 | 0.599 | 0.393 | 1e-129 | |
| 359491512 | 1078 | PREDICTED: probable LRR receptor-like se | 0.970 | 0.575 | 0.390 | 1e-124 | |
| 357439029 | 1085 | Receptor protein kinase-like protein [Me | 0.968 | 0.570 | 0.393 | 1e-124 | |
| 359487164 | 1378 | PREDICTED: probable leucine-rich repeat | 0.971 | 0.450 | 0.376 | 1e-123 | |
| 359484867 | 1217 | PREDICTED: probable leucine-rich repeat | 0.956 | 0.502 | 0.374 | 1e-122 | |
| 359486022 | 1510 | PREDICTED: probable leucine-rich repeat | 0.973 | 0.411 | 0.383 | 1e-121 | |
| 359486293 | 1028 | PREDICTED: probable LRR receptor-like se | 0.960 | 0.597 | 0.386 | 1e-121 | |
| 255545702 | 1008 | receptor protein kinase, putative [Ricin | 0.974 | 0.618 | 0.379 | 1e-121 |
| >gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 483 bits (1242), Expect = e-133, Method: Compositional matrix adjust.
Identities = 333/830 (40%), Positives = 415/830 (50%), Gaps = 203/830 (24%)
Query: 4 LAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINV 63
LA+F + N L IPPQIG +S LK+LD+ NQ SG IP EI LT+L+ L++
Sbjct: 112 LAYFDINM----NKLSGPIPPQIGFLSKLKYLDLSTNQFSGRIPSEIGLLTNLEVLHLVE 167
Query: 64 NKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLA------------------ 105
N+L GS+P E+GQL SL L LY N L G +P+S GNL+NL
Sbjct: 168 NQLNGSIPHEIGQLKSLCDLSLYTNKLEGSIPASLGNLSNLTNLYLDENKLSGLIPPEMG 227
Query: 106 ---------------IGSMPNSLSNLTSLSLF----------------------HLDLSE 128
G +P++L NL SL+L +L LS
Sbjct: 228 NLTKLVELCLNANNLTGPIPSTLGNLKSLTLLRLYNNQLSGPIPTEIGNLKHLRNLSLSS 287
Query: 129 NQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSIS 188
N LSG IP LG LS L L L DN L G IP +G ++SL+ L N LNG +P S+
Sbjct: 288 NYLSGPIPMSLGDLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPTSLG 347
Query: 189 NLSNLEGLYLY----SSLVSAEIGNLLQLIELEIDNKQ---------------------- 222
NL NLE LYL SS + EIG L +L+ELEID Q
Sbjct: 348 NLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFTVFD 407
Query: 223 --LFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGS------ 274
L G IP+SL+N SL L++N LTGNI E FG+ PNL ++LS N FYG
Sbjct: 408 NFLIGPIPESLKNCPSLARARLQRNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQNWG 467
Query: 275 -------LNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNG 327
L+ + NNIT SIP G QL L+ S NH+VGE+P +LG++ SL LN
Sbjct: 468 RCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLILND 527
Query: 328 NKVYGSLPRVLGSISDLEYLDLSTNY---------------------NNEFRKEFPVELE 366
N++ G++P LGS++DL YLDLS N NN+ PV++
Sbjct: 528 NRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPVQMG 587
Query: 367 KLV------------------QLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCI 408
KL Q+ L + +I KA+ MHGL +
Sbjct: 588 KLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFED----MHGLWQV 643
Query: 409 DISYNELRGLIRNSTGIHYNLVDALQGNKGLCGDVK---------------------LFS 447
DISYN+L+G I NS ++ LQGNKGLCG VK +FS
Sbjct: 644 DISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQPCENRSATKGTHKAVFIIIFS 703
Query: 448 IL-------TFEGKILYEEVIR----------------ATNNFDAK-------------- 470
+L F G L + R + + FD +
Sbjct: 704 LLGALLILSAFIGISLISQGRRNAKMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDFD 763
Query: 471 --YCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKF 528
YCIG G SVYKAELPS IVAVKK H DM Q+ F NEI+ALTE++HRN+VK
Sbjct: 764 PMYCIGEGGHGSVYKAELPSGNIVAVKKLHRFDIDMAHQKDFMNEIRALTEIKHRNIVKL 823
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
GF H R SFL+YEYL RGSL ILS + E W R+N+IK VA+ LSY+HHD P
Sbjct: 824 LGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWGTRVNIIKGVAHALSYLHHDCVP 883
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
PIVHRDISS NVLL Y+AHVSDFG +KFLK DSSNWS GT+GYVAP
Sbjct: 884 PIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAP 933
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 478 bits (1231), Expect = e-132, Method: Compositional matrix adjust.
Identities = 331/830 (39%), Positives = 413/830 (49%), Gaps = 203/830 (24%)
Query: 4 LAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINV 63
LA+F + N L IPPQIG +S LK+LD+ NQ SG IP EI LT+L+ L++
Sbjct: 112 LAYFDINM----NKLSGPIPPQIGFLSKLKYLDLSTNQFSGRIPSEIGLLTNLEVLHLVE 167
Query: 64 NKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLA------------------ 105
N+L GS+P E+GQL SL L LY N L G +P+S GNL+NL
Sbjct: 168 NQLNGSIPHEIGQLKSLCDLSLYTNKLEGTIPASLGNLSNLTNLYLDENKLSGLIPPEMG 227
Query: 106 ---------------IGSMPNSLSNLTSLSLF----------------------HLDLSE 128
G +P++L NL SL+L +L LS
Sbjct: 228 NLTKLVELCLNANNLTGPIPSTLGNLKSLTLLRLYNNQLSGPIPTEIGNLKHLRNLSLSS 287
Query: 129 NQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSIS 188
N LSG IP LG LS L L L DN L G IP +G ++SL+ L N LNG +P +
Sbjct: 288 NYLSGPIPMSLGDLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPTLLG 347
Query: 189 NLSNLEGLYLY----SSLVSAEIGNLLQLIELEIDNKQ---------------------- 222
NL NLE LYL SS + EIG L +L+ELEID Q
Sbjct: 348 NLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFTVFD 407
Query: 223 --LFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGS------ 274
L G IP+SL+N SL L+ N LTGNI E FG+ PNL ++LS N FYG
Sbjct: 408 NFLIGPIPESLKNCPSLARARLQGNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQNWG 467
Query: 275 -------LNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNG 327
L+ + NNIT SIP G QL L+ S NH+VGE+P +LG++ SL LN
Sbjct: 468 RCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLILND 527
Query: 328 NKVYGSLPRVLGSISDLEYLDLSTNY---------------------NNEFRKEFPVELE 366
N++ G++P LGS++DL YLDLS N NN+ PV++
Sbjct: 528 NRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPVQMG 587
Query: 367 KLV------------------QLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCI 408
KL Q+ L + +I KA+ MHGL +
Sbjct: 588 KLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFED----MHGLWQV 643
Query: 409 DISYNELRGLIRNSTGIHYNLVDALQGNKGLCGDVK---------------------LFS 447
DISYN+L+G I NS ++ LQGNKGLCG VK +FS
Sbjct: 644 DISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQPCENRSATKGTHKAVFIIIFS 703
Query: 448 IL-------TFEGKILYEEVIR----------------ATNNFDAK-------------- 470
+L F G L + R + + FD +
Sbjct: 704 LLGALLILSAFIGISLISQGRRNAKMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDFD 763
Query: 471 --YCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKF 528
YCIG G SVYKAELPS IVAVKK H DM Q+ F NEI+ALTE++HRN+VK
Sbjct: 764 PMYCIGEGGHGSVYKAELPSGNIVAVKKLHRFDIDMAHQKDFVNEIRALTEIKHRNIVKL 823
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
GF H R SFL+YEYL RGSL ILS + E W R+N+IK V++ LSY+HHD P
Sbjct: 824 LGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWGTRVNIIKGVSHALSYLHHDCVP 883
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
PIVHRDISS NVLL Y+AHVSDFG +KFLK DSSNWS GT+GYVAP
Sbjct: 884 PIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAP 933
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 468 bits (1203), Expect = e-129, Method: Compositional matrix adjust.
Identities = 322/818 (39%), Positives = 406/818 (49%), Gaps = 196/818 (23%)
Query: 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVG 75
N L IPPQIG + LK+LD+ NQ SG IP EI LT+L+ L++ N+L GS+P E+G
Sbjct: 123 NNLSGPIPPQIGLLFELKYLDLSINQFSGGIPSEIGLLTNLEVLHLVQNQLNGSIPHEIG 182
Query: 76 QLSSLKQLVLYCNGLSGWLPSSFGNLNNLA---------IGSMPNSLSNLTSL------- 119
QL+SL +L LY N L G +P+S GNL+NLA GS+P + NLT+L
Sbjct: 183 QLASLYELALYTNQLEGSIPASLGNLSNLASLYLYENQLSGSIPPEMGNLTNLVEIYSNN 242
Query: 120 ---------------------------------------SLFHLDLSENQLSGSIPHFLG 140
SL L L EN LSG IP L
Sbjct: 243 NNLTGPIPSTFGNLKRLTVLYLFNNSLSGPIPPEIGNLKSLQELSLYENNLSGPIPVSLC 302
Query: 141 HLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLY- 199
LS L +LHL N L G IP +G ++SL+ L N LNG +P S+ NL+NLE L+L
Sbjct: 303 DLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRD 362
Query: 200 ---SSLVSAEIGNLLQLIELEIDNKQLFGQ------------------------IPKSLR 232
S + EIG L +L+ LEID QLFG IPKSL+
Sbjct: 363 NQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGICQAGSLVRFAVSDNHLSGPIPKSLK 422
Query: 233 NFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLN-------------FSM 279
N +L + N LTGNI EV G PNL F+DLS N F+G L+ +
Sbjct: 423 NCRNLTRALFQGNRLTGNISEVVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAG 482
Query: 280 NNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLG 339
NNIT SIP G L LD S NH+VGE+P ++G+L SL LN N++ GS+P LG
Sbjct: 483 NNITGSIPEDFGISTNLTLLDLSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELG 542
Query: 340 SISDLEYLDLSTNY---------------------NNEFRKEFPVELEKLVQLTELDLVI 378
S+S LEYLDLS N NN+ PV++ KL L++LDL
Sbjct: 543 SLSHLEYLDLSANRLNGSIPEHLGDCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSH 602
Query: 379 TFWEERYRPKSVIWKAWRSL--------------ISRMHGLSCIDISYNELRGLIRNSTG 424
P+ ++ L M LS +DISYN+L+G I +S
Sbjct: 603 NLLAGGIPPQIQGLQSLEMLDLSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNA 662
Query: 425 IHYNLVDALQGNKGLCGDVK---------------------------------LFSILTF 451
++ L+GNK LCG+VK L + F
Sbjct: 663 FRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLFAF 722
Query: 452 EGKILYEEVIRAT---------------NNFDAK----------------YCIGTAGQAS 480
G L E T +NFD + YCIG G S
Sbjct: 723 IGIFLIAERRERTPEIEEGDVQNDLFSISNFDGRTMYEEIIKATKDFDPMYCIGKGGHGS 782
Query: 481 VYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540
VYKAELPS IVAVKK H +M Q+ F NEI+ALTE++HRN+VK GF HPR FL
Sbjct: 783 VYKAELPSSNIVAVKKLHPSDTEMANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFL 842
Query: 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNV 600
+YEYL RGSLA ILS + A + W R+N+IK VA+ L+YMHHD PPIVHRD+SS N+
Sbjct: 843 VYEYLERGSLATILSREEA-KKLGWATRVNIIKGVAHALAYMHHDCSPPIVHRDVSSNNI 901
Query: 601 LLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
LL Y+AH+SDFG +K LK DSSN S GTFGY+AP
Sbjct: 902 LLDSQYEAHISDFGTAKLLKLDSSNQSILAGTFGYLAP 939
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 453 bits (1165), Expect = e-124, Method: Compositional matrix adjust.
Identities = 312/799 (39%), Positives = 400/799 (50%), Gaps = 179/799 (22%)
Query: 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYI---NVNKLRGSVPR 72
N L IPPQIG +S LK+LD+ NQ SG IP EI LT+L+ L++ N+L GS+P
Sbjct: 151 NNLSGPIPPQIGLLSKLKYLDLSTNQFSGGIPPEIGLLTNLEVLHLLALYTNQLEGSIPA 210
Query: 73 EVGQLSSLKQLVLY------------------------CNGLSGWLPSSFGNL------- 101
+G LS+L L LY N L+G +PS+FGNL
Sbjct: 211 SLGNLSNLASLYLYENQLSGSIPPEMGNLANLVEIYSDTNNLTGLIPSTFGNLKRLTTLY 270
Query: 102 --NNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSI 159
NN G +P + NLTSL + L N LSG IP LG LS L +LHL N L G I
Sbjct: 271 LFNNQLSGHIPPEIGNLTSLQ--GISLYANNLSGPIPASLGDLSGLTLLHLYANQLSGPI 328
Query: 160 PPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSA----EIGNLLQLIE 215
PP +G ++SL+ L N LNG +P S+ NL+NLE L+L + +S EIG L +L+
Sbjct: 329 PPEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNHLSGYFPKEIGKLHKLVV 388
Query: 216 LEIDNKQLFGQ------------------------IPKSLRNFTSLNIVHLEQNHLTGNI 251
LEID +L G IPKS++N +L N LTGNI
Sbjct: 389 LEIDTNRLSGSLPEGICQGGSLVRFTVSDNLLSGPIPKSMKNCRNLTRALFGGNQLTGNI 448
Query: 252 YEVFGIYPNLTFLDLSQNNFYGSLN-------------FSMNNITRSIPPKIGKLYQLHK 298
EV G PNL ++DLS N F+G L+ + N+IT SIP G L
Sbjct: 449 SEVVGDCPNLEYIDLSYNRFHGELSHNWGRCPQLQRLEMAGNDITGSIPEDFGISTNLTL 508
Query: 299 LDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNY----- 353
LD S NH+VGE+P ++G+L SL LN N++ GS+P LGS+ L +LDLS N
Sbjct: 509 LDLSSNHLVGEIPKKMGSLTSLLELKLNDNQLSGSIPPELGSLFSLAHLDLSANRLNGSI 568
Query: 354 ----------------NNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRS 397
NN+ P ++ KL L++LDL P+ ++ +
Sbjct: 569 TENLGACLNLHYLNLSNNKLSNRIPAQMGKLSHLSQLDLSHNLLSGEIPPQIEGLESLEN 628
Query: 398 L--------------ISRMHGLSCIDISYNELRGLIRNSTGIHYNLVDALQGNKGLCGDV 443
L M GLS IDISYN+L+G I NS ++ L+GNK LCG+V
Sbjct: 629 LNLSHNNLSGFIPKAFEEMRGLSDIDISYNQLQGPIPNSKAFRDATIELLKGNKDLCGNV 688
Query: 444 K---------------------------------LFSILTFEGKILYEEVIRAT------ 464
K L + F G L E + T
Sbjct: 689 KGLQPCKNDSGAGQQPVKKGHKIVFIIVFPLLGALVLLFAFIGIFLIAERTKRTPEIEEG 748
Query: 465 ---------NNFDAK----------------YCIGTAGQASVYKAELPSWEIVAVKKFHS 499
+ FD + YCIG G SVYKAEL S IVAVKK ++
Sbjct: 749 DVQNDLFSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELSSGNIVAVKKLYA 808
Query: 500 PHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAA 559
DM Q+ F NE++ALTE++HRN+VK GF HPR SFL+YEYL RGSLA +LS + A
Sbjct: 809 SDIDMANQRDFFNEVRALTEIKHRNIVKLLGFCSHPRHSFLVYEYLERGSLAAMLSREEA 868
Query: 560 IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619
+ W R+N+IK VA+ LSYMHHD PPIVHRDISS N+LL Y+ H+SDFG +K L
Sbjct: 869 -KKLGWATRINIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEPHISDFGTAKLL 927
Query: 620 KPDSSNWSEFVGTFGYVAP 638
K DSSN S GTFGYVAP
Sbjct: 928 KLDSSNQSALAGTFGYVAP 946
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357439029|ref|XP_003589791.1| Receptor protein kinase-like protein [Medicago truncatula] gi|355478839|gb|AES60042.1| Receptor protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 452 bits (1162), Expect = e-124, Method: Compositional matrix adjust.
Identities = 280/712 (39%), Positives = 393/712 (55%), Gaps = 93/712 (13%)
Query: 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVG 75
N L IP IGN++ L L + +N L+G IP I L +L + ++ N L G +P +G
Sbjct: 282 NKLSGPIPTTIGNLTKLTMLSLFSNALTGQIPPSIYNLVNLDTIVLHTNTLSGPIPFTIG 341
Query: 76 QLSSLKQLVLYCNGLSGWLPSSFGNLNNLAI---------GSMPNSLSNLTSLSLFHLDL 126
L+ L +L L+ N L+G +P S GNL NL G +P ++ NLT L++ L L
Sbjct: 342 NLTKLTELTLFSNALTGQIPHSIGNLVNLDSIILHINKLSGPIPCTIKNLTKLTV--LSL 399
Query: 127 SENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPS 186
N L+G IP +G+L NL + + N G IPP +G + L SL N L+G +P
Sbjct: 400 FSNALTGQIPPSIGNLVNLDSITISTNKPSGPIPPTIGNLTKLSSLPPFSNALSGNIPTR 459
Query: 187 ISNLSNLEGLYLYSSLVSAEIGNLL----QLIELEIDNKQLFGQIPKSLRNFTSLNIVHL 242
++ ++NLE L L + + ++ + + +L N G +P SL+N +SL V L
Sbjct: 460 MNRVTNLEVLLLGDNNFTGQLPHNICVSGKLYWFTASNNHFTGLVPMSLKNCSSLIRVRL 519
Query: 243 EQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG-------------SLNFSMNNITRSIPPK 289
++N LTGNI + FG+YP+L +++LS NNFYG SL S NN+T SIP +
Sbjct: 520 QKNQLTGNITDGFGVYPHLVYMELSDNNFYGHISPNWGKCKKLTSLQISNNNLTGSIPQE 579
Query: 290 IGKLYQLHKLDFSLNHIVGELPIELGNL------------------------KSLNYRAL 325
+G QL +L+ S NH+ G++P ELGNL ++L L
Sbjct: 580 LGGATQLQELNLSSNHLTGKIPKELGNLSLLIKLSINNNNLLGEVPVQIASLQALTALEL 639
Query: 326 NGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERY 385
N + G +PR LG +S+L +L+LS N F P+E +L + +LDL F
Sbjct: 640 EKNNLSGFIPRRLGRLSELIHLNLS---QNRFEGNIPIEFGQLEVIEDLDLSGNFLNGTI 696
Query: 386 RPKSVIWKAWRSL--------------ISRMHGLSCIDISYNELRGLIRNSTGIHYNLVD 431
++L +M L+ +DISYN+L G I N ++
Sbjct: 697 PSMLGQLNHIQTLNLSHNNLSGTIPLSYGKMLSLTIVDISYNQLEGPIPNIPAFLKAPIE 756
Query: 432 ALQGNKGLCGDVK-----------------------LFSILTFEGKILYEEVIRATNNFD 468
AL+ NKGLCG+V LF+ +F+GK++YE +I AT +FD
Sbjct: 757 ALRNNKGLCGNVSGLEPCSTSEKKEYKPTEEFQTENLFATWSFDGKMVYENIIEATEDFD 816
Query: 469 AKYCIGTAGQASVYKAELPSWEIVAVKKFHS-PHPDMVVQQAFSNEIKALTELRHRNVVK 527
K+ IG G +VYKAELPS ++VAVKK H H +M +AF+NEI ALTE+RHRN+VK
Sbjct: 817 NKHLIGVGGHGNVYKAELPSGQVVAVKKLHLLEHEEMSNMKAFNNEIHALTEIRHRNIVK 876
Query: 528 FYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF 587
YGF H SFL+YE+L +GS+ IL ++ EF W R+N+IK +AN L Y+HHD
Sbjct: 877 LYGFCSHRLHSFLVYEFLEKGSMYNILKDNEQAAEFDWNKRVNIIKDIANALFYLHHDCS 936
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639
PPIVHRDISSKNV+L L+Y AHVSDFG SKFL P+SSN + F GTFGY AP+
Sbjct: 937 PPIVHRDISSKNVILDLEYVAHVSDFGTSKFLNPNSSNMTSFAGTFGYAAPV 988
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487164|ref|XP_003633525.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 447 bits (1150), Expect = e-123, Method: Compositional matrix adjust.
Identities = 298/791 (37%), Positives = 404/791 (51%), Gaps = 170/791 (21%)
Query: 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV- 74
N L IP +IG + +LK LD+ NN L G IP I L++L L+++ NKL GS+P+++
Sbjct: 460 NKLSGFIPSEIGLLRSLKDLDLSNNNLIGSIPTSIGNLSNLVTLFVHSNKLNGSIPQDIH 519
Query: 75 -----------------------GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAI----- 106
G+L SL L L N LSG +P S GNL+ L
Sbjct: 520 LLSSLSVLALSNNNLSGIIPHSLGKLGSLTALYLRNNSLSGSIPYSIGNLSKLDTLDLHS 579
Query: 107 ----GSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPI 162
GS+P + L SL F LD S N+L+GSIP +G+L NL LH+ N L GSIP
Sbjct: 580 NQLFGSIPREVGFLRSL--FALDSSNNKLTGSIPTSIGNLVNLTTLHISKNQLSGSIPQE 637
Query: 163 LGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSA----EIGNLLQLIELEI 218
+G ++SL L N + G +P SI NL NL LYL + ++ E+ +L +L LE+
Sbjct: 638 VGWLKSLDKLDLSDNKITGSIPASIGNLGNLTVLYLSDNKINGSIPPEMRHLTRLRSLEL 697
Query: 219 DNKQLFGQ------------------------IPKSLRNFTSLNIVHLEQNHLTGNIYEV 254
L GQ IPKSLRN TSL V LE+N L GNI E
Sbjct: 698 SENHLTGQLPHEICLGGVLENFTAEGNHLTGSIPKSLRNCTSLFRVRLERNQLAGNITED 757
Query: 255 FGIYPNLTFLDLSQNNFYG-------------SLNFSMNNITRSIPPKIGKLYQLHKLDF 301
FGIYPNL F+DLS N YG SL S NNI+ IP ++G+ +L +LD
Sbjct: 758 FGIYPNLLFIDLSYNKLYGELSHKWGQCNSLTSLKISNNNISGMIPHQLGEATKLEQLDL 817
Query: 302 SLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNY-------- 353
S NH+VGE+P ELG LKSL ++ NK+ G++P G++SDL +L+L++N+
Sbjct: 818 SSNHLVGEIPKELGMLKSLFNLVIDNNKLSGNIPLEFGNLSDLVHLNLASNHLSGPIPQQ 877
Query: 354 -------------NNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSL-- 398
NN+F + P E+ ++ L LDL + ++ +L
Sbjct: 878 VRNFRKLLSLNLSNNKFGESIPAEIGNVITLESLDLCQNMLTGEIPQQLGELQSLETLNL 937
Query: 399 ------------ISRMHGLSCIDISYNELRG--------------LIRNSTGIHYNLVDA 432
+ GL+ I+ISYN+L G +RN+ G+ N+
Sbjct: 938 SHNNLSGTIPPTFDDLRGLTSINISYNQLEGPLPNLKAFRDAPFEALRNNKGLCGNITGL 997
Query: 433 LQGNKG--------------------------------------------LCGDVKLFSI 448
N G + LF+I
Sbjct: 998 EACNTGKKKGNKFFLLIILLILSIPLLSFISYGIYFLRRMVRSRKINSREVATHQDLFAI 1057
Query: 449 LTFEGKILYEEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHP-DMVVQ 507
+G++LYE +I T +F++K CIGT G +VYKAELP+ +VAVKK HS +M
Sbjct: 1058 WGHDGEMLYEHIIEGTEDFNSKNCIGTGGYGTVYKAELPTGRVVAVKKLHSTQDGEMADL 1117
Query: 508 QAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTV 567
+AF +EI AL E+RHRN+VK YGF SFL+YE++ +GSL ILSN EF W +
Sbjct: 1118 KAFKSEIHALAEIRHRNIVKLYGFCSCSENSFLVYEFMEKGSLRNILSNKDEAIEFDWVL 1177
Query: 568 RMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627
R+NV+K +A LSYMHHD PP++HRDISS NVLL +Y AHVSDFG ++ LK DSSNW+
Sbjct: 1178 RLNVVKGMAEALSYMHHDCSPPLIHRDISSNNVLLDSEYVAHVSDFGTARLLKSDSSNWT 1237
Query: 628 EFVGTFGYVAP 638
F GTFGY+AP
Sbjct: 1238 SFAGTFGYIAP 1248
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484867|ref|XP_002273645.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 446 bits (1146), Expect = e-122, Method: Compositional matrix adjust.
Identities = 301/804 (37%), Positives = 406/804 (50%), Gaps = 193/804 (24%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPRE 73
+ N LF IP +IG++ +L L++ N LSG IP I L +L LY+ NKL GS+P E
Sbjct: 299 DENKLFGSIPHEIGSLRSLNDLELSTNNLSGPIPPSIGNLRNLTTLYLYENKLSGSIPHE 358
Query: 74 VGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAI---------GSMPNSLSNLTSLSLFHL 124
+G L SL L L N LSG +P S GNL NL GS+P+ + +L SL+ L
Sbjct: 359 IGLLRSLNDLELSTNNLSGPIPPSIGNLRNLTTLYLYENKLSGSIPHEIGSLRSLN--DL 416
Query: 125 DLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLP 184
LS N LSG IP +G+L NL L+L +N L GSIP +G ++SL L N L+G +P
Sbjct: 417 VLSTNNLSGPIPPSIGNLRNLTTLYLYENKLSGSIPHEIGSLRSLNDLVLSTNNLSGPIP 476
Query: 185 PSISNLSNLEGLYLYSSLVSA----------------------------EIGNLLQLIEL 216
PSI NL NL LYLY + +S EI NL+ L L
Sbjct: 477 PSIGNLRNLTTLYLYENKLSGFIPQEIGLLSNLTHLLLHYNQLNGPIPQEIDNLIHLKSL 536
Query: 217 EIDNKQLFGQIPK------------------------SLRNFTSLNIVHLEQNHLTGNIY 252
+D G +P+ SLRN TSL V L +N L GNI
Sbjct: 537 HLDENNFTGHLPQQMCLGGALENFTAMGNNFTGPIPMSLRNCTSLFRVRLNRNQLKGNIT 596
Query: 253 EVFGIYPNLTFLDLSQNNFYG-------------SLNFSMNNITRSIPPKIGKLYQLHKL 299
E FG+YPNL F+DLS NN YG SLN S NN++ IPP++G+ QLH+L
Sbjct: 597 EGFGVYPNLNFMDLSSNNLYGELSQKWGQCRSLTSLNISHNNLSGIIPPQLGEAIQLHQL 656
Query: 300 DFSLNHIVGELPIELGNLKS------------------------LNYRALNGNKVYGSLP 335
D S NH++G++P ELG L S L + L N + GS+P
Sbjct: 657 DLSSNHLLGKIPRELGRLTSMFNLLLSNNQLSGNIPWEVGNLFNLEHLILASNNLSGSIP 716
Query: 336 RVLGSISDLEYLDLSTN---------------------YNNEFRKEFPVELEKLVQLTEL 374
+ LG +S L +L+LS N N + P EL +L +L L
Sbjct: 717 KQLGMLSKLSFLNLSKNEFVESIPDEIGNLHSLQSLDLSQNMLNGKIPQELGELQRLEAL 776
Query: 375 DLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELR------------------ 416
+L + + + S + M L+ +DIS N+L
Sbjct: 777 NLS----------HNELSGSIPSTFADMLSLTSVDISSNQLEGPLPDIKAFQEAPFEAFI 826
Query: 417 ---GLIRNSTGI-------------------------------------HYNLVD-ALQG 435
GL N TG+ H+ + +
Sbjct: 827 NNHGLCGNVTGLKPCIPLTQKKNNRFMMIMIISSTSFLLCIFMGIYFTLHWRARNRKRKS 886
Query: 436 NKGLCGDVKLFSILTFEGKILYEEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVK 495
++ C D LF+I + +G+ILY+++I T +F++KYCIG+ GQ +VYKAELP+ +VAVK
Sbjct: 887 SETPCED--LFAIWSHDGEILYQDIIEVTEDFNSKYCIGSGGQGTVYKAELPTGRVVAVK 944
Query: 496 KFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIIL 554
K H P +M +AF++EI+ALTE+RHRN+VK YG+ H R SFL+Y+ + +GSL IL
Sbjct: 945 KLHPPQDGEMSHLKAFTSEIRALTEIRHRNIVKLYGYCSHARHSFLVYKLMEKGSLRNIL 1004
Query: 555 SNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614
S + W R+N++K VA LSYMHHD PI+HRDISS NVLL +Y+AHVSD G
Sbjct: 1005 SKEEEAIGLDWNRRLNIVKGVAAALSYMHHDCSAPIIHRDISSNNVLLDSEYEAHVSDLG 1064
Query: 615 ISKFLKPDSSNWSEFVGTFGYVAP 638
++ LKPDSSNW+ FVGTFGY AP
Sbjct: 1065 TARLLKPDSSNWTSFVGTFGYSAP 1088
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486022|ref|XP_003633374.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1137), Expect = e-121, Method: Compositional matrix adjust.
Identities = 304/792 (38%), Positives = 401/792 (50%), Gaps = 170/792 (21%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHL--------------- 59
+N L IP IGN+ NL L + +N LS IPQEI L L +L
Sbjct: 505 TNNLIGPIPSSIGNLRNLTTLYLNSNNLSDSIPQEITLLRSLNYLVLSYNNLNGSLPTSI 564
Query: 60 ---------YINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNL--------- 101
YI N+L GS+P E+G L+SL+ L L N LSG +P+S GNL
Sbjct: 565 ENWKNLIILYIYGNQLSGSIPEEIGLLTSLENLDLANNNLSGSIPASLGNLSKLSLLYLY 624
Query: 102 NNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP 161
N G +P L SL + L+L N L+G IP F+G+L NL L+L N L G IP
Sbjct: 625 GNKLSGFIPQEFELLRSLIV--LELGSNNLTGPIPSFVGNLRNLTTLYLSQNDLSGYIPR 682
Query: 162 ILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSA----EIGNLLQLIELE 217
+G ++ L L N L+G +P SI NLS+L L L+S+ +S E+ N+ L L+
Sbjct: 683 EIGLLRLLNILDLSFNNLSGSIPASIGNLSSLTTLALHSNKLSGAIPREMNNVTHLKSLQ 742
Query: 218 IDNKQLFGQ------------------------IPKSLRNFTSLNIVHLEQNHLTGNIYE 253
I G IPKSL+N TSL V LE+N LTG+I E
Sbjct: 743 IGENNFIGHLPQEICLGNALEKVSAARNHFTGPIPKSLKNCTSLFRVRLEKNQLTGDIAE 802
Query: 254 VFGIYPNLTFLDLSQNNFYG-------------SLNFSMNNITRSIPPKIGKLYQLHKLD 300
FG+YPNL ++DLS NNFYG +LN S N I+ +IPP++GK QL +LD
Sbjct: 803 SFGVYPNLNYIDLSNNNFYGELSEKWGECHMLTNLNISNNKISGAIPPQLGKAIQLQQLD 862
Query: 301 FSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTN-------- 352
S NH++G++P ELG L L L NK+ GS+P LG++SDLE LDL++N
Sbjct: 863 LSSNHLIGKIPKELGMLPLLFKLLLGNNKLSGSIPLELGNLSDLEILDLASNNLSGPIPK 922
Query: 353 -------------YNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSL- 398
N F P E+ K+ L LDL P+ + +L
Sbjct: 923 QLGNFWKLWSLNMSENRFVDSIPDEIGKMHHLQSLDLSQNMLTGEMPPRLGELQNLETLN 982
Query: 399 -------------ISRMHGLSCIDISYNELRGLI------------RNSTGIHYNLVDAL 433
+ L+ DISYN+L G + +N+ G+ N V L
Sbjct: 983 LSHNGLSGTIPHTFDDLRSLTVADISYNQLEGPLPNINAFAPFEAFKNNKGLCGNNVTHL 1042
Query: 434 Q---------------------------------------------GNKGLCGDVK-LFS 447
+ K DV+ LF+
Sbjct: 1043 KPCSASRKKANKFSILIIILLIVSSLLFLFAFVIGIFFLFQKLRKRKTKSPKADVEDLFA 1102
Query: 448 ILTFEGKILYEEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHP-DMVV 506
I +G++LYE +I+ T+NF +K CIGT G +VYKAELP+ +VAVKK HS DM
Sbjct: 1103 IWGHDGELLYEHIIQGTDNFSSKQCIGTGGYGTVYKAELPTGRVVAVKKLHSSQDGDMAD 1162
Query: 507 QQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWT 566
+AF +EI ALT++RHRN+VK YGFS SFL+YE++ +GSL IL ND ++ W
Sbjct: 1163 LKAFKSEIHALTQIRHRNIVKLYGFSLFAENSFLVYEFMEKGSLRSILRNDEEAEKLDWI 1222
Query: 567 VRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW 626
VR+NV+K VA LSYMHHD PPI+HRDISS NVLL +Y+AHVSDFG ++ LK DSSNW
Sbjct: 1223 VRLNVVKGVAKALSYMHHDCSPPIIHRDISSNNVLLDSEYEAHVSDFGTARLLKSDSSNW 1282
Query: 627 SEFVGTFGYVAP 638
+ F GTFGY AP
Sbjct: 1283 TSFAGTFGYTAP 1294
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486293|ref|XP_003633427.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 441 bits (1135), Expect = e-121, Method: Compositional matrix adjust.
Identities = 297/768 (38%), Positives = 396/768 (51%), Gaps = 154/768 (20%)
Query: 19 FAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLS 78
+ IP IGN+ NL L + N+LSG IPQEI LT L L + N L GS+P +G L
Sbjct: 135 YGTIPINIGNLRNLTTLYLHTNKLSGSIPQEIGLLTSLNDLELATNSLTGSIPPSIGNLR 194
Query: 79 SLKQLVLYCNGLSGWLPSSFG---NLNNLAI------GSMPNSLSNLTSLSLFHLDLSEN 129
+L L L+ N LSG++P G +LN+L + G +P S+ NL +L+ HL +N
Sbjct: 195 NLTTLYLFENELSGFIPQEIGLLRSLNDLELSTNNLTGPIPPSIGNLRNLTTLHL--FKN 252
Query: 130 QLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISN 189
+LSGSIP +G L +L L L N+L G IPP +G +++L +L N L+G +PPSI N
Sbjct: 253 KLSGSIPQEIGLLKSLNDLQLSTNNLTGPIPPSIGNLRNLTTLYLAANSLSGPIPPSIGN 312
Query: 190 LSNLEGLYL----YSSLVSAEIGNLLQLIELEIDNKQLFGQ------------------- 226
LS+L L+L S + E+ N+ L L++ GQ
Sbjct: 313 LSSLTFLFLDHNKLSGAIPLEMNNITHLKSLQLVENNFIGQLPQEICLGSVLENFTASGN 372
Query: 227 -----IPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNN 281
IPK L+N TSL V LE+N LTG+I E FG+YP L ++DLS NNFYG L+
Sbjct: 373 HFTGPIPKGLKNCTSLFRVRLERNQLTGDIAESFGVYPTLNYIDLSSNNFYGELSEKWGQ 432
Query: 282 I-------------TRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGN 328
+ +IPP++GK QL +LD S NH+ G++ ELG L L L N
Sbjct: 433 CHMLTNLNISNNNISGAIPPQLGKATQLRQLDLSANHLSGKILKELGMLPLLFKLLLGNN 492
Query: 329 KVYGSLPRVLGSISDLEYLDLSTN---------------------YNNEFRKEFPVELEK 367
+ GS+P LG++S+LE LDL++N N F P E+ K
Sbjct: 493 SLSGSIPLELGNLSNLEILDLASNNISGSIPKQLGNFWKLRSFNLSENRFVDSIPDEIGK 552
Query: 368 LVQLTELDLVITFWEERYRP------------------KSVIWKAWRSLISRMHGLSCID 409
L L LDL P I + LIS L+ +D
Sbjct: 553 LHHLESLDLSQNMLIGEIPPLLGELQYLETLNLSHNGLSGTIPHTFDDLIS----LTVVD 608
Query: 410 ISYNELRGLI------------RNSTGIHYNLVDALQ----------------------- 434
ISYN+L G + +N+ G+ N V L+
Sbjct: 609 ISYNQLEGPLPNIKAFAPFEAFKNNKGLCGNNVTHLKPCSASRKKANKFSVLIVILLLVS 668
Query: 435 ----------------------GNKGLCGDVK-LFSILTFEGKILYEEVIRATNNFDAKY 471
NK DV+ LF+I +G++LYE +I+ T+NF +K
Sbjct: 669 SLLFLLAFVIGIFFLFQKLRKRKNKSPEADVEDLFAIWGHDGELLYEHIIQGTDNFSSKQ 728
Query: 472 CIGTAGQASVYKAELPSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYG 530
CIGT G +VYKAELP+ +VAVKK HS DM +AF +EI ALT++RHRN+VK YG
Sbjct: 729 CIGTGGYGTVYKAELPTGRVVAVKKLHSSEDGDMADLKAFKSEIHALTQIRHRNIVKLYG 788
Query: 531 FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPI 590
FS SFL+YE++ +GSL IL ND + W VR+NVIK VA LSYMHHD PP+
Sbjct: 789 FSSFAENSFLVYEFMEKGSLQNILCNDEEAERLDWIVRLNVIKGVAKALSYMHHDCSPPV 848
Query: 591 VHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+HRDISS NVLL +Y+AHVSDFG ++ LK DSSNW+ F GTFGY AP
Sbjct: 849 IHRDISSNNVLLDSEYEAHVSDFGTARLLKSDSSNWTSFAGTFGYTAP 896
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545702|ref|XP_002513911.1| receptor protein kinase, putative [Ricinus communis] gi|223546997|gb|EEF48494.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 441 bits (1134), Expect = e-121, Method: Compositional matrix adjust.
Identities = 302/796 (37%), Positives = 404/796 (50%), Gaps = 173/796 (21%)
Query: 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVG 75
N+L + IP +I + L FLD+ +NQLSGVIP +I LT+L L ++ N+L GS+P VG
Sbjct: 118 NSLSSTIPLEITQLPKLIFLDLSSNQLSGVIPPDIGLLTNLNTLRLSANRLDGSIPSSVG 177
Query: 76 QLSSLKQLVLYCNGLSGWLPSSFGNLNNLA---------IGSMPNSLSNLTSL------- 119
L+ L L LY N SG +PS GNL NL GS+P++ +LT L
Sbjct: 178 NLTELAWLHLYDNRFSGSIPSEMGNLKNLVELFMDTNLLTGSIPSTFGSLTKLVQLFLYN 237
Query: 120 ---------------SLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILG 164
SL L L N LSG IP LG L++L +LHL N L G+IP LG
Sbjct: 238 NQLSGHIPQELGDLKSLTSLSLFGNNLSGPIPASLGGLTSLTILHLYQNQLSGTIPKELG 297
Query: 165 KVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEI----------------- 207
+ SL +L N L G +P S+ NLS LE L+L ++ +S I
Sbjct: 298 NLNSLSNLELSENKLTGSIPASLGNLSRLELLFLKNNQLSGPIPEQIANLSKLSLLQLQS 357
Query: 208 --------GNLLQ---LIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFG 256
N+ Q L +++ +L G IPKS+R+ SL +HLE N GNI E FG
Sbjct: 358 NQLTGYLPQNICQSKVLQNFSVNDNRLEGPIPKSMRDCKSLVRLHLEGNQFIGNISEDFG 417
Query: 257 IYPNLTFLDLSQNNFYGSLN-------------FSMNNITRSIPPKIGKLYQLHKLDFSL 303
+YP L F+D+ N F+G ++ S NNI+ IPP+IG +L LDFS
Sbjct: 418 VYPYLQFVDIRYNKFHGEISSKWGMCPHLGTLLISGNNISGIIPPEIGNAARLQGLDFSS 477
Query: 304 NHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNY---------- 353
N +VG +P ELG L SL L N++ +P GS++DLE LDLS N
Sbjct: 478 NQLVGRIPKELGKLTSLVRVNLEDNQLSDGVPSEFGSLTDLESLDLSANRFNQSIPGNIG 537
Query: 354 -----------NNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSL---- 398
NN+F +E P++L KLV L++LDL F + ++ L
Sbjct: 538 NLVKLNYLNLSNNQFSQEIPIQLGKLVHLSKLDLSQNFLIGEIPSELSGMQSLEVLNLSR 597
Query: 399 ----------ISRMHGLSCIDISYNELRGLIRNSTGIHYNLVDALQGNKGLCGDVK---- 444
+ MHGLS IDISYN+L G + ++ + ++A QGNKGLCG V+
Sbjct: 598 NNLSGFIPGDLKEMHGLSSIDISYNKLEGPVPDNKAFQNSSIEAFQGNKGLCGHVQGLQP 657
Query: 445 ----------------------------LFSILTFEGKILYE------------------ 458
F IL+F G + ++
Sbjct: 658 CKPSSTEQGSSIKFHKRLFLVISLPLFGAFLILSFLGVLFFQSKRSKEALEAEKSSQESE 717
Query: 459 ---------------EVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPD 503
E+I AT++F+ YCIG G SVYKA+L S VAVKK H H
Sbjct: 718 EILLITSFDGKSMHDEIIEATDSFNDIYCIGKGGCGSVYKAKLSSGSTVAVKKLHQSHDA 777
Query: 504 -MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDE 562
Q+ F +EI+ALTE++HRN+VKFYGF + SFL+YE + +GSLA IL ++ A E
Sbjct: 778 WKPYQKEFWSEIRALTEIKHRNIVKFYGFCSYSAYSFLVYECIEKGSLATILRDNEAAKE 837
Query: 563 FSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622
W R N+IK VAN LSYMHHD PPIVHRDISSKN+LL + +A VSDFGI++ L D
Sbjct: 838 LEWFKRANIIKGVANALSYMHHDCSPPIVHRDISSKNILLDSENEARVSDFGIARILNLD 897
Query: 623 SSNWSEFVGTFGYVAP 638
SS+ + GTFGY+AP
Sbjct: 898 SSHRTALAGTFGYMAP 913
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 639 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.298 | 0.182 | 0.571 | 1.7e-99 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.629 | 0.365 | 0.330 | 7.3e-78 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.629 | 0.354 | 0.320 | 4.1e-74 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.630 | 0.353 | 0.332 | 1e-73 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.638 | 0.370 | 0.311 | 3e-73 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.660 | 0.376 | 0.390 | 7.6e-72 | |
| TAIR|locus:2005507 | 976 | ER "ERECTA" [Arabidopsis thali | 0.632 | 0.413 | 0.312 | 3e-71 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.683 | 0.349 | 0.298 | 1.7e-70 | |
| TAIR|locus:2167948 | 966 | ERL1 "ERECTA-like 1" [Arabidop | 0.629 | 0.416 | 0.298 | 2.4e-68 | |
| TAIR|locus:2182855 | 967 | ERL2 "ERECTA-like 2" [Arabidop | 0.629 | 0.415 | 0.303 | 6.7e-68 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 581 (209.6 bits), Expect = 1.7e-99, Sum P(2) = 1.7e-99
Identities = 112/196 (57%), Positives = 140/196 (71%)
Query: 447 SILTFEGKILYEEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMV- 505
SI +F+GK+ Y+E+I+AT FD KY IGT G VYKA+LP+ I+AVKK + +
Sbjct: 755 SIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPN-AIMAVKKLNETTDSSIS 813
Query: 506 ---VQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDE 562
+Q F NEI+ALTE+RHRNVVK +GF H R +FL+YEY+ RGSL +L ND +
Sbjct: 814 NPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKK 873
Query: 563 FSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622
W R+NV+K VA+ LSYMHHD P IVHRDISS N+LLG DY+A +SDFG +K LKPD
Sbjct: 874 LDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPD 933
Query: 623 SSNWSEFVGTFGYVAP 638
SSNWS GT+GYVAP
Sbjct: 934 SSNWSAVAGTYGYVAP 949
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 457 (165.9 bits), Expect = 7.3e-78, Sum P(2) = 7.3e-78
Identities = 146/442 (33%), Positives = 208/442 (47%)
Query: 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVG 75
N L IPP +GNIS L+ L + N +G IP+EI LT +K LY+ N+L G +PRE+G
Sbjct: 245 NRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIG 304
Query: 76 QLSSLKQLVLYCNGLSGWLPSSFGN-LN--------NLAIGSMPXXXXXXXXXXXFHLDL 126
L ++ N L+G++P FG+ LN N+ +G +P LDL
Sbjct: 305 NLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEK--LDL 362
Query: 127 SENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQXXXXXXXXXXXXXXVLPPS 186
S N+L+G+IP L L L L L DN L G IPP++G +P
Sbjct: 363 SINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAH 422
Query: 187 ISNLSNLEGLYLYSSLVSAEIGNLLQ----LIELEIDNKQLFGQIPKSLRNFTSLNIVHL 242
L L L S+ +S I L+ L +L + + QL G +P L N +L + L
Sbjct: 423 FCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALEL 482
Query: 243 EQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFS 302
QN L+GNI G NL L L+ NNF G IPP+IG L ++ + S
Sbjct: 483 HQNWLSGNISADLGKLKNLERLRLANNNFTGE-----------IPPEIGNLTKIVGFNIS 531
Query: 303 LNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFP 362
N + G +P ELG+ ++ L+GNK G + + LG + LE L LS +N E P
Sbjct: 532 SNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLS---DNRLTGEIP 588
Query: 363 VELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRNS 422
L +L EL L E P + K IS ++IS+N L G I +S
Sbjct: 589 HSFGDLTRLMELQLGGNLLSENI-PVE-LGKLTSLQIS-------LNISHNNLSGTIPDS 639
Query: 423 TGIHYNLVDALQGNKG-LCGDV 443
G + +++ L N L G++
Sbjct: 640 LG-NLQMLEILYLNDNKLSGEI 660
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 458 (166.3 bits), Expect = 4.1e-74, Sum P(2) = 4.1e-74
Identities = 145/452 (32%), Positives = 218/452 (48%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
S L IP ++GN S L L + +N LSG +P+E+ L +L+ + + N L G +P E+
Sbjct: 260 STMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEI 319
Query: 75 GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLA---------IGSMPXXXXXXXXXXXFHLD 125
G + SL + L N SG +P SFGNL+NL GS+P F +D
Sbjct: 320 GFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQID 379
Query: 126 LSENQLSGSIPHFLGHLSNLAVLHLG-DNSLFGSIPPILGKVQXXXXXXXXXXXXXXVLP 184
NQ+SG IP +G L L + LG N L G+IP L Q LP
Sbjct: 380 A--NQISGLIPPEIGLLKELNIF-LGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLP 436
Query: 185 PSISNLSNLEGLYLYSSLVSA----EIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIV 240
+ L NL L L S+ +S EIGN L+ L + N ++ G+IPK + +L+ +
Sbjct: 437 AGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFL 496
Query: 241 HLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLD 300
L +N+L+G + L L+LS N G L S++++T+ L LD
Sbjct: 497 DLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTK-----------LQVLD 545
Query: 301 FSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKE 360
S N + G++P LG+L SLN L+ N G +P LG ++L+ LDLS+N
Sbjct: 546 VSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSN---NISGT 602
Query: 361 FPVELEKLVQLTELDLVITF-WE--ERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRG 417
P E+L + +LD+ + W + + P+ IS ++ LS +DIS+N L G
Sbjct: 603 IP---EELFDIQDLDIALNLSWNSLDGFIPER---------ISALNRLSVLDISHNMLSG 650
Query: 418 LIRNSTGIHYNLVDA-LQGNK--GLCGDVKLF 446
+ +G+ NLV + N+ G D K+F
Sbjct: 651 DLSALSGLE-NLVSLNISHNRFSGYLPDSKVF 681
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 467 (169.5 bits), Expect = 1.0e-73, Sum P(2) = 1.0e-73
Identities = 148/445 (33%), Positives = 202/445 (45%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81
IP +GN S L L + N LSG IP+EI LT L+ L++ N L G +P E+G S+LK
Sbjct: 266 IPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLK 325
Query: 82 QLVLYCNGLSGWLPSSFGNLN---------NLAIGSMPXXXXXXXXXXXFHLDLSENQLS 132
+ L N LSG +PSS G L+ N GS+P LD +NQ+S
Sbjct: 326 MIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLD--KNQIS 383
Query: 133 GSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQXXXXXXXXXXXXXXVLPPSISNLSN 192
G IP LG L+ L + N L GSIPP L +P + L N
Sbjct: 384 GLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRN 443
Query: 193 LEGLYLYSSLVSA----EIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLT 248
L L L S+ +S EIGN L+ L + ++ G+IP + + +N + N L
Sbjct: 444 LTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLH 503
Query: 249 GNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVG 308
G + + G L +DLS N+ GSL P + L L LD S N G
Sbjct: 504 GKVPDEIGSCSELQMIDLSNNSLEGSL-----------PNPVSSLSGLQVLDVSANQFSG 552
Query: 309 ELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKL 368
++P LG L SLN L+ N GS+P LG S L+ LDL +N E E P EL
Sbjct: 553 KIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSN---ELSGEIPSELG-- 607
Query: 369 VQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRNSTGIHYN 428
+ L++ + R K S I+ ++ LS +D+S+N L G + I N
Sbjct: 608 -DIENLEIALNLSSNRLTGKIP------SKIASLNKLSILDLSHNMLEGDLAPLANIE-N 659
Query: 429 LVDA-LQGNK--GLCGDVKLFSILT 450
LV + N G D KLF L+
Sbjct: 660 LVSLNISYNSFSGYLPDNKLFRQLS 684
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 436 (158.5 bits), Expect = 3.0e-73, Sum P(2) = 3.0e-73
Identities = 141/453 (31%), Positives = 215/453 (47%)
Query: 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVG 75
N L IP ++G++ +L+FL + N L+G IP+EI L++ + + N L G +P E+G
Sbjct: 275 NQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELG 334
Query: 76 QLSSLKQLVLYCNGLSGWLPSSFGNLNNLA-----IGSM--PXXXXXXXXXXXFHLDLSE 128
+ L+ L L+ N L+G +P L NL+ I ++ P F L L +
Sbjct: 335 NIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQ 394
Query: 129 NQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQXXXXXXXXXXXXXXVLPPSIS 188
N LSG+IP LG S+L VL + DN L G IP L +P I+
Sbjct: 395 NSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGIT 454
Query: 189 NLSNLEGLYLY-SSLVSAEIGNLLQLIE---LEIDNKQLFGQIPKSLRNFTSLNIVHLEQ 244
L L L ++LV NL + + +E+ + G IP+ + N ++L + L
Sbjct: 455 TCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLAD 514
Query: 245 NHLTGNIYEVFGIYPNLTFLDLSQNNFYGSL-----NFSM--------NNITRSIPPKIG 291
N TG + G+ L L++S N G + N M NN + ++P ++G
Sbjct: 515 NGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVG 574
Query: 292 KLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLST 351
LYQL L S N++ G +P+ LGNL L + GN GS+PR LGS++ L+ + L+
Sbjct: 575 SLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQ-IALNL 633
Query: 352 NYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDIS 411
+YN + E P EL LV L L L I ++ +L S + G + S
Sbjct: 634 SYN-KLTGEIPPELSNLVMLEFLLL------NNNNLSGEIPSSFANLSSLL-GYN---FS 682
Query: 412 YNELRG---LIRNSTGIHYNLVDALQGNKGLCG 441
YN L G L+RN + + + GN+GLCG
Sbjct: 683 YNSLTGPIPLLRNIS------MSSFIGNEGLCG 709
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 732 (262.7 bits), Expect = 7.6e-72, P = 7.6e-72
Identities = 182/466 (39%), Positives = 258/466 (55%)
Query: 203 VSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLT 262
+ EI N+ QL+EL++ LFG++P+++ N T+L+ + L N L+G + NL
Sbjct: 574 IPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLE 633
Query: 263 FLDLSQNNF-------YGS------LNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGE 309
LDLS NNF + S +N S N SIP ++ KL QL +LD S N + GE
Sbjct: 634 SLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGE 692
Query: 310 LPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNY-------NNEFRKEFP 362
+P +L +L+SL+ L+ N + G +P + L +D+S N FRK
Sbjct: 693 IPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATA 752
Query: 363 VELEKLVQL-TELDLV-ITFWEERYRPKS----VIWKAWRSLISRMHGLSCIDISYNELR 416
LE+ + L + + + E +PK V+W L+ + L + I N
Sbjct: 753 DALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVW----ILVPILGVLVILSICANTFT 808
Query: 417 GLIRNSTGIHYNLVDALQGNKGLCGDVKLFSILTFEGKILYEEVIRATNNFDAKYCIGTA 476
IR + D G ++ +FS+ +GK Y+++I +TN FD + IGT
Sbjct: 809 YCIRKRKLQNGRNTDPETGE-----NMSIFSV---DGKFKYQDIIESTNEFDPTHLIGTG 860
Query: 477 GQASVYKAELPSWEIVAVKKFHSPHPDM----VVQQAFSNEIKALTELRHRNVVKFYGFS 532
G + VY+A L I+AVK+ H + VV+Q F NE+KALTE+RHRNVVK +GF
Sbjct: 861 GYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFC 919
Query: 533 FHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVH 592
H R +FL+YEY+ +GSL +L+ND +WT R+NV+K VA+ LSYMHHD PIVH
Sbjct: 920 SHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVH 979
Query: 593 RDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
RDISS N+LL DY A +SDFG +K LK DSSNWS GT+GYVAP
Sbjct: 980 RDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAP 1025
|
|
| TAIR|locus:2005507 ER "ERECTA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 439 (159.6 bits), Expect = 3.0e-71, Sum P(2) = 3.0e-71
Identities = 139/445 (31%), Positives = 209/445 (46%)
Query: 10 QVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGS 69
Q++ ++N L IP + I NLK LD+ N+LSG IP+ I L++L + N L G+
Sbjct: 144 QLILKNNQLIGPIPSTLSQIPNLKILDLAQNKLSGEIPRLIYWNEVLQYLGLRGNNLVGN 203
Query: 70 VPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLN---------NLAIGSMPXXXXXXXXXX 120
+ ++ QL+ L + N L+G +P + GN N G +P
Sbjct: 204 ISPDLCQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYNQLTGEIPFDIGFLQVAT 263
Query: 121 XFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQXXXXXXXXXXXXX 180
L L NQLSG IP +G + LAVL L N L GSIPPILG +
Sbjct: 264 ---LSLQGNQLSGKIPSVIGLMQALAVLDLSGNLLSGSIPPILGNLTFTEKLYLHSNKLT 320
Query: 181 XVLPPSISNLSNLEGLYLYSSLVSA----EIGNLLQLIELEIDNKQLFGQIPKSLRNFTS 236
+PP + N+S L L L + ++ E+G L L +L + N L G IP L + T+
Sbjct: 321 GSIPPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANNDLEGPIPDHLSSCTN 380
Query: 237 LNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQL 296
LN +++ N +G I F ++T+L+LS NN G IP ++ ++ L
Sbjct: 381 LNSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGP-----------IPVELSRIGNL 429
Query: 297 HKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNE 356
LD S N I G +P LG+L+ L L+ N + G +P G++ + +DLS NN+
Sbjct: 430 DTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLS---NND 486
Query: 357 FRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELR 416
P EL +L + L L E +V SL + + L+ +++S+N L
Sbjct: 487 ISGPIPEELNQLQNIILLRL-----ENNNLTGNV-----GSLANCL-SLTVLNVSHNNLV 535
Query: 417 GLIRNSTGIHYNLVDALQGNKGLCG 441
G I + D+ GN GLCG
Sbjct: 536 GDIPKNNNFSRFSPDSFIGNPGLCG 560
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 434 (157.8 bits), Expect = 1.7e-70, Sum P(2) = 1.7e-70
Identities = 144/483 (29%), Positives = 223/483 (46%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
+NTL + P I N++NL++L + +N L G +P+EI L L+ L++ N+ G +P+E+
Sbjct: 393 NNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEI 452
Query: 75 GQLSSLKQLVLYCNGLSGWLPSSFGNLNNL---------AIGSMPXXXXXXXXXXXFHLD 125
G +SLK + ++ N G +P S G L L +G +P LD
Sbjct: 453 GNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNI--LD 510
Query: 126 LSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQXXXXXXXXXXXXXXVLPP 185
L++NQLSGSIP G L L L L +NSL G++P L ++ + P
Sbjct: 511 LADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHP 570
Query: 186 SISNLSNLEGLYL---YSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHL 242
+ S L + + E+GN L L + QL G+IP +L L+++ +
Sbjct: 571 LCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDM 630
Query: 243 EQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFS 302
N LTG I + LT +DL+ NNF ++ IPP +GKL QL +L S
Sbjct: 631 SSNALTGTIPLQLVLCKKLTHIDLN-NNF----------LSGPIPPWLGKLSQLGELKLS 679
Query: 303 LNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFP 362
N V LP EL N L +L+GN + GS+P+ +G++ L L+L N+F P
Sbjct: 680 SNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLD---KNQFSGSLP 736
Query: 363 VELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGL-SCIDISYNELRGLIRN 421
+ KL +L EL L ++ + I ++ L S +D+SYN G I +
Sbjct: 737 QAMGKLSKLYELRL----------SRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPS 786
Query: 422 STGIHYNL--VDA----LQGN-KGLCGDVKLFSILTFEGKILYEEVIRATNNFDAKYCIG 474
+ G L +D L G G GD+K L L ++ + + + A +G
Sbjct: 787 TIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLG 846
Query: 475 TAG 477
G
Sbjct: 847 NTG 849
|
|
| TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 413 (150.4 bits), Expect = 2.4e-68, Sum P(2) = 2.4e-68
Identities = 132/442 (29%), Positives = 205/442 (46%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPRE 73
++N L +P + I NLK LD+ N L+G I + + L++L + N L G++ +
Sbjct: 151 KNNQLTGPVPATLTQIPNLKRLDLAGNHLTGEISRLLYWNEVLQYLGLRGNMLTGTLSSD 210
Query: 74 VGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAI---------GSMPXXXXXXXXXXXFHL 124
+ QL+ L + N L+G +P S GN + I G +P L
Sbjct: 211 MCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQITGEIPYNIGFLQVAT---L 267
Query: 125 DLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQXXXXXXXXXXXXXXVLP 184
L N+L+G IP +G + LAVL L DN L G IPPILG + +P
Sbjct: 268 SLQGNRLTGRIPEVIGLMQALAVLDLSDNELVGPIPPILGNLSFTGKLYLHGNMLTGPIP 327
Query: 185 PSISNLSNLEGLYLYSS-LVSA---EIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIV 240
+ N+S L L L + LV E+G L QL EL + N +L G IP ++ + +LN
Sbjct: 328 SELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNISSCAALNQF 387
Query: 241 HLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLD 300
++ N L+G+I F +LT+L+LS NNF G IP ++G + L KLD
Sbjct: 388 NVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGK-----------IPVELGHIINLDKLD 436
Query: 301 FSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKE 360
S N+ G +P+ LG+L+ L L+ N + G LP G++ ++ +D+S N +
Sbjct: 437 LSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGV--- 493
Query: 361 FPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIR 420
P EL +L L L L + K ++ L +++S+N L G++
Sbjct: 494 IPTELGQLQNLNSLILN----NNKLHGKIP------DQLTNCFTLVNLNVSFNNLSGIVP 543
Query: 421 NSTGIHYNLVDALQGNKGLCGD 442
+ GN LCG+
Sbjct: 544 PMKNFSRFAPASFVGNPYLCGN 565
|
|
| TAIR|locus:2182855 ERL2 "ERECTA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 423 (154.0 bits), Expect = 6.7e-68, Sum P(2) = 6.7e-68
Identities = 134/442 (30%), Positives = 207/442 (46%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPRE 73
++N L IP + I NLK LD+ NQL+G IP+ + L++L + N L G++ +
Sbjct: 153 KNNQLTGPIPATLTQIPNLKTLDLARNQLTGEIPRLLYWNEVLQYLGLRGNMLTGTLSPD 212
Query: 74 VGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAI---------GSMPXXXXXXXXXXXFHL 124
+ QL+ L + N L+G +P S GN + I G +P L
Sbjct: 213 MCQLTGLWYFDVRGNNLTGTIPESIGNCTSFEILDVSYNQITGVIPYNIGFLQVAT---L 269
Query: 125 DLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQXXXXXXXXXXXXXXVLP 184
L N+L+G IP +G + LAVL L DN L G IPPILG + +P
Sbjct: 270 SLQGNKLTGRIPEVIGLMQALAVLDLSDNELTGPIPPILGNLSFTGKLYLHGNKLTGQIP 329
Query: 185 PSISNLSNLEGLYLYSS-LVSA---EIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIV 240
P + N+S L L L + LV E+G L QL EL + N L G IP ++ + +LN
Sbjct: 330 PELGNMSRLSYLQLNDNELVGKIPPELGKLEQLFELNLANNNLVGLIPSNISSCAALNQF 389
Query: 241 HLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLD 300
++ N L+G + F +LT+L+LS N+F G IP ++G + L LD
Sbjct: 390 NVHGNFLSGAVPLEFRNLGSLTYLNLSSNSFKGK-----------IPAELGHIINLDTLD 438
Query: 301 FSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKE 360
S N+ G +P+ LG+L+ L L+ N + G+LP G++ ++ +D+S N+
Sbjct: 439 LSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTLPAEFGNLRSIQIIDVSFNF---LAGV 495
Query: 361 FPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIR 420
P EL +L + L L + I ++ L+ ++IS+N L G+I
Sbjct: 496 IPTELGQLQNINSLIL----------NNNKIHGKIPDQLTNCFSLANLNISFNNLSGIIP 545
Query: 421 NSTGIHYNLVDALQGNKGLCGD 442
+ GN LCG+
Sbjct: 546 PMKNFTRFSPASFFGNPFLCGN 567
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 639 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-57 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-47 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-47 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-36 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-31 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-25 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-24 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-23 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-19 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-19 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-15 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-15 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-12 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-11 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-10 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-10 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-09 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-08 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-08 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-08 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-06 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-05 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-05 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-05 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-05 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-05 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-05 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-05 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.001 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 0.001 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.002 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 0.002 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.002 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.002 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.002 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.002 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.002 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 0.002 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.002 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.002 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.003 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.003 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.004 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.004 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.004 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 1e-57
Identities = 152/456 (33%), Positives = 220/456 (48%), Gaps = 50/456 (10%)
Query: 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVG 75
N L IP + N+++L+FL + +NQL G IP+E+ + LK +Y+ N L G +P E+G
Sbjct: 174 NVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG 233
Query: 76 QLSSLKQLVLYCNGLSGWLPSSFGNLNNLAI---------GSMPNSLSNLTSLSLFHLDL 126
L+SL L L N L+G +PSS GNL NL G +P S+ +L L LDL
Sbjct: 234 GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQ--KLISLDL 291
Query: 127 SENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPS 186
S+N LSG IP + L NL +LHL N+ G IP L + L L N +G +P +
Sbjct: 292 SDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKN 351
Query: 187 ISNLSNLEGLYLYSSLVSAEI-------GNLLQLIELEIDNKQLFGQIPKSLRNFTSLNI 239
+ +NL L L ++ ++ EI GNL +LI + + L G+IPKSL SL
Sbjct: 352 LGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI---LFSNSLEGEIPKSLGACRSLRR 408
Query: 240 VHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGS-------------LNFSMNNITRSI 286
V L+ N +G + F P + FLD+S NN G L+ + N +
Sbjct: 409 VRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL 468
Query: 287 PPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEY 346
P G +L LD S N G +P +LG+L L L+ NK+ G +P L S L
Sbjct: 469 PDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVS 527
Query: 347 LDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLS 406
LDLS +N+ + P ++ L++LDL + + L
Sbjct: 528 LDLS---HNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKN----------LGNVESLV 574
Query: 407 CIDISYNELRGLIRNSTGIHYNL-VDALQGNKGLCG 441
++IS+N L G + STG + A+ GN LCG
Sbjct: 575 QVNISHNHLHGSL-PSTGAFLAINASAVAGNIDLCG 609
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 2e-47
Identities = 129/369 (34%), Positives = 192/369 (52%), Gaps = 32/369 (8%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTH-LKHLYINVNKLRGSVPREVGQLSSL 80
I I + ++ +++ NNQLSG IP +I + L++L ++ N GS+PR G + +L
Sbjct: 85 ISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNL 142
Query: 81 KQLVLYCNGLSGWLPSSFGNLNNLAI---------GSMPNSLSNLTSLSLFHLDLSENQL 131
+ L L N LSG +P+ G+ ++L + G +PNSL+NLTSL L L+ NQL
Sbjct: 143 ETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEF--LTLASNQL 200
Query: 132 SGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLS 191
G IP LG + +L ++LG N+L G IP +G + SL L N L G +P S+ NL
Sbjct: 201 VGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLK 260
Query: 192 NLEGLYLYSSLVSAEIG----NLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHL 247
NL+ L+LY + +S I +L +LI L++ + L G+IP+ + +L I+HL N+
Sbjct: 261 NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNF 320
Query: 248 TGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIV 307
TG I P L L L N F G IP +GK L LD S N++
Sbjct: 321 TGKIPVALTSLPRLQVLQLWSNKFSG-----------EIPKNLGKHNNLTVLDLSTNNLT 369
Query: 308 GELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEK 367
GE+P L + +L L N + G +P+ LG+ L + L +N F E P E K
Sbjct: 370 GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQ---DNSFSGELPSEFTK 426
Query: 368 LVQLTELDL 376
L + LD+
Sbjct: 427 LPLVYFLDI 435
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 7e-47
Identities = 145/425 (34%), Positives = 211/425 (49%), Gaps = 48/425 (11%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
+N L IP IG+ S+LK LD+G N L G IP + LT L+ L + N+L G +PRE+
Sbjct: 149 NNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPREL 208
Query: 75 GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGS 134
GQ+ SLK + L N LSG +P G L SL HLDL N L+G
Sbjct: 209 GQMKSLKWIYLGYNNLSGEIPYEIGGLT-----------------SLNHLDLVYNNLTGP 251
Query: 135 IPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLE 194
IP LG+L NL L L N L G IPP + +Q L+SL N L+G +P + L NLE
Sbjct: 252 IPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLE 311
Query: 195 GLYLYSSLVSAEI----GNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGN 250
L+L+S+ + +I +L +L L++ + + G+IPK+L +L ++ L N+LTG
Sbjct: 312 ILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371
Query: 251 IYEVFGIYPNLTFLDLSQNNFYGSLNFSM-------------NNITRSIPPKIGKLYQLH 297
I E NL L L N+ G + S+ N+ + +P + KL ++
Sbjct: 372 IPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVY 431
Query: 298 KLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEF 357
LD S N++ G + ++ SL +L NK +G LP GS LE LDLS N+F
Sbjct: 432 FLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLS---RNQF 487
Query: 358 RKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRG 417
P +L L +L +L L ++ + +S L +D+S+N+L G
Sbjct: 488 SGAVPRKLGSLSELMQLKL----------SENKLSGEIPDELSSCKKLVSLDLSHNQLSG 537
Query: 418 LIRNS 422
I S
Sbjct: 538 QIPAS 542
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 8e-36
Identities = 113/331 (34%), Positives = 163/331 (49%), Gaps = 37/331 (11%)
Query: 28 NISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLS-SLKQLVLY 86
N S + +D+ +SG I I L +++ + ++ N+L G +P ++ S SL+ L L
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 87 CNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLA 146
N +G +P GS+PN L LDLS N LSG IP+ +G S+L
Sbjct: 127 NNNFTGSIPR----------GSIPN---------LETLDLSNNMLSGEIPNDIGSFSSLK 167
Query: 147 VLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYL-YSSL--- 202
VL LG N L G IP L + SL L N L G +P + + +L+ +YL Y++L
Sbjct: 168 VLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE 227
Query: 203 VSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNI-YEVFGIYPNL 261
+ EIG L L L++ L G IP SL N +L + L QN L+G I +F + L
Sbjct: 228 IPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL-QKL 286
Query: 262 TFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLN 321
LDLS N+ G IP + +L L L N+ G++P+ L +L L
Sbjct: 287 ISLDLSDNSLSG-----------EIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQ 335
Query: 322 YRALNGNKVYGSLPRVLGSISDLEYLDLSTN 352
L NK G +P+ LG ++L LDLSTN
Sbjct: 336 VLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 51/168 (30%), Positives = 82/168 (48%), Gaps = 8/168 (4%)
Query: 473 IGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
+G G +VY A + + VA+K ++++ EI+ L +L H N+VK YG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE-LLREIEILKKLNHPNIVKLYGV 59
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIV 591
+L+ EY GSL +L + + S + ++ + L Y+H + I+
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 592 HRDISSKNVLLGLDYD-AHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
HRD+ +N+LL D ++DFG+SK L D S VGT Y+AP
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAP 162
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 7/168 (4%)
Query: 472 CIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
+G+ +VYKA + +IVAVK Q EI+ L L H N+V+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 531 FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPI 590
+L+ EY G L LS + E + + + L Y+H + I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSE--DEAKK-IALQILRGLEYLHSN---GI 119
Query: 591 VHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+HRD+ +N+LL + ++DFG++K L SS+ + FVGT Y+AP
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167
|
Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 52/168 (30%), Positives = 79/168 (47%), Gaps = 7/168 (4%)
Query: 472 CIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
+G VYK P+ +I A+KK H + +Q E+K L VVK YG
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQL-LRELKTLRSCESPYVVKCYG 66
Query: 531 FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPI 590
+ + ++ EY+ GSLA +L I E V + + + L Y+H I
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPE---PVLAYIARQILKGLDYLHTKR--HI 121
Query: 591 VHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+HRDI N+L+ + ++DFGISK L+ + FVGT Y++P
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 48/168 (28%), Positives = 80/168 (47%), Gaps = 11/168 (6%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
+G VY A + + ++VA+K ++ EIK L +L+H N+V+ Y
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERIL-REIKILKKLKHPNIVRLYDV 65
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH-HDYFPPI 590
+ +L+ EY G L +L + E R ++ + + L Y+H I
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE--DEAR-FYLRQILSALEYLHSKG----I 118
Query: 591 VHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
VHRD+ +N+LL D ++DFG+++ L P + FVGT Y+AP
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT-FVGTPEYMAP 165
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 52/181 (28%), Positives = 82/181 (45%), Gaps = 25/181 (13%)
Query: 467 FDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNV 525
F+ IG G VYKA + + VA+K ++ NEI+ L + +H N+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI--KLESKEKKEKIINEIQILKKCKHPNI 59
Query: 526 VKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMN------VIKSVANTL 579
VK+YG + +++ E+ GSL +L S + V K + L
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLK--------STNQTLTESQIAYVCKELLKGL 111
Query: 580 SYMH--HDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVA 637
Y+H I+HRDI + N+LL D + + DFG+S L D+ + VGT ++A
Sbjct: 112 EYLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMA 165
Query: 638 P 638
P
Sbjct: 166 P 166
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 9e-23
Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 21/177 (11%)
Query: 472 CIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
+G SVY A + E++AVK +A EI+ L+ L+H N+V++YG
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 531 FSFHPRQSFL-LY-EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANT----LSYMH- 583
++ L ++ EY+ GSL+ +L + E VI+ L+Y+H
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-------PVIRKYTRQILEGLAYLHS 119
Query: 584 HDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE--FVGTFGYVAP 638
+ IVHRDI N+L+ D ++DFG +K L + GT ++AP
Sbjct: 120 NG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-22
Identities = 87/286 (30%), Positives = 131/286 (45%), Gaps = 44/286 (15%)
Query: 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYIN 62
C + F+++ SN+L IP +G +L+ + + +N SG +P E L + L I+
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436
Query: 63 VNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLF 122
N L+G + + SL+ L L N G LP SFG S L
Sbjct: 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG------------------SKRLE 478
Query: 123 HLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGV 182
+LDLS NQ SG++P LG LS L L L +N L G IP L + L+SL N L+G
Sbjct: 479 NLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ 538
Query: 183 LPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHL 242
+P S S + L +L++ QL G+IPK+L N SL V++
Sbjct: 539 IPASFSEMPVLS--------------------QLDLSQNQLSGEIPKNLGNVESLVQVNI 578
Query: 243 EQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPP 288
NHL G+ + FL ++ + G+++ + T +PP
Sbjct: 579 SHNHLHGS------LPSTGAFLAINASAVAGNIDLCGGDTTSGLPP 618
|
Length = 968 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 38/152 (25%), Positives = 65/152 (42%), Gaps = 14/152 (9%)
Query: 481 VYKAEL----PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR 536
VYK +L VAVK + ++ F E + + +L H NVV+ G
Sbjct: 11 VYKGKLKGKDGKTTEVAVKTLKEDASEEE-RKDFLKEARVMKKLGHPNVVRLLGVCTEEE 69
Query: 537 QSFLLYEYLGRGSL------AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPI 590
+L+ EY+ G L + + S ++ +A + Y+
Sbjct: 70 PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKF 126
Query: 591 VHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622
VHRD++++N L+G D +SDFG+S+ + D
Sbjct: 127 VHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 38/148 (25%), Positives = 62/148 (41%), Gaps = 10/148 (6%)
Query: 481 VYKAEL-----PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP 535
VYK L VAVK + F E + + +L H N+VK G
Sbjct: 15 VYKGTLKGKGDGKEVEVAVKTLKEDA-SEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE 73
Query: 536 RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDI 595
++ EY+ G L L E S + ++ +A + Y+ +HRD+
Sbjct: 74 EPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDL 129
Query: 596 SSKNVLLGLDYDAHVSDFGISKFLKPDS 623
+++N L+G + +SDFG+S+ L D
Sbjct: 130 AARNCLVGENLVVKISDFGLSRDLYDDD 157
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 38/147 (25%), Positives = 64/147 (43%), Gaps = 11/147 (7%)
Query: 481 VYKAEL-----PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP 535
VYK +L VAVK + F E + + +L H NVVK G
Sbjct: 15 VYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLDHPNVVKLLGVCTEE 73
Query: 536 RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDI 595
+++ EY+ G L L + S + ++ +A + Y+ +HRD+
Sbjct: 74 EPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLESK---NFIHRDL 128
Query: 596 SSKNVLLGLDYDAHVSDFGISKFLKPD 622
+++N L+G + +SDFG+S+ L D
Sbjct: 129 AARNCLVGENLVVKISDFGLSRDLYDD 155
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (213), Expect = 1e-18
Identities = 35/149 (23%), Positives = 63/149 (42%), Gaps = 13/149 (8%)
Query: 481 VYKAEL-----PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP 535
VYK L + VAVK ++ F E + +L H N+V+ G
Sbjct: 15 VYKGTLKGDGEGTETKVAVKTLK-EGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQG 73
Query: 536 RQSFLLYEYLGRGSLAIIL-SNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRD 594
+++ EY+ G L L + + ++M +A + Y+ VHRD
Sbjct: 74 EPLYIVTEYMPGGDLLDFLRKHGEKLT-LKDLLQM--ALQIAKGMEYLESK---NFVHRD 127
Query: 595 ISSKNVLLGLDYDAHVSDFGISKFLKPDS 623
++++N L+ + +SDFG+S+ + D
Sbjct: 128 LAARNCLVTENLVVKISDFGLSRDIYEDD 156
|
Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 59/179 (32%), Positives = 85/179 (47%), Gaps = 25/179 (13%)
Query: 473 IGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAF----SNEIKALTELRHRNVVK 527
IG A VY A LP+ E VA+K+ D+ Q E++A+++ H NVVK
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRI-----DLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 528 FYGFSFHPRQS-FLLYEYLGRGSLAIILS---NDAAIDEFSWTVRMNVIKSVANTLSYMH 583
+Y SF +L+ YL GSL I+ +DE V+K V L Y+H
Sbjct: 64 YYT-SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT---VLKEVLKGLEYLH 119
Query: 584 HDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE----FVGTFGYVAP 638
+ +HRDI + N+LLG D ++DFG+S L + FVGT ++AP
Sbjct: 120 SN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 52/173 (30%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVK--KFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFY 529
IG VY A L + E++AVK + P + + ++E+K L L+H N+VK+Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTI--KEIADEMKVLELLKHPNLVKYY 65
Query: 530 GFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP 589
G H + ++ EY G+L +L + +DE V + L+Y+H
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDE---HVIRVYTLQLLEGLAYLHSHG--- 119
Query: 590 IVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE----FVGTFGYVAP 638
IVHRDI N+ L + + DFG + LK +++ E GT Y+AP
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 48/177 (27%), Positives = 75/177 (42%), Gaps = 13/177 (7%)
Query: 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN 524
N+ IG VYK L + + VA+K+ ++ EI L L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 525 VVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLS---Y 581
+VK+ G +++ EY GSL I+ E V V L Y
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE------SLVAVYVYQVLQGLAY 114
Query: 582 MHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+H ++HRDI + N+L D ++DFG++ L S + + VGT ++AP
Sbjct: 115 LHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAP 168
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 52/173 (30%), Positives = 81/173 (46%), Gaps = 21/173 (12%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG VYKA + + + VA+KK + + NEI + + +H N+V +Y
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK---ELIINEILIMKDCKHPNIVDYYDS 83
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMN------VIKSVANTLSYMHHD 585
+ +++ EY+ GSL I I + VRMN V + V L Y+H
Sbjct: 84 YLVGDELWVVMEYMDGGSLTDI------ITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 586 YFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
++HRDI S N+LL D ++DFG + L + S + VGT ++AP
Sbjct: 136 ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 76.7 bits (187), Expect = 7e-15
Identities = 52/175 (29%), Positives = 77/175 (44%), Gaps = 14/175 (8%)
Query: 473 IGTAGQASVYKAELPSWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRH-RNVVKFYG 530
+G VY A ++VA+K + F EI+ L L H N+VK Y
Sbjct: 8 LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 531 FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPI 590
F +L+ EY+ GSL +L S + + ++ + + L Y+H I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GI 122
Query: 591 VHRDISSKNVLLGLDYD-AHVSDFGISKFLKPDSSN------WSEFVGTFGYVAP 638
+HRDI +N+LL D + DFG++K L S S VGT GY+AP
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
|
Length = 384 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 48/170 (28%), Positives = 87/170 (51%), Gaps = 16/170 (9%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFH---SPHPDMVVQQAFSNEIKALTELRHRNVVKF 528
IG +VY A ++ + + VA+K+ + P ++++ NEI + E +H N+V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELII-----NEILVMRENKHPNIVNY 81
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
+ +++ EYL GSL +++ + +DE V + L ++H +
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAA---VCRECLQALEFLHSNQ-- 135
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
++HRDI S N+LLG+D ++DFG + P+ S S VGT ++AP
Sbjct: 136 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 12/170 (7%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH---RNVVKF 528
IG +VY+ +P+ +VA+K + PD V E+ L++LR N+ K+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSD-IQREVALLSQLRQSQPPNITKY 67
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
YG + +++ EY GS+ L I E +V +I+ V L Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISV---IIREVLVALKYIHKV--- 120
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
++HRDI + N+L+ + + DFG++ L +SS S FVGT ++AP
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAP 170
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 52/161 (32%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDM-------VVQQAFSNEIKALTELRHRN 524
IG+ SVY S E++AVK+ P + A + EI L EL+H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 525 VVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH 584
+V++ G S + EY+ GS+A +L+N A +E T+ N ++ + L+Y+H+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVRNFVRQILKGLNYLHN 124
Query: 585 DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625
I+HRDI N+L+ +SDFGISK L+ +S +
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLS 162
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 16/183 (8%)
Query: 467 FDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNV 525
++ IG +V K +I+ K+ + +Q +E+ L EL+H N+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 526 VKFYGFSFHPRQSFLLY---EYLGRGSLAIILSN----DAAIDE-FSWTVRMNVIKSVAN 577
V++Y R + LY EY G LA ++ I+E F W ++ +
Sbjct: 62 VRYYD-RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLLL 116
Query: 578 TLSYMHH--DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGY 635
L H+ D ++HRD+ N+ L + + + DFG++K L DSS +VGT Y
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYY 176
Query: 636 VAP 638
++P
Sbjct: 177 MSP 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 39/130 (30%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 510 FSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL-AIILSNDAAIDEFSWTVR 568
F EI L+E +H N+V Y F+ + ++L E+ G+L +I+L + + E
Sbjct: 49 FMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY- 107
Query: 569 MNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE 628
V + + L+++H ++HRD+ + N+LL LD D ++DFG+S K
Sbjct: 108 --VCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162
Query: 629 FVGTFGYVAP 638
F+GT ++AP
Sbjct: 163 FIGTPYWMAP 172
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 45/151 (29%), Positives = 77/151 (50%), Gaps = 9/151 (5%)
Query: 490 EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGS 549
EIVA+KKF D V++ E+K L +LRH N+V + +L++EY+ R
Sbjct: 27 EIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTL 86
Query: 550 LAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH-HDYFPPIVHRDISSKNVLLGLDYDA 608
L ++ ++ + VR I + ++Y H H+ I+HRDI +N+L+
Sbjct: 87 LELLEASPGGLPPD--AVRS-YIWQLLQAIAYCHSHN----IIHRDIKPENILVSESGVL 139
Query: 609 HVSDFGISKFLK-PDSSNWSEFVGTFGYVAP 638
+ DFG ++ L+ +S +++V T Y AP
Sbjct: 140 KLCDFGFARALRARPASPLTDYVATRWYRAP 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 56/171 (32%), Positives = 84/171 (49%), Gaps = 16/171 (9%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFH-SPHPDM-VVQQAFSNEIKALTELRHRNVVKFY 529
IG+ VYKA ++ + E+VA+K P D ++QQ EI L E RH N+V ++
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ----EISMLKECRHPNIVAYF 66
Query: 530 GFSFHPRQS-FLLYEYLGRGSLAIILS-NDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF 587
G S+ R +++ EY G GSL I + E V + L+Y+H
Sbjct: 67 G-SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSE---LQIAYVCRETLKGLAYLHETG- 121
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+HRDI N+LL D D ++DFG+S L + F+GT ++AP
Sbjct: 122 --KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAP 170
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-13
Identities = 50/170 (29%), Positives = 88/170 (51%), Gaps = 16/170 (9%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFH---SPHPDMVVQQAFSNEIKALTELRHRNVVKF 528
IG +V+ A ++ + + VA+K+ + P ++++ NEI + EL++ N+V F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII-----NEILVMKELKNPNIVNF 81
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
+ F++ EYL GSL +++ + +DE V + L ++H +
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVT-ETCMDEAQIAA---VCRECLQALEFLHAN--- 134
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
++HRDI S NVLLG+D ++DFG + P+ S S VGT ++AP
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 46/168 (27%), Positives = 74/168 (44%), Gaps = 10/168 (5%)
Query: 473 IGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
+G V K P+ +I+AVK + +Q+ E+ L + +V FYG
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRL-EINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSN-DAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPI 590
++ + EY+ GSL IL I E + + +V L+Y+H + I
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPER---ILGKIAVAVLKGLTYLHEKH--KI 122
Query: 591 VHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+HRD+ N+L+ + DFG+S L + FVGT Y+AP
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAP 168
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 46/170 (27%), Positives = 87/170 (51%), Gaps = 16/170 (9%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFH---SPHPDMVVQQAFSNEIKALTELRHRNVVKF 528
IG +VY A ++ + + VA+++ + P ++++ NEI + E ++ N+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-----NEILVMRENKNPNIVNY 82
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
+ +++ EYL GSL +++ + +DE V + L ++H +
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAA---VCRECLQALEFLHSN--- 135
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
++HRDI S N+LLG+D ++DFG + P+ S S VGT ++AP
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 41/167 (24%), Positives = 75/167 (44%), Gaps = 7/167 (4%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG VYKA + + EIVA+KK + + EIK L EL H N++K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIV 591
H +L++E++ +I ++ + + + L++ H I+
Sbjct: 67 FRHKGDLYLVFEFMDTDLYKLI---KDRQRGLPESLIKSYLYQLLQGLAFCHSHG---IL 120
Query: 592 HRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
HRD+ +N+L+ + ++DFG+++ ++ +V T Y AP
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAP 167
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 21/162 (12%)
Query: 473 IGTAGQASVYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVV 526
+G V+ E E+VAVK + ++ F E + LT +H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA-RKDFEREAELLTNFQHENIV 71
Query: 527 KFYGFSFHPRQSFLLYEYLGRGSL-----------AIILSNDAAIDEFSWTVRMNVIKSV 575
KFYG +++EY+ G L A + S D+ + E + + + + +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 576 ANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
A+ + Y+ +F VHRD++++N L+G D + DFG+S+
Sbjct: 132 ASGMVYLASQHF---VHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 7e-13
Identities = 47/170 (27%), Positives = 87/170 (51%), Gaps = 16/170 (9%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFH---SPHPDMVVQQAFSNEIKALTELRHRNVVKF 528
IG +VY A ++ + + VA+K+ + P ++++ NEI + E ++ N+V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII-----NEILVMRENKNPNIVNY 81
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
+ +++ EYL GSL +++ + +DE V + L ++H +
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAA---VCRECLQALDFLHSN--- 134
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
++HRDI S N+LLG+D ++DFG + P+ S S VGT ++AP
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 9e-13
Identities = 48/174 (27%), Positives = 80/174 (45%), Gaps = 12/174 (6%)
Query: 467 FDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNV 525
FD +G SVYKA + ++VA+K D+ Q EI L + +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDL---QEIIKEISILKQCDSPYI 60
Query: 526 VKFYGFSFHPRQSFLLYEYLGRGSLA-IILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH 584
VK+YG F +++ EY G GS++ I+ + + E ++ L Y+H
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA---ILYQTLKGLEYLH- 116
Query: 585 DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+HRDI + N+LL + A ++DFG+S L + + +GT ++AP
Sbjct: 117 --SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAP 168
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 45/176 (25%), Positives = 85/176 (48%), Gaps = 16/176 (9%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKF----HSPHPDMVVQQAFSNEIKALTELRHRNVVK 527
+GT +S Y+A ++ + ++AVK+ ++ V +A EI+ + L H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 528 FYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF 587
G + L E++ GS++ +LS A F V +N + + LSY+H +
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYLHENQ- 123
Query: 588 PPIVHRDISSKNVLL-GLDYDAHVSDFGISKFLKPDSSNWSEF----VGTFGYVAP 638
I+HRD+ N+L+ ++DFG + L + EF +GT ++AP
Sbjct: 124 --IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 10/154 (6%)
Query: 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN 524
IG V + + VAVK D QAF E +T LRH N
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYRG-QKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPN 61
Query: 525 VVKFYGFSFHPRQSFLLYEYLGRGSLAIIL-SNDAAIDEFSWTVRMNVIKSVANTLSYMH 583
+V+ G +++ EY+ +GSL L S A+ + ++ V + Y+
Sbjct: 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYLE 119
Query: 584 HDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
F VHRD++++NVL+ D A VSDFG++K
Sbjct: 120 EKNF---VHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 26/177 (14%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPH-----PDMVVQQAFSNEIKALTELRHRNVV 526
IG V+KA + + E VA+KK P+ ++ EIKAL +H VV
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-----EIKALQACQHPYVV 62
Query: 527 KFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVA----NTLSYM 582
K H L+ EY+ ++ + + E +KS ++YM
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQ-------VKSYMRMLLKGVAYM 115
Query: 583 HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN-WSEFVGTFGYVAP 638
H + I+HRD+ N+L+ D ++DFG+++ + +S V T Y AP
Sbjct: 116 HAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 52/171 (30%), Positives = 83/171 (48%), Gaps = 20/171 (11%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG+ +VYK P+ + A+K + H D V +Q EI+ L ++ H NVVK +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQ-ICREIEILRDVNHPNVVKCHDM 140
Query: 532 SFHPRQSFLLYEYLGRGSL--AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP 589
H + +L E++ GSL I D V + + + ++Y+H +
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD---------VARQILSGIAYLHRRH--- 188
Query: 590 IVHRDISSKNVLLGLDYDAHVSDFGISKFLKP--DSSNWSEFVGTFGYVAP 638
IVHRDI N+L+ + ++DFG+S+ L D N S VGT Y++P
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSP 237
|
Length = 353 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 39/138 (28%), Positives = 61/138 (44%), Gaps = 12/138 (8%)
Query: 490 EIVAVKKFHSPHPDMVVQQA--FSNEIKALTELRHRNVVKFYGFSF--HPRQSFLLYEYL 545
E VAVK S + Q F EI+ L L H N+VK+ G R L+ EYL
Sbjct: 34 EQVAVK---SLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYL 90
Query: 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD 605
GSL L + + + + Y+ + +HRD++++N+L+ +
Sbjct: 91 PSGSLRDYLQRHRDQINLKRLLLFSS--QICKGMDYLGSQRY---IHRDLAARNILVESE 145
Query: 606 YDAHVSDFGISKFLKPDS 623
+SDFG++K L D
Sbjct: 146 DLVKISDFGLAKVLPEDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 54/178 (30%), Positives = 84/178 (47%), Gaps = 29/178 (16%)
Query: 472 CIGTAGQASVYKA-ELPSWEIVAVKKF---HSPHPDMVVQQAFSNEIKALTELRHRNVVK 527
CIG VYKA + + ++VA+K + +QQ EI+ L++ R + K
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ----EIQFLSQCRSPYITK 63
Query: 528 FYGFSFHPRQSFL-------LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLS 580
+YG SFL + EY G GS +L +DE +++ V L
Sbjct: 64 YYG-------SFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAF---ILREVLLGLE 112
Query: 581 YMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
Y+H + +HRDI + N+LL + D ++DFG+S L S + FVGT ++AP
Sbjct: 113 YLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAP 167
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 55/180 (30%), Positives = 81/180 (45%), Gaps = 24/180 (13%)
Query: 473 IGTAGQASVYKAELPSW-EIVAVK--KFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFY 529
I V+ A+ S +I A+K K V Q E L++ + VVK Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVL-TERDILSQAQSPYVVKLY 59
Query: 530 GFSF-HPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
+SF + +L+ EYL G LA +L N ++DE V I + L Y+H +
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE---DVARIYIAEIVLALEYLHSN--- 112
Query: 589 PIVHRDISSKNVLLGLDYDAHV--SDFGISKF--------LKPDSSNWSEFVGTFGYVAP 638
I+HRD+ N+L +D + H+ +DFG+SK L D VGT Y+AP
Sbjct: 113 GIIHRDLKPDNIL--IDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 41/127 (32%), Positives = 64/127 (50%), Gaps = 7/127 (5%)
Query: 512 NEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNV 571
NE+ + + +H+NVV+ Y + ++L E+L G+L I+S +E TV
Sbjct: 67 NEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATV---- 122
Query: 572 IKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVG 631
+SV L Y+H ++HRDI S ++LL LD +SDFG + D VG
Sbjct: 123 CESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 179
Query: 632 TFGYVAP 638
T ++AP
Sbjct: 180 TPYWMAP 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 27/160 (16%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSP----------HPDMVVQQAFSNEIKALTELR 521
IG VY A + + E++AVK+ P DMV +A +EI+ L +L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMV--KALRSEIETLKDLD 66
Query: 522 HRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANT--- 578
H N+V++ GF + EY+ GS+ L +E +++
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-------QLVRFFTEQVLE 119
Query: 579 -LSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
L+Y+H I+HRD+ + N+L+ D +SDFGISK
Sbjct: 120 GLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 36/133 (27%), Positives = 71/133 (53%), Gaps = 10/133 (7%)
Query: 492 VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLA 551
VA+K S D++ QQ F E++AL LRH++++ + +++ E + +GSL
Sbjct: 33 VAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL 90
Query: 552 IILSNDAAIDEFSWTVR--MNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAH 609
L + + V +++ VA ++Y+ +HRD++++N+L+G D
Sbjct: 91 AFLRSP---EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCK 144
Query: 610 VSDFGISKFLKPD 622
V+DFG+++ +K D
Sbjct: 145 VADFGLARLIKED 157
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-11
Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 17/99 (17%)
Query: 66 LRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLD 125
LRG +P ++ +L L+ + L N + G +P S G++ +L + LD
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEV-----------------LD 472
Query: 126 LSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILG 164
LS N +GSIP LG L++L +L+L NSL G +P LG
Sbjct: 473 LSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 23/166 (13%)
Query: 470 KYCIGTAGQASVYKAE----LPSWE--IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHR 523
K+ +G V+ AE LP + +VAVK +Q F E + LT L+H+
Sbjct: 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES--ARQDFQREAELLTVLQHQ 67
Query: 524 NVVKFYGFSFHPRQSFLLYEYLGRGSL----------AIIL--SNDAAIDEFSWTVRMNV 571
++V+FYG R +++EY+ G L A IL D A + + + +
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 572 IKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
+A+ + Y+ +F VHRD++++N L+G + DFG+S+
Sbjct: 128 ASQIASGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 24/187 (12%)
Query: 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKK---FHSPHPDMVVQQAFSN---EIKA 516
NF + IG + VYKA L +VA+KK F +M+ +A + EI
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIF-----EMMDAKARQDCLKEIDL 55
Query: 517 LTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSN----DAAIDEFS-WTVRMNV 571
L +L H NV+K+ + ++ E G L+ ++ + I E + W + +
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 572 IKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVG 631
+ L +MH I+HRDI NV + + D G+ +F ++ VG
Sbjct: 116 ----CSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168
Query: 632 TFGYVAP 638
T Y++P
Sbjct: 169 TPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 9e-11
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 21/172 (12%)
Query: 474 GTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFS 532
GT G VYKA + + EIVA+KK + + + EI L EL+H N+VK
Sbjct: 10 GTYG--VVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI 67
Query: 533 FHPRQSFLLYEYLGRGSLAIILSND--AAIDEFSWTVRMNVIKSVA----NTLSYMHHDY 586
R+ +L++EY D +D+ + N+IKS+ L+Y H
Sbjct: 68 HTERKLYLVFEY---------CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 587 FPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
I+HRD+ +N+L+ D ++DFG+++ ++ V T Y AP
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAP 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 50/171 (29%), Positives = 74/171 (43%), Gaps = 16/171 (9%)
Query: 474 GTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSF 533
G G SV K L + ++ K + P+ +Q+ E++ + +VK+YG
Sbjct: 12 GAGG--SVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69
Query: 534 HPRQSFL--LYEYLGRGSL-AI---ILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF 587
S + EY GSL +I + I E V + +SV LSY+H
Sbjct: 70 DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE---KVLGKIAESVLKGLSYLHSR-- 124
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
I+HRDI N+LL + DFG+S L +S F GT Y+AP
Sbjct: 125 -KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFTGTSFYMAP 172
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 56/177 (31%), Positives = 81/177 (45%), Gaps = 29/177 (16%)
Query: 474 GTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFS 532
GT G VY A +L + +A+K+ P D Q EI + L+HRN+V++ G S
Sbjct: 19 GTYG--IVYAARDLSTQVRIAIKEI--PERDSRYVQPLHEEIALHSYLKHRNIVQYLG-S 73
Query: 533 FHPRQSFLLY-EYLGRGSLAIIL--------SNDAAIDEFSWTVRMNVIKSVANTLSYMH 583
F ++ E + GSL+ +L N+ I ++ K + L Y+H
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT--------KQILEGLKYLH 125
Query: 584 HDYFPPIVHRDISSKNVLLGLDYDA--HVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+ IVHRDI NVL+ Y +SDFG SK L + F GT Y+AP
Sbjct: 126 DN---QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAP 178
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 38/140 (27%), Positives = 70/140 (50%), Gaps = 18/140 (12%)
Query: 491 IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550
+VAVK P + ++ F E + LT L+H ++VKFYG +++EY+ G L
Sbjct: 37 LVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL 94
Query: 551 ----------AIILSNDAAID---EFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISS 597
A+IL + E + +++ +A+ + Y+ +F VHRD+++
Sbjct: 95 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHF---VHRDLAT 151
Query: 598 KNVLLGLDYDAHVSDFGISK 617
+N L+G + + DFG+S+
Sbjct: 152 RNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 3e-10
Identities = 40/137 (29%), Positives = 65/137 (47%), Gaps = 15/137 (10%)
Query: 506 VQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS-FLLYEYLGRGSLAIILSNDAAIDEFS 564
V+ E L+ + H +VK + ++F + +L+ EY G L LS + E
Sbjct: 37 VEHTL-TERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE-- 92
Query: 565 WTVRMNVIKSVANTLSYMH-HDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKP 621
R + L Y+H I++RD+ +N+LL D D H+ +DFG++K L
Sbjct: 93 ERARF-YAAEIVLALEYLHSLG----IIYRDLKPENILL--DADGHIKLTDFGLAKELSS 145
Query: 622 DSSNWSEFVGTFGYVAP 638
+ S + F GT Y+AP
Sbjct: 146 EGSRTNTFCGTPEYLAP 162
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 35/137 (25%), Positives = 70/137 (51%), Gaps = 15/137 (10%)
Query: 491 IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550
+VAVK + ++ F E + LT L+H ++VKFYG +++EY+ G L
Sbjct: 37 LVAVKTLKDASDN--ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDL 94
Query: 551 ----------AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNV 600
A++++ E + + +++ + +A + Y+ +F VHRD++++N
Sbjct: 95 NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHF---VHRDLATRNC 151
Query: 601 LLGLDYDAHVSDFGISK 617
L+G + + DFG+S+
Sbjct: 152 LVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 41/128 (32%), Positives = 62/128 (48%), Gaps = 9/128 (7%)
Query: 512 NEIKALTELRHRNVVKFYGFSFHPRQS-FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMN 570
NE + L EL H +V + +SF ++ +L+ + L G L LS E V+
Sbjct: 49 NERRILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE--QVKF- 104
Query: 571 VIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFV 630
I + L Y+H I+HRDI N+LL H++DF I+ + PD+ +
Sbjct: 105 WICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT-TSTS 160
Query: 631 GTFGYVAP 638
GT GY+AP
Sbjct: 161 GTPGYMAP 168
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 4e-10
Identities = 43/181 (23%), Positives = 74/181 (40%), Gaps = 17/181 (9%)
Query: 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN 524
++ IG VY ++ +K+ + ++ NE+K L +L H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 525 VVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEF-------SWTVRMNVIKSVAN 577
++K+Y + ++ EY G L+ + + W V++ +A
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL----CLA- 115
Query: 578 TLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVA 637
L Y+H I+HRDI +N+ L + + DFGISK L VGT Y++
Sbjct: 116 -LKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLS 171
Query: 638 P 638
P
Sbjct: 172 P 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 27/157 (17%)
Query: 491 IVAVKKFHSPHPDMVVQQA---FSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGR 547
VAVKK D+ QQ NE+ + + +H N+V+ Y + +++ E+L
Sbjct: 46 QVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100
Query: 548 GSLAIILSNDAAIDEFSWTVRMN------VIKSVANTLSYMHHDYFPPIVHRDISSKNVL 601
G+L I+++ RMN V +V LS++H ++HRDI S ++L
Sbjct: 101 GALTDIVTH----------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSIL 147
Query: 602 LGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
L D +SDFG + + VGT ++AP
Sbjct: 148 LTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 38/119 (31%), Positives = 61/119 (51%), Gaps = 21/119 (17%)
Query: 508 QAFSNEIKALTELRHRNVVKFYGFSFHPRQS-FLLYEYLGRGSLA--------IILSNDA 558
QAF E +T+LRH N+V+ G + +++ EY+ +GSL +L D
Sbjct: 44 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 103
Query: 559 AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
+ +FS V + Y+ + F VHRD++++NVL+ D A VSDFG++K
Sbjct: 104 LL-KFSL--------DVCEAMEYLEANNF---VHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 5e-10
Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 9/167 (5%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG V+K + + ++VA+K + ++ EI L++ V K+YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYVTKYYGS 70
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIV 591
+ +++ EYLG GS A+ L DEF ++K + L Y+H + +
Sbjct: 71 YLKGTKLWIIMEYLGGGS-ALDLLRAGPFDEFQIA---TMLKEILKGLDYLHSE---KKI 123
Query: 592 HRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
HRDI + NVLL D ++DFG++ L + FVGT ++AP
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 13/169 (7%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFH-SPHPDM-VVQQAFSNEIKALTELRHRNVVKFY 529
+G+ VYKA L + E+ AVK P D ++QQ EI + E +H N+V ++
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ----EIFMVKECKHCNIVAYF 72
Query: 530 GFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP 589
G + ++ EY G GSL I + E V + L+Y+H
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY---VCRETLQGLAYLHSK---G 126
Query: 590 IVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+HRDI N+LL + D ++DFG++ + + F+GT ++AP
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAP 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 42/150 (28%), Positives = 72/150 (48%), Gaps = 8/150 (5%)
Query: 490 EIVAVKKF-HSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRG 548
+IVA+KKF S MV + A EI+ L +LRH N+V ++ +L++E++
Sbjct: 27 QIVAIKKFLESEDDKMVKKIAM-REIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85
Query: 549 SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDA 608
L + +DE VR + + + + H I+HRDI +N+L+
Sbjct: 86 VLDDLEKYPNGLDES--RVR-KYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVV 139
Query: 609 HVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+ DFG ++ L ++++V T Y AP
Sbjct: 140 KLCDFGFARTLAAPGEVYTDYVATRWYRAP 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 36/130 (27%), Positives = 59/130 (45%), Gaps = 8/130 (6%)
Query: 492 VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSF-HPRQSFLLYEYLGRGSL 550
VAVK S ++ F E + L H N+++ YG HP ++ E GSL
Sbjct: 26 VAVKCLKSDKLSDIMDD-FLKEAAIMHSLDHENLIRLYGVVLTHPLM--MVTELAPLGSL 82
Query: 551 AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV 610
L A+ F + + +AN + Y+ F +HRD++++N+LL D +
Sbjct: 83 LDRL-RKDALGHFLISTLCDYAVQIANGMRYLESKRF---IHRDLAARNILLASDDKVKI 138
Query: 611 SDFGISKFLK 620
DFG+ + L
Sbjct: 139 GDFGLMRALP 148
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 35/89 (39%), Positives = 53/89 (59%), Gaps = 3/89 (3%)
Query: 100 NLNNLAI-GSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGS 158
L+N + G +PN +S L L ++LS N + G+IP LG +++L VL L NS GS
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQ--SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 159 IPPILGKVQSLLSLGFDLNLLNGVLPPSI 187
IP LG++ SL L + N L+G +P ++
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 36/130 (27%), Positives = 62/130 (47%), Gaps = 10/130 (7%)
Query: 510 FSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRM 569
F E K + +L H N+V+ YG R F++ EY+ G L L W + M
Sbjct: 46 FIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM 105
Query: 570 NVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEF 629
V + Y+ + F +HRD++++N L+G D VSDFG+++++ D ++
Sbjct: 106 --CSDVCEAMEYLESNGF---IHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-----QY 155
Query: 630 VGTFGYVAPI 639
+ G P+
Sbjct: 156 TSSQGTKFPV 165
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSN---EIKALTELRHRNVVKF 528
+G+ SVY+ L + AVK+ Q+A EI L++L+H N+V++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
G ++ E + GSLA +L + E V + + L Y+H
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE---PVIRLYTRQILLGLEYLHDRN-- 122
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
VHRDI N+L+ + ++DFG++K + S S F G+ ++AP
Sbjct: 123 -TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-FKGSPYWMAP 170
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 46/167 (27%), Positives = 80/167 (47%), Gaps = 9/167 (5%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG VYK + + E+VA+K + ++ EI L++ + ++YG
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYITRYYGS 70
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIV 591
+ +++ EYLG GS A+ L ++E T +++ + L Y+H + +
Sbjct: 71 YLKGTKLWIIMEYLGGGS-ALDLLKPGPLEE---TYIATILREILKGLDYLHSER---KI 123
Query: 592 HRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
HRDI + NVLL D ++DFG++ L + FVGT ++AP
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 36/131 (27%), Positives = 67/131 (51%), Gaps = 12/131 (9%)
Query: 492 VAVKKFHSPHPDMVVQQA-FSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550
VA+K + D Q+ F E + + H N+++ G R ++ EY+ GSL
Sbjct: 35 VAIKTLKAGSSDK--QRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSL 92
Query: 551 AIIL-SNDAAIDEFSWTVRMNVIKSVANTLSYM-HHDYFPPIVHRDISSKNVLLGLDYDA 608
L ND +F+ + +++ +A+ + Y+ +Y VHRD++++N+L+ +
Sbjct: 93 DKFLREND---GKFTVGQLVGMLRGIASGMKYLSEMNY----VHRDLAARNILVNSNLVC 145
Query: 609 HVSDFGISKFL 619
VSDFG+S+ L
Sbjct: 146 KVSDFGLSRRL 156
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 45/170 (26%), Positives = 76/170 (44%), Gaps = 15/170 (8%)
Query: 474 GTAGQASVYK----AELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFY 529
G G+A++Y+ L W+ V + + + NEI L+ L+H N++ +Y
Sbjct: 11 GAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-----NEIVILSLLQHPNIIAYY 65
Query: 530 GFSFHPRQSFLL-YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
F + L+ EY G+L + F + + + + + +SY+H
Sbjct: 66 N-HFMDDNTLLIEMEYANGGTLYDKIVRQKG-QLFEEEMVLWYLFQIVSAVSYIHKA--- 120
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
I+HRDI + N+ L + DFGISK L + S VGT Y++P
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSP 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 84/288 (29%), Positives = 122/288 (42%), Gaps = 44/288 (15%)
Query: 91 SGWLPSSFGNLNNLAIGSMPNSL--SNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVL 148
L S N L + S L S+L+ L L S L +L L L
Sbjct: 39 DSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSL 98
Query: 149 HLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIG 208
L N L +I +L L+ L+L N +I+++ L GL
Sbjct: 99 DLNLNRLRSNISELLE-----LTNLTSLDLDN----NNITDIPPLIGL------------ 137
Query: 209 NLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQ 268
L EL++ + ++ +P LRN +L + L N L+ ++ ++ NL LDLS
Sbjct: 138 LKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSG 195
Query: 269 NNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGN 328
N +PP+I L L +LD S N I+ EL L NLK+L+ L+ N
Sbjct: 196 NKI------------SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNN 242
Query: 329 KVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
K+ LP +G++S+LE LDLS N + L L L ELDL
Sbjct: 243 KL-EDLPESIGNLSNLETLDLSNNQISSISS-----LGSLTNLRELDL 284
|
Length = 394 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 34/100 (34%), Positives = 48/100 (48%), Gaps = 11/100 (11%)
Query: 216 LEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSL 275
L +DN+ L G IP + L ++L N + GNI G +L LDLS N+F G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG-- 480
Query: 276 NFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELG 315
SIP +G+L L L+ + N + G +P LG
Sbjct: 481 ---------SIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 39/145 (26%), Positives = 60/145 (41%), Gaps = 10/145 (6%)
Query: 481 VYKAELPSWEIVAVKKFHSPHPDMVVQQA-FSNEIKALTELRHRNVVKFYGFSFHPRQSF 539
VY + VAVK H + + F E + +L H +V+ G
Sbjct: 15 VYLMKSGKEVEVAVKTLKQEH--IAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE-PLM 71
Query: 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKN 599
L+ E G L L I + VA ++Y+ +F VHRD++++N
Sbjct: 72 LVMELAPLGPLLKYLKKRREIPVSDLKELAH---QVAMGMAYLESKHF---VHRDLAARN 125
Query: 600 VLLGLDYDAHVSDFGISKFLKPDSS 624
VLL + A +SDFG+S+ L S
Sbjct: 126 VLLVNRHQAKISDFGMSRALGAGSD 150
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 9/168 (5%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG V+K + +IVA+KKF D V+++ EI+ L +L+H N+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH-HDYFPPI 590
R+ L++EY L + N + E +I +++ H H+
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHL---IKKIIWQTLQAVNFCHKHN----C 121
Query: 591 VHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+HRD+ +N+L+ + DFG ++ L +++++V T Y AP
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAP 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 54/190 (28%), Positives = 89/190 (46%), Gaps = 19/190 (10%)
Query: 457 YEEVIRATNNFDAKYCIGTAGQAS---VYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNE 513
YE V R + + IG G + VYKA+ +A K + ++ + E
Sbjct: 1 YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YMVE 59
Query: 514 IKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL-AIILSNDAAIDEFSWTVRMNVI 572
I+ L H +VK G + + +++ E+ G++ AI+L D + E V +
Sbjct: 60 IEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV---IC 116
Query: 573 KSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS----KFLKPDSSNWSE 628
+ + L Y+H I+HRD+ + NVLL LD D ++DFG+S K L+ S
Sbjct: 117 RQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS---- 169
Query: 629 FVGTFGYVAP 638
F+GT ++AP
Sbjct: 170 FIGTPYWMAP 179
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 44/167 (26%), Positives = 77/167 (46%), Gaps = 8/167 (4%)
Query: 473 IGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFS 532
+G VYKA+ ++A K + ++ + EI L H N+VK
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELED-YMVEIDILASCDHPNIVKLLDAF 71
Query: 533 FHPRQSFLLYEYLGRGSL-AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIV 591
++ ++L E+ G++ A++L + + E V V K L+Y+H + I+
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV---VCKQTLEALNYLHEN---KII 125
Query: 592 HRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
HRD+ + N+L LD D ++DFG+S F+GT ++AP
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 172
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 29/82 (35%), Positives = 48/82 (58%)
Query: 18 LFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQL 77
L IP I + +L+ +++ N + G IP + +T L+ L ++ N GS+P +GQL
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 78 SSLKQLVLYCNGLSGWLPSSFG 99
+SL+ L L N LSG +P++ G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 13/169 (7%)
Query: 473 IGTAGQASVYKAE-LPSWEIVAVKKFH-SPHPDM-VVQQAFSNEIKALTELRHRNVVKFY 529
IG+ VYKA + + E+ A+K P D VVQQ EI + + +H N+V ++
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ----EIIMMKDCKHSNIVAYF 72
Query: 530 GFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP 589
G + ++ E+ G GSL I + E V + L Y+H
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY---VSRETLQGLYYLHSK---G 126
Query: 590 IVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+HRDI N+LL + ++DFG+S + + F+GT ++AP
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 44/161 (27%), Positives = 72/161 (44%), Gaps = 33/161 (20%)
Query: 481 VYKAEL--PSWE-------IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
VYK EL P+ I +K+ P VQQ F E + +++L+H N+V G
Sbjct: 21 VYKGELTGPNERLSATSVAIKTLKENAEPK----VQQEFRQEAELMSDLQHPNIVCLLGV 76
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKS-------------VANT 578
+ + +L+EYL G L L ++ + +KS +A
Sbjct: 77 CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAG 136
Query: 579 LSYM--HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
+ Y+ HH VHRD++++N L+G +SDFG+S+
Sbjct: 137 MEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 47/182 (25%), Positives = 76/182 (41%), Gaps = 15/182 (8%)
Query: 465 NNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFH----SPHPDMVVQQAFSNEIKALTE 519
N+ +G VY ++ + +AVK+ SP V A EI+ L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVN-ALECEIQLLKN 60
Query: 520 LRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTL 579
L+H +V++YG + EY+ GS+ L A+ E TV + + +
Sbjct: 61 LQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTE---TVTRKYTRQILEGV 117
Query: 580 SYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP---DSSNWSEFVGTFGYV 636
Y+H + IVHRDI N+L + + DFG SK L+ + GT ++
Sbjct: 118 EYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 637 AP 638
+P
Sbjct: 175 SP 176
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 39/126 (30%), Positives = 64/126 (50%), Gaps = 7/126 (5%)
Query: 513 EIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVI 572
EI L++ V K+YG + +++ EYLG GS A+ L +DE T ++
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDE---TQIATIL 107
Query: 573 KSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGT 632
+ + L Y+H + +HRDI + NVLL + ++DFG++ L + FVGT
Sbjct: 108 REILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT 164
Query: 633 FGYVAP 638
++AP
Sbjct: 165 PFWMAP 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 15/150 (10%)
Query: 492 VAVKKFHSPHPDMVVQQA---FSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRG 548
VAVKK D+ QQ NE+ + + H NVV Y + +++ E+L G
Sbjct: 50 VAVKKM-----DLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104
Query: 549 SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDA 608
+L I+++ +E TV ++V+++ LSY+H+ ++HRDI S ++LL D
Sbjct: 105 ALTDIVTHTRMNEEQIATVCLSVLRA----LSYLHNQ---GVIHRDIKSDSILLTSDGRI 157
Query: 609 HVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+SDFG + + VGT ++AP
Sbjct: 158 KLSDFGFCAQVSKEVPKRKSLVGTPYWMAP 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 11/136 (8%)
Query: 490 EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQSFLLYEYLGR 547
E+VAVKK + + F EI+ L L+H N+VK+ G + R L+ EYL
Sbjct: 34 EVVAVKKLQHSTAEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPY 91
Query: 548 GSLAIILSNDAAIDEFSWTVRMNVIKS-VANTLSYMHHDYFPPIVHRDISSKNVLLGLDY 606
GSL L + ++ + S + + Y+ + VHRD++++N+L+ +
Sbjct: 92 GSLRDYLQKHRERLDHR---KLLLYASQICKGMEYLGSKRY---VHRDLATRNILVESEN 145
Query: 607 DAHVSDFGISKFLKPD 622
+ DFG++K L D
Sbjct: 146 RVKIGDFGLTKVLPQD 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 38/149 (25%), Positives = 77/149 (51%), Gaps = 9/149 (6%)
Query: 492 VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLA 551
VA+K S + + ++ F +E + + H N++ G R ++ E++ G+L
Sbjct: 35 VAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALD 93
Query: 552 IILS-NDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV 610
L ND +F+ + +++ +A + Y+ + VHRD++++N+L+ + V
Sbjct: 94 SFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEMNY---VHRDLAARNILVNSNLVCKV 147
Query: 611 SDFGISKFLKPDSSNWSEFVGTFGYVAPI 639
SDFG+S+FL+ D+S+ + + G PI
Sbjct: 148 SDFGLSRFLEDDTSD-PTYTSSLGGKIPI 175
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 46/188 (24%), Positives = 79/188 (42%), Gaps = 21/188 (11%)
Query: 463 ATNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL- 520
T F+ IG VYKA + ++VA+K D ++ E L +
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDE--EEEIKEEYNILRKYS 60
Query: 521 RHRNVVKFYGFSFHPR------QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVI-- 572
H N+ FYG Q +L+ E G GS+ ++ + ++ I
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK---RLKEEWIAY 117
Query: 573 --KSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFV 630
+ L+Y+H + ++HRDI +N+LL + + + DFG+S L + F+
Sbjct: 118 ILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174
Query: 631 GTFGYVAP 638
GT ++AP
Sbjct: 175 GTPYWMAP 182
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 35/130 (26%), Positives = 61/130 (46%), Gaps = 10/130 (7%)
Query: 510 FSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRM 569
F E K + +L H +V+ YG R +++ EY+ G L L + S + M
Sbjct: 46 FIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEM 105
Query: 570 NVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEF 629
K V ++Y+ F +HRD++++N L+ VSDFG+S+++ D E+
Sbjct: 106 --CKDVCEGMAYLESKQF---IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-----EY 155
Query: 630 VGTFGYVAPI 639
+ G P+
Sbjct: 156 TSSVGSKFPV 165
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 34/84 (40%), Positives = 44/84 (52%), Gaps = 4/84 (4%)
Query: 256 GIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELG 315
G PN D+S+ S+N S N+I +IPP +G + L LD S N G +P LG
Sbjct: 432 GFIPN----DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG 487
Query: 316 NLKSLNYRALNGNKVYGSLPRVLG 339
L SL LNGN + G +P LG
Sbjct: 488 QLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 37/201 (18%)
Query: 465 NNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIK----ALTE 519
++F IG ++V A E + + A+K ++++ +K LT
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ---LIKEKKVKYVKIEKEVLTR 57
Query: 520 L-RHRNVVKFYGFSFHPRQS-FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVAN 577
L H ++K Y ++F ++ + + EY G L + ++D T +
Sbjct: 58 LNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLD-EKCTR--FYAAEILL 113
Query: 578 TLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE--------- 628
L Y+H I+HRD+ +N+LL D ++DFG +K L P+SS S
Sbjct: 114 ALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 629 -----------FVGTFGYVAP 638
FVGT YV+P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSP 191
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 35/138 (25%), Positives = 58/138 (42%), Gaps = 20/138 (14%)
Query: 492 VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLA 551
VAVK P ++ F E+K L+ L N+ + G ++ EY+ G L
Sbjct: 49 VAVKVL-RPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 552 IILSNDAAIDEFSWTVRMNVIKSVANTLSYM------------HHDYFPPIVHRDISSKN 599
L A + N +TL YM ++ VHRD++++N
Sbjct: 108 QFLQKHVAETS---GLACNSKSLSFSTLLYMATQIASGMRYLESLNF----VHRDLATRN 160
Query: 600 VLLGLDYDAHVSDFGISK 617
L+G +Y ++DFG+S+
Sbjct: 161 CLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 15/154 (9%)
Query: 488 SWEIVAVKKFHSPHPDMVVQQA---FSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544
S ++VAVKK D+ QQ NE+ + + +H NVV+ Y + +++ E+
Sbjct: 44 SGKLVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98
Query: 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL 604
L G+L I+++ +E V + V+K+ LS +H ++HRDI S ++LL
Sbjct: 99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKA----LSVLHAQ---GVIHRDIKSDSILLTH 151
Query: 605 DYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
D +SDFG + + VGT ++AP
Sbjct: 152 DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 24/60 (40%), Positives = 38/60 (63%)
Query: 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVG 75
N++ IPP +G+I++L+ LD+ N +G IP+ + LT L+ L +N N L G VP +G
Sbjct: 452 NSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 48/178 (26%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 474 GTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-----RHRNVVK 527
GT GQ VYK + + ++ A+K M V + EIK + HRN+
Sbjct: 27 GTYGQ--VYKGRHVKTGQLAAIKV-------MDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 528 FYGFSF-------HPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLS 580
+YG +F H Q +L+ E+ G GS+ ++ N + + + + L+
Sbjct: 78 YYG-AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLA 135
Query: 581 YMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
++H ++HRDI +NVLL + + + DFG+S L + F+GT ++AP
Sbjct: 136 HLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 190
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 44/153 (28%), Positives = 81/153 (52%), Gaps = 13/153 (8%)
Query: 490 EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR-QSFLLYEYLGRG 548
EIVA+KKF + V++ E+K L L+ N+V+ +F R + +L++EY+ +
Sbjct: 27 EIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE-AFRRRGKLYLVFEYVEKN 85
Query: 549 SLAII--LSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY 606
L ++ + N ++ VR + I + + + H + IVHRDI +N+L+ +
Sbjct: 86 MLELLEEMPNGVPPEK----VR-SYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHND 137
Query: 607 DAHVSDFGISKFLKPDS-SNWSEFVGTFGYVAP 638
+ DFG ++ L S +N++E+V T Y +P
Sbjct: 138 VLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 18/139 (12%)
Query: 507 QQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSN--DAAIDEFS 564
+ A NE + L L H N++++Y + ++ EY G+LA + ++ +DE +
Sbjct: 43 RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT 102
Query: 565 WTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAH-----VSDFGISKFL 619
++ L +HH + I+HRD+ ++N+LL D H + DFGISK L
Sbjct: 103 ------ILHFFVQILLALHHVHTKLILHRDLKTQNILL----DKHKMVVKIGDFGISKIL 152
Query: 620 KPDSSNWSEFVGTFGYVAP 638
S ++ VGT Y++P
Sbjct: 153 SSKSKAYT-VVGTPCYISP 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 34/120 (28%), Positives = 58/120 (48%), Gaps = 19/120 (15%)
Query: 505 VVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFS 564
V QAF E +T+L H+N+V+ G H +++ E + +G+L L
Sbjct: 41 VTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRT-------- 91
Query: 565 WTVRMNVIKSVANTLSY-------MHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
R + SV L + M + +VHRD++++N+L+ D A VSDFG+++
Sbjct: 92 ---RGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 36/177 (20%), Positives = 77/177 (43%), Gaps = 11/177 (6%)
Query: 466 NFDAKYCIGTAGQASVYKAELPS-WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN 524
+F+ IG V+K + + A+K+ + ++ +E + L +L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 525 VVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAA---IDEFSWTVRMNVIKSVANTLSY 581
++++Y + ++ EY G L +L ++ W + ++ L++
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAH 116
Query: 582 MHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+H I+HRDI S N+ L + + D G++K L +++ + VGT Y++P
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 30/133 (22%), Positives = 65/133 (48%), Gaps = 10/133 (7%)
Query: 507 QQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWT 566
++ F E K + +L H +V+ YG + +++ E++ G L L + S
Sbjct: 43 EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG--KLSKD 100
Query: 567 VRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW 626
+ +++ + V + Y+ + F +HRD++++N L+ VSDFG+++++ D
Sbjct: 101 MLLSMCQDVCEGMEYLERNSF---IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD---- 153
Query: 627 SEFVGTFGYVAPI 639
E+ + G P+
Sbjct: 154 -EYTSSSGAKFPV 165
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 32/133 (24%), Positives = 67/133 (50%), Gaps = 7/133 (5%)
Query: 491 IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550
VAVK D + + F E + E++H N+V+ G +++ E++ G+L
Sbjct: 33 TVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 89
Query: 551 AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV 610
L + E + V + + +++ + Y+ F +HRD++++N L+G ++ V
Sbjct: 90 LDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKV 145
Query: 611 SDFGISKFLKPDS 623
+DFG+S+ + D+
Sbjct: 146 ADFGLSRLMTGDT 158
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 23/176 (13%)
Query: 474 GTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGF 531
GT GQ VYK + + ++ A+K + ++ EI L + HRN+ +YG
Sbjct: 17 GTYGQ--VYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYG- 70
Query: 532 SFHPR-------QSFLLYEYLGRGSLAIILSNDAA--IDEFSWTVRMNVIKSVANTLSYM 582
+F + Q +L+ E+ G GS+ ++ N + E W + + + LS++
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE-EWIAY--ICREILRGLSHL 127
Query: 583 HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
H ++HRDI +NVLL + + + DFG+S L + F+GT ++AP
Sbjct: 128 HQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 40/138 (28%), Positives = 66/138 (47%), Gaps = 21/138 (15%)
Query: 492 VAVKKFHSPHPDMVVQQA---FSNEIKALTELRHRNVVKFYGFSF--HPRQSFLLYEYLG 546
VAVK P+ +Q F E +++ H+N+V+ G SF PR F+L E +
Sbjct: 39 VAVKTL----PESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR--FILLELMA 92
Query: 547 RGSLAIILSNDAAIDEFSWTVRM----NVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL 602
G L L + E ++ M + VA Y+ ++F +HRDI+++N LL
Sbjct: 93 GGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHF---IHRDIAARNCLL 149
Query: 603 ---GLDYDAHVSDFGISK 617
G A ++DFG+++
Sbjct: 150 TCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 8e-08
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 19/159 (11%)
Query: 474 GTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG-- 530
GT GQ VYKA + E+VA+KK + EIK L +LRH N+V+
Sbjct: 10 GTYGQ--VYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIV 67
Query: 531 FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVA----NTLSYMHHDY 586
S ++++EY+ L +L + +F+ + IK L Y+H +
Sbjct: 68 TSKGKGSIYMVFEYMDH-DLTGLLDSPEV--KFT----ESQIKCYMKQLLEGLQYLHSN- 119
Query: 587 FPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625
I+HRDI N+L+ D ++DFG+++ +S
Sbjct: 120 --GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 32/126 (25%), Positives = 63/126 (50%), Gaps = 8/126 (6%)
Query: 507 QQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWT 566
++ F E + + +L H +V+ YG L++E++ G L+ L +FS
Sbjct: 43 EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG--KFSQE 100
Query: 567 VRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD---S 623
+ + V ++Y+ +HRD++++N L+G + VSDFG+++F+ D S
Sbjct: 101 TLLGMCLDVCEGMAYLESSNV---IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157
Query: 624 SNWSEF 629
S ++F
Sbjct: 158 STGTKF 163
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 1e-07
Identities = 45/173 (26%), Positives = 84/173 (48%), Gaps = 23/173 (13%)
Query: 474 GTAGQASVYKA-ELPSWEIVAVK----KFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVK 527
GT G SVY A + E+VA+K KF+S M + E+K+L +L H N+VK
Sbjct: 10 GTFG--SVYLARNKETGELVAIKKMKKKFYSWEECMNL-----REVKSLRKLNEHPNIVK 62
Query: 528 FYGFSFHPRQSFLLYEYLGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMH-HD 585
+ + ++EY+ ++ E +R ++I + L+++H H
Sbjct: 63 LKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSES--VIR-SIIYQILQGLAHIHKHG 119
Query: 586 YFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+F HRD+ +N+L+ ++DFG+++ ++ ++++V T Y AP
Sbjct: 120 FF----HRDLKPENLLVSGPEVVKIADFGLAREIR-SRPPYTDYVSTRWYRAP 167
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 34/114 (29%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 509 AFSNEIKALTELRHRNVVKFYG-FSFHPRQSFLLY-EYLGRGSLAIILSNDAAIDEFSWT 566
A EI+ L L+H +V++YG ++ ++ EY+ GS+ L A+ E +
Sbjct: 50 ALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE---S 106
Query: 567 VRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620
V + + +SY+H + IVHRDI N+L + + DFG SK L+
Sbjct: 107 VTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 30/84 (35%), Positives = 45/84 (53%)
Query: 124 LDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVL 183
L L L G IP+ + L +L ++L NS+ G+IPP LG + SL L N NG +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 184 PPSISNLSNLEGLYLYSSLVSAEI 207
P S+ L++L L L + +S +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 70/240 (29%), Positives = 109/240 (45%), Gaps = 26/240 (10%)
Query: 13 HESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPR 72
+ ++ ++NL LD+ NN ++ + P ++LK L ++ NK+ S+P
Sbjct: 99 DLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPS 157
Query: 73 EVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLS 132
+ L +LK L L N LS LP NL+N L +LDLS N++S
Sbjct: 158 PLRNLPNLKNLDLSFNDLS-DLPKLLSNLSN-----------------LNNLDLSGNKIS 199
Query: 133 GSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSN 192
+P + LS L L L +NS+ + L +++L L N L LP SI NLSN
Sbjct: 200 -DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSN 256
Query: 193 LEGLYLYSSLVS--AEIGNLLQLIELEIDNKQLFGQIP--KSLRNFTSLNIVHLEQNHLT 248
LE L L ++ +S + +G+L L EL++ L +P L L + L
Sbjct: 257 LETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKAL 316
|
Length = 394 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKF-HSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
IG +VY A ++ + E+VA+KK +S Q E++ L +LRH N +++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 531 FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH-HDYFPP 589
++L+ EY + ++ + + E V L+Y+H H+
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHSHN---- 135
Query: 590 IVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
++HRD+ + N+LL + DFG + + P + FVGT ++AP
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAP 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 46/172 (26%), Positives = 82/172 (47%), Gaps = 15/172 (8%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG VYKA + + E +A+KK D V EI L E++H N+V+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKS----VANTLSYMHHDYF 587
++ +L++EYL L + D++ D F+ R+ IK+ + ++Y H
Sbjct: 70 VHSEKRLYLVFEYL---DLDLKKHMDSSPD-FAKNPRL--IKTYLYQILRGIAYCHSHR- 122
Query: 588 PPIVHRDISSKNVLLGLDYDA-HVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
++HRD+ +N+L+ +A ++DFG+++ ++ V T Y AP
Sbjct: 123 --VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAP 172
|
Length = 294 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 9/128 (7%)
Query: 512 NEIKALTELRHRNVVKFYGFSFHPRQS-FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMN 570
+E + L E H +VK Y +F ++ ++L EY G L IL + DE +T R
Sbjct: 42 SEKEILEECNHPFIVKLYR-TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE--YTARF- 97
Query: 571 VIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFV 630
I V Y+H+ I++RD+ +N+LL + + DFG +K LK W+ F
Sbjct: 98 YIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FC 153
Query: 631 GTFGYVAP 638
GT YVAP
Sbjct: 154 GTPEYVAP 161
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 46/190 (24%), Positives = 81/190 (42%), Gaps = 25/190 (13%)
Query: 467 FDAKYCIGTAGQASVYKA---ELPSWEIVAVKKFHSPHPDMV-VQQAFSNEIKALTELRH 522
++ + CIG VYKA + A+KKF + Q+ EI L EL+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 523 RNVVKFYG--FSFHPRQSFLLYEYLGRGSLAII----LSNDAAIDEFSWTVRMNVIKSVA 576
NVV + +LL++Y II + +I V+ +++ +
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPS--MVK-SLLWQIL 118
Query: 577 NTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAH----VSDFGISKF----LKPDSSNWSE 628
N + Y+H ++ ++HRD+ N+L+ + + D G+++ LKP ++
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP-LADLDP 174
Query: 629 FVGTFGYVAP 638
V T Y AP
Sbjct: 175 VVVTIWYRAP 184
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 39/145 (26%), Positives = 66/145 (45%), Gaps = 6/145 (4%)
Query: 473 IGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFS 532
IG VYK L VAVK S P + ++ F E + L + H N+VK G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDL-KRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 533 FHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVH 592
+ +++ E + GSL L ++M++ A + Y+ +H
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSL--DAAAGMEYLESK---NCIH 116
Query: 593 RDISSKNVLLGLDYDAHVSDFGISK 617
RD++++N L+G + +SDFG+S+
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 16/156 (10%)
Query: 487 PSWEIVAVKKFHSPHPDMVVQQAFSNEI----KALTELRHRNVVKFYGFSFHPRQSFLLY 542
PS I+A K H + ++ A N+I K L E +V FYG + + +
Sbjct: 24 PSGLIMARKLIH-----LEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78
Query: 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL 602
E++ GSL +L I E + + +V L+Y+ + I+HRD+ N+L+
Sbjct: 79 EHMDGGSLDQVLKKAGRIPE---NILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILV 133
Query: 603 GLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+ + DFG+S L +N FVGT Y++P
Sbjct: 134 NSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSP 167
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 30/116 (25%), Positives = 63/116 (54%), Gaps = 5/116 (4%)
Query: 507 QQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWT 566
+Q F +E + + H N+++ G + + ++ EY+ G+L L + EFS
Sbjct: 50 RQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSY 107
Query: 567 VRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622
+ +++ +A + Y+ + VHRD++++N+L+ + + VSDFG+S+ L+ D
Sbjct: 108 QLVGMLRGIAAGMKYLSDMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 36/111 (32%), Positives = 52/111 (46%), Gaps = 8/111 (7%)
Query: 509 AFSNEIKALTELRHRNVVKFYGFSFHPRQSFL--LYEYLGRGSLAIILSNDAAIDEFSWT 566
A EI+ L LRH +V++YG P + L EY+ GS+ L A+ E
Sbjct: 50 ALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE---N 106
Query: 567 VRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
V + + +SY+H + IVHRDI N+L + + DFG SK
Sbjct: 107 VTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 19/162 (11%)
Query: 474 GTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFY--- 529
GT GQ VYKA + + E+VA+KK + EIK L +L HRN+V
Sbjct: 18 GTYGQ--VYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIV 75
Query: 530 -------GFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYM 582
F +L++EY+ + ++ S + FS + +K + L+Y
Sbjct: 76 TDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYC 132
Query: 583 HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624
H F +HRDI N+LL ++DFG+++ + S
Sbjct: 133 HKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 38/148 (25%), Positives = 66/148 (44%), Gaps = 12/148 (8%)
Query: 492 VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS-FLLYEYLGRGSL 550
VA+KK P V+ + E+K L LRH N++ P + + + E LG L
Sbjct: 38 VAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DL 96
Query: 551 AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV 610
+L++ +F +++ L Y+H +VHRD+ N+L+ + D +
Sbjct: 97 HRLLTSRPLEKQFIQYFLYQILRG----LKYVHS---AGVVHRDLKPSNILINENCDLKI 149
Query: 611 SDFGISKFLKPDSSNWSEFVGTFGYVAP 638
DFG++ + + +V T Y AP
Sbjct: 150 CDFGLA---RIQDPQMTGYVSTRYYRAP 174
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 39/138 (28%), Positives = 63/138 (45%), Gaps = 13/138 (9%)
Query: 491 IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550
+VAVK + F EIK ++ L++ N+++ G ++ EY+ G L
Sbjct: 46 LVAVKMLR-ADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 551 AIILSNDAAIDEFSWTVRMNVIKSVA-NTLSYMH------HDYFPPI--VHRDISSKNVL 601
LS F+ N I SV+ L YM Y + VHRD++++N L
Sbjct: 105 NQFLSQREIESTFT---HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161
Query: 602 LGLDYDAHVSDFGISKFL 619
+G Y ++DFG+S+ L
Sbjct: 162 VGNHYTIKIADFGMSRNL 179
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 41/167 (24%), Positives = 80/167 (47%), Gaps = 20/167 (11%)
Query: 459 EVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALT 518
E+ R + + K G G+ V+ VA+K P + +AF E + +
Sbjct: 2 EIPRESLRLEVKLGQGCFGE--VWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMK 56
Query: 519 ELRHRNVVKFYGF-SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRM----NVIK 573
+LRH +V+ Y S P +++ EY+ +GSL L E +R+ ++
Sbjct: 57 KLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKG-----EMGKYLRLPQLVDMAA 109
Query: 574 SVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620
+A+ ++Y+ + VHRD+ + N+L+G + V+DFG+++ ++
Sbjct: 110 QIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIE 153
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 69/226 (30%), Positives = 104/226 (46%), Gaps = 15/226 (6%)
Query: 1 LSCLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLY 60
L L + + S+ +P + N+ NLK LD+ N LS +P+ + L++L +L
Sbjct: 134 LIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192
Query: 61 INVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNL--------AIGSMPNS 112
++ NK+ +P E+ LS+L++L L N + L SS NL NL + +P S
Sbjct: 193 LSGNKIS-DLPPEIELLSALEELDLSNNSIIE-LLSSLSNLKNLSGLELSNNKLEDLPES 250
Query: 113 LSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSL 172
+ NL++L LDLS NQ+ S LG L+NL L L NSL ++P I + L L
Sbjct: 251 IGNLSNLET--LDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELL 306
Query: 173 GFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEI 218
L L + S L N L + + L L L
Sbjct: 307 LNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWT 352
|
Length = 394 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 45/161 (27%), Positives = 71/161 (44%), Gaps = 22/161 (13%)
Query: 492 VAVKKFHSPHPDMVVQQA-FSNEIKALTELRHRNVVKFY--GFSFHPRQSFLLYEYLGRG 548
VA+K + P+ Q+A F E L H N+V G + P F ++EY+
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGR 64
Query: 549 SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL---GLD 605
+L +L+ D A+ T R+ + L + + IVHRD+ +N+++ G+
Sbjct: 65 TLREVLAADGALPAGE-TGRL-----MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR 118
Query: 606 YDAHVSDFGISKFLKPDSSNW--------SEFVGTFGYVAP 638
A V DFGI L P + +E +GT Y AP
Sbjct: 119 PHAKVLDFGIGTLL-PGVRDADVATLTRTTEVLGTPTYCAP 158
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 36/130 (27%), Positives = 60/130 (46%), Gaps = 10/130 (7%)
Query: 490 EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF-SFHPRQSFLL-YEYLGR 547
E+VAVK + EI L L H N+VK+ G S + L EY+
Sbjct: 34 EMVAVKTLKRECGQQN-TSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD 607
GSL L + + + + + ++Y+H ++ +HRD++++NVLL D
Sbjct: 93 GSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQHY---IHRDLAARNVLLDNDRL 145
Query: 608 AHVSDFGISK 617
+ DFG++K
Sbjct: 146 VKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 11/134 (8%)
Query: 492 VAVKK--FHSPHPDMVVQ-QAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL--LYEYLG 546
+AVK+ F P+ + A EI+ L L H +V++YG P + L E++
Sbjct: 30 LAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMP 89
Query: 547 RGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY 606
GS+ L + A+ E V + + +SY+H + IVHRDI N+L
Sbjct: 90 GGSIKDQLKSYGALTE---NVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVG 143
Query: 607 DAHVSDFGISKFLK 620
+ + DFG SK L+
Sbjct: 144 NVKLGDFGASKRLQ 157
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 35/141 (24%), Positives = 74/141 (52%), Gaps = 12/141 (8%)
Query: 483 KAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542
K E+P VA+K + + + ++ F +E + + H N++ G + ++
Sbjct: 30 KREIP----VAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84
Query: 543 EYLGRGSL-AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVL 601
EY+ GSL A + +D +F+ + +++ +A+ + Y+ + VHRD++++N+L
Sbjct: 85 EYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNIL 138
Query: 602 LGLDYDAHVSDFGISKFLKPD 622
+ + VSDFG+S+ L+ D
Sbjct: 139 VNSNLVCKVSDFGLSRVLEDD 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 39/138 (28%), Positives = 61/138 (44%), Gaps = 31/138 (22%)
Query: 512 NEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRM-- 569
NE + L +RH +V YG +L+ EY+ G L FS +
Sbjct: 50 NEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL------------FSHLRKSGR 97
Query: 570 ---NVIK----SVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAH--VSDFGISKFLK 620
V + V L Y+H IV+RD+ +N+L LD D + ++DFG +K +K
Sbjct: 98 FPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLL--LDSDGYIKITDFGFAKRVK 152
Query: 621 PDSSNWSEFVGTFGYVAP 638
+ ++ GT Y+AP
Sbjct: 153 GRT--YT-LCGTPEYLAP 167
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 12/168 (7%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKF-HSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
IG +VY A ++ + E+VA+KK +S Q E+K L ++H N +++ G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 531 FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPI 590
++L+ EY + ++ + + E + L+Y+H +
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSH---NM 146
Query: 591 VHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+HRDI + N+LL ++DFG + P +S FVGT ++AP
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAP 190
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 15/152 (9%)
Query: 490 EIVAVKKFHSPHPDMVVQ-QAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY-LGR 547
E+VAVKK + Q E+K L +L+H N +++ G ++L+ EY LG
Sbjct: 47 EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGS 106
Query: 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVA-NTLSYMHHDYFPPIVHRDISSKNVLLGLDY 606
S ++ + + E V + I A L+Y+H ++HRDI + N+LL
Sbjct: 107 AS-DLLEVHKKPLQE----VEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPG 158
Query: 607 DAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
++DFG + P +S FVGT ++AP
Sbjct: 159 QVKLADFGSASKSSPANS----FVGTPYWMAP 186
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 36/120 (30%), Positives = 54/120 (45%), Gaps = 20/120 (16%)
Query: 524 NVVKFYGFSFHPRQS-FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYM 582
V K Y +SF + +L+ EYL G A ++ + E W I V + +
Sbjct: 58 YVAKLY-YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE-DWA--KQYIAEVVLGVEDL 113
Query: 583 HHDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISK--FLKPDSSNWSEFVGTFGYVAP 638
H I+HRDI +N+L +D H+ +DFG+S+ FVGT Y+AP
Sbjct: 114 HQR---GIIHRDIKPENLL--IDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAP 162
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 33/122 (27%), Positives = 59/122 (48%), Gaps = 17/122 (13%)
Query: 510 FSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLYEYLGRGSL------AIILSNDAAI-- 560
F+ E++ L +L H N++ G H +L EY G+L + +L D A
Sbjct: 54 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 113
Query: 561 -----DEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615
S ++ VA + Y+ F +HRD++++N+L+G +Y A ++DFG+
Sbjct: 114 ANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGL 170
Query: 616 SK 617
S+
Sbjct: 171 SR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEI---KALTELRHRNVVKF 528
IG +VYKA +L + VA+KK P + + + EI K L H N+V+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 529 YGFSFHPRQS-----FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH 583
PR L++E++ + LA LS T++ ++++ + + ++H
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFLH 124
Query: 584 -HDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
H IVHRD+ +N+L+ D ++DFG+++ + + + V T Y AP
Sbjct: 125 SHR----IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAP 175
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 26/68 (38%), Positives = 37/68 (54%)
Query: 286 IPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLE 345
IP I KL L ++ S N I G +P LG++ SL L+ N GS+P LG ++ L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 346 YLDLSTNY 353
L+L+ N
Sbjct: 494 ILNLNGNS 501
|
Length = 623 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 50/180 (27%), Positives = 83/180 (46%), Gaps = 19/180 (10%)
Query: 465 NNFDAKYCIGTAGQASVYK-AELPSWEIVAVKKFHSPHPDMVVQQAFSN----EIKALTE 519
++F+ +G V+K + PS I+A K H + ++ A N E++ L E
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIH-----LEIKPAIRNQIIRELQVLHE 59
Query: 520 LRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDE-FSWTVRMNVIKSVANT 578
+V FYG + + + E++ GSL +L I E V + VIK
Sbjct: 60 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG---- 115
Query: 579 LSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
L+Y+ + I+HRD+ N+L+ + + DFG+S L +N FVGT Y++P
Sbjct: 116 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSP 171
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 35/132 (26%), Positives = 55/132 (41%), Gaps = 8/132 (6%)
Query: 491 IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550
+V VK D +Q F E+ +L H+NVV+ G +++ EY G L
Sbjct: 37 LVLVKALQK-TKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL 95
Query: 551 AIILSNDAAIDEFSWTVRMNVIKSVANTLSY-----MHHDYFPPIVHRDISSKNVLLGLD 605
L + DE ++ + VA L M H VHRD++++N L+
Sbjct: 96 KQFLRATKSKDEKLKPPPLSTKQKVA--LCTQIALGMDHLSNARFVHRDLAARNCLVSSQ 153
Query: 606 YDAHVSDFGISK 617
+ VS +SK
Sbjct: 154 REVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 31/143 (21%), Positives = 57/143 (39%), Gaps = 7/143 (4%)
Query: 472 CIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
C + K + P+ +VAVKK + + EI +L+H N++ +
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-T 66
Query: 532 SFHPRQS-FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPI 590
SF +++ + GS +L + ++K V N L Y+H F
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKGF--- 122
Query: 591 VHRDISSKNVLLGLDYDAHVSDF 613
+HR + + ++LL D +S
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 16/156 (10%)
Query: 487 PSWEIVAVKKFHSPHPDMVVQQAFSN----EIKALTELRHRNVVKFYGFSFHPRQSFLLY 542
PS I+A K H + ++ A N E++ L E +V FYG + + +
Sbjct: 28 PSGLIMARKLIH-----LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82
Query: 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL 602
E++ GSL +L I E + V +V L+Y+ + I+HRD+ N+L+
Sbjct: 83 EHMDGGSLDQVLKEAKRIPE---EILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILV 137
Query: 603 GLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+ + DFG+S L +N FVGT Y++P
Sbjct: 138 NSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSP 171
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 33/132 (25%), Positives = 66/132 (50%), Gaps = 9/132 (6%)
Query: 492 VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLA 551
VAVK P + +AF E + + +LRH +V+ Y +++ EY+ +GSL
Sbjct: 33 VAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89
Query: 552 IILSNDAAID-EFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV 610
L + V M +A ++Y+ + +HRD++++N+L+G + +
Sbjct: 90 DFLKSGEGKKLRLPQLVDMAA--QIAEGMAYLESRNY---IHRDLAARNILVGENLVCKI 144
Query: 611 SDFGISKFLKPD 622
+DFG+++ ++ D
Sbjct: 145 ADFGLARLIEDD 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 34/137 (24%), Positives = 65/137 (47%), Gaps = 12/137 (8%)
Query: 491 IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550
+VAVK + + F EIK ++ L+ N+++ ++ EY+ G L
Sbjct: 48 LVAVKMLRE-DANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 551 AIILS-----NDAAIDE---FSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL 602
LS A + S++ + + +A+ + Y+ F VHRD++++N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF---VHRDLATRNCLV 163
Query: 603 GLDYDAHVSDFGISKFL 619
G +Y ++DFG+S+ L
Sbjct: 164 GKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 46/177 (25%), Positives = 78/177 (44%), Gaps = 15/177 (8%)
Query: 466 NFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHR 523
+ + +GT V+ + S A+K P + +Q NE + L E+ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 524 NVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH 583
+++ + R ++L EY+ G L L N FS + + + L Y+H
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLH 118
Query: 584 HDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSNWSEFVGTFGYVAP 638
IV+RD+ +N+L LD + H+ +DFG +K L+ W+ GT Y+AP
Sbjct: 119 SK---EIVYRDLKPENIL--LDKEGHIKLTDFGFAKKLR--DRTWT-LCGTPEYLAP 167
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 15/171 (8%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG +V+KA + EIVA+K+ D V + EI L EL+H+N+V+ Y
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTL----SYMHHDYF 587
++ L++EY + S + ID ++KS L ++ H
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDID-------PEIVKSFMFQLLKGLAFCHSHN- 119
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
++HRD+ +N+L+ + + ++DFG+++ +S V T Y P
Sbjct: 120 --VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPP 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 31/131 (23%), Positives = 62/131 (47%), Gaps = 7/131 (5%)
Query: 492 VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLA 551
VAVK P + QAF E + L+H +V+ Y +++ EY+ +GSL
Sbjct: 33 VAVKTLK---PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLL 89
Query: 552 IILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVS 611
L +D + ++ +A ++Y+ + +HRD+ + NVL+ ++
Sbjct: 90 DFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERKNY---IHRDLRAANVLVSESLMCKIA 145
Query: 612 DFGISKFLKPD 622
DFG+++ ++ +
Sbjct: 146 DFGLARVIEDN 156
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 27/124 (21%), Positives = 54/124 (43%), Gaps = 18/124 (14%)
Query: 507 QQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL-AIILSNDAAIDE--- 562
+ +E + + H +VV+ G + L+ + + G L + ++ I
Sbjct: 53 NKEILDEAYVMASVDHPHVVRLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYL 111
Query: 563 FSWTVRMNVIKSVANTLSY--MHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620
+W V+ +A +SY +VHRD++++NVL+ ++DFG++K L
Sbjct: 112 LNWCVQ------IAKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160
Query: 621 PDSS 624
D
Sbjct: 161 VDEK 164
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 34/146 (23%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 477 GQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF-SFHP 535
GQ + + +W + P ++ +AF E + + +LRH +V Y S P
Sbjct: 15 GQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEP 74
Query: 536 RQSFLLYEYLGRGSLAIILSN-DAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRD 594
+++ E++G+GSL L D + V M +A+ ++Y+ + +HRD
Sbjct: 75 --IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM--AAQIADGMAYIERMNY---IHRD 127
Query: 595 ISSKNVLLGLDYDAHVSDFGISKFLK 620
+ + N+L+G + ++DFG+++ ++
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIE 153
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 46/179 (25%), Positives = 72/179 (40%), Gaps = 12/179 (6%)
Query: 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHS-PHPDMVVQQAFSNEIKALTELRHR 523
NF + IG + VY+A L VA+KK D + EI L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 524 NVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRM----NVIKSVANTL 579
NV+K+Y + ++ E G L+ + I F R+ V K
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRM------IKHFKKQKRLIPEKTVWKYFVQLC 116
Query: 580 SYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
S + H + ++HRDI NV + + D G+ +F ++ VGT Y++P
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 32/129 (24%), Positives = 63/129 (48%), Gaps = 8/129 (6%)
Query: 492 VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLA 551
VAVK P + ++F E + + +LRH +V+ Y +++ EY+ +GSL
Sbjct: 33 VAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLVQLYAV-VSEEPIYIVTEYMSKGSLL 88
Query: 552 IILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVS 611
L D +++ VA ++Y+ + +HRD+ S N+L+G ++
Sbjct: 89 DFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERMNY---IHRDLRSANILVGDGLVCKIA 144
Query: 612 DFGISKFLK 620
DFG+++ ++
Sbjct: 145 DFGLARLIE 153
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 36/133 (27%), Positives = 62/133 (46%), Gaps = 7/133 (5%)
Query: 490 EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGS 549
+ VAVK + + D ++ E + +L + +V+ G L+ E G
Sbjct: 23 KTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGP 81
Query: 550 LAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAH 609
L L + + E + T ++ V+ + Y+ F VHRD++++NVLL + A
Sbjct: 82 LNKFLQKNKHVTEKNIT---ELVHQVSMGMKYLEETNF---VHRDLAARNVLLVTQHYAK 135
Query: 610 VSDFGISKFLKPD 622
+SDFG+SK L D
Sbjct: 136 ISDFGLSKALGAD 148
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 18/171 (10%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKF-HSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
IG +VY A ++ + E+VA+KK +S Q E++ L +LRH N +++ G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 531 FSFHPRQSFLLYEY-LGRGS-LAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH-HDYF 587
++L+ EY LG S + + E + + L+Y+H H+
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIA-----AICHGALQGLAYLHSHE-- 135
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+HRDI + N+LL ++DFG + + P +S FVGT ++AP
Sbjct: 136 --RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAP 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 45/177 (25%), Positives = 75/177 (42%), Gaps = 31/177 (17%)
Query: 477 GQ-ASVYKAE-LPSWEIVAVKKFH----SPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
G A VYKA + IVA+KK D + A EIK L EL+H N++
Sbjct: 11 GTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL-REIKLLQELKHPNIIGLLD 69
Query: 531 FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH------- 583
H L++E++ L ++ + +++ + A+ SYM
Sbjct: 70 VFGHKSNINLVFEFM-ETDLEKVIKD------------KSIVLTPADIKSYMLMTLRGLE 116
Query: 584 --HDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
H + I+HRD+ N+L+ D ++DFG+++ + + V T Y AP
Sbjct: 117 YLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAP 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 15/157 (9%)
Query: 490 EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP-----RQSFLLYEY 544
E VA+KK + + EIK L LRH ++V+ P + ++++E
Sbjct: 26 EKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 85
Query: 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL 604
+ +I +ND E ++++ L Y+H + HRD+ KN+L
Sbjct: 86 MESDLHQVIKANDDLTPEHHQFFLYQLLRA----LKYIHT---ANVFHRDLKPKNILANA 138
Query: 605 DYDAHVSDFGISK--FLK-PDSSNWSEFVGTFGYVAP 638
D + DFG+++ F P + W+++V T Y AP
Sbjct: 139 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 46/171 (26%), Positives = 73/171 (42%), Gaps = 31/171 (18%)
Query: 473 IGTAGQASVYKAELPS------WEIVAVKKF-HSPHPDMVVQQAFSNEIKALTELRHRNV 525
IG V++A P + +VAVK DM Q F E + E H N+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALMAEFDHPNI 70
Query: 526 VKFYGFSFHPRQSFLLYEYLGRG---------------SLAIILSNDAAIDE----FSWT 566
VK G + LL+EY+ G SL+ S+ S T
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 567 VRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
++ + K VA ++Y+ F VHRD++++N L+G + ++DFG+S+
Sbjct: 131 EQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 44/178 (24%), Positives = 77/178 (43%), Gaps = 14/178 (7%)
Query: 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN 524
NF IG VYKA + E+VA+KK V EI L EL H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 525 VVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKS----VANTLS 580
+VK + +L++E+L + + + + + + +IKS + L+
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASPLSGIP----LPLIKSYLFQLLQGLA 114
Query: 581 YMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+ H ++HRD+ +N+L+ + ++DFG+++ ++ V T Y AP
Sbjct: 115 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 34/132 (25%), Positives = 66/132 (50%), Gaps = 9/132 (6%)
Query: 492 VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLA 551
VAVK P + + F E + + +LRH +++ Y +++ E + GSL
Sbjct: 33 VAVKTLK---PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89
Query: 552 IILSNDAAIDEFSWTVRMNVIKSVANTLSYMH-HDYFPPIVHRDISSKNVLLGLDYDAHV 610
L A +++ VA+ ++Y+ +Y +HRD++++NVL+G + V
Sbjct: 90 EYLQGGAG-RALKLPQLIDMAAQVASGMAYLEAQNY----IHRDLAARNVLVGENNICKV 144
Query: 611 SDFGISKFLKPD 622
+DFG+++ +K D
Sbjct: 145 ADFGLARVIKED 156
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 31/122 (25%), Positives = 57/122 (46%), Gaps = 17/122 (13%)
Query: 510 FSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIIL------SNDAAIDEF 563
F E + EL H N+V G + +L+EYL +G L L S+ +
Sbjct: 54 FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113
Query: 564 SWTVR--------MNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615
TV+ +++ +A + Y+ +F VH+D++++N+L+G +SD G+
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGL 170
Query: 616 SK 617
S+
Sbjct: 171 SR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 6/110 (5%)
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
Y F H R F++ EY G L LS + FS + + L Y+H +
Sbjct: 62 YSFQTHDRLCFVM-EYANGGELFFHLSRERV---FSEDRARFYGAEIVSALDYLHSE--K 115
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+V+RD+ +N++L D ++DFG+ K D + F GT Y+AP
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 51/180 (28%), Positives = 81/180 (45%), Gaps = 9/180 (5%)
Query: 462 RATNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL 520
R+ F+ IG VY+A + S EIVA+KK + + + EI L L
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63
Query: 521 RHRNVVKFYGFSF--HPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANT 578
RH N+V+ H FL+ EY + LA +L N FS + ++ +
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPT--PFSESQVKCLMLQLLRG 120
Query: 579 LSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
L Y+H ++ I+HRD+ N+LL ++DFG+++ + + V T Y AP
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAP 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 34/132 (25%), Positives = 61/132 (46%), Gaps = 14/132 (10%)
Query: 512 NEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAI-----DEFSWT 566
NEI+ L + H N++ + + ++ EY G L+ +S ++ W
Sbjct: 48 NEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR 107
Query: 567 VRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW 626
+ + +++ L +H I+HRD+ S N+LL + + D GISK LK + +
Sbjct: 108 IFIQLLRG----LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT 160
Query: 627 SEFVGTFGYVAP 638
+GT Y+AP
Sbjct: 161 Q--IGTPHYMAP 170
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 30/120 (25%), Positives = 58/120 (48%), Gaps = 16/120 (13%)
Query: 508 QAFSNEIKALTELRHRNVVKFYGFSFHPRQSF-LLYEYLGRGSL-AIILSNDAAIDE--- 562
Q ++ + A+ L H +V+ G P S L+ + GSL + + ++D
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRL 111
Query: 563 FSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622
+W V+ +A + Y+ +VHR+++++N+LL D ++DFG++ L PD
Sbjct: 112 LNWCVQ------IAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 36/129 (27%), Positives = 63/129 (48%), Gaps = 5/129 (3%)
Query: 512 NEIKALTE-LRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLA-IILSNDAAIDEFSWTVRM 569
+E+ + E LRH N+V++Y + +++ + + L S F+
Sbjct: 57 SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116
Query: 570 NVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEF 629
N+ + L Y+H + IVHRD++ N++LG D ++DFG++K +P+S S
Sbjct: 117 NIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV- 173
Query: 630 VGTFGYVAP 638
VGT Y P
Sbjct: 174 VGTILYSCP 182
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 22/174 (12%)
Query: 474 GTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSF 533
G+ G+ + KA+ S V +K+ + ++A E+ L +++H N+V F+
Sbjct: 11 GSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ 69
Query: 534 HPRQSFLLYEYLGRGSL--------AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHD 585
+ F++ EY G L ++ S D + SW V+ ++ L ++H
Sbjct: 70 ENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQ------ISLGLKHIHDR 120
Query: 586 YFPPIVHRDISSKNVLLGLD-YDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
I+HRDI S+N+ L + A + DFGI++ L VGT Y++P
Sbjct: 121 ---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSP 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 35/151 (23%), Positives = 70/151 (46%), Gaps = 10/151 (6%)
Query: 473 IGTAGQASVYKAELPSWEIVAVKK--FHSPHPDMVVQQ--AFSNEIKALTELRHRNVVKF 528
+G +VY +++AVK+ + + ++ E+ L L+H N+V++
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
G + E++ GS++ IL+ + E V K + + ++Y+H++
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE---PVFCKYTKQILDGVAYLHNNC-- 122
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619
+VHRDI NV+L + + DFG ++ L
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 33/136 (24%), Positives = 53/136 (38%), Gaps = 19/136 (13%)
Query: 512 NEIKALTELRHRNVVKF--------YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEF 563
NEI AL L H N++K + + F LY ++ + D
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWKDRPL 265
Query: 564 SWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFG-ISKFLKPD 622
R ++K + + Y+H ++HRDI +N+ L D + DFG F K
Sbjct: 266 LKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321
Query: 623 SSNWSEFVGTFGYVAP 638
+ +VGT +P
Sbjct: 322 EAFDYGWVGTVATNSP 337
|
Length = 501 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 32/131 (24%), Positives = 62/131 (47%), Gaps = 14/131 (10%)
Query: 492 VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLA 551
V +K H D + AF + ++ H+++V YG ++ ++ E++ G L
Sbjct: 35 VILKVLDPSHRD--ISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92
Query: 552 IILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL---GLDYDA 608
+ + + + W + V K +A+ LSY+ +VH ++ +KN+LL G+D +
Sbjct: 93 LFMHRKSDVLTTPW--KFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGEC 147
Query: 609 ----HVSDFGI 615
+SD GI
Sbjct: 148 GPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 15/170 (8%)
Query: 473 IGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
+G SV K + +P+ ++A K H V++ E++ + E R +V FYG
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHI-GAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYM---HHDYFP 588
+ + E++ GSL I I + + +V L+Y+ H
Sbjct: 72 FLNENNICMCMEFMDCGSLDRIYKKGGPIPV---EILGKIAVAVVEGLTYLYNVHR---- 124
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
I+HRDI N+L+ + DFG+S L +S FVGT Y++P
Sbjct: 125 -IMHRDIKPSNILVNSRGQIKLCDFGVSGELI--NSIADTFVGTSTYMSP 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 7e-05
Identities = 37/127 (29%), Positives = 57/127 (44%), Gaps = 8/127 (6%)
Query: 513 EIKALTELRHRNVVKF-YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNV 571
E + L RH + Y F R F++ EY+ G L LS + FS
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVM-EYVNGGELFFHLSRERV---FSEDRTRFY 100
Query: 572 IKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVG 631
+ + L Y+H IV+RD+ +N++L D ++DFG+ K D++ F G
Sbjct: 101 GAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157
Query: 632 TFGYVAP 638
T Y+AP
Sbjct: 158 TPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 41/169 (24%), Positives = 72/169 (42%), Gaps = 13/169 (7%)
Query: 473 IGTAGQASVYKAELPSWEIVAVKKFHSPHPDM-VVQQAFSNEIKALTELRHRNVVKFYGF 531
I Q S+YK + + V ++ F H V+ NEIK L + N++K YGF
Sbjct: 28 IKENDQNSIYKGIFNN-KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86
Query: 532 SFH-----PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY 586
PR S +L EY RG L +L + + S+ ++++ L ++
Sbjct: 87 IIDIVDDLPRLSLIL-EYCTRGYLREVLDKEKDL---SFKTKLDMAIDCCKGLYNLYKYT 142
Query: 587 FPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGY 635
P +++++S + L+ +Y + G+ K L F+ F Y
Sbjct: 143 NKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSY 189
|
Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 35/145 (24%), Positives = 67/145 (46%), Gaps = 20/145 (13%)
Query: 491 IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550
+VAVK P + + F E+K L+ L+ N+++ G ++ EY+ G L
Sbjct: 48 LVAVKILR-PDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 551 AIILSN----------------DAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRD 594
LS+ + S++ ++V +A+ + Y+ F VHRD
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF---VHRD 163
Query: 595 ISSKNVLLGLDYDAHVSDFGISKFL 619
++++N L+G + ++DFG+S+ L
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNL 188
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 36/137 (26%), Positives = 63/137 (45%), Gaps = 12/137 (8%)
Query: 490 EIVAVKKFHSPHPDMVVQQA--FSNEIKALTELRHRNVVKFYGFSFHP--RQSFLLYEYL 545
E VAVK S P+ EI+ L L H N+VK+ G L+ E+L
Sbjct: 34 EQVAVK---SLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD 605
GSL L + + + ++ + + Y+ + VHRD++++NVL+ +
Sbjct: 91 PSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVESE 145
Query: 606 YDAHVSDFGISKFLKPD 622
+ + DFG++K ++ D
Sbjct: 146 HQVKIGDFGLTKAIETD 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 474 GTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSF 533
G+ G+ S+ + + V +KK + + ++A E + L++L+H N+V Y S+
Sbjct: 11 GSYGEVSLVRHRTDGKQYV-IKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA-YRESW 68
Query: 534 HPRQSFL-----------LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYM 582
L LY L ++ N W V+ +A L Y+
Sbjct: 69 EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVV----EWFVQ------IAMALQYL 118
Query: 583 HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
H + I+HRD+ ++NV L V D GI++ L+ S +GT Y++P
Sbjct: 119 HEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSP 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 46/179 (25%), Positives = 73/179 (40%), Gaps = 12/179 (6%)
Query: 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHS-PHPDMVVQQAFSNEIKALTELRHR 523
NF + IG + VY+A L + VA+KK D +Q EI L +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 524 NVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRM----NVIKSVANTL 579
NV+K+ + ++ E G L+ + I F R+ V K
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQM------IKYFKKQKRLIPERTVWKYFVQLC 116
Query: 580 SYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
S + H + ++HRDI NV + + D G+ +F ++ VGT Y++P
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 25/100 (25%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 511 SNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMN 570
S+EI + +L+H N+VK G + ++L++EY+ +L+ +L N SW R
Sbjct: 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRK 784
Query: 571 VIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV 610
+ +A L ++H P +V ++S + +++ + H+
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 28/84 (33%), Positives = 43/84 (51%), Gaps = 4/84 (4%)
Query: 172 LGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEI----GNLLQLIELEIDNKQLFGQI 227
LG D L G +P IS L +L+ + L + + I G++ L L++ G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 228 PKSLRNFTSLNIVHLEQNHLTGNI 251
P+SL TSL I++L N L+G +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 15/142 (10%)
Query: 502 PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF-LLYEYLGRGSLAIILSNDAAI 560
P+ VQ + E + L++L H +VKF+ SF R +F ++ EY L D +
Sbjct: 43 PNETVQA--NQEAQLLSKLDHPAIVKFHA-SFLERDAFCIITEYCEGRDL------DCKL 93
Query: 561 DEFSWTVRM----NVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616
+E T + V + L +H+ + I+HRD+ +KN+ L + + DFG+S
Sbjct: 94 EELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVS 152
Query: 617 KFLKPDSSNWSEFVGTFGYVAP 638
+ L + F GT Y++P
Sbjct: 153 RLLMGSCDLATTFTGTPYYMSP 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 38/128 (29%), Positives = 57/128 (44%), Gaps = 10/128 (7%)
Query: 513 EIKALTELRHRNVVKF-YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNV 571
E + L RH + Y F H R F++ EY G L LS + E R
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARF 99
Query: 572 IKS-VANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFV 630
+ + + L Y+H +V+RDI +N++L D ++DFG+ K D + F
Sbjct: 100 YGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156
Query: 631 GTFGYVAP 638
GT Y+AP
Sbjct: 157 GTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 37/158 (23%), Positives = 61/158 (38%), Gaps = 21/158 (13%)
Query: 486 LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYL 545
+ VAVK + + +E L ++ H +V+K YG L+ EY
Sbjct: 27 RAGYTTVAVKMLKE-NASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYA 85
Query: 546 GRGSLAIIL-------------------SNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY 586
GSL L S DE + T+ +I M +
Sbjct: 86 KYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGD-LISFAWQISRGMQYLA 144
Query: 587 FPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624
+VHRD++++NVL+ +SDFG+S+ + + S
Sbjct: 145 EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 26/115 (22%), Positives = 55/115 (47%), Gaps = 10/115 (8%)
Query: 510 FSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIIL-------SNDAAIDE 562
F NE + E +VV+ G + + ++ E + RG L L N+
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAP 115
Query: 563 FSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
S + + +A+ ++Y++ + F VHRD++++N ++ D+ + DFG+++
Sbjct: 116 PSLKKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 33/113 (29%), Positives = 58/113 (51%), Gaps = 14/113 (12%)
Query: 513 EIKALTELRHRNVVKFY--------GFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFS 564
EIK L L+H NVV ++ + +L++E+ LA +LSN +F+
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNV--KFT 117
Query: 565 WTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
+ V+K + N L Y+H I+HRD+ + N+L+ D ++DFG+++
Sbjct: 118 LSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 16/168 (9%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMV-VQQAFSNEIKALTELRHRNVVKFYG 530
+G +VYKA L + I+AVK P V +Q+ +E++ L + ++ FYG
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVI--PLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 531 FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPI 590
F + + E++ GSL + I E V + +V L+Y+ + I
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRK----IPE---HVLGRIAVAVVKGLTYL---WSLKI 116
Query: 591 VHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+HRD+ N+L+ + DFG+S L +S +VGT Y+AP
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAP 162
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 23/52 (44%), Positives = 32/52 (61%), Gaps = 5/52 (9%)
Query: 590 IVHRDISSKNVLLGLDYDAHV--SDFGISK-FLKPDSSNWSEFVGTFGYVAP 638
I++RDI +N+LL D + HV +DFG+SK FL + F GT Y+AP
Sbjct: 126 IIYRDIKLENILL--DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 51/190 (26%), Positives = 77/190 (40%), Gaps = 35/190 (18%)
Query: 468 DAKY----CIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSN---------E 513
D KY IG V A + E VA+KK + AF N E
Sbjct: 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN---------AFDNRIDAKRTLRE 54
Query: 514 IKALTELRHRNVVKFYGFSFHP-RQSF----LLYEYLGRGSLAIILSNDAAIDEFSWTVR 568
IK L L H NV+ P R++F ++YE + II S+ D+
Sbjct: 55 IKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFL 114
Query: 569 MNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE 628
+++ L Y+H ++HRD+ N+LL + D + DFG+++ +E
Sbjct: 115 YQLLRG----LKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE 167
Query: 629 FVGTFGYVAP 638
+V T Y AP
Sbjct: 168 YVVTRWYRAP 177
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 39/151 (25%), Positives = 69/151 (45%), Gaps = 20/151 (13%)
Query: 474 GTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFS 532
GT G VYKA + + EIVA+KK D V EI L EL H N+V+
Sbjct: 10 GTYGV--VYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV 67
Query: 533 FHPRQSFLLYEYLGRG------SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY 586
+ +L++E+L S + + I + + +++ +A Y H
Sbjct: 68 HSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY----QLLQGIA----YCHSHR 119
Query: 587 FPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
++HRD+ +N+L+ + ++DFG+++
Sbjct: 120 ---VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 27/69 (39%), Positives = 38/69 (55%), Gaps = 3/69 (4%)
Query: 308 GELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEK 367
G +P ++ L+ L L+GN + G++P LGSI+ LE LDLS N F P L +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLS---YNSFNGSIPESLGQ 488
Query: 368 LVQLTELDL 376
L L L+L
Sbjct: 489 LTSLRILNL 497
|
Length = 623 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 37/136 (27%), Positives = 63/136 (46%), Gaps = 24/136 (17%)
Query: 513 EIKALTELRHRNVVKFYGFSFHPRQS-FLLYEYLGRGSL--------AIILSNDAAIDEF 563
E+ L+ ++H N+V+ Y SF + +++ +Y G L ++ D +D
Sbjct: 49 EVAVLSNMKHPNIVQ-YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILD-- 105
Query: 564 SWTVRMNVIKSVANTLSYMH-HDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622
W V++ L+ H HD I+HRDI S+N+ L D + DFGI++ L
Sbjct: 106 -WFVQI--------CLALKHVHDR--KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154
Query: 623 SSNWSEFVGTFGYVAP 638
+GT Y++P
Sbjct: 155 VELARTCIGTPYYLSP 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 35/145 (24%), Positives = 62/145 (42%), Gaps = 6/145 (4%)
Query: 473 IGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFS 532
+G V+K L VAVK P + + F +E + L + H N+VK G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQEL-KIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 533 FHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVH 592
+ +++ E + G L DE + A ++Y+ +H
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIH 116
Query: 593 RDISSKNVLLGLDYDAHVSDFGISK 617
RD++++N L+G + +SDFG+S+
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 36/149 (24%), Positives = 65/149 (43%), Gaps = 9/149 (6%)
Query: 492 VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE--YLGRGS 549
VAVKK P ++ + E++ L ++H NV+ F P +S + YL
Sbjct: 45 VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHL 103
Query: 550 LAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAH 609
+ L+N + + +I + L Y+H I+HRD+ N+ + D +
Sbjct: 104 MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK 160
Query: 610 VSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+ DFG+++ + + +V T Y AP
Sbjct: 161 ILDFGLARHTDDEMTG---YVATRWYRAP 186
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 45/172 (26%), Positives = 66/172 (38%), Gaps = 39/172 (22%)
Query: 486 LPSWEIVAVKKFHSP--HPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543
P+ VA+KK SP H Q+ EIK L +H N++ +E
Sbjct: 27 KPTGVKVAIKKI-SPFEHQ-TFCQRTL-REIKILRRFKHENIIGILDI-----IRPPSFE 78
Query: 544 YLGRGSLAIILSNDAAI-DEFSWTVRMNVIKSVANTLSYMHHDYF-------------PP 589
ND I E T +IK+ LS H YF
Sbjct: 79 SF----------NDVYIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN 126
Query: 590 IVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS---EFVGTFGYVAP 638
++HRD+ N+LL + D + DFG+++ P+ + E+V T Y AP
Sbjct: 127 VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 29/85 (34%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKN 599
L+ E G L LS DE + + + ++ V+ + Y+ F VHRD++++N
Sbjct: 71 LVMEMASGGPLNKFLS--GKKDEITVSNVVELMHQVSMGMKYLEGKNF---VHRDLAARN 125
Query: 600 VLLGLDYDAHVSDFGISKFLKPDSS 624
VLL + A +SDFG+SK L D S
Sbjct: 126 VLLVNQHYAKISDFGLSKALGADDS 150
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 39/172 (22%), Positives = 72/172 (41%), Gaps = 17/172 (9%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFY-- 529
+G+ SV A + + E VA+KK P + + E+ L ++H NV+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 530 ---GFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY 586
S Q F L + L I+ + + D+ + ++ + L Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-----LVYQMLCGLKYIHS-- 135
Query: 587 FPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
I+HRD+ N+ + D + + DFG+++ + + +V T Y AP
Sbjct: 136 -AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG---YVVTRWYRAP 183
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 30/122 (24%), Positives = 58/122 (47%), Gaps = 17/122 (13%)
Query: 510 FSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLYEYLGRGSL------AIILSNDAAIDE 562
F+ E++ L +L H N++ G + ++ EY G+L + +L D A +
Sbjct: 49 FAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAK 108
Query: 563 FSWTVR-------MNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615
T + VA + Y+ F +HRD++++NVL+G + + ++DFG+
Sbjct: 109 EHGTASTLTSQQLLQFASDVATGMQYLSEKQF---IHRDLAARNVLVGENLASKIADFGL 165
Query: 616 SK 617
S+
Sbjct: 166 SR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 35/151 (23%), Positives = 65/151 (43%), Gaps = 16/151 (10%)
Query: 480 SVYKAEL----PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH- 534
SV + +L S VAVK + F +E + + H NV+K G F
Sbjct: 14 SVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEA 73
Query: 535 -PRQSF----LLYEYLGRGSL-AIILSNDAAIDEFSWTVRMNV--IKSVANTLSYMHHDY 586
Q ++ ++ G L + +L + ++ + + +A + Y+ +
Sbjct: 74 SSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN 133
Query: 587 FPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
F +HRD++++N +L D V+DFG+SK
Sbjct: 134 F---IHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 49/191 (25%), Positives = 82/191 (42%), Gaps = 18/191 (9%)
Query: 458 EEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQ-QAFSNEIKA 516
E + T+ ++ IG VYK +A K P D+ + +A N +++
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQS 74
Query: 517 LTELRHRNVVKFYGFSFHPR-----QSFLLYEYLGRGSLAII----LSNDAAIDEFSWTV 567
L H NVVKFYG + Q +L+ E GS+ + L +DE +
Sbjct: 75 LPN--HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE---AM 129
Query: 568 RMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627
++ L ++H++ I+HRD+ N+LL + + DFG+S L +
Sbjct: 130 ISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186
Query: 628 EFVGTFGYVAP 638
VGT ++AP
Sbjct: 187 TSVGTPFWMAP 197
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 33/122 (27%), Positives = 60/122 (49%), Gaps = 17/122 (13%)
Query: 510 FSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLYEYLGRGSL------AIILSNDAAIDE 562
F+ E++ L +L H N++ G H +L EY G+L + +L D A
Sbjct: 42 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 101
Query: 563 FSWTVR-------MNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615
+ T ++ VA + Y+ F +HRD++++N+L+G +Y A ++DFG+
Sbjct: 102 ANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGL 158
Query: 616 SK 617
S+
Sbjct: 159 SR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 34/142 (23%), Positives = 66/142 (46%), Gaps = 8/142 (5%)
Query: 483 KAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS---- 538
K+E S++ VAVK + + F E + E H NV+K G S R
Sbjct: 21 KSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80
Query: 539 --FLLYEYLGRGSL-AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDI 595
++ ++ G L +L + + F+ ++ +++ + + S M + +HRD+
Sbjct: 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQT-LVRFMIDIASGMEYLSSKNFIHRDL 139
Query: 596 SSKNVLLGLDYDAHVSDFGISK 617
+++N +L + V+DFG+SK
Sbjct: 140 AARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 24/52 (46%), Positives = 32/52 (61%), Gaps = 5/52 (9%)
Query: 590 IVHRDISSKNVLLGLDYDAHV--SDFGISK-FLKPDSSNWSEFVGTFGYVAP 638
IV+RDI +N+L LD + HV +DFG+SK FL + F GT Y+AP
Sbjct: 126 IVYRDIKLENIL--LDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 39/171 (22%), Positives = 77/171 (45%), Gaps = 16/171 (9%)
Query: 473 IGTAGQASVYKAELPSWE-IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
+G A+VYK + +VA+K+ H + A E+ L +L+H N+V +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLHDI 72
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIK----SVANTLSYMHHDYF 587
+ L++EYL + +D+ ++ M+ +K + L+Y H
Sbjct: 73 IHTEKSLTLVFEYLDK-------DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR-- 123
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
++HRD+ +N+L+ + ++DFG+++ + +S V T Y P
Sbjct: 124 -KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPP 173
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 30/108 (27%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 517 LTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVA 576
+++L H+++V YG +S ++ EY+ GSL L + + SW ++ V K +A
Sbjct: 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLA 110
Query: 577 NTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAH--------VSDFGIS 616
L ++ + H ++ +KNVLL + D +SD GIS
Sbjct: 111 WALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 9e-04
Identities = 38/181 (20%), Positives = 79/181 (43%), Gaps = 15/181 (8%)
Query: 459 EVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALT 518
E+ R + + K G G+ V+ A VAVK P + +AF E +
Sbjct: 2 EIPRESLKLEKKLGAGQFGE--VWMATYNKHTKVAVKTMK---PGSMSVEAFLAEANVMK 56
Query: 519 ELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANT 578
L+H +VK + +++ E++ +GSL L +D + ++ +A
Sbjct: 57 TLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEG 114
Query: 579 LSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
++++ + +HRD+ + N+L+ ++DFG+++ ++ + E+ G P
Sbjct: 115 MAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDN-----EYTAREGAKFP 166
Query: 639 I 639
I
Sbjct: 167 I 167
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 9e-04
Identities = 39/139 (28%), Positives = 60/139 (43%), Gaps = 15/139 (10%)
Query: 508 QAFSNEIKALTELRHRNVVKFYGFSFHPR-----QSFLLYEYLGRGSLAIILSNDAAIDE 562
+A N +KAL++ H NVVKFYG + Q +L+ E GS+ D
Sbjct: 62 EAEYNILKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVT-----DLVKGF 114
Query: 563 FSWTVRMN---VIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619
RM + + L + H + +HRD+ N+LL + + DFG+S L
Sbjct: 115 LKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174
Query: 620 KPDSSNWSEFVGTFGYVAP 638
+ VGT ++AP
Sbjct: 175 TSTRLRRNTSVGTPFWMAP 193
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.001
Identities = 22/60 (36%), Positives = 30/60 (50%)
Query: 31 NLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGL 90
NLK LD+ NN+L+ + L +LK L ++ N L P L SL+ L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 35/112 (31%), Positives = 54/112 (48%), Gaps = 13/112 (11%)
Query: 531 FSFH-PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH-HDYFP 588
FSF +L+ +Y+ G L L + FS I + L ++H +D
Sbjct: 63 FSFQTDSDLYLVTDYMSGGELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD--- 116
Query: 589 PIVHRDISSKNVLLGLDYDAHVS--DFGISKFLKPDSSNWSEFVGTFGYVAP 638
IV+RD+ +N+L LD H++ DFG+SK D+ + F GT Y+AP
Sbjct: 117 -IVYRDLKPENIL--LDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAP 165
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 39/124 (31%), Positives = 55/124 (44%), Gaps = 18/124 (14%)
Query: 517 LTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVA 576
LT L+ Y F H R F++ EY G L LS + E I S
Sbjct: 57 LTALK-------YSFQTHDRLCFVM-EYANGGELFFHLSRERVFSEDRARFYGAEIVS-- 106
Query: 577 NTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAH--VSDFGISKFLKPDSSNWSEFVGTFG 634
L Y+H +V+RD+ +N++L D D H ++DFG+ K D + F GT
Sbjct: 107 -ALGYLHSC---DVVYRDLKLENLML--DKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160
Query: 635 YVAP 638
Y+AP
Sbjct: 161 YLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 36/113 (31%), Positives = 56/113 (49%), Gaps = 9/113 (7%)
Query: 506 VQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF-LLYEYLGRGSLAIILSNDAAIDEFS 564
+QQ F E LT + VV + SF ++ ++ EY+ G A +L N A+
Sbjct: 45 IQQVFV-ERDILTFAENPFVVSMFC-SFETKRHLCMVMEYVEGGDCATLLKNIGALP--V 100
Query: 565 WTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
RM ++V L Y+H +Y IVHRD+ N+L+ ++DFG+SK
Sbjct: 101 DMARMYFAETVL-ALEYLH-NY--GIVHRDLKPDNLLITSMGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 11/102 (10%)
Query: 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKN 599
L+ +Y+ G L LS E + + L ++H I++RDI +N
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQI---YSGEIVLALEHLHK---LGIIYRDIKLEN 135
Query: 600 VLLGLDYDAHV--SDFGISK-FLKPDSSNWSEFVGTFGYVAP 638
+L LD + HV +DFG+SK F + + F GT Y+AP
Sbjct: 136 IL--LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 22/63 (34%), Positives = 36/63 (57%)
Query: 576 ANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGY 635
A +S + H + I++RD+ +NVLL D + +SD G++ LK S + GT G+
Sbjct: 104 AQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGF 163
Query: 636 VAP 638
+AP
Sbjct: 164 MAP 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 16/171 (9%)
Query: 473 IGTAGQASVYKAELPSWE-IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
+G A+V+K E +VA+K+ H + A E+ L L+H N+V +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLKHANIVTLHDI 71
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIK----SVANTLSYMHHDYF 587
R L++EYL L L N + + M+ +K + LSY H
Sbjct: 72 IHTERCLTLVFEYL-DSDLKQYLDNCGNL------MSMHNVKIFMFQLLRGLSYCHKR-- 122
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
I+HRD+ +N+L+ + ++DFG+++ + +S V T Y P
Sbjct: 123 -KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPP 172
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 23/59 (38%), Positives = 31/59 (52%), Gaps = 2/59 (3%)
Query: 582 MHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN--WSEFVGTFGYVAP 638
+HH + ++HRDI S N+LL + + DFG SK S+ F GT YVAP
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214
|
Length = 496 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 39/171 (22%), Positives = 76/171 (44%), Gaps = 16/171 (9%)
Query: 473 IGTAGQASVYKAELPSWE-IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
+G A+V+K E +VA+K+ H + A E+ L +L+H N+V +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLHDI 72
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIK----SVANTLSYMHHDYF 587
+ L++EYL + +D+ + M+ +K + L+Y H
Sbjct: 73 VHTDKSLTLVFEYLDK-------DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR-- 123
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
++HRD+ +N+L+ + ++DFG+++ + +S V T Y P
Sbjct: 124 -KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPP 173
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 35/142 (24%), Positives = 65/142 (45%), Gaps = 31/142 (21%)
Query: 507 QQAFSNEIKALTELRHRNVVKFYG-FSFH-------PRQSFLLYEYLG-RGSLAI--ILS 555
+ + E L + H ++++ G F+++ PR LY YL + ++AI IL+
Sbjct: 127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILA 186
Query: 556 NDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615
+ +SV + Y+H + I+HRDI ++N+ + D + DFG
Sbjct: 187 ---------------IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGA 228
Query: 616 SKFLKPDSSNWSEFVGTFGYVA 637
+ F P N +++ G G +A
Sbjct: 229 ACF--PVDINANKYYGWAGTIA 248
|
Length = 391 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 10/169 (5%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
+G+ SV A + + VAVKK P ++ + E++ L ++H NV+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 532 SFHPRQSFLLYE--YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP 589
F P S + YL + L+N + S +I + L Y+H
Sbjct: 83 -FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS---AG 138
Query: 590 IVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
I+HRD+ NV + D + + DFG+++ + + +V T Y AP
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTG---YVATRWYRAP 184
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 32/127 (25%), Positives = 52/127 (40%), Gaps = 26/127 (20%)
Query: 524 NVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMN------------V 571
+VKFYG F ++ E + D ++D+F V +
Sbjct: 64 YIVKFYGALFREGDCWICMELM-----------DISLDKFYKYVYEVLKSVIPEEILGKI 112
Query: 572 IKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVG 631
+ L+Y+ + I+HRD+ N+LL + + + DFGIS L DS + G
Sbjct: 113 AVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAKTRDAG 169
Query: 632 TFGYVAP 638
Y+AP
Sbjct: 170 CRPYMAP 176
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 25/116 (21%), Positives = 55/116 (47%), Gaps = 7/116 (6%)
Query: 502 PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAID 561
PD+ + F E + L + H N+V+ G + +++ E + G L +
Sbjct: 34 PDL--KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRL 91
Query: 562 EFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
+ ++M +++ A + Y+ + +HRD++++N L+ +SDFG+S+
Sbjct: 92 KVKELIQM--VENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 42/171 (24%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNV----VK 527
+G SVYK P+ +A+K+ + + ++ N+I ++ H+ V V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIR-----LELDESKFNQIIMELDILHKAVSPYIVD 63
Query: 528 FYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF 587
FYG F ++ EY+ GSL + + A + V + +V L ++ ++
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH- 122
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
I+HRD+ NVL+ + + DFG+S L + + +G Y+AP
Sbjct: 123 -NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--IGCQSYMAP 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 45/177 (25%), Positives = 75/177 (42%), Gaps = 30/177 (16%)
Query: 474 GTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSF 533
G+ G+A + + S + A+K+ P V+ + E L +++H N+V F
Sbjct: 11 GSFGRALLVQHVN-SDQKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPNIVAF----- 63
Query: 534 HPRQSF-------LLYEYLGRGSL--AIILSNDAAIDE---FSWTVRMNVIKSVANTLSY 581
++SF ++ EY G L I L E W V+M +
Sbjct: 64 --KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL---------G 112
Query: 582 MHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+ H + ++HRDI SKN+ L + + DFG ++ L + +VGT YV P
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPP 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 37/130 (28%), Positives = 59/130 (45%), Gaps = 12/130 (9%)
Query: 512 NEIKALTELRHRNVVKF-YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMN 570
E L E+ H +VK Y F + +L+ ++L G L LS + E +
Sbjct: 47 MERDILAEVNHPFIVKLHYAFQ-TEGKLYLILDFLRGGDLFTRLSKEVMFTE------ED 99
Query: 571 VIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSNWSE 628
V +A + H + I++RD+ +N+L LD + H+ +DFG+SK
Sbjct: 100 VKFYLAELALALDHLHSLGIIYRDLKPENIL--LDEEGHIKLTDFGLSKESIDHEKKAYS 157
Query: 629 FVGTFGYVAP 638
F GT Y+AP
Sbjct: 158 FCGTVEYMAP 167
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 25/114 (21%), Positives = 51/114 (44%), Gaps = 6/114 (5%)
Query: 510 FSNEIKALTELRHRNVVKFYGFSFH--PRQSF----LLYEYLGRGSLAIILSNDAAIDEF 563
F +E + E H NV++ G + + ++ ++ G L L D
Sbjct: 47 FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP 106
Query: 564 SWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
+ ++K + + S M + +HRD++++N +L + + V+DFG+SK
Sbjct: 107 QYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 0.004
Identities = 42/184 (22%), Positives = 66/184 (35%), Gaps = 69/184 (37%)
Query: 490 EIVAVKKFHSPHPDMVVQQAFSN---------EIKALTELRHRNVVKFYGFSFHPRQSFL 540
VA+KK + F + EIK L LRH N++
Sbjct: 26 RKVAIKK---------ISNVFDDLIDAKRILREIKLLRHLRHENIIGL------------ 64
Query: 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRM----------NVIKSVANTLSYMHHDYF--- 587
L I+ ++F+ V + VIKS L+ H YF
Sbjct: 65 ---------LDILRPPS--PEDFN-DVYIVTELMETDLHKVIKS-PQPLTDDHIQYFLYQ 111
Query: 588 ----------PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS---NWSEFVGTFG 634
++HRD+ N+L+ + D + DFG+++ + PD +E+V T
Sbjct: 112 ILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 635 YVAP 638
Y AP
Sbjct: 172 YRAP 175
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 32/134 (23%), Positives = 59/134 (44%), Gaps = 6/134 (4%)
Query: 492 VAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550
VAVK P ++A +E+K ++ L H N+V G ++ EY G L
Sbjct: 68 VAVKML-KPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 551 AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV 610
L + ++ VA ++++ +HRD++++NVLL +
Sbjct: 127 LNFLRRKRESFLTLEDL-LSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKI 182
Query: 611 SDFGISKFLKPDSS 624
DFG+++ + DS+
Sbjct: 183 CDFGLARDIMNDSN 196
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 48/181 (26%), Positives = 71/181 (39%), Gaps = 42/181 (23%)
Query: 480 SVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEI---KALTELR-------HRNVVKFY 529
S AE E VA+KK + FS +I +AL EL+ H+N+ Y
Sbjct: 18 SARNAETSEEETVAIKK---------ITNVFSKKILAKRALRELKLLRHFRGHKNITCLY 68
Query: 530 GFS---FHPRQSFLLYEYLGRGSL-AIILS----NDAAIDEFSWTVRMNVIKSVANTLSY 581
LYE L L II S DA F I + L Y
Sbjct: 69 DMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSF--------IYQILCGLKY 120
Query: 582 MHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD----SSNWSEFVGTFGYVA 637
+H ++HRD+ N+L+ D + + DFG+++ + + +E+V T Y A
Sbjct: 121 IHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 638 P 638
P
Sbjct: 178 P 178
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 34/106 (32%), Positives = 48/106 (45%), Gaps = 13/106 (12%)
Query: 525 VVKFYGFSFHPRQS-FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH 583
VV Y +SF Q +L+ E+L G L +L D FS V + + +H
Sbjct: 63 VVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVH 118
Query: 584 HDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISK-FLKPDSSNW 626
F +HRDI N+L +D H+ SDFG+S F K S +
Sbjct: 119 KLGF---IHRDIKPDNIL--IDRGGHIKLSDFGLSTGFHKQHDSAY 159
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 639 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.98 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.98 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.97 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.97 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.97 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.97 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.96 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.96 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.96 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.95 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.95 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.95 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.95 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.95 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.95 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.95 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.95 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.95 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.95 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.94 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.94 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.94 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.94 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.94 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.94 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.94 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.94 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.94 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.94 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.94 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.94 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.94 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.94 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.94 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.94 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.94 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.94 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.94 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.94 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.94 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.94 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.94 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.94 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.94 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.93 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.93 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.93 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.93 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.93 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.93 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.93 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.93 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.93 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.93 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.93 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.93 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.93 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.93 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.93 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.93 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.93 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.93 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.93 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.93 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.93 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.93 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.93 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.93 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.93 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.93 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.93 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.92 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.92 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.92 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.92 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.92 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.92 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.92 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.92 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.92 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.92 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.92 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.92 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.92 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.92 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.92 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.92 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.92 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.92 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.92 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.92 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.92 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.92 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.92 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.92 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.92 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.91 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.91 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.91 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.91 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.91 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.91 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.91 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.91 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.91 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.91 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.91 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.91 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.91 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.91 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.91 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.91 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.91 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.91 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.91 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.91 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.91 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.91 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.91 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.91 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.91 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.91 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.91 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.91 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.91 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.91 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.91 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.91 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.91 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.91 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.91 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.91 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.91 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.91 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.91 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.91 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.91 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.91 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.9 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.9 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.9 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.9 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.9 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.9 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.9 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.9 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.9 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.9 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.9 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.9 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.9 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.9 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.9 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.9 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.9 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.9 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.9 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.9 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.9 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.9 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.9 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.9 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.9 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.9 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.9 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.9 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.9 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.9 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.89 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.89 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.89 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.89 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.89 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.89 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.89 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.89 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.89 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.89 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.89 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.89 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.89 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.89 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.89 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.89 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.89 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.89 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.89 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.89 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.89 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.89 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.89 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.88 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.88 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.88 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.88 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.88 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.88 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.88 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.88 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.88 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.88 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.88 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.88 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.88 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.88 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.88 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.88 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.87 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.87 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.87 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.87 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.87 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.87 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.86 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.85 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.85 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.85 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.85 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.83 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.83 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.83 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.82 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.82 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.82 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.81 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.81 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.81 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.81 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.8 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.74 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.72 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.71 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.69 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.69 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.68 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.68 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.68 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.55 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.51 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.46 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.4 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.36 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.28 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.24 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.17 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.09 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.08 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.07 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.04 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.97 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.92 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.88 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.87 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.87 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.86 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.76 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.75 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.7 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.7 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.68 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.67 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.66 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.64 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.57 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.54 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.51 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.47 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.42 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.41 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.33 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.25 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.23 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.23 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.18 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.15 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.13 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.06 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.06 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.0 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-74 Score=679.05 Aligned_cols=601 Identities=31% Similarity=0.473 Sum_probs=444.1
Q ss_pred eeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEee
Q 046265 6 FFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVL 85 (639)
Q Consensus 6 ~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 85 (639)
..+..+++++|.+.+.+|..++++++|++|+|++|.+.+.+|..++++++|++|+|++|.+++.+|..++++++|++|+|
T Consensus 140 ~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 219 (968)
T PLN00113 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYL 219 (968)
T ss_pred CCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEEC
Confidence 34566778888887778888888888888888888877777877888888888888888877777777777778888888
Q ss_pred ecccCccccCccccCCCCCC---------cccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCC
Q 046265 86 YCNGLSGWLPSSFGNLNNLA---------IGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLF 156 (639)
Q Consensus 86 ~~N~l~~~~p~~~~~l~~L~---------~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 156 (639)
++|++++.+|..++++++|+ .+.+|..+.++++| ++|++++|++++.+|..+.++++|++|+|++|.+.
T Consensus 220 ~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L--~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~ 297 (968)
T PLN00113 220 GYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNL--QYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS 297 (968)
T ss_pred cCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCC--CEEECcCCeeeccCchhHhhccCcCEEECcCCeec
Confidence 77777777777777777775 23456666666665 56666666666666666666666666666666666
Q ss_pred CCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCc----cccccccccCCcEEEcCCcccCCCCC----
Q 046265 157 GSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSL----VSAEIGNLLQLIELEIDNKQLFGQIP---- 228 (639)
Q Consensus 157 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~----~~~~~~~l~~L~~L~l~~n~l~~~~p---- 228 (639)
+.+|..+..+++|+.|++++|.+.+.+|..+..+++|+.|+++.+. +|..++.+.+|+.|++++|++.+.+|
T Consensus 298 ~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~ 377 (968)
T PLN00113 298 GEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC 377 (968)
T ss_pred cCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHh
Confidence 6666666666666666666666666666666666666666665432 23344455555555555555554444
Q ss_pred --------------------ccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccc-------------cc
Q 046265 229 --------------------KSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG-------------SL 275 (639)
Q Consensus 229 --------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-------------~l 275 (639)
.++..+++|+.|++++|.+++..|..|..++.|+.|++++|.+.+ .+
T Consensus 378 ~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 457 (968)
T PLN00113 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQML 457 (968)
T ss_pred CcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEE
Confidence 444555555555555555555555555555666666666665543 14
Q ss_pred cCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCC
Q 046265 276 NFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNN 355 (639)
Q Consensus 276 ~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~ 355 (639)
++++|++.+.+|..+ ..++|+.|++++|++.+.+|..+..+++|+.|++++|++.+.+|..++.+++|+.|+|++ |
T Consensus 458 ~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~---N 533 (968)
T PLN00113 458 SLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSH---N 533 (968)
T ss_pred ECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCC---C
Confidence 566666666666544 346788888888888888888888999999999999999999999999999999999998 4
Q ss_pred cccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeeeeeecCCCcccccccccccC
Q 046265 356 EFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRNSTGIHYNLVDALQG 435 (639)
Q Consensus 356 ~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~g~~p~~~~~~~~~~~~~~~ 435 (639)
.+.+.+|..+..+++|+.|++++|.+.+.+ | ..+..++.|+.+|+++|+++|.+|...++..+...++.+
T Consensus 534 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p---------~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~ 603 (968)
T PLN00113 534 QLSGQIPASFSEMPVLSQLDLSQNQLSGEI-P---------KNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAG 603 (968)
T ss_pred cccccCChhHhCcccCCEEECCCCcccccC-C---------hhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcC
Confidence 567778999999999999999999998877 5 678889999999999999999999888777777778889
Q ss_pred CCCCCCCcce--------------e-e---------------------eeec-----------cccc----------hHH
Q 046265 436 NKGLCGDVKL--------------F-S---------------------ILTF-----------EGKI----------LYE 458 (639)
Q Consensus 436 ~~~l~g~~~~--------------~-~---------------------~~~~-----------~~~~----------~~~ 458 (639)
++.+||.... + . +... .+.. ...
T Consensus 604 n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (968)
T PLN00113 604 NIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSI 683 (968)
T ss_pred CccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhh
Confidence 9888864200 0 0 0000 0000 001
Q ss_pred HHHHHhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc
Q 046265 459 EVIRATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 459 ~~~~~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 537 (639)
........|+..++||+|+||.||+|.. .++..||||++..... ...+|++.+++++|||||+++++|.+++.
T Consensus 684 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 684 TINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 1122234577788999999999999965 6789999999874321 11356889999999999999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.|+||||+++|+|.++++ .++|..+.+++.|+++|++|+|+.+.++|+|||+||+||+++.++.+++. ||.+.
T Consensus 758 ~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred CEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 999999999999999995 37899999999999999999998777799999999999999999888876 66654
Q ss_pred cCCCCCCCcceeeeeceeeCCC
Q 046265 618 FLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~~~~~~gt~~Y~APE 639 (639)
..... ....||++|||||
T Consensus 831 ~~~~~----~~~~~t~~y~aPE 848 (968)
T PLN00113 831 LLCTD----TKCFISSAYVAPE 848 (968)
T ss_pred ccccC----CCccccccccCcc
Confidence 43211 2236899999999
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=436.81 Aligned_cols=399 Identities=37% Similarity=0.514 Sum_probs=323.9
Q ss_pred eeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEee
Q 046265 6 FFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVL 85 (639)
Q Consensus 6 ~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 85 (639)
..+..+++++|++.+.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+++.+|..++++++|++|+|
T Consensus 118 ~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 195 (968)
T PLN00113 118 SSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTL 195 (968)
T ss_pred CCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeec
Confidence 4677889999999999986 56899999999999999999999999999999999999999999999999999999999
Q ss_pred ecccCccccCccccCCCCCC---------cccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCC
Q 046265 86 YCNGLSGWLPSSFGNLNNLA---------IGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLF 156 (639)
Q Consensus 86 ~~N~l~~~~p~~~~~l~~L~---------~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 156 (639)
++|++++.+|..++++++|+ .+.+|..+.++++| ++|++++|++++.+|..++++++|++|+|++|++.
T Consensus 196 ~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L--~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 273 (968)
T PLN00113 196 ASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSL--NHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLS 273 (968)
T ss_pred cCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCC--CEEECcCceeccccChhHhCCCCCCEEECcCCeee
Confidence 99999999999999999887 24678888999988 79999999999999999999999999999999999
Q ss_pred CCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCc----cccccccccCCcEEEcCCcccCCCCCcccc
Q 046265 157 GSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSL----VSAEIGNLLQLIELEIDNKQLFGQIPKSLR 232 (639)
Q Consensus 157 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~----~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~ 232 (639)
+.+|..+..+++|+.|++++|.+.+.+|..+.++++|+.|+++.+. +|..+..+++|+.|++++|.+.+.+|..+.
T Consensus 274 ~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~ 353 (968)
T PLN00113 274 GPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLG 353 (968)
T ss_pred ccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHh
Confidence 9999999999999999999999999999999999999999998654 456788899999999999999999999999
Q ss_pred CCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccc-------------cccCcCCccccccCccccCCCCCCEE
Q 046265 233 NFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG-------------SLNFSMNNITRSIPPKIGKLYQLHKL 299 (639)
Q Consensus 233 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-------------~l~ls~n~~~~~~p~~~~~l~~L~~L 299 (639)
.+++|+.|++++|.+++..|..+..+++|+.|++++|.+.+ .+++++|++++.+|..+..++.|+.|
T Consensus 354 ~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 433 (968)
T PLN00113 354 KHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFL 433 (968)
T ss_pred CCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEE
Confidence 99999999999999998888888777778888888777654 24567777777777777777777777
Q ss_pred eccCCcccccCCccccCCCCCCeeeccCccCcccCC-----------------------cCccCCCCCCEEeCCCCCCCc
Q 046265 300 DFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLP-----------------------RVLGSISDLEYLDLSTNYNNE 356 (639)
Q Consensus 300 ~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-----------------------~~~~~l~~L~~L~Ls~N~~~~ 356 (639)
++++|.+.+.+|..+..+++|+.|++++|++.+.+| ..+..+++|+.|++++ |.
T Consensus 434 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~---N~ 510 (968)
T PLN00113 434 DISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSE---NK 510 (968)
T ss_pred ECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcC---Cc
Confidence 777777766666655555555555555555554444 4444444455555544 23
Q ss_pred ccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeeeeeecC
Q 046265 357 FRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRN 421 (639)
Q Consensus 357 ~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~g~~p~ 421 (639)
+.+.+|..+..+++|+.|++++|.+.+.. | ..+..++.|+.||+++|+++|.+|.
T Consensus 511 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p---------~~~~~l~~L~~L~Ls~N~l~~~~p~ 565 (968)
T PLN00113 511 LSGEIPDELSSCKKLVSLDLSHNQLSGQI-P---------ASFSEMPVLSQLDLSQNQLSGEIPK 565 (968)
T ss_pred ceeeCChHHcCccCCCEEECCCCcccccC-C---------hhHhCcccCCEEECCCCcccccCCh
Confidence 33444555555555555555555555444 3 4566677777777777777776664
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=333.87 Aligned_cols=184 Identities=38% Similarity=0.662 Sum_probs=163.8
Q ss_pred ccchHHHHHHHhccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEE
Q 046265 453 GKILYEEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFS 532 (639)
Q Consensus 453 ~~~~~~~~~~~~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~ 532 (639)
..++|+++..||++|...+.||+|+||.||+|.+++|+.||||++....... ..+|.+|+.++++++|||+|+++|||
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 3578999999999999999999999999999999999999999887644322 44599999999999999999999999
Q ss_pred EcCC-ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 046265 533 FHPR-QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVS 611 (639)
Q Consensus 533 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~ 611 (639)
.+.+ +.++|||||++|+|.++++..... .++|.+|++||.++|+||+|||+.+.|+||||||||+|||+|+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 499999999999999999876654 78999999999999999999999998999999999999999999999999
Q ss_pred cccccccCCCCCCCccee-eeeceeeCCC
Q 046265 612 DFGISKFLKPDSSNWSEF-VGTFGYVAPI 639 (639)
Q Consensus 612 DfGla~~~~~~~~~~~~~-~gt~~Y~APE 639 (639)
|||+|+..........+. .||.+|+|||
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PE 248 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPE 248 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChh
Confidence 999997765312222223 8999999998
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=302.08 Aligned_cols=169 Identities=27% Similarity=0.436 Sum_probs=150.8
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
..+|...+.||+|+||+||+|+++ ++..||||++.+.......++.+..|+.+++.++|||||+++++++.++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 456777788999999999999654 6789999999887656667788899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC------CceEEcccccc
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD------YDAHVSDFGIS 616 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~------~~~kl~DfGla 616 (639)
|||.||+|.++++.++. ++..++...+.|+|.|+++||.. +||||||||.|||++.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999998764 66689999999999999999999 99999999999999754 56899999999
Q ss_pred ccCCCCCCCcceeeeeceeeCCC
Q 046265 617 KFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+.+... ....+.||||.|||||
T Consensus 163 R~L~~~-~~a~tlcGSplYMAPE 184 (429)
T KOG0595|consen 163 RFLQPG-SMAETLCGSPLYMAPE 184 (429)
T ss_pred hhCCch-hHHHHhhCCccccCHH
Confidence 998743 3456789999999998
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=281.67 Aligned_cols=169 Identities=27% Similarity=0.395 Sum_probs=145.9
Q ss_pred hccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCCh-----hhHHHHHHHHHHHhccccCceeeeEEEEEcCCc
Q 046265 464 TNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDM-----VVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 537 (639)
.+.|...+.+|+|+||.|-+| +.++|+.||||.+++..... .......+|+++|++++|||||+++++|..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 355667789999999999999 67789999999998764222 122335799999999999999999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC---CceEEcccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD---YDAHVSDFG 614 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~---~~~kl~DfG 614 (639)
.|+|||||+||+|.+.+...+... ......++.|++.|+.|||.. ||+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~---ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLR---EDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccc---cchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999999998766533 366788999999999999999 99999999999999755 779999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+|+... ..+...+.||||.|.|||
T Consensus 325 lAK~~g-~~sfm~TlCGTpsYvAPE 348 (475)
T KOG0615|consen 325 LAKVSG-EGSFMKTLCGTPSYVAPE 348 (475)
T ss_pred hhhccc-cceehhhhcCCccccChh
Confidence 999875 456677899999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=279.18 Aligned_cols=170 Identities=24% Similarity=0.341 Sum_probs=151.3
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.++|+..++||+|+||+||.++. ++++.+|+|.++++.. .....+...+|..++.+++||.||+++-.|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 56788999999999999999954 5689999999987653 233456678899999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
+||+.||.|+.++++.+. +++..+.-++.+|+.||.|||.. +|||||+||+|||+|.+|+++++|||+++....
T Consensus 104 ld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999987664 55677888899999999999999 999999999999999999999999999997665
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
......++|||+.|||||
T Consensus 178 ~~~~t~tfcGT~eYmAPE 195 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPE 195 (357)
T ss_pred CCCccccccCCccccChH
Confidence 656667799999999998
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=298.86 Aligned_cols=339 Identities=23% Similarity=0.221 Sum_probs=203.8
Q ss_pred EEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccC
Q 046265 11 VVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGL 90 (639)
Q Consensus 11 ~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 90 (639)
+++++|.+..+-+..|.++++|+.+++.+|.++ .+|.......+|+.|+|.+|.|+..-..++.-++.|+.||||.|.|
T Consensus 83 LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~i 161 (873)
T KOG4194|consen 83 LDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLI 161 (873)
T ss_pred eeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchh
Confidence 455555555555555555555555555555554 4555444445555555555555544444555555555555555555
Q ss_pred ccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCccc
Q 046265 91 SGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLL 170 (639)
Q Consensus 91 ~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 170 (639)
+.+.-..|..- .+ +++|+|++|.|+..-...|.++.+|.+|.|+.|+++...+..|.+++.|+
T Consensus 162 s~i~~~sfp~~---------------~n--i~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~ 224 (873)
T KOG4194|consen 162 SEIPKPSFPAK---------------VN--IKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLE 224 (873)
T ss_pred hcccCCCCCCC---------------CC--ceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhh
Confidence 53333333221 12 35788888888766667777788888888888888765556777788888
Q ss_pred EEEcccCcCCccCCccCcCCCCCCeEEccCCccc----cccccccCCcEEEcCCcccCCCCCccccCCCCCceecccccc
Q 046265 171 SLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVS----AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNH 246 (639)
Q Consensus 171 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~----~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 246 (639)
.|+|..|+|.-.--..|.+|++|+.|.+..|.+. +.|..+.+++.|+++.|++...-..|+.++++|+.|+||.|.
T Consensus 225 ~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~Na 304 (873)
T KOG4194|consen 225 SLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNA 304 (873)
T ss_pred hhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhh
Confidence 8888888876444556777888888777766553 356677788888888888877767778888888888888888
Q ss_pred ccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeecc
Q 046265 247 LTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALN 326 (639)
Q Consensus 247 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~ 326 (639)
|..+-++.+...++|+.|+|++|+++ ..-+..|..+..|+.|+|++|.+...--..|..+++|+.|||+
T Consensus 305 I~rih~d~WsftqkL~~LdLs~N~i~-----------~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr 373 (873)
T KOG4194|consen 305 IQRIHIDSWSFTQKLKELDLSSNRIT-----------RLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR 373 (873)
T ss_pred hheeecchhhhcccceeEeccccccc-----------cCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence 88777777777788888887777664 2223334444444444444444443333444444444444444
Q ss_pred CccCcccCCc---CccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcC
Q 046265 327 GNKVYGSLPR---VLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFW 381 (639)
Q Consensus 327 ~N~l~~~~p~---~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~ 381 (639)
+|.+++.+.. .|..+++|+.|++.+|++..+.. ..|..+..|+.||+.+|.+
T Consensus 374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~k---rAfsgl~~LE~LdL~~Nai 428 (873)
T KOG4194|consen 374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPK---RAFSGLEALEHLDLGDNAI 428 (873)
T ss_pred CCeEEEEEecchhhhccchhhhheeecCceeeecch---hhhccCcccceecCCCCcc
Confidence 4444444432 23344444444444443333321 2344444444444444443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=297.47 Aligned_cols=352 Identities=23% Similarity=0.206 Sum_probs=298.2
Q ss_pred CCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCC
Q 046265 31 NLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMP 110 (639)
Q Consensus 31 ~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp 110 (639)
..+.||+++|+++.+.+..|.++++|+.++|..|.++ .+|.......+|+.|+|.+|.|+..-..++..+.
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~-------- 149 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALP-------- 149 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHh--------
Confidence 4667999999999888999999999999999999998 7997766777899999999999866666665554
Q ss_pred CCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCC
Q 046265 111 NSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNL 190 (639)
Q Consensus 111 ~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 190 (639)
.|+.||||.|.++...-..|..-.++++|+|++|+|+..--..|..+.+|..|.|+.|+++...+..|.+|
T Consensus 150 ---------alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L 220 (873)
T KOG4194|consen 150 ---------ALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRL 220 (873)
T ss_pred ---------hhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhc
Confidence 33689999999985555677777889999999999997777889999999999999999998888889999
Q ss_pred CCCCeEEccCCcccc----ccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEec
Q 046265 191 SNLEGLYLYSSLVSA----EIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDL 266 (639)
Q Consensus 191 ~~L~~L~l~~~~~~~----~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 266 (639)
++|+.|+|..|.+.. .|..+.+|+.|.+..|.+...-...|..+.+++.|+|+.|+++..-.+++.+++.|+.|+|
T Consensus 221 ~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~l 300 (873)
T KOG4194|consen 221 PKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDL 300 (873)
T ss_pred chhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhcc
Confidence 999999998776643 4788899999999999998777788899999999999999999888888888999999997
Q ss_pred cCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCE
Q 046265 267 SQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEY 346 (639)
Q Consensus 267 s~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 346 (639)
|+|.| ...-++.+.-..+|+.|||++|+|+...+.+|..|..|+.|+|++|++...-...|..+++|+.
T Consensus 301 S~NaI-----------~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~ 369 (873)
T KOG4194|consen 301 SYNAI-----------QRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHK 369 (873)
T ss_pred chhhh-----------heeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhh
Confidence 76665 4455667777889999999999999888999999999999999999998777778999999999
Q ss_pred EeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeeeeeecC
Q 046265 347 LDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRN 421 (639)
Q Consensus 347 L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~g~~p~ 421 (639)
|||++|.+.-....-...+..+++|+.|++.+|++.... . .+++.+..|+.||+.+|.+...-|.
T Consensus 370 LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~-k---------rAfsgl~~LE~LdL~~NaiaSIq~n 434 (873)
T KOG4194|consen 370 LDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIP-K---------RAFSGLEALEHLDLGDNAIASIQPN 434 (873)
T ss_pred hcCcCCeEEEEEecchhhhccchhhhheeecCceeeecc-h---------hhhccCcccceecCCCCcceeeccc
Confidence 999996543322223445778999999999999876532 2 6788999999999999998766553
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=276.10 Aligned_cols=163 Identities=29% Similarity=0.442 Sum_probs=144.5
Q ss_pred CcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC-ceeEEecccC
Q 046265 469 AKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR-QSFLLYEYLG 546 (639)
Q Consensus 469 ~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~~ 546 (639)
....||+|..|+||++.+ ++++.+|+|.+.. ..+...+++..+|++++++.+||+||++||.|..++ ++.++||||+
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 356899999999999965 4678999999953 345667788999999999999999999999999998 5999999999
Q ss_pred CCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCc
Q 046265 547 RGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW 626 (639)
Q Consensus 547 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 626 (639)
+|+|++++...+ .+++...-+++.+|++||.|||+.. +||||||||+|||++..|++||||||+++.+... ..
T Consensus 162 gGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a 234 (364)
T KOG0581|consen 162 GGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IA 234 (364)
T ss_pred CCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hc
Confidence 999999998654 4677889999999999999999742 8999999999999999999999999999988644 45
Q ss_pred ceeeeeceeeCCC
Q 046265 627 SEFVGTFGYVAPI 639 (639)
Q Consensus 627 ~~~~gt~~Y~APE 639 (639)
.+++||..|||||
T Consensus 235 ~tfvGT~~YMsPE 247 (364)
T KOG0581|consen 235 NTFVGTSAYMSPE 247 (364)
T ss_pred ccccccccccChh
Confidence 6789999999998
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=274.07 Aligned_cols=174 Identities=24% Similarity=0.353 Sum_probs=153.1
Q ss_pred ccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEE-EEEcCCc-eeEE
Q 046265 465 NNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG-FSFHPRQ-SFLL 541 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~-~~~~~~~-~~lv 541 (639)
.+|+..++||+|+||.|||+ .+.+|..||.|++.-...+...++++..|+.++++++|||||++++ -+.++.+ +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 34566789999999999999 6789999999999866667778899999999999999999999998 4445555 8999
Q ss_pred ecccCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 542 YEYLGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDYFPP--IVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
||||++|+|.+.++..+ ....++++.++++..|++.||.++|... ++ |+||||||.||.++..|.+|++|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999997533 2346888999999999999999999842 35 99999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeceeeCCC
Q 046265 619 LKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~~~~~~~gt~~Y~APE 639 (639)
+....+...+.+|||+||+||
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE 198 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPE 198 (375)
T ss_pred hcchhHHHHhhcCCCcccCHH
Confidence 987777778899999999998
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=286.86 Aligned_cols=166 Identities=30% Similarity=0.553 Sum_probs=146.1
Q ss_pred cceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC-ceeEEecccCCC
Q 046265 470 KYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR-QSFLLYEYLGRG 548 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~~~g 548 (639)
.+.+|+|+||+||+|.+++...||||++.....+....+.|.+|+.++++++|||||+++|+|.++. ...+|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 4569999999999999987666999999876544444779999999999999999999999999987 799999999999
Q ss_pred ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCC-eEeecCCCCCeeeCCCC-ceEEccccccccCCCCCCCc
Q 046265 549 SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP-IVHRDISSKNVLLGLDY-DAHVSDFGISKFLKPDSSNW 626 (639)
Q Consensus 549 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-iiHrdlk~~Nill~~~~-~~kl~DfGla~~~~~~~~~~ 626 (639)
+|.++++.. ....++|..+++++.+||+||.|||.+ + ||||||||+|||++.++ ++||+|||+++.........
T Consensus 126 sL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~ 201 (362)
T KOG0192|consen 126 SLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSM 201 (362)
T ss_pred cHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccccccc
Confidence 999999874 234689999999999999999999998 6 99999999999999997 99999999998765432333
Q ss_pred ceeeeeceeeCCC
Q 046265 627 SEFVGTFGYVAPI 639 (639)
Q Consensus 627 ~~~~gt~~Y~APE 639 (639)
+...||+.|||||
T Consensus 202 ~~~~GT~~wMAPE 214 (362)
T KOG0192|consen 202 TSVAGTYRWMAPE 214 (362)
T ss_pred cCCCCCccccChh
Confidence 4478999999998
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=285.53 Aligned_cols=169 Identities=27% Similarity=0.431 Sum_probs=154.9
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCC-CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
..|...++||+|||+.+|+++. .+|+.||+|.+.+.. .....++...+||++.+.++|||||+++++|++.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999965 889999999998754 23445678899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
|+|+.|+|..+++.++ .+++..+..+.+||+.|+.|||+. +|||||||..|++++++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999998554 467799999999999999999999 9999999999999999999999999999999877
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
..+..+.||||-|+|||
T Consensus 172 ~Erk~TlCGTPNYIAPE 188 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPE 188 (592)
T ss_pred ccccceecCCCcccChh
Confidence 77778899999999998
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=264.78 Aligned_cols=168 Identities=24% Similarity=0.392 Sum_probs=150.5
Q ss_pred cCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
.|+....+|+|+||+||+|+.+ +|+.||||++.....+....+-.++||+.+++++|||+|.++++|......++|+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4555678999999999999665 689999999998777777777789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
|+..-|.++-+...+ ++......++.|+++|+.|+|.+ +||||||||+|||+...+.+|+||||+|+.+.....
T Consensus 83 ~dhTvL~eLe~~p~G---~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 83 CDHTVLHELERYPNG---VPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred cchHHHHHHHhccCC---CCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 998877776554433 56688899999999999999999 899999999999999999999999999999987777
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
.++.++.|.+|+|||
T Consensus 157 ~YTDYVATRWYRaPE 171 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPE 171 (396)
T ss_pred hhhhhhhhhhccChh
Confidence 788899999999998
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=274.88 Aligned_cols=170 Identities=28% Similarity=0.436 Sum_probs=147.4
Q ss_pred hccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--CceeE
Q 046265 464 TNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQSFL 540 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l 540 (639)
.+.|+..+.||+|.||.||+| +..+|+.||+|+++....+........+||.+|+++.|||||++.+...+. +.+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 344555678999999999999 678899999999997665555666678999999999999999999998876 68999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
|+|||++ ||.-++...+- .++..++..+++|++.||+|+|.. +|+|||||.+|||||.+|.+||+|||+|+.+.
T Consensus 196 VFeYMdh-DL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999976 77777765432 477799999999999999999999 99999999999999999999999999999886
Q ss_pred CCCC-CcceeeeeceeeCCC
Q 046265 621 PDSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~-~~~~~~gt~~Y~APE 639 (639)
.... ..+..+.|.+|+|||
T Consensus 270 ~~~~~~~T~rVvTLWYRpPE 289 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPE 289 (560)
T ss_pred CCCCcccccceEEeeccChH
Confidence 6543 366788999999998
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-36 Score=290.44 Aligned_cols=248 Identities=31% Similarity=0.452 Sum_probs=192.1
Q ss_pred EEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccC
Q 046265 11 VVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGL 90 (639)
Q Consensus 11 ~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 90 (639)
+++++|.+. .+-+.+.++..+++|++++|+++ ..|++++.+..++.|+.++|+++ .+|++++++.+|+.|+.+.|.+
T Consensus 50 lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~ 126 (565)
T KOG0472|consen 50 LILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNEL 126 (565)
T ss_pred hhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccccce
Confidence 346666665 34446677778888888888887 67778888888888888888887 7888888888888888888887
Q ss_pred ccccCccccCCCCCC--------cccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCcc
Q 046265 91 SGWLPSSFGNLNNLA--------IGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPI 162 (639)
Q Consensus 91 ~~~~p~~~~~l~~L~--------~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 162 (639)
. .+|++++.+..|. +.++|..+.++.++ ..|++.+|++.. .|+..-++++|+.||...|-+. ++|+.
T Consensus 127 ~-el~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l--~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~L~-tlP~~ 201 (565)
T KOG0472|consen 127 K-ELPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKL--SKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNLLE-TLPPE 201 (565)
T ss_pred e-ecCchHHHHhhhhhhhccccccccCchHHHHHHHH--HHhhccccchhh-CCHHHHHHHHHHhcccchhhhh-cCChh
Confidence 7 5666666655443 55677777777666 578888888884 4444445888999998888775 78888
Q ss_pred ccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCc---cccccc-cccCCcEEEcCCcccCCCCCccccCCCCCc
Q 046265 163 LGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSL---VSAEIG-NLLQLIELEIDNKQLFGQIPKSLRNFTSLN 238 (639)
Q Consensus 163 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~---~~~~~~-~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 238 (639)
++.+.+|..|++..|.+. .+| .|.+++.|+.++++.|. +|.+.+ .+.++..||+.+|++ ..+|+.++-+.+|+
T Consensus 202 lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNkl-ke~Pde~clLrsL~ 278 (565)
T KOG0472|consen 202 LGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKL-KEVPDEICLLRSLE 278 (565)
T ss_pred hcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeecccccc-ccCchHHHHhhhhh
Confidence 999999999999999887 566 78888888888888765 355655 788899999999998 46788888899999
Q ss_pred eeccccccccCcchhhhhcCCCccEEeccCCcc
Q 046265 239 IVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNF 271 (639)
Q Consensus 239 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 271 (639)
+||+++|.+++. |..++++ .|+.|-+.+|.+
T Consensus 279 rLDlSNN~is~L-p~sLgnl-hL~~L~leGNPl 309 (565)
T KOG0472|consen 279 RLDLSNNDISSL-PYSLGNL-HLKFLALEGNPL 309 (565)
T ss_pred hhcccCCccccC-Ccccccc-eeeehhhcCCch
Confidence 999999999974 4467787 888888888876
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-34 Score=293.75 Aligned_cols=348 Identities=29% Similarity=0.389 Sum_probs=295.5
Q ss_pred eeeeEEEEeCCCccc-ccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEE
Q 046265 5 AFFFFQVVHESNTLF-AIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQL 83 (639)
Q Consensus 5 ~~~~~~~~~~~n~~~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 83 (639)
.-+...||++.|.++ +..|.+...++++++|.|...++. .+|++++.|.+|++|.+++|++. .+-.++..|+.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 346789999999999 679999999999999999999997 89999999999999999999998 677889999999999
Q ss_pred eeecccCcc-ccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCcc
Q 046265 84 VLYCNGLSG-WLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPI 162 (639)
Q Consensus 84 ~L~~N~l~~-~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 162 (639)
++..|++.. -+|..+..|. .| ..||||+|++. ..|..+..-.++-+|+||+|+|..+..+-
T Consensus 84 ~~R~N~LKnsGiP~diF~l~---------------dL--t~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~l 145 (1255)
T KOG0444|consen 84 IVRDNNLKNSGIPTDIFRLK---------------DL--TILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSL 145 (1255)
T ss_pred hhhccccccCCCCchhcccc---------------cc--eeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchH
Confidence 999998863 3555555555 33 58999999998 88999988899999999999998543356
Q ss_pred ccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCcccc----ccccccCCcEEEcCCccc-CCCCCccccCCCCC
Q 046265 163 LGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSA----EIGNLLQLIELEIDNKQL-FGQIPKSLRNFTSL 237 (639)
Q Consensus 163 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~----~~~~l~~L~~L~l~~n~l-~~~~p~~~~~l~~L 237 (639)
|-+++.|-.||||+|.+. .+|+.+..+.+|++|.+++|.+.- .+..+++|+.|.+++.+- ...+|.++.++.+|
T Consensus 146 finLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL 224 (1255)
T KOG0444|consen 146 FINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNL 224 (1255)
T ss_pred HHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhh
Confidence 788999999999999997 677788999999999999876532 345667788888887543 34588899999999
Q ss_pred ceeccccccccCcchhhhhcCCCccEEeccCCcccc------------cccCcCCccccccCccccCCCCCCEEeccCCc
Q 046265 238 NIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG------------SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNH 305 (639)
Q Consensus 238 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~------------~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~ 305 (639)
..+|+|.|.+. ..|+.+-.+++|+.|+||+|.++. ++++|.|+++ .+|..++++++|+.|++.+|+
T Consensus 225 ~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~Nk 302 (1255)
T KOG0444|consen 225 RDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNK 302 (1255)
T ss_pred hhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCc
Confidence 99999999998 578888889999999999999863 4788899887 689999999999999999998
Q ss_pred cc-ccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCc
Q 046265 306 IV-GELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITF 380 (639)
Q Consensus 306 ~~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~ 380 (639)
++ ..+|+.++.|.+|+.+..++|++. ..|..++.|..|+.|.|++|+ + .++|..+.-++.|..||+..|.
T Consensus 303 L~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~Nr---L-iTLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 303 LTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNR---L-ITLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred ccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccc---e-eechhhhhhcCCcceeeccCCc
Confidence 76 457889999999999999988886 788889999999999999864 2 4578888889999999998884
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=252.70 Aligned_cols=167 Identities=24% Similarity=0.318 Sum_probs=147.0
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.++|+....+|.|+||.|..++.+ +|..+|+|.+.+... +....+...+|..+++.+.||.++++++.|.+.+.+|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 456778889999999999999654 578899999987542 233345567899999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||++||.++.+++..+. ++...+.-+|.+|+.|++|||+. +|++||+||+|||+|.+|.+||+|||+|+.+..
T Consensus 123 meyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999987654 55688889999999999999999 999999999999999999999999999998753
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
...+.||||.|+|||
T Consensus 197 ---rT~TlCGTPeYLAPE 211 (355)
T KOG0616|consen 197 ---RTWTLCGTPEYLAPE 211 (355)
T ss_pred ---cEEEecCCccccChH
Confidence 245799999999998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=246.81 Aligned_cols=169 Identities=24% Similarity=0.361 Sum_probs=147.8
Q ss_pred ccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.+|...+.+|+|.||.||+| +.++|+.||||+++.............+||..++.++|||||+++++|-..+..-+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 35666789999999999999 56789999999999876554445566899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
||+ .+|...++.... .+.-.....++.++++|++|+|.. .|+|||+||.|+|++.+|.+||+|||+|+.+.+..
T Consensus 82 fm~-tdLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 996 589999876543 466678889999999999999999 89999999999999999999999999999987665
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
......+.|.+|+|||
T Consensus 156 ~~~~~~V~TRWYRAPE 171 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPE 171 (318)
T ss_pred cccccceeeeeccChH
Confidence 5544458899999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=270.28 Aligned_cols=168 Identities=23% Similarity=0.370 Sum_probs=151.8
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|...+.||+|+||.||||+.+ +.+.||+|.+.+..........+.+|++++++++|||||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777889999999999999654 67889999998766555556678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+.| +|+.++...+. +++..+.+++.++..||.|||.. +|+|||+||.|||++..+.+|+||||+|+.+....
T Consensus 82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9976 99999988765 66699999999999999999999 99999999999999999999999999999998766
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
...+.+.|||.|||||
T Consensus 155 ~vltsikGtPlYmAPE 170 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPE 170 (808)
T ss_pred eeeeeccCcccccCHH
Confidence 6677789999999998
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=250.65 Aligned_cols=170 Identities=22% Similarity=0.312 Sum_probs=146.4
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--CceeE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQSFL 540 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l 540 (639)
.+.|+..+.|++|+||.||||+ .++.+.||+|+++.........-.-.+||.++.+++|||||.+..+.... +.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 3456667899999999999995 55779999999987654433344457999999999999999999888754 57999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
|||||+. +|..+++.-. ..+...++..++.|+++|++|||+. -|+|||+|++|+|+.+.|.+||+|||+|+.+.
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999975 8999988654 3566788899999999999999999 89999999999999999999999999999998
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
......+..+.|.+|+|||
T Consensus 229 sp~k~~T~lVVTLWYRaPE 247 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPE 247 (419)
T ss_pred CCcccCcceEEEeeecCHH
Confidence 7777777889999999998
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=257.77 Aligned_cols=169 Identities=22% Similarity=0.365 Sum_probs=150.6
Q ss_pred hccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
..+|+..+.+|+|.||+|-+| ++..|+.||||.+++... +........+||++|+.++|||||++|++|+..+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 456777789999999999999 557899999999987543 233345578999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||..+|.|++++.+.+. ++.+.+..+++||..|+.|+|.+ +++|||+|.+|||+|.++++||+|||++-.+..
T Consensus 132 MEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999988764 67799999999999999999998 999999999999999999999999999988763
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
....+++||+|-|.+||
T Consensus 206 -~kfLqTFCGSPLYASPE 222 (668)
T KOG0611|consen 206 -KKFLQTFCGSPLYASPE 222 (668)
T ss_pred -ccHHHHhcCCcccCCcc
Confidence 45577899999999998
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-33 Score=274.11 Aligned_cols=380 Identities=30% Similarity=0.409 Sum_probs=243.4
Q ss_pred EEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecc
Q 046265 9 FQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCN 88 (639)
Q Consensus 9 ~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 88 (639)
..+++..|++. .+|++++.+..++.|+.++|+++ .+|++++++.+|+.|+.++|.+. .+|+.++.+..|..|+..+|
T Consensus 71 ~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N 147 (565)
T KOG0472|consen 71 TVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNN 147 (565)
T ss_pred eEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcccc
Confidence 34556666665 56777777788888888888877 67777788888888888777776 67777777777777777777
Q ss_pred cCccccCccccCCCCCC--------cccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCC
Q 046265 89 GLSGWLPSSFGNLNNLA--------IGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIP 160 (639)
Q Consensus 89 ~l~~~~p~~~~~l~~L~--------~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 160 (639)
+++ ..|++++++.+|. +..+|...-+++.| ++||...|-++ .+|+.++.+.+|..|+|..|++. .+|
T Consensus 148 ~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L--~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP 222 (565)
T KOG0472|consen 148 QIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRL--KHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP 222 (565)
T ss_pred ccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHH--Hhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC
Confidence 777 5566655554442 22333333334433 45555555443 44555555555555555555554 233
Q ss_pred ccccCCCcccEEEcccCcCCccCCccC-cCCCCCCeEEccCCc---cccccccccCCcEEEcCCcccCCCCCccccCC--
Q 046265 161 PILGKVQSLLSLGFDLNLLNGVLPPSI-SNLSNLEGLYLYSSL---VSAEIGNLLQLIELEIDNKQLFGQIPKSLRNF-- 234 (639)
Q Consensus 161 ~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~l~~~~---~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l-- 234 (639)
+|.++..|.+|+++.|++. .+|... .+++++..||+..|. .|.++.-+.+|..||+++|.+++ .|..++++
T Consensus 223 -ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnlhL 299 (565)
T KOG0472|consen 223 -EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDISS-LPYSLGNLHL 299 (565)
T ss_pred -CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCcccc-CCccccccee
Confidence 3444444444444444444 222222 244444444444332 23344444444444444444432 33334444
Q ss_pred --------------------------------------------------------------CCCceeccccccccCcch
Q 046265 235 --------------------------------------------------------------TSLNIVHLEQNHLTGNIY 252 (639)
Q Consensus 235 --------------------------------------------------------------~~L~~L~L~~N~l~~~~~ 252 (639)
.+.+.|+++.-+++..+.
T Consensus 300 ~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPd 379 (565)
T KOG0472|consen 300 KFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPD 379 (565)
T ss_pred eehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCH
Confidence 334444455445544444
Q ss_pred hhhhcCC--CccEEeccCCcccc-------------cccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCC
Q 046265 253 EVFGIYP--NLTFLDLSQNNFYG-------------SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNL 317 (639)
Q Consensus 253 ~~~~~l~--~L~~L~Ls~N~l~~-------------~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l 317 (639)
++|..-. -....+++.|++.. .+.+++|.++ .+|..++.+++|..|+|++|-+. .+|.+++.+
T Consensus 380 EVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~l 457 (565)
T KOG0472|consen 380 EVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSL 457 (565)
T ss_pred HHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhh
Confidence 4443322 14556667776653 1456666664 68888999999999999999886 789999999
Q ss_pred CCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhh
Q 046265 318 KSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRS 397 (639)
Q Consensus 318 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~ 397 (639)
-.|+.++++.|++. .+|..+..+..++.+-.++|+ +...-|..+..+.+|..||+.+|-+.. + | +
T Consensus 458 v~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nq---i~~vd~~~l~nm~nL~tLDL~nNdlq~-I-P---------p 522 (565)
T KOG0472|consen 458 VRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQ---IGSVDPSGLKNMRNLTTLDLQNNDLQQ-I-P---------P 522 (565)
T ss_pred hhhheecccccccc-cchHHHhhHHHHHHHHhcccc---ccccChHHhhhhhhcceeccCCCchhh-C-C---------h
Confidence 99999999999987 789888888888887777754 443345569999999999999997764 3 3 7
Q ss_pred hhhhcccCcEEccCCCeee
Q 046265 398 LISRMHGLSCIDISYNELR 416 (639)
Q Consensus 398 ~~~~l~~L~~ldls~N~l~ 416 (639)
.+++|++|+.|++++|.++
T Consensus 523 ~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 523 ILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhccccceeEEEecCCccC
Confidence 8999999999999999998
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=265.38 Aligned_cols=171 Identities=23% Similarity=0.380 Sum_probs=147.6
Q ss_pred HhccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCC---hhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCc
Q 046265 463 ATNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPD---MVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~ 537 (639)
....|...+.||+|+||+||.| ...+++.||||.+...... ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3567888899999999999999 5567899999966653211 123455678999999999 9999999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEcccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD-YDAHVSDFGIS 616 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~-~~~kl~DfGla 616 (639)
.|+||||+.+|+|.+++...+. +.+..+.++++|++.|++|+|.. +|+||||||+|||+|.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~---l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGR---LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999988544 45588899999999999999999 99999999999999999 99999999999
Q ss_pred ccCCCCCCCcceeeeeceeeCCC
Q 046265 617 KFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
...........+.|||+.|+|||
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPE 191 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPE 191 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHH
Confidence 98743345567789999999998
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=262.75 Aligned_cols=168 Identities=23% Similarity=0.372 Sum_probs=147.6
Q ss_pred hccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCC-ceeE
Q 046265 464 TNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPR-QSFL 540 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~-~~~l 540 (639)
.++|...+.+|.|.||.||+| ..++|+.||||+++....... +..=.||+..++++. |||||++.+++.+.+ .+|+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 356677889999999999999 567889999999987654433 333468999999998 999999999999888 8999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
|||||+ -.|+++++.+. ..++...+..|+.||++||+|+|.+ |+.|||+||||||+.....+||+|||+|+.+.
T Consensus 88 VfE~Md-~NLYqLmK~R~--r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDRN--RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 999995 59999998773 5789999999999999999999999 99999999999999988899999999999886
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
.. ..+++++.|.+|+|||
T Consensus 162 Sk-pPYTeYVSTRWYRAPE 179 (538)
T KOG0661|consen 162 SK-PPYTEYVSTRWYRAPE 179 (538)
T ss_pred cC-CCcchhhhcccccchH
Confidence 43 4567789999999998
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=262.03 Aligned_cols=173 Identities=28% Similarity=0.402 Sum_probs=147.9
Q ss_pred HHHhccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCCh-hhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCc
Q 046265 461 IRATNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDM-VVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 461 ~~~~~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 537 (639)
.+..++|.+.+.||+|+|++||+| +..++++||||.+.++.... ........|=.+|.++ .||.||+|+-.|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 445688999999999999999999 56678999999987654221 1234456777888888 89999999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
+|+|+||+++|+|.++++..+. ++...+..++.+|+.|++|||.. |||||||||+|||+|.++++||+|||.|+
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence 9999999999999999987765 55577888999999999999999 99999999999999999999999999999
Q ss_pred cCCCCCC-------------CcceeeeeceeeCCC
Q 046265 618 FLKPDSS-------------NWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~-------------~~~~~~gt~~Y~APE 639 (639)
.+.+... ...+++||..|.+||
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPE 257 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPE 257 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHH
Confidence 8864221 124589999999998
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=256.18 Aligned_cols=173 Identities=27% Similarity=0.362 Sum_probs=143.0
Q ss_pred HHHhccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCCh--------h----hHHHHHHHHHHHhccccCceee
Q 046265 461 IRATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDM--------V----VQQAFSNEIKALTELRHRNVVK 527 (639)
Q Consensus 461 ~~~~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~--------~----~~~~~~~e~~~l~~l~H~niv~ 527 (639)
.+..++|+....||+|.||+|-+|+ ..+++.||||.+.+..... . .-+...+||.+|+++.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3456889999999999999999995 4578999999997643211 1 1246789999999999999999
Q ss_pred eEEEEEcC--CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC
Q 046265 528 FYGFSFHP--RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD 605 (639)
Q Consensus 528 l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~ 605 (639)
++++..++ +.+|||+|||..|.+...-.. ..++...++..|.+++..||+|||.+ +||||||||+|+|++.+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d---~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPD---KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCC---cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 99999876 578999999999988644322 12388899999999999999999999 99999999999999999
Q ss_pred CceEEccccccccCCCC-----CCCcceeeeeceeeCCC
Q 046265 606 YDAHVSDFGISKFLKPD-----SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 606 ~~~kl~DfGla~~~~~~-----~~~~~~~~gt~~Y~APE 639 (639)
|++||+|||++...... .......+|||.|||||
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE 285 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPE 285 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchH
Confidence 99999999999866222 22334579999999998
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=263.74 Aligned_cols=166 Identities=26% Similarity=0.441 Sum_probs=149.0
Q ss_pred ccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
..|..-..||+|+.|.||.| +..+++.||||++..... ..++.+.+|+.+|+..+|+|||.+++.|.-.+++|.|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 44566678999999999999 556789999999986542 335667899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
||+||+|.+++..- .+++.+...|++++++||+|||.. +|+|||||.+|||++.+|.+||+|||++..+....
T Consensus 351 ym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred ecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999999998753 367789999999999999999999 99999999999999999999999999999988777
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
..+.+.+|||+|||||
T Consensus 424 ~KR~TmVGTPYWMAPE 439 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPE 439 (550)
T ss_pred CccccccCCCCccchh
Confidence 6778899999999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=250.61 Aligned_cols=168 Identities=29% Similarity=0.440 Sum_probs=142.6
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC--ceeEE
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR--QSFLL 541 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv 541 (639)
.++...+.||+|+||.||++.. ++|+..|||.+....... .+.+.+|+.++++++|||||+++|.....+ .+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 3455678999999999999955 458999999987653211 456889999999999999999999865555 58899
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEccccccccCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL-DYDAHVSDFGISKFLK 620 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~-~~~~kl~DfGla~~~~ 620 (639)
|||+++|+|.+++...+. .++...+.++++|+++||+|||++ +||||||||+|||++. .+.+||+|||.++...
T Consensus 95 mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 999999999999987664 478899999999999999999988 9999999999999999 6999999999999776
Q ss_pred CC---CCCcceeeeeceeeCCC
Q 046265 621 PD---SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~---~~~~~~~~gt~~Y~APE 639 (639)
.. ........||+.|||||
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPE 191 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPE 191 (313)
T ss_pred cccccccccccccCCccccCch
Confidence 31 12234578999999998
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-32 Score=279.01 Aligned_cols=310 Identities=26% Similarity=0.392 Sum_probs=219.7
Q ss_pred ccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCC-CCCcccCCCCCCCEEeeecccCccccCccc
Q 046265 20 AIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRG-SVPREVGQLSSLKQLVLYCNGLSGWLPSSF 98 (639)
Q Consensus 20 ~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 98 (639)
..+|..++.+.+|++|.+++|++. .+-+++..|+.|+.+++..|++.. -+|..+..|..|+.||||+|+++ ..|..+
T Consensus 45 ~~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~L 122 (1255)
T KOG0444|consen 45 EQVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNL 122 (1255)
T ss_pred hhChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhh
Confidence 478999999999999999999997 567889999999999999998864 48899999999999999999998 566666
Q ss_pred cCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCc
Q 046265 99 GNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNL 178 (639)
Q Consensus 99 ~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 178 (639)
..-+++ ..|+||+|+|..+.-+.|.+|+-|-+||||+|++. .+|+.+..+..|+.|+|++|.
T Consensus 123 E~AKn~-----------------iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NP 184 (1255)
T KOG0444|consen 123 EYAKNS-----------------IVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNP 184 (1255)
T ss_pred hhhcCc-----------------EEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCCh
Confidence 554432 36666666666322234456666666666666665 456666666666666666665
Q ss_pred CCccCCccCcCCCCCCeEEccC-----CccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchh
Q 046265 179 LNGVLPPSISNLSNLEGLYLYS-----SLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYE 253 (639)
Q Consensus 179 l~~~~p~~~~~l~~L~~L~l~~-----~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 253 (639)
+.-.--..+-.+++|+.|.+++ ..+|..+..+.+|..++++.|.+ ..+|+.+.++++|+.|+||+|+|+... -
T Consensus 185 L~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~L-p~vPecly~l~~LrrLNLS~N~iteL~-~ 262 (1255)
T KOG0444|consen 185 LNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNL-PIVPECLYKLRNLRRLNLSGNKITELN-M 262 (1255)
T ss_pred hhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCC-CcchHHHhhhhhhheeccCcCceeeee-c
Confidence 5422111222344555555543 23455555666666666666665 345555666666666666666665322 1
Q ss_pred hhhcCCCccEEeccCCcccc------------cccCcCCccc-cccCccccCCCCCCEEeccCCcccccCCccccCCCCC
Q 046265 254 VFGIYPNLTFLDLSQNNFYG------------SLNFSMNNIT-RSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSL 320 (639)
Q Consensus 254 ~~~~l~~L~~L~Ls~N~l~~------------~l~ls~n~~~-~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L 320 (639)
..+.+.+|++|++|.|+++. .+...+|+++ .-+|..++++.+|+.+..++|.+. .+|..++.|..|
T Consensus 263 ~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL 341 (1255)
T KOG0444|consen 263 TEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKL 341 (1255)
T ss_pred cHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHH
Confidence 22334555666666665542 1334455554 238999999999999999999985 889999999999
Q ss_pred CeeeccCccCcccCCcCccCCCCCCEEeCCCCC
Q 046265 321 NYRALNGNKVYGSLPRVLGSISDLEYLDLSTNY 353 (639)
Q Consensus 321 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 353 (639)
+.|.|++|++. ++|..+.-++.|+.||+..|.
T Consensus 342 ~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 342 QKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred HHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 99999999997 799999999999999999985
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=236.76 Aligned_cols=170 Identities=30% Similarity=0.489 Sum_probs=148.2
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.++|+..+.+|+|.||.||.|+. +++-.||+|.+.+.+. ....++.+.+|+++-+.++||||+++|+||.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 46788899999999999999955 5668899999987652 233467789999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
+||++.|+++..+..+.. ..++......++.|+|.|+.|+|.. +||||||||+|+|++.++..|++|||.+..-.
T Consensus 101 lEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999985443 3456677888999999999999998 99999999999999999999999999997643
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
.....+.|||.-|.|||
T Consensus 176 -~~kR~tlcgt~dyl~pE 192 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPE 192 (281)
T ss_pred -CCCceeeecccccCCHh
Confidence 44567899999999998
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=248.00 Aligned_cols=171 Identities=25% Similarity=0.423 Sum_probs=149.1
Q ss_pred hccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
...|+...+||.|..++||+| ..+.++.||||++........ .+.+.+|+..|+.++||||++++..|..+..+|+||
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 356788899999999999999 467789999999986554333 577899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
.||.+|++.++++..-. +.+++..+..|.+++++||.|||++ |-||||||+.||||+.+|.+||+|||++..+...
T Consensus 104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999986543 3477788889999999999999999 9999999999999999999999999988776543
Q ss_pred CCC---c-ceeeeeceeeCCC
Q 046265 623 SSN---W-SEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~---~-~~~~gt~~Y~APE 639 (639)
..+ . .+++||+.|||||
T Consensus 180 G~R~~~rf~tfvgtp~wmAPE 200 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPE 200 (516)
T ss_pred CceeeEeeccccCcccccChH
Confidence 322 1 4579999999998
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=245.16 Aligned_cols=170 Identities=22% Similarity=0.350 Sum_probs=144.4
Q ss_pred cCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCc-eeeeEEEEEcCC------c
Q 046265 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN-VVKFYGFSFHPR------Q 537 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~------~ 537 (639)
.|+..+.+|+|+||+||+|+ ..+|+.||+|+++....+........+|+.++++++|+| ||.+++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 34455679999999999994 567899999999876543334555689999999999999 999999999877 7
Q ss_pred eeEEecccCCCChhHHhhcCCCC-CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAI-DEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
.++||||++ -+|..++...... ..++...++.+++|+++|++|+|++ +|+||||||.|||++++|.+||+|||+|
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 899999994 5898888765422 3455578999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCcceeeeeceeeCCC
Q 046265 617 KFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+...-+....+..++|.+|.|||
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPE 190 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPE 190 (323)
T ss_pred HHhcCCcccccccEEEeeccCHH
Confidence 97765555567789999999998
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-31 Score=242.29 Aligned_cols=170 Identities=24% Similarity=0.384 Sum_probs=148.5
Q ss_pred HhccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 463 ATNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.++.|+..++||+|+|+.||++ +.++|+.+|+|.+..........+++.+|+++.+.++|||||++.+.+.+.+..|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3566777789999999999999 667899999998876655555678899999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEcccccccc
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL---DYDAHVSDFGISKF 618 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~---~~~~kl~DfGla~~ 618 (639)
+|+|.||+|..-+..+ ..+++..+-.+++|+++|+.|+|.. +|||||+||+|+++.. ...+|++|||+|+.
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999997666544 3466678888999999999999999 9999999999999953 34689999999999
Q ss_pred CCCCCCCcceeeeeceeeCCC
Q 046265 619 LKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~~~~~~~gt~~Y~APE 639 (639)
+. +...+...+|||+|||||
T Consensus 163 l~-~g~~~~G~~GtP~fmaPE 182 (355)
T KOG0033|consen 163 VN-DGEAWHGFAGTPGYLSPE 182 (355)
T ss_pred eC-CccccccccCCCcccCHH
Confidence 88 666778899999999998
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=260.20 Aligned_cols=170 Identities=24% Similarity=0.312 Sum_probs=145.3
Q ss_pred HhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCcee
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 539 (639)
..++|....++|+|.||+|+.|+.+ +++.+|||.+++... .....+..+.|.+++... +||.++.++.+|+..+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4578888999999999999999765 568899999997652 222344566777777665 6999999999999999999
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||+.||++..+.+. +.++...+.-++..|+.||+|||.+ +|||||||.+|||+|.+|++||+|||++|..
T Consensus 446 fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999995554443 3577788888999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCCcceeeeeceeeCCC
Q 046265 620 KPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~~~~~~gt~~Y~APE 639 (639)
.......+++||||.|||||
T Consensus 519 m~~g~~TsTfCGTpey~aPE 538 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPE 538 (694)
T ss_pred CCCCCccccccCChhhcChh
Confidence 65556778899999999998
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=233.22 Aligned_cols=170 Identities=24% Similarity=0.395 Sum_probs=147.4
Q ss_pred HhccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCC------hhhHHHHHHHHHHHhcc-ccCceeeeEEEEEc
Q 046265 463 ATNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPD------MVVQQAFSNEIKALTEL-RHRNVVKFYGFSFH 534 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 534 (639)
.-+.|...+.+|+|..++|-++ +.++|+..|+|++...... ....++-.+|+.+++++ .||+|+++.++|++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456778889999999999998 5668899999998754321 12345567899999997 69999999999999
Q ss_pred CCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 046265 535 PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614 (639)
Q Consensus 535 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfG 614 (639)
+...++|+|.|+.|.|++++...- .++.....+|++|+.+|++|||.. .|||||+||+|||+|++.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 999999999999999999997654 367788899999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+|..+++. ......||||+|.|||
T Consensus 169 Fa~~l~~G-ekLrelCGTPgYLAPE 192 (411)
T KOG0599|consen 169 FACQLEPG-EKLRELCGTPGYLAPE 192 (411)
T ss_pred eeeccCCc-hhHHHhcCCCcccChh
Confidence 99998754 4456789999999998
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=248.46 Aligned_cols=150 Identities=23% Similarity=0.261 Sum_probs=131.3
Q ss_pred HhccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCC-hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPD-MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
..++|+...+||+|+||.||.|+ ..+|+.+|+|++++.... .......+.|=.+|....+|+||+++-.|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 46788889999999999999995 457899999999976422 2233446778889999999999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
||||++||++..+|...+ .++...+..++.+.+-|++.+|.. |+|||||||+|+|||..|++|++|||+++.
T Consensus 219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccch
Confidence 999999999999998654 466677888899999999999999 999999999999999999999999999864
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-30 Score=240.37 Aligned_cols=163 Identities=29% Similarity=0.405 Sum_probs=145.9
Q ss_pred CCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccC
Q 046265 468 DAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLG 546 (639)
Q Consensus 468 ~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 546 (639)
+....+|+|+||.||+| +.+.|+.||||++... ...++..+||.+|.+++.|++|++||.|.....+|+|||||.
T Consensus 36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 34578999999999999 5568999999998753 245678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCc
Q 046265 547 RGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW 626 (639)
Q Consensus 547 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 626 (639)
.|+..++++.++ +.+.......+.+..++||+|||.. +-||||||+.|||++.+|.+|++|||+|..++.....+
T Consensus 112 AGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred CCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 999999998655 3577788888999999999999988 77999999999999999999999999999887665566
Q ss_pred ceeeeeceeeCCC
Q 046265 627 SEFVGTFGYVAPI 639 (639)
Q Consensus 627 ~~~~gt~~Y~APE 639 (639)
.++.|||.|||||
T Consensus 187 NTVIGTPFWMAPE 199 (502)
T KOG0574|consen 187 NTVIGTPFWMAPE 199 (502)
T ss_pred CccccCcccccHH
Confidence 7899999999998
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-29 Score=251.52 Aligned_cols=171 Identities=23% Similarity=0.352 Sum_probs=154.3
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc-eeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ-SFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-~~lv~ 542 (639)
++|...+++|+|+||.++.++++ +.+.||+|++.........++...+|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56778899999999999998654 56789999999877655566678899999999999999999999999988 99999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
+||+||++++.+....+ ..++......++.|++.|+.|||.. +|+|||||++||++..++.+|++|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k~-~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKG-VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999987663 4688899999999999999999987 9999999999999999999999999999999877
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
.....+++|||.||.||
T Consensus 160 ~~~a~tvvGTp~YmcPE 176 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPE 176 (426)
T ss_pred hhhhheecCCCcccCHH
Confidence 66778899999999998
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=253.30 Aligned_cols=166 Identities=20% Similarity=0.331 Sum_probs=147.5
Q ss_pred CCCcceeccCCCceEEEEE-cCCCcEEEEEEccCC-CCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 467 FDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSP-HPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
|+..+.+|+|+-|.|-.|+ ..+|+.+|||.+.+. ...........+||.+|+-+.||||+++|++|++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 4456789999999999994 578999999999876 33344566789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++|.|++++..++. ++.+.+.++++||+.|+.|+|+. +|+|||+||+|+|+|..+.+||+|||+|..-. ...
T Consensus 94 v~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~gk 166 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV-PGK 166 (786)
T ss_pred cCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc-CCc
Confidence 999999999988765 55588999999999999999999 99999999999999999999999999998644 445
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
-..+.||+|.|.|||
T Consensus 167 lLeTSCGSPHYA~PE 181 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPE 181 (786)
T ss_pred cccccCCCcccCCch
Confidence 567889999999998
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=248.68 Aligned_cols=162 Identities=23% Similarity=0.434 Sum_probs=138.4
Q ss_pred CcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCC
Q 046265 469 AKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRG 548 (639)
Q Consensus 469 ~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 548 (639)
..+.||+|-||.||.|.+.....||||.++... ...+.|.+|+.+|++++|+|||+++|+|..++.+|||||||+.|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~---m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS---MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccc---cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 356899999999999999988899999998643 34567899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcce
Q 046265 549 SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE 628 (639)
Q Consensus 549 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 628 (639)
+|.++++.+.+ ..+...+-+.++.|||+|++||+++ ++|||||.+.|||++++..+||+|||+|+....+.. ..
T Consensus 287 sLl~yLr~~~~-~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y--~~ 360 (468)
T KOG0197|consen 287 SLLDYLRTREG-GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY--TA 360 (468)
T ss_pred cHHHHhhhcCC-CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCce--ee
Confidence 99999987332 3567788899999999999999999 899999999999999999999999999995443221 11
Q ss_pred eeee---ceeeCCC
Q 046265 629 FVGT---FGYVAPI 639 (639)
Q Consensus 629 ~~gt---~~Y~APE 639 (639)
..|. ..|.|||
T Consensus 361 ~~~~kfPIkWtAPE 374 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPE 374 (468)
T ss_pred cCCCCCCceecCHH
Confidence 1122 3588998
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=238.36 Aligned_cols=165 Identities=25% Similarity=0.335 Sum_probs=131.2
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC---c--
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR---Q-- 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~---~-- 537 (639)
+-.|...+++|+|+||.||+|... +++.||||+.-.... .--+|+++|++++|||||++.-+|.... +
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 345667889999999999999654 568999999864321 1246999999999999999998887432 2
Q ss_pred eeEEecccCCCChhHHhhcC-CCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEccccc
Q 046265 538 SFLLYEYLGRGSLAIILSND-AAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD-YDAHVSDFGI 615 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~-~~~kl~DfGl 615 (639)
..+|||||+. +|++.++.. .....++...+.-+..|+.+|+.|||.. +|+||||||.|+|+|.+ |.+||||||.
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence 3479999975 788887641 1112345566677899999999999997 99999999999999976 8999999999
Q ss_pred cccCCCCCCCcceeeeeceeeCCC
Q 046265 616 SKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|+.+..... -.+..+|..|+|||
T Consensus 173 AK~L~~~ep-niSYicSRyYRaPE 195 (364)
T KOG0658|consen 173 AKVLVKGEP-NISYICSRYYRAPE 195 (364)
T ss_pred ceeeccCCC-ceeEEEeccccCHH
Confidence 998865433 35688999999998
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-29 Score=245.99 Aligned_cols=168 Identities=26% Similarity=0.410 Sum_probs=146.9
Q ss_pred ccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
..|...+.||+|+||.|||| ..++++.||+|.+...... ..-++.++|+.+++.++++||.++|+.|..+..+|++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 44666789999999999999 5678899999999865432 334567899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
||.||++.+.++..... ++....-+.+++..|+.|+|.+ +.+|||||++||++..+|.+|++|||++..++...
T Consensus 92 y~~gGsv~~lL~~~~~~---~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNIL---DEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HhcCcchhhhhccCCCC---ccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999999876542 3344455788999999999999 99999999999999999999999999999998776
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
....+++|||.|||||
T Consensus 166 ~rr~tfvGTPfwMAPE 181 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPE 181 (467)
T ss_pred hccccccccccccchh
Confidence 6678899999999998
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=247.04 Aligned_cols=163 Identities=22% Similarity=0.227 Sum_probs=139.4
Q ss_pred ceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCC
Q 046265 471 YCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRG 548 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 548 (639)
++||+|+||.||+|.. .+|+.||||.+..... .......+.+|+.++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999954 5789999999875321 2223456778999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcce
Q 046265 549 SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE 628 (639)
Q Consensus 549 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 628 (639)
+|.+++...+ .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 9999987543 467889999999999999999998 9999999999999999999999999999864433333455
Q ss_pred eeeeceeeCCC
Q 046265 629 FVGTFGYVAPI 639 (639)
Q Consensus 629 ~~gt~~Y~APE 639 (639)
.+||+.|||||
T Consensus 155 ~~gt~~y~aPE 165 (323)
T cd05571 155 FCGTPEYLAPE 165 (323)
T ss_pred eecCccccChh
Confidence 78999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=246.56 Aligned_cols=168 Identities=25% Similarity=0.377 Sum_probs=148.0
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCCh-hhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCceeE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDM-VVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l 540 (639)
...|+..+.+|+|.||.||+|..+ +|+.+|+|.+.+..... .....+.+|+.+|+++. |||||+++++|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456777789999999999999655 58999999998765322 23567899999999998 9999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC----CceEEcccccc
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD----YDAHVSDFGIS 616 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~----~~~kl~DfGla 616 (639)
|||++.||.|.+.+... .++...+..+++|++.|++|+|.. +|+|||+||+|+|+... +.+|++|||+|
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999999766 278899999999999999999998 99999999999999633 57999999999
Q ss_pred ccCCCCCCCcceeeeeceeeCCC
Q 046265 617 KFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+.... .......+||++|+|||
T Consensus 187 ~~~~~-~~~~~~~~Gtp~y~APE 208 (382)
T KOG0032|consen 187 KFIKP-GERLHTIVGTPEYVAPE 208 (382)
T ss_pred eEccC-CceEeeecCCccccCch
Confidence 98876 55567899999999998
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=251.69 Aligned_cols=150 Identities=21% Similarity=0.262 Sum_probs=131.2
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||+||+|.. .+++.||||.+..... .......+.+|+.++.+++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3688889999999999999954 5688999999875321 1223456788999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||+++|+|.+++...+ .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 9999999999997643 477889999999999999999998 99999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=250.71 Aligned_cols=172 Identities=20% Similarity=0.238 Sum_probs=145.3
Q ss_pred HHHhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 461 IRATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 461 ~~~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
....++|+..+.||+|+||.||+|+.. +++.||+|.+.+... .....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 334678888999999999999999654 578999999864221 222345678899999999999999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
|+||||+++|+|.+++... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+|+.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 9999999999999999653 356788889999999999999998 999999999999999999999999999987
Q ss_pred CCCCCC-CcceeeeeceeeCCC
Q 046265 619 LKPDSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~-~~~~~~gt~~Y~APE 639 (639)
+..... .....+||+.|||||
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE 213 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPE 213 (370)
T ss_pred cccCCceecccCCCCcccCCHH
Confidence 643222 223567999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=247.78 Aligned_cols=163 Identities=28% Similarity=0.408 Sum_probs=137.4
Q ss_pred CCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCC-hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 467 FDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPD-MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
|...+.||.|+||.||-|+ .++.+.||||++.-.... ...-+++.+|+..+.+++|||+|.+-|+|..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 5557789999999999995 456789999999854322 22235688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
| -|+-.+++.-++. .+..-.+..|+.+++.||+|||+. +.||||||+.|||+.+.|.+|++|||.|..+.+
T Consensus 108 C-lGSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred H-hccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 9 4577777654332 345567778999999999999998 899999999999999999999999999987653
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
..+++|||+|||||
T Consensus 179 -AnsFvGTPywMAPE 192 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPE 192 (948)
T ss_pred -hhcccCCccccchh
Confidence 35689999999998
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=244.24 Aligned_cols=163 Identities=23% Similarity=0.247 Sum_probs=139.4
Q ss_pred ceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCC
Q 046265 471 YCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRG 548 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 548 (639)
+.||+|+||.||+|+. .+++.||||.+..... .......+.+|+.++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999954 5689999999875321 2233456788999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcce
Q 046265 549 SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE 628 (639)
Q Consensus 549 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 628 (639)
+|..++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 9998886543 477889999999999999999998 9999999999999999999999999999865433333345
Q ss_pred eeeeceeeCCC
Q 046265 629 FVGTFGYVAPI 639 (639)
Q Consensus 629 ~~gt~~Y~APE 639 (639)
.+||+.|||||
T Consensus 155 ~~gt~~y~aPE 165 (328)
T cd05593 155 FCGTPEYLAPE 165 (328)
T ss_pred ccCCcCccChh
Confidence 68999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=239.33 Aligned_cols=162 Identities=33% Similarity=0.527 Sum_probs=138.5
Q ss_pred CCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHH--hccccCceeeeEEEEEcCC----ceeEE
Q 046265 468 DAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKAL--TELRHRNVVKFYGFSFHPR----QSFLL 541 (639)
Q Consensus 468 ~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l--~~l~H~niv~l~~~~~~~~----~~~lv 541 (639)
+..+++|+|+||.||+|.+.+ +.||||+++.. ..+.|..|-++- -.++|+||++++++-.... ++|+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhHHHhhcCccceeehhhccC-ceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 345689999999999998876 89999999743 345566665554 4579999999999887665 78999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhC------CCCCeEeecCCCCCeeeCCCCceEEccccc
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHD------YFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~------~~~~iiHrdlk~~Nill~~~~~~kl~DfGl 615 (639)
+||.+.|+|.++++.+ .++|....+++..+++||+|||+. ++|+|+|||||+.|||+..|+.+.|+|||+
T Consensus 287 t~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999864 589999999999999999999974 568999999999999999999999999999
Q ss_pred cccCCCCCC--CcceeeeeceeeCCC
Q 046265 616 SKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
|..+..... .....+||..|||||
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPE 388 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPE 388 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHH
Confidence 998865432 233479999999998
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=243.79 Aligned_cols=163 Identities=22% Similarity=0.235 Sum_probs=138.6
Q ss_pred ceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCC
Q 046265 471 YCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRG 548 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 548 (639)
+.||+|+||.||+|.. .+|+.||+|.+..... .......+.+|+.++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3689999999999964 5789999999875321 1223456778999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcce
Q 046265 549 SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE 628 (639)
Q Consensus 549 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 628 (639)
+|..++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 9998886543 467899999999999999999998 9999999999999999999999999998864333333345
Q ss_pred eeeeceeeCCC
Q 046265 629 FVGTFGYVAPI 639 (639)
Q Consensus 629 ~~gt~~Y~APE 639 (639)
.+||+.|||||
T Consensus 155 ~~gt~~y~aPE 165 (323)
T cd05595 155 FCGTPEYLAPE 165 (323)
T ss_pred ccCCcCcCCcc
Confidence 67999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=242.69 Aligned_cols=161 Identities=21% Similarity=0.293 Sum_probs=137.7
Q ss_pred eccCCCceEEEEEc-CCCcEEEEEEccCCC-CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCCCh
Q 046265 473 IGTAGQASVYKAEL-PSWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550 (639)
Q Consensus 473 ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 550 (639)
||+|+||.||+|.. .+++.||+|.+.... ........+.+|+.++.+++||||+++++++..++..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999965 467899999987432 1223345678899999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcceee
Q 046265 551 AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFV 630 (639)
Q Consensus 551 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 630 (639)
.+++...+ .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++............+
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 99997643 467889999999999999999998 999999999999999999999999999986543333344578
Q ss_pred eeceeeCCC
Q 046265 631 GTFGYVAPI 639 (639)
Q Consensus 631 gt~~Y~APE 639 (639)
||+.|||||
T Consensus 155 gt~~y~aPE 163 (312)
T cd05585 155 GTPEYLAPE 163 (312)
T ss_pred CCcccCCHH
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=249.63 Aligned_cols=147 Identities=20% Similarity=0.271 Sum_probs=129.2
Q ss_pred cCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.|+..+.||+|+||+||+|. ..+++.||||++..... .....+.+.+|+.++++++|||||++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 57778899999999999995 45678999999975432 22334568899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
|+++|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 999999999987643 367788888999999999999998 999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=238.56 Aligned_cols=169 Identities=21% Similarity=0.252 Sum_probs=142.7
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCC-hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPD-MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
+|+..+.||+|+||.||+|.. .+++.||||.+...... ......+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 366788999999999999964 67899999998754322 2234567889999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++|+|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG- 155 (285)
T ss_pred ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-
Confidence 9999999888764332 3478899999999999999999998 9999999999999999999999999999875432
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......||+.|||||
T Consensus 156 ~~~~~~~g~~~y~aPE 171 (285)
T cd05631 156 ETVRGRVGTVGYMAPE 171 (285)
T ss_pred CeecCCCCCCCccCHh
Confidence 2223457999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=249.40 Aligned_cols=150 Identities=25% Similarity=0.301 Sum_probs=131.3
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||.||+|+. .+++.||||++..... .......+.+|+.++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 3688889999999999999965 4689999999975321 1223456788999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||+++|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 9999999999987643 477889999999999999999998 99999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-29 Score=270.06 Aligned_cols=382 Identities=26% Similarity=0.301 Sum_probs=230.9
Q ss_pred eeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEee
Q 046265 6 FFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVL 85 (639)
Q Consensus 6 ~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 85 (639)
+++..+|++.|++. ..|..+..+.+|+.|+++.|-|. ..|.+...+.+|++|.|.+|.+. .+|..+..+.+|++|++
T Consensus 45 v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~Ldl 121 (1081)
T KOG0618|consen 45 VKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDL 121 (1081)
T ss_pred eeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhccccccc
Confidence 67778888877665 88999999999999999999998 67899999999999999999998 89999999999999999
Q ss_pred ecccCccccCccccCCCCCCcccCCC--CCcccCCCCccEEEccCCcCcccCCccccC-------------------CCC
Q 046265 86 YCNGLSGWLPSSFGNLNNLAIGSMPN--SLSNLTSLSLFHLDLSENQLSGSIPHFLGH-------------------LSN 144 (639)
Q Consensus 86 ~~N~l~~~~p~~~~~l~~L~~~~lp~--~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~-------------------l~~ 144 (639)
+.|++. .+|..+..++.+....... .+..+....++.++|..|.+.+.++..+.. +.+
T Consensus 122 S~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~~dls~~~~ 200 (1081)
T KOG0618|consen 122 SFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEVLDLSNLAN 200 (1081)
T ss_pred chhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhheeeecccchhhhhhhhhccc
Confidence 999987 6777665554332000000 000011111233344444444333333333 333
Q ss_pred CCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCC---ccccccccccCCcEEEcCCc
Q 046265 145 LAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSS---LVSAEIGNLLQLIELEIDNK 221 (639)
Q Consensus 145 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~---~~~~~~~~l~~L~~L~l~~n 221 (639)
|+.+....|++... --.-++|+.|+.++|.+....+. ..-.+|++++++.+ .+|.+++.+.+|+.++...|
T Consensus 201 l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~~lp~wi~~~~nle~l~~n~N 274 (1081)
T KOG0618|consen 201 LEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLSNLPEWIGACANLEALNANHN 274 (1081)
T ss_pred hhhhhhhhcccceE----EecCcchheeeeccCcceeeccc--cccccceeeecchhhhhcchHHHHhcccceEecccch
Confidence 33333333333210 00112344444444444321111 01124555555432 23455555555555555555
Q ss_pred ccCCCCCccc-----------------------cCCCCCceeccccccccCcchhhhhcCCC-ccEEeccCCcccc----
Q 046265 222 QLFGQIPKSL-----------------------RNFTSLNIVHLEQNHLTGNIYEVFGIYPN-LTFLDLSQNNFYG---- 273 (639)
Q Consensus 222 ~l~~~~p~~~-----------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~---- 273 (639)
++ ..+|..+ ..+++|++|+|..|.|...++..+..... +..|+.+.|.+..
T Consensus 275 ~l-~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~ 353 (1081)
T KOG0618|consen 275 RL-VALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSY 353 (1081)
T ss_pred hH-HhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccc
Confidence 55 3344444 44445555555555544433333322222 3333333333321
Q ss_pred ---------cccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCC
Q 046265 274 ---------SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDL 344 (639)
Q Consensus 274 ---------~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 344 (639)
.+.+.+|.++...-+.+-+.++|+.|+|++|++.......+.++..|+.|+||||+++ .+|..+..+..|
T Consensus 354 ~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L 432 (1081)
T KOG0618|consen 354 EENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRL 432 (1081)
T ss_pred cchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhh
Confidence 1456777777666556777788888888888886444455677888888888888887 677778888888
Q ss_pred CEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCe
Q 046265 345 EYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNE 414 (639)
Q Consensus 345 ~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~ 414 (639)
++|...+|++ -.+| .+..+++|+.+|++.|.++....|.... .++|++||+++|.
T Consensus 433 ~tL~ahsN~l----~~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p----------~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 433 HTLRAHSNQL----LSFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP----------SPNLKYLDLSGNT 487 (1081)
T ss_pred HHHhhcCCce----eech-hhhhcCcceEEecccchhhhhhhhhhCC----------CcccceeeccCCc
Confidence 8888777543 2356 7788888888888888877654342211 1678888888875
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=242.30 Aligned_cols=163 Identities=22% Similarity=0.230 Sum_probs=138.3
Q ss_pred ceeccCCCceEEEEE-cCCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCC
Q 046265 471 YCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRG 548 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 548 (639)
+.||+|+||.||+|. ..+++.||+|.+..... .......+.+|++++..++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 368999999999995 45789999999875321 2223456778999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 549 SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH-DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 549 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
+|..++.... .+++..+..++.|++.|++|||. . +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 9998886543 47889999999999999999996 5 899999999999999999999999999886443333344
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
..+||+.|||||
T Consensus 155 ~~~gt~~y~aPE 166 (325)
T cd05594 155 TFCGTPEYLAPE 166 (325)
T ss_pred cccCCcccCCHH
Confidence 567999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=245.56 Aligned_cols=166 Identities=24% Similarity=0.331 Sum_probs=142.2
Q ss_pred ccCCCcceeccCCCceEEEEEcCC--CcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS--WEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
++|+..+.||+|+||.||+|..+. +..||||++..... .....+.+.+|+.+++.++|||||++++++.+.+..|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 467788999999999999996433 36899999864321 222345678899999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 110 ~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999997654 367788999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
. ....+||+.|||||
T Consensus 184 ~---~~~~~gt~~y~aPE 198 (340)
T PTZ00426 184 R---TYTLCGTPEYIAPE 198 (340)
T ss_pred C---cceecCChhhcCHH
Confidence 2 23568999999998
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=243.29 Aligned_cols=165 Identities=25% Similarity=0.327 Sum_probs=137.7
Q ss_pred cceeccCCCceEEEEEcCC--C--cE-EEEEEccCCC-CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 470 KYCIGTAGQASVYKAELPS--W--EI-VAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~~--~--~~-vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
..+||+|+||.||+|+++. + .. ||||..+... .......+|.+|+++|+.++|||||++||++.....+|+|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 4799999999999996543 3 23 8999988532 455667889999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
+|.||+|.++++.... .++..++.+++.++|.||+|||.. ++|||||.++|+|++.++.+||+|||+++......
T Consensus 242 l~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~ 316 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV 316 (474)
T ss_pred ecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence 9999999999987543 588899999999999999999999 99999999999999999999999999987653111
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.....-.--..|+|||
T Consensus 317 ~~~~~~klPirWLAPE 332 (474)
T KOG0194|consen 317 MKKFLKKLPIRWLAPE 332 (474)
T ss_pred eccccccCcceecChh
Confidence 1100001225799998
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=244.55 Aligned_cols=166 Identities=25% Similarity=0.312 Sum_probs=143.1
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||.||+|+.. +++.||||.+..... .....+.+.+|+.++++++||||+++++++..++..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56778899999999999999654 678999999875321 2233456889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++...+ .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999987653 367788888999999999999998 9999999999999999999999999999876432
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
....+||+.|||||
T Consensus 172 ---~~~~~gt~~y~aPE 185 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPE 185 (329)
T ss_pred ---cceecCChhhcCHH
Confidence 23467999999998
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=244.61 Aligned_cols=163 Identities=26% Similarity=0.441 Sum_probs=144.1
Q ss_pred CcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCC
Q 046265 469 AKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRG 548 (639)
Q Consensus 469 ~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 548 (639)
..+.||+|+||+||||++.+ .||||.+..........+.|+.|+..+++-+|.||+=+.|||..+.. .||.-+|+|-
T Consensus 396 l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGs 472 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGS 472 (678)
T ss_pred ccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCc
Confidence 46789999999999998763 69999999887777788999999999999999999999999999887 8999999999
Q ss_pred ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC--CCCc
Q 046265 549 SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD--SSNW 626 (639)
Q Consensus 549 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~--~~~~ 626 (639)
+|+.+++..+ ..++..+...||+|||+|+.|||.+ +|||||+|..||++++++++||+|||++..-..+ ....
T Consensus 473 SLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~ 547 (678)
T KOG0193|consen 473 SLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQL 547 (678)
T ss_pred hhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeecccccc
Confidence 9999998765 3577788899999999999999999 9999999999999999999999999998754322 2334
Q ss_pred ceeeeeceeeCCC
Q 046265 627 SEFVGTFGYVAPI 639 (639)
Q Consensus 627 ~~~~gt~~Y~APE 639 (639)
....|+.-|||||
T Consensus 548 ~qp~gsilwmAPE 560 (678)
T KOG0193|consen 548 EQPHGSLLWMAPE 560 (678)
T ss_pred CCCccchhhhcHH
Confidence 4567899999998
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=248.46 Aligned_cols=148 Identities=23% Similarity=0.261 Sum_probs=129.3
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|...+.||+|+||.||+|. ..+++.||||++..... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 367888999999999999995 45789999999865321 2233456788999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
||+++|+|.+++...+ .+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+|++|||+++.
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999987543 467788888999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=236.38 Aligned_cols=164 Identities=26% Similarity=0.371 Sum_probs=142.2
Q ss_pred cceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCC
Q 046265 470 KYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRG 548 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 548 (639)
.+++|+|.||+||-|. .++|+.||||.+.+.+..+..+..+++|++++..+.||.||.+..-|+..+.++.|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 5799999999999994 568999999999877655666788899999999999999999999999999999999999665
Q ss_pred ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEEccccccccCCCCCCC
Q 046265 549 SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG---LDYDAHVSDFGISKFLKPDSSN 625 (639)
Q Consensus 549 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~---~~~~~kl~DfGla~~~~~~~~~ 625 (639)
=|..++.... ..++.+...-++.||+.||.|||.. +|+|+|+||+|||+. ....+|+||||+|+.+.+. +.
T Consensus 649 MLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sF 722 (888)
T KOG4236|consen 649 MLEMILSSEK--GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SF 722 (888)
T ss_pred HHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh-hh
Confidence 5666666543 3577788888999999999999999 999999999999995 4468999999999988653 44
Q ss_pred cceeeeeceeeCCC
Q 046265 626 WSEFVGTFGYVAPI 639 (639)
Q Consensus 626 ~~~~~gt~~Y~APE 639 (639)
+.+++|||.|.|||
T Consensus 723 RrsVVGTPAYLaPE 736 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPE 736 (888)
T ss_pred hhhhcCCccccCHH
Confidence 56789999999998
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=241.28 Aligned_cols=166 Identities=26% Similarity=0.379 Sum_probs=143.1
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||.||+|... +++.||||.+..... .....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999654 689999999875321 2233456889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++...+ .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999997654 367788889999999999999998 9999999999999999999999999999876432
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
....+||+.|+|||
T Consensus 155 ---~~~~~gt~~y~aPE 168 (291)
T cd05612 155 ---TWTLCGTPEYLAPE 168 (291)
T ss_pred ---cccccCChhhcCHH
Confidence 23467999999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-27 Score=236.60 Aligned_cols=168 Identities=24% Similarity=0.332 Sum_probs=141.4
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|+||.||+|.. .+++.||+|.++.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 4678889999999999999965 4678999999875432 2234457789999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++ +|.+++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 84 YLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 9974 8988886543 2467888999999999999999998 99999999999999999999999999998654333
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......|++.|||||
T Consensus 158 ~~~~~~~~~~~y~aPE 173 (288)
T cd07871 158 KTYSNEVVTLWYRPPD 173 (288)
T ss_pred ccccCceecccccChH
Confidence 3334567899999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=242.67 Aligned_cols=172 Identities=21% Similarity=0.320 Sum_probs=139.3
Q ss_pred hccCCCcceeccCCCceEEEEEc------CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCC
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPR 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 536 (639)
.++|+..+.||+|+||.||+|.. .+++.||||++.... .......+.+|+.++.++ +|||||+++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 35688889999999999999963 235679999987533 223456788999999999 8999999999988654
Q ss_pred -ceeEEecccCCCChhHHhhcCCC--------------------------------------------------------
Q 046265 537 -QSFLLYEYLGRGSLAIILSNDAA-------------------------------------------------------- 559 (639)
Q Consensus 537 -~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 559 (639)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 58899999999999999864321
Q ss_pred ---CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC--cceeeeece
Q 046265 560 ---IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN--WSEFVGTFG 634 (639)
Q Consensus 560 ---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~ 634 (639)
...+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++.+...... .....+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 12477888899999999999999998 9999999999999999999999999999875432221 122346688
Q ss_pred eeCCC
Q 046265 635 YVAPI 639 (639)
Q Consensus 635 Y~APE 639 (639)
|||||
T Consensus 242 y~aPE 246 (338)
T cd05102 242 WMAPE 246 (338)
T ss_pred ccCcH
Confidence 99998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=248.13 Aligned_cols=147 Identities=19% Similarity=0.234 Sum_probs=128.5
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.|+..+.||+|+||.||+|+. .+++.||||.+..... .....+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 477889999999999999954 5678999999875321 12334567899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
|+++|+|.+++...+ .+++..+..++.|++.|++|||.. +|+||||||+|||++.++.+||+|||+|..
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 999999999987543 366788888999999999999998 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-27 Score=247.22 Aligned_cols=147 Identities=20% Similarity=0.239 Sum_probs=128.1
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
+|+..+.||+|+||.||+|+. .+++.||||.+..... .....+.+.+|++++++++||||+++++.+.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 578889999999999999964 5688999999864321 11234567889999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
|+++|+|.+++...+ .++...+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+|..
T Consensus 82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 999999999997654 356688888999999999999998 999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=237.39 Aligned_cols=171 Identities=23% Similarity=0.357 Sum_probs=141.1
Q ss_pred ccCCCcceeccCCCceEEEEEcCC-----------------CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceee
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS-----------------WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVK 527 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~ 527 (639)
.+|...+.||+|+||.||+|..++ +..||||.+.... .......|.+|+.++.+++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 467778899999999999996432 3469999987543 3344667899999999999999999
Q ss_pred eEEEEEcCCceeEEecccCCCChhHHhhcCC----------------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 046265 528 FYGFSFHPRQSFLLYEYLGRGSLAIILSNDA----------------AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIV 591 (639)
Q Consensus 528 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ii 591 (639)
+++++.+.+..++||||+++|+|.+++.... ....++|.....++.|++.|++|||.. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 9999999999999999999999999886432 113478889999999999999999998 999
Q ss_pred eecCCCCCeeeCCCCceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 592 HRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 592 Hrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
||||||+||+++.++.+||+|||+++.+..... ......++..|||||
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE 210 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWE 210 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHH
Confidence 999999999999999999999999986543221 112234578899998
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=242.80 Aligned_cols=165 Identities=23% Similarity=0.296 Sum_probs=142.9
Q ss_pred cCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
+|+..+.||+|+||.||+|+.. +++.||||.+..... .......+.+|+.++..++||||+++++++..++..|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5788899999999999999765 578999999875321 12234567889999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999997543 467788899999999999999998 999999999999999999999999999986543
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.....+||+.|+|||
T Consensus 154 -~~~~~~gt~~y~aPE 168 (333)
T cd05600 154 -YANSVVGSPDYMAPE 168 (333)
T ss_pred -ccCCcccCccccChh
Confidence 233467999999998
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=245.54 Aligned_cols=175 Identities=19% Similarity=0.240 Sum_probs=146.8
Q ss_pred HHHHHHhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCC-CChhhHHHHHHHHHHHhccccCceeeeEEEEEcC
Q 046265 458 EEVIRATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP 535 (639)
Q Consensus 458 ~~~~~~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 535 (639)
.+.....++|+..+.||+|+||.||+|+.. +++.||+|.+.... ......+.+.+|+.+++.++||||+++++++..+
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344455688999999999999999999654 67889999986422 1222345678899999999999999999999999
Q ss_pred CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGl 615 (639)
+..|+||||+++|+|.+++... .++...+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999999998653 356678888999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCC-CcceeeeeceeeCCC
Q 046265 616 SKFLKPDSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~-~~~~~~gt~~Y~APE 639 (639)
|+.+..... .....+||+.|||||
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE 213 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPE 213 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHH
Confidence 987643222 223567999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=240.63 Aligned_cols=163 Identities=23% Similarity=0.278 Sum_probs=139.9
Q ss_pred ceeccCCCceEEEEEc----CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccC
Q 046265 471 YCIGTAGQASVYKAEL----PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLG 546 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 546 (639)
+.||+|+||.||+++. .+|+.||||.+............+.+|++++++++||||+++++++..++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999854 467899999997543333334567789999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCc
Q 046265 547 RGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW 626 (639)
Q Consensus 547 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 626 (639)
+|+|.+++.... .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 999999986543 478899999999999999999998 99999999999999999999999999998765433334
Q ss_pred ceeeeeceeeCCC
Q 046265 627 SEFVGTFGYVAPI 639 (639)
Q Consensus 627 ~~~~gt~~Y~APE 639 (639)
...+||+.|||||
T Consensus 156 ~~~~g~~~y~aPE 168 (318)
T cd05582 156 YSFCGTVEYMAPE 168 (318)
T ss_pred ecccCChhhcCHH
Confidence 4568999999998
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=246.72 Aligned_cols=170 Identities=20% Similarity=0.248 Sum_probs=143.4
Q ss_pred HhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
..++|+..+.||+|+||.||+|+. .+++.||||.+..... .....+.+.+|+.+++.++||||+++++++..++..|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 456788899999999999999965 4678999999864321 12234457889999999999999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||||+++|+|.+++... .++...+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999998753 256677888999999999999998 99999999999999999999999999998764
Q ss_pred CCCC-CcceeeeeceeeCCC
Q 046265 621 PDSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~-~~~~~~gt~~Y~APE 639 (639)
.... .....+||+.|||||
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE 213 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPE 213 (370)
T ss_pred CCCcccCCCCCCCcCeECHH
Confidence 3322 223467999999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=241.11 Aligned_cols=170 Identities=25% Similarity=0.380 Sum_probs=152.7
Q ss_pred HhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.+..|.....||+|.|++|..|.+ .++..||||.+.+........+.+.+|+++|..++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 456677788999999999999955 4689999999998887777777799999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+.+|.+++++..++...+ ..+..++.|+..|++|+|.+ .|||||||++||+++.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e---~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKE---KEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EEeccCchhHHHHHhcccchh---hhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec-
Confidence 999999999999988765333 77788999999999999999 89999999999999999999999999999887
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
......+.||++.|.|||
T Consensus 207 ~~~~lqt~cgsppyAaPE 224 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPE 224 (596)
T ss_pred ccccccccCCCCCccChH
Confidence 344567789999999998
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=246.65 Aligned_cols=165 Identities=25% Similarity=0.417 Sum_probs=141.4
Q ss_pred cceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC------ceeEEe
Q 046265 470 KYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR------QSFLLY 542 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 542 (639)
.+.+|+|+||.||+++ ..+|+.||||.++... .....++..+|++++++++|||||++++.-.+.. ...+||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 5689999999999997 6789999999998754 2334566789999999999999999998765443 568999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC--CCC--ceEEcccccccc
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG--LDY--DAHVSDFGISKF 618 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~--~~~--~~kl~DfGla~~ 618 (639)
|||++|||+..+........++......+...++.|+.|||.+ +|+||||||.||++- .+| --||+|||.|+.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 9999999999998776666788899999999999999999988 999999999999983 334 479999999999
Q ss_pred CCCCCCCcceeeeeceeeCCC
Q 046265 619 LKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~~~~~~~gt~~Y~APE 639 (639)
+..+ +...+++||+.|.|||
T Consensus 174 l~d~-s~~~S~vGT~~YLhPe 193 (732)
T KOG4250|consen 174 LDDN-SLFTSLVGTEEYLHPE 193 (732)
T ss_pred CCCC-CeeeeecCchhhcChH
Confidence 8754 4556799999999997
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=239.68 Aligned_cols=163 Identities=22% Similarity=0.329 Sum_probs=137.1
Q ss_pred ceeccCCCceEEEEEc----CCCcEEEEEEccCCCC--ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 471 YCIGTAGQASVYKAEL----PSWEIVAVKKFHSPHP--DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+.||+|+||.||+|+. .+++.||||.+..... .......+.+|+.++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999964 3578899999875321 122335577899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++|+|.+++...+ .+.+..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999987654 356678888999999999999998 999999999999999999999999999875433333
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
.....+||+.|+|||
T Consensus 156 ~~~~~~gt~~y~aPE 170 (323)
T cd05584 156 VTHTFCGTIEYMAPE 170 (323)
T ss_pred cccccCCCccccChh
Confidence 334467999999998
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=239.49 Aligned_cols=163 Identities=22% Similarity=0.274 Sum_probs=138.3
Q ss_pred ceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEEecccCC
Q 046265 471 YCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
++||+|+||.||+|+. .+++.||||.++.... .....+.+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999965 4678999999975422 222345678899999888 699999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
|+|.+++...+ .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 99998886543 478899999999999999999998 999999999999999999999999999975433333344
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
..+||+.|||||
T Consensus 155 ~~~gt~~y~aPE 166 (329)
T cd05588 155 TFCGTPNYIAPE 166 (329)
T ss_pred cccCCccccCHH
Confidence 578999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=229.11 Aligned_cols=171 Identities=25% Similarity=0.388 Sum_probs=144.1
Q ss_pred HHhccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc-----C
Q 046265 462 RATNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH-----P 535 (639)
Q Consensus 462 ~~~~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-----~ 535 (639)
.....|...+.||+|+||.|+.| ..++|+.||||++..........++-.+|+.+++.++|+|||.+.+.+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34455666788999999999999 55688999999998655455556667899999999999999999998875 2
Q ss_pred CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGl 615 (639)
..+|+|+|+| ..+|.++++.+.. ++...+...+.|+++|+.|+|+. +|+|||+||+|++++.+...||+|||+
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 4689999999 6799999986542 55567778889999999999999 999999999999999999999999999
Q ss_pred cccCCCC--CCCcceeeeeceeeCCC
Q 046265 616 SKFLKPD--SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~--~~~~~~~~gt~~Y~APE 639 (639)
|+..... ....+..+.|.+|.|||
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPE 197 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPE 197 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHH
Confidence 9987532 23456789999999998
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=243.72 Aligned_cols=149 Identities=23% Similarity=0.287 Sum_probs=130.2
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCC-CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||.||+|.. .+++.||||.++... ........+.+|+.++.+++||||+++++++.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3677889999999999999965 468999999987432 12233456788999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
||+++|+|.+++...+ .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 9999999999997654 367788899999999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=239.92 Aligned_cols=170 Identities=22% Similarity=0.267 Sum_probs=143.2
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCC-CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||.||+|+.. +++.||||.+.... ........+.+|+.++..++|+||+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999654 67889999986422 12223455788999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++.... ..+++..+..++.|++.|++|+|.. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999997532 2467788889999999999999998 9999999999999999999999999999876543
Q ss_pred CCC-cceeeeeceeeCCC
Q 046265 623 SSN-WSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~-~~~~~gt~~Y~APE 639 (639)
... ....+||+.|||||
T Consensus 156 ~~~~~~~~~gt~~y~aPE 173 (331)
T cd05624 156 GTVQSSVAVGTPDYISPE 173 (331)
T ss_pred CceeeccccCCcccCCHH
Confidence 221 23357999999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=235.69 Aligned_cols=169 Identities=22% Similarity=0.312 Sum_probs=141.3
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|+..+.||+|+||.||+|+.. +++.||||.+...... .....+.+|+.++++++||||+++++++.+++..|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 467888999999999999999654 6889999998754322 22345678999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||++ +++.+++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 83 EYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred ECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 9995 67777765432 2467788899999999999999998 9999999999999999999999999999765433
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
.......+||+.|||||
T Consensus 157 ~~~~~~~~~~~~y~aPE 173 (303)
T cd07869 157 SHTYSNEVVTLWYRPPD 173 (303)
T ss_pred CccCCCCcccCCCCChH
Confidence 33334567899999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=239.78 Aligned_cols=170 Identities=22% Similarity=0.251 Sum_probs=144.6
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||.||+|+. .+++.||||.++.... .......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3688889999999999999954 5689999999975432 2234556888999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++.... ..+++..+..++.|++.|++|+|.. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999997642 2477888999999999999999998 9999999999999999999999999999876543
Q ss_pred CCC-cceeeeeceeeCCC
Q 046265 623 SSN-WSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~-~~~~~gt~~Y~APE 639 (639)
... .....||+.|+|||
T Consensus 156 ~~~~~~~~~gt~~y~aPE 173 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPE 173 (330)
T ss_pred CceeeecccCCccccCHH
Confidence 222 22357999999998
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=239.68 Aligned_cols=170 Identities=22% Similarity=0.265 Sum_probs=143.0
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCC-CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||.||+|+. .+++.||||.+.+.. ......+.+.+|+.++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 3678889999999999999965 468899999986422 12223456888999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999996532 2467788899999999999999998 9999999999999999999999999998765433
Q ss_pred CCC-cceeeeeceeeCCC
Q 046265 623 SSN-WSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~-~~~~~gt~~Y~APE 639 (639)
... ....+||+.|||||
T Consensus 156 ~~~~~~~~~gt~~y~aPE 173 (331)
T cd05597 156 GTVQSNVAVGTPDYISPE 173 (331)
T ss_pred CCccccceeccccccCHH
Confidence 222 22357999999998
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=238.48 Aligned_cols=166 Identities=24% Similarity=0.297 Sum_probs=138.0
Q ss_pred CCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHH---hccccCceeeeEEEEEcCCceeEE
Q 046265 467 FDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKAL---TELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l---~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
|+..+.||+|+||.||+|.. .+++.||||.+..... .....+.+.+|++++ ++++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 55678999999999999964 5689999999875321 122234566666554 567899999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++|+|...+.. ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999988764 2478899999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
........+||+.|||||
T Consensus 154 ~~~~~~~~~g~~~y~aPE 171 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPE 171 (324)
T ss_pred CCCcccccccCccccCHh
Confidence 333344578999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=238.05 Aligned_cols=163 Identities=23% Similarity=0.273 Sum_probs=137.6
Q ss_pred ceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEEecccCC
Q 046265 471 YCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
+.||+|+||.||+|.. .+++.||+|.+..... .......+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999965 4678999999875422 223345577888888776 899999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
|+|..++.... .+++..+..++.+++.|++|||.. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 99998886543 477889999999999999999998 999999999999999999999999999986433333344
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
..+||+.|+|||
T Consensus 155 ~~~gt~~y~aPE 166 (329)
T cd05618 155 TFCGTPNYIAPE 166 (329)
T ss_pred cccCCccccCHH
Confidence 578999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=243.96 Aligned_cols=166 Identities=20% Similarity=0.343 Sum_probs=139.2
Q ss_pred CCcceeccCCCceEEEE-EcCCCcEEEEEEccCCC--CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc--eeEEe
Q 046265 468 DAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPH--PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ--SFLLY 542 (639)
Q Consensus 468 ~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~--~~lv~ 542 (639)
+...+||+|+|-+|||| +-.+|..||.-.++... ......++|..|+++++.++|||||++|.+|.+... ..+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34578999999999999 55567888865444322 223445889999999999999999999999998765 67889
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEccccccccCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG-LDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~-~~~~~kl~DfGla~~~~~ 621 (639)
|.|..|+|+.|.++.+. ++.+..+.+++||++||.|||++ .|+|||||||.+||+|+ ..|.+||+|.|+|+.+..
T Consensus 123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999987764 55688999999999999999986 57999999999999996 568999999999998864
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
. ....++|||.|||||
T Consensus 199 s--~aksvIGTPEFMAPE 214 (632)
T KOG0584|consen 199 S--HAKSVIGTPEFMAPE 214 (632)
T ss_pred c--ccceeccCccccChH
Confidence 3 334589999999998
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=237.65 Aligned_cols=163 Identities=24% Similarity=0.291 Sum_probs=134.4
Q ss_pred ceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHH-HHhccccCceeeeEEEEEcCCceeEEecccCC
Q 046265 471 YCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIK-ALTELRHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
+.||+|+||+||+|.. .+|+.||||.+..... .......+.+|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3689999999999965 4789999999875321 1122234445544 56779999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
|+|..++.... .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 99999887543 467788889999999999999998 999999999999999999999999999986543333344
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
..+||+.|||||
T Consensus 155 ~~~gt~~y~aPE 166 (323)
T cd05575 155 TFCGTPEYLAPE 166 (323)
T ss_pred cccCChhhcChh
Confidence 568999999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=237.46 Aligned_cols=168 Identities=20% Similarity=0.239 Sum_probs=139.9
Q ss_pred cCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccC-ceeeeEEEEEcCCceeEEe
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHR-NVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~ 542 (639)
+|+..+.||+|+||.||+|... +++.||||.+..... .....+.+..|++++..++|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4777889999999999999654 568899999875321 222345678899999998765 6888999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999887543 467889999999999999999998 9999999999999999999999999998754322
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
.......+||+.|+|||
T Consensus 155 ~~~~~~~~gt~~y~aPE 171 (324)
T cd05587 155 GKTTRTFCGTPDYIAPE 171 (324)
T ss_pred CCceeeecCCccccChh
Confidence 33334568999999998
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-27 Score=243.27 Aligned_cols=169 Identities=23% Similarity=0.315 Sum_probs=144.7
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|...+.||+|+||.||+|+.. +++.||||.+..... .......+.+|+.++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36788899999999999999654 789999999875321 1234466889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++... ..+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999765 3467788999999999999999998 9999999999999999999999999999876543
Q ss_pred C-----------------------------CCcceeeeeceeeCCC
Q 046265 623 S-----------------------------SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~-----------------------------~~~~~~~gt~~Y~APE 639 (639)
. .......||+.|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 200 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE 200 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHH
Confidence 2 1223467999999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=236.80 Aligned_cols=163 Identities=24% Similarity=0.309 Sum_probs=134.7
Q ss_pred ceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhc-cccCceeeeEEEEEcCCceeEEecccCC
Q 046265 471 YCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTE-LRHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
++||+|+||.||+|+. .+++.||||.++.... .....+.+..|..++.. .+||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999965 4578899999875321 12223345566666664 4899999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
|+|..++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 99999987643 367788889999999999999998 999999999999999999999999999986543333445
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
..+||+.|||||
T Consensus 155 ~~~gt~~y~aPE 166 (316)
T cd05592 155 TFCGTPDYIAPE 166 (316)
T ss_pred cccCCccccCHH
Confidence 578999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=233.56 Aligned_cols=172 Identities=21% Similarity=0.239 Sum_probs=149.3
Q ss_pred HhccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCCh-hhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDM-VVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
..+.|...++||+||||.||-+. ..+|+.+|.|++.+....+ ..+.....|-.++.++..|.||.+--.|++.+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 35778889999999999999985 4578999999987654322 234455789999999999999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
|+..|.||+|.-+|-+.+. +.++...+.-++.+|+.||++||.. +||+||+||+|||+|+.|+++|+|.|+|..+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999987665 5688899999999999999999999 99999999999999999999999999999886
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
.. ......+||.+|||||
T Consensus 339 ~g-~~~~~rvGT~GYMAPE 356 (591)
T KOG0986|consen 339 EG-KPIRGRVGTVGYMAPE 356 (591)
T ss_pred CC-CccccccCcccccCHH
Confidence 44 3334459999999998
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=231.79 Aligned_cols=164 Identities=22% Similarity=0.270 Sum_probs=138.1
Q ss_pred eccCCCceEEEEEc-CCCcEEEEEEccCCCCC-hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCCCh
Q 046265 473 IGTAGQASVYKAEL-PSWEIVAVKKFHSPHPD-MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550 (639)
Q Consensus 473 ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 550 (639)
||+|+||+||+|.. .+++.||||++...... ....+.+..|++++++++||||+++.+++...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999954 57889999998753321 12235577899999999999999999999999999999999999999
Q ss_pred hHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCccee
Q 046265 551 AIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEF 629 (639)
Q Consensus 551 ~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 629 (639)
...+.... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++..+..........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 88875422 234588899999999999999999998 99999999999999999999999999998765443334456
Q ss_pred eeeceeeCCC
Q 046265 630 VGTFGYVAPI 639 (639)
Q Consensus 630 ~gt~~Y~APE 639 (639)
.||+.|||||
T Consensus 158 ~g~~~y~aPE 167 (280)
T cd05608 158 AGTPGFMAPE 167 (280)
T ss_pred CCCcCccCHH
Confidence 7999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=237.69 Aligned_cols=163 Identities=23% Similarity=0.310 Sum_probs=136.7
Q ss_pred ceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEEecccCC
Q 046265 471 YCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
+.||+|+||.||+|+. .+++.||||.+..... .....+.+.+|..++... +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999965 4678999999875321 122345567888888776 699999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 99999887543 367788999999999999999998 999999999999999999999999999886533333344
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
..+||+.|||||
T Consensus 155 ~~~gt~~y~aPE 166 (320)
T cd05590 155 TFCGTPDYIAPE 166 (320)
T ss_pred ccccCccccCHH
Confidence 568999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=240.16 Aligned_cols=162 Identities=28% Similarity=0.441 Sum_probs=137.2
Q ss_pred CCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEeccc
Q 046265 467 FDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYL 545 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 545 (639)
|+..+.||+|+||.||+|.. .+++.||||.+.... .......+.+|++++++++|+||+++++++...+..|+||||+
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 34567899999999999964 478999999986543 2344567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC
Q 046265 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 625 (639)
++|+|.... ...+.....++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+++.+......
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 999986432 234567788999999999999998 9999999999999999999999999999876543333
Q ss_pred cceeeeeceeeCCC
Q 046265 626 WSEFVGTFGYVAPI 639 (639)
Q Consensus 626 ~~~~~gt~~Y~APE 639 (639)
....+||..|+|||
T Consensus 225 ~~~~~gt~~y~aPE 238 (353)
T PLN00034 225 CNSSVGTIAYMSPE 238 (353)
T ss_pred ccccccCccccCcc
Confidence 34568999999998
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=237.30 Aligned_cols=163 Identities=23% Similarity=0.282 Sum_probs=134.8
Q ss_pred ceeccCCCceEEEEE-cCCCcEEEEEEccCCCC-ChhhHHHHHHHHH-HHhccccCceeeeEEEEEcCCceeEEecccCC
Q 046265 471 YCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHP-DMVVQQAFSNEIK-ALTELRHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
+.||+|+||+||+|. ..+|+.||||.+..... .......+.+|.. +++.++||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 368999999999995 45789999999875321 1222344555554 46778999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
|+|..++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 99998886543 467789999999999999999998 999999999999999999999999999986433333344
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
..+||+.|||||
T Consensus 155 ~~~gt~~y~aPE 166 (325)
T cd05604 155 TFCGTPEYLAPE 166 (325)
T ss_pred cccCChhhCCHH
Confidence 578999999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=237.36 Aligned_cols=163 Identities=21% Similarity=0.276 Sum_probs=136.6
Q ss_pred ceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEEecccCC
Q 046265 471 YCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
++||+|+||.||+|+.. +++.||||.+..... .....+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999654 578999999875321 122345567888888765 799999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
|+|...+.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 99998886543 467788999999999999999998 999999999999999999999999999886543333344
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
..+||+.|||||
T Consensus 155 ~~~gt~~y~aPE 166 (321)
T cd05591 155 TFCGTPDYIAPE 166 (321)
T ss_pred ccccCccccCHH
Confidence 568999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=236.50 Aligned_cols=163 Identities=24% Similarity=0.275 Sum_probs=133.6
Q ss_pred ceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHH-HHhccccCceeeeEEEEEcCCceeEEecccCC
Q 046265 471 YCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIK-ALTELRHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
++||+|+||.||+|+. .+++.||||.+..... .......+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999965 4678999999875321 1222334555554 57789999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
|+|...+.... .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 99998886543 356678888999999999999998 999999999999999999999999999886433333334
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
..+||+.|+|||
T Consensus 155 ~~~gt~~y~aPE 166 (321)
T cd05603 155 TFCGTPEYLAPE 166 (321)
T ss_pred cccCCcccCCHH
Confidence 568999999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=236.48 Aligned_cols=168 Identities=21% Similarity=0.248 Sum_probs=139.8
Q ss_pred cCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEEe
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 542 (639)
+|...+.||+|+||.||+|... +++.||||.+..... .......+..|..++... +||+|+++++++...+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4777889999999999999654 578999999875321 122234566788888776 5899999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+.+...+ .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999998886543 467789999999999999999998 9999999999999999999999999999865433
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
.......+||+.|||||
T Consensus 155 ~~~~~~~~gt~~y~aPE 171 (323)
T cd05616 155 GVTTKTFCGTPDYIAPE 171 (323)
T ss_pred CCccccCCCChhhcCHH
Confidence 33344578999999998
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=237.64 Aligned_cols=162 Identities=31% Similarity=0.507 Sum_probs=139.9
Q ss_pred cchHHHHHHHhccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEE
Q 046265 454 KILYEEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSF 533 (639)
Q Consensus 454 ~~~~~~~~~~~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 533 (639)
.+.|+++.+ .+-+|.|+.|.||+|++++ +.||||+++.- -+.+|.-+++++|||||.+.|+|.
T Consensus 120 eiPFe~IsE-------LeWlGSGaQGAVF~Grl~n-etVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCt 182 (904)
T KOG4721|consen 120 EIPFEEISE-------LEWLGSGAQGAVFLGRLHN-ETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCT 182 (904)
T ss_pred cCCHHHhhh-------hhhhccCcccceeeeeccC-ceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeec
Confidence 456666653 4579999999999999875 88999998632 145788999999999999999999
Q ss_pred cCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 046265 534 HPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDF 613 (639)
Q Consensus 534 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~Df 613 (639)
..-.++||||||+.|-|+.+++.+... .-...+.+..+||.|+.|||.+ .|||||||.-||||..+-.+||+||
T Consensus 183 qsPcyCIiMEfCa~GqL~~VLka~~~i---tp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDF 256 (904)
T KOG4721|consen 183 QSPCYCIIMEFCAQGQLYEVLKAGRPI---TPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDF 256 (904)
T ss_pred CCceeEEeeeccccccHHHHHhccCcc---CHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccc
Confidence 999999999999999999999877653 3356677899999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCCCcceeeeeceeeCCC
Q 046265 614 GISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 614 Gla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|.++..... +....++||..|||||
T Consensus 257 GTS~e~~~~-STkMSFaGTVaWMAPE 281 (904)
T KOG4721|consen 257 GTSKELSDK-STKMSFAGTVAWMAPE 281 (904)
T ss_pred cchHhhhhh-hhhhhhhhhHhhhCHH
Confidence 999876543 4455699999999998
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=232.65 Aligned_cols=169 Identities=26% Similarity=0.417 Sum_probs=143.1
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|+||.||+|+.+ +++.||||++..........+.+.+|+.++++++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888899999999999999765 67889999997654334445678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|++++.+..+.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99998777655432 3477888999999999999999998 99999999999999999999999999998764322
Q ss_pred C-CcceeeeeceeeCCC
Q 046265 624 S-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~-~~~~~~gt~~Y~APE 639 (639)
. ......||+.|+|||
T Consensus 155 ~~~~~~~~~~~~y~aPE 171 (287)
T cd07848 155 NANYTEYVATRWYRSPE 171 (287)
T ss_pred cccccccccccccCCcH
Confidence 2 223467999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=236.11 Aligned_cols=163 Identities=23% Similarity=0.267 Sum_probs=138.0
Q ss_pred ceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEEecccCC
Q 046265 471 YCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
+.||+|+||.||+|.. .+++.||||.+..... .....+.+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999965 4678999999975432 123345678899999887 699999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
|+|..++...+ .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 99998886543 478899999999999999999998 999999999999999999999999999986433333344
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
..+||+.|||||
T Consensus 155 ~~~gt~~y~aPE 166 (327)
T cd05617 155 TFCGTPNYIAPE 166 (327)
T ss_pred cccCCcccCCHH
Confidence 578999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=236.58 Aligned_cols=168 Identities=20% Similarity=0.251 Sum_probs=139.8
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCceeEEe
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 542 (639)
+|+..+.||+|+||.||+|.. .+++.||||.+..... .....+.+..|+.++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 467788999999999999964 5689999999875321 1223345678888888875 577888999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999987543 478899999999999999999998 9999999999999999999999999999865433
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
.......+||+.|||||
T Consensus 155 ~~~~~~~~gt~~y~aPE 171 (323)
T cd05615 155 GVTTRTFCGTPDYIAPE 171 (323)
T ss_pred CccccCccCCccccCHH
Confidence 33334567999999998
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=254.14 Aligned_cols=172 Identities=25% Similarity=0.379 Sum_probs=143.1
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.+|+..+.||+|+||.||+|.. .+++.||||++..... .....+.|.+|++++++++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4678889999999999999965 4689999999975432 2334567899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCC--------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 046265 543 EYLGRGSLAIILSNDAA--------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfG 614 (639)
||+++|+|.+++..... ....++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 12356778889999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCC------------------CCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDS------------------SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~------------------~~~~~~~gt~~Y~APE 639 (639)
+|+...... ......+||+.|||||
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE 201 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE 201 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHH
Confidence 998662110 0112357999999998
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=236.79 Aligned_cols=168 Identities=22% Similarity=0.264 Sum_probs=141.0
Q ss_pred cCCCcceeccCCCceEEEEEc----CCCcEEEEEEccCCCC--ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCce
Q 046265 466 NFDAKYCIGTAGQASVYKAEL----PSWEIVAVKKFHSPHP--DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 538 (639)
+|+..+.||+|+||.||+|+. .+++.||+|.+..... .....+.+.+|+.++.++ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 467788999999999999864 3678999999864321 122345678899999999 499999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
++||||+++|+|.+++..+. .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999987543 467788999999999999999998 999999999999999999999999999986
Q ss_pred CCCCC-CCcceeeeeceeeCCC
Q 046265 619 LKPDS-SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~-~~~~~~~gt~~Y~APE 639 (639)
..... ......+||+.|||||
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE 176 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPE 176 (332)
T ss_pred ccccCCCccccccCCccccCHH
Confidence 54322 2233468999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-26 Score=246.64 Aligned_cols=168 Identities=22% Similarity=0.208 Sum_probs=140.9
Q ss_pred CCCcceeccCCCceEEEEEc-CC-CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 467 FDAKYCIGTAGQASVYKAEL-PS-WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
|...+.+|+|++|.||+|.. .+ ++.||+|.+.... ......+.+|+.++++++|||||+++++|...+..|+||||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 77788999999999999954 34 5778888765432 33345678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 545 LGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 545 ~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
+++|+|.+++.... ....+++..+..++.|++.||+|+|.. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 99999998886432 223477888899999999999999998 99999999999999999999999999998764332
Q ss_pred C--CcceeeeeceeeCCC
Q 046265 624 S--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~--~~~~~~gt~~Y~APE 639 (639)
. .....+||++|||||
T Consensus 224 ~~~~~~~~~gt~~y~aPE 241 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPE 241 (478)
T ss_pred ccccccccCCCccccCHh
Confidence 1 234567999999998
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=235.75 Aligned_cols=163 Identities=23% Similarity=0.266 Sum_probs=132.7
Q ss_pred ceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHH-HHHhccccCceeeeEEEEEcCCceeEEecccCC
Q 046265 471 YCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEI-KALTELRHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~-~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
+.||+|+||.||+|... +++.||+|.+..... .......+.+|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36899999999999654 668899999875321 112223344444 456778999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
|+|.+++.... .+.+..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 99999987643 355677888999999999999998 999999999999999999999999999986543333344
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
..+||+.|||||
T Consensus 155 ~~~gt~~y~aPE 166 (325)
T cd05602 155 TFCGTPEYLAPE 166 (325)
T ss_pred cccCCccccCHH
Confidence 578999999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-26 Score=233.97 Aligned_cols=168 Identities=26% Similarity=0.376 Sum_probs=144.4
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|+..+.||+|+||.||+|.. .++..||+|.+.... .....+.+.+|++++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 36788889999999999999965 467889999987542 2344567899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++.... .+++..+..++.+++.|+.|||+.+ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 83 EHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999997643 3677889999999999999999852 6999999999999999999999999999865432
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
......||+.|+|||
T Consensus 158 --~~~~~~g~~~y~aPE 172 (331)
T cd06649 158 --MANSFVGTRSYMSPE 172 (331)
T ss_pred --ccccCCCCcCcCCHh
Confidence 223467999999998
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-26 Score=236.59 Aligned_cols=170 Identities=21% Similarity=0.273 Sum_probs=142.4
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCC-CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||.||+|..+ +++.||+|.+.+.. ........+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36788899999999999999765 56789999986422 11223445788999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++.... ..+++..+..++.|++.|++|+|.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999997532 2477888899999999999999998 9999999999999999999999999999765432
Q ss_pred CC-CcceeeeeceeeCCC
Q 046265 623 SS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~-~~~~~~gt~~Y~APE 639 (639)
.. .....+||+.|||||
T Consensus 156 ~~~~~~~~~gt~~y~aPE 173 (332)
T cd05623 156 GTVQSSVAVGTPDYISPE 173 (332)
T ss_pred CcceecccccCccccCHH
Confidence 22 223357999999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-26 Score=234.14 Aligned_cols=163 Identities=23% Similarity=0.281 Sum_probs=135.2
Q ss_pred ceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhc-cccCceeeeEEEEEcCCceeEEecccCC
Q 046265 471 YCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTE-LRHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
++||+|+||.||+|+.. +++.||||.++.... .......+..|..++.. .+||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36899999999999654 678999999875321 11223445677777765 4899999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
|+|..++.... .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 99999887543 467788999999999999999998 999999999999999999999999999875432233344
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
..+||+.|+|||
T Consensus 155 ~~~gt~~y~aPE 166 (316)
T cd05620 155 TFCGTPDYIAPE 166 (316)
T ss_pred ccCCCcCccCHH
Confidence 578999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-26 Score=229.58 Aligned_cols=169 Identities=22% Similarity=0.256 Sum_probs=142.8
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCC-hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPD-MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
+|+..+.||+|+||.||+|.. .+++.||||++...... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 467788999999999999964 56899999998753322 2234557789999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++|+|.+++..... ..+++..+..++.|++.|++|||.. +|+||||||+||++++++.++|+|||++..+...
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG- 155 (285)
T ss_pred ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-
Confidence 9999999988865332 3578899999999999999999998 9999999999999999999999999999876432
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
......+|++.|||||
T Consensus 156 ~~~~~~~~~~~y~aPE 171 (285)
T cd05605 156 ETIRGRVGTVGYMAPE 171 (285)
T ss_pred CccccccCCCCccCcH
Confidence 2223457999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-26 Score=233.40 Aligned_cols=163 Identities=23% Similarity=0.306 Sum_probs=135.1
Q ss_pred ceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhc-cccCceeeeEEEEEcCCceeEEecccCC
Q 046265 471 YCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTE-LRHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
+.||+|+||.||+|+.. +++.||||.++.... .....+.+..|..++.. .+||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999654 578999999875321 11223445677788776 4899999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 99999987543 467888999999999999999998 999999999999999999999999999875432233334
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
..+||+.|||||
T Consensus 155 ~~~gt~~y~aPE 166 (316)
T cd05619 155 TFCGTPDYIAPE 166 (316)
T ss_pred eecCCccccCHH
Confidence 568999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=238.01 Aligned_cols=171 Identities=22% Similarity=0.310 Sum_probs=139.9
Q ss_pred ccCCCcceeccCCCceEEEEEc------CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCc
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 537 (639)
++|+..+.||+|+||.||+|.. .++..||||+++... .....+.+.+|+++++.+ +|||||+++++|...+.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 4577789999999999999953 245689999987533 223456788999999999 89999999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCC----------------------------------------------------------
Q 046265 538 SFLLYEYLGRGSLAIILSNDAA---------------------------------------------------------- 559 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 559 (639)
.++||||+++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998864321
Q ss_pred --------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC
Q 046265 560 --------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625 (639)
Q Consensus 560 --------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 625 (639)
...++|..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++.+......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 11468888999999999999999998 9999999999999999999999999999876433221
Q ss_pred --cceeeeeceeeCCC
Q 046265 626 --WSEFVGTFGYVAPI 639 (639)
Q Consensus 626 --~~~~~gt~~Y~APE 639 (639)
.....++..|||||
T Consensus 271 ~~~~~~~~~~~y~aPE 286 (375)
T cd05104 271 VVKGNARLPVKWMAPE 286 (375)
T ss_pred cccCCCCCCcceeChh
Confidence 11233556899998
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.3e-27 Score=219.40 Aligned_cols=173 Identities=22% Similarity=0.352 Sum_probs=141.9
Q ss_pred HhccCCCcceeccCCCceEEEEEcCC-----CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc-CC
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELPS-----WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH-PR 536 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~ 536 (639)
....|+....||+|.||.||+|...+ .+.+|+|+++............-+|+.+++.++|||||.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34567778889999999999994332 2369999998765444444455689999999999999999999987 77
Q ss_pred ceeEEecccCCCChhHHhhcCC--CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC----CceEE
Q 046265 537 QSFLLYEYLGRGSLAIILSNDA--AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD----YDAHV 610 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~----~~~kl 610 (639)
.+|+++||++. +|.++++-++ ....++-..+..|..|++.|+.|||+. =|+|||+||+|||+..+ |.+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence 89999999976 7878876432 224678888999999999999999998 79999999999999766 99999
Q ss_pred ccccccccCCCCCCC---cceeeeeceeeCCC
Q 046265 611 SDFGISKFLKPDSSN---WSEFVGTFGYVAPI 639 (639)
Q Consensus 611 ~DfGla~~~~~~~~~---~~~~~gt~~Y~APE 639 (639)
+|||+|+.+...-.. ...++.|.+|+|||
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPE 209 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPE 209 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChH
Confidence 999999988654332 34578999999998
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-26 Score=237.70 Aligned_cols=172 Identities=24% Similarity=0.327 Sum_probs=139.8
Q ss_pred hccCCCcceeccCCCceEEEEEc------CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCC
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPR 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 536 (639)
.++|+..+.||+|+||.||+|.. .++..||||++..... ....+.+.+|+++++.+ +|||||+++++|...+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 34678889999999999999853 2335799999975432 23456788999999999 8999999999999999
Q ss_pred ceeEEecccCCCChhHHhhcCCC---------------------------------------------------------
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAA--------------------------------------------------------- 559 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 559 (639)
..|+||||+++|+|.+++.....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999998853210
Q ss_pred ----------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC--cc
Q 046265 560 ----------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN--WS 627 (639)
Q Consensus 560 ----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~--~~ 627 (639)
...+++..+.+++.|+++|++|||+. +|+||||||+||++++++.+||+|||+++.+...... ..
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 12367888999999999999999998 9999999999999999999999999999875432211 11
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
...+++.|||||
T Consensus 273 ~~~~~~~y~aPE 284 (374)
T cd05106 273 NARLPVKWMAPE 284 (374)
T ss_pred CCCCccceeCHH
Confidence 233567899998
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=235.63 Aligned_cols=167 Identities=24% Similarity=0.420 Sum_probs=138.2
Q ss_pred cCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC-----cee
Q 046265 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR-----QSF 539 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~ 539 (639)
+|+..+.||+|+||.||+|. ..+++.||||++............+.+|+.++++++||||+++++++...+ ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 46778899999999999996 457899999998754323333456889999999999999999999886432 479
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||++ ++|.+++.... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68888886543 478899999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCC---CcceeeeeceeeCCC
Q 046265 620 KPDSS---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~---~~~~~~gt~~Y~APE 639 (639)
..... .....+||+.|+|||
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE 176 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPE 176 (338)
T ss_pred ccccCccccccCCCCCCCcCCHH
Confidence 32211 223467999999998
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=246.35 Aligned_cols=168 Identities=24% Similarity=0.395 Sum_probs=139.5
Q ss_pred CCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 468 DAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 468 ~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
...+.+|+|+||+||+|+.. +.+.||||.++... +...+++|++|+++++.++|||||+++|+|.+++..++|
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 44678999999999999653 33569999998644 445789999999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCC-----------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 046265 542 YEYLGRGSLAIILSNDAA-----------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV 610 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl 610 (639)
+|||..|||.++|....+ ...++..+.+.||.|||.||+||-.+ ..|||||...|+||++...+||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEe
Confidence 999999999999964321 12377889999999999999999998 8899999999999999999999
Q ss_pred ccccccccCCCCCC-C-cceeeeeceeeCCC
Q 046265 611 SDFGISKFLKPDSS-N-WSEFVGTFGYVAPI 639 (639)
Q Consensus 611 ~DfGla~~~~~~~~-~-~~~~~gt~~Y~APE 639 (639)
+|||+++.+-..+. . .....=-..|||||
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppE 675 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPE 675 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHH
Confidence 99999997532211 1 10112235799998
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=227.91 Aligned_cols=168 Identities=21% Similarity=0.326 Sum_probs=136.1
Q ss_pred cCCCcceeccCCCceEEEEEc-C-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc---ccCceeeeEEEEEc-----C
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-P-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL---RHRNVVKFYGFSFH-----P 535 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~-----~ 535 (639)
+|+..+.||+|+||.||+|+. . +++.||||.++...........+.+|+.+++.+ +||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 678889999999999999965 3 468899999876443333344566777777665 69999999999863 3
Q ss_pred CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGl 615 (639)
...++||||++ +++.+++..... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 46899999996 688888865332 3478899999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCcceeeeeceeeCCC
Q 046265 616 SKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
++..... .......||+.|+|||
T Consensus 157 ~~~~~~~-~~~~~~~~~~~y~aPE 179 (290)
T cd07862 157 ARIYSFQ-MALTSVVVTLWYRAPE 179 (290)
T ss_pred eEeccCC-cccccccccccccChH
Confidence 9876433 2234567999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=232.32 Aligned_cols=168 Identities=25% Similarity=0.374 Sum_probs=143.4
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|+..+.||+|+||.||+|... +++.+|+|.+.... .......+.+|++++++++||||++++++|.+++..|+||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 367888899999999999999655 67889999887542 2334567899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++...+ .+++.....++.+++.|++|||+.+ +|+||||||+||+++.++.+||+|||++..+...
T Consensus 83 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999997643 3677888899999999999999742 6999999999999999999999999999765322
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
......||+.|+|||
T Consensus 158 --~~~~~~~~~~y~aPE 172 (333)
T cd06650 158 --MANSFVGTRSYMSPE 172 (333)
T ss_pred --ccccCCCCccccCHH
Confidence 223457999999998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-26 Score=237.78 Aligned_cols=161 Identities=19% Similarity=0.288 Sum_probs=137.5
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
..+|+..+.||+|+||.||+|. ..+++.||+|+... ..+.+|++++++++|||||++++++......++||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 3578899999999999999995 46788999997532 34678999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+. ++|..++.... .+++..+..++.|++.||+|+|.. +|+||||||+||+++.++.+||+|||+|+.....
T Consensus 163 e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 163 PRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred ecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 9995 68888876543 477899999999999999999998 9999999999999999999999999999754322
Q ss_pred -CCCcceeeeeceeeCCC
Q 046265 623 -SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 -~~~~~~~~gt~~Y~APE 639 (639)
.......+||+.|+|||
T Consensus 236 ~~~~~~~~~gt~~y~aPE 253 (391)
T PHA03212 236 NANKYYGWAGTIATNAPE 253 (391)
T ss_pred cccccccccCccCCCChh
Confidence 12233468999999998
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=199.69 Aligned_cols=168 Identities=23% Similarity=0.363 Sum_probs=143.7
Q ss_pred cCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.||+|.||+||+|+ ..+++.||+|+++....+........+||.+++.++|.|||++++...++...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 34456789999999999995 45679999999987665555566678999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
|. .+|..+...-. ..++...+...+.|+++|+.|+|++ .++|||+||.|.+++.+|..|++|||+|+.+.-...
T Consensus 83 cd-qdlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 94 57777765433 3566678888999999999999999 899999999999999999999999999998765555
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
..+..+.|.+|.+|.
T Consensus 157 cysaevvtlwyrppd 171 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPD 171 (292)
T ss_pred eeeceeeeeeccCcc
Confidence 566778899999985
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.5e-26 Score=233.58 Aligned_cols=161 Identities=24% Similarity=0.271 Sum_probs=132.4
Q ss_pred eccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhcc---ccCceeeeEEEEEcCCceeEEecccCC
Q 046265 473 IGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTEL---RHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 473 ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
||+|+||.||+|+. .+++.||||.+..... .......+..|..++.+. +||||+++++++..++..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999965 5689999999864321 111223345566666654 699999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
|+|..++.... .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 99998887543 467789999999999999999998 999999999999999999999999999976433333344
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
..+||+.|||||
T Consensus 155 ~~~gt~~y~aPE 166 (330)
T cd05586 155 TFCGTTEYLAPE 166 (330)
T ss_pred CccCCccccCHH
Confidence 578999999998
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=223.61 Aligned_cols=169 Identities=18% Similarity=0.251 Sum_probs=140.7
Q ss_pred ccCCCcceeccCCCceEEEEEcC----CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP----SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
++|+..+.||+|+||.||+|... .+..||+|.++... .......|.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 45778899999999999999643 35689999988643 23345678999999999999999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||||+++|+|.+++.... ..++|..+..++.|++.|++|||.. +++||||||+||+++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999987543 3578999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCC-CcceeeeeceeeCCC
Q 046265 621 PDSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~-~~~~~~gt~~Y~APE 639 (639)
.... ......++..|+|||
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE 178 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPE 178 (266)
T ss_pred ccchhcccCCCCceeecCHH
Confidence 2211 111234567899998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-26 Score=244.92 Aligned_cols=175 Identities=22% Similarity=0.220 Sum_probs=146.0
Q ss_pred HHhccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC----
Q 046265 462 RATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR---- 536 (639)
Q Consensus 462 ~~~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~---- 536 (639)
....+|...+.||+|+||.||+|+ ..+++.||||.+............+.+|+..+..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 345788899999999999999995 567899999999765544455667889999999999999999988775432
Q ss_pred ----ceeEEecccCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 046265 537 ----QSFLLYEYLGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVS 611 (639)
Q Consensus 537 ----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~ 611 (639)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|+|.. +|+||||||+||+++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 3689999999999999987533 224578889999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCCC--CCcceeeeeceeeCCC
Q 046265 612 DFGISKFLKPDS--SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 612 DfGla~~~~~~~--~~~~~~~gt~~Y~APE 639 (639)
|||+++.+.... ......+||+.|||||
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE 215 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHH
Confidence 999998764321 1234568999999998
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=219.91 Aligned_cols=170 Identities=23% Similarity=0.247 Sum_probs=145.1
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.++|+..+++|+|.||+|-.++ ..+++.+|+|.+++.-. .......-..|-+++...+||.+..+--.|+..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3677888999999999999994 56789999999986532 122233346788999999999999998888999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+.||.|+-++.+.+. ++.....-+-.+|..||.|||+. +||.||+|.+|.|+|++|++||+|||+++.-..
T Consensus 247 MeyanGGeLf~HLsrer~---FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERV---FSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhhhhc---ccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence 999999999988876543 45566666788999999999998 999999999999999999999999999998666
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
.....+++||||.|.|||
T Consensus 321 ~g~t~kTFCGTPEYLAPE 338 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPE 338 (516)
T ss_pred ccceeccccCChhhcCch
Confidence 666778899999999998
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=223.68 Aligned_cols=164 Identities=27% Similarity=0.362 Sum_probs=135.1
Q ss_pred cCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHH--HhccccCceeeeEEEEEcCC----cee
Q 046265 466 NFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKA--LTELRHRNVVKFYGFSFHPR----QSF 539 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~--l~~l~H~niv~l~~~~~~~~----~~~ 539 (639)
+-...+.||+|.||.||+|+++ |+.||||.+...+ ++.+.+|.++ -..++|+||.++++.-..+. ++|
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred eeEEEEEecCccccceeecccc-CCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 3455789999999999999988 5889999998644 2334455554 45579999999998765443 689
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeecCCCCCeeeCCCCceEEcccc
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHD-----YFPPIVHRDISSKNVLLGLDYDAHVSDFG 614 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----~~~~iiHrdlk~~Nill~~~~~~kl~DfG 614 (639)
+|.||.+.|+|++++... .++-...++++..+|.||+|||.. ..|.|.|||||+.|||+.+++.+-|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 999999999999999863 467788999999999999999964 46899999999999999999999999999
Q ss_pred ccccCCCCCC----CcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSS----NWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~----~~~~~~gt~~Y~APE 639 (639)
+|........ .....+||..|||||
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPE 390 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPE 390 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChH
Confidence 9987654422 224569999999998
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=231.46 Aligned_cols=163 Identities=23% Similarity=0.282 Sum_probs=137.1
Q ss_pred ceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEEecccCC
Q 046265 471 YCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
++||+|+||.||+|+.. +++.||||.++.... .......+.+|++++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999654 578999999875321 122345567888888877 699999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
|+|...+.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 99998887543 478899999999999999999998 999999999999999999999999999876433333334
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
..+||+.|||||
T Consensus 155 ~~~g~~~y~aPE 166 (318)
T cd05570 155 TFCGTPDYIAPE 166 (318)
T ss_pred ceecCccccCHH
Confidence 568999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=235.15 Aligned_cols=172 Identities=22% Similarity=0.303 Sum_probs=140.8
Q ss_pred hccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCC
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPR 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~ 536 (639)
.+.|...+.||+|+||.||+|... .+..||||++.... .....+.+.+|+++++++. |||||+++++|...+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 356777899999999999999642 23469999997543 2334567899999999996 999999999999999
Q ss_pred ceeEEecccCCCChhHHhhcCCC---------------------------------------------------------
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAA--------------------------------------------------------- 559 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 559 (639)
..|+|||||++|+|.++++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999988864210
Q ss_pred ------------------------------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC
Q 046265 560 ------------------------------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG 603 (639)
Q Consensus 560 ------------------------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~ 603 (639)
...+++..+..++.|+++|++|||.. +|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 12377888899999999999999998 999999999999999
Q ss_pred CCCceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 604 LDYDAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 604 ~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
.++.+|++|||+++....... ......+++.|||||
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 309 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE 309 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence 999999999999986543221 122345778899998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-26 Score=229.69 Aligned_cols=167 Identities=24% Similarity=0.331 Sum_probs=141.6
Q ss_pred CCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCC
Q 046265 468 DAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 468 ~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
...+.||+|.||.|..++...+..||||+++... ....+.+|.+||.+|.+++|||||+++|+|..++.+++++|||++
T Consensus 541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn 619 (807)
T KOG1094|consen 541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN 619 (807)
T ss_pred ehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence 4567999999999999999989999999998654 344578899999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC-Cc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS-NW 626 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~-~~ 626 (639)
|+|.+++..+.... .......+|+.||+.|++||.+. ++||||+.+.|+|+|.++++||+|||.++-+-.... ..
T Consensus 620 GDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 620 GDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred CcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 99999998764432 34456778999999999999998 899999999999999999999999999995533222 11
Q ss_pred c-eeeeeceeeCCC
Q 046265 627 S-EFVGTFGYVAPI 639 (639)
Q Consensus 627 ~-~~~gt~~Y~APE 639 (639)
. ..+=-..|||||
T Consensus 696 qgr~vlpiRwmawE 709 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWE 709 (807)
T ss_pred ecceeeeeeehhHH
Confidence 1 233346899998
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=215.76 Aligned_cols=172 Identities=22% Similarity=0.340 Sum_probs=146.2
Q ss_pred chHHHHHHHhccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEE
Q 046265 455 ILYEEVIRATNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFS 532 (639)
Q Consensus 455 ~~~~~~~~~~~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~ 532 (639)
.+|+++.+-| .+.+|+|+|+.|..+ .+.+|.+||||.+.+.. ...+.+..+|++++...+ |+||+++++||
T Consensus 73 g~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefF 145 (463)
T KOG0607|consen 73 GKFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFF 145 (463)
T ss_pred chHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence 3578888777 578999999999998 68899999999998753 345667889999999985 99999999999
Q ss_pred EcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC---CceE
Q 046265 533 FHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD---YDAH 609 (639)
Q Consensus 533 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~---~~~k 609 (639)
+++...|+|||-|.||++-++++.+. .+.+..+.+++++|+.||.|||.. +|.|||+||+|||-.+. .-+|
T Consensus 146 Edd~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 146 EDDTRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred cccceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCcee
Confidence 99999999999999999999998765 466788999999999999999999 99999999999998543 4589
Q ss_pred EccccccccCCCCC--C-----CcceeeeeceeeCCC
Q 046265 610 VSDFGISKFLKPDS--S-----NWSEFVGTFGYVAPI 639 (639)
Q Consensus 610 l~DfGla~~~~~~~--~-----~~~~~~gt~~Y~APE 639 (639)
||||.++..+.... + ...+.+|+..|||||
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPE 256 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPE 256 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchh
Confidence 99998877543221 1 123579999999998
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=228.14 Aligned_cols=168 Identities=21% Similarity=0.350 Sum_probs=140.3
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|...+.||+|+||.||+|+.+ +++.||||+++..... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 46778889999999999999654 6788999998754322 223457789999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++ ++.+++...+ ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 85 YLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 9975 7877776443 2467888899999999999999998 99999999999999999999999999998654333
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......+|+.|+|||
T Consensus 159 ~~~~~~~~~~~y~aPE 174 (309)
T cd07872 159 KTYSNEVVTLWYRPPD 174 (309)
T ss_pred cccccccccccccCCH
Confidence 3334457899999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=224.09 Aligned_cols=170 Identities=22% Similarity=0.313 Sum_probs=143.1
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.||+|++|.||+|.. .+++.||||++............+.+|+.++++++||||+++++++..++..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 366778999999999999965 4689999999876443333446678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
++ +++.+++........+++..+..++.|+++||+|||.. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 68888886544334688899999999999999999998 999999999999999999999999999876543332
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......+++.|+|||
T Consensus 157 ~~~~~~~~~~y~aPE 171 (285)
T cd07861 157 VYTHEVVTLWYRAPE 171 (285)
T ss_pred cccCCcccccccChH
Confidence 233446789999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=238.09 Aligned_cols=180 Identities=23% Similarity=0.436 Sum_probs=152.0
Q ss_pred cchHHHHHHHhccC---------CCcceeccCCCceEEEEEcCC----CcEEEEEEccCCCCChhhHHHHHHHHHHHhcc
Q 046265 454 KILYEEVIRATNNF---------DAKYCIGTAGQASVYKAELPS----WEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL 520 (639)
Q Consensus 454 ~~~~~~~~~~~~~f---------~~~~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l 520 (639)
.++||+.-+|...| ..+++||.|.||.||+|+++. ...||||.++... ....+.+|..|+.+|.++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccC
Confidence 56677776666555 345799999999999997753 2469999998754 345678899999999999
Q ss_pred ccCceeeeEEEEEcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 046265 521 RHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNV 600 (639)
Q Consensus 521 ~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Ni 600 (639)
.|||||++.|+......++||.|||++|+|+.+|+.+.+ .+.|.+...+.++||.|+.||-.+ +.|||||.+.||
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNI 762 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNI 762 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhe
Confidence 999999999999999999999999999999999987653 588999999999999999999998 899999999999
Q ss_pred eeCCCCceEEccccccccCCCCCCC-cceeeee--ceeeCCC
Q 046265 601 LLGLDYDAHVSDFGISKFLKPDSSN-WSEFVGT--FGYVAPI 639 (639)
Q Consensus 601 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~gt--~~Y~APE 639 (639)
|++.+..+||+|||+++.++.+... +++.-|. ..|.|||
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPE 804 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPE 804 (996)
T ss_pred eeccceEEEeccccceeecccCCCccccccCCccceeecChh
Confidence 9999999999999999988765432 2222222 4799998
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=220.27 Aligned_cols=170 Identities=21% Similarity=0.321 Sum_probs=147.5
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.||+|++|.||+|.. .+++.||+|.+..........+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 366778999999999999965 4678999999876544455677889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++++|.+++..... ..+++..+..++.+++.|++|||.. +|+|||+||+||+++.++.+|++|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQRG-RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 999999999976422 3578899999999999999999988 999999999999999999999999999987654433
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......|++.|+|||
T Consensus 157 ~~~~~~~~~~y~aPE 171 (256)
T cd08529 157 FANTIVGTPYYLSPE 171 (256)
T ss_pred hhhccccCccccCHH
Confidence 334567899999998
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-28 Score=258.36 Aligned_cols=376 Identities=30% Similarity=0.432 Sum_probs=254.4
Q ss_pred cceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCE
Q 046265 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQ 82 (639)
Q Consensus 3 ~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 82 (639)
|..-.+.++.+++|-+. ..|.+.+++.+|++|+|.+|.+. .+|..+..+++|++||+++|++. .+|..+..++.+..
T Consensus 65 t~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~ 141 (1081)
T KOG0618|consen 65 TLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEE 141 (1081)
T ss_pred hhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHH
Confidence 44455667778888776 67889999999999999999987 78999999999999999999997 78877766666655
Q ss_pred Eeeecc-------------------cCccccCccccCCCC-CC-----cccCC-CCCcccC-------------------
Q 046265 83 LVLYCN-------------------GLSGWLPSSFGNLNN-LA-----IGSMP-NSLSNLT------------------- 117 (639)
Q Consensus 83 L~L~~N-------------------~l~~~~p~~~~~l~~-L~-----~~~lp-~~~~~l~------------------- 117 (639)
+..++| .+.+.++.++.+++. |. +.... ..+.+++
T Consensus 142 ~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~~dls~~~~l~~l~c~rn~ls~l~~~g~~l 221 (1081)
T KOG0618|consen 142 LAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEVLDLSNLANLEVLHCERNQLSELEISGPSL 221 (1081)
T ss_pred HhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhheeeecccchhhhhhhhhccchhhhhhhhcccceEEecCcch
Confidence 555555 444445555555544 11 00000 0000000
Q ss_pred ------------------CCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcC
Q 046265 118 ------------------SLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLL 179 (639)
Q Consensus 118 ------------------~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 179 (639)
...++++|++.|+++ .+|+|++.+.+|+.++...|+++ .+|..+...++|+.|.+..|.+
T Consensus 222 ~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel 299 (1081)
T KOG0618|consen 222 TALYADHNPLTTLDVHPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNEL 299 (1081)
T ss_pred heeeeccCcceeeccccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhh
Confidence 113456666666666 45566666666666666666664 5666666666666666666666
Q ss_pred CccCCccCcCCCCCCeEEccCCcccc---cc-ccc-cCCcEEEcCCcccCCCCCc-cccCCCCCceeccccccccCcchh
Q 046265 180 NGVLPPSISNLSNLEGLYLYSSLVSA---EI-GNL-LQLIELEIDNKQLFGQIPK-SLRNFTSLNIVHLEQNHLTGNIYE 253 (639)
Q Consensus 180 ~~~~p~~~~~l~~L~~L~l~~~~~~~---~~-~~l-~~L~~L~l~~n~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~~ 253 (639)
. -+|+....++.|+.|++..+.++. .+ ..+ ..|..|+.+.|.+.. .|. .=..+..|+.|++.+|+++...-.
T Consensus 300 ~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~-lp~~~e~~~~~Lq~LylanN~Ltd~c~p 377 (1081)
T KOG0618|consen 300 E-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLST-LPSYEENNHAALQELYLANNHLTDSCFP 377 (1081)
T ss_pred h-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccc-cccccchhhHHHHHHHHhcCcccccchh
Confidence 5 345556666667777766554432 11 111 124455555555532 221 112456788899999999887777
Q ss_pred hhhcCCCccEEeccCCcccccccCcCCccccccCc-cccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcc
Q 046265 254 VFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPP-KIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYG 332 (639)
Q Consensus 254 ~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~-~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~ 332 (639)
.+.++..|+.|+|++|++ +++|. .+.++..|+.|+||+|+++ .+|.++.++..|++|...+|.+.
T Consensus 378 ~l~~~~hLKVLhLsyNrL------------~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~- 443 (1081)
T KOG0618|consen 378 VLVNFKHLKVLHLSYNRL------------NSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL- 443 (1081)
T ss_pred hhccccceeeeeeccccc------------ccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-
Confidence 888889999999888887 35665 4577888999999999997 78899999999999999999987
Q ss_pred cCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCC
Q 046265 333 SLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISY 412 (639)
Q Consensus 333 ~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~ 412 (639)
.+| ++..++.|+++|+|.|++.... +|..... ++|++||+++|.+.... - ..+..+..+..+|+.-
T Consensus 444 ~fP-e~~~l~qL~~lDlS~N~L~~~~--l~~~~p~-p~LkyLdlSGN~~l~~d-~---------~~l~~l~~l~~~~i~~ 509 (1081)
T KOG0618|consen 444 SFP-ELAQLPQLKVLDLSCNNLSEVT--LPEALPS-PNLKYLDLSGNTRLVFD-H---------KTLKVLKSLSQMDITL 509 (1081)
T ss_pred ech-hhhhcCcceEEecccchhhhhh--hhhhCCC-cccceeeccCCcccccc-h---------hhhHHhhhhhheeccc
Confidence 788 7889999999999998665442 3333322 78999999999753221 1 3455666667777766
Q ss_pred C
Q 046265 413 N 413 (639)
Q Consensus 413 N 413 (639)
|
T Consensus 510 ~ 510 (1081)
T KOG0618|consen 510 N 510 (1081)
T ss_pred C
Confidence 6
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=223.19 Aligned_cols=161 Identities=22% Similarity=0.338 Sum_probs=136.6
Q ss_pred cceeccCCCceEEEEEcCCCcEEEEEEccCCCCC-hhhHHHHHHHHHHHhccccCceeeeEEEEEc----CCceeEEecc
Q 046265 470 KYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPD-MVVQQAFSNEIKALTELRHRNVVKFYGFSFH----PRQSFLLYEY 544 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~ 544 (639)
...||+|++|.||+|.. +|+.||||+++..... ....+.|.+|+.++++++|||||++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46899999999999987 5789999999764322 2234678899999999999999999999977 3467899999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++|+|.+++.... .++|..+..++.+++.|++|+|... +++||||||+||++++++.+||+|||+++.+....
T Consensus 104 ~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 104 CTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999997643 5788999999999999999999742 67899999999999999999999999998764322
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
....|++.|+|||
T Consensus 178 --~~~~~~~~y~aPE 190 (283)
T PHA02988 178 --FKNVNFMVYFSYK 190 (283)
T ss_pred --ccccCcccccCHH
Confidence 2356899999998
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=240.94 Aligned_cols=170 Identities=25% Similarity=0.330 Sum_probs=138.6
Q ss_pred cCCCcceeccCCCceEEEEEcCCC-cEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEE-EEEcC------C
Q 046265 466 NFDAKYCIGTAGQASVYKAELPSW-EIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYG-FSFHP------R 536 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~-~~~~~------~ 536 (639)
+.++.++|.+|||+.||.|....+ ..||+|++-.. +....+.+.+||++|++++ |+|||.+++ ..... -
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 445678999999999999976655 99999998764 4566778899999999997 999999999 33321 2
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
++++.||||++|.|-+++..+... .++...+++|+.++++|+++||.. .|+|||||||.|||||+.++..||||||.|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 578999999999999999865543 388899999999999999999975 568999999999999999999999999988
Q ss_pred ccCCCCCCCcc---------eeeeeceeeCCC
Q 046265 617 KFLKPDSSNWS---------EFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~~~~---------~~~gt~~Y~APE 639 (639)
..-........ ..--|+-|+|||
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPE 225 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPE 225 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChH
Confidence 75322221110 124588999998
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-25 Score=219.74 Aligned_cols=167 Identities=20% Similarity=0.359 Sum_probs=141.5
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
++|+..+.||+|+||.||+|+..++..+|+|.+.... ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 4577788999999999999988888889999886432 2245688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++|+|.++++... ..++|..+..++.+++.|++|+|+. +|+||||||+||+++.++.+|++|||.++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 81 MENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 99999999987543 2578899999999999999999998 999999999999999999999999999886532211
Q ss_pred -CcceeeeeceeeCCC
Q 046265 625 -NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 -~~~~~~gt~~Y~APE 639 (639)
......++..|+|||
T Consensus 156 ~~~~~~~~~~~y~aPE 171 (256)
T cd05114 156 TSSSGAKFPVKWSPPE 171 (256)
T ss_pred eccCCCCCchhhCChh
Confidence 112234567899998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-25 Score=220.73 Aligned_cols=167 Identities=26% Similarity=0.383 Sum_probs=143.3
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.+|+..+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.++++++||||+++++++...+..|+|||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 4678889999999999999964 5778999999875432 223457889999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++++|.++++... .+++..+..++.|++.|++|||+. +|+|||+||+||+++.++.+||+|||+++.+....
T Consensus 87 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 87 YCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999999887543 467889999999999999999998 99999999999999999999999999998764333
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......|++.|+|||
T Consensus 161 ~~~~~~~~~~~y~~PE 176 (267)
T cd06646 161 AKRKSFIGTPYWMAPE 176 (267)
T ss_pred cccCccccCccccCHh
Confidence 3334467899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=236.92 Aligned_cols=176 Identities=24% Similarity=0.415 Sum_probs=152.6
Q ss_pred HHHHHHHhccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEc
Q 046265 457 YEEVIRATNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFH 534 (639)
Q Consensus 457 ~~~~~~~~~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 534 (639)
++.....++.|+..++||.|.+|+||++ ..++++.+|||...... ...++.+.|.++++.. .|||++.++|+|.-
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 4444555778888999999999999999 45678899999887532 3345667788888876 59999999999973
Q ss_pred -----CCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 046265 535 -----PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAH 609 (639)
Q Consensus 535 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~k 609 (639)
++++|+|||||.+|+..+++++-. ...+.|.....|++++++|+.+||.. .++|||||-.|||+..++.+|
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEE
Confidence 578999999999999999998765 35688899999999999999999998 899999999999999999999
Q ss_pred EccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 610 VSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 610 l~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
++|||++..++.......+.+|||.|||||
T Consensus 164 LvDFGvSaQldsT~grRnT~iGtP~WMAPE 193 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVGRRNTFIGTPYWMAPE 193 (953)
T ss_pred EeeeeeeeeeecccccccCcCCCcccccce
Confidence 999999999887777778899999999998
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=233.26 Aligned_cols=167 Identities=24% Similarity=0.335 Sum_probs=139.9
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC-----cee
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR-----QSF 539 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~ 539 (639)
+|+..+.||+|+||.||+|.. .+++.||||++............+.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 467788999999999999964 57899999998754433444567889999999999999999999998776 789
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||+. +++.+.+.... .+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57777775432 478899999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCC-CcceeeeeceeeCCC
Q 046265 620 KPDSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~-~~~~~~gt~~Y~APE 639 (639)
..... ......+|+.|+|||
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE 174 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPE 174 (372)
T ss_pred ccCccccCCCCCcCCCcCCHH
Confidence 43322 223356899999998
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-25 Score=221.72 Aligned_cols=162 Identities=20% Similarity=0.238 Sum_probs=135.4
Q ss_pred eccCCCceEEEEEc-CCCcEEEEEEccCCCCC-hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCCCh
Q 046265 473 IGTAGQASVYKAEL-PSWEIVAVKKFHSPHPD-MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550 (639)
Q Consensus 473 ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 550 (639)
||+|+||.||+++. .+|+.||+|++...... ......+..|++++++++||||+++++++..+...|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999965 56899999998643221 12234456799999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcceee
Q 046265 551 AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFV 630 (639)
Q Consensus 551 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 630 (639)
.+++..... ..+++..+..++.|++.|++|+|.. +|+||||||+||+++.++.+||+|||++....... ......
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRA 155 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccC
Confidence 988865432 3478889999999999999999998 99999999999999999999999999998764322 223357
Q ss_pred eeceeeCCC
Q 046265 631 GTFGYVAPI 639 (639)
Q Consensus 631 gt~~Y~APE 639 (639)
|++.|+|||
T Consensus 156 ~~~~y~aPE 164 (277)
T cd05607 156 GTNGYMAPE 164 (277)
T ss_pred CCCCccCHH
Confidence 899999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=218.75 Aligned_cols=169 Identities=22% Similarity=0.372 Sum_probs=142.4
Q ss_pred ccCCCcceeccCCCceEEEEEcCC----CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS----WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
++|+..+.||+|+||.||+|..+. ...||||.+.... .......|.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 568889999999999999997642 3579999987543 33445678999999999999999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||||+++++|.+++..... .++|..+..++.+++.|++|||.. +|+||||||+||+++.++.+|++|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999876432 578999999999999999999998 99999999999999999999999999998774
Q ss_pred CCCCCc--ceeeeeceeeCCC
Q 046265 621 PDSSNW--SEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~--~~~~gt~~Y~APE 639 (639)
...... ....+++.|+|||
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe 178 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPE 178 (266)
T ss_pred ccccceeccCCCCCccccChh
Confidence 222211 1234567899998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-25 Score=221.16 Aligned_cols=171 Identities=20% Similarity=0.360 Sum_probs=141.0
Q ss_pred ccCCCcceeccCCCceEEEEEc-----CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-----PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
++|+..+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|++++++++||||+++++++..++..|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4567778999999999999963 355789999987533 2334467889999999999999999999999999999
Q ss_pred EEecccCCCChhHHhhcCCC--------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC
Q 046265 540 LLYEYLGRGSLAIILSNDAA--------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD 605 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~ 605 (639)
+||||+++|+|.+++..... ...+++.....++.+++.|++|+|+. +|+||||||+||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence 99999999999999853221 13478889999999999999999998 99999999999999999
Q ss_pred CceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 606 YDAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 606 ~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
+.+|++|||+++....... ......++..|+|||
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 196 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPE 196 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChH
Confidence 9999999999987543221 122345677899998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=221.13 Aligned_cols=173 Identities=19% Similarity=0.327 Sum_probs=141.8
Q ss_pred HhccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR 536 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 536 (639)
.+++|+..+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4567888999999999999998643 24679999986432 2234556889999999999999999999999999
Q ss_pred ceeEEecccCCCChhHHhhcCCC-------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAA-------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAH 609 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~k 609 (639)
..++||||+++|+|.+++..... ....+|..+..++.++++|++|||.. +++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 99999999999999999865322 12367888999999999999999998 999999999999999999999
Q ss_pred EccccccccCCCCCCC--cceeeeeceeeCCC
Q 046265 610 VSDFGISKFLKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 610 l~DfGla~~~~~~~~~--~~~~~gt~~Y~APE 639 (639)
++|||+++........ .....+++.|||||
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChh
Confidence 9999998865432211 11234578899998
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-25 Score=220.53 Aligned_cols=172 Identities=23% Similarity=0.326 Sum_probs=145.4
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCC-CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||.||+|.. .+++.||||.+.... .+......+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4688889999999999999965 478999999886533 23344567889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 543 EYLGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
||+++|+|.+++.... ....+++..+..++.++++|++|||+. +|+||||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998886422 123467888999999999999999998 999999999999999999999999999887654
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
.........|++.|+|||
T Consensus 159 ~~~~~~~~~~~~~~~aPE 176 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPE 176 (267)
T ss_pred hhHHHhcCCCCccccChh
Confidence 333334467899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.9e-25 Score=217.40 Aligned_cols=170 Identities=23% Similarity=0.294 Sum_probs=147.2
Q ss_pred cCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..++||+|+||.||.++ ..+++.+|+|++............+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47788999999999999985 45688999999876554445566788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++|+|.+++.... ...+++..+..++.++++|++|+|+. +++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999997643 23578899999999999999999988 999999999999999999999999999987654433
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......|++.|+|||
T Consensus 157 ~~~~~~~~~~y~ape 171 (256)
T cd08221 157 MAETVVGTPYYMSPE 171 (256)
T ss_pred cccccCCCccccCHh
Confidence 334567899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=222.09 Aligned_cols=168 Identities=20% Similarity=0.242 Sum_probs=141.6
Q ss_pred CCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCC-hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 467 FDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPD-MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
|+..+.||+|+||.||+|.. .+++.||||.+...... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678899999999999954 57899999998754322 22345578899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++++|.+++...+. ..+++..+..++.|++.|++|||.. +|+||||||+||++++++.+||+|||++...... .
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-E 156 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC-C
Confidence 999999988865432 3588999999999999999999988 9999999999999999999999999998765432 2
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......|++.|+|||
T Consensus 157 ~~~~~~g~~~~~aPE 171 (285)
T cd05632 157 SIRGRVGTVGYMAPE 171 (285)
T ss_pred cccCCCCCcCccChH
Confidence 223457999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-25 Score=218.74 Aligned_cols=168 Identities=20% Similarity=0.362 Sum_probs=143.2
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
++|+..+.||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..|+||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 5677889999999999999988888899999986432 2356788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++|+|.++++.... ..+++..+..++.++++|++|||+. +++||||||+||+++.++.+|++|||++........
T Consensus 83 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 83 MAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 999999999975432 3578889999999999999999998 999999999999999999999999999987643221
Q ss_pred -CcceeeeeceeeCCC
Q 046265 625 -NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 -~~~~~~gt~~Y~APE 639 (639)
......++..|+|||
T Consensus 159 ~~~~~~~~~~~y~aPE 174 (261)
T cd05072 159 TAREGAKFPIKWTAPE 174 (261)
T ss_pred eccCCCccceecCCHH
Confidence 112234677899998
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=222.00 Aligned_cols=168 Identities=21% Similarity=0.265 Sum_probs=141.3
Q ss_pred CCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCC-hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 467 FDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPD-MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
|+..+.||+|+||.||+|.. .+++.||||.+...... ......+.+|+.++++++|++|+.+++++.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 66778999999999999954 57889999998754322 22335577899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++|+|.+++..... ..+++..+..++.|++.|++|+|.. +|+||||||+||+++.++.++++|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 999999998864332 3478889999999999999999988 99999999999999999999999999987654322
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......||..|||||
T Consensus 157 ~~~~~~g~~~y~aPE 171 (285)
T cd05630 157 TIKGRVGTVGYMAPE 171 (285)
T ss_pred cccCCCCCccccChH
Confidence 223357999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-25 Score=224.76 Aligned_cols=168 Identities=20% Similarity=0.335 Sum_probs=138.5
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCc----EEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWE----IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
.+|+..+.||+|+||.||+|.+. +++ .||||.+.... .....+.+.+|+.+++.++||||++++++|... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 46888899999999999999643 343 38999987432 234456788999999999999999999999874 578
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+|+||+++|++.+++.... ..+++.....++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 9999999999999987643 3478889999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCCc--ceeeeeceeeCCC
Q 046265 620 KPDSSNW--SEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~~--~~~~gt~~Y~APE 639 (639)
....... ....++..|||||
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE 181 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALE 181 (316)
T ss_pred cCCCcceeccCCccceeecChH
Confidence 5432211 1223467899998
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-25 Score=237.00 Aligned_cols=165 Identities=20% Similarity=0.283 Sum_probs=132.2
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC-------
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP------- 535 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------- 535 (639)
..+|+..+.||+|+||.||+|.. .+++.||||++.... ....+|+.++++++|||||++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 45688899999999999999965 567899999886422 2235799999999999999999887532
Q ss_pred -CceeEEecccCCCChhHHhhcC-CCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEcc
Q 046265 536 -RQSFLLYEYLGRGSLAIILSND-AAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY-DAHVSD 612 (639)
Q Consensus 536 -~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~-~~kl~D 612 (639)
...++||||+++ ++.+++... .....+++..+..++.|++.||+|||.. +|+||||||+||+++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 146789999975 666665431 2224578899999999999999999998 999999999999999664 799999
Q ss_pred ccccccCCCCCCCcceeeeeceeeCCC
Q 046265 613 FGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 613 fGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
||+|+.+.... .....+||+.|||||
T Consensus 215 FGla~~~~~~~-~~~~~~~t~~y~aPE 240 (440)
T PTZ00036 215 FGSAKNLLAGQ-RSVSYICSRFYRAPE 240 (440)
T ss_pred cccchhccCCC-CcccCCCCcCccCHH
Confidence 99998765332 223467899999998
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=216.57 Aligned_cols=149 Identities=24% Similarity=0.261 Sum_probs=128.7
Q ss_pred ccCCCcceeccCCCceEEEEEcCCC-cEEEEEEccCCCCC-hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSW-EIVAVKKFHSPHPD-MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~-~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
+.|+..+.+|.|.-|.||.|++++. ...|+|.+.+.... .....+...|-+||+.++||.++++|+.++.+...++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 3445567899999999999988764 78999999865422 222344567889999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
|||+||+|..+.+.+.. ..++...+.-+|.+|+-||+|||.. |||+|||||+|||+-++|++.++||-++.
T Consensus 157 eyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred ecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccc
Confidence 99999999999886544 5688888889999999999999999 99999999999999999999999997754
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=222.61 Aligned_cols=167 Identities=31% Similarity=0.441 Sum_probs=142.4
Q ss_pred CCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEeccc
Q 046265 467 FDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYL 545 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 545 (639)
|+..+.||+|+||.||+|... +++.||+|.+..............+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 455789999999999999655 5678999999876543333344566999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC
Q 046265 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 625 (639)
++++|.+++... ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++|+|||.+..+......
T Consensus 81 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp TTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred cccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 999999999833 3468899999999999999999998 9999999999999999999999999999865333334
Q ss_pred cceeeeeceeeCCC
Q 046265 626 WSEFVGTFGYVAPI 639 (639)
Q Consensus 626 ~~~~~gt~~Y~APE 639 (639)
.....+++.|+|||
T Consensus 155 ~~~~~~~~~y~aPE 168 (260)
T PF00069_consen 155 FNPFVGTPEYMAPE 168 (260)
T ss_dssp BSSSSSSGGGSCHH
T ss_pred cccccccccccccc
Confidence 45578999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-26 Score=235.65 Aligned_cols=164 Identities=26% Similarity=0.365 Sum_probs=139.3
Q ss_pred CcceeccCCCceEEEEEcCC-CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCC
Q 046265 469 AKYCIGTAGQASVYKAELPS-WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 469 ~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
....+|.|+||+||+|.-+. +-..|.|.+.... ....++|.-||++++.++||+||++++.|+..+.+|+..|||+|
T Consensus 36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetks--eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS--EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHhhhcCccchhhhhhhcccchhhhhhhhhcccc--hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 34578999999999996554 3445677776433 33457788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
|..+.++-.-+ ..+...++.-++.+++.||.|||.. .|||||+|+.|||+.-+|.++++|||++...........
T Consensus 114 GAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred chHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence 99988876543 2577788889999999999999999 999999999999999999999999999877655445566
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
+++|||+|||||
T Consensus 189 sFIGTPYWMAPE 200 (1187)
T KOG0579|consen 189 SFIGTPYWMAPE 200 (1187)
T ss_pred cccCCcccccch
Confidence 799999999998
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=220.05 Aligned_cols=167 Identities=26% Similarity=0.381 Sum_probs=142.8
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|+||.||+|.. .+++.||+|.++... ......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 4566678899999999999954 568899999987543 2233457889999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++++|.+++...+ .+++.++..++.+++.|++|+|+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 87 FCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred ccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 999999999987543 467889999999999999999998 99999999999999999999999999987664333
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......|++.|+|||
T Consensus 161 ~~~~~~~~~~~y~aPE 176 (267)
T cd06645 161 AKRKSFIGTPYWMAPE 176 (267)
T ss_pred cccccccCcccccChh
Confidence 3334567999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=218.48 Aligned_cols=174 Identities=26% Similarity=0.323 Sum_probs=144.0
Q ss_pred HHHhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 461 IRATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 461 ~~~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
+.+++++.....||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++++..++..+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34567777788999999999999964 466789999887543 334567889999999999999999999999999999
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEcccccccc
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL-DYDAHVSDFGISKF 618 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~-~~~~kl~DfGla~~ 618 (639)
+||||+++++|.+++.........++..+..++.|++.|++|||.. +|+||||||+||+++. .+.+||+|||.+..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999997543211126778888999999999999988 9999999999999986 67999999999876
Q ss_pred CCCCCCCcceeeeeceeeCCC
Q 046265 619 LKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~~~~~~~gt~~Y~APE 639 (639)
............|++.|+|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE 179 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPE 179 (268)
T ss_pred cccCCCccccCCCCccccChh
Confidence 643333333456899999998
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=219.22 Aligned_cols=171 Identities=23% Similarity=0.430 Sum_probs=146.4
Q ss_pred HhccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
...+|+..+.||+|+||.||+|...+++.+|+|.+.... ......+.+|+.++++++||||+++++++...+..++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 455688889999999999999988888999999987543 223556889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++..... ..+++..+..++.+++.|++|||.. +|+||||||+||+++.++.+|++|||.+..+...
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 82 ELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred eecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999999999976433 3578899999999999999999988 8999999999999999999999999999876433
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
........++..|+|||
T Consensus 158 ~~~~~~~~~~~~~~~PE 174 (261)
T cd05148 158 VYLSSDKKIPYKWTAPE 174 (261)
T ss_pred cccccCCCCceEecCHH
Confidence 22222344677899997
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=219.53 Aligned_cols=171 Identities=25% Similarity=0.418 Sum_probs=142.1
Q ss_pred ccCCCcceeccCCCceEEEEEcCC------CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS------WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
.+|+..+.||+|+||.||+|...+ .+.||+|.+.... .....+.|.+|+.++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 467778899999999999996533 2579999987543 334456789999999999999999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCCC-------------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC
Q 046265 539 FLLYEYLGRGSLAIILSNDAAI-------------DEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD 605 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~ 605 (639)
|++|||+++|+|.+++...... ..+++.....++.|++.|++|||.. +|+||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence 9999999999999998753221 3478889999999999999999998 99999999999999999
Q ss_pred CceEEccccccccCCCCC--CCcceeeeeceeeCCC
Q 046265 606 YDAHVSDFGISKFLKPDS--SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 606 ~~~kl~DfGla~~~~~~~--~~~~~~~gt~~Y~APE 639 (639)
+.+||+|||+++...... .......+++.|||||
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 196 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPE 196 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHH
Confidence 999999999998653222 1122346788999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=216.03 Aligned_cols=169 Identities=21% Similarity=0.347 Sum_probs=142.8
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.++|+..+.||+|++|.||+|...+++.||||.++... ...+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 35678889999999999999987777889999987533 234568899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++++|.+++.... ...++|..+..++.+++.|+.|+|.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999997644 23578999999999999999999998 99999999999999999999999999998765322
Q ss_pred CC-cceeeeeceeeCCC
Q 046265 624 SN-WSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~-~~~~~gt~~Y~APE 639 (639)
.. .....++..|+|||
T Consensus 158 ~~~~~~~~~~~~y~aPE 174 (261)
T cd05068 158 YEAREGAKFPIKWTAPE 174 (261)
T ss_pred ccccCCCcCceeccCcc
Confidence 11 11122345799998
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-25 Score=228.82 Aligned_cols=167 Identities=20% Similarity=0.278 Sum_probs=137.7
Q ss_pred HhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC-----
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR----- 536 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----- 536 (639)
..++|+..+.||+|+||.||+|.. .+++.||||++............+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457888899999999999999954 56899999999765434444566789999999999999999999987543
Q ss_pred -ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 046265 537 -QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615 (639)
Q Consensus 537 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGl 615 (639)
..|+||||+++ ++.+.+.. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999975 55555532 366788888999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCcceeeeeceeeCCC
Q 046265 616 SKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
++..... .......||+.|+|||
T Consensus 170 a~~~~~~-~~~~~~~~t~~y~aPE 192 (359)
T cd07876 170 ARTACTN-FMMTPYVVTRYYRAPE 192 (359)
T ss_pred ccccccC-ccCCCCcccCCCCCch
Confidence 9865432 2223467899999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=218.71 Aligned_cols=164 Identities=22% Similarity=0.285 Sum_probs=133.6
Q ss_pred eeccCCCceEEEEEcCC---CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCC
Q 046265 472 CIGTAGQASVYKAELPS---WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRG 548 (639)
Q Consensus 472 ~ig~g~~g~vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 548 (639)
.||+|+||+||+|...+ ...+|+|.+.... .......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999996443 3568888876433 2334567889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCC--CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC--
Q 046265 549 SLAIILSNDAA--IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS-- 624 (639)
Q Consensus 549 ~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~-- 624 (639)
+|.+++..... ....++.....++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 23356788889999999999999998 999999999999999999999999999875432211
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......+++.|+|||
T Consensus 158 ~~~~~~~~~~y~aPE 172 (269)
T cd05042 158 TKDCHAVPLRWLAPE 172 (269)
T ss_pred ccCCCCCcccccCHH
Confidence 112234677899998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=217.07 Aligned_cols=172 Identities=25% Similarity=0.334 Sum_probs=146.6
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|++|.||+|... +++.||+|.++.... .....+.+.+|++++++++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999665 789999998875332 2334667899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 543 EYLGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
||+++|+|.+++.... ....+++..+..++.++++|++|||.. +|+||||||+||+++.++.++++|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986432 223478899999999999999999998 999999999999999999999999999887654
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
.........|++.|+|||
T Consensus 159 ~~~~~~~~~~~~~y~apE 176 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPE 176 (267)
T ss_pred CCcccceecCCccccCHH
Confidence 333334467899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=228.60 Aligned_cols=163 Identities=28% Similarity=0.347 Sum_probs=138.3
Q ss_pred eeccCCCceEEEEEcCCC-cEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCCCh
Q 046265 472 CIGTAGQASVYKAELPSW-EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550 (639)
Q Consensus 472 ~ig~g~~g~vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 550 (639)
++|+|.||+||-|+..+. ..+|||.+..+. ....+.+.+||.+.++++|.|||+++|.|.+++..-+.||-++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 799999999999976554 569999998654 33445678899999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEccccccccCCCCCCCccee
Q 046265 551 AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG-LDYDAHVSDFGISKFLKPDSSNWSEF 629 (639)
Q Consensus 551 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~ 629 (639)
.++++..=+.-.-.+.+.-.+.+||++||.|||.. .|||||||-+|||++ -.|.+||+|||.++.+..-.-...++
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 99997542211114466677899999999999999 899999999999997 46899999999999886555556679
Q ss_pred eeeceeeCCC
Q 046265 630 VGTFGYVAPI 639 (639)
Q Consensus 630 ~gt~~Y~APE 639 (639)
.||..|||||
T Consensus 737 TGTLQYMAPE 746 (1226)
T KOG4279|consen 737 TGTLQYMAPE 746 (1226)
T ss_pred ccchhhhChH
Confidence 9999999998
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=226.90 Aligned_cols=167 Identities=23% Similarity=0.358 Sum_probs=140.2
Q ss_pred HHhccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC-----
Q 046265 462 RATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP----- 535 (639)
Q Consensus 462 ~~~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~----- 535 (639)
+..++|+..+.||+|+||.||+|. ..+++.||||++............+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 456788889999999999999995 45778999999876443333445677899999999999999999987643
Q ss_pred -CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 046265 536 -RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614 (639)
Q Consensus 536 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfG 614 (639)
...|++||++ +++|.+++... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3468999988 78898887542 478889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+++..... ....+||+.|+|||
T Consensus 164 ~~~~~~~~---~~~~~~t~~y~aPE 185 (343)
T cd07878 164 LARQADDE---MTGYVATRWYRAPE 185 (343)
T ss_pred cceecCCC---cCCccccccccCch
Confidence 99876432 23457999999998
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-25 Score=219.18 Aligned_cols=172 Identities=24% Similarity=0.341 Sum_probs=146.4
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|++|.||+|. ..+++.+|||.+..... .....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 467778899999999999996 45789999998875432 2334567889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcC-CCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 543 EYLGRGSLAIILSND-AAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 543 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
||+++++|.+++... .....++|..+..++.++++|++|||.. +|+|+||||+||+++.++.++++|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988642 2234578999999999999999999998 999999999999999999999999999887654
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
.........|++.|+|||
T Consensus 159 ~~~~~~~~~~~~~~~ape 176 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPE 176 (267)
T ss_pred CCcccccccCCcCccCHH
Confidence 433334567899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.9e-25 Score=233.01 Aligned_cols=162 Identities=22% Similarity=0.276 Sum_probs=137.1
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
...|...+.||+|+||.||+|..+ +++.||||.... ..+.+|++++++++|||||++++++...+..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 446888899999999999999654 578899996432 23568999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+. +++..++.... ..++|..+..++.|+++||+|||.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 240 e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 240 PKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 9995 68888876432 2589999999999999999999998 9999999999999999999999999999876432
Q ss_pred CC--CcceeeeeceeeCCC
Q 046265 623 SS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~--~~~~~~gt~~Y~APE 639 (639)
.. .....+||+.|||||
T Consensus 314 ~~~~~~~~~~GT~~Y~APE 332 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPE 332 (461)
T ss_pred cccccccccCCCcCCcCHH
Confidence 22 122467999999998
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=219.10 Aligned_cols=170 Identities=24% Similarity=0.420 Sum_probs=141.7
Q ss_pred ccCCCcceeccCCCceEEEEEc------CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
++|...+.||+|+||.||++.. .++..+|+|.+.... ......+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 5677889999999999999963 234568999987532 33456789999999999999999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCC----------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 046265 539 FLLYEYLGRGSLAIILSNDAA----------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDA 608 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~ 608 (639)
++||||+++++|.+++...+. ...+++..+..++.|++.|++|+|+. +|+||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 999999999999999875431 23489999999999999999999998 99999999999999999999
Q ss_pred EEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 609 HVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 609 kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
|++|||+++....... ......+++.|+|||
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 192 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 192 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHH
Confidence 9999999986543221 112334678899998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=216.17 Aligned_cols=164 Identities=21% Similarity=0.254 Sum_probs=134.8
Q ss_pred eeccCCCceEEEEEcCC---CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCC
Q 046265 472 CIGTAGQASVYKAELPS---WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRG 548 (639)
Q Consensus 472 ~ig~g~~g~vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 548 (639)
.||+|+||.||+|...+ +..+|+|+++.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999996543 35799999875432 233457889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCC--CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC--
Q 046265 549 SLAIILSNDAA--IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS-- 624 (639)
Q Consensus 549 ~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~-- 624 (639)
+|.+++..... ....++..+..++.|+++|++|+|+. +++||||||+||+++.++.+|++|||+++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975432 12456778888999999999999998 999999999999999999999999999975432211
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......|++.|+|||
T Consensus 158 ~~~~~~~~~~y~aPE 172 (269)
T cd05087 158 TPDQLWVPLRWIAPE 172 (269)
T ss_pred cCCCcCCcccccCHh
Confidence 112345788999998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-26 Score=249.23 Aligned_cols=171 Identities=32% Similarity=0.487 Sum_probs=147.1
Q ss_pred HhccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 463 ATNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.+-+++....||.|.||.||.| ...+|+..|||.++....+...-....+|..++..++|||+|++||+-...+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 3566777889999999999999 677899999999886554444455678899999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
||||++|+|.++++..+..++ .....+..|++.|+.|||.+ +||||||||+||+++..|.+|.+|||.|+.+..
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE---~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDE---MVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhh---hHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999999987665443 55555788999999999999 999999999999999999999999999998765
Q ss_pred CCC----CcceeeeeceeeCCC
Q 046265 622 DSS----NWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~----~~~~~~gt~~Y~APE 639 (639)
..+ ......||+.|||||
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPE 1408 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPE 1408 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCch
Confidence 432 234579999999998
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=219.33 Aligned_cols=169 Identities=24% Similarity=0.410 Sum_probs=144.1
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+....||+|++|.||+|..+ +++.||+|++..........+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36778889999999999999665 68999999987543333345567899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|++++.+..+..... .++|..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999999988775432 478899999999999999999998 99999999999999999999999999998765443
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......++..|+|||
T Consensus 155 ~~~~~~~~~~~~~aPE 170 (286)
T cd07847 155 DDYTDYVATRWYRAPE 170 (286)
T ss_pred ccccCcccccccCCHH
Confidence 2333456888999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=218.27 Aligned_cols=171 Identities=24% Similarity=0.440 Sum_probs=142.6
Q ss_pred ccCCCcceeccCCCceEEEEEcCC------CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS------WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
.+|...+.||+|+||.||+|...+ ++.||||.+..... ....+.+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 457778899999999999996533 47899999875432 23457889999999999999999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCC-----------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 046265 539 FLLYEYLGRGSLAIILSNDAA-----------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD 607 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~ 607 (639)
|+||||+++|+|.+++...+. ...+++..+..++.+++.|++|+|.. +|+||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999975431 23478899999999999999999998 9999999999999999999
Q ss_pred eEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 608 AHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 608 ~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
+|++|||+++....... ......+++.|+|||
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPE 194 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChh
Confidence 99999999976532211 112345678999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=227.98 Aligned_cols=168 Identities=19% Similarity=0.280 Sum_probs=138.7
Q ss_pred HHhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC----
Q 046265 462 RATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR---- 536 (639)
Q Consensus 462 ~~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~---- 536 (639)
...++|+..+.||+|+||.||+|.. .+++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3457888899999999999999954 46789999999765444444567788999999999999999999886543
Q ss_pred --ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 046265 537 --QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614 (639)
Q Consensus 537 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfG 614 (639)
..|+||||+++ ++.+.+.. .+++..+..++.|+++||+|||.. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 46999999975 56655542 367788889999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+++..... .......||+.|+|||
T Consensus 165 ~~~~~~~~-~~~~~~~~t~~y~aPE 188 (355)
T cd07874 165 LARTAGTS-FMMTPYVVTRYYRAPE 188 (355)
T ss_pred ccccCCCc-cccCCccccCCccCHH
Confidence 99865432 2223467999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=220.65 Aligned_cols=167 Identities=26% Similarity=0.370 Sum_probs=142.5
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|+||.||+|.. .++..||+|.+.... .......+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 3688889999999999999964 467889999887532 23345668899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++++|.++++.. ..+++..+..++.|+++|++|||+.+ +++||||||+||+++.++.+|++|||++..+...
T Consensus 80 y~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 80 HMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred ccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999999754 34678889999999999999999732 8999999999999999999999999998765432
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.....+|++.|+|||
T Consensus 154 -~~~~~~~~~~~~aPE 168 (308)
T cd06615 154 -MANSFVGTRSYMSPE 168 (308)
T ss_pred -ccccCCCCcCccChh
Confidence 223467899999998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=221.14 Aligned_cols=178 Identities=24% Similarity=0.358 Sum_probs=146.3
Q ss_pred hHHHHHHHhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEE
Q 046265 456 LYEEVIRATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSF 533 (639)
Q Consensus 456 ~~~~~~~~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~ 533 (639)
.+++...++++|+..+.||+|+||.||+|.. .+++.+|+|.+.... .....+.+|+.+++++ +||||++++++|.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 3455666788999999999999999999955 567899999876432 2235678899999998 6999999999885
Q ss_pred -----cCCceeEEecccCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 046265 534 -----HPRQSFLLYEYLGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD 607 (639)
Q Consensus 534 -----~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~ 607 (639)
.++..++||||+++++|.+++.... ....+++..+..++.|+++|+.|||.. +|+|||+||+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence 3356899999999999999876422 223578888999999999999999998 9999999999999999999
Q ss_pred eEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 608 AHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 608 ~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+|++|||+++.+...........|++.|+|||
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 194 (286)
T cd06638 163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194 (286)
T ss_pred EEEccCCceeecccCCCccccccCCCcccChh
Confidence 99999999987654333334457999999998
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=220.04 Aligned_cols=168 Identities=24% Similarity=0.328 Sum_probs=143.4
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCC---hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPD---MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
+|+..+.||+|++|.||+|.. .+++.||||++...... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 366778999999999999965 46899999999764422 23345677899999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+ +|+|.+++.... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999997644 2588899999999999999999998 999999999999999999999999999987654
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
.........+++.|+|||
T Consensus 155 ~~~~~~~~~~~~~y~aPE 172 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPE 172 (298)
T ss_pred CCccccccccceeeeCHH
Confidence 433333446788999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=244.66 Aligned_cols=177 Identities=20% Similarity=0.314 Sum_probs=143.8
Q ss_pred HHhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--Cce
Q 046265 462 RATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQS 538 (639)
Q Consensus 462 ~~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 538 (639)
...++|.....||+|+||.||+|.. .+++.||+|.+............|.+|+.++++++|||||+++++|... +..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3456788899999999999999965 4567899999876554445567789999999999999999999988653 568
Q ss_pred eEEecccCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCC----CCeEeecCCCCCeeeCC---------
Q 046265 539 FLLYEYLGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDYF----PPIVHRDISSKNVLLGL--------- 604 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~----~~iiHrdlk~~Nill~~--------- 604 (639)
|+||||+++|+|.+++.... ....+++..++.|+.||+.||+|||.... .+||||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999987532 22458899999999999999999998521 26999999999999964
Q ss_pred --------CCceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 605 --------DYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 605 --------~~~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
.+.+||+|||+++.+... ......+||+.|||||
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPE 211 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPE 211 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHH
Confidence 234899999999876432 2223467999999998
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=215.13 Aligned_cols=166 Identities=22% Similarity=0.351 Sum_probs=140.2
Q ss_pred cCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEeccc
Q 046265 466 NFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYL 545 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 545 (639)
+|+..+.||+|+||.||+|+..++..||||.+..... ..+.+.+|+.++++++||||++++++|...+..|+||||+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 4667789999999999999887777899999875332 2456889999999999999999999999989999999999
Q ss_pred CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC
Q 046265 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 625 (639)
++|+|.+++..... .++|..++.++.+++.|++|||.. +|+||||||+||+++.++.+|++|||.++........
T Consensus 82 ~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 82 SNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999875432 578999999999999999999998 9999999999999999999999999998865432211
Q ss_pred -cceeeeeceeeCCC
Q 046265 626 -WSEFVGTFGYVAPI 639 (639)
Q Consensus 626 -~~~~~gt~~Y~APE 639 (639)
.....++..|+|||
T Consensus 157 ~~~~~~~~~~y~~pe 171 (256)
T cd05113 157 SSVGSKFPVRWSPPE 171 (256)
T ss_pred ecCCCccChhhCCHH
Confidence 11123557799998
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=220.37 Aligned_cols=168 Identities=22% Similarity=0.332 Sum_probs=140.8
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|...+.||+|+||.||+|..+ +++.||+|.+..... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 46778889999999999999654 678999999875432 2223456789999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|++ +++.+++.... ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 85 YLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred ccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 997 58888876543 2467889999999999999999998 99999999999999999999999999998654333
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......+++.|+|||
T Consensus 159 ~~~~~~~~~~~y~~PE 174 (301)
T cd07873 159 KTYSNEVVTLWYRPPD 174 (301)
T ss_pred CcccccceeecccCcH
Confidence 3333456899999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-24 Score=214.87 Aligned_cols=169 Identities=22% Similarity=0.369 Sum_probs=140.5
Q ss_pred ccCCCcceeccCCCceEEEEEcC-C---CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-S---WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
.+|+..+.||+|+||.||+|... + +..+|+|.+.... .....+.+.+|+.++++++||||+++++++..++..|+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46777899999999999999653 2 3479999987543 23345678999999999999999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||||+++++|.+++.... ..+++..+..++.|++.|++|+|.. +++||||||+||+++.++.+|++|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999999997543 3578899999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCCc---ceeeeeceeeCCC
Q 046265 621 PDSSNW---SEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~---~~~~gt~~Y~APE 639 (639)
...... ....++..|+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe 179 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPE 179 (267)
T ss_pred cccceeeecCCCccceeecCHh
Confidence 332211 1122356899998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=227.16 Aligned_cols=171 Identities=25% Similarity=0.334 Sum_probs=139.2
Q ss_pred ccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~ 537 (639)
++|...+.||+|+||.||+|.+. .++.||||++...... ...+.+.+|+.++.++. |||||+++++|...+.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 34666789999999999999743 3467999999864322 23456889999999997 9999999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCC----------------------------------------------------------
Q 046265 538 SFLLYEYLGRGSLAIILSNDAA---------------------------------------------------------- 559 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 559 (639)
.++||||+++|+|.++++..+.
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999864321
Q ss_pred -------------------------------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 046265 560 -------------------------------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL 602 (639)
Q Consensus 560 -------------------------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill 602 (639)
...++|.....++.|++.|++|||+. +|+||||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 12367778889999999999999988 99999999999999
Q ss_pred CCCCceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 603 GLDYDAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 603 ~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
++++.+|++|||+++....... ......+++.|||||
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 311 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPE 311 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChH
Confidence 9999999999999986532221 112345778899998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-24 Score=212.51 Aligned_cols=163 Identities=20% Similarity=0.313 Sum_probs=135.6
Q ss_pred ceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCCC
Q 046265 471 YCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGS 549 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 549 (639)
+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|++++++++||||++++++|...+..|+||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 3689999999999965 478899999886432 23445678999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCc--c
Q 046265 550 LAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW--S 627 (639)
Q Consensus 550 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~--~ 627 (639)
|.+++.... ..++|..+..++.|+++|++|+|.. +|+||||||+||+++.++.+|++|||++.......... .
T Consensus 80 L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 80 FLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999987543 2478899999999999999999998 99999999999999999999999999988654221111 1
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
...++..|+|||
T Consensus 155 ~~~~~~~y~aPE 166 (252)
T cd05084 155 MKQIPVKWTAPE 166 (252)
T ss_pred CCCCceeecCch
Confidence 112345799998
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=219.12 Aligned_cols=171 Identities=23% Similarity=0.348 Sum_probs=140.6
Q ss_pred ccCCCcceeccCCCceEEEEEcCC---------------CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS---------------WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFY 529 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~ 529 (639)
++|+..+.||+|+||.||+|..+. ...||||.++... .......|.+|++++++++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 568888999999999999986532 2358999987542 334456789999999999999999999
Q ss_pred EEEEcCCceeEEecccCCCChhHHhhcCCC---------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 046265 530 GFSFHPRQSFLLYEYLGRGSLAIILSNDAA---------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNV 600 (639)
Q Consensus 530 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Ni 600 (639)
+++...+..++||||+++++|.+++..... ...++|..+..++.+++.|++|||.. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999864321 12468899999999999999999998 999999999999
Q ss_pred eeCCCCceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 601 LLGLDYDAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 601 ll~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
++++++.+|++|||++........ ......+++.|+|||
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 201 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE 201 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChh
Confidence 999999999999999986542211 112234567899998
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-25 Score=219.80 Aligned_cols=169 Identities=22% Similarity=0.336 Sum_probs=149.5
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.-|+..+.||+|-|++|-.|+ .-+|+.||||.+.+...+......+.+|++-|+.++|||||++|++......+|+|.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 346667889999999999995 4689999999999888777778888999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEccccccccCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG-LDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~-~~~~~kl~DfGla~~~~~~ 622 (639)
.-.+|+|++++-.+. ..+.+..+.+++.||..|+.|+|.. .+||||+||+||.+- +-|-+|+.|||++-.+.+.
T Consensus 98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999986543 2467788899999999999999998 799999999999874 5689999999999887754
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
....+.||+..|-|||
T Consensus 173 -~kL~TsCGSLAYSAPE 188 (864)
T KOG4717|consen 173 -KKLTTSCGSLAYSAPE 188 (864)
T ss_pred -chhhcccchhhccCch
Confidence 4567799999999998
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-24 Score=213.83 Aligned_cols=170 Identities=21% Similarity=0.285 Sum_probs=143.5
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC-CceeEEec
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP-RQSFLLYE 543 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e 543 (639)
+|+..+.+|+|++|.||+|.. .+++.||+|++..........+.+.+|++++++++|||++++++.+... ...|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 467788999999999999964 4578899999876444344456788999999999999999999988654 46799999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|++++++.+++..... ..+++.++..++.+++.|++|+|.. +|+||||||+||+++.++.++++|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999999875432 3478899999999999999999998 99999999999999999999999999998765433
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......|++.|+|||
T Consensus 157 ~~~~~~~~~~~y~aPE 172 (257)
T cd08223 157 DMASTLIGTPYYMSPE 172 (257)
T ss_pred CccccccCCcCccChh
Confidence 3344567899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=242.33 Aligned_cols=169 Identities=23% Similarity=0.299 Sum_probs=146.4
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|...+.||+|+||.||+|... +++.||||.++.... .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56788899999999999999655 688999999875432 2334567889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++++|.+++...+ .+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~ 157 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR 157 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence 9999999999997543 367788899999999999999998 9999999999999999999999999999976544
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
........+|+.|+|||
T Consensus 158 ~~~~~~~~~t~~~~~pe 174 (669)
T cd05610 158 ELNMMDILTTPSMAKPK 174 (669)
T ss_pred cccccccccCccccCcc
Confidence 44455678999999997
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=216.74 Aligned_cols=166 Identities=24% Similarity=0.363 Sum_probs=140.8
Q ss_pred CCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEeccc
Q 046265 467 FDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYL 545 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 545 (639)
|+....||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+++++.++||||+++++++..++..|+||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 345678999999999999654 56788999986532 334567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC
Q 046265 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 625 (639)
++|++..++.... ..++|..+..++.|+++|++|||+. +|+||||||+||+++.++.+|++|||++.........
T Consensus 85 ~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~ 159 (282)
T cd06643 85 AGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 159 (282)
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence 9999998876432 2578899999999999999999998 9999999999999999999999999998765433333
Q ss_pred cceeeeeceeeCCC
Q 046265 626 WSEFVGTFGYVAPI 639 (639)
Q Consensus 626 ~~~~~gt~~Y~APE 639 (639)
.....|++.|+|||
T Consensus 160 ~~~~~~~~~y~aPE 173 (282)
T cd06643 160 RDSFIGTPYWMAPE 173 (282)
T ss_pred cccccccccccCHh
Confidence 34567999999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=224.05 Aligned_cols=171 Identities=22% Similarity=0.329 Sum_probs=138.5
Q ss_pred ccCCCcceeccCCCceEEEEEc------CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcC-C
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHP-R 536 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~ 536 (639)
++|+..+.||+|+||.||+|.. .+++.||+|+++.... ....+.+.+|+.++.++ +||||++++++|... .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 4678889999999999999953 2347899999875432 23345678899999999 799999999988755 5
Q ss_pred ceeEEecccCCCChhHHhhcCCC---------------------------------------------------------
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAA--------------------------------------------------------- 559 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 559 (639)
..++||||+++|+|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 68899999999999998854211
Q ss_pred -CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC--Ccceeeeeceee
Q 046265 560 -IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS--NWSEFVGTFGYV 636 (639)
Q Consensus 560 -~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~ 636 (639)
...++|..+..++.|++.|++|+|.. +|+||||||+||+++.++.+||+|||+++.+..... ......++..||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 12578999999999999999999998 999999999999999999999999999987643222 122345677899
Q ss_pred CCC
Q 046265 637 API 639 (639)
Q Consensus 637 APE 639 (639)
|||
T Consensus 243 aPE 245 (337)
T cd05054 243 APE 245 (337)
T ss_pred CcH
Confidence 998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=217.38 Aligned_cols=173 Identities=17% Similarity=0.306 Sum_probs=140.6
Q ss_pred HhccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR 536 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 536 (639)
..++|+..+.||+|+||.||+|..+ .+..||||.+.... .......+.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3567888999999999999998543 24579999886433 2334456888999999999999999999999999
Q ss_pred ceeEEecccCCCChhHHhhcCCC-------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAA-------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAH 609 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~k 609 (639)
..|+||||+++|+|.+++..... ....++..+..++.|++.|++|||.. +|+||||||+||+++.++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999975321 23456778888999999999999998 999999999999999999999
Q ss_pred EccccccccCCCCCCC--cceeeeeceeeCCC
Q 046265 610 VSDFGISKFLKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 610 l~DfGla~~~~~~~~~--~~~~~gt~~Y~APE 639 (639)
++|||+++........ .....++..|+|||
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE 191 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHH
Confidence 9999999865432211 12234567899998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=218.42 Aligned_cols=168 Identities=22% Similarity=0.336 Sum_probs=134.7
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc---ccCceeeeEEEEEcC-----C
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL---RHRNVVKFYGFSFHP-----R 536 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~-----~ 536 (639)
+|+..+.||+|+||.||+|.. .+++.||+|.+............+.+|+++++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 467788999999999999955 4688999999876432222233456677777665 699999999998653 3
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
..++||||++ +++.+++..... ..+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 5789999997 488888765332 3478899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCCcceeeeeceeeCCC
Q 046265 617 KFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+...... ......||+.|+|||
T Consensus 156 ~~~~~~~-~~~~~~~~~~y~aPE 177 (288)
T cd07863 156 RIYSCQM-ALTPVVVTLWYRAPE 177 (288)
T ss_pred ccccCcc-cCCCccccccccCch
Confidence 8764322 223457899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-25 Score=241.56 Aligned_cols=168 Identities=20% Similarity=0.325 Sum_probs=139.2
Q ss_pred CCcceeccCCCceEEEEEcCC--Cc----EEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 468 DAKYCIGTAGQASVYKAELPS--WE----IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 468 ~~~~~ig~g~~g~vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
+..+.||+|.||.||+|...+ |. .||||.++... +.....+|.+|+.+|++++|||||+++|.|.+.+..+++
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 345789999999999996543 33 49999998643 455678899999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCC----CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 542 YEYLGRGSLAIILSNDAA----IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
+|||++|+|..+|++.+. ...+.......++.+||+|+.||++. +.|||||.++|+|++....+||+|||+|+
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhH
Confidence 999999999999987532 24577888999999999999999999 89999999999999999999999999999
Q ss_pred cCCCCCCCcceeeee--ceeeCCC
Q 046265 618 FLKPDSSNWSEFVGT--FGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~~~~~~gt--~~Y~APE 639 (639)
.+-..........+. ..|||||
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PE 874 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPE 874 (1025)
T ss_pred hhhhchheeccCccccceecCCHH
Confidence 653322211111222 3799998
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=221.91 Aligned_cols=162 Identities=22% Similarity=0.345 Sum_probs=130.3
Q ss_pred cceeccCCCceEEEEEcC---CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc--CCceeEEecc
Q 046265 470 KYCIGTAGQASVYKAELP---SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH--PRQSFLLYEY 544 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~ 544 (639)
...||+|+||.||+|... +++.||+|.+..... ...+.+|+.++++++||||+++++++.. +...|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999754 457899999875332 2346789999999999999999999865 3568899999
Q ss_pred cCCCChhHHhhcCC------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee----CCCCceEEcccc
Q 046265 545 LGRGSLAIILSNDA------AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL----GLDYDAHVSDFG 614 (639)
Q Consensus 545 ~~~g~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill----~~~~~~kl~DfG 614 (639)
++ +++.+++.... ....+++..+..++.|++.|++|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 85 57877765321 112478888999999999999999998 99999999999999 456789999999
Q ss_pred ccccCCCCCC---CcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSS---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~---~~~~~~gt~~Y~APE 639 (639)
+|+....... .....+||+.|||||
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE 185 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPE 185 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCH
Confidence 9987643221 223468999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=216.68 Aligned_cols=168 Identities=24% Similarity=0.350 Sum_probs=143.3
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
+.|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..++..|+|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 45677889999999999999664 57899999987532 3345678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|++++++..++.... ..+++..+..++.|++.|++|||.. +|+|||+||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 90 FCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred cCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 999999988875433 2478899999999999999999998 99999999999999999999999999987654333
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......|++.|+|||
T Consensus 165 ~~~~~~~~~~~y~aPE 180 (292)
T cd06644 165 QRRDSFIGTPYWMAPE 180 (292)
T ss_pred cccceecCCccccCce
Confidence 3334567899999998
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=213.74 Aligned_cols=166 Identities=22% Similarity=0.370 Sum_probs=139.4
Q ss_pred cCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEeccc
Q 046265 466 NFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYL 545 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 545 (639)
+|+..+.||+|+||.||+|..+++..+|||.+..... ....+.+|+.++++++||||+++++++...+..|+||||+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 4677889999999999999887778899999864332 2356888999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC
Q 046265 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 625 (639)
++++|.+++..... .++|..+..++.|++.|++|||.. +|+||||||+||+++.++.+|++|||+++........
T Consensus 82 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 82 ANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999999875432 578899999999999999999998 8999999999999999999999999998865432111
Q ss_pred -cceeeeeceeeCCC
Q 046265 626 -WSEFVGTFGYVAPI 639 (639)
Q Consensus 626 -~~~~~gt~~Y~APE 639 (639)
.....++..|+|||
T Consensus 157 ~~~~~~~~~~y~~Pe 171 (256)
T cd05059 157 SSQGTKFPVKWAPPE 171 (256)
T ss_pred ccCCCCCCccccCHH
Confidence 11122345799998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=216.64 Aligned_cols=170 Identities=25% Similarity=0.435 Sum_probs=142.4
Q ss_pred HhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcC-----
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHP----- 535 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~----- 535 (639)
++..|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 456677788999999999999965 467889999987532 2345678899999998 699999999998753
Q ss_pred -CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 046265 536 -RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614 (639)
Q Consensus 536 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfG 614 (639)
...|+||||+++|+|.+++..... ..++|..+..++.|++.|++|||+. +|+|||+||+||++++++.+||+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 357999999999999999876432 3578899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+++.............|++.|+|||
T Consensus 157 ~~~~~~~~~~~~~~~~g~~~y~aPE 181 (272)
T cd06637 157 VSAQLDRTVGRRNTFIGTPYWMAPE 181 (272)
T ss_pred CceecccccccCCcccccccccCHh
Confidence 9987644333344567999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=212.86 Aligned_cols=169 Identities=21% Similarity=0.308 Sum_probs=143.2
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.||+|+||.||++.. .+++.+|+|.++.... ....+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 467788999999999999954 4678999999865432 23456678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++|++.+++..... ..+++.....++.+++.|++|+|.. +|+|+||||+||++++++.++++|||.+........
T Consensus 80 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 80 CDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 999999998864332 3467788999999999999999998 999999999999999999999999999987654333
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......|++.|+|||
T Consensus 156 ~~~~~~~~~~~~aPE 170 (255)
T cd08219 156 YACTYVGTPYYVPPE 170 (255)
T ss_pred ccccccCCccccCHH
Confidence 334467899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=226.15 Aligned_cols=162 Identities=17% Similarity=0.253 Sum_probs=136.6
Q ss_pred HhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
...+|+..+.||+|+||.||+|... +++.||+|...... ...|+.++++++|||||++++++...+..++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 3467999999999999999999654 56789999754321 24689999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+. +++.+++.... ..++|..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 136 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 99995 68888876533 3578999999999999999999998 999999999999999999999999999975432
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
. .......||+.|+|||
T Consensus 210 ~-~~~~~~~gt~~y~aPE 226 (357)
T PHA03209 210 A-PAFLGLAGTVETNAPE 226 (357)
T ss_pred C-cccccccccccccCCe
Confidence 2 2223467999999998
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=219.11 Aligned_cols=169 Identities=24% Similarity=0.339 Sum_probs=143.4
Q ss_pred cCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.++++++||||+++++++..++..|+||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 5677889999999999999665 78999999887532 233346788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++++|.++++.......+++..+..++.+++.|++|||+.+ +|+||||||+||+++.++.+|++|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999999876433346789999999999999999999642 8999999999999999999999999999765422
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......|++.|+|||
T Consensus 157 ~~~~~~~~~~y~aPE 171 (286)
T cd06622 157 LAKTNIGCQSYMAPE 171 (286)
T ss_pred ccccCCCccCccCcc
Confidence 223356889999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=215.74 Aligned_cols=168 Identities=26% Similarity=0.404 Sum_probs=137.8
Q ss_pred ccCCCcceeccCCCceEEEEEc-----CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--Cc
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-----PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQ 537 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~ 537 (639)
.+|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 4677788999999999999964 357889999987532 33456788999999999999999999987643 46
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.++||||+++|+|.+++.... ..++|..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 889999999999999987543 2478899999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCCc---ceeeeeceeeCCC
Q 046265 618 FLKPDSSNW---SEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~~---~~~~gt~~Y~APE 639 (639)
.+....... ....++..|+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE 181 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPE 181 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHH
Confidence 764332211 1123445699998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=218.87 Aligned_cols=166 Identities=27% Similarity=0.346 Sum_probs=143.2
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|++|.||+|.. .+++.||+|.+..... .....+.+.+|++++++++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3677889999999999999965 4679999999875321 2233466889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++++|.+++.... .+++..+..++.|++.|++|||.. +|+||||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999987653 467788999999999999999998 9999999999999999999999999999876533
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
.....|++.|+|||
T Consensus 155 ---~~~~~~~~~y~aPE 168 (290)
T cd05580 155 ---TYTLCGTPEYLAPE 168 (290)
T ss_pred ---CCCCCCCccccChh
Confidence 23457899999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=223.92 Aligned_cols=171 Identities=20% Similarity=0.322 Sum_probs=137.6
Q ss_pred ccCCCcceeccCCCceEEEEEc------CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcC-C
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHP-R 536 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~ 536 (639)
++|+..+.||+|+||.||+|.. .+++.||||.++.... ....+.+.+|+.++.++ +|||||+++++|... .
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 4688899999999999999952 4568899999975432 23345678999999999 689999999988765 4
Q ss_pred ceeEEecccCCCChhHHhhcCCC---------------------------------------------------------
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAA--------------------------------------------------------- 559 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 559 (639)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999864221
Q ss_pred -------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC--Ccceee
Q 046265 560 -------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS--NWSEFV 630 (639)
Q Consensus 560 -------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~--~~~~~~ 630 (639)
...++|..+..++.|+++|++|+|.. +|+||||||+||+++.++.+|++|||+++....... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12367888899999999999999998 999999999999999999999999999986533221 112234
Q ss_pred eeceeeCCC
Q 046265 631 GTFGYVAPI 639 (639)
Q Consensus 631 gt~~Y~APE 639 (639)
+++.|+|||
T Consensus 243 ~~~~y~aPE 251 (343)
T cd05103 243 LPLKWMAPE 251 (343)
T ss_pred CCcceECcH
Confidence 567899998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=217.28 Aligned_cols=168 Identities=26% Similarity=0.390 Sum_probs=144.6
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++..++..|+|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 45777889999999999999664 6789999998653 23345678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++++|.+++.... ..+++..+..++.|++.|++|+|.. +|+||||||+||+++.++.+|++|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 83 FCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred ccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999999987543 2478899999999999999999998 99999999999999999999999999987654333
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......|++.|+|||
T Consensus 158 ~~~~~~~~~~~y~~PE 173 (280)
T cd06611 158 QKRDTFIGTPYWMAPE 173 (280)
T ss_pred cccceeecchhhcCHH
Confidence 3334567999999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=215.61 Aligned_cols=161 Identities=26% Similarity=0.387 Sum_probs=138.3
Q ss_pred cCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.||+|+||.||+|. ..+++.||+|.+.... .....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 56777899999999999995 4678899999987542 233456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
++++++..+. .+++..+..++.|++.|++|+|+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999997542 356788889999999999999998 9999999999999999999999999999865432
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
.....+|++.|+|||
T Consensus 149 ~~~~~~~~~~y~aPE 163 (279)
T cd06619 149 IAKTYVGTNAYMAPE 163 (279)
T ss_pred cccCCCCChhhcCce
Confidence 223467999999998
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=220.18 Aligned_cols=168 Identities=24% Similarity=0.384 Sum_probs=140.8
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.||+|+||.||+|.. .+|+.||+|++............+.+|++++++++||||+++++++.+.+..|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 367778999999999999965 4689999999876443333345678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
++ +++.+++.... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 57777765432 2478899999999999999999998 999999999999999999999999999986543333
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......+++.|+|||
T Consensus 155 ~~~~~~~~~~y~aPE 169 (284)
T cd07839 155 CYSAEVVTLWYRPPD 169 (284)
T ss_pred CcCCCccccCCcChH
Confidence 333456789999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=219.96 Aligned_cols=169 Identities=23% Similarity=0.388 Sum_probs=145.3
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|+||.||+|..+ +++.||+|++..........+.+.+|++++++++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35777899999999999999765 57899999987644333345678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|++++++..+..... .++|..+..++.|++.|++|||.. +|+|||++|+||++++++.+|++|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999988775432 378899999999999999999998 99999999999999999999999999998765443
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......++..|+|||
T Consensus 155 ~~~~~~~~~~~y~aPE 170 (286)
T cd07846 155 EVYTDYVATRWYRAPE 170 (286)
T ss_pred cccCcccceeeccCcH
Confidence 4344567899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=218.53 Aligned_cols=172 Identities=18% Similarity=0.281 Sum_probs=141.3
Q ss_pred hccCCCcceeccCCCceEEEEEcC--------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEc
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP--------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFH 534 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 534 (639)
.++|...+.||+|+||.||+|... ++..||+|.+.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 356677889999999999999531 23579999887432 233456788999999999 89999999999999
Q ss_pred CCceeEEecccCCCChhHHhhcCCC-------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCee
Q 046265 535 PRQSFLLYEYLGRGSLAIILSNDAA-------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVL 601 (639)
Q Consensus 535 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil 601 (639)
.+..|+||||+++|+|.+++..... ...++|..+..++.|+++|++|||.. +|+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 9999999999999999999975432 13578899999999999999999998 9999999999999
Q ss_pred eCCCCceEEccccccccCCCCCCC--cceeeeeceeeCCC
Q 046265 602 LGLDYDAHVSDFGISKFLKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 602 l~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~Y~APE 639 (639)
++.++.+|++|||+++.+...... .....+++.|+|||
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE 209 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPE 209 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCch
Confidence 999999999999999876432211 12234677899998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=215.70 Aligned_cols=168 Identities=23% Similarity=0.339 Sum_probs=139.9
Q ss_pred cCCCcceeccCCCceEEEEEc-----CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--Cce
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-----PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQS 538 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 538 (639)
.|+..+.||+|+||.||+|.. .++..||+|.+.... .......+.+|+.++++++||||+++++++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 467788999999999999963 356889999987543 233446789999999999999999999999875 568
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
++||||+++++|.+++.... ..++|..+..++.+++.|++|+|+. +|+||||||+||+++.++.+|++|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 99999999999999986543 2578999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCC---CcceeeeeceeeCCC
Q 046265 619 LKPDSS---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~---~~~~~~gt~~Y~APE 639 (639)
...... ......|+..|+|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE 182 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPE 182 (284)
T ss_pred cccCccceeecCCCCCCccccCHH
Confidence 643222 112345677899998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=213.45 Aligned_cols=167 Identities=20% Similarity=0.381 Sum_probs=139.6
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
.+|...+.||+|+||.||+|...+...||+|++..... ..+.+.+|++++++++||||+++++++. .+..|+||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 45778899999999999999877777899999875332 3456889999999999999999999875 4568999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++|+|.+++..... ..++|..+..++.++++|++|+|.. +|+||||||+||++++++.+||+|||.++.+.....
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 82 MSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999999975432 3578899999999999999999998 999999999999999999999999999986643322
Q ss_pred C-cceeeeeceeeCCC
Q 046265 625 N-WSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~-~~~~~gt~~Y~APE 639 (639)
. .....++..|+|||
T Consensus 158 ~~~~~~~~~~~y~~PE 173 (262)
T cd05071 158 TARQGAKFPIKWTAPE 173 (262)
T ss_pred ccccCCcccceecCHh
Confidence 1 12345677899998
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=210.62 Aligned_cols=163 Identities=22% Similarity=0.328 Sum_probs=137.1
Q ss_pred ceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCCCh
Q 046265 471 YCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 550 (639)
++||+|+||.||+|..++++.||+|.+.... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999988888999999987543 233445688999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCc-cee
Q 046265 551 AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW-SEF 629 (639)
Q Consensus 551 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~ 629 (639)
.+++.... ..++|..+..++.+++.|+.|+|.. +++||||||+||+++.++.+|++|||++.......... ...
T Consensus 80 ~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 80 LSFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 99986543 3478899999999999999999988 99999999999999999999999999987543222111 112
Q ss_pred eeeceeeCCC
Q 046265 630 VGTFGYVAPI 639 (639)
Q Consensus 630 ~gt~~Y~APE 639 (639)
.+++.|+|||
T Consensus 155 ~~~~~y~aPE 164 (250)
T cd05085 155 QIPIKWTAPE 164 (250)
T ss_pred CCcccccCHH
Confidence 3457799998
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=218.11 Aligned_cols=166 Identities=26% Similarity=0.449 Sum_probs=142.6
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.+|+..+.||+|++|.||+|. ..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 467778899999999999996 456889999998754322 34568899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++++|.+++... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred ccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 99999999998643 367889999999999999999998 99999999999999999999999999988764433
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......|++.|+|||
T Consensus 171 ~~~~~~~~~~~y~aPE 186 (296)
T cd06654 171 SKRSTMVGTPYWMAPE 186 (296)
T ss_pred cccCcccCCccccCHH
Confidence 3333457899999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=216.28 Aligned_cols=170 Identities=24% Similarity=0.437 Sum_probs=141.2
Q ss_pred ccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
.+|...+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 34667789999999999999632 34568999986432 33446788999999999999999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCC-------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC
Q 046265 539 FLLYEYLGRGSLAIILSNDAA-------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD 605 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~ 605 (639)
++||||+++++|.+++..... ...++|..+..++.+++.|++|||.. +|+||||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 999999999999999975431 23578999999999999999999998 99999999999999999
Q ss_pred CceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 606 YDAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 606 ~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
+.+|++|||+++....... ......|+..|+|||
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 195 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 195 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChH
Confidence 9999999999986543221 122345688999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=226.49 Aligned_cols=167 Identities=19% Similarity=0.275 Sum_probs=138.0
Q ss_pred HhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC------
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP------ 535 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------ 535 (639)
..++|+..+.||+|+||.||+|.. ..++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 356788899999999999999954 5678899999976543344456678899999999999999999987643
Q ss_pred CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGl 615 (639)
...|+||||+++ ++.+.+.. .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999965 66666642 367788889999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCcceeeeeceeeCCC
Q 046265 616 SKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
++..... .......||+.|+|||
T Consensus 173 a~~~~~~-~~~~~~~~t~~y~aPE 195 (364)
T cd07875 173 ARTAGTS-FMMTPYVVTRYYRAPE 195 (364)
T ss_pred ccccCCC-CcccCCcccCCcCCHH
Confidence 9865432 2223467999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=213.20 Aligned_cols=167 Identities=20% Similarity=0.369 Sum_probs=140.2
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
++|+..+.||+|+||.||+|..+++..||+|.+..... ..+.+.+|+.++++++|||++++++++. .+..|+||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 45777889999999999999888888899999875432 2456899999999999999999999875 4568999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++++|.+++..... ..+++..+..++.+++.|++|||+. +|+||||||+||++++++.+|++|||++..+.....
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999999999975432 3478999999999999999999998 899999999999999999999999999987643221
Q ss_pred -CcceeeeeceeeCCC
Q 046265 625 -NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 -~~~~~~gt~~Y~APE 639 (639)
......++..|+|||
T Consensus 158 ~~~~~~~~~~~y~aPE 173 (260)
T cd05070 158 TARQGAKFPIKWTAPE 173 (260)
T ss_pred ccccCCCCCccccChH
Confidence 112234567899998
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=217.88 Aligned_cols=167 Identities=26% Similarity=0.433 Sum_probs=144.1
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
..+|+..+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 35678889999999999999964 6789999999875432 23466789999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++++|.+++... .+++..+..++.+++.|+.|||.. +|+||||||+||+++.++.+|++|||++......
T Consensus 96 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred cccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 999999999998643 367788999999999999999998 9999999999999999999999999999876544
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
........|++.|+|||
T Consensus 169 ~~~~~~~~~~~~y~aPE 185 (297)
T cd06656 169 QSKRSTMVGTPYWMAPE 185 (297)
T ss_pred ccCcCcccCCccccCHH
Confidence 33334457899999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=212.97 Aligned_cols=169 Identities=25% Similarity=0.338 Sum_probs=142.6
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCCh---hhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDM---VVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
++|+..+.||+|++|.||+|.. .+++.||+|.+....... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999954 568999999987543221 223568899999999999999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||||+++++|.+.+.... .+++..+..++.+++.|++|||.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999987543 367788899999999999999998 99999999999999999999999999998654
Q ss_pred CCCCC---cceeeeeceeeCCC
Q 046265 621 PDSSN---WSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~---~~~~~gt~~Y~APE 639 (639)
..... .....|+..|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE 177 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPE 177 (263)
T ss_pred ccccccccccCCCcCccccCcc
Confidence 32111 12356889999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=213.74 Aligned_cols=169 Identities=19% Similarity=0.291 Sum_probs=135.4
Q ss_pred CCcceeccCCCceEEEEEcCCC-c--EEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC------Cce
Q 046265 468 DAKYCIGTAGQASVYKAELPSW-E--IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP------RQS 538 (639)
Q Consensus 468 ~~~~~ig~g~~g~vy~~~~~~~-~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~ 538 (639)
...+.||+|+||.||+|..... + .||||.+..........+.+.+|++++++++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4567899999999999976543 3 589999876544444567789999999999999999999988542 246
Q ss_pred eEEecccCCCChhHHhhcCC---CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDA---AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGl 615 (639)
++||||+++|+|.+++.... ....++|.....++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874322 223478999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCC--cceeeeeceeeCCC
Q 046265 616 SKFLKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~~--~~~~~gt~~Y~APE 639 (639)
++.+...... .....+++.|+|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe 184 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIE 184 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHH
Confidence 9876432211 11234567899997
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-24 Score=212.99 Aligned_cols=168 Identities=17% Similarity=0.344 Sum_probs=141.0
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.++|+..+.||+|+||.||+|..++++.||+|.+..... ..+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 356778899999999999999988899999999875432 2457889999999999999999999874 467899999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++|+|.+++..... ..+++..+..++.+++.|++|||.. +++||||||+||++++++.++++|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999999865433 3578899999999999999999988 99999999999999999999999999998665222
Q ss_pred C-CcceeeeeceeeCCC
Q 046265 624 S-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~-~~~~~~gt~~Y~APE 639 (639)
. ......++..|+|||
T Consensus 157 ~~~~~~~~~~~~y~~pe 173 (260)
T cd05067 157 YTAREGAKFPIKWTAPE 173 (260)
T ss_pred cccccCCcccccccCHH
Confidence 1 112234567899998
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=216.57 Aligned_cols=172 Identities=22% Similarity=0.331 Sum_probs=142.5
Q ss_pred hccCCCcceeccCCCceEEEEEcCC-----------------CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCcee
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPS-----------------WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVV 526 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv 526 (639)
..+|+..+.||+|+||.||+|.... +..||+|.+.... .....+.+.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3567888999999999999986532 2458999987543 234456789999999999999999
Q ss_pred eeEEEEEcCCceeEEecccCCCChhHHhhcCCC--------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCC
Q 046265 527 KFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAA--------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSK 598 (639)
Q Consensus 527 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~ 598 (639)
+++++|..++..++||||+++++|.+++..... ...+++.....++.|++.|++|||.. +|+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence 999999999999999999999999999875431 12578999999999999999999988 9999999999
Q ss_pred CeeeCCCCceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 599 NVLLGLDYDAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 599 Nill~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
||+++.++.+|++|||+++....... ......+++.|||||
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 202 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWE 202 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHH
Confidence 99999999999999999886533221 122345678999998
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=220.53 Aligned_cols=166 Identities=17% Similarity=0.242 Sum_probs=137.1
Q ss_pred cceeccC--CCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccC
Q 046265 470 KYCIGTA--GQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLG 546 (639)
Q Consensus 470 ~~~ig~g--~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 546 (639)
.++||+| +|++||++. .++|+.||||++..........+.+.+|+++++.++|||||+++++|..++..|+||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4689999 688999995 4678999999997654444445677889999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC--
Q 046265 547 RGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS-- 624 (639)
Q Consensus 547 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~-- 624 (639)
+|++.+++..... ..+++..+..++.|++.||+|||.. +|+||||||+||+++.++.++++|||.+........
T Consensus 83 ~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 83 YGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999865432 3478899999999999999999998 999999999999999999999999986554322111
Q ss_pred -----CcceeeeeceeeCCC
Q 046265 625 -----NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 -----~~~~~~gt~~Y~APE 639 (639)
......++..|||||
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE 178 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPE 178 (327)
T ss_pred cccccccccccceecccChH
Confidence 011235778899998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=215.10 Aligned_cols=171 Identities=18% Similarity=0.317 Sum_probs=142.1
Q ss_pred ccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
++|...+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.++++++||||+++++++...+..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 56778899999999999999654 23679999986543 233456788999999999999999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCC-------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 046265 539 FLLYEYLGRGSLAIILSNDAA-------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVS 611 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~ 611 (639)
|+||||+++|+|.+++..... ...++|..+..++.|++.|++|+|.. +|+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 999999999999999875432 12368889999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 612 DFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 612 DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
|||+++.+..... ......++..|+|||
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHH
Confidence 9999986543221 122345778999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=213.13 Aligned_cols=164 Identities=21% Similarity=0.270 Sum_probs=133.0
Q ss_pred eeccCCCceEEEEEcCCC---cEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCC
Q 046265 472 CIGTAGQASVYKAELPSW---EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRG 548 (639)
Q Consensus 472 ~ig~g~~g~vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 548 (639)
.||+|+||.||+|+..++ ..+++|.+.... .....+.+.+|+.++++++||||++++++|......|+||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 589999999999965443 346677765432 2234677899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCC-CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC--CC
Q 046265 549 SLAIILSNDAA-IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS--SN 625 (639)
Q Consensus 549 ~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~--~~ 625 (639)
+|.+++..... ....++.....++.|+++|++|+|+. +|+||||||+||+++.++.+|++|||++....... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999975432 23456677888999999999999998 99999999999999999999999999986432211 11
Q ss_pred cceeeeeceeeCCC
Q 046265 626 WSEFVGTFGYVAPI 639 (639)
Q Consensus 626 ~~~~~gt~~Y~APE 639 (639)
....+|+..|+|||
T Consensus 158 ~~~~~~~~~y~aPE 171 (268)
T cd05086 158 EDDKCVPLRWLAPE 171 (268)
T ss_pred ccCCcCcccccCch
Confidence 23456889999998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=213.33 Aligned_cols=167 Identities=22% Similarity=0.377 Sum_probs=140.2
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|...+.||+|+||.||+|.. +.++.||+|.+.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 466778999999999999965 457889999987432 2345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++++|.+++..... ..+++..+..++.|+++|++|||.. +++||||||+||++++++.+|++|||++........
T Consensus 84 ~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999875432 4578999999999999999999998 999999999999999999999999999987653321
Q ss_pred C-cceeeeeceeeCCC
Q 046265 625 N-WSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~-~~~~~gt~~Y~APE 639 (639)
. .....+++.|+|||
T Consensus 160 ~~~~~~~~~~~y~aPE 175 (263)
T cd05052 160 TAHAGAKFPIKWTAPE 175 (263)
T ss_pred eccCCCCCccccCCHH
Confidence 1 11223456899998
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-24 Score=213.02 Aligned_cols=170 Identities=21% Similarity=0.317 Sum_probs=138.8
Q ss_pred CCCcceeccCCCceEEEEEcC----CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc-----
Q 046265 467 FDAKYCIGTAGQASVYKAELP----SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ----- 537 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----- 537 (639)
|...+.||+|+||.||+|... .+..||||+++...........+.+|+..++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456789999999999999653 23679999988654444455678999999999999999999999876554
Q ss_pred -eeEEecccCCCChhHHhhcCC---CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 046265 538 -SFLLYEYLGRGSLAIILSNDA---AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDF 613 (639)
Q Consensus 538 -~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~Df 613 (639)
.++||||+++|+|..++.... ....+++..+..++.|++.|++|+|+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 799999999999999885432 224688999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCCC--cceeeeeceeeCCC
Q 046265 614 GISKFLKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 614 Gla~~~~~~~~~--~~~~~gt~~Y~APE 639 (639)
|+++.+...... .....++..|+|||
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe 185 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIE 185 (273)
T ss_pred cceeeccccccccccccccCCccccCHh
Confidence 999876433221 11234567899998
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=217.70 Aligned_cols=169 Identities=22% Similarity=0.309 Sum_probs=142.6
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--CceeEE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQSFLL 541 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv 541 (639)
++|+..+.||+|+||.||+|..+ +++.+|||.++...........+.+|+.++++++||||+++++++..+ +..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46778899999999999999665 678999999975443333344567899999999999999999999877 789999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||++ ++|.+++..... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+|++|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 589888865432 578899999999999999999998 999999999999999999999999999987654
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
.........+++.|+|||
T Consensus 159 ~~~~~~~~~~~~~~~aPE 176 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPE 176 (293)
T ss_pred CccccccccccccccCch
Confidence 433334456889999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-24 Score=212.01 Aligned_cols=158 Identities=23% Similarity=0.393 Sum_probs=131.2
Q ss_pred ceeccCCCceEEEEEcCC-------------CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc
Q 046265 471 YCIGTAGQASVYKAELPS-------------WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 537 (639)
+.||+|+||.||+|...+ ...||+|.+.... ......|.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999996532 1248889876532 2334578889999999999999999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc-------eEE
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD-------AHV 610 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~-------~kl 610 (639)
.++||||+++|++..++.... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++. +|+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred CEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 999999999999998886543 2478889999999999999999998 9999999999999987654 899
Q ss_pred ccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 611 SDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 611 ~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+|||++...... ....|+..|||||
T Consensus 154 ~d~g~~~~~~~~----~~~~~~~~y~aPE 178 (262)
T cd05077 154 SDPGIPITVLSR----QECVERIPWIAPE 178 (262)
T ss_pred CCCCCCccccCc----ccccccccccChh
Confidence 999998765422 2346788999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=217.23 Aligned_cols=170 Identities=22% Similarity=0.308 Sum_probs=141.3
Q ss_pred ccCCCcceeccCCCceEEEEEc------CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCc
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 537 (639)
++|...+.||+|+||.||+|.. .++..||||+++.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 5688889999999999999953 2345799999875432 33456789999999999 79999999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.|+||||+++|+|.++++.... ..+++.++..++.+++.|++|+|.. +|+||||||+||+++.++.+|++|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999975432 2378999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCC--cceeeeeceeeCCC
Q 046265 618 FLKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~--~~~~~gt~~Y~APE 639 (639)
........ .....++..|+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE 213 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPE 213 (302)
T ss_pred cccCCCceeecCCCCcccccCCHh
Confidence 66433211 11234577899998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=216.43 Aligned_cols=170 Identities=22% Similarity=0.273 Sum_probs=139.8
Q ss_pred HhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
++++|...+.||+|+||.||+|.. .+++.||+|.+..... ......+.+|+.++++++|+||+++++++..++..|+|
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 457788899999999999999954 5688999999875432 22234567899999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||++ +++.+.+.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 82 FEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred Eeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 99996 66666654332 2467788888999999999999998 999999999999999999999999999986543
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
.........+++.|+|||
T Consensus 156 ~~~~~~~~~~~~~y~aPE 173 (291)
T cd07870 156 PSQTYSSEVVTLWYRPPD 173 (291)
T ss_pred CCCCCCCccccccccCCc
Confidence 333334456899999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-24 Score=211.06 Aligned_cols=161 Identities=24% Similarity=0.331 Sum_probs=134.5
Q ss_pred eeccCCCceEEEEEc---CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCC
Q 046265 472 CIGTAGQASVYKAEL---PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRG 548 (639)
Q Consensus 472 ~ig~g~~g~vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 548 (639)
.||+|+||.||+|.+ .+++.+|+|.+..........+.+.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999954 35688999998765544455677899999999999999999999886 45678999999999
Q ss_pred ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC---
Q 046265 549 SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN--- 625 (639)
Q Consensus 549 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~--- 625 (639)
+|.+++.... .+++..+..++.|++.|++|+|.. +|+||||||+||++++++.+||+|||+++.+......
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999997543 477899999999999999999988 9999999999999999999999999999876543221
Q ss_pred cceeeeeceeeCCC
Q 046265 626 WSEFVGTFGYVAPI 639 (639)
Q Consensus 626 ~~~~~gt~~Y~APE 639 (639)
.....+++.|||||
T Consensus 155 ~~~~~~~~~y~aPE 168 (257)
T cd05116 155 KTHGKWPVKWYAPE 168 (257)
T ss_pred cCCCCCCccccCHh
Confidence 11223457899998
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-25 Score=243.04 Aligned_cols=176 Identities=22% Similarity=0.222 Sum_probs=150.3
Q ss_pred HHHHHHhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCC-hhhHHHHHHHHHHHhccccCceeeeEEEEEcC
Q 046265 458 EEVIRATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPD-MVVQQAFSNEIKALTELRHRNVVKFYGFSFHP 535 (639)
Q Consensus 458 ~~~~~~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 535 (639)
.++....++|....+||+|+||.|..+++ .+++.||.|++.+...- ......|..|=.+|.-...+.||+++-.|+++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 34445578899999999999999999966 46788999999863311 22345688888999988999999999999999
Q ss_pred CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGl 615 (639)
.++|+|||||+||+|-.++.... .++...+.-++.++..|+..+|.. |.|||||||+|||+|..|++|++|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence 99999999999999999997654 467788888899999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCC-cceeeeeceeeCCC
Q 046265 616 SKFLKPDSSN-WSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~~-~~~~~gt~~Y~APE 639 (639)
+-.+..++.. ....+|||-|++||
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPE 246 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPE 246 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHH
Confidence 9888755543 34578999999998
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=215.12 Aligned_cols=165 Identities=34% Similarity=0.502 Sum_probs=134.7
Q ss_pred cceeccCCCceEEEEEcC-----CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 470 KYCIGTAGQASVYKAELP-----SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
.+.||.|+||.||+|.+. .+..||||.+... ......+.|.+|++.+++++||||++++|+|...+..++||||
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccccc
Confidence 468999999999999766 2467999999653 2334467899999999999999999999999988889999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++|+|.++++.... ..+++..+..++.|+++||+|||.. +|+|+||+++||+++.++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK-EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTCT-TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccc-ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999987622 4578999999999999999999998 899999999999999999999999999987632211
Q ss_pred --CcceeeeeceeeCCC
Q 046265 625 --NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 --~~~~~~gt~~Y~APE 639 (639)
......+...|+|||
T Consensus 159 ~~~~~~~~~~~~~~aPE 175 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPE 175 (259)
T ss_dssp EEESTTSESGGGGS-HH
T ss_pred ccccccccccccccccc
Confidence 112245677899998
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=210.82 Aligned_cols=161 Identities=26% Similarity=0.361 Sum_probs=132.0
Q ss_pred eeccCCCceEEEEEcC---CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCC
Q 046265 472 CIGTAGQASVYKAELP---SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRG 548 (639)
Q Consensus 472 ~ig~g~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 548 (639)
.||+|+||.||+|... ++..||||.+.... .....+.+.+|+.++++++||||+++++++.. +..++||||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 3899999999999653 34579999987543 33445678999999999999999999998864 5789999999999
Q ss_pred ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCc--
Q 046265 549 SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW-- 626 (639)
Q Consensus 549 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-- 626 (639)
+|.+++.... ..+++..+.+++.+++.|++|+|.. +++||||||+||+++.++.+|++|||+++.........
T Consensus 80 ~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 80 PLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999987533 3578899999999999999999998 99999999999999999999999999998654332211
Q ss_pred -ceeeeeceeeCCC
Q 046265 627 -SEFVGTFGYVAPI 639 (639)
Q Consensus 627 -~~~~gt~~Y~APE 639 (639)
....+++.|+|||
T Consensus 155 ~~~~~~~~~y~aPE 168 (257)
T cd05115 155 RSAGKWPLKWYAPE 168 (257)
T ss_pred cCCCCCCcccCCHH
Confidence 1122357899998
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=212.71 Aligned_cols=169 Identities=25% Similarity=0.338 Sum_probs=139.6
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC---ChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--Cce
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP---DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQS 538 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 538 (639)
.+|+..+.||+|+||.||+|.. .+++.||||.+..... .....+.+.+|+.++++++||||+++++++.++ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4678889999999999999965 5689999998864321 122345788899999999999999999998764 467
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
++||||+++++|.+++.... .+++.....++.+++.|++|+|+. +|+|+||||+||+++.++.+||+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999987543 367788889999999999999998 999999999999999999999999999886
Q ss_pred CCCCC---CCcceeeeeceeeCCC
Q 046265 619 LKPDS---SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~---~~~~~~~gt~~Y~APE 639 (639)
..... .......|+..|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE 179 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPE 179 (265)
T ss_pred cccccccccccccCCCCccccChh
Confidence 54211 1223356899999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=217.89 Aligned_cols=171 Identities=23% Similarity=0.332 Sum_probs=138.2
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCc--EEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCcee
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWE--IVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 539 (639)
.++|+..+.||+|+||.||+|..+ ++. .+|+|++.... .....+.+.+|++++.++ +||||+++++++..++..|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 356788899999999999999754 454 46788766422 233456788999999999 8999999999999999999
Q ss_pred EEecccCCCChhHHhhcCCC-------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 046265 540 LLYEYLGRGSLAIILSNDAA-------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY 606 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~ 606 (639)
+||||+++|+|.++++..+. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCC
Confidence 99999999999999975431 12578899999999999999999988 999999999999999999
Q ss_pred ceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 607 DAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 607 ~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
.+||+|||+++....... .....++..|+|||
T Consensus 162 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE 193 (303)
T cd05088 162 VAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIE 193 (303)
T ss_pred cEEeCccccCcccchhhh-cccCCCcccccCHH
Confidence 999999999864321111 11123466799998
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=216.40 Aligned_cols=170 Identities=17% Similarity=0.286 Sum_probs=139.0
Q ss_pred cCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 466 NFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
+|...+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.++++++||||+++++++...+..+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 3555678999999999999653 34779999997543 2334567889999999999999999999999999999
Q ss_pred EEecccCCCChhHHhhcCC-------------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 046265 540 LLYEYLGRGSLAIILSNDA-------------AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY 606 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~ 606 (639)
+++||+++++|.+++.... ....+++..+..++.|+++|++|+|.. +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 112478888999999999999999988 999999999999999999
Q ss_pred ceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 607 DAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 607 ~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
.+|++|||+++.+..... ......+++.|||||
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 196 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPE 196 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHH
Confidence 999999999886543221 112344678999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-24 Score=215.90 Aligned_cols=172 Identities=19% Similarity=0.290 Sum_probs=141.2
Q ss_pred hccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCC
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPR 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 536 (639)
.++|+..+.||+|+||.||+|... ....+|+|.+..... ......+.+|+.++.++ +||||+++++++..++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 356777889999999999999653 236799999875432 23345688999999999 8999999999999999
Q ss_pred ceeEEecccCCCChhHHhhcCC-------------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC
Q 046265 537 QSFLLYEYLGRGSLAIILSNDA-------------AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG 603 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~ 603 (639)
..++||||+++|+|.++++... ....++|..++.++.|++.|++|||.. +|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 9999999999999999986431 234688999999999999999999988 999999999999999
Q ss_pred CCCceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 604 LDYDAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 604 ~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
+++.+|++|||+++.+..... ......++..|+|||
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 204 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPE 204 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHH
Confidence 999999999999987643221 112233567899998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-24 Score=216.53 Aligned_cols=169 Identities=25% Similarity=0.375 Sum_probs=142.4
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.||+|++|.||+|.. .+++.||||++............+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 477788999999999999965 4689999999875443333445788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
++ +++..++..... ..+++..+..++.++++|++|||.. +++||||+|+||+++.++.+|++|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 688888765332 3578899999999999999999998 999999999999999999999999999886643333
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......+++.|+|||
T Consensus 156 ~~~~~~~~~~y~aPE 170 (284)
T cd07860 156 TYTHEVVTLWYRAPE 170 (284)
T ss_pred ccccccccccccCCe
Confidence 333456788999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=212.53 Aligned_cols=156 Identities=26% Similarity=0.408 Sum_probs=131.1
Q ss_pred ceeccCCCceEEEEEcCCCc-----------EEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 471 YCIGTAGQASVYKAELPSWE-----------IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
+.||+|+||.||+|...... .||+|.+..... ....|.+|+.++++++||||+++++++.. +..+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 36899999999999765432 477787654321 15778899999999999999999999988 7789
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-------ceEEcc
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY-------DAHVSD 612 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~-------~~kl~D 612 (639)
+||||+++|+|.+++..... .+++..++.++.|++.|++|||.. +|+||||||+||+++.++ .+|++|
T Consensus 77 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 99999999999999976442 578899999999999999999988 999999999999999887 799999
Q ss_pred ccccccCCCCCCCcceeeeeceeeCCC
Q 046265 613 FGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 613 fGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
||++..... .....++..|+|||
T Consensus 152 fg~a~~~~~----~~~~~~~~~y~aPE 174 (259)
T cd05037 152 PGIPITVLS----REERVERIPWIAPE 174 (259)
T ss_pred CCccccccc----ccccccCCCccChh
Confidence 999987543 12345678899998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.5e-24 Score=214.89 Aligned_cols=170 Identities=23% Similarity=0.308 Sum_probs=138.7
Q ss_pred cCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 466 NFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
+|+..+.||+|+||.||+|... +...+|+|.+.... .....+.+.+|+.++++++||||+++++.|...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 3677889999999999999642 23568898887543 2333467889999999999999999999999999999
Q ss_pred EEecccCCCChhHHhhcCC---------------------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCC
Q 046265 540 LLYEYLGRGSLAIILSNDA---------------------AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSK 598 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~ 598 (639)
+||||+++|+|.+++.... ....+++..+..++.|++.|++|||+. +|+||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhh
Confidence 9999999999999886421 113478899999999999999999988 9999999999
Q ss_pred CeeeCCCCceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 599 NVLLGLDYDAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 599 Nill~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
||++++++.+||+|||+++....... ......++..|+|||
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE 199 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIE 199 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHH
Confidence 99999999999999999986533221 112234567899998
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=214.50 Aligned_cols=157 Identities=21% Similarity=0.340 Sum_probs=128.5
Q ss_pred eeccCCCceEEEEEcCC-------------------------CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCcee
Q 046265 472 CIGTAGQASVYKAELPS-------------------------WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVV 526 (639)
Q Consensus 472 ~ig~g~~g~vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv 526 (639)
.||+|+||.||+|.+.. ...||+|.+.... ......|.+|+.++++++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 58999999999996421 1348889886432 23345688899999999999999
Q ss_pred eeEEEEEcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 046265 527 KFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY 606 (639)
Q Consensus 527 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~ 606 (639)
+++++|.++...|+||||+++|+|..++.... ..+++..+..++.|+++|++|||+. +|+||||||+||+++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 99999999999999999999999999986533 2578889999999999999999988 999999999999997543
Q ss_pred -------ceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 607 -------DAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 607 -------~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
.+|++|||++...... ....+++.|+|||
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe 190 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPE 190 (274)
T ss_pred cccCccceeeecCCccccccccc----cccccCCcccCch
Confidence 3799999988654322 2235788899998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-25 Score=238.95 Aligned_cols=173 Identities=26% Similarity=0.386 Sum_probs=138.7
Q ss_pred HHHhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC----
Q 046265 461 IRATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP---- 535 (639)
Q Consensus 461 ~~~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~---- 535 (639)
.+...+|++...+|+||||.||+++-+ ||+.||||+++... .........+|+..+++++|||||+++..|.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 456778888999999999999999654 89999999998765 334455678999999999999999998743210
Q ss_pred --------------------------------------------------------------------------------
Q 046265 536 -------------------------------------------------------------------------------- 535 (639)
Q Consensus 536 -------------------------------------------------------------------------------- 535 (639)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred -----------------------------------CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHH
Q 046265 536 -----------------------------------RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLS 580 (639)
Q Consensus 536 -----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 580 (639)
..+||-||||+...++++++...... .-...++++++|++|++
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHH
Confidence 11477899999888888887654321 23456788999999999
Q ss_pred HHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC----C-------------CCC-CcceeeeeceeeCCC
Q 046265 581 YMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK----P-------------DSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 581 ~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~----~-------------~~~-~~~~~~gt~~Y~APE 639 (639)
|+|.+ +||||||||.||++|.+..+||+|||+|.... . ... ..+..+||.-|+|||
T Consensus 712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence 99999 99999999999999999999999999998722 0 001 234579999999998
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-24 Score=211.03 Aligned_cols=167 Identities=19% Similarity=0.389 Sum_probs=139.2
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
++|.....||+|++|.||+|...++..+|+|.+.... ...+.+.+|+.++++++|||++++++++. .+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 4577788999999999999988777789999886432 23467889999999999999999999875 4568999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++|+|.+++..... ..++|..+..++.+++.|++|||.. +|+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 82 MGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999999975432 3478999999999999999999988 999999999999999999999999999986643221
Q ss_pred -CcceeeeeceeeCCC
Q 046265 625 -NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 -~~~~~~gt~~Y~APE 639 (639)
......++..|+|||
T Consensus 158 ~~~~~~~~~~~y~~Pe 173 (260)
T cd05069 158 TARQGAKFPIKWTAPE 173 (260)
T ss_pred cccCCCccchhhCCHH
Confidence 112234677899998
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=214.71 Aligned_cols=169 Identities=23% Similarity=0.373 Sum_probs=142.6
Q ss_pred cCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.||+|++|.||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 4778899999999999999764 688999999876432 22345567899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++ ++.+++........+++..+..++.|+++|++|+|+. +|+||||||+||++++++.+|++|||++........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 985 8888887654444689999999999999999999988 999999999999999999999999999986543322
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......+++.|+|||
T Consensus 156 ~~~~~~~~~~y~~PE 170 (284)
T cd07836 156 TFSNEVVTLWYRAPD 170 (284)
T ss_pred ccccccccccccChH
Confidence 233456789999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-24 Score=214.45 Aligned_cols=168 Identities=26% Similarity=0.367 Sum_probs=144.7
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.||+|++|.||+|.. .+++.||||++............+.+|+.++++++||||+++++++..+...|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 467788999999999999965 4689999999986543344456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+ +++|.+++.... ..+++..+..++.|+++|++|||+. +|+|+||||+||+++.++.++++|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999987543 3578899999999999999999998 999999999999999999999999999987654321
Q ss_pred -CcceeeeeceeeCCC
Q 046265 625 -NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 -~~~~~~gt~~Y~APE 639 (639)
......|+..|+|||
T Consensus 155 ~~~~~~~~~~~y~aPE 170 (286)
T cd07832 155 RLYSHQVATRWYRAPE 170 (286)
T ss_pred CccccccCcccccCce
Confidence 233457899999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-24 Score=211.26 Aligned_cols=165 Identities=25% Similarity=0.400 Sum_probs=141.3
Q ss_pred ceeccCCCceEEEEEcCC----CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccC
Q 046265 471 YCIGTAGQASVYKAELPS----WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLG 546 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 546 (639)
+.||+|+||.||+|.... +..||||.+....... ..+.+.+|+..+.+++|+||+++++++......++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 468999999999996653 7889999998654332 46778999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCC------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 547 RGSLAIILSNDAA------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 547 ~g~L~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
+++|.+++..... ...+++..+..++.+++.|++|||.. +|+||||||+||+++.++.+|++|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999986521 24688999999999999999999998 99999999999999999999999999998765
Q ss_pred CCC--CCcceeeeeceeeCCC
Q 046265 621 PDS--SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~--~~~~~~~gt~~Y~APE 639 (639)
... .......+++.|+|||
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE 177 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPE 177 (262)
T ss_pred cccccccccCCCcCccccCHH
Confidence 432 1223456788999998
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=216.94 Aligned_cols=171 Identities=20% Similarity=0.289 Sum_probs=139.8
Q ss_pred ccCCCcceeccCCCceEEEEEcC--------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcC
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP--------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHP 535 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 535 (639)
++|...+.||+|+||.||+|... +...+|+|.+.... .......+.+|+.+++++ +||||++++++|...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 46788899999999999999642 23569999987532 223345688899999999 799999999999999
Q ss_pred CceeEEecccCCCChhHHhhcCCC-------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDAA-------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL 602 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill 602 (639)
+..|+||||+++|+|.+++..... ...++|..+..++.|++.|++|+|.. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999975432 13488999999999999999999988 99999999999999
Q ss_pred CCCCceEEccccccccCCCCCCC--cceeeeeceeeCCC
Q 046265 603 GLDYDAHVSDFGISKFLKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 603 ~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~Y~APE 639 (639)
+.++.+|++|||.++........ .....+++.|||||
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 212 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 212 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChH
Confidence 99999999999999865432111 11123457899998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=216.04 Aligned_cols=166 Identities=28% Similarity=0.465 Sum_probs=143.8
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.+|+..+.||.|++|.||+|. ..+++.||||.+.... ....+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 457888899999999999995 4678999999987533 2234667899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++++|.+++... .+++..+..++.+++.|++|||.. +++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 97 YLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred ecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 99999999988643 378899999999999999999998 99999999999999999999999999988765443
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......|++.|+|||
T Consensus 170 ~~~~~~~~~~~y~aPE 185 (296)
T cd06655 170 SKRSTMVGTPYWMAPE 185 (296)
T ss_pred ccCCCcCCCccccCcc
Confidence 3333457899999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-24 Score=217.31 Aligned_cols=160 Identities=19% Similarity=0.219 Sum_probs=125.5
Q ss_pred HhccCCCcceeccCCCceEEEEEcC--CCcEEEEEEccCCCC---ChhhHHHHHHHHHHHhccccCceee-eEEEEEcCC
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP--SWEIVAVKKFHSPHP---DMVVQQAFSNEIKALTELRHRNVVK-FYGFSFHPR 536 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~-l~~~~~~~~ 536 (639)
....|...+.||+|+||+||+|..+ +++.||||++..... .....+.|.+|++++++++|+|+|. ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 4567888999999999999999654 577789998763311 2334567899999999999999985 4432 4
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC-CCCCeeeCCCCceEEccccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDI-SSKNVLLGLDYDAHVSDFGI 615 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdl-k~~Nill~~~~~~kl~DfGl 615 (639)
..|+||||++|++|... ... . ...++.++++|++|+|+. +|+|||| ||+||+++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~~---~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RPH---G------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHh-Ccc---c------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 68999999999999732 110 1 135678899999999998 9999999 99999999999999999999
Q ss_pred cccCCCCCCC--------cceeeeeceeeCCC
Q 046265 616 SKFLKPDSSN--------WSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~~--------~~~~~gt~~Y~APE 639 (639)
|+.+...... .....+++.|+|||
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe 190 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPD 190 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcc
Confidence 9976543211 13457888899998
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-24 Score=213.26 Aligned_cols=168 Identities=22% Similarity=0.320 Sum_probs=136.0
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCc----EEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWE----IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
.+|+..+.||+|+||.||+|.. .+++ .+|+|++.... ......++..|+..+++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 4567788999999999999965 3444 47788875332 22334567888889999999999999998764 5578
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+++||+++|+|.+++.... ..++|..+..++.|++.|++|+|+. +++||||||+||+++.++.+|++|||+++.+
T Consensus 85 ~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999997543 2578999999999999999999998 8999999999999999999999999999865
Q ss_pred CCCCC--CcceeeeeceeeCCC
Q 046265 620 KPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~--~~~~~~gt~~Y~APE 639 (639)
..... ......|+..|+|||
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE 181 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALE 181 (279)
T ss_pred cCCCcccccCCCCCcccccCHH
Confidence 43221 122345778999998
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=209.94 Aligned_cols=164 Identities=26% Similarity=0.395 Sum_probs=141.3
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
++|+..+.||+|++|.||+|... ++.||||.+..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 46778899999999999999765 68899999975432 456788999999999999999999999998999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++++|.+++..... ..++|..+..++.|++.|++|||.. +|+||||||+||+++.++.+|++|||.++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 82 MAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred cCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 999999999976442 3578999999999999999999998 999999999999999999999999999987632221
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
...++..|+|||
T Consensus 158 ---~~~~~~~~~ape 169 (256)
T cd05039 158 ---SGKLPVKWTAPE 169 (256)
T ss_pred ---cCCCcccccCch
Confidence 233456799998
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=211.45 Aligned_cols=170 Identities=19% Similarity=0.274 Sum_probs=144.4
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.+|+|+||.||++.. .+++.||+|++............+.+|+.++++++||||+++++++.+.+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477788999999999999954 5678999999875443344456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++++|.+.+..... ..+++..+..++.|++.|++|+|.. +++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999998875432 2467889999999999999999998 999999999999999999999999999987644332
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......|++.|+|||
T Consensus 157 ~~~~~~~~~~~~~pe 171 (256)
T cd08218 157 LARTCIGTPYYLSPE 171 (256)
T ss_pred hhhhccCCccccCHH
Confidence 223456889999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=210.74 Aligned_cols=168 Identities=30% Similarity=0.448 Sum_probs=144.5
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.+|+|++|.||+|.. .+++.+|+|.+...... ..+.+.+|++++++++||||+++++++...+..|++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 5678889999999999999965 45788999998764322 45678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++++|.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+|++|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 81 YCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999999987542 2467788999999999999999998 99999999999999999999999999998765433
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......|+..|+|||
T Consensus 156 ~~~~~~~~~~~y~~Pe 171 (262)
T cd06613 156 AKRKSFIGTPYWMAPE 171 (262)
T ss_pred hccccccCCccccCch
Confidence 2334467899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=212.55 Aligned_cols=169 Identities=20% Similarity=0.307 Sum_probs=138.6
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCc----EEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWE----IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
.++|+..+.||+|+||.||+|.. ++++ .||||.+.... .......+.+|+.++++++||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 45677889999999999999964 4554 48999987543 334456788999999999999999999999764 57
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
+++|||+++|++.++++... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 89999999999999987543 3578899999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCCC--cceeeeeceeeCCC
Q 046265 619 LKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~~--~~~~~gt~~Y~APE 639 (639)
+...... .....+++.|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE 181 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALE 181 (279)
T ss_pred cccccceeecCCCccchhhCCHH
Confidence 6532221 11223567899998
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-24 Score=215.08 Aligned_cols=168 Identities=23% Similarity=0.350 Sum_probs=139.6
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|++|.||+|..+ +++.||||.+...... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 56788899999999999999654 6789999998753321 223446789999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++ +|.+++..... .+++.....++.|+++|+.|||+. +|+||||||+||+++.++.+|++|||+++......
T Consensus 84 ~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9974 89888865432 578889999999999999999998 99999999999999999999999999987543222
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......++..|+|||
T Consensus 158 ~~~~~~~~~~~~~aPE 173 (291)
T cd07844 158 KTYSNEVVTLWYRPPD 173 (291)
T ss_pred ccccccccccccCCcH
Confidence 2223345788999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=214.81 Aligned_cols=170 Identities=19% Similarity=0.286 Sum_probs=137.0
Q ss_pred ccCCCcceeccCCCceEEEEEcCC-Cc--EEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS-WE--IVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 540 (639)
++|+..++||+|+||+||+|..++ +. .+|+|.++... .....+.+.+|+.+++++ +||||+++++++...+..|+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 467888999999999999997643 33 47888876422 233456788999999999 79999999999999999999
Q ss_pred EecccCCCChhHHhhcCCC-------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 046265 541 LYEYLGRGSLAIILSNDAA-------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD 607 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~ 607 (639)
||||+++|+|.++++.... ...+++..+..++.|++.|++|||.. +|+||||||+||+++.++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence 9999999999999965321 12478899999999999999999998 9999999999999999999
Q ss_pred eEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 608 AHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 608 ~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+||+|||++........ ......+..|+|||
T Consensus 158 ~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE 188 (297)
T cd05089 158 SKIADFGLSRGEEVYVK-KTMGRLPVRWMAIE 188 (297)
T ss_pred EEECCcCCCccccceec-cCCCCcCccccCch
Confidence 99999999864321111 11122355799998
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=210.88 Aligned_cols=168 Identities=23% Similarity=0.344 Sum_probs=141.6
Q ss_pred cCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCC----hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 466 NFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPD----MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
+|+..+.||+|+||.||+|...+++.+|||.+...... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 36678899999999999998888899999988753221 12235688999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++++|.+++.... .+++..+..++.|++.|++|+|.. +|+|+||||+||++++++.+|++|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999997643 367788889999999999999988 899999999999999999999999999876432
Q ss_pred CC------CCcceeeeeceeeCCC
Q 046265 622 DS------SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~------~~~~~~~gt~~Y~APE 639 (639)
.. .......|+..|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe 178 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPE 178 (265)
T ss_pred ccccccccccccccCCCccccChh
Confidence 11 1122356899999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=216.99 Aligned_cols=162 Identities=22% Similarity=0.359 Sum_probs=129.8
Q ss_pred cceeccCCCceEEEEEcC---CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc--CCceeEEecc
Q 046265 470 KYCIGTAGQASVYKAELP---SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH--PRQSFLLYEY 544 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~ 544 (639)
...||+|+||.||+|+.. ++..||+|.+..... ...+.+|+.++++++||||+++++++.. +...|+||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 458999999999999764 346899999875331 2356789999999999999999999864 4568999999
Q ss_pred cCCCChhHHhhcCC------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee----CCCCceEEcccc
Q 046265 545 LGRGSLAIILSNDA------AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL----GLDYDAHVSDFG 614 (639)
Q Consensus 545 ~~~g~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill----~~~~~~kl~DfG 614 (639)
+++ ++.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 864 7777664221 123478889999999999999999998 99999999999999 566789999999
Q ss_pred ccccCCCCCC---CcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSS---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~---~~~~~~gt~~Y~APE 639 (639)
+++....... ......||+.|+|||
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE 185 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPE 185 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcH
Confidence 9987643221 223467899999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=210.43 Aligned_cols=171 Identities=30% Similarity=0.472 Sum_probs=146.5
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||.|+||.||+|.. .++..+|+|++....... ..+.+.+|+..++.++|+||+++++.+..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4688889999999999999964 467889999987544333 45678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++++|.++++.......+++..+..++.|++.|++|||.. +|+||||||+||++++++.+|++|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999997654334678899999999999999999988 99999999999999999999999999998765433
Q ss_pred CC----cceeeeeceeeCCC
Q 046265 624 SN----WSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~----~~~~~gt~~Y~APE 639 (639)
.. .....|+..|+|||
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe 176 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPE 176 (267)
T ss_pred cccccccccccCChhhcChH
Confidence 22 13457899999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=211.70 Aligned_cols=171 Identities=20% Similarity=0.336 Sum_probs=142.2
Q ss_pred ccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
.+|+....||+|+||.||+|+.+ +.+.||+|.+..... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 46777889999999999999753 236799998865332 22456789999999999999999999999998999
Q ss_pred eEEecccCCCChhHHhhcCCCC------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAI------DEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSD 612 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~D 612 (639)
|+||||+++|+|.+++...... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+|++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999754421 1588999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCCC-CCcceeeeeceeeCCC
Q 046265 613 FGISKFLKPDS-SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 613 fGla~~~~~~~-~~~~~~~gt~~Y~APE 639 (639)
||+++...... .......+++.|+|||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE 188 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPE 188 (275)
T ss_pred cccccccCcccccccCCceeEEeecChh
Confidence 99987543221 1223456788899998
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=210.88 Aligned_cols=174 Identities=23% Similarity=0.363 Sum_probs=144.3
Q ss_pred cCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc--CCceeEEe
Q 046265 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH--PRQSFLLY 542 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~ 542 (639)
+|+..+.+|.|+||.||+|. ..+++.||+|.+..........+.+.+|+.++++++||||+++++++.. ....|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 46778899999999999995 4577899999987654445556778899999999999999999998864 34579999
Q ss_pred cccCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 543 EYLGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDY--FPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
||+++++|.+++.... ....+++..++.++.++++|++|+|..+ ..+|+||||||+||+++.++.+|++|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999987532 2345788999999999999999999332 238999999999999999999999999999887
Q ss_pred CCCCCCcceeeeeceeeCCC
Q 046265 620 KPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~~~~~~gt~~Y~APE 639 (639)
...........|++.|+|||
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE 180 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPE 180 (265)
T ss_pred cCCcccccccccCCCccChh
Confidence 64443234467899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=210.22 Aligned_cols=170 Identities=23% Similarity=0.399 Sum_probs=140.5
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CC---cEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SW---EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
.++|+..+.||+|+||.||+|..+ ++ ..+|||++.... .....+.+.+|++++++++||||+++++++...+..|
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 356788899999999999999764 33 369999987543 2334567889999999999999999999999999999
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||+++++|.+++.... ..++|..+..++.+++.|++|+|.. +|+|||+||+||+++.++.+|++|||++...
T Consensus 83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 83 IITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999987543 3578899999999999999999998 9999999999999999999999999999866
Q ss_pred CCCCCCcc---eeeeeceeeCCC
Q 046265 620 KPDSSNWS---EFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~~~---~~~gt~~Y~APE 639 (639)
........ ....++.|+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE 180 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPE 180 (268)
T ss_pred ccccccceeccCCCcCceecCHH
Confidence 43222111 122345799998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=216.26 Aligned_cols=177 Identities=26% Similarity=0.364 Sum_probs=146.0
Q ss_pred HHHHHHHhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEc
Q 046265 457 YEEVIRATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFH 534 (639)
Q Consensus 457 ~~~~~~~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 534 (639)
.+++..++++|...+.||+|+||.||+|.. .+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 345556688999999999999999999965 568899999986432 2245677899999998 79999999999875
Q ss_pred C-----CceeEEecccCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 046265 535 P-----RQSFLLYEYLGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDA 608 (639)
Q Consensus 535 ~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~ 608 (639)
. +..|+||||+++|+|.++++... ....++|..+..++.|++.|++|||.. +|+||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 4 35899999999999999886422 123578899999999999999999998 99999999999999999999
Q ss_pred EEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 609 HVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 609 kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
||+|||+++.............|+..|+|||
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 198 (291)
T cd06639 168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198 (291)
T ss_pred EEeecccchhcccccccccCccCCccccChh
Confidence 9999999887653332233457899999998
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-25 Score=215.41 Aligned_cols=170 Identities=22% Similarity=0.264 Sum_probs=142.2
Q ss_pred hccCCCcceeccCCCceEEEEEcCC-CcEEEEEEccCCCC-ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPS-WEIVAVKKFHSPHP-DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 540 (639)
..+|.+..+||+|+||+|..|+.++ .+.+|||.+++.-. .....+--+.|-++++.. +-|.+++++.+++.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3468889999999999999997665 46799999986431 111112224566677655 67899999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||||+.||+|..++++-+..++ ..+.-+|.+||-||-|||.. +||.||+|.+||++|.+|++||+|||+++.-.
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKE---p~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKE---PVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHhcccCC---chhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999999987766444 78888999999999999999 99999999999999999999999999999765
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
.+.....++||||.|+|||
T Consensus 502 ~~~~TTkTFCGTPdYiAPE 520 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPE 520 (683)
T ss_pred cCCcceeeecCCCcccccc
Confidence 5556667899999999998
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=216.22 Aligned_cols=171 Identities=20% Similarity=0.293 Sum_probs=139.4
Q ss_pred ccCCCcceeccCCCceEEEEEcC--------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcC
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP--------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHP 535 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 535 (639)
++|...+.||+|+||.||+|... ....||+|.+.... .......+.+|+.+++++ +||||++++++|...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 46777899999999999999532 23569999987533 233455688999999999 699999999999999
Q ss_pred CceeEEecccCCCChhHHhhcCCC-------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDAA-------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL 602 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill 602 (639)
+..|+||||+++|+|.+++..... ...++|.....++.|++.|++|+|.. +|+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 999999999999999999975321 23588999999999999999999988 99999999999999
Q ss_pred CCCCceEEccccccccCCCCCCC--cceeeeeceeeCCC
Q 046265 603 GLDYDAHVSDFGISKFLKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 603 ~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~Y~APE 639 (639)
+.++.+|++|||+++.+...... .....+++.|||||
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 206 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPE 206 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHH
Confidence 99999999999999876432211 11223456899998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=210.30 Aligned_cols=163 Identities=25% Similarity=0.389 Sum_probs=137.8
Q ss_pred ceeccCCCceEEEEEcCC--C--cEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccC
Q 046265 471 YCIGTAGQASVYKAELPS--W--EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLG 546 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 546 (639)
+.||+|++|.||+|.... + ..||||.+...... ...+.+.+|+.++++++||||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 368999999999996543 3 36999999865433 456788999999999999999999999988 88999999999
Q ss_pred CCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC-
Q 046265 547 RGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN- 625 (639)
Q Consensus 547 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~- 625 (639)
+|+|.+.+..... ..++|.....++.|+++|++|+|.. +++||||||+||+++.++.+|++|||+++.+......
T Consensus 79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 9999999976543 4688999999999999999999998 9999999999999999999999999999876542221
Q ss_pred --cceeeeeceeeCCC
Q 046265 626 --WSEFVGTFGYVAPI 639 (639)
Q Consensus 626 --~~~~~gt~~Y~APE 639 (639)
.....++..|+|||
T Consensus 155 ~~~~~~~~~~~y~~pE 170 (257)
T cd05040 155 VMEEHLKVPFAWCAPE 170 (257)
T ss_pred ecccCCCCCceecCHH
Confidence 11245778999998
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=214.27 Aligned_cols=171 Identities=22% Similarity=0.346 Sum_probs=139.7
Q ss_pred ccCCCcceeccCCCceEEEEEcC-----------------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceee
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-----------------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVK 527 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~ 527 (639)
++|+..+.||+|+||.||+|+.. +...||+|.+.... .......+.+|+.++++++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 46888899999999999998532 23468999987542 2344567899999999999999999
Q ss_pred eEEEEEcCCceeEEecccCCCChhHHhhcCCCC--------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCC
Q 046265 528 FYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAI--------DEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKN 599 (639)
Q Consensus 528 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~N 599 (639)
+++++..++..++||||+++|+|.+++...... ..+++.++..++.|++.|++|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999998754321 2477889999999999999999998 99999999999
Q ss_pred eeeCCCCceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 600 VLLGLDYDAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 600 ill~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
|+++.++.+|++|||+++.+..... ......+++.|+|||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 202 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWE 202 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHH
Confidence 9999999999999999986543221 111233467899997
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=212.14 Aligned_cols=170 Identities=24% Similarity=0.423 Sum_probs=140.5
Q ss_pred ccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
.++...+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 35667889999999999999532 35679999887532 34456789999999999999999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCC------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 046265 539 FLLYEYLGRGSLAIILSNDAA------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY 606 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~ 606 (639)
++||||+++|+|.+++..... ...+++..+..++.|++.|++|||.. +|+||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCC
Confidence 999999999999999875432 13478999999999999999999988 999999999999999999
Q ss_pred ceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 607 DAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 607 ~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
.+||+|||++..+..... ......+++.|+|||
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE 194 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHH
Confidence 999999999986543221 112234567899998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=209.59 Aligned_cols=167 Identities=25% Similarity=0.355 Sum_probs=142.7
Q ss_pred cCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC---ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP---DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
+|+..+.||+|++|+||+|... +++.||+|.+..... .....+.+.+|+.++++++||||+++++++..++..|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999665 789999999875432 123446788999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++++|.+++.... .+++..+..++.+++.|++|+|.. +|+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999997543 467889999999999999999998 999999999999999999999999999887543
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
.. ......|++.|+|||
T Consensus 155 ~~-~~~~~~~~~~y~~pe 171 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPE 171 (258)
T ss_pred cc-cccccCCCcceeCHH
Confidence 32 223456899999998
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=214.09 Aligned_cols=172 Identities=26% Similarity=0.429 Sum_probs=141.9
Q ss_pred hccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 537 (639)
.++|+..+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.++++++||||+++++++..++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 457888899999999999999753 45789999987543 23445678999999999999999999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCC-------------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCC
Q 046265 538 SFLLYEYLGRGSLAIILSNDAA-------------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSK 598 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~-------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~ 598 (639)
.++||||+++|+|.+++..... ...+++..++.++.+++.|++|+|.. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 9999999999999999964321 12468889999999999999999998 9999999999
Q ss_pred CeeeCCCCceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 599 NVLLGLDYDAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 599 Nill~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
||+++.++.+|++|||++..+..... ......+++.|+|||
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 202 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPE 202 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHH
Confidence 99999999999999999876532211 112234567899998
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=209.54 Aligned_cols=169 Identities=24% Similarity=0.336 Sum_probs=139.9
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCC---hhhHHHHHHHHHHHhccccCceeeeEEEEEcC--Cce
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPD---MVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQS 538 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 538 (639)
.+|+..+.||+|+||.||+|.. .++..||+|++...... ......+.+|+.++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999999999955 56889999998754321 22345688899999999999999999988753 567
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
+++|||+++++|.+++.... .+++.....++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999987543 367888889999999999999988 999999999999999999999999999886
Q ss_pred CCCCC---CCcceeeeeceeeCCC
Q 046265 619 LKPDS---SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~---~~~~~~~gt~~Y~APE 639 (639)
+.... .......|+..|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE 179 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPE 179 (266)
T ss_pred cccccccCCccccCCccccccCHH
Confidence 54211 1122356889999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=212.19 Aligned_cols=172 Identities=18% Similarity=0.254 Sum_probs=142.1
Q ss_pred hccCCCcceeccCCCceEEEEEcCC-----CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc-CCc
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPS-----WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH-PRQ 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~ 537 (639)
.++|+..+.||+|+||.||+|.... +..||+|++.... .......+.+|+.++++++||||+++++++.. +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4678888999999999999997654 6789999887432 33445678899999999999999999999876 467
Q ss_pred eeEEecccCCCChhHHhhcCCCC-----CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAI-----DEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSD 612 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~D 612 (639)
.++++||+++|+|.+++...... ..+++..+..++.+++.|++|||.. +++||||||+||++++++.+|++|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998754322 4588999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCCCCC--cceeeeeceeeCCC
Q 046265 613 FGISKFLKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 613 fGla~~~~~~~~~--~~~~~gt~~Y~APE 639 (639)
||+++.+...... .....++..|+|||
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE 189 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALE 189 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHH
Confidence 9999876432211 11234567899998
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=215.16 Aligned_cols=168 Identities=26% Similarity=0.416 Sum_probs=143.9
Q ss_pred cCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.||+|++|.||+|..+ +++.||||+++...........+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5778899999999999999655 678999999876544444567789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
++++.+..+..... .+++..+..++.+++.|++|||.. +|+|||++|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99887776665432 367889999999999999999998 999999999999999999999999999987654432
Q ss_pred -CcceeeeeceeeCCC
Q 046265 625 -NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 -~~~~~~gt~~Y~APE 639 (639)
......++..|+|||
T Consensus 156 ~~~~~~~~~~~~~~PE 171 (288)
T cd07833 156 SPLTDYVATRWYRAPE 171 (288)
T ss_pred ccccCcccccCCcCCc
Confidence 334467899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=220.66 Aligned_cols=163 Identities=24% Similarity=0.346 Sum_probs=139.3
Q ss_pred cCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-c-----CceeeeEEEEEcCCce
Q 046265 466 NFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-H-----RNVVKFYGFSFHPRQS 538 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H-----~niv~l~~~~~~~~~~ 538 (639)
+|.+.++||+|+||+|-|| ++.+++.||||.++... ....+-..|+.+|..++ | -|+|++++||...++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 6788999999999999999 67789999999998643 33344567999999986 4 3999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC--CceEEcccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD--YDAHVSDFGIS 616 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~--~~~kl~DfGla 616 (639)
|||+|.. ..+|+++++.... ..++......++.||+.||.+||.. +|||+||||||||+.+- ..+||+|||.|
T Consensus 264 ciVfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999988 5699999987654 4588899999999999999999988 99999999999999643 47999999999
Q ss_pred ccCCCCCCCcceeeeeceeeCCC
Q 046265 617 KFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
...... ..+.+-+..|+|||
T Consensus 339 c~~~q~---vytYiQSRfYRAPE 358 (586)
T KOG0667|consen 339 CFESQR---VYTYIQSRFYRAPE 358 (586)
T ss_pred cccCCc---ceeeeeccccccch
Confidence 875432 23678899999999
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=214.86 Aligned_cols=171 Identities=19% Similarity=0.284 Sum_probs=139.7
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCc-----
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQ----- 537 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~----- 537 (639)
++|+..+.||+|+||.||+|.. .+++.||||++............+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3678889999999999999965 46899999998754333333456788999999995 6999999999987665
Q ss_pred eeEEecccCCCChhHHhhcCCC--CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEcccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAA--IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL-DYDAHVSDFG 614 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~-~~~~kl~DfG 614 (639)
.|+||||+++ ++.+++..... ...+++..+..++.|++.||+|||.. +|+||||||+||+++. ++.+|++|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 78888764332 24578999999999999999999998 9999999999999998 8899999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+++.............+++.|+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE 181 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPE 181 (295)
T ss_pred cceecCCCccccCCcccccCCCChH
Confidence 9986543323233346788999998
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=212.50 Aligned_cols=170 Identities=22% Similarity=0.332 Sum_probs=136.9
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHH-HhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKA-LTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||.||+|.. .+|+.||+|++....... ....+..|+.. ++..+||||+++++++..++..|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 3678889999999999999965 468999999987643222 23445566665 55568999999999999999999999
Q ss_pred cccCCCChhHHhhcC-CCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 543 EYLGRGSLAIILSND-AAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 543 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
||++ |+|.+++... .....+++..+..++.|++.|++|||+.+ +++||||||+||+++.++.+||+|||++..+..
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9996 6887777542 22246889999999999999999999753 799999999999999999999999999986643
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
.. ......|+..|+|||
T Consensus 157 ~~-~~~~~~~~~~y~aPE 173 (283)
T cd06617 157 SV-AKTIDAGCKPYMAPE 173 (283)
T ss_pred cc-ccccccCCccccChh
Confidence 21 122356889999998
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=208.58 Aligned_cols=163 Identities=26% Similarity=0.379 Sum_probs=137.2
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEE-cCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSF-HPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e 543 (639)
.+|+..+.||+|+||.||+|..+ +..||+|.+.... ..+.+.+|+.++++++|+|++++++++. .++..++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 46778899999999999999765 6789999986422 2456889999999999999999999865 4467899999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++|+|.+++..... ..++|..+..++.+++.|++|+|.. +|+||||||+||++++++.+|++|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999999876433 3478899999999999999999998 99999999999999999999999999988654322
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
....++..|||||
T Consensus 157 ---~~~~~~~~y~aPE 169 (256)
T cd05082 157 ---DTGKLPVKWTAPE 169 (256)
T ss_pred ---CCCccceeecCHH
Confidence 2234567899998
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=211.44 Aligned_cols=166 Identities=27% Similarity=0.439 Sum_probs=142.6
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc---cCceeeeEEEEEcCCceeEE
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR---HRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv 541 (639)
.|+..+.||+|+||.||+|.. .+++.||||.+.... .......+.+|+.++++++ |||++++++++......|+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 466778999999999999964 578999999987532 2233456788999999986 99999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++++|.++++.. .+++.....++.+++.|++|+|+. +|+||||+|+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 81 MEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred EecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 9999999999998653 478899999999999999999998 999999999999999999999999999987754
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
.........|++.|+|||
T Consensus 154 ~~~~~~~~~~~~~y~aPE 171 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPE 171 (277)
T ss_pred CccccccccCCcceeCHH
Confidence 443344567999999998
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=210.20 Aligned_cols=169 Identities=20% Similarity=0.410 Sum_probs=143.2
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.++|...+.||+|+||.||+|..++++.||||.+.... ...+.+.+|+.++++++||||+++++++......++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 45778889999999999999988888889999987533 234568899999999999999999999999899999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++++|.+++..... ..+++..+..++.+++.|++|+|.. +|+||||||+||++++++.+|++|||+++.+....
T Consensus 82 ~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999976432 3578999999999999999999998 89999999999999999999999999988764321
Q ss_pred C-CcceeeeeceeeCCC
Q 046265 624 S-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~-~~~~~~gt~~Y~APE 639 (639)
. ......++..|+|||
T Consensus 158 ~~~~~~~~~~~~y~~PE 174 (261)
T cd05034 158 YTAREGAKFPIKWTAPE 174 (261)
T ss_pred hhhhhccCCCccccCHH
Confidence 1 111233456899998
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=209.25 Aligned_cols=166 Identities=28% Similarity=0.408 Sum_probs=144.9
Q ss_pred ccCCCcceeccCCCceEEEEEcCC-CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS-WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|+||.||+|.... ++.||+|.+.... ..+.+.+|++++++++||||+++++++..+...|+++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 568888999999999999997654 7899999987432 25678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++++|.+++.... ..++|..+..++.++++|+.|||.. +|+|||++|+||+++.++.+|++|||++.......
T Consensus 79 ~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 79 YCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 999999999986533 3578899999999999999999998 99999999999999999999999999998765443
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......|+..|+|||
T Consensus 154 ~~~~~~~~~~~y~~PE 169 (256)
T cd06612 154 AKRNTVIGTPFWMAPE 169 (256)
T ss_pred cccccccCCccccCHH
Confidence 3334456899999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=209.46 Aligned_cols=167 Identities=32% Similarity=0.488 Sum_probs=140.3
Q ss_pred CCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCCh-------hhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 467 FDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDM-------VVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
|.....||+|++|.||+|.. .+++.||+|.+....... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 56678999999999999965 467899999887543221 1235678999999999999999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
++||||+++++|.+++...+ .+++..+..++.+++.|++|+|.. +++||||+|+||++++++.+||+|||.++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999997643 467788899999999999999988 999999999999999999999999999987
Q ss_pred CCCCCC------CcceeeeeceeeCCC
Q 046265 619 LKPDSS------NWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~------~~~~~~gt~~Y~APE 639 (639)
...... ......|++.|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe 182 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPE 182 (267)
T ss_pred cccccccCCccccccccCCCcCccChh
Confidence 653211 112356889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=211.64 Aligned_cols=166 Identities=30% Similarity=0.436 Sum_probs=143.9
Q ss_pred cCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.||.|++|.||+|... +++.||+|.+.... .......+.+|+.++++++||||+++++++.++...|+|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 5777889999999999999654 67899999987543 223345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++++|.+++... .+++..+..++.|++.|+.|+|.. +++||||+|+||++++++.++++|||+++.+.....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999998754 578899999999999999999998 899999999999999999999999999988754433
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......|++.|+|||
T Consensus 154 ~~~~~~~~~~y~~PE 168 (274)
T cd06609 154 KRNTFVGTPFWMAPE 168 (274)
T ss_pred ccccccCCccccChh
Confidence 334567899999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=209.21 Aligned_cols=168 Identities=23% Similarity=0.439 Sum_probs=138.8
Q ss_pred cCCCcceeccCCCceEEEEEcC-CC---cEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-SW---EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.|+..+.||+|+||.||+|... ++ ..||||.+.... .......|..|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 4667889999999999999754 23 369999987543 334456799999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999987543 3578899999999999999999998 999999999999999999999999999886543
Q ss_pred CCCC--cc-ee--eeeceeeCCC
Q 046265 622 DSSN--WS-EF--VGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~--~~-~~--~gt~~Y~APE 639 (639)
.... .. .. .++..|+|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE 181 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPE 181 (269)
T ss_pred CccccccccccCCCcceeecCHh
Confidence 2211 11 11 1245799998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=211.22 Aligned_cols=165 Identities=23% Similarity=0.313 Sum_probs=136.2
Q ss_pred CCCcceeccCCCceEEEEE-----cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--Ccee
Q 046265 467 FDAKYCIGTAGQASVYKAE-----LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQSF 539 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~ 539 (639)
|+..+.||+|+||+||++. ..+++.||+|.+.... .......+.+|++++++++||||+++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 3778899999999998763 2467889999987543 223456788999999999999999999998764 3578
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||+++|+|.+++... .++|..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+++.+
T Consensus 85 lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 999999999999998653 378999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCC---cceeeeeceeeCCC
Q 046265 620 KPDSSN---WSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~---~~~~~gt~~Y~APE 639 (639)
...... .....++..|+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE 180 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVE 180 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHh
Confidence 533221 11234567799998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-24 Score=215.66 Aligned_cols=161 Identities=28% Similarity=0.382 Sum_probs=138.4
Q ss_pred cceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCC
Q 046265 470 KYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRG 548 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 548 (639)
...||+|+||.||+|.. .+++.||||++.... ....+.+.+|+..+++++||||+++++.+..++..|+||||++++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 35699999999999965 467899999986532 234566889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcce
Q 046265 549 SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE 628 (639)
Q Consensus 549 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 628 (639)
+|.+++... .+++..+..++.+++.|++|+|+. +|+||||||+||++++++.+||+|||++............
T Consensus 105 ~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 105 ALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred cHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence 999988542 367889999999999999999998 9999999999999999999999999998765433333345
Q ss_pred eeeeceeeCCC
Q 046265 629 FVGTFGYVAPI 639 (639)
Q Consensus 629 ~~gt~~Y~APE 639 (639)
..|++.|+|||
T Consensus 178 ~~~~~~y~aPE 188 (292)
T cd06658 178 LVGTPYWMAPE 188 (292)
T ss_pred eecCccccCHH
Confidence 67999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=208.52 Aligned_cols=168 Identities=29% Similarity=0.477 Sum_probs=146.8
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|++|.||+|... +++.||||++...... .....+.+|+..+.+++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 36778899999999999999665 5899999998765432 446778999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH-DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
|+++++|.+++... ..+++..+..++.|+++|++|+|. . +++||||+|+||+++.++.++++|||.+......
T Consensus 80 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 80 YMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred ecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 99999999999765 346788999999999999999999 7 9999999999999999999999999999877544
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
........++..|+|||
T Consensus 154 ~~~~~~~~~~~~y~~pE 170 (264)
T cd06623 154 LDQCNTFVGTVTYMSPE 170 (264)
T ss_pred CCcccceeecccccCHh
Confidence 44334567899999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=212.39 Aligned_cols=177 Identities=24% Similarity=0.401 Sum_probs=145.7
Q ss_pred hHHHHHHHhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEE
Q 046265 456 LYEEVIRATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSF 533 (639)
Q Consensus 456 ~~~~~~~~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~ 533 (639)
+..+.......|+..+.+|+|+||.||+|.. .+++.||+|.+.... .....+..|+.+++++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 4455555677888889999999999999965 567899999886432 2345678899999998 6999999999986
Q ss_pred c------CCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 046265 534 H------PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD 607 (639)
Q Consensus 534 ~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~ 607 (639)
. .+..|+||||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +|+|||+||+||++++++.
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 3 3568999999999999999875432 2467788889999999999999998 9999999999999999999
Q ss_pred eEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 608 AHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 608 ~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+||+|||++..............|++.|+|||
T Consensus 160 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 191 (282)
T cd06636 160 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 191 (282)
T ss_pred EEEeeCcchhhhhccccCCCcccccccccCHh
Confidence 99999999886543333334567999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-24 Score=223.88 Aligned_cols=162 Identities=17% Similarity=0.275 Sum_probs=136.4
Q ss_pred hccCCCcceeccCCCceEEEEEcC---CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP---SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
..+|.....||+|+||.||+|... .++.||||.+.... .+.+|++++++++|||||++++++......|+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 356888899999999999999543 35779999876422 24679999999999999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||||+. +++.+++... ..++|..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 164 v~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred EehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 999995 6888887433 3578999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCC--cceeeeeceeeCCC
Q 046265 621 PDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~--~~~~~gt~~Y~APE 639 (639)
..... ....+||+.|+|||
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE 257 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPE 257 (392)
T ss_pred cccccccccccccccCccCHh
Confidence 33221 22467999999998
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=209.43 Aligned_cols=168 Identities=21% Similarity=0.346 Sum_probs=138.3
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCc----EEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWE----IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
.+|+..+.||+|+||.||+|..+ +|+ .||+|.+..... ......+.+|+.++++++||||++++++|.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 45677889999999999999653 332 589998875432 3345678899999999999999999999987 7889
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||+++|+|.+++..... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+|++|||+++..
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999999976433 478899999999999999999997 9999999999999999999999999999876
Q ss_pred CCCCCCc--ceeeeeceeeCCC
Q 046265 620 KPDSSNW--SEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~~--~~~~gt~~Y~APE 639 (639)
....... ....++..|+|||
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE 181 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALE 181 (279)
T ss_pred cCcccceecCCCcccccccCHH
Confidence 5332211 1122356799998
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=216.05 Aligned_cols=171 Identities=19% Similarity=0.283 Sum_probs=139.4
Q ss_pred ccCCCcceeccCCCceEEEEEcC--------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcC
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP--------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHP 535 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 535 (639)
.+|+..+.||+|+||.||+|... .+..||+|.+.... .....+.+.+|+.+++++ +||||++++++|..+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 35777889999999999999532 12368999887432 233456788999999999 799999999999999
Q ss_pred CceeEEecccCCCChhHHhhcCC-------------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDA-------------AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL 602 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill 602 (639)
+..|+||||+++|+|.+++.... ....++|..+..++.|++.|++|||.. +|+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence 99999999999999999987532 123578999999999999999999998 99999999999999
Q ss_pred CCCCceEEccccccccCCCCCCC--cceeeeeceeeCCC
Q 046265 603 GLDYDAHVSDFGISKFLKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 603 ~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~Y~APE 639 (639)
+.++.+||+|||+++........ .....++..|||||
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 206 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPE 206 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHH
Confidence 99999999999999865432211 12233457899998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-24 Score=214.04 Aligned_cols=165 Identities=27% Similarity=0.422 Sum_probs=140.2
Q ss_pred CCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEeccc
Q 046265 467 FDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYL 545 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 545 (639)
|+..+.||+|+||.||+|.. .+++.||+|.+..... ....+.+.+|+.++++++||||+++++++..+...|+||||+
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 44456899999999999954 5678899998875432 234567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC
Q 046265 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 625 (639)
++++|.+++... .+++..+..++.++++|++|+|+. +++|+||+|+||+++.++.+|++|||++..+......
T Consensus 85 ~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 85 GGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 999999988642 467889999999999999999998 9999999999999999999999999999876543333
Q ss_pred cceeeeeceeeCCC
Q 046265 626 WSEFVGTFGYVAPI 639 (639)
Q Consensus 626 ~~~~~gt~~Y~APE 639 (639)
.....|+..|+|||
T Consensus 158 ~~~~~~~~~y~aPE 171 (277)
T cd06642 158 RNTFVGTPFWMAPE 171 (277)
T ss_pred hhcccCcccccCHH
Confidence 33456899999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=207.39 Aligned_cols=169 Identities=23% Similarity=0.353 Sum_probs=143.6
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.||+|++|.||+|.. .+++.+|||.+............+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 467788999999999999954 4678899999876544444567789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEccccccccCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD-YDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~-~~~kl~DfGla~~~~~~~ 623 (639)
+++++|.+++..... ..+++..+..++.++++|++|+|.. +|+||||||+||+++.+ +.+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999999976432 3478899999999999999999998 99999999999999855 468999999998765332
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
......|+..|+|||
T Consensus 157 -~~~~~~~~~~y~aPE 171 (256)
T cd08220 157 -KAYTVVGTPCYISPE 171 (256)
T ss_pred -cccccccCCcccCch
Confidence 223457899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=209.90 Aligned_cols=166 Identities=27% Similarity=0.402 Sum_probs=141.9
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
-|+..+.||+|+||.||+|.. .+++.||||.+..... ....+.+.+|+.++++++||||+++++++..++..|+||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 356678899999999999954 5678999998765432 23456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
++++++.+++... .+++..+..++.+++.|++|||+. +++|+||||+||+++.++.++++|||++..+.....
T Consensus 84 ~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999999998643 468899999999999999999998 999999999999999999999999999887654333
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......|+..|+|||
T Consensus 157 ~~~~~~~~~~y~~PE 171 (277)
T cd06641 157 KRNTFVGTPFWMAPE 171 (277)
T ss_pred hhccccCCccccChh
Confidence 333457889999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=209.86 Aligned_cols=168 Identities=25% Similarity=0.432 Sum_probs=141.4
Q ss_pred cCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCC----hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPD----MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
+|+..+.||+|++|.||+|. ..+++.||+|.+...... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47778899999999999995 467899999998754321 1234678899999999999999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEccccccccC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY-DAHVSDFGISKFL 619 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~-~~kl~DfGla~~~ 619 (639)
||||+++++|.+++...+ .+++..+..++.|++.|++|||+. +++||||||+||+++.++ .+|++|||.+..+
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999997543 467889999999999999999998 999999999999998776 5999999999876
Q ss_pred CCCCC----CcceeeeeceeeCCC
Q 046265 620 KPDSS----NWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~----~~~~~~gt~~Y~APE 639 (639)
..... ......|+..|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE 178 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPE 178 (268)
T ss_pred ccccccCCccccccccccceeCHh
Confidence 54321 112356899999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=214.52 Aligned_cols=170 Identities=29% Similarity=0.352 Sum_probs=140.3
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--CceeE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQSFL 540 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l 540 (639)
.++|+..+.||+|+||.||+|.. .+|+.||+|+++...........+.+|+.++++++||||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46788889999999999999965 5689999999875443333334567899999999999999999998765 46899
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||||++ +++.+++.... ..+++..+..++.|++.|++|||.. +++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 47888776533 3578899999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
..........+++.|+|||
T Consensus 160 ~~~~~~~~~~~~~~y~aPE 178 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPE 178 (309)
T ss_pred CccCCCCcccccccccChh
Confidence 4332333345688899998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=211.61 Aligned_cols=170 Identities=23% Similarity=0.354 Sum_probs=139.2
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|++|.||+|... +++.||||++............+.+|++++++++||||+++++++..++..|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46788899999999999999654 68899999987644333344567889999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEccccccccCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL-DYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~-~~~~kl~DfGla~~~~~~ 622 (639)
|++ +++.+.+..... ...++.....++.|++.|++|||.. +|+||||||+||+++. ++.+|++|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 577777754332 2356788888999999999999998 9999999999999985 457999999999865433
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
........|++.|+|||
T Consensus 157 ~~~~~~~~~~~~y~~PE 173 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPE 173 (294)
T ss_pred ccccccCceeecccCHH
Confidence 33333456889999998
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=208.16 Aligned_cols=164 Identities=23% Similarity=0.339 Sum_probs=132.5
Q ss_pred ceeccCCCceEEEEEcC-CCc--EEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEEecccC
Q 046265 471 YCIGTAGQASVYKAELP-SWE--IVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLYEYLG 546 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 546 (639)
+.||+|+||.||+|... ++. .+|+|.+.... .....+.+.+|++++.++ +||||+++++++...+..|+||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 36899999999999764 343 46888876422 233456788999999999 79999999999999999999999999
Q ss_pred CCChhHHhhcCCC-------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 046265 547 RGSLAIILSNDAA-------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDF 613 (639)
Q Consensus 547 ~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~Df 613 (639)
+|+|.+++..... ...+++..+..++.+++.|++|+|.. +++||||||+||+++.++.+|++||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence 9999999875331 12478899999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCCCCCcceeeeeceeeCCC
Q 046265 614 GISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 614 Gla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|++........ ......++.|+|||
T Consensus 157 gl~~~~~~~~~-~~~~~~~~~y~apE 181 (270)
T cd05047 157 GLSRGQEVYVK-KTMGRLPVRWMAIE 181 (270)
T ss_pred CCccccchhhh-ccCCCCccccCChH
Confidence 99864321111 11123456799998
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=207.52 Aligned_cols=167 Identities=19% Similarity=0.354 Sum_probs=140.4
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
++|+..+.||+|+||.||+|...++..+|+|.+... ....+.+.+|+.++++++|+||+++++++.. ...|+||||
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 467788999999999999998777788999988743 2234678899999999999999999999887 778999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++|+|.+++..... ...+|..++.++.+++.|++|+|+. +++||||||+||+++.++.+|++|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 999999999976432 3578889999999999999999988 999999999999999999999999999986543221
Q ss_pred -CcceeeeeceeeCCC
Q 046265 625 -NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 -~~~~~~gt~~Y~APE 639 (639)
......++..|+|||
T Consensus 158 ~~~~~~~~~~~y~~PE 173 (260)
T cd05073 158 TAREGAKFPIKWTAPE 173 (260)
T ss_pred ccccCCcccccccCHh
Confidence 112234567899998
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=207.69 Aligned_cols=168 Identities=29% Similarity=0.442 Sum_probs=144.3
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.||+|+||.||+|.. .+++.||+|.+..........+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 467788999999999999965 4678999999986554444567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++++|.+++.... .+++..+..++.+++.|++|||.. +|+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999997643 367788999999999999999998 999999999999999999999999999887643322
Q ss_pred C----cceeeeeceeeCCC
Q 046265 625 N----WSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~----~~~~~gt~~Y~APE 639 (639)
. .....+++.|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~PE 173 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPE 173 (264)
T ss_pred cccccccCCcCCcCccChh
Confidence 1 11356889999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=209.38 Aligned_cols=168 Identities=28% Similarity=0.381 Sum_probs=139.9
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCC--------hhhHHHHHHHHHHHhccccCceeeeEEEEEcCC
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPD--------MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR 536 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 536 (639)
+|...+.||+|++|.||+|.. .+++.||||.+...... ....+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 356678999999999999954 56899999988642211 112346788999999999999999999999999
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
..++||||+++|+|.+++.... .+++..+..++.|++.|++|+|+. +++||||+|+||+++.++.+|++|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999997653 477888899999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCC--CcceeeeeceeeCCC
Q 046265 617 KFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
+....... ......|+..|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE 180 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPE 180 (272)
T ss_pred ccccccccccccccccCCccccCHH
Confidence 86543211 123356889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-24 Score=215.43 Aligned_cols=162 Identities=30% Similarity=0.405 Sum_probs=138.7
Q ss_pred CcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCC
Q 046265 469 AKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 469 ~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
....||+|+||.||+|.. .+++.||||.+..... ...+.+.+|+.+++.++||||+++++++..++..|+||||+++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 345799999999999965 4688999999865332 2345678999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
++|..++.. ..+++..+..++.|++.|++|+|.. +|+||||||+||+++.++.+||+|||++...........
T Consensus 103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 999988754 2467889999999999999999998 999999999999999999999999999876544333334
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
...|++.|+|||
T Consensus 176 ~~~~~~~y~aPE 187 (297)
T cd06659 176 SLVGTPYWMAPE 187 (297)
T ss_pred ceecCccccCHH
Confidence 567999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-24 Score=203.32 Aligned_cols=165 Identities=19% Similarity=0.261 Sum_probs=136.8
Q ss_pred HhccCCCc-ceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcC----
Q 046265 463 ATNNFDAK-YCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHP---- 535 (639)
Q Consensus 463 ~~~~f~~~-~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~---- 535 (639)
.+++|+.. ++||-|-.|+|..+ +.++++.+|+|.+... +..++|+++.-+. .|||||.++++|...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 45666544 57999999999999 4567888999998742 3346788887665 699999999998753
Q ss_pred CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEEcc
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG---LDYDAHVSD 612 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~---~~~~~kl~D 612 (639)
..+.+|||.|+||.|++.++.++. ..++++.+-.|++||+.|++|||.. .|.||||||+|+|.. .+..+|++|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 457899999999999999987764 3578899999999999999999999 999999999999995 456799999
Q ss_pred ccccccCCCCCCCcceeeeeceeeCCC
Q 046265 613 FGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 613 fGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
||+|+.-+. .....+.|.||+|.|||
T Consensus 208 fGFAK~t~~-~~~L~TPc~TPyYvaPe 233 (400)
T KOG0604|consen 208 FGFAKETQE-PGDLMTPCFTPYYVAPE 233 (400)
T ss_pred cccccccCC-CccccCCcccccccCHH
Confidence 999997553 33456789999999998
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=214.42 Aligned_cols=151 Identities=23% Similarity=0.233 Sum_probs=132.2
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCCh-hhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDM-VVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|++|.||+|... +++.||+|.+....... ...+.+.+|++++++++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36778899999999999999655 58999999998654332 34566889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
||+++++|.+++..... ..+++..+..++.|+++|++|||.. +++||||||+||+++.++.++++|||++...
T Consensus 81 e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 81 DYCPGGELFRLLQRQPG-KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred EecCCCCHHHHHHhCCC-CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 99999999999875422 4578899999999999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=212.48 Aligned_cols=167 Identities=25% Similarity=0.380 Sum_probs=141.7
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|+||.||+|.. ++++.||+|.+.... .......+.+|+++++.++||||+++++++...+..|+|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 4566778999999999999964 568899999886533 23345678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++|+|.+++...+ .+++..+..++.+++.|+.|||+.+ +|+||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred cCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 999999999887543 4788999999999999999999742 7999999999999999999999999998755322
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
......|+..|+|||
T Consensus 158 -~~~~~~~~~~~~aPE 172 (284)
T cd06620 158 -IADTFVGTSTYMSPE 172 (284)
T ss_pred -ccCccccCcccCCHH
Confidence 123457899999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.8e-24 Score=210.87 Aligned_cols=158 Identities=23% Similarity=0.361 Sum_probs=131.5
Q ss_pred ceeccCCCceEEEEEcCC-C-------cEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 471 YCIGTAGQASVYKAELPS-W-------EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
+.||+|+||.||+|.... + ..||+|.+.... ....+.+.+|+.+++.++|||||++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 368999999999996532 2 348888875422 334567888999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc--------eEEcccc
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD--------AHVSDFG 614 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~--------~kl~DfG 614 (639)
||+++|+|.++++..+. .++|..+..++.|++.|++|||+. +|+||||||+||+++.++. +|++|||
T Consensus 79 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 79 EYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred ecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999999976543 578899999999999999999998 9999999999999987765 6999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
++...... ....+++.|||||
T Consensus 154 ~~~~~~~~----~~~~~~~~y~aPE 174 (258)
T cd05078 154 ISITVLPK----EILLERIPWVPPE 174 (258)
T ss_pred cccccCCc----hhccccCCccCch
Confidence 98765422 2356889999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=210.89 Aligned_cols=168 Identities=24% Similarity=0.367 Sum_probs=141.5
Q ss_pred CCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEeccc
Q 046265 467 FDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYL 545 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 545 (639)
|+..+.||+|++|.||+|.. .+|+.||||++............+.+|++++++++|||++++++++.+++..|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56678999999999999964 57899999998764433333456788999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC
Q 046265 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 625 (639)
+ +++.+++..... ..+++..+..++.|+++|++|+|+. +++||||+|+||+++.++.+|++|||++..+......
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 689988875442 3578999999999999999999998 9999999999999999999999999999865433222
Q ss_pred cceeeeeceeeCCC
Q 046265 626 WSEFVGTFGYVAPI 639 (639)
Q Consensus 626 ~~~~~gt~~Y~APE 639 (639)
.....+++.|+|||
T Consensus 156 ~~~~~~~~~~~aPE 169 (283)
T cd07835 156 YTHEVVTLWYRAPE 169 (283)
T ss_pred cCccccccCCCCCc
Confidence 33346789999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=205.30 Aligned_cols=168 Identities=27% Similarity=0.391 Sum_probs=146.2
Q ss_pred cCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.||+|++|.||+|... +++.||||.+..........+.+.+|++++++++|||++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3667889999999999999654 678999999987654334567789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++++|.+++... ..+++..+..++.+++.|+.|+|.. +|+||||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998765 3578899999999999999999988 999999999999999999999999999987654433
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......|+..|+|||
T Consensus 155 ~~~~~~~~~~y~~pe 169 (254)
T cd06627 155 DDASVVGTPYWMAPE 169 (254)
T ss_pred cccccccchhhcCHh
Confidence 334467899999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.5e-24 Score=214.69 Aligned_cols=167 Identities=26% Similarity=0.432 Sum_probs=144.9
Q ss_pred cCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
.|+..+.||+||.++||++...+.+.||+|++.....+....+.|..|+.+|.+++ |.+||++++|-..++.+|+||||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~ 441 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC 441 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence 35566799999999999999888899999999876667777788999999999996 99999999999999999999996
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
- .-+|..+|+....... .| .++.+..|++.|+.++|.+ ||||.||||+|+|+- +|.+||+|||+|..+..+.+
T Consensus 442 G-d~DL~kiL~k~~~~~~-~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 442 G-DIDLNKILKKKKSIDP-DW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred c-cccHHHHHHhccCCCc-hH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 4 6799999987765432 34 5677899999999999999 999999999999984 58899999999999887654
Q ss_pred C--cceeeeeceeeCCC
Q 046265 625 N--WSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~--~~~~~gt~~Y~APE 639 (639)
. ..+.+||+-||+||
T Consensus 515 sI~kdsQvGT~NYMsPE 531 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPE 531 (677)
T ss_pred ceeeccccCcccccCHH
Confidence 3 24579999999998
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=211.60 Aligned_cols=166 Identities=27% Similarity=0.454 Sum_probs=142.9
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.+|+..+.||+|+||.||+|. ..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++..++..|+|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 567788899999999999995 4567899999986432 2334668899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++++|.+++... .+++..+..++.+++.|+.|||.. +++|||+||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 97 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred cCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 99999999998653 367888999999999999999998 99999999999999999999999999987665443
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......|++.|+|||
T Consensus 170 ~~~~~~~~~~~y~~PE 185 (293)
T cd06647 170 SKRSTMVGTPYWMAPE 185 (293)
T ss_pred cccccccCChhhcCch
Confidence 3334457899999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-24 Score=198.40 Aligned_cols=173 Identities=22% Similarity=0.273 Sum_probs=145.3
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC-----c
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR-----Q 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~ 537 (639)
.++|...+.+|+|||+.||.++ ..++..||+|++.+.. ....+..++|++..++++||||+++++++..+. +
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3567888999999999999994 6778899999998755 445667789999999999999999999886543 4
Q ss_pred eeEEecccCCCChhHHhhcCCC-CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAA-IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
.|++++|...|+|.+.+..... ...+++.+.+.++.++++|+++||.. .|+..||||||.||++.+.+.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999976443 24789999999999999999999986 346999999999999999999999999988
Q ss_pred ccCCCCC---------CCcceeeeeceeeCCC
Q 046265 617 KFLKPDS---------SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~---------~~~~~~~gt~~Y~APE 639 (639)
....-.- +.+....+|..|.|||
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPE 208 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPE 208 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCch
Confidence 7653111 1234467899999998
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=206.23 Aligned_cols=163 Identities=20% Similarity=0.320 Sum_probs=131.3
Q ss_pred ceeccCCCceEEEEEcC----CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc-CCceeEEeccc
Q 046265 471 YCIGTAGQASVYKAELP----SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH-PRQSFLLYEYL 545 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~ 545 (639)
+.||+|+||.||+|... +...||||++.... .....+.+.+|+.+++.++||||+++++++.. ++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999643 23579999986422 23345678899999999999999999998764 45689999999
Q ss_pred CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC-
Q 046265 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS- 624 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~- 624 (639)
.+|+|.+++..... ..++..+..++.++++|++|+|.. +|+||||||+||++++++.+|++|||+++.+.....
T Consensus 80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 80 KHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999975432 356778888999999999999998 999999999999999999999999999986543211
Q ss_pred ---CcceeeeeceeeCCC
Q 046265 625 ---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ---~~~~~~gt~~Y~APE 639 (639)
......+++.|+|||
T Consensus 155 ~~~~~~~~~~~~~y~aPE 172 (262)
T cd05058 155 SVHNHTGAKLPVKWMALE 172 (262)
T ss_pred eecccccCcCCccccChh
Confidence 112235677899998
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=208.63 Aligned_cols=170 Identities=24% Similarity=0.341 Sum_probs=143.2
Q ss_pred cCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|...+.||+|+||.||+|... +|..||+|.+..........+.+.+|+.++++++||||+++++.+..++..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999654 578899999876433333456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEccccccccCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY-DAHVSDFGISKFLKPDS 623 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~-~~kl~DfGla~~~~~~~ 623 (639)
+++++|.+++..... ..++|..+..++.++++|++|||+. +++|+|+||+||++++++ .+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999875433 3478899999999999999999998 999999999999999885 46999999998765433
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......|++.|+|||
T Consensus 157 ~~~~~~~~~~~~~ape 172 (257)
T cd08225 157 ELAYTCVGTPYYLSPE 172 (257)
T ss_pred ccccccCCCccccCHH
Confidence 3333456899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=206.58 Aligned_cols=169 Identities=25% Similarity=0.355 Sum_probs=139.9
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCC---CChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--Cce
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPH---PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQS 538 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 538 (639)
.+|...+.||+|+||.||+|.. .+++.||+|.+.... ........+.+|++++++++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4678889999999999999964 568999999875432 1223345788999999999999999999998764 457
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
++||||+++++|.+++.... .+++.....++.+++.|++|||.. +|+||||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999987543 367788899999999999999988 999999999999999999999999999986
Q ss_pred CCCC---CCCcceeeeeceeeCCC
Q 046265 619 LKPD---SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~---~~~~~~~~gt~~Y~APE 639 (639)
.... ........|+..|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE 179 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPE 179 (264)
T ss_pred cccccccCccccccCCcccccCHh
Confidence 5321 11223456899999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=209.26 Aligned_cols=160 Identities=24% Similarity=0.246 Sum_probs=129.7
Q ss_pred eeccCCCceEEEEEc-CCCcEEEEEEccCCCCCh-hhHHHHHHHHHHH---hccccCceeeeEEEEEcCCceeEEecccC
Q 046265 472 CIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDM-VVQQAFSNEIKAL---TELRHRNVVKFYGFSFHPRQSFLLYEYLG 546 (639)
Q Consensus 472 ~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l---~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 546 (639)
.||+|+||.||+|.. .+++.||||.+....... .....+.+|..++ ...+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999965 568899999987543221 1223334444433 33479999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCc
Q 046265 547 RGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW 626 (639)
Q Consensus 547 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 626 (639)
+|+|.+++...+ .++|..+..++.|++.|++|+|.. +|+||||||+||+++.++.+|++|||++....... .
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 152 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--c
Confidence 999999887543 478899999999999999999998 89999999999999999999999999987553222 2
Q ss_pred ceeeeeceeeCCC
Q 046265 627 SEFVGTFGYVAPI 639 (639)
Q Consensus 627 ~~~~gt~~Y~APE 639 (639)
....|++.|||||
T Consensus 153 ~~~~~~~~y~aPE 165 (279)
T cd05633 153 HASVGTHGYMAPE 165 (279)
T ss_pred cCcCCCcCccCHH
Confidence 2356999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=204.38 Aligned_cols=163 Identities=25% Similarity=0.361 Sum_probs=137.0
Q ss_pred ceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCCCh
Q 046265 471 YCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 550 (639)
+.||+|++|.||+|...+++.||+|.+...... .....+.+|+.++++++||||+++++++...+..|+||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 368999999999998777899999998764432 3456789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCc--ce
Q 046265 551 AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW--SE 628 (639)
Q Consensus 551 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~--~~ 628 (639)
.+++.... ..+++.....++.+++.|++|+|+. +++||||||+||+++.++.+|++|||+++......... ..
T Consensus 80 ~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 80 LTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 99986543 2467888999999999999999998 99999999999999999999999999998654221111 11
Q ss_pred eeeeceeeCCC
Q 046265 629 FVGTFGYVAPI 639 (639)
Q Consensus 629 ~~gt~~Y~APE 639 (639)
..++..|+|||
T Consensus 155 ~~~~~~y~~PE 165 (251)
T cd05041 155 KQIPIKWTAPE 165 (251)
T ss_pred CcceeccCChH
Confidence 23456799998
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=211.68 Aligned_cols=169 Identities=24% Similarity=0.261 Sum_probs=140.0
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36788899999999999999654 578899999875432 1223456789999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++++|.+++...+ .+++..+..++.+++.|++|+|+. +|+||||||+||+++.++.+|++|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999997643 478888889999999999999998 9999999999999999999999999998742110
Q ss_pred CC---------------CcceeeeeceeeCCC
Q 046265 623 SS---------------NWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~---------------~~~~~~gt~~Y~APE 639 (639)
.. ......|+..|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 186 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCch
Confidence 00 011246788999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-24 Score=196.95 Aligned_cols=163 Identities=18% Similarity=0.296 Sum_probs=131.4
Q ss_pred cceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEEecccCC
Q 046265 470 KYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
...+|.|+.|+|++++.+ +|..+|||.+..... .....+....+.++.+. ..|.||+.+|||..+..+++.||.|.
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 457899999999999665 589999999986542 33445566777777665 48999999999999999999999984
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
.-...+++.-. ..+++...-++...+.+||.||.+.+ +|+|||+||+|||+|+.|++|+||||++..+... .+.+
T Consensus 175 ~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-kAht 249 (391)
T KOG0983|consen 175 TCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-KAHT 249 (391)
T ss_pred HHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc-cccc
Confidence 34444444322 24666777788888999999999887 8999999999999999999999999999887643 3345
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
..+|.+.|||||
T Consensus 250 rsAGC~~YMaPE 261 (391)
T KOG0983|consen 250 RSAGCAAYMAPE 261 (391)
T ss_pred cccCCccccCcc
Confidence 578999999998
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-23 Score=205.34 Aligned_cols=161 Identities=27% Similarity=0.327 Sum_probs=132.9
Q ss_pred ceeccCCCceEEEEEcC--C--CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccC
Q 046265 471 YCIGTAGQASVYKAELP--S--WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLG 546 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 546 (639)
+.||+|+||.||+|... + +..+|+|.+...... ...+.+.+|+.++++++|||||++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 36899999999999542 2 267999998865433 34567899999999999999999999876 456899999999
Q ss_pred CCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCc
Q 046265 547 RGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW 626 (639)
Q Consensus 547 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 626 (639)
+|+|.+++.... .+++..+..++.|++.|++|||.. +++||||||+||+++.++.+|++|||+++.+.......
T Consensus 79 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 79 LGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999997654 478899999999999999999988 99999999999999999999999999998764333221
Q ss_pred c---eeeeeceeeCCC
Q 046265 627 S---EFVGTFGYVAPI 639 (639)
Q Consensus 627 ~---~~~gt~~Y~APE 639 (639)
. ...++..|+|||
T Consensus 153 ~~~~~~~~~~~y~aPE 168 (257)
T cd05060 153 RATTAGRWPLKWYAPE 168 (257)
T ss_pred ccccCccccccccCHH
Confidence 1 122356799998
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-22 Score=235.81 Aligned_cols=338 Identities=24% Similarity=0.273 Sum_probs=233.7
Q ss_pred CCccccCCCCCCEEECcCCC------CccCCCCCCCCCC-CCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCcccc
Q 046265 22 IPPQIGNISNLKFLDMGNNQ------LSGVIPQEIDPLT-HLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWL 94 (639)
Q Consensus 22 ~p~~~~~l~~L~~L~Ls~n~------l~~~~p~~~~~L~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 94 (639)
-+..|.++++|+.|.+..+. +...+|+.|..++ +|+.|++.+|.+. .+|..| ...+|+.|+|.+|++. .+
T Consensus 550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L 626 (1153)
T PLN03210 550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KL 626 (1153)
T ss_pred cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cc
Confidence 44568889999999886653 3345777777764 6999999999887 788877 4689999999998877 45
Q ss_pred CccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEc
Q 046265 95 PSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGF 174 (639)
Q Consensus 95 p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 174 (639)
|..+..+++ | +.|+|+++...+.+|. ++.+++|++|+|++|.....+|..++.+++|+.|++
T Consensus 627 ~~~~~~l~~---------------L--k~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 627 WDGVHSLTG---------------L--RNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred ccccccCCC---------------C--CEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 555555543 3 5788887654446664 677888888888888776778888888888888888
Q ss_pred ccCcCCccCCccCcCCCCCCeEEccCCcccccc-ccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccc------
Q 046265 175 DLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEI-GNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHL------ 247 (639)
Q Consensus 175 ~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~-~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l------ 247 (639)
++|..-+.+|..+ ++++|+.|+++++..-..+ ....+|+.|++++|.+ ..+|..+ .+++|+.|.+.++..
T Consensus 689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i-~~lP~~~-~l~~L~~L~l~~~~~~~l~~~ 765 (1153)
T PLN03210 689 SRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAI-EEFPSNL-RLENLDELILCEMKSEKLWER 765 (1153)
T ss_pred CCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCcc-ccccccc-cccccccccccccchhhcccc
Confidence 8865555667655 6788888888754322222 1235778888888886 3466554 467777777766321
Q ss_pred -cCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeecc
Q 046265 248 -TGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALN 326 (639)
Q Consensus 248 -~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~ 326 (639)
....+..+...++|+.|++++|.. .+.+|.+++++++|+.|++++|...+.+|... ++++|+.|+++
T Consensus 766 ~~~l~~~~~~~~~sL~~L~Ls~n~~-----------l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls 833 (1153)
T PLN03210 766 VQPLTPLMTMLSPSLTRLFLSDIPS-----------LVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLS 833 (1153)
T ss_pred ccccchhhhhccccchheeCCCCCC-----------ccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECC
Confidence 112222233446777777665543 34678888888888888888876555677655 67888888888
Q ss_pred CccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCC-cCceeecCcchhhhhhhhhhhhcccC
Q 046265 327 GNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVIT-FWEERYRPKSVIWKAWRSLISRMHGL 405 (639)
Q Consensus 327 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n-~~~~~~~~~~~~~~~~~~~~~~l~~L 405 (639)
+|.....+|.. .++|+.|+|++|.+. .+|.++..+++|+.|+++++ .+.. + | ..+..++.|
T Consensus 834 ~c~~L~~~p~~---~~nL~~L~Ls~n~i~----~iP~si~~l~~L~~L~L~~C~~L~~-l-~---------~~~~~L~~L 895 (1153)
T PLN03210 834 GCSRLRTFPDI---STNISDLNLSRTGIE----EVPWWIEKFSNLSFLDMNGCNNLQR-V-S---------LNISKLKHL 895 (1153)
T ss_pred CCCcccccccc---ccccCEeECCCCCCc----cChHHHhcCCCCCEEECCCCCCcCc-c-C---------cccccccCC
Confidence 87665566643 357888888885433 46777888888888888763 3332 2 2 335567777
Q ss_pred cEEccCCC
Q 046265 406 SCIDISYN 413 (639)
Q Consensus 406 ~~ldls~N 413 (639)
+.++++++
T Consensus 896 ~~L~l~~C 903 (1153)
T PLN03210 896 ETVDFSDC 903 (1153)
T ss_pred CeeecCCC
Confidence 77777766
|
syringae 6; Provisional |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=211.25 Aligned_cols=172 Identities=28% Similarity=0.413 Sum_probs=141.4
Q ss_pred HHhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC----
Q 046265 462 RATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR---- 536 (639)
Q Consensus 462 ~~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~---- 536 (639)
...++|+..+.||+|+||.||+|... +++.||||.++...........+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678888999999999999999664 6789999999754433334456788999999999999999999987654
Q ss_pred ------ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 046265 537 ------QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV 610 (639)
Q Consensus 537 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl 610 (639)
..++|+||+++ ++...+.... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 78999999976 6666665432 3578899999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCCC-CCcceeeeeceeeCCC
Q 046265 611 SDFGISKFLKPDS-SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 611 ~DfGla~~~~~~~-~~~~~~~gt~~Y~APE 639 (639)
+|||++....... .......+++.|+|||
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE 187 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPE 187 (302)
T ss_pred CcccccccccCCcccccccceeccCccChH
Confidence 9999998765332 2223345788899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=213.15 Aligned_cols=170 Identities=24% Similarity=0.382 Sum_probs=137.5
Q ss_pred cCCCcceeccCCCceEEEEEcC---CCcEEEEEEccCCC-CChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--Ccee
Q 046265 466 NFDAKYCIGTAGQASVYKAELP---SWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQSF 539 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~ 539 (639)
.|+....||+|++|.||+|... +++.||+|.+.... ......+.+.+|+.++++++||||+++++++.+. +..|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3667788999999999999654 47899999988632 1122335577899999999999999999999988 7899
Q ss_pred EEecccCCCChhHHhhcCCC--CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC----CCceEEccc
Q 046265 540 LLYEYLGRGSLAIILSNDAA--IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL----DYDAHVSDF 613 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~----~~~~kl~Df 613 (639)
+||||+++ ++.+.+..... ...+++..+..++.|++.|++|||.. +|+||||||+||+++. ++.+|++||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 66666643221 12578888999999999999999998 9999999999999999 899999999
Q ss_pred cccccCCCCCC---CcceeeeeceeeCCC
Q 046265 614 GISKFLKPDSS---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 614 Gla~~~~~~~~---~~~~~~gt~~Y~APE 639 (639)
|+++.+..... .....++++.|+|||
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE 185 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPE 185 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHH
Confidence 99987643222 223457899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=210.17 Aligned_cols=168 Identities=23% Similarity=0.287 Sum_probs=140.3
Q ss_pred cCCCcceeccCCCceEEEEEc----CCCcEEEEEEccCCCC--ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCce
Q 046265 466 NFDAKYCIGTAGQASVYKAEL----PSWEIVAVKKFHSPHP--DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 538 (639)
+|+..+.||+|+||.||+|.. .+|+.||+|.+..... .....+.+.+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999965 4688999999875321 122345678899999999 599999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
|+||||+++++|.+++.... .+++.....++.|+++|++|||.. +++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999987543 467788888899999999999998 999999999999999999999999999987
Q ss_pred CCCCC-CCcceeeeeceeeCCC
Q 046265 619 LKPDS-SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~-~~~~~~~gt~~Y~APE 639 (639)
..... .......|+..|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE 176 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPD 176 (290)
T ss_pred cccccccccccccCCcccCChh
Confidence 54322 1223467899999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=207.50 Aligned_cols=166 Identities=28% Similarity=0.407 Sum_probs=141.6
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
.|+..+.||+|+||.||+|.. .+++.||||.+..... ......+.+|+.++++++||||+++++++.++...|+||||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 456677899999999999965 4678999998875432 23456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++|+|.+++... .+++.....++.+++.|++|+|+. +++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 9999999998643 367788889999999999999998 999999999999999999999999999987654333
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......++..|+|||
T Consensus 157 ~~~~~~~~~~y~apE 171 (277)
T cd06640 157 KRNTFVGTPFWMAPE 171 (277)
T ss_pred ccccccCcccccCHh
Confidence 333456889999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=209.23 Aligned_cols=167 Identities=27% Similarity=0.341 Sum_probs=143.6
Q ss_pred cCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCC-hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPD-MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
+|+..+.||.|+||.||+|... +++.||+|.+...... ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4777899999999999999665 6889999999754322 2345678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++++|.+++... ..+++..+..++.++++|++|+|.. +++|+||+|+||++++++.++++|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999999765 2467788999999999999999998 99999999999999999999999999988764332
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
......|+..|+|||
T Consensus 155 -~~~~~~~~~~y~~PE 169 (258)
T cd05578 155 -LTTSTSGTPGYMAPE 169 (258)
T ss_pred -cccccCCChhhcCHH
Confidence 223456889999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=207.26 Aligned_cols=172 Identities=22% Similarity=0.334 Sum_probs=140.1
Q ss_pred hccCCCcceeccCCCceEEEEEcCC------CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPS------WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 537 (639)
+++|+..+.||+|++|.||+|.... +..||+|.+.... .......|.+|+.++++++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4678888999999999999996643 4678999886433 23345678999999999999999999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCC----CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC---ceEE
Q 046265 538 SFLLYEYLGRGSLAIILSNDAA----IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY---DAHV 610 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~---~~kl 610 (639)
.++||||+++|+|.+++...+. ...++|..+..++.+++.|++|||.. +++||||||+||+++.++ .+|+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976432 13588999999999999999999998 899999999999998654 5999
Q ss_pred ccccccccCCCCCCC--cceeeeeceeeCCC
Q 046265 611 SDFGISKFLKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 611 ~DfGla~~~~~~~~~--~~~~~gt~~Y~APE 639 (639)
+|||+++.+...... .....+++.|||||
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPE 191 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHH
Confidence 999999876322111 11223356899998
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-23 Score=204.55 Aligned_cols=167 Identities=22% Similarity=0.378 Sum_probs=140.1
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
.+|+..+.||+|+||.||+|....++.+|+|.+..... ....|.+|++++++++||||+++++++......++||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 35677889999999999999877778899999875332 245688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++++|.+++..... .+++..+..++.+++.|++|||.. +++||||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 81 MEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999999875432 467899999999999999999988 899999999999999999999999999876532211
Q ss_pred -CcceeeeeceeeCCC
Q 046265 625 -NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 -~~~~~~gt~~Y~APE 639 (639)
......++.+|+|||
T Consensus 156 ~~~~~~~~~~~~~aPe 171 (256)
T cd05112 156 TSSTGTKFPVKWSSPE 171 (256)
T ss_pred cccCCCccchhhcCHh
Confidence 111233567899998
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=208.32 Aligned_cols=162 Identities=24% Similarity=0.263 Sum_probs=136.5
Q ss_pred eccCCCceEEEEE-cCCCcEEEEEEccCCCCC-hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCCCh
Q 046265 473 IGTAGQASVYKAE-LPSWEIVAVKKFHSPHPD-MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550 (639)
Q Consensus 473 ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 550 (639)
||+|+||.||+|. ..+|+.||+|.+...... ....+.+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999995 456889999998753321 22345667899999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcceee
Q 046265 551 AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFV 630 (639)
Q Consensus 551 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 630 (639)
.+++..... ..+++..+..++.|++.|+.|+|.. +|+||||+|+||+++.++.+|++|||.+...... .......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRA 155 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Ccccccc
Confidence 999875443 3578899999999999999999998 9999999999999999999999999998865432 2223356
Q ss_pred eeceeeCCC
Q 046265 631 GTFGYVAPI 639 (639)
Q Consensus 631 gt~~Y~APE 639 (639)
++..|+|||
T Consensus 156 ~~~~y~~PE 164 (277)
T cd05577 156 GTPGYMAPE 164 (277)
T ss_pred CCCCcCCHH
Confidence 888999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=207.42 Aligned_cols=171 Identities=26% Similarity=0.411 Sum_probs=143.9
Q ss_pred HhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCC----
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPR---- 536 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~---- 536 (639)
++++|+..+.||+|++|.||+|..+ +++.+|+|.+.... ...+.+.+|+.+++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 5678999999999999999999764 57889999987533 2346789999999998 6999999999997644
Q ss_pred --ceeEEecccCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 046265 537 --QSFLLYEYLGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDF 613 (639)
Q Consensus 537 --~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~Df 613 (639)
..|+||||+++++|.+++.... ....+++..+..++.|+++|++|||.. +++||||+|+||+++.++.+|++||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence 4899999999999999886532 124578899999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCCCcceeeeeceeeCCC
Q 046265 614 GISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 614 Gla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|.+..............|++.|+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE 183 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPE 183 (275)
T ss_pred ccceecccchhhhcCccccccccCHh
Confidence 99876543333334467899999998
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-23 Score=203.92 Aligned_cols=168 Identities=24% Similarity=0.364 Sum_probs=139.9
Q ss_pred CCCcceeccCCCceEEEEEcCC-----CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 467 FDAKYCIGTAGQASVYKAELPS-----WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
|+..+.||+|+||.||+|.... +..||+|.+..... ....+.+.+|++.+.+++||||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3456889999999999996653 37899999975432 22456788999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||+++....
T Consensus 80 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999999875432 1278899999999999999999998 999999999999999999999999999987654
Q ss_pred CCCCcc-eeeeeceeeCCC
Q 046265 622 DSSNWS-EFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~-~~~gt~~Y~APE 639 (639)
...... ...+++.|+|||
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe 174 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPE 174 (258)
T ss_pred ccccccccCCCcccccChH
Confidence 322111 123678999998
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-23 Score=208.53 Aligned_cols=169 Identities=28% Similarity=0.422 Sum_probs=146.3
Q ss_pred HhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.++.|+..+.+|+|++|.||+|..+ +++.||+|.+..... ..+.+.+|++.+++++|+||+++++++...+..|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4567788889999999999999765 678899999875432 456788999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
+||+++++|.+++.... ..+++..+..++.+++.|++|||.. +|+|+|++|+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 99999999999998654 3588899999999999999999997 999999999999999999999999999876543
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
.........+++.|+|||
T Consensus 169 ~~~~~~~~~~~~~y~~PE 186 (286)
T cd06614 169 EKSKRNSVVGTPYWMAPE 186 (286)
T ss_pred chhhhccccCCcccCCHh
Confidence 333333456888999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-23 Score=210.14 Aligned_cols=168 Identities=21% Similarity=0.362 Sum_probs=136.3
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCc----EEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWE----IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
.+|+..+.||+|+||.||+|.. .+++ .||+|.+.... .......+.+|+.++++++||||++++++|..+ ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 4567788999999999999964 3444 47888886533 233345688999999999999999999999764 467
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+|+||+++|++.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 9999999999999987543 2478889999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCC--cceeeeeceeeCCC
Q 046265 620 KPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~--~~~~~gt~~Y~APE 639 (639)
...... .....++..|||||
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE 181 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALE 181 (303)
T ss_pred cCcccccccCCCccccccCCHH
Confidence 432221 12234577899998
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-23 Score=206.95 Aligned_cols=169 Identities=24% Similarity=0.354 Sum_probs=139.7
Q ss_pred ccCCCcceeccCCCceEEEEEcC-----CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc--CCc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-----SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH--PRQ 537 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~ 537 (639)
..|+..+.||+|+||.||+|... +++.||||.+...... ...+.|.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 34666789999999999999753 4678999999865432 346679999999999999999999999887 457
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.++||||+++++|.+++..... .++|..+..++.+++.|++|||.. +|+||||||+||+++.++.+|++|||.+.
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 8999999999999999976432 478899999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCCc---ceeeeeceeeCCC
Q 046265 618 FLKPDSSNW---SEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~~---~~~~gt~~Y~APE 639 (639)
......... ....++..|+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe 182 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPE 182 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcH
Confidence 765322211 1123456799997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=211.09 Aligned_cols=170 Identities=28% Similarity=0.394 Sum_probs=137.9
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc-----
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ----- 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----- 537 (639)
.++|+....||+|+||.||+|.. .+++.||||++............+.+|+.++++++||||++++++|...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 35688889999999999999965 468999999987543333333456789999999999999999999876543
Q ss_pred ---eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 046265 538 ---SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614 (639)
Q Consensus 538 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfG 614 (639)
.++||||++ +++.+.+.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 499999996 47877776543 2478899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCC----CcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSS----NWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~----~~~~~~gt~~Y~APE 639 (639)
++..+..... ......++..|+|||
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 193 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPE 193 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcH
Confidence 9986543221 112346788999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-23 Score=214.76 Aligned_cols=169 Identities=25% Similarity=0.399 Sum_probs=140.1
Q ss_pred HhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcC--Cce
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHP--RQS 538 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~--~~~ 538 (639)
..++|+..+.||+|+||.||+|... +++.+|||++............+.+|+.+++++ +||||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888899999999999999654 678999999865433333445677899999999 999999999998754 357
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
|+||||++ ++|..++... .++|..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5898888653 467888999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCC-----CcceeeeeceeeCCC
Q 046265 619 LKPDSS-----NWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~-----~~~~~~gt~~Y~APE 639 (639)
...... ......||+.|+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE 182 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPE 182 (337)
T ss_pred cccccccccCcchhcccccccccCce
Confidence 643321 223467899999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-23 Score=225.12 Aligned_cols=168 Identities=18% Similarity=0.198 Sum_probs=131.6
Q ss_pred HHHHhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcccc------CceeeeEEEE
Q 046265 460 VIRATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH------RNVVKFYGFS 532 (639)
Q Consensus 460 ~~~~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H------~niv~l~~~~ 532 (639)
+...+.+|+..+.||+|+||.||+|.. .+++.||||+++... .....+..|+.++.+++| ++++.+++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 334567899999999999999999965 567889999986421 123345567777766654 4588999998
Q ss_pred EcC-CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-----
Q 046265 533 FHP-RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY----- 606 (639)
Q Consensus 533 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~----- 606 (639)
... +..|+|||++ +++|.+++...+ .+++..+..++.|++.||+|||+.. +||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccc
Confidence 765 4688999988 678888876543 4788999999999999999999732 899999999999998665
Q ss_pred -----------ceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 607 -----------DAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 607 -----------~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
.+||+|||.+.... ......+||+.|||||
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE 315 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPE 315 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc---cccccccCCccccCcH
Confidence 49999999886432 2234578999999998
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-23 Score=205.85 Aligned_cols=168 Identities=24% Similarity=0.347 Sum_probs=137.4
Q ss_pred ccCCCcceeccCCCceEEEEEcCC----CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS----WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
++|...+.||+|+||.||+|...+ ...||||...... .....+.+.+|+.++++++||||+++++++.. +..|+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 456778899999999999996543 2468999886533 23445678999999999999999999998875 56789
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||||+++|+|.+++.... ..+++..+..++.+++.|++|+|+. +++||||||+||+++..+.+|++|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 999999999999997543 2478899999999999999999988 99999999999999999999999999998764
Q ss_pred CCCC-CcceeeeeceeeCCC
Q 046265 621 PDSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~-~~~~~~gt~~Y~APE 639 (639)
.... ......+++.|+|||
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE 178 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPE 178 (270)
T ss_pred cccceecCCCCccccccChh
Confidence 3321 111233456899998
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-23 Score=206.37 Aligned_cols=160 Identities=23% Similarity=0.236 Sum_probs=130.2
Q ss_pred eeccCCCceEEEEEc-CCCcEEEEEEccCCCCCh-hhHHHHHHHHH---HHhccccCceeeeEEEEEcCCceeEEecccC
Q 046265 472 CIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDM-VVQQAFSNEIK---ALTELRHRNVVKFYGFSFHPRQSFLLYEYLG 546 (639)
Q Consensus 472 ~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~---~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 546 (639)
+||+|+||.||+|.. .+++.||+|.+....... .....+..|.. .++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999965 567899999987643221 11222334433 3444579999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCc
Q 046265 547 RGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW 626 (639)
Q Consensus 547 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 626 (639)
+|+|.+++... ..++|..+..++.|+++|++|+|.. +|+||||||+||+++.++.+|++|||++....... .
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~ 152 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--C
Confidence 99999988654 3588999999999999999999998 89999999999999999999999999987654322 2
Q ss_pred ceeeeeceeeCCC
Q 046265 627 SEFVGTFGYVAPI 639 (639)
Q Consensus 627 ~~~~gt~~Y~APE 639 (639)
...+|+..|+|||
T Consensus 153 ~~~~~~~~y~aPE 165 (278)
T cd05606 153 HASVGTHGYMAPE 165 (278)
T ss_pred cCcCCCcCCcCcH
Confidence 3457999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-23 Score=209.09 Aligned_cols=166 Identities=26% Similarity=0.385 Sum_probs=142.6
Q ss_pred cCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.||+|++|.||+|..+ +++.||+|.+..... ......+.+|+.++++++||||+++++++..++..++|+||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 5677789999999999999655 678999999876432 34566788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH-DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
+++++|.+++.... ..+++....+++.+++.|++|+|. . +++||||||+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999997643 356778889999999999999998 6 99999999999999999999999999987654322
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
. ....|+..|+|||
T Consensus 156 ~--~~~~~~~~y~~PE 169 (265)
T cd06605 156 A--KTFVGTSSYMAPE 169 (265)
T ss_pred h--hcccCChhccCHH
Confidence 1 1267889999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-23 Score=203.57 Aligned_cols=162 Identities=26% Similarity=0.392 Sum_probs=135.5
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
.+|+..+.||+|+||.||+|.. +++.||+|.+.... ..+.+.+|+.++++++||||+++++++... ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4577889999999999999974 56789999986432 245688999999999999999999998764 47999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++|+|.+++..... ..+++..+..++.|++.|++|+|.. +++||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 80 MSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999976432 3478899999999999999999988 9999999999999999999999999998764321
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......+..|+|||
T Consensus 154 -~~~~~~~~~y~~pe 167 (254)
T cd05083 154 -VDNSKLPVKWTAPE 167 (254)
T ss_pred -CCCCCCCceecCHH
Confidence 11233457899998
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=202.70 Aligned_cols=171 Identities=24% Similarity=0.348 Sum_probs=147.6
Q ss_pred cCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.||+|++|.||+|... +++.||+|++............+.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999654 678999999986554445667788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 545 LGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 545 ~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
+++++|.+.+.... ....+++.....++.+++.|++|||.. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997642 124688999999999999999999998 99999999999999999999999999998765443
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......|++.|+|||
T Consensus 158 ~~~~~~~~~~~y~~pe 173 (258)
T cd08215 158 DLAKTVVGTPYYLSPE 173 (258)
T ss_pred ceecceeeeecccChh
Confidence 2334467899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-23 Score=206.47 Aligned_cols=165 Identities=26% Similarity=0.371 Sum_probs=140.1
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
.|...+.||+|++|.||+|.. .+++.+|+|++.... ....+.+.+|+.++++++||||+++++++..++..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 344567999999999999964 567899999886432 23345678999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++++|.+++... .+++..+..++.+++.|++|+|.. +|+||||+|+||+++.++.+|++|||.+........
T Consensus 98 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 98 LEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 9999999998762 367888999999999999999998 999999999999999999999999998876543322
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......|++.|+|||
T Consensus 171 ~~~~~~~~~~y~aPE 185 (285)
T cd06648 171 RRKSLVGTPYWMAPE 185 (285)
T ss_pred ccccccCCccccCHH
Confidence 233457899999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-25 Score=202.51 Aligned_cols=166 Identities=25% Similarity=0.335 Sum_probs=130.8
Q ss_pred CcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEEecccC
Q 046265 469 AKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLYEYLG 546 (639)
Q Consensus 469 ~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 546 (639)
....||.|+||+|++- +.+.|+.+|||+++.... ...+.++..|.+...+- +.||||++||.+..++..|+-||.|.
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 4568999999999998 556789999999987554 34567788888876554 78999999999999999999999994
Q ss_pred CCChhHHhhc--CCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 547 RGSLAIILSN--DAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 547 ~g~L~~~l~~--~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
.+++.+-+. .....++++...-.|......||.||.... .|||||+||+|||+|..|.+|+||||++..+... -
T Consensus 147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-i 222 (361)
T KOG1006|consen 147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-I 222 (361)
T ss_pred -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH-H
Confidence 455433221 111234566666667777889999999875 8999999999999999999999999999877532 2
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
+.+.-+|...|||||
T Consensus 223 AkT~daGCrpYmAPE 237 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPE 237 (361)
T ss_pred HhhhccCCccccChh
Confidence 233457999999998
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-23 Score=213.57 Aligned_cols=167 Identities=19% Similarity=0.299 Sum_probs=138.1
Q ss_pred HhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC------
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP------ 535 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------ 535 (639)
..++|+..+.||+|+||.||+|.. .+++.||||.+............+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457788899999999999999954 5789999999875433333445677899999999999999999998644
Q ss_pred CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGl 615 (639)
...|+||||++ +++.+.+... +++..+..++.|++.|++|||.. +|+||||||+||+++.++.+|++|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 24799999996 5787777532 67788888999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCcceeeeeceeeCCC
Q 046265 616 SKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
++...... ......|++.|+|||
T Consensus 165 ~~~~~~~~-~~~~~~~~~~y~aPE 187 (353)
T cd07850 165 ARTAGTSF-MMTPYVVTRYYRAPE 187 (353)
T ss_pred ceeCCCCC-CCCCCcccccccCHH
Confidence 98764322 223456899999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-23 Score=213.18 Aligned_cols=173 Identities=21% Similarity=0.344 Sum_probs=144.0
Q ss_pred hHHHHHHHhccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc
Q 046265 456 LYEEVIRATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH 534 (639)
Q Consensus 456 ~~~~~~~~~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 534 (639)
...++..++++|...+.||+|+||.||+|. ..+++.||||++..........+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 345667788999999999999999999995 4678999999987643333345567889999999999999999998864
Q ss_pred C------CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 046265 535 P------RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDA 608 (639)
Q Consensus 535 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~ 608 (639)
. ...|+++|++ ++++.+++... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 3 3468888887 78998887642 478899999999999999999998 99999999999999999999
Q ss_pred EEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 609 HVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 609 kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|++|||+++.... ......|++.|+|||
T Consensus 160 kl~dfg~~~~~~~---~~~~~~~~~~y~aPE 187 (345)
T cd07877 160 KILDFGLARHTDD---EMTGYVATRWYRAPE 187 (345)
T ss_pred EEecccccccccc---cccccccCCCccCHH
Confidence 9999999876532 223457889999998
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=226.34 Aligned_cols=173 Identities=19% Similarity=0.250 Sum_probs=131.2
Q ss_pred HhccCCCcceeccCCCceEEEEEcCC--CcEEEEEEcc--------------C-CCCChhhHHHHHHHHHHHhccccCce
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELPS--WEIVAVKKFH--------------S-PHPDMVVQQAFSNEIKALTELRHRNV 525 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~~--~~~vavK~~~--------------~-~~~~~~~~~~~~~e~~~l~~l~H~ni 525 (639)
...+|+..+.||+|+||+||+|..+. +..+++|.+. + ..........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999986432 2222222111 0 01112234567899999999999999
Q ss_pred eeeEEEEEcCCceeEEecccCCCChhHHhhcCCC--CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC
Q 046265 526 VKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAA--IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG 603 (639)
Q Consensus 526 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~ 603 (639)
|++++++...+..|+|+|++. +++.+++..... ...........++.|++.||+|||.. +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999985 566666643221 11223456678999999999999998 999999999999999
Q ss_pred CCCceEEccccccccCCCCCC-CcceeeeeceeeCCC
Q 046265 604 LDYDAHVSDFGISKFLKPDSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 604 ~~~~~kl~DfGla~~~~~~~~-~~~~~~gt~~Y~APE 639 (639)
.++.+||+|||+++.+..... .....+||+.|+|||
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE 338 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPE 338 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCch
Confidence 999999999999987654322 223467999999998
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.6e-23 Score=213.33 Aligned_cols=167 Identities=20% Similarity=0.337 Sum_probs=140.2
Q ss_pred HHhccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC----
Q 046265 462 RATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR---- 536 (639)
Q Consensus 462 ~~~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~---- 536 (639)
...++|+..+.||+|+||.||+|. ..+++.||||++............+.+|+.++++++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 346778889999999999999995 557899999998654333344566789999999999999999999987654
Q ss_pred --ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 046265 537 --QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614 (639)
Q Consensus 537 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfG 614 (639)
..++||||+ ++++.+++.. ..+++..+..++.|+++|++|+|.. +|+||||||+||+++.++.+|++|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 7789888764 2478899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
++...... .....+++.|+|||
T Consensus 164 ~~~~~~~~---~~~~~~~~~y~aPE 185 (343)
T cd07880 164 LARQTDSE---MTGYVVTRWYRAPE 185 (343)
T ss_pred cccccccC---ccccccCCcccCHH
Confidence 99865432 23356889999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=204.06 Aligned_cols=170 Identities=22% Similarity=0.339 Sum_probs=136.2
Q ss_pred CCCcceeccCCCceEEEEEcC----CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC------
Q 046265 467 FDAKYCIGTAGQASVYKAELP----SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR------ 536 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 536 (639)
|...++||+|+||.||+|..+ +++.||||.+..........+.+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999643 4688999999765444445667889999999999999999999887542
Q ss_pred ceeEEecccCCCChhHHhhcCC---CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDA---AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDF 613 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~Df 613 (639)
..++++||+++|++.+++.... ....+++.....++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988875322 122478888999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCCC--CcceeeeeceeeCCC
Q 046265 614 GISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 614 Gla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
|+++....... ......+++.|+|||
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe 185 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALE 185 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHh
Confidence 99986643221 112234567899997
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=211.76 Aligned_cols=163 Identities=24% Similarity=0.399 Sum_probs=136.6
Q ss_pred CcceeccCCCceEEEEEcC---CCc--EEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 469 AKYCIGTAGQASVYKAELP---SWE--IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 469 ~~~~ig~g~~g~vy~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
..++||+|-||.||+|... .|+ .||||..+... +....+.|.+|+.+|+.++|||||+++|.|.+ ...|+|||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE 470 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME 470 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence 4578999999999999532 233 48999877543 34457899999999999999999999999986 57899999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
.++-|.|+.+++... ..++......++.|++.||+|||+. +.|||||.+.|||+....-+|++|||+++.+..+.
T Consensus 471 L~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 471 LAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred cccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 999999999998654 3577788889999999999999999 89999999999999999999999999999887443
Q ss_pred CCcceeeee--ceeeCCC
Q 046265 624 SNWSEFVGT--FGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt--~~Y~APE 639 (639)
.+...+|. ..|||||
T Consensus 546 -yYkaS~~kLPIKWmaPE 562 (974)
T KOG4257|consen 546 -YYKASRGKLPIKWMAPE 562 (974)
T ss_pred -hhhccccccceeecCcc
Confidence 22222343 4699998
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=207.23 Aligned_cols=165 Identities=28% Similarity=0.399 Sum_probs=138.5
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
..|+..+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+.++++++||||++++++|..++..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4577788999999999999965 4689999999865432 2333456889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||++ |++.+.+.... ..+++..+..++.|++.|+.|||.. +|+||||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 56666665332 2478899999999999999999988 9999999999999999999999999998765432
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
....|++.|+|||
T Consensus 169 ----~~~~~~~~y~aPE 181 (307)
T cd06607 169 ----NSFVGTPYWMAPE 181 (307)
T ss_pred ----CCccCCccccCce
Confidence 2356888999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-24 Score=216.42 Aligned_cols=165 Identities=25% Similarity=0.330 Sum_probs=142.2
Q ss_pred CCcceeccCCCceEEEEEcCCCc-EEEEEEccCCC-CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEeccc
Q 046265 468 DAKYCIGTAGQASVYKAELPSWE-IVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYL 545 (639)
Q Consensus 468 ~~~~~ig~g~~g~vy~~~~~~~~-~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 545 (639)
+..-.+|-||||.|-.+...... .+|.|.+++.. .+...++....|-.+|...+.|.||++|..|.++..+|+.||-|
T Consensus 423 ~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaC 502 (732)
T KOG0614|consen 423 KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEAC 502 (732)
T ss_pred hhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhh
Confidence 34457899999999988655433 48888888765 34455666778999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC
Q 046265 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 625 (639)
-||.+...++.++..+. .++.-++..+.+|++|||+. +||+||+||+|.++|.+|.+|+.|||+|+.+......
T Consensus 503 lGGElWTiLrdRg~Fdd---~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 503 LGGELWTILRDRGSFDD---YTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred cCchhhhhhhhcCCccc---chhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence 99999999998776444 77777889999999999999 9999999999999999999999999999998765444
Q ss_pred cceeeeeceeeCCC
Q 046265 626 WSEFVGTFGYVAPI 639 (639)
Q Consensus 626 ~~~~~gt~~Y~APE 639 (639)
.++||||.|.|||
T Consensus 577 -wTFcGTpEYVAPE 589 (732)
T KOG0614|consen 577 -WTFCGTPEYVAPE 589 (732)
T ss_pred -eeecCCcccccch
Confidence 4699999999998
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=204.07 Aligned_cols=171 Identities=23% Similarity=0.432 Sum_probs=139.6
Q ss_pred cCCCcceeccCCCceEEEEEcCC--CcEEEEEEccCCC--------CChhhHHHHHHHHHHHhc-cccCceeeeEEEEEc
Q 046265 466 NFDAKYCIGTAGQASVYKAELPS--WEIVAVKKFHSPH--------PDMVVQQAFSNEIKALTE-LRHRNVVKFYGFSFH 534 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~ 534 (639)
+|+..+.||+|+||.||+|.... ++.+|||.+.... .......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46778899999999999997654 6889999886432 112233456788888865 799999999999999
Q ss_pred CCceeEEecccCCCChhHHhhcC-CCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 046265 535 PRQSFLLYEYLGRGSLAIILSND-AAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDF 613 (639)
Q Consensus 535 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~Df 613 (639)
++..++||||+++++|.+++... .....+++..++.++.|++.|++|+|+.. +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887532 12235788899999999999999999632 7999999999999999999999999
Q ss_pred cccccCCCCCCCcceeeeeceeeCCC
Q 046265 614 GISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 614 Gla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|.+....... ......|+..|+|||
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe 183 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPE 183 (269)
T ss_pred cceeeccccc-ccccccCcccCcChh
Confidence 9998765432 334467899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=203.20 Aligned_cols=160 Identities=28% Similarity=0.348 Sum_probs=137.6
Q ss_pred eccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCCCh
Q 046265 473 IGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550 (639)
Q Consensus 473 ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 550 (639)
||+|++|.||+|... +++.||+|.+..... .....+.+.+|+.++++++||||+++++++.++...|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999654 578999999875432 223456789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcceee
Q 046265 551 AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFV 630 (639)
Q Consensus 551 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 630 (639)
.+++.... .+++..+..++.+++.|++|+|.. +++|+||+|+||+++.++.+|++|||+++...... ......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~ 153 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC 153 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence 99997643 367788999999999999999998 99999999999999999999999999998765432 223357
Q ss_pred eeceeeCCC
Q 046265 631 GTFGYVAPI 639 (639)
Q Consensus 631 gt~~Y~APE 639 (639)
|++.|+|||
T Consensus 154 ~~~~~~~PE 162 (262)
T cd05572 154 GTPEYVAPE 162 (262)
T ss_pred CCcCccChh
Confidence 899999998
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=214.67 Aligned_cols=150 Identities=19% Similarity=0.261 Sum_probs=126.8
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChh-hHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMV-VQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
..-|...+.||-|+||+|.+++. ++...||.|.+++.+.-.. .....+.|=.||+....+.||++|-.|++.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 34466677899999999999954 4556799999987653222 223456788999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
|||++||++..+|-.-+. +++..+.-++.+++.|+++.|.. |.|||||||+|||||.+|++|++|||++.-+
T Consensus 708 MdYIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EeccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccc
Confidence 999999999999876554 45577777888999999999999 9999999999999999999999999998754
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-23 Score=213.19 Aligned_cols=169 Identities=25% Similarity=0.364 Sum_probs=139.9
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC-----Cc
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP-----RQ 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 537 (639)
.++|.....||+|+||.||+|. ..+++.||||++............+.+|+.++++++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4568888999999999999995 45789999999875433333345667899999999999999999988654 34
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.|+||||+. ++|.+++...+ .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 68888886543 477899999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCCcceeeeeceeeCCC
Q 046265 618 FLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~~~~~~gt~~Y~APE 639 (639)
.............|+..|+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE 178 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPE 178 (337)
T ss_pred ccCCCcccccccccccCccChH
Confidence 7654323334457899999998
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=207.06 Aligned_cols=160 Identities=28% Similarity=0.394 Sum_probs=137.7
Q ss_pred ceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCCC
Q 046265 471 YCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGS 549 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 549 (639)
..||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++..++..|+||||+++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 5799999999999965 578999999986432 2345678899999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCccee
Q 046265 550 LAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEF 629 (639)
Q Consensus 550 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 629 (639)
|.+++... .+++.....++.|++.|++|+|.. +++||||+|+||+++.++.++++|||++.............
T Consensus 104 L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 104 LTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence 99987543 367888999999999999999998 99999999999999999999999999987664333333446
Q ss_pred eeeceeeCCC
Q 046265 630 VGTFGYVAPI 639 (639)
Q Consensus 630 ~gt~~Y~APE 639 (639)
.|++.|+|||
T Consensus 177 ~~~~~y~~pE 186 (292)
T cd06657 177 VGTPYWMAPE 186 (292)
T ss_pred ccCccccCHH
Confidence 7899999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=186.55 Aligned_cols=165 Identities=23% Similarity=0.322 Sum_probs=131.9
Q ss_pred cceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEEecccCC
Q 046265 470 KYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
...||+|+||.|-+-+ ..+|+.+|||+++.+-. ...+.+..+|+.+..+. ..|.+|++||.+.+.+.+|+.||.|.
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~- 128 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD- 128 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-
Confidence 4679999999998875 46789999999987543 34566678888887664 79999999999999999999999994
Q ss_pred CChhHHhhcC-CCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCc
Q 046265 548 GSLAIILSND-AAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW 626 (639)
Q Consensus 548 g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 626 (639)
.++..+-++. ......++...-+||..+..||.|||++- .|||||+||+|||++.+|++|+||||.+..+...- ..
T Consensus 129 tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi-Ak 205 (282)
T KOG0984|consen 129 TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI-AK 205 (282)
T ss_pred hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhh-HH
Confidence 4665443221 11134666778889999999999999875 79999999999999999999999999998776322 22
Q ss_pred ceeeeeceeeCCC
Q 046265 627 SEFVGTFGYVAPI 639 (639)
Q Consensus 627 ~~~~gt~~Y~APE 639 (639)
+--+|...|||||
T Consensus 206 t~daGCkpYmaPE 218 (282)
T KOG0984|consen 206 TMDAGCKPYMAPE 218 (282)
T ss_pred HHhcCCCccCChh
Confidence 2257889999998
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=213.69 Aligned_cols=169 Identities=21% Similarity=0.333 Sum_probs=139.8
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc----CCce
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH----PRQS 538 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~ 538 (639)
.++|+..+.||+|++|.||+|. ..+++.||+|++............+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 4678888999999999999995 4568999999987644333345567789999999999999999998764 3467
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
|+||||++ |++.+++.... .+++..+..++.|+++|++|||.. +|+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999995 68988886543 378899999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCC----CcceeeeeceeeCCC
Q 046265 619 LKPDSS----NWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~----~~~~~~gt~~Y~APE 639 (639)
...... .....+|+..|+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE 181 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPE 181 (334)
T ss_pred ecccCcCCCcccccccccccccChH
Confidence 543221 112457899999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=205.00 Aligned_cols=167 Identities=27% Similarity=0.408 Sum_probs=140.4
Q ss_pred CCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--CceeEEec
Q 046265 467 FDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQSFLLYE 543 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 543 (639)
|+..+.||+|++|.||+|... +++.+|||++............+.+|++++++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456788999999999999655 578999999986543334456788999999999999999999999988 78999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++ ++.+++.... ..+++..+..++.++++|++|||.. +++|+||||+||++++++.+|++|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9974 8888886543 3578899999999999999999998 99999999999999999999999999998765432
Q ss_pred C-CcceeeeeceeeCCC
Q 046265 624 S-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~-~~~~~~gt~~Y~APE 639 (639)
. ......++..|+|||
T Consensus 155 ~~~~~~~~~~~~y~~PE 171 (287)
T cd07840 155 SADYTNRVITLWYRPPE 171 (287)
T ss_pred cccccccccccccCCce
Confidence 1 123346788999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-23 Score=211.09 Aligned_cols=169 Identities=24% Similarity=0.288 Sum_probs=140.8
Q ss_pred HhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC--Chhh----HHHHHHHHHHHhccc---cCceeeeEEEE
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP--DMVV----QQAFSNEIKALTELR---HRNVVKFYGFS 532 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~----~~~~~~e~~~l~~l~---H~niv~l~~~~ 532 (639)
...+|.....+|+|+||+|+.|.++ ...+|+||.+.+.+. +... ....-.||++|+.++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3456777889999999999999554 457799999886541 1111 122467999999997 99999999999
Q ss_pred EcCCceeEEeccc-CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 046265 533 FHPRQSFLLYEYL-GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVS 611 (639)
Q Consensus 533 ~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~ 611 (639)
++++..|++||-. ++-+|++++.-+. .+++..+..|++||+.|+++||.. +|||||||-+|+.++.+|-+|++
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence 9999999999964 5678999997654 466689999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCCCcceeeeeceeeCCC
Q 046265 612 DFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 612 DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|||.|...... .-..++||.+|.|||
T Consensus 713 dfgsaa~~ksg--pfd~f~gtv~~aape 738 (772)
T KOG1152|consen 713 DFGSAAYTKSG--PFDVFVGTVDYAAPE 738 (772)
T ss_pred eccchhhhcCC--Ccceeeeeccccchh
Confidence 99998866533 234689999999998
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.7e-23 Score=217.34 Aligned_cols=174 Identities=17% Similarity=0.238 Sum_probs=130.9
Q ss_pred HhccCCCcceeccCCCceEEEEEc-----------------CCCcEEEEEEccCCCCCh------------hhHHHHHHH
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL-----------------PSWEIVAVKKFHSPHPDM------------VVQQAFSNE 513 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~-----------------~~~~~vavK~~~~~~~~~------------~~~~~~~~e 513 (639)
..++|+..++||+|+||.||+|.. ..++.||||++....... ...+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999953 234679999987532110 011223457
Q ss_pred HHHHhccccCce-----eeeEEEEEc--------CCceeEEecccCCCChhHHhhcCCC---------------------
Q 046265 514 IKALTELRHRNV-----VKFYGFSFH--------PRQSFLLYEYLGRGSLAIILSNDAA--------------------- 559 (639)
Q Consensus 514 ~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------- 559 (639)
+..+.+++|.++ ++++++|.. .+..|+||||+++|+|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 677777753 3568999999999999999874311
Q ss_pred CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC-CcceeeeeceeeCC
Q 046265 560 IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS-NWSEFVGTFGYVAP 638 (639)
Q Consensus 560 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~gt~~Y~AP 638 (639)
...++|..+..++.|+++|++|+|.. +|+||||||+||+++.++.+||+|||+++.+..... ......+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356788889999999999999998 899999999999999999999999999976543221 11123458899999
Q ss_pred C
Q 046265 639 I 639 (639)
Q Consensus 639 E 639 (639)
|
T Consensus 380 E 380 (507)
T PLN03224 380 E 380 (507)
T ss_pred h
Confidence 8
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=209.88 Aligned_cols=170 Identities=25% Similarity=0.390 Sum_probs=141.5
Q ss_pred HHHHHhccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc-CC
Q 046265 459 EVIRATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH-PR 536 (639)
Q Consensus 459 ~~~~~~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~ 536 (639)
++...+++|+..+.||+|+||.||+|. ..+++.||||++..........+.+.+|++++++++||||++++++|.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 445678899999999999999999995 5578999999987543333345667889999999999999999999876 45
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
..|+||||+ ++++..+++.. .+++.....++.|+++|++|||.. +|+||||||+||+++.++.+|++|||.+
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence 789999998 56888887642 356677888999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCCcceeeeeceeeCCC
Q 046265 617 KFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
...... .....+++.|+|||
T Consensus 156 ~~~~~~---~~~~~~~~~y~aPE 175 (328)
T cd07856 156 RIQDPQ---MTGYVSTRYYRAPE 175 (328)
T ss_pred cccCCC---cCCCcccccccCce
Confidence 765322 23356788999998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=200.24 Aligned_cols=168 Identities=28% Similarity=0.391 Sum_probs=146.0
Q ss_pred cCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--CceeEEe
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQSFLLY 542 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 542 (639)
+|+..+.||+|++|.||+|... +++.|++|.+..........+.+.+|+..+++++||||+++++++... +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999665 788999999876554345567889999999999999999999999988 8899999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++++|.+++.... .++|..+..++.++++|++|||+. +++|+|++|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999997654 578899999999999999999997 9999999999999999999999999999876544
Q ss_pred CC--CcceeeeeceeeCCC
Q 046265 623 SS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~--~~~~~~gt~~Y~APE 639 (639)
.. ......++..|+|||
T Consensus 155 ~~~~~~~~~~~~~~y~~pE 173 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPE 173 (260)
T ss_pred cccccccCCCCCccccCHh
Confidence 32 123457889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=204.88 Aligned_cols=169 Identities=27% Similarity=0.333 Sum_probs=139.7
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--CceeEE
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQSFLL 541 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv 541 (639)
++|...+.||.|++|.||+|.. .+++.+|+|.+..... ......+.+|++++++++||||++++++|... +..|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 3577788999999999999976 4678899999875432 24456788999999999999999999998654 468999
Q ss_pred ecccCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 542 YEYLGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
|||+++++|.+++.... ....+++.....++.+++.|++|+|.. +++|+|++|+||+++.++.+|++|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999998875422 223467888999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
.... ....++..|+|||
T Consensus 157 ~~~~--~~~~~~~~y~~pE 173 (287)
T cd06621 157 NSLA--GTFTGTSFYMAPE 173 (287)
T ss_pred cccc--ccccCCccccCHH
Confidence 3221 2356788999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-24 Score=221.32 Aligned_cols=168 Identities=29% Similarity=0.424 Sum_probs=145.8
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|.....+|.|.||.||||+ .+.++..|||.++....+. -....+|+-+++..+|||||.++|.|...+..|+.|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 4567778899999999999995 5678999999988654322 234567999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
|||.+|+|.++-+.-+. ++..+...++++..+|++|+|.. +-+|||||-.||++.+.|.+|++|||.+..++..
T Consensus 92 EycgggslQdiy~~Tgp---lselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceeeeccc---chhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999988765443 56678888999999999999998 7789999999999999999999999999988765
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
-.....+.||++|||||
T Consensus 166 i~KrksfiGtpywmapE 182 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPE 182 (829)
T ss_pred hhhhhcccCCccccchh
Confidence 55567799999999998
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=203.37 Aligned_cols=164 Identities=23% Similarity=0.308 Sum_probs=134.6
Q ss_pred CCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcC--CceeEEe
Q 046265 467 FDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHP--RQSFLLY 542 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~ 542 (639)
|+..+.||+|+||.||+|.. .+++.||||+++...... ......+|+..+.++. ||||+++++++.++ +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 45678899999999999964 568899999987543222 2233457899998885 99999999999987 8899999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||++ |++.+.+.... ..++|..+..++.|++.|++|||.. +|+||||||+||+++. +.+||+|||+++.+...
T Consensus 80 e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 80 ELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred ecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 9997 57777776533 3578999999999999999999998 9999999999999999 99999999999876433
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
.. .....+++.|+|||
T Consensus 153 ~~-~~~~~~~~~y~aPE 168 (282)
T cd07831 153 PP-YTEYISTRWYRAPE 168 (282)
T ss_pred CC-cCCCCCCcccCChh
Confidence 22 23356889999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=205.25 Aligned_cols=163 Identities=27% Similarity=0.400 Sum_probs=137.0
Q ss_pred CCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 467 FDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
|+..+.||+|+||.||+|.. .+++.||+|++..... .......+.+|++++++++|||++++++++.+++..|+||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 56678899999999999964 5678999999875432 223345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
++ |++.+.+.... ..++|..+..++.+++.|+.|||.. +|+||||+|+||+++.++.+|++|||++......
T Consensus 107 ~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 97 47777765433 2478899999999999999999998 9999999999999999999999999998754322
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
....|++.|+|||
T Consensus 179 --~~~~~~~~y~aPE 191 (317)
T cd06635 179 --NSFVGTPYWMAPE 191 (317)
T ss_pred --ccccCCccccChh
Confidence 2356889999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=210.53 Aligned_cols=167 Identities=24% Similarity=0.387 Sum_probs=137.5
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC-----c
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR-----Q 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~ 537 (639)
.++|+..+.||+|+||.||+|. ..+++.||||++.... .......+.+|+.++++++||||+++++++.... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 4678889999999999999995 4578999999986432 2233456788999999999999999999876543 4
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.|+||||++ +++.+++... .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 83 VYIVQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEEehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 799999996 4787777542 478889999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCC---CcceeeeeceeeCCC
Q 046265 618 FLKPDSS---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~---~~~~~~gt~~Y~APE 639 (639)
....... ......||+.|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE 179 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPE 179 (336)
T ss_pred eccccccccCCcCCcCcCCCccChH
Confidence 6543221 123357899999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=197.54 Aligned_cols=166 Identities=30% Similarity=0.453 Sum_probs=144.3
Q ss_pred cCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
.|+..+.||+|++|.||+|... +++.+|+|++..... .....+.+|++.+++++||||+++++++..++..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 3667789999999999999765 688999999976432 3456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++++|.+++.... ..+++..+..++.+++.|++|+|.. +++||||+|+||++++++.+||+|||.+........
T Consensus 79 ~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 79 CSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 99999999987643 3578899999999999999999997 999999999999999999999999999987654332
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
.....|+..|+|||
T Consensus 154 -~~~~~~~~~~~~PE 167 (253)
T cd05122 154 -RNTMVGTPYWMAPE 167 (253)
T ss_pred -ccceecCCcccCHH
Confidence 34467899999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=203.56 Aligned_cols=161 Identities=27% Similarity=0.360 Sum_probs=137.0
Q ss_pred eccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCCCh
Q 046265 473 IGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550 (639)
Q Consensus 473 ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 550 (639)
||+|+||.||+|... +++.||+|.+..... .....+.+.+|++++++++||||+++++.+..++..|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999766 489999999875432 123456788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC------
Q 046265 551 AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS------ 624 (639)
Q Consensus 551 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~------ 624 (639)
.++++..+ .+++..+..++.|+++|++|+|.. +++||||+|+||+++.++.+|++|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99997644 478899999999999999999998 999999999999999999999999999876533211
Q ss_pred --CcceeeeeceeeCCC
Q 046265 625 --NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 --~~~~~~gt~~Y~APE 639 (639)
......++..|+|||
T Consensus 155 ~~~~~~~~~~~~~~~Pe 171 (265)
T cd05579 155 EKEDKRIVGTPDYIAPE 171 (265)
T ss_pred cccccCcccCccccCHH
Confidence 223456888999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=221.41 Aligned_cols=258 Identities=27% Similarity=0.313 Sum_probs=149.7
Q ss_pred cceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCE
Q 046265 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQ 82 (639)
Q Consensus 3 ~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 82 (639)
|..-....++++.+++. .+|+.+. ++|+.|++++|+++ .+|.. +++|++|+|++|+|+ .+|.. .++|+.
T Consensus 198 Cl~~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~ 266 (788)
T PRK15387 198 CLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLE 266 (788)
T ss_pred HhcCCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccce
Confidence 54445556778888776 5777775 37888888888887 45642 578888888888887 46643 357788
Q ss_pred EeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCcc
Q 046265 83 LVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPI 162 (639)
Q Consensus 83 L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 162 (639)
|++++|.++. +|..+.+ |..|++++|+++ .+|.. +++|+.|+|++|++++ +|..
T Consensus 267 L~Ls~N~L~~-Lp~lp~~--------------------L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l 320 (788)
T PRK15387 267 LSIFSNPLTH-LPALPSG--------------------LCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL 320 (788)
T ss_pred eeccCCchhh-hhhchhh--------------------cCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC
Confidence 8888888773 4432221 246778888887 45542 4678888888888875 4442
Q ss_pred ccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceecc
Q 046265 163 LGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHL 242 (639)
Q Consensus 163 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L 242 (639)
. .+|+.|++++|.+++ +|... . +|+.|++++|++.+ +|.. .++|+.|++
T Consensus 321 p---~~L~~L~Ls~N~L~~-LP~lp---~--------------------~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~L 369 (788)
T PRK15387 321 P---SELCKLWAYNNQLTS-LPTLP---S--------------------GLQELSVSDNQLAS-LPTL---PSELYKLWA 369 (788)
T ss_pred c---ccccccccccCcccc-ccccc---c--------------------ccceEecCCCccCC-CCCC---Ccccceehh
Confidence 2 356677788887763 34211 2 34455555555543 3332 234455555
Q ss_pred ccccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCe
Q 046265 243 EQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNY 322 (639)
Q Consensus 243 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~ 322 (639)
++|++++ +|.. ..+|+.|++++|.+. .+|.. ..+|+.|++++|++.+ +|..+ .+|+.
T Consensus 370 s~N~L~~-LP~l---~~~L~~LdLs~N~Lt------------~LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~ 426 (788)
T PRK15387 370 YNNRLTS-LPAL---PSGLKELIVSGNRLT------------SLPVL---PSELKELMVSGNRLTS-LPMLP---SGLLS 426 (788)
T ss_pred hcccccc-Cccc---ccccceEEecCCccc------------CCCCc---ccCCCEEEccCCcCCC-CCcch---hhhhh
Confidence 5565554 2221 234555555544442 23321 1345555555555542 34322 23455
Q ss_pred eeccCccCcccCCcCccCCCCCCEEeCCCC
Q 046265 323 RALNGNKVYGSLPRVLGSISDLEYLDLSTN 352 (639)
Q Consensus 323 L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 352 (639)
|++++|.++ .+|..++.+++|+.|+|++|
T Consensus 427 L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N 455 (788)
T PRK15387 427 LSVYRNQLT-RLPESLIHLSSETTVNLEGN 455 (788)
T ss_pred hhhccCccc-ccChHHhhccCCCeEECCCC
Confidence 555555555 45555555555555555553
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-21 Score=230.19 Aligned_cols=318 Identities=19% Similarity=0.210 Sum_probs=180.1
Q ss_pred cccccCCccccCCC-CCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccC
Q 046265 17 TLFAIIPPQIGNIS-NLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLP 95 (639)
Q Consensus 17 ~~~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 95 (639)
++...+|..+..++ +|+.|++.++.+. .+|..| ...+|+.|+|++|++. .+|..+..+++|+.|+|+++...+.+|
T Consensus 575 ~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip 651 (1153)
T PLN03210 575 EVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP 651 (1153)
T ss_pred cceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC
Confidence 34456777777664 5899999998886 678777 5688999999999887 688888889999999998776444555
Q ss_pred ccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcc
Q 046265 96 SSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFD 175 (639)
Q Consensus 96 ~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 175 (639)
. ++.+++| ++|+|++|.....+|..+.++++|+.|++++|...+.+|..+ ++++|+.|+++
T Consensus 652 ~-ls~l~~L-----------------e~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Ls 712 (1153)
T PLN03210 652 D-LSMATNL-----------------ETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLS 712 (1153)
T ss_pred c-cccCCcc-----------------cEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCC
Confidence 3 4444433 456666554444556666666666666666654444555443 45666666666
Q ss_pred cCcCCccCCccCcCCCCCCeEEccCCcc---ccccccccCCcEEEcCCccc-------CCCCCccccCCCCCceeccccc
Q 046265 176 LNLLNGVLPPSISNLSNLEGLYLYSSLV---SAEIGNLLQLIELEIDNKQL-------FGQIPKSLRNFTSLNIVHLEQN 245 (639)
Q Consensus 176 ~N~l~~~~p~~~~~l~~L~~L~l~~~~~---~~~~~~l~~L~~L~l~~n~l-------~~~~p~~~~~l~~L~~L~L~~N 245 (639)
+|...+.+|.. ..+|+.|+++.+.+ |..+ .+++|..|.+.++.. ....|......++|+.|++++|
T Consensus 713 gc~~L~~~p~~---~~nL~~L~L~~n~i~~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n 788 (1153)
T PLN03210 713 GCSRLKSFPDI---STNISWLDLDETAIEEFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDI 788 (1153)
T ss_pred CCCCccccccc---cCCcCeeecCCCccccccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCC
Confidence 65444444432 23555555554332 2222 244455555544221 1111111222345666666666
Q ss_pred cccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeec
Q 046265 246 HLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRAL 325 (639)
Q Consensus 246 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l 325 (639)
...+.+|..++.+++|+.|++++|... +.+|..+ .+++|+.|++++|.....+|.. .++|+.|+|
T Consensus 789 ~~l~~lP~si~~L~~L~~L~Ls~C~~L-----------~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 789 PSLVELPSSIQNLHKLEHLEIENCINL-----------ETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred CCccccChhhhCCCCCCEEECCCCCCc-----------CeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 555555666666666666665554321 2344433 4556666666665443333332 235556666
Q ss_pred cCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCC
Q 046265 326 NGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVIT 379 (639)
Q Consensus 326 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n 379 (639)
++|.+. .+|..+..+++|+.|+++++ +.+ ..+|..+..+++|+.++++++
T Consensus 854 s~n~i~-~iP~si~~l~~L~~L~L~~C--~~L-~~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 854 SRTGIE-EVPWWIEKFSNLSFLDMNGC--NNL-QRVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred CCCCCc-cChHHHhcCCCCCEEECCCC--CCc-CccCcccccccCCCeeecCCC
Confidence 666655 45555666666666666553 222 224444555555555555443
|
syringae 6; Provisional |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=202.03 Aligned_cols=169 Identities=25% Similarity=0.338 Sum_probs=144.1
Q ss_pred cCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+|+..+.||+|++|.||+|. ..+++.+|+|++............+.+|+.++++++||||+++++++......|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 46778899999999999994 45778999999876543444556788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 545 LGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 545 ~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
+++++|.+++.... ....+++..++.++.+++.|++|+|.. +++||||+|+||+++.++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999986532 124578899999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
......|++.|+|||
T Consensus 157 -~~~~~~~~~~~~~Pe 171 (256)
T cd08530 157 -MAKTQIGTPHYMAPE 171 (256)
T ss_pred -CcccccCCccccCHH
Confidence 222356889999998
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-23 Score=203.46 Aligned_cols=170 Identities=28% Similarity=0.387 Sum_probs=136.9
Q ss_pred cCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCC-CC----hhhHHHHHHHHHHHhccccCceeeeEEEEEc-CCce
Q 046265 466 NFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPH-PD----MVVQQAFSNEIKALTELRHRNVVKFYGFSFH-PRQS 538 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~-~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~ 538 (639)
+|-....+|+|||+.||+| ++...+.||||.-.... +. ........+|.++.+.+.||.||++|+|+.- .+..
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 3344568999999999999 56666789999654321 11 1122334689999999999999999999974 4678
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEEccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG---LDYDAHVSDFGI 615 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~---~~~~~kl~DfGl 615 (639)
+-|.|||+|.+|+-+++.++. ++...+..|+.||..||.||... .|+|||-|+||.|||+- .-|.+||+|||+
T Consensus 544 CTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred eeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 899999999999999987754 56688999999999999999865 57999999999999994 458899999999
Q ss_pred cccCCCCCCC-------cceeeeeceeeCCC
Q 046265 616 SKFLKPDSSN-------WSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~~-------~~~~~gt~~Y~APE 639 (639)
++.|..+... .+..+||.+|++||
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPE 650 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPE 650 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcc
Confidence 9998754322 34578999999998
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=210.02 Aligned_cols=167 Identities=24% Similarity=0.393 Sum_probs=142.0
Q ss_pred cCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC-----cee
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR-----QSF 539 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~ 539 (639)
+|+..+.||+|++|.||+|... +++.||||++..........+.+.+|+.+++.++||||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4777889999999999999764 5889999999865433445567899999999999999999999998775 789
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||++ +++.+++.... .+++..+..++.+++.|++|||.. +|+||||||+||+++.++.++++|||.+...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 58888886543 578899999999999999999998 9999999999999999999999999999876
Q ss_pred CCCC---CCcceeeeeceeeCCC
Q 046265 620 KPDS---SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~---~~~~~~~gt~~Y~APE 639 (639)
.... .......+++.|+|||
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE 176 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPE 176 (330)
T ss_pred cccccccccccccccccCcCCce
Confidence 5432 1233457899999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=208.69 Aligned_cols=164 Identities=23% Similarity=0.356 Sum_probs=135.7
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC------
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR------ 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 536 (639)
.++|.....||+|+||.||+|.. .+++.||||++............+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47888889999999999999964 57899999998754333333456789999999999999999999987543
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
..|+|+||+.. ++..+.. ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+|++|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 45899999964 6766542 2477888999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCCcceeeeeceeeCCC
Q 046265 617 KFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+..... .....|++.|+|||
T Consensus 165 ~~~~~~---~~~~~~~~~y~aPE 184 (342)
T cd07879 165 RHADAE---MTGYVVTRWYRAPE 184 (342)
T ss_pred cCCCCC---CCCceeeecccChh
Confidence 865322 23457899999998
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=202.88 Aligned_cols=165 Identities=19% Similarity=0.316 Sum_probs=134.0
Q ss_pred ceeccCCCceEEEEEcCC-------CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 471 YCIGTAGQASVYKAELPS-------WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
+.||+|+||.||+|...+ ++.+|||.+.... .......+.+|+.++++++||||++++++|...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999996532 2579999886532 12345678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCC----CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-----ceEEcccc
Q 046265 544 YLGRGSLAIILSNDA----AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY-----DAHVSDFG 614 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~-----~~kl~DfG 614 (639)
|+++|+|.+++.... ....++|..+..++.+++.|++|+|.. +++|+||||+||+++.++ .+|++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 999999999997532 123478899999999999999999988 899999999999999877 89999999
Q ss_pred ccccCCCCCC--CcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
+++....... ......++..|+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE 183 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPE 183 (269)
T ss_pred cccccccccccccCcccCCCccccCHH
Confidence 9986532211 112234567899998
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=205.23 Aligned_cols=168 Identities=24% Similarity=0.326 Sum_probs=134.6
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCceeEEec
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 543 (639)
+|...+.||+|+||.||++.. .+++.||||++...... .....+.+|+.++.++. ||||+++++++..++..+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 455567899999999999954 56799999998754322 44567889999999996 9999999999999999999999
Q ss_pred ccCCCChhHHh---hcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 544 YLGRGSLAIIL---SNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 544 ~~~~g~L~~~l---~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
|++. ++.++. .... ...+++..+..++.+++.|++|+|+.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~~-~l~~l~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVL-KSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9864 444332 2211 135788999999999999999999743 89999999999999999999999999997654
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
.... .....|++.|+|||
T Consensus 160 ~~~~-~~~~~~~~~y~aPE 177 (288)
T cd06616 160 DSIA-KTRDAGCRPYMAPE 177 (288)
T ss_pred cCCc-cccccCccCccCHH
Confidence 3221 23346899999998
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=204.71 Aligned_cols=169 Identities=25% Similarity=0.393 Sum_probs=143.3
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCceeEE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv 541 (639)
++|...+.||+|++|.||+|... +++.||+|.+..... .....+.+.+|+.++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36778889999999999999654 789999999875322 2233466788999999998 99999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++++|.+++...+ .+++..+..++.|++.|++|||.. +++|+|++|+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999997653 588899999999999999999998 999999999999999999999999999886543
Q ss_pred CC--------------------CCcceeeeeceeeCCC
Q 046265 622 DS--------------------SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~--------------------~~~~~~~gt~~Y~APE 639 (639)
.. .......|+..|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe 192 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPE 192 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHH
Confidence 22 1122356789999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=204.39 Aligned_cols=167 Identities=27% Similarity=0.396 Sum_probs=141.9
Q ss_pred CCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEeccc
Q 046265 467 FDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYL 545 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 545 (639)
|+....||+|++|.||+|... +++.||+|.+..........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999655 5899999999865433344566788999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC
Q 046265 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 625 (639)
+ ++|.+++.... ..+++..+..++.+++.|++|||.. +|+||||+|+||++++++.+||+|||.++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 7 58999997653 3578899999999999999999998 9999999999999999999999999999876543333
Q ss_pred cceeeeeceeeCCC
Q 046265 626 WSEFVGTFGYVAPI 639 (639)
Q Consensus 626 ~~~~~gt~~Y~APE 639 (639)
.....++..|+|||
T Consensus 155 ~~~~~~~~~~~aPE 168 (282)
T cd07829 155 YTHEVVTLWYRAPE 168 (282)
T ss_pred cCccccCcCcCChH
Confidence 33456678899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-23 Score=196.51 Aligned_cols=170 Identities=22% Similarity=0.264 Sum_probs=144.7
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 540 (639)
.++|+..++||+|+|++|..++++ +.+.+|+|.+++.-. +...-+....|-.+..+. +||.+|.++.+|+....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467888999999999999999765 558899999886432 222334556676666655 79999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
|.||++||+|.-++++++. ++...+.-+..+|+-||.|||.. +||.||+|..|+|+|.+|++|++|+|.++.--
T Consensus 329 vieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999888877665 55577777888999999999999 99999999999999999999999999999866
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
.+....+++||||-|+|||
T Consensus 403 ~~gd~tstfcgtpnyiape 421 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPE 421 (593)
T ss_pred CCCcccccccCCCcccchh
Confidence 6666778899999999998
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=207.14 Aligned_cols=167 Identities=22% Similarity=0.361 Sum_probs=135.0
Q ss_pred cCCCcceeccCCCceEEEEEcC-C--CcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcC----Cc
Q 046265 466 NFDAKYCIGTAGQASVYKAELP-S--WEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHP----RQ 537 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~----~~ 537 (639)
+|+..+.||+|+||.||+|+.. + ++.||||++..........+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4667889999999999999654 3 67899999875433333455678899999998 599999999876533 45
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.|+++||++ ++|.+.+.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788999986 68888886543 477899999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCC----CcceeeeeceeeCCC
Q 046265 618 FLKPDSS----NWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~----~~~~~~gt~~Y~APE 639 (639)
....... ......||+.|+|||
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE 179 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPE 179 (332)
T ss_pred ecccccccccccccCcccCccccCcH
Confidence 6543211 123457899999998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=206.32 Aligned_cols=164 Identities=18% Similarity=0.228 Sum_probs=133.3
Q ss_pred ceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCCCh
Q 046265 471 YCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 550 (639)
+.+|.|+++.||++.. +++.||||++..........+.+.+|++++++++||||+++++++...+..|++|||+++|++
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3445555555555544 689999999986533444566789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC------
Q 046265 551 AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS------ 624 (639)
Q Consensus 551 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~------ 624 (639)
.+++..... ..+++.....++.|+++|++|||.. +|+||||||+||+++.++.+|++|||.+..+.....
T Consensus 87 ~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 999976432 3477888889999999999999998 999999999999999999999999998875532211
Q ss_pred -CcceeeeeceeeCCC
Q 046265 625 -NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 -~~~~~~gt~~Y~APE 639 (639)
......++..|+|||
T Consensus 163 ~~~~~~~~~~~y~aPE 178 (314)
T cd08216 163 DFPKSSVKNLPWLSPE 178 (314)
T ss_pred cccccccccccccCHH
Confidence 122346788999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=206.57 Aligned_cols=164 Identities=20% Similarity=0.241 Sum_probs=134.3
Q ss_pred CcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChh------------hHHHHHHHHHHHhccccCceeeeEEEEEcC
Q 046265 469 AKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMV------------VQQAFSNEIKALTELRHRNVVKFYGFSFHP 535 (639)
Q Consensus 469 ~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 535 (639)
..+.||+|+||.||+|.. .+++.||||++........ ....+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 356799999999999964 4689999999875432110 112467899999999999999999999999
Q ss_pred CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGl 615 (639)
+..++||||++ |++.+++.... .+++.....++.|++.|++|||.. +|+||||||+||+++.++.+|++|||.
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccc
Confidence 99999999996 68988886543 467788999999999999999988 999999999999999999999999999
Q ss_pred cccCCC--------------CCCCcceeeeeceeeCCC
Q 046265 616 SKFLKP--------------DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~--------------~~~~~~~~~gt~~Y~APE 639 (639)
+..... .........+++.|+|||
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 203 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPE 203 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCCh
Confidence 876541 111122345788999998
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=206.07 Aligned_cols=165 Identities=19% Similarity=0.229 Sum_probs=133.8
Q ss_pred ceeccC--CCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCC
Q 046265 471 YCIGTA--GQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 471 ~~ig~g--~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
..||+| +||+||+|.. .+|+.||||.+..........+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 8999999965 5789999999876543344456788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCc-
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW- 626 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~- 626 (639)
|++.+++..... ..+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999876433 3478889999999999999999988 99999999999999999999999998654332111110
Q ss_pred ------ceeeeeceeeCCC
Q 046265 627 ------SEFVGTFGYVAPI 639 (639)
Q Consensus 627 ------~~~~gt~~Y~APE 639 (639)
....++..|||||
T Consensus 160 ~~~~~~~~~~~~~~y~aPE 178 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPE 178 (328)
T ss_pred ccccccccccCccCccChh
Confidence 1123566799998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=8e-22 Score=197.75 Aligned_cols=165 Identities=20% Similarity=0.291 Sum_probs=132.8
Q ss_pred HHHHHHhccCCCccee--ccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhc-cccCceeeeEEEEE
Q 046265 458 EEVIRATNNFDAKYCI--GTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTE-LRHRNVVKFYGFSF 533 (639)
Q Consensus 458 ~~~~~~~~~f~~~~~i--g~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~ 533 (639)
.+.....++|+..+.+ |+|+||.||++.. .+++.+|+|.+....... .|+..... .+||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEe
Confidence 3444445666666665 9999999999964 567889999987533211 12222221 27999999999999
Q ss_pred cCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEcc
Q 046265 534 HPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY-DAHVSD 612 (639)
Q Consensus 534 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~-~~kl~D 612 (639)
.++..|+||||+++|+|.+++.... .++|..+..++.|+++|++|+|.. +++||||||+||+++.++ .++++|
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence 9999999999999999999997653 578899999999999999999998 899999999999999988 999999
Q ss_pred ccccccCCCCCCCcceeeeeceeeCCC
Q 046265 613 FGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 613 fGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
||+++..... ....|++.|+|||
T Consensus 154 fg~~~~~~~~----~~~~~~~~y~aPE 176 (267)
T PHA03390 154 YGLCKIIGTP----SCYDGTLDYFSPE 176 (267)
T ss_pred CccceecCCC----ccCCCCCcccChh
Confidence 9998865422 2346899999998
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-23 Score=209.94 Aligned_cols=164 Identities=24% Similarity=0.465 Sum_probs=140.0
Q ss_pred CCCcceeccCCCceEEEEEcCCC-cEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEeccc
Q 046265 467 FDAKYCIGTAGQASVYKAELPSW-EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYL 545 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 545 (639)
......+|-|.||.||.|.++.. -.||||.++. +....++|..|+.+|+.++|||+|+++|+|......|||.|||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 34567899999999999987754 5699999974 3445678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC
Q 046265 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 625 (639)
..|.|-+++++-.. .+++.-..+.++.||+.|++||... .+||||+.+.|+|+.++..+||+|||+++.|+.+.
T Consensus 346 ~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-- 419 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-- 419 (1157)
T ss_pred cCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCc--
Confidence 99999999975332 3566677888999999999999998 88999999999999999999999999999998653
Q ss_pred cceeeee---ceeeCCC
Q 046265 626 WSEFVGT---FGYVAPI 639 (639)
Q Consensus 626 ~~~~~gt---~~Y~APE 639 (639)
++..+|. ..|.|||
T Consensus 420 YTAHAGAKFPIKWTAPE 436 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPE 436 (1157)
T ss_pred eecccCccCcccccCcc
Confidence 3334454 3588887
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=202.13 Aligned_cols=167 Identities=25% Similarity=0.382 Sum_probs=141.5
Q ss_pred CCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEeccc
Q 046265 467 FDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYL 545 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 545 (639)
|+..+.||+|++|.||+|.. .+++.+|+|++............+.+|+.++++++||||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45667899999999999965 46889999998765444345567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC
Q 046265 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 625 (639)
++ ++.+.+.... ..+++..+..++.++++|++|||.. +|+|+||||+||+++.++.+||+|||.+.........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 75 8888776543 3578899999999999999999998 9999999999999999999999999999877544322
Q ss_pred cceeeeeceeeCCC
Q 046265 626 WSEFVGTFGYVAPI 639 (639)
Q Consensus 626 ~~~~~gt~~Y~APE 639 (639)
.....++..|+|||
T Consensus 155 ~~~~~~~~~~~~PE 168 (283)
T cd05118 155 YTHYVVTRWYRAPE 168 (283)
T ss_pred ccCccCcccccCcH
Confidence 33356888999998
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.1e-22 Score=199.85 Aligned_cols=167 Identities=26% Similarity=0.404 Sum_probs=136.8
Q ss_pred CCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc---ccCceeeeEEEEEcCCc-----
Q 046265 467 FDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL---RHRNVVKFYGFSFHPRQ----- 537 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~----- 537 (639)
|+..+.||+|+||.||+|..+ +++.||||++............+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999765 489999999975443333345566788777655 59999999999998776
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.+++|||++ +++.+++..... ..++|..+..++.++++|++|||.. +++|+|++|+||+++.++.+|++|||.+.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 478888865432 3588999999999999999999998 89999999999999999999999999998
Q ss_pred cCCCCCCCcceeeeeceeeCCC
Q 046265 618 FLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~~~~~~gt~~Y~APE 639 (639)
...... ......++..|+|||
T Consensus 156 ~~~~~~-~~~~~~~~~~~~~PE 176 (287)
T cd07838 156 IYSFEM-ALTSVVVTLWYRAPE 176 (287)
T ss_pred eccCCc-ccccccccccccChH
Confidence 764332 223346888999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-22 Score=205.21 Aligned_cols=170 Identities=22% Similarity=0.345 Sum_probs=136.7
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC------
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR------ 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 536 (639)
.++|+..+.||+|+||.||+|.. .+++.||||++............+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46788889999999999999965 46789999998754332223345678999999999999999999876543
Q ss_pred --ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 046265 537 --QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614 (639)
Q Consensus 537 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfG 614 (639)
..|+||||+++ ++...+.... ..+++..+..++.|+++|++|+|.. +|+||||||+||++++++.+|++|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999965 6666665432 3588899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCC-----------CcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSS-----------NWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~-----------~~~~~~gt~~Y~APE 639 (639)
+++....... ......|++.|+|||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 196 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPE 196 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChH
Confidence 9986543211 112356789999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-22 Score=197.63 Aligned_cols=159 Identities=24% Similarity=0.267 Sum_probs=129.9
Q ss_pred ceeccCCCceEEEEEc-CCCcEEEEEEccCCCCC-hhhHHHHHHHHHHH-hccccCceeeeEEEEEcCCceeEEecccCC
Q 046265 471 YCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPD-MVVQQAFSNEIKAL-TELRHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
+.||+|+||.||+|.. .+++.||||.+...... ......+..|..++ ...+|||++++++++..++..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999965 46789999998754321 11223344555444 455899999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
++|.+++.... .+++..+..++.|++.|+.|+|.. +|+||||+|+||+++.++.+|++|||+++.... ..
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 151 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK 151 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence 99999997543 367788899999999999999998 999999999999999999999999999876432 22
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
...|++.|+|||
T Consensus 152 ~~~~~~~y~~pe 163 (260)
T cd05611 152 KFVGTPDYLAPE 163 (260)
T ss_pred cCCCCcCccChh
Confidence 356889999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-22 Score=202.80 Aligned_cols=168 Identities=23% Similarity=0.293 Sum_probs=139.3
Q ss_pred cCCCcceeccCCCceEEEEEc----CCCcEEEEEEccCCCC--ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCce
Q 046265 466 NFDAKYCIGTAGQASVYKAEL----PSWEIVAVKKFHSPHP--DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 538 (639)
+|+..+.||+|++|.||+|.. .+++.||||.++.... .....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366778999999999999863 3568899999875321 122345678899999999 599999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
++||||+++|+|.+++.... .+++..+..++.|+++|++|||.. +++||||||+||+++.++.++++|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999886543 467888899999999999999988 999999999999999999999999999887
Q ss_pred CCCCCCC-cceeeeeceeeCCC
Q 046265 619 LKPDSSN-WSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~~-~~~~~gt~~Y~APE 639 (639)
....... .....|++.|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE 176 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPE 176 (288)
T ss_pred cccccccccccccCCccccCHH
Confidence 5433221 22356899999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-22 Score=201.90 Aligned_cols=166 Identities=25% Similarity=0.405 Sum_probs=139.4
Q ss_pred CCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCceeEEecc
Q 046265 467 FDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
|...+.||+|++|.||+|... +++.||||++...... .......+|+..+++++ ||||+++++++..++..|+||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 456788999999999999765 5788999998754322 22334567999999999 99999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+ +|++.+.+..... ..++|..+..++.|++.|+.|||+. +++|+||+|+||++++++.++++|||+++......
T Consensus 80 ~-~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 80 M-EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred C-CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 9 8899988876542 3578999999999999999999998 99999999999999999999999999998764322
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......|+..|+|||
T Consensus 154 ~~~~~~~~~~~~aPE 168 (283)
T cd07830 154 PYTDYVSTRWYRAPE 168 (283)
T ss_pred CcCCCCCcccccCce
Confidence 223456889999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-24 Score=196.74 Aligned_cols=166 Identities=28% Similarity=0.388 Sum_probs=133.1
Q ss_pred CCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--------Cce
Q 046265 468 DAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--------RQS 538 (639)
Q Consensus 468 ~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------~~~ 538 (639)
.....||+|.||.||+|+.+ +|+.||+|+.-.............+|+.++..++|+|++.+++.|... ...
T Consensus 20 ek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ 99 (376)
T KOG0669|consen 20 EKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATF 99 (376)
T ss_pred HHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccccee
Confidence 33458999999999999654 567799988765433334445567899999999999999998887642 247
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
|+||++|+. +|+-++..... .++.....+++.++..||.|+|+. .|+|||+||+|+||+.+|.+|++|||+|+.
T Consensus 100 ylVf~~ceh-DLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 100 YLVFDFCEH-DLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeHHHhhh-hHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 999999975 88888876532 467788899999999999999999 999999999999999999999999999976
Q ss_pred CCCCC-C---CcceeeeeceeeCCC
Q 046265 619 LKPDS-S---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~-~---~~~~~~gt~~Y~APE 639 (639)
+.... . .++..+.|.+|.+||
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppE 198 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPE 198 (376)
T ss_pred eecccccCCCCcccceeeeecCCHH
Confidence 53221 1 234467799999998
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=199.72 Aligned_cols=163 Identities=28% Similarity=0.385 Sum_probs=135.9
Q ss_pred CCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 467 FDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
|...+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|++++++++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 44567899999999999965 4678999999875432 223345678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+. |++.+.+.... ..++|..+..++.|++.|++|||.. +|+||||||+||+++.++.+|++|||++.....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 57777765433 3478899999999999999999998 999999999999999999999999999865332
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
.....|+..|+|||
T Consensus 174 -~~~~~~~~~y~aPE 187 (313)
T cd06633 174 -ANSFVGTPYWMAPE 187 (313)
T ss_pred -CCCccccccccChh
Confidence 23457899999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-22 Score=195.15 Aligned_cols=161 Identities=25% Similarity=0.308 Sum_probs=138.0
Q ss_pred eccCCCceEEEEEcC-CCcEEEEEEccCCCCC-hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCCCh
Q 046265 473 IGTAGQASVYKAELP-SWEIVAVKKFHSPHPD-MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550 (639)
Q Consensus 473 ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 550 (639)
||+|+||.||+|... +++.+|+|.+...... ....+.+.+|+.++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999654 5889999998764322 22455788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcceee
Q 046265 551 AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFV 630 (639)
Q Consensus 551 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 630 (639)
.+++.... .+++.....++.|+++|+.|+|.. +++|+||+|+||+++.++.++++|||.+..............
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 99997653 478899999999999999999997 999999999999999999999999999987654322334467
Q ss_pred eeceeeCCC
Q 046265 631 GTFGYVAPI 639 (639)
Q Consensus 631 gt~~Y~APE 639 (639)
|+..|+|||
T Consensus 155 ~~~~~~~Pe 163 (250)
T cd05123 155 GTPEYLAPE 163 (250)
T ss_pred CCccccChH
Confidence 889999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-21 Score=212.41 Aligned_cols=261 Identities=27% Similarity=0.316 Sum_probs=198.8
Q ss_pred CCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccC
Q 046265 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSM 109 (639)
Q Consensus 30 ~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~l 109 (639)
.+-..|+|++|.++ .+|+.+. ++|+.|++++|+++ .+|.. +++|++|+|++|+++. +|..+.
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~lp~---------- 262 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVLPP---------- 262 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCccc----------
Confidence 45778999999998 6888776 48999999999998 57753 5789999999999984 454221
Q ss_pred CCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcC
Q 046265 110 PNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISN 189 (639)
Q Consensus 110 p~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 189 (639)
+|+.|++++|.++ .+|..+ ++|+.|++++|+++. +|.. +++|+.|++++|++++ +|...
T Consensus 263 ----------sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~-Lp~lp-- 321 (788)
T PRK15387 263 ----------GLLELSIFSNPLT-HLPALP---SGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPALP-- 321 (788)
T ss_pred ----------ccceeeccCCchh-hhhhch---hhcCEEECcCCcccc-cccc---ccccceeECCCCcccc-CCCCc--
Confidence 2258899999998 566533 678899999999984 5652 4689999999999985 34211
Q ss_pred CCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCC
Q 046265 190 LSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQN 269 (639)
Q Consensus 190 l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 269 (639)
.+|..|++++|++.+ +|.. ..+|+.|+|++|+|++.+ .. .++|+.|++++|
T Consensus 322 ---------------------~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~LP-~l---p~~L~~L~Ls~N 372 (788)
T PRK15387 322 ---------------------SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLASLP-TL---PSELYKLWAYNN 372 (788)
T ss_pred ---------------------ccccccccccCcccc-cccc---ccccceEecCCCccCCCC-CC---Ccccceehhhcc
Confidence 135566778888854 5642 257999999999999743 32 357888887777
Q ss_pred cccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeC
Q 046265 270 NFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDL 349 (639)
Q Consensus 270 ~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 349 (639)
++. .+|.. ..+|+.|++++|++.+ +|.. .++|+.|++++|+++ .+|... .+|+.|++
T Consensus 373 ~L~------------~LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~L 429 (788)
T PRK15387 373 RLT------------SLPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSV 429 (788)
T ss_pred ccc------------cCccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhh
Confidence 763 35543 2479999999999984 5643 357899999999998 477643 46889999
Q ss_pred CCCCCCcccccCChhhhccccCCeeeccCCcCceee
Q 046265 350 STNYNNEFRKEFPVELEKLVQLTELDLVITFWEERY 385 (639)
Q Consensus 350 s~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~ 385 (639)
++|++. .+|..+..+.+|+.+++++|.+++..
T Consensus 430 s~NqLt----~LP~sl~~L~~L~~LdLs~N~Ls~~~ 461 (788)
T PRK15387 430 YRNQLT----RLPESLIHLSSETTVNLEGNPLSERT 461 (788)
T ss_pred ccCccc----ccChHHhhccCCCeEECCCCCCCchH
Confidence 997644 57888999999999999999999765
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.2e-22 Score=198.31 Aligned_cols=170 Identities=21% Similarity=0.255 Sum_probs=135.8
Q ss_pred cCCCcceeccCCCceEEEEEcCC-CcEEEEEEccC---CCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 466 NFDAKYCIGTAGQASVYKAELPS-WEIVAVKKFHS---PHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
+|...+.||+|+||.||+|.... +..+++|.++. ..........+.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 36778899999999999996543 34455554432 222223344567899999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 542 YEYLGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
|||+++++|.+++.... ....+++..++.++.|++.|++|+|+. +++|+|+||+||+++. +.+|++|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999998886422 234688999999999999999999998 9999999999999975 569999999998765
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
..........|++.|+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~pe 175 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPE 175 (260)
T ss_pred CCcccccCCCCCcCccCHH
Confidence 4333334466889999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=200.29 Aligned_cols=164 Identities=27% Similarity=0.401 Sum_probs=136.3
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCC-CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.|+..+.||+|++|.||+|.. .+++.+|||.+.... ........+.+|++++++++|||++++++++......|+|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 355667899999999999965 467889999986432 222334567889999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+. |++.+.+.... ..+++..+..++.+++.|++|||.. +++||||||+||+++.++.+|++|||++......
T Consensus 96 ~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 996 57777765433 2467888999999999999999988 9999999999999999999999999998765432
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
....|++.|+|||
T Consensus 169 ---~~~~~~~~y~aPE 181 (308)
T cd06634 169 ---NXFVGTPYWMAPE 181 (308)
T ss_pred ---ccccCCccccCHH
Confidence 2356889999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-22 Score=207.77 Aligned_cols=166 Identities=20% Similarity=0.337 Sum_probs=139.9
Q ss_pred HhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc----
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ---- 537 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~---- 537 (639)
..++|+....||+|++|.||+|... +++.||||++............+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4577888899999999999999664 67899999987543333344567789999999999999999998876654
Q ss_pred --eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 046265 538 --SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615 (639)
Q Consensus 538 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGl 615 (639)
.++|+||+ +++|.+++.. ..+++..+..++.|+++|++|+|.. +|+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 6799988865 2478899999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCcceeeeeceeeCCC
Q 046265 616 SKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+...... .....++..|+|||
T Consensus 165 ~~~~~~~---~~~~~~~~~y~aPE 185 (343)
T cd07851 165 ARHTDDE---MTGYVATRWYRAPE 185 (343)
T ss_pred ccccccc---ccCCcccccccCHH
Confidence 9876432 23456889999998
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=198.31 Aligned_cols=168 Identities=21% Similarity=0.343 Sum_probs=134.9
Q ss_pred ccCCCcceeccCCCceEEEEEcCC-CcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS-WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|++|.||+|...+ ++.||||.+...... .....+.+|+.++.+.. ||||+++++++.++...|+||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 456778899999999999997764 889999999754322 23445666777776664 999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||++ +.+..+..... ..+++..+..++.+++.|++|||..+ +|+||||+|+||+++.++.+||+|||++..+...
T Consensus 94 e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9985 46766665422 25788999999999999999999732 8999999999999999999999999998865432
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
.. .....+++.|+|||
T Consensus 169 ~~-~~~~~~~~~y~aPE 184 (296)
T cd06618 169 KA-KTRSAGCAAYMAPE 184 (296)
T ss_pred Cc-ccCCCCCccccCHh
Confidence 22 22345788999998
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.3e-22 Score=204.36 Aligned_cols=164 Identities=21% Similarity=0.359 Sum_probs=135.9
Q ss_pred cceeccCCCceEEEEEcC--CCc--EEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEeccc
Q 046265 470 KYCIGTAGQASVYKAELP--SWE--IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYL 545 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 545 (639)
.+.||+|.||+|++|.+. .|+ .||||+++...... ...+|.+|+.+|.+++|||+|++||...+ ....+|||.+
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 468999999999999664 454 49999998654332 56789999999999999999999999987 6788999999
Q ss_pred CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC
Q 046265 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 625 (639)
+.|+|.+.++. ...+.+.......++.|||+|+.||..+ +.||||+.+.|+++...-.+||+|||+.+.+......
T Consensus 193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 99999999987 3335666777888999999999999999 9999999999999999999999999999987654433
Q ss_pred cc---eeeeeceeeCCC
Q 046265 626 WS---EFVGTFGYVAPI 639 (639)
Q Consensus 626 ~~---~~~gt~~Y~APE 639 (639)
+. ..---+.|.|||
T Consensus 269 Yvm~p~rkvPfAWCaPE 285 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPE 285 (1039)
T ss_pred eEecCCCcCcccccCHh
Confidence 21 111234688887
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=181.97 Aligned_cols=142 Identities=20% Similarity=0.208 Sum_probs=108.3
Q ss_pred cceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhh------------------------HHHHHHHHHHHhccccCce
Q 046265 470 KYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVV------------------------QQAFSNEIKALTELRHRNV 525 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~H~ni 525 (639)
...||+|+||.||+|..++|+.||||.++........ .....+|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999998889999999999754221111 1223459999999988877
Q ss_pred eeeEEEEEcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeecCCCCCeeeCC
Q 046265 526 VKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYM-HHDYFPPIVHRDISSKNVLLGL 604 (639)
Q Consensus 526 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~~~iiHrdlk~~Nill~~ 604 (639)
.....+.. ...++||||++++++....... ..+++.....++.|++.+++|+ |.. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 54333322 2348999999988776443222 2467788999999999999999 566 899999999999998
Q ss_pred CCceEEccccccccCC
Q 046265 605 DYDAHVSDFGISKFLK 620 (639)
Q Consensus 605 ~~~~kl~DfGla~~~~ 620 (639)
++.++++|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-21 Score=195.56 Aligned_cols=168 Identities=21% Similarity=0.286 Sum_probs=120.7
Q ss_pred ccCCCcceeccCCCceEEEEEcCCC----cEEEEEEccCCCCChhhH---------HHHHHHHHHHhccccCceeeeEEE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSW----EIVAVKKFHSPHPDMVVQ---------QAFSNEIKALTELRHRNVVKFYGF 531 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~----~~vavK~~~~~~~~~~~~---------~~~~~e~~~l~~l~H~niv~l~~~ 531 (639)
.+|+..+.||+|+||.||+|...+. ..+|+|...........+ .....+...+..++|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5678889999999999999976543 456666543222111111 112233445566789999999997
Q ss_pred EEcCC----ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 046265 532 SFHPR----QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD 607 (639)
Q Consensus 532 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~ 607 (639)
+.... ..++++|++. .++.+.++... ..++..+..++.|+++|++|+|+. +|+||||||+||+++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence 76543 3467888764 35655554432 246678889999999999999998 9999999999999999999
Q ss_pred eEEccccccccCCCCC-------CCcceeeeeceeeCCC
Q 046265 608 AHVSDFGISKFLKPDS-------SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 608 ~kl~DfGla~~~~~~~-------~~~~~~~gt~~Y~APE 639 (639)
+||+|||+|+.+.... .......||+.|||||
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape 203 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLD 203 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHH
Confidence 9999999998653221 1112357999999997
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.8e-21 Score=188.50 Aligned_cols=148 Identities=16% Similarity=0.120 Sum_probs=123.9
Q ss_pred CCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCCChhHHh
Q 046265 476 AGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIIL 554 (639)
Q Consensus 476 g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l 554 (639)
|.+|.||+|. ..+++.||+|+++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 7899999995 4578899999987532 2334555555667999999999999999999999999999999998
Q ss_pred hcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcceeeeece
Q 046265 555 SNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFG 634 (639)
Q Consensus 555 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~ 634 (639)
.... .+++..+..++.|+++|++|+|.. +|+||||||+||+++.++.++++|||.+..+... .....++..
T Consensus 77 ~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~ 147 (237)
T cd05576 77 SKFL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENM 147 (237)
T ss_pred HHhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCcc
Confidence 6543 378899999999999999999998 9999999999999999999999999988765432 123456778
Q ss_pred eeCCC
Q 046265 635 YVAPI 639 (639)
Q Consensus 635 Y~APE 639 (639)
|||||
T Consensus 148 y~aPE 152 (237)
T cd05576 148 YCAPE 152 (237)
T ss_pred ccCCc
Confidence 99998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-21 Score=200.27 Aligned_cols=165 Identities=26% Similarity=0.354 Sum_probs=133.7
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--------
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP-------- 535 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-------- 535 (639)
.+|...+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 5678889999999999999954 5689999999875432 3345678899999999999999999876654
Q ss_pred ------CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCce
Q 046265 536 ------RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL-DYDA 608 (639)
Q Consensus 536 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~-~~~~ 608 (639)
...|+||||++ +++.+.+... .+++..+..++.|+++|++|||.. +|+||||||+||+++. ++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 34789999997 5888877542 467889999999999999999998 9999999999999984 5578
Q ss_pred EEccccccccCCCCCC---CcceeeeeceeeCCC
Q 046265 609 HVSDFGISKFLKPDSS---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 609 kl~DfGla~~~~~~~~---~~~~~~gt~~Y~APE 639 (639)
|++|||.++.+..... ......|+..|+|||
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 188 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPR 188 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHH
Confidence 9999999986542211 112346788999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=211.71 Aligned_cols=168 Identities=21% Similarity=0.239 Sum_probs=118.1
Q ss_pred HhccCCCcceeccCCCceEEEEEcC-C----CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEE------
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP-S----WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF------ 531 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~------ 531 (639)
..++|+..+.||+|+||.||+|... + +..||||++..... .+....| .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 4578888999999999999999664 4 68899999764221 1111111 1111122222222111
Q ss_pred EEcCCceeEEecccCCCChhHHhhcCCCC-----------------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeec
Q 046265 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAI-----------------DEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRD 594 (639)
Q Consensus 532 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrd 594 (639)
+..+...|+||||+++++|.+++...... ....+..+..++.|++.||+|+|.. +|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCc
Confidence 24556789999999999999998753210 0112234557899999999999998 999999
Q ss_pred CCCCCeeeCC-CCceEEccccccccCCCCC-CCcceeeeeceeeCCC
Q 046265 595 ISSKNVLLGL-DYDAHVSDFGISKFLKPDS-SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 595 lk~~Nill~~-~~~~kl~DfGla~~~~~~~-~~~~~~~gt~~Y~APE 639 (639)
|||+|||++. ++.+||+|||+|+.+.... ......+||+.|||||
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE 327 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 327 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChH
Confidence 9999999985 5799999999998764322 2234578999999998
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.6e-21 Score=203.92 Aligned_cols=164 Identities=29% Similarity=0.375 Sum_probs=129.7
Q ss_pred cCCCcceeccCCCc-eEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEEec
Q 046265 466 NFDAKYCIGTAGQA-SVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 466 ~f~~~~~ig~g~~g-~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 543 (639)
-|...+++|.|+.| .||+|..+ |+.||||++.... .....+||..++.- +|||||++|+.-.+++..|+..|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 34556788898766 48999776 4799999987432 33457899999887 59999999998888899999999
Q ss_pred ccCCCChhHHhhcCCCC-CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---C--CceEEccccccc
Q 046265 544 YLGRGSLAIILSNDAAI-DEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL---D--YDAHVSDFGISK 617 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~---~--~~~kl~DfGla~ 617 (639)
.| ..+|.+++...+.. ....-.....+..|+++|+++||.. +|||||+||.||||+. + .+++|+|||+++
T Consensus 584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 99 56999999874211 1111133456788999999999997 9999999999999965 3 579999999999
Q ss_pred cCCCCCC---CcceeeeeceeeCCC
Q 046265 618 FLKPDSS---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~---~~~~~~gt~~Y~APE 639 (639)
.+..+.+ ...+..||-||+|||
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE 684 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPE 684 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHH
Confidence 9876544 345678999999998
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=176.05 Aligned_cols=142 Identities=21% Similarity=0.258 Sum_probs=111.0
Q ss_pred cceeccCCCceEEEEEcCCCcEEEEEEccCCCCCh------------------------hhHHHHHHHHHHHhccccCce
Q 046265 470 KYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDM------------------------VVQQAFSNEIKALTELRHRNV 525 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l~~l~H~ni 525 (639)
...||+|++|+||+|...+|+.||||.++...... .....+.+|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35799999999999987789999999988642110 012234679999999999988
Q ss_pred eeeEEEEEcCCceeEEecccCCCChhHH-hhcCCCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeC
Q 046265 526 VKFYGFSFHPRQSFLLYEYLGRGSLAII-LSNDAAIDEFSWTVRMNVIKSVANTLSYMHH-DYFPPIVHRDISSKNVLLG 603 (639)
Q Consensus 526 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~iiHrdlk~~Nill~ 603 (639)
.....+... ..|+||||++++++... +.. . .++......++.+++.++.++|+ . +|+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-~---~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-V---PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-c---cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 655444333 34899999998855433 332 1 34567788899999999999999 7 999999999999999
Q ss_pred CCCceEEccccccccCCC
Q 046265 604 LDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 604 ~~~~~kl~DfGla~~~~~ 621 (639)
++.++++|||+|+.+..
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 88999999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.1e-23 Score=199.35 Aligned_cols=274 Identities=22% Similarity=0.255 Sum_probs=200.6
Q ss_pred ccceeeeEEE-EeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCC
Q 046265 2 SCLAFFFFQV-VHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSL 80 (639)
Q Consensus 2 ~~~~~~~~~~-~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L 80 (639)
+|.|...... +-.++.-...+|..+. ...+.++|..|+|+.+.|.+|+.+++|+.|||++|+|+-+-|++|..|.+|
T Consensus 40 pC~Cs~~~g~~VdCr~~GL~eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l 117 (498)
T KOG4237|consen 40 PCTCSDVEGGIVDCRGKGLTEVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASL 117 (498)
T ss_pred CcccCCCCCceEEccCCCcccCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhh
Confidence 4666653332 2344555557887775 367889999999998888899999999999999999998889999999999
Q ss_pred CEEeeec-ccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCC
Q 046265 81 KQLVLYC-NGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSI 159 (639)
Q Consensus 81 ~~L~L~~-N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 159 (639)
.+|-+.+ |+|+....+.|++|..| +.|.+.-|++.-.....|..+++|..|.+.+|.+. .+
T Consensus 118 ~~Lvlyg~NkI~~l~k~~F~gL~sl-----------------qrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i 179 (498)
T KOG4237|consen 118 LSLVLYGNNKITDLPKGAFGGLSSL-----------------QRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SI 179 (498)
T ss_pred hHHHhhcCCchhhhhhhHhhhHHHH-----------------HHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hh
Confidence 8888766 99997777788888743 46777788887666677888888888888888886 34
Q ss_pred Cc-cccCCCcccEEEcccCcC------------CccCCccCcCCCCCCeEEc------------------------cCCc
Q 046265 160 PP-ILGKVQSLLSLGFDLNLL------------NGVLPPSISNLSNLEGLYL------------------------YSSL 202 (639)
Q Consensus 160 p~-~~~~l~~L~~L~l~~N~l------------~~~~p~~~~~l~~L~~L~l------------------------~~~~ 202 (639)
+. .|..+.+++.+.+..|.+ .-..|..++......-..+ +...
T Consensus 180 ~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d 259 (498)
T KOG4237|consen 180 CKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSED 259 (498)
T ss_pred ccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhcccc
Confidence 44 788888888888877762 1122333333221111111 0111
Q ss_pred c-----c-cccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCccccccc
Q 046265 203 V-----S-AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLN 276 (639)
Q Consensus 203 ~-----~-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ 276 (639)
. | ..|..+++|+.|++++|+++..-+.+|.++.+++.|.|..|++...-...|.++..|+.|+|.+|+|
T Consensus 260 ~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~i----- 334 (498)
T KOG4237|consen 260 FPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQI----- 334 (498)
T ss_pred CcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCee-----
Confidence 1 1 1467888899999999999888888899999999999999998877778888888999988776665
Q ss_pred CcCCccccccCccccCCCCCCEEeccCCcc
Q 046265 277 FSMNNITRSIPPKIGKLYQLHKLDFSLNHI 306 (639)
Q Consensus 277 ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~ 306 (639)
+...|..|..+..|..|+|-.|.+
T Consensus 335 ------t~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 335 ------TTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred ------EEEecccccccceeeeeehccCcc
Confidence 455666666667777777766654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-22 Score=184.43 Aligned_cols=165 Identities=24% Similarity=0.317 Sum_probs=133.2
Q ss_pred CCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC-----CceeEE
Q 046265 468 DAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP-----RQSFLL 541 (639)
Q Consensus 468 ~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv 541 (639)
+-.+-||-|+||+||-+. -++|+.||.|++..-...-...+.+.+|+.++.-++|.|++..++...-. +++|.+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 446789999999999884 46799999999986554555667888999999999999999888876543 357888
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
.|.|. .+|..++.... .++-...+-...||++|+.|||+. +|+||||||.|.|++.+...||||||+|+.-+.
T Consensus 136 TELmQ-SDLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-hhhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 99884 57777775432 344445556788999999999999 999999999999999999999999999997654
Q ss_pred CCC-CcceeeeeceeeCCC
Q 046265 622 DSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~-~~~~~~gt~~Y~APE 639 (639)
+.. ..+..+.|.+|.|||
T Consensus 209 d~~~hMTqEVVTQYYRAPE 227 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPE 227 (449)
T ss_pred hhhhhhHHHHHHHHhccHH
Confidence 433 234467899999998
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.2e-20 Score=205.21 Aligned_cols=168 Identities=24% Similarity=0.378 Sum_probs=138.2
Q ss_pred CCcceeccCCCceEEEEEcC----C----CcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCce
Q 046265 468 DAKYCIGTAGQASVYKAELP----S----WEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 468 ~~~~~ig~g~~g~vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 538 (639)
+..+.+|+|.||+|++|... . ...||||.++..... ...+.+..|+.+|+.+ +||||+.++|+|..++..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 34459999999999999532 1 356999999876544 6678899999999998 699999999999999999
Q ss_pred eEEecccCCCChhHHhhcCC---------C--C--CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC
Q 046265 539 FLLYEYLGRGSLAIILSNDA---------A--I--DEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD 605 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~---------~--~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~ 605 (639)
++|+||++.|+|..+++..+ . . +.+.......++.|||.|++||++. ++||||+.+.|||+.++
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKN 454 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCC
Confidence 99999999999999998665 0 0 1377888999999999999999999 89999999999999999
Q ss_pred CceEEccccccccCCCCCCCc-ceeeeec--eeeCCC
Q 046265 606 YDAHVSDFGISKFLKPDSSNW-SEFVGTF--GYVAPI 639 (639)
Q Consensus 606 ~~~kl~DfGla~~~~~~~~~~-~~~~gt~--~Y~APE 639 (639)
..+||+|||+|+......... ..-.|+. .|||||
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApE 491 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPE 491 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCccceeecCHH
Confidence 999999999999755432221 1122222 499998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=176.90 Aligned_cols=167 Identities=31% Similarity=0.488 Sum_probs=142.4
Q ss_pred CCCcceeccCCCceEEEEEcCC-CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEeccc
Q 046265 467 FDAKYCIGTAGQASVYKAELPS-WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYL 545 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 545 (639)
|...+.||+|++|.||+|...+ ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 4567889999999999997765 789999999865432 24567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC-C
Q 046265 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS-S 624 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~-~ 624 (639)
++++|.+++..... .+++.....++.+++.++.|+|.. +++|+|++|+||+++.++.++++|||.+....... .
T Consensus 80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 80 EGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 99999999976442 167889999999999999999998 99999999999999999999999999998765432 1
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......++..|+|||
T Consensus 155 ~~~~~~~~~~~~~pe 169 (225)
T smart00221 155 LLKTVKGTPFYLAPE 169 (225)
T ss_pred cccceeccCCcCCHh
Confidence 223467888999998
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.8e-20 Score=206.60 Aligned_cols=118 Identities=26% Similarity=0.380 Sum_probs=60.4
Q ss_pred CCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCC
Q 046265 31 NLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMP 110 (639)
Q Consensus 31 ~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp 110 (639)
+.+.|++++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|++++|+++ .+|..+..
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~~---------- 241 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLPD---------- 241 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhhc----------
Confidence 3455666666555 3454442 35566666666665 4554443 35666666666555 23332210
Q ss_pred CCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCC
Q 046265 111 NSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN 180 (639)
Q Consensus 111 ~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 180 (639)
.|+.|+|++|+++ .+|..+. ++|+.|+|++|+++ .+|..+. .+|+.|++++|+++
T Consensus 242 ---------~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt 296 (754)
T PRK15370 242 ---------TIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR 296 (754)
T ss_pred ---------cccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc
Confidence 1235566666655 4454443 35666666666655 3444332 35666666666555
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-20 Score=199.06 Aligned_cols=152 Identities=22% Similarity=0.379 Sum_probs=129.8
Q ss_pred CcceeccCCCceEEEEE-cCCC----cEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 469 AKYCIGTAGQASVYKAE-LPSW----EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 469 ~~~~ig~g~~g~vy~~~-~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
...+||+|+||.||+|. .+.| .+||||.+.... ......++.+|+-+|++++|||+++++|+|..+. +.||.+
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 35699999999999994 4444 459999987543 2334567899999999999999999999999876 889999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
||+.|.|.++++.++. .+-.+..+.+..|||+||.|||.+ +++||||.++|||+..-..+||.|||+|+.+..+.
T Consensus 778 ~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999987653 455578889999999999999998 99999999999999999999999999999987665
Q ss_pred CCcc
Q 046265 624 SNWS 627 (639)
Q Consensus 624 ~~~~ 627 (639)
..++
T Consensus 853 ~ey~ 856 (1177)
T KOG1025|consen 853 KEYS 856 (1177)
T ss_pred cccc
Confidence 5443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.7e-22 Score=193.14 Aligned_cols=308 Identities=21% Similarity=0.185 Sum_probs=213.9
Q ss_pred EEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCC
Q 046265 34 FLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSL 113 (639)
Q Consensus 34 ~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~ 113 (639)
..|-++-+++ .+|..+- ..-..++|..|+|+...|.+|+.+++|+.|||++|+|+.+-|++|.++.+|.
T Consensus 50 ~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~-------- 118 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLL-------- 118 (498)
T ss_pred eEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhh--------
Confidence 4466666776 5676553 2457889999999976677899999999999999999999999999988654
Q ss_pred cccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCC
Q 046265 114 SNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNL 193 (639)
Q Consensus 114 ~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 193 (639)
+.++.++|+|+......|++|.+|+.|.+.-|++.-...+.|..+++|..|.+-.|.+..+--.+|..+..+
T Consensus 119 --------~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i 190 (498)
T KOG4237|consen 119 --------SLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAI 190 (498)
T ss_pred --------HHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhcc
Confidence 335667799996666789999999999999999998888899999999999999999985544488888888
Q ss_pred CeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEE--eccCCcc
Q 046265 194 EGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFL--DLSQNNF 271 (639)
Q Consensus 194 ~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L--~Ls~N~l 271 (639)
+.+.+..+.+-. ..+++.+... ....|..++.+.-..-..+.++++..+.+..|... ++.+ .++.
T Consensus 191 ~tlhlA~np~ic-dCnL~wla~~-------~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~--~esl~s~~~~--- 257 (498)
T KOG4237|consen 191 KTLHLAQNPFIC-DCNLPWLADD-------LAMNPIETSGARCVSPYRLYYKRINQEDARKFLCS--LESLPSRLSS--- 257 (498)
T ss_pred chHhhhcCcccc-ccccchhhhH-------HhhchhhcccceecchHHHHHHHhcccchhhhhhh--HHhHHHhhcc---
Confidence 888887554211 1222222211 11223334444444445555666655554444322 1111 0000
Q ss_pred cccccCcCCccccccC-ccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCC
Q 046265 272 YGSLNFSMNNITRSIP-PKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLS 350 (639)
Q Consensus 272 ~~~l~ls~n~~~~~~p-~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 350 (639)
........| ..|..+++|++|+|++|+++++-+.+|..+..++.|.|..|++...-...|.++..|+.|+|+
T Consensus 258 -------~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~ 330 (498)
T KOG4237|consen 258 -------EDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLY 330 (498)
T ss_pred -------ccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeec
Confidence 011112233 346777788888888888877777778888888888888888775556677778888888888
Q ss_pred CCCCCcccccCChhhhccccCCeeeccCCcCce
Q 046265 351 TNYNNEFRKEFPVELEKLVQLTELDLVITFWEE 383 (639)
Q Consensus 351 ~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~ 383 (639)
+|+ +...-|..|..+.+|.+|++-.|.|.-
T Consensus 331 ~N~---it~~~~~aF~~~~~l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 331 DNQ---ITTVAPGAFQTLFSLSTLNLLSNPFNC 360 (498)
T ss_pred CCe---eEEEecccccccceeeeeehccCcccC
Confidence 754 344447777777888888877776654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.8e-19 Score=170.72 Aligned_cols=161 Identities=31% Similarity=0.511 Sum_probs=137.1
Q ss_pred eccCCCceEEEEEcCC-CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCCChh
Q 046265 473 IGTAGQASVYKAELPS-WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLA 551 (639)
Q Consensus 473 ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 551 (639)
||+|++|.||++.... ++.++||.+....... ..+.+.+|++.+++++|++|+++++++......+++|||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999997654 7899999988644221 3467899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEccccccccCCCCCCCcceee
Q 046265 552 IILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL-DYDAHVSDFGISKFLKPDSSNWSEFV 630 (639)
Q Consensus 552 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 630 (639)
+++.... ..+++..+..++.+++++++|||.. +++|+|++|.||+++. ++.++++|||.+..............
T Consensus 80 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 80 DLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 9987642 3477899999999999999999998 9999999999999999 89999999999987654321223356
Q ss_pred eeceeeCCC
Q 046265 631 GTFGYVAPI 639 (639)
Q Consensus 631 gt~~Y~APE 639 (639)
+...|++||
T Consensus 155 ~~~~~~~pe 163 (215)
T cd00180 155 GTPAYMAPE 163 (215)
T ss_pred CCCCccChh
Confidence 788899997
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=200.79 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=151.6
Q ss_pred CCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcc
Q 046265 54 THLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSG 133 (639)
Q Consensus 54 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~ 133 (639)
.+...|+++++.++ .+|..+. ++|+.|+|++|+++. +|..+. . + |++|++++|+++
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~---------------n--L~~L~Ls~N~Lt- 233 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ--G---------------N--IKTLYANSNQLT- 233 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc--c---------------C--CCEEECCCCccc-
Confidence 45778999999988 6787665 578999999998884 454332 1 2 258899999988
Q ss_pred cCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCC
Q 046265 134 SIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQL 213 (639)
Q Consensus 134 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L 213 (639)
.+|..+. ++|+.|+|++|++. .+|..+. .+|+.|++++|.++ .+|..+. .+ |
T Consensus 234 sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~s--------------------L 285 (754)
T PRK15370 234 SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EE--------------------L 285 (754)
T ss_pred cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CC--------------------C
Confidence 5676554 57899999999987 5776654 47899999999887 4565432 24 4
Q ss_pred cEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCC
Q 046265 214 IELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKL 293 (639)
Q Consensus 214 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l 293 (639)
+.|++++|++.+ +|..+. ++|+.|++++|.++..+ ..+ .++|+.|++++|.++ .+|..+.
T Consensus 286 ~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~LP-~~l--~~sL~~L~Ls~N~Lt------------~LP~~l~-- 345 (754)
T PRK15370 286 RYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTALP-ETL--PPGLKTLEAGENALT------------SLPASLP-- 345 (754)
T ss_pred cEEECCCCcccc-Ccccch--hhHHHHHhcCCccccCC-ccc--cccceeccccCCccc------------cCChhhc--
Confidence 455555555543 333322 34566666666666432 211 245666665555442 2343332
Q ss_pred CCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCe
Q 046265 294 YQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTE 373 (639)
Q Consensus 294 ~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~ 373 (639)
++|+.|++++|++. .+|..+. ++|+.|++++|+++ .+|..+. ..|+.|++++|++..++..+|.....++.+..
T Consensus 346 ~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~ 419 (754)
T PRK15370 346 PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLVRLPESLPHFRGEGPQPTR 419 (754)
T ss_pred CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcccCchhHHHHhhcCCCccE
Confidence 45666666666665 3444442 45666666666665 3444332 24666666665555444444444444455666
Q ss_pred eeccCCcCc
Q 046265 374 LDLVITFWE 382 (639)
Q Consensus 374 l~l~~n~~~ 382 (639)
+++.+|.++
T Consensus 420 L~L~~Npls 428 (754)
T PRK15370 420 IIVEYNPFS 428 (754)
T ss_pred EEeeCCCcc
Confidence 666666554
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.8e-20 Score=168.59 Aligned_cols=161 Identities=20% Similarity=0.388 Sum_probs=133.1
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCC--cee
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPR--QSF 539 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~~ 539 (639)
.++|+..+.+|+|.|+.|+.|. ..+.+.++||.++. .......+|+.++..+. |||||++++...++. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 4567778899999999999994 56678899999874 34566889999999996 999999999998764 467
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEcccccccc
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD-YDAHVSDFGISKF 618 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~-~~~kl~DfGla~~ 618 (639)
+|+||+.+.+...+-. .++......++.++++||.|+|+. ||+|||+||.|+++|.. -..+++|.|+|..
T Consensus 112 LiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence 9999999988876643 355566777899999999999999 99999999999999965 5799999999998
Q ss_pred CCCCCCCcceeeeeceeeCCC
Q 046265 619 LKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~~~~~~~gt~~Y~APE 639 (639)
+.+. ....-.+.+.+|.-||
T Consensus 183 YHp~-~eYnVRVASRyfKGPE 202 (338)
T KOG0668|consen 183 YHPG-KEYNVRVASRYFKGPE 202 (338)
T ss_pred cCCC-ceeeeeeehhhcCCch
Confidence 8754 3344456778888887
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-19 Score=176.24 Aligned_cols=155 Identities=28% Similarity=0.460 Sum_probs=133.6
Q ss_pred CCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCCChhHHhh
Q 046265 477 GQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILS 555 (639)
Q Consensus 477 ~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~ 555 (639)
+||.||+|... +++.+|+|.+........ .+.+.+|++.+++++|+||+++++++..+...++||||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999765 489999999976543221 5778999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcceeeeecee
Q 046265 556 NDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGY 635 (639)
Q Consensus 556 ~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~Y 635 (639)
.... +++..+..++.++++++.|||.. +|+|+||+|+||+++.++.++++|||.+....... ......|+..|
T Consensus 80 ~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~ 152 (244)
T smart00220 80 KRGR---LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEY 152 (244)
T ss_pred hccC---CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCC
Confidence 6433 78899999999999999999998 99999999999999999999999999998765432 22345688999
Q ss_pred eCCC
Q 046265 636 VAPI 639 (639)
Q Consensus 636 ~APE 639 (639)
+|||
T Consensus 153 ~~pE 156 (244)
T smart00220 153 MAPE 156 (244)
T ss_pred CCHH
Confidence 9998
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.3e-20 Score=169.32 Aligned_cols=146 Identities=19% Similarity=0.327 Sum_probs=120.1
Q ss_pred ccCCCcceeccCCCceEEEEEcCC-CcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEE-EEEcCCceeEE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS-WEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYG-FSFHPRQSFLL 541 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~-~~~~~~~~~lv 541 (639)
+.|...+.+|+|.||++-.|+++. .+.+|+|.++.+. ...++|.+|...--.+ -|.|||.-|+ .|+..+..+++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 456677899999999999997765 4779999988654 3467899999876666 4899998775 45667788899
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee--CCCCceEEccccccccC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL--GLDYDAHVSDFGISKFL 619 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill--~~~~~~kl~DfGla~~~ 619 (639)
+||++.|+|.+-+...+ +.+....+++.|++.|++|||+. .+||||||.+|||+ .+..++|+||||..+..
T Consensus 101 qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999998886533 44477888999999999999999 99999999999999 24568999999998764
Q ss_pred C
Q 046265 620 K 620 (639)
Q Consensus 620 ~ 620 (639)
.
T Consensus 174 g 174 (378)
T KOG1345|consen 174 G 174 (378)
T ss_pred C
Confidence 3
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-19 Score=186.03 Aligned_cols=161 Identities=25% Similarity=0.324 Sum_probs=132.9
Q ss_pred HhccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeE
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 540 (639)
.++.|.....+|.|+|+.|-++. ..+.+..|||.+..+..+ ..+|+.++.+. +||||+++.+.|.+..+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeee
Confidence 46677778889999999999994 456788999999865322 24577776665 69999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee-CCCCceEEccccccccC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL-GLDYDAHVSDFGISKFL 619 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill-~~~~~~kl~DfGla~~~ 619 (639)
|||++.+|-+.+.+.... ... ..+..|+.+++.|+.|||.+ +|||||+||+|||+ +..+.++|+|||.++..
T Consensus 394 v~e~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred eehhccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 999999988877665433 222 56777999999999999998 99999999999999 68899999999999987
Q ss_pred CCCCCCcceeeeeceeeCCC
Q 046265 620 KPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~~~~~~gt~~Y~APE 639 (639)
+.. ..+.|-|..|.|||
T Consensus 467 ~~~---~~tp~~t~~y~APE 483 (612)
T KOG0603|consen 467 ERS---CDTPALTLQYVAPE 483 (612)
T ss_pred chh---hcccchhhcccChh
Confidence 644 33456788999998
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=164.29 Aligned_cols=139 Identities=16% Similarity=0.237 Sum_probs=105.7
Q ss_pred CCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-----ccCceeeeEEEEEcCC---ce
Q 046265 467 FDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-----RHRNVVKFYGFSFHPR---QS 538 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~H~niv~l~~~~~~~~---~~ 538 (639)
......||+|+||.||. ++.....+||++.... ....+.+.+|+.+++.+ .||||++++|++.++. .+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34567999999999996 4433334799887533 22356789999999999 5799999999999873 43
Q ss_pred e-EEecc--cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeecCCCCCeeeCC----CCceEE
Q 046265 539 F-LLYEY--LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTL-SYMHHDYFPPIVHRDISSKNVLLGL----DYDAHV 610 (639)
Q Consensus 539 ~-lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l-~~lH~~~~~~iiHrdlk~~Nill~~----~~~~kl 610 (639)
+ +|+|| +.+|+|.+++++.. +++. ..++.+++.++ +|||+. +|+||||||+||+++. ...++|
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence 4 78999 55899999997632 3333 34567777777 999999 9999999999999974 347999
Q ss_pred cc-cccccc
Q 046265 611 SD-FGISKF 618 (639)
Q Consensus 611 ~D-fGla~~ 618 (639)
+| ||.+..
T Consensus 151 iDg~G~~~~ 159 (210)
T PRK10345 151 CDNIGESTF 159 (210)
T ss_pred EECCCCcce
Confidence 99 555443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-19 Score=170.40 Aligned_cols=163 Identities=21% Similarity=0.324 Sum_probs=128.5
Q ss_pred cCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC------ce
Q 046265 466 NFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR------QS 538 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~ 538 (639)
+|....-+|.|.- .|.-| ..-.++.||+|++..+......-+...+|...+..++|+|||+++.++.-.. +.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4445566777766 45445 3445788999998766433333344578999999999999999999987543 57
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
|+||||| .+++.+.+.. +++-.+...+..|++.|++|+|+. +|+|||+||+||++..+..+||.|||+|+.
T Consensus 97 y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 97 YLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 9999999 5688877762 244477788999999999999999 999999999999999999999999999987
Q ss_pred CCCCCCCcceeeeeceeeCCC
Q 046265 619 LKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~~~~~~~gt~~Y~APE 639 (639)
-..+ -..+..+.|..|.|||
T Consensus 168 e~~~-~~mtpyVvtRyyrape 187 (369)
T KOG0665|consen 168 EDTD-FMMTPYVVTRYYRAPE 187 (369)
T ss_pred cCcc-cccCchhheeeccCch
Confidence 5433 2445678999999998
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=160.83 Aligned_cols=135 Identities=13% Similarity=0.079 Sum_probs=106.9
Q ss_pred CCcceeccCCCceEEEEEcCCCcEEEEEEccCCCC--ChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCceeEEecc
Q 046265 468 DAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHP--DMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 468 ~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
.+...+++|+||+||.+.. ++..++.+.+..... .......+.+|+++++++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998866 557777777764332 1122336889999999995 5889999886 457999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC-CCCCeeeCCCCceEEccccccccCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDI-SSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdl-k~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
++|.+|.+.... ....++.+++++++++|.. +|+|||| ||+||+++.++.++|+|||+|....
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 999999754321 1134678899999999999 9999999 7999999999999999999998544
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2e-18 Score=168.27 Aligned_cols=165 Identities=21% Similarity=0.234 Sum_probs=136.2
Q ss_pred hccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcccc--C----ceeeeEEEEEcCC
Q 046265 464 TNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH--R----NVVKFYGFSFHPR 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H--~----niv~l~~~~~~~~ 536 (639)
+++|.....+|+|.||+|-.+ ..+.+..||||.++.- ...+++.+-|++++.++.+ | -+|++.+|+.-.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 678888899999999999999 4555789999998742 3455666779999999842 2 4788889999999
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-------------
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG------------- 603 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~------------- 603 (639)
..++|+|.+ |-++++.+....- ..++...+..++.|++++++|||+. +++|-|+||+|||+-
T Consensus 165 hiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCc
Confidence 999999987 6699999987543 4578889999999999999999999 999999999999982
Q ss_pred -------CCCceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 604 -------LDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 604 -------~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
....+||+|||.|....+. .++++.|..|.|||
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPE 279 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPE 279 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC---cceeeeccccCCch
Confidence 1234799999999875433 35688999999999
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=163.03 Aligned_cols=144 Identities=24% Similarity=0.275 Sum_probs=110.5
Q ss_pred CCCcceeccCCCceEEEEE--cCCCcEEEEEEccCCCCCh----------------------hhHHHHHHHHHHHhcccc
Q 046265 467 FDAKYCIGTAGQASVYKAE--LPSWEIVAVKKFHSPHPDM----------------------VVQQAFSNEIKALTELRH 522 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~--~~~~~~vavK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~H 522 (639)
|+..+.||+|++|.||+|. ..+|+.||||.++...... ..+..+.+|++.+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5667899999999999997 6789999999987542100 012346789999999976
Q ss_pred Cc--eeeeEEEEEcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCC-eEeecCCCCC
Q 046265 523 RN--VVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP-IVHRDISSKN 599 (639)
Q Consensus 523 ~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-iiHrdlk~~N 599 (639)
.. +++.+++ ...++||||++++++........ .........++.+++.+++++|.. + |+|||+||+|
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N 179 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN 179 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence 33 3444443 23589999999988876542222 234455678999999999999998 8 9999999999
Q ss_pred eeeCCCCceEEccccccccCCC
Q 046265 600 VLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 600 ill~~~~~~kl~DfGla~~~~~ 621 (639)
|+++ ++.++++|||.|.....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCC
Confidence 9999 88999999999986543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=158.27 Aligned_cols=147 Identities=19% Similarity=0.152 Sum_probs=112.7
Q ss_pred HHHHHhccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCCh--------------------hhHHHHHHHHHHHh
Q 046265 459 EVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDM--------------------VVQQAFSNEIKALT 518 (639)
Q Consensus 459 ~~~~~~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~e~~~l~ 518 (639)
++.+....|...+.||+|+||.||+|..++|+.||||.++...... .....+.+|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 4444444477788999999999999988889999999876432100 01123577899999
Q ss_pred ccccCc--eeeeEEEEEcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCC
Q 046265 519 ELRHRN--VVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDIS 596 (639)
Q Consensus 519 ~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk 596 (639)
.+.|++ ++..++ ....++||||++++++...... .....++.+++.++.++|+. +|+|||+|
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 998874 444443 2456899999999998765431 23456788999999999997 99999999
Q ss_pred CCCeeeCCCCceEEccccccccCCC
Q 046265 597 SKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 597 ~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|+||++++++.++|+|||.+.....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.5e-17 Score=156.52 Aligned_cols=151 Identities=14% Similarity=0.190 Sum_probs=118.3
Q ss_pred cchHHHHHH--HhccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCCh-hhH------HHHHHHHHHHhccccCc
Q 046265 454 KILYEEVIR--ATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDM-VVQ------QAFSNEIKALTELRHRN 524 (639)
Q Consensus 454 ~~~~~~~~~--~~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~-~~~------~~~~~e~~~l~~l~H~n 524 (639)
...|.++.. ...+|...+++|.|+||.||.++. ++..+|||.++...... ... +.+.+|+..+.++.||+
T Consensus 18 ~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~G 96 (232)
T PRK10359 18 DNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEG 96 (232)
T ss_pred cccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCC
Confidence 333444432 267889999999999999999866 46789999997544222 111 22689999999999999
Q ss_pred eeeeEEEEEcC--------CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCC
Q 046265 525 VVKFYGFSFHP--------RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDIS 596 (639)
Q Consensus 525 iv~l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk 596 (639)
|..+..++... +..++||||++|.+|.++.. .+ .....+++.++..+|.. +++|||+|
T Consensus 97 I~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~----~~~~~~i~~~l~~lH~~---gi~H~Dik 162 (232)
T PRK10359 97 LASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------IS----EDVKAKIKASIESLHQH---GMVSGDPH 162 (232)
T ss_pred CCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------cc----HHHHHHHHHHHHHHHHc---CCccCCCC
Confidence 99999886643 35789999999999987732 11 12456889999999999 99999999
Q ss_pred CCCeeeCCCCceEEccccccccCC
Q 046265 597 SKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 597 ~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
|+||++++++ ++++|||..+...
T Consensus 163 p~Nili~~~g-i~liDfg~~~~~~ 185 (232)
T PRK10359 163 KGNFIVSKNG-LRIIDLSGKRCTA 185 (232)
T ss_pred hHHEEEeCCC-EEEEECCCccccc
Confidence 9999999988 9999999887653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.5e-18 Score=168.91 Aligned_cols=145 Identities=23% Similarity=0.324 Sum_probs=124.3
Q ss_pred HHHHhccCCCcceeccCCCceEEEEEcC----CCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEc
Q 046265 460 VIRATNNFDAKYCIGTAGQASVYKAELP----SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFH 534 (639)
Q Consensus 460 ~~~~~~~f~~~~~ig~g~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 534 (639)
+....+.|...+.||+|.|+.||+|... ..+.||+|.+.... .......|++.+.++ .+.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3445667788899999999999999543 34779999987543 234578999999998 49999999999999
Q ss_pred CCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEccc
Q 046265 535 PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL-DYDAHVSDF 613 (639)
Q Consensus 535 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~-~~~~kl~Df 613 (639)
.+.+.+|+||++.....++... ++......+.+.+..||+++|+. |||||||||+|++.+. .++..|+||
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence 9999999999999999888753 45677888999999999999999 9999999999999985 478899999
Q ss_pred cccc
Q 046265 614 GISK 617 (639)
Q Consensus 614 Gla~ 617 (639)
|+|.
T Consensus 178 gLA~ 181 (418)
T KOG1167|consen 178 GLAQ 181 (418)
T ss_pred hhHH
Confidence 9987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.3e-17 Score=158.11 Aligned_cols=137 Identities=15% Similarity=0.276 Sum_probs=114.4
Q ss_pred ceeccCCCceEEEEEcCCCcEEEEEEccCCCCCh------hhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 471 YCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDM------VVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+.||+|++|.||+|.. .+..|+||......... .....+.+|++++..++|++|+....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4789999999999977 56789999865432211 1234678899999999999998888888777889999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
++|++|.+++.... + .+..++.+++.++.++|.. +++|||++|+||+++ ++.++++|||.+...
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 99999999886422 1 6778899999999999998 999999999999999 788999999998764
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-19 Score=157.30 Aligned_cols=159 Identities=35% Similarity=0.618 Sum_probs=113.6
Q ss_pred EEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeeccc
Q 046265 10 QVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNG 89 (639)
Q Consensus 10 ~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 89 (639)
++.++.|++. .+|+.|+.+.+|+.|++++|++. .+|.++++|++|+.|+++.|++. .+|..|+.++.|+.|||..|+
T Consensus 37 rLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynn 113 (264)
T KOG0617|consen 37 RLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNN 113 (264)
T ss_pred hhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccc
Confidence 4456666665 56667777777777777777775 66777777777777777777776 677777777777777777766
Q ss_pred CccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcc
Q 046265 90 LSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSL 169 (639)
Q Consensus 90 l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 169 (639)
+.. ..+|.+|..++.| +.|+|++|.+. .+|+.++++++|+.|.+.+|.+- ++|..++.++.|
T Consensus 114 l~e--------------~~lpgnff~m~tl--ralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~l 175 (264)
T KOG0617|consen 114 LNE--------------NSLPGNFFYMTTL--RALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRL 175 (264)
T ss_pred ccc--------------ccCCcchhHHHHH--HHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHH
Confidence 653 1334444444444 57888888887 78888888888888888888886 688888888888
Q ss_pred cEEEcccCcCCccCCccCcCC
Q 046265 170 LSLGFDLNLLNGVLPPSISNL 190 (639)
Q Consensus 170 ~~L~l~~N~l~~~~p~~~~~l 190 (639)
++|.+.+|.++ .+|+.++++
T Consensus 176 relhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 176 RELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred HHHhcccceee-ecChhhhhh
Confidence 88888888887 556555543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.7e-17 Score=150.55 Aligned_cols=164 Identities=20% Similarity=0.279 Sum_probs=128.7
Q ss_pred hccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcccc-CceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH-RNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv 541 (639)
...|...+.||.|+||.+|.| ....|+.||||.=.... ....+..|..+-..++| ..|..+..|..+...-.+|
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 356788899999999999999 67889999999855322 23446678888877765 5777778888888888999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEEcccccccc
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG---LDYDAHVSDFGISKF 618 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~---~~~~~kl~DfGla~~ 618 (639)
||.. |.+|.++..- ....++..+++..|-|++.-++|+|.. +.|||||||+|+|.+ ....+.++|||+|+.
T Consensus 90 MdLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhh
Confidence 9987 7888887741 223467788999999999999999999 789999999999996 335689999999998
Q ss_pred CCCCCCC-------cceeeeeceeeC
Q 046265 619 LKPDSSN-------WSEFVGTFGYVA 637 (639)
Q Consensus 619 ~~~~~~~-------~~~~~gt~~Y~A 637 (639)
+....+. -...+||..|.+
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYAS 189 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYAS 189 (341)
T ss_pred hccccccccCccccCCccceeeeehh
Confidence 7543221 123678888864
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.2e-19 Score=155.78 Aligned_cols=179 Identities=31% Similarity=0.478 Sum_probs=100.5
Q ss_pred CCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcc
Q 046265 28 NISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIG 107 (639)
Q Consensus 28 ~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~ 107 (639)
++++++.|.||+|+++ .+|+.++.|.+|+.|++++|+++ .+|.+++++++|+.|+++
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvg--------------------- 87 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVG--------------------- 87 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecc---------------------
Confidence 3444555555555554 44445555555555555555554 455555555555555544
Q ss_pred cCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCC-CCCccccCCCcccEEEcccCcCCccCCcc
Q 046265 108 SMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFG-SIPPILGKVQSLLSLGFDLNLLNGVLPPS 186 (639)
Q Consensus 108 ~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 186 (639)
-|++. ..|..|+.++.|++|||.+|++.. .+|..|..++.|+.|+++.|.+. .+|..
T Consensus 88 --------------------mnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~d 145 (264)
T KOG0617|consen 88 --------------------MNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPD 145 (264)
T ss_pred --------------------hhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChh
Confidence 44444 556666666666666666666643 45666666666666666666665 55555
Q ss_pred CcCCCCCCeEEccCCc---cccccccccCCcEEEcCCcccCCCCCccccCCC---CCceeccccccccCcch
Q 046265 187 ISNLSNLEGLYLYSSL---VSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFT---SLNIVHLEQNHLTGNIY 252 (639)
Q Consensus 187 ~~~l~~L~~L~l~~~~---~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~---~L~~L~L~~N~l~~~~~ 252 (639)
++++++|+.|.+..+. +|.+++.+++|++|.+.+|+++ .+|+.+.++. +-+.+.+.+|.....+.
T Consensus 146 vg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~pIa 216 (264)
T KOG0617|consen 146 VGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNPIA 216 (264)
T ss_pred hhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCChHH
Confidence 6666666655555432 3566777777778888888874 3454444332 22344455554443333
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.9e-17 Score=178.52 Aligned_cols=142 Identities=20% Similarity=0.333 Sum_probs=114.0
Q ss_pred HhccCCCcceeccCCCceEEEEEcCCCcEEEEEE-ccCCCC-----ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKK-FHSPHP-----DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR 536 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~-~~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 536 (639)
....|...+.||+|+||.||+|...+.. +++|+ ..+... .....+.+.+|++++.+++|++++....++....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 3445566789999999999999776544 33333 222111 1123456889999999999999998888888878
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
..++||||+++++|.+++. .+..++.++++++.|+|.. +|+|||+||+||++ .++.++++|||++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 8899999999999998774 3456889999999999998 99999999999999 5789999999999
Q ss_pred ccCC
Q 046265 617 KFLK 620 (639)
Q Consensus 617 ~~~~ 620 (639)
+...
T Consensus 475 ~~~~ 478 (535)
T PRK09605 475 KYSD 478 (535)
T ss_pred ccCC
Confidence 8754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.4e-17 Score=153.39 Aligned_cols=134 Identities=18% Similarity=0.331 Sum_probs=108.3
Q ss_pred eeccCCCceEEEEEcCCCcEEEEEEccCCCCC------hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEeccc
Q 046265 472 CIGTAGQASVYKAELPSWEIVAVKKFHSPHPD------MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYL 545 (639)
Q Consensus 472 ~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 545 (639)
.||+|++|.||+|.. ++..|+||........ ......+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 479999999999985 4678999986532211 112356778999999999988766666666677789999999
Q ss_pred CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
+|+++.+.+..... .++.+++.++.++|.. +++|||++|+||+++ ++.+++.|||.++...
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 99999988754211 6789999999999998 999999999999999 7899999999988653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.8e-17 Score=165.41 Aligned_cols=174 Identities=17% Similarity=0.243 Sum_probs=140.5
Q ss_pred chHHHHHHHhccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcccc------Cceee
Q 046265 455 ILYEEVIRATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH------RNVVK 527 (639)
Q Consensus 455 ~~~~~~~~~~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H------~niv~ 527 (639)
+.+.|+. ...|.+.-..|+|-|+.|.+|. ...|+.||||.++... .....=.+|+++|.++.. -|+++
T Consensus 424 v~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 424 VRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred Eehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 3344443 4677777788999999999994 4557899999998632 223334679999999852 38999
Q ss_pred eEEEEEcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-C
Q 046265 528 FYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD-Y 606 (639)
Q Consensus 528 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~-~ 606 (639)
++..|...+++++|+|-. .-.|.++++..+..-.+....+..++.|+..||..|..+ +|+|.||||.|||++.. .
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence 999999999999999976 568999999877766788888899999999999999988 99999999999999854 5
Q ss_pred ceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 607 DAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 607 ~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
..||||||.|...... ..+.+..+..|.|||
T Consensus 575 iLKLCDfGSA~~~~en--eitPYLVSRFYRaPE 605 (752)
T KOG0670|consen 575 ILKLCDFGSASFASEN--EITPYLVSRFYRAPE 605 (752)
T ss_pred eeeeccCccccccccc--cccHHHHHHhccCcc
Confidence 7899999999876432 233456778899998
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=152.49 Aligned_cols=163 Identities=21% Similarity=0.303 Sum_probs=129.3
Q ss_pred ccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 542 (639)
-+|.+.+.||+|+||+++.| .+-+++.||||.=.... ....+..|.+.-+.+ ..+.|...|-|..++-.-.+|+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 46788999999999999999 56678999999755322 223456677777766 4689998887777777778999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-----CceEEccccccc
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD-----YDAHVSDFGISK 617 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~-----~~~kl~DfGla~ 617 (639)
|.. |.+|.++.+-= ...++..++..+|.|++.-++|+|++ ..|.|||||+|+||+.- ..+.++|||+|+
T Consensus 104 dLL-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhh-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 987 77888877521 13477789999999999999999999 89999999999999743 458999999999
Q ss_pred cCCCCCC-------CcceeeeeceeeC
Q 046265 618 FLKPDSS-------NWSEFVGTFGYVA 637 (639)
Q Consensus 618 ~~~~~~~-------~~~~~~gt~~Y~A 637 (639)
.+....+ ......||..||+
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMS 204 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMS 204 (449)
T ss_pred hhcCccccccCccccccccccceeeeE
Confidence 8865432 2345789999995
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.6e-16 Score=161.29 Aligned_cols=168 Identities=31% Similarity=0.447 Sum_probs=139.8
Q ss_pred CCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChh-hHHHHHHHHHHHhccccC-ceeeeEEEEEcCCceeEEecc
Q 046265 467 FDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMV-VQQAFSNEIKALTELRHR-NVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~ 544 (639)
|.....+|.|+||.||++... ..+|+|.+........ ....+.+|+.+++.+.|+ +++++.+++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556678999999999999766 7899999986554332 567889999999999988 799999999777778999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEccccccccCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY-DAHVSDFGISKFLKPDS 623 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~-~~kl~DfGla~~~~~~~ 623 (639)
+.++++.+++........+.......++.+++.+++|+|.. +++|||+||+||+++..+ .++++|||.++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776543112466688889999999999999999 899999999999999988 79999999998655433
Q ss_pred C------CcceeeeeceeeCCC
Q 046265 624 S------NWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~------~~~~~~gt~~Y~APE 639 (639)
. .....+||..|+|||
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe 178 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPE 178 (384)
T ss_pred ccccccccccccccccccCCHH
Confidence 2 235678999999998
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-18 Score=179.52 Aligned_cols=36 Identities=33% Similarity=0.269 Sum_probs=16.4
Q ss_pred CCCCeeeccCccCc----ccCCcCccCCCCCCEEeCCCCC
Q 046265 318 KSLNYRALNGNKVY----GSLPRVLGSISDLEYLDLSTNY 353 (639)
Q Consensus 318 ~~L~~L~l~~N~l~----~~~p~~~~~l~~L~~L~Ls~N~ 353 (639)
+.|+.|++++|.++ ..++..+..+++|+++++++|.
T Consensus 250 ~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~ 289 (319)
T cd00116 250 ISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNK 289 (319)
T ss_pred CCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCC
Confidence 34455555555443 1122233344555555665543
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-18 Score=178.49 Aligned_cols=86 Identities=19% Similarity=0.189 Sum_probs=43.7
Q ss_pred EEeCCCccc-ccCCccccCCCCCCEEECcCCCCcc----CCCCCCCCCCCCCEEEcccCcCCC------CCCcccCCCCC
Q 046265 11 VVHESNTLF-AIIPPQIGNISNLKFLDMGNNQLSG----VIPQEIDPLTHLKHLYINVNKLRG------SVPREVGQLSS 79 (639)
Q Consensus 11 ~~~~~n~~~-~~~p~~~~~l~~L~~L~Ls~n~l~~----~~p~~~~~L~~L~~L~L~~N~l~~------~~p~~~~~l~~ 79 (639)
+++..+.+. ...+..+..+++|++|+++++.++. .++..+...+.|++|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 345555554 3344445555566666666666532 133444555556666666655541 12233444555
Q ss_pred CCEEeeecccCccccCc
Q 046265 80 LKQLVLYCNGLSGWLPS 96 (639)
Q Consensus 80 L~~L~L~~N~l~~~~p~ 96 (639)
|+.|++++|.+.+..+.
T Consensus 83 L~~L~l~~~~~~~~~~~ 99 (319)
T cd00116 83 LQELDLSDNALGPDGCG 99 (319)
T ss_pred eeEEEccCCCCChhHHH
Confidence 55555555555443333
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.5e-16 Score=161.85 Aligned_cols=166 Identities=22% Similarity=0.274 Sum_probs=128.5
Q ss_pred cCCCcceeccCCCceEEEEEcCCC--cEEEEEEccCCCCChhhHHHHHHHHHHHhcccc----CceeeeEEEE-EcCCce
Q 046265 466 NFDAKYCIGTAGQASVYKAELPSW--EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH----RNVVKFYGFS-FHPRQS 538 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H----~niv~l~~~~-~~~~~~ 538 (639)
+|...+.||+|+||.||.|..... +.+|+|.-....... ...+..|+.++..+.. +++.++++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 788899999999999999965443 578888766432111 1146778888888763 5899999998 477789
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-----CceEEccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD-----YDAHVSDF 613 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~-----~~~kl~Df 613 (639)
|+||+.+ |.+|.++..... ...++..++.+++.|++.+++++|+. +++||||||+|+.++.. ..+.+.||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 9999977 889999876544 45688899999999999999999998 99999999999999854 46999999
Q ss_pred cccc--cCCCCC----C---C-cceeeeeceeeCC
Q 046265 614 GISK--FLKPDS----S---N-WSEFVGTFGYVAP 638 (639)
Q Consensus 614 Gla~--~~~~~~----~---~-~~~~~gt~~Y~AP 638 (639)
|+|+ .+.... . . .....||..|+++
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~ 206 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI 206 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccH
Confidence 9998 321111 0 1 2235699999875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.1e-16 Score=141.64 Aligned_cols=151 Identities=17% Similarity=0.125 Sum_probs=121.7
Q ss_pred cceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcccc--CceeeeEEEEEcCCceeEEecccCC
Q 046265 470 KYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH--RNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
.+.+|+|.++.||++...+ ..++||....... ...+.+|+..+..++| +.++++++++..++..|++|||+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 4679999999999998765 7899999865432 4568899999999987 5899999998888889999999998
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
+.+..+ ++.....++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..... ..
T Consensus 78 ~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~~----~~ 143 (155)
T cd05120 78 ETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP----AF 143 (155)
T ss_pred eecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCCh----HH
Confidence 877643 4456677889999999999987555799999999999999989999999999875432 22
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
..+....++++|
T Consensus 144 d~~~~~~~~~~~ 155 (155)
T cd05120 144 DLAAALLFNLLE 155 (155)
T ss_pred HHHHHHHHhccC
Confidence 344455556554
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-15 Score=144.16 Aligned_cols=139 Identities=21% Similarity=0.224 Sum_probs=98.9
Q ss_pred cceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHH----------------------HHHHHHHHHhccccCc--e
Q 046265 470 KYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQ----------------------AFSNEIKALTELRHRN--V 525 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~----------------------~~~~e~~~l~~l~H~n--i 525 (639)
.+.||+|+||.||+|...+++.||||.++.......... ....|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 357999999999999888899999998875322111111 1135666666665443 4
Q ss_pred eeeEEEEEcCCceeEEecccCCCChhH-HhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeC
Q 046265 526 VKFYGFSFHPRQSFLLYEYLGRGSLAI-ILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH-DYFPPIVHRDISSKNVLLG 603 (639)
Q Consensus 526 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~iiHrdlk~~Nill~ 603 (639)
.+.+++ ...++||||++++.+.. .+..... . .....++.+++.++.++|. . +|+|||+||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~----~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL----L-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhh----c-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 444443 34689999999855421 1111110 0 4466788999999999998 6 999999999999999
Q ss_pred CCCceEEccccccccCCC
Q 046265 604 LDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 604 ~~~~~kl~DfGla~~~~~ 621 (639)
++.++++|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 89999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.2e-15 Score=143.91 Aligned_cols=139 Identities=14% Similarity=0.208 Sum_probs=107.3
Q ss_pred cceec-cCCCceEEEEEcCCCcEEEEEEccCCCC-----------ChhhHHHHHHHHHHHhccccCce--eeeEEEEEcC
Q 046265 470 KYCIG-TAGQASVYKAELPSWEIVAVKKFHSPHP-----------DMVVQQAFSNEIKALTELRHRNV--VKFYGFSFHP 535 (639)
Q Consensus 470 ~~~ig-~g~~g~vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~H~ni--v~l~~~~~~~ 535 (639)
...+| .||.|.||.+... +..+|||.+..... .......+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999999775 57789998853211 11234567889999999998875 6777765443
Q ss_pred C-c---eeEEecccCC-CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 046265 536 R-Q---SFLLYEYLGR-GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV 610 (639)
Q Consensus 536 ~-~---~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl 610 (639)
. . .++||||+++ .+|.+++... .++. ..+.+++.++.++|.. +|+|||+||+|||++.++.+++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 2 2 3599999997 6898888643 1222 2356889999999999 9999999999999999899999
Q ss_pred ccccccccCC
Q 046265 611 SDFGISKFLK 620 (639)
Q Consensus 611 ~DfGla~~~~ 620 (639)
+|||.+....
T Consensus 184 IDfg~~~~~~ 193 (239)
T PRK01723 184 IDFDRGELRT 193 (239)
T ss_pred EECCCcccCC
Confidence 9999988754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.7e-14 Score=144.93 Aligned_cols=133 Identities=23% Similarity=0.355 Sum_probs=109.7
Q ss_pred ccCCCcceeccCCCceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-----c---CceeeeEEEEEcC
Q 046265 465 NNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-----H---RNVVKFYGFSFHP 535 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----H---~niv~l~~~~~~~ 535 (639)
.+|.+.+.+|=|-|++||.| ...+.+.||+|..+.. ....+....||.++++++ | .+||+++++|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 57788899999999999999 5566788999998743 345566788999999874 3 3799999999754
Q ss_pred ----CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC
Q 046265 536 ----RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL 604 (639)
Q Consensus 536 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~ 604 (639)
..+++|+|+. |..|-.+|.... ...++...+..|++||+.||.|||+.| +|||-||||+|||+..
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCS 223 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeec
Confidence 4789999998 667777776432 245788999999999999999999998 9999999999999953
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.6e-15 Score=144.33 Aligned_cols=178 Identities=16% Similarity=0.234 Sum_probs=138.1
Q ss_pred HHHHHHhccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEE
Q 046265 458 EEVIRATNNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531 (639)
Q Consensus 458 ~~~~~~~~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~ 531 (639)
.++.....+++...++-+|.||.||+|.++ +.+.|-||.++... .......+..|...+..+.|||+.++.++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 344444566777788899999999999443 34567888876533 33345678899999999999999999999
Q ss_pred EEcC-CceeEEecccCCCChhHHhh-----cCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC
Q 046265 532 SFHP-RQSFLLYEYLGRGSLAIILS-----NDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD 605 (639)
Q Consensus 532 ~~~~-~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~ 605 (639)
+.++ +..+..|.++.-|+|..++. .......+.-.+...++.|++.|++|+|.+ +|||.||.+.|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 9765 46788899999999999997 333334567778888999999999999999 99999999999999999
Q ss_pred CceEEccccccccCCCCCCC-cc-eeeeeceeeCCC
Q 046265 606 YDAHVSDFGISKFLKPDSSN-WS-EFVGTFGYVAPI 639 (639)
Q Consensus 606 ~~~kl~DfGla~~~~~~~~~-~~-~~~gt~~Y~APE 639 (639)
.++|++|-.+++.+.+.+.. .. ..-.-..||+||
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslE 468 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLE 468 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHH
Confidence 99999999999987543221 10 111224688887
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=7.5e-15 Score=160.53 Aligned_cols=164 Identities=18% Similarity=0.233 Sum_probs=124.5
Q ss_pred CcceeccCCCceEEEEE-cCCCcEEEEEEcc----CCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 469 AKYCIGTAGQASVYKAE-LPSWEIVAVKKFH----SPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 469 ~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~----~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
...++|.|++|.|+.+. ....+..+.|..+ ...........+..|..+-..++|||++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 46789999999887773 3344445555443 211122222235677888888999999888777776666666699
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
||++ +|+..+.... .+.-..+..+.+|+..|+.|+|.. +|.|||+|++|+++...|.+||+|||.+....-+.
T Consensus 402 ~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 9999987653 244466778999999999999999 99999999999999999999999999988654322
Q ss_pred ----CCcceeeeeceeeCCC
Q 046265 624 ----SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ----~~~~~~~gt~~Y~APE 639 (639)
.....++|+..|+|||
T Consensus 475 e~~~~~~~g~~gS~pY~apE 494 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPE 494 (601)
T ss_pred chhhhhhcCcccCCcCcCcc
Confidence 2345689999999999
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.9e-15 Score=168.29 Aligned_cols=115 Identities=17% Similarity=0.128 Sum_probs=85.3
Q ss_pred cccc-CceeeeEEEE-------EcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 046265 519 ELRH-RNVVKFYGFS-------FHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPI 590 (639)
Q Consensus 519 ~l~H-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i 590 (639)
..+| +||.+++++| ...+..+.+|||+ +++|++++.... ..+++..++.++.||++||+|||+. +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 3455 5788888877 2334567788987 669999997532 3478899999999999999999998 99
Q ss_pred EeecCCCCCeeeCC-------------------CCceEEccccccccCCCCC----------------CCcceeeeecee
Q 046265 591 VHRDISSKNVLLGL-------------------DYDAHVSDFGISKFLKPDS----------------SNWSEFVGTFGY 635 (639)
Q Consensus 591 iHrdlk~~Nill~~-------------------~~~~kl~DfGla~~~~~~~----------------~~~~~~~gt~~Y 635 (639)
+||||||+|||++. ++.+|++|||+++...... ......+||++|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4556777777776432100 001124689999
Q ss_pred eCCC
Q 046265 636 VAPI 639 (639)
Q Consensus 636 ~APE 639 (639)
||||
T Consensus 182 ~APE 185 (793)
T PLN00181 182 TSPE 185 (793)
T ss_pred EChh
Confidence 9999
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.6e-14 Score=158.19 Aligned_cols=162 Identities=22% Similarity=0.235 Sum_probs=120.3
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChh-hHHHHHHHHHHHhccc---cCceeeeEEEEEcCCcee
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMV-VQQAFSNEIKALTELR---HRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~ 539 (639)
-..|.....+|+|+||+||+|...+|+.||+|.=+.+..-.. .. .+++.|++ -+-|+.+...+.-.+..+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~------~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYIC------LQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeeh------HHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 355667789999999999999888899999998765442111 11 12233333 234556666666678889
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-------CCCceEEcc
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG-------LDYDAHVSD 612 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~-------~~~~~kl~D 612 (639)
+|+||.+.|+|-+++.. .+..+|...+.++.++++.+++||.. +|||+||||+|+||. +...++|+|
T Consensus 771 lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEe
Confidence 99999999999999973 34688899999999999999999999 999999999999993 234589999
Q ss_pred ccccccCCC--CCCCcceeeeeceeeC
Q 046265 613 FGISKFLKP--DSSNWSEFVGTFGYVA 637 (639)
Q Consensus 613 fGla~~~~~--~~~~~~~~~gt~~Y~A 637 (639)
||.+..|.- +...-...++|-++-.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C 871 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDC 871 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchh
Confidence 999988743 2222233445544433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.6e-13 Score=145.64 Aligned_cols=144 Identities=22% Similarity=0.213 Sum_probs=101.2
Q ss_pred cceeccCCCceEEEEEcCCCcEEEEEEccCCCCChh--------------------------------------hHHHHH
Q 046265 470 KYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMV--------------------------------------VQQAFS 511 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~--------------------------------------~~~~~~ 511 (639)
.+.||+|++|+||+|++++|+.||||..+....... .+-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 467999999999999999999999999865321100 011355
Q ss_pred HHHHHHhccc----cCceeeeEEEEE-cCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHH-HHHHHHhC
Q 046265 512 NEIKALTELR----HRNVVKFYGFSF-HPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVAN-TLSYMHHD 585 (639)
Q Consensus 512 ~e~~~l~~l~----H~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~-~l~~lH~~ 585 (639)
+|++.+.+++ |.+-|.+-..|. ..+..++||||++|+++.+....... .. .+..++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 6666666653 333333333333 24567999999999999887653211 11 23345555555 46778877
Q ss_pred CCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 586 YFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 586 ~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
+++|+|++|.||++++++.++++|||++..+..
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=9.4e-15 Score=152.18 Aligned_cols=158 Identities=23% Similarity=0.249 Sum_probs=126.3
Q ss_pred eeccCCCceEEEEE----cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCceeEEecccC
Q 046265 472 CIGTAGQASVYKAE----LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQSFLLYEYLG 546 (639)
Q Consensus 472 ~ig~g~~g~vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~ 546 (639)
++|+|+||+|+.++ ...|+.+|.|..++.............|-.++..++ ||.+|+++-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 46999999999763 344677898888765432222224456777888886 9999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCc
Q 046265 547 RGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW 626 (639)
Q Consensus 547 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 626 (639)
+|++...+..... +.......+...++-+++++|.. +|+|||+|++||+++.+|++|+.|||+++.......
T Consensus 81 gg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 9999988765543 44455556677788899999998 999999999999999999999999999987643221
Q ss_pred ceeeeeceeeCCC
Q 046265 627 SEFVGTFGYVAPI 639 (639)
Q Consensus 627 ~~~~gt~~Y~APE 639 (639)
.|||..|||||
T Consensus 153 --~cgt~eymApE 163 (612)
T KOG0603|consen 153 --ACGTYEYRAPE 163 (612)
T ss_pred --cccchhhhhhH
Confidence 29999999998
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.3e-15 Score=150.61 Aligned_cols=177 Identities=32% Similarity=0.507 Sum_probs=138.4
Q ss_pred cCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCc
Q 046265 27 GNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAI 106 (639)
Q Consensus 27 ~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 106 (639)
..++.....||+.|++. .+|.++..+..|+.+.|..|.+. .+|..+++|..|++|||+.|+++ .+|..++.+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp---- 144 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP---- 144 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc----
Confidence 45677778899999887 78888888888999999999887 78888999999999999999888 6777766654
Q ss_pred ccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCcc
Q 046265 107 GSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPS 186 (639)
Q Consensus 107 ~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 186 (639)
|+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|.+..|++. .+|..
T Consensus 145 --------------Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~E 207 (722)
T KOG0532|consen 145 --------------LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEE 207 (722)
T ss_pred --------------ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHH
Confidence 367888888887 78888888888899999998887 67888888889998888888887 34444
Q ss_pred CcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccC
Q 046265 187 ISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTG 249 (639)
Q Consensus 187 ~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 249 (639)
+..| .|..||++.|++ ..+|-.|..|+.|++|.|.+|.++.
T Consensus 208 l~~L---------------------pLi~lDfScNki-s~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 208 LCSL---------------------PLIRLDFSCNKI-SYLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred HhCC---------------------ceeeeecccCce-eecchhhhhhhhheeeeeccCCCCC
Confidence 4332 355666777766 3467677777777777777777765
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.9e-13 Score=127.52 Aligned_cols=158 Identities=17% Similarity=0.299 Sum_probs=126.3
Q ss_pred ceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCCCh
Q 046265 471 YCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL 550 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 550 (639)
..+.+.-.|+.|+|+++. ..+++|.+..+.......++|.+|...++-+.||||+.++|.|.++....++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 367778899999999885 5567787777666666677899999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEee-cCCCCCeeeCCCCceEEc--cccccccCCCCCCCcc
Q 046265 551 AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHR-DISSKNVLLGLDYDAHVS--DFGISKFLKPDSSNWS 627 (639)
Q Consensus 551 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHr-dlk~~Nill~~~~~~kl~--DfGla~~~~~~~~~~~ 627 (639)
+.++++.... .++-.++.+.+.++|+|++|||+.. +++-| -+.+..+++|++.+++|+ |--++. +. .
T Consensus 275 ynvlhe~t~v-vvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsf--qe-----~ 344 (448)
T KOG0195|consen 275 YNVLHEQTSV-VVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--QE-----V 344 (448)
T ss_pred HHHHhcCccE-EEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeee--ec-----c
Confidence 9999986542 4566889999999999999999863 45544 588999999999988875 322221 11 1
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
...-+|.||+||
T Consensus 345 gr~y~pawmspe 356 (448)
T KOG0195|consen 345 GRAYSPAWMSPE 356 (448)
T ss_pred ccccCcccCCHH
Confidence 123468899998
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.6e-12 Score=139.32 Aligned_cols=146 Identities=16% Similarity=0.159 Sum_probs=95.5
Q ss_pred ccCCCcceeccCCCceEEEEEcCC-CcEEEEEEccCCCCCh--------------------------------hhH----
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS-WEIVAVKKFHSPHPDM--------------------------------VVQ---- 507 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~~~--------------------------------~~~---- 507 (639)
..|+. +-+|+|++|+||+|++++ |+.||||..+...... ...
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 44665 689999999999999887 9999999997531100 001
Q ss_pred --HHHHHHHHHHhccc----cCceeeeEEEEEc-CCceeEEecccCCCChhHHh--hcCCCC-CCcCHHHHHHHHHHHHH
Q 046265 508 --QAFSNEIKALTELR----HRNVVKFYGFSFH-PRQSFLLYEYLGRGSLAIIL--SNDAAI-DEFSWTVRMNVIKSVAN 577 (639)
Q Consensus 508 --~~~~~e~~~l~~l~----H~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~-~~~~~~~~~~i~~~i~~ 577 (639)
-+|.+|+..+.+++ +...+.+-.+|.+ ....++||||++|+.+.++- ...+.. ..+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 12455665555553 4444554455543 45678999999999997642 222110 01111112222222
Q ss_pred HHHHHHhCCCCCeEeecCCCCCeeeCCCC----ceEEccccccccCCC
Q 046265 578 TLSYMHHDYFPPIVHRDISSKNVLLGLDY----DAHVSDFGISKFLKP 621 (639)
Q Consensus 578 ~l~~lH~~~~~~iiHrdlk~~Nill~~~~----~~kl~DfGla~~~~~ 621 (639)
++.. +++|+|+||.||+++.++ ++++.|||+...+..
T Consensus 276 ----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3334 899999999999999888 999999999887753
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.28 E-value=7.9e-14 Score=142.67 Aligned_cols=168 Identities=30% Similarity=0.423 Sum_probs=142.2
Q ss_pred EEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeeccc
Q 046265 10 QVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNG 89 (639)
Q Consensus 10 ~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 89 (639)
.+|++.|++. .+|..+..+-.|..|.|..|.+. .+|..+++|..|.+|||+.|+++ .+|..++.|+ |+.|.+++|+
T Consensus 79 ~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNk 154 (722)
T KOG0532|consen 79 FADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNK 154 (722)
T ss_pred hhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCc
Confidence 4678888887 78988988899999999999998 78999999999999999999998 8999999887 9999999999
Q ss_pred CccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcc
Q 046265 90 LSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSL 169 (639)
Q Consensus 90 l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 169 (639)
++ .+|..++.+. +|.+||.+.|++. .+|..++.+.+|+.|.+..|++. .+|.++..| .|
T Consensus 155 l~-~lp~~ig~~~-----------------tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pL 213 (722)
T KOG0532|consen 155 LT-SLPEEIGLLP-----------------TLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PL 213 (722)
T ss_pred cc-cCCcccccch-----------------hHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ce
Confidence 98 7788887544 3358889999887 77888889999999999999887 577777754 68
Q ss_pred cEEEcccCcCCccCCccCcCCCCCCeEEccCCcc
Q 046265 170 LSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLV 203 (639)
Q Consensus 170 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~ 203 (639)
..||++.|+++ .+|-.|.+|+.|++|.|.+|.+
T Consensus 214 i~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPL 246 (722)
T KOG0532|consen 214 IRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPL 246 (722)
T ss_pred eeeecccCcee-ecchhhhhhhhheeeeeccCCC
Confidence 89999999987 6777888888777777776654
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.26 E-value=8.5e-12 Score=132.48 Aligned_cols=103 Identities=35% Similarity=0.484 Sum_probs=52.9
Q ss_pred EEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCc
Q 046265 58 HLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPH 137 (639)
Q Consensus 58 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~ 137 (639)
.++++.|.+. ..+..+..++.++.|++.+|.++ .+|.....+. .+| ..|++++|++. .+|.
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~--------------~nL--~~L~l~~N~i~-~l~~ 157 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLK--------------SNL--KELDLSDNKIE-SLPS 157 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccch--------------hhc--ccccccccchh-hhhh
Confidence 4555555553 22333444455666666666555 2333332221 011 35566666655 4444
Q ss_pred cccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCC
Q 046265 138 FLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN 180 (639)
Q Consensus 138 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 180 (639)
.+..+++|+.|++++|+++ .+|...+.++.|+.|++++|+++
T Consensus 158 ~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~ 199 (394)
T COG4886 158 PLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199 (394)
T ss_pred hhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc
Confidence 5556666666666666665 34444445556666666666665
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.6e-11 Score=112.49 Aligned_cols=131 Identities=18% Similarity=0.165 Sum_probs=95.6
Q ss_pred ceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCcee-eeEEEEEcCCceeEEecccCCCC
Q 046265 471 YCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVV-KFYGFSFHPRQSFLLYEYLGRGS 549 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~~g~ 549 (639)
+.++.|.++.||+++.. ++.|++|....... ....+.+|+..+..+.+.+++ +++.+. .+..++||||++|.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 46788999999999865 67899998764321 123457889998888665544 444443 334589999999988
Q ss_pred hhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 550 LAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY--FPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 550 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+... . .....++.+++++++.||... ..+++|+|++|.||+++ ++.++++|||.+...
T Consensus 78 l~~~---~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 78 LLTE---D--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccc---c--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 7643 0 011235678899999999873 12469999999999999 668999999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.2e-11 Score=131.23 Aligned_cols=192 Identities=37% Similarity=0.519 Sum_probs=135.9
Q ss_pred EEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCC-CCCEEeeecccCccccCccccCCCCCCcccCCCC
Q 046265 34 FLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLS-SLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNS 112 (639)
Q Consensus 34 ~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~ 112 (639)
.|+++.|.+. ..+..+..++.++.|++.+|.++ .+|+....+. +|+.|++++|++. .+|..+..++
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~---------- 163 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLP---------- 163 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccc----------
Confidence 5888888875 34556777789999999999998 7888888885 9999999999988 4555555555
Q ss_pred CcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCC
Q 046265 113 LSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSN 192 (639)
Q Consensus 113 ~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 192 (639)
.| +.|++++|+++ .+|...+.+++|+.|++++|++. .+|...+....|+++.+++|.+. ..+..+.++.+
T Consensus 164 -----~L--~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~ 233 (394)
T COG4886 164 -----NL--KNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKN 233 (394)
T ss_pred -----cc--cccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhccc
Confidence 33 58999999998 77777768899999999999997 67776667777999999999632 23334444444
Q ss_pred CCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcc
Q 046265 193 LEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNF 271 (639)
Q Consensus 193 L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 271 (639)
+.. +.+.+|++. .+|..+..++++++|++++|.++.... ++.+.+++.|++++|.+
T Consensus 234 l~~--------------------l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~ 289 (394)
T COG4886 234 LSG--------------------LELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSL 289 (394)
T ss_pred ccc--------------------cccCCceee-eccchhccccccceecccccccccccc--ccccCccCEEeccCccc
Confidence 444 444444442 224555666666666666666665433 55566666666655554
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.2e-11 Score=135.37 Aligned_cols=113 Identities=35% Similarity=0.548 Sum_probs=94.3
Q ss_pred CCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCccc
Q 046265 55 HLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGS 134 (639)
Q Consensus 55 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~ 134 (639)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++| +.|||++|+++|.
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L-----------------~~LdLs~N~lsg~ 481 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSL-----------------EVLDLSYNSFNGS 481 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCC-----------------CEEECCCCCCCCC
Confidence 47888999999998999999999999999999999998888888777743 4899999999999
Q ss_pred CCccccCCCCCCEEeccCCCCCCCCCccccCC-CcccEEEcccCcCCccCC
Q 046265 135 IPHFLGHLSNLAVLHLGDNSLFGSIPPILGKV-QSLLSLGFDLNLLNGVLP 184 (639)
Q Consensus 135 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p 184 (639)
+|..++++++|++|+|++|+++|.+|..++.+ .++..+++++|......|
T Consensus 482 iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 99999999999999999999999999887764 467788888886543333
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.1e-10 Score=106.87 Aligned_cols=138 Identities=19% Similarity=0.223 Sum_probs=97.7
Q ss_pred ceeccCCCceEEEEEcCC-------CcEEEEEEccCCCC-----------C---------hhhHHHH----HHHHHHHhc
Q 046265 471 YCIGTAGQASVYKAELPS-------WEIVAVKKFHSPHP-----------D---------MVVQQAF----SNEIKALTE 519 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~-------~~~vavK~~~~~~~-----------~---------~~~~~~~----~~e~~~l~~ 519 (639)
.+||.|.-+.||.|.-.+ +..+|||..+.... + ...+..+ ++|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999996543 47899997763210 0 0112223 489999999
Q ss_pred ccc--CceeeeEEEEEcCCceeEEecccCCCChh-HHhhcCCCCCCcCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeecC
Q 046265 520 LRH--RNVVKFYGFSFHPRQSFLLYEYLGRGSLA-IILSNDAAIDEFSWTVRMNVIKSVANTLSYM-HHDYFPPIVHRDI 595 (639)
Q Consensus 520 l~H--~niv~l~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~~~iiHrdl 595 (639)
+.. -++.+.+++ ..-++||||++++.+. ..++.. .++......+..+++.++.++ |.. +|||+|+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 863 466677765 5668999999775442 122221 123344566778999999999 666 9999999
Q ss_pred CCCCeeeCCCCceEEccccccccCC
Q 046265 596 SSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 596 k~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
++.||+++ ++.+.++|||.|....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.5e-11 Score=132.27 Aligned_cols=92 Identities=32% Similarity=0.564 Sum_probs=57.9
Q ss_pred eEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeec
Q 046265 8 FFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYC 87 (639)
Q Consensus 8 ~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 87 (639)
...+++++|++.|.+|..++.+++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++++++|++|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 44556666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred ccCccccCcccc
Q 046265 88 NGLSGWLPSSFG 99 (639)
Q Consensus 88 N~l~~~~p~~~~ 99 (639)
|+++|.+|..+.
T Consensus 500 N~l~g~iP~~l~ 511 (623)
T PLN03150 500 NSLSGRVPAALG 511 (623)
T ss_pred CcccccCChHHh
Confidence 666666665554
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.3e-09 Score=97.78 Aligned_cols=133 Identities=20% Similarity=0.348 Sum_probs=100.1
Q ss_pred eeccCCCceEEEEEcCCCcEEEEEE-ccCCCC-----ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEeccc
Q 046265 472 CIGTAGQASVYKAELPSWEIVAVKK-FHSPHP-----DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYL 545 (639)
Q Consensus 472 ~ig~g~~g~vy~~~~~~~~~vavK~-~~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 545 (639)
.+++|+-+.+|.+.+.+.. +.+|. +++.-. ..-......+|+.++++++--.|...+=+..+++...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5788999999999775544 44442 222211 1123455688999999988766666666777888889999999
Q ss_pred CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+|..+.+.+... +..++..+-.-+.-||.. +|+|+|+.++||++..+. +.++|||++..-
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999888654 133566666777789999 999999999999998665 999999999853
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=9.5e-10 Score=106.77 Aligned_cols=144 Identities=19% Similarity=0.155 Sum_probs=106.2
Q ss_pred ceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcccc--CceeeeEEEEEcCC---ceeEEeccc
Q 046265 471 YCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH--RNVVKFYGFSFHPR---QSFLLYEYL 545 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~---~~~lv~e~~ 545 (639)
+.++.|..+.||+++..+|+.+++|........ .....+.+|++++..+++ ..+.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998877788999997654321 123457889999998875 34677777776542 668999999
Q ss_pred CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 046265 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY--------------------------------------- 586 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--------------------------------------- 586 (639)
+|.++.+.+.. ..++...+..++.++++++.++|+..
T Consensus 83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99888765431 12444566667777777777777420
Q ss_pred --------------CCCeEeecCCCCCeeeCC--CCceEEccccccccC
Q 046265 587 --------------FPPIVHRDISSKNVLLGL--DYDAHVSDFGISKFL 619 (639)
Q Consensus 587 --------------~~~iiHrdlk~~Nill~~--~~~~kl~DfGla~~~ 619 (639)
...++|+|+.+.||+++. ++.+.++||+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 236799999999999998 667899999988653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.6e-11 Score=132.91 Aligned_cols=170 Identities=24% Similarity=0.301 Sum_probs=130.1
Q ss_pred ccCCCcceeccCCCceEEEEEcCC--CcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCceeEE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS--WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv 541 (639)
..|...+.||+|+|+.|-.+.... ...+|+|.+...............|..+-..+. |+|+++.++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 345566779999999998775432 245777777654322222333445666666665 99999999999999999999
Q ss_pred ecccCCCChhHHh-hcCCCCCCcCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeecCCCCCeeeCCCC-ceEEcccccccc
Q 046265 542 YEYLGRGSLAIIL-SNDAAIDEFSWTVRMNVIKSVANTLSYMH-HDYFPPIVHRDISSKNVLLGLDY-DAHVSDFGISKF 618 (639)
Q Consensus 542 ~e~~~~g~L~~~l-~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~~~iiHrdlk~~Nill~~~~-~~kl~DfGla~~ 618 (639)
.||..+|++.+.+ +... ...+-..+..+..|+..++.|+| .. ++.|||+||+|.+++..+ ..|++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999888 4433 12233556678899999999999 66 899999999999999999 999999999998
Q ss_pred CCC-CCC--Ccceeee-eceeeCCC
Q 046265 619 LKP-DSS--NWSEFVG-TFGYVAPI 639 (639)
Q Consensus 619 ~~~-~~~--~~~~~~g-t~~Y~APE 639 (639)
+.. ... .....+| ++.|+|||
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E 199 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPE 199 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcc
Confidence 754 222 2345788 99999998
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.7e-11 Score=131.28 Aligned_cols=144 Identities=19% Similarity=0.214 Sum_probs=111.8
Q ss_pred cCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHH--HhccccCceeeeEEEEEcCCceeEEec
Q 046265 466 NFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKA--LTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~--l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++...+.+|++.|=+|.||+.+.|. |+||.+.+..... ..+.|.++++- ...++|||.+.+-.+-..+...|+|=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~-sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTI-SLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCC-CchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4566789999999999999988887 8899887654221 22333333322 455689999998888777777888888
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
|+ .-+|++.+..+. .+.....+=|+.|++.|+.-+|.. +|+|+|||.+|||+..-..+.++||..-|.
T Consensus 102 yv-khnLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 102 YV-KHNLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKP 169 (1431)
T ss_pred HH-hhhhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCC
Confidence 88 458888876542 344455666899999999999999 999999999999999999999999986553
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.4e-10 Score=110.54 Aligned_cols=165 Identities=20% Similarity=0.217 Sum_probs=97.7
Q ss_pred CCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccc----------cCceeeeEEEEE--
Q 046265 468 DAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELR----------HRNVVKFYGFSF-- 533 (639)
Q Consensus 468 ~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~----------H~niv~l~~~~~-- 533 (639)
.....||.|+++.||.+.. ++++.+|||....... ....-+.+.+|.-....+. |-.++-.++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 3467899999999999955 5689999998865442 2223455666654444322 212222222211
Q ss_pred -------cC--C------ceeEEecccCCCChhHHhhc---CCC-CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeec
Q 046265 534 -------HP--R------QSFLLYEYLGRGSLAIILSN---DAA-IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRD 594 (639)
Q Consensus 534 -------~~--~------~~~lv~e~~~~g~L~~~l~~---~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrd 594 (639)
.. . ..+++|+-+ .++|.+++.. ... ........+..+..|+.+.++++|+. +|+|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 11 1 124566655 5688777542 211 12233455666778999999999999 999999
Q ss_pred CCCCCeeeCCCCceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 595 ISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 595 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|||+|++++.+|.++++||+......... .....+.+|.+||
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~~~~~~~~~PPe 212 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRY---RCSEFPVAFTPPE 212 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEE---EGGGS-TTTS-HH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCcee---eccCCCcccCChh
Confidence 99999999999999999998776543211 1122346677776
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.9e-10 Score=103.84 Aligned_cols=109 Identities=31% Similarity=0.376 Sum_probs=29.9
Q ss_pred ccCCCCCCEEECcCCCCccCCCCCCC-CCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccc-cCCCC
Q 046265 26 IGNISNLKFLDMGNNQLSGVIPQEID-PLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSF-GNLNN 103 (639)
Q Consensus 26 ~~~l~~L~~L~Ls~n~l~~~~p~~~~-~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~ 103 (639)
+.+...+++|+|++|.|+. +. .++ .+.+|+.|||++|.|+ .++ .+..+++|++|++++|+|+. +++.+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred ccccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 3445567778888887763 32 354 5677777777777777 343 36667777777777777763 22222 12332
Q ss_pred CCcccCCCCCcccCCCCccEEEccCCcCcccC-CccccCCCCCCEEeccCCCCC
Q 046265 104 LAIGSMPNSLSNLTSLSLFHLDLSENQLSGSI-PHFLGHLSNLAVLHLGDNSLF 156 (639)
Q Consensus 104 L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~ 156 (639)
| ++|+|++|++...- -..+..+++|++|+|.+|.++
T Consensus 90 ---------------L--~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 ---------------L--QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -------------------EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred ---------------C--CEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 2 46667777665211 123455666666666666665
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=9.6e-10 Score=108.51 Aligned_cols=112 Identities=21% Similarity=0.304 Sum_probs=77.6
Q ss_pred cccCceeeeEEEEEcC---------------------------CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHH
Q 046265 520 LRHRNVVKFYGFSFHP---------------------------RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVI 572 (639)
Q Consensus 520 l~H~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~ 572 (639)
-+|||||++.++|.+. ...|+||.-++ -+|++++..+. .+...+.-+.
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~l 347 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVIL 347 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHH
Confidence 3688888888776541 23688887663 47888886542 3334555678
Q ss_pred HHHHHHHHHHHhCCCCCeEeecCCCCCeee--CCCC--ceEEccccccccCCCCC------CCcceeeeeceeeCCC
Q 046265 573 KSVANTLSYMHHDYFPPIVHRDISSKNVLL--GLDY--DAHVSDFGISKFLKPDS------SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 573 ~~i~~~l~~lH~~~~~~iiHrdlk~~Nill--~~~~--~~kl~DfGla~~~~~~~------~~~~~~~gt~~Y~APE 639 (639)
.|+++|+.|||.+ +|.|||+|++|||+ |+|+ ...|+|||.+-...... +.....-|.-.-||||
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPE 421 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPE 421 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchh
Confidence 8999999999999 99999999999999 4444 57899999765322210 1111234556678998
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.6e-09 Score=101.03 Aligned_cols=74 Identities=24% Similarity=0.166 Sum_probs=62.8
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCCcc
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 627 (639)
|+|.++++..+ ..++|..+..++.|++.|++|+|+. + ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 68889987543 2589999999999999999999987 4 999999999999999 99998764321
Q ss_pred eeeeeceeeCCC
Q 046265 628 EFVGTFGYVAPI 639 (639)
Q Consensus 628 ~~~gt~~Y~APE 639 (639)
..||+.|||||
T Consensus 64 -~~g~~~y~aPE 74 (176)
T smart00750 64 -SRVDPYFMAPE 74 (176)
T ss_pred -CCCcccccChH
Confidence 26899999998
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.6e-08 Score=90.30 Aligned_cols=146 Identities=15% Similarity=0.228 Sum_probs=102.9
Q ss_pred CcceeccCCCceEEEEEcCCCcEEEEEE-ccCCC----C-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 469 AKYCIGTAGQASVYKAELPSWEIVAVKK-FHSPH----P-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 469 ~~~~ig~g~~g~vy~~~~~~~~~vavK~-~~~~~----~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
....+-+|+-+.|+++...+ +...||. +.+.- . ....+++..+|++.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~G-e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG-EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCC-ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 45678899999999998764 5555553 32221 1 1223466789999999987666665555666667778999
Q ss_pred cccCC-CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc---eEEcccccccc
Q 046265 543 EYLGR-GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD---AHVSDFGISKF 618 (639)
Q Consensus 543 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~---~kl~DfGla~~ 618 (639)
||++| -++.+++.........+ ......++.+-+.+.-||.. +|||+|+..+||++.+++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 36777775433322211 22256778888889999999 9999999999999976543 57999999865
Q ss_pred C
Q 046265 619 L 619 (639)
Q Consensus 619 ~ 619 (639)
-
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.3e-09 Score=120.07 Aligned_cols=131 Identities=25% Similarity=0.320 Sum_probs=88.7
Q ss_pred hccCCCcceeccCCCceEEEEEcCC-CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPS-WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
..+|+..+.|..|+||.||..+++. .+..|. ++++... ..+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccch-------hhhc--cccccCCccee----------------
Confidence 4677788999999999999997764 466777 4443210 1110 22222233332
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
|+-...++.-+..+. +.+.+++|+|+- +|+|||+||+|.+|..-|++|+.|||+.+..-..
T Consensus 136 -----gDc~tllk~~g~lPv-----------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 -----GDCATLLKNIGPLPV-----------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred -----chhhhhcccCCCCcc-----------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 555656655433211 116789999988 9999999999999999999999999998853211
Q ss_pred CC---------------CcceeeeeceeeCCC
Q 046265 623 SS---------------NWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~---------------~~~~~~gt~~Y~APE 639 (639)
.. .-..+||||.|+|||
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 00 113469999999998
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.1e-09 Score=112.65 Aligned_cols=118 Identities=29% Similarity=0.526 Sum_probs=97.0
Q ss_pred HhccccCceeeeEEEEEcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCe-EeecC
Q 046265 517 LTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPI-VHRDI 595 (639)
Q Consensus 517 l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i-iHrdl 595 (639)
|+.+.|.|+.+++|.+.++...+.|.+||+.|+|.+.+.... -.++|.....+++++++|++|+|.. +| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 356789999999999999999999999999999999998743 3578999999999999999999987 45 99999
Q ss_pred CCCCeeeCCCCceEEccccccccCCCC--CCCcceeeeeceeeCCC
Q 046265 596 SSKNVLLGLDYDAHVSDFGISKFLKPD--SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 596 k~~Nill~~~~~~kl~DfGla~~~~~~--~~~~~~~~gt~~Y~APE 639 (639)
+++|.++|..-.+|++|||+....... ........-..-|.|||
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPe 121 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPE 121 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHH
Confidence 999999999999999999998876421 11111122344577776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.9e-08 Score=92.37 Aligned_cols=128 Identities=25% Similarity=0.352 Sum_probs=82.8
Q ss_pred eEEEEEcCCCcEEEEEEccCCCC------------------------ChhhHHHHHHHHHHHhccccC--ceeeeEEEEE
Q 046265 480 SVYKAELPSWEIVAVKKFHSPHP------------------------DMVVQQAFSNEIKALTELRHR--NVVKFYGFSF 533 (639)
Q Consensus 480 ~vy~~~~~~~~~vavK~~~~~~~------------------------~~~~~~~~~~e~~~l~~l~H~--niv~l~~~~~ 533 (639)
-||.|..++|+.+|||..+.... ....+....+|++.|.++..- ++.+.+++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 38999989999999997764311 011234567899999998755 56677655
Q ss_pred cCCceeEEecccC--CCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeecCCCCCeeeCCCCceEE
Q 046265 534 HPRQSFLLYEYLG--RGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYM-HHDYFPPIVHRDISSKNVLLGLDYDAHV 610 (639)
Q Consensus 534 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~~~iiHrdlk~~Nill~~~~~~kl 610 (639)
+.-.+||||++ |..+..+...... ......++.+++..+..+ |.. +|+|+|+.+.||+++++ .+.+
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~~~-----~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVDLS-----PEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCGGG-----GSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcccc-----chhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 24579999998 6555544432211 123445667777756654 566 99999999999999887 9999
Q ss_pred ccccccccCC
Q 046265 611 SDFGISKFLK 620 (639)
Q Consensus 611 ~DfGla~~~~ 620 (639)
+|||.|....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2e-10 Score=109.14 Aligned_cols=133 Identities=25% Similarity=0.305 Sum_probs=77.1
Q ss_pred ccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCC
Q 046265 26 IGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLA 105 (639)
Q Consensus 26 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 105 (639)
+...+.|+.||||+|.|+ .+.++..-++.++.|++|+|.|+ .+. .+..|++|+.||||+|.++.. -.+=..+.|
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~~-~Gwh~KLGN-- 353 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAEC-VGWHLKLGN-- 353 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHhh-hhhHhhhcC--
Confidence 334455677777777776 56666666777777777777776 333 266667777777777766521 111111221
Q ss_pred cccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCC-ccccCCCcccEEEcccCcCCc
Q 046265 106 IGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIP-PILGKVQSLLSLGFDLNLLNG 181 (639)
Q Consensus 106 ~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~ 181 (639)
+..|.|+.|.+. . -..++.|-+|..||+++|+|...-. ..+++++.|+.+.|-+|.+.+
T Consensus 354 ---------------IKtL~La~N~iE-~-LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 354 ---------------IKTLKLAQNKIE-T-LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred ---------------EeeeehhhhhHh-h-hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 135666666654 2 1335566666677777776653211 345666666666666666654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.87 E-value=5.4e-10 Score=106.22 Aligned_cols=133 Identities=28% Similarity=0.239 Sum_probs=84.4
Q ss_pred cCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCC
Q 046265 232 RNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELP 311 (639)
Q Consensus 232 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p 311 (639)
...+.|+.+||++|.|+.+. +.....|.++.|++|+|.+. .+ ..+..+++|+.||||+|.++ .+-
T Consensus 281 dTWq~LtelDLS~N~I~~iD-ESvKL~Pkir~L~lS~N~i~------------~v-~nLa~L~~L~~LDLS~N~Ls-~~~ 345 (490)
T KOG1259|consen 281 DTWQELTELDLSGNLITQID-ESVKLAPKLRRLILSQNRIR------------TV-QNLAELPQLQLLDLSGNLLA-ECV 345 (490)
T ss_pred chHhhhhhccccccchhhhh-hhhhhccceeEEecccccee------------ee-hhhhhcccceEeecccchhH-hhh
Confidence 34466777888888777533 44566677888887777662 12 22555677788888888776 333
Q ss_pred ccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCce
Q 046265 312 IELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEE 383 (639)
Q Consensus 312 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~ 383 (639)
.+-..|-+++.|.|++|.+. .+ +.++.+.+|+.||+++|++.++... ..+++++.|+.+.+.+|.+.+
T Consensus 346 Gwh~KLGNIKtL~La~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie~ldeV--~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 346 GWHLKLGNIKTLKLAQNKIE-TL-SGLRKLYSLVNLDLSSNQIEELDEV--NHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhHhhhcCEeeeehhhhhHh-hh-hhhHhhhhheeccccccchhhHHHh--cccccccHHHHHhhcCCCccc
Confidence 44455667777777777764 22 3356667777888887766655432 345666666666666665543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.86 E-value=2e-09 Score=98.37 Aligned_cols=105 Identities=26% Similarity=0.255 Sum_probs=42.6
Q ss_pred CCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCc-cCCCCCCEEeCCCCCCCcccccCChhhhccccC
Q 046265 293 LYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVL-GSISDLEYLDLSTNYNNEFRKEFPVELEKLVQL 371 (639)
Q Consensus 293 l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L 371 (639)
+.+|+.||+++|.|... + .+..++.|+.|++++|+++. ++..+ ..+++|+.|++++|++..+... ..+..+++|
T Consensus 41 l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l--~~L~~l~~L 115 (175)
T PF14580_consen 41 LDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKISDLNEL--EPLSSLPKL 115 (175)
T ss_dssp -TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCC--GGGGG-TT-
T ss_pred hcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcCCChHHh--HHHHcCCCc
Confidence 45566666666666532 2 35566667777777777663 32222 3467777777777766655432 346677888
Q ss_pred CeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEc
Q 046265 372 TELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCID 409 (639)
Q Consensus 372 ~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ld 409 (639)
+.|++.+|++.... ......+..+++|+.||
T Consensus 116 ~~L~L~~NPv~~~~-------~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 116 RVLSLEGNPVCEKK-------NYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp -EEE-TT-GGGGST-------THHHHHHHH-TT-SEET
T ss_pred ceeeccCCcccchh-------hHHHHHHHHcChhheeC
Confidence 88888888765421 11224577888888887
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.7e-09 Score=81.24 Aligned_cols=61 Identities=33% Similarity=0.485 Sum_probs=54.6
Q ss_pred CCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccC
Q 046265 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGL 90 (639)
Q Consensus 30 ~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 90 (639)
++|++|++++|+++...+..|..+++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4789999999999977778899999999999999999977778899999999999999975
|
... |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.82 E-value=6.9e-10 Score=114.10 Aligned_cols=97 Identities=22% Similarity=0.414 Sum_probs=84.8
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
..|+.|++|...+|.+++.++....+.+|.....++.|++.|++| + +.+|||+||.||....+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 478999999999999999887777788999999999999999999 4 7899999999999999999999999998
Q ss_pred ccCCCCC------CCcceeeeeceeeCCC
Q 046265 617 KFLKPDS------SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~------~~~~~~~gt~~Y~APE 639 (639)
..+.... ...+.-+||..||+||
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPE 432 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPE 432 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHH
Confidence 8765443 1234568999999998
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.6e-08 Score=95.52 Aligned_cols=143 Identities=22% Similarity=0.172 Sum_probs=98.4
Q ss_pred ceeccCCCceEEEEEcCCCcEEEEEEccCCCCChh---------hHHHHHHHHHHHhccccCce--eeeEEEEEc-----
Q 046265 471 YCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMV---------VQQAFSNEIKALTELRHRNV--VKFYGFSFH----- 534 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~H~ni--v~l~~~~~~----- 534 (639)
+++-+-....|++.++ +|+.|.||+......... ....+.+|...+.++...+| ++.+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445667765 457899997753321100 01136789888888754333 444566543
Q ss_pred CCceeEEecccCCC-ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-------CC
Q 046265 535 PRQSFLLYEYLGRG-SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL-------DY 606 (639)
Q Consensus 535 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~-------~~ 606 (639)
....++|+|++++. ++.+++..... ...+...+..++.+++..+.-||.. +|+|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 23578999999886 79888753211 1233456678899999999999999 9999999999999975 46
Q ss_pred ceEEcccccccc
Q 046265 607 DAHVSDFGISKF 618 (639)
Q Consensus 607 ~~kl~DfGla~~ 618 (639)
.+.++||+-+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 799999998754
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=8e-10 Score=117.66 Aligned_cols=64 Identities=30% Similarity=0.198 Sum_probs=32.1
Q ss_pred ccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCccc---CCcC-ccCCCCCCEEeCCCCC
Q 046265 288 PKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGS---LPRV-LGSISDLEYLDLSTNY 353 (639)
Q Consensus 288 ~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~---~p~~-~~~l~~L~~L~Ls~N~ 353 (639)
..+..+..+..|++.+|++... ..+...+.+..+....|.+... .... .+..+.++...+..|.
T Consensus 249 ~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (414)
T KOG0531|consen 249 EGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNP 316 (414)
T ss_pred ccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCc
Confidence 3444555666666666665432 1233344455555555554311 1111 3455666777777654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=4e-09 Score=120.01 Aligned_cols=268 Identities=25% Similarity=0.266 Sum_probs=126.8
Q ss_pred CCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCc--CCCCCCc-ccCCCCCCCEEeeecccCccccCccccCCCCCCc
Q 046265 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNK--LRGSVPR-EVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAI 106 (639)
Q Consensus 30 ~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~--l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 106 (639)
...+...+-+|.+. .++..... ++|++|-+..|. +. .++. .|..++.|+.|||++|.=-+.+|..+++|-
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li---- 595 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELV---- 595 (889)
T ss_pred hheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhh----
Confidence 45566666666554 33333222 256666666664 33 2332 355566666666666443334444444333
Q ss_pred ccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCC--ccCC
Q 046265 107 GSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN--GVLP 184 (639)
Q Consensus 107 ~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~p 184 (639)
+| ++|+|++..++ .+|..+.+|..|.+|++..+.-...+|.....+++|++|.+...... +..-
T Consensus 596 -----------~L--ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l 661 (889)
T KOG4658|consen 596 -----------HL--RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLL 661 (889)
T ss_pred -----------hh--hcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhH
Confidence 33 36666666665 56666666666666666665544444555555666666666443311 1111
Q ss_pred ccCcCCCCCCeEEccCCcc--ccccccccCCc----EEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhc-
Q 046265 185 PSISNLSNLEGLYLYSSLV--SAEIGNLLQLI----ELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGI- 257 (639)
Q Consensus 185 ~~~~~l~~L~~L~l~~~~~--~~~~~~l~~L~----~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~- 257 (639)
..+.++.+|+.+....... -..+..++.|. .+.+..+.. ...+..+..+.+|+.|.+.++.+.......+..
T Consensus 662 ~el~~Le~L~~ls~~~~s~~~~e~l~~~~~L~~~~~~l~~~~~~~-~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~ 740 (889)
T KOG4658|consen 662 KELENLEHLENLSITISSVLLLEDLLGMTRLRSLLQSLSIEGCSK-RTLISSLGSLGNLEELSILDCGISEIVIEWEESL 740 (889)
T ss_pred HhhhcccchhhheeecchhHhHhhhhhhHHHHHHhHhhhhccccc-ceeecccccccCcceEEEEcCCCchhhccccccc
Confidence 1223333333333321111 01112222222 222222222 223445667777788887777765432222111
Q ss_pred -----CCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCc
Q 046265 258 -----YPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVY 331 (639)
Q Consensus 258 -----l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~ 331 (639)
++++..+...+.. ....+.+.-..++|+.|.+..+.....+.+....+..+..+.+..+.+.
T Consensus 741 ~~~~~f~~l~~~~~~~~~------------~~r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~ 807 (889)
T KOG4658|consen 741 IVLLCFPNLSKVSILNCH------------MLRDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLE 807 (889)
T ss_pred chhhhHHHHHHHHhhccc------------cccccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccc
Confidence 1111111111100 0112333334568888888877666555555555555555444444444
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2e-09 Score=107.77 Aligned_cols=208 Identities=22% Similarity=0.234 Sum_probs=124.8
Q ss_pred cCCCCCCEEECcCCCCccCCC--CCCCCCCCCCEEEcccCcCCCCC--CcccCCCCCCCEEeeecccCccccCccccCCC
Q 046265 27 GNISNLKFLDMGNNQLSGVIP--QEIDPLTHLKHLYINVNKLRGSV--PREVGQLSSLKQLVLYCNGLSGWLPSSFGNLN 102 (639)
Q Consensus 27 ~~l~~L~~L~Ls~n~l~~~~p--~~~~~L~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 102 (639)
.++++|+...|.++.+. ..+ .....|++++.|||+.|-+.... -.-...|++|+.|+|+.|++.-........
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~-- 194 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTL-- 194 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchh--
Confidence 46778888889888875 334 35678899999999999887532 233567889999999999876322111110
Q ss_pred CCCcccCCCCCcccCCCCccEEEccCCcCcc-cCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCc
Q 046265 103 NLAIGSMPNSLSNLTSLSLFHLDLSENQLSG-SIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNG 181 (639)
Q Consensus 103 ~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 181 (639)
.+..| ..|.|+.+.++- .+-.....+|+|+.|+|..|...+.-.....-++.|+.|||++|++-.
T Consensus 195 ------------~l~~l--K~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~ 260 (505)
T KOG3207|consen 195 ------------LLSHL--KQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID 260 (505)
T ss_pred ------------hhhhh--heEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc
Confidence 11222 577788887762 222334567889999998885433333445567788888998888752
Q ss_pred cC-CccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCC-CCcc-----ccCCCCCceeccccccccCcc-hh
Q 046265 182 VL-PPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQ-IPKS-----LRNFTSLNIVHLEQNHLTGNI-YE 253 (639)
Q Consensus 182 ~~-p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~p~~-----~~~l~~L~~L~L~~N~l~~~~-~~ 253 (639)
.- -...+.++.|+.|.+ +.+.+... .|+. ...+++|++|+++.|++..-. -+
T Consensus 261 ~~~~~~~~~l~~L~~Lnl--------------------s~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~ 320 (505)
T KOG3207|consen 261 FDQGYKVGTLPGLNQLNL--------------------SSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLN 320 (505)
T ss_pred cccccccccccchhhhhc--------------------cccCcchhcCCCccchhhhcccccceeeecccCccccccccc
Confidence 21 022344444444444 44333221 1221 235677778888777774311 12
Q ss_pred hhhcCCCccEEeccCCcc
Q 046265 254 VFGIYPNLTFLDLSQNNF 271 (639)
Q Consensus 254 ~~~~l~~L~~L~Ls~N~l 271 (639)
.+..+++|+.|....|.+
T Consensus 321 ~l~~l~nlk~l~~~~n~l 338 (505)
T KOG3207|consen 321 HLRTLENLKHLRITLNYL 338 (505)
T ss_pred hhhccchhhhhhcccccc
Confidence 234456666666555554
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.8e-09 Score=113.45 Aligned_cols=191 Identities=26% Similarity=0.296 Sum_probs=103.5
Q ss_pred cEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCC
Q 046265 122 FHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSS 201 (639)
Q Consensus 122 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~ 201 (639)
..+++..|.+. .+-..+..+.+|..|++.+|+|.+. ...+..+.+|+.|++++|.|+...+ +.
T Consensus 75 ~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~~--l~------------- 137 (414)
T KOG0531|consen 75 KELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLEG--LS------------- 137 (414)
T ss_pred Hhhccchhhhh-hhhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccccc--hh-------------
Confidence 34556666665 3334456677777777777777643 2225667777777777777764321 22
Q ss_pred ccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcch-hhhhcCCCccEEeccCCcccccccCcCC
Q 046265 202 LVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIY-EVFGIYPNLTFLDLSQNNFYGSLNFSMN 280 (639)
Q Consensus 202 ~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~l~ls~n 280 (639)
.++.|+.|++++|.+... ..+..++.|+.+++++|++....+ . ...+.+++.+++.+|.+.
T Consensus 138 -------~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~-------- 199 (414)
T KOG0531|consen 138 -------TLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR-------- 199 (414)
T ss_pred -------hccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--------
Confidence 233355556666655331 234446666667777776665443 1 345566666666665542
Q ss_pred ccccccCccccCCCCCCEEeccCCcccccCCccccCCC--CCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCC
Q 046265 281 NITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLK--SLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNN 355 (639)
Q Consensus 281 ~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~ 355 (639)
....+..+..+..+++..|.++..-+ +..+. +|+.+++++|++. ..+..+..+..+..|+++.|++.
T Consensus 200 -----~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 200 -----EIEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred -----cccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccc
Confidence 12223333344444556665542221 11122 2566666666665 22244555666666777665433
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.68 E-value=5.9e-09 Score=104.39 Aligned_cols=210 Identities=20% Similarity=0.256 Sum_probs=105.8
Q ss_pred cCCCCCCEEeccCCCCCCCCC--ccccCCCcccEEEcccCcCCccC--CccCcCCCCCCeEEccCCccccccccccCCcE
Q 046265 140 GHLSNLAVLHLGDNSLFGSIP--PILGKVQSLLSLGFDLNLLNGVL--PPSISNLSNLEGLYLYSSLVSAEIGNLLQLIE 215 (639)
Q Consensus 140 ~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~--p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~ 215 (639)
.++.+|+...|.+.... ..+ .....+++++.|||+.|.+..-. -... ..+++|+.
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~--------------------eqLp~Le~ 176 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIA--------------------EQLPSLEN 176 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHH--------------------Hhcccchh
Confidence 45667777777766654 222 23456667777777777665321 1122 23455555
Q ss_pred EEcCCcccCCCCCccc-cCCCCCceeccccccccCcc-hhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCC
Q 046265 216 LEIDNKQLFGQIPKSL-RNFTSLNIVHLEQNHLTGNI-YEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKL 293 (639)
Q Consensus 216 L~l~~n~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l 293 (639)
|+++.|++.-...... ..+++|+.|.++.|.++... ....-.+|+|..|+|..|... ..-.....-+
T Consensus 177 LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~-----------~~~~~~~~i~ 245 (505)
T KOG3207|consen 177 LNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEII-----------LIKATSTKIL 245 (505)
T ss_pred cccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhccccc-----------ceecchhhhh
Confidence 5555555532221111 13456666666666665321 122344566666666555311 0111111223
Q ss_pred CCCCEEeccCCcccccC-CccccCCCCCCeeeccCccCccc-CCcC-----ccCCCCCCEEeCCCCCCCcccccCChhhh
Q 046265 294 YQLHKLDFSLNHIVGEL-PIELGNLKSLNYRALNGNKVYGS-LPRV-----LGSISDLEYLDLSTNYNNEFRKEFPVELE 366 (639)
Q Consensus 294 ~~L~~L~Ls~N~~~~~~-p~~~~~l~~L~~L~l~~N~l~~~-~p~~-----~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~ 366 (639)
..|+.|||++|++.... -...+.++.|+.|+++.+.+... +|+. ...+++|++|+++.|++.++.. -..+.
T Consensus 246 ~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~s--l~~l~ 323 (505)
T KOG3207|consen 246 QTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRS--LNHLR 323 (505)
T ss_pred hHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccc--cchhh
Confidence 45666666666654221 12345566666666666665422 1222 2345677788887766544421 12344
Q ss_pred ccccCCeeeccCCcCce
Q 046265 367 KLVQLTELDLVITFWEE 383 (639)
Q Consensus 367 ~l~~L~~l~l~~n~~~~ 383 (639)
.+.+|+.+....|++..
T Consensus 324 ~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 324 TLENLKHLRITLNYLNK 340 (505)
T ss_pred ccchhhhhhcccccccc
Confidence 45555656655665543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.2e-08 Score=105.08 Aligned_cols=167 Identities=22% Similarity=0.210 Sum_probs=123.7
Q ss_pred CCCcceecc--CCCceEEEEEc---CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCceeE
Q 046265 467 FDAKYCIGT--AGQASVYKAEL---PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 467 f~~~~~ig~--g~~g~vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l 540 (639)
|.....+|. |.+|.||.+.. .++..+|+|+-+...........=.+|+...++++ |+|.++.+..+.+.+..++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 445677899 99999999854 56788999985443221112222256777777775 9999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHH----HHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEccccc
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVAN----TLSYMHHDYFPPIVHRDISSKNVLLGLD-YDAHVSDFGI 615 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~----~l~~lH~~~~~~iiHrdlk~~Nill~~~-~~~kl~DfGl 615 (639)
-.|++. .++..+.+.... .++......+..+..+ |+.++|.. .|+|-|+||+||....+ ...+.+|||+
T Consensus 196 qtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 196 QTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcce
Confidence 999885 788777765432 2344555566666666 99999988 89999999999999998 8899999999
Q ss_pred cccCCCCCCCc-----ceeeeeceeeCCC
Q 046265 616 SKFLKPDSSNW-----SEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~~~-----~~~~gt~~Y~APE 639 (639)
...+....-.. ....|..-|+|||
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke 298 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKE 298 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChh
Confidence 88775443111 1125777899997
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=5.8e-09 Score=118.75 Aligned_cols=99 Identities=22% Similarity=0.318 Sum_probs=76.1
Q ss_pred eeEEEEeCCCcc-cccCC-ccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEe
Q 046265 7 FFFQVVHESNTL-FAIIP-PQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLV 84 (639)
Q Consensus 7 ~~~~~~~~~n~~-~~~~p-~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 84 (639)
.+..+.+..|.. ...++ ..|..++.|++|||++|.=-+.+|..++.|-+|++|+|+...++ .+|..+++|..|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 455666666652 33444 44777999999999988766788999999999999999999988 7899999999999999
Q ss_pred eecccCccccCccccCCCCCCc
Q 046265 85 LYCNGLSGWLPSSFGNLNNLAI 106 (639)
Q Consensus 85 L~~N~l~~~~p~~~~~l~~L~~ 106 (639)
+..+.-...+|.....|++|+.
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~ 646 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRV 646 (889)
T ss_pred cccccccccccchhhhcccccE
Confidence 9887765566666666776663
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.1e-07 Score=101.03 Aligned_cols=123 Identities=15% Similarity=0.208 Sum_probs=97.6
Q ss_pred EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCCChhHHhhcCCCCCCcC
Q 046265 485 ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFS 564 (639)
Q Consensus 485 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 564 (639)
+..++..|.|........ ...+...+.+..++.+|||||++++..+..++..|+|.|-+ ..|..++++.+
T Consensus 33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~------ 102 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG------ 102 (690)
T ss_pred eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH------
Confidence 556778888888775443 22344567788899999999999999999999999999987 35555665433
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 565 WTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 565 ~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
-......+.||+.||.|||+.+ +++|++|.-+.|.++..|.-||++|-++...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 1233446789999999999876 8999999999999999999999999877543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.6e-08 Score=74.68 Aligned_cols=60 Identities=37% Similarity=0.564 Sum_probs=42.8
Q ss_pred CCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcc
Q 046265 212 QLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNF 271 (639)
Q Consensus 212 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 271 (639)
+|+.|++++|++....+.+|.++++|++|++++|.++...++.|..+++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 566777777777665556777777777777777777777677777777777777766653
|
... |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.2e-08 Score=103.96 Aligned_cols=150 Identities=20% Similarity=0.208 Sum_probs=118.1
Q ss_pred hccCCCcceeccCCCceEEEEEc--CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL--PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 540 (639)
..+|.....||.|.|+.|+.... .++..||+|.+............-..|+.+...+ .|.++++++..|...+..|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 45677788999999999999853 4678899998876554444444445677777766 59999999988888888889
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEccccccccC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD-YDAHVSDFGISKFL 619 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~-~~~kl~DfGla~~~ 619 (639)
--|||++++....+. ....++...++++..+++.++.++|.. .++|+|+||+||++..+ +..++.|||.++.+
T Consensus 344 p~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccc
Confidence 999999998865542 112344456777888999999999977 89999999999999876 88999999988643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.4e-07 Score=86.16 Aligned_cols=135 Identities=24% Similarity=0.217 Sum_probs=95.2
Q ss_pred CcceeccCCCceEEEEEcCCCcEEEEEEccCCCC------------------C--hhhHHHHHHHHHHHhccccC--cee
Q 046265 469 AKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHP------------------D--MVVQQAFSNEIKALTELRHR--NVV 526 (639)
Q Consensus 469 ~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~------------------~--~~~~~~~~~e~~~l~~l~H~--niv 526 (639)
....||.|.-+.||.|..+.|..+|||.=+.... . ...+....+|.++|.++.-. .|.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 4678999999999999999999999995432110 0 12234457899999988644 677
Q ss_pred eeEEEEEcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 046265 527 KFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY 606 (639)
Q Consensus 527 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~ 606 (639)
+.+++ +...+||||++|-.|+..-- +. .....++..|++-+.-.-.. ||||+|+.+=||+++++|
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~---en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRLRL-----DV---ENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDG 239 (304)
T ss_pred Ccccc----ccceeeeehcccceeecccC-----cc---cCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCC
Confidence 76665 56789999999977764421 11 12223334444433333345 899999999999999999
Q ss_pred ceEEcccccccc
Q 046265 607 DAHVSDFGISKF 618 (639)
Q Consensus 607 ~~kl~DfGla~~ 618 (639)
.+.++||--+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999976654
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=4.3e-09 Score=102.65 Aligned_cols=245 Identities=18% Similarity=0.212 Sum_probs=129.8
Q ss_pred ccCCCCCCEEECcCCCCcc----CCCCCCCCCCCCCEEEcccCcCCC----CCCc-------ccCCCCCCCEEeeecccC
Q 046265 26 IGNISNLKFLDMGNNQLSG----VIPQEIDPLTHLKHLYINVNKLRG----SVPR-------EVGQLSSLKQLVLYCNGL 90 (639)
Q Consensus 26 ~~~l~~L~~L~Ls~n~l~~----~~p~~~~~L~~L~~L~L~~N~l~~----~~p~-------~~~~l~~L~~L~L~~N~l 90 (639)
+..+..++.|+||+|.+.. .+.+.+.+.++|+.-+++.= ++| .+|+ ++-..++|++|+||.|-|
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~ 104 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAF 104 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeecccccc
Confidence 4456677888888887753 23344566777777777642 222 2333 233455777777777776
Q ss_pred ccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCcc-------------ccCCCCCCEEeccCCCCCC
Q 046265 91 SGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHF-------------LGHLSNLAVLHLGDNSLFG 157 (639)
Q Consensus 91 ~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~-------------~~~l~~L~~L~L~~N~l~~ 157 (639)
.-.-+..|..+ +.+++.| ++|.|++|.+...-... .+.-+.|+++..+.|++..
T Consensus 105 G~~g~~~l~~l-----------l~s~~~L--~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen 171 (382)
T KOG1909|consen 105 GPKGIRGLEEL-----------LSSCTDL--EELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLEN 171 (382)
T ss_pred CccchHHHHHH-----------HHhccCH--HHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccccc
Confidence 64333333322 1222333 67777777654111111 2233456666666665532
Q ss_pred CC----CccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCC----CCc
Q 046265 158 SI----PPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQ----IPK 229 (639)
Q Consensus 158 ~~----p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~----~p~ 229 (639)
.. ...|...+.|+.+.+..|.|... .. ..+...+..++.|+.|+|.+|-++.. +..
T Consensus 172 ~ga~~~A~~~~~~~~leevr~~qN~I~~e---G~-------------~al~eal~~~~~LevLdl~DNtft~egs~~Lak 235 (382)
T KOG1909|consen 172 GGATALAEAFQSHPTLEEVRLSQNGIRPE---GV-------------TALAEALEHCPHLEVLDLRDNTFTLEGSVALAK 235 (382)
T ss_pred ccHHHHHHHHHhccccceEEEecccccCc---hh-------------HHHHHHHHhCCcceeeecccchhhhHHHHHHHH
Confidence 11 11233444555555555544311 00 00011344556666777777766432 233
Q ss_pred cccCCCCCceeccccccccCcchhhh-----hcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCC
Q 046265 230 SLRNFTSLNIVHLEQNHLTGNIYEVF-----GIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLN 304 (639)
Q Consensus 230 ~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N 304 (639)
.++.+++|+.|+++++.+...-...| ...|+|+.|.+.+|.++..- ...+-..+...+.|..|+|+.|
T Consensus 236 aL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da-------~~~la~~~~ek~dL~kLnLngN 308 (382)
T KOG1909|consen 236 ALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDA-------ALALAACMAEKPDLEKLNLNGN 308 (382)
T ss_pred HhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHH-------HHHHHHHHhcchhhHHhcCCcc
Confidence 45667778888888877765433222 23578888887777664210 0012223344667888888888
Q ss_pred ccc
Q 046265 305 HIV 307 (639)
Q Consensus 305 ~~~ 307 (639)
.+.
T Consensus 309 ~l~ 311 (382)
T KOG1909|consen 309 RLG 311 (382)
T ss_pred ccc
Confidence 883
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.7e-08 Score=97.18 Aligned_cols=252 Identities=19% Similarity=0.159 Sum_probs=126.8
Q ss_pred cccCCCCCCEEeccCCCCCCC----CCccccCCCcccEEEcccCcCCc----cCCccCcCCCCCCeEEccCCcccccccc
Q 046265 138 FLGHLSNLAVLHLGDNSLFGS----IPPILGKVQSLLSLGFDLNLLNG----VLPPSISNLSNLEGLYLYSSLVSAEIGN 209 (639)
Q Consensus 138 ~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~~~~~~~~~~ 209 (639)
.+..+.+++.++|++|.+... +...+.+.++|+..++++= ++| .+|+.+.. +...+..
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~-------------l~~aL~~ 90 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKM-------------LSKALLG 90 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHH-------------HHHHHhc
Confidence 345567788888888877432 2233455566666666542 222 23322211 1112333
Q ss_pred ccCCcEEEcCCcccCCCCCc----cccCCCCCceeccccccccCcchhh-------------hhcCCCccEEeccCCccc
Q 046265 210 LLQLIELEIDNKQLFGQIPK----SLRNFTSLNIVHLEQNHLTGNIYEV-------------FGIYPNLTFLDLSQNNFY 272 (639)
Q Consensus 210 l~~L~~L~l~~n~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~~~~-------------~~~l~~L~~L~Ls~N~l~ 272 (639)
.++|+.++||+|-+...-+. -+.+++.|+.|.|.||.+...--.. ...-+.|+++...+|++.
T Consensus 91 ~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrle 170 (382)
T KOG1909|consen 91 CPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLE 170 (382)
T ss_pred CCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccc
Confidence 44666667776666333222 2345667777777777654221111 122355666666666652
Q ss_pred ccccCcCCccccccCccccCCCCCCEEeccCCccccc----CCccccCCCCCCeeeccCccCccc----CCcCccCCCCC
Q 046265 273 GSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGE----LPIELGNLKSLNYRALNGNKVYGS----LPRVLGSISDL 344 (639)
Q Consensus 273 ~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L 344 (639)
. .-...+-..+...+.|+.+.+++|.|... +...+..+++|+.|||..|-++.. +...++.+++|
T Consensus 171 n-------~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L 243 (382)
T KOG1909|consen 171 N-------GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHL 243 (382)
T ss_pred c-------ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchh
Confidence 1 00011223344455666666666665311 223455667777777777666421 22344556667
Q ss_pred CEEeCCCCCCCccc-ccCChhh-hccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeee
Q 046265 345 EYLDLSTNYNNEFR-KEFPVEL-EKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELR 416 (639)
Q Consensus 345 ~~L~Ls~N~~~~~~-~~~p~~~-~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~ 416 (639)
+.|++++..+..-. ..+-..+ ...++|+.+.+..|.+...- ..+....+...+.|..|+++.|.+.
T Consensus 244 ~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da------~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 244 RELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDA------ALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred eeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHH------HHHHHHHHhcchhhHHhcCCccccc
Confidence 77777663222100 0011111 12456777777777654321 1112234555777888888888873
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.2e-06 Score=93.97 Aligned_cols=141 Identities=23% Similarity=0.238 Sum_probs=93.9
Q ss_pred cceeccCCCceEEEEEcCCCcEEEEEEccCCCCChh--------------------------------------hHHHHH
Q 046265 470 KYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMV--------------------------------------VQQAFS 511 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~--------------------------------------~~~~~~ 511 (639)
.+-|+.++-|+||+|++++|+.||||..+..-.... .+-++.
T Consensus 130 ~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 130 PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 367899999999999999999999998874311000 011235
Q ss_pred HHHHHHhccc-----cCceeeeEEEEE-cCCceeEEecccCCCChhHHh--hcCCCCCCcCHHHHHHHHHHHHHH-HHHH
Q 046265 512 NEIKALTELR-----HRNVVKFYGFSF-HPRQSFLLYEYLGRGSLAIIL--SNDAAIDEFSWTVRMNVIKSVANT-LSYM 582 (639)
Q Consensus 512 ~e~~~l~~l~-----H~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~~~i~~~i~~~-l~~l 582 (639)
+|+.-+.+++ .|++ .+-..|+ -.+...++|||++|-.+.+.. +.. + .+ +..++..++++ +..+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~-g---~d---~k~ia~~~~~~f~~q~ 281 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA-G---ID---RKELAELLVRAFLRQL 281 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhc-C---CC---HHHHHHHHHHHHHHHH
Confidence 6666666553 2333 3334443 356778999999999888774 332 2 22 22233332222 2222
Q ss_pred HhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 583 HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 583 H~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
-.. +++|.|..|.||+++.+|++-..|||+...+.+
T Consensus 282 ~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 282 LRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred Hhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 234 899999999999999999999999999877653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.5e-06 Score=83.01 Aligned_cols=108 Identities=19% Similarity=0.280 Sum_probs=82.7
Q ss_pred HHHHHHHHHHHhccccC--ceeeeEEEEEcCC----ceeEEecccCCC-ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHH
Q 046265 507 QQAFSNEIKALTELRHR--NVVKFYGFSFHPR----QSFLLYEYLGRG-SLAIILSNDAAIDEFSWTVRMNVIKSVANTL 579 (639)
Q Consensus 507 ~~~~~~e~~~l~~l~H~--niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l 579 (639)
.....+|...+.++... .+++.+++..... ..++|+|++++. +|.+++..... .+......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 34567888887777533 3456667666532 458999999874 79998875332 23356778899999999
Q ss_pred HHHHhCCCCCeEeecCCCCCeeeCCCC---ceEEccccccccCC
Q 046265 580 SYMHHDYFPPIVHRDISSKNVLLGLDY---DAHVSDFGISKFLK 620 (639)
Q Consensus 580 ~~lH~~~~~~iiHrdlk~~Nill~~~~---~~kl~DfGla~~~~ 620 (639)
+-||.. +|+|+|+++.|||++.+. .+.++||+-++...
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999 999999999999999877 89999999877543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.33 E-value=1e-05 Score=75.82 Aligned_cols=148 Identities=19% Similarity=0.145 Sum_probs=105.1
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCC---CC-hhhHHHHHHHHHHHhccccC--ceeeeEEEEE-cC--
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPH---PD-MVVQQAFSNEIKALTELRHR--NVVKFYGFSF-HP-- 535 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~---~~-~~~~~~~~~e~~~l~~l~H~--niv~l~~~~~-~~-- 535 (639)
..+.+.---|+||-+.|++..+.+. .+-+|+-...- .. +..+..|.+|...+.++... .+.+.. ++. ..
T Consensus 18 ~~wve~pN~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~ 95 (216)
T PRK09902 18 GDWVEEPNYRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIE 95 (216)
T ss_pred CceecCCCcCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccC
Confidence 3333444558899999999877654 68888765211 11 33567899999999988643 344555 332 21
Q ss_pred --CceeEEecccCC-CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc--eEE
Q 046265 536 --RQSFLLYEYLGR-GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD--AHV 610 (639)
Q Consensus 536 --~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~--~kl 610 (639)
...+||+|-+++ -+|.+++..... ...+...+..+..+++.+++-||.. ++.|+|+.+.||+++.++. +++
T Consensus 96 ~~~rA~LVTe~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~l 171 (216)
T PRK09902 96 GEWRALLVTEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGF 171 (216)
T ss_pred CceEEEEEEEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEE
Confidence 245799997653 688888765432 2345566778999999999999999 9999999999999986666 999
Q ss_pred cccccccc
Q 046265 611 SDFGISKF 618 (639)
Q Consensus 611 ~DfGla~~ 618 (639)
+||--++.
T Consensus 172 IDlEk~r~ 179 (216)
T PRK09902 172 LDLEKSRR 179 (216)
T ss_pred EEhhccch
Confidence 99976553
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=6e-06 Score=88.16 Aligned_cols=142 Identities=20% Similarity=0.250 Sum_probs=89.5
Q ss_pred cceeccCCCceEEEEEcCCCcEEEEEEccCCCCChh-----------------------------------hHHHHHHHH
Q 046265 470 KYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMV-----------------------------------VQQAFSNEI 514 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~-----------------------------------~~~~~~~e~ 514 (639)
.+-||..+.|+||+|++++|+.||||.-+..-.... .+-+|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 467899999999999999999999998765321110 011245666
Q ss_pred HHHhcc----ccCce---eeeEEEEEc-CCceeEEecccCCCChhHHh--hcCCCCCCcCHHHHHHHHHHHHHHHHHHHh
Q 046265 515 KALTEL----RHRNV---VKFYGFSFH-PRQSFLLYEYLGRGSLAIIL--SNDAAIDEFSWTVRMNVIKSVANTLSYMHH 584 (639)
Q Consensus 515 ~~l~~l----~H~ni---v~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 584 (639)
+-..++ +|-+. |.+-..|++ .....++||||+|..+.+.- +..+. +-. .++..+.++ |++.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi----~~~---~i~~~l~~~--~~~q 316 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGI----SPH---DILNKLVEA--YLEQ 316 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCC----CHH---HHHHHHHHH--HHHH
Confidence 554443 45551 112233333 34678999999998876654 33222 112 233322222 2222
Q ss_pred CCCCCeEeecCCCCCeeeCC----CCceEEccccccccCC
Q 046265 585 DYFPPIVHRDISSKNVLLGL----DYDAHVSDFGISKFLK 620 (639)
Q Consensus 585 ~~~~~iiHrdlk~~Nill~~----~~~~kl~DfGla~~~~ 620 (639)
-...|.+|+|-.|.||++.+ ++.+.+-|||+.+.+.
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 11228999999999999984 6789999999987654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=7.8e-07 Score=86.33 Aligned_cols=97 Identities=22% Similarity=0.389 Sum_probs=77.9
Q ss_pred HHHhccccCceeeeEEEEEcCC-----ceeEEecccCCCChhHHhhcCCC-CCCcCHHHHHHHHHHHHHHHHHHHhCCCC
Q 046265 515 KALTELRHRNVVKFYGFSFHPR-----QSFLLYEYLGRGSLAIILSNDAA-IDEFSWTVRMNVIKSVANTLSYMHHDYFP 588 (639)
Q Consensus 515 ~~l~~l~H~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 588 (639)
.-+-.+.|.|||+++.||.+.. +..++.|||+.|++.+++++-+. ...+......+++-||..|+.|||. |.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 4455567999999999997643 46788999999999999975332 1234445556789999999999996 468
Q ss_pred CeEeecCCCCCeeeCCCCceEEcc
Q 046265 589 PIVHRDISSKNVLLGLDYDAHVSD 612 (639)
Q Consensus 589 ~iiHrdlk~~Nill~~~~~~kl~D 612 (639)
+|+|+++...-|.+...|-+|+.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~ 221 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGS 221 (458)
T ss_pred ccccCCcchhheeecCCceEEecc
Confidence 999999999999999888888763
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.23 E-value=7.6e-06 Score=84.52 Aligned_cols=141 Identities=19% Similarity=0.242 Sum_probs=105.7
Q ss_pred CceEEEE-EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc----CCceeEEecccCC-CChh
Q 046265 478 QASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH----PRQSFLLYEYLGR-GSLA 551 (639)
Q Consensus 478 ~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~ 551 (639)
-.+.||| .-.||..|+.|+++..+... ......-++.++++.|+|||++.+++.. +..+++||+|.++ ++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3478898 55689999999995322111 1122345788999999999999998873 3467899999985 5776
Q ss_pred HHhhcCCC------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 552 IILSNDAA------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 552 ~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
++-..... ....++...+.++.|++.||.++|+. |..-+-+.+.+|+++.+.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 66532111 12356678889999999999999998 7777999999999999889999988877666
Q ss_pred CCCC
Q 046265 620 KPDS 623 (639)
Q Consensus 620 ~~~~ 623 (639)
..+.
T Consensus 444 ~~d~ 447 (655)
T KOG3741|consen 444 QEDP 447 (655)
T ss_pred cCCC
Confidence 5443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.18 E-value=3.2e-05 Score=74.90 Aligned_cols=140 Identities=12% Similarity=0.116 Sum_probs=85.4
Q ss_pred ceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCc--eeeeEEEEEcCCceeEEecccCCC
Q 046265 471 YCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN--VVKFYGFSFHPRQSFLLYEYLGRG 548 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~g 548 (639)
..||+|..+.||+. .+..+++|..+... ......+|.++++.+..-. +.+.+++....+..++|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 57899999999984 24567788876422 2234578999998876433 467778877777888999999886
Q ss_pred C-hhHHh---------------------hcCCCCCCcCHHHHHH-HHH----------HHHH-HHHHHHhC-CCCCeEee
Q 046265 549 S-LAIIL---------------------SNDAAIDEFSWTVRMN-VIK----------SVAN-TLSYMHHD-YFPPIVHR 593 (639)
Q Consensus 549 ~-L~~~l---------------------~~~~~~~~~~~~~~~~-i~~----------~i~~-~l~~lH~~-~~~~iiHr 593 (639)
+ +...+ +.-. ........... +.. .+.+ ..+++... ..+.++|+
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 3 21111 1100 01111111110 000 0111 12222211 12367899
Q ss_pred cCCCCCeeeCCCCceEEccccccccC
Q 046265 594 DISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 594 dlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
|+.|.||++++++ +.|+||+.+...
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCcC
Confidence 9999999999888 999999987643
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.5e-05 Score=74.20 Aligned_cols=155 Identities=21% Similarity=0.249 Sum_probs=97.7
Q ss_pred chHHHHHHHhccCCCcc---eeccCCCceEEEEEcCCCcEEEEEEccCCCCCh----------------------hhHHH
Q 046265 455 ILYEEVIRATNNFDAKY---CIGTAGQASVYKAELPSWEIVAVKKFHSPHPDM----------------------VVQQA 509 (639)
Q Consensus 455 ~~~~~~~~~~~~f~~~~---~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~----------------------~~~~~ 509 (639)
.+.+.+.+..+...... +|++|.-+.||+|.-.++..+|||..+..-..- .....
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 44555555544444443 566788889999988888999999887432110 01122
Q ss_pred HHHHHHHHhccc--cCceeeeEEEEEcCCceeEEecccCCC-ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCC
Q 046265 510 FSNEIKALTELR--HRNVVKFYGFSFHPRQSFLLYEYLGRG-SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY 586 (639)
Q Consensus 510 ~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 586 (639)
..+|..-|.++. +-.+.+.+++. .-.+||||++.. .-+-.|+.-. ........+..++.+.+.-|-..+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~----~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVP----LELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCC----cCchhHHHHHHHHHHHHHHHHHhc
Confidence 356666666664 33444444442 346999998654 2222222211 111245556667777777776632
Q ss_pred CCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 587 FPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 587 ~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
++||+|+..=|||+. ++.+.|+|||-|....
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 899999999999999 8899999999887654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.13 E-value=9.6e-06 Score=75.83 Aligned_cols=104 Identities=22% Similarity=0.208 Sum_probs=81.4
Q ss_pred HHHHHHHhcccc-CceeeeEEEEEcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 046265 511 SNEIKALTELRH-RNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP 589 (639)
Q Consensus 511 ~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ 589 (639)
..|.-++..+++ +++++++|+|-. ++|.||.+.+++...-..-......+|..|.+||.++++.++++++...-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 347788888876 699999999943 678999988776532111011124689999999999999999999865546
Q ss_pred eEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 590 IVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 590 iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
+.-.|++++|+-+++++++|+.|..-+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 77899999999999999999999976554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.06 E-value=8.3e-08 Score=101.77 Aligned_cols=21 Identities=29% Similarity=0.365 Sum_probs=16.5
Q ss_pred CCCCCCCCCCCEEEcccCcCC
Q 046265 47 PQEIDPLTHLKHLYINVNKLR 67 (639)
Q Consensus 47 p~~~~~L~~L~~L~L~~N~l~ 67 (639)
|-.|...++|++|.|.++.|.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~ 122 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLS 122 (1096)
T ss_pred CceeccccceeeEEecCcchh
Confidence 556778888888888888775
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.06 E-value=2e-07 Score=99.01 Aligned_cols=89 Identities=26% Similarity=0.304 Sum_probs=50.8
Q ss_pred cCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCc-CccCCCCCCEEeCCCCCCCcccccCChh
Q 046265 286 IPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPR-VLGSISDLEYLDLSTNYNNEFRKEFPVE 364 (639)
Q Consensus 286 ~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~~~~~~~~~p~~ 364 (639)
....+.-++.|+.|||++|+++.. ..+..|+.|+.|||++|.+. .+|. ...++ .|+.|.+++|.+..+. .
T Consensus 179 mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lrnN~l~tL~-----g 249 (1096)
T KOG1859|consen 179 MDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLRNNALTTLR-----G 249 (1096)
T ss_pred HHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeeeecccHHHhhh-----h
Confidence 344445555666666666666533 24556666666666666665 3333 12233 2666666665544443 3
Q ss_pred hhccccCCeeeccCCcCce
Q 046265 365 LEKLVQLTELDLVITFWEE 383 (639)
Q Consensus 365 ~~~l~~L~~l~l~~n~~~~ 383 (639)
+.+|.+|+.||++.|-+++
T Consensus 250 ie~LksL~~LDlsyNll~~ 268 (1096)
T KOG1859|consen 250 IENLKSLYGLDLSYNLLSE 268 (1096)
T ss_pred HHhhhhhhccchhHhhhhc
Confidence 5666666666666666554
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.00 E-value=4.4e-06 Score=57.40 Aligned_cols=36 Identities=31% Similarity=0.489 Sum_probs=19.0
Q ss_pred CCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCc
Q 046265 55 HLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLS 91 (639)
Q Consensus 55 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 91 (639)
+|++|++++|+|+ .+|+.+++|++|++|++++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4555555555555 44545555555555555555555
|
... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 639 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-26 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 8e-17 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-04 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-26 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 9e-17 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-04 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-21 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-21 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-17 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-15 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-13 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-13 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-13 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-06 | ||
| 2wfh_A | 193 | The Human Slit 2 Dimerization Domain D4 Length = 19 | 6e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-05 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-05 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-04 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-04 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-04 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-04 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-04 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-04 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-04 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-04 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-04 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-04 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-04 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-04 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-04 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-04 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-04 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-04 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 2e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-04 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-04 | ||
| 2z7x_A | 549 | Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu | 3e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-04 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-04 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 6e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-04 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 6e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2Z7X|A Chain A, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 549 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 257 bits (660), Expect = 3e-76
Identities = 109/417 (26%), Positives = 158/417 (37%), Gaps = 58/417 (13%)
Query: 15 SNTLFAIIPPQI-GNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPRE 73
N IP + G L LD+ N G +P + L+ L ++ N G +P +
Sbjct: 278 ENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMD 337
Query: 74 V-GQLSSLKQLVLYCNGLSGWLPSSFGNL----------NNLAIGSMPNSLSNLTSLSLF 122
++ LK L L N SG LP S NL +N G + +L +L
Sbjct: 338 TLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQ 397
Query: 123 HLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGV 182
L L N +G IP L + S L LHL N L G+IP LG + L L LN+L G
Sbjct: 398 ELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGE 457
Query: 183 LPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHL 242
+P + + LE L L N L G+IP L N T+LN + L
Sbjct: 458 IPQELMYVKTLETLILD--------FNDLT------------GEIPSGLSNCTNLNWISL 497
Query: 243 EQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFS 302
N LTG I + G NL L LS N+F G +IP ++G L LD +
Sbjct: 498 SNNRLTGEIPKWIGRLENLAILKLSNNSFSG-----------NIPAELGDCRSLIWLDLN 546
Query: 303 LNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFP 362
N G +P + + N + G + + + + N F+
Sbjct: 547 TNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLE-FQGIRS 601
Query: 363 VELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLI 419
+L +L ++ + P + +D+SYN L G I
Sbjct: 602 EQLNRLSTRNPCNITSRVYGGHTSP----------TFDNNGSMMFLDMSYNMLSGYI 648
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 4e-75
Identities = 100/348 (28%), Positives = 159/348 (45%), Gaps = 28/348 (8%)
Query: 15 SNTLFAIIPPQIGNI--SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPR 72
SN I P + + L+ L + NN +G IP + + L L+++ N L G++P
Sbjct: 377 SNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPS 436
Query: 73 EVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAI---------GSMPNSLSNLTSLSLFH 123
+G LS L+ L L+ N L G +P + L G +P+ LSN T+L+
Sbjct: 437 SLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLN--W 494
Query: 124 LDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVL 183
+ LS N+L+G IP ++G L NLA+L L +NS G+IP LG +SL+ L + NL NG +
Sbjct: 495 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 554
Query: 184 PPSISNLSNLEGLYLYSSLVSAEIGNL--LQLIELEIDNKQLFGQIPKSLRNFTSLNIVH 241
P ++ S + I N + + + G + L ++ N +
Sbjct: 555 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCN 614
Query: 242 LEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG-------------SLNFSMNNITRSIPP 288
+ G+ F ++ FLD+S N G LN N+I+ SIP
Sbjct: 615 ITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674
Query: 289 KIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPR 336
++G L L+ LD S N + G +P + L L L+ N + G +P
Sbjct: 675 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 722
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 1e-74
Identities = 103/399 (25%), Positives = 158/399 (39%), Gaps = 47/399 (11%)
Query: 15 SNTLFAIIPP--QIGNISNLKFLDMGNNQLSGVIPQEIDP-LTHLKHLYINVNKLRGSVP 71
N+L + +G+ S LKFL++ +N L L L+ L ++ N + G+
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 72 REV---GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAI---------GSMPNSLSNLTSL 119
LK L + N +SG + NL +P L + ++L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSAL 225
Query: 120 SLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLL 179
HLD+S N+LSG + + L +L++ N G IPP ++SL L N
Sbjct: 226 Q--HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKF 281
Query: 180 NGVLPPSIS-NLSNLEGLYLYSSLVS----AEIGNLLQLIELEIDNKQLFGQIPK-SLRN 233
G +P +S L GL L + G+ L L + + G++P +L
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341
Query: 234 FTSLNIVHLEQNHLTGNIYEVFG-IYPNLTFLDLSQNNFYGS---------------LNF 277
L ++ L N +G + E + +L LDLS NNF G L
Sbjct: 342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYL 401
Query: 278 SMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRV 337
N T IPP + +L L S N++ G +P LG+L L L N + G +P+
Sbjct: 402 QNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE 461
Query: 338 LGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
L + LE L L N+ E P L L + L
Sbjct: 462 LMYVKTLETLILD---FNDLTGEIPSGLSNCTNLNWISL 497
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 3e-73
Identities = 105/446 (23%), Positives = 170/446 (38%), Gaps = 74/446 (16%)
Query: 15 SNTLFAIIPPQIGNIS-NLKFLDMGNNQLSGVIPQEI--DPLTHLKHLYINVNKLRGSVP 71
N +P + N+S +L LD+ +N SG I + +P L+ LY+ N G +P
Sbjct: 352 FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP 411
Query: 72 REVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAI---------GSMPNSLSNLTSLSLF 122
+ S L L L N LSG +PSS G+L+ L G +P L + +L
Sbjct: 412 PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE-- 469
Query: 123 HLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGV 182
L L N L+G IP L + +NL + L +N L G IP +G++++L L N +G
Sbjct: 470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGN 529
Query: 183 LPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHL 242
+P + + +L L L + N G IP ++ + +
Sbjct: 530 IPAELGDCRSLIWLDLNT-------------------NL-FNGTIPAAMFKQSGK----I 565
Query: 243 EQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFS 302
N + G Y + N ++ +L + + +
Sbjct: 566 AANFIAGKRYVYIKNDGMKKECHGAGNL---------LEFQGIRSEQLNRLSTRNPCNIT 616
Query: 303 LNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFP 362
G N S+ + ++ N + G +P+ +GS+ L L+L +N+ P
Sbjct: 617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG---HNDISGSIP 673
Query: 363 VELEKLVQLTELDL-------VITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNEL 415
E+ L L LDL I P++ +S + L+ ID+S N L
Sbjct: 674 DEVGDLRGLNILDLSSNKLDGRI--------PQA---------MSALTMLTEIDLSNNNL 716
Query: 416 RGLIRNSTGIHYNLVDALQGNKGLCG 441
G I N GLCG
Sbjct: 717 SGPIPEMGQFETFPPAKFLNNPGLCG 742
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-65
Identities = 104/388 (26%), Positives = 151/388 (38%), Gaps = 52/388 (13%)
Query: 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVP--RE 73
N F+ + + +++ L+ L + N+ ++G + L L ++ N L G V
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTS 121
Query: 74 VGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSG 133
+G S LK L + N L S L SL LDLS N +SG
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGKVS--------------GGLKLNSLE--VLDLSANSISG 165
Query: 134 SIP---HFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNL 190
+ L L + N + G + + + +L L N + + P + +
Sbjct: 166 ANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI-PFLGDC 222
Query: 191 SNLEGLYLY----SSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNH 246
S L+ L + S S I +L L I + Q G IP SL + L +N
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENK 280
Query: 247 LTGNI-YEVFGIYPNLTFLDLSQNNFYGS-------------LNFSMNNITRSIPPK-IG 291
TG I + G LT LDLS N+FYG+ L S NN + +P +
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340
Query: 292 KLYQLHKLDFSLNHIVGELPIELGNLK-SLNYRALNGNKVYGSLPRVLGSI--SDLEYLD 348
K+ L LD S N GELP L NL SL L+ N G + L + L+ L
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400
Query: 349 LSTNYNNEFRKEFPVELEKLVQLTELDL 376
L NN F + P L +L L L
Sbjct: 401 LQ---NNGFTGKIPPTLSNCSELVSLHL 425
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-41
Identities = 82/338 (24%), Positives = 125/338 (36%), Gaps = 56/338 (16%)
Query: 112 SLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLS 171
+TS+ L L N ++ L L+ L L L ++ + GS+ SL S
Sbjct: 48 RDDKVTSIDLSSKPL--NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGF-KCSASLTS 104
Query: 172 LGFDLNLLNGVLPP--SISNLSNLEGLYLYSSLVSAEI-----GNLLQLIELEIDNKQLF 224
L N L+G + S+ + S L+ L + S+ + L L L++ +
Sbjct: 105 LDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSIS 164
Query: 225 GQIPKSLR---NFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGS------- 274
G L + + N ++G++ NL FLD+S NNF
Sbjct: 165 GANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDC 222
Query: 275 -----LNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNK 329
L+ S N ++ I +L L+ S N VG +P LKSL Y +L NK
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENK 280
Query: 330 VYGSLPRVL-GSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL-------VITFW 381
G +P L G+ L LDLS N F P L L L +
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLS---GNHFYGAVPPFFGSCSLLESLALSSNNFSGELP-- 335
Query: 382 EERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLI 419
+ +M GL +D+S+NE G +
Sbjct: 336 --------------MDTLLKMRGLKVLDLSFNEFSGEL 359
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-26
Identities = 40/159 (25%), Positives = 62/159 (38%), Gaps = 17/159 (10%)
Query: 2 SCLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYI 61
+ I Q+ +S ++ + G D + L +
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639
Query: 62 NVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSL 121
+ N L G +P+E+G + L L L N +SG +P G+L L I
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI--------------- 684
Query: 122 FHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIP 160
LDLS N+L G IP + L+ L + L +N+L G IP
Sbjct: 685 --LDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-08
Identities = 34/173 (19%), Positives = 53/173 (30%), Gaps = 49/173 (28%)
Query: 260 NLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKS 319
+T +DLS + ++ + L L L S +HI G + S
Sbjct: 51 KVTSIDLSSKPLNVGFS--------AVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSAS 101
Query: 320 LNYRALNGNKVYGSLPRV--LGSISDLEYLDLSTNYNNEFRKEFPVELE-KLVQLTELDL 376
L L+ N + G + + LGS S L++L++S +N V KL L LDL
Sbjct: 102 LTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVS---SNTLDFPGKVSGGLKLNSLEVLDL 158
Query: 377 VITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRNSTGIHYNL 429
S N + G +
Sbjct: 159 ----------------------------------SANSISGANVVGWVLSDGC 177
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 9e-63
Identities = 79/318 (24%), Positives = 127/318 (39%), Gaps = 55/318 (17%)
Query: 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGV--IPQEIDPLTHLKHLYI-NVNKLRGSVPR 72
T ++ + LD+ L IP + L +L LYI +N L G +P
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 73 EVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLS 132
+ +L+ L L + +SG +P + L LD S N LS
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKT-----------------LVTLDFSYNALS 138
Query: 133 GSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLL-SLGFDLNLLNGVLPPSISNLS 191
G++P + L NL + N + G+IP G L S+ N L G +PP+ +NL+
Sbjct: 139 GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN 198
Query: 192 NLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNI 251
L +++ L G + + +HL +N L ++
Sbjct: 199 ---------------------LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237
Query: 252 YEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELP 311
+ G+ NL LDL N YG ++P + +L LH L+ S N++ GE+P
Sbjct: 238 GK-VGLSKNLNGLDLRNNRIYG-----------TLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 312 IELGNLKSLNYRALNGNK 329
+ GNL+ + A NK
Sbjct: 286 -QGGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 2e-57
Identities = 80/338 (23%), Positives = 134/338 (39%), Gaps = 57/338 (16%)
Query: 22 IPPQIGNISNL----KFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGS--VPREVG 75
I +GN + L D N GV+ + +L ++ L +P +
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 76 QLSSLKQLVLY-CNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGS 134
L L L + N L G +P + L L +L ++ +SG+
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLH-----------------YLYITHTNVSGA 116
Query: 135 IPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLE 194
IP FL + L L N+L G++PP + + +L+ + FD N ++G +P S + S L
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL- 175
Query: 195 GLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEV 254
+ I +L G+IP + N +L V L +N L G+ +
Sbjct: 176 ------------------FTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVL 216
Query: 255 FGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIEL 314
FG N + L++N+ L K+G L+ LD N I G LP L
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDL------------GKVGLSKNLNGLDLRNNRIYGTLPQGL 264
Query: 315 GNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTN 352
LK L+ ++ N + G +P+ G++ + + N
Sbjct: 265 TQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-55
Identities = 64/270 (23%), Positives = 108/270 (40%), Gaps = 42/270 (15%)
Query: 1 LSCLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLY 60
L L F + N L IPP I ++ L +L + + +SG IP + + L L
Sbjct: 75 LPYLNFLYI---GGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131
Query: 61 INVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLS 120
+ N L G++P + L +L + N +SG +P S+G+ + L
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT-------------- 177
Query: 121 LFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN 180
+ +S N+L+G IP +L NLA + L N L G + G ++ + N L
Sbjct: 178 --SMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 181 GVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIV 240
L + NL GL L + N +++G +P+ L L+ +
Sbjct: 235 FDL-GKVGLSKNLNGLDLRN--------N------------RIYGTLPQGLTQLKFLHSL 273
Query: 241 HLEQNHLTGNIYEVFGIYPNLTFLDLSQNN 270
++ N+L G I + G + N
Sbjct: 274 NVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-54
Identities = 84/367 (22%), Positives = 134/367 (36%), Gaps = 77/367 (20%)
Query: 79 SLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGS--IP 136
+K+ + LS WLP++ +G + ++ + ++ +LDLS L IP
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTW-LGVLCDTDTQTYRVN--NLDLSGLNLPKPYPIP 69
Query: 137 HFLGHLSNLAVLHLGD-NSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEG 195
L +L L L++G N+L G IPP + K+ L L ++G +P +S + L
Sbjct: 70 SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129
Query: 196 LYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNI-YEV 254
L N L G +P S+ + +L + + N ++G I
Sbjct: 130 LDFSY-------------------NA-LSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
Query: 255 FGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIEL 314
T + +S+N G IPP L L +D S N + G+ +
Sbjct: 170 GSFSKLFTSMTISRNRLTGK-----------IPPTFANL-NLAFVDLSRNMLEGDASVLF 217
Query: 315 GNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTEL 374
G+ K+ L N + L + +G +L LDL NN P L +L L L
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR---NNRIYGTLPQGLTQLKFLHSL 273
Query: 375 DLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRNSTGIHYNLVDALQ 434
++ S+N L G I + V A
Sbjct: 274 NV----------------------------------SFNNLCGEIPQGGNLQRFDVSAYA 299
Query: 435 GNKGLCG 441
NK LCG
Sbjct: 300 NNKCLCG 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-60
Identities = 55/388 (14%), Positives = 117/388 (30%), Gaps = 45/388 (11%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81
+ + ++ L+ MGN+ E + + + + L L
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDLKWDNLKDLT 252
Query: 82 QLVLYCNGLSGWLPSSFGNLNNL-----------AIGSMPNSLSNLTSL----SLFHLDL 126
+ +Y LP+ L + + + + L + + +
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312
Query: 127 SENQL-SGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPP 185
N L + + L + L +L N L G P G L SL N + +
Sbjct: 313 GYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPAN 371
Query: 186 SISNLSNLEGLYLY----SSLV-SAEIGNLLQLIELEIDNKQL-------FGQIPKSLRN 233
+E L + + ++ + ++ ++ F + +
Sbjct: 372 FCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK 431
Query: 234 FTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKL 293
+++ ++L N ++ E+F L+ ++L N N +
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE----IPKNSLKDENENFKNT 487
Query: 294 YQLHKLDFSLNHIVGELP--IELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLST 351
Y L +D N + L L L L+ N P + S L+ +
Sbjct: 488 YLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRN 545
Query: 352 NYN---NEFRKEFPVELEKLVQLTELDL 376
+ N +E+P + LT+L +
Sbjct: 546 QRDAQGNRTLREWPEGITLCPSLTQLQI 573
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 5e-51
Identities = 49/384 (12%), Positives = 111/384 (28%), Gaps = 51/384 (13%)
Query: 25 QIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRG----SVPREVGQLSSL 80
+ + + L + SG +P I LT L+ L + + + P+ + S
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 81 KQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLG 140
+Q + + L ++ + SI
Sbjct: 136 EQKQKMRMHYQ---------------KTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180
Query: 141 HLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYS 200
+ N++ + + ++ L + N E Y
Sbjct: 181 ITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYK 239
Query: 201 SLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLT--------GNIY 252
+ + NL L ++E+ N ++P L+ + ++++ N
Sbjct: 240 TE-DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298
Query: 253 EVFGIYPNLTFLDLSQNNFYG--------------SLNFSMNNITRSIPPKIGKLYQLHK 298
+ + + + NN L N + P G +L
Sbjct: 299 ADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE-GKLPAFGSEIKLAS 357
Query: 299 LDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVL--GSISDLEYLDLSTN---- 352
L+ + N I G + + + NK+ +P + S+S + +D S N
Sbjct: 358 LNLAYNQITEIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGS 416
Query: 353 YNNEFRKEFPVELEKLVQLTELDL 376
+ + K + ++ ++L
Sbjct: 417 VDGKNFDPLDPTPFKGINVSSINL 440
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-48
Identities = 61/470 (12%), Positives = 127/470 (27%), Gaps = 78/470 (16%)
Query: 21 IIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPL--THLKHLYINVNKLRGSVPREVGQLS 78
P I + + + L IN + + S+ +
Sbjct: 124 FGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183
Query: 79 SLKQLVLYCNGLSGWLPSSFGNLNNL---AIGSMPNSLSNLTSLSLFHL-DLSENQLSGS 134
Q+ N ++ + + L L +G+ + + + Q +
Sbjct: 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGN--SPFVAENICEAWENENSEYAQQYKT 240
Query: 135 IPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLL--------NGVLPPS 186
+L +L + + + +P L + + + N +
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALAD 300
Query: 187 ISNLSNLEGLYLY-----SSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVH 241
++ +Y+ + V + + +L LE QL G++P + + L ++
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN 359
Query: 242 LEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG--------------SLNFSMNNIT---- 283
L N +T G + L + N +++FS N I
Sbjct: 360 LAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419
Query: 284 ---RSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNK-------VYGS 333
+ P K + ++ S N I L+ L GN
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 334 LPRVLGSISDLEYLDLSTNY----------------------NNEFRKEFPVELEKLVQL 371
+ L +DL N N F +FP + L
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTL 538
Query: 372 TELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRN 421
+ + R + I+ L+ + I N++R +
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEG----ITLCPSLTQLQIGSNDIRKVNEK 584
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 8e-42
Identities = 50/369 (13%), Positives = 105/369 (28%), Gaps = 52/369 (14%)
Query: 22 IPPQIGNISNLKFLDMGNNQL-SGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSL 80
++ + +G N L + + + + L L N+L G +P G L
Sbjct: 297 ALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKL 355
Query: 81 KQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSG-SIPHFL 139
L L N ++ + G + +L + N+L
Sbjct: 356 ASLNLAYNQITEIPANFCGFTEQV-----------------ENLSFAHNKLKYIPNIFDA 398
Query: 140 GHLSNLAVLHLGDNSL-------FGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSN 192
+S ++ + N + F + P K ++ S+ N ++ S S
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458
Query: 193 LEGLYLYS-----------SLVSAEIGNLLQLIELEIDNKQLFGQIPKSLR--NFTSLNI 239
L + L + N L +++ +L ++ R L
Sbjct: 459 LSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVG 517
Query: 240 VHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKL 299
+ L N + L + + N R P I L +L
Sbjct: 518 IDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ-----RDAQGNRTLREWPEGITLCPSLTQL 571
Query: 300 DFSLNHIVGELPIE-LGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFR 358
N I + + N+ L+ + N + + L + + R
Sbjct: 572 QIGSNDIRK-VNEKITPNISVLD---IKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIR 627
Query: 359 KEFPVELEK 367
+++++
Sbjct: 628 GCDALDIKR 636
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-34
Identities = 39/317 (12%), Positives = 88/317 (27%), Gaps = 37/317 (11%)
Query: 87 CNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLA 146
+ W + ++ G NS +T L L SG +P +G L+ L
Sbjct: 54 TQPGANWNFNKELDMWGAQPGVSLNSNGRVT-----GLSLEGFGASGRVPDAIGQLTELE 108
Query: 147 VLHLGDNSLFG----SIPPILGKVQSLLSLGFDLNLLNGVLPPSIS--NLSNLEGLYLYS 200
VL LG + P + S + S+L + S
Sbjct: 109 VLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINS 168
Query: 201 ----SLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFG 256
+ L+ ++ + + + K++ T L ++ +
Sbjct: 169 DPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAW 227
Query: 257 IYPNLTFLDLSQNNFYG--------SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIV- 307
N + + + +P + L ++ ++ + N +
Sbjct: 228 ENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287
Query: 308 -------GELPIELGNLKSLNYRALNGNK-VYGSLPRVLGSISDLEYLDLSTNYNNEFRK 359
+ + + + + N + L + L L+ N+
Sbjct: 288 GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECL---YNQLEG 344
Query: 360 EFPVELEKLVQLTELDL 376
+ P ++L L+L
Sbjct: 345 KLP-AFGSEIKLASLNL 360
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-26
Identities = 33/209 (15%), Positives = 60/209 (28%), Gaps = 27/209 (12%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRG------ 68
F + P N+ +++ NNQ+S + + L + + N L
Sbjct: 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSL 477
Query: 69 -SVPREVGQLSSLKQLVLYCNGLSGWLPSSF--GNLNNL--------AIGSMPNSLSNLT 117
L + L N L+ L F L L + P N +
Sbjct: 478 KDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSS 536
Query: 118 SLSLFHL----DLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSL 172
+L F + D N+ P + +L L +G N + + I ++ L
Sbjct: 537 TLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT---PNISVL 592
Query: 173 GFDLNLLNGVLPPSISNLSNLEGLYLYSS 201
N + + L+
Sbjct: 593 DIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 23/155 (14%), Positives = 47/155 (30%), Gaps = 18/155 (11%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDP--LTHLKHLYINVNKLRGSVPR 72
N L +D+ N+L+ + + L +L + ++ N P
Sbjct: 473 PKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPT 530
Query: 73 EVGQLSSLKQLVL------YCNGLSGWLPSSFGNLNNLA---IGSMPNSLSNLTSL---S 120
+ S+LK + N P +L IGS N + + +
Sbjct: 531 QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGS--NDIRKVNEKITPN 588
Query: 121 LFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSL 155
+ LD+ +N ++ + L +
Sbjct: 589 ISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-50
Identities = 90/490 (18%), Positives = 149/490 (30%), Gaps = 80/490 (16%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPRE 73
+ N L + +NL L + +N + + +L L ++ N L +
Sbjct: 81 QHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGT 140
Query: 74 VGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAI-----------GSMPNSLSNLTSLSLF 122
QL +L++L+L N + N ++ P + L
Sbjct: 141 QVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLF-- 198
Query: 123 HLDLSENQLSGSIPHFLG---HLSNLAVLHLGDNSLFGSIPPILG--KVQSLLSLGFDLN 177
L L+ QL S+ L +++ L L ++ L + K +L L N
Sbjct: 199 GLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258
Query: 178 LLNGVLPPSISNLSNLEGLYLY----SSLVSAEIGNLLQLIELEIDN---------KQLF 224
LN V S + L LE +L L S + L + L + L
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318
Query: 225 GQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG----------- 273
S + L +++E N + G +F NL +L LS +
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378
Query: 274 ------SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPI-ELGNLKSLNYRALN 326
LN + N I++ L L LD LN I EL E L+++ L+
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 327 GNKVYGSLPRVLGSISDLEYLDLSTNY-----------------------NNEFRKEFPV 363
NK + L+ L L NN
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498
Query: 364 ELEKLVQLTELDL---VITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIR 420
LE L +L LDL + K + + L +++ N +
Sbjct: 499 MLEGLEKLEILDLQHNNLA-----RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553
Query: 421 NSTGIHYNLV 430
+ L
Sbjct: 554 EVFKDLFELK 563
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-49
Identities = 87/460 (18%), Positives = 153/460 (33%), Gaps = 62/460 (13%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEID--PLTHLKHLYINVNKLRGSVPR 72
N L + + NL+ L + NN++ + +E+D + LK L ++ N+++ P
Sbjct: 130 HNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPG 189
Query: 73 EVGQLSSLKQLVLYCNGLSGWLPSSFG------NLNNLAIGSM------PNSLSNLTSLS 120
+ L L L L L ++ NL++ + + L +
Sbjct: 190 CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTN 249
Query: 121 LFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSL---------LS 171
L LDLS N L+ L L L N++ L + ++
Sbjct: 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309
Query: 172 LGFDLNLLNGVLPPSISNLSNLEGLYLY----SSLVSAEIGNLLQLIELEIDN--KQLFG 225
L L + S L LE L + + S L+ L L + N L
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369
Query: 226 QIPKSLRNF--TSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGS--------- 274
++ + + L+I++L +N ++ + F +L LDL N
Sbjct: 370 LTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGL 429
Query: 275 -----LNFSMNNITRSIPPKIGKLYQLHKLDFSLNHI--VGELPIELGNLKSLNYRALNG 327
+ S N + + L +L + V P L++L L+
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 328 NKVYGSLPRVLGSISDLEYLDLSTNY-----NNEFRKEFPVELEKLVQLTELDLVITFWE 382
N + +L + LE LDL N + L+ L L L+L
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL------ 543
Query: 383 ERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRNS 422
E + + ++ L L ID+ N L L +
Sbjct: 544 ESNGFDEIPVEVFKDLFE----LKIIDLGLNNLNTLPASV 579
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-47
Identities = 80/425 (18%), Positives = 148/425 (34%), Gaps = 62/425 (14%)
Query: 31 NLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGL 90
+ + D + +L+ +P ++ T++ L + N+LR + S L L + N +
Sbjct: 5 SHEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 91 SGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHL 150
S P L L L+L N+LS +NL LHL
Sbjct: 62 SKLEPELCQKLPMLK-----------------VLNLQHNELSQLSDKTFAFCTNLTELHL 104
Query: 151 GDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLY----SSLVSAE 206
NS+ K ++L++L N L+ + L NL+ L L +L S E
Sbjct: 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE 164
Query: 207 IG--NLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIY---PNL 261
+ L +LE+ + Q+ P L + L L ++ E + ++
Sbjct: 165 LDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSI 224
Query: 262 TFLDLSQNNFYG---------------SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHI 306
L LS + L+ S NN+ L QL N+I
Sbjct: 225 RNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI 284
Query: 307 VGELPIELGNLKSLNYRALNGNKVYGSL---------PRVLGSISDLEYLDLSTNYNNEF 357
L L ++ Y L + S+ + LE+L++ +N+
Sbjct: 285 QHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNME---DNDI 341
Query: 358 RKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRG 417
L+ L L L +F +++ + + SL L ++++ N++
Sbjct: 342 PGIKSNMFTGLINLKYLSLSNSFTS----LRTLTNETFVSL--AHSPLHILNLTKNKISK 395
Query: 418 LIRNS 422
+ ++
Sbjct: 396 IESDA 400
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-44
Identities = 66/366 (18%), Positives = 127/366 (34%), Gaps = 31/366 (8%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLY---------INVNK 65
N L + + L++ + N + + + L ++++L I++
Sbjct: 257 YNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLAS 316
Query: 66 LRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNL----------NNLAIGSMPN-SLS 114
L L L+ L + N + G + F L + ++ ++ N +
Sbjct: 317 LPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFV 376
Query: 115 NLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLG 173
+L L L+L++N++S L +L VL LG N + + ++++ +
Sbjct: 377 SLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIY 436
Query: 174 FDLNLLNGVLPPSISNLSNLEGLYLYS------SLVSAEIGNLLQLIELEIDNKQLFGQI 227
N + S + + +L+ L L + L L L++ N +
Sbjct: 437 LSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIN 496
Query: 228 PKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIP 287
L L I+ L+ N+L P LS + LN N
Sbjct: 497 DDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH---ILNLESNGFDEIPV 553
Query: 288 PKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLG-SISDLEY 346
L++L +D LN++ N SL L N + +V G + +L
Sbjct: 554 EVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTE 613
Query: 347 LDLSTN 352
LD+ N
Sbjct: 614 LDMRFN 619
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-27
Identities = 61/277 (22%), Positives = 103/277 (37%), Gaps = 44/277 (15%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIP-QEIDPLTHLKHLYINVNKLRGSVPRE 73
N + I + +L+ LD+G N++ + QE L ++ +Y++ NK
Sbjct: 390 KNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS 449
Query: 74 VGQLSSLKQLVLYCNGLSG--WLPSSFGNLNNLAI---------GSMPNSLSNLTSLSLF 122
+ SL++L+L L PS F L NL I + L L L
Sbjct: 450 FALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLE-- 507
Query: 123 HLDLSENQLS--------GSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGF 174
LDL N L+ G +FL LS+L +L+L N + + L +
Sbjct: 508 ILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDL 567
Query: 175 DLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNF 234
LN LN + +N +L+ L L NL+ + K++FG F
Sbjct: 568 GLNNLNTLPASVFNNQVSLKSLNLQK--------NLITSV-----EKKVFG------PAF 608
Query: 235 TSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNF 271
+L + + N I + +++ + N
Sbjct: 609 RNLTELDMRFNPFDCTCE---SIAWFVNWINETHTNI 642
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 25/164 (15%), Positives = 49/164 (29%), Gaps = 23/164 (14%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPRE 73
+ + +S+L L++ +N + + L LK + + +N L
Sbjct: 520 WKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579
Query: 74 VGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSG 133
SLK L L N ++ FG +L LD+ N
Sbjct: 580 FNNQVSLKSLNLQKNLITSVEKKVFGPAFR----------------NLTELDMRFNPFDC 623
Query: 134 SIPHFLG-----HLSNLAVLHLGDNSLFGSIPPILGKVQSLLSL 172
+ + ++ + L + L + P G +
Sbjct: 624 TCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGF--PVRLF 665
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 23/124 (18%), Positives = 44/124 (35%), Gaps = 11/124 (8%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
SN I ++ LK +D+G N L+ + + LK L + N + +
Sbjct: 545 SNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVF 604
Query: 75 G-QLSSLKQLVLYCN----------GLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFH 123
G +L +L + N W+ + N+ L+ + N+ + +
Sbjct: 605 GPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRL 664
Query: 124 LDLS 127
D S
Sbjct: 665 FDTS 668
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-46
Identities = 88/468 (18%), Positives = 143/468 (30%), Gaps = 75/468 (16%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
N L + + L+ LD+ ++ + L+HL L + N ++
Sbjct: 37 FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF 96
Query: 75 GQLSSLKQLVLYCNGLSGWLPSSFGNL----------NNLAIGSMPNSLSNLTSLSLFHL 124
LSSL++LV L+ G+L N + +P SNLT+L HL
Sbjct: 97 SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE--HL 154
Query: 125 DLSENQLSGSIPHFLGHLSNL----AVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN 180
DLS N++ L L + L L N + I P K L L N +
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDS 213
Query: 181 GVLPP-SISNLSNLEGLYLY-------SSLVSAEIGNLLQLIELEIDNKQL------FGQ 226
+ I L+ LE L +L + L L L I+ +L
Sbjct: 214 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDD 273
Query: 227 IPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNF--------YGSLNFS 278
I T+++ L + + L+L F +
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHLELVNCKFGQFPTLKLKSLKRLT 331
Query: 279 MNNITRSIPPKIGKLYQLHKLDFSLNHI--VGELPIELGNLKSLNYRALNGNKVYGSLPR 336
+ L L LD S N + G SL Y L+ N V +
Sbjct: 332 FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSS 390
Query: 337 VLGSISDLEYLDLSTNY----------------------NNEFRKEFPVELEKLVQLTEL 374
+ LE+LD + + R F L L L
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450
Query: 375 DLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRNS 422
+ ++ + + L + L+ +D+S +L L +
Sbjct: 451 KM-----AGNSFQENFLPDIFTELRN----LTFLDLSQCQLEQLSPTA 489
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-43
Identities = 69/382 (18%), Positives = 126/382 (32%), Gaps = 50/382 (13%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81
IP + + K LD+ N L + L+ L ++ +++ LS L
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 82 QLVLYCNGLSGWLPSSFGNLNNLAI---------GSMPNSLSNLTSLSLFHLDLSENQL- 131
L+L N + +F L++L + +L +L L+++ N +
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK--ELNVAHNLIQ 137
Query: 132 SGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN---GVLPPSIS 188
S +P + +L+NL L L N + L + + L L+L + P
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 189 NLSNLEGLYLYSSLVSAEI-----GNLLQLIELEIDNKQLFGQ------IPKSLRNFTSL 237
L L L ++ S + L L + + + +L +L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 238 NIVHLEQNHL---TGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLY 294
I +L +I ++F N++ L +FS +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY-------------NF 304
Query: 295 QLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYN 354
L+ ++L +LK L + + G + + LE+LDLS N
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS-----EVDLPSLEFLDLSRN-G 358
Query: 355 NEFRKEFPVELEKLVQLTELDL 376
F+ L LDL
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDL 380
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 9e-42
Identities = 65/392 (16%), Positives = 126/392 (32%), Gaps = 44/392 (11%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLK----HLYINVNKLRGSVPREVGQL 77
+P N++NL+ LD+ +N++ + ++ L + L +++N + + +
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKE 199
Query: 78 SSLKQLVLYCNGLSGWLPS-SFGNLNNLAI---------------GSMPNSLSNLTSLSL 121
L +L L N S + L L + ++L L +L++
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 122 FHLDLSENQLS-GSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN 180
L+ I L+N++ L ++ L
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFG 317
Query: 181 GVLPPSISNLSNLEGLYLYSSLVSAEIG-NLLQLIELEIDNKQLFGQIPKSLRNFTSLNI 239
+ +L L +E+ L+ ++L + G +S TSL
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 240 VHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG--------------SLNFSMNNITRS 285
+ L N + + F L LD +N L+ S + +
Sbjct: 378 LDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 286 IPPKIGKLYQLHKLDFSLNHIVGEL-PIELGNLKSLNYRALNGNKVYGSLPRVLGSISDL 344
L L L + N P L++L + L+ ++ P S+S L
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496
Query: 345 EYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
+ L++S +N F + L L LD
Sbjct: 497 QVLNMS---HNNFFSLDTFPYKCLNSLQVLDY 525
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-34
Identities = 63/358 (17%), Positives = 119/358 (33%), Gaps = 40/358 (11%)
Query: 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVG 75
+ I ++N+ + + + V +HL + K
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPT---L 322
Query: 76 QLSSLKQLVLYCNGLSGWLPSSFGNLNNL-----------AIGSMPNSLSNLTSLSLFHL 124
+L SLK+L G S +L +L G S TSL +L
Sbjct: 323 KLKSLKRLTF--TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK--YL 378
Query: 125 DLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVL 183
DLS N + +FLG L L L ++L + +++L+ L
Sbjct: 379 DLSFNGVITMSSNFLG-LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 184 PPSISNLSNLEGLYL-----YSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLN 238
+ LS+LE L + + + L L L++ QL P + + +SL
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497
Query: 239 IVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHK 298
++++ N+ + +L LD S N+ S + + S L
Sbjct: 498 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS----------LAF 547
Query: 299 LDFSLNHIVGELPIE--LGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYN 354
L+ + N + L +K + ++ + P + + L+++ N
Sbjct: 548 LNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNITCQMN 604
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-32
Identities = 59/289 (20%), Positives = 102/289 (35%), Gaps = 24/289 (8%)
Query: 100 NLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSI 159
L +P++L S +LDLS N L + L VL L +
Sbjct: 13 QCMELNFYKIPDNLPF----STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68
Query: 160 PPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLY----SSLVSAEIGNLLQLIE 215
+ L +L N + + + S LS+L+ L +SL + IG+L L E
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 216 LEIDNKQL-FGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGS 274
L + + + ++P+ N T+L + L N + + + L+L S
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL-------S 181
Query: 275 LNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIE-LGNLKSLNYRAL------NG 327
L+ S+N + I P K +LHKL N + + L L L N
Sbjct: 182 LDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
Query: 328 NKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
+ L + +L + Y + + + L ++ L
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSL 289
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-26
Identities = 45/237 (18%), Positives = 84/237 (35%), Gaps = 21/237 (8%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
+ ++LK+LD+ N + + L L+HL + L+ V
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 75 -GQLSSLKQLVLYCNGLSGWLPSSFGNL----------NNLAIGSMPNSLSNLTSLSLFH 123
L +L L + F L N+ +P+ + L +L+
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT--F 474
Query: 124 LDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVL 183
LDLS+ QL P LS+L VL++ N+ F + SL L + LN +
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 534
Query: 184 PPSISNL-SNLEGLYLYS-----SLVSAE-IGNLLQLIELEIDNKQLFGQIPKSLRN 233
+ + S+L L L + + + +L ++ +++ P +
Sbjct: 535 KQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG 591
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 6e-16
Identities = 33/161 (20%), Positives = 58/161 (36%), Gaps = 20/161 (12%)
Query: 15 SNTLFAIIPPQI-GNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPRE 73
N+ P I + NL FLD+ QL + P + L+ L+ L ++ N
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 513
Query: 74 VGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSG 133
L+SL+ L N + + + SL L+L++N +
Sbjct: 514 YKCLNSLQVLDYSLNHIMTSKKQELQHFPS----------------SLAFLNLTQNDFAC 557
Query: 134 SIPH--FLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSL 172
+ H FL + + L + + + P +LSL
Sbjct: 558 TCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG-MPVLSL 597
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 4e-46
Identities = 60/379 (15%), Positives = 113/379 (29%), Gaps = 56/379 (14%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRG----- 68
+ + N+ +L +++ N +P + L L+ L I N+
Sbjct: 475 DYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLK 534
Query: 69 ----SVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHL 124
+ + ++ + N L P+S SL + L L
Sbjct: 535 ADWTRLADDEDTGPKIQIFYMGYNNLEE-FPAS-------------ASLQKMVKLG--LL 578
Query: 125 DLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVL 183
D N++ + F G L L L N + IP + LGF N L +
Sbjct: 579 DCVHNKVR-HLEAF-GTNVKLTDLKLDYNQI-EEIPEDFCAFTDQVEGLGFSHNKLKYIP 635
Query: 184 PP-SISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHL 242
+ ++ + + N + I + + V L
Sbjct: 636 NIFNAKSVYVMGSVDFS--------YNKIGSEGRNIS-------CSMDDYKGINASTVTL 680
Query: 243 EQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFS 302
N + E+F ++ + LS N S+ N + Y L +D
Sbjct: 681 SYNEIQKFPTELFATGSPISTIILSNNLM-TSIP---ENSLKPKDGNYKNTYLLTTIDLR 736
Query: 303 LNHIVGELP--IELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTN---YNNEF 357
N + L L L+ ++ N S P + S L+ + N
Sbjct: 737 FNKLT-SLSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQRDAEGNRI 794
Query: 358 RKEFPVELEKLVQLTELDL 376
+++P + L +L +
Sbjct: 795 LRQWPTGITTCPSLIQLQI 813
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-41
Identities = 66/441 (14%), Positives = 132/441 (29%), Gaps = 66/441 (14%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
+P IG ++ LK L G + + D +++R +
Sbjct: 332 GFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMF 391
Query: 75 GQ-LSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSG 133
L L + ++ N +S +L + N+++
Sbjct: 392 LDYDQRLNLSDLLQDAINR---------NPEMKPIKKDSRISLKDT---QIGNLTNRIT- 438
Query: 134 SIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNL 193
I + L+ L +++ ++ + + + S SNL +L
Sbjct: 439 FISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD-----YAKQYENEELSWSNLKDL 493
Query: 194 EGLYLYS----SLVSAEIGNLLQLIELEIDNKQL---------FGQIPKSLRNFTSLNIV 240
+ LY+ + + + +L +L L I + + ++ + I
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 241 HLEQNHLTG-NIYEVFGIYPNLTFLDLSQNNFYG-----------SLNFSMNNITRSIPP 288
++ N+L L LD N L N I IP
Sbjct: 554 YMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEAFGTNVKLTDLKLDYNQIE-EIPE 612
Query: 289 KIGK-LYQLHKLDFSLNHIVGELP--IELGNLKSLNYRALNGNKVYGSLPRVLGSISD-- 343
Q+ L FS N + +P ++ + + NK+ + S+ D
Sbjct: 613 DFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYK 671
Query: 344 ---LEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL---VITFWEERYRPKSVIWKAWRS 397
+ LS NE +K ++ + L ++T E K
Sbjct: 672 GINASTVTLS---YNEIQKFPTELFATGSPISTIILSNNLMTSIPEN------SLKPKDG 722
Query: 398 LISRMHGLSCIDISYNELRGL 418
+ L+ ID+ +N+L L
Sbjct: 723 NYKNTYLLTTIDLRFNKLTSL 743
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-39
Identities = 54/421 (12%), Positives = 107/421 (25%), Gaps = 102/421 (24%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
I I ++ L+ + N+ + + + K +
Sbjct: 433 LTNRITFISKAIQRLTKLQIIYFANSPFTYDNIA-----VDWEDANSDYAKQYENEELSW 487
Query: 75 GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSG- 133
L L + LY LP +L L L+++ N+
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFLYDLPELQ-----------------SLNIACNRGISA 530
Query: 134 --------SIPHFLGHLSNLAVLHLGDNSLFGSIPP--ILGKVQSLLSLGFDLNLLNGVL 183
+ + + ++G N+L P L K+ L L N + +
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNL-EEFPASASLQKMVKLGLLDCVHNKVRHL- 588
Query: 184 PPSISNLSNLEGLYLYS---SLVSAEIGNLL-QLIELEIDNKQLFGQIPK--SLRNFTSL 237
+ L L L + + Q+ L + +L IP + ++ +
Sbjct: 589 -EAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSVYVM 646
Query: 238 NIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLH 297
V N + + + ++ S ++ S N I + +
Sbjct: 647 GSVDFSYNKIGSEGRNISCSMDDYKGINAS------TVTLSYNEIQKFPTELFATGSPIS 700
Query: 298 KLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEF 357
+ S N + +P + L +DL N
Sbjct: 701 TIILSNNLM-TSIP----------------ENSLKPKDGNYKNTYLLTTIDLRFN----- 738
Query: 358 RKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRG 417
+LT L + + LS +D+SYN
Sbjct: 739 ------------KLTSLSDDFRA-------------------TTLPYLSNMDVSYNCFSS 767
Query: 418 L 418
Sbjct: 768 F 768
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 2e-37
Identities = 57/423 (13%), Positives = 123/423 (29%), Gaps = 55/423 (13%)
Query: 35 LDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWL 94
+ + ++D + L + +G VP +GQL+ LK L + +
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 95 PSSFG-----NLNNLAIGSMPNSLSNLTSL---SLFHLDLSENQLSGSIPHFLGHLSNLA 146
+++ + + L DL ++ ++ + + + +
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPE--MKPIKKDS 421
Query: 147 VLHLGDNSL------FGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYS 200
+ L D + I + ++ L + F + ++
Sbjct: 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTY-DNIAVDWEDANSDYAKQY 480
Query: 201 SLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTG---------NI 251
NL L ++E+ N Q+P L + L +++ N +
Sbjct: 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540
Query: 252 YEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPP--KIGKLYQLHKLDFSLNHIVGE 309
+ P + + NN P + K+ +L LD N +
Sbjct: 541 ADDEDTGPKIQIFYMGYNNL------------EEFPASASLQKMVKLGLLDCVHNKVR-H 587
Query: 310 LPIELGNLKSLNYRALNGNKVYGSLPRVLGS-ISDLEYLDLSTNYNNEFRKEFPVELEKL 368
L G L L+ N++ +P + +E L S N F + +
Sbjct: 588 LE-AFGTNVKLTDLKLDYNQI-EEIPEDFCAFTDQVEGLGFSHNKLKYIPNIF--NAKSV 643
Query: 369 VQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHG--LSCIDISYNELRGLIRNSTGIH 426
+ +D Y + + G S + +SYNE++
Sbjct: 644 YVMGSVDF-------SYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATG 696
Query: 427 YNL 429
+
Sbjct: 697 SPI 699
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-37
Identities = 61/362 (16%), Positives = 105/362 (29%), Gaps = 65/362 (17%)
Query: 9 FQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGV-IPQEIDPLTHLKHLYINVNKLR 67
+ + + ++ MG N L + + L L NK+
Sbjct: 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV- 585
Query: 68 GSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLS 127
G L L L N + +P F + + L S
Sbjct: 586 -RHLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTD----------------QVEGLGFS 627
Query: 128 ENQLSGSIPH--FLGHLSNLAVLHLGDNSLFGSIPPILG------KVQSLLSLGFDLNLL 179
N+L IP+ + + + N + GS + K + ++ N +
Sbjct: 628 HNKLK-YIPNIFNAKSVYVMGSVDFSYNKI-GSEGRNISCSMDDYKGINASTVTLSYNEI 685
Query: 180 NGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNI 239
+ S + + L NL+ I + +N L
Sbjct: 686 QKFPTELFATGSPISTIILS--------NNLMTSIPENS-----LKPKDGNYKNTYLLTT 732
Query: 240 VHLEQNHLTGNIYEV-FGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQL-- 296
+ L N LT + P L+ +D+S N F S P + QL
Sbjct: 733 IDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCF------------SSFPTQPLNSSQLKA 780
Query: 297 ----HKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTN 352
H+ D N I+ + P + SL + N + + L L LD++ N
Sbjct: 781 FGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADN 837
Query: 353 YN 354
N
Sbjct: 838 PN 839
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 7e-31
Identities = 48/357 (13%), Positives = 106/357 (29%), Gaps = 38/357 (10%)
Query: 53 LTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNS 112
LT ++ I + + + + + L ++ + N +
Sbjct: 251 LTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDM 310
Query: 113 LSNLTSLSLF------HLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKV 166
+ + L L L+ G +P +G L+ L VL G +S S +
Sbjct: 311 WGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEE 370
Query: 167 QSLLSLGFDLNLLNGVLPP-SISNLSNLEGLYLYSSLVSA--EIGNLLQLIELEIDNKQL 223
+ + + + L L ++ E+ + + + + + Q+
Sbjct: 371 LTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQI 430
Query: 224 ------FGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG---- 273
I K+++ T L I++ + T + V N + +N
Sbjct: 431 GNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNL 490
Query: 274 ----SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVG---------ELPIELGNLKSL 320
+ +P + L +L L+ + N + L + +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 321 NYRALNGNKVYG-SLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
+ N + L + L LD +N+ + V+LT+L L
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCV---HNKV-RHLE-AFGTNVKLTDLKL 602
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-19
Identities = 29/203 (14%), Positives = 60/203 (29%), Gaps = 34/203 (16%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLS-------GVIPQEIDPLTHLKHLYINVNKL 66
N + S + + + NN ++ L + + NKL
Sbjct: 681 SYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740
Query: 67 RGSVPRE--VGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFH- 123
S+ + L L + + N S P+ N S L + + H
Sbjct: 741 T-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNS------------SQLKAFGIRHQ 786
Query: 124 LDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDL---NLL 179
D N++ P + +L L +G N + + + ++ L D+ +
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTPQLYIL-----DIADNPNI 840
Query: 180 NGVLPPSISNLSNLEGLYLYSSL 202
+ + + + LY
Sbjct: 841 SIDVTSVCPYIEAGMYVLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 14/77 (18%), Positives = 24/77 (31%), Gaps = 3/77 (3%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
N + P I +L L +G+N + + +++ L L I N V
Sbjct: 791 GNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSV 847
Query: 75 GQLSSLKQLVLYCNGLS 91
VL +
Sbjct: 848 CPYIEAGMYVLLYDKTQ 864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-45
Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 441 GDVKLFSILTFEGKILYEEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSP 500
G +K FS E+ A++NF K +G G VYK L +VAVK+
Sbjct: 15 GQLKRFS---------LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE 65
Query: 501 HPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIIL-SNDAA 559
Q F E++ ++ HRN+++ GF P + L+Y Y+ GS+A L +
Sbjct: 66 RTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES 124
Query: 560 IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619
W R + A L+Y+H P I+HRD+ + N+LL +++A V DFG++K +
Sbjct: 125 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184
Query: 620 KPDSSNWS-EFVGTFGYVAP 638
++ + GT G++AP
Sbjct: 185 DYKDTHVTTAVRGTIGHIAP 204
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-43
Identities = 79/453 (17%), Positives = 127/453 (28%), Gaps = 57/453 (12%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
N L I + NL FLD+ Q+ + L L + N L +
Sbjct: 42 FNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETAL 101
Query: 75 GQLSSLKQLVLYCNGLSGWLPSSFGNLNNL--------AIGSMP-NSLSNLTSLSLFHLD 125
+LK L G+S N L I S+ L LD
Sbjct: 102 SGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLK--VLD 159
Query: 126 LSENQLSGSIPHFLGHLSNLAV--LHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVL 183
N + + L L+L N + I P SL F V+
Sbjct: 160 FQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVI 218
Query: 184 PPSISN--LSNLEGLYLYSSLVSAEIGNL------LQLIELEIDNKQLFGQIPKSLRNFT 235
+ N + +L + + + + + F + F+
Sbjct: 219 FKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFS 278
Query: 236 SLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG-------------SLNFSMNNI 282
L + L HL+ + L L LS N F L+ N
Sbjct: 279 GLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTK 337
Query: 283 TRSIPPK-IGKLYQLHKLDFSLNHI--VGELPIELGNLKSLNYRALNGNKVYGSLPRVLG 339
+ + L L +LD S + I ++L NL L L+ N+
Sbjct: 338 RLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFK 397
Query: 340 SISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLV---ITFWEERYRPKSVIWKAWR 396
LE LDL+ + K+ + L L L+L + + +
Sbjct: 398 ECPQLELLDLA--FTRLKVKDAQSPFQNLHLLKVLNLSHSLLD---------ISSEQLFD 446
Query: 397 SLISRMHGLSCIDISYNELRGLIRNSTGIHYNL 429
L + L +++ N T L
Sbjct: 447 GLPA----LQHLNLQGNHFPKGNIQKTNSLQTL 475
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 6e-43
Identities = 80/425 (18%), Positives = 142/425 (33%), Gaps = 54/425 (12%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81
IP + ++ + L+ N L + L +L L + ++ L
Sbjct: 27 IPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84
Query: 82 QLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGH 141
LVL N L ++ L HL + +S L +
Sbjct: 85 TLVLTANPLIFMAETALSGPKALK-----------------HLFFIQTGISSIDFIPLHN 127
Query: 142 LSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSS 201
L L+LG N + P + L L F N ++ + +S+L L L +
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLN 187
Query: 202 L-----VSAEIGNLLQLIELEIDNKQLFGQIPKSLRN--FTSLNIVHLEQNHLTGNIYEV 254
+ + L Q I K L+N SL + E V
Sbjct: 188 GNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247
Query: 255 FGIYP--NLTFLDLSQNNFYG-------------SLNFSMNNITRSIPPKIGKLYQLHKL 299
F ++ ++L ++ F+ L+ + +++ +P + L L KL
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKL 306
Query: 300 DFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSL-PRVLGSISDLEYLDLSTNYNNEFR 358
S N I N SL + ++ GN L L ++ +L LDLS + + E
Sbjct: 307 VLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD-DIETS 365
Query: 359 KEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGL 418
++L L L L+L P S+ +A++ L +D+++ L+
Sbjct: 366 DCCNLQLRNLSHLQSLNL------SYNEPLSLKTEAFKECPQ----LELLDLAFTRLKVK 415
Query: 419 IRNST 423
S
Sbjct: 416 DAQSP 420
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-42
Identities = 68/396 (17%), Positives = 126/396 (31%), Gaps = 36/396 (9%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
+N L + + LK L +S + + L+ LY+ N + +
Sbjct: 90 ANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKG 149
Query: 75 GQLSSLKQLVLYCNGLSGWLPSSFGNLNNL----------AIGSMPNSLSNLTSLSLFHL 124
LK L N + +L I + + L
Sbjct: 150 FPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQS--L 207
Query: 125 DLSENQLSGSIPHFLGH--LSNLAVLHLGDNSLFGSIPPILGKVQ--SLLSLGFDLNLLN 180
+ Q I L + + +L + D P + + S+ S+ +
Sbjct: 208 NFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF 267
Query: 181 GVLPPSISNLSNLEGLYLYS---SLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSL 237
+ + S L+ L L + S + + + L L +L + + S NF SL
Sbjct: 268 NISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327
Query: 238 NIVHLEQNHLTGNIY-EVFGIYPNLTFLDLSQNNFYGS---------------LNFSMNN 281
+ ++ N + NL LDLS ++ S LN S N
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387
Query: 282 ITRSIPPKIGKLYQLHKLDFSLNHIVG-ELPIELGNLKSLNYRALNGNKVYGSLPRVLGS 340
+ QL LD + + + NL L L+ + + S ++
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG 447
Query: 341 ISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
+ L++L+L N+ + + L+ L +L L L
Sbjct: 448 LPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-39
Identities = 71/376 (18%), Positives = 136/376 (36%), Gaps = 39/376 (10%)
Query: 13 HESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEID--PLTHLKHLYINVNKLRGSV 70
+ + A I P + + + L+ G Q VI + + + L
Sbjct: 185 NLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDIS 244
Query: 71 PREVGQLS--SLKQLVLYCNGLSGWLPSSFGNLNNLA--------IGSMPNSLSNLTSLS 120
P L S++ + L + ++F + L + +P+ L L++L
Sbjct: 245 PAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLK 304
Query: 121 LFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLL 179
L LS N+ + +L L + N+ + L +++L L + +
Sbjct: 305 --KLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDI 362
Query: 180 N--GVLPPSISNLSNLEGLYLY----SSLVSAEIGNLLQLIELEIDNKQLFGQIPKS-LR 232
+ NLS+L+ L L SL + QL L++ +L + +S +
Sbjct: 363 ETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422
Query: 233 NFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG----------------SLN 276
N L +++L + L + ++F P L L+L N+F L
Sbjct: 423 NLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILV 482
Query: 277 FSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPR 336
S +++ L ++ +D S N + L +LK + Y L N + LP
Sbjct: 483 LSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPS 541
Query: 337 VLGSISDLEYLDLSTN 352
+L +S ++L N
Sbjct: 542 LLPILSQQRTINLRQN 557
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-34
Identities = 66/320 (20%), Positives = 101/320 (31%), Gaps = 35/320 (10%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNG 89
+++ +++ + + + L+ L + L +P + LS+LK+LVL N
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANK 312
Query: 90 LSGWLPSSFGNL----------NNLAIGSMPNSLSNLTSLSLFHLDLSENQL--SGSIPH 137
S N N + L NL +L LDLS + + S
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLR--ELDLSHDDIETSDCCNL 370
Query: 138 FLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSI-SNLSNLEGL 196
L +LS+L L+L N + L L L S NL L+ L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 197 YLY----SSLVSAEIGNLLQLIELEIDN---KQLFGQIPKSLRNFTSLNIVHLEQNHLTG 249
L L L L + + Q SL+ L I+ L L+
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 250 NIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGE 309
F + +DLS N S + + L+ + NHI
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRL------------TSSSIEALSHLKGIYLNLASNHISII 538
Query: 310 LPIELGNLKSLNYRALNGNK 329
LP L L L N
Sbjct: 539 LPSLLPILSQQRTINLRQNP 558
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-30
Identities = 58/299 (19%), Positives = 95/299 (31%), Gaps = 30/299 (10%)
Query: 100 NLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSI 159
N NL + +P +L N S L+ S N L L NL L L ++
Sbjct: 18 NCENLGLNEIPGTLPN----STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 160 PPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLY----SSLVSAEIGNLLQLIE 215
L +L N L + ++S L+ L+ SS+ + N L
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 216 LEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLT--FLDLSQNNFYG 273
L + + + L ++ + N + E T L+L+ N+ G
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
Query: 274 ------------SLNFSMNNITRSIPPKIG--KLYQLHKLDFSLNHIVGELPIELGNLKS 319
SLNF I + + L F P L
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253
Query: 320 LNYRALN--GNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
++ ++N + + S L+ LDL+ + + E P L L L +L L
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS----ELPSGLVGLSTLKKLVL 308
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-20
Identities = 47/275 (17%), Positives = 87/275 (31%), Gaps = 43/275 (15%)
Query: 15 SNTLFAIIPPQ-IGNISNLKFLDMGNNQL--SGVIPQEIDPLTHLKHLYINVNKLRGSVP 71
NT + + N+ NL+ LD+ ++ + S ++ L+HL+ L ++ N+
Sbjct: 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKT 393
Query: 72 REVGQLSSLKQLVLYCNGLSG-WLPSSFGNLNNLAI---------GSMPNSLSNLTSLSL 121
+ L+ L L L S F NL+ L + S L +L
Sbjct: 394 EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQ- 452
Query: 122 FHLDLSENQLSGSI---PHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNL 178
HL+L N + L L L +L L L ++ + + N
Sbjct: 453 -HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR 511
Query: 179 LNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLN 238
L ++S+L + L + + + +P L +
Sbjct: 512 LTSSSIEALSHLKGI---------------------YLNLASNHISIILPSLLPILSQQR 550
Query: 239 IVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG 273
++L QN L L + +
Sbjct: 551 TINLRQNPLDCTC----SNIYFLEWYKENMQKLED 581
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 52/195 (26%), Positives = 84/195 (43%), Gaps = 21/195 (10%)
Query: 457 YEEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKA 516
E + + V+KA+L + E VAVK F E+ +
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQ---SWQNEYEVYS 71
Query: 517 LTELRHRNVVKFYGFSFHPR----QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVI 572
L ++H N+++F G +L+ + +GSL+ L + SW ++
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIA 127
Query: 573 KSVANTLSYMHHDYF-------PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625
+++A L+Y+H D P I HRDI SKNVLL + A ++DFG++ + S
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 626 WS--EFVGTFGYVAP 638
VGT Y+AP
Sbjct: 188 GDTHGQVGTRRYMAP 202
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 62/188 (32%), Positives = 91/188 (48%), Gaps = 14/188 (7%)
Query: 457 YEEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQA---FSNE 513
++ ATNNFD K+ IG VYK L VA+K+ Q F E
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-----SQGIEEFETE 85
Query: 514 IKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILS-NDAAIDEFSWTVRMNVI 572
I+ L+ RH ++V GF + L+Y+Y+ G+L L +D SW R+ +
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 573 KSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK-FLKPDSSNWSEFV- 630
A L Y+H I+HRD+ S N+LL ++ ++DFGISK + D ++ S V
Sbjct: 146 IGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202
Query: 631 GTFGYVAP 638
GT GY+ P
Sbjct: 203 GTLGYIDP 210
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-39
Identities = 80/360 (22%), Positives = 141/360 (39%), Gaps = 46/360 (12%)
Query: 26 IGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVL 85
+++ + ++ V+ + L + L + K+ S+ + L++L+ L L
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNL 73
Query: 86 YCNGLSGWLPSSFGNLNNLAI-------GSMPNSLSNLTSLSLFHLDLSENQLSGSIPHF 138
N ++ S NL L + ++L NLT+L L L+E+ +S P
Sbjct: 74 NGNQITD--ISPLSNLVKLTNLYIGTNKITDISALQNLTNLR--ELYLNEDNISDISP-- 127
Query: 139 LGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYL 198
L +L+ + L+LG N + P L + L L + + V I+NL++L L L
Sbjct: 128 LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDV--TPIANLTDLYSLSL 184
Query: 199 YSSLVSA--EIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFG 256
+ + + +L L Q+ P + N T LN + + N +T
Sbjct: 185 NYNQIEDISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD--LSPLA 240
Query: 257 IYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGN 316
LT+L++ N S + L +L L+ N I L N
Sbjct: 241 NLSQLTWLEIGTNQI-------------SDINAVKDLTKLKMLNVGSNQISD--ISVLNN 285
Query: 317 LKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
L LN LN N++ V+G +++L L LS N+ + R L L ++ D
Sbjct: 286 LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR-----PLASLSKMDSADF 340
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 71/293 (24%), Positives = 119/293 (40%), Gaps = 39/293 (13%)
Query: 24 PQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQL 83
+ N+ L L +G N+++ + LT+L+ LY+N + + P + L+ + L
Sbjct: 82 SPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSL 137
Query: 84 VLYCNGLSGWLPSSFGNLNNL--------AIGSMPNSLSNLTSLSLFHLDLSENQLSGSI 135
L N S N+ L + + ++NLT L L L+ NQ+
Sbjct: 138 NLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP-IANLTDLY--SLSLNYNQIEDIS 193
Query: 136 PHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEG 195
P L L++L N + P + + L SL N + + ++NLS L
Sbjct: 194 P--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL--SPLANLSQLTW 247
Query: 196 LYLYSSLVSA--EIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYE 253
L + ++ +S + +L +L L + + Q+ L N + LN + L N L E
Sbjct: 248 LEIGTNQISDINAVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDME 305
Query: 254 VFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHI 306
V G NLT L LSQN+ I P + L ++ DF+ I
Sbjct: 306 VIGGLTNLTTLFLSQNHI------------TDIRP-LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 56/266 (21%), Positives = 112/266 (42%), Gaps = 27/266 (10%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
I + N++NL+ L + + +S + P + LT + L + N S +
Sbjct: 96 GTNKITDISA-LQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPL 151
Query: 75 GQLSSLKQLVLYCNGLSGWLPSSFGNLNNL--------AIGSMPNSLSNLTSLSLFHLDL 126
++ L L + + + + NL +L I + L++LTSL +
Sbjct: 152 SNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP-LASLTSLH--YFTA 206
Query: 127 SENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPS 186
NQ++ P + +++ L L +G+N + P L + L L N ++ + +
Sbjct: 207 YVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NA 260
Query: 187 ISNLSNLEGLYLYSSLVS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQ 244
+ +L+ L+ L + S+ +S + + NL QL L ++N QL + + + T+L + L Q
Sbjct: 261 VKDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQ 320
Query: 245 NHLTGNIYEVFGIYPNLTFLDLSQNN 270
NH+T + D +
Sbjct: 321 NHITD--IRPLASLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 47/234 (20%), Positives = 95/234 (40%), Gaps = 22/234 (9%)
Query: 24 PQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQL 83
+ N++ + L++G N + + +T L +L + +K++ P + L+ L L
Sbjct: 126 SPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL 182
Query: 84 VLYCNGLSGWLP-SSFGNLNNLAIGSMPNSLSNLTSL----SLFHLDLSENQLSGSIPHF 138
L N + P +S +L+ N ++++T + L L + N+++ P
Sbjct: 183 SLNYNQIEDISPLASLTSLHYFTAYV--NQITDITPVANMTRLNSLKIGNNKITDLSP-- 238
Query: 139 LGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYL 198
L +LS L L +G N + S + + L L N ++ + ++NLS L L+L
Sbjct: 239 LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFL 294
Query: 199 Y----SSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLT 248
+ IG L L L + + P L + + ++ +
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 8e-20
Identities = 49/300 (16%), Positives = 109/300 (36%), Gaps = 51/300 (17%)
Query: 124 LDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVL 183
L ++ P L+ L S+ + +++S+ L + +
Sbjct: 5 LATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASI- 59
Query: 184 PPSISNLSNLEGLYLYSSLVS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVH 241
I L+NLE L L + ++ + + NL++L L I ++ +L+N T+L ++
Sbjct: 60 -QGIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELY 116
Query: 242 LEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDF 301
L +++++ + L+L N+ S + + L+ L
Sbjct: 117 LNEDNISD--ISPLANLTKMYSLNLGANHN------------LSDLSPLSNMTGLNYLTV 162
Query: 302 SLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEF 361
+ + + + NL L +LN N++ P L S++ L Y N +
Sbjct: 163 TESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDIT--- 215
Query: 362 PVELEKLVQLTELDL---VITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGL 418
+ + +L L + IT ++ + L+ ++I N++ +
Sbjct: 216 --PVANMTRLNSLKIGNNKITDLSP---------------LANLSQLTWLEIGTNQISDI 258
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 4e-10
Identities = 30/123 (24%), Positives = 54/123 (43%), Gaps = 11/123 (8%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
+N + + P + N+S L +L++G NQ+S + + LT LK L + N++ +
Sbjct: 230 NNKITDLSP--LANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD--ISVL 283
Query: 75 GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMP-NSLSNLTSLS----LFHLDLSEN 129
LS L L L N L G L NL + N ++++ L+ + D +
Sbjct: 284 NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQ 343
Query: 130 QLS 132
+
Sbjct: 344 VIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 3e-05
Identities = 31/211 (14%), Positives = 59/211 (27%), Gaps = 65/211 (30%)
Query: 211 LQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN 270
L + I Q+F + L++ +T + ++T L ++
Sbjct: 5 LATLPAPI--NQIF-----PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEK 55
Query: 271 FYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKV 330
SI I L L L+ + N I L NL L + NK+
Sbjct: 56 V------------ASIQG-IEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKI 100
Query: 331 YGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSV 390
+ L ++++L L L+ + ++ L L ++ L+L
Sbjct: 101 --TDISALQNLTNLRELYLNEDNISDIS-----PLANLTKMYSLNL-------------- 139
Query: 391 IWKAWRSLISRMHGLSCIDISYNELRGLIRN 421
N +
Sbjct: 140 --------------------GANHNLSDLSP 150
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-38
Identities = 73/400 (18%), Positives = 129/400 (32%), Gaps = 46/400 (11%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRG-SVPRE 73
N + + P +++L+ L +L+ + I L LK L + N + +P
Sbjct: 89 GNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY 148
Query: 74 VGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSN----------LTSLSLFH 123
L++L + L N + + L ++ +S + L
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHE 208
Query: 124 LDLSENQLSGSIP-HFLGHLSNLAVLHLGDNSLFGSI------PPILGKVQSLLSLGFDL 176
L L N S +I L +L+ L V L P I+ + + F L
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268
Query: 177 NLLN--GVLPPSISNLSNLEGLYLYSSLVSA--EIGNLLQLIELEIDNKQLFGQIPKSLR 232
N L+N+ + L + ++ + L I QL Q P
Sbjct: 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQL-KQFPTL-- 325
Query: 233 NFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG---------------SLNF 277
+ L + L N + I P+L++LDLS+N L+
Sbjct: 326 DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDL 383
Query: 278 SMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIE-LGNLKSLNYRALNGNKVYGSLPR 336
S N + L +L LDF + + +L+ L Y ++
Sbjct: 384 SFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDG 442
Query: 337 VLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
+ ++ L L ++ N + LT LDL
Sbjct: 443 IFLGLTSLNTLKMAGNSFKDN--TLSNVFANTTNLTFLDL 480
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-35
Identities = 80/448 (17%), Positives = 134/448 (29%), Gaps = 58/448 (12%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPRE 73
+ I + +L L + N + P LT L++L KL
Sbjct: 64 SRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFP 123
Query: 74 VGQLSSLKQLVLYCNGLSG-WLPSSFGNLNNLAI---------GSMPNSLSNLTSL--SL 121
+GQL +LK+L + N + LP+ F NL NL N L L
Sbjct: 124 IGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVN 183
Query: 122 FHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILG------KVQSLLSLGF- 174
LD+S N + I L L L N +I V L+ F
Sbjct: 184 LSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFK 242
Query: 175 DLNLLNGVLPPSISNLSNLEGLYLY------SSLVSAEIGNLLQLIELEIDNKQLFGQIP 228
D L P + L ++ S + L + + + + +
Sbjct: 243 DERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYL 300
Query: 229 KSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGS-----------LNF 277
+ + + + + L P L L L+ N S L+
Sbjct: 301 EDVPKHFKWQSLSIIRCQLKQF---PTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDL 357
Query: 278 SMNNITRSIP--PKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLP 335
S N ++ S L LD S N + + L+ L + + +
Sbjct: 358 SRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTE 416
Query: 336 R-VLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKA 394
S+ L YLD+S + +F L L L + K
Sbjct: 417 FSAFLSLEKLLYLDIS---YTNTKIDFDGIFLGLTSLNTLKM------AGNSFKDNT--- 464
Query: 395 WRSLISRMHGLSCIDISYNELRGLIRNS 422
++ + L+ +D+S +L +
Sbjct: 465 LSNVFANTTNLTFLDLSKCQLEQISWGV 492
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-35
Identities = 77/444 (17%), Positives = 143/444 (32%), Gaps = 69/444 (15%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81
+P I S+ K +D+ N L + + L+ L ++ ++ + L L
Sbjct: 26 VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83
Query: 82 QLVLYCNGLSGWLPSSFGNLNNL--------AIGSMP-NSLSNLTSLSLFHLDLSENQLS 132
L+L N + + P SF L +L + S+ + L +L L+++ N +
Sbjct: 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK--KLNVAHNFIH 141
Query: 133 G-SIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN---GVLPPSIS 188
+P + +L+NL + L N + L ++ + L++ +
Sbjct: 142 SCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAF 201
Query: 189 NLSNLEGLYLYSSLVSAEI-----GNLLQLIELEIDNKQLFGQI------PKSLRNFTSL 237
L L L + S+ I NL L + + + P + +
Sbjct: 202 QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV 261
Query: 238 NIVHLE--QNHLTGNIYEVFGIYPNLTFLDLSQNNFYG-----------SLNFSMNNITR 284
I + + F N++ + L+ + SL+ +
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLK- 320
Query: 285 SIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVL--GSIS 342
P L L L ++N + + L SL+Y L+ N + S +
Sbjct: 321 QFPT--LDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTN 376
Query: 343 DLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL----VITFWEERYRPKSVIWKAWRSL 398
L +LDLS N F L +L LD + E S
Sbjct: 377 SLRHLDLSFNGAIIMSANF----MGLEELQHLDFQHSTLKRVTE-------------FSA 419
Query: 399 ISRMHGLSCIDISYNELRGLIRNS 422
+ L +DISY +
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGI 443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-35
Identities = 60/415 (14%), Positives = 116/415 (27%), Gaps = 67/415 (16%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLK----HLYINVNKLRGSVPREVGQL 77
+P N++NL +D+ N + + ++ L L +++N + + + Q
Sbjct: 145 LPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQG 203
Query: 78 SSLKQLVLYCNGLSGWLPS-SFGNLNNLAIGSM---------------PNSLSNLTSLSL 121
L +L L N S + NL L + + P+ + L +++
Sbjct: 204 IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263
Query: 122 FHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNG 181
L+ L+N++ + L S+ + K SL L
Sbjct: 264 DEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQ 321
Query: 182 V-------------------LPPSISNLSNLEGLYLYSSLVSA------EIGNLLQLIEL 216
+ L +L L L + +S L L
Sbjct: 322 FPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHL 381
Query: 217 EIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIY-EVFGIYPNLTFLDLSQNNFYG-- 273
++ + + L + + + L F L +LD+S N
Sbjct: 382 DLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDF 440
Query: 274 -----------SLNFSMNNITRSIPPKI-GKLYQLHKLDFSLNHIVGELPIELGNLKSLN 321
+L + N+ + + L LD S + L L
Sbjct: 441 DGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ 500
Query: 322 YRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
++ N + + L LD S N + L +L
Sbjct: 501 LLNMSHNNLLFLDSSHYNQLYSLSTLDCS---FNRIETSKGILQHFPKSLAFFNL 552
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-30
Identities = 52/308 (16%), Positives = 97/308 (31%), Gaps = 36/308 (11%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
F+ + ++N+ + + + + +++ + L I +L+
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLKQFPT--- 324
Query: 75 GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAI---------GSMPNSLSNLTSLSLFHLD 125
L LK L L N S + L +L+ S S S+L + SL HLD
Sbjct: 325 LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382
Query: 126 LSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVLP 184
LS N + L L L ++L ++ LL L
Sbjct: 383 LSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441
Query: 185 PSISNLSNLEGLYL-----YSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNI 239
L++L L + + +S N L L++ QL L +
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL 501
Query: 240 VHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGK-LYQLHK 298
+++ N+L + +L+ LD S N + + L
Sbjct: 502 LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI------------ETSKGILQHFPKSLAF 549
Query: 299 LDFSLNHI 306
+ + N +
Sbjct: 550 FNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 59/289 (20%), Positives = 107/289 (37%), Gaps = 25/289 (8%)
Query: 100 NLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSI 159
+ + +P+ + + S ++DLS N L + + S L L L +
Sbjct: 17 QCMDQKLSKVPDDIPS----STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72
Query: 160 PPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLY----SSLVSAEIGNLLQLIE 215
+ L +L N + P S S L++LE L +SL S IG L+ L +
Sbjct: 73 DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKK 132
Query: 216 LEIDNKQLFG-QIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGS 274
L + + + ++P N T+L V L N++ ++L S
Sbjct: 133 LNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNL-------S 185
Query: 275 LNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELP-IELGNLKSLNYRALNGNKVYGS 333
L+ S+N I I + + +LH+L N + L NL L+ L +
Sbjct: 186 LDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE 244
Query: 334 L------PRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
P ++ + D+ + Y N + V+ L ++ + L
Sbjct: 245 RNLEIFEPSIMEGLCDVTIDEFRLTYTN-DFSDDIVKFHCLANVSAMSL 292
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-18
Identities = 36/196 (18%), Positives = 59/196 (30%), Gaps = 18/196 (9%)
Query: 1 LSCLAFFFF-----QVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQE-IDPLT 54
C ++ + + S I+ + L+ LD ++ L V L
Sbjct: 365 SGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLE 424
Query: 55 HLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSS-FGNLNNLAI------- 106
L +L I+ + L+SL L + N S+ F N NL
Sbjct: 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484
Query: 107 --GSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILG 164
L L L++S N L L +L+ L N + S +
Sbjct: 485 LEQISWGVFDTLHRLQ--LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQH 542
Query: 165 KVQSLLSLGFDLNLLN 180
+SL N +
Sbjct: 543 FPKSLAFFNLTNNSVA 558
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 60/349 (17%), Positives = 106/349 (30%), Gaps = 79/349 (22%)
Query: 23 PPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTH--LKHLYINVNKLRGSVPREVGQLSSL 80
+ N +N + L ++ T L + L P + +LS L
Sbjct: 49 AWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHL 106
Query: 81 KQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLG 140
+ + + GL LP + L L L+ N L ++P +
Sbjct: 107 QHMTIDAAGLME-LPDTMQQFAGLE-----------------TLTLARNPLR-ALPASIA 147
Query: 141 HLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYL-Y 199
L+ L L + +P L + L NL+ L L +
Sbjct: 148 SLNRLRELSIRACPELTELPEPLA---------------STDASGEHQGLVNLQSLRLEW 192
Query: 200 SSLVS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGI 257
+ + S A I NL L L+I N L + ++ +
Sbjct: 193 TGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLP---------------------- 229
Query: 258 YPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFS-LNHIVGELPIELGN 316
L LDL R+ PP G L +L ++++ LP+++
Sbjct: 230 --KLEELDLRGCTA-----------LRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHR 275
Query: 317 LKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVEL 365
L L L G LP ++ + + + + + + PV
Sbjct: 276 LTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 47/239 (19%), Positives = 94/239 (39%), Gaps = 18/239 (7%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
+ P Q +S+L+ + + L +P + L+ L + N LR ++P +
Sbjct: 89 RSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASI 146
Query: 75 GQLSSLKQLVL-YCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSG 133
L+ L++L + C L+ LP + L +L L L +
Sbjct: 147 ASLNRLRELSIRACPELTE-LPEPLAST------DASGEHQGLVNLQ--SLRLEWTGIR- 196
Query: 134 SIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNL 193
S+P + +L NL L + ++ L ++ P + + L L PP + L
Sbjct: 197 SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL 255
Query: 194 EGLYL--YSSLVS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLT 248
+ L L S+L++ +I L QL +L++ ++P + + I+ + +
Sbjct: 256 KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 61/331 (18%), Positives = 103/331 (31%), Gaps = 64/331 (19%)
Query: 53 LTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSS----FGNLNNLAIGS 108
+ ++LY + + Q + +S A+ +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKA 70
Query: 109 MPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQS 168
+ L + T L+L L P LS+L + + L
Sbjct: 71 TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL------------- 116
Query: 169 LLSLGFDLNLLNGVLPPSISNLSNLEGLYL-YSSLVS--AEIGNLLQLIELEIDNKQLFG 225
LP ++ + LE L L + L + A I +L +L EL I
Sbjct: 117 ------------MELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELT 164
Query: 226 QIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRS 285
++P+ L + + E L NL L L RS
Sbjct: 165 ELPEPLASTDASG----EHQGLV-----------NLQSLRLEWTGI------------RS 197
Query: 286 IPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLE 345
+P I L L L + + L + +L L L G + P + G + L+
Sbjct: 198 LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256
Query: 346 YLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
L L + P+++ +L QL +LDL
Sbjct: 257 RLILK--DCSNLL-TLPLDIHRLTQLEKLDL 284
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 44/214 (20%), Positives = 76/214 (35%), Gaps = 21/214 (9%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
+P + + L+ L + N L +P I L L+ L I +P +
Sbjct: 112 DAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPL 170
Query: 75 GQ---------LSSLKQLVLYCNGLSGWLPSSFGNLNNL--------AIGSMPNSLSNLT 117
L +L+ L L G+ LP+S NL NL + ++ ++ +L
Sbjct: 171 ASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSALGPAIHHLP 229
Query: 118 SLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLN 177
L LDL + P G + L L L D S ++P + ++ L L
Sbjct: 230 KLE--ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC 287
Query: 178 LLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLL 211
+ LP I+ L + + L + +
Sbjct: 288 VNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRP 321
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 46/268 (17%), Positives = 81/268 (30%), Gaps = 33/268 (12%)
Query: 133 GSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFD---------------LN 177
GS H H S L+ ++ +L + Q + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 178 LLNG----VLPPSISNLS--NLEGLYL-YSSLVS--AEIGNLLQLIELEIDNKQLFGQIP 228
G + + + L L L + L L + ID L ++P
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGL-MELP 120
Query: 229 KSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPP 288
+++ F L + L +N L + L L + L + +
Sbjct: 121 DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST--DASG 177
Query: 289 KIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLD 348
+ L L L I LP + NL++L + + + +L + + LE LD
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL-SALGPAIHHLPKLEELD 235
Query: 349 LSTNYNNEFRKEFPVELEKLVQLTELDL 376
L R +P L L L
Sbjct: 236 LR--GCTALR-NYPPIFGGRAPLKRLIL 260
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 19/151 (12%), Positives = 46/151 (30%), Gaps = 30/151 (19%)
Query: 274 SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGS 333
+L F + R + + + + D + H N + + +
Sbjct: 16 NLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA-NSNNPQIE----TRTGRALKA 70
Query: 334 LPRVLGSISD--LEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL----VITFWEERYRP 387
+L + L+L + +FP + +L L + + ++ +
Sbjct: 71 TADLLEDATQPGRVALELR---SVPL-PQFPDQAFRLSHLQHMTIDAAGLMELPDT---- 122
Query: 388 KSVIWKAWRSLISRMHGLSCIDISYNELRGL 418
+ + GL + ++ N LR L
Sbjct: 123 -----------MQQFAGLETLTLARNPLRAL 142
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 139 bits (354), Expect = 3e-37
Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 441 GDVKLFSILTFEGKILYEEVIRATNNFDAKYC------IGTAGQASVYKAELPSWEIVAV 494
FS + E+ TNNFD + +G G VYK + + VAV
Sbjct: 10 TRFHSFS---------FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAV 59
Query: 495 KKFHSPHPDMVVQ--QAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAI 552
KK + + Q F EIK + + +H N+V+ GFS L+Y Y+ GSL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 553 ILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSD 612
LS SW +R + + AN ++++H + +HRDI S N+LL + A +SD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISD 176
Query: 613 FGISK-FLKPDSSNWSE-FVGTFGYVAP 638
FG+++ K + + VGT Y+AP
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAP 204
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-36
Identities = 88/380 (23%), Positives = 147/380 (38%), Gaps = 47/380 (12%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
+T I ++ +G ++ + Q L + L + + V
Sbjct: 10 QDTPINQIFT-DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGV 64
Query: 75 GQLSSLKQLVLYCNGLSGWLP-SSFGNLNNLAIG----SMPNSLSNLTSLSLFHLDLSEN 129
L++L Q+ N L+ P + L ++ + + L+NLT+L+ L L N
Sbjct: 65 EYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLT--GLTLFNN 122
Query: 130 QLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISN 189
Q++ P L +L+NL L L N++ S L + SL L F + + ++N
Sbjct: 123 QITDIDP--LKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSFGNQVTD---LKPLAN 175
Query: 190 LSNLEGLYLYSSLVS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHL 247
L+ LE L + S+ VS + + L L L N Q+ P L T+L+ + L N L
Sbjct: 176 LTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL 233
Query: 248 TGNIYEVFGIYPNLTFLDLSQNNFYG-----------SLNFSMNNITRSIPPKIGKLYQL 296
NLT LDL+ N L N I+ +I P + L L
Sbjct: 234 KDI--GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQIS-NISP-LAGLTAL 289
Query: 297 HKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNE 356
L+ + N + + NLK+L Y L N + P + S++ L+ L N ++
Sbjct: 290 TNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD 345
Query: 357 FRKEFPVELEKLVQLTELDL 376
L L + L
Sbjct: 346 VS-----SLANLTNINWLSA 360
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-35
Identities = 84/372 (22%), Positives = 154/372 (41%), Gaps = 48/372 (12%)
Query: 23 PPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQ 82
+ ++NL ++ NNQL+ + P + LT L + +N N++ P + L++L
Sbjct: 61 IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116
Query: 83 LVLYCNGLSGWLPSSFGNLNNLAIGSM-------PNSLSNLTSLSLFHLDLSENQLSGSI 135
L L+ N ++ NL NL + ++LS LTSL L NQ++
Sbjct: 117 LTLFNNQITD--IDPLKNLTNLNRLELSSNTISDISALSGLTSLQ--QLSFG-NQVTDLK 171
Query: 136 PHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEG 195
P L +L+ L L + N + S +L K+ +L SL N ++ + + L+NL+
Sbjct: 172 P--LANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDI--TPLGILTNLDE 225
Query: 196 LYLYSSLVS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYE 253
L L + + + +L L +L++ N Q+ P L T L + L N ++
Sbjct: 226 LSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--IS 281
Query: 254 VFGIYPNLTFLDLSQNNFYG-----------SLNFSMNNITRSIPPKIGKLYQLHKLDFS 302
LT L+L++N L NNI+ P + L +L +L F
Sbjct: 282 PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFY 339
Query: 303 LNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFP 362
N + L NL ++N+ + N++ P L +++ + L L+ + +
Sbjct: 340 NNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN---DQAWTNAPV 392
Query: 363 VELEKLVQLTEL 374
+ +
Sbjct: 393 NYKANVSIPNTV 404
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 68/286 (23%), Positives = 114/286 (39%), Gaps = 46/286 (16%)
Query: 23 PPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQ 82
+ ++NL+ L NNQ+S + P + LT+L L +N N+L+ + L++L
Sbjct: 192 ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTD 247
Query: 83 LVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHL 142
L L N +S P LS LT L+ L L NQ+S P L L
Sbjct: 248 LDLANNQISNLAP-----------------LSGLTKLT--ELKLGANQISNISP--LAGL 286
Query: 143 SNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSL 202
+ L L L +N L P + +++L L N ++ + P +S+L+ L+ L+ Y++
Sbjct: 287 TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNK 342
Query: 203 VS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPN 260
VS + + NL + L + Q+ P L N T + + L T N
Sbjct: 343 VSDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYK---AN 397
Query: 261 LTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHI 306
++ + +N P I + D + N
Sbjct: 398 VSIPNTVKN----------VTGALIAPATISDGGSYTEPDITWNLP 433
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 52/168 (30%), Positives = 79/168 (47%), Gaps = 6/168 (3%)
Query: 473 IGTAGQASVYKAELPSW--EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
IG +V++A W VAVK F E+ + LRH N+V F G
Sbjct: 45 IGAGSFGTVHRA---EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 531 FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPI 590
P ++ EYL RGSL +L A ++ R+++ VA ++Y+H+ PPI
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 591 VHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
VHR++ S N+L+ Y V DFG+S+ + GT ++AP
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 43/169 (25%), Positives = 78/169 (46%), Gaps = 15/169 (8%)
Query: 473 IGTAGQASVYKAELPSW--EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
+G V KA+ W + VA+K+ S ++AF E++ L+ + H N+VK YG
Sbjct: 16 VGRGAFGVVCKAK---WRAKDVAIKQIESES----ERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 531 FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPI 590
+P L+ EY GSL +L + ++ M+ + ++Y+H +
Sbjct: 69 ACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 591 VHRDISSKNVLLGLDYD-AHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+HRD+ N+LL + DFG + ++ +N G+ ++AP
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN---NKGSAAWMAP 172
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 57/203 (28%), Positives = 79/203 (38%), Gaps = 31/203 (15%)
Query: 457 YEEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNE--I 514
E +N IG +VYK L VAVK F + +Q F NE I
Sbjct: 5 ASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE-RPVAVKVFSFAN-----RQNFINEKNI 58
Query: 515 KALTELRHRNVVKFYGFSFHP-----RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRM 569
+ + H N+ +F + L+ EY GSL LS W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114
Query: 570 NVIKSVANTLSYMHHDYF------PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623
+ SV L+Y+H + P I HRD++S+NVL+ D +SDFG+S L +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 624 SNWSEF--------VGTFGYVAP 638
VGT Y+AP
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAP 197
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-32
Identities = 83/383 (21%), Positives = 134/383 (34%), Gaps = 69/383 (18%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81
+P ++ +L + LS + P L++L ++ N+L +P E+ S LK
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLK 156
Query: 82 QLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSL----SLFHLDLSENQLSGSIPH 137
+ + N L LP +L +A G+ N L L L L + N L +P
Sbjct: 157 IIDVDNNSLKK-LPDLPPSLEFIAAGN--NQLEELPELQNLPFLTAIYADNNSLK-KLP- 211
Query: 138 FLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLY 197
+L + G+N L P L + L ++ D NLL LP +L L
Sbjct: 212 --DLPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRD 266
Query: 198 LYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGI 257
Y + + +L L E L + N LN E L
Sbjct: 267 NYLTDLPELPQSLTFLDVSENIFSGL----SELPPNLYYLNASSNEIRSLCDLP------ 316
Query: 258 YPNLTFLDLSQNNFYG---------SLNFSMNNITRSIPPKIGKLYQLH----KL----- 299
P+L L++S N L S N++ +P L QLH L
Sbjct: 317 -PSLEELNVSNNKLIELPALPPRLERLIASFNHLA-EVPELPQNLKQLHVEYNPLREFPD 374
Query: 300 ------DFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNY 353
D +N + E+P NLK L+ + N + P + S +E L ++
Sbjct: 375 IPESVEDLRMNSHLAEVPELPQNLKQLH---VETNPLR-EFPDIPES---VEDLRMN--- 424
Query: 354 NNEFRKEFPVELEKLVQLTELDL 376
+ + E +L +
Sbjct: 425 SERVVDPYEFAHETTDKLEDDVF 447
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-32
Identities = 76/399 (19%), Positives = 133/399 (33%), Gaps = 71/399 (17%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81
I P+ + + L+ ++ L+ +P E + + Y ++ + P G+ +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 82 QLVLYCNGLSG--WLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFL 139
L L LNNL + S+P +L L S N L+ +P
Sbjct: 62 VSRLRDCLDRQAHEL-----ELNNLGLSSLPELPPHLE-----SLVASCNSLT-ELPELP 110
Query: 140 GHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLY 199
L +L V + +L P L LG N L + P + N S L+ + +
Sbjct: 111 QSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEKL--PELQNSSFLKIIDVD 161
Query: 200 SSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYP 259
++ + L + N QL + L+N L ++ + N L ++ +
Sbjct: 162 NNSLKKLPDLPPSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK----KLPDLPL 215
Query: 260 NLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKS 319
+L + N P++ L L + N + LP +L++
Sbjct: 216 SLESIVAGNNIL-------------EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA 261
Query: 320 LNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVIT 379
LN R LP + S L +LD+S N + L L I
Sbjct: 262 LNVRDNYLT----DLPELPQS---LTFLDVSENIFS----GLSELPPNLYYLNASSNEIR 310
Query: 380 FWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGL 418
SL L +++S N+L L
Sbjct: 311 -----------------SLCDLPPSLEELNVSNNKLIEL 332
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-30
Identities = 89/394 (22%), Positives = 143/394 (36%), Gaps = 67/394 (17%)
Query: 15 SNTLFAIIPPQIGN-------------ISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYI 61
+ PP G L++ N LS +P+ HL+ L
Sbjct: 43 WSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELP---PHLESLVA 98
Query: 62 NVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPS-SFGNLNNLAIGSMPNSLSNLTSLS 120
+ N L +P L SL LS P + ++N + +P L N + L
Sbjct: 99 SCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLP-ELQNSSFLK 156
Query: 121 LFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN 180
+D+ N L +P +L + G+N L P L + L ++ D N L
Sbjct: 157 --IIDVDNNSLK-KLPDLPP---SLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK 208
Query: 181 GVLPPSISNLSNLEGLYLYSSLVSA--EIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLN 238
LP +L + + ++++ E+ NL L + DN L +P + +LN
Sbjct: 209 -KLPDLPLSLES---IVAGNNILEELPELQNLPFLTTIYADNNLL-KTLPDLPPSLEALN 263
Query: 239 IVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG---------SLNFSMNNITRSIPPK 289
+ L +LTFLD+S+N F G LN S N I S+
Sbjct: 264 VRDNYLTDLPELP-------QSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR-SLCDL 315
Query: 290 IGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDL 349
L +L+ S N ++ ELP L+ L + N + +P + + L+ L +
Sbjct: 316 PP---SLEELNVSNNKLI-ELPALPPRLERLI---ASFNHL-AEVPELPQN---LKQLHV 364
Query: 350 STNYNNEFRKEFPVELEKLVQLTELDLVITFWEE 383
N R EFP E + L + E
Sbjct: 365 E---YNPLR-EFPDIPESVEDLRMNSHLAEVPEL 394
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-23
Identities = 62/308 (20%), Positives = 95/308 (30%), Gaps = 47/308 (15%)
Query: 24 PQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQL 83
P++ N+ L + NN L + L+ + N L E+ L L +
Sbjct: 189 PELQNLPFLTAIYADNNSLKKLPDL----PLSLESIVAGNNIL--EELPELQNLPFLTTI 242
Query: 84 VLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSL--SLFHLDLSENQLSGSIPHFLGH 141
N L LP +L L + N L++L L SL LD+SEN S + +
Sbjct: 243 YADNNLLK-TLPDLPPSLEALNVRD--NYLTDLPELPQSLTFLDVSENIFS-GLSELPPN 298
Query: 142 LSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSS 201
L L SL P SL L N L LP L L + + +
Sbjct: 299 LYYLNASSNEIRSLCDLPP-------SLEELNVSNNKLI-ELPALPPRLERLIASFNHLA 350
Query: 202 LVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNL 261
V NL +L ++ L + P + L + ++ EV + NL
Sbjct: 351 EVPELPQNL---KQLHVEYNPL-REFPDIPESVEDL--------RMNSHLAEVPELPQNL 398
Query: 262 TFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLN 321
L + N R P + L + +V L
Sbjct: 399 KQLHVETNPL------------REFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLE 443
Query: 322 YRALNGNK 329
+
Sbjct: 444 DDVFEHHH 451
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 36/216 (16%), Positives = 74/216 (34%), Gaps = 36/216 (16%)
Query: 10 QVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGS 69
+ ++ + +P +++ L + + LS + P +L +L + N++R S
Sbjct: 260 EALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-S 311
Query: 70 VPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNL-----AIGSMPNSLSNLTSLSLFHL 124
+ SL++L + N L LP+ L L + +P NL L
Sbjct: 312 LC---DLPPSLEELNVSNNKLIE-LPALPPRLERLIASFNHLAEVPELPQNLKQ-----L 362
Query: 125 DLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDL--NLLNGV 182
+ N L P + +L + NS +P + ++ L + N L
Sbjct: 363 HVEYNPLR-EFPDIPESVEDLRM-----NSHLAEVPELPQNLKQL-----HVETNPLR-E 410
Query: 183 LPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEI 218
P ++ +L +E ++
Sbjct: 411 FPDIPESVEDLRMNSERVVDPYEFAHETTDKLEDDV 446
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 40/197 (20%), Positives = 62/197 (31%), Gaps = 40/197 (20%)
Query: 29 ISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCN 88
+L FLD+ N SG + + +L +L + N++R S+ SL++L + N
Sbjct: 276 PQSLTFLDVSENIFSG-LSELP---PNLYYLNASSNEIR-SLC---DLPPSLEELNVSNN 327
Query: 89 GLSGWLPSSFGNLNNL-----AIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHL- 142
L LP+ L L + +P NL L + N L P +
Sbjct: 328 KLIE-LPALPPRLERLIASFNHLAEVPELPQNLKQL-----HVEYNPLR-EFPDIPESVE 380
Query: 143 ---------------SNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSI 187
NL LH+ N L P I V+ L + +
Sbjct: 381 DLRMNSHLAEVPELPQNLKQLHVETNPL-REFPDIPESVEDLRMNS---ERVVDPYEFAH 436
Query: 188 SNLSNLEGLYLYSSLVS 204
LE
Sbjct: 437 ETTDKLEDDVFEHHHHH 453
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-31
Identities = 82/403 (20%), Positives = 130/403 (32%), Gaps = 52/403 (12%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
N L + + L+ LD+ ++ + L+HL L + N ++
Sbjct: 37 FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF 96
Query: 75 GQLSSLKQLVLYCNGLSGWLPSSFGNL----------NNLAIGSMPNSLSNLTSLSLFHL 124
LSSL++LV L+ G+L N + +P SNLT+L HL
Sbjct: 97 SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE--HL 154
Query: 125 DLSENQLSGSIPHFLGHLSNL----AVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN 180
DLS N++ L L + L L N + I P K L L N +
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDS 213
Query: 181 GVLPP-SISNLSNLEGLYLY----------SSLVSAEIGNLLQLIELEIDNKQL---FGQ 226
+ I L+ LE L + + L L E L
Sbjct: 214 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDD 273
Query: 227 IPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG----------SLN 276
I T+++ L + + L+L F L
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPTLKLKSLKRLT 331
Query: 277 FSMNNITRSIPPKIGKLYQLHKLDFSLNHI--VGELPIELGNLKSLNYRALNGNKVYGSL 334
F+ N + ++ L L LD S N + G SL Y L+ N V ++
Sbjct: 332 FTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TM 388
Query: 335 PRVLGSISDLEYLDLSTNYNNEFRKEFPVE-LEKLVQLTELDL 376
+ LE+LD ++ ++ L L LD+
Sbjct: 389 SSNFLGLEQLEHLDFQ---HSNLKQMSEFSVFLSLRNLIYLDI 428
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-30
Identities = 82/395 (20%), Positives = 143/395 (36%), Gaps = 53/395 (13%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81
IP + + K LD+ N L + L+ L ++ +++ LS L
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 82 QLVLYCNGLSGWLPSSFGNLNNL--------AIGSMPN-SLSNLTSLSLFHLDLSENQL- 131
L+L N + +F L++L + S+ N + +L +L L+++ N +
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK--ELNVAHNLIQ 137
Query: 132 SGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN---GVLPPSIS 188
S +P + +L+NL L L N + L + + L L+L + P
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 189 NLSNLEGLYLYSSLVSAEIGNL-------LQLIELEIDNKQLFGQIPK----SLRNFTSL 237
L L L ++ S + L++ L + + G + K +L +L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 238 NIVHLEQNHLTG---NIYEVFGIYPNLTFLDLSQNNFYGSLNFSM----------NNITR 284
I +L +I ++F N++ L +FS N
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317
Query: 285 SIPPKIGKLYQLHKLDFSLNHIVGELP-IELGNLKSLNYRALNGNK--VYGSLPRVLGSI 341
P KL L +L F+ N ++L +L+ L+ L+ N G +
Sbjct: 318 QFPT--LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLD---LSRNGLSFKGCCSQSDFGT 372
Query: 342 SDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
+ L+YLDLS N F L QL LD
Sbjct: 373 TSLKYLDLSFNGVITMSSNFL----GLEQLEHLDF 403
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-29
Identities = 75/388 (19%), Positives = 128/388 (32%), Gaps = 46/388 (11%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLR-GSVPRE 73
N + ++ +S+L+ L L+ + I L LK L + N ++ +P
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 74 VGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSN----------LTSLSLFH 123
L++L+ L L N + + L+ + + ++ LS + L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHK 204
Query: 124 LDLSENQLSGSIPH-FLGHLSNLAVLHLGDNSLFGSI------PPILGKVQSLLSLGFDL 176
L L N S ++ + L+ L V L L + +L F L
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 177 NLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNL------LQLIELEIDNKQLFGQIPKS 230
L+ L I + L + SLVS I + LE+ N +
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVS-SFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLK 323
Query: 231 LRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKI 290
L++ L N P+L FLDLS+N +
Sbjct: 324 LKSLKRLT---FTSNKGGNAF--SEVDLPSLEFLDLSRNGL---------SFKGCCSQSD 369
Query: 291 GKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPR--VLGSISDLEYLD 348
L LD S N ++ + L+ L + + + + V S+ +L YLD
Sbjct: 370 FGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLD 427
Query: 349 LSTNYNNEFRKEFPVELEKLVQLTELDL 376
+S + R F L L L +
Sbjct: 428 IS---HTHTRVAFNGIFNGLSSLEVLKM 452
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 83/398 (20%), Positives = 143/398 (35%), Gaps = 41/398 (10%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGV-IPQEIDPLTHLKHLYINVNKLRGSVPRE 73
L ++ IG++ LK L++ +N + +P+ LT+L+HL ++ NK++ +
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
Query: 74 VGQLSSLK----QLVLYCNGLSGWLPSSFGNL---------NNLAIGSMPNSLSNLTSLS 120
+ L + L L N ++ P +F + N ++ M + L L
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLE 228
Query: 121 LFHLDL----SENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSL-GFD 175
+ L L +E L L L NL + L + I+ L ++ F
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS 288
Query: 176 LNLLNGVLPPSISNLSNLEGLYLYS-SLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNF 234
L + S + L L + L L L + + S +
Sbjct: 289 LVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKG--GNAFSEVDL 346
Query: 235 TSLNIVHLEQNHLT--GNIYEVFGIYPNLTFLDLSQN-------NFYG-----SLNFSMN 280
SL + L +N L+ G + +L +LDLS N NF G L+F +
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 281 NITRSIPPKI-GKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPR-VL 338
N+ + + L L LD S H L SL + GN + +
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 339 GSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
+ +L +LDLS + + P L L L++
Sbjct: 467 TELRNLTFLDLS---QCQLEQLSPTAFNSLSSLQVLNM 501
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-20
Identities = 69/354 (19%), Positives = 122/354 (34%), Gaps = 40/354 (11%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQE-IDPLTHLKHLYINVNKLRGS---VPREVGQL 77
I P L L + NN S + + I L L+ + + + R + L
Sbjct: 192 IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251
Query: 78 SSLKQLVLYCNGLSGW------LPSSFGNLNNLAIGSMP-NSLSNLTSLS----LFHLDL 126
L L + L+ + F L N++ S+ ++ + S HL+L
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLEL 311
Query: 127 SENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN--GVLP 184
+ L +L L N G+ + + SL L N L+ G
Sbjct: 312 VNCKFGQFPTL---KLKSLKRLTFTSNKG-GNAFSEVD-LPSLEFLDLSRNGLSFKGCCS 366
Query: 185 PSISNLSNLEGLYLYS---SLVSAEIGNLLQLIELEIDNKQLFGQIPKS-LRNFTSLNIV 240
S ++L+ L L +S+ L QL L+ + L S + +L +
Sbjct: 367 QSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426
Query: 241 HLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKI-GKLYQLHKL 299
+ H +F +L L ++ N+ + P I +L L L
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAG-----------NSFQENFLPDIFTELRNLTFL 475
Query: 300 DFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPR-VLGSISDLEYLDLSTN 352
D S + P +L SL + N++ S+P + ++ L+ + L TN
Sbjct: 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 6e-19
Identities = 52/254 (20%), Positives = 93/254 (36%), Gaps = 43/254 (16%)
Query: 1 LSCLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLS--GVIPQEIDPLTHLKH 58
L + + ++ ++ ++ +L+FLD+ N LS G Q T LK+
Sbjct: 319 FPTLKLKSLKRLTFTSNKGGNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 59 LYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSG-WLPSSFGNLNNLAIGSMPNSLSNLT 117
L ++ N + ++ L L+ L + L S F +L NL
Sbjct: 378 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL------------- 423
Query: 118 SLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDL 176
+LD+S + LS+L VL + NS + P I ++++L L
Sbjct: 424 ----IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 177 NLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTS 236
L + P + ++LS+L+ L + N L+ + I TS
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMA--------SNQLKSVPDGI------------FDRLTS 519
Query: 237 LNIVHLEQNHLTGN 250
L + L N +
Sbjct: 520 LQKIWLHTNPWDCS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 55/306 (17%), Positives = 95/306 (31%), Gaps = 29/306 (9%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHL-YINVNKLRGSVPRE 73
L + + NL + L + ID L ++ ++ + ++
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
Query: 74 VGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAI----GSMPNSLSNLTSLSLFHLDLSEN 129
+ L L + +L L G S +L SL LDLS N
Sbjct: 300 FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLE--FLDLSRN 357
Query: 130 QLS--GSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSI 187
LS G ++L L L N + ++ ++ L L F + L + S+
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 188 -SNLSNLEGLYLY----SSLVSAEIGNLLQLIELEIDNKQLFGQIPK-SLRNFTSLNIVH 241
+L NL L + + L L L++ +L +
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 242 LEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKI-GKLYQLHKLD 300
L Q L F +L L+++ N +S+P I +L L K+
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMASNQL------------KSVPDGIFDRLTSLQKIW 524
Query: 301 FSLNHI 306
N
Sbjct: 525 LHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 9e-16
Identities = 36/160 (22%), Positives = 62/160 (38%), Gaps = 13/160 (8%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEI-DPLTHLKHLYINVNKLRGSVPRE 73
S + + L+ LD ++ L + + L +L +L I+ R +
Sbjct: 381 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 74 VGQLSSLKQLVLYCNGLSG-WLPSSFGNLNNL--------AIGSMPNS-LSNLTSLSLFH 123
LSSL+ L + N +LP F L NL + + + ++L+SL
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ--V 498
Query: 124 LDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPIL 163
L+++ NQL L++L + L N S P I
Sbjct: 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-31
Identities = 80/372 (21%), Positives = 128/372 (34%), Gaps = 76/372 (20%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNG 89
+ L++G + L+ +P + H+ L I N L S+P L+ L + N
Sbjct: 40 NGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQ 92
Query: 90 LSGWLPSSFGNLNNLAIGSMPNSLSNLTSL--SLFHLDLSENQLSGSIPHFLGHLSNLAV 147
L+ LP L L+I S N L++L +L L L + NQL+ S+P L
Sbjct: 93 LTS-LPVLPPGLLELSIFS--NPLTHLPALPSGLCKLWIFGNQLT-SLPVLPPGLQE--- 145
Query: 148 LHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEI 207
L + DN L S+P + ++ L + N L LP S L
Sbjct: 146 LSVSDNQL-ASLPALPSELCKLWAYN---NQLT-SLPMLPSGLQ---------------- 184
Query: 208 GNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLS 267
EL + + QL +P L + L L L +S
Sbjct: 185 -------ELSVSDNQL-ASLPTLPSELYKLWAYNNRLTSLPALP-------SGLKELIVS 229
Query: 268 QNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNG 327
N S+P +L +L S N + LP+ L SL+ +
Sbjct: 230 GNRL------------TSLPVLPS---ELKELMVSGNRLT-SLPMLPSGLLSLS---VYR 270
Query: 328 NKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLV----QLTELDLVITFWEE 383
N++ LP L +S ++L N +E + E+ + D+
Sbjct: 271 NQL-TRLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPR 329
Query: 384 RYRPKSVIWKAW 395
R + W
Sbjct: 330 ETRALHLAAADW 341
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-30
Identities = 65/356 (18%), Positives = 113/356 (31%), Gaps = 49/356 (13%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81
+P + ++ L + +N L+ +P L+ L ++ N+L S+P L L
Sbjct: 55 LPDCLPA--HITTLVIPDNNLT-SLPALP---PELRTLEVSGNQLT-SLPVLPPGLLELS 107
Query: 82 QLVLYCNGLSGWLPSSFGNLN--NLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFL 139
L LPS L + S+P L L +S+NQL+ S+P
Sbjct: 108 IFSNPLTHLPA-LPSGLCKLWIFGNQLTSLPVLPPGLQE-----LSVSDNQLA-SLPALP 160
Query: 140 GHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLY 199
L L +N L S+P + L L N L LP S L L
Sbjct: 161 SELCK---LWAYNNQL-TSLPMLPS---GLQELSVSDNQLA-SLPTLPSELYKLWAYNNR 212
Query: 200 SSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYP 259
+ + A L EL + +L +P L + N LT + +
Sbjct: 213 LTSLPALPSG---LKELIVSGNRL-TSLPVLPSELKELM---VSGNRLT----SLPMLPS 261
Query: 260 NLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKS 319
L L + +N +P + L ++ N + L + S
Sbjct: 262 GLLSLSVYRNQL------------TRLPESLIHLSSETTVNLEGNPLSERTLQALREITS 309
Query: 320 LNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELD 375
+ + + L + ++ R+ P ++ + D
Sbjct: 310 APGYSGPIIRFDMAGASAPRETRALH--LAAADWLVPAREGEPAPADRWHMFGQED 363
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 68/358 (18%), Positives = 117/358 (32%), Gaps = 54/358 (15%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81
+P + L L + + L L+I N+L S+P L+
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPVL---PPGLQ 144
Query: 82 QLVLYCNGLSGWLPSSFGNLNNL-----AIGSMPNSLSNLTSLSLFHLDLSENQLSGSIP 136
+L + N L+ LP+ L L + S+P S L L +S+NQL+ S+P
Sbjct: 145 ELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQE-----LSVSDNQLA-SLP 197
Query: 137 HFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGL 196
L L + SL P + ++ L+ G N L LP S L L
Sbjct: 198 TLPSELYKLWAYNNRLTSL----PALPSGLKELIVSG---NRLTS-LPVLPSELKELMVS 249
Query: 197 YLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFG 256
+ + L+ L + QL ++P+SL + +S V+LE N L+ +
Sbjct: 250 GNRLTSLPMLPSG---LLSLSVYRNQL-TRLPESLIHLSSETTVNLEGNPLSERTLQ--- 302
Query: 257 IYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGN 316
+T + S P + L+ P
Sbjct: 303 ALREITSAPGYSGP-----IIRFDMAGASAPRETRALHLAAADWLVPARE--GEPAPADR 355
Query: 317 LKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTEL 374
+ + L +S+ E + + F+ + L +L + L
Sbjct: 356 WHMF--GQEDNAD---AFSLFLDRLSETE----NFIKDAGFKAQISSWLAQLAEDEAL 404
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-25
Identities = 62/303 (20%), Positives = 103/303 (33%), Gaps = 60/303 (19%)
Query: 99 GNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGS 158
+ M L+N L++ E+ L+ ++P L +++ L + DN+L S
Sbjct: 24 SRGRAAVVQKMRACLNN----GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNL-TS 75
Query: 159 IPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEI 218
+P + + L +L N L LP L L + + A L +L I
Sbjct: 76 LPALPPE---LRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG---LCKLWI 128
Query: 219 DNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG----- 273
QL +P L++ + L L L N
Sbjct: 129 FGNQL-TSLPVLPPGLQELSVSDNQLASLPALP-------SELCKLWAYNNQLTSLPMLP 180
Query: 274 ----SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHI----------------VGELPIE 313
L+ S N + S+P +LY+L + L + + LP+
Sbjct: 181 SGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVL 239
Query: 314 LGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTE 373
LK L ++GN++ SLP S L L + N+ P L L T
Sbjct: 240 PSELKELM---VSGNRL-TSLPM---LPSGLLSLSVY---RNQLT-RLPESLIHLSSETT 288
Query: 374 LDL 376
++L
Sbjct: 289 VNL 291
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 6e-21
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 26/212 (12%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
+P L+ L + +NQL+ +P + L L+ N+L S+P
Sbjct: 129 FGNQLTSLPVLPP---GLQELSVSDNQLA-SLPALP---SELCKLWAYNNQLT-SLPML- 179
Query: 75 GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSL--SLFHLDLSENQLS 132
S L++L + N L+ LP+ L L + N L++L +L L L +S N+L+
Sbjct: 180 --PSGLQELSVSDNQLAS-LPTLPSELYKLWAYN--NRLTSLPALPSGLKELIVSGNRLT 234
Query: 133 GSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSN 192
S+P L L + N L S+P + LLSL N L LP S+ +LS+
Sbjct: 235 -SLPVLPSELKE---LMVSGNRL-TSLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSS 285
Query: 193 LEGLYLYS-SLVSAEIGNLLQLIELEIDNKQL 223
+ L L + L ++ + +
Sbjct: 286 ETTVNLEGNPLSERTLQALREITSAPGYSGPI 317
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-31
Identities = 42/178 (23%), Positives = 74/178 (41%), Gaps = 21/178 (11%)
Query: 473 IGTAGQASVYKAELPSW--EIVAVKKFHSPHPDMVVQ--QAFSNEIKALTELRHRNVVKF 528
IG G VY+A W + VAVK + + Q + E K L+H N++
Sbjct: 15 IGIGGFGKVYRA---FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
G L+ E+ G L +LS + +N +A ++Y+H +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 589 PIVHRDISSKNVLLGLDYDAH--------VSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
PI+HRD+ S N+L+ + ++DFG+++ + G + ++AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAYAWMAP 183
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-31
Identities = 66/350 (18%), Positives = 121/350 (34%), Gaps = 40/350 (11%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPRE 73
+ T + ++N K + N+ + + +D ++ L +N ++ +
Sbjct: 29 DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTY 87
Query: 74 V-GQLSSLKQLVLYCNGLSGWLPSSFGNLNNL--------AIGSMP-NSLSNLTSLSLFH 123
++++L + N + P F N+ L + S+P N L+
Sbjct: 88 AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT--T 145
Query: 124 LDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVL 183
L +S N L ++L L L N L + + SL NLL+
Sbjct: 146 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-THVDL--SLIPSLFHANVSYNLLS--- 199
Query: 184 PPSISNLSNLEGLYLYS-SLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHL 242
+++ +E L S+ ++L L++ + L L N+ L V L
Sbjct: 200 --TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDL 255
Query: 243 EQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFS 302
N L +Y F L L +S N ++ + L LD S
Sbjct: 256 SYNELEKIMYHPFVKMQRLERLYISNNRL------------VALNLYGQPIPTLKVLDLS 303
Query: 303 LNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTN 352
NH++ + L L+ N + +L L + L+ L LS N
Sbjct: 304 HNHLL-HVERNQPQFDRLENLYLDHNSI-VTLK--LSTHHTLKNLTLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 61/354 (17%), Positives = 117/354 (33%), Gaps = 43/354 (12%)
Query: 46 IPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNL- 104
I + ++I++ E L++ K + + + + + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 105 -------AIGSMP-NSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLF 156
I + + + ++ L + N + PH ++ L VL L N L
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQ--KLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL- 129
Query: 157 GSIPP-ILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYS-SLVSAEIGNLLQLI 214
S+P I L +L N L + + ++L+ L L S L ++ + L
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLF 189
Query: 215 ELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN---- 270
+ L +L ++ + N + + + LT L L NN
Sbjct: 190 HANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTDT 241
Query: 271 --FYG-----SLNFSMNNITRSIPPKI-GKLYQLHKLDFSLNHIVGELPIELGNLKSLNY 322
++ S N + I K+ +L +L S N +V L + + +L
Sbjct: 242 AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 299
Query: 323 RALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
L+ N + + R LE L L +N ++L L L L
Sbjct: 300 LDLSHNHLL-HVERNQPQFDRLENLYLD---HNSIVT---LKLSTHHTLKNLTL 346
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 47/292 (16%), Positives = 92/292 (31%), Gaps = 59/292 (20%)
Query: 102 NNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP 161
+ ++L H+D+ + L+N ++ ++++ +P
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDI--TLNNQKIVTFKNSTM-RKLPA 62
Query: 162 ILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLY----SSLVSAEIGNLLQLIELE 217
L + + +E L L + + + +L
Sbjct: 63 AL-----------------------LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLY 99
Query: 218 IDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN------- 270
+ + P +N L ++ LE+N L+ +F P LT L +S NN
Sbjct: 100 MGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD 159
Query: 271 -FYG-----SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRA 324
F +L S N +T + + L + S N + L I ++ L+
Sbjct: 160 TFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLL-STLAI-PIAVEELD--- 211
Query: 325 LNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
+ N + + +L L L N + L L E+DL
Sbjct: 212 ASHNSI-NVVRG--PVNVELTILKLQHNNLTDTA-----WLLNYPGLVEVDL 255
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-30
Identities = 80/428 (18%), Positives = 146/428 (34%), Gaps = 70/428 (16%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
N + I + +NL+ L + +++++ + L L+HL ++ N L S+
Sbjct: 35 FNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSW 93
Query: 75 -GQLSSLKQLVLYCNGLSG-WLPSSFGNLNNL---------AIGSMP-NSLSNLTSL--- 119
G LSSLK L L N + S F NL NL + + LTSL
Sbjct: 94 FGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNEL 153
Query: 120 -------------------SLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIP 160
+ HL L ++ + + F LS++ L L D +L
Sbjct: 154 EIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQF 213
Query: 161 PILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDN 220
L + + + + S + L L L S V + L L +
Sbjct: 214 SPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSE 273
Query: 221 KQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG------- 273
+ ++ K ++ +H+ Q +L ++ V+ + + + + + +
Sbjct: 274 SDVVSELGK--VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQ 331
Query: 274 ------SLNFSMNNITRSIPPK---IGKLYQLHKLDFSLNHI--VGELPIELGNLKSLNY 322
L+ S N + G L L S NH+ + + L LK+L
Sbjct: 332 HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391
Query: 323 RALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKL-------------- 368
++ N +P + +L+LS+ + P LE L
Sbjct: 392 LDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFL 450
Query: 369 VQLTELDL 376
+L EL +
Sbjct: 451 PRLQELYI 458
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 67/403 (16%), Positives = 140/403 (34%), Gaps = 40/403 (9%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLYCN 88
+ +K LD+ N+++ + ++ +L+ L + +++ ++ + L SL+ L L N
Sbjct: 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDN 84
Query: 89 GLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSG-SIPHFLGHLSNLAV 147
LS S FG L++L +L+L N + +L+NL
Sbjct: 85 HLSSLSSSWFGPLSSLK-----------------YLNLMGNPYQTLGVTSLFPNLTNLQT 127
Query: 148 LHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLY----SSL 202
L +G+ F I + SL L L S+ ++ ++ L L+ + L
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187
Query: 203 VSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLT-------GNIYEVF 255
+ L + LE+ + L L + + + + ++
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247
Query: 256 GIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELG 315
L+ ++ G +F+ + + + +L ++ +L
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS 307
Query: 316 NLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELD 375
L+ + + +KV+ + LE+LDLS N E + L L
Sbjct: 308 LLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLV 367
Query: 376 LVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGL 418
L + K ++ + L+ +DIS N +
Sbjct: 368 L-------SQNHLRSMQKTG-EILLTLKNLTSLDISRNTFHPM 402
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 73/390 (18%), Positives = 133/390 (34%), Gaps = 48/390 (12%)
Query: 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVG 75
T I +++L L++ L Q + + + HL +++++ +
Sbjct: 134 ETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFAD 193
Query: 76 QLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSI 135
LSS++ L L L+ + S + + L D S N+L +
Sbjct: 194 ILSSVRYLELRDTNLARFQFSPLPVDEVS------SPMKKLAFRGSVLTDESFNELL-KL 246
Query: 136 PHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQ--------SLLSLGFDLNLLNGVLPPSI 187
++ LS + N L P V ++ L L L
Sbjct: 247 LRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVY 306
Query: 188 SNLSNLEGLYLY----SSLVSAEIGNLLQLIELEIDN---KQLFGQIPKSLRNFTSLNIV 240
S L ++ + + + + +L L L++ + + + + SL +
Sbjct: 307 SLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366
Query: 241 HLEQNHLT--GNIYEVFGIYPNLTFLDLSQNNFYG------------SLNFSMNNITRSI 286
L QNHL E+ NLT LD+S+N F+ LN S I +
Sbjct: 367 VLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VV 425
Query: 287 PPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEY 346
I L LD S N++ + L L+ L ++ NK+ +LP L
Sbjct: 426 KTCI--PQTLEVLDVSNNNL-DSFSLFLPRLQELY---ISRNKLK-TLPDASLFPV-LLV 477
Query: 347 LDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
+ +S N ++L L ++ L
Sbjct: 478 MKISRNQLKSVPDGI---FDRLTSLQKIWL 504
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 50/251 (19%), Positives = 87/251 (34%), Gaps = 24/251 (9%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQ-LSSLKQLVLYCN 88
++ L + L + L +K + + +K+ VP Q L SL+ L L N
Sbjct: 286 VTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSEN 344
Query: 89 GLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLS--GSIPHFLGHLSNLA 146
+ + SL L LS+N L L L NL
Sbjct: 345 LMVEEYLKNSACKGAWP--------------SLQTLVLSQNHLRSMQKTGEILLTLKNLT 390
Query: 147 VLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAE 206
L + N+ +P + + L + V+ I LE L + ++ + +
Sbjct: 391 SLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSF 446
Query: 207 IGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDL 266
L +L EL I +L +P + F L ++ + +N L +F +L + L
Sbjct: 447 SLFLPRLQELYISRNKL-KTLPDAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWL 504
Query: 267 SQNNFYGSLNF 277
N + S
Sbjct: 505 HTNPWDCSCPR 515
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 54/321 (16%), Positives = 104/321 (32%), Gaps = 39/321 (12%)
Query: 100 NLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSI 159
+ + + S+P+ L+ ++ LDLS N+++ L +NL VL L + + +I
Sbjct: 11 DGRSRSFTSIPSGLTA----AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NTI 65
Query: 160 PP-ILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEI 218
+ SL L N L+ + LS+L+ L L GN Q +
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLM--------GNPYQTLG--- 114
Query: 219 DNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYE-VFGIYPNLTFLDLSQNNFYGSLNF 277
+ N T+L + + I F +L L++ +
Sbjct: 115 --------VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL------ 160
Query: 278 SMNNITRSIPPK-IGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPR 336
R+ + + + +H L L+ L I L S+ Y L +
Sbjct: 161 ------RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFS 214
Query: 337 VLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWR 396
L + + E EL KL++ + F + +
Sbjct: 215 PLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSES 274
Query: 397 SLISRMHGLSCIDISYNELRG 417
++S + + + I +
Sbjct: 275 DVVSELGKVETVTIRRLHIPQ 295
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 29/154 (18%), Positives = 46/154 (29%), Gaps = 25/154 (16%)
Query: 26 IGNISNLKFLDMGNNQLS--GVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQL 83
G +L+ L + N L + + L +L L I+ N +P ++ L
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFL 415
Query: 84 VLYCNGLSGWLPSSFGNLNNL-----AIGSMPNSLSNLTSL-----------------SL 121
L G+ L L + S L L L L
Sbjct: 416 NLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKTLPDASLFPVL 475
Query: 122 FHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSL 155
+ +S NQL L++L + L N
Sbjct: 476 LVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 28/170 (16%), Positives = 57/170 (33%), Gaps = 14/170 (8%)
Query: 473 IGTAGQASVYKAELPSW--EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
+ ++K W + VK + F+ E L H NV+ G
Sbjct: 18 LNENHSGELWKG---RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 531 FSFHPRQSFL--LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
P + ++ GSL +L + + +A ++++H P
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARGMAFLHT-LEP 132
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
I ++S++V++ D A +S + + + +VAP
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-----MYAPAWVAP 177
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 19/177 (10%)
Query: 473 IGTAGQASVYKAELPSW-EIVAVKKFHSPHPD-----MVVQQAFSNEIKALTELRHRNVV 526
IG G V+K L +VA+K + + Q F E+ ++ L H N+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 527 KFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY 586
K YG +P ++ E++ G L L + A W+V++ ++ +A + YM +
Sbjct: 87 KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 587 FPPIVHRDISSKNVLL-----GLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
PPIVHRD+ S N+ L A V+DFG+S+ S +G F ++AP
Sbjct: 143 -PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG---LLGNFQWMAP 195
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-29
Identities = 54/402 (13%), Positives = 107/402 (26%), Gaps = 57/402 (14%)
Query: 26 IGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVL 85
N + K + ++ L + ++K L ++ N L ++ + L+ L L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 86 YCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNL 145
N L +L+ L LDL+ N + L ++
Sbjct: 66 SSNVLYE--TLDLESLST-----------------LRTLDLNNNYVQE-----LLVGPSI 101
Query: 146 AVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVS- 204
LH +N++ + G Q ++ N + + S ++ L L + +
Sbjct: 102 ETLHAANNNI-SRVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT 158
Query: 205 ----AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPN 260
+ L L + ++ + + F L + L N L + F
Sbjct: 159 VNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAG 215
Query: 261 LTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSL 320
+T++ L N I + L D N + K+
Sbjct: 216 VTWISLRNNKL------------VLIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQ 262
Query: 321 NYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITF 380
+ + V + + + F L L + L
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQG 322
Query: 381 WEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRNS 422
E ID + R +I
Sbjct: 323 SETE---------RLECERENQARQREIDALKEQYRTVIDQV 355
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-29
Identities = 55/420 (13%), Positives = 124/420 (29%), Gaps = 60/420 (14%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVP--- 71
++L + + N+K LD+ N LS + ++ P T L+ L ++ N L ++
Sbjct: 19 DSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLES 78
Query: 72 --------------REVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGS------MPN 111
+E+ S++ L N +S S N+ + +
Sbjct: 79 LSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDL 138
Query: 112 SLSNLTSLSLFHLDLSENQLSG-SIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLL 170
+ + +LDL N++ + L L+L N ++ + + L
Sbjct: 139 DEGCRSRVQ--YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLK 194
Query: 171 SLGFDLNLLNGVLPPSISNLSNLEGLYLYS---SLVSAEIGNLLQLIELEIDN------- 220
+L N L + P + + + + L + L+ + L ++
Sbjct: 195 TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGT 253
Query: 221 -----------KQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVF--GIYPNLTFLDLS 267
+ + Q K L H E L L
Sbjct: 254 LRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRK 313
Query: 268 QNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNG 327
++ +L + T + + + ++D + ++
Sbjct: 314 EH----ALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKK 369
Query: 328 NKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRP 387
+ + + ++L+ E + E+ L L ++ +EE Y
Sbjct: 370 KALDEQVSNGRRAHAELDGTLQQAVGQIELQHAT----EEQSPLQLLRAIVKRYEEMYVE 425
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 51/417 (12%), Positives = 107/417 (25%), Gaps = 58/417 (13%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIP-----------------QEIDPLTHLK 57
N L I + + L+ L++ +N L + QE+ ++
Sbjct: 43 GNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIE 102
Query: 58 HLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNL----------NNLAIG 107
L+ N + V GQ K + L N ++ G N +
Sbjct: 103 TLHAANNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159
Query: 108 SMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQ 167
+ ++ +L HL+L N + + + + L L L N L + P
Sbjct: 160 NFAELAASSDTLE--HLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKL-AFMGPEFQSAA 214
Query: 168 SLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYS---SLVSAEIGNLLQLIELEIDNKQLF 224
+ + N L ++ ++ NLE L + + + +
Sbjct: 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
Query: 225 GQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG----------- 273
++ T + H L + + + G
Sbjct: 274 KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERE 333
Query: 274 ------SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNG 327
++ I + L+ + ++ L+
Sbjct: 334 NQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQA 393
Query: 328 NKVYGSLPRVLGSISDLEYLDLSTN-YNNEFRKEFPVELEKLVQLTELDLVITFWEE 383
L S L+ L Y + ++ V+ + T E
Sbjct: 394 VG-QIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAE 449
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 51/262 (19%), Positives = 91/262 (34%), Gaps = 29/262 (11%)
Query: 105 AIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILG 164
AI + + + ++++ L ++ N+ L L N L L
Sbjct: 1 AIHEIKQNGNRYKI-----EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLA 55
Query: 165 KVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLF 224
L L N+L + +LS L L L ++ V E+ + L N +
Sbjct: 56 PFTKLELLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQ-ELLVGPSIETLHAANNNI- 111
Query: 225 GQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN--------FYGS-- 274
++ S ++L N +T G + +LDL N S
Sbjct: 112 SRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 275 ----LNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKV 330
LN N I + ++ +L LD S N + + E + + + +L NK+
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 331 YGSLPRVLGSISDLEYLDLSTN 352
+ + L +LE+ DL N
Sbjct: 227 -VLIEKALRFSQNLEHFDLRGN 247
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 27/258 (10%), Positives = 57/258 (22%), Gaps = 47/258 (18%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV------- 74
+ P+ + + + ++ + NN+L +I + + +L+H + N R+
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 75 -------------------GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSN 115
+ C L L + S
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSE 324
Query: 116 LTSL--------SLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQ 167
L +D + Q I L +L +
Sbjct: 325 TERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHA 384
Query: 168 SLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQI 227
L L + S L+ L +++ E +Q
Sbjct: 385 ELDGTLQQAVGQI-ELQHATEEQSPLQLLR-----------AIVKRYEEMYVEQQSVQNN 432
Query: 228 PKSLRNFTSLNIVHLEQN 245
+ L +
Sbjct: 433 AIRDWDMYQHKETQLAEE 450
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 47/184 (25%), Positives = 79/184 (42%), Gaps = 29/184 (15%)
Query: 472 CIGTAGQASVYKAELPSW--EIVAVKKFHSPHPDMVVQQAFSNE--IKALTELRHRNVVK 527
C+G V++ SW E VAVK F S ++++ E + LRH N++
Sbjct: 15 CVGKGRYGEVWRG---SWQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILG 66
Query: 528 FYG----FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH 583
F Q +L+ Y GSL L + ++ S+A+ L+++H
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLH 122
Query: 584 HDYF-----PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEF----VGTFG 634
+ F P I HRD+ SKN+L+ + ++D G++ ++ VGT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 635 YVAP 638
Y+AP
Sbjct: 183 YMAP 186
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 53/362 (14%), Positives = 106/362 (29%), Gaps = 55/362 (15%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81
I N + K + ++ L + ++K L ++ N L ++ + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 82 QLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGH 141
L L N L +L+ L LDL+ N + L
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLR-----------------TLDLNNNYVQ-----ELLV 97
Query: 142 LSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYS- 200
++ LH +N++ + G Q ++ N + + S ++ L L
Sbjct: 98 GPSIETLHAANNNI-SRVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN 154
Query: 201 SLVS----AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFG 256
+ + + L L + ++ + + F L + L N L + F
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQ 211
Query: 257 IYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIV-GELPIELG 315
+T++ L N I + L D N G L
Sbjct: 212 SAAGVTWISLRNNKL------------VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259
Query: 316 NLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFP-VELEKLVQLTEL 374
+ + A K ++ L +Y ++ P ++L+ L
Sbjct: 260 KNQRVQTVAKQTVKKLTGQNEEECTVPTL------GHYGAYCCEDLPAPFADRLIALGHH 313
Query: 375 DL 376
Sbjct: 314 HH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 51/264 (19%), Positives = 102/264 (38%), Gaps = 17/264 (6%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
++L + + N+K LD+ N LS + ++ P T L+ L ++ N L ++
Sbjct: 19 DSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDL 76
Query: 75 GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSL---SLFHLDLSENQL 131
LS+L+ L L N + L ++ L + N++S ++ ++ L+ N++
Sbjct: 77 ESLSTLRTLDLNNNYVQELLVGP--SIETLHAAN--NNISRVSCSRGQGKKNIYLANNKI 132
Query: 132 SGSIPHFLGHLSNLAVLHLGDNSLFG-SIPPILGKVQSLLSLGFDLNLLNGVLPPSISNL 190
+ G S + L L N + + + +L L N + V
Sbjct: 133 TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQVVF 190
Query: 191 SNLEGLYLYS---SLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHL 247
+ L+ L L S + + E + + + + N +L I K+LR +L L N
Sbjct: 191 AKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGF 249
Query: 248 T-GNIYEVFGIYPNLTFLDLSQNN 270
G + + F + +
Sbjct: 250 HCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 47/286 (16%), Positives = 96/286 (33%), Gaps = 41/286 (14%)
Query: 69 SVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSE 128
++ + K + + L L S + N + LDLS
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWN-----------------VKELDLSG 43
Query: 129 NQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSIS 188
N LS L + L +L+L N L + + +L +L + N + +
Sbjct: 44 NPLSQISAADLAPFTKLELLNLSSNVL-YETLDL-ESLSTLRTLDLNNNYVQ-----ELL 96
Query: 189 NLSNLEGLYLYS-SLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHL 247
++E L+ + ++ + + N ++ + + + L+ N +
Sbjct: 97 VGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156
Query: 248 TG-NIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHI 306
N E+ L L+L N + ++ +L LD S N +
Sbjct: 157 DTVNFAELAASSDTLEHLNLQYNFI------------YDVKGQVV-FAKLKTLDLSSNKL 203
Query: 307 VGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTN 352
+ E + + + +L NK+ + + L +LE+ DL N
Sbjct: 204 A-FMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGN 247
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 43/261 (16%), Positives = 94/261 (36%), Gaps = 35/261 (13%)
Query: 134 SIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNL 193
+I + + + + D+SL ++ + ++ L N L+ + ++ + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 194 EGLYLYSSLVS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNI 251
E L L S+++ ++ +L L L+++N + + L S+ +H N+++
Sbjct: 61 ELLNLSSNVLYETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVS 115
Query: 252 YEVFGIYPNLTFLDLSQNN--------FYG-----SLNFSMNNITR-SIPPKIGKLYQLH 297
+ L+ N L+ +N I + L
Sbjct: 116 CSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 298 KLDFSLNHIVGELP--IELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNN 355
L+ N I ++ + LK+L+ L+ NK+ + S + + ++ L NN
Sbjct: 173 HLNLQYNFIY-DVKGQVVFAKLKTLD---LSSNKL-AFMGPEFQSAAGVTWISLR---NN 224
Query: 356 EFRKEFPVELEKLVQLTELDL 376
+ L L DL
Sbjct: 225 KLV-LIEKALRFSQNLEHFDL 244
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 35/196 (17%), Positives = 65/196 (33%), Gaps = 42/196 (21%)
Query: 227 IPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSI 286
I + +N I + + L + + N+ LDLS N +++
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNP-----------LSQIS 50
Query: 287 PPKIGKLYQLHKLDFSLNHIVGELPIE-LGNLKSLNYRALNGNKVYGSLPRVLGSISDLE 345
+ +L L+ S N + L +E L L++L+ LN N V + L +E
Sbjct: 51 AADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLD---LNNNYV-----QELLVGPSIE 102
Query: 346 YLDLSTNYNNEFRKEFPVELEKLVQLTELDL---VITFWEERYRPKSVIWKAWRSLISRM 402
L + NN + V + + L IT +
Sbjct: 103 TLHAA---NNNISR---VSCSRGQGKKNIYLANNKIT---------MLRDLDEGCRSR-- 145
Query: 403 HGLSCIDISYNELRGL 418
+ +D+ NE+ +
Sbjct: 146 --VQYLDLKLNEIDTV 159
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-29
Identities = 66/350 (18%), Positives = 121/350 (34%), Gaps = 40/350 (11%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPRE 73
+ T + ++N K + N+ + + +D ++ L +N ++ +
Sbjct: 35 DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTY 93
Query: 74 V-GQLSSLKQLVLYCNGLSGWLPSSFGNLNNL--------AIGSMP-NSLSNLTSLSLFH 123
++++L + N + P F N+ L + S+P N L+
Sbjct: 94 AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT--T 151
Query: 124 LDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVL 183
L +S N L ++L L L N L + + SL NLL+
Sbjct: 152 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-THVDL--SLIPSLFHANVSYNLLS--- 205
Query: 184 PPSISNLSNLEGLYLYS-SLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHL 242
+++ +E L S+ ++L L++ + L L N+ L V L
Sbjct: 206 --TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDL 261
Query: 243 EQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFS 302
N L +Y F L L +S N ++ + L LD S
Sbjct: 262 SYNELEKIMYHPFVKMQRLERLYISNNRL------------VALNLYGQPIPTLKVLDLS 309
Query: 303 LNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTN 352
NH++ + L L+ N + +L L + L+ L LS N
Sbjct: 310 HNHLL-HVERNQPQFDRLENLYLDHNSI-VTLK--LSTHHTLKNLTLSHN 355
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 62/354 (17%), Positives = 116/354 (32%), Gaps = 43/354 (12%)
Query: 46 IPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNL- 104
I + ++I++ E L++ K + + + + + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 105 -------AIGSMP-NSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLF 156
I + + + ++ L + N + PH ++ L VL L N L
Sbjct: 79 LLNLNDLQIEEIDTYAFAYAHTIQ--KLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL- 135
Query: 157 GSIPP-ILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYS-SLVSAEIGNLLQLI 214
S+P I L +L N L + + ++L+ L L S L ++ + L
Sbjct: 136 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLF 195
Query: 215 ELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN---- 270
+ L +L ++ + N + V LT L L NN
Sbjct: 196 HANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVN---VELTILKLQHNNLTDT 247
Query: 271 --FYG-----SLNFSMNNITRSIPPKI-GKLYQLHKLDFSLNHIVGELPIELGNLKSLNY 322
++ S N + I K+ +L +L S N +V L + + +L
Sbjct: 248 AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 305
Query: 323 RALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
L+ N + + R LE L L +N ++L L L L
Sbjct: 306 LDLSHNHLL-HVERNQPQFDRLENLYLD---HNSIVT---LKLSTHHTLKNLTL 352
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 9e-11
Identities = 53/323 (16%), Positives = 104/323 (32%), Gaps = 27/323 (8%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
N L I+ + L+ L + NN+L + P+ LK L ++ N L V R
Sbjct: 263 YNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 320
Query: 75 GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSL--SLFHLDLSENQLS 132
Q L+ L L N + S+ L NL + ++L +L ++ + +
Sbjct: 321 PQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380
Query: 133 GSIPHFLGH----------LSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGV 182
I + L H + + ++ S+ + G+ + ++ +L + +
Sbjct: 381 CKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYI 440
Query: 183 LPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHL 242
L E L + + AE+ L E + L G + N +
Sbjct: 441 TQQGGVPLQGNEQLEAEVNELRAEVQQLTN--EQIQQEQLLQGLHAEIDTNLRRYRLPKD 498
Query: 243 EQNHLTGNIYEVFGIYPNLTFLDLSQNNF-----------YGSLNFSMNNITRSIPPKIG 291
+ N+ +VF L + L + + + K
Sbjct: 499 GLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRA 558
Query: 292 KLYQLHKLDFSLNHIVGELPIEL 314
K +L + V +L +
Sbjct: 559 KQAELRQETSLKRQKVKQLEAKK 581
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 9e-11
Identities = 46/288 (15%), Positives = 91/288 (31%), Gaps = 59/288 (20%)
Query: 106 IGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGK 165
+ ++L H+D+ + L+N ++ ++++ +P L
Sbjct: 16 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDI--TLNNQKIVTFKNSTM-RKLPAAL-- 70
Query: 166 VQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLY----SSLVSAEIGNLLQLIELEIDNK 221
+ + +E L L + + + +L +
Sbjct: 71 ---------------------LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 109
Query: 222 QLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN--------FYG 273
+ P +N L ++ LE+N L+ +F P LT L +S NN F
Sbjct: 110 AIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 169
Query: 274 -----SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGN 328
+L S N +T + + L + S N + L ++ L+ + N
Sbjct: 170 TTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLL-STLA-IPIAVEELD---ASHN 221
Query: 329 KVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
+ + +L L L N + L L E+DL
Sbjct: 222 SI-NVVRG--PVNVELTILKLQHNNLTDTA-----WLLNYPGLVEVDL 261
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 44/184 (23%), Positives = 73/184 (39%), Gaps = 29/184 (15%)
Query: 472 CIGTAGQASVYKAELPSW--EIVAVKKFHSPHPDMVVQQAFSNE--IKALTELRHRNVVK 527
IG V+ W E VAVK F + + ++ E I +RH N++
Sbjct: 44 QIGKGRYGEVWMG---KWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILG 95
Query: 528 FYGFSFHPRQS----FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH 583
F S +L+ +Y GSL L + + + S + L ++H
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLH 151
Query: 584 HDYF-----PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEF----VGTFG 634
+ F P I HRD+ SKN+L+ + ++D G++ D++ VGT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 635 YVAP 638
Y+ P
Sbjct: 212 YMPP 215
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 74/432 (17%), Positives = 134/432 (31%), Gaps = 43/432 (9%)
Query: 28 NISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLY 86
++ + L + N + V L L+ L + ++ +E L +L+ L L
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 87 CNGLSGWLPSSFGNLNNL-----------AIGSMPNSLSNLTSLSLFHLDLSENQLSG-S 134
+ + P +F L +L NL +L+ LDLS+NQ+
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT--RLDLSKNQIRSLY 139
Query: 135 IPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQ--SLLSLGFDLNLLNGVLPPSISNLSN 192
+ G L++L + N +F L +Q +L N L + N
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 193 -LEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNI 251
+ L VS GN + + + SL + +++
Sbjct: 200 PFRNMVLEILDVS---GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPD 256
Query: 252 YEVFG--IYPNLTFLDLSQNNFYG-------------SLNFSMNNITRSIPPKIGKLYQL 296
F ++ LDLS + LN + N I + L L
Sbjct: 257 QNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNL 316
Query: 297 HKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNE 356
L+ S N + L + Y L N + + + L+ LDL N
Sbjct: 317 QVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT 376
Query: 357 FR-----KEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDIS 411
+ + KLV L +++L + + R+ L + ++
Sbjct: 377 IHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENL--DILYFLLRVPHLQILILN 434
Query: 412 YNELRGLIRNST 423
N + T
Sbjct: 435 QNRFSSCSGDQT 446
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 80/401 (19%), Positives = 142/401 (35%), Gaps = 61/401 (15%)
Query: 14 ESNTLFAIIPPQI-GNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSV-- 70
S I + N+ NL+ LD+G++++ + P L HL L + L +V
Sbjct: 56 GSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLK 115
Query: 71 PREVGQLSSLKQLVLYCNGLSG-WLPSSFGNLNNL--------AIGSMP-NSLSNLTSLS 120
L +L +L L N + +L SFG LN+L I + + L L +
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175
Query: 121 LFHLDLSENQLSGSIPHFLGHLSN------LAVLHLGDNSLFGSIPPILGKVQSLLSLGF 174
L L+ N L + G N L +L + N ++ G
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGW------------TVDITGN 223
Query: 175 DLNLLNGVLPPSISNLSNLEGLYL-YSSLVSAEIGNL-----LQLIELEIDNKQLFGQIP 228
N ++ S+ ++ G + ++ + + L++ + +F
Sbjct: 224 FSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS 283
Query: 229 KSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN--------FYG-----SL 275
+ L +++L N + E F NL L+LS N FYG +
Sbjct: 284 RVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYI 343
Query: 276 NFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLP 335
+ N+I L +L LD N + + + S+ L+GNK +LP
Sbjct: 344 DLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNK-LVTLP 397
Query: 336 RVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
++ + + LS N + L ++ L L L
Sbjct: 398 KINLT---ANLIHLSENRLENLDILYF--LLRVPHLQILIL 433
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 78/403 (19%), Positives = 137/403 (33%), Gaps = 79/403 (19%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLT--HLKHLYINVNKLRGSVPREVGQLS- 78
+ P G +++LK +D +NQ+ V E++PL L + N L V + G+
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 79 -----SLKQLVLYCNGLSGWLPSSFGN-LNNLAIGSM--------------------PNS 112
L+ L + NG + + +F N ++ S+ N+
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259
Query: 113 LSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSL 172
+ L S+ HLDLS + L +L VL+L N + + +L L
Sbjct: 260 FAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVL 319
Query: 173 GFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLR 232
NLL + + L + + L N + +I+ ++ +
Sbjct: 320 NLSYNLLGELYSSNFYGLPKVAYIDLQ--------KNHIAIIQ------------DQTFK 359
Query: 233 NFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG---------SLNFSMNNIT 283
L + L N LT P++ + LS N ++ S N +
Sbjct: 360 FLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLE 414
Query: 284 R-SIPPKIGKLYQLHKLDFSLNHIVG----ELPIELGNLKSLNYRALNGNKVYGS----- 333
I + ++ L L + N + P E +L+ L L N + +
Sbjct: 415 NLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLF---LGENMLQLAWETEL 471
Query: 334 LPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
V +S L+ L L+ +N P L L L L
Sbjct: 472 CWDVFEGLSHLQVLYLN---HNYLNSLPPGVFSHLTALRGLSL 511
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 7e-21
Identities = 59/317 (18%), Positives = 104/317 (32%), Gaps = 44/317 (13%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNG 89
S+++ LD+ + + + + + L LK L + NK+ L +L+ L L N
Sbjct: 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325
Query: 90 LSGWLPSSFGNLNNLAI---------GSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLG 140
L S+F L +A + L L LDL +N L+ +
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQ--TLDLRDNALT-----TIH 378
Query: 141 HLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSI-SNLSNLEGLYLY 199
+ ++ + L N L ++P I + + N L + + +L+ L L
Sbjct: 379 FIPSIPDIFLSGNKL-VTLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILN 434
Query: 200 SSLVS-----AEIGNLLQLIELEIDNKQLFGQIPKSL-----RNFTSLNIVHLEQNHLTG 249
+ S L +L + L L + L +++L N+L
Sbjct: 435 QNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNS 494
Query: 250 NIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGE 309
VF L L L+ N + L LD S N ++
Sbjct: 495 LPPGVFSHLTALRGLSLNSNRL------------TVLSHND-LPANLEILDISRNQLLAP 541
Query: 310 LPIELGNLKSLNYRALN 326
P +L L+
Sbjct: 542 NPDVFVSLSVLDITHNK 558
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 4e-16
Identities = 59/347 (17%), Positives = 100/347 (28%), Gaps = 47/347 (13%)
Query: 100 NLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSI 159
+ +P L+ L LS N + L L +L LG +I
Sbjct: 10 FYRFCNLTQVPQVLNTTER-----LLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 160 PP-ILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYS------SLVSAEIGNLLQ 212
+ +L L + + + P + L +L L LY L NL
Sbjct: 65 DKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKA 124
Query: 213 LIELEI-DNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFG--IYPNLTFLDLSQN 269
L L++ N+ + S SL + N + L+F L+ N
Sbjct: 125 LTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAAN 184
Query: 270 NFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELP------------IELGNL 317
+ Y ++ + L LD S N ++ L
Sbjct: 185 SLYSRVSVDWGKCMNPF-----RNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILA 239
Query: 318 KSLNYRALNGNKVYGSLPRVLGSI--SDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELD 375
+ + + + S + +LDLS + E L L L+
Sbjct: 240 HHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLS---HGFVFSLNSRVFETLKDLKVLN 296
Query: 376 LVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRNS 422
L I K + L +++SYN L L ++
Sbjct: 297 LAYNK----------INKIADEAFYGLDNLQVLNLSYNLLGELYSSN 333
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 47/182 (25%), Positives = 76/182 (41%), Gaps = 25/182 (13%)
Query: 472 CIGTAGQASVYKAELPSW--EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFY 529
IG V++ W E VAVK F S ++A EI LRH N++ F
Sbjct: 49 SIGKGRFGEVWRG---KWRGEEVAVKIFSSREERSWFREA---EIYQTVMLRHENILGFI 102
Query: 530 G----FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHD 585
+ Q +L+ +Y GSL L+ + + + S A+ L+++H +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHME 158
Query: 586 YF-----PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEF----VGTFGYV 636
P I HRD+ SKN+L+ + ++D G++ + VGT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 637 AP 638
AP
Sbjct: 219 AP 220
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 35/172 (20%), Positives = 61/172 (35%), Gaps = 15/172 (8%)
Query: 473 IGTAGQASVYKAELPSW-EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG VY W VA++ + +AF E+ A + RH NVV F G
Sbjct: 41 IGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIV 591
P ++ +L ++ + + + + + Y+H I+
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 592 HRDISSKNVLLGLDYDAHVSDFGISK-----FLKPDSSNWSEFVGTFGYVAP 638
H+D+ SKNV + ++DFG+ G ++AP
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-27
Identities = 77/346 (22%), Positives = 130/346 (37%), Gaps = 42/346 (12%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
F +P I + + LD+G N++ + E HL+ L +N N + P
Sbjct: 19 HRKRFVAVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAF 76
Query: 75 GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGS 134
L +L+ L L N L F L+NL LD+SEN++
Sbjct: 77 NNLFNLRTLGLRSNRLKLIPLGVFTGLSNLT-----------------KLDISENKIVIL 119
Query: 135 IPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVLPPSISNLSNL 193
+ + L NL L +GDN L I + SL L + L + ++S+L L
Sbjct: 120 LDYMFQDLYNLKSLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGL 178
Query: 194 EGLYLY----SSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTG 249
L L +++ L +L LEI + + + +L + + +LT
Sbjct: 179 IVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA 238
Query: 250 NIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKI-GKLYQLHKLDFSLNHIVG 308
Y L FL+LS N +I + +L +L ++ +
Sbjct: 239 VPYLAVRHLVYLRFLNLSYNPI------------STIEGSMLHELLRLQEIQLVGGQL-A 285
Query: 309 ELPIE-LGNLKSLNYRALNGNKVYGSLPR-VLGSISDLEYLDLSTN 352
+ L L ++GN++ +L V S+ +LE L L +N
Sbjct: 286 VVEPYAFRGLNYLRVLNVSGNQL-TTLEESVFHSVGNLETLILDSN 330
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-25
Identities = 67/271 (24%), Positives = 112/271 (41%), Gaps = 17/271 (6%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
N + A+ P N+ NL+ L + +N+L + L++L L I+ NK+ + +
Sbjct: 65 ENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYM 123
Query: 75 -GQLSSLKQLVLYCNGLSGWLPSSFGNLNNL--------AIGSMP-NSLSNLTSLSLFHL 124
L +LK L + N L +F LN+L + S+P +LS+L L L
Sbjct: 124 FQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLI--VL 181
Query: 125 DLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLP 184
L ++ + L L VL + ++ P +L SL L V
Sbjct: 182 RLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPY 241
Query: 185 PSISNLSNLEGLYLY----SSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIV 240
++ +L L L L S++ + + LL+L E+++ QL P + R L ++
Sbjct: 242 LAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVL 301
Query: 241 HLEQNHLTGNIYEVFGIYPNLTFLDLSQNNF 271
++ N LT VF NL L L N
Sbjct: 302 NVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 37/188 (19%), Positives = 64/188 (34%), Gaps = 19/188 (10%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPRE 73
E L +I + ++ L L + + ++ + L LK L I+ ++
Sbjct: 160 EKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN 219
Query: 74 VGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSG 133
+L L + L+ +P ++ +L L L+LS N +S
Sbjct: 220 CLYGLNLTSLSITHCNLTA-VP--------------YLAVRHLVYLR--FLNLSYNPIST 262
Query: 134 SIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVLPPSISNLSN 192
L L L + L L + P + L L N L + ++ N
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQL-AVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGN 321
Query: 193 LEGLYLYS 200
LE L L S
Sbjct: 322 LETLILDS 329
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 24/128 (18%), Positives = 51/128 (39%), Gaps = 13/128 (10%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
+ P NL L + + L+ V + L +L+ L ++ N + ++ +
Sbjct: 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSM 267
Query: 75 -GQLSSLKQLVLYCNGLSGWLPSSFGNLNNL--------AIGSMP-NSLSNLTSLSLFHL 124
+L L+++ L L+ P +F LN L + ++ + ++ +L L
Sbjct: 268 LHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLE--TL 325
Query: 125 DLSENQLS 132
L N L+
Sbjct: 326 ILDSNPLA 333
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 18/172 (10%)
Query: 473 IGTAGQASVYKAELPSW-EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG+ +VYK W VAVK + P QAF NE+ L + RH N++ F G+
Sbjct: 32 IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 532 SFHPRQSFLLY---EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
S P+ L ++ SL L +F +++ + A + Y+H
Sbjct: 89 STAPQ----LAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHA---K 139
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLK--PDSSNWSEFVGTFGYVAP 638
I+HRD+ S N+ L D + DFG++ S + + G+ ++AP
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-25
Identities = 75/391 (19%), Positives = 132/391 (33%), Gaps = 75/391 (19%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEI-DPLTHLKHLYINVNKLRGSVPR 72
N++ + + +L+FL + VI L+ L L ++ N+ +
Sbjct: 38 SLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLET 96
Query: 73 EV-GQLSSLKQLVLYCNGL-SGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQ 130
L++L+ L L L L N LTSL L L +N
Sbjct: 97 GAFNGLANLEVLTLTQCNLDGAVLS--------------GNFFKPLTSLE--MLVLRDNN 140
Query: 131 LSGSIPH-FLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDL----------NLL 179
+ P F ++ VL L N + L Q L L
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWL 200
Query: 180 NGVLPPSISNLSNLEGLYLYS----SLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRN-- 233
+ +++ L L ++ + + +++ + S +
Sbjct: 201 GWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTN 260
Query: 234 -------------FTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN--------FY 272
+ + L ++ + + VF + +L L L+QN F+
Sbjct: 261 FKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFW 320
Query: 273 G-----SLNFSMNNITRSIPPKI-GKLYQLHKLDFSLNHIVGELPIE----LGNLKSLNY 322
G LN S N + SI ++ L +L LD S NHI L + L NLK L
Sbjct: 321 GLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELA- 377
Query: 323 RALNGNKVYGSLPR-VLGSISDLEYLDLSTN 352
L+ N++ S+P + ++ L+ + L TN
Sbjct: 378 --LDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 8e-14
Identities = 49/295 (16%), Positives = 88/295 (29%), Gaps = 38/295 (12%)
Query: 108 SMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKV 166
+P +++ ++DLS N ++ L +L L + + I +
Sbjct: 24 QVPELPAHVN-----YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGL 78
Query: 167 QSLLSLGFDLNLLNGVLPPSI-SNLSNLEGLYLYS-SLVSAEIG-----NLLQLIELEID 219
SL+ L D N L + L+NLE L L +L A + L L L +
Sbjct: 79 SSLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137
Query: 220 NKQLFGQIPKSL-RNFTSLNIVHLEQNHLTGNIYEVFG--IYPNLTFLDLSQNNFYGSLN 276
+ + P S N +++ L N + E + T L LS +
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITL---QD 194
Query: 277 FSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLN-----YRALNGNKVY 331
+ + K + LD S N + + + + + N
Sbjct: 195 MNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS 254
Query: 332 GSLPRVLGSI----------SDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
S ++ DLS ++ L +L L
Sbjct: 255 SFGHTNFKDPDNFTFKGLEASGVKTCDLS---KSKIFALLKSVFSHFTDLEQLTL 306
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 32/137 (23%), Positives = 55/137 (40%), Gaps = 15/137 (10%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLYCN 88
S +K D+ +++ ++ T L+ L + N++ + L+ L +L L N
Sbjct: 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQN 333
Query: 89 GLSGWLPSSFGNLNNL--------AIGSMPN-SLSNLTSLSLFHLDLSENQLSGSIPH-F 138
L F NL+ L I ++ + S L +L L L NQL S+P
Sbjct: 334 FLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLK--ELALDTNQLK-SVPDGI 390
Query: 139 LGHLSNLAVLHLGDNSL 155
L++L + L N
Sbjct: 391 FDRLTSLQKIWLHTNPW 407
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-25
Identities = 69/380 (18%), Positives = 130/380 (34%), Gaps = 42/380 (11%)
Query: 8 FFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLR 67
F V + + A ++ L LD N+ ++ + I+ LT L L N +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT 77
Query: 68 GSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSL---SLFHL 124
++ + Q ++L L N L+ + L L + N L+ L L +L
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDT--NKLTKLDVSQNPLLTYL 132
Query: 125 DLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLP 184
+ + N L+ I + H + L L N + L +L N + +
Sbjct: 133 NCARNTLT-EID--VSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKITEL-- 185
Query: 185 PSISNLSNLEGLYLYS-SLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLE 243
+S L L + ++ ++ +QL L+ + +L +I + T L
Sbjct: 186 -DVSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKL-TEID--VTPLTQLTYFDCS 241
Query: 244 QNHLT-------GNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQL 296
N LT + + I +L +DL+ N + + + QL
Sbjct: 242 VNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELD--VTHNTQL 299
Query: 297 HKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNE 356
+ LD I ++L L Y LN ++ L + + L+ L + +
Sbjct: 300 YLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD 353
Query: 357 FRKEFPVELEKLVQLTELDL 376
F + K+ L
Sbjct: 354 FS-----SVGKIPALNNNFE 368
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 44/273 (16%), Positives = 96/273 (35%), Gaps = 42/273 (15%)
Query: 21 IIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSL 80
I + + L LD N+++ + ++ L L + N + + + Q L
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQL 214
Query: 81 KQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLG 140
L N L+ ++ ++ LT L+ + D S N L+ + +
Sbjct: 215 TFLDCSSNKLT--------EID----------VTPLTQLT--YFDCSVNPLT-ELD--VS 251
Query: 141 HLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYS 200
LS L LH L I L L+ + +++ + L L +
Sbjct: 252 TLSKLTTLHCIQTDL-LEID--LTHNTQLIYF--QAEGCRKIKELDVTHNTQLYLLDCQA 306
Query: 201 -SLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYP 259
+ ++ +L+ L ++N +L ++ + + T L + H+ + G P
Sbjct: 307 AGITELDLSQNPKLVYLYLNNTEL-TELD--VSHNTKLKSLSCVNAHIQD--FSSVGKIP 361
Query: 260 NLTFLDLSQNNFYG--SLNFSMNNITRSIPPKI 290
L ++ + N++T ++ P +
Sbjct: 362 ALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 43/173 (24%), Positives = 85/173 (49%), Gaps = 22/173 (12%)
Query: 481 VYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539
K + E++ +K+ + Q+ F E+K + L H NV+KF G + ++
Sbjct: 26 AIKVTHRETGEVMVMKELIRFDEET--QRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83
Query: 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKN 599
+ EY+ G+L I+ + + ++ W+ R++ K +A+ ++Y+H I+HRD++S N
Sbjct: 84 FITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHN 138
Query: 600 VLLGLDYDAHVSDFGISKFL--------------KPDSSNWSEFVGTFGYVAP 638
L+ + + V+DFG+++ + KPD VG ++AP
Sbjct: 139 CLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 60/310 (19%), Positives = 117/310 (37%), Gaps = 60/310 (19%)
Query: 15 SNTLFAIIPP-QIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPRE 73
N I N+ NL L + NN++S + P PL L+ LY++ N+L+ +P +
Sbjct: 60 QNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEK 118
Query: 74 VGQLSSLKQLVLYCNGLSGWLPSSFGNLNNL--------AIGSM---PNSLSNLTSLSLF 122
+ +L++L ++ N ++ S F LN + + S + + LS
Sbjct: 119 M--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS-- 174
Query: 123 HLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNG 181
++ +++ ++ +IP G +L LHL N + + L + +L LG N ++
Sbjct: 175 YIRIADTNIT-TIPQ--GLPPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSISA 230
Query: 182 VLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVH 241
V S++N +L L+L N L ++P L + + +V+
Sbjct: 231 VDNGSLANTPHLRELHLN--------NNKLV-------------KVPGGLADHKYIQVVY 269
Query: 242 LEQNHLTGNIYEVFGI------YPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKI-GKLY 294
L N+++ F + + + L N I P +Y
Sbjct: 270 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV----------QYWEIQPSTFRCVY 319
Query: 295 QLHKLDFSLN 304
+
Sbjct: 320 VRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 52/351 (14%), Positives = 112/351 (31%), Gaps = 61/351 (17%)
Query: 31 NLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGL 90
+L+ + + L +P+++ P L + NK+ + L +L L+L N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 91 SGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHL 150
S P +F L L L LS+NQL +P + L L +
Sbjct: 89 SKISPGAFAPLVKLE-----------------RLYLSKNQLK-ELPEKM--PKTLQELRV 128
Query: 151 GDNSLFGSIPP-ILGKVQSLLSLGFDLNLL-NGVLPPSI-SNLSNLEGLYLYS-SLVSAE 206
+N + + + + ++ + N L + + + L + + ++ +
Sbjct: 129 HENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIP 187
Query: 207 IGNLLQLIELEIDNKQLFGQIPK-SLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLD 265
G L EL +D ++ ++ SL+ +L + L N ++ P+L L
Sbjct: 188 QGLPPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 246
Query: 266 LSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRAL 325
L+ N +P + + + N+I ++
Sbjct: 247 LNNNKL------------VKVPGGLADHKYIQVVYLHNNNI-----------SAIGSNDF 283
Query: 326 NGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
+ L +N + + P + + L
Sbjct: 284 CPPGYNTKKAS-------YSGVSLFSNPVQYWEIQ-PSTFRCVYVRAAVQL 326
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 54/303 (17%), Positives = 107/303 (35%), Gaps = 47/303 (15%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLYCN 88
+K LD+ NN+++ + ++ +L+ L + N + ++ + L SL+ L L N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110
Query: 89 GLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPH--FLGHLSNLA 146
LS S F L++L L+L N ++ HL+ L
Sbjct: 111 YLSNLSSSWFKPLSSLT-----------------FLNLLGNPYK-TLGETSLFSHLTKLQ 152
Query: 147 VLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSA 205
+L +G+ F I + L L D + L P S+ ++ N+ L L+
Sbjct: 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH------ 206
Query: 206 EIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLD 265
L+ + +S+ + L L +
Sbjct: 207 --MKQHILLL------------EIFVDVTSSVECLELRDTDLDTFHFSEL---STGETNS 249
Query: 266 LSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRAL 325
L + + ++ + ++ + + ++ L +L+FS N + L SL L
Sbjct: 250 LIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWL 308
Query: 326 NGN 328
+ N
Sbjct: 309 HTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 54/271 (19%), Positives = 97/271 (35%), Gaps = 30/271 (11%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
+N + I + NL+ L + +N ++ + L L+HL ++ N L ++
Sbjct: 61 NNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSW 119
Query: 75 -GQLSSLKQLVLYCNGLSGWLPSS-FGNLNNLAIGSM----------PNSLSNLTSLSLF 122
LSSL L L N +S F +L L I + + LT L
Sbjct: 120 FKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLE-- 177
Query: 123 HLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPIL-GKVQSLLSLGFDLNLLNG 181
L++ + L P L + N++ L L + I S+ L L+
Sbjct: 178 ELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH-ILLLEIFVDVTSSVECLELRDTDLDT 236
Query: 182 VLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVH 241
+ S L S+ + + ++I ++ LF Q+ K L + L +
Sbjct: 237 F------HFSEL------STGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELE 283
Query: 242 LEQNHLTGNIYEVFGIYPNLTFLDLSQNNFY 272
+N L +F +L + L N +
Sbjct: 284 FSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 53/285 (18%), Positives = 90/285 (31%), Gaps = 45/285 (15%)
Query: 100 NLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSI 159
++ ++ S+P+ L+ LDLS N+++ L NL L L N + +I
Sbjct: 37 KGSSGSLNSIPSGLTEAVK----SLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTI 91
Query: 160 PP-ILGKVQSLLSLGFDLNLLNGVLPPSI-SNLSNLEGLYLYSSLVSAEIGNLLQLIELE 217
+ SL L N L L S LS+L L L GN +
Sbjct: 92 EEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLL--------GNPYK----T 138
Query: 218 IDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNF 277
+ LF + L I+ + I + LTFL+ L
Sbjct: 139 LGETSLFSHLT-------KLQILRVGNMDTFTKIQR--KDFAGLTFLE--------ELEI 181
Query: 278 SMNNITRSIPPKI-GKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYG---- 332
+++ S PK + + L + + L I + S+ L +
Sbjct: 182 DASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFS 240
Query: 333 SLPR-VLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
L S+ + + L ++ L EL+
Sbjct: 241 ELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEF 284
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 26/143 (18%), Positives = 54/143 (37%), Gaps = 12/143 (8%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPRE 73
+++ L + P + +I N+ L + Q ++ +D + ++ L + L
Sbjct: 182 DASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTF---- 237
Query: 74 VGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSG 133
S L N L + + ++ + L+ ++ L L+ S NQL
Sbjct: 238 --HFSELSTGET--NSLIKKFTFRNVKITDESLFQVMKLLNQISGLL--ELEFSRNQLK- 290
Query: 134 SIPH-FLGHLSNLAVLHLGDNSL 155
S+P L++L + L N
Sbjct: 291 SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-24
Identities = 69/397 (17%), Positives = 134/397 (33%), Gaps = 64/397 (16%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPR--EVGQLSSLKQLVLYC 87
L++LD+ +N+L + P +LKHL ++ N ++P E G +S LK L L
Sbjct: 69 QELEYLDLSHNKLVKIS---CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLST 124
Query: 88 NGLSGWLPSSFGNL----------NNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPH 137
L +L P L + + SL + + + +
Sbjct: 125 THLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDV 184
Query: 138 FLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLY 197
+ ++NL + ++ L + L + NL + + ++ + L
Sbjct: 185 SVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV 244
Query: 198 LYSSLVSAEIGN------------------LLQLIELEIDNKQLFGQIPKSLRNFTSLNI 239
++++ I N L L ++ + F+++NI
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 240 VHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG-------------SLNFSMNNITRSI 286
+ + LD S N +L MN + +
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-EL 363
Query: 287 PPKIG---KLYQLHKLDFSLNHIVGELPIE----LGNLKSLNYRALNGNKVYGSLPRVLG 339
++ L +LD S N + + +L SLN ++ N + ++ R L
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN---MSSNILTDTIFRCLP 420
Query: 340 SISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
++ LDL +N K P ++ KL L EL++
Sbjct: 421 P--RIKVLDLHSNKI----KSIPKQVVKLEALQELNV 451
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 66/390 (16%), Positives = 132/390 (33%), Gaps = 41/390 (10%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
N + + I ++S L+ L + +N++ + L++L ++ NKL +
Sbjct: 30 QNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS--C 86
Query: 75 GQLSSLKQLVLYCNGL-SGWLPSSFGNLNNLAIGSMPN------SLSNLTSLSLFHLDLS 127
+LK L L N + + FGN++ L + S+ + L++ + L
Sbjct: 87 HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146
Query: 128 ENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVL---- 183
+ G L + L + V +L+ + VL
Sbjct: 147 LGETYGEKEDP-EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNK 205
Query: 184 -------PPSISNLSNLEGLYLYSSLVSAEIG-------NLLQLIELEIDNKQLFGQIPK 229
+ L L L + + + I N +L GQ+
Sbjct: 206 CSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDF 265
Query: 230 SLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPK 289
+++ ++ L + + + VFG + + S N NF+++
Sbjct: 266 RDFDYSGTSLKALSIHQVVSD---VFGFPQSYIYEIFSNMNI---KNFTVSGTRMVHMLC 319
Query: 290 IGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLG---SISDLEY 346
K+ LDFS N + + G+L L L N++ L ++ + L+
Sbjct: 320 PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL-KELSKIAEMTTQMKSLQQ 378
Query: 347 LDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
LD+S N + E + L L++
Sbjct: 379 LDISQNSVSYD--EKKGDCSWTKSLLSLNM 406
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 44/188 (23%), Positives = 79/188 (42%), Gaps = 23/188 (12%)
Query: 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVG 75
+ + IS LD NN L+ + + LT L+ L + +N+L+ + +
Sbjct: 310 SGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAE 368
Query: 76 ---QLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLS 132
Q+ SL+QL + N+++ S SL L++S N L+
Sbjct: 369 MTTQMKSLQQLDISQ--------------NSVSYDEKKGDCSWTKSLL--SLNMSSNILT 412
Query: 133 GSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSN 192
+I L + VL L N + SIP + K+++L L N L V L++
Sbjct: 413 DTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTS 469
Query: 193 LEGLYLYS 200
L+ ++L++
Sbjct: 470 LQKIWLHT 477
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-15
Identities = 47/282 (16%), Positives = 93/282 (32%), Gaps = 36/282 (12%)
Query: 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDP-----LTHLK 57
+ N+ I Q+ + + + + N +L G + L L
Sbjct: 222 LSNLTLNNIETTWNSFIRI--LQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279
Query: 58 HLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLT 117
+ + S++ + + + P+ +S
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMNIKNFTVS-----------GTRMVHMLC-PSKISPFL 327
Query: 118 SLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILG---KVQSLLSLGF 174
HLD S N L+ ++ GHL+ L L L N L + I +++SL L
Sbjct: 328 -----HLDFSNNLLTDTVFENCGHLTELETLILQMNQL-KELSKIAEMTTQMKSLQQLDI 381
Query: 175 DLNLLNGVLPPSI-SNLSNLEGLYLYS----SLVSAEIGNLLQLIELEIDNKQLFGQIPK 229
N ++ S +L L + S + + +++++L NK IPK
Sbjct: 382 SQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLH-SNK--IKSIPK 438
Query: 230 SLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNF 271
+ +L +++ N L +F +L + L N +
Sbjct: 439 QVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 6e-15
Identities = 55/335 (16%), Positives = 109/335 (32%), Gaps = 35/335 (10%)
Query: 1 LSCLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLY 60
F F + T+ + I + + L+ + L ++
Sbjct: 172 FPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIE 231
Query: 61 INVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLS 120
N + ++ +++ + L G L + + +L +LS
Sbjct: 232 TTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT----------SLKALS 279
Query: 121 LFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN 180
+ + + + SN+ + + + K+ L L F NLL
Sbjct: 280 I--HQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT 337
Query: 181 GVLPPSISNLSNLEGLYLYS------SLVSAEIGNLLQLIELEIDNKQL-FGQIPKSLRN 233
+ + +L+ LE L L S ++ + L +L+I + + +
Sbjct: 338 DTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSW 397
Query: 234 FTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKL 293
SL +++ N LT I+ P + LDL N +SIP ++ KL
Sbjct: 398 TKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKI------------KSIPKQVVKL 443
Query: 294 YQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGN 328
L +L+ + N + L SL L+ N
Sbjct: 444 EALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 37/220 (16%), Positives = 73/220 (33%), Gaps = 14/220 (6%)
Query: 215 ELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG- 273
L I + + + + L I+ + N + VF L +LDLS N
Sbjct: 25 ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKI 84
Query: 274 ---------SLNFSMNNITRSIPPK--IGKLYQLHKLDFSLNHIVGELPIELGNLKSLNY 322
L+ S N ++P G + QL L S H+ + + +L
Sbjct: 85 SCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKV 143
Query: 323 RALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWE 382
+ G + E L + N EF V ++ + L ++ +
Sbjct: 144 LLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLED 203
Query: 383 ER-YRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRN 421
+ S++ K + L+ I+ ++N +++
Sbjct: 204 NKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQL 243
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 49/335 (14%), Positives = 98/335 (29%), Gaps = 46/335 (13%)
Query: 24 PQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQL 83
+ I+ L + LS +P + + L I N L S+P +SL+ L
Sbjct: 53 LKECLINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPEL---PASLEYL 105
Query: 84 VLYCNGLSGWLPSSFGNLNNLAIG-----SMPNSLSNLTSLSLFH--------------- 123
N LS LP +L +L + +P + L ++ +
Sbjct: 106 DACDNRLST-LPELPASLKHLDVDNNQLTMLPELPALLEYINADNNQLTMLPELPTSLEV 164
Query: 124 LDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN--- 180
L + NQL+ +P +L L + N L S+P + +
Sbjct: 165 LSVRNNQLT-FLPELPE---SLEALDVSTNLL-ESLPAVPVRNHHSEETEIFFRCRENRI 219
Query: 181 GVLPPSISNLSNLEGLYLY----SSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTS 236
+P +I +L + L SS + + + +
Sbjct: 220 THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRP 279
Query: 237 LNIVHL-----EQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRS-IPPKI 290
L + I+ F + + +++ + R + +
Sbjct: 280 LADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWL 339
Query: 291 GKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRAL 325
KL +L + + + +L + L
Sbjct: 340 EKLSASAELRQQSFAVAADATESCEDRVALTWNNL 374
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 3e-19
Identities = 60/360 (16%), Positives = 115/360 (31%), Gaps = 68/360 (18%)
Query: 25 QIGNISNLKFLDMGNNQLSGV---IPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81
I N +L + N +SG D N N+ S+ +E ++
Sbjct: 6 PINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAV-SLLKE-CLINQFS 62
Query: 82 QLVLYCNGLSGWLPSSFG------NLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSI 135
+L L LS LP + + A+ S+P ++L +LD +N+LS ++
Sbjct: 63 ELQLNRLNLSS-LPDNLPPQITVLEITQNALISLPELPASLE-----YLDACDNRLS-TL 115
Query: 136 PHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEG 195
P L +L + +N L +P + L + D N L +LP ++L E
Sbjct: 116 PELPASLKHL---DVDNNQL-TMLPELPA---LLEYINADNNQLT-MLPELPTSL---EV 164
Query: 196 LYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVF 255
L + N L +P+ + +L+ + N L ++ V
Sbjct: 165 LSVR--------NNQLT-------------FLPELPESLEALD---VSTNLLE-SLPAVP 199
Query: 256 GIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELG 315
+ ++ N IT IP I L + N + + L
Sbjct: 200 VRNHHSEETEIF-------FRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLS 251
Query: 316 NLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELD 375
+ + + + L+ F + ++ ++ E +
Sbjct: 252 QQTAQPDYHGPRI-----YFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHE 306
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 25/205 (12%), Positives = 60/205 (29%), Gaps = 14/205 (6%)
Query: 29 ISNLKFLDMGNNQLSGVIPQEIDPLTHLK----HLYINVNKLRGSVPREVGQLSSLKQLV 84
+L+ LD+ N L +P H + N++ +P + L ++
Sbjct: 179 PESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTII 236
Query: 85 LYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFH-----LDLSENQLSGSIPHFL 139
L N LS + S P +++ D + +
Sbjct: 237 LEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDV 296
Query: 140 GHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNL-EGLYL 198
+ + N+ + + V + + GF + +S + L + +
Sbjct: 297 SQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAA--WLEKLSASAELRQQSFA 354
Query: 199 YSSLVSAEIGNLLQLIELEIDNKQL 223
++ + + + L + L
Sbjct: 355 VAADATESCEDRVALTWNNLRKTLL 379
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 62/303 (20%), Positives = 106/303 (34%), Gaps = 51/303 (16%)
Query: 15 SNTLFAIIPP-QIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPRE 73
N + + + +L L + NN++S + + PL L+ LYI+ N L +P
Sbjct: 62 QNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPN 120
Query: 74 VGQLSSLKQLVLYCNGLSGWLPSSFGNLNNL--------AIGSMPNSLSNLTSLSLFHLD 125
+ SSL +L ++ N + F L N+ + + L L +L
Sbjct: 121 L--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLR 178
Query: 126 LSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVLP 184
+SE +L+ IP L LHL N + +I L + L LG N + +
Sbjct: 179 ISEAKLT-GIPK--DLPETLNELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIEN 234
Query: 185 PSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQ 244
S+S L L L+L N L ++P L + L +V+L
Sbjct: 235 GSLSFLPTLRELHLD--------NNKLS-------------RVPAGLPDLKLLQVVYLHT 273
Query: 245 NHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNF---SMNNIT-RSIPPKI-GKLYQLHKL 299
N++T + F + N N + + P + +
Sbjct: 274 NNIT-KV-------GVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAI 325
Query: 300 DFS 302
F
Sbjct: 326 QFG 328
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 60/302 (19%), Positives = 101/302 (33%), Gaps = 59/302 (19%)
Query: 100 NLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSI 159
++L + ++P +S T+ LDL N +S L +L L L +N + I
Sbjct: 39 QCSDLGLKAVPKEISPDTT----LLDLQNNDISELRKDDFKGLQHLYALVLVNNKI-SKI 93
Query: 160 PP-ILGKVQSLLSLGFDLNLLNGV---LPPSI------------------SNLSNLEGLY 197
++ L L N L + LP S+ S L N+ +
Sbjct: 94 HEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIE 153
Query: 198 L-----YSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIY 252
+ +S + L+L L I +L IPK L +LN +HL+ N +
Sbjct: 154 MGGNPLENSGFEPGAFDGLKLNYLRISEAKL-TGIPKDL--PETLNELHLDHNKIQAIEL 210
Query: 253 EVFGIYPNLTFLDLSQNN--------FYG-----SLNFSMNNITRSIPPKIGKLYQLHKL 299
E Y L L L N L+ N ++ +P + L L +
Sbjct: 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVV 269
Query: 300 DFSLNHIVGELPIE-------LGNLKSLNYRALNGNKV-YGSL-PRVLGSISDLEYLDLS 350
N+I ++ + N +L N V Y + P ++D +
Sbjct: 270 YLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG 328
Query: 351 TN 352
Sbjct: 329 NY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 39/204 (19%), Positives = 71/204 (34%), Gaps = 26/204 (12%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGV-IPQEIDPLTHLKHLYINVNKLRGSVPR 72
N + + + N+ ++MG N L L +L I+ KL +P+
Sbjct: 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK 189
Query: 73 EVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLA--------IGSMP-NSLSNLTSLSLFH 123
++ +L +L L N + + L I + SLS L +L
Sbjct: 190 DL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLR--E 245
Query: 124 LDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-------ILGKVQSLLSLGFDL 176
L L N+LS +P L L L V++L N++ + K +
Sbjct: 246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI-TKVGVNDFCPVGFGVKRAYYNGISLFN 303
Query: 177 NLL--NGVLPPSISNLSNLEGLYL 198
N + V P + +++ +
Sbjct: 304 NPVPYWEVQPATFRCVTDRLAIQF 327
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 51/248 (20%), Positives = 98/248 (39%), Gaps = 26/248 (10%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLYCN 88
+N + L++ NQ+ + L HL+ L ++ N +R ++ L++L L L+ N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDN 122
Query: 89 GLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVL 148
L+ +F L+ L L L N + + + +L L
Sbjct: 123 RLTTIPNGAFVYLSKLK-----------------ELWLRNNPIESIPSYAFNRIPSLRRL 165
Query: 149 HLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLY----SSLV 203
LG+ I + +L L + L + P+++ L L+ L L S++
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIR 223
Query: 204 SAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTF 263
L+ L +L + Q+ + N SL ++L N+LT +++F +L
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLER 283
Query: 264 LDLSQNNF 271
+ L N +
Sbjct: 284 IHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 56/291 (19%), Positives = 93/291 (31%), Gaps = 67/291 (23%)
Query: 100 NLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSI 159
+ +P+ +S T L+L ENQ+ + HL +L +L L N + +I
Sbjct: 49 ICVRKNLREVPDGISTNTR----LLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTI 103
Query: 160 PPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEID 219
G + L+NL L L+ N L I
Sbjct: 104 EI-------------------GAF----NGLANLNTLELFD--------NRLTTIP---- 128
Query: 220 NKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN--------- 270
+ + L + L N + F P+L LDL +
Sbjct: 129 --------NGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGA 180
Query: 271 FYG-----SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRAL 325
F G LN +M N+ P + L +L +LD S NH+ P L L +
Sbjct: 181 FEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238
Query: 326 NGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
+++ ++ L ++L+ +N L L + L
Sbjct: 239 IQSQIQVIERNAFDNLQSLVEINLA---HNNLTLLPHDLFTPLHHLERIHL 286
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 42/190 (22%), Positives = 70/190 (36%), Gaps = 24/190 (12%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYI-NVNKLRGSVPR 72
N L I +S LK L + NN + + + + L+ L + + +L +
Sbjct: 120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS-YISE 178
Query: 73 EV-GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQL 131
LS+L+ L L L +L+ L L LDLS N L
Sbjct: 179 GAFEGLSNLRYLNLAMCNL-----------------REIPNLTPLIKLD--ELDLSGNHL 219
Query: 132 SGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVLPPSISNL 190
S P L +L L + + + I +QSL+ + N L + + L
Sbjct: 220 SAIRPGSFQGLMHLQKLWMIQSQI-QVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278
Query: 191 SNLEGLYLYS 200
+LE ++L+
Sbjct: 279 HHLERIHLHH 288
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 27/133 (20%), Positives = 47/133 (35%), Gaps = 43/133 (32%)
Query: 24 PQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQL 83
P + + L LD+ N LS + P L HL+ L++ ++++ +
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIE------------ 247
Query: 84 VLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPH-FLGHL 142
N+ NL SL ++L+ N L+ +PH L
Sbjct: 248 --------------------------RNAFDNLQSLV--EINLAHNNLT-LLPHDLFTPL 278
Query: 143 SNLAVLHLGDNSL 155
+L +HL N
Sbjct: 279 HHLERIHLHHNPW 291
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 53/249 (21%), Positives = 95/249 (38%), Gaps = 28/249 (11%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLYCN 88
SN ++L++ N + + L HL+ L + N +R + L+SL L L+ N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDN 133
Query: 89 GLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHF-LGHLSNLAV 147
L+ +F L+ L L L N + SIP + + +L
Sbjct: 134 WLTVIPSGAFEYLSKLR-----------------ELWLRNNPIE-SIPSYAFNRVPSLMR 175
Query: 148 LHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLY----SSL 202
L LG+ I + +L L + + + P+++ L LE L + +
Sbjct: 176 LDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEI 233
Query: 203 VSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLT 262
L L +L + N Q+ + SL ++L N+L+ +++F L
Sbjct: 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLV 293
Query: 263 FLDLSQNNF 271
L L N +
Sbjct: 294 ELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 38/189 (20%), Positives = 66/189 (34%), Gaps = 24/189 (12%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYI-NVNKLRGSVPRE 73
N L I +S L+ L + NN + + + + L L + + KL +
Sbjct: 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE-YISEG 190
Query: 74 V-GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLS 132
L +LK L L + +L+ L L L++S N
Sbjct: 191 AFEGLFNLKYLNLGMCNI-----------------KDMPNLTPLVGLE--ELEMSGNHFP 231
Query: 133 GSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVLPPSISNLS 191
P LS+L L + ++ + I + SL+ L N L+ + + L
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQV-SLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290
Query: 192 NLEGLYLYS 200
L L+L+
Sbjct: 291 YLVELHLHH 299
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 35/137 (25%), Positives = 56/137 (40%), Gaps = 24/137 (17%)
Query: 22 IPPQI-GNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSS 79
I + NLK+L++G + + + PL L+ L ++ N + LSS
Sbjct: 187 ISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSS 243
Query: 80 LKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPH-F 138
LK+L + + +S ++F L +L L+L+ N LS S+PH
Sbjct: 244 LKKLWVMNSQVSLIERNAFDGLASLV-----------------ELNLAHNNLS-SLPHDL 285
Query: 139 LGHLSNLAVLHLGDNSL 155
L L LHL N
Sbjct: 286 FTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 35/176 (19%), Positives = 68/176 (38%), Gaps = 31/176 (17%)
Query: 220 NKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN--------F 271
++ ++P+ + ++ ++L +N++ + F +L L L +N+ F
Sbjct: 62 TRRGLSEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAF 119
Query: 272 YG-----SLNFSMNNITRSIPPKI-GKLYQLHKLDFSLNHIVGELPIE----LGNLKSLN 321
G +L N +T IP L +L +L N I +P + +L L+
Sbjct: 120 NGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLD 177
Query: 322 YRALNGNKVYGSLPR-VLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
L K + + +L+YL+L + L LV L EL++
Sbjct: 178 ---LGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMP-----NLTPLVGLEELEM 225
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 69/396 (17%), Positives = 121/396 (30%), Gaps = 66/396 (16%)
Query: 31 NLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPR--EVGQLSSLKQLVLYCN 88
+L++LD+ +N+L + P+ L+HL ++ N +P E G L+ L L L
Sbjct: 101 DLEYLDVSHNRLQNI---SCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAA 156
Query: 89 GL---------SGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFL 139
L +L + I + + ++ HL N L
Sbjct: 157 KFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ--VN 214
Query: 140 GHLSNLAVLHLGDNSL-----FGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLE 194
++ L L L + L + + + L L + S+
Sbjct: 215 MSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFW 274
Query: 195 GLYL--------------YSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIV 240
+ + L L+ + N+ F +NI
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
Query: 241 HLEQNHLTGNIYEVFGIYPNLTFLDLSQN--------NFYG-----SLNFSMNNITRSIP 287
L + + TFL+ +QN +L N + +
Sbjct: 335 MLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFF 393
Query: 288 PKIGKLYQLHKL---DFSLN----HIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGS 340
+ L D SLN H ++ LN L+ N + GS+ R L
Sbjct: 394 KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLN---LSSNMLTGSVFRCLP- 449
Query: 341 ISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
++ LDL NN P ++ L L EL++
Sbjct: 450 -PKVKVLDLH---NNRI-MSIPKDVTHLQALQELNV 480
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-15
Identities = 37/185 (20%), Positives = 70/185 (37%), Gaps = 17/185 (9%)
Query: 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVG 75
+ I + S+ FL+ N + + Q L L+ L + N L+ + +
Sbjct: 339 SDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVAL 397
Query: 76 QLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSI 135
++ L L+ ++ ++ L+LS N L+GS+
Sbjct: 398 MTKNMSSLETLDVSLNSLNSHAYDRTCAW--------AESIL-----VLNLSSNMLTGSV 444
Query: 136 PHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEG 195
L + VL L +N + SIP + +Q+L L N L V L++L+
Sbjct: 445 FRCL--PPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQY 501
Query: 196 LYLYS 200
++L+
Sbjct: 502 IWLHD 506
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 9e-14
Identities = 51/328 (15%), Positives = 100/328 (30%), Gaps = 27/328 (8%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81
+ I N L + + S Q + L HL ++ KL +L +
Sbjct: 186 GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLN---DENCQRLMTFL 242
Query: 82 QLVLYCNGLSGWLPSSFGNLNNLAIGSMPN-SLSNLTSLSLFHLDLSENQLSGSIPHFLG 140
+ L ++ + L++++L ++E +
Sbjct: 243 SELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSET 302
Query: 141 HLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLY- 199
L +L + H+ + S + + ++ + + S+ L
Sbjct: 303 ALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQ 362
Query: 200 ---SSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVF- 255
+ V L +L L + L K +++ + L +
Sbjct: 363 NVFTDSVFQGCSTLKRLQTLILQRNGL-KNFFKVALMTKNMSSLETLDVSLNSLNSHAYD 421
Query: 256 ---GIYPNLTFLDLSQNNFYGS-----------LNFSMNNITRSIPPKIGKLYQLHKLDF 301
++ L+LS N GS L+ N I SIP + L L +L+
Sbjct: 422 RTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNV 480
Query: 302 SLNHIVGELPIE-LGNLKSLNYRALNGN 328
+ N + +P L SL Y L+ N
Sbjct: 481 ASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 45/294 (15%), Positives = 104/294 (35%), Gaps = 27/294 (9%)
Query: 1 LSCLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEI---DPLTHLK 57
L L ++ E+ ++ L + + + + + ++ ++
Sbjct: 220 LGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279
Query: 58 HLYINVNKLRGSVPREVGQ-----LSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNS 112
+L I + + RE L SL + + + + I S
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI--KMLS 337
Query: 113 LSNLTSL---------SLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPIL 163
+S+ + S L+ ++N + S+ L L L L N L + +
Sbjct: 338 ISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL-KNFFKVA 396
Query: 164 GKVQSLLSLGFDLNLLN----GVLPPSISNLSNLEGLYLYSSLVSAEIGNLL--QLIELE 217
+++ SL LN + + ++ L L S++++ + L ++ L+
Sbjct: 397 LMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLD 456
Query: 218 IDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNF 271
+ N ++ IPK + + +L +++ N L VF +L ++ L N +
Sbjct: 457 LHNNRI-MSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 58/256 (22%), Positives = 104/256 (40%), Gaps = 37/256 (14%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKL--RGSVPREVGQLSSLKQLVLYC 87
S+ L++ +N+L + D LT L L ++ N L +G + +SLK L L
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 88 NGLSGWLPSSFGNLNNL--------AIGSMPNS--LSNLTSLSLFHLDLSENQLSGSIPH 137
NG+ + S+F L L + M +L +L +LD+S +
Sbjct: 88 NGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR--NLIYLDISHTHTRVAFNG 144
Query: 138 FLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGL 196
LS+L VL + NS + P I ++++L L L + P + ++LS+L+ L
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 204
Query: 197 YLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVF- 255
+ N ++ + SL ++ NH+ + +
Sbjct: 205 NMS--------HNNFFSLD------------TFPYKCLNSLQVLDYSLNHIMTSKKQELQ 244
Query: 256 GIYPNLTFLDLSQNNF 271
+L FL+L+QN+F
Sbjct: 245 HFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 62/301 (20%), Positives = 88/301 (29%), Gaps = 82/301 (27%)
Query: 57 KHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNL 116
+ N L SVP + SS +L L N L F L L
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLT----------- 55
Query: 117 TSLSLFHLDLSENQLS-GSIPHF-LGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGF 174
L LS N LS ++L L L N + ++ ++ L L F
Sbjct: 56 ------KLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDF 108
Query: 175 DLNLLNGVLPPSI-SNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRN 233
+ L + S+ +L NL L + ++
Sbjct: 109 QHSNLKQMSEFSVFLSLRNLIYLDISH--------THTRVAF------------NGIFNG 148
Query: 234 FTSLNIVHLEQNHLTGNIYE-VFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKI-G 291
+SL ++ + N N +F NLTFLDLSQ + P
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL------------EQLSPTAFN 196
Query: 292 KLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLST 351
L L L+ S N N SL+ L L+ LD S
Sbjct: 197 SLSSLQVLNMSHN-----------NFFSLDTFPYKC------LNS-------LQVLDYSL 232
Query: 352 N 352
N
Sbjct: 233 N 233
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 33/159 (20%), Positives = 59/159 (37%), Gaps = 16/159 (10%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEI-DPLTHLKHLYINVNKLRGSVPRE 73
S + + L+ LD ++ L + + L +L +L I+ R
Sbjct: 86 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNG 144
Query: 74 V-GQLSSLKQLVLYCN-GLSGWLPSSFGNLNNL--------AIGSMP-NSLSNLTSLSLF 122
+ LSSL+ L + N +LP F L NL + + + ++L+SL
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ-- 202
Query: 123 HLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP 161
L++S N L++L VL N + +
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI-MTSKK 240
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 39/167 (23%), Positives = 65/167 (38%), Gaps = 21/167 (12%)
Query: 226 QIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN----------FYG-- 273
+P + +S + LE N L + VF LT L LS N +G
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 274 ---SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIEL-GNLKSLNYRALNGNK 329
L+ S N + ++ L QL LDF +++ + +L++L Y ++
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 330 VYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
+ + +S LE L ++ N+ P +L LT LDL
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMA--GNSFQENFLPDIFTELRNLTFLDL 182
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 50/257 (19%), Positives = 75/257 (29%), Gaps = 64/257 (24%)
Query: 123 HLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGV 182
+ + L+ S+P + S+ L L N L QSL F
Sbjct: 11 EIRCNSKGLT-SVPTGI--PSSATRLELESNKL-----------QSLPHGVF-------- 48
Query: 183 LPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHL 242
L+ L L L S N L +S TSL + L
Sbjct: 49 -----DKLTQLTKLSLSS--------NGLSFKGCC----------SQSDFGTTSLKYLDL 85
Query: 243 EQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKI-GKLYQLHKLDF 301
N + + F L LD +N + + + L L LD
Sbjct: 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSN-----------LKQMSEFSVFLSLRNLIYLDI 133
Query: 302 SLNHIVGELPIE-LGNLKSLNYRALNGNKVYGSLPR-VLGSISDLEYLDLSTNYNNEFRK 359
S H L SL + GN + + + +L +LDLS + +
Sbjct: 134 SHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS---QCQLEQ 189
Query: 360 EFPVELEKLVQLTELDL 376
P L L L++
Sbjct: 190 LSPTAFNSLSSLQVLNM 206
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 30/130 (23%), Positives = 51/130 (39%), Gaps = 14/130 (10%)
Query: 15 SNTLFAIIPPQI-GNISNLKFLDMGNNQLSGVIPQEI-DPLTHLKHLYINVNKLRGSVPR 72
S+T + I +S+L+ L M N +I L +L L ++ +L +
Sbjct: 134 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSP 192
Query: 73 EV-GQLSSLKQLVLYCNGLSGWLPSSFGNLNNL--------AIGSMP-NSLSNLTSLSLF 122
LSSL+ L + N + LN+L I + L + S SL
Sbjct: 193 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS-SLA 251
Query: 123 HLDLSENQLS 132
L+L++N +
Sbjct: 252 FLNLTQNDFA 261
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 46/170 (27%), Positives = 71/170 (41%), Gaps = 9/170 (5%)
Query: 472 CIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
+G VY +L + +A+K+ Q EI L+H+N+V++ G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS--QPLHEEIALHKHLKHKNIVQYLG 86
Query: 531 FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPI 590
+ E + GSL+ +L + + + K + L Y+H + I
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143
Query: 591 VHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSNWSEFVGTFGYVAP 638
VHRDI NVL+ Y + SDFG SK L + F GT Y+AP
Sbjct: 144 VHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 46/181 (25%), Positives = 78/181 (43%), Gaps = 8/181 (4%)
Query: 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHR 523
+++ Y IGT K +I+ K+ +Q +E+ L EL+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 524 NVVKFYGFSFHPRQSFLLY---EYLGRGSLAIILSNDAAIDE-FSWTVRMNVIKSVANTL 579
N+V++Y R + LY EY G LA +++ + + V+ + L
Sbjct: 66 NIVRYYD-RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 580 SYMH--HDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVA 637
H D ++HRD+ NV L + + DFG+++ L D+S FVGT Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 638 P 638
P
Sbjct: 185 P 185
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 41/176 (23%), Positives = 67/176 (38%), Gaps = 20/176 (11%)
Query: 470 KYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKF 528
+ +G V++ + + AVKK + ++ E+ A L +V
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKK-------VRLEVFRVEELVACAGLSSPRIVPL 115
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
YG + E L GSL ++ + E + + L Y+H
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTRR-- 170
Query: 589 PIVHRDISSKNVLLGLD-YDAHVSDFGISKFLKPDSSNWSE-----FVGTFGYVAP 638
I+H D+ + NVLL D A + DFG + L+PD S GT ++AP
Sbjct: 171 -ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 49/180 (27%), Positives = 84/180 (46%), Gaps = 18/180 (10%)
Query: 464 TNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFS---NEIKALTE 519
FD +G SVYKA + +IVA+K+ + V+ EI + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ-------VPVESDLQEIIKEISIMQQ 80
Query: 520 LRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLA-IILSNDAAIDEFSWTVRMNVIKSVANT 578
+VVK+YG F +++ EY G GS++ II + + E +++S
Sbjct: 81 CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT---ILQSTLKG 137
Query: 579 LSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
L Y+H +HRDI + N+LL + A ++DFG++ L + + +GT ++AP
Sbjct: 138 LEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAP 194
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 47/245 (19%), Positives = 87/245 (35%), Gaps = 42/245 (17%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLYCN 88
+ + + + N++S V +L L+++ N L + L+ L+QL L N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDN 90
Query: 89 GLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPH-FLGHLSNLAV 147
+ P + L L L L L + L+ L
Sbjct: 91 AQLRSVD--------------PATFHGLGRLH--TLHLDRCGLQ-ELGPGLFRGLAALQY 133
Query: 148 LHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAE 206
L+L DN+L ++P + +L L N ++ V + L +L+ L L+
Sbjct: 134 LYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH------- 185
Query: 207 IGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDL 266
N + + P + R+ L ++L N+L+ E L +L L
Sbjct: 186 -QNRVAHVH------------PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
Query: 267 SQNNF 271
+ N +
Sbjct: 233 NDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 59/263 (22%), Positives = 92/263 (34%), Gaps = 55/263 (20%)
Query: 69 SVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSE 128
+VP + ++ +++ L+ N +S +SF NL L L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLT-----------------ILWLHS 65
Query: 129 NQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVLPPSI 187
N L+ L+ L L L DN+ S+ P + L +L D L + P
Sbjct: 66 NVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLF 125
Query: 188 SNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHL 247
L+ L+ LYL N LQ + + R+ +L + L N +
Sbjct: 126 RGLAALQYLYLQD--------NALQALP------------DDTFRDLGNLTHLFLHGNRI 165
Query: 248 TGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKI-GKLYQLHKLDFSLNHI 306
+ F +L L L QN + P L +L L N++
Sbjct: 166 SSVPERAFRGLHSLDRLLLHQNRV------------AHVHPHAFRDLGRLMTLYLFANNL 213
Query: 307 VGELPIE-LGNLKSLNYRALNGN 328
LP E L L++L Y LN N
Sbjct: 214 S-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 37/154 (24%), Positives = 61/154 (39%), Gaps = 16/154 (10%)
Query: 14 ESNTLFAIIPPQI-GNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPR 72
N + P + L L + L + P L L++LY+ N L+ ++P
Sbjct: 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPD 146
Query: 73 EV-GQLSSLKQLVLYCNGLSGWLPSSFGNLNNL--------AIGSMP-NSLSNLTSLSLF 122
+ L +L L L+ N +S +F L++L + + ++ +L L
Sbjct: 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM-- 204
Query: 123 HLDLSENQLSGSIPH-FLGHLSNLAVLHLGDNSL 155
L L N LS ++P L L L L L DN
Sbjct: 205 TLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 39/167 (23%), Positives = 55/167 (32%), Gaps = 23/167 (13%)
Query: 226 QIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN--------FYG---- 273
+P + + + L N ++ F NLT L L N F G
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 274 -SLNFSMNNITRSIPPKI-GKLYQLHKLDFSLNHIVGELPIE-LGNLKSLNYRALNGNKV 330
L+ S N RS+ P L +LH L + EL L +L Y L N +
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 331 YGSLP-RVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
+LP + +L +L L N L L L L
Sbjct: 142 -QALPDDTFRDLGNLTHLFLH---GNRISSVPERAFRGLHSLDRLLL 184
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 43/169 (25%), Positives = 75/169 (44%), Gaps = 13/169 (7%)
Query: 467 FDAKYCIGTAGQASVYKA-ELPSWEIVAVK--KFHSPHPDMVVQQAFSNEIKALTELRHR 523
F IG V+K + + ++VA+K ++ + EI L++
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI---EDIQQEITVLSQCDSP 80
Query: 524 NVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH 583
V K+YG + +++ EYLG GS +L +DE +++ + L Y+H
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIAT---ILREILKGLDYLH 136
Query: 584 HDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGT 632
+ +HRDI + NVLL + ++DFG++ L + FVGT
Sbjct: 137 SEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT 182
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 9e-20
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 12/174 (6%)
Query: 467 FDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFH-SPHPDMVVQQAFSNEIKALTELRHRN 524
+ IG +VY A ++ + + VA+++ + P ++ NEI + E ++ N
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPN 78
Query: 525 VVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH 584
+V + + +++ EYL GSL +++ +DE V + L ++H
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAA---VCRECLQALEFLHS 134
Query: 585 DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+ ++HRDI S N+LLG+D ++DFG + P+ S S VGT ++AP
Sbjct: 135 NQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 45/181 (24%), Positives = 82/181 (45%), Gaps = 13/181 (7%)
Query: 457 YEEVIRATN---NFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSN 512
YE V R + ++ +G VYKA + + A K + + + + +
Sbjct: 8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL--EDYIV 65
Query: 513 EIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLA-IILSNDAAIDEFSWTVRMNV 571
EI+ L H +VK G +H + +++ E+ G++ I+L D + E V V
Sbjct: 66 EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV---V 122
Query: 572 IKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVG 631
+ + L+++H I+HRD+ + NVL+ L+ D ++DFG+S F+G
Sbjct: 123 CRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG 179
Query: 632 T 632
T
Sbjct: 180 T 180
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 38/173 (21%), Positives = 70/173 (40%), Gaps = 12/173 (6%)
Query: 472 CIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
IG +VYK + + VA + +Q F E + L L+H N+V+FY
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 531 -FSFHPRQSFLLY---EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY 586
+ + + E + G+L L + V + + + L ++H
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI---KVLRSWCRQILKGLQFLHTRT 149
Query: 587 FPPIVHRDISSKNVLL-GLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
PPI+HRD+ N+ + G + D G++ + + +GT ++AP
Sbjct: 150 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAP 199
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 11/166 (6%)
Query: 474 GTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFS 532
G G V+K PS ++A K H ++ E++ L E +V FYG
Sbjct: 44 GNGG--VVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 533 FHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVH 592
+ + + E++ GSL +L I E + V +V L+Y+ + I+H
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLREKHK--IMH 155
Query: 593 RDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
RD+ N+L+ + + DFG+S L S + FVGT Y++P
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSP 199
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 53/176 (30%), Positives = 80/176 (45%), Gaps = 16/176 (9%)
Query: 467 FDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFS---NEIKALTELRH 522
D+ IG V A E S VAVK D+ QQ NE+ + + +H
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM-----DLRKQQRRELLFNEVVIMRDYQH 101
Query: 523 RNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYM 582
NVV+ Y + ++L E+L G+L I+S ++E V ++V L+Y+
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIAT---VCEAVLQALAYL 157
Query: 583 HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
H ++HRDI S ++LL LD +SDFG + D VGT ++AP
Sbjct: 158 HAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 210
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 37/191 (19%), Positives = 77/191 (40%), Gaps = 30/191 (15%)
Query: 464 TNNFDAKYCIGT---AGQ-ASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALT 518
F +Y + G + V + ++ + + A ++ Q E +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 519 ELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSN-----DAAIDEFSWTVRMNV 571
L+H N+V+ + +L+++ + G L I+ DA+ +
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS----------HC 115
Query: 572 IKSVANTLSYMH-HDYFPPIVHRDISSKNVLL-GLDYDAHV--SDFGISKFLKPDSSNWS 627
I+ + + + H +VHR++ +N+LL A V +DFG++ ++ + W
Sbjct: 116 IQQILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171
Query: 628 EFVGTFGYVAP 638
F GT GY++P
Sbjct: 172 GFAGTPGYLSP 182
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 40/202 (19%), Positives = 84/202 (41%), Gaps = 29/202 (14%)
Query: 462 RATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL 520
R +F+ C+G G V++A+ A+K+ P+ ++ ++ E+KAL +L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKV-MREVKALAKL 60
Query: 521 RHRNVVKFYGF---------SFHPRQSFLLY---EYLGRGSLAIILSNDAAIDEFSWTVR 568
H +V+++ LY + + +L ++ I+E +V
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 569 MNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK-------- 620
+++ +A + ++H ++HRD+ N+ +D V DFG+ +
Sbjct: 121 LHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 621 ----PDSSNWSEFVGTFGYVAP 638
P + + VGT Y++P
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSP 199
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 23/183 (12%)
Query: 465 NNFDAKYCIGTAGQASVYKA-ELPSWEIVAVK--KFHSPHPDMVVQQAFSNEIKALTELR 521
++++ + IG+ A V A P E VA+K M EI+A+++
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM---DELLKEIQAMSQCH 71
Query: 522 HRNVVKFYGFSFHPRQS-FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMN------VIKS 574
H N+V +Y SF + +L+ + L GS+ I+ + + ++ +++
Sbjct: 72 HPNIVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKH-IVAKGEHKSGVLDESTIATILRE 129
Query: 575 VANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE-----F 629
V L Y+H + +HRD+ + N+LLG D ++DFG+S FL F
Sbjct: 130 VLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 630 VGT 632
VGT
Sbjct: 187 VGT 189
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 87.7 bits (217), Expect = 1e-18
Identities = 28/185 (15%), Positives = 67/185 (36%), Gaps = 14/185 (7%)
Query: 464 TNNFDAKYCIG--TAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL 520
++ IG +V A P+ E V V++ + + E+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 521 RHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLS 580
H N+V + + +++ ++ GS ++ +D + +++ V L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT-HFMDGMNELAIAYILQGVLKALD 142
Query: 581 YMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL-------KPDSSNWSEFVGTF 633
Y+HH VHR + + ++L+ +D ++S + + + V
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 634 GYVAP 638
+++P
Sbjct: 200 PWLSP 204
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 41/172 (23%), Positives = 79/172 (45%), Gaps = 14/172 (8%)
Query: 472 CIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN--VVKFY 529
IG+ G + V++ +I A+K + D ++ NEI L +L+ + +++ Y
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 530 GFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH-HDYFP 588
+ + +++ E L L +ID W + + K++ + +H H
Sbjct: 95 DYEITDQYIYMVMECGN-IDLNSWLKKKKSIDP--WERK-SYWKNMLEAVHTIHQHG--- 147
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE--FVGTFGYVAP 638
IVH D+ N L+ D + DFGI+ ++PD+++ + VGT Y+ P
Sbjct: 148 -IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 18/178 (10%)
Query: 470 KYCIG-TAGQ---ASVYKA-ELPSWEIVAVK---KFHSPHPDMVVQQAFSNEIKALTELR 521
+Y G G+ A ++ + + E+ A K K P + S EI L
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLA 99
Query: 522 HRNVVKFYGFSFHPRQS-FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLS 580
H++VV F+GF F F++ E R SL + A+ E R ++ +
Sbjct: 100 HQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTE--PEAR-YYLRQIVLGCQ 155
Query: 581 YMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
Y+H + ++HRD+ N+ L D + + DFG++ ++ D GT Y+AP
Sbjct: 156 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 210
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 12/174 (6%)
Query: 467 FDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFH-SPHPDMVVQQAFSNEIKALTELRHRN 524
F IG +VY A ++ + E+VA+KK S Q E++ L +LRH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 525 VVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH 584
+++ G ++L+ EY + ++ + + E V L+Y+H
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHS 172
Query: 585 DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
++HRD+ + N+LL + DFG + + P +S FVGT ++AP
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAP 219
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 33/188 (17%), Positives = 61/188 (32%), Gaps = 20/188 (10%)
Query: 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN 524
++ +G G + V E L A+K+ ++ E H N
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD--REEAQREADMHRLFNHPN 87
Query: 525 VVKFYGFSFHPRQS----FLLYEYLGRGSLA-IILSNDAAIDEFSWTVRMNVIKSVANTL 579
+++ + R + +LL + RG+L I + + + ++ + L
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 580 SYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN---------WSEFV 630
+H HRD+ N+LLG + + D G W+
Sbjct: 148 EAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 631 GTFGYVAP 638
T Y AP
Sbjct: 205 CTISYRAP 212
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 16/177 (9%)
Query: 470 KYCIG-TAGQ---ASVYKA-ELPSWEIVAVK---KFHSPHPDMVVQQAFSNEIKALTELR 521
+Y G G+ A ++ + + E+ A K K P + S EI L
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLA 73
Query: 522 HRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSY 581
H++VV F+GF F++ E R SL + A+ E R ++ + Y
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE--PEAR-YYLRQIVLGCQY 130
Query: 582 MHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+H + ++HRD+ N+ L D + + DFG++ ++ D GT Y+AP
Sbjct: 131 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 184
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 3e-18
Identities = 37/175 (21%), Positives = 67/175 (38%), Gaps = 23/175 (13%)
Query: 472 CIGTAGQASVYKAE---LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKF 528
CI G +Y A + + V +K D Q E + L E+ H ++V+
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLV-HSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 529 YGFSFHPRQS-----FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH 583
+ F H + +++ EY+G SL + E + + + LSY+H
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEA-----IAYLLEILPALSYLH 199
Query: 584 HDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+V+ D+ +N++L + + D G + GT G+ AP
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY----LYGTPGFQAP 246
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 3e-18
Identities = 39/183 (21%), Positives = 72/183 (39%), Gaps = 22/183 (12%)
Query: 466 NFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRN 524
+F K +G + ++ + VAVK+ E++ L E H N
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA-----DREVQLLRESDEHPN 79
Query: 525 VVKFYGFSFHPRQSFLLYEYLGRGSLA-IILSNDAAIDEFSWTVRMNVIKSVANTLSYMH 583
V++++ + ++ E +L + D A + +++ + L+++H
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLH 135
Query: 584 HDYFPPIVHRDISSKNVLL-----GLDYDAHVSDFGISKFLKPDSS---NWSEFVGTFGY 635
IVHRD+ N+L+ A +SDFG+ K L S GT G+
Sbjct: 136 SLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 636 VAP 638
+AP
Sbjct: 193 IAP 195
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 41/174 (23%), Positives = 78/174 (44%), Gaps = 18/174 (10%)
Query: 472 CIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH--RNVVKFY 529
IG+ G + V++ +I A+K + D ++ NEI L +L+ +++ Y
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 530 GFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH-HDYFP 588
+ + +++ E L L +ID W + + K++ + +H H
Sbjct: 76 DYEITDQYIYMVMECGN-IDLNSWLKKKKSIDP--WERK-SYWKNMLEAVHTIHQHG--- 128
Query: 589 PIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSNWSE--FVGTFGYVAP 638
IVH D+ N L+ D + DFGI+ ++PD+++ + VGT Y+ P
Sbjct: 129 -IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 40/196 (20%), Positives = 78/196 (39%), Gaps = 32/196 (16%)
Query: 462 RATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL 520
R +F IG+ G V+KA+ + +K+ + E+KAL +L
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKL 61
Query: 521 RHRNVVKFYGF-------------SFHPRQSFLLY---EYLGRGSLA--IILSNDAAIDE 562
H N+V + G + ++ L+ E+ +G+L I +D+
Sbjct: 62 DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 563 FSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622
+ + + + + + Y+H +++RD+ N+ L + DFG+ LK D
Sbjct: 122 ---VLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 623 SSNWSEFVGTFGYVAP 638
+ GT Y++P
Sbjct: 176 GKR-TRSKGTLRYMSP 190
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 5e-18
Identities = 40/172 (23%), Positives = 77/172 (44%), Gaps = 14/172 (8%)
Query: 472 CIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH--RNVVKFY 529
IG+ G + V++ +I A+K + D ++ NEI L +L+ +++ Y
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 530 GFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH-HDYFP 588
+ + +++ E L L +ID W + + K++ + +H H
Sbjct: 123 DYEITDQYIYMVMECGN-IDLNSWLKKKKSIDP--WERK-SYWKNMLEAVHTIHQHG--- 175
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE--FVGTFGYVAP 638
IVH D+ N L+ D + DFGI+ ++PD+++ + VG Y+ P
Sbjct: 176 -IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 8e-18
Identities = 42/179 (23%), Positives = 80/179 (44%), Gaps = 19/179 (10%)
Query: 470 KYCIG-TAGQ---ASVYKA-ELPSWEIVAVK---KFHSPHPDMVVQQAFSNEIKALTELR 521
+ +G G+ A VY+A + + VA+K K MV + NE+K +L+
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR--VQNEVKIHCQLK 69
Query: 522 HRNVVKFYGFSFH-PRQSFLLYEYLGRGSLA-IILSNDAAIDEFSWTVRMNVIKSVANTL 579
H ++++ Y + F +L+ E G + + + E R + + + +
Sbjct: 70 HPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE--NEAR-HFMHQIITGM 125
Query: 580 SYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
Y+H I+HRD++ N+LL + + ++DFG++ LK GT Y++P
Sbjct: 126 LYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISP 181
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 44/178 (24%), Positives = 70/178 (39%), Gaps = 8/178 (4%)
Query: 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFH-SPHPDMVVQQAFSNEIKALTELRH 522
NF + IG + VY+A L VA+KK D + EI L +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 523 RNVVKFYGFSFHPRQSFLLY-EYLGRGSLAIILSNDAAIDE-FSWTVRMNVIKSVANTLS 580
NV+K+Y SF + E G L+ ++ + + + L
Sbjct: 92 PNVIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 581 YMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+MH ++HRDI NV + + D G+ +F ++ VGT Y++P
Sbjct: 151 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 32/177 (18%), Positives = 65/177 (36%), Gaps = 9/177 (5%)
Query: 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHR 523
+ IG + +K+ + ++ E+ L ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 524 NVVKFYGFSFHPRQSFLLYEYLGRGSLAIILS--NDAAIDEFSWTVRMNVIKSVANTLSY 581
N+V++ +++ +Y G L ++ E ++ + L +
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE---DQILDWFVQICLALKH 140
Query: 582 MHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+H I+HRDI S+N+ L D + DFGI++ L +GT Y++P
Sbjct: 141 VHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSP 194
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 45/196 (22%), Positives = 81/196 (41%), Gaps = 40/196 (20%)
Query: 462 RATNNFDAKYCIGT---AGQ-ASVYKA-ELPSWEIVAVK---KFHSPHPDMVVQQAFSNE 513
T N + +G + V+ + + ++ A+K K + + NE
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSL-----ENE 56
Query: 514 IKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILS-----NDAAIDEFSWT 566
I L +++H N+V +L+ + + G L I+ DA+
Sbjct: 57 IAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS------- 109
Query: 567 VRMNVIKSVANTLSYMH-HDYFPPIVHRDISSKNVLL-GLDYDAHV--SDFGISKFLKPD 622
VI+ V + + Y+H + IVHRD+ +N+L + ++ + +DFG+SK +
Sbjct: 110 ---LVIQQVLSAVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161
Query: 623 SSNWSEFVGTFGYVAP 638
S GT GYVAP
Sbjct: 162 -GIMSTACGTPGYVAP 176
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 55/250 (22%), Positives = 89/250 (35%), Gaps = 53/250 (21%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLYCN 88
+ K LD+ N L + L+ L ++ +++ ++ LS L L+L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 89 GLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFL-GHLSNLAV 147
+ +LA+G + LS+L L E L+ S+ +F GHL L
Sbjct: 87 PIQ-----------SLALG-AFSGLSSLQ-----KLVAVETNLA-SLENFPIGHLKTLKE 128
Query: 148 LHLGDNSLFGSIPPILGKVQSLLSLG-FDLNLLNGVLPPSISNLSNLEGLYLYS-SLVSA 205
L++ N + QS F NL+NLE L L S + S
Sbjct: 129 LNVAHNLI-----------QSFKLPEYFS-------------NLTNLEHLDLSSNKIQSI 164
Query: 206 EIGNLLQLIELEIDNKQLF------GQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYP 259
+L L ++ + N L I L + L+ N L +F
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLT 224
Query: 260 NLTFLDLSQN 269
+L + L N
Sbjct: 225 SLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 35/142 (24%), Positives = 56/142 (39%), Gaps = 20/142 (14%)
Query: 227 IPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN--------FYG----- 273
IP +L S + L N L F +P L LDLS+ +
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 274 SLNFSMNNITRSIPPKI-GKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYG 332
+L + N I S+ L L KL ++ +G+LK+L + N +
Sbjct: 80 TLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI-Q 137
Query: 333 SLPR--VLGSISDLEYLDLSTN 352
S ++++LE+LDLS+N
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSN 159
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 34/167 (20%), Positives = 63/167 (37%), Gaps = 11/167 (6%)
Query: 474 GTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKAL-TELRHRNVVKFYGF 531
GT G V+K + ++AVK+ + + ++ + +V+ +G
Sbjct: 36 GTCG--QVWKMRFRKTGHVIAVKQMRR-SGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIV 591
F+ E +G + + I E + + ++ L Y+ + ++
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIPE---RILGKMTVAIVKALYYLKEKH--GVI 147
Query: 592 HRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
HRD+ N+LL + DFGIS L D G Y+AP
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAP 193
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 465 NNFDAKYCIGTAGQASVYKA-ELPSWEIVAVK---KFHSPHPDMVVQQAFSNEIKALTEL 520
+F+ +G +VY A E S I+A+K K + Q E++ + L
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ--LRREVEIQSHL 66
Query: 521 RHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLS 580
RH N+++ YG+ + +L+ EY G++ L + DE I +AN LS
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTA-TYITELANALS 123
Query: 581 YMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
Y H ++HRDI +N+LLG + ++DFG S SS ++ GT Y+ P
Sbjct: 124 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTDLCGTLDYLPP 176
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 38/173 (21%), Positives = 78/173 (45%), Gaps = 12/173 (6%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
+G A+V++ + ++ A+K F++ + E + L +L H+N+VK +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 532 --SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP 589
R L+ E+ GSL +L + + + V++ V ++++ +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 590 IVHRDISSKNVLLGLDYDAH----VSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
IVHR+I N++ + D ++DFG ++ L+ D + GT Y+ P
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHP 184
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 42/198 (21%), Positives = 71/198 (35%), Gaps = 36/198 (18%)
Query: 462 RATNNFDAKYCIG-TAGQ---ASVYKA-ELPSWEIVAVKKFH------SPHPDMVVQQAF 510
+Y + T G V A E + + VA++ +
Sbjct: 128 VYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNV 187
Query: 511 SNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSN-----DAAIDEF 563
EI+ L +L H ++K F F +++ E + G L ++ +
Sbjct: 188 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK---- 242
Query: 564 SWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL-GLDYDAHV--SDFGISKFLK 620
+ + Y+H + I+HRD+ +NVLL + D + +DFG SK L
Sbjct: 243 ------LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293
Query: 621 PDSSNWSEFVGTFGYVAP 638
S GT Y+AP
Sbjct: 294 ETSL-MRTLCGTPTYLAP 310
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-17
Identities = 33/197 (16%), Positives = 70/197 (35%), Gaps = 24/197 (12%)
Query: 10 QVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGS 69
++ + +++L ++ + N ++ + I+ ++K L IN
Sbjct: 24 AYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNY 81
Query: 70 VPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSEN 129
P + LS+L++L + ++ + L +L LD+S +
Sbjct: 82 NP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT-----------------LLDISHS 122
Query: 130 QLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISN 189
SI + L + + L N I P L + L SL + ++ I +
Sbjct: 123 AHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IED 179
Query: 190 LSNLEGLYLYSSLVSAE 206
L LY +S + +
Sbjct: 180 FPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 30/146 (20%), Positives = 51/146 (34%), Gaps = 16/146 (10%)
Query: 187 ISNLSNLEGLYLYSSLVS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQ 244
I N++ L + + + I L L L I K + +L TSL ++ +
Sbjct: 62 IEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121
Query: 245 NHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLN 304
+ +I P + +DLS N IT I P + L +L L+ +
Sbjct: 122 SAHDDSILTKINTLPKVNSIDLSYN----------GAIT-DIMP-LKTLPELKSLNIQFD 169
Query: 305 HIVGELPIELGNLKSLNYRALNGNKV 330
+ IE + LN +
Sbjct: 170 GVHDYRGIE--DFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-12
Identities = 34/180 (18%), Positives = 68/180 (37%), Gaps = 12/180 (6%)
Query: 78 SSLKQLVLYCNGLSGWLPSSFGNLNNL-AIGSMPNSLSNLTSLSLFH----LDLSENQLS 132
S+ K + G S + +N+L I ++++LT + H L ++ +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGIEYAHNIKDLTINNIHAT 79
Query: 133 GSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSN 192
P + LSNL L + + P L + SL L + + + I+ L
Sbjct: 80 NYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPK 137
Query: 193 LEGLYL-YSSLVS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTG 249
+ + L Y+ ++ + L +L L I + + +F LN ++ + G
Sbjct: 138 VNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 25/179 (13%), Positives = 60/179 (33%), Gaps = 22/179 (12%)
Query: 209 NLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQ 268
+ + + + T + + ++ LTG N+ L ++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75
Query: 269 NNFYG-----------SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNL 317
+ L ++T P + L L LD S + + ++ L
Sbjct: 76 IHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 318 KSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
+N L+ N + L ++ +L+ L++ + +++R +E +L +L
Sbjct: 136 PKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYR-----GIEDFPKLNQLYA 188
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 41/187 (21%), Positives = 70/187 (37%), Gaps = 24/187 (12%)
Query: 473 IGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYG 530
+ G A VY+A+ + S A+K+ S + +A E+ + +L H N+V+F
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK--NRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 531 FSFHPRQS-------FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH 583
+ ++ FLL L +G L L + S + + + +MH
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 584 HDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN------------WSEFVG 631
PPI+HRD+ +N+LL + DFG + +
Sbjct: 154 RQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 632 TFGYVAP 638
T Y P
Sbjct: 213 TPMYRTP 219
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 42/197 (21%), Positives = 82/197 (41%), Gaps = 31/197 (15%)
Query: 458 EEVIRATNNFDAKYCIGT---AGQ-ASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSN 512
E ++ A+ F Y + G + V + + A K ++ Q
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 513 EIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSN-----DAAIDEFSW 565
E + +L+H N+V+ + +L+++ + G L I+ DA+
Sbjct: 78 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS------ 131
Query: 566 TVRMNVIKSVANTLSYMH-HDYFPPIVHRDISSKNVLL-GLDYDAHV--SDFGISKFLKP 621
+ I+ + +++Y H + IVHR++ +N+LL A V +DFG++ +
Sbjct: 132 ----HCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
Query: 622 DSSNWSEFVGTFGYVAP 638
+ W F GT GY++P
Sbjct: 184 SEA-WHGFAGTPGYLSP 199
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 44/195 (22%), Positives = 71/195 (36%), Gaps = 38/195 (19%)
Query: 466 NFDAKYCIG-TAGQ---ASVYKA-ELPSWEIVAVKKFH------SPHPDMVVQQAFSNEI 514
+Y + T G V A E + + VA+K + EI
Sbjct: 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 515 KALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AII----LS-NDAAIDEFSWTV 567
+ L +L H ++K F F +++ E + G L ++ L
Sbjct: 67 EILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK-------- 117
Query: 568 RMNVIKSVANTLSYMH-HDYFPPIVHRDISSKNVLL-GLDYDAHV--SDFGISKFLKPDS 623
+ + Y+H + I+HRD+ +NVLL + D + +DFG SK L S
Sbjct: 118 --LYFYQMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
Query: 624 SNWSEFVGTFGYVAP 638
GT Y+AP
Sbjct: 172 L-MRTLCGTPTYLAP 185
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 51/272 (18%), Positives = 111/272 (40%), Gaps = 33/272 (12%)
Query: 26 IGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVL 85
++ + L ++ + + + L +L L + N++ + + L+ + +L L
Sbjct: 37 QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQI--TDLAPLKNLTKITELEL 92
Query: 86 YCNGLSGWLPSSFGNLNNL--------AIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPH 137
N L S+ L ++ I + L+ L++L L L NQ++ P
Sbjct: 93 SGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP-LAGLSNLQ--VLYLDLNQITNISP- 146
Query: 138 FLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLY 197
L L+NL L +G+ + + P L + L +L D N ++ + +++L NL ++
Sbjct: 147 -LAGLTNLQYLSIGNAQV-SDLTP-LANLSKLTTLKADDNKISDI--SPLASLPNLIEVH 201
Query: 198 LYSSLVS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVF 255
L ++ +S + + N L + + N+ + Q N N+V +G
Sbjct: 202 LKNNQISDVSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKG----PSGAPIAPA 257
Query: 256 GIYPNLTFLDL----SQNNFYGSLNFSMNNIT 283
I N T+ + +F +++++ N
Sbjct: 258 TISDNGTYASPNLTWNLTSFINNVSYTFNQSV 289
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 8e-16
Identities = 50/287 (17%), Positives = 101/287 (35%), Gaps = 50/287 (17%)
Query: 39 NNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSF 98
++ + P L + + + + +V L + L + G++
Sbjct: 6 PTAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT------- 54
Query: 99 GNLNNLAIGSMPNSLSNLTSL-SLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFG 157
++ + L +L L+L +NQ++ + L +L+ + L L N L
Sbjct: 55 -------------TIEGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPL-K 98
Query: 158 SIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVS--AEIGNLLQLIE 215
++ + +QS+ +L + V ++ LSNL+ LYL + ++ + + L L
Sbjct: 99 NVSA-IAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQY 155
Query: 216 LEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSL 275
L I N Q+ L N + L + + N ++ PNL + L N
Sbjct: 156 LSIGNAQV--SDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQI---- 207
Query: 276 NFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNY 322
+ P + L + + I + NL N
Sbjct: 208 --------SDVSP-LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNV 245
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 42/211 (19%), Positives = 77/211 (36%), Gaps = 30/211 (14%)
Query: 168 SLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVS--AEIGNLLQLIELEIDNKQLFG 225
+ + + + + + ++L + L + + V+ + L LI LE+ + Q+
Sbjct: 20 NAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQI-- 75
Query: 226 QIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRS 285
L+N T + + L N L N+ ++ LDL+
Sbjct: 76 TDLAPLKNLTKITELELSGNPLK-NV-SAIAGLQSIKTLDLTSTQI------------TD 121
Query: 286 IPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLE 345
+ P + L L L LN I + L L +L Y ++ +V P L ++S L
Sbjct: 122 VTP-LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLT 176
Query: 346 YLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
L N ++ L L L E+ L
Sbjct: 177 TLKADDNKISDIS-----PLASLPNLIEVHL 202
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 35/192 (18%), Positives = 69/192 (35%), Gaps = 28/192 (14%)
Query: 187 ISNLSNLEGLYLYSSLVS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQ 244
L+N + S V+ +L + L + + ++ +L + L+
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKD 72
Query: 245 NHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLN 304
N +T ++ +T L+LS N +++ I L + LD +
Sbjct: 73 NQIT-DL-APLKNLTKITELELSGNPL------------KNVSA-IAGLQSIKTLDLTST 117
Query: 305 HIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVE 364
I L L +L L+ N++ P L +++L+YL + ++
Sbjct: 118 QITD--VTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLT-----P 168
Query: 365 LEKLVQLTELDL 376
L L +LT L
Sbjct: 169 LANLSKLTTLKA 180
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 37/188 (19%), Positives = 70/188 (37%), Gaps = 17/188 (9%)
Query: 464 TNNFDAKYCIGT---AGQ-ASVYKA-ELPSWEIVAVK---KFHSPHPDMVVQQAFSNEIK 515
F+ Y + G + V + + + AVK + + E
Sbjct: 19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 516 ALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAI-ILSNDAAIDEFSWTVRMNVIKS 574
L+H ++V+ ++++E++ L I+ A +S V + ++
Sbjct: 79 ICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 575 VANTLSYMH-HDYFPPIVHRDISSKNVLL-GLDYDAHV--SDFGISKFLKPDSSNWSEFV 630
+ L Y H ++ I+HRD+ VLL + A V FG++ L V
Sbjct: 139 ILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 631 GTFGYVAP 638
GT ++AP
Sbjct: 195 GTPHFMAP 202
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 40/191 (20%), Positives = 79/191 (41%), Gaps = 31/191 (16%)
Query: 464 TNNFDAKYCIG-TAGQ---ASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALT 518
+ F Y + G+ + V + + A K ++ Q E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 519 ELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSN-----DAAIDEFSWTVRMNV 571
+L+H N+V+ + +L+++ + G L I+ DA+ +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----------HC 110
Query: 572 IKSVANTLSYMH-HDYFPPIVHRDISSKNVLL-GLDYDAHV--SDFGISKFLKPDSSNWS 627
I+ + +++Y H + IVHR++ +N+LL A V +DFG++ + + W
Sbjct: 111 IQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WH 165
Query: 628 EFVGTFGYVAP 638
F GT GY++P
Sbjct: 166 GFAGTPGYLSP 176
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 42/207 (20%), Positives = 72/207 (34%), Gaps = 40/207 (19%)
Query: 462 RATNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL 520
R ++F+ +G V KA A+KK +E+ L L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK---LSTILSEVMLLASL 59
Query: 521 RHRNVVKFYGF----------SFHPRQSFLLY---EYLGRGSLA-IILSNDAAIDE-FSW 565
H+ VV++Y ++ L+ EY G+L +I S + W
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 566 TVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625
+ + + LSY+H I+HRD+ N+ + + + DFG++K +
Sbjct: 120 ----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 626 WSE--------------FVGTFGYVAP 638
+GT YVA
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVAT 199
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 81.7 bits (201), Expect = 2e-16
Identities = 59/304 (19%), Positives = 118/304 (38%), Gaps = 26/304 (8%)
Query: 28 NISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYC 87
+ ++ ++ + Q + L + + N + ++ SV + L ++ +L L
Sbjct: 19 AFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 74
Query: 88 NGLSGWLP-SSFGNLNNLAIGSMPNSLSNLTSLS----LFHLDLSENQLSGSIPHFLGHL 142
N L+ P ++ NL L + N + +L+SL L L L N +S I L HL
Sbjct: 75 NKLTDIKPLTNLKNLGWLFLDE--NKIKDLSSLKDLKKLKSLSLEHNGIS-DING-LVHL 130
Query: 143 SNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSL 202
L L+LG+N + I L ++ L +L + N ++ + ++ L+ L+ LYL +
Sbjct: 131 PQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNH 186
Query: 203 VS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLT-------GNIYE 253
+S + L L LE+ +++ + N N V L YE
Sbjct: 187 ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYE 246
Query: 254 VFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIE 313
+ +L + + R L +++ + + ++ V + +E
Sbjct: 247 KPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVE 306
Query: 314 LGNL 317
G
Sbjct: 307 AGTR 310
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 81.3 bits (200), Expect = 3e-16
Identities = 58/366 (15%), Positives = 115/366 (31%), Gaps = 77/366 (21%)
Query: 32 LKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLS 91
+ + + + P D + + +V +L+S+ Q++ + +
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 92 GWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLG 151
++ + L N+T L L+ N+L+ I L +L NL L L
Sbjct: 57 --------SVQGIQ------YLPNVT-----KLFLNGNKLT-DIKP-LTNLKNLGWLFLD 95
Query: 152 DNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVS--AEIGN 209
+N + + + +L L+ L L + +S + +
Sbjct: 96 ENKI-KDLSSL-------------------------KDLKKLKSLSLEHNGISDINGLVH 129
Query: 210 LLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQN 269
L QL L + N ++ L T L+ + LE N ++ +I L L LS+N
Sbjct: 130 LPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKN 185
Query: 270 NFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNY-RALNGN 328
+ I+ + + L L L+ + + NL N + +G+
Sbjct: 186 H-----------IS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 232
Query: 329 KVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPK 388
ISD + + V +T F +P
Sbjct: 233 ------LVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPL 286
Query: 389 SVIWKA 394
++
Sbjct: 287 KEVYTV 292
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 73.2 bits (179), Expect = 9e-14
Identities = 51/270 (18%), Positives = 102/270 (37%), Gaps = 32/270 (11%)
Query: 26 IGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVL 85
I + N+ L + N+L+ + P + L +L L+++ NK++ + L LK L L
Sbjct: 61 IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSL 116
Query: 86 YCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNL 145
NG+S ++N L L L L L N+++ I L L+ L
Sbjct: 117 EHNGIS--------DINGL------VHLPQLE-----SLYLGNNKIT-DIT-VLSRLTKL 155
Query: 146 AVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSA 205
L L DN + I P L + L +L N ++ + +++ L NL+ L L+S
Sbjct: 156 DTLSLEDNQI-SDIVP-LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211
Query: 206 EIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLD 265
+ N + + K G + + E+ ++ ++ E + +
Sbjct: 212 KPINHQSNLVVPNTVKNTDGSLVT---PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQP 268
Query: 266 LSQNNFYGSLNFSMNNITRSIPPKIGKLYQ 295
++ + + + + +
Sbjct: 269 VTIGKAKARFHGRVTQPLKEVYTVSYDVDG 298
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 34/210 (16%), Positives = 75/210 (35%), Gaps = 11/210 (5%)
Query: 26 IGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVL 85
+ ++ LK L + +N +S + + L L+ LY+ NK+ + + +L+ L L L
Sbjct: 105 LKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSL 160
Query: 86 YCNGLSGWLP-SSFGNLNNLAIGSMPNSLSNLTSLS----LFHLDLSENQLSGSIPHFLG 140
N +S +P + L NL + N +S+L +L+ L L+L + +
Sbjct: 161 EDNQISDIVPLAGLTKLQNLYLSK--NHISDLRALAGLKNLDVLELFSQECLNKPINHQS 218
Query: 141 HLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYS 200
+L + D SL ++ + L + +
Sbjct: 219 NLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARF 278
Query: 201 SLVSAEIGNLLQLIELEIDNKQLFGQIPKS 230
+ + + ++D + ++
Sbjct: 279 HGRVTQPLKEVYTVSYDVDGTVIKTKVEAG 308
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 3e-16
Identities = 38/173 (21%), Positives = 78/173 (45%), Gaps = 12/173 (6%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
+G A+V++ + ++ A+K F++ + E + L +L H+N+VK +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 532 --SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP 589
R L+ E+ GSL +L + + + V++ V ++++ +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 590 IVHRDISSKNVLLGLDYDAH----VSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
IVHR+I N++ + D ++DFG ++ L+ D + GT Y+ P
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHP 184
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 58/188 (30%), Positives = 90/188 (47%), Gaps = 27/188 (14%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLYCN 88
++ K LD+ +N+LS + + LT L+ LY+N NKL+ ++P + +L +L+ L + N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 89 GLSGWLPSS-FGNLNNL--------AIGSMPN----SLSNLTSLSLFHLDLSENQLSGSI 135
L LP F L NL + S+P SL+ LT +L L N+L S+
Sbjct: 96 KLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLT-----YLSLGYNELQ-SL 148
Query: 136 PH--FLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVLPPSISNLSN 192
P F L++L L L +N L +P K+ L +L D N L V + +L
Sbjct: 149 PKGVF-DKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEK 206
Query: 193 LEGLYLYS 200
L+ L L
Sbjct: 207 LKMLQLQE 214
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 38/135 (28%), Positives = 56/135 (41%), Gaps = 15/135 (11%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLYCN 88
NL+ L + +N+L + D L +L L ++ N+L+ S+P V L+ L L L N
Sbjct: 85 KNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYN 143
Query: 89 GLSGWLPSSFGNLNNL--------AIGSMPNSL-SNLTSLSLFHLDLSENQLSGSIPH-F 138
L F L +L + +P LT L L L NQL +P
Sbjct: 144 ELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELK--TLKLDNNQLK-RVPEGA 200
Query: 139 LGHLSNLAVLHLGDN 153
L L +L L +N
Sbjct: 201 FDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 45/158 (28%), Positives = 63/158 (39%), Gaps = 18/158 (11%)
Query: 124 LDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGV 182
LDL N+LS L+ L +L+L DN L ++P I ++++L +L N L
Sbjct: 42 LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ-A 99
Query: 183 LPPSI-SNLSNLEGLYLYS-SLVSAEIG---NLLQLIELEIDNKQLFGQIPKSL-----R 232
LP + L NL L L L S +L +L L + +L +SL
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNEL-----QSLPKGVFD 154
Query: 233 NFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN 270
TSL + L N L F L L L N
Sbjct: 155 KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ 192
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 54/261 (20%), Positives = 96/261 (36%), Gaps = 58/261 (22%)
Query: 183 LPPSISNLSNLEGLYLY----SSLVSAEIGNLLQLIELEIDNKQLFGQIPKSL-RNFTSL 237
+P +I ++ + L L SSL S L +L L +++ +L +P + + +L
Sbjct: 31 IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNL 87
Query: 238 NIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKI-GKLYQL 296
+ + N L VF NL L L +N +S+PP++ L +L
Sbjct: 88 ETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQL------------KSLPPRVFDSLTKL 135
Query: 297 HKLDFSLNHIVGELPI----ELGNLKSLNYRALNGNKVYGSLPR-VLGSISDLEYLDLST 351
L N + LP +L +LK L L N++ +P +++L+ L L
Sbjct: 136 TYLSLGYNELQ-SLPKGVFDKLTSLKELR---LYNNQL-KRVPEGAFDKLTELKTLKL-- 188
Query: 352 NYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDIS 411
NN+ ++ + L +L L L W+ +C I
Sbjct: 189 -DNNQLKRVPEGAFDSLEKLKMLQLQENPWD----------------------CTCNGII 225
Query: 412 YNELRGLIRNSTGIHYNLVDA 432
Y + ++ VD
Sbjct: 226 Y--MAKWLKKKADEGLGGVDT 244
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 28/76 (36%), Positives = 37/76 (48%), Gaps = 12/76 (15%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLY-- 86
++LK L + NNQL V D LT LK L ++ N+L+ VP L LK L L
Sbjct: 157 TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
Query: 87 -----CNG---LSGWL 94
CNG ++ WL
Sbjct: 216 PWDCTCNGIIYMAKWL 231
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 43/198 (21%), Positives = 81/198 (40%), Gaps = 36/198 (18%)
Query: 462 RATNNFDAKYCIG-TAGQ---ASVYKA-ELPSWEIVAVK-------KFHSPHPDMVVQQA 509
+T+ F Y G+ + V + P+ + AVK S +++A
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 510 FSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AII----LS-NDAAID 561
E+ L ++ H N+++ FL+++ + +G L + LS +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-- 127
Query: 562 EFSWTVRMNVIKSVANTLSYMH-HDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620
+++++ + +H + IVHRD+ +N+LL D + ++DFG S L
Sbjct: 128 --------KIMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 621 PDSSNWSEFVGTFGYVAP 638
P E GT Y+AP
Sbjct: 176 PGEK-LREVCGTPSYLAP 192
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 47/197 (23%), Positives = 83/197 (42%), Gaps = 35/197 (17%)
Query: 462 RATNNFDAKYCIG-TAGQ---ASVYKA-ELPSWEIVAVK------KFHSPHPDMVVQQAF 510
A F KY G+ + V + + AVK + SP V++A
Sbjct: 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146
Query: 511 SNEIKALTELR-HRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AII----LS-NDAAIDE 562
E L ++ H +++ FL+++ + +G L + LS +
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR--- 203
Query: 563 FSWTVRMNVIKSVANTLSYMH-HDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621
++++S+ +S++H ++ IVHRD+ +N+LL + +SDFG S L+P
Sbjct: 204 -------SIMRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252
Query: 622 DSSNWSEFVGTFGYVAP 638
E GT GY+AP
Sbjct: 253 GEK-LRELCGTPGYLAP 268
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 9e-16
Identities = 47/259 (18%), Positives = 84/259 (32%), Gaps = 31/259 (11%)
Query: 31 NLKFLDMGNNQLSGVIPQ---EIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYC 87
+LK L + ++ I + ++ L+ L + ++ G+ P + + + +L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL-- 126
Query: 88 NGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAV 147
+ N++ + L L L +++ + L+
Sbjct: 127 ---------NLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALST 177
Query: 148 LHLGDNSLFGSI-------PPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYL-- 198
L L DN G P +Q L + +GV + L+GL L
Sbjct: 178 LDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSH 237
Query: 199 --YSSLVSAEIGNLLQ-LIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVF 255
A + L L + L Q+PK L L+++ L N L N
Sbjct: 238 NSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPKGL--PAKLSVLDLSYNRLDRN--PSP 292
Query: 256 GIYPNLTFLDLSQNNFYGS 274
P + L L N F S
Sbjct: 293 DELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 54/286 (18%), Positives = 83/286 (29%), Gaps = 25/286 (8%)
Query: 87 CNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLA 146
CN S P N L + SL + G + LS L
Sbjct: 15 CN-FSDPKPDWSSAFNCLGAADVELYGGGR-SLEYLLKRVDTEADLGQFTDIIKSLS-LK 71
Query: 147 VLHLGDNSLFGSIPPILGKVQS---LLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLV 203
L + + I +V L L + + G PP + + + L V
Sbjct: 72 RLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131
Query: 204 SAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTF 263
S + +L + L+ + + Q H E ++P L+
Sbjct: 132 S--------WATRDAWLAELQQWLKPGLKVLS------IAQAHSLNFSCEQVRVFPALST 177
Query: 264 LDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYR 323
LDLS N G I+ P K L L + + G L
Sbjct: 178 LDLSDNPELGERGL----ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGL 233
Query: 324 ALNGNKVYGSLPRVLGSI-SDLEYLDLSTNYNNEFRKEFPVELEKL 368
L+ N + + S L L+LS + K P +L L
Sbjct: 234 DLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVL 279
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 7e-11
Identities = 31/159 (19%), Positives = 44/159 (27%), Gaps = 18/159 (11%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEI----DPLTHLKHLYINVNKLR-- 67
Q+ L LD+ +N G L+ L + +
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216
Query: 68 -GSVPREVGQLSSLKQLVLYCNGLSGWLPSSF----GNLNNLAIGSMPNSLSNLTSL--- 119
G L+ L L N L + LN+L + L +
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSF--TGLKQVPKGLPA 274
Query: 120 SLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGS 158
L LDLS N+L P L + L L N S
Sbjct: 275 KLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 37/216 (17%), Positives = 73/216 (33%), Gaps = 25/216 (11%)
Query: 177 NLLNGVLPPSISNLSNLEGLYLYSSLVSAE-------IGNLLQLIELEIDNKQLFGQIPK 229
+ I +L+ L + ++ + + + + L EL ++N ++ G P
Sbjct: 54 TEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113
Query: 230 SLRNFTSLNIVHLEQNHLTGNIYEVF-GIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPP 288
L T ++ L +++ + + L L+ + +
Sbjct: 114 PLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLK------VLSIAQAHSLNFSCE 167
Query: 289 KIGKLYQLHKLDFSLNHIVGEL-------PIELGNLKSLNYRALNGNKVYGSLPRVLGSI 341
++ L LD S N +GE P++ L+ L R G + +
Sbjct: 168 QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227
Query: 342 SDLEYLDLSTNYNNEFRKEFPVEL-EKLVQLTELDL 376
L+ LDLS +N R + QL L+L
Sbjct: 228 VQLQGLDLS---HNSLRDAAGAPSCDWPSQLNSLNL 260
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 32/207 (15%), Positives = 57/207 (27%), Gaps = 17/207 (8%)
Query: 227 IPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSI 286
+ + + L++ + ++ L L +S L +T +
Sbjct: 55 EADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ---ELTLENLEVTGTA 111
Query: 287 PPKIGKLY--QLHKLDFSLNHIVGELPI--ELGNLKSLNYRALN--GNKVYGSLPRVLGS 340
PP + + L+ L+ EL + L+ +
Sbjct: 112 PPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV 171
Query: 341 ISDLEYLDLSTNY-NNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLI 399
L LDLS N E + K L L L R +L
Sbjct: 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL-------RNAGMETPSGVCSALA 224
Query: 400 SRMHGLSCIDISYNELRGLIRNSTGIH 426
+ L +D+S+N LR +
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDW 251
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 41/171 (23%), Positives = 68/171 (39%), Gaps = 16/171 (9%)
Query: 474 GTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIK-ALTELRHRNVVKFYGF 531
G G V K +PS +I+AVK+ + + Q+ ++ ++ + V FYG
Sbjct: 18 GAYG--VVEKMRHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 532 SFHPRQSFLLYEYLGRGSLAIIL----SNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF 587
F ++ E + SL I E + + S+ L ++H
Sbjct: 75 LFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPE---DILGKIAVSIVKALEHLHSKL- 129
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
++HRD+ NVL+ + DFGIS +L D G Y+AP
Sbjct: 130 -SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAP 178
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 46/227 (20%), Positives = 76/227 (33%), Gaps = 17/227 (7%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQL-VLYC 87
N L +L + L+ + I+ N + + +V L L ++ +
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 88 NGLSGWLPSSFGNLNNL--------AIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPH-- 137
N L P +F NL NL I +P + + SL LD+ +N +I
Sbjct: 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLP-DVHKIHSLQKVLLDIQDNINIHTIERNS 148
Query: 138 FLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGF-DLNLLNGVLPPSISNLSNLEGL 196
F+G +L L N + I L L D N L + S L
Sbjct: 149 FVGLSFESVILWLNKNGI-QEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL 207
Query: 197 YLYS-SLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHL 242
+ + S L L +L + ++P +L +L L
Sbjct: 208 DISRTRIHSLPSYGLENLKKLRARSTYNLKKLP-TLEKLVALMEASL 253
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 48/237 (20%), Positives = 72/237 (30%), Gaps = 27/237 (11%)
Query: 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV 74
+N L I P N+ NL++L + N + + L I N ++ R
Sbjct: 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148
Query: 75 --GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLS 132
G L L NG+ + NS N T L N L
Sbjct: 149 FVGLSFESVILWLNKNGIQ----------------EIHNSAFNGTQL-DELNLSDNNNLE 191
Query: 133 GSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVLPPSISNLS 191
S +L + + S+P L ++ L + L + P++ L
Sbjct: 192 ELPNDVFHGASGPVILDISRTRI-HSLPSYGLENLKKLRAR--STYNLKKL--PTLEKLV 246
Query: 192 NLEGLYL-YSSLVSAEIGNLLQLIELE-IDNKQLFGQIPKSLRNFTSLNIVHLEQNH 246
L L Y S A Q+ EL I NK + Q + E N
Sbjct: 247 ALMEASLTYPSHCCAFANWRRQISELHPICNKSILRQEVDYMTQARGQRSSLAEDNE 303
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 23/131 (17%), Positives = 45/131 (34%), Gaps = 15/131 (11%)
Query: 226 QIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRS 285
+IP L + + L F + +L +++SQ N++
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQ-----------NDVLEV 69
Query: 286 IPPKI-GKLYQLHKLDFS-LNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISD 343
I + L +LH++ N+++ P NL +L Y ++ +
Sbjct: 70 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 129
Query: 344 LEYLDLSTNYN 354
LD+ N N
Sbjct: 130 KVLLDIQDNIN 140
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 42/177 (23%), Positives = 77/177 (43%), Gaps = 21/177 (11%)
Query: 467 FDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRN 524
F+ +G VYK + + ++ A+K + ++ EI L + HRN
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRN 82
Query: 525 VVKFYGFSFHPRQSF-------LLYEYLGRGSLAIILSN--DAAIDEFSWTVRMNVIKSV 575
+ +YG +F + L+ E+ G GS+ ++ N + E + + +
Sbjct: 83 IATYYG-AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY---ICREI 138
Query: 576 ANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGT 632
LS++H ++HRDI +NVLL + + + DFG+S L + F+GT
Sbjct: 139 LRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 45/193 (23%), Positives = 78/193 (40%), Gaps = 35/193 (18%)
Query: 462 RATNNFDAKYCIGT---AGQ-ASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKA 516
+ + + + G + VY+ + + + A+K V ++ EI
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL----KKTVDKKIVRTEIGV 101
Query: 517 LTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSN-----DAAIDEFSWTVRM 569
L L H N++K P + L+ E + G L I+ DAA
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA---------- 151
Query: 570 NVIKSVANTLSYMH-HDYFPPIVHRDISSKNVLL-GLDYDAHV--SDFGISKFLKPDSSN 625
+ +K + ++Y+H + IVHRD+ +N+L DA + +DFG+SK ++
Sbjct: 152 DAVKQILEAVAYLHENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL- 206
Query: 626 WSEFVGTFGYVAP 638
GT GY AP
Sbjct: 207 MKTVCGTPGYCAP 219
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 41/189 (21%), Positives = 78/189 (41%), Gaps = 33/189 (17%)
Query: 473 IGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGF 531
+G +V VAVK+ D+ EIK LTE H NV+++Y
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA-----LMEIKLLTESDDHPNVIRYYCS 77
Query: 532 SFHPRQSFLLYEYLGRGSLA-IILSNDAAIDEFSWTVRM---NVIKSVANTLSYMH-HDY 586
R ++ E +L ++ S + + + ++++ +A+ ++++H
Sbjct: 78 ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK- 135
Query: 587 FPPIVHRDISSKNVLL-------------GLDYDAHVSDFGISKFLKPDSSNW----SEF 629
I+HRD+ +N+L+ + +SDFG+ K L S++ +
Sbjct: 136 ---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 630 VGTFGYVAP 638
GT G+ AP
Sbjct: 193 SGTSGWRAP 201
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 48/191 (25%), Positives = 80/191 (41%), Gaps = 31/191 (16%)
Query: 464 TNNFDAKYCIG-TAGQ---ASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALT 518
F +Y I G+ V K + + + AVK + E++ L
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 519 ELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSN-----DAAIDEFSWTVRMNV 571
+L H N++K + +++ E G L II DAA +
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RI 126
Query: 572 IKSVANTLSYMH-HDYFPPIVHRDISSKNVLL-GLDYDAHV--SDFGISKFLKPDSSNWS 627
IK V + ++YMH H+ IVHRD+ +N+LL + D + DFG+S + ++
Sbjct: 127 IKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MK 181
Query: 628 EFVGTFGYVAP 638
+ +GT Y+AP
Sbjct: 182 DRIGTAYYIAP 192
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 46/189 (24%), Positives = 73/189 (38%), Gaps = 19/189 (10%)
Query: 460 VIRATNNFDAKYCIGT---AGQ-ASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEI 514
+ + Y +G V + + A+K E+
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 515 KALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSNDAAIDEFSWTVRMNVI 572
L L H N++K Y F R +L+ E G L II +F+ +I
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII-----HRMKFNEVDAAVII 142
Query: 573 KSVANTLSYMHHDYFPPIVHRDISSKNVLL-GLDYDAHV--SDFGISKFLKPDSSNWSEF 629
K V + ++Y+H IVHRD+ +N+LL + DA + DFG+S + E
Sbjct: 143 KQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-MKER 198
Query: 630 VGTFGYVAP 638
+GT Y+AP
Sbjct: 199 LGTAYYIAP 207
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 45/194 (23%), Positives = 71/194 (36%), Gaps = 29/194 (14%)
Query: 22 IPPQIGNI-SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSL 80
+PP ++ + L + N L + P T L L ++ +L + G L L
Sbjct: 25 LPP---DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVL 79
Query: 81 KQLVLYCNGLSGWLPSSFGNLNNL--------AIGSMP----NSLSNLTSLSLFHLDLSE 128
L L N L LP L L + S+P L L L L
Sbjct: 80 GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQ-----ELYLKG 133
Query: 129 NQLSGSIPH-FLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVLPPS 186
N+L ++P L L L L +N+L +P +L +++L +L N L + P
Sbjct: 134 NELK-TLPPGLLTPTPKLEKLSLANNNL-TELPAGLLNGLENLDTLLLQENSLYTI-PKG 190
Query: 187 ISNLSNLEGLYLYS 200
L +L+
Sbjct: 191 FFGSHLLPFAFLHG 204
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 45/206 (21%), Positives = 65/206 (31%), Gaps = 37/206 (17%)
Query: 124 LDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVL 183
L LSEN L L + L L+L L + + G + L +L N L L
Sbjct: 36 LHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SL 92
Query: 184 PPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLE 243
P L L L + N L + +LR L ++L+
Sbjct: 93 PLLGQTLPALTVLDVSF--------NRLTSLP------------LGALRGLGELQELYLK 132
Query: 244 QNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKI-GKLYQLHKLDFS 302
N L + P L L L+ NN +P + L L L
Sbjct: 133 GNELKTLPPGLLTPTPKLEKLSLANNNL------------TELPAGLLNGLENLDTLLLQ 180
Query: 303 LNHIVGELPIELGNLKSLNYRALNGN 328
N + +P L + L+GN
Sbjct: 181 ENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 50/168 (29%), Positives = 68/168 (40%), Gaps = 29/168 (17%)
Query: 215 ELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGS 274
L + L+ +L +T L ++L++ LT +V G P L LDLS N
Sbjct: 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQVDGTLPVLGTLDLSHNQL--- 89
Query: 275 LNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPI----ELGNLKSLNYRALNGNKV 330
+S+P L L LD S N + LP+ LG L+ L L GN++
Sbjct: 90 ---------QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELY---LKGNEL 136
Query: 331 YGSLP-RVLGSISDLEYLDLSTNYNNEFRKEFPVEL-EKLVQLTELDL 376
+LP +L LE L L NN E P L L L L L
Sbjct: 137 -KTLPPGLLTPTPKLEKLSL---ANNNLT-ELPAGLLNGLENLDTLLL 179
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 31/151 (20%), Positives = 57/151 (37%), Gaps = 28/151 (18%)
Query: 230 SLRNFTSLNIVHLEQNHLTGNIYEV-FGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPP 288
+ S V+ ++ +LT + + + T L LS+N +
Sbjct: 5 EVSKVASHLEVNCDKRNLT----ALPPDLPKDTTILHLSENLL------------YTFSL 48
Query: 289 KI-GKLYQLHKLDFSLNHIVGELPI--ELGNLKSLNYRALNGNKVYGSLPRVLGSISDLE 345
+L +L+ + +L + L L +L+ L+ N++ SLP + ++ L
Sbjct: 49 ATLMPYTRLTQLNLDRAEL-TKLQVDGTLPVLGTLD---LSHNQL-QSLPLLGQTLPALT 103
Query: 346 YLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
LD+S N L L +L EL L
Sbjct: 104 VLDVS---FNRLTSLPLGALRGLGELQELYL 131
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 37/145 (25%), Positives = 54/145 (37%), Gaps = 21/145 (14%)
Query: 234 FTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKL 293
I+HL +N L Y LT L+L + + G L
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL------------TKLQVD-GTL 76
Query: 294 YQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPR-VLGSISDLEYLDLSTN 352
L LD S N + LP+ L +L ++ N++ SLP L + +L+ L L
Sbjct: 77 PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL-TSLPLGALRGLGELQELYLK-- 132
Query: 353 YNNEFRKEFPVEL-EKLVQLTELDL 376
NE K P L +L +L L
Sbjct: 133 -GNEL-KTLPPGLLTPTPKLEKLSL 155
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 34/196 (17%), Positives = 63/196 (32%), Gaps = 26/196 (13%)
Query: 464 TNNFDAKYCIGTAGQASVYKAELPSW------EIVAVKKFHSPHPDMVVQQAFSNEIKAL 517
+ + +G A VY+A + +K +P + ++ L
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF--YIGTQLMERL 121
Query: 518 TELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSNDAAIDEFSWTVRMNVIKSV 575
+KFY S L+ E G+L AI L + + ++ +
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 576 ANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAH-----------VSDFGISKFLK--PD 622
+ +H I+H DI N +LG + + D G S +K P
Sbjct: 182 LYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 623 SSNWSEFVGTFGYVAP 638
+ ++ T G+
Sbjct: 239 GTIFTAKCETSGFQCV 254
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 41/173 (23%), Positives = 69/173 (39%), Gaps = 17/173 (9%)
Query: 473 IGTAGQASVYKAE---LPSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKF 528
+G G VY+AE IVA+K D V + E + L+ +VV
Sbjct: 42 VGRGGMGDVYEAEDTVRE--RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
+ F Q ++ + LA +L + V +++ + + L H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLA-PPRAVA--IVRQIGSALDAAHAAG-- 154
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE---FVGTFGYVAP 638
HRD+ +N+L+ D A++ DFGI+ ++ VGT Y+AP
Sbjct: 155 -ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAP 204
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 13/171 (7%)
Query: 473 IGTAGQASVYKAE---LPSWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKF 528
+G G ++VY AE L VA+K P + F E+ ++L H+N+V
Sbjct: 19 LGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
+L+ EY+ +L+ + + + S +N + + + + H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPL---SVDTAINFTNQILDGIKHAHDM--- 130
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS-SNWSEFVGTFGYVAP 638
IVHRDI +N+L+ + + DFGI+K L S + + +GT Y +P
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 41/196 (20%), Positives = 77/196 (39%), Gaps = 23/196 (11%)
Query: 454 KILYEEVIRATNNFDAKYCI----GTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQ 508
K + + V + Y I G+ V++ E + + K ++P+P + +
Sbjct: 36 KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKY 93
Query: 509 AFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSNDAAIDEFSWT 566
NEI + +L H ++ + + L+ E+L G L I +++ +
Sbjct: 94 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA------AEDYKMS 147
Query: 567 VR--MNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPD 622
+N ++ L +MH IVH DI +N++ + V DFG++ L PD
Sbjct: 148 EAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204
Query: 623 SSNWSEFVGTFGYVAP 638
T + AP
Sbjct: 205 -EIVKVTTATAEFAAP 219
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 50/192 (26%), Positives = 81/192 (42%), Gaps = 24/192 (12%)
Query: 460 VIRATNNFDAKYCIGT---AGQ-ASVYKA-ELPSWEIVAVK---KFHSPHPDMVVQQAFS 511
V +T F +Y G V + + + AVK K ++
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK--ESLL 74
Query: 512 NEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSNDAAIDEFSWTVRM 569
E++ L +L H N++K Y F +L+ E G L II + FS
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-----SRKRFSEVDAA 129
Query: 570 NVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL-GLDYDAHV--SDFGISKFLKPDSSNW 626
+I+ V + ++YMH + IVHRD+ +N+LL DA++ DFG+S +
Sbjct: 130 RIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-M 185
Query: 627 SEFVGTFGYVAP 638
+ +GT Y+AP
Sbjct: 186 KDKIGTAYYIAP 197
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 16/165 (9%)
Query: 479 ASVYKA-ELPSWEIVAVK---KFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH 534
+VY A E + I+A+K K + Q EI+ + LRH N+++ Y + FH
Sbjct: 28 GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ--LRREIEIQSHLRHPNILRMYNY-FH 84
Query: 535 -PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHR 593
++ +L+ E+ RG L L DE ++ +A+ L Y H ++HR
Sbjct: 85 DRKRIYLMLEFAPRGELYKELQKHGRFDE--QRSA-TFMEELADALHYCHERK---VIHR 138
Query: 594 DISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
DI +N+L+G + ++DFG S P + GT Y+ P
Sbjct: 139 DIKPENLLMGYKGELKIADFGWSV-HAPSLRRRT-MCGTLDYLPP 181
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 77.6 bits (190), Expect = 7e-15
Identities = 73/494 (14%), Positives = 142/494 (28%), Gaps = 154/494 (31%)
Query: 141 HLSNLA-----VLHLGDNSLFGSIPPILGK----VQSLLSLGFDLNLLNGVLPPSISN-- 189
L L ++ G + GS GK + LS + + ++ N
Sbjct: 143 ALLELRPAKNVLID-G---VLGS-----GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCN 193
Query: 190 -----LSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQ 244
L L+ L N + + K I LR +
Sbjct: 194 SPETVLEMLQKLLYQID------PNWTSRSDHSSNIKLRIHSIQAELRRLLKS---KPYE 244
Query: 245 NHL-------TGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLH 297
N L + F + + L ++ + ++ T + L
Sbjct: 245 NCLLVLLNVQNAKAWNAFNL--SCKILLTTRFK---QVTDFLSAATTTHISLDHHSMTLT 299
Query: 298 KLD----FS--LNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDL--EYLDL 349
+ L+ +LP E L N PR L I++ + L
Sbjct: 300 PDEVKSLLLKYLDCRPQDLPRE----------VLTTN------PRRLSIIAESIRDGLAT 343
Query: 350 STNYNNEFRKEF------------PVELEKL----------VQLTELDLVITFWEE---- 383
N+ + + P E K+ + + L + W +
Sbjct: 344 WDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSL-IWFDVIKS 402
Query: 384 -------RYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRNSTGIHYNLVDALQGN 436
+ S++ K + + + Y EL+ + N +H ++VD
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKESTISIPSI------YLELKVKLENEYALHRSIVDHYNIP 456
Query: 437 KGLCGD---------------------------VKLFSILTFEGKILYEEVIRATNNFDA 469
K D + LF ++ + + L +++ + ++A
Sbjct: 457 KTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNA 516
Query: 470 KYCIG-TAGQASVYKAEL----PSWE--IVAVKKF---------HSPHPDMVVQQAFSNE 513
I T Q YK + P +E + A+ F S + D +++ A E
Sbjct: 517 SGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTD-LLRIALMAE 575
Query: 514 IKALTELRHRNVVK 527
+A+ E H+ V +
Sbjct: 576 DEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 1e-04
Identities = 57/400 (14%), Positives = 116/400 (29%), Gaps = 122/400 (30%)
Query: 243 EQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFS-MNNITRSI------------PPK 289
E + +I VF ++ F + + + ++ +SI
Sbjct: 13 EHQYQYKDILSVF------------EDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDA 60
Query: 290 IGKLYQL-HKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLD 348
+ +L L +V + + + +NY+ L + + +E D
Sbjct: 61 VSGTLRLFWTLLSKQEEMVQKF---VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRD 117
Query: 349 LSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCI 408
N N F K L+ ++L +
Sbjct: 118 RLYNDNQVFAKYNVSRLQPYLKLRQA---------------------------------- 143
Query: 409 DISYNELRGLIRNSTGIHYNLVDALQGNKGLCGDVKLFSILTFEGKILYEEVIRATNNFD 468
L L R + + + G G G K + + + + ++ +F
Sbjct: 144 ------LLEL-RPAKNV------LIDGVLG-SG--K--TWVALD--VCLSYKVQCKMDF- 182
Query: 469 AKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKA--LTELRHRNVV 526
++ W + +K +SP + + Q +I + H + +
Sbjct: 183 -----------KIF------W--LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223
Query: 527 KFYGFSFHPRQSFLLYEYLGRGSLAIILSN--DA-AIDEFSWTVRMNVI---KSVANTLS 580
K S LL L ++L N +A A + F+ + ++ + K V + LS
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCL-LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLS 282
Query: 581 YMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620
IS + + L D S K+L
Sbjct: 283 --------AATTTHISLDHHSMTLTPDEVKSLL--LKYLD 312
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 3e-04
Identities = 48/299 (16%), Positives = 90/299 (30%), Gaps = 64/299 (21%)
Query: 50 IDPLTHLKHLYINVNKLRGSV-PREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGS 108
D L+ +I+++ ++ P E L+ Y + LP N +
Sbjct: 278 TDFLSAATTTHISLDHHSMTLTPDE-----VKSLLLKYLDCRPQDLPREVLTTNPRRLSI 332
Query: 109 MPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLS---------NLAVLHLGDNSLFGSI 159
+ S+ + + ++ ++L+ I L L L+V ++ I
Sbjct: 333 IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP--PSAH---I 387
Query: 160 PPILGKVQSLL----SLGFDLNLLNGVLPPSISNLSNLEGLY----LYSSLVSAEIGNLL 211
P + SL+ + ++N + S+ E +Y L ++ N
Sbjct: 388 PT---ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLEL-KVKLENEY 443
Query: 212 QL----IE--LEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTG-NIYEVFGIYPNLTFL 264
L ++ IP L + +I H HL E ++ + FL
Sbjct: 444 ALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH----HLKNIEHPERMTLFRMV-FL 498
Query: 265 DL------------------SQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNH 305
D S N L F I + P + + LDF
Sbjct: 499 DFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAI--LDFLPKI 555
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 8e-15
Identities = 38/196 (19%), Positives = 75/196 (38%), Gaps = 19/196 (9%)
Query: 452 EGKILYEEVIRATNNFDAKYCI----GTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVV 506
+ + V ++ Y I GT V++ E + A K P
Sbjct: 140 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV--MTPHESD 197
Query: 507 QQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSNDAAIDEFS 564
++ EI+ ++ LRH +V + + ++YE++ G L + + ++ S
Sbjct: 198 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH----NKMS 253
Query: 565 WTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPD 622
+ ++ V L +MH + VH D+ +N++ + DFG++ L P
Sbjct: 254 EDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310
Query: 623 SSNWSEFVGTFGYVAP 638
+ GT + AP
Sbjct: 311 -QSVKVTTGTAEFAAP 325
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 48/205 (23%), Positives = 75/205 (36%), Gaps = 40/205 (19%)
Query: 460 VIRATNNFDAKYCIGT---AGQ-ASVYKA-ELPSWEIVAVK-----------KFHSPHPD 503
V + Y +G V E A+K
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 504 MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSN----- 556
+ NEI L L H N++K + + +L+ E+ G L II +
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 557 DAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL-GLDYDAH--VSDF 613
DAA N++K + + + Y+H IVHRDI +N+LL + + + DF
Sbjct: 147 DAA----------NIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDF 193
Query: 614 GISKFLKPDSSNWSEFVGTFGYVAP 638
G+S F D + +GT Y+AP
Sbjct: 194 GLSSFFSKDYK-LRDRLGTAYYIAP 217
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 47/191 (24%), Positives = 78/191 (40%), Gaps = 19/191 (9%)
Query: 458 EEVIRATNNFDAKYCIGT---AGQ-ASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSN 512
E + F +Y I G V K + + + AVK +
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR 70
Query: 513 EIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSNDAAIDEFSWTVRMN 570
E++ L +L H N++K + +++ E G L II FS
Sbjct: 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII-----KRKRFSEHDAAR 125
Query: 571 VIKSVANTLSYMHHDYFPPIVHRDISSKNVLL-GLDYDAH--VSDFGISKFLKPDSSNWS 627
+IK V + ++YMH IVHRD+ +N+LL + D + DFG+S + ++
Sbjct: 126 IIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MK 181
Query: 628 EFVGTFGYVAP 638
+ +GT Y+AP
Sbjct: 182 DRIGTAYYIAP 192
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 42/171 (24%), Positives = 68/171 (39%), Gaps = 15/171 (8%)
Query: 474 GTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIK-ALTELRHRNVVKFYGF 531
G G SV K PS +I+AVK+ S D Q+ ++ + +V+FYG
Sbjct: 33 GAYG--SVNKMVHKPSGQIMAVKRIRS-TVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVI----KSVANTLSYMHHDYF 587
F ++ E + S + ++ + L+++ +
Sbjct: 90 LFREGDCWICMELMS-TSFDKFY--KYVYSVLDDVIPEEILGKITLATVKALNHLKENL- 145
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
I+HRDI N+LL + + DFGIS L DS + G Y+AP
Sbjct: 146 -KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAP 194
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 28/144 (19%), Positives = 56/144 (38%), Gaps = 7/144 (4%)
Query: 481 VYKAELPSWEI-VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539
V+ L + VAVK ++ F E + L + H N+V+ G + +
Sbjct: 130 VFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188
Query: 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKN 599
++ E + G L + + ++ A + Y+ +HRD++++N
Sbjct: 189 IVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKCC---IHRDLAARN 243
Query: 600 VLLGLDYDAHVSDFGISKFLKPDS 623
L+ +SDFG+S+
Sbjct: 244 CLVTEKNVLKISDFGMSREEADGV 267
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 42/191 (21%), Positives = 76/191 (39%), Gaps = 26/191 (13%)
Query: 464 TNNFDAKYCIGT---AGQ-ASVYKA-ELPSWEIVAVK----KFHSPHPDMVVQQAFSNEI 514
+ Y IG +GQ A V K E + A K + V ++ E+
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 515 KALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVR--MNVI 572
L ++ H NV+ + + L+ E + G L D + S + + I
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELF-----DFLAQKESLSEEEATSFI 121
Query: 573 KSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAH-----VSDFGISKFLKPDSSNWS 627
K + + ++Y+H I H D+ +N++L LD + + DFG++ ++ +
Sbjct: 122 KQILDGVNYLHTKK---IAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDGVE-FK 176
Query: 628 EFVGTFGYVAP 638
GT +VAP
Sbjct: 177 NIFGTPEFVAP 187
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 42/196 (21%), Positives = 69/196 (35%), Gaps = 41/196 (20%)
Query: 464 TNNFDAKYCIGTAGQ-------ASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIK 515
+ F Y + + + K S + AVK EI
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT-----QKEIT 57
Query: 516 ALTELR-HRNVVKFYGFSFHPRQSFLL-YEYLGRGSL--AIILSN-----DAAIDEFSWT 566
AL H N+VK + FH + L E L G L I +A+
Sbjct: 58 ALKLCEGHPNIVKLHEV-FHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS------- 109
Query: 567 VRMNVIKSVANTLSYMH-HDYFPPIVHRDISSKNVLL-GLDYDAHV--SDFGISKFLKPD 622
+++ + + +S+MH +VHRD+ +N+L + + + DFG ++ PD
Sbjct: 110 ---YIMRKLVSAVSHMHDVG----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162
Query: 623 SSNWSEFVGTFGYVAP 638
+ T Y AP
Sbjct: 163 NQPLKTPCFTLHYAAP 178
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 37/188 (19%), Positives = 65/188 (34%), Gaps = 32/188 (17%)
Query: 466 NFDAKYCIGT---AGQ-ASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL 520
KY I G+ V++ E S + K D Q EI L
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIA 58
Query: 521 RHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSN------DAAIDEFSWTVRMNVI 572
RHRN++ + + +++E++ + I S + + +
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV----------SYV 108
Query: 573 KSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSNWSEFV 630
V L ++H I H DI +N++ + + +FG ++ LKP N+
Sbjct: 109 HQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLF 164
Query: 631 GTFGYVAP 638
Y AP
Sbjct: 165 TAPEYYAP 172
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 41/191 (21%), Positives = 76/191 (39%), Gaps = 26/191 (13%)
Query: 464 TNNFDAKYCIGT---AGQ-ASVYKA-ELPSWEIVAVK----KFHSPHPDMVVQQAFSNEI 514
+ Y IG +GQ A V K E + A K + V ++ E+
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 515 KALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVR--MNVI 572
L ++ H N++ + + L+ E + G L D + S + + I
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELF-----DFLAQKESLSEEEATSFI 121
Query: 573 KSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAH-----VSDFGISKFLKPDSSNWS 627
K + + ++Y+H I H D+ +N++L LD + + DFG++ ++ +
Sbjct: 122 KQILDGVNYLHTKK---IAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDGVE-FK 176
Query: 628 EFVGTFGYVAP 638
GT +VAP
Sbjct: 177 NIFGTPEFVAP 187
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 44/192 (22%), Positives = 75/192 (39%), Gaps = 20/192 (10%)
Query: 459 EVIRATNNFDAKYCIGT---AGQ-ASVYKA-ELPSWEIVAVK---KFHSPHPDMVVQQAF 510
E + D + +G V+ E S +K K S P +
Sbjct: 12 ENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP----MEQI 67
Query: 511 SNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL-AIILSNDAAIDEFSWTVRM 569
EI+ L L H N++K + +++ E G L I+S A S
Sbjct: 68 EAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA 127
Query: 570 NVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL-GLDYDAH--VSDFGISKFLKPDSSNW 626
++K + N L+Y H + +VH+D+ +N+L + + DFG+++ K D
Sbjct: 128 ELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-S 183
Query: 627 SEFVGTFGYVAP 638
+ GT Y+AP
Sbjct: 184 TNAAGTALYMAP 195
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 41/199 (20%), Positives = 74/199 (37%), Gaps = 33/199 (16%)
Query: 457 YEEVIRATNNFDAKYCIGTA-----GQ-ASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQA 509
+ V ++ Y + G+ V+K E + +A K + ++
Sbjct: 75 HRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK--DKEE 132
Query: 510 FSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSN------DAAID 561
NEI + +L H N+++ Y L+ EY+ G L II + D
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI-- 190
Query: 562 EFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFL 619
+K + + +MH Y I+H D+ +N+L + DFG+++
Sbjct: 191 --------LFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
Query: 620 KPDSSNWSEFVGTFGYVAP 638
KP GT ++AP
Sbjct: 240 KPR-EKLKVNFGTPEFLAP 257
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 19/197 (9%), Positives = 45/197 (22%), Gaps = 37/197 (18%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFH-SPHPDMVVQQAFSNEIKALTELRHRNVVKFY- 529
+ ++ V+ ++ E A+K F + A L + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 530 ------------------------GFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEF-- 563
G + ++LL L ++ S + F
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 564 --SWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621
+ + + + +VH + N+ + D + D
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL---WK 243
Query: 622 DSSNWSEFVGTFGYVAP 638
+ Y
Sbjct: 244 VGTRGPASSVPVTYAPR 260
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 6e-14
Identities = 43/193 (22%), Positives = 73/193 (37%), Gaps = 33/193 (17%)
Query: 462 RATNNFDAKYCIGT---AGQ-ASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKA 516
+ + Y + G V A + + A KK P + F EI+
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI--PKYFVEDVDRFKQEIEI 59
Query: 517 LTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILS-----NDAAIDEFSWTVRM 569
+ L H N+++ Y +L+ E G L ++ +DAA
Sbjct: 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA---------- 109
Query: 570 NVIKSVANTLSYMH-HDYFPPIVHRDISSKNVLL-GLDYDAH--VSDFGISKFLKPDSSN 625
++K V + ++Y H + + HRD+ +N L D+ + DFG++ KP
Sbjct: 110 RIMKDVLSAVAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KM 164
Query: 626 WSEFVGTFGYVAP 638
VGT YV+P
Sbjct: 165 MRTKVGTPYYVSP 177
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 6e-14
Identities = 41/192 (21%), Positives = 77/192 (40%), Gaps = 32/192 (16%)
Query: 466 NFDAKYCIGT---AGQ-ASVYKA-ELPSWEIVAVK----KFHSPHPDMVVQQAFSNEIKA 516
+ Y +G +GQ A V K + + + A K + S V ++ E+
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 517 LTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AII----LSNDAAIDEFSWTVRMN 570
L E+RH N++ + + L+ E + G L + L+ D A
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ--------- 112
Query: 571 VIKSVANTLSYMHHDYFPPIVHRDISSKNVLL----GLDYDAHVSDFGISKFLKPDSSNW 626
+K + + + Y+H I H D+ +N++L + + DFGI+ ++ + +
Sbjct: 113 FLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-F 168
Query: 627 SEFVGTFGYVAP 638
GT +VAP
Sbjct: 169 KNIFGTPEFVAP 180
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 43/196 (21%), Positives = 74/196 (37%), Gaps = 36/196 (18%)
Query: 464 TNNFDAKYCIGT---AGQ-ASVYKA-ELPSWEIVAVK----KFHSPHPDMVVQQAFSNEI 514
N D Y G +GQ A V K E + A K + V ++ E+
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 515 KALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSN-----DAAIDEFSWTV 567
L E++H NV+ + + L+ E + G L + +A
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------- 117
Query: 568 RMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAH-----VSDFGISKFLKPD 622
+K + N + Y+H I H D+ +N++L LD + + DFG++ +
Sbjct: 118 --EFLKQILNGVYYLHSLQ---IAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 623 SSNWSEFVGTFGYVAP 638
+ + GT +VAP
Sbjct: 172 NE-FKNIFGTPEFVAP 186
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 34/179 (18%), Positives = 62/179 (34%), Gaps = 9/179 (5%)
Query: 462 RATNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL 520
+F +G V+K + AVK+ SP + E+ + ++
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 521 -RHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTL 579
+H V+ +L E G + A++ E V ++ L
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEA--QVW-GYLRDTLLAL 170
Query: 580 SYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+++H +VH D+ N+ LG + DFG+ L + G Y+AP
Sbjct: 171 AHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG-EVQEGDPRYMAP 225
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 36/151 (23%), Positives = 70/151 (46%), Gaps = 10/151 (6%)
Query: 473 IGTAGQ-ASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG +GQ V+ + + VA+K + ++ F E + + +L H +V+ YG
Sbjct: 16 IG-SGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIV 591
L+ E++ G L+ L F+ + + V ++Y+ +
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEACV---I 126
Query: 592 HRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622
HRD++++N L+G + VSDFG+++F+ D
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 19/228 (8%)
Query: 28 NISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYC 87
+ ++ ++ + Q L + + N + + + + L ++ +L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNG 77
Query: 88 NGLSGWLP-SSFGNLNNLAIGSMPNSLSNLTSLS----LFHLDLSENQLSGSIPHFLGHL 142
N L+ P ++ NL L + N + +L+SL L L L N +S I L HL
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDE--NKVKDLSSLKDLKKLKSLSLEHNGIS-DING-LVHL 133
Query: 143 SNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSL 202
L L+LG+N + I L ++ L +L + N ++ + ++ L+ L+ LYL +
Sbjct: 134 PQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNH 189
Query: 203 VS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLT 248
+S + L L LE+ +++ + N N V L
Sbjct: 190 ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 58/324 (17%), Positives = 108/324 (33%), Gaps = 67/324 (20%)
Query: 39 NNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSF 98
+ + D + + +V +L+S+ Q++ + +
Sbjct: 11 PTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK------- 59
Query: 99 GNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGS 158
++ + L N+T L L+ N+L+ I L +L NL L L +N +
Sbjct: 60 -SVQGIQ------YLPNVT-----KLFLNGNKLT-DIKP-LANLKNLGWLFLDENKV-KD 104
Query: 159 IPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEI 218
+ L ++ L SL + N ++ + + +L LE LYL N + I
Sbjct: 105 LSS-LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLG--------NNKITDIT--- 150
Query: 219 DNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFS 278
L T L+ + LE N ++ +I L L LS+N+
Sbjct: 151 -----------VLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNH-------- 189
Query: 279 MNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNY-RALNGNKVYGSLPRV 337
I+ + + L L L+ + + NL N + +G+ V +
Sbjct: 190 ---IS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISD 244
Query: 338 LGSISDLEYLDLSTNYNNEFRKEF 361
G + NE F
Sbjct: 245 DGDYEKPNVKWHLPEFTNEVSFIF 268
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 39/178 (21%), Positives = 66/178 (37%), Gaps = 29/178 (16%)
Query: 26 IGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVL 85
+ ++ LK L + +N +S + + L L+ LY+ NK+ + + +L+ L L L
Sbjct: 108 LKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSL 163
Query: 86 YCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSL-SLFHLDLSENQLSGSIPHFLGHLSN 144
N +S + L L L +L LS+N +S + L L N
Sbjct: 164 EDNQIS--------------------DIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKN 201
Query: 145 LAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSL 202
L VL L + ++ L V P IS+ + E + L
Sbjct: 202 LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHL 257
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 44/204 (21%), Positives = 77/204 (37%), Gaps = 30/204 (14%)
Query: 187 ISNLSNLEGLYLYSSLVS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQ 244
+ L V+ L + ++ +N + + + ++ ++ + L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNG 77
Query: 245 NHLTGNIYEVFGIYPNLTFLDLSQN------NFYG-----SLNFSMNNITRSIPPKIGKL 293
N LT +I + NL +L L +N + SL+ N I+ I + L
Sbjct: 78 NKLT-DI-KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS-DING-LVHL 133
Query: 294 YQLHKLDFSLNHIVGELPIE-LGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTN 352
QL L N I I L L L+ +L N++ S L ++ L+ L LS N
Sbjct: 134 PQLESLYLGNNKITD---ITVLSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKN 188
Query: 353 YNNEFRKEFPVELEKLVQLTELDL 376
+ ++ R L L L L+L
Sbjct: 189 HISDLR-----ALAGLKNLDVLEL 207
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 35/152 (23%), Positives = 63/152 (41%), Gaps = 13/152 (8%)
Query: 480 SVYKAELPSW-----EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH 534
V E VAVK EI+ L L H N+VK+ G
Sbjct: 36 KVELCRYDPEGDNTGEQVAVKSLKPESGGNH-IADLKKEIEILRNLYHENIVKYKGICTE 94
Query: 535 PRQS--FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVH 592
+ L+ E+L GSL L + ++ + ++ + + Y+ + VH
Sbjct: 95 DGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQY---VH 149
Query: 593 RDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624
RD++++NVL+ ++ + DFG++K ++ D
Sbjct: 150 RDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 72.8 bits (178), Expect = 2e-13
Identities = 42/176 (23%), Positives = 70/176 (39%), Gaps = 15/176 (8%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFY-- 529
+GT G V + + E VA+K+ ++ + EI+ + +L H NVV
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 530 ----GFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHD 585
L EY G L L+ ++ +++ L Y+H +
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 586 YFPPIVHRDISSKNVLLGLDYDAH---VSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
I+HRD+ +N++L + D G +K L +EFVGT Y+AP
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAP 192
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 42/228 (18%), Positives = 75/228 (32%), Gaps = 54/228 (23%)
Query: 462 RATNNFDAKYCIGT---AGQ-ASVYKA-ELPSWEIVAVK---KFHSPHPDMVVQQAFSNE 513
+ KY + G V A E + I A+K K + + E
Sbjct: 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTE 78
Query: 514 IKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSNDAAIDEFSWTVRM-- 569
++ + +L H N+ + Y + L+ E G L + + D + + + V
Sbjct: 79 VRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138
Query: 570 ---------------------------------NVIKSVANTLSYMHHDYFPPIVHRDIS 596
N+++ + + L Y+H+ I HRDI
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIK 195
Query: 597 SKNVLLGLDYDAHV--SDFGISKFLKP----DSSNWSEFVGTFGYVAP 638
+N L + + DFG+SK + + GT +VAP
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 39/177 (22%), Positives = 73/177 (41%), Gaps = 19/177 (10%)
Query: 473 IGTAGQASVYKAE---LPSWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKF 528
+G G + V+ A VAVK + D F E + L H +V
Sbjct: 20 LGFGGMSEVHLARDLRDH--RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 529 Y--GFSFHPRQS--FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH 584
Y G + P +++ EY+ +L I+ + + + + VI L++ H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRAIEVIADACQALNFSHQ 134
Query: 585 DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW---SEFVGTFGYVAP 638
+ I+HRD+ N+++ V DFGI++ + ++ + +GT Y++P
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 39/185 (21%), Positives = 64/185 (34%), Gaps = 29/185 (15%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEI-DPLTHLKHLYINVNKLRGSVPREV-GQLSS 79
+P + S LD+ +N LS + + LT+L L ++ N L + E + +
Sbjct: 33 VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPN 89
Query: 80 LKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHF- 138
L+ L L N L L S+L +L L L N + +
Sbjct: 90 LRYLDLSSNHLHT-LD--------------EFLFSDLQALE--VLLLYNNHIV-VVDRNA 131
Query: 139 LGHLSNLAVLHLGDNSLFGSIPP----ILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLE 194
++ L L+L N + P K+ L+ L N L + + L
Sbjct: 132 FEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWV 190
Query: 195 GLYLY 199
LY
Sbjct: 191 KNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 35/155 (22%), Positives = 66/155 (42%), Gaps = 24/155 (15%)
Query: 28 NISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLY 86
++NL L + +N L+ + + P+ +L++L ++ N L ++ + L +L+ L+LY
Sbjct: 62 RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLY 120
Query: 87 CNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIP----HFLGHL 142
N + + N+ ++ L L LS+NQ+S P L
Sbjct: 121 NNHIVV-VD--------------RNAFEDMAQLQ--KLYLSQNQIS-RFPVELIKDGNKL 162
Query: 143 SNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLN 177
L +L L N L L K+ + + G L+
Sbjct: 163 PKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 32/131 (24%), Positives = 51/131 (38%), Gaps = 18/131 (13%)
Query: 28 NISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLY 86
+ NL++LD+ +N L + L L+ L + N + V R ++ L++L L
Sbjct: 86 PVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLS 144
Query: 87 CNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLA 146
N +S + + N L L LDLS N+L L L
Sbjct: 145 QNQISRFPVELIKDGNKLP--------------KLMLLDLSSNKLKKLPLTDLQKLPAWV 190
Query: 147 V--LHLGDNSL 155
L+L +N L
Sbjct: 191 KNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 47/201 (23%), Positives = 74/201 (36%), Gaps = 37/201 (18%)
Query: 108 SMPNSLSNLTSLSLFHLDLSENQLSGSIP--HFLGHLSNLAVLHLGDNSLFGSIPP-ILG 164
++P SL + T+ LDLS N LS + L+NL L L N L I
Sbjct: 32 NVPQSLPSYTA----LLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFV 85
Query: 165 KVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLF 224
V +L L N L+ + S+L LE L LY N + +++
Sbjct: 86 PVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY--------NNHIVVVD--------- 128
Query: 225 GQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITR 284
+ + L ++L QN ++ E+ L L L L+ S N + +
Sbjct: 129 ---RNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLML--------LDLSSNKLKK 177
Query: 285 SIPPKIGKLYQLHKLDFSLNH 305
+ KL K L++
Sbjct: 178 LPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 40/174 (22%), Positives = 60/174 (34%), Gaps = 27/174 (15%)
Query: 100 NLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIP-HFLGHLSNLAVLHLGDNSLFGS 158
NL+ L P L+NL S L LS N L+ I + NL L L N L +
Sbjct: 50 NLSRLRAEWTPTRLTNLHS-----LLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHL-HT 102
Query: 159 IPP-ILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELE 217
+ + +Q+L L N + V + +++ L+ LYL N + +E
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQ--------NQISRFPVE 154
Query: 218 IDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLS-QNN 270
+ K L ++ L N L P L NN
Sbjct: 155 L-----I----KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 38/143 (26%), Positives = 51/143 (35%), Gaps = 22/143 (15%)
Query: 230 SLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN--------FYG-----SLN 276
+ T+L+ + L NHL E F PNL +LDLS N+ F L
Sbjct: 59 TPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLL 118
Query: 277 FSMNNITRSIPPKI-GKLYQLHKLDFSLNHIVGELPIE----LGNLKSLNYRALNGNKVY 331
N+I + + QL KL S N I P+E L L L+ NK+
Sbjct: 119 LYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176
Query: 332 GSLPRVLGSISDL--EYLDLSTN 352
L + L L N
Sbjct: 177 KLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 34/153 (22%), Positives = 63/153 (41%), Gaps = 27/153 (17%)
Query: 275 LNFSMNNITRSIPPKI--GKLYQLHKLDFSLNHIVGELPIE-LGNLKSLNYRALNGNKVY 331
L+ S NN++ + + +L LH L S NH+ + E + +L Y L+ N +
Sbjct: 44 LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHL- 100
Query: 332 GSLPR-VLGSISDLEYLDLSTNY-----NNEFRKEFPVELEKLVQLTELDLVITFWEERY 385
+L + + LE L L N+ N F + QL +L L +
Sbjct: 101 HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFED--------MAQLQKLYL------SQN 146
Query: 386 RPKSVIWKAWRSLISRMHGLSCIDISYNELRGL 418
+ + + +++ L +D+S N+L+ L
Sbjct: 147 QISRFPVELIKDG-NKLPKLMLLDLSSNKLKKL 178
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 32/128 (25%), Positives = 54/128 (42%), Gaps = 21/128 (16%)
Query: 28 NISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLY 86
L+ +D+ NNQ+S + P L L L + NK+ +P+ + L SL+ L+L
Sbjct: 54 PYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLN 112
Query: 87 CNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPH-FLGHLSNL 145
N ++ +F +L+NL L L +N+L +I L +
Sbjct: 113 ANKINCLRVDAFQDLHNLN-----------------LLSLYDNKLQ-TIAKGTFSPLRAI 154
Query: 146 AVLHLGDN 153
+HL N
Sbjct: 155 QTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 30/150 (20%), Positives = 54/150 (36%), Gaps = 24/150 (16%)
Query: 124 LDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGV 182
+ L +N + P L + L +N + + P ++SL SL N +
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 183 LPPSI-SNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVH 241
LP S+ L +L+ L L N + + + ++ +LN++
Sbjct: 95 LPKSLFEGLFSLQLLLLN--------ANKINCLR------------VDAFQDLHNLNLLS 134
Query: 242 LEQNHLTGNIYEVFGIYPNLTFLDLSQNNF 271
L N L F + + L+QN F
Sbjct: 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 13/69 (18%), Positives = 33/69 (47%), Gaps = 3/69 (4%)
Query: 22 IPPQI-GNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSS 79
+P + + +L+ L + N+++ + L +L L + NKL+ ++ + L +
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRA 153
Query: 80 LKQLVLYCN 88
++ + L N
Sbjct: 154 IQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 35/128 (27%), Positives = 50/128 (39%), Gaps = 28/128 (21%)
Query: 256 GIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKI-GKLYQLHKLDFSLNHIVGELPI-- 312
+ +T + L QN + IPP +L ++D S N I EL
Sbjct: 29 NLPETITEIRLEQNTI------------KVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDA 75
Query: 313 --ELGNLKSLNYRALNGNKVYGSLP-RVLGSISDLEYLDLSTNYNNEFRKE-FPVELEKL 368
L +L SL L GNK+ LP + + L+ L L+ N N R + F + L
Sbjct: 76 FQGLRSLNSLV---LYGNKI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAF----QDL 127
Query: 369 VQLTELDL 376
L L L
Sbjct: 128 HNLNLLSL 135
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 39/152 (25%), Positives = 64/152 (42%), Gaps = 14/152 (9%)
Query: 480 SVYKAELPSW-----EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH 534
SV +VAVK+ PD Q+ F EI+ L L +VK+ G S+
Sbjct: 38 SVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFIVKYRGVSYG 95
Query: 535 PRQS--FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVH 592
P + L+ EYL G L L + + + + Y+ VH
Sbjct: 96 PGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRRC---VH 150
Query: 593 RDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624
RD++++N+L+ + ++DFG++K L D
Sbjct: 151 RDLAARNILVESEAHVKIADFGLAKLLPLDKD 182
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 35/164 (21%), Positives = 66/164 (40%), Gaps = 12/164 (7%)
Query: 481 VYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH-PRQSF 539
K+ L F NE++ +T++++ + G + +
Sbjct: 62 YEKSLLEKKRDFTKSNNDKISIKSKYDD-FKNELQIITDIKNEYCLTCEGI-ITNYDEVY 119
Query: 540 LLYEYLGRGSLAIILSNDAAIDE-----FSWTVRMNVIKSVANTLSYMHHDYFPPIVHRD 594
++YEY+ S+ +D+ V +IKSV N+ SY+H I HRD
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRD 177
Query: 595 ISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+ N+L+ + +SDFG S+++ GT+ ++ P
Sbjct: 178 VKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGSRGTYEFMPP 219
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 36/142 (25%), Positives = 60/142 (42%), Gaps = 8/142 (5%)
Query: 481 VYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540
V + VA+K + + F E K + L H +V+ YG R F+
Sbjct: 40 VKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96
Query: 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNV 600
+ EY+ G L L F + + K V + Y+ F +HRD++++N
Sbjct: 97 ITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQF---LHRDLAARNC 151
Query: 601 LLGLDYDAHVSDFGISKFLKPD 622
L+ VSDFG+S+++ D
Sbjct: 152 LVNDQGVVKVSDFGLSRYVLDD 173
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 43/199 (21%), Positives = 70/199 (35%), Gaps = 29/199 (14%)
Query: 462 RATNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL 520
R T F IG+ SV+K + I A+K+ P V +Q E+ A L
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 521 -RHRNVVKFYGFSFHPRQSFLLYEYLGRGSLA-IILSNDAAIDEFSWTVRMNVIKSVANT 578
+H +VV+++ + EY GSLA I N + F +++ V
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 579 LSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVS-------------------DFGISKFL 619
L Y+H +VH DI N+ + + + D G +
Sbjct: 128 LRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 620 KPDSSNWSEFVGTFGYVAP 638
S+ G ++A
Sbjct: 185 ----SSPQVEEGDSRFLAN 199
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 38/157 (24%), Positives = 66/157 (42%), Gaps = 14/157 (8%)
Query: 473 IGTAGQ-ASVYKAEL--PSWEI-VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKF 528
+G +G +V K VAVK + D ++ E + +L + +V+
Sbjct: 25 LG-SGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 529 YGF-SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF 587
G L+ E G L L + + ++ V+ + Y+ F
Sbjct: 84 IGICEAESW--MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624
VHRD++++NVLL + A +SDFG+SK L+ D +
Sbjct: 139 ---VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 34/151 (22%), Positives = 63/151 (41%), Gaps = 15/151 (9%)
Query: 480 SVYKAEL-----PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH 534
V + E+VAVK + + + EI L L H +++K+ G
Sbjct: 46 KVSLYCYDPTNDGTGEMVAVKALKADAGPQH-RSGWKQEIDILRTLYHEHIIKYKGCCED 104
Query: 535 PRQS--FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVH 592
+ L+ EY+ GSL L + + + ++Y+H ++ +H
Sbjct: 105 AGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQHY---IH 157
Query: 593 RDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623
RD++++NVLL D + DFG++K +
Sbjct: 158 RDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 38/191 (19%), Positives = 74/191 (38%), Gaps = 19/191 (9%)
Query: 460 VIRATNNFDAKYCIGT----AGQ-ASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNE 513
++ NF+ Y + + G+ A V + + + A K + +E
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78
Query: 514 IKALTELRHR-NVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSNDAAIDEFSWTVRMN 570
I L + V+ + + + L+ EY G + + + S +
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL---PELAEMVSENDVIR 135
Query: 571 VIKSVANTLSYMHHDYFPPIVHRDISSKNVLL-GLDYDAHV--SDFGISKFLKPDSSNWS 627
+IK + + Y+H + IVH D+ +N+LL + + DFG+S+ +
Sbjct: 136 LIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LR 191
Query: 628 EFVGTFGYVAP 638
E +GT Y+AP
Sbjct: 192 EIMGTPEYLAP 202
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 39/156 (25%), Positives = 66/156 (42%), Gaps = 12/156 (7%)
Query: 473 IGTAGQ-ASVYKAEL--PSWEI-VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKF 528
+G G SV + +I VA+K + E + + +L + +V+
Sbjct: 344 LG-CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYIVRL 401
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
G L+ E G G L L +E + ++ V+ + Y+ F
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKNF- 457
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624
VHR+++++NVLL + A +SDFG+SK L D S
Sbjct: 458 --VHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 33/142 (23%), Positives = 63/142 (44%), Gaps = 8/142 (5%)
Query: 481 VYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540
V + VAVK + + F E + + +L H +VKFYG ++
Sbjct: 24 VKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI 80
Query: 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNV 600
+ EY+ G L L + + + + V ++++ F +HRD++++N
Sbjct: 81 VTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQF---IHRDLAARNC 135
Query: 601 LLGLDYDAHVSDFGISKFLKPD 622
L+ D VSDFG+++++ D
Sbjct: 136 LVDRDLCVKVSDFGMTRYVLDD 157
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 39/208 (18%), Positives = 76/208 (36%), Gaps = 40/208 (19%)
Query: 450 TFEGKILYEEVIRATNNFDAKYCIGT---AGQ-ASVYKA-ELPSWEIVAVKKFHSPHPDM 504
T + +++ R + F Y + G + + + AVK D
Sbjct: 3 TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP 62
Query: 505 VVQQAFSNEIKAL-TELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AIILSN----- 556
+ EI+ L +H N++ + +++ E + G L I+
Sbjct: 63 ------TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER 116
Query: 557 DAAIDEFSWTVRMNVIKSVANTLSYMH-HDYFPPIVHRDISSKNVLLGLDYDAHVS---- 611
+A+ V+ ++ T+ Y+H +VHRD+ N+L +D +
Sbjct: 117 EAS----------AVLFTITKTVEYLHAQG----VVHRDLKPSNILY-VDESGNPESIRI 161
Query: 612 -DFGISKFLKPDSSNWSEFVGTFGYVAP 638
DFG +K L+ ++ T +VAP
Sbjct: 162 CDFGFAKQLRAENGLLMTPCYTANFVAP 189
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 37/153 (24%), Positives = 74/153 (48%), Gaps = 10/153 (6%)
Query: 472 CIGTAGQ-ASVYKAELPSWEI-VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFY 529
+G GQ VY+ + + VAVK D + + F E + E++H N+V+
Sbjct: 227 KLG-GGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 530 GFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP 589
G +++ E++ G+L L E S V + + +++ + Y+ F
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNF-- 339
Query: 590 IVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622
+HR+++++N L+G ++ V+DFG+S+ + D
Sbjct: 340 -IHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 48/183 (26%), Positives = 76/183 (41%), Gaps = 27/183 (14%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSL 80
+P I ++ + LD+ + L+ + LT L L ++ N+L+ ++ V L+ L
Sbjct: 29 VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85
Query: 81 KQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPH--F 138
L L N L+ LP + + L+ L L L NQL S+P F
Sbjct: 86 GTLGLANNQLAS-LPL-----------GVFDHLTQLD-----KLYLGGNQLK-SLPSGVF 127
Query: 139 LGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLY 197
L+ L L L N L SIP K+ +L +L N L V + L L+ +
Sbjct: 128 -DRLTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTIT 185
Query: 198 LYS 200
L+
Sbjct: 186 LFG 188
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 8e-09
Identities = 42/130 (32%), Positives = 57/130 (43%), Gaps = 29/130 (22%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLYCN 88
+ L L + NNQL+ + D LT L LY+ N+L+ S+P V +L+ LK+L L N
Sbjct: 83 TELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTN 141
Query: 89 GLSGWLPSSFGNLNNLAIGSMPN----SLSNLTSLSLFHLDLSENQLSGSIPH-FLGHLS 143
L S+P L+NL L LS NQL S+PH L
Sbjct: 142 QLQ----------------SIPAGAFDKLTNLQ-----TLSLSTNQLQ-SVPHGAFDRLG 179
Query: 144 NLAVLHLGDN 153
L + L N
Sbjct: 180 KLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 43/155 (27%), Positives = 63/155 (40%), Gaps = 10/155 (6%)
Query: 124 LDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNGV 182
LDL L+ L+ L L+L N L ++ + + L +LG N L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 183 LPPSI-SNLSNLEGLYLYSS-LVSAEIG---NLLQLIELEIDNKQLFGQIPKSL-RNFTS 236
LP + +L+ L+ LYL + L S G L +L EL ++ QL IP T+
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLTN 156
Query: 237 LNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNF 271
L + L N L + F L + L N F
Sbjct: 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 12/159 (7%)
Query: 470 KYCIGTAGQ-ASVYKAEL--PSWEI-VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNV 525
+G G SV + +I VA+K + E + + +L + +
Sbjct: 15 DIELG-CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYI 72
Query: 526 VKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHD 585
V+ G L+ E G G L L +E + ++ V+ + Y+
Sbjct: 73 VRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 586 YFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624
F VHRD++++NVLL + A +SDFG+SK L D S
Sbjct: 130 NF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 25/128 (19%), Positives = 56/128 (43%), Gaps = 21/128 (16%)
Query: 28 NISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLY 86
+ L+ ++ NN+++ + + + + + + N+L +V ++ L SLK L+L
Sbjct: 55 KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLR 113
Query: 87 CNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPH-FLGHLSNL 145
N ++ SF L+++ L L +NQ++ ++ L +L
Sbjct: 114 SNRITCVGNDSFIGLSSVR-----------------LLSLYDNQIT-TVAPGAFDTLHSL 155
Query: 146 AVLHLGDN 153
+ L+L N
Sbjct: 156 STLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 33/182 (18%), Positives = 60/182 (32%), Gaps = 48/182 (26%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEI-DPLTHLKHLYINVNKLRGSVPREV-GQLSS 79
IP I L + NN+ + + I L L+ + + NK+ + S
Sbjct: 26 IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82
Query: 80 LKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFL 139
+ +++L N L + L SL L L N+++ + +
Sbjct: 83 VNEILLTSNRLEN-VQ--------------HKMFKGLESLK--TLMLRSNRIT-CVGNDS 124
Query: 140 -GHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYL 198
LS++ +L L DN + ++ FD L +L L L
Sbjct: 125 FIGLSSVRLLSLYDNQI-----------TTVAPGAFD-------------TLHSLSTLNL 160
Query: 199 YS 200
+
Sbjct: 161 LA 162
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 14/154 (9%)
Query: 472 CIGTAGQ-ASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
+G G V+ VA+K P + +AF E + + +LRH +V+ Y
Sbjct: 274 KLG-QGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 531 -FSFHPRQSFLLYEYLGRGSLAIIL-SNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
S P +++ EY+ +GSL L V M +A+ ++Y+ +
Sbjct: 330 VVSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQIASGMAYVERMNY- 384
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622
VHRD+ + N+L+G + V+DFG+++ ++ +
Sbjct: 385 --VHRDLRAANILVGENLVCKVADFGLARLIEDN 416
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 35/143 (24%), Positives = 70/143 (48%), Gaps = 8/143 (5%)
Query: 481 VYKAELPSWEI-VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539
VY+ + + VAVK D + + F E + E++H N+V+ G +
Sbjct: 29 VYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85
Query: 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKN 599
++ E++ G+L L E S V + + +++ + Y+ F +HRD++++N
Sbjct: 86 IITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNF---IHRDLAARN 141
Query: 600 VLLGLDYDAHVSDFGISKFLKPD 622
L+G ++ V+DFG+S+ + D
Sbjct: 142 CLVGENHLVKVADFGLSRLMTGD 164
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 39/152 (25%), Positives = 65/152 (42%), Gaps = 14/152 (9%)
Query: 480 SVYKAELPSW-----EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH 534
SV E+VAVKK H + F EI+ L L+H N+VK+ G +
Sbjct: 56 SVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113
Query: 535 PRQS--FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVH 592
+ L+ EYL GSL L + + + + Y+ + +H
Sbjct: 114 AGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKRY---IH 168
Query: 593 RDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624
RD++++N+L+ + + DFG++K L D
Sbjct: 169 RDLATRNILVENENRVKIGDFGLTKVLPQDKE 200
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 39/151 (25%), Positives = 65/151 (43%), Gaps = 14/151 (9%)
Query: 480 SVYKAELPSW-----EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH 534
SV E+VAVKK H + F EI+ L L+H N+VK+ G +
Sbjct: 25 SVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82
Query: 535 PRQS--FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVH 592
+ L+ EYL GSL L + + + + Y+ + +H
Sbjct: 83 AGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKRY---IH 137
Query: 593 RDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623
RD++++N+L+ + + DFG++K L D
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 34/154 (22%), Positives = 72/154 (46%), Gaps = 14/154 (9%)
Query: 472 CIGTAGQ-ASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
+G AGQ V+ A VAVK P + +AF E + L+H +VK +
Sbjct: 195 KLG-AGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 531 -FSFHPRQSFLLYEYLGRGSLAIIL-SNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
+ P +++ E++ +GSL L S++ + + +A ++++ +
Sbjct: 251 VVTKEP--IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMAFIEQRNY- 305
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622
+HRD+ + N+L+ ++DFG+++ ++ +
Sbjct: 306 --IHRDLRAANILVSASLVCKIADFGLARVIEDN 337
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 40/204 (19%), Positives = 79/204 (38%), Gaps = 12/204 (5%)
Query: 26 IGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVL 85
++N ++G ++ ++ Q+ L+ +++ + + + + ++LK+L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHL 70
Query: 86 YCNGLSGWLP-SSFGNLNNLAIGSMP-NSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLS 143
N +S P L L++ +L+ + S L L L N+L L HL
Sbjct: 71 SHNQISDLSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRD--TDSLIHLK 128
Query: 144 NLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLV 203
NL +L + +N L SI LG + L L N + ++ L + + L
Sbjct: 129 NLEILSIRNNKL-KSIVM-LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKC 184
Query: 204 SAEIGNLLQLIELEIDNKQLFGQI 227
E + + K G+
Sbjct: 185 VNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 40/227 (17%), Positives = 85/227 (37%), Gaps = 29/227 (12%)
Query: 110 PNSLSNLTSLS----LFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGK 165
P ++ + +L + ++ + LS + + ++++ S+ +
Sbjct: 6 PTPINQVFPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI-QSLAG-MQF 61
Query: 166 VQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYS-SLVSAEIGNLLQLIELEIDNKQLF 224
+L L N ++ + + +L+ LE L + L + L L +DN +L
Sbjct: 62 FTNLKELHLSHNQISDL--SPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNEL- 118
Query: 225 GQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITR 284
+ SL + +L I+ + N L +I + G L LDL N IT
Sbjct: 119 -RDTDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNE-----------IT- 163
Query: 285 SIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNY-RALNGNKV 330
+ + +L +++ +D + V E L N + +G +
Sbjct: 164 NTGG-LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWI 209
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 36/201 (17%), Positives = 68/201 (33%), Gaps = 22/201 (10%)
Query: 187 ISNLSNLEGLYLYSSLVS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQ 244
L+N L V+ L + DN + Q ++ FT+L +HL
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSH 72
Query: 245 NHLTGNIYEVFGIYPNLTFLDLSQNNFYG----------SLNFSMNNITRSIPPKIGKLY 294
N ++ ++ L L +++N L N + + L
Sbjct: 73 NQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELR-DTDS-LIHLK 128
Query: 295 QLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYN 354
L L N + + LG L L L+GN++ + L + + ++DL+
Sbjct: 129 NLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWIDLTGQKC 184
Query: 355 NEFRKEFPVELEKLVQLTELD 375
++ EL + + D
Sbjct: 185 VNEPVKYQPELYITNTVKDPD 205
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 30/170 (17%), Positives = 60/170 (35%), Gaps = 27/170 (15%)
Query: 207 IGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDL 266
L ++ + + + S + + + + + +++ ++ + NL L L
Sbjct: 15 DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHL 70
Query: 267 SQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALN 326
S N I+ + P + L +L +L + N + I L L L+
Sbjct: 71 SHNQ-----------IS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LD 114
Query: 327 GNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL 376
N++ L + +LE L + N L L +L LDL
Sbjct: 115 NNEL--RDTDSLIHLKNLEILSIRNNKLKSIV-----MLGFLSKLEVLDL 157
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 14/154 (9%)
Query: 472 CIGTAGQ-ASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
+G G V+ VA+K P + +AF E + + +LRH +V+ Y
Sbjct: 191 KLG-QGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 531 -FSFHPRQSFLLYEYLGRGSLAIIL-SNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
S P +++ EY+ +GSL L V M +A+ ++Y+ +
Sbjct: 247 VVSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQIASGMAYVERMNY- 301
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622
VHRD+ + N+L+G + V+DFG+++ ++ +
Sbjct: 302 --VHRDLRAANILVGENLVCKVADFGLARLIEDN 333
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 9e-12
Identities = 20/148 (13%), Positives = 42/148 (28%), Gaps = 14/148 (9%)
Query: 472 CIGTAGQASVYKAE---LPSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVK 527
G ++A L VA+ V Q + L+ + V +
Sbjct: 38 FHGGVPPLQFWQALDTALD--RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 528 FYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF 587
++ E++ GSL + + +R ++S+A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG---AIR--AMQSLAAAADAAHRA-- 148
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGI 615
+ V + +D D ++
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYPAT 175
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 44/205 (21%), Positives = 76/205 (37%), Gaps = 51/205 (24%)
Query: 464 TNNFDAKYCIGT----AGQ-ASVYKA-ELPSWEIVAVK-----KFHSPHPDMVVQQAFSN 512
+ F+ Y + G A V L + + AVK H +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI-------RSRVFR 59
Query: 513 EIKALTELR-HRNVVKFYGFSFHPRQSFLL-YEYLGRGSL--AIILSN-----DAAIDEF 563
E++ L + + HRNV++ F F F L +E + GS+ I +A+
Sbjct: 60 EVEMLYQCQGHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS---- 114
Query: 564 SWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL-GLDYDAHV--SDFGISKFLK 620
V++ VA+ L ++H I HRD+ +N+L + + V DF + +K
Sbjct: 115 ------VVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165
Query: 621 PDSS-------NWSEFVGTFGYVAP 638
+ G+ Y+AP
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAP 190
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 21/204 (10%)
Query: 434 QGNKGLCGDVKLFSILTFEGKILYEEVIRATNNF----DAKY-----CIGTAGQ-ASVYK 483
G + L KL + YEE RA +F +A IG +G V
Sbjct: 9 SGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIG-SGDSGEVCY 67
Query: 484 AELPSWE----IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539
L VA+K + + + ++ F +E + + H N+++ G R +
Sbjct: 68 GRLRVPGQRDVPVAIKALKAGYTE-RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126
Query: 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKN 599
++ EY+ GSL L +F+ + +++ V + Y+ + VHRD++++N
Sbjct: 127 IVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLGY---VHRDLAARN 181
Query: 600 VLLGLDYDAHVSDFGISKFLKPDS 623
VL+ + VSDFG+S+ L+ D
Sbjct: 182 VLVDSNLVCKVSDFGLSRVLEDDP 205
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 49/191 (25%), Positives = 79/191 (41%), Gaps = 48/191 (25%)
Query: 12 VHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVP 71
V + A +P I +N + L + +NQ++ + P D L +LK LY+ N+L ++P
Sbjct: 24 VDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALP 80
Query: 72 REV-GQLSSLKQLVLYCNGLSGWLPSS-FGNLNNLAIGSMPNSLSNLTSLSLFHLDLSEN 129
V L+ L L L N L+ LPS+ F + L +L L + N
Sbjct: 81 VGVFDSLTQLTVLDLGTNQLTV-LPSAVF------------DRLVHLK-----ELFMCCN 122
Query: 130 QLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISN 189
+L+ +P + L++L L L N L +S+ FD
Sbjct: 123 KLT-ELPRGIERLTHLTHLALDQNQL-----------KSIPHGAFD-------------R 157
Query: 190 LSNLEGLYLYS 200
LS+L YL+
Sbjct: 158 LSSLTHAYLFG 168
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 46/143 (32%), Positives = 66/143 (46%), Gaps = 24/143 (16%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPRE 73
N + + P ++ NLK L +G+NQL + D LT L L + N+L +P
Sbjct: 48 HDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VLPSA 106
Query: 74 V-GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLS 132
V +L LK+L + CN L+ +P + LT L+ HL L +NQL
Sbjct: 107 VFDRLVHLKELFMCCNKLT----------------ELPRGIERLTHLT--HLALDQNQLK 148
Query: 133 GSIPH--FLGHLSNLAVLHLGDN 153
SIPH F LS+L +L N
Sbjct: 149 -SIPHGAF-DRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 38/150 (25%), Positives = 58/150 (38%), Gaps = 29/150 (19%)
Query: 124 LDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVL 183
L L +NQ++ P L NL L+LG N L +L FD
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQL-----------GALPVGVFD-------- 85
Query: 184 PPSISNLSNLEGLYLYSS-LVSAEIG---NLLQLIELEIDNKQLFGQIPKSLRNFTSLNI 239
+L+ L L L ++ L L+ L EL + +L ++P+ + T L
Sbjct: 86 -----SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTH 139
Query: 240 VHLEQNHLTGNIYEVFGIYPNLTFLDLSQN 269
+ L+QN L + F +LT L N
Sbjct: 140 LALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 31/156 (19%), Positives = 64/156 (41%), Gaps = 25/156 (16%)
Query: 492 VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLA 551
V +K H + ++F +++L H+++V YG ++ L+ E++ GSL
Sbjct: 43 VLLKVLDKAHRN--YSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLD 100
Query: 552 IILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAH-- 609
L + + + ++ V K +A + ++ + +H ++ +KN+LL + D
Sbjct: 101 TYLKKNK--NCINILWKLEVAKQLAAAMHFLEENTL---IHGNVCAKNILLIREEDRKTG 155
Query: 610 ------VSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639
+SD GIS + P I
Sbjct: 156 NPPFIKLSDPGISITVLPKD----------ILQERI 181
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 36/194 (18%), Positives = 67/194 (34%), Gaps = 37/194 (19%)
Query: 464 TNNFDAKYCIGT----AGQ-ASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKAL 517
Y + G V + + + A+K + E+
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-------SPKARQEVDHH 75
Query: 518 TEL-RHRNVVKFYGF---SFHPRQSFLL-YEYLGRGSL--AIILSNDAAIDEFSWTVRM- 569
+ ++V H ++ L+ E + G L I D A E R
Sbjct: 76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE-----REA 130
Query: 570 -NVIKSVANTLSYMH-HDYFPPIVHRDISSKNVLL-GLDYDAHV--SDFGISKFLKPDSS 624
+++ + + ++H H+ I HRD+ +N+L + DA + +DFG +K ++
Sbjct: 131 AEIMRDIGTAIQFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA- 185
Query: 625 NWSEFVGTFGYVAP 638
T YVAP
Sbjct: 186 -LQTPCYTPYYVAP 198
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 32/153 (20%), Positives = 71/153 (46%), Gaps = 12/153 (7%)
Query: 472 CIGTAGQ-ASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
+G AGQ V+ VAVK + AF E + +L+H+ +V+ Y
Sbjct: 20 RLG-AGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 531 -FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP 589
+ P +++ EY+ GSL L + + + +++ +A ++++ +
Sbjct: 76 VVTQEPI--YIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERNY-- 130
Query: 590 IVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622
+HRD+ + N+L+ ++DFG+++ ++ +
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLIEDN 162
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 51/209 (24%), Positives = 88/209 (42%), Gaps = 34/209 (16%)
Query: 10 QVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGS 69
+ Q ++++ + N+ + V I L ++++L + NKL
Sbjct: 22 IKANLKKKSVTDAVTQNE-LNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKL--- 75
Query: 70 VPREVG---QLSSLKQLVLYCNGLSGWLPSSFGNLNNL--------AIGSMP----NSLS 114
++ +L++L L+L N L F L NL + S+P + L+
Sbjct: 76 --HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLT 133
Query: 115 NLTSLSLFHLDLSENQLSGSIPH--FLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLS 171
NLT +L+L+ NQL S+P F L+NL L L N L S+P + K+ L
Sbjct: 134 NLT-----YLNLAHNQLQ-SLPKGVF-DKLTNLTELDLSYNQL-QSLPEGVFDKLTQLKD 185
Query: 172 LGFDLNLLNGVLPPSISNLSNLEGLYLYS 200
L N L V L++L+ ++L+
Sbjct: 186 LRLYQNQLKSVPDGVFDRLTSLQYIWLHD 214
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 31/131 (23%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLYCN 88
+NLK L + NQL + D LT+L +L + N+L+ S+P+ V +L++L +L L N
Sbjct: 109 TNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYN 167
Query: 89 GLSGWLPSSFGNLNNLAIGSMPN----SLSNLTSLSLFHLDLSENQLSGSIPH--FLGHL 142
L S+P L+ L L L +NQL S+P F L
Sbjct: 168 QLQ----------------SLPEGVFDKLTQLK-----DLRLYQNQLK-SVPDGVF-DRL 204
Query: 143 SNLAVLHLGDN 153
++L + L DN
Sbjct: 205 TSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 48/203 (23%), Positives = 80/203 (39%), Gaps = 36/203 (17%)
Query: 183 LPPSISNLSNLEGLYLYS-SLVSAEIGN-LLQLIELEIDNKQLFGQIPKSLRNFTSLNIV 240
P + L S+ A N L + ++ +N + + + ++ ++ +
Sbjct: 13 FPDDAF--AETIKANLKKKSVTDAVTQNELNSIDQIIANNSDI--KSVQGIQYLPNVRYL 68
Query: 241 HLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKI-GKLYQLHKL 299
L N L NLT+L L+ N +S+P + KL L +L
Sbjct: 69 ALGGNKLHD--ISALKELTNLTYLILTGNQL------------QSLPNGVFDKLTNLKEL 114
Query: 300 DFSLNHIVGELPI----ELGNLKSLNYRALNGNKVYGSLP-RVLGSISDLEYLDLSTNYN 354
N + LP +L NL LN L N++ SLP V +++L LDL
Sbjct: 115 VLVENQLQ-SLPDGVFDKLTNLTYLN---LAHNQL-QSLPKGVFDKLTNLTELDL---SY 166
Query: 355 NEFRKEFPVEL-EKLVQLTELDL 376
N+ + P + +KL QL +L L
Sbjct: 167 NQL-QSLPEGVFDKLTQLKDLRL 188
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 30/149 (20%), Positives = 60/149 (40%), Gaps = 15/149 (10%)
Query: 481 VYKAEL----PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSF--H 534
V + L + VAVK + + F +E + + H NV++ G
Sbjct: 50 VMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109
Query: 535 PRQSFLLY---EYLGRGSL-AIILSNDAAIDEFSWTVR--MNVIKSVANTLSYMHHDYFP 588
+ ++ G L +L + ++ + + +A + Y+ + F
Sbjct: 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF- 168
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISK 617
+HRD++++N +L D V+DFG+SK
Sbjct: 169 --LHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 28/178 (15%), Positives = 56/178 (31%), Gaps = 27/178 (15%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLYCN 88
+ + L + L + L ++ +Y++++ + LS + + +
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR-- 88
Query: 89 GLSGWLPSSFGNLNNLAIGSMP-NSLSNLTSLSLFHLDLSENQLSGSIPH--FLGHLSNL 145
N + + ++L L L L + L P +
Sbjct: 89 -------------NTRNLTYIDPDALKELPLLK--FLGIFNTGLK-MFPDLTKVYSTDIF 132
Query: 146 AVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN---GVLPPSISNLSNLEGLYLYS 200
+L + DN SIP Q L + L L N + N + L+ +YL
Sbjct: 133 FILEITDNPYMTSIPV--NAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNK 188
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 35/202 (17%), Positives = 70/202 (34%), Gaps = 18/202 (8%)
Query: 15 SNTLFAIIPPQI-GNISNLKFLDM-GNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPR 72
T IP N+ N+ + + + L + L+ + H+ I + +
Sbjct: 39 IETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP 98
Query: 73 EV-GQLSSLKQLVLYCNGLSGWLPSSFGN----------LNNLAIGSMP-NSLSNLTSLS 120
+ +L LK L ++ GL + + +N + S+P N+ L +
Sbjct: 99 DALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE- 157
Query: 121 LFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLS-LGFDLNL 178
L L N + S+ + + + L ++L N I G V S S L
Sbjct: 158 TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTS 216
Query: 179 LNGVLPPSISNLSNLEGLYLYS 200
+ + + +L L ++
Sbjct: 217 VTALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 42/205 (20%), Positives = 71/205 (34%), Gaps = 24/205 (11%)
Query: 158 SIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIG-----NLLQ 212
IP + S +L L + + SNL N+ +Y+ + ++ NL +
Sbjct: 25 RIPSLP---PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSK 81
Query: 213 LIELEIDNKQLFGQIPKS-LRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNF 271
+ +EI N + I L+ L + + L ++P+LT + + F
Sbjct: 82 VTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK--------MFPDLTKVYSTDIFF 133
Query: 272 YGSLNFSMNNITRSIPPKI--GKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNK 329
L + N SIP G + L N + N L+ LN NK
Sbjct: 134 I--LEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNK 190
Query: 330 VYGSLPRVL--GSISDLEYLDLSTN 352
+ + G S LD+S
Sbjct: 191 YLTVIDKDAFGGVYSGPSLLDVSQT 215
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 39/159 (24%), Positives = 62/159 (38%), Gaps = 15/159 (9%)
Query: 473 IGTAGQ-ASVYKAELPSWEI----VAVK--KFHSPHPDMVVQQAFSNEIKALTELRHRNV 525
+G G V + E + VAVK K + F E+ A+ L HRN+
Sbjct: 26 LG-DGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDHRNL 83
Query: 526 VKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHD 585
++ YG P ++ E GSL L F VA + Y+
Sbjct: 84 IRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 586 YFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624
F +HRD++++N+LL + DFG+ + L +
Sbjct: 141 RF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 31/158 (19%), Positives = 63/158 (39%), Gaps = 14/158 (8%)
Query: 473 IGTAGQ-ASVYKAEL----PSWEI-VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVV 526
+G +G +VYK +I VA+K+ + +E + + + +V
Sbjct: 23 LG-SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNPHVC 80
Query: 527 KFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY 586
+ G L+ + + G L + D +N +A ++Y+
Sbjct: 81 RLLGICLTS-TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 587 FPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624
VHRD++++NVL+ ++DFG++K L +
Sbjct: 138 L---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 35/156 (22%), Positives = 72/156 (46%), Gaps = 12/156 (7%)
Query: 473 IGTAGQ-ASVYKAELPSWE----IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVK 527
+G AG+ V L VA+K + + ++ F E + + H N+++
Sbjct: 53 VG-AGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNIIR 110
Query: 528 FYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF 587
G + ++ EY+ GSL L +F+ + +++ +A+ + Y+ +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623
VHRD++++N+L+ + VSDFG+ + L+ D
Sbjct: 169 ---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 2e-10
Identities = 29/161 (18%), Positives = 58/161 (36%), Gaps = 28/161 (17%)
Query: 13 HESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPR 72
+ ++++ L + + L+ + ++ L + HL ++ N+LR ++P
Sbjct: 424 DLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLC--HLEQLLLVTHLDLSHNRLR-ALPP 480
Query: 73 EVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSL-SLFHLDLSENQL 131
+ L L+ L N L ++ + +L L L L N+L
Sbjct: 481 ALAALRCLEVLQASDNALE--------------------NVDGVANLPRLQELLLCNNRL 520
Query: 132 SGSIPHF--LGHLSNLAVLHLGDNSLFGSIPPILGKVQSLL 170
L L +L+L NSL I ++ +L
Sbjct: 521 Q-QSAAIQPLVSCPRLVLLNLQGNSL-CQEEGIQERLAEML 559
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 4e-09
Identities = 45/263 (17%), Positives = 81/263 (30%), Gaps = 44/263 (16%)
Query: 93 WLPSSFGNLNNLAIGSMPNSLSNLTSL-SLFHLDLSENQLSGSIPHFLGHLSNLAVLHLG 151
W S L + + LF +LS + + + L L L
Sbjct: 322 WTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPE 380
Query: 152 DNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLL 211
+ +L + + +L L + S L+ + + +
Sbjct: 381 ------NKWCLLTIILLMRALDPLLYEKET-----LQYFSTLKAV------------DPM 417
Query: 212 QLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNF 271
+ L+ + + + + ++HL LT + +T LDLS N
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRL 475
Query: 272 YGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVY 331
R++PP + L L L S N + + + NL L L N++
Sbjct: 476 ------------RALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL- 520
Query: 332 GSLPRV--LGSISDLEYLDLSTN 352
+ L S L L+L N
Sbjct: 521 QQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 6e-07
Identities = 50/330 (15%), Positives = 102/330 (30%), Gaps = 46/330 (13%)
Query: 97 SFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLF 156
S S P ++ + L +D + + P S++ + L SL
Sbjct: 251 SREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLN 310
Query: 157 GSIP-PILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLY------SSLVSAEIGN 209
+P + + + LL + + E L+ S+++ +E+ +
Sbjct: 311 DQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELES 370
Query: 210 LLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQN 269
+L ELE +NK I +R L + + L +D +
Sbjct: 371 CKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFS-----------TLKAVDPMRA 419
Query: 270 NFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIE-LGNLKSLNYRALNGN 328
+ + + + + L + + +E L + L+ L+ N
Sbjct: 420 AYL---DDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTHLD---LSHN 473
Query: 329 KVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLV---ITFWEERY 385
++ +LP L ++ LE L S N + L +L EL L +
Sbjct: 474 RL-RALPPALAALRCLEVLQASDNALENVD-----GVANLPRLQELLLCNNRLQQSAAIQ 527
Query: 386 RPKSVIWKAWRSLISRMHGLSCIDISYNEL 415
+ L +++ N L
Sbjct: 528 P------------LVSCPRLVLLNLQGNSL 545
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 17/160 (10%)
Query: 473 IGTAGQ-ASVYKAEL--PSWEI---VAVK--KFHSPHPDMVVQQAFSNEIKALTELRHRN 524
IG AG+ VYK L S + VA+K K + F E + + H N
Sbjct: 52 IG-AGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ---RVDFLGEAGIMGQFSHHN 107
Query: 525 VVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH 584
+++ G + ++ EY+ G+L L EFS + +++ +A + Y+ +
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 585 DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624
+ VHRD++++N+L+ + VSDFG+S+ L+ D
Sbjct: 166 MNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 34/150 (22%), Positives = 65/150 (43%), Gaps = 16/150 (10%)
Query: 481 VYKAEL----PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSF--- 533
V +A+L S+ VAVK + + F E + E H +V K G S
Sbjct: 39 VREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98
Query: 534 ---HPRQSFLLYEYLGRGSLAIIL-SNDAAIDEFSWTVR--MNVIKSVANTLSYMHHDYF 587
++ ++ G L L ++ + F+ ++ + + +A + Y+ F
Sbjct: 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF 158
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
+HRD++++N +L D V+DFG+S+
Sbjct: 159 ---IHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 38/158 (24%), Positives = 67/158 (42%), Gaps = 14/158 (8%)
Query: 473 IGTAGQ-ASVYKAEL----PSWEI-VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVV 526
+G +G +V+K S +I V +K Q A ++ + A+ L H ++V
Sbjct: 21 LG-SGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ-AVTDHMLAIGSLDHAHIV 78
Query: 527 KFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY 586
+ G L+ +YL GSL + + +N +A + Y+
Sbjct: 79 RLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 587 FPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624
VHR+++++NVLL V+DFG++ L PD
Sbjct: 136 M---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 42/156 (26%), Positives = 68/156 (43%), Gaps = 27/156 (17%)
Query: 481 VYKAEL------PSWEIVAVK--KFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFS 532
V+ AE +VAVK K S +Q F E + LT L+H+++V+F+G
Sbjct: 57 VFLAECHNLLPEQDKMLVAVKALKEASESA----RQDFQREAELLTMLQHQHIVRFFGVC 112
Query: 533 FHPRQSFLLYEYLGRGSL------------AIILSNDAAIDEFSWTVRMNVIKSVANTLS 580
R +++EY+ G L + D A + V VA +
Sbjct: 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMV 172
Query: 581 YMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616
Y+ +F VHRD++++N L+G + DFG+S
Sbjct: 173 YLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 32/150 (21%), Positives = 68/150 (45%), Gaps = 17/150 (11%)
Query: 481 VYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH 534
VY+ VA+K + M + F NE + E +VV+ G
Sbjct: 41 VYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99
Query: 535 PRQSFLLYEYLGRGSLAIIL-------SNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF 587
+ + ++ E + RG L L +N+ + S + + + +A+ ++Y++ + F
Sbjct: 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF 159
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
VHRD++++N ++ D+ + DFG+++
Sbjct: 160 ---VHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 34/139 (24%), Positives = 57/139 (41%), Gaps = 21/139 (15%)
Query: 512 NEIKALTEL-RHRNVVKFYGF---SFHPRQSFLL-YEYLGRGSL--AIILSNDAAIDEFS 564
E++ + ++V+ + R+ L+ E L G L I D A E
Sbjct: 103 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE-- 160
Query: 565 WTVRM--NVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL-GLDYDAHV--SDFGISKFL 619
R ++KS+ + Y+H I HRD+ +N+L +A + +DFG +K
Sbjct: 161 ---REASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214
Query: 620 KPDSSNWSEFVGTFGYVAP 638
+S + T YVAP
Sbjct: 215 TSHNS-LTTPCYTPYYVAP 232
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 28/157 (17%)
Query: 481 VYKAEL------PSWEIVAVK--KFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFS 532
V+ AE +VAVK K + + ++ F E + LT L+H ++VKFYG
Sbjct: 31 VFLAECYNLSPTKDKMLVAVKALKDPT----LAARKDFQREAELLTNLQHEHIVKFYGVC 86
Query: 533 FHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKS-------------VANTL 579
+++EY+ G L L + K +A+ +
Sbjct: 87 GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGM 146
Query: 580 SYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616
Y+ +F VHRD++++N L+G + + DFG+S
Sbjct: 147 VYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 32/210 (15%), Positives = 72/210 (34%), Gaps = 17/210 (8%)
Query: 443 VKLFSILTFEGKILYEEVIRATNNFD--AKYCIGTAGQASVYKAELPSWEIVAVKKFHSP 500
++L + K++ E A +Y E + + P
Sbjct: 39 IRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98
Query: 501 HPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAI 560
A S +I+ + +N V S ++ + + +L ++ ++
Sbjct: 99 LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158
Query: 561 DEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620
++ V +++ +A + ++H ++HRD+ N+ +D V DFG+ +
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215
Query: 621 PDSS------------NWSEFVGTFGYVAP 638
D + VGT Y++P
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 32/144 (22%), Positives = 57/144 (39%), Gaps = 11/144 (7%)
Query: 481 VYKAELPSWE----IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR 536
VY L + AVK + V Q F E + + H NV+ G
Sbjct: 41 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVLSLLGICLRSE 99
Query: 537 -QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDI 595
++ Y+ G L + N+ + + VA + Y+ F VHRD+
Sbjct: 100 GSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKKF---VHRDL 154
Query: 596 SSKNVLLGLDYDAHVSDFGISKFL 619
+++N +L + V+DFG+++ +
Sbjct: 155 AARNCMLDEKFTVKVADFGLARDM 178
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 6e-10
Identities = 34/168 (20%), Positives = 63/168 (37%), Gaps = 39/168 (23%)
Query: 481 VYKAEL------PSWEIVAVK--KFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFS 532
V KA + VAVK K ++ ++ + +E L ++ H +V+K YG
Sbjct: 39 VVKATAFHLKGRAGYTTVAVKMLKENASPSEL---RDLLSEFNVLKQVNHPHVIKLYGAC 95
Query: 533 FHPRQSFLLYEYLGRGSL------------AIILSNDAAIDEFSWTVRMNVIKS------ 574
L+ EY GSL + S + +
Sbjct: 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISF 155
Query: 575 ---VANTLSYM--HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
++ + Y+ +VHRD++++N+L+ +SDFG+S+
Sbjct: 156 AWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 37/150 (24%), Positives = 66/150 (44%), Gaps = 17/150 (11%)
Query: 481 VYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH 534
VY+ ++ PS VAVK + + F E +++ H+N+V+ G S
Sbjct: 87 VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-ELDFLMEALIISKFNHQNIVRCIGVSLQ 145
Query: 535 PRQSFLLYEYLGRGSLAIIL--SNDAAIDEFSWTVR--MNVIKSVANTLSYMHHDYFPPI 590
F+L E + G L L + S + ++V + +A Y+ ++F
Sbjct: 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF--- 202
Query: 591 VHRDISSKNVLLGLDYDAHV---SDFGISK 617
+HRDI+++N LL V DFG+++
Sbjct: 203 IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 29/150 (19%), Positives = 59/150 (39%), Gaps = 12/150 (8%)
Query: 480 SVYKAEL----PSWEI-VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH 534
+VYK +I VA+K+ + +E + + + +V + G
Sbjct: 30 TVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNPHVCRLLGICLT 88
Query: 535 PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRD 594
L+ + + G L + D +N +A ++Y+ VHRD
Sbjct: 89 S-TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRRL---VHRD 142
Query: 595 ISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624
++++NVL+ ++DFG++K L +
Sbjct: 143 LAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 7e-10
Identities = 49/192 (25%), Positives = 73/192 (38%), Gaps = 49/192 (25%)
Query: 12 VHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVP 71
V + +P I + +LD+ N L + D LT L LY+ NKL+ S+P
Sbjct: 12 VECYSQGRTSVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLP 68
Query: 72 REV-GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQ 130
V +L+SL L L N L F + L+ L L L+ NQ
Sbjct: 69 NGVFNKLTSLTYLNLSTNQLQSLPNGVF------------DKLTQLK-----ELALNTNQ 111
Query: 131 LSGSIPH--FLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSIS 188
L S+P F L+ L L L N L +S+ FD
Sbjct: 112 LQ-SLPDGVF-DKLTQLKDLRLYQNQL-----------KSVPDGVFD------------- 145
Query: 189 NLSNLEGLYLYS 200
L++L+ ++L+
Sbjct: 146 RLTSLQYIWLHD 157
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 41/147 (27%), Positives = 69/147 (46%), Gaps = 31/147 (21%)
Query: 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPRE 73
E+N+L ++ +++L L +G N+L + + LT L +L ++ N+L+ S+P
Sbjct: 36 ETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNG 94
Query: 74 V-GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPN----SLSNLTSLSLFHLDLSE 128
V +L+ LK+L L N L S+P+ L+ L L L +
Sbjct: 95 VFDKLTQLKELALNTNQLQ----------------SLPDGVFDKLTQLK-----DLRLYQ 133
Query: 129 NQLSGSIPH--FLGHLSNLAVLHLGDN 153
NQL S+P F L++L + L DN
Sbjct: 134 NQLK-SVPDGVF-DRLTSLQYIWLHDN 158
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 8e-10
Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 15/156 (9%)
Query: 473 IGTAGQ-ASVYKAELPSWE----IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVK 527
IG GQ V++ S E VA+K + D V ++ F E + + H ++VK
Sbjct: 23 IG-EGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHIVK 80
Query: 528 FYG-FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY 586
G + +P +++ E G L L + ++ L+Y+
Sbjct: 81 LIGVITENPV--WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR 136
Query: 587 FPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622
F VHRDI+++NVL+ + + DFG+S++++
Sbjct: 137 F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 35/166 (21%), Positives = 64/166 (38%), Gaps = 35/166 (21%)
Query: 481 VYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH 534
V++A + +VAVK + Q F E + E + N+VK G
Sbjct: 63 VFQARAPGLLPYEPFTMVAVKMLKEEASADM-QADFQREAALMAEFDNPNIVKLLGVCAV 121
Query: 535 PRQSFLLYEYLGRGSL------------AIILSNDAAIDEFSWTVRMNVIKS-------- 574
+ LL+EY+ G L + +D + + +
Sbjct: 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR 181
Query: 575 -VANTLSYM--HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
VA ++Y+ VHRD++++N L+G + ++DFG+S+
Sbjct: 182 QVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 9e-10
Identities = 42/221 (19%), Positives = 73/221 (33%), Gaps = 51/221 (23%)
Query: 449 LTFEGKILYEEVIRATNNFDAKY----CIGTAGQASVYKAELPSWEIVAVKKFHSPHPDM 504
+ +G+ ++I + + Y I + +V VA+K+ + D
Sbjct: 2 MQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDG 61
Query: 505 VVQQAFSN---------EIKALTELRHRNVVKFYG-FSFHPRQSF----LLYEYLGRGSL 550
S+ EI+ L H N++ F + L+ E + L
Sbjct: 62 RTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DL 120
Query: 551 AIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF-------------PPIVHRDISS 597
A VI +S H YF +VHRD+
Sbjct: 121 A------------------QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHP 162
Query: 598 KNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
N+LL + D + DF +++ D +N + +V Y AP
Sbjct: 163 GNILLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAP 202
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 31/144 (21%), Positives = 57/144 (39%), Gaps = 11/144 (7%)
Query: 481 VYKAELPSWE----IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR 536
VY L + AVK + V Q F E + + H NV+ G
Sbjct: 105 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVLSLLGICLRSE 163
Query: 537 -QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDI 595
++ Y+ G L + N+ + + VA + ++ F VHRD+
Sbjct: 164 GSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKKF---VHRDL 218
Query: 596 SSKNVLLGLDYDAHVSDFGISKFL 619
+++N +L + V+DFG+++ +
Sbjct: 219 AARNCMLDEKFTVKVADFGLARDM 242
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 33/158 (20%), Positives = 58/158 (36%), Gaps = 26/158 (16%)
Query: 481 VYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSF 533
V +A + VAVK ++A +E+K L+ L H N+V G
Sbjct: 39 VVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-REALMSELKVLSYLGNHMNIVNLLGACT 97
Query: 534 HPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKS---------------VANT 578
+ ++ EY G L L S T + VA
Sbjct: 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKG 157
Query: 579 LSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616
++++ +HRD++++N+LL + DFG++
Sbjct: 158 MAFLASKNC---IHRDLAARNILLTHGRITKICDFGLA 192
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 35/157 (22%), Positives = 61/157 (38%), Gaps = 27/157 (17%)
Query: 481 VYKAELPSWE------IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH 534
VYK L VA+K + ++ F +E L+H NVV G
Sbjct: 25 VYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL-REEFRHEAMLRARLQHPNVVCLLGVVTK 83
Query: 535 PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKS-------------VANTLSY 581
+ +++ Y G L L + + T +KS +A + Y
Sbjct: 84 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEY 143
Query: 582 M--HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616
+ HH +VH+D++++NVL+ + +SD G+
Sbjct: 144 LSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 32/157 (20%), Positives = 64/157 (40%), Gaps = 15/157 (9%)
Query: 473 IGTAGQ-ASVYKAELPSWEI----VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVK 527
+G G VY+ + + VAVK + ++ F +E + L H ++VK
Sbjct: 20 LG-EGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 528 FYG-FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY 586
G P +++ E G L L + + + + ++Y+
Sbjct: 78 LIGIIEEEPT--WIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 587 FPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623
VHRDI+ +N+L+ + DFG+S++++ +
Sbjct: 134 C---VHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 38/159 (23%), Positives = 66/159 (41%), Gaps = 31/159 (19%)
Query: 481 VYKAEL---PSWEIVAVK--KFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFH 534
V KA + A+K K ++ D + F+ E++ L +L H N++ G H
Sbjct: 41 VLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCKLGHHPNIINLLGACEH 97
Query: 535 PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKS-------------VANTLSY 581
+L EY G+L L ++ N S VA + Y
Sbjct: 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 157
Query: 582 ---MHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
+HRD++++N+L+G +Y A ++DFG+S+
Sbjct: 158 LSQKQ------FIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 24/198 (12%), Positives = 55/198 (27%), Gaps = 39/198 (19%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFH-SPHPDMVVQQAFSNEIKALTELR--------- 521
+G + +A + + E V + + P + E+ L LR
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 522 ----------------HRNVVKFYGFSFHPR-QSFLLYEYLGRGSLAI----ILSNDAAI 560
+ +++ S + +L +LS+ +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 561 DEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620
R+ + V L+ +HH +VH + +++L ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256
Query: 621 PDSSNWSEFVGTFGYVAP 638
+ G+ P
Sbjct: 257 ---GARVVSSVSRGFEPP 271
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 28/161 (17%), Positives = 59/161 (36%), Gaps = 30/161 (18%)
Query: 481 VYKAELP--------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGF 531
V AE VAVK + +E++ + + +H+N++ G
Sbjct: 51 VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHKNIINLLGA 109
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKS-------------VANT 578
+++ EY +G+L L V + +A
Sbjct: 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 169
Query: 579 LSYM--HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
+ Y+ +HRD++++NVL+ + ++DFG+++
Sbjct: 170 MEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 36/150 (24%), Positives = 63/150 (42%), Gaps = 17/150 (11%)
Query: 481 VYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH 534
VY+ ++ PS VAVK + + F E +++ H+N+V+ G S
Sbjct: 46 VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-ELDFLMEALIISKFNHQNIVRCIGVSLQ 104
Query: 535 PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKS----VANTLSYMHHDYFPPI 590
F+L E + G L L ++ M + +A Y+ ++F
Sbjct: 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF--- 161
Query: 591 VHRDISSKNVLLGLDYDAHV---SDFGISK 617
+HRDI+++N LL V DFG+++
Sbjct: 162 IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 28/161 (17%), Positives = 58/161 (36%), Gaps = 30/161 (18%)
Query: 481 VYKAEL--------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGF 531
V AE VAVK +E++ + + +H+N++ G
Sbjct: 97 VVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKS-------------VANT 578
+++ EY +G+L L V + +A
Sbjct: 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 215
Query: 579 LSYM--HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
+ Y+ +HRD++++NVL+ + ++DFG+++
Sbjct: 216 MEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 40/138 (28%), Positives = 63/138 (45%), Gaps = 10/138 (7%)
Query: 481 VYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF-SFHPRQSF 539
V + VAVK + QAF E +T+LRH N+V+ G +
Sbjct: 37 VMLGDYRG-NKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 91
Query: 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKN 599
++ EY+ +GSL L + + V + Y+ + F VHRD++++N
Sbjct: 92 IVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAARN 147
Query: 600 VLLGLDYDAHVSDFGISK 617
VL+ D A VSDFG++K
Sbjct: 148 VLVSEDNVAKVSDFGLTK 165
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 33/142 (23%), Positives = 56/142 (39%), Gaps = 11/142 (7%)
Query: 481 VYKAELPSWE----IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR 536
VY E A+K V+ AF E + L H NV+ G P
Sbjct: 37 VYHGEYIDQAQNRIQCAIKSLSRITEMQQVE-AFLREGLLMRGLNHPNVLALIGIMLPPE 95
Query: 537 -QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDI 595
+L Y+ G L + + + ++ VA + Y+ F VHRD+
Sbjct: 96 GLPHVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQKF---VHRDL 150
Query: 596 SSKNVLLGLDYDAHVSDFGISK 617
+++N +L + V+DFG+++
Sbjct: 151 AARNCMLDESFTVKVADFGLAR 172
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 32/158 (20%), Positives = 60/158 (37%), Gaps = 25/158 (15%)
Query: 481 VYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSF 533
V +A+ + VAVK +A +E+K L + H NVV G
Sbjct: 43 VIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 101
Query: 534 HPRQS-FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKS-------------VANTL 579
P ++ E+ G+L+ L + ++ K VA +
Sbjct: 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM 161
Query: 580 SYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
++ +HRD++++N+LL + DFG+++
Sbjct: 162 EFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 24/199 (12%), Positives = 51/199 (25%), Gaps = 36/199 (18%)
Query: 473 IGTAGQASVYKAE-LPSWEIVAVKKFHSP-HPDMVVQQAFSNEIKALTELR--------- 521
+G + +A + E V + P + E+ L LR
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 522 -------------HRNVVKFYGFSFHPRQSFLLYEYLGR-------GSLAIILSNDAAID 561
K R ++L + + +L + ++
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 562 E-FSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL- 619
+ R+ + V L+ +HH +VH + +++L ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 620 KPDSSNWSEFVGTFGYVAP 638
S A
Sbjct: 263 ASAVSPIGRGFAPPETTAE 281
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 29/159 (18%), Positives = 60/159 (37%), Gaps = 26/159 (16%)
Query: 481 VYKAELP--------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGF 531
V AE VAVK +E++ + + +H+N++ G
Sbjct: 85 VVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143
Query: 532 SFHPRQSFLLYEYLGRGSL---------AIILSNDAAIDEFSWTVRMNVIKS----VANT 578
+++ EY +G+L + + + + S VA
Sbjct: 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARG 203
Query: 579 LSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
+ Y+ +HRD++++NVL+ D ++DFG+++
Sbjct: 204 MEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 5e-09
Identities = 42/170 (24%), Positives = 76/170 (44%), Gaps = 17/170 (10%)
Query: 474 GTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFS 532
G+ G V+K + +IVA+KKF D V+++ EI+ L +L+H N+V
Sbjct: 14 GSYGV--VFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF 71
Query: 533 FHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKS----VANTLSYMHHDYFP 588
R+ L++EY L + + E +++KS +++ H
Sbjct: 72 RRKRRLHLVFEYCDHTVLHELDRYQRGVPE-------HLVKSITWQTLQAVNFCHKHN-- 122
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+HRD+ +N+L+ + DFG ++ L S + + V T Y +P
Sbjct: 123 -CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 14/149 (9%)
Query: 472 CIGTAGQ-ASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
IG G+ V + VAVK D QAF E +T+LRH N+V+ G
Sbjct: 200 TIG-KGEFGDVMLGDYRG-NKVAVKCIK---NDAT-AQAFLAEASVMTQLRHSNLVQLLG 253
Query: 531 FSFHPRQSFLL-YEYLGRGSLAIIL-SNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
+ + EY+ +GSL L S ++ ++ V + Y+ + F
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF--SLDVCEAMEYLEGNNF- 310
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISK 617
VHRD++++NVL+ D A VSDFG++K
Sbjct: 311 --VHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 35/158 (22%), Positives = 69/158 (43%), Gaps = 30/158 (18%)
Query: 481 VYKAE---LPSWE---IVAVK--KFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGF 531
V +A L + VAVK K + + +A +E+K ++ L +H N+V G
Sbjct: 62 VVEATAFGLGKEDAVLKVAVKMLKSTAHADEK---EALMSELKIMSHLGQHENIVNLLGA 118
Query: 532 SFHPRQSFLLYEYLGRGSLAIIL--SNDAAIDEFSWTVRMNVIKS---------VANTLS 580
H ++ EY G L L + + ++ + + + VA ++
Sbjct: 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMA 178
Query: 581 YM--HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616
++ + +HRD++++NVLL + A + DFG++
Sbjct: 179 FLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 46/184 (25%), Positives = 80/184 (43%), Gaps = 30/184 (16%)
Query: 474 GTAGQASVYKA---ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
GT G VYKA + + A+K+ + + EI L EL+H NV+
Sbjct: 32 GTYGH--VYKAKRKDGKDDKDYALKQIE----GTGISMSACREIALLRELKHPNVISLQK 85
Query: 531 -FSFHPRQS-FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMN--VIKSVA----NTLSYM 582
F H + +LL++Y L I+ A V++ ++KS+ + + Y+
Sbjct: 86 VFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 583 HHDYFPPIVHRDISSKNVLLGLDYDAH----VSDFGISKF----LKPDSSNWSEFVGTFG 634
H ++ ++HRD+ N+L+ + ++D G ++ LKP + V TF
Sbjct: 145 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 635 YVAP 638
Y AP
Sbjct: 201 YRAP 204
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 8e-09
Identities = 34/146 (23%), Positives = 61/146 (41%), Gaps = 24/146 (16%)
Query: 10 QVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGS 69
VV SN ++P I ++ L + NQ + ++P+E+ HL + ++ N++ +
Sbjct: 13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-T 68
Query: 70 VPREV-GQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSE 128
+ + ++ L L+L N L P +F L +L L L
Sbjct: 69 LSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLR-----------------LLSLHG 111
Query: 129 NQLSGSIPHFL-GHLSNLAVLHLGDN 153
N +S +P LS L+ L +G N
Sbjct: 112 NDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 31/115 (26%), Positives = 56/115 (48%), Gaps = 21/115 (18%)
Query: 19 FAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQL 77
F ++P ++ N +L +D+ NN++S + Q +T L L ++ N+LR +P L
Sbjct: 43 FTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGL 101
Query: 78 SSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPN-SLSNLTSLSLFHLDLSENQL 131
SL+ L L+ N +S +P + ++L++LS HL + N L
Sbjct: 102 KSLRLLSLHGNDIS----------------VVPEGAFNDLSALS--HLAIGANPL 138
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 40/189 (21%), Positives = 72/189 (38%), Gaps = 35/189 (18%)
Query: 470 KYCIG-TAGQ---ASVYKAE-LPSWEIVAVK---K---FHSPHPDMVVQQAFSNEIKALT 518
KY G V+ A + V VK K + + EI L+
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 519 ELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTV---RMN----- 570
+ H N++K + L+ E G G +D F++ R++
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSG-----------LDLFAFIDRHPRLDEPLAS 133
Query: 571 -VIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEF 629
+ + + + + Y+ I+HRDI +N+++ D+ + DFG + +L+ + F
Sbjct: 134 YIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTF 189
Query: 630 VGTFGYVAP 638
GT Y AP
Sbjct: 190 CGTIEYCAP 198
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 39/133 (29%), Positives = 63/133 (47%), Gaps = 19/133 (14%)
Query: 513 EIKALTELRHRNVVKFYGFSFHPRQS--FLLYEYLGRGSL-AII----LSNDAAIDEFSW 565
EI L +L H NVVK P + ++++E + +G + + LS D A F
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYF-- 143
Query: 566 TVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625
+ + + Y+H+ I+HRDI N+L+G D ++DFG+S K +
Sbjct: 144 -------QDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 626 WSEFVGTFGYVAP 638
S VGT ++AP
Sbjct: 194 LSNTVGTPAFMAP 206
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 17/170 (10%)
Query: 474 GTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFS 532
G+ G V K + IVA+KKF D +V++ EIK L +LRH N+V
Sbjct: 36 GSYGM--VMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC 93
Query: 533 FHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVA----NTLSYMHHDYFP 588
++ +L++E++ L + +D V++ N + + H
Sbjct: 94 KKKKRWYLVFEFVDHTILDDLELFPNGLDY-------QVVQKYLFQIINGIGFCHSHN-- 144
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
I+HRDI +N+L+ + DFG ++ L + + V T Y AP
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 41/173 (23%), Positives = 69/173 (39%), Gaps = 20/173 (11%)
Query: 473 IGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG A V A + + VA+K + Q E++ + L H N+VK +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 532 SFHPRQSFLLYEYLGRGSLA--II----LSNDAAIDEFSWTVRMNVIKSVANTLSYMHHD 585
+ +L+ EY G + ++ + A +F + + + + Y H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF---------RQIVSAVQYCHQK 133
Query: 586 YFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
IVHRD+ ++N+LL D + ++DFG S F G Y AP
Sbjct: 134 R---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAP 182
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 34/165 (20%), Positives = 58/165 (35%), Gaps = 35/165 (21%)
Query: 481 VYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSF 533
V A VAVK ++A +E+K +T+L H N+V G
Sbjct: 61 VMNATAYGISKTGVSIQVAVKMLKEKADSSE-REALMSELKMMTQLGSHENIVNLLGACT 119
Query: 534 HPRQSFLLYEYLGRGSL-----------AIILSNDAAIDEFSWTVRMNVIKS-------- 574
+L++EY G L + +NV+
Sbjct: 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179
Query: 575 -VANTLSYM--HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616
VA + ++ VHRD++++NVL+ + DFG++
Sbjct: 180 QVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 25/75 (33%), Positives = 44/75 (58%), Gaps = 2/75 (2%)
Query: 31 NLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLYCNG 89
+L L++ NQL+G+ P + +H++ L + NK++ + ++ L LK L LY N
Sbjct: 55 HLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQ 113
Query: 90 LSGWLPSSFGNLNNL 104
+S +P SF +LN+L
Sbjct: 114 ISCVMPGSFEHLNSL 128
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 29/100 (29%), Positives = 46/100 (46%), Gaps = 13/100 (13%)
Query: 111 NSLSNLTSLSLFH-------LDLSENQLSGSIPH--FLGHLSNLAVLHLGDNSLFGSIPP 161
N L ++S LF L+L NQL+ I F S++ L LG+N + I
Sbjct: 39 NELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAF-EGASHIQELQLGENKI-KEISN 95
Query: 162 -ILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYS 200
+ + L +L N ++ V+P S +L++L L L S
Sbjct: 96 KMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLAS 135
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 34/149 (22%), Positives = 66/149 (44%), Gaps = 15/149 (10%)
Query: 481 VYKAELPSWE----IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG-FSFHP 535
V++ S E VA+K + D V ++ F E + + H ++VK G + +P
Sbjct: 406 VHQGIYMSPENPAMAVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHIVKLIGVITENP 464
Query: 536 RQSFLLYEYLGRGSLAIIL-SNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRD 594
+++ E G L L + ++ L+Y+ F VHRD
Sbjct: 465 V--WIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESKRF---VHRD 516
Query: 595 ISSKNVLLGLDYDAHVSDFGISKFLKPDS 623
I+++NVL+ + + DFG+S++++ +
Sbjct: 517 IAARNVLVSSNDCVKLGDFGLSRYMEDST 545
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 37/182 (20%), Positives = 68/182 (37%), Gaps = 36/182 (19%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
+G+ +V A + + VA+KK + P + + E++ L +RH NV+
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 532 SFHPRQSFLLYE--YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF-- 587
F P ++ + YL + F T ++K L +
Sbjct: 93 -FTPDETLDDFTDFYL--------------VMPFMGTDLGKLMKH--EKLGEDRIQFLVY 135
Query: 588 -----------PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYV 636
I+HRD+ N+ + D + + DFG++ + S + +V T Y
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMTGYVVTRWYR 192
Query: 637 AP 638
AP
Sbjct: 193 AP 194
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 36/175 (20%)
Query: 481 VYKAEL-PSWEIVAVKKFHSPHPDMVVQQA-FSN-EIKALTELRHRNVVKFYGFSFHPRQ 537
VY+A+L S E+VA+KK V+Q F N E++ + +L H N+V+ F + +
Sbjct: 70 VYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 121
Query: 538 SF------LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKS----VANTLSYMH-HDY 586
L+ +Y+ + A + +K + +L+Y+H
Sbjct: 122 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP----VIYVKLYMYQLFRSLAYIHSFG- 176
Query: 587 FPPIVHRDISSKNVLLGLDYDAHV---SDFGISKFLKPDSSNWSEFVGTFGYVAP 638
I HRDI +N+L LD D V DFG +K L N ++ + Y AP
Sbjct: 177 ---ICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAP 225
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 40/138 (28%), Positives = 61/138 (44%), Gaps = 26/138 (18%)
Query: 512 NEIKALTELRHRNVVKFYGFSFH-PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMN 570
E ++ L H VK Y F+F + + Y G L + + DE
Sbjct: 79 RERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-------T 130
Query: 571 VIK----SVANTLSYMH-HDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDS 623
+ + + L Y+H I+HRD+ +N+L L+ D H+ +DFG +K L P+S
Sbjct: 131 CTRFYTAEIVSALEYLHGKG----IIHRDLKPENIL--LNEDMHIQITDFGTAKVLSPES 184
Query: 624 SN---WSEFVGTFGYVAP 638
S FVGT YV+P
Sbjct: 185 KQARANS-FVGTAQYVSP 201
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 21/63 (33%), Positives = 31/63 (49%), Gaps = 10/63 (15%)
Query: 579 LSYMH-HDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSNWSEFVGTFGY 635
L Y+ I+HRD+ N+LL D HV +DF I+ L ++ + GT Y
Sbjct: 128 LDYLQNQR----IIHRDMKPDNILL--DEHGHVHITDFNIAAMLPRETQITT-MAGTKPY 180
Query: 636 VAP 638
+AP
Sbjct: 181 MAP 183
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 49/187 (26%), Positives = 75/187 (40%), Gaps = 37/187 (19%)
Query: 470 KYCIG-TAGQ---ASVYKAE-LPSWEIVAVK---KFHSPHPDMVVQQAFSNEIKALTELR 521
Y +G T G V E + VAVK + D+V + EI+ L R
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK--IKREIQNLKLFR 69
Query: 522 HRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AII----LSNDAAIDEFSWTVRMNVIKSV 575
H +++K Y P F++ EY+ G L I + A F + +
Sbjct: 70 HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF---------QQI 120
Query: 576 ANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTF-- 633
+ + Y H +VHRD+ +NVLL +A ++DFG+S + EF+ T
Sbjct: 121 LSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-----EFLRTSCG 172
Query: 634 --GYVAP 638
Y AP
Sbjct: 173 SPNYAAP 179
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-07
Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 23/127 (18%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLYCN 88
S+ L++ +N+L + D LT L L ++ N+++ S+P V +L+ L L L+ N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86
Query: 89 GLSGWLPSSFGNLNNLAIGSMPNSL-SNLTSLSLFHLDLSENQLSGSIPH-FLGHLSNLA 146
L S+PN + LT L L L NQL S+P L++L
Sbjct: 87 KLQ----------------SLPNGVFDKLTQLK--ELALDTNQLK-SVPDGIFDRLTSLQ 127
Query: 147 VLHLGDN 153
+ L N
Sbjct: 128 KIWLHTN 134
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 40/201 (19%), Positives = 75/201 (37%), Gaps = 40/201 (19%)
Query: 458 EEVIRATNNFDAKY----CIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSN 512
+E+ + +Y +G+ SV A + + VAVKK P ++ +
Sbjct: 18 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 77
Query: 513 EIKALTELRHRNVVKFYGFSFHPRQSFLLYE--YLGRGSLAIILSNDAAIDEFSWTVRMN 570
E++ L ++H NV+ F P +S + YL + N
Sbjct: 78 ELRLLKHMKHENVIGLLDV-FTPARSLEEFNDVYL--------------VTHLMGADLNN 122
Query: 571 VIKSVANTLSYMHHDYF-------------PPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
++K L+ H + I+HRD+ N+ + D + + DFG++
Sbjct: 123 IVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA- 179
Query: 618 FLKPDSSNWSEFVGTFGYVAP 638
+ + + +V T Y AP
Sbjct: 180 --RHTADEMTGYVATRWYRAP 198
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 68/383 (17%), Positives = 119/383 (31%), Gaps = 94/383 (24%)
Query: 30 SNLKFLDMGNNQLS-GVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQL----SSLKQLV 84
+++ LD+ +LS + + L + + ++ L + +++ +L +L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 85 LYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLS----GSIPHFLG 140
L N L ++ + + L S + L L L+ G + L
Sbjct: 63 LRSN-----------ELGDVGVHCVLQGLQT-PSCKIQKLSLQNCCLTGAGCGVLSSTLR 110
Query: 141 HLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYS 200
L L LHL DN L + G L L G+L P LE L L
Sbjct: 111 TLPTLQELHLSDNLLGDA--------------GLQL-LCEGLLDPQ----CRLEKLQLEY 151
Query: 201 SLVSAE----IGNLLQ----LIELEIDNKQL----FGQIPKSLRNFT-SLNIVHLEQNHL 247
+SA + ++L+ EL + N + + + L++ L + LE +
Sbjct: 152 CSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGV 211
Query: 248 T----GNIYEVFGIYPNLTFLDLSQNNFYGS------------------LNFSMNNIT-- 283
T ++ + +L L L N L IT
Sbjct: 212 TSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAK 271
Query: 284 --RSIPPKIGKLYQLHKLDFSLNHIVGE--------LPIELGNLKSLNYRALNGNKV--- 330
+ + L +L + N + E L L+SL +
Sbjct: 272 GCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW---VKSCSFTAA 328
Query: 331 -YGSLPRVLGSISDLEYLDLSTN 352
VL L L +S N
Sbjct: 329 CCSHFSSVLAQNRFLLELQISNN 351
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 8e-06
Identities = 59/306 (19%), Positives = 105/306 (34%), Gaps = 68/306 (22%)
Query: 28 NISNLKFLDMGNNQLSGVIPQEI-----DPLTHLKHLYINVNKLRGSVPREVGQL----S 78
+ L+ L + +N L Q + DP L+ L + L + + +
Sbjct: 111 TLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKP 170
Query: 79 SLKQLVLYCNGLSGW--------LPSSFGNLNNLAIGSMPNSLSN----------LTSLS 120
K+L + N ++ L S L L + S +++ + S
Sbjct: 171 DFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLES--CGVTSDNCRDLCGIVASKAS 228
Query: 121 LFHLDLSENQLSGS-----IPHFLGHLSNLAVLHLGDNSL----FGSIPPILGKVQSLLS 171
L L L N+L P L S L L + + + G + +L +SL
Sbjct: 229 LRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKE 288
Query: 172 LGFDLN---------LLNGVLPPSISNLSNLEGLYLYSSLVSAE----IGNLLQ----LI 214
L N L +L P LE L++ S +A ++L L+
Sbjct: 289 LSLAGNELGDEGARLLCETLLEPG----CQLESLWVKSCSFTAACCSHFSSVLAQNRFLL 344
Query: 215 ELEIDNKQL----FGQIPKSLRNF-TSLNIVHLEQNHLT----GNIYEVFGIYPNLTFLD 265
EL+I N +L ++ + L + L ++ L ++ ++ +L LD
Sbjct: 345 ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELD 404
Query: 266 LSQNNF 271
LS N
Sbjct: 405 LSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 45/274 (16%), Positives = 76/274 (27%), Gaps = 77/274 (28%)
Query: 118 SLSLFHLDLSENQLS-GSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDL 176
SL + LD+ +LS L L V+ L D L +
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGL---------TEARCKDISS-- 50
Query: 177 NLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTS 236
++ L L L S+ + + + L L+ + ++
Sbjct: 51 ---------ALRVNPALAELNLRSNELGDVGVHCV-LQGLQTPSCKI-----------QK 89
Query: 237 LNIVHLEQNHLT----GNIYEVFGIYPNLTFLDLSQNNFYGS------------------ 274
L+ L+ LT G + P L L LS N +
Sbjct: 90 LS---LQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146
Query: 275 LNFSMNNIT----RSIPPKIGKLYQLHKLDFSLNHIVGE--------LPIELGNLKSLNY 322
L +++ + + +L S N I L L++L
Sbjct: 147 LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK- 205
Query: 323 RALNGNKV----YGSLPRVLGSISDLEYLDLSTN 352
L V L ++ S + L L L +N
Sbjct: 206 --LESCGVTSDNCRDLCGIVASKASLRELALGSN 237
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 49/183 (26%), Positives = 69/183 (37%), Gaps = 28/183 (15%)
Query: 470 KYCIG-TAGQ---ASVYKAE-LPSWEIVAVKKFH-SPHPDMVVQQAFSNEIKALTELRHR 523
+ + T G+ V A + E VAVK D EI L H
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHE 65
Query: 524 NVVKFYGFSFHPRQSFLLYEYLGRGSL--AII----LSNDAAIDEFSWTVRMNVIKSVAN 577
NVVKFYG +L EY G L I + A F +
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 116
Query: 578 TLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW--SEFVGTFGY 635
+ Y+H I HRDI +N+LL + +SDFG++ + ++ ++ GT Y
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 636 VAP 638
VAP
Sbjct: 174 VAP 176
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 40/155 (25%), Positives = 69/155 (44%), Gaps = 31/155 (20%)
Query: 474 GTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSN----EIKALTELRHRNVVKF 528
GT G+ VYKA + + E VA+K+ H + + E+ L EL+HRN+++
Sbjct: 45 GTYGE--VYKAIDTVTNETVAIKRIRLEHEE----EGVPGTAIREVSLLKELQHRNIIEL 98
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKS----VANTLSYMHH 584
H + L++EY L + + + M VIKS + N +++ H
Sbjct: 99 KSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVS-------MRVIKSFLYQLINGVNFCHS 150
Query: 585 DYFPPIVHRDISSKNVLLGLDYDAH-----VSDFG 614
+HRD+ +N+LL + + + DFG
Sbjct: 151 RR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 3e-07
Identities = 33/146 (22%), Positives = 62/146 (42%), Gaps = 13/146 (8%)
Query: 474 GTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFS 532
GT VYK + VA+K+ + A EI + EL+H N+V+ Y
Sbjct: 16 GTYAT--VYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-REISLMKELKHENIVRLYDVI 72
Query: 533 FHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVA----NTLSYMHHDYFP 588
+ L++E++ L + + + + +N++K L++ H +
Sbjct: 73 HTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-- 128
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFG 614
I+HRD+ +N+L+ + DFG
Sbjct: 129 -ILHRDLKPQNLLINKRGQLKLGDFG 153
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 51/212 (24%), Positives = 80/212 (37%), Gaps = 47/212 (22%)
Query: 452 EGKILYEEVIRATNNF--DAKYCI------GTAGQASVYKAELPSWEIVAVKKFHSPHPD 503
K++ + Y G+ G V++A+L + VA+KK
Sbjct: 21 PNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFG--VVFQAKLVESDEVAIKK------- 71
Query: 504 MVVQQA-FSN-EIKALTELRHRNVVKFYGFSFHPRQS-------FLLYEYLGRGSLAIIL 554
V+Q F N E++ + ++H NVV F F+ L+ EY+
Sbjct: 72 -VLQDKRFKNRELQIMRIVKHPNVVDLKAF-FYSNGDKKDEVFLNLVLEYVPETVYRASR 129
Query: 555 SNDAAIDEFSWTVRMNVIKS----VANTLSYMH-HDYFPPIVHRDISSKNVLLGLDYDAH 609
M +IK + +L+Y+H I HRDI +N+L LD +
Sbjct: 130 HYAKLKQTMP----MLLIKLYMYQLLRSLAYIHSIG----ICHRDIKPQNLL--LDPPSG 179
Query: 610 V---SDFGISKFLKPDSSNWSEFVGTFGYVAP 638
V DFG +K L N S + + Y AP
Sbjct: 180 VLKLIDFGSAKILIAGEPNVSY-ICSRYYRAP 210
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 37/191 (19%), Positives = 67/191 (35%), Gaps = 53/191 (27%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSN---------EIKALTELRH 522
IG+ Q V A + VA+KK + + F N E+ + + H
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKK---------LSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 523 RNVVKFYGFSFHPRQSFLLYE--YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLS 580
+N++ F P++S ++ Y+ + E VI+ L
Sbjct: 84 KNIIGLLNV-FTPQKSLEEFQDVYI--------------VMELMDANLCQVIQM---ELD 125
Query: 581 YMHHDYF-------------PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627
+ Y I+HRD+ N+++ D + DFG+++ +
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMT 184
Query: 628 EFVGTFGYVAP 638
+V T Y AP
Sbjct: 185 PYVVTRYYRAP 195
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 41/198 (20%), Positives = 66/198 (33%), Gaps = 64/198 (32%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSN---------EIKALTELRH 522
IG V A + + VA+KK F + EIK L RH
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKIS----------PFEHQTYCQRTLREIKILLRFRH 84
Query: 523 RNVVKFYGFSFHPRQS------FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVA 576
N++ +++ + + T ++K+
Sbjct: 85 ENIIGINDI-IRAPTIEQMKDVYIVQDLME-------------------TDLYKLLKT-- 122
Query: 577 NTLSYMHHDYF-------------PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623
LS H YF ++HRD+ N+LL D + DFG+++ PD
Sbjct: 123 QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 624 SN---WSEFVGTFGYVAP 638
+ +E+V T Y AP
Sbjct: 183 DHTGFLTEYVATRWYRAP 200
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 5e-07
Identities = 25/122 (20%), Positives = 37/122 (30%), Gaps = 21/122 (17%)
Query: 12 VHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQE-IDPLTHLKHLYINVNKLRGSV 70
+ + + NL L + N Q + + L L++L I + LR V
Sbjct: 13 LRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FV 71
Query: 71 PREVGQ-LSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSEN 129
+ L +L L N L + LSL L LS N
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKTV------------------QGLSLQELVLSGN 113
Query: 130 QL 131
L
Sbjct: 114 PL 115
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 38/191 (19%), Positives = 68/191 (35%), Gaps = 53/191 (27%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSN---------EIKALTELRH 522
IG+ Q V A + VA+KK + + F N E+ + + H
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKK---------LSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 523 RNVVKFYGFSFHPRQSFLLYE--YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLS 580
+N++ F P+++ ++ YL + E VI+ L
Sbjct: 121 KNIISLLNV-FTPQKTLEEFQDVYL--------------VMELMDANLCQVIQM---ELD 162
Query: 581 YMHHDYF-------------PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627
+ Y I+HRD+ N+++ D + DFG+++ S +
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMT 221
Query: 628 EFVGTFGYVAP 638
+V T Y AP
Sbjct: 222 PYVVTRYYRAP 232
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 39/182 (21%), Positives = 65/182 (35%), Gaps = 37/182 (20%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
+G+ SV A + S E VA+KK P + + E+ L ++H NV+
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 532 SFHPRQSFLLYE--YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF-- 587
F P S + YL + F T ++ S Y
Sbjct: 92 -FTPASSLRNFYDFYL--------------VMPFMQTDLQKIMGL---KFSEEKIQYLVY 133
Query: 588 -----------PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYV 636
+VHRD+ N+ + D + + DFG++ + + + +V T Y
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYR 190
Query: 637 AP 638
AP
Sbjct: 191 AP 192
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 22/62 (35%), Positives = 33/62 (53%), Gaps = 9/62 (14%)
Query: 579 LSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSNWSEFVGTFGYV 636
L +MH+ + +V+RD+ N+LL D HV SD G++ + VGT GY+
Sbjct: 305 LEHMHNRF---VVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPH--ASVGTHGYM 357
Query: 637 AP 638
AP
Sbjct: 358 AP 359
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 49/185 (26%), Positives = 65/185 (35%), Gaps = 35/185 (18%)
Query: 470 KYCIG-TAGQ---ASVYKAE-LPSWEIVAVK---KFHSPHPDMVVQQAFSNEIKALTELR 521
+Y G + E+VAVK + + + EI LR
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER------GAAIDENVQREIINHRSLR 74
Query: 522 HRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AII----LSNDAAIDEFSWTVRMNVIKSV 575
H N+V+F P ++ EY G L I S D A F ++ V
Sbjct: 75 HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFF-----QQLLSGV 129
Query: 576 ANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAH--VSDFGISKFLKPDSSNWSEFVGTF 633
SY H I HRD+ +N LL + DFG SK S S VGT
Sbjct: 130 ----SYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTP 181
Query: 634 GYVAP 638
Y+AP
Sbjct: 182 AYIAP 186
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 48/187 (25%), Positives = 75/187 (40%), Gaps = 37/187 (19%)
Query: 470 KYCIG-TAGQ---ASVYKAE-LPSWEIVAVK---KFHSPHPDMVVQQAFSNEIKALTELR 521
Y +G T G V + + VAVK + D+V + EI+ L R
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK--IRREIQNLKLFR 74
Query: 522 HRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AII----LSNDAAIDEFSWTVRMNVIKSV 575
H +++K Y P F++ EY+ G L I L + F + +
Sbjct: 75 HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF---------QQI 125
Query: 576 ANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTF-- 633
+ + Y H +VHRD+ +NVLL +A ++DFG+S + EF+ T
Sbjct: 126 LSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-----EFLRTSCG 177
Query: 634 --GYVAP 638
Y AP
Sbjct: 178 SPNYAAP 184
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 49/183 (26%), Positives = 69/183 (37%), Gaps = 28/183 (15%)
Query: 470 KYCIG-TAGQ---ASVYKAE-LPSWEIVAVKKFH-SPHPDMVVQQAFSNEIKALTELRHR 523
+ + T G+ V A + E VAVK D EI L H
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHE 65
Query: 524 NVVKFYGFSFHPRQSFLLYEYLGRGSL------AIILSNDAAIDEFSWTVRMNVIKSVAN 577
NVVKFYG +L EY G L I + A F +
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 116
Query: 578 TLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW--SEFVGTFGY 635
+ Y+H I HRDI +N+LL + +SDFG++ + ++ ++ GT Y
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 636 VAP 638
VAP
Sbjct: 174 VAP 176
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 38/200 (19%), Positives = 66/200 (33%), Gaps = 39/200 (19%)
Query: 462 RATNNFDAKYCIG-TAGQ---ASVYKAE-LPSWEIVAVK----KFHSPHPDMVVQQAFSN 512
+ F+A+Y +G G+ +V+ L VA+K +
Sbjct: 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 513 EIKALTELR----HRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTV- 567
E+ L ++ H V++ + L+ E D F +
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA-----------QDLFDYITE 132
Query: 568 --RM------NVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY-DAHVSDFGISKF 618
+ V + + H +VHRDI +N+L+ L A + DFG
Sbjct: 133 KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGAL 189
Query: 619 LKPDSSNWSEFVGTFGYVAP 638
L +++F GT Y P
Sbjct: 190 LH--DEPYTDFDGTRVYSPP 207
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 22/62 (35%), Positives = 35/62 (56%), Gaps = 7/62 (11%)
Query: 579 LSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSNWSEFVGTFGYV 636
L ++H I++RD+ +NVLL D D +V SD G++ LK + + GT G++
Sbjct: 302 LEHLHQRN---IIYRDLKPENVLL--DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 637 AP 638
AP
Sbjct: 357 AP 358
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 21/62 (33%), Positives = 33/62 (53%), Gaps = 8/62 (12%)
Query: 579 LSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSNWSEFVGTFGYV 636
L +H + IV+RD+ +N+LL D H+ SD G++ + + VGT GY+
Sbjct: 299 LEDLHRER---IVYRDLKPENILL--DDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYM 352
Query: 637 AP 638
AP
Sbjct: 353 AP 354
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 40/196 (20%), Positives = 72/196 (36%), Gaps = 33/196 (16%)
Query: 462 RATNNFDAKYCIG-TAGQ---ASVYKAE-LPSWEIVAVK----KFHSPHPDMVVQQAFSN 512
+ +++Y +G G SVY + VA+K S ++
Sbjct: 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 513 EIKALTELRHR--NVVKFYGFSFHPRQSFLLYEY-LGRGSL--AII----LSNDAAIDEF 563
E+ L ++ V++ + P L+ E L I L + A F
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155
Query: 564 SWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY-DAHVSDFGISKFLKPD 622
V + + H+ ++HRDI +N+L+ L+ + + DFG LK
Sbjct: 156 ---------WQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-- 201
Query: 623 SSNWSEFVGTFGYVAP 638
+ +++F GT Y P
Sbjct: 202 DTVYTDFDGTRVYSPP 217
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 47/187 (25%), Positives = 75/187 (40%), Gaps = 38/187 (20%)
Query: 470 KYCIG-TAGQ---ASVYKAE-LPSWEIVAVK---KFHSPHPDMVVQQAFSNEIKALTELR 521
Y I T G+ V A + + VA+K + DM ++ EI L LR
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR--VEREISYLKLLR 67
Query: 522 HRNVVKFYGFSFHPRQSFLLYEYLGRGSL--AII----LSNDAAIDEFSWTVRMNVIKSV 575
H +++K Y P ++ EY G G L I+ ++ D F + +
Sbjct: 68 HPHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFF---------QQI 117
Query: 576 ANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTF-- 633
+ Y H IVHRD+ +N+LL + + ++DFG+S + F+ T
Sbjct: 118 ICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-----NFLKTSCG 169
Query: 634 --GYVAP 638
Y AP
Sbjct: 170 SPNYAAP 176
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 45/186 (24%), Positives = 73/186 (39%), Gaps = 31/186 (16%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKK--FHSPHPDMVVQQAFSNEIKALTELRHRNVVKFY 529
+G G V+ A + + VA+KK P V+ A EIK + L H N+VK +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP---QSVKHAL-REIKIIRRLDHDNIVKVF 74
Query: 530 GFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF-- 587
P S L + L + + E+ T NV++ L H F
Sbjct: 75 EI-LGPSGSQLTDDVGSLTELNSVY----IVQEYMETDLANVLEQ--GPLLEEHARLFMY 127
Query: 588 -----------PPIVHRDISSKNVLL-GLDYDAHVSDFGISKFLKPDSSN---WSEFVGT 632
++HRD+ N+ + D + DFG+++ + P S+ SE + T
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 633 FGYVAP 638
Y +P
Sbjct: 188 KWYRSP 193
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 22/150 (14%)
Query: 474 GTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSN----EIKALTELRHRNVVKF 528
G VYKA + + +IVA+KK H + + EIK L EL H N++
Sbjct: 21 GQFAT--VYKARDKNTNQIVAIKKIKLGHRS-EAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKS----VANTLSYMHH 584
H L+++++ L +I+ +++ + + + IK+ L Y+H
Sbjct: 78 LDAFGHKSNISLVFDFMET-DLEVIIKDNSLV--LT----PSHIKAYMLMTLQGLEYLHQ 130
Query: 585 DYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614
+ I+HRD+ N+LL + ++DFG
Sbjct: 131 HW---ILHRDLKPNNLLLDENGVLKLADFG 157
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 21/52 (40%), Positives = 28/52 (53%), Gaps = 5/52 (9%)
Query: 590 IVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSNWSE-FVGTFGYVAP 638
VHRDI N+L LD H+ +DFG L+ D + S VGT Y++P
Sbjct: 183 YVHRDIKPDNIL--LDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 3e-06
Identities = 40/151 (26%), Positives = 65/151 (43%), Gaps = 28/151 (18%)
Query: 474 GTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSN----EIKALTELRHRNVVKFY 529
GT G VYKA+ E A+KK D + + EI L EL+H N+VK Y
Sbjct: 13 GTYGV--VYKAQNNYGETFALKKIRLEKED----EGIPSTTIREISILKELKHSNIVKLY 66
Query: 530 GFSFHPRQSFLLYEYLGRGSLAIILSND--AAIDEFSWTVRMNVIKSVA----NTLSYMH 583
++ L++E+ L D +D + KS N ++Y H
Sbjct: 67 DVIHTKKRLVLVFEH---------LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 584 HDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614
++HRD+ +N+L+ + + ++DFG
Sbjct: 118 DRR---VLHRDLKPQNLLINREGELKIADFG 145
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 23/135 (17%), Positives = 50/135 (37%), Gaps = 27/135 (20%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81
+ + + K L + N + + + + +L+ L + N ++ + +L+
Sbjct: 40 MDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 82 QLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSL-SLFHLDLSENQLSGSIPHF-- 138
+L + N ++ SLS + L +L L +S N+++ +
Sbjct: 97 ELWISYNQIA--------------------SLSGIEKLVNLRVLYMSNNKIT-NWGEIDK 135
Query: 139 LGHLSNLAVLHLGDN 153
L L L L L N
Sbjct: 136 LAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 44/176 (25%), Positives = 60/176 (34%), Gaps = 36/176 (20%)
Query: 100 NLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSI 159
+ I M +LS L + HL LS N + I L + NL +L LG N + I
Sbjct: 31 HGMIPPIEKMDATLSTLKACK--HLALSTNNIE-KISS-LSGMENLRILSLGRNLI-KKI 85
Query: 160 PPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEID 219
+ +L L N + + I L NL LY+ + N + EID
Sbjct: 86 ENLDAVADTLEELWISYNQIASLSG--IEKLVNLRVLYMSN--------NKITNWG-EID 134
Query: 220 NKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYE----------VFGIYPNLTFLD 265
L L + L N L + E V PNL LD
Sbjct: 135 K----------LAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 35/159 (22%)
Query: 474 GTAGQASVYKA-ELPSWEIVAVKKFHSPH-----PDMVVQQAFSNEIKALTELRHRNVVK 527
GT G+ V+KA + + VA+KK + P ++ EIK L L+H NVV
Sbjct: 28 GTFGE--VFKARHRKTGQKVALKKVLMENEKEGFPITALR-----EIKILQLLKHENVVN 80
Query: 528 FYG--------FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVA--- 576
++ +L++++ LA +LSN +F+ ++ IK V
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV--KFT----LSEIKRVMQML 133
Query: 577 -NTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614
N L Y+H + I+HRD+ + NVL+ D ++DFG
Sbjct: 134 LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 4e-06
Identities = 39/151 (25%), Positives = 63/151 (41%), Gaps = 28/151 (18%)
Query: 474 GTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSN----EIKALTELRHRNVVKFY 529
GT G VYKA+ IVA+K+ D + + EI L EL H N+V
Sbjct: 32 GTYGV--VYKAKDSQGRIVALKRIRLDAED----EGIPSTAIREISLLKELHHPNIVSLI 85
Query: 530 GFSFHPRQSFLLYEYLGRGSLAIILSNDAA--IDEFSWTVRMNVIKSVA----NTLSYMH 583
R L++E+ + D +DE ++ + IK +++ H
Sbjct: 86 DVIHSERCLTLVFEF---------MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 584 HDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614
I+HRD+ +N+L+ D ++DFG
Sbjct: 137 QHR---ILHRDLKPQNLLINSDGALKLADFG 164
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 41/192 (21%), Positives = 72/192 (37%), Gaps = 40/192 (20%)
Query: 470 KYCIG-TAGQ---ASVYKAE-LPSWEIVAVK-----KFHSPHPDMVVQQAFSNEIKALTE 519
KY +G G+ V + + AVK K P+ EI+ L
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR-IPNGEAN--VKKEIQLLRR 62
Query: 520 LRHRNVVKFYGFSFH--PRQSFLLYEYLGRGS---LAII----LSNDAAIDEFSWTVRMN 570
LRH+NV++ ++ ++ +++ EY G L + A F
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF------- 115
Query: 571 VIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFV 630
+ + L Y+H IVH+DI N+LL +S G+++ L P +++ +
Sbjct: 116 --CQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD--DTC 168
Query: 631 GTF----GYVAP 638
T + P
Sbjct: 169 RTSQGSPAFQPP 180
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 31/134 (23%), Positives = 54/134 (40%), Gaps = 16/134 (11%)
Query: 510 FSNEIKALTELRHRNVVKFYGFSFH-PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVR 568
F E + VV+ + ++F R +++ EY+ G L ++SN +
Sbjct: 116 FWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNY----DVPEKWA 170
Query: 569 MNVIKSVANTLSYMH-HDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSN 625
V L +H +HRD+ N+L LD H+ +DFG + +
Sbjct: 171 RFYTAEVVLALDAIHSMG----FIHRDVKPDNML--LDKSGHLKLADFGTCMKMNKEGMV 224
Query: 626 WSE-FVGTFGYVAP 638
+ VGT Y++P
Sbjct: 225 RCDTAVGTPDYISP 238
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 20/52 (38%), Positives = 28/52 (53%), Gaps = 5/52 (9%)
Query: 590 IVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSNWSE-FVGTFGYVAP 638
VHRDI N+L +D + H+ +DFG L D + S VGT Y++P
Sbjct: 196 YVHRDIKPDNIL--MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 47.1 bits (113), Expect = 9e-06
Identities = 39/150 (26%), Positives = 68/150 (45%), Gaps = 24/150 (16%)
Query: 474 GTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSN----EIKALTELRHRNVVKF 528
GT G VYKA + E+VA+KK + + EI L EL H N+VK
Sbjct: 14 GTYGV--VYKARNKLTGEVVALKKIRLDTET----EGVPSTAIREISLLKELNHPNIVKL 67
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVA----NTLSYMHH 584
+ +L++E+L + L + + +A+ + +IKS L++ H
Sbjct: 68 LDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIP----LPLIKSYLFQLLQGLAFCHS 121
Query: 585 DYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614
++HRD+ +N+L+ + ++DFG
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFG 148
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 39/177 (22%), Positives = 64/177 (36%), Gaps = 34/177 (19%)
Query: 481 VYKA-ELPSWEIVAVKKFHSPHPDMVVQQA-FSN----EIKALTELRHRNVVKFYGFSFH 534
V E + VA+KK V+Q F N ++ L L H N+V+ + F+
Sbjct: 39 VQLGKEKSTGMSVAIKK--------VIQDPRFRNRELQIMQDLAVLHHPNIVQLQSY-FY 89
Query: 535 PRQS--------FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKS----VANTLSYM 582
++ EY+ + +IK + ++ +
Sbjct: 90 TLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPP----PILIKVFLFQLIRSIGCL 145
Query: 583 HHDYFPPIVHRDISSKNVLL-GLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
H + HRDI NVL+ D + DFG +K L P N ++ + Y AP
Sbjct: 146 HLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-VAYICSRYYRAP 200
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 34/143 (23%), Positives = 64/143 (44%), Gaps = 20/143 (13%)
Query: 479 ASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ 537
A+VYK + +VA+K+ H + A E+ L +L+H N+V + +
Sbjct: 16 ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLHDIIHTEKS 74
Query: 538 SFLLYEYLGRGSLAIILSNDAA--IDEFSWTVRMNVIKS----VANTLSYMHHDYFPPIV 591
L++EY L D +D+ + M+ +K + L+Y H ++
Sbjct: 75 LTLVFEY---------LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VL 122
Query: 592 HRDISSKNVLLGLDYDAHVSDFG 614
HRD+ +N+L+ + ++DFG
Sbjct: 123 HRDLKPQNLLINERGELKLADFG 145
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 46.7 bits (112), Expect = 1e-05
Identities = 35/152 (23%), Positives = 67/152 (44%), Gaps = 29/152 (19%)
Query: 474 GTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSN----EIKALTELRHRNVVKF 528
GT G V+KA + EIVA+K+ D + + EI L EL+H+N+V+
Sbjct: 13 GTYGT--VFKAKNRETHEIVALKRVRLDDDD----EGVPSSALREICLLKELKHKNIVRL 66
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSND--AAIDEFSWTVRMNVIKSVA----NTLSYM 582
+ ++ L++E+ D D + + ++KS L +
Sbjct: 67 HDVLHSDKKLTLVFEF---------CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 583 HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614
H ++HRD+ +N+L+ + + +++FG
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLANFG 146
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 28/102 (27%), Positives = 39/102 (38%), Gaps = 13/102 (12%)
Query: 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81
I NL+FL + N L V + L LK L ++ N++ G + +L +L
Sbjct: 41 IEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98
Query: 82 QLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFH 123
L L N L L L L L SL LF+
Sbjct: 99 HLNLSGNKL-----KDISTLEPLK------KLECLKSLDLFN 129
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 42/159 (26%), Positives = 65/159 (40%), Gaps = 23/159 (14%)
Query: 232 RNFTSLNIVHLEQNHLT-GNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKI 290
R ++ + L+ G I + + NL FL L N S+ +
Sbjct: 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLI------------NVGLISVSN-L 67
Query: 291 GKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKV--YGSLPRVLGSISDLEYLD 348
KL +L KL+ S N I G L + L +L + L+GNK+ +L L + L+ LD
Sbjct: 68 PKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLD 126
Query: 349 LSTN---YNNEFRKEFPVELEKLVQLTELDLVITFWEER 384
L N++R+ + L QLT LD +E
Sbjct: 127 LFNCEVTNLNDYRESV---FKLLPQLTYLDGYDREDQEA 162
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 37/174 (21%), Positives = 65/174 (37%), Gaps = 35/174 (20%)
Query: 460 VIRATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVK--KFHSPHPDMVVQQAFSNEIKA 516
V+ NF IG + + L + E VA+K S P + E +
Sbjct: 4 VLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLH------LEYRF 57
Query: 517 LTELRH-RNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSV 575
+L + + Y F + + ++ E LG SL D F R +K+V
Sbjct: 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELLGP-SLE---------DLFDLCDRTFSLKTV 107
Query: 576 A-------NTLSYMHHDYFPPIVHRDISSKNVLLGLDYDA-----HVSDFGISK 617
+ + Y+H ++RD+ +N L+G + H+ DF ++K
Sbjct: 108 LMIAIQLISRMEYVHSKNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 32/141 (22%), Positives = 54/141 (38%), Gaps = 15/141 (10%)
Query: 481 VYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYG-FSFHPRQS 538
V +A + +VA+KK D++ + EI L L H +VVK +
Sbjct: 69 VCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128
Query: 539 F----LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH-HDYFPPIVHR 593
F ++ E + + + T+ N++ + Y+H I+HR
Sbjct: 129 FDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVG----VKYVHSAG----ILHR 180
Query: 594 DISSKNVLLGLDYDAHVSDFG 614
D+ N L+ D V DFG
Sbjct: 181 DLKPANCLVNQDCSVKVCDFG 201
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 52/356 (14%), Positives = 105/356 (29%), Gaps = 93/356 (26%)
Query: 116 LTSLSLFHLDLSENQLSG----SIPHFLGHLSNLAVLHLGDNSL----FGSIPPILGKVQ 167
+ S+ L + ++ S+ L ++ + L N++ + + +
Sbjct: 1 MARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 60
Query: 168 SLLSLGFDLNLLN----------GVLPPSISNLSNLEGLYLYSSLVSAE----IGNLLQ- 212
L F +L ++ L + L + + + L
Sbjct: 61 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120
Query: 213 ---LIELEIDNKQL-------------FGQIPKSLRNFTSLNIVHLEQNHLTGN----IY 252
L L + N L + K +N L + +N L
Sbjct: 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 180
Query: 253 EVFGIYPNLTFLDLSQNNFYG------------------SLNFSMNNIT----RSIPPKI 290
+ F + L + + QN L+ N T ++ +
Sbjct: 181 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 240
Query: 291 GKLYQLHKLDFSLNHI-------VGELPIELGN--LKSLNYRALNGNKVYG----SLPRV 337
L +L + + V + +L N L++L L N++ +L V
Sbjct: 241 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLR---LQYNEIELDAVRTLKTV 297
Query: 338 LGS-ISDLEYLDLSTNYNNEFRKEFPV--------ELEKLVQLTELDLVITFWEER 384
+ + DL +L+L+ N F +E V +L ELD + +E
Sbjct: 298 IDEKMPDLLFLELN---GNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTDEE 350
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 43/264 (16%), Positives = 84/264 (31%), Gaps = 62/264 (23%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPL----THLKHLYINVNKL-------------RGSVPR 72
L + + +N + + T L+HLY++ N L +V +
Sbjct: 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNK 153
Query: 73 EVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQL- 131
+ L+ ++ N L N + + L + + +N +
Sbjct: 154 KAKNAPPLRSIICGRNRL--------ENGSMKEWAKT---FQSHRLLH--TVKMVQNGIR 200
Query: 132 ----SGSIPHFLGHLSNLAVLHLGDNSLFG-----SIPPILGKVQSLLSLGFDLNLL--N 180
+ L + L VL L DN+ F ++ L +L LG + LL
Sbjct: 201 PEGIEHLLLEGLAYCQELKVLDLQDNT-FTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259
Query: 181 GV--LPPSISNLSN--LEGLYLYS---------SLVSAEIGNLLQLIELEIDNKQL---- 223
G + + S L N L+ L L +L + + L+ LE++ +
Sbjct: 260 GAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319
Query: 224 --FGQIPKSLRNFTSLNIVHLEQN 245
+I + + L+
Sbjct: 320 DVVDEIREVFSTRGRGELDELDDM 343
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 36/181 (19%), Positives = 65/181 (35%), Gaps = 41/181 (22%)
Query: 473 IGTAGQASVYKAELPSWEIV------AVKKFHSPHPDMVVQQAF---------SNEIKAL 517
IG G +Y A++ S E V VK S + + + F +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 518 TELRHRNVVKFYGFSFHPRQS----FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIK 573
+L++ V K++G H + F++ + G L + + K
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQ---------KIYEANAKRFSRK 152
Query: 574 SVA-------NTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSS 624
+V + L Y+H + VH DI + N+LL V D+G++ P+
Sbjct: 153 TVLQLSLRILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209
Query: 625 N 625
+
Sbjct: 210 H 210
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 22/62 (35%), Positives = 35/62 (56%), Gaps = 6/62 (9%)
Query: 579 LSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSNWSEFVGTFGYV 636
L Y+H + +V+RD+ +N++ LD D H+ +DFG+ K D + F GT Y+
Sbjct: 261 LDYLHSEK--NVVYRDLKLENLM--LDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316
Query: 637 AP 638
AP
Sbjct: 317 AP 318
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 40/188 (21%), Positives = 70/188 (37%), Gaps = 41/188 (21%)
Query: 473 IGTAGQASVYKAE-LPSWEIVAVK--KFHSPHPDMVVQQAFSNEIKALTELRH-RNVVKF 528
IG+ +Y + + E VA+K + HP + E K ++ +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLH------IESKIYKMMQGGVGIPTI 70
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVA-------NTLSY 581
+ ++ E LG SL D F++ R +K+V + + Y
Sbjct: 71 RWCGAEGDYNVMVMELLGP-SLE---------DLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 582 MHHDYFPPIVHRDISSKNVLLGLDYDAH---VSDFGISKFLKPDSSNW-------SEFVG 631
+H F +HRD+ N L+GL + + DFG++K + ++ G
Sbjct: 121 IHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177
Query: 632 TFGYVAPI 639
T Y A I
Sbjct: 178 TARY-ASI 184
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 6e-05
Identities = 24/76 (31%), Positives = 39/76 (51%), Gaps = 2/76 (2%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLYCN 88
+ + L + +NQ++ + P D LT L L ++ N+L +P V +L+ L QL L N
Sbjct: 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDN 88
Query: 89 GLSGWLPSSFGNLNNL 104
L +F NL +L
Sbjct: 89 QLKSIPRGAFDNLKSL 104
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 23/93 (24%), Positives = 37/93 (39%), Gaps = 13/93 (13%)
Query: 31 NLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGL 90
L+FL N L+ + + L LK L ++ N++ G + + +L L L N +
Sbjct: 43 ELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI 100
Query: 91 SGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFH 123
+ L L NL SL LF+
Sbjct: 101 -----KDLSTIEPLK------KLENLKSLDLFN 122
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 4e-04
Identities = 36/149 (24%), Positives = 61/149 (40%), Gaps = 21/149 (14%)
Query: 232 RNFTSLNIVHLEQNHLT-GNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKI 290
R + + + L+ + G + + + L FL S+ N+
Sbjct: 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANL-------- 60
Query: 291 GKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYG-SLPRVLGSISDLEYLDL 349
KL +L KL+ S N + G L + +L + L+GNK+ S L + +L+ LDL
Sbjct: 61 PKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDL 120
Query: 350 STN---YNNEFRKEFPVELEKLVQLTELD 375
N++R+ + L QLT LD
Sbjct: 121 FNCEVTNLNDYRENV---FKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 33/128 (25%), Positives = 51/128 (39%), Gaps = 21/128 (16%)
Query: 28 NISNLKFLDMGNNQLS-GVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLY 86
S++K L + N++ + G + D L+ L L S+ + +L+ LK+L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72
Query: 87 CNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSG-SIPHFLGHLSNL 145
N +SG L NL HL+LS N++ S L L NL
Sbjct: 73 DNRVSGGLEVLAEKCPNLT-----------------HLNLSGNKIKDLSTIEPLKKLENL 115
Query: 146 AVLHLGDN 153
L L +
Sbjct: 116 KSLDLFNC 123
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 34/197 (17%), Positives = 65/197 (32%), Gaps = 48/197 (24%)
Query: 481 VYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSN-EIKALTELRHRNVVKFYGFSFHPRQS 538
V + ++ S + A+KK + N E+ + L H N++K + F+
Sbjct: 23 VCEVFDIESGKRFALKKVL-------QDPRYKNRELDIMKVLDHVNIIKLVDY-FYTTGD 74
Query: 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMN--------------------VIKSVAN- 577
+ + ++ +V +N V+KS
Sbjct: 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRS 134
Query: 578 --TLSYMHHDYF-------------PPIVHRDISSKNVLL-GLDYDAHVSDFGISKFLKP 621
++ + I HRDI +N+L+ D + DFG +K L P
Sbjct: 135 GRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP 194
Query: 622 DSSNWSEFVGTFGYVAP 638
+ ++ + Y AP
Sbjct: 195 SEPS-VAYICSRFYRAP 210
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 7e-05
Identities = 27/76 (35%), Positives = 42/76 (55%), Gaps = 2/76 (2%)
Query: 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLYCN 88
++ + L + NNQ++ + P D L +L+ LY N NKL ++P V +L+ L QL L N
Sbjct: 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDN 91
Query: 89 GLSGWLPSSFGNLNNL 104
L +F NL +L
Sbjct: 92 HLKSIPRGAFDNLKSL 107
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 39/180 (21%), Positives = 64/180 (35%), Gaps = 64/180 (35%)
Query: 490 EIVAVKKFHSPHPDMVVQQAFSN---------EIKALTELRHRNVVKFYGFSFHP--RQS 538
EIVA+KK F EIK L +H N++ + P ++
Sbjct: 37 EIVAIKKIE----------PFDKPLFALRTLREIKILKHFKHENIITIFNI-QRPDSFEN 85
Query: 539 F----LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF------- 587
F ++ E + T VI + LS H YF
Sbjct: 86 FNEVYIIQELMQ-------------------TDLHRVIST--QMLSDDHIQYFIYQTLRA 124
Query: 588 ------PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFG----YVA 637
++HRD+ N+L+ + D V DFG+++ + +++ SE G +VA
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 36/157 (22%), Positives = 58/157 (36%), Gaps = 27/157 (17%)
Query: 474 GTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSN---EIKALTELR---HRNVV 526
G G VYKA + S VA+K P+ + E+ L L H NVV
Sbjct: 20 GAYGT--VYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77
Query: 527 K----FYGFSFHPRQS-FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVA----N 577
+ L++E++ + L L + IK +
Sbjct: 78 RLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG-----LPAETIKDLMRQFLR 131
Query: 578 TLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614
L ++H + IVHRD+ +N+L+ ++DFG
Sbjct: 132 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFG 165
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 43/184 (23%), Positives = 72/184 (39%), Gaps = 40/184 (21%)
Query: 473 IGTAGQASVYKAE-LPSWEIVAVK--KFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKF 528
IG+ +Y + + E VA+K + HP ++ E K L+ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLL------YESKIYRILQGGTGIPNV 68
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVA-------NTLSY 581
F + L+ + LG SL D F++ R +K+V N + +
Sbjct: 69 RWFGVEGDYNVLVMDLLGP-SLE---------DLFNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 582 MHHDYFPPIVHRDISSKNVLLGLDYDAH---VSDFGISKFLKPDSSNW-------SEFVG 631
+H F +HRDI N L+GL A+ + DFG++K + S++ G
Sbjct: 119 VHSKSF---LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 632 TFGY 635
T Y
Sbjct: 176 TARY 179
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 39/186 (20%), Positives = 62/186 (33%), Gaps = 42/186 (22%)
Query: 473 IGTAGQASVYKAE-LPSWEIVAVK--KFHSPHPDMVVQQAFSNEIKALTELRH-RNVVKF 528
IG +++ L + + VA+K S P + +E + L +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLR------DEYRTYKLLAGCTGIPNV 71
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVA-------NTLSY 581
Y F + L+ + LG SL D R +K+VA +
Sbjct: 72 YYFGQEGLHNVLVIDLLGP-SLE---------DLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 582 MHHDYFPPIVHRDISSKNVLLGLDYDA-----HVSDFGISKFLKPDSSNW-------SEF 629
+H V+RDI N L+G +V DFG+ KF + +
Sbjct: 122 IHEKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 178
Query: 630 VGTFGY 635
GT Y
Sbjct: 179 SGTARY 184
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 51/285 (17%), Positives = 89/285 (31%), Gaps = 47/285 (16%)
Query: 69 SVPREVGQLSSLKQLVL-YCNGLS--GWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLD 125
S + + ++ + L + +P +G I +M +S + L + L +
Sbjct: 57 SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMV 116
Query: 126 LSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPP 185
++++ L N VL L F + L ++
Sbjct: 117 VTDDCLE----LIAKSFKNFKVLVLSSCEGFST--------DGLAAIA------------ 152
Query: 186 SISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQN 245
+ NL+ L L S V G+ L P + + SLNI L
Sbjct: 153 --ATCRNLKELDLRESDVDDVSGHWLS-------------HFPDTYTSLVSLNISCLASE 197
Query: 246 HLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNH 305
+ + PNL L L++ L + P++ +L
Sbjct: 198 VSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRA-----PQLEELGTGGYTAEVRPD 252
Query: 306 IVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLS 350
+ L + L K L + + V LP V S L L+LS
Sbjct: 253 VYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLS 297
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 2e-04
Identities = 32/226 (14%), Positives = 51/226 (22%), Gaps = 61/226 (26%)
Query: 459 EVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVV------QQAFSN 512
T IG V++ VA+K PD+V +
Sbjct: 14 SHCLPTEKLQRCEKIGEGVFGEVFQTIADH-TPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 513 EIKALTEL---------RHRNVVKFYGF------------------------------SF 533
EI EL R + F
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 534 HPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHR 593
Q F++ E+ G S +++ + +L+ HR
Sbjct: 133 KDDQLFIVLEFEFGGIDL----EQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHR 186
Query: 594 DISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639
D+ NVLL + K + + G I
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSST---------IPSCGLQVSI 223
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 43/323 (13%), Positives = 103/323 (31%), Gaps = 41/323 (12%)
Query: 54 THLKHLYINVNKLRGSVPREVGQLS----SLKQLVLYCNGLSGWLPSSFGNLNNLAIGSM 109
+K L + + + + +L+ SL+ L Y + ++ + ++
Sbjct: 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFA--------KISPKDLETI 215
Query: 110 PNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSL 169
+ +L S+ + ++ E +L L ++ L + L
Sbjct: 216 ARNCRSLVSVKVGDFEILELV---GFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKL 272
Query: 170 LSLGFDLNLLNGVLPPSISNLSNLEGLYL-YSSLVSAE----IGNLLQLIELEIDNK--- 221
LG + +P + + L L Y+ L + + I L LE N
Sbjct: 273 CRLGLS-YMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGD 331
Query: 222 QLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVF---GIY------PNLTFLDLSQNNFY 272
+ + + + L I + + G+ L ++ + ++
Sbjct: 332 RGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDIT 391
Query: 273 GSLNFSMNNITRSIPP----KIGKLYQLHKL-DFSLNHIVGELPIELGNLKSLNYRALNG 327
N S+ +I + ++ L + ++ D L++ V L I L+ + G
Sbjct: 392 ---NESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQG 448
Query: 328 NKVYGSLPRVLGSISDLEYLDLS 350
L + ++ ++ L
Sbjct: 449 GLTDLGLSYIGQYSPNVRWMLLG 471
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 31/135 (22%), Positives = 56/135 (41%), Gaps = 25/135 (18%)
Query: 512 NEIKALTELRHRNVVKFYGFSFH-PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMN 570
NE + L + +VK FSF +++ EY+ G + L E
Sbjct: 90 NEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-------P 141
Query: 571 VIK----SVANTLSYMH-HDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDS 623
+ + T Y+H D +++RD+ +N+L +D ++ +DFG +K +
Sbjct: 142 HARFYAAQIVLTFEYLHSLD----LIYRDLKPENLL--IDQQGYIQVTDFGFAK--RVKG 193
Query: 624 SNWSEFVGTFGYVAP 638
W+ GT +AP
Sbjct: 194 RTWT-LCGTPEALAP 207
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 23/93 (24%), Positives = 37/93 (39%), Gaps = 13/93 (13%)
Query: 31 NLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGL 90
+D +N++ + L LK L +N N++ L L +L+L N L
Sbjct: 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 100
Query: 91 SGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFH 123
G+L+ LA SL +LT L +
Sbjct: 101 -----VELGDLDPLA------SLKSLTYLCILR 122
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 9e-04
Identities = 31/160 (19%), Positives = 45/160 (28%), Gaps = 23/160 (14%)
Query: 230 SLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPK 289
N + L + I + +D S N F
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP----------- 61
Query: 290 IGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKV--YGSLPRVLGSISDLEYL 347
L +L L + N I L L L N + G L L S+ L YL
Sbjct: 62 --LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYL 118
Query: 348 DLSTN---YNNEFRKEFPVELEKLVQLTELDLVITFWEER 384
+ N +R + K+ Q+ LD +ER
Sbjct: 119 CILRNPVTNKKHYRLYV---IYKVPQVRVLDFQKVKLKER 155
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 24/64 (37%), Positives = 38/64 (59%), Gaps = 10/64 (15%)
Query: 579 LSYMH-HDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISK-FLKPDSSNWSEFVGTFG 634
L ++H I++RDI +N+L LD + HV +DFG+SK F+ ++ +F GT
Sbjct: 172 LEHLHKLG----IIYRDIKLENIL--LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 635 YVAP 638
Y+AP
Sbjct: 226 YMAP 229
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 24/63 (38%), Positives = 35/63 (55%), Gaps = 9/63 (14%)
Query: 579 LSYMH-HDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSNWSEFVGTFGY 635
L Y+H D +V+RDI +N++ LD D H+ +DFG+ K D + F GT Y
Sbjct: 118 LEYLHSRD----VVYRDIKLENLM--LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 171
Query: 636 VAP 638
+AP
Sbjct: 172 LAP 174
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 5e-04
Identities = 20/63 (31%), Positives = 34/63 (53%), Gaps = 9/63 (14%)
Query: 579 LSYMH-HDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSNWSEFVGTFGY 635
L ++H I++RD+ +N++ L++ HV +DFG+ K D + F GT Y
Sbjct: 134 LGHLHQKG----IIYRDLKPENIM--LNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEY 187
Query: 636 VAP 638
+AP
Sbjct: 188 MAP 190
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 23/64 (35%), Positives = 38/64 (59%), Gaps = 11/64 (17%)
Query: 579 LSYMH-HDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISK-FLKPDSSNWSEFVGTFG 634
L Y+H + IV+RD+ +N+L LD H+ +DFG+ K ++ +S+ + F GT
Sbjct: 152 LGYLHSLN----IVYRDLKPENIL--LDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPE 204
Query: 635 YVAP 638
Y+AP
Sbjct: 205 YLAP 208
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 6e-04
Identities = 22/64 (34%), Positives = 37/64 (57%), Gaps = 11/64 (17%)
Query: 579 LSYMH-HDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISK-FLKPDSSNWSEFVGTFG 634
L ++H I++RD+ +N+L LD + H+ +DFG+SK + + +S F GT
Sbjct: 139 LDHLHSLG----IIYRDLKPENIL--LDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVE 191
Query: 635 YVAP 638
Y+AP
Sbjct: 192 YMAP 195
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 20/62 (32%), Positives = 31/62 (50%), Gaps = 7/62 (11%)
Query: 579 LSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSNWSEFVGTFGYV 636
L ++ I++RD+ NV+ LD + H+ +DFG+ K D F GT Y+
Sbjct: 455 LFFLQSK---GIIYRDLKLDNVM--LDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYI 509
Query: 637 AP 638
AP
Sbjct: 510 AP 511
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 31/172 (18%), Positives = 65/172 (37%), Gaps = 29/172 (16%)
Query: 473 IGTAGQASVYKAE---------LPSWEIVAVKKFHSPHPDMVVQQAF---------SNEI 514
Q +Y+A P + ++K + + +Q F N+
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 515 KALTELRHRNVVKFYGFSFH-PRQSFLLYEYLGRGSLAIILSNDAAIDEFSW-TVRMNVI 572
K L + GF H + FL+ LGR SL L + + S +V
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSAL-DVSPKHVLSERSVLQVAC 166
Query: 573 KSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPD 622
+ + + L ++H + + VH +++++N+ + + + V + +G + P
Sbjct: 167 RLL-DALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 39/173 (22%), Positives = 69/173 (39%), Gaps = 28/173 (16%)
Query: 473 IGTAGQASVYKAE-LPSWEIVA---VKKFHSPHPDMVVQQAF---------SNEIKALTE 519
IG+ G +Y A E A VK + + + + F + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 520 LRHRNVVKFYGFSFHPRQS----FLLYEYLGRGSLAIILSNDAAIDEFSW-TVRMNVIKS 574
L + + FYG + F++ E LG L I + F TV I+
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGT---FKKSTVLQLGIRM 160
Query: 575 VANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD--AHVSDFGISKFLKPDSSN 625
+ + L Y+H + + VH DI + N+LLG +++D+G+S P+ ++
Sbjct: 161 L-DVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 9e-04
Identities = 34/177 (19%), Positives = 65/177 (36%), Gaps = 32/177 (18%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYG 530
+G + V++A + + E V VK V ++ EIK L LR N++
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGGPNIITLAD 98
Query: 531 FSFHPRQSF---LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKS----VANTLSYMH 583
S L++E++ + + I+ + L Y H
Sbjct: 99 I-VKDPVSRTPALVFEHVNNTDFKQL------YQTLT----DYDIRFYMYEILKALDYCH 147
Query: 584 -HDYFPPIVHRDISSKNVLL-GLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
I+HRD+ NV++ + D+G+++F P ++ V + + P
Sbjct: 148 SMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGP 199
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 639 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.96 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.96 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.96 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.96 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.96 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.96 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.96 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.96 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.96 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.96 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.96 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.96 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.96 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.96 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.96 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.96 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.96 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.96 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.96 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.96 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.96 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.96 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.96 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.96 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.96 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.96 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.96 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.95 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.95 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.95 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.95 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.95 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.95 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.95 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.95 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.95 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.95 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.95 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.95 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.95 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.95 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.95 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.95 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.95 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.95 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.95 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.95 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.95 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.95 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.95 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.95 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.95 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.95 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.95 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.95 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.95 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.95 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.95 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.95 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.95 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.95 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.95 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.95 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.95 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.95 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.95 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.95 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.95 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.95 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.95 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.95 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.95 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.95 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.95 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.94 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.94 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.94 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.94 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.94 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.94 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.94 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.94 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.94 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.94 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.94 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.94 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.94 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.94 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.94 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.94 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.94 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.94 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.94 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.94 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.94 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.94 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.94 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.94 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.94 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.94 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.94 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.94 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.94 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.94 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.94 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.94 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.94 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.94 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.94 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.94 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.94 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.94 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.94 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.94 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.94 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.94 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.94 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.94 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.94 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.94 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.94 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.94 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.94 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.94 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.94 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.94 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.94 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.94 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.94 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.94 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.94 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.94 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.94 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.94 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.94 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.94 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.93 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.93 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.93 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.93 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.93 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.93 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.93 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.93 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.93 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.93 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.93 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.93 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.93 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.93 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.93 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.93 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.93 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.93 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.93 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.93 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.93 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.93 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.93 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.93 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.93 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.93 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.93 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.93 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.93 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.93 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.93 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.93 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.93 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.93 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.93 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.93 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.93 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.93 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.93 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.93 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.92 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.92 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.92 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.92 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.92 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.92 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.92 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.92 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.92 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.92 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.92 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.92 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.92 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.92 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.92 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.92 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.91 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.89 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.85 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.85 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.85 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.84 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.83 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.76 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.76 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.73 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.7 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.69 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.69 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.55 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.48 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.47 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.46 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.46 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.44 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.38 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.27 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.25 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.23 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.01 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.99 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.96 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.88 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.61 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.58 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.53 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.5 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.49 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.37 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.3 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.21 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.2 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.18 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.16 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.12 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.08 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.01 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.89 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.83 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.8 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.69 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.49 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.08 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.07 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.97 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.96 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.89 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.72 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.69 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.67 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.45 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.25 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.2 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.01 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.99 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.59 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.25 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.24 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.07 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.76 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.59 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.06 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=481.05 Aligned_cols=421 Identities=32% Similarity=0.442 Sum_probs=307.8
Q ss_pred eeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCC---------------
Q 046265 7 FFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVP--------------- 71 (639)
Q Consensus 7 ~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p--------------- 71 (639)
.+..+++++|++.+.+|. ++++++|++|+|++|.+++.+|..++.+++|++|+|++|++++.+|
T Consensus 201 ~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n 279 (768)
T 3rgz_A 201 NLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAEN 279 (768)
T ss_dssp TCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSS
T ss_pred cCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCC
Confidence 445566666666666665 6666666666666666666666666666666666666666555444
Q ss_pred -------cccCCC-CCCCEEeeecccCccccCccccCCCCCC---------cccCCCC-CcccCCCCccEEEccCCcCcc
Q 046265 72 -------REVGQL-SSLKQLVLYCNGLSGWLPSSFGNLNNLA---------IGSMPNS-LSNLTSLSLFHLDLSENQLSG 133 (639)
Q Consensus 72 -------~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~---------~~~lp~~-~~~l~~L~L~~L~L~~N~l~~ 133 (639)
..+..+ ++|++|+|++|++++.+|..|+++++|+ .+.+|.. +.++++| ++|++++|++++
T Consensus 280 ~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L--~~L~Ls~n~l~~ 357 (768)
T 3rgz_A 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGL--KVLDLSFNEFSG 357 (768)
T ss_dssp EEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTC--CEEECCSSEEEE
T ss_pred ccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCC--CEEeCcCCccCc
Confidence 444332 4444444444444444444444444443 1133332 4444444 455555555555
Q ss_pred cCCccccCCC-CCCEEeccCCCCCCCCCccccC--CCcccEEEcccCcCCccCCccCcCCCCCCeEEccCC----ccccc
Q 046265 134 SIPHFLGHLS-NLAVLHLGDNSLFGSIPPILGK--VQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSS----LVSAE 206 (639)
Q Consensus 134 ~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~--l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~----~~~~~ 206 (639)
.+|..+.+++ +|++|++++|++++.+|..+.. +++|++|++++|.+++.+|..+.++++|+.|+++.+ .+|..
T Consensus 358 ~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 437 (768)
T 3rgz_A 358 ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS 437 (768)
T ss_dssp CCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGG
T ss_pred cccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHH
Confidence 5555555444 5555555555555555554444 556777777777777777777777778888888754 34566
Q ss_pred cccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCccccc------------
Q 046265 207 IGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGS------------ 274 (639)
Q Consensus 207 ~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~------------ 274 (639)
++.+++|+.|++++|.+.+.+|..+..+++|++|++++|.+++.+|..++.+++|++|++++|++.+.
T Consensus 438 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 517 (768)
T 3rgz_A 438 LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLA 517 (768)
T ss_dssp GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCC
T ss_pred HhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCC
Confidence 77788888888888888888888888888888888888888888888888888888888888887752
Q ss_pred -ccCcCCccccccCccccCCCCCCEEeccCCcccccCCccc---------------------------------------
Q 046265 275 -LNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIEL--------------------------------------- 314 (639)
Q Consensus 275 -l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~--------------------------------------- 314 (639)
+++++|++++.+|..++.+++|+.|++++|.+.|.+|..+
T Consensus 518 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (768)
T 3rgz_A 518 ILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ 597 (768)
T ss_dssp EEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECT
T ss_pred EEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccc
Confidence 5788888888888888888889999999888887777543
Q ss_pred -------------------------------cCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCCh
Q 046265 315 -------------------------------GNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPV 363 (639)
Q Consensus 315 -------------------------------~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~ 363 (639)
..+++|+.|++++|+++|.+|..++.+++|+.|+|++ |++.+.+|.
T Consensus 598 ~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~---N~l~g~ip~ 674 (768)
T 3rgz_A 598 GIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGH---NDISGSIPD 674 (768)
T ss_dssp TCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCS---SCCCSCCCG
T ss_pred cccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcC---CccCCCCCh
Confidence 3356788999999999999999999999999999999 567788999
Q ss_pred hhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeeeeeecCCCcccccccccccCCCCCCCCc
Q 046265 364 ELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRNSTGIHYNLVDALQGNKGLCGDV 443 (639)
Q Consensus 364 ~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~g~~p~~~~~~~~~~~~~~~~~~l~g~~ 443 (639)
.+..+++|+.||++.|.+++.+ | ..+..++.|+.+|+|+|+++|.+|...++..+...++.||+++||.+
T Consensus 675 ~l~~L~~L~~LdLs~N~l~g~i-p---------~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~ 744 (768)
T 3rgz_A 675 EVGDLRGLNILDLSSNKLDGRI-P---------QAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744 (768)
T ss_dssp GGGGCTTCCEEECCSSCCEECC-C---------GGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred HHhCCCCCCEEECCCCcccCcC-C---------hHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCC
Confidence 9999999999999999999988 6 77899999999999999999999999999988888999999999975
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=448.96 Aligned_cols=397 Identities=31% Similarity=0.442 Sum_probs=287.8
Q ss_pred eeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEee
Q 046265 6 FFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVL 85 (639)
Q Consensus 6 ~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 85 (639)
..+..+++++|++.+.+|. ..+++|++|+|++|.+++.+|. ++.+++|++|+|++|++++.+|..++++++|++|++
T Consensus 178 ~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L 254 (768)
T 3rgz_A 178 GELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNI 254 (768)
T ss_dssp TTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEEC
T ss_pred CCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEEC
Confidence 4567889999999987775 8899999999999999988887 999999999999999999999999999999999999
Q ss_pred ecccCccccCccccCCCCCC---------cccCCCCCccc-CCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCC
Q 046265 86 YCNGLSGWLPSSFGNLNNLA---------IGSMPNSLSNL-TSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSL 155 (639)
Q Consensus 86 ~~N~l~~~~p~~~~~l~~L~---------~~~lp~~~~~l-~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 155 (639)
++|++++.+|.. .+++|+ .+.+|..+..+ ++| ++|+|++|++++.+|..|+++++|++|+|++|++
T Consensus 255 s~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L--~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l 330 (768)
T 3rgz_A 255 SSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTL--TGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 330 (768)
T ss_dssp CSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTC--SEEECCSSEEEECCCGGGGGCTTCCEEECCSSEE
T ss_pred CCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcC--CEEECcCCcCCCccchHHhcCCCccEEECCCCcc
Confidence 999998877764 555554 23566666554 555 5777777777767777777777777777777777
Q ss_pred CCCCCcc-ccCCCcccEEEcccCcCCccCCccCcCCC-CCCeEEc--------------------------cCC----cc
Q 046265 156 FGSIPPI-LGKVQSLLSLGFDLNLLNGVLPPSISNLS-NLEGLYL--------------------------YSS----LV 203 (639)
Q Consensus 156 ~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~l--------------------------~~~----~~ 203 (639)
+|.+|.. ++.+++|++|++++|.+++.+|..+..++ +|+.|++ +.+ .+
T Consensus 331 ~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~ 410 (768)
T 3rgz_A 331 SGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI 410 (768)
T ss_dssp EEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEEC
T ss_pred cCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCcccccc
Confidence 6666654 66666666666666666666665555544 4555544 433 23
Q ss_pred ccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccc----------
Q 046265 204 SAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG---------- 273 (639)
Q Consensus 204 ~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---------- 273 (639)
|..+..+++|+.|++++|++.+.+|..+..+++|+.|++++|.+++.+|..+..+++|++|++++|++.+
T Consensus 411 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 490 (768)
T 3rgz_A 411 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT 490 (768)
T ss_dssp CGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT
T ss_pred CHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCC
Confidence 4455666666666666666666666666666677777777777766666666666777777777776654
Q ss_pred ---cccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCc------------
Q 046265 274 ---SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVL------------ 338 (639)
Q Consensus 274 ---~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~------------ 338 (639)
.+++++|++++.+|.+++.+++|+.|++++|++.+.+|..+..+++|+.|++++|++.|.+|..+
T Consensus 491 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~ 570 (768)
T 3rgz_A 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFI 570 (768)
T ss_dssp TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTT
T ss_pred CCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcc
Confidence 24667777777777777777777777777777777777777777777777777777666655433
Q ss_pred ----------------------------------------------------------cCCCCCCEEeCCCCCCCccccc
Q 046265 339 ----------------------------------------------------------GSISDLEYLDLSTNYNNEFRKE 360 (639)
Q Consensus 339 ----------------------------------------------------------~~l~~L~~L~Ls~N~~~~~~~~ 360 (639)
+.+++|+.|||++ |++.+.
T Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~---N~l~g~ 647 (768)
T 3rgz_A 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSY---NMLSGY 647 (768)
T ss_dssp CSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCS---SCCBSC
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcC---Cccccc
Confidence 2245567777776 455667
Q ss_pred CChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeeeeeecCC
Q 046265 361 FPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRNS 422 (639)
Q Consensus 361 ~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~g~~p~~ 422 (639)
+|.++..++.|+.|+++.|.+++.+ | ..++.++.|+.||+|+|+++|.+|..
T Consensus 648 ip~~l~~l~~L~~L~Ls~N~l~g~i-p---------~~l~~L~~L~~LdLs~N~l~g~ip~~ 699 (768)
T 3rgz_A 648 IPKEIGSMPYLFILNLGHNDISGSI-P---------DEVGDLRGLNILDLSSNKLDGRIPQA 699 (768)
T ss_dssp CCGGGGGCTTCCEEECCSSCCCSCC-C---------GGGGGCTTCCEEECCSSCCEECCCGG
T ss_pred CCHHHhccccCCEEeCcCCccCCCC-C---------hHHhCCCCCCEEECCCCcccCcCChH
Confidence 7777777777777888877777766 5 66788888888888888888888753
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=410.62 Aligned_cols=379 Identities=19% Similarity=0.261 Sum_probs=262.7
Q ss_pred eeEEEEeCCCcccccCCccccCCCCCCEEECcCCC---------------------------------------------
Q 046265 7 FFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQ--------------------------------------------- 41 (639)
Q Consensus 7 ~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~--------------------------------------------- 41 (639)
....++++++++.|.+|++|+++++|++|+|++|.
T Consensus 82 ~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~ 161 (636)
T 4eco_A 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDL 161 (636)
T ss_dssp CEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHH
T ss_pred CEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHH
Confidence 67889999999999999999999999999999883
Q ss_pred ---------------------------------CccCCCCCCCCCCCCCEEEcccCcCCCC-----------------CC
Q 046265 42 ---------------------------------LSGVIPQEIDPLTHLKHLYINVNKLRGS-----------------VP 71 (639)
Q Consensus 42 ---------------------------------l~~~~p~~~~~L~~L~~L~L~~N~l~~~-----------------~p 71 (639)
++| +|.+|+++++|++|+|++|++++. +|
T Consensus 162 ~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip 240 (636)
T 4eco_A 162 IKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT 240 (636)
T ss_dssp HHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTT
T ss_pred HHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCc
Confidence 445 788899999999999999999986 99
Q ss_pred cccC--CCCCCCEEeeecccCccccCccccCCCCCCcc-----------cCCCCCccc------CCCCccEEEccCCcCc
Q 046265 72 REVG--QLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIG-----------SMPNSLSNL------TSLSLFHLDLSENQLS 132 (639)
Q Consensus 72 ~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~-----------~lp~~~~~l------~~L~L~~L~L~~N~l~ 132 (639)
..++ ++++|++|+|++|++.+.+|..|+++++|+.. .+|..+.++ ++| ++|++++|+++
T Consensus 241 ~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L--~~L~L~~n~l~ 318 (636)
T 4eco_A 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI--QIIYIGYNNLK 318 (636)
T ss_dssp SCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTC--CEEECCSSCCS
T ss_pred hhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCC--CEEECCCCcCC
Confidence 9999 99999999999999999999999988876611 233333333 444 45555555555
Q ss_pred ccCCc--cccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCC-CCeEEccCCc---cccc
Q 046265 133 GSIPH--FLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSN-LEGLYLYSSL---VSAE 206 (639)
Q Consensus 133 ~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~-L~~L~l~~~~---~~~~ 206 (639)
.+|. .++++++|++|++++|+++|.+| .++.+++|+.|++++|.++ .+|..+..+++ |+.|+++.+. +|..
T Consensus 319 -~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp~~ 395 (636)
T 4eco_A 319 -TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIPNI 395 (636)
T ss_dssp -SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCCSC
T ss_pred -ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCcccchh
Confidence 5555 55555555555555555555555 5555555555555555555 45555555555 5555555433 2333
Q ss_pred ccccc--CCcEEEcCCcccCCCCCcccc-------CCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccC
Q 046265 207 IGNLL--QLIELEIDNKQLFGQIPKSLR-------NFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNF 277 (639)
Q Consensus 207 ~~~l~--~L~~L~l~~n~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~l 277 (639)
+..+. +|+.|++++|.+.+.+|..+. .+++|+.|++++|.+++.++..+..+++|++|++++|++
T Consensus 396 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l------ 469 (636)
T 4eco_A 396 FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML------ 469 (636)
T ss_dssp CCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCC------
T ss_pred hhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCC------
Confidence 33322 555555555555555555555 455555556665555544444445555555555555544
Q ss_pred cCCccccccCccccC--------CCCCCEEeccCCcccccCCcccc--CCCCCCeeeccCccCcccCCcCccCCCCCCEE
Q 046265 278 SMNNITRSIPPKIGK--------LYQLHKLDFSLNHIVGELPIELG--NLKSLNYRALNGNKVYGSLPRVLGSISDLEYL 347 (639)
Q Consensus 278 s~n~~~~~~p~~~~~--------l~~L~~L~Ls~N~~~~~~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 347 (639)
+ .+|..+.. +++|+.|++++|+++ .+|..+. .+++|+.|++++|++++ +|..++.+++|+.|
T Consensus 470 -----~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L 541 (636)
T 4eco_A 470 -----T-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGF 541 (636)
T ss_dssp -----S-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEE
T ss_pred -----C-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEE
Confidence 3 44443322 337888888888887 6777776 88888888888888886 78888888888888
Q ss_pred eCCCCC---CCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeeeee
Q 046265 348 DLSTNY---NNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGL 418 (639)
Q Consensus 348 ~Ls~N~---~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~g~ 418 (639)
++++|+ .|.+.+.+|..+..+++|+.|++++|.+ +.+ | ..+. ++|+.||+++|++...
T Consensus 542 ~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~i-p---------~~~~--~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 542 GIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKV-N---------EKIT--PNISVLDIKDNPNISI 602 (636)
T ss_dssp ECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBC-C---------SCCC--TTCCEEECCSCTTCEE
T ss_pred ECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-Ccc-C---------HhHh--CcCCEEECcCCCCccc
Confidence 887654 3667777888888888888888888888 445 4 2222 5788888888877643
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=393.95 Aligned_cols=401 Identities=20% Similarity=0.167 Sum_probs=257.0
Q ss_pred eEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeec
Q 046265 8 FFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYC 87 (639)
Q Consensus 8 ~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 87 (639)
...+++++|++.+..|..|.++++|++|+|++|.+++..|.+|+.+++|++|+|++|++++..|..|+++++|++|++++
T Consensus 35 l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 114 (606)
T 3t6q_A 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQ 114 (606)
T ss_dssp CCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTT
T ss_pred CcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccc
Confidence 45667777777777777777777788888887777777777777777888888877777766777777777788888877
Q ss_pred ccCccccCccccCCCCCCc--------ccCC-CCCcccCCCCccEEEccCCcCcccCCccccCCCCCC--EEeccCCCCC
Q 046265 88 NGLSGWLPSSFGNLNNLAI--------GSMP-NSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLA--VLHLGDNSLF 156 (639)
Q Consensus 88 N~l~~~~p~~~~~l~~L~~--------~~lp-~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~--~L~L~~N~l~ 156 (639)
|++++..|..|+++++|+. ..++ ..+..+++| ++|++++|.+++..|..++.+++|+ .|++++|.++
T Consensus 115 n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~ 192 (606)
T 3t6q_A 115 TGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKL--KVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192 (606)
T ss_dssp SCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTC--CEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCC
T ss_pred cCcccCCcchhccCCcccEEECCCCcccccCcccccCCccc--CEEEcccCcccccChhhhhhhcccceeEEecCCCccC
Confidence 7777766777777777652 1221 222235555 6777777777766666677777777 6777777776
Q ss_pred CCCCccccCC---------------------------------------------------CcccEEEcccCcCCccCCc
Q 046265 157 GSIPPILGKV---------------------------------------------------QSLLSLGFDLNLLNGVLPP 185 (639)
Q Consensus 157 ~~~p~~~~~l---------------------------------------------------~~L~~L~l~~N~l~~~~p~ 185 (639)
+..|..+... .+|+.|++++|.+++..+.
T Consensus 193 ~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~ 272 (606)
T 3t6q_A 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272 (606)
T ss_dssp EECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTT
T ss_pred ccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHH
Confidence 6555443321 0456666666666666666
Q ss_pred cCcCCCCCCeEEccCCc---cccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcch-hhhhcCCCc
Q 046265 186 SISNLSNLEGLYLYSSL---VSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIY-EVFGIYPNL 261 (639)
Q Consensus 186 ~~~~l~~L~~L~l~~~~---~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L 261 (639)
.|..+++|+.|+++.+. +|..+..+++|+.|++++|.+.+..|..+..+++|+.|++++|.+.+.++ ..+..+++|
T Consensus 273 ~~~~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L 352 (606)
T 3t6q_A 273 TFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENL 352 (606)
T ss_dssp TTTTCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTC
T ss_pred HhccccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcC
Confidence 66667777777776543 34556666677777777777666666666667777777777776664443 336666777
Q ss_pred cEEeccCCcccc---------------cccCcCCccccccCccccCCCCCCEEeccCCcccccCCcc-ccCCCCCCeeec
Q 046265 262 TFLDLSQNNFYG---------------SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIE-LGNLKSLNYRAL 325 (639)
Q Consensus 262 ~~L~Ls~N~l~~---------------~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~-~~~l~~L~~L~l 325 (639)
++|++++|.+.+ .+++++|.+++..|..+..+++|+.|++++|.+.+..|.. +..+++|+.|++
T Consensus 353 ~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l 432 (606)
T 3t6q_A 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432 (606)
T ss_dssp CEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEEC
T ss_pred CEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEEC
Confidence 777777666543 1455666666555666666666666666666666554433 566666666666
Q ss_pred cCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccC
Q 046265 326 NGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGL 405 (639)
Q Consensus 326 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L 405 (639)
++|.+.+..|..++.+++|+.|++++|++.......+..+..+++|+.|++++|.+.+.. | ..+..++.|
T Consensus 433 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-~---------~~~~~l~~L 502 (606)
T 3t6q_A 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSID-Q---------HAFTSLKMM 502 (606)
T ss_dssp TTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEEC-T---------TTTTTCTTC
T ss_pred CCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccC-h---------hhhccccCC
Confidence 666666666666666666666666664433221122345566666666666666665543 3 345566666
Q ss_pred cEEccCCCeeeeeec
Q 046265 406 SCIDISYNELRGLIR 420 (639)
Q Consensus 406 ~~ldls~N~l~g~~p 420 (639)
+.||+++|++++..|
T Consensus 503 ~~L~Ls~N~l~~~~~ 517 (606)
T 3t6q_A 503 NHVDLSHNRLTSSSI 517 (606)
T ss_dssp CEEECCSSCCCGGGG
T ss_pred CEEECCCCccCcCCh
Confidence 666666666665544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=389.10 Aligned_cols=401 Identities=17% Similarity=0.173 Sum_probs=273.2
Q ss_pred eeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEee
Q 046265 6 FFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVL 85 (639)
Q Consensus 6 ~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 85 (639)
-.+..+++++|++.+..|..|.++++|++|+|++|.+++..|..|+.+++|++|++++|++++..|..++++++|++|++
T Consensus 57 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L 136 (606)
T 3t6q_A 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136 (606)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEEC
T ss_pred ccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEEC
Confidence 34667889999999888999999999999999999998888888999999999999999988655777888889999999
Q ss_pred ecccCccccCccccCCCCCCcccC---------CCCCcccCCCCccEEEccCCcCcccCCccccCC--------------
Q 046265 86 YCNGLSGWLPSSFGNLNNLAIGSM---------PNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHL-------------- 142 (639)
Q Consensus 86 ~~N~l~~~~p~~~~~l~~L~~~~l---------p~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l-------------- 142 (639)
++|++++..++.+..+++|+...+ |..+..+++|....|++++|.+++..|..+...
T Consensus 137 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~ 216 (606)
T 3t6q_A 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLL 216 (606)
T ss_dssp CSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHH
T ss_pred CCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHH
Confidence 988888755455555777762211 233445555522256777776665555443221
Q ss_pred -------------------------------------CCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCc
Q 046265 143 -------------------------------------SNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPP 185 (639)
Q Consensus 143 -------------------------------------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 185 (639)
.+|+.|++++|.+++..+..|+.+++|++|++++|.++ .+|.
T Consensus 217 ~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~ 295 (606)
T 3t6q_A 217 VIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPS 295 (606)
T ss_dssp HHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCS
T ss_pred HHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCCh
Confidence 04556666666666555555666666666666666666 5566
Q ss_pred cCcCCCCCCeEEccCCcc----ccccccccCCcEEEcCCcccCCCCCc-cccCCCCCceeccccccccCcc--hhhhhcC
Q 046265 186 SISNLSNLEGLYLYSSLV----SAEIGNLLQLIELEIDNKQLFGQIPK-SLRNFTSLNIVHLEQNHLTGNI--YEVFGIY 258 (639)
Q Consensus 186 ~~~~l~~L~~L~l~~~~~----~~~~~~l~~L~~L~l~~n~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l 258 (639)
.+..+++|+.|+++.+.+ +..+..+++|+.|++++|.+.+.+|. .+..+++|++|++++|.+++.. +..+..+
T Consensus 296 ~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l 375 (606)
T 3t6q_A 296 GLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL 375 (606)
T ss_dssp SCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTC
T ss_pred hhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccC
Confidence 666666666666665433 33455666666666666666655543 3566666666666666666554 4556666
Q ss_pred CCccEEeccCCcccc-------------cccCcCCccccccCcc-ccCCCCCCEEeccCCcccccCCccccCCCCCCeee
Q 046265 259 PNLTFLDLSQNNFYG-------------SLNFSMNNITRSIPPK-IGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRA 324 (639)
Q Consensus 259 ~~L~~L~Ls~N~l~~-------------~l~ls~n~~~~~~p~~-~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ 324 (639)
++|++|++++|.+.+ .+++++|.+++..|.. +..+++|+.|++++|.+.+..|..+..+++|+.|+
T Consensus 376 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 455 (606)
T 3t6q_A 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455 (606)
T ss_dssp TTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEE
Confidence 666666666666542 2456666666655543 67777788888888877777777777777888888
Q ss_pred ccCccCccc---CCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhh
Q 046265 325 LNGNKVYGS---LPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISR 401 (639)
Q Consensus 325 l~~N~l~~~---~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~ 401 (639)
+++|++.+. .+..+..+++|+.|++++|+ +.+..|..+..+++|+.|++++|.+.+.. | ..+..
T Consensus 456 L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~---l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~---------~~l~~ 522 (606)
T 3t6q_A 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD---LSSIDQHAFTSLKMMNHVDLSHNRLTSSS-I---------EALSH 522 (606)
T ss_dssp CTTCBCGGGEECSSCGGGGCTTCCEEECTTSC---CCEECTTTTTTCTTCCEEECCSSCCCGGG-G---------GGGTT
T ss_pred CCCCCCCccccccchhhccCCCccEEECCCCc---cCccChhhhccccCCCEEECCCCccCcCC-h---------hHhCc
Confidence 888877652 23456777778888887743 44445667777777888888777776544 3 45667
Q ss_pred cccCcEEccCCCeeeeeecC
Q 046265 402 MHGLSCIDISYNELRGLIRN 421 (639)
Q Consensus 402 l~~L~~ldls~N~l~g~~p~ 421 (639)
++.| .+|+++|++++.+|.
T Consensus 523 l~~L-~L~L~~N~l~~~~~~ 541 (606)
T 3t6q_A 523 LKGI-YLNLASNHISIILPS 541 (606)
T ss_dssp CCSC-EEECCSSCCCCCCGG
T ss_pred cccc-EEECcCCcccccCHh
Confidence 7777 777788777766653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=400.04 Aligned_cols=382 Identities=18% Similarity=0.206 Sum_probs=303.0
Q ss_pred eeeEEEEeCCCcccccCCccccCCCCCCEEEC-cCCCCccC---------------------------------------
Q 046265 6 FFFFQVVHESNTLFAIIPPQIGNISNLKFLDM-GNNQLSGV--------------------------------------- 45 (639)
Q Consensus 6 ~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~L-s~n~l~~~--------------------------------------- 45 (639)
-....++++++++.|.+|++|++|++|++|+| ++|.++|.
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 46788999999999999999999999999999 77765444
Q ss_pred -------------------------------------CCCCCCCCCCCCEEEcccCcCCC-----------------CCC
Q 046265 46 -------------------------------------IPQEIDPLTHLKHLYINVNKLRG-----------------SVP 71 (639)
Q Consensus 46 -------------------------------------~p~~~~~L~~L~~L~L~~N~l~~-----------------~~p 71 (639)
+|.+|++|++|++|+|++|++++ .+|
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP 482 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN 482 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCC
Confidence 78889999999999999999998 399
Q ss_pred cccC--CCCCCCEEeeecccCccccCccccCCCCCCcc-----------cCCCCCcccC-------CCCccEEEccCCcC
Q 046265 72 REVG--QLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIG-----------SMPNSLSNLT-------SLSLFHLDLSENQL 131 (639)
Q Consensus 72 ~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~-----------~lp~~~~~l~-------~L~L~~L~L~~N~l 131 (639)
..++ ++++|++|+|++|++.+.+|..|+++++|+.. .+|..+.+++ +| ++|+|++|++
T Consensus 483 ~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L--~~L~Ls~N~L 560 (876)
T 4ecn_A 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI--QIFYMGYNNL 560 (876)
T ss_dssp SCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTC--CEEECCSSCC
T ss_pred hhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCc--cEEEeeCCcC
Confidence 9988 99999999999999999999999999888722 2444444443 55 6888888888
Q ss_pred cccCCc--cccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCC-CCeEEccCCcc---cc
Q 046265 132 SGSIPH--FLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSN-LEGLYLYSSLV---SA 205 (639)
Q Consensus 132 ~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~-L~~L~l~~~~~---~~ 205 (639)
+ .+|. .++++++|++|+|++|+++ .+| .|+.+++|+.|++++|.++ .+|..+..+++ |+.|+++.+.+ |.
T Consensus 561 ~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp~ 636 (876)
T 4ecn_A 561 E-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPN 636 (876)
T ss_dssp C-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCCS
T ss_pred C-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCch
Confidence 7 7777 7888888888888888887 677 7788888888888888887 77777888887 88888876543 44
Q ss_pred cccccc--CCcEEEcCCcccCCCCCccc---c--CCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccCc
Q 046265 206 EIGNLL--QLIELEIDNKQLFGQIPKSL---R--NFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFS 278 (639)
Q Consensus 206 ~~~~l~--~L~~L~l~~n~l~~~~p~~~---~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls 278 (639)
.+..+. +|+.|++++|++.+.+|... . .+++|+.|++++|.++..++..+..+++|+.|+|++|++.
T Consensus 637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~------ 710 (876)
T 4ecn_A 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT------ 710 (876)
T ss_dssp CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS------
T ss_pred hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC------
Confidence 444443 38888888888877665322 2 3347888888888888655555667788888887777663
Q ss_pred CCccccccCcccc--------CCCCCCEEeccCCcccccCCcccc--CCCCCCeeeccCccCcccCCcCccCCCCCCEEe
Q 046265 279 MNNITRSIPPKIG--------KLYQLHKLDFSLNHIVGELPIELG--NLKSLNYRALNGNKVYGSLPRVLGSISDLEYLD 348 (639)
Q Consensus 279 ~n~~~~~~p~~~~--------~l~~L~~L~Ls~N~~~~~~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 348 (639)
.+|..+. ++++|+.|+|++|++. .+|..+. .+++|+.|+|++|++++ +|..++.+++|+.|+
T Consensus 711 ------~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~ 782 (876)
T 4ecn_A 711 ------SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFG 782 (876)
T ss_dssp ------CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEE
T ss_pred ------ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEE
Confidence 4554433 3348999999999998 7888887 89999999999999997 788899999999999
Q ss_pred CCCCC---CCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeeeeeec
Q 046265 349 LSTNY---NNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIR 420 (639)
Q Consensus 349 Ls~N~---~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~g~~p 420 (639)
|++|+ .|.+.+.+|..+..+++|+.|++++|.+ +.+ | ..+. ++|+.||+++|++....+
T Consensus 783 Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~I-p---------~~l~--~~L~~LdLs~N~l~~i~~ 844 (876)
T 4ecn_A 783 IRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKV-D---------EKLT--PQLYILDIADNPNISIDV 844 (876)
T ss_dssp CCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBC-C---------SCCC--SSSCEEECCSCTTCEEEC
T ss_pred CCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-Ccc-C---------Hhhc--CCCCEEECCCCCCCccCh
Confidence 98864 3667788899999999999999999998 556 4 2222 589999999999876544
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=381.67 Aligned_cols=413 Identities=23% Similarity=0.219 Sum_probs=254.3
Q ss_pred EEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecc
Q 046265 9 FQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCN 88 (639)
Q Consensus 9 ~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 88 (639)
..+++++|++.+..|..|.++++|++|+|++|.+++..|.+|+++++|++|+|++|++++..|..|+++++|++|++++|
T Consensus 35 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 114 (606)
T 3vq2_A 35 KNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET 114 (606)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTS
T ss_pred CEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCC
Confidence 44555555555555555556666666666666655555555566666666666666655544555666666666666666
Q ss_pred cCccccCccccCCCCCC--------cc--cCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCC----EEeccCCC
Q 046265 89 GLSGWLPSSFGNLNNLA--------IG--SMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLA----VLHLGDNS 154 (639)
Q Consensus 89 ~l~~~~p~~~~~l~~L~--------~~--~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~L~~N~ 154 (639)
++++..|..|+++++|+ +. .+|..+.++++| ++|++++|++++..|..++.+++|+ +|++++|.
T Consensus 115 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L--~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~ 192 (606)
T 3vq2_A 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNL--VHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192 (606)
T ss_dssp CCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTC--CEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCC
T ss_pred ccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCC--CEEEccCCcceecChhhhhhhhccccccceeeccCCC
Confidence 65555555555555554 11 234445555544 4555555555544444444333332 44444444
Q ss_pred CCCCCCccccCCCcccEEEcccCcCC------------------------------------------------------
Q 046265 155 LFGSIPPILGKVQSLLSLGFDLNLLN------------------------------------------------------ 180 (639)
Q Consensus 155 l~~~~p~~~~~l~~L~~L~l~~N~l~------------------------------------------------------ 180 (639)
+++..+..+... +|+.|++++|.++
T Consensus 193 l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~ 271 (606)
T 3vq2_A 193 IDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYT 271 (606)
T ss_dssp CCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCC
T ss_pred cceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecccc
Confidence 443322222222 4455555444332
Q ss_pred ----ccCCccCcCCCCCCeEEccCCcc---ccccccccCCcEEEcCCcccCCCCCc--------------------cccC
Q 046265 181 ----GVLPPSISNLSNLEGLYLYSSLV---SAEIGNLLQLIELEIDNKQLFGQIPK--------------------SLRN 233 (639)
Q Consensus 181 ----~~~p~~~~~l~~L~~L~l~~~~~---~~~~~~l~~L~~L~l~~n~l~~~~p~--------------------~~~~ 233 (639)
+.+|. +..+++|+.|+++.+.+ + .+..+++|+.|++++|.+ +.+|. .+..
T Consensus 272 ~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~-~l~~~~~L~~L~l~~n~l-~~lp~~~l~~L~~L~l~~n~~~~~~~~~~ 348 (606)
T 3vq2_A 272 NDFSDDIVK-FHCLANVSAMSLAGVSIKYLE-DVPKHFKWQSLSIIRCQL-KQFPTLDLPFLKSLTLTMNKGSISFKKVA 348 (606)
T ss_dssp TTCCGGGGS-CGGGTTCSEEEEESCCCCCCC-CCCTTCCCSEEEEESCCC-SSCCCCCCSSCCEEEEESCSSCEECCCCC
T ss_pred ccccccccc-cccCCCCCEEEecCccchhhh-hccccccCCEEEcccccC-cccccCCCCccceeeccCCcCccchhhcc
Confidence 11111 22333334443332211 1 334444555555555555 44442 3445
Q ss_pred CCCCceeccccccccCcc--hhhhhcCCCccEEeccCCcccc------------cccCcCCccccccC-ccccCCCCCCE
Q 046265 234 FTSLNIVHLEQNHLTGNI--YEVFGIYPNLTFLDLSQNNFYG------------SLNFSMNNITRSIP-PKIGKLYQLHK 298 (639)
Q Consensus 234 l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~------------~l~ls~n~~~~~~p-~~~~~l~~L~~ 298 (639)
+++|++|++++|.+++.. +..+..+++|++|++++|.+.+ .+++++|++.+..| ..+..+++|+.
T Consensus 349 l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 428 (606)
T 3vq2_A 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428 (606)
T ss_dssp CTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCE
T ss_pred CCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCE
Confidence 677777777777777653 6777888888888888887653 36788888887777 67888889999
Q ss_pred EeccCCcccccCCccccCCCCCCeeeccCccCcc-cCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeecc
Q 046265 299 LDFSLNHIVGELPIELGNLKSLNYRALNGNKVYG-SLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLV 377 (639)
Q Consensus 299 L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~ 377 (639)
|++++|.+.+..|..+..+++|+.|++++|.+.+ .+|..++.+++|+.|++++| ++.+..|..+..+++|+.|+++
T Consensus 429 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n---~l~~~~~~~~~~l~~L~~L~Ls 505 (606)
T 3vq2_A 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC---QLEQISWGVFDTLHRLQLLNMS 505 (606)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS---CCCEECTTTTTTCTTCCEEECC
T ss_pred EECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCC---cCCccChhhhcccccCCEEECC
Confidence 9999999888888888889999999999999887 47888888999999999985 4455567788888999999999
Q ss_pred CCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeeeeeecCC-Ccccc-cccccccCCCCCCC
Q 046265 378 ITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRNS-TGIHY-NLVDALQGNKGLCG 441 (639)
Q Consensus 378 ~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~g~~p~~-~~~~~-~~~~~~~~~~~l~g 441 (639)
+|.+.+.. | ..+..+++|+.||+++|+++. +|.. ..+.. .....+.+|+-.|.
T Consensus 506 ~N~l~~~~-~---------~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~ 560 (606)
T 3vq2_A 506 HNNLLFLD-S---------SHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACI 560 (606)
T ss_dssp SSCCSCEE-G---------GGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCS
T ss_pred CCcCCCcC-H---------HHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccC
Confidence 99888765 4 567888999999999999984 4533 11111 22234556665554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=381.59 Aligned_cols=240 Identities=23% Similarity=0.192 Sum_probs=146.9
Q ss_pred eeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeee
Q 046265 7 FFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLY 86 (639)
Q Consensus 7 ~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 86 (639)
.+..+++++|++.+..|..|+++++|++|+|++|.+++..+..|+.+++|++|+|++|++++..|..|+++++|++|+++
T Consensus 50 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 129 (680)
T 1ziw_A 50 QLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLS 129 (680)
T ss_dssp TCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECC
T ss_pred cCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECC
Confidence 34556666666666666666666666667776666664444456677777777777777665555566677777777777
Q ss_pred cccCccccCccccCCCCCCcccCCC---------CCc--ccCCC------------------------------------
Q 046265 87 CNGLSGWLPSSFGNLNNLAIGSMPN---------SLS--NLTSL------------------------------------ 119 (639)
Q Consensus 87 ~N~l~~~~p~~~~~l~~L~~~~lp~---------~~~--~l~~L------------------------------------ 119 (639)
+|.+++..|..++++++|+.-.+.. .+. .+++|
T Consensus 130 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~ 209 (680)
T 1ziw_A 130 HNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGP 209 (680)
T ss_dssp SSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHH
T ss_pred CCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccCh
Confidence 7777666666666666665211110 000 11112
Q ss_pred -------------CccEEEccCCcCcccCCccccCCCC--CCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCC
Q 046265 120 -------------SLFHLDLSENQLSGSIPHFLGHLSN--LAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLP 184 (639)
Q Consensus 120 -------------~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 184 (639)
+|++|++++|++++..|.+|..++. |++|+|++|++++..|..|+.+++|++|++++|.+++..|
T Consensus 210 ~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 289 (680)
T 1ziw_A 210 SLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFS 289 (680)
T ss_dssp HHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECT
T ss_pred hhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccCh
Confidence 1234444444444444444544433 7777777777776666667777777777777777777777
Q ss_pred ccCcCCCCCCeEEccCC---------cccc----ccccccCCcEEEcCCcccCCCCCccccCCCCCceecccccc
Q 046265 185 PSISNLSNLEGLYLYSS---------LVSA----EIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNH 246 (639)
Q Consensus 185 ~~~~~l~~L~~L~l~~~---------~~~~----~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 246 (639)
..|..+++|+.|+++.+ .+|. .+..+++|+.|++++|.+.+..|..|.++++|++|++++|.
T Consensus 290 ~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 364 (680)
T 1ziw_A 290 HSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364 (680)
T ss_dssp TTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCB
T ss_pred hhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCc
Confidence 77777777777777532 1222 45667777777777777777666667776666666666554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=380.28 Aligned_cols=399 Identities=23% Similarity=0.213 Sum_probs=300.8
Q ss_pred eeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeee
Q 046265 7 FFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLY 86 (639)
Q Consensus 7 ~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 86 (639)
....+++++|++.+..|..|.++++|++|+|++|.+++..|..|+.+++|++|+|++|++++..+..|+++++|++|+++
T Consensus 26 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~ 105 (680)
T 1ziw_A 26 NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM 105 (680)
T ss_dssp TCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECC
T ss_pred CCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECC
Confidence 45678899999988888889999999999999999998888889999999999999999985444579999999999999
Q ss_pred cccCccccCccccCCCCCCc---------ccCCCCCcccCCCCccEEEccCCcCcccCCcccc--CCCCCCEEeccCCCC
Q 046265 87 CNGLSGWLPSSFGNLNNLAI---------GSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLG--HLSNLAVLHLGDNSL 155 (639)
Q Consensus 87 ~N~l~~~~p~~~~~l~~L~~---------~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~N~l 155 (639)
+|++++..|..|+++++|+. +..|..+.++++| ++|++++|++++..+..+. .+++|++|++++|.+
T Consensus 106 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L--~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l 183 (680)
T 1ziw_A 106 SNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENL--QELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183 (680)
T ss_dssp SSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTC--CEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred CCccCccChhHccccCCCCEEECCCCcccccCchhhcccccC--CEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence 99999888888998888872 2335567778877 7899999998877666554 457888888888888
Q ss_pred CCCCCccccCC---------------------------CcccEEEcccCcCCccCCccCcCCCC--CCeEEccCCcc---
Q 046265 156 FGSIPPILGKV---------------------------QSLLSLGFDLNLLNGVLPPSISNLSN--LEGLYLYSSLV--- 203 (639)
Q Consensus 156 ~~~~p~~~~~l---------------------------~~L~~L~l~~N~l~~~~p~~~~~l~~--L~~L~l~~~~~--- 203 (639)
++..|..+..+ ++|+.|++++|.+++..|..|..++. |+.|+++.+.+
T Consensus 184 ~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~ 263 (680)
T 1ziw_A 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263 (680)
T ss_dssp CCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEE
T ss_pred cccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCcc
Confidence 77666554433 23344444444444444444444432 55555443322
Q ss_pred -ccccccccCCcEEEcCCcccCCCCCc---------------------------------cccCCCCCceeccccccccC
Q 046265 204 -SAEIGNLLQLIELEIDNKQLFGQIPK---------------------------------SLRNFTSLNIVHLEQNHLTG 249 (639)
Q Consensus 204 -~~~~~~l~~L~~L~l~~n~l~~~~p~---------------------------------~~~~l~~L~~L~L~~N~l~~ 249 (639)
+..+..+++|+.|++++|.+.+..|. .+..+++|++|++++|.+++
T Consensus 264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~ 343 (680)
T 1ziw_A 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCC
T ss_pred CcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCC
Confidence 22344444444444444444333332 45667788888888888888
Q ss_pred cchhhhhcCCCccEEeccCCcccc-----------------cccCcCCccccccCccccCCCCCCEEeccCCcccccCC-
Q 046265 250 NIYEVFGIYPNLTFLDLSQNNFYG-----------------SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELP- 311 (639)
Q Consensus 250 ~~~~~~~~l~~L~~L~Ls~N~l~~-----------------~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p- 311 (639)
..+..|..+++|++|++++|.+.+ .+++++|++++..|..+..+++|+.|++++|.+.+.+|
T Consensus 344 ~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 423 (680)
T 1ziw_A 344 IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423 (680)
T ss_dssp CCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCS
T ss_pred CChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCc
Confidence 888888899999999999886431 35688999998888899999999999999999987665
Q ss_pred ccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchh
Q 046265 312 IELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVI 391 (639)
Q Consensus 312 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~ 391 (639)
..|..+++|+.|++++|++.+..|..+..+++|+.|++++|.+..+ +.+|..+..+++|+.|++++|.+++.. +
T Consensus 424 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~p~~~~~l~~L~~L~Ls~N~l~~i~-~---- 497 (680)
T 1ziw_A 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV-DSSPSPFQPLRNLTILDLSNNNIANIN-D---- 497 (680)
T ss_dssp GGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCT-TCSSCTTTTCTTCCEEECCSSCCCCCC-T----
T ss_pred ccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccccccc-ccCCcccccCCCCCEEECCCCCCCcCC-h----
Confidence 6788999999999999999888888888899999999988765433 467888888899999999998887543 3
Q ss_pred hhhhhhhhhhcccCcEEccCCCeeeee
Q 046265 392 WKAWRSLISRMHGLSCIDISYNELRGL 418 (639)
Q Consensus 392 ~~~~~~~~~~l~~L~~ldls~N~l~g~ 418 (639)
..+..+++|+.||+++|++++.
T Consensus 498 -----~~~~~l~~L~~L~Ls~N~l~~~ 519 (680)
T 1ziw_A 498 -----DMLEGLEKLEILDLQHNNLARL 519 (680)
T ss_dssp -----TTTTTCTTCCEEECCSSCCGGG
T ss_pred -----hhhccccccCEEeCCCCCcccc
Confidence 4567788888888888888764
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=379.57 Aligned_cols=346 Identities=20% Similarity=0.255 Sum_probs=303.4
Q ss_pred CCcccccCCccccCCCCCCEEECcCCCCccC-----------------CCCCCC--CCCCCCEEEcccCcCCCCCCcccC
Q 046265 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGV-----------------IPQEID--PLTHLKHLYINVNKLRGSVPREVG 75 (639)
Q Consensus 15 ~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~-----------------~p~~~~--~L~~L~~L~L~~N~l~~~~p~~~~ 75 (639)
.|++.+ +|+.|+++++|++|+|++|.+++. +|.+++ ++++|++|+|++|++.+.+|..|+
T Consensus 192 ~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~ 270 (636)
T 4eco_A 192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK 270 (636)
T ss_dssp SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT
T ss_pred cCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh
Confidence 678888 999999999999999999999986 999999 999999999999999999999999
Q ss_pred CCCCCCEEeeeccc-Ccc-ccCccccCC------CCCC--------cccCCC--CCcccCCCCccEEEccCCcCcccCCc
Q 046265 76 QLSSLKQLVLYCNG-LSG-WLPSSFGNL------NNLA--------IGSMPN--SLSNLTSLSLFHLDLSENQLSGSIPH 137 (639)
Q Consensus 76 ~l~~L~~L~L~~N~-l~~-~~p~~~~~l------~~L~--------~~~lp~--~~~~l~~L~L~~L~L~~N~l~~~~p~ 137 (639)
++++|++|++++|+ +++ .+|..++.+ ++|+ +..+|. .+.++++| ++|++++|+++|.+|
T Consensus 271 ~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L--~~L~L~~N~l~g~ip- 347 (636)
T 4eco_A 271 ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKL--GMLECLYNQLEGKLP- 347 (636)
T ss_dssp TCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTC--CEEECCSCCCEEECC-
T ss_pred cCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCC--CEEeCcCCcCccchh-
Confidence 99999999999998 998 899988765 6665 457888 88899988 799999999999999
Q ss_pred cccCCCCCCEEeccCCCCCCCCCccccCCCc-ccEEEcccCcCCccCCccCcCCC--CCCeEEccCCcc----ccccc--
Q 046265 138 FLGHLSNLAVLHLGDNSLFGSIPPILGKVQS-LLSLGFDLNLLNGVLPPSISNLS--NLEGLYLYSSLV----SAEIG-- 208 (639)
Q Consensus 138 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~p~~~~~l~--~L~~L~l~~~~~----~~~~~-- 208 (639)
.++.+++|++|+|++|+++ .+|..+..+++ |++|++++|.++ .+|..+..++ +|+.|+++.+.+ |..+.
T Consensus 348 ~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~ 425 (636)
T 4eco_A 348 AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL 425 (636)
T ss_dssp CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTT
T ss_pred hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhccc
Confidence 8999999999999999998 88999999999 999999999999 7888887765 899999997655 34455
Q ss_pred -----cccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCC-------CccEEeccCCccccccc
Q 046265 209 -----NLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYP-------NLTFLDLSQNNFYGSLN 276 (639)
Q Consensus 209 -----~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-------~L~~L~Ls~N~l~~~l~ 276 (639)
.+++|+.|++++|++....+..+..+++|+.|++++|.++...+..+.... +|+.|++++|++
T Consensus 426 ~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l----- 500 (636)
T 4eco_A 426 DPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL----- 500 (636)
T ss_dssp CSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCC-----
T ss_pred ccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcC-----
Confidence 677999999999999854444566799999999999999965555554443 899999877776
Q ss_pred CcCCccccccCcccc--CCCCCCEEeccCCcccccCCccccCCCCCCeeec------cCccCcccCCcCccCCCCCCEEe
Q 046265 277 FSMNNITRSIPPKIG--KLYQLHKLDFSLNHIVGELPIELGNLKSLNYRAL------NGNKVYGSLPRVLGSISDLEYLD 348 (639)
Q Consensus 277 ls~n~~~~~~p~~~~--~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l------~~N~l~~~~p~~~~~l~~L~~L~ 348 (639)
+ .+|..+. .+++|+.|++++|++.+ +|..+..+++|+.|++ ++|++.+.+|..++.+++|+.|+
T Consensus 501 ------~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~ 572 (636)
T 4eco_A 501 ------T-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572 (636)
T ss_dssp ------C-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEE
T ss_pred ------C-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEE
Confidence 3 6888887 89999999999999997 8999999999999999 56888999999999999999999
Q ss_pred CCCCCCCcccccCChhhhccccCCeeeccCCcCceee
Q 046265 349 LSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERY 385 (639)
Q Consensus 349 Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~ 385 (639)
|++|++ +.+|..+. ++|+.|++++|.+....
T Consensus 573 Ls~N~l----~~ip~~~~--~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 573 IGSNDI----RKVNEKIT--PNISVLDIKDNPNISID 603 (636)
T ss_dssp CCSSCC----CBCCSCCC--TTCCEEECCSCTTCEEE
T ss_pred CCCCcC----CccCHhHh--CcCCEEECcCCCCcccc
Confidence 999765 45666654 79999999999877533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=370.10 Aligned_cols=383 Identities=24% Similarity=0.258 Sum_probs=182.8
Q ss_pred eEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeec
Q 046265 8 FFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYC 87 (639)
Q Consensus 8 ~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 87 (639)
...+++++|++.+..|..|.++++|++|+|++|.+++..|..|+.+++|++|+|++|++++..|..|+++++|++|++++
T Consensus 30 l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 109 (570)
T 2z63_A 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109 (570)
T ss_dssp CCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred ccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccc
Confidence 34455666666655555666666666666666666655555566666666666666666554455566666666666666
Q ss_pred ccCccccCccccCCCCCC--------cc--cCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCC----CEEeccCC
Q 046265 88 NGLSGWLPSSFGNLNNLA--------IG--SMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNL----AVLHLGDN 153 (639)
Q Consensus 88 N~l~~~~p~~~~~l~~L~--------~~--~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L----~~L~L~~N 153 (639)
|++++..+..|+++++|+ +. .+|..+.++++| ++|++++|++++..|..++.+++| +.|++++|
T Consensus 110 n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L--~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 110 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL--EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp SCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTC--CEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccCCCccccccccccEEecCCCccceecChhhhcccCCC--CEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 666544444455555444 11 134444444444 455555555544444444444444 44444444
Q ss_pred CCCCCCCccccCCCcccEEEcccC--------------------------------------------------------
Q 046265 154 SLFGSIPPILGKVQSLLSLGFDLN-------------------------------------------------------- 177 (639)
Q Consensus 154 ~l~~~~p~~~~~l~~L~~L~l~~N-------------------------------------------------------- 177 (639)
.+.+..|..+... +|+.|++++|
T Consensus 188 ~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 266 (570)
T 2z63_A 188 PMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266 (570)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred CceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence 4443333333222 3333333332
Q ss_pred --cCCccCCccCcCCCCCCeEEccCCc---cccccccccCCcEEEcCCcccCCCCCcc--------------------cc
Q 046265 178 --LLNGVLPPSISNLSNLEGLYLYSSL---VSAEIGNLLQLIELEIDNKQLFGQIPKS--------------------LR 232 (639)
Q Consensus 178 --~l~~~~p~~~~~l~~L~~L~l~~~~---~~~~~~~l~~L~~L~l~~n~l~~~~p~~--------------------~~ 232 (639)
.+.+..|..+..+++|+.|+++.+. +|..+..+ +|+.|++++|.+. .+|.. ..
T Consensus 267 ~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~~~~~-~L~~L~l~~n~~~-~l~~~~l~~L~~L~l~~n~~~~~~~~~ 344 (570)
T 2z63_A 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF-GWQHLELVNCKFG-QFPTLKLKSLKRLTFTSNKGGNAFSEV 344 (570)
T ss_dssp TTEEESCSTTTTGGGTTCSEEEEESCEECSCCBCCSCC-CCSEEEEESCBCS-SCCBCBCSSCCEEEEESCBSCCBCCCC
T ss_pred chhhhhhchhhhcCcCcccEEEecCccchhhhhhhccC-CccEEeeccCccc-ccCcccccccCEEeCcCCccccccccc
Confidence 1112223333334444444443221 22233333 4444444444432 22221 02
Q ss_pred CCCCCceeccccccccCcc--hhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccC
Q 046265 233 NFTSLNIVHLEQNHLTGNI--YEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGEL 310 (639)
Q Consensus 233 ~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~ 310 (639)
.+++|+.|++++|.+++.. +..+..+++|++|++ ++|.+++.. ..+..+++|+.|++++|.+.+..
T Consensus 345 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l-----------~~n~l~~~~-~~~~~l~~L~~L~l~~n~l~~~~ 412 (570)
T 2z63_A 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL-----------SFNGVITMS-SNFLGLEQLEHLDFQHSNLKQMS 412 (570)
T ss_dssp BCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEEC-----------CSCSEEEEE-EEEETCTTCCEEECTTSEEESCT
T ss_pred cCCCCCEEeCcCCccCccccccccccccCccCEEEC-----------CCCcccccc-ccccccCCCCEEEccCCcccccc
Confidence 3344444444444444332 334444444444444 444444322 22555555555555555555443
Q ss_pred C-ccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCccc-ccCChhhhccccCCeeeccCCcCceeecCc
Q 046265 311 P-IELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFR-KEFPVELEKLVQLTELDLVITFWEERYRPK 388 (639)
Q Consensus 311 p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~-~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~ 388 (639)
| ..+..+++|+.|++++|.+.+..|..+..+++|+.|++++| .+. +.+|..+..+++|+.|++++|.+.+.. |
T Consensus 413 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n---~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~-~- 487 (570)
T 2z63_A 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN---SFQENFLPDIFTELRNLTFLDLSQCQLEQLS-P- 487 (570)
T ss_dssp TSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTC---EEGGGEECSCCTTCTTCCEEECTTSCCCEEC-T-
T ss_pred chhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCC---cCccccchhhhhcccCCCEEECCCCccccCC-h-
Confidence 3 34455555555555555555555555555555555555553 222 234455555555555555555554433 2
Q ss_pred chhhhhhhhhhhhcccCcEEccCCCeeeeeec
Q 046265 389 SVIWKAWRSLISRMHGLSCIDISYNELRGLIR 420 (639)
Q Consensus 389 ~~~~~~~~~~~~~l~~L~~ldls~N~l~g~~p 420 (639)
..+..+++|+.|++++|++++..|
T Consensus 488 --------~~~~~l~~L~~L~l~~n~l~~~~~ 511 (570)
T 2z63_A 488 --------TAFNSLSSLQVLNMASNQLKSVPD 511 (570)
T ss_dssp --------TTTTTCTTCCEEECCSSCCSCCCT
T ss_pred --------hhhhcccCCCEEeCCCCcCCCCCH
Confidence 334455555555555555555443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=371.69 Aligned_cols=395 Identities=18% Similarity=0.224 Sum_probs=286.2
Q ss_pred cccee-eeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCC
Q 046265 2 SCLAF-FFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSL 80 (639)
Q Consensus 2 ~~~~~-~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L 80 (639)
+|.+. ....++.+++++. .+|..+. +++++|+|++|.+++..|..|.++++|++|+|++|++++..|.+|+++++|
T Consensus 6 ~c~~~~~~~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L 82 (606)
T 3vq2_A 6 PCIEVVPNITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82 (606)
T ss_dssp CCEEEETTTEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTC
T ss_pred CceecCCCCceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhc
Confidence 36553 2346777777775 6787765 799999999999998888899999999999999999998888899999999
Q ss_pred CEEeeecccCccccCccccCCCCCCc--------ccCC-CCCcccCCCCccEEEccCCcCcc-cCCccccCCCCCCEEec
Q 046265 81 KQLVLYCNGLSGWLPSSFGNLNNLAI--------GSMP-NSLSNLTSLSLFHLDLSENQLSG-SIPHFLGHLSNLAVLHL 150 (639)
Q Consensus 81 ~~L~L~~N~l~~~~p~~~~~l~~L~~--------~~lp-~~~~~l~~L~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L 150 (639)
++|+|++|++++..|..|+++++|+. ..+| ..+.++++| ++|++++|++++ .+|..++++++|++|+|
T Consensus 83 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~n~l~~~~lp~~~~~l~~L~~L~L 160 (606)
T 3vq2_A 83 SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL--KKLNVAHNFIHSCKLPAYFSNLTNLVHVDL 160 (606)
T ss_dssp CEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTC--CEEECCSSCCCCCCCCGGGGTCTTCCEEEC
T ss_pred CEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCC--CEEeCCCCcccceechHhHhhcCCCCEEEc
Confidence 99999999999988999999999872 2333 567888877 799999999875 57899999999999999
Q ss_pred cCCCCCCCCCccccCCCccc----EEEcccCcCCccCCccCcCCCCCCeEEccCCccc----------------------
Q 046265 151 GDNSLFGSIPPILGKVQSLL----SLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVS---------------------- 204 (639)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~----~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~---------------------- 204 (639)
++|++++..|..++.+++|+ .|++++|.+++..+..+... +|+.|+++.+.+.
T Consensus 161 s~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~ 239 (606)
T 3vq2_A 161 SYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILG 239 (606)
T ss_dssp CSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEE
T ss_pred cCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhcccccccccccccc
Confidence 99999988888888777665 79999999987766666544 7888888755321
Q ss_pred ---------------------------------------cccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccc
Q 046265 205 ---------------------------------------AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQN 245 (639)
Q Consensus 205 ---------------------------------------~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N 245 (639)
..+..+++|+.|++++|.+. .+| ++..+++|+.|++++|
T Consensus 240 ~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n 317 (606)
T 3vq2_A 240 EFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRC 317 (606)
T ss_dssp CCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESC
T ss_pred ccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccch-hhh-hccccccCCEEEcccc
Confidence 01445678889999999884 466 7888999999999999
Q ss_pred cccCcchhhhhcCCCccEEeccCCcccc-----------cccCcCCccccc--cCccccCCCCCCEEeccCCcccccCCc
Q 046265 246 HLTGNIYEVFGIYPNLTFLDLSQNNFYG-----------SLNFSMNNITRS--IPPKIGKLYQLHKLDFSLNHIVGELPI 312 (639)
Q Consensus 246 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-----------~l~ls~n~~~~~--~p~~~~~l~~L~~L~Ls~N~~~~~~p~ 312 (639)
.+ +.+|. + .+++|+.|++++|...+ .+++++|.+++. +|..+..+++|+.|++++|.+.+ +|.
T Consensus 318 ~l-~~lp~-~-~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~ 393 (606)
T 3vq2_A 318 QL-KQFPT-L-DLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSA 393 (606)
T ss_dssp CC-SSCCC-C-CCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECC
T ss_pred cC-ccccc-C-CCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chh
Confidence 99 45553 3 67777777777774322 356666666654 35556666666666666666553 445
Q ss_pred cccCCCCCCeeeccCccCcccCC-cCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchh
Q 046265 313 ELGNLKSLNYRALNGNKVYGSLP-RVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVI 391 (639)
Q Consensus 313 ~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~ 391 (639)
.+..+++|+.|++++|++.+..| ..+..+++|+.|++++| .+.+..|..+..+++|+.|++++|.+.+...|
T Consensus 394 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n---~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~---- 466 (606)
T 3vq2_A 394 NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT---NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLS---- 466 (606)
T ss_dssp CCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTS---CCEECCTTTTTTCTTCCEEECTTCEEGGGEEC----
T ss_pred hccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCC---CCCccchhhhcCCCCCCEEECCCCcCCCcchH----
Confidence 56666666666666666665555 45566666666666663 33444455555666666666666655542213
Q ss_pred hhhhhhhhhhcccCcEEccCCCeeeeeec
Q 046265 392 WKAWRSLISRMHGLSCIDISYNELRGLIR 420 (639)
Q Consensus 392 ~~~~~~~~~~l~~L~~ldls~N~l~g~~p 420 (639)
..+..+++|+.||+++|++++.+|
T Consensus 467 -----~~~~~l~~L~~L~Ls~n~l~~~~~ 490 (606)
T 3vq2_A 467 -----NVFANTTNLTFLDLSKCQLEQISW 490 (606)
T ss_dssp -----SCCTTCTTCCEEECTTSCCCEECT
T ss_pred -----HhhccCCCCCEEECCCCcCCccCh
Confidence 334455555555555555555444
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=390.43 Aligned_cols=398 Identities=21% Similarity=0.204 Sum_probs=276.7
Q ss_pred eeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCC-CCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEe
Q 046265 6 FFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVI-PQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLV 84 (639)
Q Consensus 6 ~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 84 (639)
-....+++++|++.+..|..|.++++|++|+|++|...+.+ |.+|.++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 103 (844)
T 3j0a_A 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR 103 (844)
T ss_dssp TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEE
T ss_pred CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEee
Confidence 34567778888888777777777777777777777554444 66777777777777777777766677777777777777
Q ss_pred eecccCccccCcc--ccCCCCCC--------cccC--CCCCcccCCCCccEEEccCCcCcccCCccccCC--CC------
Q 046265 85 LYCNGLSGWLPSS--FGNLNNLA--------IGSM--PNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHL--SN------ 144 (639)
Q Consensus 85 L~~N~l~~~~p~~--~~~l~~L~--------~~~l--p~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l--~~------ 144 (639)
|++|.+++.+|.. |.++++|+ +..+ +..+.++++| ++|+|++|.+++..|..+..+ ++
T Consensus 104 Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L--~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L 181 (844)
T 3j0a_A 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSL--KSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181 (844)
T ss_dssp CTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSC--CEEEEESSCCCCCCSGGGHHHHHCSSCCCEE
T ss_pred CcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCC--CEEECCCCcCCeeCHHHcccccCCccceEEC
Confidence 7777777655554 66777665 1121 2346666666 567777776665555554433 23
Q ss_pred ------------------------CCEEeccCCCCCCCCCccccC-----------------------------------
Q 046265 145 ------------------------LAVLHLGDNSLFGSIPPILGK----------------------------------- 165 (639)
Q Consensus 145 ------------------------L~~L~L~~N~l~~~~p~~~~~----------------------------------- 165 (639)
|++|++++|.+++..|..+..
T Consensus 182 ~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~ 261 (844)
T 3j0a_A 182 AANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA 261 (844)
T ss_dssp CCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTT
T ss_pred CCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhh
Confidence 566666666555544443321
Q ss_pred ---CCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCcc----ccccccccCCcEEEcCCcccCCCCCccccCCCCCc
Q 046265 166 ---VQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLV----SAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLN 238 (639)
Q Consensus 166 ---l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~----~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 238 (639)
.++|+.|++++|.+.+..|..|..+++|+.|+++.+.+ +..+..+++|+.|++++|.+.+..|..+.++++|+
T Consensus 262 ~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 341 (844)
T 3j0a_A 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVA 341 (844)
T ss_dssp TTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCC
T ss_pred ccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCC
Confidence 14677788888888777778888888888888876654 34577788888888888888887788888888888
Q ss_pred eeccccccccCcchhhhhcCCCccEEeccCCcccc--------cccCcCCccccccCc----------------------
Q 046265 239 IVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG--------SLNFSMNNITRSIPP---------------------- 288 (639)
Q Consensus 239 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--------~l~ls~n~~~~~~p~---------------------- 288 (639)
.|++++|.+++..+..|..+++|+.|++++|.+.+ .+++++|+++ .+|.
T Consensus 342 ~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~-~l~~~~~~l~~L~ls~N~l~~l~~~~ 420 (844)
T 3j0a_A 342 YIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLV-TLPKINLTANLIHLSENRLENLDILY 420 (844)
T ss_dssp EEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCC-CCCCCCTTCCEEECCSCCCCSSTTHH
T ss_pred EEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcc-cccccccccceeecccCccccCchhh
Confidence 88888888888877788888888888888888764 2344555544 2222
Q ss_pred cccCCCCCCEEeccCCcccccCCc-cccCCCCCCeeeccCccCc-----ccCCcCccCCCCCCEEeCCCCCCCcccccCC
Q 046265 289 KIGKLYQLHKLDFSLNHIVGELPI-ELGNLKSLNYRALNGNKVY-----GSLPRVLGSISDLEYLDLSTNYNNEFRKEFP 362 (639)
Q Consensus 289 ~~~~l~~L~~L~Ls~N~~~~~~p~-~~~~l~~L~~L~l~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p 362 (639)
.++.+++|+.|++++|++.+..+. .+..+++|+.|++++|.+. +..|..+..+++|+.|+|++| .+.+..|
T Consensus 421 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N---~l~~~~~ 497 (844)
T 3j0a_A 421 FLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHN---YLNSLPP 497 (844)
T ss_dssp HHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHH---HHTTCCT
T ss_pred hhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCC---cccccCh
Confidence 234677788888888887754432 3455677777778777775 334456777788888888874 4445556
Q ss_pred hhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeeeeeecC
Q 046265 363 VELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRN 421 (639)
Q Consensus 363 ~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~g~~p~ 421 (639)
..+..+++|+.|++++|.+++.. + ..+. ++|+.||+++|++++.+|.
T Consensus 498 ~~~~~l~~L~~L~Ls~N~l~~l~-~---------~~~~--~~L~~L~Ls~N~l~~~~~~ 544 (844)
T 3j0a_A 498 GVFSHLTALRGLSLNSNRLTVLS-H---------NDLP--ANLEILDISRNQLLAPNPD 544 (844)
T ss_dssp TSSSSCCSCSEEEEESCCCSSCC-C---------CCCC--SCCCEEEEEEECCCCCCSC
T ss_pred hHccchhhhheeECCCCCCCccC-h---------hhhh--ccccEEECCCCcCCCCChh
Confidence 66778888888888888777533 2 1122 5688888888888887774
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=378.16 Aligned_cols=344 Identities=20% Similarity=0.245 Sum_probs=297.8
Q ss_pred CCcccccCCccccCCCCCCEEECcCCCCcc-----------------CCCCCCC--CCCCCCEEEcccCcCCCCCCcccC
Q 046265 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSG-----------------VIPQEID--PLTHLKHLYINVNKLRGSVPREVG 75 (639)
Q Consensus 15 ~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~-----------------~~p~~~~--~L~~L~~L~L~~N~l~~~~p~~~~ 75 (639)
.|++.+ +|+.|+++++|++|+|++|.+++ .+|..++ .+++|++|+|++|++.+.+|..|+
T Consensus 434 ~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~ 512 (876)
T 4ecn_A 434 TNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLY 512 (876)
T ss_dssp SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGG
T ss_pred cCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHh
Confidence 478888 89999999999999999999998 3899988 999999999999999999999999
Q ss_pred CCCCCCEEeeeccc-Ccc-ccCccccCCC-------CCC--------cccCCC--CCcccCCCCccEEEccCCcCcccCC
Q 046265 76 QLSSLKQLVLYCNG-LSG-WLPSSFGNLN-------NLA--------IGSMPN--SLSNLTSLSLFHLDLSENQLSGSIP 136 (639)
Q Consensus 76 ~l~~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~--------~~~lp~--~~~~l~~L~L~~L~L~~N~l~~~~p 136 (639)
++++|++|+|++|+ +++ .+|..++++. +|+ +..+|. .+.++++| ++|+|++|+++ .+|
T Consensus 513 ~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~~L--~~L~Ls~N~l~-~lp 589 (876)
T 4ecn_A 513 DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKL--GLLDCVHNKVR-HLE 589 (876)
T ss_dssp GCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCTTC--CEEECTTSCCC-BCC
T ss_pred CCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCCCC--CEEECCCCCcc-cch
Confidence 99999999999998 998 8898776554 665 457888 88999988 79999999999 888
Q ss_pred ccccCCCCCCEEeccCCCCCCCCCccccCCCc-ccEEEcccCcCCccCCccCcCCCC--CCeEEccCCcccccc------
Q 046265 137 HFLGHLSNLAVLHLGDNSLFGSIPPILGKVQS-LLSLGFDLNLLNGVLPPSISNLSN--LEGLYLYSSLVSAEI------ 207 (639)
Q Consensus 137 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~p~~~~~l~~--L~~L~l~~~~~~~~~------ 207 (639)
.|+.+++|+.|+|++|+++ .+|..+..+++ |+.|++++|.++ .+|..+..++. |+.|+++.+.+...+
T Consensus 590 -~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~ 666 (876)
T 4ecn_A 590 -AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCS 666 (876)
T ss_dssp -CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSC
T ss_pred -hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhh
Confidence 8999999999999999999 89999999999 999999999999 78888887765 999999987764322
Q ss_pred -c--cccCCcEEEcCCcccCCCCCccc-cCCCCCceeccccccccCcchhhhhcC-------CCccEEeccCCccccccc
Q 046265 208 -G--NLLQLIELEIDNKQLFGQIPKSL-RNFTSLNIVHLEQNHLTGNIYEVFGIY-------PNLTFLDLSQNNFYGSLN 276 (639)
Q Consensus 208 -~--~l~~L~~L~l~~n~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l-------~~L~~L~Ls~N~l~~~l~ 276 (639)
. .+++|+.|++++|++. .+|..+ ..+++|+.|+|++|.++...+..+... ++|+.|+|++|++
T Consensus 667 l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L----- 740 (876)
T 4ecn_A 667 MDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL----- 740 (876)
T ss_dssp TTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCC-----
T ss_pred hccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCC-----
Confidence 2 3348999999999997 566654 589999999999999996554444433 3899999887776
Q ss_pred CcCCccccccCcccc--CCCCCCEEeccCCcccccCCccccCCCCCCeeeccC------ccCcccCCcCccCCCCCCEEe
Q 046265 277 FSMNNITRSIPPKIG--KLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNG------NKVYGSLPRVLGSISDLEYLD 348 (639)
Q Consensus 277 ls~n~~~~~~p~~~~--~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~------N~l~~~~p~~~~~l~~L~~L~ 348 (639)
+ .+|..+. .+++|+.|+|++|++.+ +|..+..+++|+.|+|++ |++.+.+|..++.+++|+.|+
T Consensus 741 ------~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~ 812 (876)
T 4ecn_A 741 ------T-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQ 812 (876)
T ss_dssp ------C-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEE
T ss_pred ------c-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEE
Confidence 3 6888887 89999999999999997 799999999999999976 888999999999999999999
Q ss_pred CCCCCCCcccccCChhhhccccCCeeeccCCcCceee
Q 046265 349 LSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERY 385 (639)
Q Consensus 349 Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~ 385 (639)
|++|++ +.+|..+. ++|+.|++++|.+....
T Consensus 813 Ls~N~L----~~Ip~~l~--~~L~~LdLs~N~l~~i~ 843 (876)
T 4ecn_A 813 IGSNDI----RKVDEKLT--PQLYILDIADNPNISID 843 (876)
T ss_dssp CCSSCC----CBCCSCCC--SSSCEEECCSCTTCEEE
T ss_pred CCCCCC----CccCHhhc--CCCCEEECCCCCCCccC
Confidence 999654 55676654 69999999999887644
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=359.63 Aligned_cols=397 Identities=20% Similarity=0.234 Sum_probs=327.4
Q ss_pred ccceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCC
Q 046265 2 SCLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81 (639)
Q Consensus 2 ~~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 81 (639)
.|.|..-......++.-...+|..+. +++++|+|++|.+++..+.+|..+++|++|+|++|++++..|..|+++++|+
T Consensus 2 ~c~~~~~~~~~~c~~~~l~~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~ 79 (570)
T 2z63_A 2 PCVEVVPNITYQCMELNFYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79 (570)
T ss_dssp CSEEEETTTEEECCSSCCSSCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CccccCCCcEEEeCCCCccccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCC
Confidence 46555543333344444457887664 5899999999999988888999999999999999999987788899999999
Q ss_pred EEeeecccCccccCccccCCCCCCc--------ccCCC-CCcccCCCCccEEEccCCcCcc-cCCccccCCCCCCEEecc
Q 046265 82 QLVLYCNGLSGWLPSSFGNLNNLAI--------GSMPN-SLSNLTSLSLFHLDLSENQLSG-SIPHFLGHLSNLAVLHLG 151 (639)
Q Consensus 82 ~L~L~~N~l~~~~p~~~~~l~~L~~--------~~lp~-~~~~l~~L~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~ 151 (639)
+|+|++|++++..|..|+++++|+. ..+|. .+.++++| ++|++++|.+++ .+|..|+++++|++|+++
T Consensus 80 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L--~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~ 157 (570)
T 2z63_A 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL--KELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157 (570)
T ss_dssp EEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTC--CEEECCSSCCCCCCCCGGGGGCTTCCEEECT
T ss_pred EEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccc--cEEecCCCccceecChhhhcccCCCCEEeCc
Confidence 9999999999988899999998872 33333 57788877 799999999986 478999999999999999
Q ss_pred CCCCCCCCCccccCCCcc----cEEEcccCcCCccCCccCcCCCCCCeEEccCC--------------------------
Q 046265 152 DNSLFGSIPPILGKVQSL----LSLGFDLNLLNGVLPPSISNLSNLEGLYLYSS-------------------------- 201 (639)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L----~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~-------------------------- 201 (639)
+|++++..|..++.+++| +.|++++|.+++..|..+..+ +|+.|+++.+
T Consensus 158 ~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~ 236 (570)
T 2z63_A 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE 236 (570)
T ss_dssp TSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEE
T ss_pred CCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeecccc
Confidence 999998778888888888 899999999998888777655 6777766543
Q ss_pred ------------------------------------ccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccc
Q 046265 202 ------------------------------------LVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQN 245 (639)
Q Consensus 202 ------------------------------------~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N 245 (639)
..+..+..+++|+.|++++|.+. .+|.++..+ +|+.|++++|
T Consensus 237 ~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n 314 (570)
T 2z63_A 237 FRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNC 314 (570)
T ss_dssp CCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESC
T ss_pred ccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccC
Confidence 12234566788999999999886 578888888 9999999999
Q ss_pred cccCcchhhhhcCCCccEEeccCCcccc-----------cccCcCCcccccc--CccccCCCCCCEEeccCCcccccCCc
Q 046265 246 HLTGNIYEVFGIYPNLTFLDLSQNNFYG-----------SLNFSMNNITRSI--PPKIGKLYQLHKLDFSLNHIVGELPI 312 (639)
Q Consensus 246 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-----------~l~ls~n~~~~~~--p~~~~~l~~L~~L~Ls~N~~~~~~p~ 312 (639)
.+..... ..+++|+.|++++|.+.+ .+++++|.+++.. |..+..+++|+.|++++|.+.+..+
T Consensus 315 ~~~~l~~---~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~- 390 (570)
T 2z63_A 315 KFGQFPT---LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS- 390 (570)
T ss_dssp BCSSCCB---CBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-
T ss_pred cccccCc---ccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-
Confidence 9885433 467889999999888754 3678889888654 7788899999999999999986554
Q ss_pred cccCCCCCCeeeccCccCcccCC-cCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCc-eeecCcch
Q 046265 313 ELGNLKSLNYRALNGNKVYGSLP-RVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWE-ERYRPKSV 390 (639)
Q Consensus 313 ~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~-~~~~~~~~ 390 (639)
.+..+++|+.|++++|.+.+..| ..+..+++|+.|++++| .+.+..|..+..+++|+.|++++|.+. +.. |
T Consensus 391 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n---~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-p--- 463 (570)
T 2z63_A 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT---HTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-P--- 463 (570)
T ss_dssp EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTS---CCEECCTTTTTTCTTCCEEECTTCEEGGGEE-C---
T ss_pred cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCC---cccccchhhhhcCCcCcEEECcCCcCccccc-h---
Confidence 49999999999999999998766 57899999999999995 556667888999999999999999887 344 4
Q ss_pred hhhhhhhhhhhcccCcEEccCCCeeeeeecCC
Q 046265 391 IWKAWRSLISRMHGLSCIDISYNELRGLIRNS 422 (639)
Q Consensus 391 ~~~~~~~~~~~l~~L~~ldls~N~l~g~~p~~ 422 (639)
..+..+++|+.||+++|++++..|..
T Consensus 464 ------~~~~~l~~L~~L~l~~n~l~~~~~~~ 489 (570)
T 2z63_A 464 ------DIFTELRNLTFLDLSQCQLEQLSPTA 489 (570)
T ss_dssp ------SCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred ------hhhhcccCCCEEECCCCccccCChhh
Confidence 56788999999999999999987753
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=349.17 Aligned_cols=369 Identities=19% Similarity=0.192 Sum_probs=297.7
Q ss_pred EEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCC-CcccCCCCCCCEEeeec
Q 046265 9 FQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSV-PREVGQLSSLKQLVLYC 87 (639)
Q Consensus 9 ~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~ 87 (639)
..++.+++++. .+|. +. ++|++|+|++|.+++..|..|+.+++|++|+|++|.+.+.+ |..|.++++|++|+|++
T Consensus 13 ~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 34566656554 6776 43 78999999999999888999999999999999999997655 56799999999999999
Q ss_pred ccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCcc--ccCCCCCCEEeccCCCCCCCCCcc-cc
Q 046265 88 NGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHF--LGHLSNLAVLHLGDNSLFGSIPPI-LG 164 (639)
Q Consensus 88 N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~ 164 (639)
|++++..|..|+++++| ++|+|++|++++.+|.. +..+++|++|+|++|++++..|.. +.
T Consensus 89 n~l~~~~~~~~~~l~~L-----------------~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 151 (455)
T 3v47_A 89 NQFLQLETGAFNGLANL-----------------EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151 (455)
T ss_dssp CTTCEECTTTTTTCTTC-----------------CEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGG
T ss_pred CccCccChhhccCcccC-----------------CEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccC
Confidence 99998888888888744 59999999999766655 899999999999999999887876 89
Q ss_pred CCCcccEEEcccCcCCccCCccCcCC--CCCCeEEccCCcccc------------ccccccCCcEEEcCCcccCCCCCcc
Q 046265 165 KVQSLLSLGFDLNLLNGVLPPSISNL--SNLEGLYLYSSLVSA------------EIGNLLQLIELEIDNKQLFGQIPKS 230 (639)
Q Consensus 165 ~l~~L~~L~l~~N~l~~~~p~~~~~l--~~L~~L~l~~~~~~~------------~~~~l~~L~~L~l~~n~l~~~~p~~ 230 (639)
.+++|++|++++|.+++..|..+..+ .+|+.|+++.+.+.. .+..+++|+.|++++|++.+..|..
T Consensus 152 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~ 231 (455)
T 3v47_A 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKR 231 (455)
T ss_dssp GCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHH
T ss_pred CCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhh
Confidence 99999999999999999988888776 567777777554432 1224467778888888777776666
Q ss_pred ccCC---CCCceeccccccccCcc----------hhhhhc--CCCccEEeccCCcccccccCcCCccccccCccccCCCC
Q 046265 231 LRNF---TSLNIVHLEQNHLTGNI----------YEVFGI--YPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQ 295 (639)
Q Consensus 231 ~~~l---~~L~~L~L~~N~l~~~~----------~~~~~~--l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~ 295 (639)
+..+ ++|+.|++++|.+.+.. +..+.. .++|+.|++++| .+++..|..++.+++
T Consensus 232 ~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n-----------~l~~~~~~~~~~l~~ 300 (455)
T 3v47_A 232 FFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKS-----------KIFALLKSVFSHFTD 300 (455)
T ss_dssp HHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSS-----------CCCEECTTTTTTCTT
T ss_pred hhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCc-----------cccccchhhcccCCC
Confidence 5443 67777777777554321 111111 246667775554 455678888999999
Q ss_pred CCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeee
Q 046265 296 LHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELD 375 (639)
Q Consensus 296 L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~ 375 (639)
|+.|++++|++.+..|..|..+++|+.|++++|.+.+..|..++.+++|+.|++++|+ +.+..|..+..+++|+.|+
T Consensus 301 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~---l~~~~~~~~~~l~~L~~L~ 377 (455)
T 3v47_A 301 LEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNH---IRALGDQSFLGLPNLKELA 377 (455)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSC---CCEECTTTTTTCTTCCEEE
T ss_pred CCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCc---ccccChhhccccccccEEE
Confidence 9999999999998889999999999999999999998888899999999999999964 4555678899999999999
Q ss_pred ccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeeeeeecCC
Q 046265 376 LVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRNS 422 (639)
Q Consensus 376 l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~g~~p~~ 422 (639)
+++|.+.+.. + ..+..+++|+.+++++|++++.+|..
T Consensus 378 L~~N~l~~~~-~---------~~~~~l~~L~~L~l~~N~l~~~~~~~ 414 (455)
T 3v47_A 378 LDTNQLKSVP-D---------GIFDRLTSLQKIWLHTNPWDCSCPRI 414 (455)
T ss_dssp CCSSCCSCCC-T---------TTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred CCCCccccCC-H---------hHhccCCcccEEEccCCCcccCCCcc
Confidence 9999888633 3 45678899999999999999988753
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=357.46 Aligned_cols=387 Identities=21% Similarity=0.200 Sum_probs=258.4
Q ss_pred eeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeee
Q 046265 7 FFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLY 86 (639)
Q Consensus 7 ~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 86 (639)
.+..+++++|++.+..|..|.++++|++|+|++|.+++..|.+|+.+++|++|+|++|++++..|..|+++++|++|+++
T Consensus 27 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 106 (549)
T 2z81_A 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLM 106 (549)
T ss_dssp TCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECT
T ss_pred CccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECC
Confidence 46678888898888888889999999999999999988888889999999999999999987666668899999999999
Q ss_pred cccCcc-ccCccccCCCCCC---------cccCC-CCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCC
Q 046265 87 CNGLSG-WLPSSFGNLNNLA---------IGSMP-NSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSL 155 (639)
Q Consensus 87 ~N~l~~-~~p~~~~~l~~L~---------~~~lp-~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 155 (639)
+|++++ ..|..++++++|+ ++.+| ..+.++++| ++|++++|++++..|..+..+++|++|+++.|.+
T Consensus 107 ~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L--~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~ 184 (549)
T 2z81_A 107 GNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL--NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES 184 (549)
T ss_dssp TCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEE--EEEEEEETTCCEECTTTTTTCSEEEEEEEECSBS
T ss_pred CCcccccchhhhhhccCCccEEECCCCccccccCHhhhhccccc--CeeeccCCcccccChhhhhccccCceEecccCcc
Confidence 998886 3567788888776 23444 467777766 7888888888888888888888888888877776
Q ss_pred CCCCCcc-ccCCCcccEEEcccCcCCccC--Cc-cCcCCCCCCeEEccCCc-----------------------------
Q 046265 156 FGSIPPI-LGKVQSLLSLGFDLNLLNGVL--PP-SISNLSNLEGLYLYSSL----------------------------- 202 (639)
Q Consensus 156 ~~~~p~~-~~~l~~L~~L~l~~N~l~~~~--p~-~~~~l~~L~~L~l~~~~----------------------------- 202 (639)
.. +|.. ++.+++|++|++++|.+++.. |. ....+++|+.|+++.+.
T Consensus 185 ~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~ 263 (549)
T 2z81_A 185 AF-LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTL 263 (549)
T ss_dssp TT-HHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEE
T ss_pred cc-cchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccc
Confidence 53 3433 356788888888888887641 11 11223344444433221
Q ss_pred -----------------------------cccc---------cccccCCcEEEcCCcccCCCCCccc-cCCCCCceeccc
Q 046265 203 -----------------------------VSAE---------IGNLLQLIELEIDNKQLFGQIPKSL-RNFTSLNIVHLE 243 (639)
Q Consensus 203 -----------------------------~~~~---------~~~l~~L~~L~l~~n~l~~~~p~~~-~~l~~L~~L~L~ 243 (639)
++.. +....+|+.|++++|.+. .+|..+ ..+++|++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls 342 (549)
T 2z81_A 264 NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLS 342 (549)
T ss_dssp ECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECC
T ss_pred cccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEcc
Confidence 1110 111246777788887774 567665 578999999999
Q ss_pred cccccCcchhh---hhcCCCccEEeccCCcccc---------------cccCcCCccccccCccccCCCCCCEEeccCCc
Q 046265 244 QNHLTGNIYEV---FGIYPNLTFLDLSQNNFYG---------------SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNH 305 (639)
Q Consensus 244 ~N~l~~~~~~~---~~~l~~L~~L~Ls~N~l~~---------------~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~ 305 (639)
+|.+++..|.. ++.+++|++|++++|++.+ .+++++|+++ .+|..+..+++|+.|++++|.
T Consensus 343 ~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~ 421 (549)
T 2z81_A 343 ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTG 421 (549)
T ss_dssp SSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSC
T ss_pred CCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCC
Confidence 99998876543 6778999999998888742 1445555555 455555555566666666665
Q ss_pred ccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceee
Q 046265 306 IVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERY 385 (639)
Q Consensus 306 ~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~ 385 (639)
+. .+|..+. ++|+.|++++|++++.+ ..+++|+.|++++|++. .+|. ...+++|+.|++++|.+++..
T Consensus 422 l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~----~ip~-~~~l~~L~~L~Ls~N~l~~~~ 489 (549)
T 2z81_A 422 IR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK----TLPD-ASLFPVLLVMKISRNQLKSVP 489 (549)
T ss_dssp CS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS----SCCC-GGGCTTCCEEECCSSCCCCCC
T ss_pred cc-cccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC----cCCC-cccCccCCEEecCCCccCCcC
Confidence 54 2232221 35566666666655422 34556666666664433 2333 244556666666666555433
Q ss_pred cCcchhhhhhhhhhhhcccCcEEccCCCeeeeeec
Q 046265 386 RPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIR 420 (639)
Q Consensus 386 ~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~g~~p 420 (639)
| ..+..+++|+.+|+++|++.+..|
T Consensus 490 -~---------~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 490 -D---------GIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp -T---------TGGGGCTTCCEEECCSSCBCCCHH
T ss_pred -H---------HHHhcCcccCEEEecCCCccCCCc
Confidence 2 335555666666666666655544
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=375.69 Aligned_cols=403 Identities=20% Similarity=0.173 Sum_probs=298.2
Q ss_pred ccceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCC-CcccCCCCCC
Q 046265 2 SCLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSV-PREVGQLSSL 80 (639)
Q Consensus 2 ~~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~-p~~~~~l~~L 80 (639)
+|.+.. ..++-+++++. .+|. ..+++++|||++|.+++..|..|..+++|++|+|++|...+.+ |.+|+++++|
T Consensus 1 ~C~~~~-~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L 75 (844)
T 3j0a_A 1 SCSFDG-RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNL 75 (844)
T ss_dssp CCBTTT-EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTC
T ss_pred CceEec-eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCC
Confidence 465543 55677777776 5665 4579999999999999999999999999999999999766566 7889999999
Q ss_pred CEEeeecccCccccCccccCCCCCCc---------ccCCCC--CcccCCCCccEEEccCCcCcccCC-ccccCCCCCCEE
Q 046265 81 KQLVLYCNGLSGWLPSSFGNLNNLAI---------GSMPNS--LSNLTSLSLFHLDLSENQLSGSIP-HFLGHLSNLAVL 148 (639)
Q Consensus 81 ~~L~L~~N~l~~~~p~~~~~l~~L~~---------~~lp~~--~~~l~~L~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L 148 (639)
++|+|++|.+++..|..|+++++|+. +.+|.. +.++++| ++|+|++|.+++..+ ..|+++++|++|
T Consensus 76 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L--~~L~Ls~N~l~~~~~~~~~~~L~~L~~L 153 (844)
T 3j0a_A 76 RILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKAL--TRLDLSKNQIRSLYLHPSFGKLNSLKSI 153 (844)
T ss_dssp CEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSC--CEEEEESCCCCCCCCCGGGGTCSSCCEE
T ss_pred CEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCC--CEEECCCCcccccccchhHhhCCCCCEE
Confidence 99999999999999999999999972 223443 7788887 799999999987655 578999999999
Q ss_pred eccCCCCCCCCCccccCC--CcccEEEcccCcCCccCCccCcCCCC------CCeEEccCCccc----ccc---------
Q 046265 149 HLGDNSLFGSIPPILGKV--QSLLSLGFDLNLLNGVLPPSISNLSN------LEGLYLYSSLVS----AEI--------- 207 (639)
Q Consensus 149 ~L~~N~l~~~~p~~~~~l--~~L~~L~l~~N~l~~~~p~~~~~l~~------L~~L~l~~~~~~----~~~--------- 207 (639)
+|++|.+++..|..+..+ ++|+.|+++.|.+.+..|..+..+.+ |+.|+++.+.+. ..+
T Consensus 154 ~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l 233 (844)
T 3j0a_A 154 DFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQA 233 (844)
T ss_dssp EEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCB
T ss_pred ECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccc
Confidence 999999999888888877 88999999999998888877776665 888888765321 111
Q ss_pred ---------------------------cc--ccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcC
Q 046265 208 ---------------------------GN--LLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIY 258 (639)
Q Consensus 208 ---------------------------~~--l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 258 (639)
.. .++|+.|++++|.+.+..|..+..+++|+.|++++|.+++..+..|..+
T Consensus 234 ~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l 313 (844)
T 3j0a_A 234 FSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGL 313 (844)
T ss_dssp SEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTC
T ss_pred cceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCC
Confidence 11 2578999999999988888888999999999999999998888889999
Q ss_pred CCccEEeccCCcccc-------------cccCcCCccccccCccccCCCCCCEEeccCCcccccCC--------------
Q 046265 259 PNLTFLDLSQNNFYG-------------SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELP-------------- 311 (639)
Q Consensus 259 ~~L~~L~Ls~N~l~~-------------~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p-------------- 311 (639)
++|++|++++|.+.+ .+++++|.+++..+..+..+++|+.|++++|.+.+...
T Consensus 314 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l 393 (844)
T 3j0a_A 314 DNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKL 393 (844)
T ss_dssp SSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCC
T ss_pred CCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCc
Confidence 999999999988754 25677888877666677778888888888887763211
Q ss_pred ----c----------------------cccCCCCCCeeeccCccCcccCCc-CccCCCCCCEEeCCCCCCCccc--ccCC
Q 046265 312 ----I----------------------ELGNLKSLNYRALNGNKVYGSLPR-VLGSISDLEYLDLSTNYNNEFR--KEFP 362 (639)
Q Consensus 312 ----~----------------------~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~~~~~~--~~~p 362 (639)
. .+..+++|+.|++++|++++..+. .+..+++|+.|++++|.+.... +..|
T Consensus 394 ~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~ 473 (844)
T 3j0a_A 394 VTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCW 473 (844)
T ss_dssp CCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCS
T ss_pred ccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccch
Confidence 0 011334444444444444432221 1233444444444443332111 2223
Q ss_pred hhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeeeeeecC
Q 046265 363 VELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRN 421 (639)
Q Consensus 363 ~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~g~~p~ 421 (639)
..+..+++|+.|++++|.+++.. | ..+..+++|+.||+++|++++..|.
T Consensus 474 ~~~~~l~~L~~L~Ls~N~l~~~~-~---------~~~~~l~~L~~L~Ls~N~l~~l~~~ 522 (844)
T 3j0a_A 474 DVFEGLSHLQVLYLNHNYLNSLP-P---------GVFSHLTALRGLSLNSNRLTVLSHN 522 (844)
T ss_dssp SCSSCBCCEECCCCCHHHHTTCC-T---------TSSSSCCSCSEEEEESCCCSSCCCC
T ss_pred hhhcCcccccEEECCCCcccccC-h---------hHccchhhhheeECCCCCCCccChh
Confidence 34555666666666666655433 2 5577889999999999999876553
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=354.60 Aligned_cols=195 Identities=23% Similarity=0.254 Sum_probs=151.9
Q ss_pred EEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccC
Q 046265 11 VVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGL 90 (639)
Q Consensus 11 ~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 90 (639)
.+.+++++. .+|..+. ++|++|+|++|.+++..|.+|..+++|++|+|++|++++..|.+|+++++|++|+|++|++
T Consensus 10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 86 (549)
T 2z81_A 10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86 (549)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence 567777776 6777665 7999999999999988899999999999999999999988888999999999999999999
Q ss_pred ccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcc-cCCccccCCCCCCEEeccCCCCCCCCC-ccccCCCc
Q 046265 91 SGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSG-SIPHFLGHLSNLAVLHLGDNSLFGSIP-PILGKVQS 168 (639)
Q Consensus 91 ~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~ 168 (639)
++..|..|+++++|+ +|++++|++++ ..|..++++++|++|++++|.+.+.+| ..+.++++
T Consensus 87 ~~~~~~~~~~l~~L~-----------------~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~ 149 (549)
T 2z81_A 87 SSLSSSWFGPLSSLK-----------------YLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS 149 (549)
T ss_dssp CSCCHHHHTTCTTCC-----------------EEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCE
T ss_pred CccCHHHhccCCCCc-----------------EEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccc
Confidence 988777788887554 77777777765 345667777777777777777544454 46777777
Q ss_pred ccEEEcccCcCCccCCccCcCCCCCCeEEccCCcc---ccc-cccccCCcEEEcCCcccCC
Q 046265 169 LLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLV---SAE-IGNLLQLIELEIDNKQLFG 225 (639)
Q Consensus 169 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~---~~~-~~~l~~L~~L~l~~n~l~~ 225 (639)
|++|++++|.+++..|..+..+++|+.|+++.+.+ +.. +..+++|+.|++++|++.+
T Consensus 150 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~ 210 (549)
T 2z81_A 150 LNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210 (549)
T ss_dssp EEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTT
T ss_pred cCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCcccc
Confidence 77777777777777777777777777777764432 222 2346677777777777655
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=353.92 Aligned_cols=369 Identities=21% Similarity=0.223 Sum_probs=268.0
Q ss_pred EEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecc
Q 046265 9 FQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCN 88 (639)
Q Consensus 9 ~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 88 (639)
..+++++|++. .+|..+. ++|++|+|++|.+++..|..|..+++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 35788999888 5887776 89999999999999877788999999999999999999777889999999999999999
Q ss_pred cCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcc-cCCccccCCCCCCEEeccCCCCCCCCCccccCCC
Q 046265 89 GLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSG-SIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQ 167 (639)
Q Consensus 89 ~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 167 (639)
+++. +|.. .+++| ++|+|++|++++ .+|..|+++++|++|++++|.+++ ..+..++
T Consensus 80 ~l~~-lp~~--~l~~L-----------------~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~ 136 (520)
T 2z7x_B 80 KLVK-ISCH--PTVNL-----------------KHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIA 136 (520)
T ss_dssp CCCE-EECC--CCCCC-----------------SEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGT
T ss_pred ceee-cCcc--ccCCc-----------------cEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccc
Confidence 9984 5544 45543 355566565554 345555555566666665555543 2344444
Q ss_pred cc--cEEEcccCcC--CccCCccCcC------------------------------------------------------
Q 046265 168 SL--LSLGFDLNLL--NGVLPPSISN------------------------------------------------------ 189 (639)
Q Consensus 168 ~L--~~L~l~~N~l--~~~~p~~~~~------------------------------------------------------ 189 (639)
+| +.|++++|.+ .+..|..+..
T Consensus 137 ~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l 216 (520)
T 2z7x_B 137 HLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKL 216 (520)
T ss_dssp TSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGG
T ss_pred cceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhh
Confidence 44 5555555555 4444443333
Q ss_pred --CCCCCeEEccCCccccc-------cccccCCcEEEcCCcccCCCCCccc-----cCCCCCceeccccccccCcchhhh
Q 046265 190 --LSNLEGLYLYSSLVSAE-------IGNLLQLIELEIDNKQLFGQIPKSL-----RNFTSLNIVHLEQNHLTGNIYEVF 255 (639)
Q Consensus 190 --l~~L~~L~l~~~~~~~~-------~~~l~~L~~L~l~~n~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~~~~~ 255 (639)
+++|+.|+++.+.+... ....++|+.|++++|++.|.+|.++ ..+++|+.+++++|.+ ..+...+
T Consensus 217 ~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~ 295 (520)
T 2z7x_B 217 QTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYI 295 (520)
T ss_dssp GGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHH
T ss_pred ccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhhh
Confidence 33344444432221110 0013478888999999988899888 8899999999999988 3332444
Q ss_pred hcC---CCccEEeccCCcccc-----------cccCcCCccccccCccccCCCCCCEEeccCCcccc--cCCccccCCCC
Q 046265 256 GIY---PNLTFLDLSQNNFYG-----------SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVG--ELPIELGNLKS 319 (639)
Q Consensus 256 ~~l---~~L~~L~Ls~N~l~~-----------~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~--~~p~~~~~l~~ 319 (639)
..+ .+|+.|++++|.+.. .+++++|++++.+|..++.+++|+.|++++|++.+ .+|..+..+++
T Consensus 296 ~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~ 375 (520)
T 2z7x_B 296 YEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKS 375 (520)
T ss_dssp HHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTT
T ss_pred hcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCC
Confidence 433 568888888887643 36788888888889999999999999999999986 56677899999
Q ss_pred CCeeeccCccCcccCCc-CccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhh
Q 046265 320 LNYRALNGNKVYGSLPR-VLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSL 398 (639)
Q Consensus 320 L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~ 398 (639)
|+.|++++|.+.+.+|. .+..+++|+.|++++|+ +.+.+|..+. ++|+.|++++|.++ .+ | ..
T Consensus 376 L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~---l~~~~~~~l~--~~L~~L~Ls~N~l~-~i-p---------~~ 439 (520)
T 2z7x_B 376 LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI---LTDTIFRCLP--PRIKVLDLHSNKIK-SI-P---------KQ 439 (520)
T ss_dssp CCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSC---CCGGGGGSCC--TTCCEEECCSSCCC-CC-C---------GG
T ss_pred CCEEECCCCcCCcccccchhccCccCCEEECcCCC---CCcchhhhhc--ccCCEEECCCCccc-cc-c---------hh
Confidence 99999999999875665 47888999999999864 4444554443 68899999999887 34 4 45
Q ss_pred hhhcccCcEEccCCCeeeeeecC
Q 046265 399 ISRMHGLSCIDISYNELRGLIRN 421 (639)
Q Consensus 399 ~~~l~~L~~ldls~N~l~g~~p~ 421 (639)
+..++.|+.||+++|+++. +|.
T Consensus 440 ~~~l~~L~~L~L~~N~l~~-l~~ 461 (520)
T 2z7x_B 440 VVKLEALQELNVASNQLKS-VPD 461 (520)
T ss_dssp GGGCTTCCEEECCSSCCCC-CCT
T ss_pred hhcCCCCCEEECCCCcCCc-cCH
Confidence 6688999999999999984 553
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=348.61 Aligned_cols=375 Identities=21% Similarity=0.172 Sum_probs=268.4
Q ss_pred cceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCE
Q 046265 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQ 82 (639)
Q Consensus 3 ~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 82 (639)
|.|-....+++++|++.+ +|..+. ++|++|+|++|.+++..|.+|..+++|++|+|++|++++..|..|+++++|++
T Consensus 28 ~~~~~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 104 (562)
T 3a79_B 28 FSNELESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEY 104 (562)
T ss_dssp -----CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCE
T ss_pred cccCCCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCE
Confidence 445555789999999985 887775 89999999999999888889999999999999999999888999999999999
Q ss_pred EeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcc-cCCccccCCCCCCEEeccCCCCCCCCCc
Q 046265 83 LVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSG-SIPHFLGHLSNLAVLHLGDNSLFGSIPP 161 (639)
Q Consensus 83 L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 161 (639)
|+|++|+++ .+|.. .+++| ++|+|++|++++ .+|..|+++++|++|+|++|++++.
T Consensus 105 L~Ls~N~l~-~lp~~--~l~~L-----------------~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~--- 161 (562)
T 3a79_B 105 LDVSHNRLQ-NISCC--PMASL-----------------RHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL--- 161 (562)
T ss_dssp EECTTSCCC-EECSC--CCTTC-----------------SEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---
T ss_pred EECCCCcCC-ccCcc--ccccC-----------------CEEECCCCCccccCchHhhcccCcccEEecCCCccccC---
Confidence 999999998 45554 44433 588888888875 3467888888888888888888753
Q ss_pred cccCCCcc--cEEEcccCcC--CccCCccCcCC--------------------------CCCCeEEccCCc-----ccc-
Q 046265 162 ILGKVQSL--LSLGFDLNLL--NGVLPPSISNL--------------------------SNLEGLYLYSSL-----VSA- 205 (639)
Q Consensus 162 ~~~~l~~L--~~L~l~~N~l--~~~~p~~~~~l--------------------------~~L~~L~l~~~~-----~~~- 205 (639)
.+..+++| +.|++++|.+ ++..|..+..+ ++|+.++++.+. ++.
T Consensus 162 ~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~ 241 (562)
T 3a79_B 162 DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF 241 (562)
T ss_dssp TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH
T ss_pred chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHH
Confidence 34445555 8888888888 66666665543 345555554431 000
Q ss_pred --cc---------------------------ccccCCcEEEcCCcccCCCCCccc-----cCCCCCceeccccccccCcc
Q 046265 206 --EI---------------------------GNLLQLIELEIDNKQLFGQIPKSL-----RNFTSLNIVHLEQNHLTGNI 251 (639)
Q Consensus 206 --~~---------------------------~~l~~L~~L~l~~n~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~ 251 (639)
.+ ....+|++|++++|.+.|.+|..+ .+++.|+.++++.|.+ ..+
T Consensus 242 ~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-~~p 320 (562)
T 3a79_B 242 LSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF-LFS 320 (562)
T ss_dssp HHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-SSC
T ss_pred HHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee-ecC
Confidence 00 112378888888888888888776 5666666666666655 222
Q ss_pred hhhhhc---CCCccEEeccCCcccc-----------cccCcCCccccccCccccCCCCCCEEeccCCccccc--CCcccc
Q 046265 252 YEVFGI---YPNLTFLDLSQNNFYG-----------SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGE--LPIELG 315 (639)
Q Consensus 252 ~~~~~~---l~~L~~L~Ls~N~l~~-----------~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~--~p~~~~ 315 (639)
...+.. ..+|+.|++++|.+.. .+++++|.+++.+|..++.+++|+.|++++|++.+. +|..+.
T Consensus 321 ~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 400 (562)
T 3a79_B 321 KEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTK 400 (562)
T ss_dssp HHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTT
T ss_pred hhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhc
Confidence 122211 2456777777766532 256777777777888888888888888888888763 346678
Q ss_pred CCCCCCeeeccCccCcccCCc-CccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhh
Q 046265 316 NLKSLNYRALNGNKVYGSLPR-VLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKA 394 (639)
Q Consensus 316 ~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~ 394 (639)
.+++|+.|++++|++.+.+|. .+..+++|+.|++++|+ +.+..|..+. ++|+.|++++|.++. + |
T Consensus 401 ~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~---l~~~~~~~l~--~~L~~L~L~~N~l~~-i-p------- 466 (562)
T 3a79_B 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNM---LTGSVFRCLP--PKVKVLDLHNNRIMS-I-P------- 466 (562)
T ss_dssp TCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSC---CCGGGGSSCC--TTCSEEECCSSCCCC-C-C-------
T ss_pred CCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCC---CCcchhhhhc--CcCCEEECCCCcCcc-c-C-------
Confidence 888888888888888875554 47778888888888854 3344444433 578888888887763 3 3
Q ss_pred hhhhhhhcccCcEEccCCCeeeeeecC
Q 046265 395 WRSLISRMHGLSCIDISYNELRGLIRN 421 (639)
Q Consensus 395 ~~~~~~~l~~L~~ldls~N~l~g~~p~ 421 (639)
..+..++.|+.||+++|++++ +|.
T Consensus 467 --~~~~~l~~L~~L~L~~N~l~~-l~~ 490 (562)
T 3a79_B 467 --KDVTHLQALQELNVASNQLKS-VPD 490 (562)
T ss_dssp --TTTTSSCCCSEEECCSSCCCC-CCT
T ss_pred --hhhcCCCCCCEEECCCCCCCC-CCH
Confidence 344578888888888888884 443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.20 Aligned_cols=348 Identities=19% Similarity=0.166 Sum_probs=297.6
Q ss_pred eeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCC-CCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEee
Q 046265 7 FFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVI-PQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVL 85 (639)
Q Consensus 7 ~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 85 (639)
.+..+++++|++.+..|..|+++++|++|+|++|.+.+.+ |..|..+++|++|+|++|++++..|..|+++++|++|+|
T Consensus 31 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 110 (455)
T 3v47_A 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTL 110 (455)
T ss_dssp TCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEEC
T ss_pred ccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeC
Confidence 3678899999999999999999999999999999997555 567999999999999999999888999999999999999
Q ss_pred ecccCccccCcc--ccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCcc-ccCCCCCCEEeccCCCCCCCCCcc
Q 046265 86 YCNGLSGWLPSS--FGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHF-LGHLSNLAVLHLGDNSLFGSIPPI 162 (639)
Q Consensus 86 ~~N~l~~~~p~~--~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~ 162 (639)
++|++++..|.. |..+++| ++|+|++|++++..|.. +.++++|++|++++|++++..|..
T Consensus 111 ~~n~l~~~~~~~~~~~~l~~L-----------------~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 173 (455)
T 3v47_A 111 TQCNLDGAVLSGNFFKPLTSL-----------------EMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEED 173 (455)
T ss_dssp TTSCCBTHHHHSSTTTTCTTC-----------------CEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTT
T ss_pred CCCCCCccccCcccccCcccC-----------------CEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhh
Confidence 999999765554 6666633 59999999999887876 899999999999999999998988
Q ss_pred ccCC--CcccEEEcccCcCCccCCcc--------CcCCCCCCeEEccCCccc----ccccc---ccCCcEEEcCCcccCC
Q 046265 163 LGKV--QSLLSLGFDLNLLNGVLPPS--------ISNLSNLEGLYLYSSLVS----AEIGN---LLQLIELEIDNKQLFG 225 (639)
Q Consensus 163 ~~~l--~~L~~L~l~~N~l~~~~p~~--------~~~l~~L~~L~l~~~~~~----~~~~~---l~~L~~L~l~~n~l~~ 225 (639)
+..+ .+|+.|++++|.+.+..+.. +..+++|+.|+++.+.+. ..+.. ..+|+.|++++|...+
T Consensus 174 l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~ 253 (455)
T 3v47_A 174 LLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253 (455)
T ss_dssp SGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTS
T ss_pred hhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccc
Confidence 8876 79999999999998765544 336789999999987653 23333 3789999999886554
Q ss_pred CC----------CccccC--CCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCC
Q 046265 226 QI----------PKSLRN--FTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKL 293 (639)
Q Consensus 226 ~~----------p~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l 293 (639)
.. +..+.. .++|+.|++++|.+++..+..++.+++|++|++++|++ ++..|..+..+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l-----------~~~~~~~~~~l 322 (455)
T 3v47_A 254 SSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEI-----------NKIDDNAFWGL 322 (455)
T ss_dssp CCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCC-----------CEECTTTTTTC
T ss_pred cccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcc-----------cccChhHhcCc
Confidence 31 122222 36899999999999999999999999999999777765 45677889999
Q ss_pred CCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCe
Q 046265 294 YQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTE 373 (639)
Q Consensus 294 ~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~ 373 (639)
++|+.|++++|.+.+..|..+..+++|+.|++++|++++..|..+..+++|+.|++++|++..+ .+..+..+++|+.
T Consensus 323 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~ 399 (455)
T 3v47_A 323 THLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSV---PDGIFDRLTSLQK 399 (455)
T ss_dssp TTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCC---CTTTTTTCTTCCE
T ss_pred ccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccC---CHhHhccCCcccE
Confidence 9999999999999988899999999999999999999998899999999999999999765433 3446788999999
Q ss_pred eeccCCcCceee
Q 046265 374 LDLVITFWEERY 385 (639)
Q Consensus 374 l~l~~n~~~~~~ 385 (639)
|++++|.+++..
T Consensus 400 L~l~~N~l~~~~ 411 (455)
T 3v47_A 400 IWLHTNPWDCSC 411 (455)
T ss_dssp EECCSSCBCCCT
T ss_pred EEccCCCcccCC
Confidence 999999999876
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=345.62 Aligned_cols=383 Identities=19% Similarity=0.200 Sum_probs=300.5
Q ss_pred eeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeee
Q 046265 7 FFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLY 86 (639)
Q Consensus 7 ~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 86 (639)
.+..+++++|++.+..|..|.++++|++|+|++|.+++..|..|+.+++|++|+|++|+++ .+|.. .+++|++|+|+
T Consensus 22 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~ 98 (520)
T 2z7x_B 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLS 98 (520)
T ss_dssp TCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECC
T ss_pred cccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEecc
Confidence 4567899999999888889999999999999999999888999999999999999999998 67766 89999999999
Q ss_pred cccCcc-ccCccccCCCCCCcccCC------CCCcccCCCCccEEEccCCcC--cccCCccccC----------------
Q 046265 87 CNGLSG-WLPSSFGNLNNLAIGSMP------NSLSNLTSLSLFHLDLSENQL--SGSIPHFLGH---------------- 141 (639)
Q Consensus 87 ~N~l~~-~~p~~~~~l~~L~~~~lp------~~~~~l~~L~L~~L~L~~N~l--~~~~p~~~~~---------------- 141 (639)
+|++++ .+|..|+++++|+...+. ..+..+++|+|++|++++|.+ ++..|..+..
T Consensus 99 ~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~ 178 (520)
T 2z7x_B 99 FNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEF 178 (520)
T ss_dssp SSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCC
T ss_pred CCccccccchhhhccCCcceEEEecCcccchhhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcch
Confidence 999987 478899999888722111 234555555556777777777 5555655544
Q ss_pred ----------CCCCCEEeccCCC-------CCCCCCccccC---------------------------CCcccEEEcccC
Q 046265 142 ----------LSNLAVLHLGDNS-------LFGSIPPILGK---------------------------VQSLLSLGFDLN 177 (639)
Q Consensus 142 ----------l~~L~~L~L~~N~-------l~~~~p~~~~~---------------------------l~~L~~L~l~~N 177 (639)
+++|+.|++++|. +.+.+| .++. .++|++|++++|
T Consensus 179 ~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n 257 (520)
T 2z7x_B 179 HFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNV 257 (520)
T ss_dssp CCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEE
T ss_pred hhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecc
Confidence 3344444444443 221111 1121 237888888889
Q ss_pred cCCccCCccC-----cCCCCCCeEEccCCcc--c-cccccc---cCCcEEEcCCcccCCCCCccccCCCCCceecccccc
Q 046265 178 LLNGVLPPSI-----SNLSNLEGLYLYSSLV--S-AEIGNL---LQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNH 246 (639)
Q Consensus 178 ~l~~~~p~~~-----~~l~~L~~L~l~~~~~--~-~~~~~l---~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 246 (639)
.++|.+|..+ ..+++|+.++++.+.+ | ..+..+ .+|+.|++++|.+.... .+..+++|++|++++|.
T Consensus 258 ~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~ 335 (520)
T 2z7x_B 258 KLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNL 335 (520)
T ss_dssp EEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSC
T ss_pred cccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCc
Confidence 9988999988 8899999999986654 3 233333 57999999999885432 12688999999999999
Q ss_pred ccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCcc-ccCCCCCCeeec
Q 046265 247 LTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIE-LGNLKSLNYRAL 325 (639)
Q Consensus 247 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~-~~~l~~L~~L~l 325 (639)
+++..|..++.+++|++|++++|++.+. ..+|..++.+++|+.|++++|.+.+.+|.. +..+++|+.|++
T Consensus 336 l~~~~~~~~~~l~~L~~L~L~~N~l~~l---------~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L 406 (520)
T 2z7x_B 336 LTDTVFENCGHLTELETLILQMNQLKEL---------SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM 406 (520)
T ss_dssp CCTTTTTTCCCCSSCCEEECCSSCCCBH---------HHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEEC
T ss_pred cChhhhhhhccCCCCCEEEccCCccCcc---------ccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEEC
Confidence 9998889999999999999888776320 146677899999999999999999856654 888999999999
Q ss_pred cCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccC
Q 046265 326 NGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGL 405 (639)
Q Consensus 326 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L 405 (639)
++|++++.+|..+. ++|+.|++++|++. .+|..+..+++|+.|++++|.+.. + |. ..+..+++|
T Consensus 407 s~N~l~~~~~~~l~--~~L~~L~Ls~N~l~----~ip~~~~~l~~L~~L~L~~N~l~~-l-~~--------~~~~~l~~L 470 (520)
T 2z7x_B 407 SSNILTDTIFRCLP--PRIKVLDLHSNKIK----SIPKQVVKLEALQELNVASNQLKS-V-PD--------GIFDRLTSL 470 (520)
T ss_dssp CSSCCCGGGGGSCC--TTCCEEECCSSCCC----CCCGGGGGCTTCCEEECCSSCCCC-C-CT--------TTTTTCTTC
T ss_pred cCCCCCcchhhhhc--ccCCEEECCCCccc----ccchhhhcCCCCCEEECCCCcCCc-c-CH--------HHhccCCcc
Confidence 99999988887664 79999999996543 678888899999999999999884 4 31 247789999
Q ss_pred cEEccCCCeeeeeec
Q 046265 406 SCIDISYNELRGLIR 420 (639)
Q Consensus 406 ~~ldls~N~l~g~~p 420 (639)
+.+|+++|++++..+
T Consensus 471 ~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 471 QKIWLHTNPWDCSCP 485 (520)
T ss_dssp CEEECCSSCBCCCHH
T ss_pred cEEECcCCCCcccCC
Confidence 999999999998765
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=328.15 Aligned_cols=171 Identities=19% Similarity=0.274 Sum_probs=145.6
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|+||+||+|+ ..+|+.||||++..........+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 578888999999999999995 4678999999998766556667889999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
||+||+|.+++...+. ..+++..+..++.|++.||+|||.. +||||||||+|||++.++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999975433 3467888999999999999999998 99999999999999999999999999999875432
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
....+.+||+.|||||
T Consensus 180 ~~~~~~~GT~~YmAPE 195 (350)
T 4b9d_A 180 ELARACIGTPYYLSPE 195 (350)
T ss_dssp HHHHHHHSCCTTCCHH
T ss_pred ccccccCCCccccCHH
Confidence 3334578999999998
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=314.01 Aligned_cols=167 Identities=25% Similarity=0.380 Sum_probs=141.6
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
+++...+.||+|+||+||+|++++ .||||.++.........+.|.+|+.++++++|||||+++++|.+ +..|+||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 456678899999999999998764 59999998665556667889999999999999999999998865 568999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC-
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS- 623 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~- 623 (639)
|++|+|.++++... ..++|..+..++.|+|+||+|||+. +||||||||+|||+++++.+||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999999997543 3589999999999999999999998 99999999999999999999999999998764322
Q ss_pred -CCcceeeeeceeeCCC
Q 046265 624 -SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 -~~~~~~~gt~~Y~APE 639 (639)
......+||+.|||||
T Consensus 188 ~~~~~~~~GT~~ymAPE 204 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPE 204 (307)
T ss_dssp ------CCCCTTSCCHH
T ss_pred ceeecccccCCCccCHH
Confidence 2334578999999998
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=333.22 Aligned_cols=383 Identities=19% Similarity=0.199 Sum_probs=285.5
Q ss_pred eeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeee
Q 046265 7 FFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLY 86 (639)
Q Consensus 7 ~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 86 (639)
....+++++|++.+..|..|.++++|++|+|++|.+++..|..|+.+++|++|+|++|+++ .+|.. .+++|++|+|+
T Consensus 53 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls 129 (562)
T 3a79_B 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLS 129 (562)
T ss_dssp TCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECC
T ss_pred CcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECC
Confidence 4567899999999988899999999999999999999988999999999999999999998 68876 89999999999
Q ss_pred cccCccc-cCccccCCCCCCcccC------CCCCcccCCCCccEEEccCCcC--cccCCccccCCC--CCCEEeccCCCC
Q 046265 87 CNGLSGW-LPSSFGNLNNLAIGSM------PNSLSNLTSLSLFHLDLSENQL--SGSIPHFLGHLS--NLAVLHLGDNSL 155 (639)
Q Consensus 87 ~N~l~~~-~p~~~~~l~~L~~~~l------p~~~~~l~~L~L~~L~L~~N~l--~~~~p~~~~~l~--~L~~L~L~~N~l 155 (639)
+|++++. +|..|+++++|+...+ ...+..++.|.|++|++++|++ ++..|..+..+. .| .+++++|.+
T Consensus 130 ~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l~~n~~ 208 (562)
T 3a79_B 130 FNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVFHPNSL 208 (562)
T ss_dssp SSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEECSSSC
T ss_pred CCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEecCccc
Confidence 9999973 5689999988772211 1234555555556777777777 666666655433 11 122233333
Q ss_pred CCCCCcc-ccC-------------------------------------------------------CCcccEEEcccCcC
Q 046265 156 FGSIPPI-LGK-------------------------------------------------------VQSLLSLGFDLNLL 179 (639)
Q Consensus 156 ~~~~p~~-~~~-------------------------------------------------------l~~L~~L~l~~N~l 179 (639)
.+.++.. +.. ..+|++|++++|.+
T Consensus 209 ~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l 288 (562)
T 3a79_B 209 FSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288 (562)
T ss_dssp CCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEE
T ss_pred hhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEe
Confidence 2222210 111 12677888888888
Q ss_pred CccCCccC-----cCCCCCCeEEccCCcc--c-ccccc---ccCCcEEEcCCcccCCCCCccccCCCCCceecccccccc
Q 046265 180 NGVLPPSI-----SNLSNLEGLYLYSSLV--S-AEIGN---LLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLT 248 (639)
Q Consensus 180 ~~~~p~~~-----~~l~~L~~L~l~~~~~--~-~~~~~---l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 248 (639)
+|.+|..+ ..++.|+.+++..+.+ | ..+.. ..+|+.|++++|.+.... ....+++|++|++++|.++
T Consensus 289 ~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~ 366 (562)
T 3a79_B 289 TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFT 366 (562)
T ss_dssp CSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCC
T ss_pred eccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccc
Confidence 88888776 5555555555544332 2 11211 256889999998874322 1267889999999999999
Q ss_pred CcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCc-cccCCCCCCeeeccC
Q 046265 249 GNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPI-ELGNLKSLNYRALNG 327 (639)
Q Consensus 249 ~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~-~~~~l~~L~~L~l~~ 327 (639)
+..|..++.+++|++|++++|++.+. ..+|..+..+++|+.|++++|++.+.+|. .+..+++|+.|++++
T Consensus 367 ~~~~~~~~~l~~L~~L~L~~N~l~~~---------~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~ 437 (562)
T 3a79_B 367 DSVFQGCSTLKRLQTLILQRNGLKNF---------FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSS 437 (562)
T ss_dssp TTTTTTCCSCSSCCEEECCSSCCCBT---------THHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCS
T ss_pred cchhhhhcccCCCCEEECCCCCcCCc---------ccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCC
Confidence 98888899999999999888776320 13456788899999999999999875554 578889999999999
Q ss_pred ccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcE
Q 046265 328 NKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSC 407 (639)
Q Consensus 328 N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ 407 (639)
|++++..|..+. ++|+.|++++|++. .+|..+..+++|+.|++++|.++. + |. ..+..++.|+.
T Consensus 438 n~l~~~~~~~l~--~~L~~L~L~~N~l~----~ip~~~~~l~~L~~L~L~~N~l~~-l-~~--------~~~~~l~~L~~ 501 (562)
T 3a79_B 438 NMLTGSVFRCLP--PKVKVLDLHNNRIM----SIPKDVTHLQALQELNVASNQLKS-V-PD--------GVFDRLTSLQY 501 (562)
T ss_dssp SCCCGGGGSSCC--TTCSEEECCSSCCC----CCCTTTTSSCCCSEEECCSSCCCC-C-CT--------TSTTTCTTCCC
T ss_pred CCCCcchhhhhc--CcCCEEECCCCcCc----ccChhhcCCCCCCEEECCCCCCCC-C-CH--------HHHhcCCCCCE
Confidence 999888777554 68999999997544 567777789999999999998884 4 31 23778889999
Q ss_pred EccCCCeeeeeec
Q 046265 408 IDISYNELRGLIR 420 (639)
Q Consensus 408 ldls~N~l~g~~p 420 (639)
+++++|++++..|
T Consensus 502 L~l~~N~~~c~c~ 514 (562)
T 3a79_B 502 IWLHDNPWDCTCP 514 (562)
T ss_dssp EECCSCCBCCCHH
T ss_pred EEecCCCcCCCcc
Confidence 9999999988765
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.98 Aligned_cols=342 Identities=18% Similarity=0.172 Sum_probs=265.9
Q ss_pred eeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeee
Q 046265 7 FFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLY 86 (639)
Q Consensus 7 ~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 86 (639)
.+..+++++|++.+. | .++.+++|++|+|++|.+++. | ++.+++|++|++++|++++ +| ++++++|++|+++
T Consensus 43 ~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~ 114 (457)
T 3bz5_A 43 TLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCD 114 (457)
T ss_dssp TCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECC
T ss_pred CCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECC
Confidence 345667777777654 4 577777777777777777753 3 7777777777777777775 33 6777777777777
Q ss_pred cccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCC
Q 046265 87 CNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKV 166 (639)
Q Consensus 87 ~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 166 (639)
+|++++. | ++.++ +| ++|++++|++++. + ++.+++|++|++++|+..+.+ .++.+
T Consensus 115 ~N~l~~l-~--~~~l~---------------~L--~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l 169 (457)
T 3bz5_A 115 TNKLTKL-D--VSQNP---------------LL--TYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQ 169 (457)
T ss_dssp SSCCSCC-C--CTTCT---------------TC--CEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTC
T ss_pred CCcCCee-c--CCCCC---------------cC--CEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccC
Confidence 7777652 2 44443 34 6899999999864 3 788999999999999776666 47889
Q ss_pred CcccEEEcccCcCCccCCccCcCCCCCCeEEccCCcccc-ccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccc
Q 046265 167 QSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSA-EIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQN 245 (639)
Q Consensus 167 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N 245 (639)
++|+.|++++|.+++. | +..+++|+.|+++.+.+.. .++.+++|+.|++++|++.+ +| +..+++|+.|++++|
T Consensus 170 ~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N 243 (457)
T 3bz5_A 170 TQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVN 243 (457)
T ss_dssp TTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCCCCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSS
T ss_pred CcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCeeccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCC
Confidence 9999999999999874 4 7889999999998776543 47788999999999999987 56 788999999999999
Q ss_pred cccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCcc--------ccCC
Q 046265 246 HLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIE--------LGNL 317 (639)
Q Consensus 246 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~--------~~~l 317 (639)
.+++.. .+.+++|+.|++++|++. .+++++|.+.+.+| ++.+++|+.|++++|...+.+|.. +..+
T Consensus 244 ~l~~~~---~~~l~~L~~L~l~~n~L~-~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~ 317 (457)
T 3bz5_A 244 PLTELD---VSTLSKLTTLHCIQTDLL-EIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQN 317 (457)
T ss_dssp CCSCCC---CTTCTTCCEEECTTCCCS-CCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTC
T ss_pred cCCCcC---HHHCCCCCEEeccCCCCC-EEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhc
Confidence 999865 456788999999999874 68899999888887 467899999999999887776643 4556
Q ss_pred CCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhh
Q 046265 318 KSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRS 397 (639)
Q Consensus 318 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~ 397 (639)
++|+.|++++|++++. | ++.+++|+.|++++|++..+ +.|..++++.|.+++..
T Consensus 318 ~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~l-----------~~L~~L~l~~n~l~g~~------------ 371 (457)
T 3bz5_A 318 PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQDF-----------SSVGKIPALNNNFEAEG------------ 371 (457)
T ss_dssp TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCBC-----------TTGGGSSGGGTSEEEEE------------
T ss_pred ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCCc-----------cccccccccCCcEEecc------------
Confidence 7888899999999873 3 78889999999998654432 34556677888777642
Q ss_pred hhhhcccCcEEccCCCeeeeeecCC
Q 046265 398 LISRMHGLSCIDISYNELRGLIRNS 422 (639)
Q Consensus 398 ~~~~l~~L~~ldls~N~l~g~~p~~ 422 (639)
.+..+..+|+++|+++|.+|..
T Consensus 372 ---~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 372 ---QTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp ---EEEECCCBCCBTTBEEEECCTT
T ss_pred ---eeeecCccccccCcEEEEcChh
Confidence 3456788999999999999953
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=320.30 Aligned_cols=166 Identities=27% Similarity=0.387 Sum_probs=148.3
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
..|+..+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|+.++++++|||||+++++|.+++..|+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4588888999999999999964 5789999999975432 234557899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
||++|+|.+++... .+++..+..++.|++.||+|||.. +||||||||+|||++.++.+||+|||+|+.+....
T Consensus 152 y~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 152 FLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 99999999999753 478899999999999999999999 99999999999999999999999999999876555
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
....+.+||+.|||||
T Consensus 225 ~~~~~~~GTp~YmAPE 240 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPE 240 (346)
T ss_dssp CCBCCCCSCGGGCCHH
T ss_pred CcccccccCcCcCCHH
Confidence 5566789999999998
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=335.07 Aligned_cols=396 Identities=21% Similarity=0.211 Sum_probs=246.7
Q ss_pred CCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccc
Q 046265 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGW 93 (639)
Q Consensus 14 ~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 93 (639)
+++.-...+|..+. +++++|||++|.|+++.|.+|.++++|++|||++|+|++..|.+|.++++|++|+|++|++++.
T Consensus 38 c~~~~l~~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l 115 (635)
T 4g8a_A 38 CMELNFYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 115 (635)
T ss_dssp CTTSCCSSCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEE
T ss_pred CCCCCcCccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCC
Confidence 34433446777664 4788888888888877777888888888888888888866667788888888888888888877
Q ss_pred cCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCC-CCCccccCCCcccEE
Q 046265 94 LPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFG-SIPPILGKVQSLLSL 172 (639)
Q Consensus 94 ~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L 172 (639)
.+..|.++++|+ +|+|++|++++..+..|+++++|++|+|++|.+++ .+|..++.+++|++|
T Consensus 116 ~~~~f~~L~~L~-----------------~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L 178 (635)
T 4g8a_A 116 ALGAFSGLSSLQ-----------------KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 178 (635)
T ss_dssp CGGGGTTCTTCC-----------------EEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEE
T ss_pred CHHHhcCCCCCC-----------------EEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhh
Confidence 777777777554 44555555544333344455555555555554433 234444444555555
Q ss_pred EcccCcCCccCCccCcCCCC---------------------------CCeEEccCCcc----------------------
Q 046265 173 GFDLNLLNGVLPPSISNLSN---------------------------LEGLYLYSSLV---------------------- 203 (639)
Q Consensus 173 ~l~~N~l~~~~p~~~~~l~~---------------------------L~~L~l~~~~~---------------------- 203 (639)
++++|.+++..|..+..+.+ ++.+++..+..
T Consensus 179 ~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~ 258 (635)
T 4g8a_A 179 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 258 (635)
T ss_dssp ECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEE
T ss_pred cccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccc
Confidence 55555444443333322111 11111110000
Q ss_pred ----------------------------------------c----------------------cccccccCCcEEEcCCc
Q 046265 204 ----------------------------------------S----------------------AEIGNLLQLIELEIDNK 221 (639)
Q Consensus 204 ----------------------------------------~----------------------~~~~~l~~L~~L~l~~n 221 (639)
. ..+.....++.|++.+|
T Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~ 338 (635)
T 4g8a_A 259 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNC 338 (635)
T ss_dssp ECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESC
T ss_pred cccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccc
Confidence 0 00111223455555555
Q ss_pred ccCCCCCc-------------------cccCCCCCceeccccccccC--cchhhhhcCCCccEEeccCCcccc-------
Q 046265 222 QLFGQIPK-------------------SLRNFTSLNIVHLEQNHLTG--NIYEVFGIYPNLTFLDLSQNNFYG------- 273 (639)
Q Consensus 222 ~l~~~~p~-------------------~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~------- 273 (639)
.+.+..+. ....+++|+.|++++|.+.. ..+..+..+.+|+.++++.|....
T Consensus 339 ~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~ 418 (635)
T 4g8a_A 339 KFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLG 418 (635)
T ss_dssp EESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTT
T ss_pred cccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccc
Confidence 44332221 11234555556666555532 223344445555555555554322
Q ss_pred -----cccCcCCccccccC-ccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccC-cccCCcCccCCCCCCE
Q 046265 274 -----SLNFSMNNITRSIP-PKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKV-YGSLPRVLGSISDLEY 346 (639)
Q Consensus 274 -----~l~ls~n~~~~~~p-~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l-~~~~p~~~~~l~~L~~ 346 (639)
.++++.++.....+ ..+..+.+++.++++.|.+.+..|..+..++.|+.|++++|.+ .+..|..+..+++|+.
T Consensus 419 l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~ 498 (635)
T 4g8a_A 419 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 498 (635)
T ss_dssp CTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred cccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCE
Confidence 13455555544433 4567788899999999999888888889999999999999875 4457888999999999
Q ss_pred EeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeeeeeecCCCc-c
Q 046265 347 LDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRNSTG-I 425 (639)
Q Consensus 347 L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~g~~p~~~~-~ 425 (639)
|||++|+ +.+..|..+..+++|+.|++++|.+.+.. | ..+..+++|+.||+++|++++.+|..-. +
T Consensus 499 L~Ls~N~---L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~-~---------~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l 565 (635)
T 4g8a_A 499 LDLSQCQ---LEQLSPTAFNSLSSLQVLNMSHNNFFSLD-T---------FPYKCLNSLQVLDYSLNHIMTSKKQELQHF 565 (635)
T ss_dssp EECTTSC---CCEECTTTTTTCTTCCEEECTTSCCCBCC-C---------GGGTTCTTCCEEECTTSCCCBCCSSCTTCC
T ss_pred EECCCCc---cCCcChHHHcCCCCCCEEECCCCcCCCCC-h---------hHHhCCCCCCEEECCCCcCCCCCHHHHHhh
Confidence 9999954 45556788899999999999999887754 4 5578889999999999999988875322 1
Q ss_pred -cccccccccCCCCCCC
Q 046265 426 -HYNLVDALQGNKGLCG 441 (639)
Q Consensus 426 -~~~~~~~~~~~~~l~g 441 (639)
.........+|+-.|.
T Consensus 566 ~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 566 PSSLAFLNLTQNDFACT 582 (635)
T ss_dssp CTTCCEEECTTCCBCCS
T ss_pred hCcCCEEEeeCCCCccc
Confidence 1223334556665564
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=316.43 Aligned_cols=169 Identities=26% Similarity=0.384 Sum_probs=148.5
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..++||+|+||+||+|+ ..+++.||||.+.+... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 568899999999999999995 56789999999975321 1223467899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
|||+||+|.+++...+ .+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999998654 477799999999999999999999 9999999999999999999999999999987533
Q ss_pred C--CCcceeeeeceeeCCC
Q 046265 623 S--SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~--~~~~~~~gt~~Y~APE 639 (639)
. ....+.+||+.|||||
T Consensus 186 ~~~~~~~~~~GTp~YmAPE 204 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPE 204 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHH
T ss_pred CCcccccCcccCcccCCHH
Confidence 2 2345689999999998
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=326.10 Aligned_cols=320 Identities=24% Similarity=0.283 Sum_probs=227.7
Q ss_pred ccceeee-EEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCC
Q 046265 2 SCLAFFF-FQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSL 80 (639)
Q Consensus 2 ~~~~~~~-~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L 80 (639)
.|.|... ..++.+++++. .+|..+. +++++|+|++|.+++..|..|..+++|++|+|++|.+++..|..|.++++|
T Consensus 6 ~C~C~~~~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 82 (477)
T 2id5_A 6 RCECSAQDRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82 (477)
T ss_dssp TCEEETTTTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred CCeECCCCCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccC
Confidence 3778753 45666666665 6787764 689999999999998889999999999999999999998889999999999
Q ss_pred CEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCC
Q 046265 81 KQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIP 160 (639)
Q Consensus 81 ~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 160 (639)
++|+|++|++++..+..|.++++| ++|+|++|++++..|..|..+++|++|+|++|.+.+..|
T Consensus 83 ~~L~L~~n~l~~~~~~~~~~l~~L-----------------~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 145 (477)
T 2id5_A 83 RTLGLRSNRLKLIPLGVFTGLSNL-----------------TKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISH 145 (477)
T ss_dssp CEEECCSSCCCSCCTTSSTTCTTC-----------------CEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECT
T ss_pred CEEECCCCcCCccCcccccCCCCC-----------------CEEECCCCccccCChhHccccccCCEEECCCCccceeCh
Confidence 999999999997666667777643 589999999998889999999999999999999998888
Q ss_pred ccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccc----cccccccCCcEEEcCCcccCCCCCccccCCCC
Q 046265 161 PILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVS----AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTS 236 (639)
Q Consensus 161 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~----~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~ 236 (639)
..|..+++|+.|++++|.+++..+..+..+++|+.|+++.+.+. ..+..+++|+.|++++|...+.+|.......+
T Consensus 146 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~ 225 (477)
T 2id5_A 146 RAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN 225 (477)
T ss_dssp TSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCC
T ss_pred hhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCcc
Confidence 89999999999999999998776666777777777766654332 23445555666666655555555554444445
Q ss_pred CceeccccccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccC
Q 046265 237 LNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGN 316 (639)
Q Consensus 237 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~ 316 (639)
|+.|++++|.+++..+..+..+++|+.|++++|.+ ++..+..+..+++|+.|++++|++.+..|..|..
T Consensus 226 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l-----------~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 294 (477)
T 2id5_A 226 LTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI-----------STIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRG 294 (477)
T ss_dssp CSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCC-----------CEECTTSCTTCTTCCEEECCSSCCSEECTTTBTT
T ss_pred ccEEECcCCcccccCHHHhcCccccCeeECCCCcC-----------CccChhhccccccCCEEECCCCccceECHHHhcC
Confidence 55566665555554445555555555555444433 2233344455555555555555555555555555
Q ss_pred CCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCC
Q 046265 317 LKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTN 352 (639)
Q Consensus 317 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 352 (639)
+++|+.|++++|++++..+..|..+++|+.|++++|
T Consensus 295 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 330 (477)
T 2id5_A 295 LNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330 (477)
T ss_dssp CTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS
T ss_pred cccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC
Confidence 555555555555555444444455555555555553
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=324.73 Aligned_cols=363 Identities=26% Similarity=0.292 Sum_probs=246.9
Q ss_pred eeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCC-------------CEEEcccCcCCCCCCcc
Q 046265 7 FFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHL-------------KHLYINVNKLRGSVPRE 73 (639)
Q Consensus 7 ~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L-------------~~L~L~~N~l~~~~p~~ 73 (639)
.+..+++++|++ +.+|++|+++++|++|++++|.++|.+|.+++.+++| ++|++++|.+++ +|..
T Consensus 12 ~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~ 89 (454)
T 1jl5_A 12 FLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL 89 (454)
T ss_dssp -----------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC
T ss_pred cchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC
Confidence 355678889999 8999999999999999999999999999999999875 999999999985 6652
Q ss_pred cCCCCCCCEEeeecccCccccCccccCCCCCCcccC-CCCCccc-CCCCccEEEccCCcCcccCCccccCCCCCCEEecc
Q 046265 74 VGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSM-PNSLSNL-TSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLG 151 (639)
Q Consensus 74 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~l-p~~~~~l-~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 151 (639)
.++|++|++++|++++ +|..+.+++.|.+..- -..+..+ ++ |++|++++|++++ +| .++++++|++|+++
T Consensus 90 ---~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~--L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~ 161 (454)
T 1jl5_A 90 ---PPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPL--LEYLGVSNNQLEK-LP-ELQNSSFLKIIDVD 161 (454)
T ss_dssp ---CTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTT--CCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred ---cCCCCEEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCC--CCEEECcCCCCCC-Cc-ccCCCCCCCEEECC
Confidence 3789999999999997 7776655555432110 0011111 33 4899999999996 77 59999999999999
Q ss_pred CCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccc
Q 046265 152 DNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSL 231 (639)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~ 231 (639)
+|++++ +|..+ .+|++|++++|.+++ +| .+..+++|+.|+++.+.+...-....+|+.|++++|.+. .+|. +
T Consensus 162 ~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~~~~L~~L~l~~n~l~-~lp~-~ 233 (454)
T 1jl5_A 162 NNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILE-ELPE-L 233 (454)
T ss_dssp SSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCS-SCCC-C
T ss_pred CCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCCcCcccEEECcCCcCC-cccc-c
Confidence 999986 66543 589999999999997 56 689999999999998766532123358999999999997 6774 8
Q ss_pred cCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccc---------cccCcCCccccccCccccCCCCCCEEecc
Q 046265 232 RNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG---------SLNFSMNNITRSIPPKIGKLYQLHKLDFS 302 (639)
Q Consensus 232 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---------~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls 302 (639)
..+++|++|++++|++++.. . .+++|+.|++++|++.+ .+++++|++++ +|.. .++|+.|+++
T Consensus 234 ~~l~~L~~L~l~~N~l~~l~-~---~~~~L~~L~l~~N~l~~l~~~~~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~ 305 (454)
T 1jl5_A 234 QNLPFLTTIYADNNLLKTLP-D---LPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSG-LSEL---PPNLYYLNAS 305 (454)
T ss_dssp TTCTTCCEEECCSSCCSSCC-S---CCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSE-ESCC---CTTCCEEECC
T ss_pred CCCCCCCEEECCCCcCCccc-c---cccccCEEECCCCcccccCcccCcCCEEECcCCccCc-ccCc---CCcCCEEECc
Confidence 89999999999999999743 2 34789999999998875 36788888876 2221 1578888888
Q ss_pred CCcccccCCccccCC-CCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcC
Q 046265 303 LNHIVGELPIELGNL-KSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFW 381 (639)
Q Consensus 303 ~N~~~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~ 381 (639)
+|++.+ ++ .+ ++|+.|++++|++++ +|.. +++|+.|++++|++.. +|. .+++|+.|+++.|.+
T Consensus 306 ~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~----lp~---~l~~L~~L~L~~N~l 369 (454)
T 1jl5_A 306 SNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE----VPE---LPQNLKQLHVEYNPL 369 (454)
T ss_dssp SSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC----CCC---CCTTCCEEECCSSCC
T ss_pred CCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc----ccc---hhhhccEEECCCCCC
Confidence 888875 22 23 478899999999885 6653 5789999999875543 454 467889999999988
Q ss_pred ce--eecCcchhhhhhhhhhhhc-------------ccCcEEccCCCeeee--eecC
Q 046265 382 EE--RYRPKSVIWKAWRSLISRM-------------HGLSCIDISYNELRG--LIRN 421 (639)
Q Consensus 382 ~~--~~~~~~~~~~~~~~~~~~l-------------~~L~~ldls~N~l~g--~~p~ 421 (639)
.+ .+ | ..+..+ ++|+.||+++|++++ .+|.
T Consensus 370 ~~l~~i-p---------~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~ 416 (454)
T 1jl5_A 370 REFPDI-P---------ESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPE 416 (454)
T ss_dssp SSCCCC-C---------TTCCEEECCC------------------------------
T ss_pred CcCCCC-h---------HHHHhhhhcccccccccccCcCCEEECCCCcCCccccchh
Confidence 87 44 3 223333 778899999999987 5653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=309.63 Aligned_cols=166 Identities=23% Similarity=0.343 Sum_probs=142.4
Q ss_pred CCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc----CCceeEEe
Q 046265 468 DAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH----PRQSFLLY 542 (639)
Q Consensus 468 ~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~ 542 (639)
+..+.||+|+||+||+|.. .+++.||||++..........+.|.+|++++++++|||||+++++|.+ ++..|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4456899999999999954 568999999998665555567789999999999999999999999875 34589999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEccccccccCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG-LDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~-~~~~~kl~DfGla~~~~~ 621 (639)
|||++|+|.++++..+ .+++..+..++.|++.||+|||++. ++||||||||+|||++ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999998653 4788999999999999999999871 2399999999999997 479999999999986542
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
....+.+||+.|||||
T Consensus 185 --~~~~~~~GTp~YmAPE 200 (290)
T 3fpq_A 185 --SFAKAVIGTPEFMAPE 200 (290)
T ss_dssp --TSBEESCSSCCCCCGG
T ss_pred --CccCCcccCccccCHH
Confidence 3445689999999998
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=313.50 Aligned_cols=170 Identities=24% Similarity=0.417 Sum_probs=145.0
Q ss_pred ccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
++|...+.||+|+||+||+|++. +++.||||+++.. .....+.|.+|++++++++|||||+++|+|.+++..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 45667889999999999999753 4678999999753 344567899999999999999999999999999999
Q ss_pred eEEecccCCCChhHHhhcCC----------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 046265 539 FLLYEYLGRGSLAIILSNDA----------AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDA 608 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~ 608 (639)
|+|||||++|+|.++++..+ ....++|..+..++.|+++||+|||+. +||||||||+|||++.++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999997542 234689999999999999999999998 99999999999999999999
Q ss_pred EEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 609 HVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 609 kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
||+|||+|+....... .....+||+.|||||
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE 200 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 200 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHH
Confidence 9999999987643322 123367999999998
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=315.11 Aligned_cols=170 Identities=24% Similarity=0.408 Sum_probs=139.7
Q ss_pred ccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
++|...+.||+|+||+||+|+++ +++.||||+++.. .....+.|.+|++++++++|||||+++|+|.+++..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45566789999999999999764 4788999999753 345567899999999999999999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCC------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 046265 539 FLLYEYLGRGSLAIILSNDAA------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY 606 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~ 606 (639)
|+|||||++|+|.++++.... ...++|..+..++.|+|+||+|||+. +||||||||+|||++.++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCC
Confidence 999999999999999976432 23589999999999999999999998 999999999999999999
Q ss_pred ceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 607 DAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 607 ~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
.+||+|||+|+.+..... .....+||+.|||||
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE 230 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE 230 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChh
Confidence 999999999997643322 223468999999998
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=322.38 Aligned_cols=166 Identities=27% Similarity=0.391 Sum_probs=149.0
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
..|+..+.||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+.+|++++|||||+++++|.+++.+|+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 5688889999999999999954 57899999999765422 34568899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
||+||+|.++++.. .+++..+..++.|++.||+|||.. +||||||||+|||++.+|.+||+|||+|+.+....
T Consensus 229 y~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 229 FLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 99999999999753 378899999999999999999999 99999999999999999999999999999876655
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
....+.+||+.|||||
T Consensus 302 ~~~~~~~GTp~YmAPE 317 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPE 317 (423)
T ss_dssp CCBCCCEECTTTCCHH
T ss_pred ccccccccCcCcCCHH
Confidence 5566789999999998
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=316.26 Aligned_cols=169 Identities=22% Similarity=0.290 Sum_probs=140.8
Q ss_pred ccCCCcceeccCCCceEEEEEc----CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL----PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
++|+..+.||+|+||+||+|+. .+++.||||.++...........+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5788899999999999999964 246889999997644333334467899999999999999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
|||||+||+|.+++...+ .+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999998654 477899999999999999999999 99999999999999999999999999999765
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
.......+.+||+.|||||
T Consensus 178 ~~~~~~~~~~GT~~YmAPE 196 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPE 196 (304)
T ss_dssp ---CCCCSCCCCGGGCCHH
T ss_pred CCCccccccccCcccCCHH
Confidence 4444556689999999998
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=311.82 Aligned_cols=169 Identities=20% Similarity=0.307 Sum_probs=143.8
Q ss_pred CCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 467 FDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
++..+.||+|+||+||+|++. +++.||||+++... .....+.|.+|+.++++++|||||+++|+|.+++..++
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 445678999999999999763 46789999997543 33446789999999999999999999999999999999
Q ss_pred EecccCCCChhHHhhcCCC-------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 046265 541 LYEYLGRGSLAIILSNDAA-------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD 607 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~ 607 (639)
|||||++|+|.+++..... ...++|..+.+++.|||+||+|||+. +||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 9999999999999965421 23589999999999999999999998 9999999999999999999
Q ss_pred eEEccccccccCCCCC--CCcceeeeeceeeCCC
Q 046265 608 AHVSDFGISKFLKPDS--SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 608 ~kl~DfGla~~~~~~~--~~~~~~~gt~~Y~APE 639 (639)
+||+|||+|+.+.... ......+||+.|||||
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE 217 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPE 217 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHH
Confidence 9999999998764322 2234568999999998
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=309.96 Aligned_cols=172 Identities=22% Similarity=0.430 Sum_probs=139.7
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC------
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR------ 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 536 (639)
..+|+..+.||+|+||+||+|+. .+|+.||||+++... .....+.+.+|+.++++++|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 34688899999999999999964 578999999997644 3345677899999999999999999999997544
Q ss_pred ------ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 046265 537 ------QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV 610 (639)
Q Consensus 537 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl 610 (639)
..|+|||||++|+|.+++.......+.++..+..++.|+++||+|||+. +||||||||+|||++.++.+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEE
Confidence 3689999999999999998877666778888999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCCC------------CcceeeeeceeeCCC
Q 046265 611 SDFGISKFLKPDSS------------NWSEFVGTFGYVAPI 639 (639)
Q Consensus 611 ~DfGla~~~~~~~~------------~~~~~~gt~~Y~APE 639 (639)
+|||+|+.+..... ...+.+||+.|||||
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE 200 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE 200 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHH
Confidence 99999997654321 123468999999998
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=302.57 Aligned_cols=168 Identities=23% Similarity=0.334 Sum_probs=132.6
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.++|+..+.||+|+||+||+|.. .+|+.||||.+.+... .....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 36799999999999999999965 5789999999976542 233456789999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||| +|+|.+++...+ .+++..+..++.|++.|++|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999 689999987654 478899999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
. ....+.+||+.|||||
T Consensus 165 ~-~~~~~~~GT~~Y~APE 181 (275)
T 3hyh_A 165 G-NFLKTSCGSPNYAAPE 181 (275)
T ss_dssp -----------CTTSCHH
T ss_pred C-CccCCeeECcccCChh
Confidence 3 2345679999999998
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=327.21 Aligned_cols=385 Identities=21% Similarity=0.198 Sum_probs=258.1
Q ss_pred eeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeee
Q 046265 7 FFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLY 86 (639)
Q Consensus 7 ~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 86 (639)
....+|+++|+|.+..|.+|.++++|++|||++|+|+++.|.+|.+|++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 45688999999999888999999999999999999998888899999999999999999997666789999999999999
Q ss_pred cccCccccCccccCCCCCCc----------ccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCC----CEEeccC
Q 046265 87 CNGLSGWLPSSFGNLNNLAI----------GSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNL----AVLHLGD 152 (639)
Q Consensus 87 ~N~l~~~~p~~~~~l~~L~~----------~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L----~~L~L~~ 152 (639)
+|++++..+..|+++++|+. ..+|..+.+++.| ++|+|++|++++..|..+..+.++ ..++++.
T Consensus 133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L--~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~ 210 (635)
T 4g8a_A 133 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL--EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 210 (635)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTC--CEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred CCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhh--hhhcccCccccccccccccchhhhhhhhhhhhccc
Confidence 99999888888998887761 1234455555555 566666666666656555544433 2456666
Q ss_pred CCCCCCCCccccCCCcccEEEcccCcCCcc--------------------------------------------------
Q 046265 153 NSLFGSIPPILGKVQSLLSLGFDLNLLNGV-------------------------------------------------- 182 (639)
Q Consensus 153 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-------------------------------------------------- 182 (639)
|.+....|..+. ...+..+++.+|.....
T Consensus 211 n~l~~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~ 289 (635)
T 4g8a_A 211 NPMNFIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 289 (635)
T ss_dssp CCCCEECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEE
T ss_pred CcccccCccccc-chhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 655432221111 11112222222111000
Q ss_pred --------CC----------------------ccCcCCCCCCeEEccCCcc-----------------------cccccc
Q 046265 183 --------LP----------------------PSISNLSNLEGLYLYSSLV-----------------------SAEIGN 209 (639)
Q Consensus 183 --------~p----------------------~~~~~l~~L~~L~l~~~~~-----------------------~~~~~~ 209 (639)
.+ ..+....+++.|++.++.+ +.....
T Consensus 290 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~ 369 (635)
T 4g8a_A 290 YLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD 369 (635)
T ss_dssp CCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCB
T ss_pred hhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCccccc
Confidence 00 0011112233333321110 001123
Q ss_pred ccCCcEEEcCCcccCC-------------------------CCCccccCCCCCceeccccccccCcc-hhhhhcCCCccE
Q 046265 210 LLQLIELEIDNKQLFG-------------------------QIPKSLRNFTSLNIVHLEQNHLTGNI-YEVFGIYPNLTF 263 (639)
Q Consensus 210 l~~L~~L~l~~n~l~~-------------------------~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~ 263 (639)
+++|+.++++.|.+.. .++..+..+++|+.++++.|...... ...|..+++++.
T Consensus 370 l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~ 449 (635)
T 4g8a_A 370 LPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 449 (635)
T ss_dssp CTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCE
T ss_pred ccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccccccccc
Confidence 4455555555544321 13445667888999999887766544 356788889999
Q ss_pred EeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCccc-ccCCccccCCCCCCeeeccCccCcccCCcCccCCC
Q 046265 264 LDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIV-GELPIELGNLKSLNYRALNGNKVYGSLPRVLGSIS 342 (639)
Q Consensus 264 L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 342 (639)
++++.|.+ .+..|..+..++.++.|++++|.+. +.+|..|..+++|+.|+|++|++++..|..|.+++
T Consensus 450 l~ls~n~l-----------~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~ 518 (635)
T 4g8a_A 450 LDISHTHT-----------RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 518 (635)
T ss_dssp EECTTSCC-----------EECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred cccccccc-----------ccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCC
Confidence 99776665 3456666777788888888888644 44677788888888888888888887788888888
Q ss_pred CCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhc-ccCcEEccCCCeeeee
Q 046265 343 DLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRM-HGLSCIDISYNELRGL 418 (639)
Q Consensus 343 ~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l-~~L~~ldls~N~l~g~ 418 (639)
+|+.|+|++|++ .+..|..+..+++|+.|++++|.+++.. | ..+..+ ++|+.||+++|+++-.
T Consensus 519 ~L~~L~Ls~N~l---~~l~~~~~~~l~~L~~L~Ls~N~l~~~~-~---------~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 519 SLQVLNMSHNNF---FSLDTFPYKCLNSLQVLDYSLNHIMTSK-K---------QELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp TCCEEECTTSCC---CBCCCGGGTTCTTCCEEECTTSCCCBCC-S---------SCTTCCCTTCCEEECTTCCBCCS
T ss_pred CCCEEECCCCcC---CCCChhHHhCCCCCCEEECCCCcCCCCC-H---------HHHHhhhCcCCEEEeeCCCCccc
Confidence 888888888543 3444666778888888888888877655 4 445555 5688888888887654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.59 Aligned_cols=162 Identities=24% Similarity=0.253 Sum_probs=139.2
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
+.|+..+.||+|+||+||+|+. .+|+.||||+++.... ..+|+.++++++|||||++++++.+++..|+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4566778899999999999964 5789999999975432 2469999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEccccccccCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY-DAHVSDFGISKFLKPD 622 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~-~~kl~DfGla~~~~~~ 622 (639)
||+||+|.++++..+ .+++..+..++.|++.||+|||.. +||||||||+|||++.++ .+||+|||+|+.+...
T Consensus 131 y~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999998654 478899999999999999999998 999999999999999988 6999999999987543
Q ss_pred CC-----CcceeeeeceeeCCC
Q 046265 623 SS-----NWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~-----~~~~~~gt~~Y~APE 639 (639)
.. .....+||+.|||||
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE 226 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPE 226 (336)
T ss_dssp ---------CCCCCCGGGCCHH
T ss_pred CcccceecCCccccCccccCHH
Confidence 21 123468999999998
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=311.57 Aligned_cols=318 Identities=22% Similarity=0.191 Sum_probs=258.7
Q ss_pred CCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCC
Q 046265 32 LKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPN 111 (639)
Q Consensus 32 L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~ 111 (639)
-+.++.++++++ .+|..+. ++++.|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|
T Consensus 13 ~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L------- 82 (477)
T 2id5_A 13 DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL------- 82 (477)
T ss_dssp TTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTC-------
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccC-------
Confidence 468999999998 6787664 689999999999998788899999999999999999998888888888744
Q ss_pred CCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCC
Q 046265 112 SLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLS 191 (639)
Q Consensus 112 ~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 191 (639)
++|+|++|++++..+..|.++++|++|+|++|++.+..|..|..+++|+.|++++|.+++..|..|..++
T Consensus 83 ----------~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 152 (477)
T 2id5_A 83 ----------RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLN 152 (477)
T ss_dssp ----------CEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCT
T ss_pred ----------CEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCC
Confidence 5999999999966667789999999999999999998899999999999999999999999898999999
Q ss_pred CCCeEEccCCccc----cccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEecc
Q 046265 192 NLEGLYLYSSLVS----AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLS 267 (639)
Q Consensus 192 ~L~~L~l~~~~~~----~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 267 (639)
+|+.|+++.+.+. ..+..+++|+.|++++|.+.+..+..+..+++|+.|++++|.+.+.++.......+|+.|+++
T Consensus 153 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~ 232 (477)
T 2id5_A 153 SLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSIT 232 (477)
T ss_dssp TCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEE
T ss_pred CCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECc
Confidence 9999888765442 346777888888888888877777778888888888888877766666555555678888876
Q ss_pred CCcccccccCcCCccccccC-ccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCE
Q 046265 268 QNNFYGSLNFSMNNITRSIP-PKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEY 346 (639)
Q Consensus 268 ~N~l~~~l~ls~n~~~~~~p-~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 346 (639)
+|++. .+| ..+..+++|+.|++++|.+.+..+..|..+++|+.|++++|++.+..|..|..+++|+.
T Consensus 233 ~n~l~------------~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 300 (477)
T 2id5_A 233 HCNLT------------AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRV 300 (477)
T ss_dssp SSCCC------------SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCE
T ss_pred CCccc------------ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCE
Confidence 66652 344 45677788888888888888777777888888888888888888777888888888888
Q ss_pred EeCCCCCCCcccccCChhhhccccCCeeeccCCcCcee
Q 046265 347 LDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEER 384 (639)
Q Consensus 347 L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~ 384 (639)
|+|++|++.. ..+..+..+++|+.|++++|.+...
T Consensus 301 L~L~~N~l~~---~~~~~~~~l~~L~~L~l~~N~l~c~ 335 (477)
T 2id5_A 301 LNVSGNQLTT---LEESVFHSVGNLETLILDSNPLACD 335 (477)
T ss_dssp EECCSSCCSC---CCGGGBSCGGGCCEEECCSSCEECS
T ss_pred EECCCCcCce---eCHhHcCCCcccCEEEccCCCccCc
Confidence 8888855433 2344567777888888888877654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=308.06 Aligned_cols=341 Identities=25% Similarity=0.366 Sum_probs=270.0
Q ss_pred eEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeec
Q 046265 8 FFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYC 87 (639)
Q Consensus 8 ~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 87 (639)
+..+++.++.+.. +| .+..+++|++|+|++|.+++..| +..+++|++|++++|++++ +++ ++++++|++|++++
T Consensus 48 l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L~~ 121 (466)
T 1o6v_A 48 VTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITP-LANLTNLTGLTLFN 121 (466)
T ss_dssp CCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCS
T ss_pred ccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCcccc-Chh-hcCCCCCCEEECCC
Confidence 4566777777764 55 47788889999999888885543 8888899999999888885 444 88888899999988
Q ss_pred ccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCC
Q 046265 88 NGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQ 167 (639)
Q Consensus 88 N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 167 (639)
|++++..+ +.+++ +| ++|++++|.+++ +| .+..+++|++|+++ |.+.+. + .+..++
T Consensus 122 n~l~~~~~--~~~l~---------------~L--~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~-~-~~~~l~ 177 (466)
T 1o6v_A 122 NQITDIDP--LKNLT---------------NL--NRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDL-K-PLANLT 177 (466)
T ss_dssp SCCCCCGG--GTTCT---------------TC--SEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCC-G-GGTTCT
T ss_pred CCCCCChH--HcCCC---------------CC--CEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCc-h-hhccCC
Confidence 88875433 55554 33 589999998874 44 47889999999986 555543 2 388899
Q ss_pred cccEEEcccCcCCccCCccCcCCCCCCeEEccCCcccc--ccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccc
Q 046265 168 SLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSA--EIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQN 245 (639)
Q Consensus 168 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~--~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N 245 (639)
+|+.|++++|.+++. ..+..+++|+.|+++.+.+.. .++.+++|+.|++++|++.+. ..+..+++|+.|++++|
T Consensus 178 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n 253 (466)
T 1o6v_A 178 TLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANN 253 (466)
T ss_dssp TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSS
T ss_pred CCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcccccccccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCC
Confidence 999999999998754 347888999999998765532 266788999999999988653 35788899999999999
Q ss_pred cccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeec
Q 046265 246 HLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRAL 325 (639)
Q Consensus 246 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l 325 (639)
.+++..+ +..+++|+.|++++|.+. + +|. +..+++|+.|++++|++.+..| +..+++|+.|++
T Consensus 254 ~l~~~~~--~~~l~~L~~L~l~~n~l~-----------~-~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L 316 (466)
T 1o6v_A 254 QISNLAP--LSGLTKLTELKLGANQIS-----------N-ISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316 (466)
T ss_dssp CCCCCGG--GTTCTTCSEEECCSSCCC-----------C-CGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEEC
T ss_pred ccccchh--hhcCCCCCEEECCCCccC-----------c-ccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEEC
Confidence 9988765 788899999998777763 2 333 7788999999999999986544 789999999999
Q ss_pred cCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccC
Q 046265 326 NGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGL 405 (639)
Q Consensus 326 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L 405 (639)
++|++++..| +..+++|+.|++++|++..+ ..+..+++|+.|++++|.+.+.. | +..++.|
T Consensus 317 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-----~~l~~l~~L~~L~l~~n~l~~~~-~-----------~~~l~~L 377 (466)
T 1o6v_A 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDV-----SSLANLTNINWLSAGHNQISDLT-P-----------LANLTRI 377 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-----GGGTTCTTCCEEECCSSCCCBCG-G-----------GTTCTTC
T ss_pred cCCcCCCchh--hccCccCCEeECCCCccCCc-----hhhccCCCCCEEeCCCCccCccc-h-----------hhcCCCC
Confidence 9999997766 78999999999999765443 36888999999999999887644 2 6788999
Q ss_pred cEEccCCCeeeee
Q 046265 406 SCIDISYNELRGL 418 (639)
Q Consensus 406 ~~ldls~N~l~g~ 418 (639)
+.+++++|++++.
T Consensus 378 ~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 378 TQLGLNDQAWTNA 390 (466)
T ss_dssp CEEECCCEEEECC
T ss_pred CEEeccCCcccCC
Confidence 9999999999884
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=302.60 Aligned_cols=166 Identities=27% Similarity=0.312 Sum_probs=135.6
Q ss_pred cCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC----ceeEE
Q 046265 466 NFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR----QSFLL 541 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv 541 (639)
++...+.||+|+||+||+|++ +|+.||||++.... .....+++|+..+.+++|||||+++++|.+++ ..|+|
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 456678999999999999987 47999999986422 22223345677777899999999999998754 57999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHD-----YFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
||||++|+|.++++.. .++|..+.+++.|+++||+|+|+. +.++||||||||+|||++.++.+||+|||+|
T Consensus 80 ~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999754 478999999999999999999976 2468999999999999999999999999999
Q ss_pred ccCCCCCC----CcceeeeeceeeCCC
Q 046265 617 KFLKPDSS----NWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~----~~~~~~gt~~Y~APE 639 (639)
+....... .....+||+.|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE 182 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPE 182 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHH
T ss_pred ccccCCCCceeeecccccccccccCHH
Confidence 87644322 223468999999998
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=316.70 Aligned_cols=335 Identities=19% Similarity=0.150 Sum_probs=230.5
Q ss_pred CCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcc
Q 046265 28 NISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIG 107 (639)
Q Consensus 28 ~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~ 107 (639)
.+++++.|++++|.+....+..|..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--- 125 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL--- 125 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC---
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCC---
Confidence 46788999999999886655567889999999999999987777789999999999999999988777777777743
Q ss_pred cCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccC
Q 046265 108 SMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSI 187 (639)
Q Consensus 108 ~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 187 (639)
++|+|++|.+++..+..|+++++|++|+|++|.+++..|..|+.+++|+.|++++|.+++.. +
T Consensus 126 --------------~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~ 188 (597)
T 3oja_B 126 --------------TVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---L 188 (597)
T ss_dssp --------------CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---G
T ss_pred --------------CEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---h
Confidence 48899999988655566788999999999999998888888888999999999999887642 3
Q ss_pred cCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEecc
Q 046265 188 SNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLS 267 (639)
Q Consensus 188 ~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 267 (639)
..+++|+. |++++|.+.+ +...++|+.|++++|.++...+. ..++|+.|+++
T Consensus 189 ~~l~~L~~--------------------L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~---~~~~L~~L~L~ 240 (597)
T 3oja_B 189 SLIPSLFH--------------------ANVSYNLLST-----LAIPIAVEELDASHNSINVVRGP---VNVELTILKLQ 240 (597)
T ss_dssp GGCTTCSE--------------------EECCSSCCSE-----EECCTTCSEEECCSSCCCEEECS---CCSCCCEEECC
T ss_pred hhhhhhhh--------------------hhcccCcccc-----ccCCchhheeeccCCcccccccc---cCCCCCEEECC
Confidence 33444444 4455554432 22334566666666666543322 12566677766
Q ss_pred CCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEE
Q 046265 268 QNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYL 347 (639)
Q Consensus 268 ~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 347 (639)
+|.+. + +..++.+++|+.|++++|.+.+.+|..|..+++|+.|+|++|.+++ +|..+..+++|+.|
T Consensus 241 ~n~l~-----------~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L 306 (597)
T 3oja_B 241 HNNLT-----------D--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVL 306 (597)
T ss_dssp SSCCC-----------C--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEE
T ss_pred CCCCC-----------C--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEE
Confidence 65552 1 3456666777777777777777667777777777777777777764 45556667777777
Q ss_pred eCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeeeeeecCCCcccc
Q 046265 348 DLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIRNSTGIHY 427 (639)
Q Consensus 348 ~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~g~~p~~~~~~~ 427 (639)
+|++|.+. .+|..+..+++|+.|++++|.+.+.. +..++.|+.|++++|++++..+. ..+..
T Consensus 307 ~Ls~N~l~----~i~~~~~~l~~L~~L~L~~N~l~~~~-------------~~~~~~L~~L~l~~N~~~~~~~~-~~~~~ 368 (597)
T 3oja_B 307 DLSHNHLL----HVERNQPQFDRLENLYLDHNSIVTLK-------------LSTHHTLKNLTLSHNDWDCNSLR-ALFRN 368 (597)
T ss_dssp ECCSSCCC----CCGGGHHHHTTCSEEECCSSCCCCCC-------------CCTTCCCSEEECCSSCEEHHHHH-HHTTT
T ss_pred ECCCCCCC----ccCcccccCCCCCEEECCCCCCCCcC-------------hhhcCCCCEEEeeCCCCCChhHH-HHHHH
Confidence 77775433 35666667777777777777665421 34566777777887777654321 11222
Q ss_pred cccccccCCCCCCCC
Q 046265 428 NLVDALQGNKGLCGD 442 (639)
Q Consensus 428 ~~~~~~~~~~~l~g~ 442 (639)
.....+.++...|+.
T Consensus 369 ~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 369 VARPAVDDADQHCKI 383 (597)
T ss_dssp CCTTTBCCCCCCCCT
T ss_pred HhhhccccccccCCc
Confidence 222334455566664
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.17 Aligned_cols=311 Identities=19% Similarity=0.167 Sum_probs=214.4
Q ss_pred CCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcc
Q 046265 28 NISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIG 107 (639)
Q Consensus 28 ~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~ 107 (639)
.++++++|++++|.++...+..+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..|..|+++++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--- 119 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL--- 119 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC---
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCC---
Confidence 46889999999999985544457889999999999999987777789999999999999999998777777777643
Q ss_pred cCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccC
Q 046265 108 SMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSI 187 (639)
Q Consensus 108 ~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 187 (639)
++|+|++|+++...+..|.++++|++|++++|++++..|..+..+++|++|++++|.+++. .+
T Consensus 120 --------------~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~ 182 (390)
T 3o6n_A 120 --------------TVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DL 182 (390)
T ss_dssp --------------CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CG
T ss_pred --------------CEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---cc
Confidence 5899999999854445578899999999999999887788899999999999999998854 23
Q ss_pred cCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEecc
Q 046265 188 SNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLS 267 (639)
Q Consensus 188 ~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 267 (639)
..+++|+.|+++ +|.+.+ +...++|+.|++++|.++.... ...++|+.|+++
T Consensus 183 ~~l~~L~~L~l~--------------------~n~l~~-----~~~~~~L~~L~l~~n~l~~~~~---~~~~~L~~L~l~ 234 (390)
T 3o6n_A 183 SLIPSLFHANVS--------------------YNLLST-----LAIPIAVEELDASHNSINVVRG---PVNVELTILKLQ 234 (390)
T ss_dssp GGCTTCSEEECC--------------------SSCCSE-----EECCSSCSEEECCSSCCCEEEC---CCCSSCCEEECC
T ss_pred ccccccceeecc--------------------cccccc-----cCCCCcceEEECCCCeeeeccc---cccccccEEECC
Confidence 444555555554 444322 1223455556666665554322 123556666655
Q ss_pred CCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEE
Q 046265 268 QNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYL 347 (639)
Q Consensus 268 ~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 347 (639)
+|.+.+ ++.+..+++|+.|++++|.+.+..|..+..+++|+.|++++|++++ +|..+..+++|+.|
T Consensus 235 ~n~l~~-------------~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L 300 (390)
T 3o6n_A 235 HNNLTD-------------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVL 300 (390)
T ss_dssp SSCCCC-------------CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEE
T ss_pred CCCCcc-------------cHHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEE
Confidence 555421 1345556666666666666666666666666666666666666653 45555566667777
Q ss_pred eCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeeee
Q 046265 348 DLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRG 417 (639)
Q Consensus 348 ~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~g 417 (639)
++++|++. .+|..+..+++|+.|++++|.+.... +..++.|+.|++++|+++.
T Consensus 301 ~L~~n~l~----~~~~~~~~l~~L~~L~L~~N~i~~~~-------------~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 301 DLSHNHLL----HVERNQPQFDRLENLYLDHNSIVTLK-------------LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp ECCSSCCC----CCGGGHHHHTTCSEEECCSSCCCCCC-------------CCTTCCCSEEECCSSCEEH
T ss_pred ECCCCcce----ecCccccccCcCCEEECCCCccceeC-------------chhhccCCEEEcCCCCccc
Confidence 77665432 34555666666777777666654321 3455667777777777665
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=299.46 Aligned_cols=172 Identities=21% Similarity=0.314 Sum_probs=145.5
Q ss_pred hccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhcccc-CceeeeEEEEEcC-
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH-RNVVKFYGFSFHP- 535 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~- 535 (639)
.++|+..+.||+|+||+||+|... +++.||||++.... .....+.|.+|+.++++++| ||||+++|+|.++
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 367888899999999999999653 24689999997643 33446779999999999976 8999999999765
Q ss_pred CceeEEecccCCCChhHHhhcCCC-------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDAA-------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL 602 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill 602 (639)
+..|+|||||++|+|.++++.... ...++|..+..++.|||+||+|||+. +||||||||+|||+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceee
Confidence 568999999999999999975321 23589999999999999999999999 99999999999999
Q ss_pred CCCCceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 603 GLDYDAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 603 ~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
++++.+||+|||+|+.+..... .....+||+.|||||
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE 257 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 257 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHH
Confidence 9999999999999997754433 233578999999998
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-33 Score=292.35 Aligned_cols=307 Identities=23% Similarity=0.255 Sum_probs=221.2
Q ss_pred eEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeec
Q 046265 8 FFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYC 87 (639)
Q Consensus 8 ~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 87 (639)
...+++++|.+....+..+..+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..|..|+++++|++|++++
T Consensus 47 l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 126 (390)
T 3o6n_A 47 QKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLER 126 (390)
T ss_dssp CSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred ceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCC
Confidence 34567788877765555678999999999999999988888999999999999999999987788899999999999999
Q ss_pred ccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCC
Q 046265 88 NGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQ 167 (639)
Q Consensus 88 N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 167 (639)
|+++...+..|.++++| ++|++++|++++..|..+..+++|++|++++|++++. .++.++
T Consensus 127 n~l~~l~~~~~~~l~~L-----------------~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~ 186 (390)
T 3o6n_A 127 NDLSSLPRGIFHNTPKL-----------------TTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIP 186 (390)
T ss_dssp SCCCCCCTTTTTTCTTC-----------------CEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCT
T ss_pred CccCcCCHHHhcCCCCC-----------------cEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---cccccc
Confidence 99995555556666633 5999999999988888899999999999999999864 367789
Q ss_pred cccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccc
Q 046265 168 SLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHL 247 (639)
Q Consensus 168 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 247 (639)
+|+.|++++|.+++. ....+| +.|++++|.+... |.. ..++|+.|++++|.+
T Consensus 187 ~L~~L~l~~n~l~~~-----~~~~~L--------------------~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l 238 (390)
T 3o6n_A 187 SLFHANVSYNLLSTL-----AIPIAV--------------------EELDASHNSINVV-RGP--VNVELTILKLQHNNL 238 (390)
T ss_dssp TCSEEECCSSCCSEE-----ECCSSC--------------------SEEECCSSCCCEE-ECC--CCSSCCEEECCSSCC
T ss_pred ccceeeccccccccc-----CCCCcc--------------------eEEECCCCeeeec-ccc--ccccccEEECCCCCC
Confidence 999999999988743 222344 4555555555332 221 235666666666666
Q ss_pred cCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccC
Q 046265 248 TGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNG 327 (639)
Q Consensus 248 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~ 327 (639)
++. ..+..+++|++|++++|.+ ++..|..+..+++|+.|++++|++.+ +|..+..+++|+.|++++
T Consensus 239 ~~~--~~l~~l~~L~~L~Ls~n~l-----------~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~ 304 (390)
T 3o6n_A 239 TDT--AWLLNYPGLVEVDLSYNEL-----------EKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSH 304 (390)
T ss_dssp CCC--GGGGGCTTCSEEECCSSCC-----------CEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCS
T ss_pred ccc--HHHcCCCCccEEECCCCcC-----------CCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCC
Confidence 653 3456666666666554443 33455666666666677776666653 344555666677777777
Q ss_pred ccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCce
Q 046265 328 NKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEE 383 (639)
Q Consensus 328 N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~ 383 (639)
|++. .+|..+..+++|+.|++++|++..+ | +..+++|+.|++++|.+..
T Consensus 305 n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~----~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 305 NHLL-HVERNQPQFDRLENLYLDHNSIVTL----K--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp SCCC-CCGGGHHHHTTCSEEECCSSCCCCC----C--CCTTCCCSEEECCSSCEEH
T ss_pred Ccce-ecCccccccCcCCEEECCCCcccee----C--chhhccCCEEEcCCCCccc
Confidence 7666 4555566667777777777554332 2 4556667777777776654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=295.78 Aligned_cols=327 Identities=19% Similarity=0.188 Sum_probs=259.0
Q ss_pred CcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccC
Q 046265 16 NTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLP 95 (639)
Q Consensus 16 n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 95 (639)
....+..+.+++++++|++|++++|.+++. | +++.+++|++|+|++|++++ +| ++.+++|++|++++|++++. |
T Consensus 28 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~ 101 (457)
T 3bz5_A 28 FEMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D 101 (457)
T ss_dssp TTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C
T ss_pred cCcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e
Confidence 344556677889999999999999999964 6 79999999999999999996 45 89999999999999999874 2
Q ss_pred ccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcc
Q 046265 96 SSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFD 175 (639)
Q Consensus 96 ~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 175 (639)
+++++ +| ++|++++|++++ +| ++.+++|++|++++|++++. | ++.+++|++|+++
T Consensus 102 --~~~l~---------------~L--~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~ 156 (457)
T 3bz5_A 102 --VTPLT---------------KL--TYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCH 156 (457)
T ss_dssp --CTTCT---------------TC--CEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECT
T ss_pred --cCCCC---------------cC--CEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECC
Confidence 55555 33 699999999996 45 88999999999999999974 3 8899999999999
Q ss_pred cCcCCccCCccCcCCCCCCeEEccCCcccc-ccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhh
Q 046265 176 LNLLNGVLPPSISNLSNLEGLYLYSSLVSA-EIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEV 254 (639)
Q Consensus 176 ~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~ 254 (639)
+|...+.+ .+..+++|+.|+++.+.+.. .+..+++|+.|++++|++.+. .+..+++|+.|++++|++++. |
T Consensus 157 ~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l~l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p-- 228 (457)
T 3bz5_A 157 LNKKITKL--DVTPQTQLTTLDCSFNKITELDVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D-- 228 (457)
T ss_dssp TCSCCCCC--CCTTCTTCCEEECCSSCCCCCCCTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--
T ss_pred CCCccccc--ccccCCcCCEEECCCCccceeccccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--
Confidence 99766666 47889999999998765532 377889999999999999775 388899999999999999984 4
Q ss_pred hhcCCCccEEeccCCcccccccCcCCccccccCccccCCC-------CCCEEeccCCcccccCCccccCCCCCCeeeccC
Q 046265 255 FGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLY-------QLHKLDFSLNHIVGELPIELGNLKSLNYRALNG 327 (639)
Q Consensus 255 ~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~-------~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~ 327 (639)
++.+++|+.|++++|++.+ ..+..+..+. +|+.|++++|.+.+.+| +..+++|+.|++++
T Consensus 229 ~~~l~~L~~L~l~~N~l~~-----------~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~ 295 (457)
T 3bz5_A 229 VTPLTQLTYFDCSVNPLTE-----------LDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTH 295 (457)
T ss_dssp CTTCTTCSEEECCSSCCSC-----------CCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTT
T ss_pred ccccCCCCEEEeeCCcCCC-----------cCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCC
Confidence 7888999999988887754 2222333333 56777888887777766 46788999999999
Q ss_pred ccCcccCCcC--------ccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhh
Q 046265 328 NKVYGSLPRV--------LGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLI 399 (639)
Q Consensus 328 N~l~~~~p~~--------~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~ 399 (639)
|...+.+|.. +..+++|+.|++++|++.. ++ +..+++|+.|++++|.+++ +
T Consensus 296 n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~----l~--l~~l~~L~~L~l~~N~l~~-l-------------- 354 (457)
T 3bz5_A 296 NTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTE----LD--VSHNTKLKSLSCVNAHIQD-F-------------- 354 (457)
T ss_dssp CTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSC----CC--CTTCTTCSEEECCSSCCCB-C--------------
T ss_pred CcccceeccCCCcceEechhhcccCCEEECCCCcccc----cc--cccCCcCcEEECCCCCCCC-c--------------
Confidence 9887777642 4556677888888755433 22 6777888888888887664 1
Q ss_pred hhcccCcEEccCCCeeeee
Q 046265 400 SRMHGLSCIDISYNELRGL 418 (639)
Q Consensus 400 ~~l~~L~~ldls~N~l~g~ 418 (639)
+.|..++++.|.++|.
T Consensus 355 ---~~L~~L~l~~n~l~g~ 370 (457)
T 3bz5_A 355 ---SSVGKIPALNNNFEAE 370 (457)
T ss_dssp ---TTGGGSSGGGTSEEEE
T ss_pred ---cccccccccCCcEEec
Confidence 2355567788888775
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=296.04 Aligned_cols=320 Identities=27% Similarity=0.388 Sum_probs=262.9
Q ss_pred eeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEee
Q 046265 6 FFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVL 85 (639)
Q Consensus 6 ~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 85 (639)
-.+..+++++|++.+..| +.++++|++|++++|.+++..| ++.+++|++|++++|++++ +|. +.++++|++|++
T Consensus 68 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~-~~~-~~~l~~L~~L~l 141 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD-IDP-LKNLTNLNRLEL 141 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGG-GTTCTTCSEEEE
T ss_pred cCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCC-ChH-HcCCCCCCEEEC
Confidence 456788999999887654 9999999999999999986554 9999999999999999985 454 999999999999
Q ss_pred ecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccC
Q 046265 86 YCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGK 165 (639)
Q Consensus 86 ~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 165 (639)
++|.+++. + .++.+++| ++|+++ |.+.+. + .+.++++|++|++++|.+++. ..+..
T Consensus 142 ~~n~l~~~-~-~~~~l~~L-----------------~~L~l~-~~~~~~-~-~~~~l~~L~~L~l~~n~l~~~--~~l~~ 197 (466)
T 1o6v_A 142 SSNTISDI-S-ALSGLTSL-----------------QQLSFG-NQVTDL-K-PLANLTTLERLDISSNKVSDI--SVLAK 197 (466)
T ss_dssp EEEEECCC-G-GGTTCTTC-----------------SEEEEE-ESCCCC-G-GGTTCTTCCEEECCSSCCCCC--GGGGG
T ss_pred CCCccCCC-h-hhccCCcc-----------------cEeecC-CcccCc-h-hhccCCCCCEEECcCCcCCCC--hhhcc
Confidence 99998853 3 35555533 477776 455533 3 278899999999999998753 34788
Q ss_pred CCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccc--cccccccCCcEEEcCCcccCCCCCccccCCCCCceeccc
Q 046265 166 VQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLE 243 (639)
Q Consensus 166 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~ 243 (639)
+++|++|++++|.+++..| ++.+++|+.|+++.+.+. ..+..+++|+.|++++|.+.+..| +..+++|+.|+++
T Consensus 198 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~ 273 (466)
T 1o6v_A 198 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 273 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred CCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccchhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECC
Confidence 8999999999999987655 677889999999876554 357788999999999999977655 8899999999999
Q ss_pred cccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCee
Q 046265 244 QNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYR 323 (639)
Q Consensus 244 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L 323 (639)
+|.+++..+ +..+++|+.|++++|++. + ++. +..+++|+.|++++|++.+..| +..+++|+.|
T Consensus 274 ~n~l~~~~~--~~~l~~L~~L~L~~n~l~-----------~-~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 336 (466)
T 1o6v_A 274 ANQISNISP--LAGLTALTNLELNENQLE-----------D-ISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336 (466)
T ss_dssp SSCCCCCGG--GTTCTTCSEEECCSSCCS-----------C-CGG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred CCccCcccc--ccCCCccCeEEcCCCccc-----------C-chh-hcCCCCCCEEECcCCcCCCchh--hccCccCCEe
Confidence 999998665 788999999998887763 2 222 7788999999999999987765 7889999999
Q ss_pred eccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCce
Q 046265 324 ALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEE 383 (639)
Q Consensus 324 ~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~ 383 (639)
++++|++++. ..+..+++|+.|++++|++ .+..| +..+++|+.|++++|.+.+
T Consensus 337 ~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l---~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 337 FFYNNKVSDV--SSLANLTNINWLSAGHNQI---SDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp ECCSSCCCCC--GGGTTCTTCCEEECCSSCC---CBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred ECCCCccCCc--hhhccCCCCCEEeCCCCcc---Cccch--hhcCCCCCEEeccCCcccC
Confidence 9999999865 4688999999999999654 44444 8889999999999998876
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-33 Score=307.46 Aligned_cols=300 Identities=22% Similarity=0.240 Sum_probs=198.9
Q ss_pred EEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecc
Q 046265 9 FQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCN 88 (639)
Q Consensus 9 ~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 88 (639)
..+++++|.+....+..+.++++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 54 ~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 133 (597)
T 3oja_B 54 KIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 133 (597)
T ss_dssp SEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCC
Confidence 45677788777666667889999999999999999888889999999999999999999888888999999999999999
Q ss_pred cCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCc
Q 046265 89 GLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQS 168 (639)
Q Consensus 89 ~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 168 (639)
.+++..+..|+++++| ++|+|++|.+++..|..|+.+++|++|+|++|.+++. + ++.+++
T Consensus 134 ~l~~l~~~~~~~l~~L-----------------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~--~~~l~~ 193 (597)
T 3oja_B 134 DLSSLPRGIFHNTPKL-----------------TTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D--LSLIPS 193 (597)
T ss_dssp CCCCCCTTTTTTCTTC-----------------CEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-C--GGGCTT
T ss_pred CCCCCCHHHhccCCCC-----------------CEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc-C--hhhhhh
Confidence 9997666666777643 5999999999998888999999999999999999864 3 567889
Q ss_pred ccEEEcccCcCCccCCccCcCCCCCCeEEccCCcccccc-ccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccc
Q 046265 169 LLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEI-GNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHL 247 (639)
Q Consensus 169 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~-~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 247 (639)
|+.|++++|.+++. ....+|+.|+++.+.+.... ...++|+.|++++|.+.+ +.++..+++|+.|++++|.+
T Consensus 194 L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l 266 (597)
T 3oja_B 194 LFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL 266 (597)
T ss_dssp CSEEECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCC
T ss_pred hhhhhcccCccccc-----cCCchhheeeccCCcccccccccCCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCcc
Confidence 99999999998753 23345666666554432111 112345555555555443 23444444555555555555
Q ss_pred cCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccC
Q 046265 248 TGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNG 327 (639)
Q Consensus 248 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~ 327 (639)
++..|..|+.+++|+.|+|++|.+. .+|..+..+++|+.|+|++|.+. .+|..+..+++|+.|++++
T Consensus 267 ~~~~~~~~~~l~~L~~L~Ls~N~l~------------~l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~ 333 (597)
T 3oja_B 267 EKIMYHPFVKMQRLERLYISNNRLV------------ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDH 333 (597)
T ss_dssp CEEESGGGTTCSSCCEEECTTSCCC------------EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCS
T ss_pred CCCCHHHhcCccCCCEEECCCCCCC------------CCCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCC
Confidence 4444444444444444444444331 12333334444444444444444 3344444444444444444
Q ss_pred ccCcccCCcCccCCCCCCEEeCCC
Q 046265 328 NKVYGSLPRVLGSISDLEYLDLST 351 (639)
Q Consensus 328 N~l~~~~p~~~~~l~~L~~L~Ls~ 351 (639)
|.+.+. | +..+++|+.|++++
T Consensus 334 N~l~~~-~--~~~~~~L~~L~l~~ 354 (597)
T 3oja_B 334 NSIVTL-K--LSTHHTLKNLTLSH 354 (597)
T ss_dssp SCCCCC-C--CCTTCCCSEEECCS
T ss_pred CCCCCc-C--hhhcCCCCEEEeeC
Confidence 444322 1 23344444444444
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=298.96 Aligned_cols=168 Identities=20% Similarity=0.330 Sum_probs=144.6
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc------CCc
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH------PRQ 537 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~ 537 (639)
++|+..+.||+|+||+||+|. ..+|+.||||+++.........+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 568888999999999999995 4678999999998765555556778899999999999999999998764 357
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
+|+|||||+ |+|.+++...+ .+++..+..++.|++.||+|||.. +||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 67999997654 478899999999999999999999 99999999999999999999999999998
Q ss_pred cCCCC----CCCcceeeeeceeeCCC
Q 046265 618 FLKPD----SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~----~~~~~~~~gt~~Y~APE 639 (639)
.+... .....+.+||+.|||||
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APE 232 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPE 232 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHH
T ss_pred ecccCccccccccccceeChHhcCHH
Confidence 76432 12345679999999998
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=287.24 Aligned_cols=248 Identities=30% Similarity=0.495 Sum_probs=123.1
Q ss_pred CCCEEECcCCCCcc--CCCCCCCCCCCCCEEEccc-CcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcc
Q 046265 31 NLKFLDMGNNQLSG--VIPQEIDPLTHLKHLYINV-NKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIG 107 (639)
Q Consensus 31 ~L~~L~Ls~n~l~~--~~p~~~~~L~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~ 107 (639)
+++.|+|++|.+++ .+|..|+.+++|++|+|++ |.+++.+|..|+++++|++|+|++|++++.+|..|.++++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L--- 127 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL--- 127 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTC---
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCC---
Confidence 45555555555555 5555555555555555552 55555555555555555555555555555555555444422
Q ss_pred cCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCC-cccEEEcccCcCCccCCcc
Q 046265 108 SMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQ-SLLSLGFDLNLLNGVLPPS 186 (639)
Q Consensus 108 ~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~ 186 (639)
++|+|++|++++.+|..+..+++|++|+|++|++++.+|..++.++ +|+.|++++|.+++.+|..
T Consensus 128 --------------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~ 193 (313)
T 1ogq_A 128 --------------VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193 (313)
T ss_dssp --------------CEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGG
T ss_pred --------------CEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChH
Confidence 3555555555555555555555555555555555555555555554 5555555555555444443
Q ss_pred CcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEec
Q 046265 187 ISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDL 266 (639)
Q Consensus 187 ~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 266 (639)
+..+ . |+.|++++|.+.+.+|..+..+++|+.|++++|.+++.++. +..+++|++|++
T Consensus 194 ~~~l--------------------~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L 251 (313)
T 1ogq_A 194 FANL--------------------N-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDL 251 (313)
T ss_dssp GGGC--------------------C-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEEC
T ss_pred HhCC--------------------c-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEEC
Confidence 3221 1 33444444444444444455555555555555555443333 334444444443
Q ss_pred cCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCcc
Q 046265 267 SQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNK 329 (639)
Q Consensus 267 s~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~ 329 (639)
++|++ ++.+|..+..+++|+.|++++|++++.+|.. ..+++|+.+++++|.
T Consensus 252 s~N~l-----------~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 252 RNNRI-----------YGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp CSSCC-----------EECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred cCCcc-----------cCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 33322 2334444444444444444444444444433 344444444444443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-32 Score=279.80 Aligned_cols=289 Identities=23% Similarity=0.271 Sum_probs=173.5
Q ss_pred CCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCC
Q 046265 31 NLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMP 110 (639)
Q Consensus 31 ~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp 110 (639)
+++.++++++.++ .+|..+. ++|++|++++|.+++..|..|.++++|++|++++|++++..|..|+++++|
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L------ 104 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL------ 104 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTC------
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCC------
Confidence 6888888888887 6676664 688888888888886667778888888888888888887777777777633
Q ss_pred CCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCC--ccCCccCc
Q 046265 111 NSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN--GVLPPSIS 188 (639)
Q Consensus 111 ~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~p~~~~ 188 (639)
++|++++|+++ .+|..+. ++|++|++++|++++..+..|..+++|+.|++++|.++ +..|..+.
T Consensus 105 -----------~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 170 (332)
T 2ft3_A 105 -----------QKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170 (332)
T ss_dssp -----------CEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSC
T ss_pred -----------CEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCccccc
Confidence 47888888887 5666554 78888888888888666667888888888888888885 35555555
Q ss_pred CCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccC
Q 046265 189 NLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQ 268 (639)
Q Consensus 189 ~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 268 (639)
.+ +|+.|+++ +|++.+ +|..+. ++|+.|++++|.+++..+..+..+++|+.|++++
T Consensus 171 ~l-~L~~L~l~--------------------~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~ 226 (332)
T 2ft3_A 171 GL-KLNYLRIS--------------------EAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGH 226 (332)
T ss_dssp SC-CCSCCBCC--------------------SSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCS
T ss_pred CC-ccCEEECc--------------------CCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCC
Confidence 55 55555444 344332 232222 3444555555555544444444445555544433
Q ss_pred CcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccC------CC
Q 046265 269 NNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGS------IS 342 (639)
Q Consensus 269 N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~------l~ 342 (639)
|++ ++..|..+..+++|+.|++++|++. .+|..+..+++|+.|++++|++++..+..|.. ..
T Consensus 227 N~l-----------~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~ 294 (332)
T 2ft3_A 227 NQI-----------RMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRA 294 (332)
T ss_dssp SCC-----------CCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSC
T ss_pred CcC-----------CcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccc
Confidence 333 2223334444455555555555554 44444555555555555555554433333332 23
Q ss_pred CCCEEeCCCCCCCcccccCChhhhccccCCeeeccCC
Q 046265 343 DLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVIT 379 (639)
Q Consensus 343 ~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n 379 (639)
+|+.|++++|.+... ...|..+..++.|+.+++++|
T Consensus 295 ~l~~L~l~~N~~~~~-~~~~~~~~~l~~L~~l~l~~n 330 (332)
T 2ft3_A 295 YYNGISLFNNPVPYW-EVQPATFRCVTDRLAIQFGNY 330 (332)
T ss_dssp CBSEEECCSSSSCGG-GSCGGGGTTBCCSTTEEC---
T ss_pred cccceEeecCccccc-ccCcccccccchhhhhhcccc
Confidence 455666665542211 233445555666666666554
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=285.65 Aligned_cols=249 Identities=28% Similarity=0.475 Sum_probs=213.4
Q ss_pred CCCCEEEcccCcCCC--CCCcccCCCCCCCEEeeec-ccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCc
Q 046265 54 THLKHLYINVNKLRG--SVPREVGQLSSLKQLVLYC-NGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQ 130 (639)
Q Consensus 54 ~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~ 130 (639)
.+++.|+|++|.+++ .+|..|+++++|++|++++ |.+.+.+|..|+++++| ++|+|++|+
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L-----------------~~L~Ls~n~ 112 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL-----------------HYLYITHTN 112 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTC-----------------SEEEEEEEC
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCC-----------------CEEECcCCe
Confidence 689999999999998 8999999999999999995 99999899888887744 589999999
Q ss_pred CcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccc
Q 046265 131 LSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNL 210 (639)
Q Consensus 131 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l 210 (639)
+++.+|..|.++++|++|+|++|.+++.+|..+..+++|++|++++|.+++.+|..+..++
T Consensus 113 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~------------------- 173 (313)
T 1ogq_A 113 VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS------------------- 173 (313)
T ss_dssp CEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCC-------------------
T ss_pred eCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhh-------------------
Confidence 9999999999999999999999999999999999999999999999999988887766543
Q ss_pred cCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccc
Q 046265 211 LQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKI 290 (639)
Q Consensus 211 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~ 290 (639)
++|+.|++++|++.+.+|..+..++ |+.|++++|.+++..+..+..+++|+.|++++|.+. +.+|. +
T Consensus 174 ~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-----------~~~~~-~ 240 (313)
T 1ogq_A 174 KLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA-----------FDLGK-V 240 (313)
T ss_dssp TTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEEC-----------CBGGG-C
T ss_pred hcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCcee-----------eecCc-c
Confidence 1466777788888888888888887 999999999999888888888899999997777663 33443 6
Q ss_pred cCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCC
Q 046265 291 GKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTN 352 (639)
Q Consensus 291 ~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 352 (639)
..+++|+.|++++|++.+.+|..+..+++|+.|++++|+++|.+|.. +.+++|+.|++++|
T Consensus 241 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N 301 (313)
T 1ogq_A 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301 (313)
T ss_dssp CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSS
T ss_pred cccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCC
Confidence 77788888888888888888888888888888888888888888875 77888888888886
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-31 Score=275.69 Aligned_cols=287 Identities=18% Similarity=0.238 Sum_probs=138.5
Q ss_pred CCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCC
Q 046265 31 NLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMP 110 (639)
Q Consensus 31 ~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp 110 (639)
++++++++++.++ .+|..+. ++|++|+|++|++++..+..|+++++|++|+|++|++++..|..|.++++|
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L------ 102 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL------ 102 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTC------
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCC------
Confidence 4555666655555 3444433 455556666666554444455556666666666665555555555544422
Q ss_pred CCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCc--cCCccCc
Q 046265 111 NSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNG--VLPPSIS 188 (639)
Q Consensus 111 ~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~ 188 (639)
++|++++|+++ .+|..+. ++|++|++++|.+++..+..+..+++|+.|++++|.+.. ..+..+.
T Consensus 103 -----------~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 168 (330)
T 1xku_A 103 -----------ERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168 (330)
T ss_dssp -----------CEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGG
T ss_pred -----------CEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhcc
Confidence 35566666555 3444332 456666666666555444455556666666666665532 3333333
Q ss_pred CCCCCCeEEccCCccc---cccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEe
Q 046265 189 NLSNLEGLYLYSSLVS---AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLD 265 (639)
Q Consensus 189 ~l~~L~~L~l~~~~~~---~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 265 (639)
.+++|+.|+++.+.+. ..+ .++|+.|++++|++.+..|..+..+++|+.|++++|.+++..+..+..+++|++|+
T Consensus 169 ~l~~L~~L~l~~n~l~~l~~~~--~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 246 (330)
T 1xku_A 169 GMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 246 (330)
T ss_dssp GCTTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEE
T ss_pred CCCCcCEEECCCCccccCCccc--cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEE
Confidence 3333333322221110 000 12344444444444444444444555555555555555444444444444444444
Q ss_pred ccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccC-----
Q 046265 266 LSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGS----- 340 (639)
Q Consensus 266 Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~----- 340 (639)
+++|++. .+|..+..+++|+.|++++|++++..+..|..
T Consensus 247 -----------------------------------L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~ 290 (330)
T 1xku_A 247 -----------------------------------LNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNT 290 (330)
T ss_dssp -----------------------------------CCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCT
T ss_pred -----------------------------------CCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCccccc
Confidence 4444444 34444444444444555444444333333322
Q ss_pred -CCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCC
Q 046265 341 -ISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVIT 379 (639)
Q Consensus 341 -l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n 379 (639)
...|+.|++++|.+... ...|..+..+..++.+++++|
T Consensus 291 ~~~~l~~l~l~~N~~~~~-~i~~~~f~~~~~l~~l~L~~N 329 (330)
T 1xku_A 291 KKASYSGVSLFSNPVQYW-EIQPSTFRCVYVRAAVQLGNY 329 (330)
T ss_dssp TSCCCSEEECCSSSSCGG-GSCGGGGTTCCCGGGEEC---
T ss_pred ccccccceEeecCccccc-ccCccccccccceeEEEeccc
Confidence 24566666666543322 223455556666666666655
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-31 Score=278.07 Aligned_cols=308 Identities=23% Similarity=0.320 Sum_probs=199.2
Q ss_pred cccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCC
Q 046265 25 QIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNL 104 (639)
Q Consensus 25 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 104 (639)
.+..+++|++|++++|.+.. +| .+..+++|++|++++|++++ +|. +..+++|++|++++|.++. +| .+.+++
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~-- 110 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-IS-ALQNLT-- 110 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCT--
T ss_pred cchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-ch-HHcCCC--
Confidence 35578889999999999974 45 48889999999999999984 555 8999999999999998875 22 455555
Q ss_pred CcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCC
Q 046265 105 AIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLP 184 (639)
Q Consensus 105 ~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 184 (639)
+| ++|++++|.+++ +|. +..+++|++|++++|.....++ .+..+++|++|++++|.+.+..+
T Consensus 111 -------------~L--~~L~l~~n~i~~-~~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~ 172 (347)
T 4fmz_A 111 -------------NL--RELYLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP 172 (347)
T ss_dssp -------------TC--SEEECTTSCCCC-CGG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG
T ss_pred -------------cC--CEEECcCCcccC-chh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh
Confidence 33 589999999884 444 7889999999999997665544 48889999999999998875433
Q ss_pred ccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEE
Q 046265 185 PSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFL 264 (639)
Q Consensus 185 ~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 264 (639)
+..+++|+ .|++++|.+.+. +. +..+++|+.|++++|.+++..+ +..+++|+.|
T Consensus 173 --~~~l~~L~--------------------~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L 226 (347)
T 4fmz_A 173 --IANLTDLY--------------------SLSLNYNQIEDI-SP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSL 226 (347)
T ss_dssp --GGGCTTCS--------------------EEECTTSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred --hccCCCCC--------------------EEEccCCccccc-cc-ccCCCccceeecccCCCCCCch--hhcCCcCCEE
Confidence 44455555 445555554332 22 5555666666666666655433 5555666666
Q ss_pred eccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCC
Q 046265 265 DLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDL 344 (639)
Q Consensus 265 ~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 344 (639)
++++|.+. .+|. +..+++|+.|++++|.+.+. ..+..+++|+.|++++|++++. ..+..+++|
T Consensus 227 ~l~~n~l~------------~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L 289 (347)
T 4fmz_A 227 KIGNNKIT------------DLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQL 289 (347)
T ss_dssp ECCSSCCC------------CCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTC
T ss_pred EccCCccC------------CCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCC
Confidence 65555442 1222 55556666666666665532 3455666666666666666542 235566666
Q ss_pred CEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeee
Q 046265 345 EYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELR 416 (639)
Q Consensus 345 ~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~ 416 (639)
+.|++++|+ +.+..|..+..+++|+.|++++|.+.+.. . +..++.|+.+|+++|+++
T Consensus 290 ~~L~L~~n~---l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-----------~-~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 290 NSLFLNNNQ---LGNEDMEVIGGLTNLTTLFLSQNHITDIR-----------P-LASLSKMDSADFANQVIK 346 (347)
T ss_dssp SEEECCSSC---CCGGGHHHHHTCTTCSEEECCSSSCCCCG-----------G-GGGCTTCSEESSSCC---
T ss_pred CEEECcCCc---CCCcChhHhhccccCCEEEccCCcccccc-----------C-hhhhhccceeehhhhccc
Confidence 666666643 33334455666666666666666655422 1 455666777777777654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=305.52 Aligned_cols=168 Identities=21% Similarity=0.231 Sum_probs=142.5
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCC-hhhHHHH---HHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPD-MVVQQAF---SNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~---~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
.++|+..++||+|+||+||+|+. .+|+.||||++.+.... ......+ ..++.+++.++|||||+++++|.+++.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 46799999999999999999954 57899999999743211 1111222 3446777888999999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
|+|||||+||+|.+++...+ .+++..+..++.||+.||+|||.. +||||||||+|||++.+|.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999998654 477899999999999999999998 999999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeceeeCCC
Q 046265 619 LKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~~~~~~~gt~~Y~APE 639 (639)
+... ...+.+||+.|||||
T Consensus 342 ~~~~--~~~t~~GTp~YmAPE 360 (689)
T 3v5w_A 342 FSKK--KPHASVGTHGYMAPE 360 (689)
T ss_dssp CSSC--CCCSCCSCGGGCCHH
T ss_pred cCCC--CCCCccCCcCccCHH
Confidence 7543 234579999999998
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=289.41 Aligned_cols=170 Identities=25% Similarity=0.282 Sum_probs=142.8
Q ss_pred HHHHHHHhccCCCcceeccCCCceEEEEEc----CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEE
Q 046265 457 YEEVIRATNNFDAKYCIGTAGQASVYKAEL----PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGF 531 (639)
Q Consensus 457 ~~~~~~~~~~f~~~~~ig~g~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~ 531 (639)
++++....+.|+..+.||+|+||+||+|+. .+++.||||++.... ....+.+|+++++++ +|||||+++++
T Consensus 13 ~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~ 88 (361)
T 4f9c_A 13 YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYC 88 (361)
T ss_dssp HHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEE
T ss_pred HHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEE
Confidence 444555678899999999999999999964 246789999987533 234578899999988 69999999999
Q ss_pred EEcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEE
Q 046265 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD-YDAHV 610 (639)
Q Consensus 532 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~-~~~kl 610 (639)
+.+.+..|+|||||++|+|.+++. .+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||
T Consensus 89 ~~~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl 159 (361)
T 4f9c_A 89 FRKNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYAL 159 (361)
T ss_dssp EEETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred EEECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEE
Confidence 999999999999999999999984 377889999999999999999999 99999999999999876 79999
Q ss_pred ccccccccCCCCC----------------------------CCcceeeeeceeeCCC
Q 046265 611 SDFGISKFLKPDS----------------------------SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 611 ~DfGla~~~~~~~----------------------------~~~~~~~gt~~Y~APE 639 (639)
+|||+|+...... ....+.+||++|||||
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE 216 (361)
T 4f9c_A 160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE 216 (361)
T ss_dssp CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHH
T ss_pred CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHH
Confidence 9999998654221 1123468999999998
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-31 Score=275.54 Aligned_cols=300 Identities=25% Similarity=0.411 Sum_probs=192.3
Q ss_pred eEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeec
Q 046265 8 FFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYC 87 (639)
Q Consensus 8 ~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 87 (639)
+..++++++.+.. +| .+..+++|++|++++|.+++. |. +..+++|++|++++|.++. +| .+..+++|++|++++
T Consensus 46 L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l~~ 119 (347)
T 4fmz_A 46 ITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYLNE 119 (347)
T ss_dssp CSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECTT
T ss_pred ccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEECcC
Confidence 4677888888864 44 489999999999999999854 44 9999999999999999984 54 699999999999999
Q ss_pred ccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCC
Q 046265 88 NGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQ 167 (639)
Q Consensus 88 N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 167 (639)
|++++..+ +..++ +| ++|++++|.....++ .+..+++|++|++++|.+.+..+ +..++
T Consensus 120 n~i~~~~~--~~~l~---------------~L--~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~ 177 (347)
T 4fmz_A 120 DNISDISP--LANLT---------------KM--YSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLT 177 (347)
T ss_dssp SCCCCCGG--GTTCT---------------TC--CEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCT
T ss_pred CcccCchh--hccCC---------------ce--eEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCC
Confidence 99985433 55555 33 699999996664544 48999999999999999986443 88999
Q ss_pred cccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccc
Q 046265 168 SLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHL 247 (639)
Q Consensus 168 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 247 (639)
+|+.|++++|.+.+..+ +..+++|+.++++ +|.+.+..+ +..+++|+.|++++|.+
T Consensus 178 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~--------------------~n~l~~~~~--~~~~~~L~~L~l~~n~l 233 (347)
T 4fmz_A 178 DLYSLSLNYNQIEDISP--LASLTSLHYFTAY--------------------VNQITDITP--VANMTRLNSLKIGNNKI 233 (347)
T ss_dssp TCSEEECTTSCCCCCGG--GGGCTTCCEEECC--------------------SSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred CCCEEEccCCccccccc--ccCCCccceeecc--------------------cCCCCCCch--hhcCCcCCEEEccCCcc
Confidence 99999999999875432 5555666555555 444433222 44444555555555555
Q ss_pred cCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccC
Q 046265 248 TGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNG 327 (639)
Q Consensus 248 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~ 327 (639)
++..+ +..+++|++|++++|.+.+ + +.+..+++|+.|++++|.+.+. ..+..+++|+.|++++
T Consensus 234 ~~~~~--~~~l~~L~~L~l~~n~l~~------------~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~ 296 (347)
T 4fmz_A 234 TDLSP--LANLSQLTWLEIGTNQISD------------I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNN 296 (347)
T ss_dssp CCCGG--GTTCTTCCEEECCSSCCCC------------C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCS
T ss_pred CCCcc--hhcCCCCCEEECCCCccCC------------C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcC
Confidence 44332 4444555555544444311 1 2344444555555555555432 2344455555555555
Q ss_pred ccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcC
Q 046265 328 NKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFW 381 (639)
Q Consensus 328 N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~ 381 (639)
|.+.+..|..++.+++|+.|++++|++.. ..| +..+++|+.+++++|.+
T Consensus 297 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~---~~~--~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 297 NQLGNEDMEVIGGLTNLTTLFLSQNHITD---IRP--LASLSKMDSADFANQVI 345 (347)
T ss_dssp SCCCGGGHHHHHTCTTCSEEECCSSSCCC---CGG--GGGCTTCSEESSSCC--
T ss_pred CcCCCcChhHhhccccCCEEEccCCcccc---ccC--hhhhhccceeehhhhcc
Confidence 55554444445555555555555533221 111 44455555555555543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.98 E-value=9.5e-31 Score=280.71 Aligned_cols=335 Identities=26% Similarity=0.313 Sum_probs=184.3
Q ss_pred eeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeee
Q 046265 7 FFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLY 86 (639)
Q Consensus 7 ~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 86 (639)
....+++++|++.+ +|.. .++|++|++++|.+++ +|.. +++|++|++++|++++ +|.. .++|++|+++
T Consensus 72 ~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~ 139 (454)
T 1jl5_A 72 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVS 139 (454)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECC
T ss_pred CCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECc
Confidence 45778899999876 4442 3689999999999986 6754 4789999999999884 4432 1689999999
Q ss_pred cccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCC
Q 046265 87 CNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKV 166 (639)
Q Consensus 87 ~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 166 (639)
+|++++ +| +|+++++|+ +|++++|++++ +|..+ ++|++|++++|++++ +| .++.+
T Consensus 140 ~n~l~~-lp-~~~~l~~L~-----------------~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l 194 (454)
T 1jl5_A 140 NNQLEK-LP-ELQNSSFLK-----------------IIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNL 194 (454)
T ss_dssp SSCCSS-CC-CCTTCTTCC-----------------EEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTC
T ss_pred CCCCCC-Cc-ccCCCCCCC-----------------EEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCC
Confidence 999986 66 477777554 55555555542 33322 345555555555544 33 34555
Q ss_pred CcccEEEcccCcCCccCCccCcCCCCCCeEEccCCcc---ccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccc
Q 046265 167 QSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLV---SAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLE 243 (639)
Q Consensus 167 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~---~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~ 243 (639)
++|+.|++++|.+++ +|... ++|+.|+++.+.+ | .++.+++|+.|++++|++.+ +|.. +++|+.|+++
T Consensus 195 ~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~ 265 (454)
T 1jl5_A 195 PFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILEELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVR 265 (454)
T ss_dssp TTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECC
T ss_pred CCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCCccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECC
Confidence 555555555555543 22211 3455555543322 2 24445555555555555543 3321 2445555555
Q ss_pred cccccCcchhhhhcCCCccEEeccCCcccc---------cccCcCCccccccCccccCCCCCCEEeccCCcccccCCccc
Q 046265 244 QNHLTGNIYEVFGIYPNLTFLDLSQNNFYG---------SLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIEL 314 (639)
Q Consensus 244 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---------~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~ 314 (639)
+|++++. |. ..++|+.|++++|++.+ .+++++|++++ ++.. .++|+.|++++|++.+ +|..
T Consensus 266 ~N~l~~l-~~---~~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-lp~~- 335 (454)
T 1jl5_A 266 DNYLTDL-PE---LPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-LPAL- 335 (454)
T ss_dssp SSCCSCC-CC---CCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-CCCC-
T ss_pred CCccccc-Cc---ccCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-cccc-
Confidence 5555542 21 12445555555555443 13455555554 2221 2489999999999986 6654
Q ss_pred cCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhcc-------------ccCCeeeccCCcC
Q 046265 315 GNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKL-------------VQLTELDLVITFW 381 (639)
Q Consensus 315 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l-------------~~L~~l~l~~n~~ 381 (639)
+++|+.|++++|+++ .+|. .+++|+.|++++|++..+. .+|.++..+ ++|+.|++++|.+
T Consensus 336 --~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~-~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l 408 (454)
T 1jl5_A 336 --PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFP-DIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPL 408 (454)
T ss_dssp --CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCC-CCCTTCCEEECCC----------------------
T ss_pred --CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCC-CChHHHHhhhhcccccccccccCcCCEEECCCCcC
Confidence 578999999999998 5676 4789999999997655432 578888887 7899999999998
Q ss_pred ce--eecCcchhhhhhhhhhhhcccCcEEccCCCeeeeeec
Q 046265 382 EE--RYRPKSVIWKAWRSLISRMHGLSCIDISYNELRGLIR 420 (639)
Q Consensus 382 ~~--~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~g~~p 420 (639)
.+ .+ | . .++.+++.+|.+.+.+|
T Consensus 409 ~~~~~i-P---------~------sl~~L~~~~~~~~~~~~ 433 (454)
T 1jl5_A 409 REFPDI-P---------E------SVEDLRMNSERVVDPYE 433 (454)
T ss_dssp -----------------------------------------
T ss_pred Cccccc-h---------h------hHhheeCcCcccCCccc
Confidence 86 44 3 1 25566788888877765
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-30 Score=265.31 Aligned_cols=295 Identities=21% Similarity=0.214 Sum_probs=232.1
Q ss_pred CCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcc
Q 046265 54 THLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSG 133 (639)
Q Consensus 54 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~ 133 (639)
.+|+.++++++.++ .+|..+. ++|++|++++|++++..+..|.++++| ++|+|++|++++
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L-----------------~~L~L~~n~l~~ 90 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNL-----------------HTLILINNKISK 90 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTC-----------------CEEECCSSCCCC
T ss_pred CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCC-----------------CEEECCCCcCCe
Confidence 47899999999998 6887765 689999999999998777788777743 599999999998
Q ss_pred cCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCC
Q 046265 134 SIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQL 213 (639)
Q Consensus 134 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L 213 (639)
..|..|.++++|++|+|++|+++ .+|..+. ++|++|++++|.+++..+..+..+++|+
T Consensus 91 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~------------------- 148 (330)
T 1xku_A 91 ISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMI------------------- 148 (330)
T ss_dssp BCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCC-------------------
T ss_pred eCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCcccc-------------------
Confidence 88999999999999999999998 5676554 7999999999999977666666555555
Q ss_pred cEEEcCCcccC--CCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCcccc
Q 046265 214 IELEIDNKQLF--GQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIG 291 (639)
Q Consensus 214 ~~L~l~~n~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~ 291 (639)
.|++++|.+. +..|..+.++++|+.|++++|.++..... + .++|++|++++|.+ ++..|..+.
T Consensus 149 -~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~-~--~~~L~~L~l~~n~l-----------~~~~~~~~~ 213 (330)
T 1xku_A 149 -VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG-L--PPSLTELHLDGNKI-----------TKVDAASLK 213 (330)
T ss_dssp -EEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSS-C--CTTCSEEECTTSCC-----------CEECTGGGT
T ss_pred -EEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCcc-c--cccCCEEECCCCcC-----------CccCHHHhc
Confidence 4555555553 35667788888999999999988864432 2 37899999776665 455678889
Q ss_pred CCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCCh---hhhcc
Q 046265 292 KLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPV---ELEKL 368 (639)
Q Consensus 292 ~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~---~~~~l 368 (639)
.+++|+.|++++|.+.+..+..+..+++|+.|++++|+++ .+|..+..+++|+.|++++|++..+....-. .....
T Consensus 214 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~ 292 (330)
T 1xku_A 214 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK 292 (330)
T ss_dssp TCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTS
T ss_pred CCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCccccccc
Confidence 9999999999999999888888999999999999999998 7888999999999999999876655322110 11224
Q ss_pred ccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCe
Q 046265 369 VQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNE 414 (639)
Q Consensus 369 ~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~ 414 (639)
..++.+++++|.+... ...+..+..+..++.+|+++|+
T Consensus 293 ~~l~~l~l~~N~~~~~--------~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 293 ASYSGVSLFSNPVQYW--------EIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CCCSEEECCSSSSCGG--------GSCGGGGTTCCCGGGEEC----
T ss_pred ccccceEeecCccccc--------ccCccccccccceeEEEecccC
Confidence 6788999999976531 1122567788999999999985
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-32 Score=296.78 Aligned_cols=168 Identities=21% Similarity=0.370 Sum_probs=147.8
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|+..+.||+|+||+||+|. ..+|+.||||.+.... ....+.+.+|+.+|+.++|||||+++++|.+++..|+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 3678889999999999999995 4678999999997643 344667889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC--CceEEccccccccCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD--YDAHVSDFGISKFLK 620 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~--~~~kl~DfGla~~~~ 620 (639)
|||+||+|.+++.... ..+++..+..++.|++.||+|||.. +|+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 234 E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 234 EFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp ECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred eecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 9999999999986543 2578899999999999999999999 99999999999999854 899999999999876
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
.. ......+||+.|||||
T Consensus 309 ~~-~~~~~~~GT~~y~APE 326 (573)
T 3uto_A 309 PK-QSVKVTTGTAEFAAPE 326 (573)
T ss_dssp TT-SEEEEECSSGGGCCHH
T ss_pred CC-CceeeeEECccccCHH
Confidence 43 3345679999999998
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-30 Score=264.19 Aligned_cols=291 Identities=22% Similarity=0.222 Sum_probs=231.9
Q ss_pred CCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcc
Q 046265 54 THLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSG 133 (639)
Q Consensus 54 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~ 133 (639)
.+|+.+++++|.++ .+|..+. ++|++|++++|.+++..|..|.++++| ++|++++|++++
T Consensus 33 c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L-----------------~~L~L~~n~l~~ 92 (332)
T 2ft3_A 33 CHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHL-----------------YALVLVNNKISK 92 (332)
T ss_dssp EETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTC-----------------CEEECCSSCCCE
T ss_pred ccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCC-----------------cEEECCCCccCc
Confidence 37899999999998 7888775 689999999999998878788877743 589999999998
Q ss_pred cCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCC
Q 046265 134 SIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQL 213 (639)
Q Consensus 134 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L 213 (639)
..|..|.++++|++|+|++|+++ .+|..+. ++|++|++++|.+++..+..|..+++ |
T Consensus 93 ~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~--------------------L 149 (332)
T 2ft3_A 93 IHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRN--------------------M 149 (332)
T ss_dssp ECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSS--------------------C
T ss_pred cCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCcc--------------------C
Confidence 88999999999999999999998 5676555 79999999999998666555555554 5
Q ss_pred cEEEcCCcccC--CCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCcccc
Q 046265 214 IELEIDNKQLF--GQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIG 291 (639)
Q Consensus 214 ~~L~l~~n~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~ 291 (639)
+.|++++|.+. +..|..+..+ +|+.|++++|.+++... .+ .++|++|++++|.+ ++..|..+.
T Consensus 150 ~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~-~~--~~~L~~L~l~~n~i-----------~~~~~~~l~ 214 (332)
T 2ft3_A 150 NCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPK-DL--PETLNELHLDHNKI-----------QAIELEDLL 214 (332)
T ss_dssp CEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCCS-SS--CSSCSCCBCCSSCC-----------CCCCTTSST
T ss_pred CEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccCc-cc--cCCCCEEECCCCcC-----------CccCHHHhc
Confidence 55566666663 3667778888 99999999999998543 32 37888888766655 455667899
Q ss_pred CCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhc----
Q 046265 292 KLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEK---- 367 (639)
Q Consensus 292 ~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~---- 367 (639)
.+++|+.|++++|++.+..|..+..+++|+.|++++|+++ .+|..+..+++|+.|++++|++..+. +..+..
T Consensus 215 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~---~~~~~~~~~~ 290 (332)
T 2ft3_A 215 RYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVG---VNDFCPVGFG 290 (332)
T ss_dssp TCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCC---TTSSSCSSCC
T ss_pred CCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccC---hhHccccccc
Confidence 9999999999999999888889999999999999999998 78888999999999999997765543 223322
Q ss_pred --cccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCe
Q 046265 368 --LVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNE 414 (639)
Q Consensus 368 --l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~ 414 (639)
...|+.+++++|.+.... ..+..+..++.|+.+++++|+
T Consensus 291 ~~~~~l~~L~l~~N~~~~~~--------~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 291 VKRAYYNGISLFNNPVPYWE--------VQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp SSSCCBSEEECCSSSSCGGG--------SCGGGGTTBCCSTTEEC----
T ss_pred cccccccceEeecCcccccc--------cCcccccccchhhhhhccccc
Confidence 467889999999876211 112567889999999999885
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=264.53 Aligned_cols=169 Identities=24% Similarity=0.371 Sum_probs=149.7
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
..+|+..+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45788889999999999999965 68899999999765545555677889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++...+ .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 9999999999997654 377899999999999999999998 9999999999999999999999999999876533
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
......+||+.|+|||
T Consensus 168 -~~~~~~~gt~~y~aPE 183 (328)
T 3fe3_A 168 -GKLDAFCGAPPYAAPE 183 (328)
T ss_dssp -CGGGTTSSSGGGCCHH
T ss_pred -CccccccCCcceeCcc
Confidence 2345578999999998
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=264.64 Aligned_cols=172 Identities=30% Similarity=0.419 Sum_probs=140.9
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
..+|+..+.||+|+||.||+|+. +++.||||.+..........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 46778889999999999999976 57889999998766555566788999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP--IVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|+++|+|.+++........+++..+..++.|+++|++|||.. + |+||||||+||+++.++.+||+|||+++....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999999998755434588899999999999999999998 7 99999999999999999999999999986554
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
........+||+.|+|||
T Consensus 192 ~~~~~~~~~gt~~y~aPE 209 (309)
T 3p86_A 192 TFLSSKSAAGTPEWMAPE 209 (309)
T ss_dssp ----------CCTTSCHH
T ss_pred cccccccCCCCccccChh
Confidence 433344578999999998
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-30 Score=264.34 Aligned_cols=169 Identities=23% Similarity=0.253 Sum_probs=147.0
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||+||+|+. .+++.||||.+++... .....+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 5788889999999999999965 4689999999874321 1123456789999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++...+ .+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+|+.....
T Consensus 85 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999997643 467889999999999999999998 9999999999999999999999999999875544
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
.......+||+.|||||
T Consensus 159 ~~~~~~~~gt~~y~aPE 175 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPE 175 (337)
T ss_dssp TCCBCCCEECGGGCCGG
T ss_pred CCcccccccChhhCChh
Confidence 44456689999999998
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=261.74 Aligned_cols=173 Identities=20% Similarity=0.417 Sum_probs=146.7
Q ss_pred HhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC-----
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR----- 536 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----- 536 (639)
..++|+..+.||+|+||.||+|+.+ +++.||||++.... .....+.+.+|+.++++++|||||+++++|.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 3467888999999999999999765 78999999997644 2335677899999999999999999999986543
Q ss_pred ----------------------------------------------------ceeEEecccCCCChhHHhhcCCCCCCcC
Q 046265 537 ----------------------------------------------------QSFLLYEYLGRGSLAIILSNDAAIDEFS 564 (639)
Q Consensus 537 ----------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 564 (639)
..++||||+++|+|.+++.........+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 2799999999999999999877666778
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC------------Ccceeeee
Q 046265 565 WTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS------------NWSEFVGT 632 (639)
Q Consensus 565 ~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~------------~~~~~~gt 632 (639)
+..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++....... .....+||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 888999999999999999998 999999999999999999999999999987754321 12345799
Q ss_pred ceeeCCC
Q 046265 633 FGYVAPI 639 (639)
Q Consensus 633 ~~Y~APE 639 (639)
+.|+|||
T Consensus 240 ~~y~aPE 246 (332)
T 3qd2_B 240 KLYMSPE 246 (332)
T ss_dssp GGGSCHH
T ss_pred cCccChH
Confidence 9999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=258.88 Aligned_cols=177 Identities=28% Similarity=0.370 Sum_probs=153.1
Q ss_pred cchHHHHHHHhcc----------CCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhcccc
Q 046265 454 KILYEEVIRATNN----------FDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH 522 (639)
Q Consensus 454 ~~~~~~~~~~~~~----------f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H 522 (639)
.++++++..+++. |+..+.||+|+||.||+|... +|+.||||.+..... ...+.+.+|+.++++++|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCC
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCC
Confidence 4567777777654 556678999999999999765 789999999875432 235678899999999999
Q ss_pred CceeeeEEEEEcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 046265 523 RNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL 602 (639)
Q Consensus 523 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill 602 (639)
|||++++++|...+..|+||||+++|+|.+++... .+++..+..++.|+++|++|||.. +|+||||||+||++
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 174 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence 99999999999999999999999999999998753 478999999999999999999998 99999999999999
Q ss_pred CCCCceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 603 GLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 603 ~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+.++.+||+|||+++............+||+.|+|||
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE 211 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE 211 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHH
T ss_pred CCCCcEEEeeeeeeeecccCccccccccCCccccCHh
Confidence 9999999999999987765444445678999999998
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-30 Score=262.07 Aligned_cols=185 Identities=30% Similarity=0.561 Sum_probs=159.3
Q ss_pred cchHHHHHHHhccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEE
Q 046265 454 KILYEEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSF 533 (639)
Q Consensus 454 ~~~~~~~~~~~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 533 (639)
.+++.++....++|+..+.||+|+||.||+|+.++++.||||++...... .....+.+|+.++++++||||++++++|.
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 45678888999999999999999999999999888999999999764322 22335889999999999999999999999
Q ss_pred cCCceeEEecccCCCChhHHhhcCCC-CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 046265 534 HPRQSFLLYEYLGRGSLAIILSNDAA-IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSD 612 (639)
Q Consensus 534 ~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~D 612 (639)
.++..++||||+++|+|.+++..... ...++|..+..++.|++.|++|||..+.++|+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999999986543 34589999999999999999999998777999999999999999999999999
Q ss_pred ccccccCCCCCC-CcceeeeeceeeCCC
Q 046265 613 FGISKFLKPDSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 613 fGla~~~~~~~~-~~~~~~gt~~Y~APE 639 (639)
||+++....... ......||+.|+|||
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE 205 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPE 205 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHH
T ss_pred CccccccCcccccccccccCCcCccCHH
Confidence 999987653322 233456999999998
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=274.58 Aligned_cols=178 Identities=20% Similarity=0.256 Sum_probs=149.4
Q ss_pred HHHHHHHhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEc
Q 046265 457 YEEVIRATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFH 534 (639)
Q Consensus 457 ~~~~~~~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 534 (639)
+.+.....++|+..++||+|+||+||+|+.+ +++.||||++.+... .....+.+.+|+.++..++|||||+++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3444455788999999999999999999765 578999999864211 01112347889999999999999999999999
Q ss_pred CCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 046265 535 PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614 (639)
Q Consensus 535 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfG 614 (639)
++..|+|||||++|+|.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+|||++.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999997632 3578899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCC-CcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~-~~~~~~gt~~Y~APE 639 (639)
+|+....... .....+||+.|||||
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE 246 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPE 246 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHH
T ss_pred hhhhcccCCCcccccccCCcCeeChH
Confidence 9987654332 223468999999998
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=266.28 Aligned_cols=170 Identities=21% Similarity=0.306 Sum_probs=141.3
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 540 (639)
.++|+..++||+|+||+||+|+. .+++.||||++++... .....+.+.+|..+++.+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 46788899999999999999965 5689999999875321 122345678899999987 69999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||||+++|+|.+++...+ .+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 102 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999997654 478899999999999999999998 99999999999999999999999999998755
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
.........+||+.|||||
T Consensus 176 ~~~~~~~~~~gt~~y~aPE 194 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPE 194 (353)
T ss_dssp C---------CCGGGCCHH
T ss_pred cCCccccccCCCcCeEChh
Confidence 4444455679999999998
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-30 Score=267.59 Aligned_cols=170 Identities=22% Similarity=0.279 Sum_probs=145.8
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 540 (639)
.++|+..++||+|+||+||+|+.+ +++.||||++++... .....+.+.+|..++.++ +|||||++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467888999999999999999654 678999999975432 122234577899999887 89999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||||+++|+|..++...+ .+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999997653 478899999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
.........+||+.|||||
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE 223 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPE 223 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHH
T ss_pred cCCCccccccCCcccCCch
Confidence 4444556789999999998
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=256.38 Aligned_cols=167 Identities=26% Similarity=0.444 Sum_probs=148.2
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
..+|+..+.||+|+||.||+|. ..+++.||||++..... ...+.+.+|+.++++++||||+++++++..++..|+||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 4678889999999999999996 46789999999875432 23566889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 97 e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 999999999999754 377889999999999999999999 9999999999999999999999999999887655
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
.......+||+.|+|||
T Consensus 170 ~~~~~~~~gt~~y~aPE 186 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPE 186 (297)
T ss_dssp TCCBCCCCSCGGGCCHH
T ss_pred ccccCCccCCcCccChh
Confidence 55555678999999998
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=268.89 Aligned_cols=172 Identities=19% Similarity=0.307 Sum_probs=150.1
Q ss_pred HHhccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 462 RATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 462 ~~~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
...++|+..+.||+|+||.||+|. ..+|+.||+|.+..........+.+.+|+.++++++|||||++++++.+++..|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 346778889999999999999995 5678999999998766555556778999999999999999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEEccccccc
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG---LDYDAHVSDFGISK 617 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~---~~~~~kl~DfGla~ 617 (639)
||||+++|+|.+.+.... .+++..+..++.|++.|++|||.. +|+||||||+||+++ .++.+||+|||+|+
T Consensus 88 v~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999987654 478899999999999999999999 999999999999998 46789999999998
Q ss_pred cCCCCCCCcceeeeeceeeCCC
Q 046265 618 FLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~~~~~~gt~~Y~APE 639 (639)
............+||++|||||
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE 183 (444)
T 3soa_A 162 EVEGEQQAWFGFAGTPGYLSPE 183 (444)
T ss_dssp CCCTTCCBCCCSCSCGGGCCHH
T ss_pred EecCCCceeecccCCcccCCHH
Confidence 8765544455678999999998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-30 Score=271.34 Aligned_cols=178 Identities=21% Similarity=0.243 Sum_probs=150.6
Q ss_pred HHHHHHHhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEc
Q 046265 457 YEEVIRATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFH 534 (639)
Q Consensus 457 ~~~~~~~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 534 (639)
+.+.....++|+..++||+|+||+||+|+. .+++.||||++.+... .....+.+.+|..++.+++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 445555678899999999999999999966 5789999999874221 11123447889999999999999999999999
Q ss_pred CCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 046265 535 PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614 (639)
Q Consensus 535 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfG 614 (639)
.+..|+||||+++|+|.+++...+ ..+++..+..++.|++.|++|||.. +|+||||||+|||++.++.+||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence 999999999999999999997543 2578899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCC-CcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~-~~~~~~gt~~Y~APE 639 (639)
+|+.+..... .....+||+.|||||
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE 233 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPE 233 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHH
T ss_pred hheeccCCCccccceeccccCcCCHH
Confidence 9987754332 123468999999998
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=255.44 Aligned_cols=168 Identities=25% Similarity=0.463 Sum_probs=145.3
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|...+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 5677889999999999999965 56899999998643 35566789999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++|+|.+++.... ..++|..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 88 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 88 YIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999998643 3588999999999999999999998 99999999999999999999999999998764332
Q ss_pred CC--------------cceeeeeceeeCCC
Q 046265 624 SN--------------WSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~--------------~~~~~gt~~Y~APE 639 (639)
.. ....+||+.|+|||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 192 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192 (310)
T ss_dssp -----------------CCCCSCGGGCCHH
T ss_pred ccccccccccccccccccccCCCcceeCHH
Confidence 21 11467999999998
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=260.51 Aligned_cols=169 Identities=23% Similarity=0.284 Sum_probs=147.3
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEE
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 541 (639)
++|+..+.||+|+||.||+|+. .+++.||||.+.+... .....+.+.+|+.++.++ +|||||++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5678889999999999999965 4688999999976432 333456678999999887 899999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+|+....
T Consensus 89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999997643 478899999999999999999998 999999999999999999999999999987544
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
........+||+.|+|||
T Consensus 163 ~~~~~~~~~gt~~y~aPE 180 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPE 180 (345)
T ss_dssp TTCCBCCCCSCGGGCCHH
T ss_pred CCCcccccCCCccccCcc
Confidence 444455678999999998
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=259.40 Aligned_cols=177 Identities=32% Similarity=0.492 Sum_probs=153.0
Q ss_pred HHHHHHhccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc
Q 046265 458 EEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 458 ~~~~~~~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 537 (639)
.++..++++|+..+.||+|+||.||+|..++++.||||++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 34445678999999999999999999998889999999987643 2345678999999999999999999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCC-CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAA-IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
.|+||||+++|+|.+++..... ...++|..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999976432 23589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCC--CCcceeeeeceeeCCC
Q 046265 617 KFLKPDS--SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~--~~~~~~~gt~~Y~APE 639 (639)
+...... .......||+.|+|||
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE 211 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPE 211 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHH
T ss_pred cccccccccccccccCCCccccCHH
Confidence 8654322 1223467999999998
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=257.24 Aligned_cols=170 Identities=23% Similarity=0.332 Sum_probs=143.8
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.++|+..+.||+|+||.||+|+..+++.||||++............+.+|+.++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 36678889999999999999988889999999997654444455778899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++ ++.+.+.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 7877776543 3478899999999999999999998 99999999999999999999999999998775444
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
......+||+.|+|||
T Consensus 174 ~~~~~~~~t~~y~aPE 189 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPD 189 (311)
T ss_dssp C---CCCCCCTTCCHH
T ss_pred ccccCCcccCCcCCHH
Confidence 4445568999999998
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-32 Score=294.59 Aligned_cols=350 Identities=20% Similarity=0.133 Sum_probs=204.7
Q ss_pred eeeEEEEeCCCcccccCCcc-ccCCCCCCEEECcCCCCcc----CCCCCCCCCCCCCEEEcccCcCCCCCCccc-CCCC-
Q 046265 6 FFFFQVVHESNTLFAIIPPQ-IGNISNLKFLDMGNNQLSG----VIPQEIDPLTHLKHLYINVNKLRGSVPREV-GQLS- 78 (639)
Q Consensus 6 ~~~~~~~~~~n~~~~~~p~~-~~~l~~L~~L~Ls~n~l~~----~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~-~~l~- 78 (639)
-.+..+++++|++....... +..+++|++|+|++|.++. .+|..+..+++|++|+|++|.++...+..+ ..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 34567778777776544333 6677788888888888763 345666777888888888888764333332 2344
Q ss_pred ---CCCEEeeecccCcc----ccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCcccc-----CCCCCC
Q 046265 79 ---SLKQLVLYCNGLSG----WLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLG-----HLSNLA 146 (639)
Q Consensus 79 ---~L~~L~L~~N~l~~----~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~-----~l~~L~ 146 (639)
+|++|+|++|+++. .+|..+..+++| ++|++++|.++...+..+. ..++|+
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L-----------------~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~ 145 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTL-----------------QELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTC-----------------CEEECCSSBCHHHHHHHHHHHHTSTTCCCC
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCce-----------------eEEECCCCcCchHHHHHHHHHHhcCCCcce
Confidence 58888888887773 445555555532 4778888877654343332 245688
Q ss_pred EEeccCCCCCCCC----CccccCCCcccEEEcccCcCCccCCccCc-----CCCCCCeEEccCCccc--------ccccc
Q 046265 147 VLHLGDNSLFGSI----PPILGKVQSLLSLGFDLNLLNGVLPPSIS-----NLSNLEGLYLYSSLVS--------AEIGN 209 (639)
Q Consensus 147 ~L~L~~N~l~~~~----p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~l~~L~~L~l~~~~~~--------~~~~~ 209 (639)
+|+|++|++++.. +..+..+++|++|++++|.++...+..+. ..++|+.|+++.+.+. ..+..
T Consensus 146 ~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~ 225 (461)
T 1z7x_W 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVAS 225 (461)
T ss_dssp EEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHH
T ss_pred EEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHh
Confidence 8888888776532 44556667788888888777654333332 2456667766655432 23445
Q ss_pred ccCCcEEEcCCcccCCCC-----CccccCCCCCceeccccccccCc----chhhhhcCCCccEEeccCCcccccccCcCC
Q 046265 210 LLQLIELEIDNKQLFGQI-----PKSLRNFTSLNIVHLEQNHLTGN----IYEVFGIYPNLTFLDLSQNNFYGSLNFSMN 280 (639)
Q Consensus 210 l~~L~~L~l~~n~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n 280 (639)
+++|+.|++++|.+.... +..+..+++|+.|++++|.++.. ++..+..+++|++|++++|.+.+
T Consensus 226 ~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~------- 298 (461)
T 1z7x_W 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD------- 298 (461)
T ss_dssp CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHH-------
T ss_pred CCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCch-------
Confidence 566666666666654321 12222456666666666666653 34455556666666666555421
Q ss_pred ccccccCcccc-----CCCCCCEEeccCCccccc----CCccccCCCCCCeeeccCccCcccCCcCccC-----CCCCCE
Q 046265 281 NITRSIPPKIG-----KLYQLHKLDFSLNHIVGE----LPIELGNLKSLNYRALNGNKVYGSLPRVLGS-----ISDLEY 346 (639)
Q Consensus 281 ~~~~~~p~~~~-----~l~~L~~L~Ls~N~~~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~ 346 (639)
..+..+. ..++|+.|++++|.+++. +|..+..+++|+.|++++|.+.+..+..+.. .++|+.
T Consensus 299 ----~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~ 374 (461)
T 1z7x_W 299 ----EGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRV 374 (461)
T ss_dssp ----HHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCE
T ss_pred ----HHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEE
Confidence 1111111 124666677776666544 3444555666667777666665443333321 456666
Q ss_pred EeCCCCCCCccc-ccCChhhhccccCCeeeccCCcCce
Q 046265 347 LDLSTNYNNEFR-KEFPVELEKLVQLTELDLVITFWEE 383 (639)
Q Consensus 347 L~Ls~N~~~~~~-~~~p~~~~~l~~L~~l~l~~n~~~~ 383 (639)
|++++|++.... ..+|..+..+++|+.|++++|.+.+
T Consensus 375 L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 375 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp EECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred EECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 777664322100 1345556666666666666665543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=271.75 Aligned_cols=174 Identities=19% Similarity=0.241 Sum_probs=147.2
Q ss_pred HHHHHhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC
Q 046265 459 EVIRATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR 536 (639)
Q Consensus 459 ~~~~~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 536 (639)
++....++|+..++||+|+||.||+|+.+ +++.||||.+.+... .....+.+.+|+.+++.++|||||+++++|.+++
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34445688999999999999999999654 678999999864210 0111234778999999999999999999999999
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
..|+||||+++|+|.++++.. .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+|
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecccee
Confidence 999999999999999999753 367889999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCC-CcceeeeeceeeCCC
Q 046265 617 KFLKPDSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~-~~~~~~gt~~Y~APE 639 (639)
+.+..... ...+.+||+.|||||
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE 239 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPE 239 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHH
T ss_pred EeeccCCcccccCCcCCccccCHH
Confidence 87654322 233578999999998
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-29 Score=251.93 Aligned_cols=182 Identities=34% Similarity=0.528 Sum_probs=158.1
Q ss_pred cchHHHHHHHhccCCCc------ceeccCCCceEEEEEcCCCcEEEEEEccCCC--CChhhHHHHHHHHHHHhccccCce
Q 046265 454 KILYEEVIRATNNFDAK------YCIGTAGQASVYKAELPSWEIVAVKKFHSPH--PDMVVQQAFSNEIKALTELRHRNV 525 (639)
Q Consensus 454 ~~~~~~~~~~~~~f~~~------~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~H~ni 525 (639)
.++++++..++++|... +.||+|+||.||+|.. +++.||||++.... ......+.+.+|+.++++++||||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 56789999999999887 8899999999999986 57899999987543 223346778999999999999999
Q ss_pred eeeEEEEEcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC
Q 046265 526 VKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD 605 (639)
Q Consensus 526 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~ 605 (639)
+++++++...+..++||||+++|+|.+++........++|..+..++.|++.|++|||.. +|+||||||+||+++.+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEA 169 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCC
Confidence 999999999999999999999999999997654445689999999999999999999998 99999999999999999
Q ss_pred CceEEccccccccCCCCCCC--cceeeeeceeeCCC
Q 046265 606 YDAHVSDFGISKFLKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 606 ~~~kl~DfGla~~~~~~~~~--~~~~~gt~~Y~APE 639 (639)
+.+||+|||+++........ .....||+.|+|||
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE 205 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205 (307)
T ss_dssp CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHH
T ss_pred CcEEEeecccccccccccccccccccCCCcCcCChH
Confidence 99999999999876533221 23457999999998
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-29 Score=252.98 Aligned_cols=169 Identities=22% Similarity=0.357 Sum_probs=145.3
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|+||.||+|.. .+++.||||++..........+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4678889999999999999965 568999999998765555556778899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++ ++.+.+.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9986 4544443322 3478899999999999999999999 99999999999999999999999999998776444
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
......+||+.|+|||
T Consensus 156 ~~~~~~~~t~~y~aPE 171 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPD 171 (292)
T ss_dssp SCCCSCCSCGGGCCHH
T ss_pred ccccCCccccCCcChH
Confidence 4455678999999998
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=261.54 Aligned_cols=171 Identities=22% Similarity=0.288 Sum_probs=146.2
Q ss_pred HhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCcee
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 539 (639)
..++|...++||+|+||.||+|+. .+++.||||.++.... .....+.+.+|..++.++ +||||+++++++.+.+..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 457888899999999999999965 4689999999875321 112245577899999876 8999999999999999999
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||+++|+|.+++...+ .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+|+..
T Consensus 95 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999997643 478899999999999999999998 9999999999999999999999999999875
Q ss_pred CCCCCCcceeeeeceeeCCC
Q 046265 620 KPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~~~~~~gt~~Y~APE 639 (639)
..........+||+.|+|||
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE 188 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPE 188 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHH
T ss_pred ccCCCcccCCCCCcccCChh
Confidence 44444455678999999998
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=263.27 Aligned_cols=168 Identities=21% Similarity=0.342 Sum_probs=146.2
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCC-CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||.||+|.. .+++.||||.+.... ......+.+.+|+.++++++|||||+++++|.+.+..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 5678889999999999999964 567899999986432 11123456889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+|+.+...
T Consensus 95 e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999998653 478899999999999999999998 9999999999999999999999999999876533
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
......+||+.|||||
T Consensus 169 -~~~~~~~gt~~Y~aPE 184 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPE 184 (384)
T ss_dssp -CCBCCCCSCGGGCCGG
T ss_pred -CceeccCCCccccCCe
Confidence 3345678999999998
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=256.29 Aligned_cols=276 Identities=21% Similarity=0.247 Sum_probs=169.7
Q ss_pred EEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccC
Q 046265 11 VVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGL 90 (639)
Q Consensus 11 ~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 90 (639)
.+.+++++. .+|..+. ++|++|+|++|.+++..+..|..+++|++|++++|++++..|..|.++++|++|++++|++
T Consensus 36 c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 112 (353)
T 2z80_A 36 CKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112 (353)
T ss_dssp EECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred eeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcC
Confidence 455555554 4555444 3677777777777655555667777777777777777655566667777777777777776
Q ss_pred ccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCc--cccCCCCCCEEeccCCC-CCCCCCccccCCC
Q 046265 91 SGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPH--FLGHLSNLAVLHLGDNS-LFGSIPPILGKVQ 167 (639)
Q Consensus 91 ~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~ 167 (639)
++..+..|.++++| ++|++++|++++ +|. .+.++++|++|++++|+ +.+..|..+..++
T Consensus 113 ~~~~~~~~~~l~~L-----------------~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~ 174 (353)
T 2z80_A 113 SNLSSSWFKPLSSL-----------------TFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT 174 (353)
T ss_dssp SSCCHHHHTTCTTC-----------------SEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC
T ss_pred CcCCHhHhCCCccC-----------------CEEECCCCCCcc-cCchhhhccCCCCcEEECCCCccccccCHHHccCCC
Confidence 65444445555422 366777776663 333 56666777777777663 4444455666667
Q ss_pred cccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccc
Q 046265 168 SLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHL 247 (639)
Q Consensus 168 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 247 (639)
+|++|++++|.+++..|..+..+++ |+.|++++|++....+..+..+++|+.|++++|.+
T Consensus 175 ~L~~L~l~~n~l~~~~~~~l~~l~~--------------------L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l 234 (353)
T 2z80_A 175 FLEELEIDASDLQSYEPKSLKSIQN--------------------VSHLILHMKQHILLLEIFVDVTSSVECLELRDTDL 234 (353)
T ss_dssp EEEEEEEEETTCCEECTTTTTTCSE--------------------EEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBC
T ss_pred CCCEEECCCCCcCccCHHHHhcccc--------------------CCeecCCCCccccchhhhhhhcccccEEECCCCcc
Confidence 7777777777766666665555544 45555555555332222334466666777777666
Q ss_pred cCcchhhh---hcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCcc-ccCCCCCCee
Q 046265 248 TGNIYEVF---GIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIE-LGNLKSLNYR 323 (639)
Q Consensus 248 ~~~~~~~~---~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~-~~~l~~L~~L 323 (639)
++..+..+ ...+.++.++++++.+. ++.+. .+|..+..+++|+.|++++|+++ .+|.. |..+++|+.|
T Consensus 235 ~~~~~~~l~~~~~~~~l~~l~L~~~~l~------~~~l~-~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L 306 (353)
T 2z80_A 235 DTFHFSELSTGETNSLIKKFTFRNVKIT------DESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKI 306 (353)
T ss_dssp TTCCCC------CCCCCCEEEEESCBCC------HHHHH-HHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred ccccccccccccccchhhcccccccccc------Ccchh-hhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEE
Confidence 65443322 23455667776666542 23332 46777778888888888888887 44444 5788888888
Q ss_pred eccCccCcccCC
Q 046265 324 ALNGNKVYGSLP 335 (639)
Q Consensus 324 ~l~~N~l~~~~p 335 (639)
++++|.+.+..|
T Consensus 307 ~L~~N~~~~~~~ 318 (353)
T 2z80_A 307 WLHTNPWDCSCP 318 (353)
T ss_dssp ECCSSCBCCCHH
T ss_pred EeeCCCccCcCC
Confidence 888888775544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=258.92 Aligned_cols=169 Identities=21% Similarity=0.309 Sum_probs=146.9
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCCh----hhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDM----VVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
.+.|+..+.||+|+||.||+|.. .+|+.||||.+....... ...+.+.+|+.++++++|||||++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 46788889999999999999965 468999999998654221 2356789999999999999999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC----ceEEcccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY----DAHVSDFG 614 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~----~~kl~DfG 614 (639)
|+||||+++|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999997643 478899999999999999999998 999999999999998776 79999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+++.+... ......+||+.|+|||
T Consensus 165 ~a~~~~~~-~~~~~~~gt~~y~aPE 188 (361)
T 2yab_A 165 LAHEIEDG-VEFKNIFGTPEFVAPE 188 (361)
T ss_dssp SCEECCTT-CCCCCCCSCGGGCCHH
T ss_pred CceEcCCC-CccccCCCCccEECch
Confidence 99877543 2334578999999998
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-29 Score=258.94 Aligned_cols=170 Identities=22% Similarity=0.360 Sum_probs=148.5
Q ss_pred HhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
..++|+..+.||+|+||.||+|.. .+++.||||.+..........+.+.+|+.++++++|||||++++++.+.+..|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 356788899999999999999965 5689999999987655555567789999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC---CceEEcccccccc
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD---YDAHVSDFGISKF 618 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~---~~~kl~DfGla~~ 618 (639)
|||+++|+|.+.+.... .+++..+..++.|+++|++|||.. +|+||||||+||+++.+ +.+||+|||+++.
T Consensus 107 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999987543 478899999999999999999999 99999999999999865 4599999999987
Q ss_pred CCCCCCCcceeeeeceeeCCC
Q 046265 619 LKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~~~~~~~gt~~Y~APE 639 (639)
.... ......+||+.|+|||
T Consensus 181 ~~~~-~~~~~~~gt~~y~aPE 200 (362)
T 2bdw_A 181 VNDS-EAWHGFAGTPGYLSPE 200 (362)
T ss_dssp CTTC-CSCCCSCSCTTTCCHH
T ss_pred ecCC-cccccCCCCccccCHH
Confidence 6533 2334578999999998
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=254.10 Aligned_cols=169 Identities=24% Similarity=0.381 Sum_probs=142.3
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
++|+..+.||+|+||.||+|+..+++.||||++..........+.+.+|+.++++++||||+++++++...+..|+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46778899999999999999888899999999976543333456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++ +|.+++.... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 975 8988887543 3478899999999999999999998 999999999999999999999999999987654333
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
.....+||+.|+|||
T Consensus 156 ~~~~~~~t~~y~aPE 170 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPD 170 (288)
T ss_dssp ------CCCTTCCHH
T ss_pred ccccccccccccCch
Confidence 344568999999998
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-27 Score=241.37 Aligned_cols=231 Identities=22% Similarity=0.240 Sum_probs=193.4
Q ss_pred cceeee--EEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCC
Q 046265 3 CLAFFF--FQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSL 80 (639)
Q Consensus 3 ~~~~~~--~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L 80 (639)
|.|... ..++.+.+++. .+|..+ .++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|..+++|
T Consensus 6 C~C~~~~~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 82 (285)
T 1ozn_A 6 CVCYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82 (285)
T ss_dssp CEEECSSSCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred ceECCCCCeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCC
Confidence 777554 46777777765 567655 4689999999999998877889999999999999999998778899999999
Q ss_pred CEEeeeccc-CccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCC
Q 046265 81 KQLVLYCNG-LSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSI 159 (639)
Q Consensus 81 ~~L~L~~N~-l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 159 (639)
++|++++|+ ++...|..|..+++| ++|++++|++++..|..+.++++|++|++++|++++..
T Consensus 83 ~~L~l~~n~~l~~~~~~~~~~l~~L-----------------~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 145 (285)
T 1ozn_A 83 EQLDLSDNAQLRSVDPATFHGLGRL-----------------HTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP 145 (285)
T ss_dssp CEEECCSCTTCCCCCTTTTTTCTTC-----------------CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CEEeCCCCCCccccCHHHhcCCcCC-----------------CEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccC
Confidence 999999997 776667777776633 58999999999887888999999999999999998777
Q ss_pred CccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCce
Q 046265 160 PPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNI 239 (639)
Q Consensus 160 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 239 (639)
+..++.+++|+.|++++|.+++..+..+..+ ++|+.|++++|.+.+..|.++..+++|+.
T Consensus 146 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l--------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 205 (285)
T 1ozn_A 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGL--------------------HSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTC--------------------TTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred HhHhccCCCccEEECCCCcccccCHHHhcCc--------------------cccCEEECCCCcccccCHhHccCcccccE
Confidence 7778999999999999999986655555544 45666777788887878888999999999
Q ss_pred eccccccccCcchhhhhcCCCccEEeccCCcccc
Q 046265 240 VHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYG 273 (639)
Q Consensus 240 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 273 (639)
|++++|.+++..+..+..+++|+.|++++|.+..
T Consensus 206 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 239 (285)
T 1ozn_A 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (285)
T ss_dssp EECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred eeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence 9999999999888889999999999988888753
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.96 E-value=8.7e-32 Score=290.75 Aligned_cols=359 Identities=18% Similarity=0.106 Sum_probs=271.2
Q ss_pred CCCCEEECcCCCCccCCCCC-CCCCCCCCEEEcccCcCCC----CCCcccCCCCCCCEEeeecccCccccCccccC-CCC
Q 046265 30 SNLKFLDMGNNQLSGVIPQE-IDPLTHLKHLYINVNKLRG----SVPREVGQLSSLKQLVLYCNGLSGWLPSSFGN-LNN 103 (639)
Q Consensus 30 ~~L~~L~Ls~n~l~~~~p~~-~~~L~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~ 103 (639)
++|++|||++|.++...... +..+++|++|+|++|.++. .++..+..+++|++|+|++|.++...+..+.. +..
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 56899999999997543333 7789999999999999984 35777888999999999999998755544432 221
Q ss_pred CCcccCCCCCcccCCCCccEEEccCCcCcc----cCCccccCCCCCCEEeccCCCCCCCCCcccc-----CCCcccEEEc
Q 046265 104 LAIGSMPNSLSNLTSLSLFHLDLSENQLSG----SIPHFLGHLSNLAVLHLGDNSLFGSIPPILG-----KVQSLLSLGF 174 (639)
Q Consensus 104 L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~l 174 (639)
- ..+ |++|+|++|+++. .+|..+..+++|++|+|++|.++...+..+. ..++|++|++
T Consensus 83 ~-----------~~~--L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L 149 (461)
T 1z7x_W 83 P-----------SCK--IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQL 149 (461)
T ss_dssp T-----------TCC--CCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred C-----------CCc--eeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEEC
Confidence 0 002 3699999999984 5688899999999999999998754343332 3568999999
Q ss_pred ccCcCCcc----CCccCcCCCCCCeEEccCCccccc----cc-----cccCCcEEEcCCcccCCC----CCccccCCCCC
Q 046265 175 DLNLLNGV----LPPSISNLSNLEGLYLYSSLVSAE----IG-----NLLQLIELEIDNKQLFGQ----IPKSLRNFTSL 237 (639)
Q Consensus 175 ~~N~l~~~----~p~~~~~l~~L~~L~l~~~~~~~~----~~-----~l~~L~~L~l~~n~l~~~----~p~~~~~l~~L 237 (639)
++|.+++. ++..+..+++|+.|+++.+.+... +. ..++|+.|++++|.+... ++..+..+++|
T Consensus 150 ~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L 229 (461)
T 1z7x_W 150 EYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASL 229 (461)
T ss_dssp TTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTC
T ss_pred CCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCc
Confidence 99999874 466677789999999998776431 22 255999999999999764 57778889999
Q ss_pred ceeccccccccCcc-----hhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCc
Q 046265 238 NIVHLEQNHLTGNI-----YEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPI 312 (639)
Q Consensus 238 ~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~ 312 (639)
+.|++++|.++... +..+..+++|++|++++|.+++.- ...++..+..+++|+.|++++|.+.+..+.
T Consensus 230 ~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~-------~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 302 (461)
T 1z7x_W 230 RELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKG-------CGDLCRVLRAKESLKELSLAGNELGDEGAR 302 (461)
T ss_dssp CEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH-------HHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred cEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHH-------HHHHHHHHhhCCCcceEECCCCCCchHHHH
Confidence 99999999988643 223345899999998888763200 012566777889999999999998765444
Q ss_pred cccC-----CCCCCeeeccCccCccc----CCcCccCCCCCCEEeCCCCCCCcccccCChhhhc-----cccCCeeeccC
Q 046265 313 ELGN-----LKSLNYRALNGNKVYGS----LPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEK-----LVQLTELDLVI 378 (639)
Q Consensus 313 ~~~~-----l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~-----l~~L~~l~l~~ 378 (639)
.+.. .++|+.|++++|.+++. +|..+..+++|+.|++++|+ +....+..+.. .++|+.|++++
T Consensus 303 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~---i~~~~~~~l~~~l~~~~~~L~~L~L~~ 379 (461)
T 1z7x_W 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNR---LEDAGVRELCQGLGQPGSVLRVLWLAD 379 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSB---CHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred HHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCc---cccccHHHHHHHHcCCCCceEEEECCC
Confidence 4433 36999999999999865 56677788999999999964 43333333332 56999999999
Q ss_pred CcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeeee
Q 046265 379 TFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRG 417 (639)
Q Consensus 379 n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~g 417 (639)
|.+.+.. ....+..+..+++|+.+|+++|++++
T Consensus 380 n~i~~~~------~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 380 CDVSDSS------CSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp SCCCHHH------HHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred CCCChhh------HHHHHHHHHhCCCccEEECCCCCCCH
Confidence 9876411 12334667889999999999999874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8e-29 Score=259.10 Aligned_cols=172 Identities=17% Similarity=0.290 Sum_probs=146.0
Q ss_pred hccCCCcceeccCCCceEEEEEc--------CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEc
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL--------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFH 534 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 534 (639)
.++|+..+.||+|+||.||+|+. .++..||||.++... .....+.+.+|+++++++ +|||||+++++|..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 35677889999999999999964 245679999997543 334456789999999999 89999999999999
Q ss_pred CCceeEEecccCCCChhHHhhcCCC-------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCee
Q 046265 535 PRQSFLLYEYLGRGSLAIILSNDAA-------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVL 601 (639)
Q Consensus 535 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil 601 (639)
.+..|+||||+++|+|.+++..... ...+++..+..++.|+++||+|||.. +|+||||||+||+
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 9999999999999999999976432 23578999999999999999999998 9999999999999
Q ss_pred eCCCCceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 602 LGLDYDAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 602 l~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
++.++.+||+|||+|+....... ......||+.|||||
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE 275 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 275 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHh
Confidence 99999999999999987653322 223356789999998
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-28 Score=249.53 Aligned_cols=284 Identities=22% Similarity=0.229 Sum_probs=180.9
Q ss_pred cceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCC--CCCcccCCCCCC
Q 046265 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRG--SVPREVGQLSSL 80 (639)
Q Consensus 3 ~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~--~~p~~~~~l~~L 80 (639)
|.|-. ..++.+++++. .+|..+. ++|++|+|++|.++...+..|..+++|++|+|++|+++. ..|..+..+++|
T Consensus 5 C~C~~-~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L 80 (306)
T 2z66_A 5 CSCSG-TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSL 80 (306)
T ss_dssp CEEET-TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCC
T ss_pred CeeCC-CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCccccccccccc
Confidence 66643 45666666654 5565553 578888888888875444456788888888888887762 235566677788
Q ss_pred CEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCC-ccccCCCCCCEEeccCCCCCCCC
Q 046265 81 KQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIP-HFLGHLSNLAVLHLGDNSLFGSI 159 (639)
Q Consensus 81 ~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~ 159 (639)
++|++++|.++ .+|..+..+++| ++|++++|++++..+ ..+..+++|++|++++|.+.+..
T Consensus 81 ~~L~Ls~n~i~-~l~~~~~~l~~L-----------------~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 142 (306)
T 2z66_A 81 KYLDLSFNGVI-TMSSNFLGLEQL-----------------EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 142 (306)
T ss_dssp CEEECCSCSEE-EEEEEEETCTTC-----------------CEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECS
T ss_pred CEEECCCCccc-cChhhcCCCCCC-----------------CEEECCCCcccccccchhhhhccCCCEEECCCCcCCccc
Confidence 88888887776 345555555532 477777777765443 46777777777777777777666
Q ss_pred CccccCCCcccEEEcccCcCCc-cCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCc
Q 046265 160 PPILGKVQSLLSLGFDLNLLNG-VLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLN 238 (639)
Q Consensus 160 p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 238 (639)
|..+..+++|++|++++|.+++ .+|..+. .+++|+.|++++|++.+..|.++..+++|+
T Consensus 143 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~--------------------~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 202 (306)
T 2z66_A 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFT--------------------ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 202 (306)
T ss_dssp TTTTTTCTTCCEEECTTCEEGGGEECSCCT--------------------TCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred hhhcccCcCCCEEECCCCccccccchhHHh--------------------hCcCCCEEECCCCCcCCcCHHHhcCCCCCC
Confidence 6777777777777777777765 3444444 344455566666666666667777777777
Q ss_pred eeccccccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCC-CCCCEEeccCCcccccCCc-c-cc
Q 046265 239 IVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKL-YQLHKLDFSLNHIVGELPI-E-LG 315 (639)
Q Consensus 239 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l-~~L~~L~Ls~N~~~~~~p~-~-~~ 315 (639)
.|++++|.+++..+..+..+++|+.|++++|++ ++..|..+..+ ++|+.|++++|.+.+..+. + ..
T Consensus 203 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l-----------~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~ 271 (306)
T 2z66_A 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI-----------MTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQ 271 (306)
T ss_dssp EEECTTSCCSBCCSGGGTTCTTCCEEECTTSCC-----------CBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHH
T ss_pred EEECCCCccCccChhhccCcccCCEeECCCCCC-----------cccCHHHHHhhhccCCEEEccCCCeecccChHHHHH
Confidence 777777777776666677777777777555544 34556666666 3677777777777643211 0 11
Q ss_pred CCCCCCeeeccCccCcccCCcCcc
Q 046265 316 NLKSLNYRALNGNKVYGSLPRVLG 339 (639)
Q Consensus 316 ~l~~L~~L~l~~N~l~~~~p~~~~ 339 (639)
.+...+.+....+.+....|..+.
T Consensus 272 ~l~~~~~~~~~~~~~~C~~p~~~~ 295 (306)
T 2z66_A 272 WIKDQRQLLVEVERMECATPSDKQ 295 (306)
T ss_dssp HHHHTGGGBSCGGGCBEEESGGGT
T ss_pred HHHhhhhhhccccccccCCchhhC
Confidence 122333444444555555555443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-28 Score=252.59 Aligned_cols=275 Identities=21% Similarity=0.220 Sum_probs=204.1
Q ss_pred ccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCC
Q 046265 26 IGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLA 105 (639)
Q Consensus 26 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 105 (639)
-..++.....++++|.++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|++++..|..|.++++|
T Consensus 27 ~~~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L- 102 (353)
T 2z80_A 27 SLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL- 102 (353)
T ss_dssp CCEECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTC-
T ss_pred CCCCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCC-
Confidence 344566677999999998 6787665 489999999999996666689999999999999999998878888777743
Q ss_pred cccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCC-ccccCCCcccEEEcccCc-CCccC
Q 046265 106 IGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIP-PILGKVQSLLSLGFDLNL-LNGVL 183 (639)
Q Consensus 106 ~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~-l~~~~ 183 (639)
++|++++|++++..+..+.++++|++|+|++|++++..+ ..+..+++|++|++++|. +.+..
T Consensus 103 ----------------~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~ 166 (353)
T 2z80_A 103 ----------------EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ 166 (353)
T ss_dssp ----------------CEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred ----------------CEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccC
Confidence 589999999986555568899999999999999985433 378899999999999984 66555
Q ss_pred CccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccE
Q 046265 184 PPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTF 263 (639)
Q Consensus 184 p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 263 (639)
|..+. .+++|+.|++++|++.+..|..+..+++|++|++++|.++......+..+++|+.
T Consensus 167 ~~~~~--------------------~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~ 226 (353)
T 2z80_A 167 RKDFA--------------------GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVEC 226 (353)
T ss_dssp TTTTT--------------------TCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEE
T ss_pred HHHcc--------------------CCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccE
Confidence 54444 4455667777888888888999999999999999999998766666677899999
Q ss_pred EeccCCcccccccCcCCccccccCcc---ccCCCCCCEEeccCCcccc----cCCccccCCCCCCeeeccCccCcccCCc
Q 046265 264 LDLSQNNFYGSLNFSMNNITRSIPPK---IGKLYQLHKLDFSLNHIVG----ELPIELGNLKSLNYRALNGNKVYGSLPR 336 (639)
Q Consensus 264 L~Ls~N~l~~~l~ls~n~~~~~~p~~---~~~l~~L~~L~Ls~N~~~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 336 (639)
|++++|.+.+ ..+.. ......++.++++++.+.+ .+|..+..+++|+.|++++|+++ .+|.
T Consensus 227 L~L~~n~l~~-----------~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~ 294 (353)
T 2z80_A 227 LELRDTDLDT-----------FHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPD 294 (353)
T ss_dssp EEEESCBCTT-----------CCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCT
T ss_pred EECCCCcccc-----------ccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCH
Confidence 9988887753 11111 1234456667777666654 24555666666666666666666 3443
Q ss_pred C-ccCCCCCCEEeCCCC
Q 046265 337 V-LGSISDLEYLDLSTN 352 (639)
Q Consensus 337 ~-~~~l~~L~~L~Ls~N 352 (639)
. +..+++|+.|++++|
T Consensus 295 ~~~~~l~~L~~L~L~~N 311 (353)
T 2z80_A 295 GIFDRLTSLQKIWLHTN 311 (353)
T ss_dssp TTTTTCTTCCEEECCSS
T ss_pred HHHhcCCCCCEEEeeCC
Confidence 3 356666666666664
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=260.55 Aligned_cols=170 Identities=20% Similarity=0.230 Sum_probs=146.4
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 540 (639)
.++|+..++||+|+||.||+|+.+ +++.||||.+..... .....+.+.+|..++..+ +||||+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467888999999999999999765 578999999875321 112345678899999887 79999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||||+++|+|.+++...+ .+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+|+...
T Consensus 99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999997643 478899999999999999999998 99999999999999999999999999998754
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
.........+||+.|||||
T Consensus 173 ~~~~~~~~~~gt~~y~aPE 191 (353)
T 2i0e_A 173 WDGVTTKTFCGTPDYIAPE 191 (353)
T ss_dssp CTTCCBCCCCSCGGGCCHH
T ss_pred cCCcccccccCCccccChh
Confidence 4444455678999999998
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=257.31 Aligned_cols=170 Identities=22% Similarity=0.334 Sum_probs=136.1
Q ss_pred hccCCCcceeccCCCceEEEEEc----CCCcEEEEEEccCCCC--ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL----PSWEIVAVKKFHSPHP--DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 537 (639)
.++|+..+.||+|+||.||+|+. .+++.||||.+..... .......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46788889999999999999976 4789999999986432 12234567889999999999999999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.|+||||+++|+|.+++...+ .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999997643 367788999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCCcceeeeeceeeCCC
Q 046265 618 FLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~~~~~~gt~~Y~APE 639 (639)
............+||+.|+|||
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE 191 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPE 191 (327)
T ss_dssp ---------CTTSSCCTTSCHH
T ss_pred ccccCCccccccCCCcCccCHh
Confidence 6543333344568999999998
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-29 Score=250.79 Aligned_cols=169 Identities=25% Similarity=0.388 Sum_probs=141.6
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCC-CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||.||+|+ ..+++.||||.+.... ......+.+.+|+.++++++||||+++++++..++..|+||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 567888999999999999996 4578999999986543 23345577899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++...+ .+++..+..++.|++.|++|+|.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999997654 478899999999999999999998 9999999999999999999999999999876533
Q ss_pred C-CCcceeeeeceeeCCC
Q 046265 623 S-SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~-~~~~~~~gt~~Y~APE 639 (639)
. ......+||+.|+|||
T Consensus 165 ~~~~~~~~~gt~~y~aPE 182 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPE 182 (294)
T ss_dssp ----------CCSSCCHH
T ss_pred cccccCccccCccccCHh
Confidence 2 2233467999999998
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-29 Score=255.23 Aligned_cols=167 Identities=22% Similarity=0.345 Sum_probs=144.6
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.++|+..+.||+|+||.||+|+. .+|+.||||.+.+... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 35788889999999999999965 4789999999874321 112345678899999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999997643 477899999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
. ....+||+.|||||
T Consensus 159 ~---~~~~~gt~~y~aPE 173 (318)
T 1fot_A 159 V---TYTLCGTPDYIAPE 173 (318)
T ss_dssp C---BCCCCSCTTTCCHH
T ss_pred c---cccccCCccccCHh
Confidence 2 33568999999998
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-29 Score=251.76 Aligned_cols=168 Identities=25% Similarity=0.317 Sum_probs=139.7
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCCh------------------------hhHHHHHHHHHHHhc
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDM------------------------VVQQAFSNEIKALTE 519 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l~~ 519 (639)
++|+..+.||+|+||.||+|.. .+++.||||.+....... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 5688889999999999999964 568999999987543111 113468899999999
Q ss_pred cccCceeeeEEEEEc--CCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 046265 520 LRHRNVVKFYGFSFH--PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISS 597 (639)
Q Consensus 520 l~H~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~ 597 (639)
++||||+++++++.+ .+..|+||||+++|+|.+++.. ..+++..+..++.|+++|++|||.. +|+||||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 165 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP 165 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence 999999999999987 5678999999999999876543 3578899999999999999999999 999999999
Q ss_pred CCeeeCCCCceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 598 KNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 598 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+||+++.++.+||+|||+++............+||+.|+|||
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE 207 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPE 207 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGG
T ss_pred HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChh
Confidence 999999999999999999987764433344568999999998
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-28 Score=248.94 Aligned_cols=195 Identities=26% Similarity=0.306 Sum_probs=114.4
Q ss_pred CCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCccc
Q 046265 29 ISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGS 108 (639)
Q Consensus 29 l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~ 108 (639)
.+++++|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++++++|
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L---- 152 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRL---- 152 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTC----
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCC----
Confidence 466777777777776 66777777777777777777777 67777777777777777777776 556666655532
Q ss_pred CCCCCcccCCCCccEEEccCCcCcccCCccccC---------CCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcC
Q 046265 109 MPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGH---------LSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLL 179 (639)
Q Consensus 109 lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~---------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 179 (639)
++|++++|++.+.+|..+.. +++|++|+|++|+++ .+|..++.+++|++|++++|.+
T Consensus 153 -------------~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l 218 (328)
T 4fcg_A 153 -------------RELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL 218 (328)
T ss_dssp -------------CEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCC
T ss_pred -------------CEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCC
Confidence 46777776666677765543 555666666666555 4555555555555555555555
Q ss_pred CccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCC
Q 046265 180 NGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYP 259 (639)
Q Consensus 180 ~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 259 (639)
++ +|..+ ..+++|+.|++++|.+.+.+|..+.++++|+.|++++|.+.+.+|..++.++
T Consensus 219 ~~-l~~~l--------------------~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~ 277 (328)
T 4fcg_A 219 SA-LGPAI--------------------HHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277 (328)
T ss_dssp CC-CCGGG--------------------GGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCT
T ss_pred Cc-Cchhh--------------------ccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCC
Confidence 43 22222 2233334444444444444454444444444444444444444443344444
Q ss_pred CccEEe
Q 046265 260 NLTFLD 265 (639)
Q Consensus 260 ~L~~L~ 265 (639)
+|++|+
T Consensus 278 ~L~~L~ 283 (328)
T 4fcg_A 278 QLEKLD 283 (328)
T ss_dssp TCCEEE
T ss_pred CCCEEe
Confidence 444444
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-28 Score=248.55 Aligned_cols=232 Identities=18% Similarity=0.237 Sum_probs=197.8
Q ss_pred eeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeee
Q 046265 7 FFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLY 86 (639)
Q Consensus 7 ~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 86 (639)
....+++++|++. .+|+.++.+++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..++++++|++|+++
T Consensus 82 ~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~ 158 (328)
T 4fcg_A 82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR 158 (328)
T ss_dssp TCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEE
T ss_pred ceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECC
Confidence 4567899999998 88999999999999999999999 89999999999999999999999 899999999999999999
Q ss_pred cccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCC
Q 046265 87 CNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKV 166 (639)
Q Consensus 87 ~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 166 (639)
+|++.+.+|..+.... ++..+.++++| ++|+|++|+++ .+|..++++++|++|+|++|++++ +|..++.+
T Consensus 159 ~n~~~~~~p~~~~~~~------~~~~~~~l~~L--~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l 228 (328)
T 4fcg_A 159 ACPELTELPEPLASTD------ASGEHQGLVNL--QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHL 228 (328)
T ss_dssp EETTCCCCCSCSEEEC-------CCCEEESTTC--CEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGC
T ss_pred CCCCccccChhHhhcc------chhhhccCCCC--CEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccC
Confidence 9999999998876521 23334455565 79999999998 889999999999999999999995 77789999
Q ss_pred CcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceecccccc
Q 046265 167 QSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNH 246 (639)
Q Consensus 167 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 246 (639)
++|++|++++|.+.+.+|..+..+++| +.|++++|++.+.+|..+.++++|+.|++++|.
T Consensus 229 ~~L~~L~Ls~n~~~~~~p~~~~~l~~L--------------------~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~ 288 (328)
T 4fcg_A 229 PKLEELDLRGCTALRNYPPIFGGRAPL--------------------KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288 (328)
T ss_dssp TTCCEEECTTCTTCCBCCCCTTCCCCC--------------------CEEECTTCTTCCBCCTTGGGCTTCCEEECTTCT
T ss_pred CCCCEEECcCCcchhhhHHHhcCCCCC--------------------CEEECCCCCchhhcchhhhcCCCCCEEeCCCCC
Confidence 999999999999999988877665554 555666777777788888888888888888888
Q ss_pred ccCcchhhhhcCCCccEEeccCCcc
Q 046265 247 LTGNIYEVFGIYPNLTFLDLSQNNF 271 (639)
Q Consensus 247 l~~~~~~~~~~l~~L~~L~Ls~N~l 271 (639)
+.+.+|..++.+++++.+++..|.+
T Consensus 289 ~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 289 NLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp TCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred chhhccHHHhhccCceEEeCCHHHH
Confidence 8888888888888888887665544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-29 Score=261.01 Aligned_cols=170 Identities=24% Similarity=0.272 Sum_probs=137.4
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHH-HhccccCceeeeEEEEEcCCceeE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKA-LTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
.++|+..++||+|+||+||+|+.+ +++.||||.+.+... .......+.+|..+ ++.++|||||++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357888999999999999999654 678999999975432 12233455667776 567899999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||||+++|+|.+++...+ .+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999997644 367788899999999999999998 99999999999999999999999999998754
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
.........+||+.|||||
T Consensus 191 ~~~~~~~~~~gt~~y~aPE 209 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPE 209 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHH
T ss_pred cCCCccccccCCccccCHH
Confidence 4444455679999999998
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=281.28 Aligned_cols=213 Identities=21% Similarity=0.175 Sum_probs=111.0
Q ss_pred cEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCC
Q 046265 122 FHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSS 201 (639)
Q Consensus 122 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~ 201 (639)
++|+|++|.+++..|..|..+++|++|+|++|.+++..| ++.+++|++|++++|.+++..+ .++|+.|+++
T Consensus 37 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~-- 107 (487)
T 3oja_A 37 KELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA-- 107 (487)
T ss_dssp CEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC--
T ss_pred cEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc--
Confidence 677777777777666777777778888888777776544 7777777777777777764322 1455555554
Q ss_pred ccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccCcCCc
Q 046265 202 LVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNN 281 (639)
Q Consensus 202 ~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~ 281 (639)
+|.+.+..+. .+++|+.|++++|.+++..|..++.+++|+.|++++|.+
T Consensus 108 ------------------~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l---------- 156 (487)
T 3oja_A 108 ------------------NNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI---------- 156 (487)
T ss_dssp ------------------SSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCC----------
T ss_pred ------------------CCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCC----------
Confidence 4444433222 234444455555555444444444444555554333333
Q ss_pred cccccCcccc-CCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCccccc
Q 046265 282 ITRSIPPKIG-KLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKE 360 (639)
Q Consensus 282 ~~~~~p~~~~-~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~ 360 (639)
++..|..+. .+++|+.|+|++|.+++..+ ...+++|+.|+|++|.+++..| .+..+++|+.|++++|.+..
T Consensus 157 -~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~---- 228 (487)
T 3oja_A 157 -DTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL---- 228 (487)
T ss_dssp -CEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE----
T ss_pred -CCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc----
Confidence 223333333 34445555555555443311 2234455555555555543222 24444555555555533221
Q ss_pred CChhhhccccCCeeeccCCcCc
Q 046265 361 FPVELEKLVQLTELDLVITFWE 382 (639)
Q Consensus 361 ~p~~~~~l~~L~~l~l~~n~~~ 382 (639)
+|..+..+++|+.+++++|.+.
T Consensus 229 lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 229 IEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp ECTTCCCCTTCCEEECTTCCBC
T ss_pred cchhhccCCCCCEEEcCCCCCc
Confidence 3334444445555555555443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=251.45 Aligned_cols=167 Identities=19% Similarity=0.239 Sum_probs=146.0
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|+..+.||+|+||.||+|.. .+++.||+|.+... ......+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 35788889999999999999965 46789999998743 234567889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC--CCceEEccccccccCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL--DYDAHVSDFGISKFLK 620 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~--~~~~kl~DfGla~~~~ 620 (639)
||+++|+|.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++. ++.+||+|||+++.+.
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 81 EFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 9999999999997543 2578899999999999999999998 9999999999999987 7899999999998875
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
.. .......||+.|+|||
T Consensus 156 ~~-~~~~~~~gt~~y~aPE 173 (321)
T 1tki_A 156 PG-DNFRLLFTAPEYYAPE 173 (321)
T ss_dssp TT-CEEEEEESCGGGSCHH
T ss_pred CC-CccccccCChhhcCcH
Confidence 43 3334578999999998
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-29 Score=260.62 Aligned_cols=168 Identities=18% Similarity=0.213 Sum_probs=140.9
Q ss_pred hccCCCcceeccCCCceEEEE------EcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc---cCceeeeEEEEEc
Q 046265 464 TNNFDAKYCIGTAGQASVYKA------ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR---HRNVVKFYGFSFH 534 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~ 534 (639)
.++|...+.||+|+||.||+| ...+++.||||++.... ...+.+|++++.+++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 466778899999999999999 35567899999997532 345677888877776 9999999999999
Q ss_pred CCceeEEecccCCCChhHHhhcCC--CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC--------
Q 046265 535 PRQSFLLYEYLGRGSLAIILSNDA--AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL-------- 604 (639)
Q Consensus 535 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~-------- 604 (639)
++..|+||||+++|+|.+++.... ....++|..+..++.|+++||+|||.. +|+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence 999999999999999999997422 234689999999999999999999998 9999999999999998
Q ss_pred ---CCceEEccccccccCCC--CCCCcceeeeeceeeCCC
Q 046265 605 ---DYDAHVSDFGISKFLKP--DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 605 ---~~~~kl~DfGla~~~~~--~~~~~~~~~gt~~Y~APE 639 (639)
++.+||+|||+|+.+.. ........+||++|||||
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE 255 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE 255 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHH
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChH
Confidence 89999999999976532 222334568999999998
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-29 Score=260.23 Aligned_cols=173 Identities=20% Similarity=0.275 Sum_probs=145.4
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCC---CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPH---PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
.+.|+..+.||+|+||.||+|.. .+++.||||.+.... ......+.+.+|+.++++++|||||++++++.+++..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45688889999999999999954 578999999986321 11123567899999999999999999999999999999
Q ss_pred EEecccCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc---eEEccccc
Q 046265 540 LLYEYLGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD---AHVSDFGI 615 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~---~kl~DfGl 615 (639)
+||||+++|+|.+.+.... ....+++..+..++.|+++|++|||.. +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775432 223478899999999999999999998 9999999999999986554 99999999
Q ss_pred cccCCCCCCCcceeeeeceeeCCC
Q 046265 616 SKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
++............+||+.|+|||
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE 203 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPE 203 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHH
T ss_pred eeEecCCCeeecCCcCCcCccCHH
Confidence 988765443344578999999998
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.95 E-value=9.8e-29 Score=268.50 Aligned_cols=173 Identities=21% Similarity=0.266 Sum_probs=149.1
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCC-hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPD-MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.++|...++||+|+||+||+|+. .+|+.||||++.+.... ....+.+.+|+.++++++|||||++++++...+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 46788889999999999999976 46899999999743211 12245688999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCC-CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 542 YEYLGRGSLAIILSNDAA-IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
|||+++|+|.+++..... ...+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999876432 34588999999999999999999998 99999999999999999999999999999876
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
.........+||+.|||||
T Consensus 341 ~~~~~~~~~~GT~~Y~APE 359 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPE 359 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHH
T ss_pred CCCcccccccCCccccChh
Confidence 5444445568999999998
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=250.98 Aligned_cols=168 Identities=19% Similarity=0.183 Sum_probs=141.5
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||+||+|... +++.||||++............+.+|+..+.++ +||||++++++|.+++..|+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57888999999999999999665 789999999876554455555666777776665 8999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+ +++|.+++.... ..++|..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 678988886543 3589999999999999999999998 9999999999999999999999999999876533
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
. ......||++|+|||
T Consensus 211 ~-~~~~~~gt~~y~aPE 226 (311)
T 3p1a_A 211 G-AGEVQEGDPRYMAPE 226 (311)
T ss_dssp -----CCCCCGGGCCGG
T ss_pred C-CCcccCCCccccCHh
Confidence 2 234467999999998
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=8.5e-29 Score=256.51 Aligned_cols=167 Identities=22% Similarity=0.227 Sum_probs=145.1
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.++|+..+.||+|+||.||+|+. .+|+.||||.+..... .....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 35788889999999999999965 4789999999864321 112345678999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999997653 377899999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
. ....+||+.|+|||
T Consensus 194 ~---~~~~~gt~~y~aPE 208 (350)
T 1rdq_E 194 R---TWTLCGTPEALAPE 208 (350)
T ss_dssp C---BCCCEECGGGCCHH
T ss_pred C---cccccCCccccCHH
Confidence 2 23578999999998
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=256.74 Aligned_cols=170 Identities=21% Similarity=0.368 Sum_probs=135.4
Q ss_pred hccCCCcceeccCCCceEEEEEcC----CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP----SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
..+|+..+.||+|+||.||+|+.. ++..||||.++... .....+.|.+|+.++++++|||||++++++...+..|
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 357888999999999999999764 56789999997643 3445678999999999999999999999999999999
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||+++|+|.++++... ..+++..+..++.|+++||+|||.. +|+||||||+||+++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999997643 3588999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCC---cceeeeeceeeCCC
Q 046265 620 KPDSSN---WSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~---~~~~~gt~~Y~APE 639 (639)
...... .....+++.|+|||
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE 220 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPE 220 (373)
T ss_dssp ----------------CTTSCHH
T ss_pred ccCCccceeccCCCcCCCccChh
Confidence 543221 12234577899998
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=250.85 Aligned_cols=169 Identities=21% Similarity=0.312 Sum_probs=146.2
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCCh----hhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDM----VVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
.+.|+..+.||+|+||.||+|.. .+++.||||.+....... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 35688889999999999999965 468999999997643221 2357789999999999999999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC----ceEEcccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY----DAHVSDFG 614 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~----~~kl~DfG 614 (639)
|+||||+++|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999997543 478899999999999999999998 999999999999998877 79999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+++...... .....+||+.|+|||
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aPE 187 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAPE 187 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCHH
T ss_pred CCeECCCCC-ccccccCCcCcCCce
Confidence 998765332 234568999999998
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=255.74 Aligned_cols=246 Identities=20% Similarity=0.163 Sum_probs=114.4
Q ss_pred CCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCC
Q 046265 32 LKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPN 111 (639)
Q Consensus 32 L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~ 111 (639)
.+.++.++++++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L------- 125 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL------- 125 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC-------
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccC-------
Confidence 344555555554 3444333 355555555555554445555555555555555555555444444444422
Q ss_pred CCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccC-cCCccCCccCcCC
Q 046265 112 SLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLN-LLNGVLPPSISNL 190 (639)
Q Consensus 112 ~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l 190 (639)
++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++| .+....+..|.++
T Consensus 126 ----------~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l 195 (452)
T 3zyi_A 126 ----------NTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL 195 (452)
T ss_dssp ----------CEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTC
T ss_pred ----------CEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCC
Confidence 35555555555444444555555555555555555444444555555555555552 2222222223322
Q ss_pred CCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCc
Q 046265 191 SNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN 270 (639)
Q Consensus 191 ~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 270 (639)
++ |+.|++++|++.+ +| .+..+++|+.|++++|.+++..+..|..+++|+.|++++|+
T Consensus 196 ~~--------------------L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~ 253 (452)
T 3zyi_A 196 FN--------------------LKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253 (452)
T ss_dssp TT--------------------CCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSC
T ss_pred CC--------------------CCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCc
Confidence 22 2333333333322 12 23344444444444444444444444444445444433333
Q ss_pred ccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccC
Q 046265 271 FYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKV 330 (639)
Q Consensus 271 l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l 330 (639)
+ ++..|..+..+++|+.|+|++|++++..+..|..+++|+.|++++|.+
T Consensus 254 l-----------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~ 302 (452)
T 3zyi_A 254 V-----------SLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302 (452)
T ss_dssp C-----------CEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCE
T ss_pred C-----------ceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCc
Confidence 2 223344444445555555555555444444444455555555555544
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=268.89 Aligned_cols=171 Identities=22% Similarity=0.271 Sum_probs=147.5
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.++|+..++||+|+||.||+|.. .+|+.||||++..... .......+.+|+.++++++|||||++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 46788889999999999999965 5789999999864321 112345678999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++|+|.+++...+. ..+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+|+.+..
T Consensus 263 mEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999976542 3478899999999999999999999 999999999999999999999999999987754
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
.. .....+||+.|||||
T Consensus 339 ~~-~~~~~~GT~~Y~APE 355 (576)
T 2acx_A 339 GQ-TIKGRVGTVGYMAPE 355 (576)
T ss_dssp TC-CEECCCSCGGGCCHH
T ss_pred Cc-cccccCCCccccCHH
Confidence 32 334568999999998
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=249.82 Aligned_cols=169 Identities=23% Similarity=0.360 Sum_probs=142.1
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|+||.||+|.. .+++.||||++..........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 5688889999999999999965 468999999998766555566778999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|++++++.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999999887543 478899999999999999999998 99999999999999999999999999998876444
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
......+||+.|+|||
T Consensus 157 ~~~~~~~~~~~y~aPE 172 (311)
T 4agu_A 157 DYYDDEVATRWYRSPE 172 (311)
T ss_dssp ---------GGGCCHH
T ss_pred cccCCCcCCccccChH
Confidence 4445678999999998
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=251.01 Aligned_cols=171 Identities=22% Similarity=0.333 Sum_probs=132.8
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
..+|+..+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|+.++++++|||||++++++..++..|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 46788899999999999999965 4689999999975432 223456789999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCC---CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 543 EYLGRGSLAIILSNDA---AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
||++ |+|.+++.... ....+++..+..++.|+++||+|||.. +|+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 69998886432 223578899999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCCcceeeeeceeeCCC
Q 046265 620 KPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~~~~~~gt~~Y~APE 639 (639)
..........+||+.|+|||
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE 178 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPD 178 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHH
T ss_pred CCCcccCCCCcccccccCch
Confidence 54433444568999999998
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=250.30 Aligned_cols=169 Identities=23% Similarity=0.374 Sum_probs=141.9
Q ss_pred ccCCCcceeccCCCceEEEEEcC----CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP----SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
.+|+..+.||+|+||.||+|... .+..||||.+.... .....+.|.+|+.++++++||||+++++++.+++..|+
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 56777899999999999999763 34569999997543 34456779999999999999999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||||+++|+|.++++... ..+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999997543 3588899999999999999999998 99999999999999999999999999998775
Q ss_pred CCCCC---cceeeeeceeeCCC
Q 046265 621 PDSSN---WSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~---~~~~~gt~~Y~APE 639 (639)
..... .....+|+.|+|||
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE 224 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPE 224 (325)
T ss_dssp ----CCEECC---CCGGGSCHH
T ss_pred cCccceeeccCCCCcccccCHh
Confidence 43222 12245678899998
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=252.91 Aligned_cols=169 Identities=27% Similarity=0.375 Sum_probs=143.4
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|+..+.||+|+||.||+|.. .+++.||||.+..... ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 35788889999999999999965 4789999999875432 223456889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999999987543 478899999999999999999998 9999999999999999999999999999865322
Q ss_pred C--CCcceeeeeceeeCCC
Q 046265 623 S--SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~--~~~~~~~gt~~Y~APE 639 (639)
. ......+||+.|+|||
T Consensus 159 ~~~~~~~~~~gt~~y~aPE 177 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPE 177 (323)
T ss_dssp TEECCBCSCCSCGGGSCHH
T ss_pred CcccccCCCccCcCccCcH
Confidence 1 2234568999999998
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-29 Score=267.99 Aligned_cols=170 Identities=22% Similarity=0.241 Sum_probs=136.6
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCC-CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.++|+..+.||+|+||.||+|. ..+++.||||.+.... ........+.+|+.++++++||||++++++|...+..|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 4678889999999999999995 4578999999987431 1122345678899999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH-DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+|+...
T Consensus 227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999997643 47889999999999999999998 6 89999999999999999999999999998755
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
.........+||+.|||||
T Consensus 301 ~~~~~~~~~~gt~~y~aPE 319 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPE 319 (446)
T ss_dssp C-----CCSSSCGGGCCHH
T ss_pred CCCcccccccCCccccCHh
Confidence 4444455678999999998
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=264.34 Aligned_cols=169 Identities=22% Similarity=0.317 Sum_probs=132.8
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC-----Cc
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP-----RQ 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 537 (639)
.++|+..+.||+|+||.||+|.. .+++.||||++..........+.+.+|+.++++++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36788899999999999999954 5789999999976555555667889999999999999999999999543 46
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.|+||||+ +|+|.+++.... .+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|||+|+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 578999887643 478899999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCC---------------------------CCcceeeeeceeeCCC
Q 046265 618 FLKPDS---------------------------SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~---------------------------~~~~~~~gt~~Y~APE 639 (639)
.+.... ......+||++|||||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 253 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPE 253 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHH
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChH
Confidence 764221 1234468999999998
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=249.76 Aligned_cols=170 Identities=21% Similarity=0.349 Sum_probs=145.6
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC--ceeEE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR--QSFLL 541 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv 541 (639)
++|...+.||+|+||.||+|... +++.||||++..... ....+.+.+|++++++++||||+++++++...+ ..|+|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 56778899999999999999654 589999999875331 223466789999999999999999999998765 67999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee----CCCCceEEccccccc
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL----GLDYDAHVSDFGISK 617 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill----~~~~~~kl~DfGla~ 617 (639)
|||+++|+|.+++........+++..+..++.|++.|++|||.. +|+||||||+||++ +.++.+||+|||+|+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999998765544589999999999999999999999 99999999999999 778889999999998
Q ss_pred cCCCCCCCcceeeeeceeeCCC
Q 046265 618 FLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~~~~~~gt~~Y~APE 639 (639)
...... .....+||+.|+|||
T Consensus 165 ~~~~~~-~~~~~~gt~~y~aPE 185 (319)
T 4euu_A 165 ELEDDE-QFVSLYGTEEYLHPD 185 (319)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHH
T ss_pred ecCCCC-ceeecccCCCccCHH
Confidence 775433 234567999999998
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=253.90 Aligned_cols=167 Identities=22% Similarity=0.347 Sum_probs=143.6
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.+|...+.||+|+||.||+|.. .+++.||||.+..... .......+.+|+.+++.++||||+++++++..++..|+||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5678889999999999999964 6789999999864211 1122356889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+ +|++.+++...+ .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 788988886543 478899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
......+||+.|+|||
T Consensus 162 -~~~~~~~gt~~y~aPE 177 (336)
T 3h4j_B 162 -NFLKTSCGSPNYAAPE 177 (336)
T ss_dssp -BTTCCCTTSTTTSCGG
T ss_pred -cccccccCCcCcCCHH
Confidence 2334568999999998
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=250.92 Aligned_cols=168 Identities=30% Similarity=0.422 Sum_probs=141.8
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc----ee
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ----SF 539 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----~~ 539 (639)
.++|+..+.||+|+||.||+|+.. ++.||||++... ......+.+|+.++++++|||||++++++..... .|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 356788899999999999999876 689999998642 2334456779999999999999999999987543 69
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhC-------CCCCeEeecCCCCCeeeCCCCceEEcc
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHD-------YFPPIVHRDISSKNVLLGLDYDAHVSD 612 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-------~~~~iiHrdlk~~Nill~~~~~~kl~D 612 (639)
+||||+++|+|.++++.. .++|..+..++.|+++|++|||.. +.++|+||||||+||+++.++.+||+|
T Consensus 99 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 999999999999999753 388999999999999999999976 234899999999999999999999999
Q ss_pred ccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 613 FGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 613 fGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
||+|+.+..... .....+||+.|+|||
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE 203 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPE 203 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHH
T ss_pred CCcccccccccCccccccCccCccccCHh
Confidence 999987654322 233468999999998
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-27 Score=252.80 Aligned_cols=246 Identities=22% Similarity=0.186 Sum_probs=118.6
Q ss_pred CCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCC
Q 046265 32 LKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPN 111 (639)
Q Consensus 32 L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~ 111 (639)
.+.++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L------- 114 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL------- 114 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSC-------
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccC-------
Confidence 445555555554 4444443 455555555555554444555555555555555555555444555444422
Q ss_pred CCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCc-CCccCCccCcCC
Q 046265 112 SLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNL-LNGVLPPSISNL 190 (639)
Q Consensus 112 ~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l 190 (639)
++|+|++|++++..+..|..+++|++|+|++|.++...+..|..+++|+.|++++|. +....+..|.++
T Consensus 115 ----------~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l 184 (440)
T 3zyj_A 115 ----------NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL 184 (440)
T ss_dssp ----------CEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTC
T ss_pred ----------CEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcc
Confidence 355555555554444455555555555555555554444455555555555555532 222222233333
Q ss_pred CCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCc
Q 046265 191 SNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN 270 (639)
Q Consensus 191 ~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 270 (639)
++|+ .|++++|++. .+| .+..+++|+.|+|++|.+++..+..|..+++|+.|++++|+
T Consensus 185 ~~L~--------------------~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~ 242 (440)
T 3zyj_A 185 SNLR--------------------YLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ 242 (440)
T ss_dssp SSCC--------------------EEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred cccC--------------------eecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCc
Confidence 3333 3333333332 122 23344444444444444444444444444445544433333
Q ss_pred ccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccC
Q 046265 271 FYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKV 330 (639)
Q Consensus 271 l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l 330 (639)
+ ++..|..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+
T Consensus 243 l-----------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~ 291 (440)
T 3zyj_A 243 I-----------QVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291 (440)
T ss_dssp C-----------CEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCE
T ss_pred e-----------eEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCc
Confidence 2 223334444445555555555555444444444555555555555544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=243.67 Aligned_cols=167 Identities=21% Similarity=0.369 Sum_probs=145.1
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
++|+..+.||+|+||.||+|...+++.||||++..... ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 56778899999999999999988889999999985432 346789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC-
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS- 623 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~- 623 (639)
+++|+|.+++.... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 87 MEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp CTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 99999999997644 2578899999999999999999998 99999999999999999999999999998764321
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......||+.|+|||
T Consensus 162 ~~~~~~~~~~~y~aPE 177 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPE 177 (269)
T ss_dssp HSTTSTTCCGGGCCHH
T ss_pred ccccCcccccccCCHH
Confidence 1222345788999998
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-29 Score=259.80 Aligned_cols=163 Identities=17% Similarity=0.142 Sum_probs=134.0
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCC------ChhhHHHHHHHHHHHhccc---------cCceeee
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHP------DMVVQQAFSNEIKALTELR---------HRNVVKF 528 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------H~niv~l 528 (639)
.++|+..+.||+|+||+||+|+. +|+.||||++..... .....+.+.+|+.++++++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35677889999999999999987 679999999986532 1223367889999998886 7777777
Q ss_pred EEEEE-----------------c-------------CCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHH
Q 046265 529 YGFSF-----------------H-------------PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANT 578 (639)
Q Consensus 529 ~~~~~-----------------~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~ 578 (639)
.+.+. + .+..|+||||+++|++.+.+.. ..+++..+..++.|++.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 66543 2 6789999999999976666643 246889999999999999
Q ss_pred HHHHH-hCCCCCeEeecCCCCCeeeCCCC--------------------ceEEccccccccCCCCCCCcceeeeeceeeC
Q 046265 579 LSYMH-HDYFPPIVHRDISSKNVLLGLDY--------------------DAHVSDFGISKFLKPDSSNWSEFVGTFGYVA 637 (639)
Q Consensus 579 l~~lH-~~~~~~iiHrdlk~~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~A 637 (639)
|+||| .. +|+||||||+|||++.++ .+||+|||+|+.... ...+||+.|||
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTC
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEEEeecccC
Confidence 99999 78 999999999999999887 899999999987642 24589999999
Q ss_pred CC
Q 046265 638 PI 639 (639)
Q Consensus 638 PE 639 (639)
||
T Consensus 246 PE 247 (336)
T 2vuw_A 246 ED 247 (336)
T ss_dssp SG
T ss_pred hh
Confidence 98
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=7.9e-28 Score=252.37 Aligned_cols=168 Identities=21% Similarity=0.301 Sum_probs=145.7
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.+.|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 45788899999999999999955 578999999987543 334567899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC--CCceEEccccccccCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL--DYDAHVSDFGISKFLK 620 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~--~~~~kl~DfGla~~~~ 620 (639)
||+++|+|.+++.... ..+++..+..++.|++.||+|||.. +|+||||||+||+++. .+.+||+|||+|+.+.
T Consensus 128 E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 128 EFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp ECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 9999999999987543 2478899999999999999999998 9999999999999974 4789999999998875
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
.. ......+||+.|+|||
T Consensus 203 ~~-~~~~~~~gt~~y~aPE 220 (387)
T 1kob_A 203 PD-EIVKVTTATAEFAAPE 220 (387)
T ss_dssp TT-SCEEEECSSGGGCCHH
T ss_pred CC-cceeeeccCCCccCch
Confidence 43 2334568999999998
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-27 Score=240.24 Aligned_cols=246 Identities=23% Similarity=0.254 Sum_probs=156.5
Q ss_pred CCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccc--cCccccCCCCCCcccC
Q 046265 32 LKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGW--LPSSFGNLNNLAIGSM 109 (639)
Q Consensus 32 L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~~~l 109 (639)
-+.++.+++.++ .+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|+++.. .|..+..+++
T Consensus 9 ~~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~------ 79 (306)
T 2z66_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS------ 79 (306)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSC------
T ss_pred CCEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccc------
Confidence 357888888887 5676554 6888888888888843333478888888888888887732 2444444442
Q ss_pred CCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCC-ccccCCCcccEEEcccCcCCccCCccCc
Q 046265 110 PNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIP-PILGKVQSLLSLGFDLNLLNGVLPPSIS 188 (639)
Q Consensus 110 p~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 188 (639)
| ++|++++|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+.+..|..+.
T Consensus 80 ---------L--~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 147 (306)
T 2z66_A 80 ---------L--KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 147 (306)
T ss_dssp ---------C--CEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTT
T ss_pred ---------c--CEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcc
Confidence 2 47778877776 456667777777777777777765444 4566666666666666666555444333
Q ss_pred CCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccC-cchhhhhcCCCccEEecc
Q 046265 189 NLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTG-NIYEVFGIYPNLTFLDLS 267 (639)
Q Consensus 189 ~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls 267 (639)
.+++|++|++++|.+++ ..|..+..+++|++|+++
T Consensus 148 --------------------------------------------~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls 183 (306)
T 2z66_A 148 --------------------------------------------GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183 (306)
T ss_dssp --------------------------------------------TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECT
T ss_pred --------------------------------------------cCcCCCEEECCCCccccccchhHHhhCcCCCEEECC
Confidence 33344444444444433 233344444555555544
Q ss_pred CCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCC-CCCE
Q 046265 268 QNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSIS-DLEY 346 (639)
Q Consensus 268 ~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~ 346 (639)
+|.+ ++..|..+..+++|+.|++++|.+.+..+..+..+++|+.|++++|++.+..|..+..++ +|+.
T Consensus 184 ~n~l-----------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~ 252 (306)
T 2z66_A 184 QCQL-----------EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 252 (306)
T ss_dssp TSCC-----------CEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCE
T ss_pred CCCc-----------CCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCE
Confidence 4333 233345555666666666666666655555667777777777777777777777777774 7888
Q ss_pred EeCCCCC
Q 046265 347 LDLSTNY 353 (639)
Q Consensus 347 L~Ls~N~ 353 (639)
|++++|+
T Consensus 253 L~L~~N~ 259 (306)
T 2z66_A 253 LNLTQND 259 (306)
T ss_dssp EECTTCC
T ss_pred EEccCCC
Confidence 8888754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=246.23 Aligned_cols=159 Identities=26% Similarity=0.343 Sum_probs=124.8
Q ss_pred cceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCceeEEecccCC
Q 046265 470 KYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
.+.||+|+||.||+|.. .+++.||||.+.. .....+.+|+.++.+++ ||||+++++++.+++..|+||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG-----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh-----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 47899999999999965 5689999999864 23456788999999997 99999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC---ceEEccccccccCCCCCC
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY---DAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~---~~kl~DfGla~~~~~~~~ 624 (639)
|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++ .+||+|||+++.......
T Consensus 91 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 91 GELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp CBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 99999998653 478899999999999999999998 999999999999997665 899999999987665544
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
.....+||+.|+|||
T Consensus 165 ~~~~~~~t~~y~aPE 179 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPE 179 (325)
T ss_dssp ---------------
T ss_pred cccccCCCcCccCHH
Confidence 455678999999998
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-28 Score=259.07 Aligned_cols=169 Identities=22% Similarity=0.344 Sum_probs=143.1
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC-----Cc
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP-----RQ 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 537 (639)
.++|...+.||+|+||.||+|. ..+++.||||++..........+.+.+|+.++++++|||||++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4678888999999999999995 45688999999986555555667889999999999999999999999876 56
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.|+||||++ |+|.+++.... .+++..+..++.|+++||+|||.. +|+||||||+||+++.++.+||+|||+|+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999996 69999997643 478899999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCC----------------------CcceeeeeceeeCCC
Q 046265 618 FLKPDSS----------------------NWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~----------------------~~~~~~gt~~Y~APE 639 (639)
....... .....+||++|+|||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 221 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPE 221 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHH
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHH
Confidence 7643221 135578999999998
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=250.50 Aligned_cols=171 Identities=20% Similarity=0.330 Sum_probs=147.2
Q ss_pred HHhccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCCh------hhHHHHHHHHHHHhccccCceeeeEEEEEc
Q 046265 462 RATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDM------VVQQAFSNEIKALTELRHRNVVKFYGFSFH 534 (639)
Q Consensus 462 ~~~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 534 (639)
...++|+..+.||+|+||.||+|. ..+++.||||.+....... ...+.+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 346788999999999999999996 5678999999998653211 123456789999999999999999999999
Q ss_pred CCceeEEecccCCC-ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 046265 535 PRQSFLLYEYLGRG-SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDF 613 (639)
Q Consensus 535 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~Df 613 (639)
.+..++||||+.+| +|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 99999999999777 9999997654 478899999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCcceeeeeceeeCCC
Q 046265 614 GISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 614 Gla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|+++.+.... .....+||+.|+|||
T Consensus 175 g~a~~~~~~~-~~~~~~gt~~y~aPE 199 (335)
T 3dls_A 175 GSAAYLERGK-LFYTFCGTIEYCAPE 199 (335)
T ss_dssp TTCEECCTTC-CBCEECSCGGGCCHH
T ss_pred ccceECCCCC-ceeccCCCccccChh
Confidence 9998775432 334578999999998
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=253.35 Aligned_cols=173 Identities=21% Similarity=0.322 Sum_probs=145.0
Q ss_pred HhccCCCcceeccCCCceEEEEE------cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcC
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAE------LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHP 535 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 535 (639)
..++|+..+.||+|+||.||+|+ ..+++.||||++.... .....+.+.+|++++.++ +|||||+++++|.+.
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 46788889999999999999996 2356889999997543 334456789999999999 799999999999876
Q ss_pred Cc-eeEEecccCCCChhHHhhcCCC-------------------------------------------------------
Q 046265 536 RQ-SFLLYEYLGRGSLAIILSNDAA------------------------------------------------------- 559 (639)
Q Consensus 536 ~~-~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 559 (639)
+. .++||||+++|+|.++++....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 54 8999999999999999976432
Q ss_pred --------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC--Cccee
Q 046265 560 --------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS--NWSEF 629 (639)
Q Consensus 560 --------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~--~~~~~ 629 (639)
...+++..+..++.|+++||+|||.. +|+||||||+||+++.++.+||+|||+++.+..... .....
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 11288999999999999999999999 999999999999999999999999999987643322 23346
Q ss_pred eeeceeeCCC
Q 046265 630 VGTFGYVAPI 639 (639)
Q Consensus 630 ~gt~~Y~APE 639 (639)
.||+.|||||
T Consensus 256 ~~t~~y~aPE 265 (359)
T 3vhe_A 256 RLPLKWMAPE 265 (359)
T ss_dssp EECGGGCCHH
T ss_pred CCCceeEChh
Confidence 7899999998
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-28 Score=252.31 Aligned_cols=166 Identities=28% Similarity=0.344 Sum_probs=135.1
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|+..+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+.++++++|||||++++++..++..|+||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 356788899999999999999654 789999999975432 2356789999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc--eEEccccccccCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD--AHVSDFGISKFLK 620 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~--~kl~DfGla~~~~ 620 (639)
||+++|+|.+++...+ .+++..+..++.|++.|++|||.. +|+||||||+||+++.++. +||+|||+|+...
T Consensus 96 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 96 EYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999999987643 478899999999999999999998 9999999999999987765 9999999998543
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
.. ......+||+.|+|||
T Consensus 170 ~~-~~~~~~~gt~~y~aPE 187 (361)
T 3uc3_A 170 LH-SQPKSTVGTPAYIAPE 187 (361)
T ss_dssp ------------CTTSCHH
T ss_pred cc-CCCCCCcCCCCcCChh
Confidence 22 2234568999999998
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=261.01 Aligned_cols=168 Identities=23% Similarity=0.386 Sum_probs=145.9
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.+|...+.||+|+||.||+|.. .+|+.||||.+..... .....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5677788999999999999965 4789999999874321 1123457889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++...+ .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999997643 478899999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
......+||+.|+|||
T Consensus 170 -~~~~~~~gt~~y~aPE 185 (476)
T 2y94_A 170 -EFLRTSCGSPNYAAPE 185 (476)
T ss_dssp -CCBCCCCSCSTTCCHH
T ss_pred -ccccccCCCcCeEChh
Confidence 2334578999999998
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=250.61 Aligned_cols=173 Identities=24% Similarity=0.415 Sum_probs=146.4
Q ss_pred HhccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR 536 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 536 (639)
..++|+..+.||+|+||.||+|+.. +++.||||.++... .....+.+.+|+.++++++||||+++++++..++
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 4678888999999999999999764 34889999997543 3445677899999999999999999999999999
Q ss_pred ceeEEecccCCCChhHHhhcCCC---------------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAA---------------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDI 595 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdl 595 (639)
..|+||||+++|+|.+++..... ...+++..+..++.|+++|++|||.. +|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 99999999999999999975321 14588999999999999999999998 9999999
Q ss_pred CCCCeeeCCCCceEEccccccccCCCCC--CCcceeeeeceeeCCC
Q 046265 596 SSKNVLLGLDYDAHVSDFGISKFLKPDS--SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 596 k~~Nill~~~~~~kl~DfGla~~~~~~~--~~~~~~~gt~~Y~APE 639 (639)
||+||+++.++.+||+|||+++...... .......||+.|+|||
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 246 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 246 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChh
Confidence 9999999999999999999998654321 1223457899999998
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=252.42 Aligned_cols=162 Identities=22% Similarity=0.309 Sum_probs=135.7
Q ss_pred cceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCC
Q 046265 470 KYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRG 548 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 548 (639)
.+.||+|+||.||+|.. .+|+.||||.+.... ....+.+.+|+.++++++|||||++++++.+.+..|+||||+++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 56899999999999964 578999999997643 345677899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee--CCCCceEEccccccccCCCCCCCc
Q 046265 549 SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL--GLDYDAHVSDFGISKFLKPDSSNW 626 (639)
Q Consensus 549 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill--~~~~~~kl~DfGla~~~~~~~~~~ 626 (639)
+|.+++.... ..+++..+..++.|+++||+|||.. +|+||||||+||++ +.++.+||+|||+++.+.... ..
T Consensus 172 ~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~ 245 (373)
T 2x4f_A 172 ELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KL 245 (373)
T ss_dssp EEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BC
T ss_pred cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-cc
Confidence 9998886543 2478899999999999999999998 99999999999999 567899999999998775432 23
Q ss_pred ceeeeeceeeCCC
Q 046265 627 SEFVGTFGYVAPI 639 (639)
Q Consensus 627 ~~~~gt~~Y~APE 639 (639)
...+||+.|+|||
T Consensus 246 ~~~~gt~~y~aPE 258 (373)
T 2x4f_A 246 KVNFGTPEFLAPE 258 (373)
T ss_dssp CCCCSSCTTCCHH
T ss_pred ccccCCCcEeChh
Confidence 3457999999998
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-28 Score=254.80 Aligned_cols=172 Identities=16% Similarity=0.232 Sum_probs=147.5
Q ss_pred hccCCCcceeccC--CCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 464 TNNFDAKYCIGTA--GQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 464 ~~~f~~~~~ig~g--~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
..+|+..+.||+| +||.||+|+.. +++.||||++..........+.+.+|+.++++++|||||++++++.+++..|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3567888999999 99999999654 78999999998655455566778899999999999999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
|||||++|+|.+++..... ..+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 9999999999999976432 3478899999999999999999998 99999999999999999999999999886542
Q ss_pred CCC-------CCcceeeeeceeeCCC
Q 046265 621 PDS-------SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~-------~~~~~~~gt~~Y~APE 639 (639)
... ......+||+.|+|||
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE 205 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPE 205 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHH
T ss_pred cccccccccccccccccccccccCHH
Confidence 211 1122347999999998
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-28 Score=254.21 Aligned_cols=169 Identities=19% Similarity=0.304 Sum_probs=143.4
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|...+.||+|+||.||+|... +++.||||.++... .....+.|.+|+.++++++|||||+++++|..++..|+|||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 56777889999999999999765 78999999987542 23345578899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++|+|.++++..+ ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 999999999997543 2478899999999999999999998 99999999999999999999999999998654321
Q ss_pred C--CcceeeeeceeeCCC
Q 046265 624 S--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~--~~~~~~gt~~Y~APE 639 (639)
. ......+++.|+|||
T Consensus 268 ~~~~~~~~~~~~~y~aPE 285 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPE 285 (377)
T ss_dssp EECCSSCCEEEGGGSCHH
T ss_pred eeecCCCCCCCcCcCCHh
Confidence 1 111234678899998
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-28 Score=248.57 Aligned_cols=170 Identities=25% Similarity=0.387 Sum_probs=142.9
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|+..+.||+|+||.||+|.. .+++.||||++..........+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 35678889999999999999965 45899999999776555556677889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||++++++.++..... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999998876543 478899999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
.......+||+.|+|||
T Consensus 178 ~~~~~~~~~t~~y~aPE 194 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPE 194 (331)
T ss_dssp ------CCCCCTTCCHH
T ss_pred ccccCCCcCCccccCcc
Confidence 44445568999999998
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.95 E-value=8.7e-28 Score=248.23 Aligned_cols=165 Identities=22% Similarity=0.303 Sum_probs=141.2
Q ss_pred HhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeE
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 540 (639)
..++|+..+.||+|+||.||+|.. .+++.||||.+...... ..+|++++.++ +||||+++++++.+++..|+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 356788899999999999999965 46899999999764322 34688888887 79999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC----CceEEcccccc
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD----YDAHVSDFGIS 616 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~----~~~kl~DfGla 616 (639)
||||+++|+|.+++...+ .+++..+..++.|++.|++|||.. +|+||||||+||++.++ +.+||+|||++
T Consensus 94 v~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp EECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 999999999999997653 478899999999999999999999 99999999999998433 35999999999
Q ss_pred ccCCCCCCCcceeeeeceeeCCC
Q 046265 617 KFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+............+||+.|+|||
T Consensus 168 ~~~~~~~~~~~~~~gt~~y~aPE 190 (342)
T 2qr7_A 168 KQLRAENGLLMTPCYTANFVAPE 190 (342)
T ss_dssp EECBCTTCCBCCSSCCSSCCCHH
T ss_pred ccCcCCCCceeccCCCccccCHH
Confidence 97755444445678999999998
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-28 Score=240.28 Aligned_cols=168 Identities=21% Similarity=0.333 Sum_probs=145.4
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.++|+..+.||+|+||.||+|+.+++..||||.+..... ..+.+.+|+.++.+++||||+++++++..++..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 356788899999999999999988888999999975432 34568999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++|+|.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 84 YISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred ccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999997643 2478899999999999999999998 99999999999999999999999999998765432
Q ss_pred C-CcceeeeeceeeCCC
Q 046265 624 S-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~-~~~~~~gt~~Y~APE 639 (639)
. ......||+.|+|||
T Consensus 159 ~~~~~~~~~~~~y~aPE 175 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPE 175 (268)
T ss_dssp EEECCSCCCCGGGCCHH
T ss_pred hhcccCCCcCcccCCHH
Confidence 1 122345677899998
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=249.35 Aligned_cols=170 Identities=22% Similarity=0.393 Sum_probs=137.5
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc----
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ---- 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~---- 537 (639)
.++|+..+.||+|+||.||+|+ ..+++.||||.+..... .......+.+|+.++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 3568888999999999999996 46789999999986432 33445678999999999999999999999886654
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.|+||||+++|+|.++++..+ .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 399999999999999997653 478899999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCC---CcceeeeeceeeCCC
Q 046265 618 FLKPDSS---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~---~~~~~~gt~~Y~APE 639 (639)
.+..... .....+||+.|+|||
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE 189 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPE 189 (311)
T ss_dssp -----------------CCTTCCHH
T ss_pred cccccccccccccccCcCcccCCHH
Confidence 7643322 223467999999998
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=251.52 Aligned_cols=172 Identities=20% Similarity=0.289 Sum_probs=146.0
Q ss_pred hccCCCcceeccCCCceEEEEEc--------CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEc
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL--------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFH 534 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 534 (639)
.++|...+.||+|+||.||+|+. ..++.||||++.... .....+.+.+|+++++++ +|||||+++++|..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 35677889999999999999964 233679999997643 334457789999999999 89999999999999
Q ss_pred CCceeEEecccCCCChhHHhhcCCC-------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCee
Q 046265 535 PRQSFLLYEYLGRGSLAIILSNDAA-------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVL 601 (639)
Q Consensus 535 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil 601 (639)
++..|+||||+++|+|.+++..... ...+++..+..++.|++.||+|||.. +|+||||||+||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 9999999999999999999976432 23589999999999999999999998 9999999999999
Q ss_pred eCCCCceEEccccccccCCCCC--CCcceeeeeceeeCCC
Q 046265 602 LGLDYDAHVSDFGISKFLKPDS--SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 602 l~~~~~~kl~DfGla~~~~~~~--~~~~~~~gt~~Y~APE 639 (639)
++.++.+||+|||+|+...... .......||+.|+|||
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE 263 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 263 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHH
Confidence 9999999999999998765432 1223456889999998
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.8e-28 Score=252.86 Aligned_cols=169 Identities=24% Similarity=0.395 Sum_probs=134.3
Q ss_pred HhccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCC--ce
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPR--QS 538 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~ 538 (639)
..++|+..+.||+|+||.||+|. ..+++.||||++..........+.+.+|+.++.++. |||||++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 45788899999999999999995 567899999999765545556677889999999997 999999999998654 68
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
|+|||||+ |+|.+++... .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+|+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 6898888753 477888999999999999999999 999999999999999999999999999986
Q ss_pred CCCC---------------------CCCcceeeeeceeeCCC
Q 046265 619 LKPD---------------------SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~---------------------~~~~~~~~gt~~Y~APE 639 (639)
+... .......+||++|+|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 200 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPE 200 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHH
Confidence 5321 11123468999999998
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-26 Score=247.85 Aligned_cols=243 Identities=20% Similarity=0.161 Sum_probs=109.3
Q ss_pred CEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCC
Q 046265 57 KHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIP 136 (639)
Q Consensus 57 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p 136 (639)
..++.+++.++ .+|..+. ++|++|+|++|++++..|..|.++++| ++|+|++|++++..|
T Consensus 57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L-----------------~~L~Ls~n~i~~~~~ 116 (452)
T 3zyi_A 57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHL-----------------EVLQLGRNSIRQIEV 116 (452)
T ss_dssp CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTC-----------------CEEECCSSCCCEECT
T ss_pred cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCC-----------------CEEECCCCccCCcCh
Confidence 34444444444 3444333 345555555555554444444444322 245555555544444
Q ss_pred ccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEE
Q 046265 137 HFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIEL 216 (639)
Q Consensus 137 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L 216 (639)
..|.++++|++|+|++|++++..+..|..+++|++|++++|.++...+..|..+++|+.|++
T Consensus 117 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l------------------ 178 (452)
T 3zyi_A 117 GAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDL------------------ 178 (452)
T ss_dssp TTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC------------------
T ss_pred hhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeC------------------
Confidence 44555555555555555554433344444555555555555544333333333333332222
Q ss_pred EcCCcccCCCCC-ccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCC
Q 046265 217 EIDNKQLFGQIP-KSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQ 295 (639)
Q Consensus 217 ~l~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~ 295 (639)
++|+..+.+| ..|.++++|++|++++|.+++.. .+..+++|+.|++++|.+ ++..|..+..+++
T Consensus 179 --~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~l-----------~~~~~~~~~~l~~ 243 (452)
T 3zyi_A 179 --GELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMP--NLTPLVGLEELEMSGNHF-----------PEIRPGSFHGLSS 243 (452)
T ss_dssp --CCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCC--CCTTCTTCCEEECTTSCC-----------SEECGGGGTTCTT
T ss_pred --CCCCCccccChhhccCCCCCCEEECCCCcccccc--cccccccccEEECcCCcC-----------cccCcccccCccC
Confidence 2211111222 23444455555555555554331 234444455555333332 2333444444555
Q ss_pred CCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCC
Q 046265 296 LHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTN 352 (639)
Q Consensus 296 L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 352 (639)
|+.|++++|++.+..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|
T Consensus 244 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 300 (452)
T 3zyi_A 244 LKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300 (452)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSS
T ss_pred CCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCC
Confidence 555555555554444444555555555555555554444444444555555555543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.5e-28 Score=248.93 Aligned_cols=167 Identities=23% Similarity=0.381 Sum_probs=141.9
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcccc--CceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH--RNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~ 542 (639)
+.|+..+.||+|+||.||+|..++++.||||++..........+.+.+|+.++.+++| |||+++++++..++..|+||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 4577889999999999999988889999999998765555566788999999999987 99999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
| +.+|+|.+++.... .+++..+..++.|++.||+|||.. +|+||||||+||+++ ++.+||+|||+++.+...
T Consensus 89 e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp C-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred e-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9 56889999998653 477899999999999999999998 999999999999997 678999999999876543
Q ss_pred CC--CcceeeeeceeeCCC
Q 046265 623 SS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~--~~~~~~gt~~Y~APE 639 (639)
.. .....+||+.|+|||
T Consensus 161 ~~~~~~~~~~gt~~y~aPE 179 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPE 179 (343)
T ss_dssp ---------CCCCSSCCHH
T ss_pred cccccCCCCcCCcCcCCHH
Confidence 22 223568999999998
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=249.97 Aligned_cols=171 Identities=23% Similarity=0.370 Sum_probs=135.3
Q ss_pred HHhccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 462 RATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 462 ~~~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
...++|+..+.||+|+||.||+|. ..+++.||||++..........+.+.+|+.++++++||||+++++++..++..|+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 345788899999999999999995 5578999999998655444445667899999999999999999999999999999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee-----CCCCceEEccccc
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL-----GLDYDAHVSDFGI 615 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill-----~~~~~~kl~DfGl 615 (639)
||||++ |+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||++ +.++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999997 59999987654 378899999999999999999998 99999999999999 4555699999999
Q ss_pred cccCCCCCCCcceeeeeceeeCCC
Q 046265 616 SKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|+............+||+.|+|||
T Consensus 184 a~~~~~~~~~~~~~~~t~~y~aPE 207 (329)
T 3gbz_A 184 ARAFGIPIRQFTHEIITLWYRPPE 207 (329)
T ss_dssp HHHHC-----------CCTTCCHH
T ss_pred ccccCCcccccCCCcCCccccCHH
Confidence 987654444445568899999998
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-28 Score=252.54 Aligned_cols=171 Identities=22% Similarity=0.322 Sum_probs=143.0
Q ss_pred ccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
++|+..+.||+|+||.||+|... +++.||||+++... .......+.+|+.++++++|||||++++++...+..
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 56778899999999999999743 45789999997533 344556788999999999999999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCC----CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC---ceEEc
Q 046265 539 FLLYEYLGRGSLAIILSNDAA----IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY---DAHVS 611 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~---~~kl~ 611 (639)
|+||||+++|+|.+++..... ...+++..+..++.|+++||+|||.. +|+||||||+||+++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999975432 23588999999999999999999999 999999999999999555 59999
Q ss_pred cccccccCCCC--CCCcceeeeeceeeCCC
Q 046265 612 DFGISKFLKPD--SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 612 DfGla~~~~~~--~~~~~~~~gt~~Y~APE 639 (639)
|||+|+.+... ........||+.|||||
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE 256 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPE 256 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHH
T ss_pred CCccccccccccccccCCCcCCcccEECHH
Confidence 99999854221 12223456899999998
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-28 Score=241.26 Aligned_cols=171 Identities=25% Similarity=0.407 Sum_probs=133.8
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.++|+..+.||+|+||.||+|.. .+++.||||.+..... .....+.+.+|+.++++++||||+++++++...+..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46788889999999999999965 6789999999864221 112246788999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++++|.+++.... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999997643 3578899999999999999999998 999999999999999999999999999987654
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
.........||+.|+|||
T Consensus 165 ~~~~~~~~~~~~~y~aPE 182 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPE 182 (278)
T ss_dssp ------------------
T ss_pred CCCcceeccCCCCcCCcc
Confidence 333334568999999998
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-28 Score=271.45 Aligned_cols=171 Identities=20% Similarity=0.226 Sum_probs=146.6
Q ss_pred HhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCcee
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 539 (639)
..++|+..++||+|+||+||+|+. .+++.||||++++... .....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 356788899999999999999965 4678999999874311 112345677899999887 7999999999999999999
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||+++|+|.++++..+ .+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999998654 478899999999999999999999 9999999999999999999999999999975
Q ss_pred CCCCCCcceeeeeceeeCCC
Q 046265 620 KPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~~~~~~gt~~Y~APE 639 (639)
..........+||+.|||||
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE 512 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPE 512 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHH
T ss_pred ccCCcccccccCCCcccCHh
Confidence 44444456689999999998
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=241.37 Aligned_cols=170 Identities=24% Similarity=0.291 Sum_probs=145.8
Q ss_pred HhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeE
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 540 (639)
..++|+..+.||+|+||.||+|... +++.||||.+............+.+|+..+.++ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567888999999999999999654 789999999987655555667788999999998 99999999999999999999
Q ss_pred EecccCCCChhHHhhcCCC-CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC--------------
Q 046265 541 LYEYLGRGSLAIILSNDAA-IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD-------------- 605 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~-------------- 605 (639)
||||+++|+|.+++..... ...+++..+..++.|++.||+|||.. +|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999975421 13578899999999999999999998 99999999999999844
Q ss_pred -----CceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 606 -----YDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 606 -----~~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
..+||+|||.+....... ...||+.|+|||
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE 200 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANE 200 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHH
T ss_pred ccCCceEEEEcccccccccCCcc----ccCCCccccChh
Confidence 479999999998765332 246999999998
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.2e-28 Score=249.43 Aligned_cols=166 Identities=25% Similarity=0.399 Sum_probs=129.0
Q ss_pred HhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
..+.|+..+.||+|+||.||+|... +++.||||.+.... ..+.+.+|+.++++++||||++++++|..++..++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 3567888899999999999999665 57899999997532 245678999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEcccccccc
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL---DYDAHVSDFGISKF 618 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~---~~~~kl~DfGla~~ 618 (639)
|||+++|+|.+++...+ .+++..+..++.|+++|++|||.. +|+||||||+||+++. ++.+||+|||+++.
T Consensus 127 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp ECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999999997643 478899999999999999999998 9999999999999975 88999999999987
Q ss_pred CCCCCCCcceeeeeceeeCCC
Q 046265 619 LKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~~~~~~~gt~~Y~APE 639 (639)
.... ......+||+.|+|||
T Consensus 201 ~~~~-~~~~~~~gt~~y~aPE 220 (349)
T 2w4o_A 201 VEHQ-VLMKTVCGTPGYCAPE 220 (349)
T ss_dssp -------------CGGGSCHH
T ss_pred cCcc-cccccccCCCCccCHH
Confidence 6432 2234568999999998
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-28 Score=241.67 Aligned_cols=168 Identities=23% Similarity=0.355 Sum_probs=142.4
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.++|+..+.||+|+||.||+|+..++..||||++..... ..+.+.+|++++++++||||+++++++...+..|+|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 356778899999999999999998888999999985432 24668999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++|+|.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 100 YMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999997633 2478899999999999999999998 99999999999999999999999999998764321
Q ss_pred -CCcceeeeeceeeCCC
Q 046265 624 -SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 -~~~~~~~gt~~Y~APE 639 (639)
.......||+.|+|||
T Consensus 175 ~~~~~~~~~~~~y~aPE 191 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPE 191 (283)
T ss_dssp HHSTTSTTSCGGGCCHH
T ss_pred cccccCCccCcccCCHH
Confidence 1122345788899998
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=251.95 Aligned_cols=167 Identities=23% Similarity=0.375 Sum_probs=142.7
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc--cCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR--HRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~ 542 (639)
..|+..+.||+|+||.||+|...+++.||||++..........+.+.+|+.++++++ |||||++++++..++..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 457888999999999999998888999999999876555556678999999999997 599999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
| +.+++|.+++.... .+++..+..++.|++.||+|||.. +|+||||||+||+++ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 56889999998654 467788999999999999999998 999999999999995 589999999999876543
Q ss_pred CC--CcceeeeeceeeCCC
Q 046265 623 SS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~--~~~~~~gt~~Y~APE 639 (639)
.. .....+||+.|||||
T Consensus 208 ~~~~~~~~~~gt~~y~aPE 226 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPE 226 (390)
T ss_dssp ------CCSCCCGGGCCHH
T ss_pred CccccCCCCCcCCCccChH
Confidence 22 123568999999998
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=242.51 Aligned_cols=163 Identities=26% Similarity=0.405 Sum_probs=135.6
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhc--cccCceeeeEEEEEcC----Cc
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTE--LRHRNVVKFYGFSFHP----RQ 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~----~~ 537 (639)
.++|+..+.||+|+||.||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++... ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 46788899999999999999987 5789999998642 23445566666655 7999999999997653 45
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeecCCCCCeeeCCCCceE
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH--------HDYFPPIVHRDISSKNVLLGLDYDAH 609 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------~~~~~~iiHrdlk~~Nill~~~~~~k 609 (639)
.|+||||+++|+|.++++.. .+++..+..++.|+++|++||| .. +|+||||||+||+++.++.+|
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred eEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence 89999999999999999643 5888999999999999999999 55 999999999999999999999
Q ss_pred EccccccccCCCCCCC----cceeeeeceeeCCC
Q 046265 610 VSDFGISKFLKPDSSN----WSEFVGTFGYVAPI 639 (639)
Q Consensus 610 l~DfGla~~~~~~~~~----~~~~~gt~~Y~APE 639 (639)
|+|||+|+........ ....+||+.|+|||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 187 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHH
T ss_pred EeeCCCeeecccccccccccccccccccceeChh
Confidence 9999999865433221 22348999999998
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=242.79 Aligned_cols=172 Identities=22% Similarity=0.310 Sum_probs=145.8
Q ss_pred hccCCCcceeccCCCceEEEEEc------CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 537 (639)
..+|...+.||+|+||.||+|.. .+++.||||.+.... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 45677788999999999999964 345789999997543 34455778999999999999999999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCC---------------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCC
Q 046265 538 SFLLYEYLGRGSLAIILSNDAA---------------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDIS 596 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk 596 (639)
.++||||+++|+|.+++..... ...+++..+..++.|+++|++|||.. +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999976432 12478899999999999999999998 99999999
Q ss_pred CCCeeeCCCCceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 597 SKNVLLGLDYDAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 597 ~~Nill~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
|+||+++.++.+||+|||+++....... ......||+.|+|||
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 222 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE 222 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHH
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChh
Confidence 9999999999999999999987644322 123356788999998
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-28 Score=244.67 Aligned_cols=169 Identities=25% Similarity=0.384 Sum_probs=139.1
Q ss_pred hccCCCcceeccCCCceEEEEEc-----CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--C
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-----PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--R 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~ 536 (639)
.++|+..+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 35677889999999999999973 36789999999753 344456789999999999999999999998654 4
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
..++||||+++|+|.+++..... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||++
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred ceEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 58999999999999999976532 478899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCC---CcceeeeeceeeCCC
Q 046265 617 KFLKPDSS---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~---~~~~~~gt~~Y~APE 639 (639)
+....... ......|++.|+|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE 187 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPE 187 (295)
T ss_dssp C-------------CTTCGGGGCCHH
T ss_pred ccccCCcceeeeccCCCCccceeCcH
Confidence 87654322 122345778899998
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=240.83 Aligned_cols=170 Identities=22% Similarity=0.328 Sum_probs=147.9
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCC-CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
..+|...+.||+|+||.||+|... +++.||+|.+.... ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356778899999999999999654 57899999987543 2344567789999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++++|.+++.... .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999887543 478899999999999999999998 999999999999999999999999999987654
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
.........||+.|+|||
T Consensus 168 ~~~~~~~~~~~~~y~aPE 185 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPE 185 (294)
T ss_dssp TTCCBCCCCSCCSSCCHH
T ss_pred CccccccccCCCCcCCcc
Confidence 444445568999999998
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=239.85 Aligned_cols=169 Identities=27% Similarity=0.337 Sum_probs=142.3
Q ss_pred cCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
.|....+||+|+||.||+|. ..+++.||||.+.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 34556699999999999996 4678899999997643 23456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEccccccccCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL-DYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~-~~~~kl~DfGla~~~~~~~ 623 (639)
+++++|.+++.........++..+..++.|++.|++|||.. +|+||||||+||+++. ++.+||+|||+++......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99999999998654444567888999999999999999998 9999999999999987 8999999999998765433
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......||+.|+|||
T Consensus 178 ~~~~~~~~~~~y~aPE 193 (295)
T 2clq_A 178 PCTETFTGTLQYMAPE 193 (295)
T ss_dssp ---CCCCCCGGGCCHH
T ss_pred CcccccCCCccccChh
Confidence 3334567999999998
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=245.71 Aligned_cols=170 Identities=22% Similarity=0.328 Sum_probs=148.5
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCC-CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
..+|...+.||+|+||.||+|... +++.||+|.+.... ......+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467888899999999999999654 57899999987543 2334567789999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++++|.+++.... .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999987543 478899999999999999999998 999999999999999999999999999987754
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
.........||+.|+|||
T Consensus 194 ~~~~~~~~~gt~~y~aPE 211 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPE 211 (335)
T ss_dssp TTCCBCCCCSCCSSCCHH
T ss_pred CcccccccCCCccccCHH
Confidence 444445578999999998
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=239.56 Aligned_cols=169 Identities=22% Similarity=0.368 Sum_probs=146.6
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|+..+.||+|+||.||+|.. .+++.||||.+..........+.+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46788889999999999999964 56899999999765545555677889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc---eEEccccccccC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD---AHVSDFGISKFL 619 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~---~kl~DfGla~~~ 619 (639)
||+++|+|.+.+.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999988887653 478899999999999999999998 9999999999999986655 999999999876
Q ss_pred CCCCCCcceeeeeceeeCCC
Q 046265 620 KPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~~~~~~gt~~Y~APE 639 (639)
... .......||+.|+|||
T Consensus 159 ~~~-~~~~~~~~~~~y~aPE 177 (284)
T 3kk8_A 159 NDS-EAWHGFAGTPGYLSPE 177 (284)
T ss_dssp CSS-CBCCCSCSCGGGCCHH
T ss_pred ccC-ccccCCCCCcCCcCch
Confidence 533 2334568999999998
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.7e-28 Score=253.81 Aligned_cols=170 Identities=21% Similarity=0.349 Sum_probs=145.0
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC--ceeEE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR--QSFLL 541 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv 541 (639)
++|...+.||+|+||.||+|+.. +++.||||.+..... ....+.+.+|++++++++||||+++++++...+ ..|+|
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 56778899999999999999654 589999999875321 223466789999999999999999999998765 67999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee----CCCCceEEccccccc
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL----GLDYDAHVSDFGISK 617 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill----~~~~~~kl~DfGla~ 617 (639)
|||+++|+|.+++........+++..+..++.|++.|++|||.. +|+||||||+||++ +.++.+||+|||+|+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999998765444589999999999999999999999 99999999999999 777889999999998
Q ss_pred cCCCCCCCcceeeeeceeeCCC
Q 046265 618 FLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~~~~~~gt~~Y~APE 639 (639)
...... .....+||+.|+|||
T Consensus 165 ~~~~~~-~~~~~~gt~~y~aPE 185 (396)
T 4eut_A 165 ELEDDE-QFVSLYGTEEYLHPD 185 (396)
T ss_dssp ECCCGG-GSSCSSSCCTTCCHH
T ss_pred EccCCC-ccccccCCccccCHH
Confidence 765432 233467999999998
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=245.67 Aligned_cols=165 Identities=20% Similarity=0.265 Sum_probs=141.9
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.+|+..+.||+|+||.||+|. ..+++.||||.+..... .+.+.+|+.+++++ +||||+++++++...+..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 567888999999999999996 46789999999875432 23478899999999 8999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc-----eEEccccccc
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD-----AHVSDFGISK 617 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~-----~kl~DfGla~ 617 (639)
||+ +++|.+++.... ..+++..+..++.|++.||+|||.. +|+||||||+||+++.++. +||+|||+|+
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 999 999999997542 3588999999999999999999998 9999999999999998887 9999999998
Q ss_pred cCCCCCC-------CcceeeeeceeeCCC
Q 046265 618 FLKPDSS-------NWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~-------~~~~~~gt~~Y~APE 639 (639)
.+..... .....+||+.|+|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 187 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSIN 187 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred eeecCCCCccccccccCCcCCCccccChH
Confidence 7643322 124578999999998
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-27 Score=246.26 Aligned_cols=177 Identities=25% Similarity=0.387 Sum_probs=151.4
Q ss_pred hHHHHHHHhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCC------hhhHHHHHHHHHHHhcc-ccCceee
Q 046265 456 LYEEVIRATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPD------MVVQQAFSNEIKALTEL-RHRNVVK 527 (639)
Q Consensus 456 ~~~~~~~~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l-~H~niv~ 527 (639)
.+.......++|+..+.||+|+||.||+|... +|+.||||.+...... ....+.+.+|+.+++++ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34444556678999999999999999999764 7899999998754321 12245678999999999 7999999
Q ss_pred eEEEEEcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 046265 528 FYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD 607 (639)
Q Consensus 528 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~ 607 (639)
+++++...+..|+||||+++|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 9999999999999999999999999997543 478899999999999999999998 9999999999999999999
Q ss_pred eEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 608 AHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 608 ~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+||+|||++..+.... .....+||+.|+|||
T Consensus 239 ikl~DfG~~~~~~~~~-~~~~~~gt~~y~aPE 269 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE-KLRELCGTPGYLAPE 269 (365)
T ss_dssp EEECCCTTCEECCTTC-CBCCCCSCGGGCCHH
T ss_pred EEEEecCcccccCCCc-ccccCCCCCCccChh
Confidence 9999999998775432 334578999999998
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=247.71 Aligned_cols=166 Identities=27% Similarity=0.408 Sum_probs=142.8
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
...|+..+.||+|+||.||+|+ ..+++.||||++..... .....+.+.+|+.++++++|||||+++++|..++..|+|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 3457788999999999999996 46789999999976432 233446789999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||++ |++.+++.... ..+++..+..++.|+++||+|||.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 67877775432 3578899999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
. ...+||+.|+|||
T Consensus 207 ~----~~~~gt~~y~aPE 220 (348)
T 1u5q_A 207 A----NSFVGTPYWMAPE 220 (348)
T ss_dssp B----CCCCSCGGGCCHH
T ss_pred C----CcccCCcceeCHh
Confidence 2 3467999999998
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=237.44 Aligned_cols=165 Identities=16% Similarity=0.209 Sum_probs=145.1
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--CceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 542 (639)
++|+..+.||+|+||.||+|+.+ ++.||||.+..........+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56788899999999999999875 78899999987665566677899999999999999999999999887 7789999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP--IVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||+++|+|.+++..... ..+++..+..++.|+++|++|||.. + |+||||||+||+++.++.+|++|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999986543 3578999999999999999999987 6 9999999999999999999999998876533
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
. ....||+.|+|||
T Consensus 165 ~-----~~~~~t~~y~aPE 178 (271)
T 3kmu_A 165 S-----PGRMYAPAWVAPE 178 (271)
T ss_dssp C-----TTCBSCGGGSCHH
T ss_pred c-----cCccCCccccChh
Confidence 2 2357899999998
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=243.18 Aligned_cols=169 Identities=21% Similarity=0.310 Sum_probs=146.5
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCCh----hhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDM----VVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
.+.|+..+.||+|+||.||+|.. .+++.||||.+....... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45688889999999999999965 468999999997643221 2357789999999999999999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC----ceEEcccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY----DAHVSDFG 614 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~----~~kl~DfG 614 (639)
|+||||+++++|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999997643 478899999999999999999998 999999999999999887 79999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+++...... ......||+.|+|||
T Consensus 165 ~~~~~~~~~-~~~~~~gt~~y~aPE 188 (321)
T 2a2a_A 165 LAHEIEDGV-EFKNIFGTPEFVAPE 188 (321)
T ss_dssp TCEECCTTC-CCCCCCSCGGGCCHH
T ss_pred cceecCccc-cccccCCCCCccCcc
Confidence 998765432 234567999999998
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.1e-27 Score=235.43 Aligned_cols=255 Identities=22% Similarity=0.195 Sum_probs=185.5
Q ss_pred CCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCC
Q 046265 32 LKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPN 111 (639)
Q Consensus 32 L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~ 111 (639)
-++++.++++++ .+|..+ .++|++|++++|.+++..+..|..+++|++|++++|.+++..|..|.++++|
T Consensus 13 ~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L------- 82 (285)
T 1ozn_A 13 KVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL------- 82 (285)
T ss_dssp SCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC-------
T ss_pred CeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCC-------
Confidence 368899999987 567654 4689999999999987666788999999999999999988778777777633
Q ss_pred CCcccCCCCccEEEccCCc-CcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCC
Q 046265 112 SLSNLTSLSLFHLDLSENQ-LSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNL 190 (639)
Q Consensus 112 ~~~~l~~L~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 190 (639)
++|++++|. ++...|..+..+++|++|++++|.+++..|..+..+++|++|++++|.+++..+..+..+
T Consensus 83 ----------~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 152 (285)
T 1ozn_A 83 ----------EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152 (285)
T ss_dssp ----------CEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred ----------CEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccC
Confidence 588999997 776667888889999999999999988778888888899999998888876655445444
Q ss_pred CCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCc
Q 046265 191 SNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN 270 (639)
Q Consensus 191 ~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 270 (639)
++|+.|++++|++.+..+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|.
T Consensus 153 --------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 212 (285)
T 1ozn_A 153 --------------------GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212 (285)
T ss_dssp --------------------TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred --------------------CCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCc
Confidence 445556666677665555667788888888888888887777777778888888866665
Q ss_pred ccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCc
Q 046265 271 FYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVL 338 (639)
Q Consensus 271 l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 338 (639)
+ ++..+..+..+++|+.|++++|.+....+.. .-...++.+..+.+.+....|..+
T Consensus 213 l-----------~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 213 L-----------SALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp C-----------SCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGG
T ss_pred C-----------CcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHh
Confidence 5 2333445677778888888888776433211 111223334445555555555543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.9e-28 Score=258.35 Aligned_cols=166 Identities=19% Similarity=0.288 Sum_probs=135.0
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC------
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR------ 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 536 (639)
.++|+..+.||+|+||.||+|. ..+++.||||++..........+.+.+|+.+++.++|||||++++++...+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4678888999999999999995 557899999999865444455677889999999999999999999997653
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
..|+||||++++ +.+.+.. .+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999765 5555542 377889999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCcceeeeeceeeCCC
Q 046265 617 KFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+..... ......+||++|+|||
T Consensus 212 ~~~~~~-~~~~~~~gt~~y~aPE 233 (464)
T 3ttj_A 212 RTAGTS-FMMTPYVVTRYYRAPE 233 (464)
T ss_dssp -----C-CCC----CCCTTCCHH
T ss_pred eecCCC-cccCCCcccccccCHH
Confidence 876532 2345578999999998
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=259.95 Aligned_cols=169 Identities=25% Similarity=0.359 Sum_probs=140.6
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.+.|+..+.||+|+||.||+|+. .+++.||||.+............+.+|+.++++++|||||+++++|.+.+..|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45688889999999999999965 47889999999865443444667899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEccccccccC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL---DYDAHVSDFGISKFL 619 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~---~~~~kl~DfGla~~~ 619 (639)
|||++|+|.+.+.... .+++..+..++.|++.|++|||.. +|+||||||+||+++. ++.+||+|||+|+..
T Consensus 116 e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999998887553 477899999999999999999998 9999999999999975 455999999999876
Q ss_pred CCCCCCcceeeeeceeeCCC
Q 046265 620 KPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~~~~~~gt~~Y~APE 639 (639)
... ......+||+.|+|||
T Consensus 190 ~~~-~~~~~~~gt~~y~aPE 208 (494)
T 3lij_A 190 ENQ-KKMKERLGTAYYIAPE 208 (494)
T ss_dssp BTT-BCBCCCCSCTTTCCHH
T ss_pred CCC-ccccccCCCcCeeCHH
Confidence 543 2334568999999998
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-26 Score=245.05 Aligned_cols=244 Identities=22% Similarity=0.196 Sum_probs=118.1
Q ss_pred CCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccC
Q 046265 56 LKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSI 135 (639)
Q Consensus 56 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~ 135 (639)
.+.++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++| ++|+|++|++++..
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L-----------------~~L~Ls~n~i~~i~ 104 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHL-----------------EILQLSRNHIRTIE 104 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSC-----------------CEEECCSSCCCEEC
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCC-----------------CEEECCCCcCCccC
Confidence 344555555554 4554443 345555555555554444444444422 35555555555444
Q ss_pred CccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcE
Q 046265 136 PHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIE 215 (639)
Q Consensus 136 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~ 215 (639)
+..|.++++|++|+|++|++++..+..|..+++|++|++++|.++...+..|..+++|+.|+
T Consensus 105 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~------------------ 166 (440)
T 3zyj_A 105 IGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLD------------------ 166 (440)
T ss_dssp GGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEE------------------
T ss_pred hhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeC------------------
Confidence 45555555555555555555544334455555555555555555544433343333333322
Q ss_pred EEcCCcccCCCC-CccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCC
Q 046265 216 LEIDNKQLFGQI-PKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLY 294 (639)
Q Consensus 216 L~l~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~ 294 (639)
+++|+..+.+ +..|.++++|++|++++|.++... .+..+++|+.|+|++|.+ ++..|..+..++
T Consensus 167 --l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~l-----------~~~~~~~~~~l~ 231 (440)
T 3zyj_A 167 --LGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP--NLTPLIKLDELDLSGNHL-----------SAIRPGSFQGLM 231 (440)
T ss_dssp --CCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC--CCTTCSSCCEEECTTSCC-----------CEECTTTTTTCT
T ss_pred --CCCCCCcceeCcchhhcccccCeecCCCCcCcccc--ccCCCcccCEEECCCCcc-----------CccChhhhccCc
Confidence 2222111222 224445555555555555555322 244455555555443333 233344555555
Q ss_pred CCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCC
Q 046265 295 QLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTN 352 (639)
Q Consensus 295 ~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 352 (639)
+|+.|++++|++.+..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|
T Consensus 232 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 289 (440)
T 3zyj_A 232 HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289 (440)
T ss_dssp TCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSS
T ss_pred cCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCC
Confidence 5555555555555555555555555555555555555444444555555555555554
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=246.27 Aligned_cols=172 Identities=23% Similarity=0.353 Sum_probs=143.2
Q ss_pred hccCCCcceeccCCCceEEEEEc------CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCC
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPR 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 536 (639)
.++|+..+.||+|+||.||+|.. .+++.||||.+.... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 46788889999999999999975 245689999997543 233456789999999999 8999999999999999
Q ss_pred ceeEEecccCCCChhHHhhcCCCC--------------------CCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCC
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAI--------------------DEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDIS 596 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk 596 (639)
..|+||||+++|+|.+++...... ..+++..+..++.|++.||+|||.. +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 999999999999999999764321 2378999999999999999999998 99999999
Q ss_pred CCCeeeCCCCceEEccccccccCCCCCCC--cceeeeeceeeCCC
Q 046265 597 SKNVLLGLDYDAHVSDFGISKFLKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 597 ~~Nill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~Y~APE 639 (639)
|+||+++.++.+||+|||+++........ .....||+.|+|||
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 244 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 244 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHH
Confidence 99999999999999999999876433221 23457889999998
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=248.16 Aligned_cols=172 Identities=25% Similarity=0.356 Sum_probs=139.2
Q ss_pred HHhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCC---hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc
Q 046265 462 RATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPD---MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 462 ~~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 537 (639)
....+|+..+.||+|+||.||+|... +|+.||||++...... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578899999999999999999764 6899999999753321 1123467899999999999999999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.++||||+++ ++.+++.... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 8888886543 2467788899999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCCCcceeeeeceeeCCC
Q 046265 618 FLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~~~~~~gt~~Y~APE 639 (639)
.+..........+||+.|+|||
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE 182 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPE 182 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHH
T ss_pred eccCCcccCCcccccccccCch
Confidence 8754444445578999999998
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=252.58 Aligned_cols=169 Identities=22% Similarity=0.297 Sum_probs=133.9
Q ss_pred HhccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCC------ChhhHHHHHHHHHHHhccccCceeeeEEEEEcC
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHP------DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP 535 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 535 (639)
..++|...+.||+|+||.||+|. ..+++.||||.+..... .......+.+|+.++++++|||||++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 45789999999999999999995 45689999999875321 11122347899999999999999999999864
Q ss_pred CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC---CceEEcc
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD---YDAHVSD 612 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~---~~~kl~D 612 (639)
+..|+||||+++|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.+ +.+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 55799999999999999887543 478899999999999999999998 99999999999999654 4599999
Q ss_pred ccccccCCCCCCCcceeeeeceeeCCC
Q 046265 613 FGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 613 fGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
||+|+..... ......+||+.|||||
T Consensus 286 FG~a~~~~~~-~~~~~~~gt~~y~aPE 311 (419)
T 3i6u_A 286 FGHSKILGET-SLMRTLCGTPTYLAPE 311 (419)
T ss_dssp SSTTTSCC------------CTTCCTT
T ss_pred cccceecCCC-ccccccCCCCCccCce
Confidence 9999876532 2334578999999999
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=240.92 Aligned_cols=171 Identities=25% Similarity=0.365 Sum_probs=140.3
Q ss_pred HhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC---ChhhHHHHHHHHHHHhccc---cCceeeeEEEEEcC
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP---DMVVQQAFSNEIKALTELR---HRNVVKFYGFSFHP 535 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~ 535 (639)
..++|+..+.||+|+||.||+|.. .+++.||||.+..... .......+.+|+.++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 367899999999999999999975 5789999999874321 1122345677888877765 99999999999876
Q ss_pred C-----ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 046265 536 R-----QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV 610 (639)
Q Consensus 536 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl 610 (639)
. ..++||||++ |+|.+++..... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 5 4799999997 699999876543 3488999999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 611 SDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 611 ~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+|||+|+..... ......+||+.|+|||
T Consensus 162 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE 189 (308)
T 3g33_A 162 ADFGLARIYSYQ-MALTPVVVTLWYRAPE 189 (308)
T ss_dssp CSCSCTTTSTTC-CCSGGGGCCCSSCCHH
T ss_pred eeCccccccCCC-cccCCccccccccCch
Confidence 999999876533 2334578999999998
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-28 Score=250.35 Aligned_cols=263 Identities=20% Similarity=0.181 Sum_probs=187.2
Q ss_pred EeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCc
Q 046265 12 VHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLS 91 (639)
Q Consensus 12 ~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 91 (639)
+++.+++...++..+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..| +..+++|++|++++|+++
T Consensus 16 ~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~ 93 (317)
T 3o53_A 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ 93 (317)
T ss_dssp SCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEE
T ss_pred eccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccc
Confidence 455666655555556677789999999999987777788899999999999998885443 888889999999999887
Q ss_pred cccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccE
Q 046265 92 GWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLS 171 (639)
Q Consensus 92 ~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 171 (639)
+..+. + +|++|++++|++++..+. .+++|++|++++|++++..|..++.+++|++
T Consensus 94 ~l~~~-----~-----------------~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 148 (317)
T 3o53_A 94 ELLVG-----P-----------------SIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQY 148 (317)
T ss_dssp EEEEC-----T-----------------TCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEE
T ss_pred cccCC-----C-----------------CcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCE
Confidence 53321 2 235888888888865443 3577888888888888777778888888888
Q ss_pred EEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcc
Q 046265 172 LGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNI 251 (639)
Q Consensus 172 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 251 (639)
|++++|.+++..|..+. ..+++|+.|++++|.+.+. |. ...+++|+.|++++|.+++..
T Consensus 149 L~Ls~N~l~~~~~~~~~-------------------~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~ 207 (317)
T 3o53_A 149 LDLKLNEIDTVNFAELA-------------------ASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMG 207 (317)
T ss_dssp EECTTSCCCEEEGGGGG-------------------GGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEEC
T ss_pred EECCCCCCCcccHHHHh-------------------hccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcch
Confidence 88888888766554432 2344556666666666543 22 224777888888888887654
Q ss_pred hhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCccc-ccCCccccCCCCCCeeeccC-cc
Q 046265 252 YEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIV-GELPIELGNLKSLNYRALNG-NK 329 (639)
Q Consensus 252 ~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~-~~~p~~~~~l~~L~~L~l~~-N~ 329 (639)
+. +..+++|+.|++++|++. .+|..+..+++|+.|++++|.+. +.+|..+..++.|+.+++++ +.
T Consensus 208 ~~-~~~l~~L~~L~L~~N~l~------------~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~ 274 (317)
T 3o53_A 208 PE-FQSAAGVTWISLRNNKLV------------LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK 274 (317)
T ss_dssp GG-GGGGTTCSEEECTTSCCC------------EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHH
T ss_pred hh-hcccCcccEEECcCCccc------------chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchh
Confidence 43 677777888887666652 46666777777888888888777 66677777777777777773 33
Q ss_pred CcccCC
Q 046265 330 VYGSLP 335 (639)
Q Consensus 330 l~~~~p 335 (639)
+.|..|
T Consensus 275 l~~~~~ 280 (317)
T 3o53_A 275 LTGQNE 280 (317)
T ss_dssp HHSSSS
T ss_pred ccCCch
Confidence 444443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=259.57 Aligned_cols=169 Identities=25% Similarity=0.386 Sum_probs=143.6
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|+..+.||+|+||.||+|.. .+++.||||++............+.+|+.++++++|||||++++++...+..|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 45688899999999999999965 47899999998643222234567899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEEccccccccC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG---LDYDAHVSDFGISKFL 619 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~---~~~~~kl~DfGla~~~ 619 (639)
||+++|+|.+.+.... .+++..+..++.|++.|++|||.. +|+||||||+||+++ .++.+||+|||+|+..
T Consensus 101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999887653 478899999999999999999998 999999999999995 4567999999999876
Q ss_pred CCCCCCcceeeeeceeeCCC
Q 046265 620 KPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~~~~~~gt~~Y~APE 639 (639)
... ......+||+.|+|||
T Consensus 175 ~~~-~~~~~~~gt~~y~aPE 193 (486)
T 3mwu_A 175 QQN-TKMKDRIGTAYYIAPE 193 (486)
T ss_dssp CCC-----CCTTGGGGCCGG
T ss_pred CCC-CccCCCcCCCCCCCHH
Confidence 543 2334568999999998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=247.54 Aligned_cols=165 Identities=20% Similarity=0.331 Sum_probs=137.3
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC------
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR------ 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 536 (639)
.++|+..+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35678889999999999999965 67899999999765545555677899999999999999999999998763
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
..|+||||+ +++|.+++... .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 88999998752 477889999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCCcceeeeeceeeCCC
Q 046265 617 KFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+..... ....+||++|+|||
T Consensus 176 ~~~~~~---~~~~~~t~~y~aPE 195 (367)
T 1cm8_A 176 RQADSE---MTGYVVTRWYRAPE 195 (367)
T ss_dssp EECCSS---CCSSCSCGGGCCTH
T ss_pred cccccc---cCcCcCCCCcCCHH
Confidence 876432 33468999999998
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=245.36 Aligned_cols=173 Identities=21% Similarity=0.303 Sum_probs=129.8
Q ss_pred hccCCCcceeccCCCceEEEEEcCCC----cEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCce-
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSW----EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS- 538 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~- 538 (639)
.++|+..+.||+|+||.||+|..... ..||||.+..........+.+.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 46788899999999999999976543 2799999986544445567899999999999999999999999887655
Q ss_pred -----eEEecccCCCChhHHhhcCCC---CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 046265 539 -----FLLYEYLGRGSLAIILSNDAA---IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV 610 (639)
Q Consensus 539 -----~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl 610 (639)
++||||+++|+|.+++..... ...+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence 999999999999999864321 12588999999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 611 SDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 611 ~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
+|||+|+....... ......+++.|+|||
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 209 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALE 209 (323)
T ss_dssp CCCCC-----------------CCGGGCCHH
T ss_pred eeccccccccccccccccccccCcccccCch
Confidence 99999987643321 122346788999998
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=245.59 Aligned_cols=169 Identities=27% Similarity=0.375 Sum_probs=142.4
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--------
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP-------- 535 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-------- 535 (639)
.+|+..+.||+|+||.||+|.. .+++.||||++............+.+|+.++++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5688889999999999999965 6789999999976554444456788999999999999999999999873
Q ss_pred CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGl 615 (639)
+..|+||||+++ ++.+.+.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999975 7766665433 2478899999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCC----CCcceeeeeceeeCCC
Q 046265 616 SKFLKPDS----SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~----~~~~~~~gt~~Y~APE 639 (639)
|+.+.... ......+||+.|+|||
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE 198 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPE 198 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHH
T ss_pred cccccccccccccccCCcccccCccCch
Confidence 98764221 2234467999999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-28 Score=266.07 Aligned_cols=159 Identities=18% Similarity=0.136 Sum_probs=125.6
Q ss_pred eeccCCCceEEEE-EcCCCcEEEEEEccCCCCC--------hhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEE
Q 046265 472 CIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPD--------MVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 472 ~ig~g~~g~vy~~-~~~~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 541 (639)
..+.|+.|.++.+ +.-.|+.||||.+.+.... ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3456666666665 3445789999999754211 12346799999999999 699999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||++||+|.+++...+. ++. .+|+.||+.||+|+|.+ +||||||||+|||++.++.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~~~~---l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEE---IDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTTCC---CCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhCCC---CCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999987654 333 35899999999999999 999999999999999999999999999998766
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
......+.+||++|||||
T Consensus 392 ~~~~~~t~vGTp~YmAPE 409 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNE 409 (569)
T ss_dssp --CCSHHHHHHHHHHHHH
T ss_pred CCccccCceechhhccHH
Confidence 555566789999999998
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=258.18 Aligned_cols=169 Identities=21% Similarity=0.369 Sum_probs=144.8
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
..+|+..+.||+|+||.||+|... +++.||||.+.... ...+.|.+|+.++++++|||||+++++|...+..|+||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 355777889999999999999765 47899999997543 23567899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++..... ..+++..+..++.|+++||+|||.. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 296 E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp ECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999999975432 3578899999999999999999998 9999999999999999999999999999876533
Q ss_pred CC-CcceeeeeceeeCCC
Q 046265 623 SS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~-~~~~~~gt~~Y~APE 639 (639)
.. ......+++.|+|||
T Consensus 372 ~~~~~~~~~~~~~y~aPE 389 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPE 389 (495)
T ss_dssp CEECCTTCCCCGGGCCHH
T ss_pred ceeecCCCcCCcceeCHh
Confidence 21 122345678999998
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=243.05 Aligned_cols=172 Identities=17% Similarity=0.295 Sum_probs=144.1
Q ss_pred hccCCCcceeccCCCceEEEEEc--------CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEc
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL--------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFH 534 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 534 (639)
.++|...+.||+|+||.||+|+. .+++.||||.+.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 35677889999999999999975 346789999997543 334456789999999999 89999999999999
Q ss_pred CCceeEEecccCCCChhHHhhcCCC-------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCee
Q 046265 535 PRQSFLLYEYLGRGSLAIILSNDAA-------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVL 601 (639)
Q Consensus 535 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil 601 (639)
.+..|+||||+++|+|.+++..... ...+++..+..++.|+++|++|||.. +|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 9999999999999999999986542 12488999999999999999999998 9999999999999
Q ss_pred eCCCCceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 602 LGLDYDAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 602 l~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
++.++.+||+|||+++....... ......||+.|+|||
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 229 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 229 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChH
Confidence 99999999999999987654321 123346788999998
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-28 Score=251.44 Aligned_cols=250 Identities=19% Similarity=0.191 Sum_probs=160.5
Q ss_pred cCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCC-CCCCcccC-------CCCCCCEEeeecccCccccCccc
Q 046265 27 GNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLR-GSVPREVG-------QLSSLKQLVLYCNGLSGWLPSSF 98 (639)
Q Consensus 27 ~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~-~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~ 98 (639)
+..++|++|++++|.+ .+|..+... |+.|+|++|+++ +.+|..+. ++++|++|+|++|++++.+|..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 3445566666666666 455544433 666666666662 34555444 56666666666666665555544
Q ss_pred --cCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCC-----CCCCEEeccCCCCCCCCCccccCCCcccE
Q 046265 99 --GNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHL-----SNLAVLHLGDNSLFGSIPPILGKVQSLLS 171 (639)
Q Consensus 99 --~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 171 (639)
..+++| ++|+|++|++++. |..+..+ ++|++|+|++|++++..|..|+.+++|++
T Consensus 116 ~~~~l~~L-----------------~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 177 (312)
T 1wwl_A 116 LEATGPDL-----------------NILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALST 177 (312)
T ss_dssp SSCCSCCC-----------------SEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCE
T ss_pred HHhcCCCc-----------------cEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCE
Confidence 344322 3666666666644 5555554 56666666666666555566666666666
Q ss_pred EEcccCcCCccC--CccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCC--CCC-ccccCCCCCceecccccc
Q 046265 172 LGFDLNLLNGVL--PPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFG--QIP-KSLRNFTSLNIVHLEQNH 246 (639)
Q Consensus 172 L~l~~N~l~~~~--p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~--~~p-~~~~~l~~L~~L~L~~N~ 246 (639)
|++++|.+.+.+ |..+ .+..+++|++|++++|++.+ .++ ..+.++++|+.|++++|.
T Consensus 178 L~Ls~N~l~~~~~~~~~~------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~ 239 (312)
T 1wwl_A 178 LDLSDNPELGERGLISAL------------------CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239 (312)
T ss_dssp EECCSCTTCHHHHHHHHS------------------CTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSC
T ss_pred EECCCCCcCcchHHHHHH------------------HhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCc
Confidence 666666655431 1111 12556677777777777763 222 334577888889999888
Q ss_pred ccCcch-hhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeec
Q 046265 247 LTGNIY-EVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRAL 325 (639)
Q Consensus 247 l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l 325 (639)
+++..| ..+..+++|++|++++|++ + .+|..+. ++|+.||+++|++++. |. +..+++|+.|++
T Consensus 240 l~~~~~~~~~~~l~~L~~L~Ls~N~l-----------~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L 303 (312)
T 1wwl_A 240 LRDAAGAPSCDWPSQLNSLNLSFTGL-----------K-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSL 303 (312)
T ss_dssp CCSSCCCSCCCCCTTCCEEECTTSCC-----------S-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEEC
T ss_pred CCcccchhhhhhcCCCCEEECCCCcc-----------C-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEec
Confidence 888664 4456678899999777766 2 5676666 7899999999999866 65 888999999999
Q ss_pred cCccCcc
Q 046265 326 NGNKVYG 332 (639)
Q Consensus 326 ~~N~l~~ 332 (639)
++|.+++
T Consensus 304 ~~N~l~~ 310 (312)
T 1wwl_A 304 KGNPFLD 310 (312)
T ss_dssp TTCTTTC
T ss_pred cCCCCCC
Confidence 9998874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=241.12 Aligned_cols=169 Identities=22% Similarity=0.321 Sum_probs=141.0
Q ss_pred ccCCCcceeccCCCceEEEEE-----cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--Cc
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-----LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQ 537 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~ 537 (639)
..|+..+.||+|+||.||+|+ ..+++.||||++.... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 446778899999999999997 3467899999997543 223456789999999999999999999999877 56
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.++||||+++|+|.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 899999999999999996543 2478899999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCC---CcceeeeeceeeCCC
Q 046265 618 FLKPDSS---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~---~~~~~~gt~~Y~APE 639 (639)
....... ......||..|+|||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE 199 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPE 199 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHH
T ss_pred cccCCCcceeccCCCCCCccccCCe
Confidence 7754432 123456888999998
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-27 Score=237.70 Aligned_cols=167 Identities=24% Similarity=0.317 Sum_probs=145.1
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|+..+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 467888999999999999999654 568899999875432 23567899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEccccccccC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL---GLDYDAHVSDFGISKFL 619 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill---~~~~~~kl~DfGla~~~ 619 (639)
||+++++|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||++ +.++.+||+|||++..+
T Consensus 86 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 86 ELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred eccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999999887643 478899999999999999999998 99999999999999 78899999999999876
Q ss_pred CCCCCCcceeeeeceeeCCC
Q 046265 620 KPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~~~~~~gt~~Y~APE 639 (639)
.... ......||+.|+|||
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE 178 (277)
T 3f3z_A 160 KPGK-MMRTKVGTPYYVSPQ 178 (277)
T ss_dssp CTTS-CBCCCCSCTTTCCHH
T ss_pred cCcc-chhccCCCCCccChH
Confidence 5432 234567999999998
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=241.52 Aligned_cols=171 Identities=22% Similarity=0.315 Sum_probs=146.1
Q ss_pred ccCCCcceeccCCCceEEEEEc------CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCc
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 537 (639)
++|+..+.||+|+||.||+|.. .+++.||||.+.... .....+.+.+|+.+++++ +||||+++++++..++.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 5677889999999999999964 356889999997543 334567789999999999 89999999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCC---------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 046265 538 SFLLYEYLGRGSLAIILSNDAA---------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL 602 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill 602 (639)
.++||||+++|+|.+++..... ...+++..+..++.|+++|++|||.. +|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 9999999999999999976432 12488999999999999999999998 99999999999999
Q ss_pred CCCCceEEccccccccCCCCCCC--cceeeeeceeeCCC
Q 046265 603 GLDYDAHVSDFGISKFLKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 603 ~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~Y~APE 639 (639)
+.++.+||+|||+++........ .....||+.|+|||
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 217 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE 217 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChH
Confidence 99999999999999877543321 23356888999998
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-28 Score=242.08 Aligned_cols=173 Identities=24% Similarity=0.420 Sum_probs=145.8
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc--CCceeE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH--PRQSFL 540 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~l 540 (639)
.++|+..+.||+|+||.||+|.. .+++.||||.+..........+.+.+|+.++++++||||+++++++.. .+..|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46788889999999999999965 478999999998765555667789999999999999999999998854 567899
Q ss_pred EecccCCCChhHHhhcCCC-CCCcCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEeecCCCCCeeeCCCCceEEcccc
Q 046265 541 LYEYLGRGSLAIILSNDAA-IDEFSWTVRMNVIKSVANTLSYMHHDYFPP-----IVHRDISSKNVLLGLDYDAHVSDFG 614 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-----iiHrdlk~~Nill~~~~~~kl~DfG 614 (639)
||||+++|+|.+++..... ...+++..+..++.|++.|++|||.. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999975332 23488999999999999999999998 6 9999999999999999999999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+++.............||+.|+|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE 186 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPE 186 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHH
T ss_pred hheeeccccccccccCCCccccChH
Confidence 9987654332233467999999998
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-26 Score=251.15 Aligned_cols=263 Identities=25% Similarity=0.240 Sum_probs=147.6
Q ss_pred eeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEee
Q 046265 6 FFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVL 85 (639)
Q Consensus 6 ~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 85 (639)
-....+++++|++. .+|..+. ++|++|+|++|.++ .+|. .+++|++|+|++|+++ .+|. .+++|++|+|
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEEC
Confidence 34566777777776 6676665 67888888888877 4555 5677888888888877 4665 5677888888
Q ss_pred ecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccC
Q 046265 86 YCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGK 165 (639)
Q Consensus 86 ~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 165 (639)
++|++++ +|. .++ + |++|++++|++++ +|.. +++|++|+|++|++++ +|. .
T Consensus 109 s~N~l~~-l~~---~l~---------------~--L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~ 159 (622)
T 3g06_A 109 FSNPLTH-LPA---LPS---------------G--LCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---L 159 (622)
T ss_dssp CSCCCCC-CCC---CCT---------------T--CCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---C
T ss_pred cCCcCCC-CCC---CCC---------------C--cCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---c
Confidence 8887774 333 112 2 2477888888773 5553 4778888888887774 443 2
Q ss_pred CCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccc
Q 046265 166 VQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQN 245 (639)
Q Consensus 166 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N 245 (639)
+.+|+.|++++|.+++ +| ..+++|+.|+++.|.+...-..+++|+.|++++|.+.. +|.. +++|+.|++++|
T Consensus 160 ~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l~~~~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N 231 (622)
T 3g06_A 160 PSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASLPTLPSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGN 231 (622)
T ss_dssp CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSS
T ss_pred cCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCCCCccchhhEEECcCCcccc-cCCC---CCCCCEEEccCC
Confidence 4567778888887774 33 23455555555544433211223444555555554432 2321 244444455555
Q ss_pred cccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeec
Q 046265 246 HLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRAL 325 (639)
Q Consensus 246 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l 325 (639)
.+++.. ..+++|+.|++++|++. .+|. .+++|+.|+|++|+++ .+|..+..+++|+.|++
T Consensus 232 ~L~~lp----~~l~~L~~L~Ls~N~L~------------~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L 291 (622)
T 3g06_A 232 RLTSLP----VLPSELKELMVSGNRLT------------SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291 (622)
T ss_dssp CCSCCC----CCCTTCCEEECCSSCCS------------CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred ccCcCC----CCCCcCcEEECCCCCCC------------cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence 444422 23344444444444331 2332 2334444444444444 33444444444444444
Q ss_pred cCccCcccCCc
Q 046265 326 NGNKVYGSLPR 336 (639)
Q Consensus 326 ~~N~l~~~~p~ 336 (639)
++|.+++..|.
T Consensus 292 ~~N~l~~~~~~ 302 (622)
T 3g06_A 292 EGNPLSERTLQ 302 (622)
T ss_dssp CSCCCCHHHHH
T ss_pred cCCCCCCcCHH
Confidence 44444444443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=241.69 Aligned_cols=165 Identities=24% Similarity=0.385 Sum_probs=134.5
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
++|+..+.||+|+||.||+|... ++.||||++... ...+.|.+|+.++++++||||+++++++. +..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 46777889999999999999875 688999998642 24567899999999999999999999887 358999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc-eEEccccccccCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD-AHVSDFGISKFLKPDS 623 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~-~kl~DfGla~~~~~~~ 623 (639)
+++|+|.+++........+++..+..++.|+++|++|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 999999999987665556788999999999999999999943238999999999999998886 799999999865432
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.....||+.|+|||
T Consensus 160 --~~~~~gt~~y~aPE 173 (307)
T 2eva_A 160 --MTNNKGSAAWMAPE 173 (307)
T ss_dssp -------CCTTSSCHH
T ss_pred --cccCCCCCceEChh
Confidence 23357999999998
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=239.70 Aligned_cols=171 Identities=23% Similarity=0.330 Sum_probs=140.3
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.+.|...+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 35678889999999999999965 5688999999875432 223567899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEcccccccc
Q 046265 543 EYLGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL---GLDYDAHVSDFGISKF 618 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill---~~~~~~kl~DfGla~~ 618 (639)
||+++|+|.+.+.... ....+++..+..++.|+++|++|||.. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 9999999999885431 123578899999999999999999998 99999999999999 4568899999999987
Q ss_pred CCCCCCCcceeeeeceeeCCC
Q 046265 619 LKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~~~~~~~gt~~Y~APE 639 (639)
..... ......||+.|+|||
T Consensus 177 ~~~~~-~~~~~~~t~~y~aPE 196 (285)
T 3is5_A 177 FKSDE-HSTNAAGTALYMAPE 196 (285)
T ss_dssp -----------CTTGGGCCHH
T ss_pred cCCcc-cCcCcccccCcCChH
Confidence 65432 234567999999998
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=257.09 Aligned_cols=168 Identities=18% Similarity=0.358 Sum_probs=143.1
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.++|+..+.||+|+||.||+|...+++.||||+++... ...+.|.+|+.++++++|||||++++++. .+..|+|||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 45677889999999999999998888999999997533 23567999999999999999999999986 567899999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++|+|.++++.... ..+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 263 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred ecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 9999999999975432 2467889999999999999999998 99999999999999999999999999998764321
Q ss_pred -CCcceeeeeceeeCCC
Q 046265 624 -SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 -~~~~~~~gt~~Y~APE 639 (639)
.......+++.|+|||
T Consensus 339 ~~~~~~~~~~~~y~aPE 355 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPE 355 (454)
T ss_dssp HHTTCSSSSCGGGSCHH
T ss_pred eeccCCCcccccccCHH
Confidence 1112345678999998
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.9e-28 Score=247.10 Aligned_cols=168 Identities=21% Similarity=0.336 Sum_probs=134.3
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|...+.||+|+||.||+|... +++.||||++...... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 46778899999999999999654 7899999998754321 112234579999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|++ |++.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CCS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred ccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 997 58888887543 2578899999999999999999998 99999999999999999999999999998765444
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
......+||+.|+|||
T Consensus 155 ~~~~~~~~t~~y~aPE 170 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPD 170 (324)
T ss_dssp --------CGGGCCHH
T ss_pred cccccccCcccccChh
Confidence 4445568999999998
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=257.10 Aligned_cols=169 Identities=25% Similarity=0.401 Sum_probs=142.7
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCCh-----------hhHHHHHHHHHHHhccccCceeeeEEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDM-----------VVQQAFSNEIKALTELRHRNVVKFYGF 531 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~H~niv~l~~~ 531 (639)
.++|...+.||+|+||.||+|.. .+++.||||.+....... ...+.+.+|+.++++++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 46788899999999999999965 467899999997643221 235678999999999999999999999
Q ss_pred EEcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC---ce
Q 046265 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY---DA 608 (639)
Q Consensus 532 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~---~~ 608 (639)
|.+.+..|+|||||++|+|.+.+.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence 999999999999999999999887643 478899999999999999999998 999999999999998775 69
Q ss_pred EEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 609 HVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 609 kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
||+|||+|+..... ......+||+.|+|||
T Consensus 189 kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE 218 (504)
T 3q5i_A 189 KIVDFGLSSFFSKD-YKLRDRLGTAYYIAPE 218 (504)
T ss_dssp EECCCTTCEECCTT-SCBCCCCSCTTTCCHH
T ss_pred EEEECCCCEEcCCC-CccccccCCcCCCCHH
Confidence 99999999877543 2334568999999998
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-27 Score=237.01 Aligned_cols=165 Identities=22% Similarity=0.323 Sum_probs=141.7
Q ss_pred CCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc----CCceeEE
Q 046265 467 FDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH----PRQSFLL 541 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv 541 (639)
|...+.||+|+||.||+|.. .++..||+|.+..........+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 55667899999999999954 567899999998655555667789999999999999999999999875 3458999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeecCCCCCeeeC-CCCceEEcccccccc
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP--IVHRDISSKNVLLG-LDYDAHVSDFGISKF 618 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlk~~Nill~-~~~~~kl~DfGla~~ 618 (639)
|||+++|+|.+++.... .+++..+..++.+++.|++|||.. + |+||||||+||+++ .++.+||+|||++..
T Consensus 108 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999997643 477899999999999999999998 6 99999999999997 789999999999976
Q ss_pred CCCCCCCcceeeeeceeeCCC
Q 046265 619 LKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~~~~~~~gt~~Y~APE 639 (639)
... .......||+.|+|||
T Consensus 182 ~~~--~~~~~~~~t~~y~aPE 200 (290)
T 1t4h_A 182 KRA--SFAKAVIGTPEFMAPE 200 (290)
T ss_dssp CCT--TSBEESCSSCCCCCGG
T ss_pred ccc--cccccccCCcCcCCHH
Confidence 543 2334567999999998
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=240.58 Aligned_cols=170 Identities=25% Similarity=0.381 Sum_probs=142.3
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|+||.||+|... +++.||||++..........+.+.+|+.++++++||||+++++++..++..|+|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 46788899999999999999654 78999999997654333345678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|++ |+|.+++..... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~-~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 157 (299)
T 2r3i_A 83 FLH-QDLKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157 (299)
T ss_dssp CCS-EEHHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ccc-CCHHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHeEEcCCCCEEECcchhhhhccCCc
Confidence 997 699999875432 3478899999999999999999998 99999999999999999999999999998765433
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......||+.|+|||
T Consensus 158 ~~~~~~~~~~~y~aPE 173 (299)
T 2r3i_A 158 RTYTHEVVTLWYRAPE 173 (299)
T ss_dssp BCTTSCBCCCTTCCHH
T ss_pred cccCcccccccccCcH
Confidence 3334567899999998
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-27 Score=235.04 Aligned_cols=165 Identities=30% Similarity=0.512 Sum_probs=139.6
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhH-----HHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQ-----QAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~-----~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
++|+..+.||+|+||.||+|.. .+++.||||.+.......... +.+.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 5677788999999999999965 578999999997644322111 67899999999999999999999987654
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeecCCCCCeeeCCCCc-----eEEc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP--IVHRDISSKNVLLGLDYD-----AHVS 611 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlk~~Nill~~~~~-----~kl~ 611 (639)
++||||+++|+|.+.+.... ..+++..+..++.|++.|++|||.. + |+||||||+||+++.++. +||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 79999999999998886543 3588999999999999999999998 7 999999999999988776 9999
Q ss_pred cccccccCCCCCCCcceeeeeceeeCCC
Q 046265 612 DFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 612 DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|||+++.... ......||+.|+|||
T Consensus 172 Dfg~~~~~~~---~~~~~~g~~~y~aPE 196 (287)
T 4f0f_A 172 DFGLSQQSVH---SVSGLLGNFQWMAPE 196 (287)
T ss_dssp CCTTCBCCSS---CEECCCCCCTTSCGG
T ss_pred CCCccccccc---cccccCCCccccCch
Confidence 9999985432 234567999999998
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=237.58 Aligned_cols=169 Identities=21% Similarity=0.324 Sum_probs=131.8
Q ss_pred hccCCCcceeccCCCceEEEEEcCC----CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPS----WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
.++|+..+.||+|+||.||+|.... +..||||.+.... .....+.+.+|+.++++++||||+++++++. ++..|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 3567788999999999999996542 4579999987543 3445677899999999999999999999984 56789
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||+++|+|.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence 9999999999999997543 2478899999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCC-CcceeeeeceeeCCC
Q 046265 620 KPDSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~-~~~~~~gt~~Y~APE 639 (639)
..... ......+|+.|+|||
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE 187 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPE 187 (281)
T ss_dssp ------------CCGGGCCHH
T ss_pred CcccccccccCCCcccccChh
Confidence 53322 223356788999998
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=257.45 Aligned_cols=169 Identities=25% Similarity=0.395 Sum_probs=147.0
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.++|+..+.||+|+||.||+|.. .+++.||||++..... .....+.+.+|+.++++++|||||++++++.+.+..|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 45688889999999999999965 4789999999976542 233467789999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEcccccccc
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL---GLDYDAHVSDFGISKF 618 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill---~~~~~~kl~DfGla~~ 618 (639)
|||+++|+|.+.+.... .+++..+..++.|++.|++|||.. +|+||||||+||++ +.++.+||+|||+|+.
T Consensus 105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999987654 478899999999999999999999 99999999999999 4678999999999987
Q ss_pred CCCCCCCcceeeeeceeeCCC
Q 046265 619 LKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~~~~~~~gt~~Y~APE 639 (639)
+... ......+||+.|+|||
T Consensus 179 ~~~~-~~~~~~~gt~~y~aPE 198 (484)
T 3nyv_A 179 FEAS-KKMKDKIGTAYYIAPE 198 (484)
T ss_dssp BCCC-CSHHHHTTGGGTCCHH
T ss_pred cccc-cccccCCCCccccCce
Confidence 7543 2334568999999998
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=252.83 Aligned_cols=164 Identities=26% Similarity=0.382 Sum_probs=139.9
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC-ceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR-QSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~ 542 (639)
.++|+..+.||+|+||.||+|... ++.||||.++... ..+.|.+|+.++++++|||||++++++...+ ..|+||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 456777889999999999999876 6799999997543 3467899999999999999999999988765 789999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++...+. ..+++..+..++.|+++||+|||.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999999986432 3468899999999999999999998 9999999999999999999999999999865422
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
. ....+++.|+|||
T Consensus 343 ~---~~~~~~~~y~aPE 356 (450)
T 1k9a_A 343 Q---DTGKLPVKWTAPE 356 (450)
T ss_dssp -------CCCTTTSCHH
T ss_pred c---cCCCCCcceeCHH
Confidence 1 2346788999998
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-28 Score=249.59 Aligned_cols=248 Identities=19% Similarity=0.225 Sum_probs=199.8
Q ss_pred CCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCc-cccCcccc-------CCCCCCcccCCCCCcccCCCCc
Q 046265 50 IDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLS-GWLPSSFG-------NLNNLAIGSMPNSLSNLTSLSL 121 (639)
Q Consensus 50 ~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~-------~l~~L~~~~lp~~~~~l~~L~L 121 (639)
++.+++|+.|++++|.+ .+|..+... |+.|+|++|+++ +.+|..+. +++ +|
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~---------------~L-- 97 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGIS---------------GL-- 97 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTS---------------CC--
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcC---------------Cc--
Confidence 56778899999999999 688877654 999999999994 45665554 444 33
Q ss_pred cEEEccCCcCcccCCccc--cCCCCCCEEeccCCCCCCCCCccccCC-----CcccEEEcccCcCCccCCccCcCCCCCC
Q 046265 122 FHLDLSENQLSGSIPHFL--GHLSNLAVLHLGDNSLFGSIPPILGKV-----QSLLSLGFDLNLLNGVLPPSISNLSNLE 194 (639)
Q Consensus 122 ~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 194 (639)
++|+|++|++++.+|..+ ..+++|++|+|++|++++. |..++.+ ++|++|++++|.+++..|..|..+++|
T Consensus 98 ~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L- 175 (312)
T 1wwl_A 98 QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL- 175 (312)
T ss_dssp CEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSC-
T ss_pred cEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCC-
Confidence 699999999999899876 8999999999999999987 8888877 899999999999998877777665554
Q ss_pred eEEccCCccccccccccCCcEEEcCCcccCCC--CCccc--cCCCCCceeccccccccCc---chhhhhcCCCccEEecc
Q 046265 195 GLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQ--IPKSL--RNFTSLNIVHLEQNHLTGN---IYEVFGIYPNLTFLDLS 267 (639)
Q Consensus 195 ~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~p~~~--~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~Ls 267 (639)
+.|++++|++.+. +|..+ ..+++|++|++++|.+++. ....+..+++|++|+++
T Consensus 176 -------------------~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls 236 (312)
T 1wwl_A 176 -------------------STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLS 236 (312)
T ss_dssp -------------------CEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECT
T ss_pred -------------------CEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECC
Confidence 4555666666554 23334 7899999999999999942 23456788999999988
Q ss_pred CCcccccccCcCCccccccC-ccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCE
Q 046265 268 QNNFYGSLNFSMNNITRSIP-PKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEY 346 (639)
Q Consensus 268 ~N~l~~~l~ls~n~~~~~~p-~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 346 (639)
+|++. +..| ..+..+++|+.|++++|+++ .+|..+. ++|+.|++++|++++. |. +..+++|+.
T Consensus 237 ~N~l~-----------~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~ 300 (312)
T 1wwl_A 237 HNSLR-----------DAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGN 300 (312)
T ss_dssp TSCCC-----------SSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEE
T ss_pred CCcCC-----------cccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCE
Confidence 77764 3443 34556889999999999998 7787776 8999999999999966 66 899999999
Q ss_pred EeCCCCCCC
Q 046265 347 LDLSTNYNN 355 (639)
Q Consensus 347 L~Ls~N~~~ 355 (639)
|++++|++.
T Consensus 301 L~L~~N~l~ 309 (312)
T 1wwl_A 301 LSLKGNPFL 309 (312)
T ss_dssp EECTTCTTT
T ss_pred EeccCCCCC
Confidence 999997643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=238.95 Aligned_cols=168 Identities=27% Similarity=0.468 Sum_probs=140.9
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.++|+..+.||+|+||.||+|.. .+++.||||.+..... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 46788889999999999999954 5678999999864221 112346688999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999987653 477899999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
. ......||+.|+|||
T Consensus 162 ~--~~~~~~~~~~y~aPE 177 (279)
T 3fdn_A 162 S--RRTDLCGTLDYLPPE 177 (279)
T ss_dssp --------CCCCTTCCHH
T ss_pred c--cccccCCCCCccCHh
Confidence 2 234567999999998
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=247.07 Aligned_cols=176 Identities=22% Similarity=0.275 Sum_probs=141.3
Q ss_pred HHHhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCC---CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC
Q 046265 461 IRATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPH---PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR 536 (639)
Q Consensus 461 ~~~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 536 (639)
....++|+..+.||+|+||.||+|.. .+++.||||.+.... ......+.+.+|+.++++++|||||++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 45567899999999999999999955 567899999986431 12334567899999999999999999999999999
Q ss_pred ceeEEecccCCCChhHHhhcCCC-------------------------------------CCCcCHHHHHHHHHHHHHHH
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAA-------------------------------------IDEFSWTVRMNVIKSVANTL 579 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------~~~~~~~~~~~i~~~i~~~l 579 (639)
..++||||+++|+|.+++..... ...+++..+..++.|++.|+
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 99999999999999999852100 11235667788999999999
Q ss_pred HHHHhCCCCCeEeecCCCCCeeeCCCC--ceEEccccccccCCCCCC----CcceeeeeceeeCCC
Q 046265 580 SYMHHDYFPPIVHRDISSKNVLLGLDY--DAHVSDFGISKFLKPDSS----NWSEFVGTFGYVAPI 639 (639)
Q Consensus 580 ~~lH~~~~~~iiHrdlk~~Nill~~~~--~~kl~DfGla~~~~~~~~----~~~~~~gt~~Y~APE 639 (639)
+|||.. +|+||||||+||+++.++ .+||+|||+++.+..... ......||+.|+|||
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 244 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCch
Confidence 999999 999999999999998766 899999999986532211 234568999999998
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-27 Score=238.20 Aligned_cols=168 Identities=27% Similarity=0.435 Sum_probs=134.4
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
..+|+..+.||+|+||.||+|.... .||||.++.........+.+.+|+.++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4567888999999999999998653 599999987665566677899999999999999999999965 4567899999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC-
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD- 622 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~- 622 (639)
|+++++|.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999999996543 3588899999999999999999998 9999999999999999999999999999865432
Q ss_pred -CCCcceeeeeceeeCCC
Q 046265 623 -SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 -~~~~~~~~gt~~Y~APE 639 (639)
........||+.|+|||
T Consensus 175 ~~~~~~~~~gt~~y~aPE 192 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPE 192 (289)
T ss_dssp ---------CCCTTCCHH
T ss_pred ccccccccCCCccccCch
Confidence 12234467999999998
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-28 Score=251.11 Aligned_cols=170 Identities=22% Similarity=0.299 Sum_probs=143.9
Q ss_pred hccCCCcceeccCCCceEEEEEc----CCCcEEEEEEccCCCC--ChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCC
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL----PSWEIVAVKKFHSPHP--DMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPR 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 536 (639)
.++|+..+.||+|+||.||+|+. .+++.||||.++.... .....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36788899999999999999976 4789999999874321 112234567899999999 5999999999999999
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
..|+||||+++|+|.+++.... .+++..+..++.|+++||+|||.. +|+||||||+||+++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999997643 478899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCC-CcceeeeeceeeCCC
Q 046265 617 KFLKPDSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~-~~~~~~gt~~Y~APE 639 (639)
+.+..... .....+||+.|+|||
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE 230 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPD 230 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHH
T ss_pred eecccCCCCcccCcccCcCccChh
Confidence 87643222 223468999999998
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=241.55 Aligned_cols=170 Identities=22% Similarity=0.372 Sum_probs=146.6
Q ss_pred HhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
..++|+..+.||+|+||.||+|... +++.||||.+.... ...+.+.+|+.++++++||||+++++++..++..|+|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3567788899999999999999655 57889999997532 3456789999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++|+|.+++..... ..+++..+..++.+++.|++|||.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 999999999999976433 4578899999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-CcceeeeeceeeCCC
Q 046265 622 DSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~-~~~~~~gt~~Y~APE 639 (639)
... ......||+.|+|||
T Consensus 164 ~~~~~~~~~~~~~~y~aPE 182 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPE 182 (288)
T ss_dssp SSSEEETTEEECGGGCCHH
T ss_pred CccccccCCccccCcCChh
Confidence 332 223456788999998
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=249.46 Aligned_cols=163 Identities=19% Similarity=0.265 Sum_probs=129.3
Q ss_pred ccCCCc-ceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhc-cccCceeeeEEEEEc----CCc
Q 046265 465 NNFDAK-YCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTE-LRHRNVVKFYGFSFH----PRQ 537 (639)
Q Consensus 465 ~~f~~~-~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~----~~~ 537 (639)
++|... ++||+|+||+||+|.. .+++.||||++.. ...+.+|+.++.+ .+||||++++++|.. .+.
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 445444 6899999999999954 5789999999863 1346788888754 589999999999875 557
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEcccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL---DYDAHVSDFG 614 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~---~~~~kl~DfG 614 (639)
.|+||||+++|+|.+++..... ..+++..+..++.|++.||+|||.. +|+||||||+||+++. ++.+||+|||
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 8999999999999999986432 3588999999999999999999998 9999999999999987 7899999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+++..... ......+||+.|||||
T Consensus 210 ~a~~~~~~-~~~~~~~gt~~y~aPE 233 (400)
T 1nxk_A 210 FAKETTSH-NSLTTPCYTPYYVAPE 233 (400)
T ss_dssp TCEECC------------CTTCCGG
T ss_pred cccccCCC-CccccCCCCCCccCHh
Confidence 99876532 2234578999999998
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.9e-27 Score=237.28 Aligned_cols=167 Identities=26% Similarity=0.413 Sum_probs=146.5
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
+.|+..+.||+|+||.||+|. ..+++.||||.+...... ...+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 457778899999999999995 457899999999765432 345678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++++|.+++... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 101 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999998642 478899999999999999999998 99999999999999999999999999998765443
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......||+.|+|||
T Consensus 174 ~~~~~~~~~~~y~aPE 189 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPE 189 (303)
T ss_dssp CCBCCCCSCGGGCCHH
T ss_pred cccCccCCCcCccCHH
Confidence 3445568999999998
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=243.34 Aligned_cols=173 Identities=19% Similarity=0.344 Sum_probs=145.7
Q ss_pred HhccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR 536 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 536 (639)
..++|+..+.||+|+||.||+|... +++.||||.+.... .......+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 3467888899999999999999654 36789999997543 3344567899999999999999999999999999
Q ss_pred ceeEEecccCCCChhHHhhcCC-------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceE
Q 046265 537 QSFLLYEYLGRGSLAIILSNDA-------AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAH 609 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~k 609 (639)
..++||||+++|+|.+++.... ....+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEE
Confidence 9999999999999999987532 123568899999999999999999999 999999999999999999999
Q ss_pred EccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 610 VSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 610 l~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
|+|||+++....... ......||+.|+|||
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 210 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred ECcCccccccccccccccccCCCCCCCccChh
Confidence 999999986543221 123356889999998
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-27 Score=238.56 Aligned_cols=173 Identities=24% Similarity=0.326 Sum_probs=135.5
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCC-CChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
..+|+..+.||+|+||.||+|.. .+++.||||++.... ......+.+.+|+.++++++||||+++++++..++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35688889999999999999964 678999999997543 2344567789999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 542 YEYLGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
|||+++|+|.+++.... ....+++..+..++.++++|++|||.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999986421 223578899999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
..........||+.|+|||
T Consensus 188 ~~~~~~~~~~~~~~y~aPE 206 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPE 206 (310)
T ss_dssp -----------CCSSCCHH
T ss_pred CCCccccccCCCeeEeChH
Confidence 4433344567999999998
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-27 Score=253.89 Aligned_cols=168 Identities=20% Similarity=0.389 Sum_probs=137.9
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.++|+..+.||+|+||.||+|...++..||||+++... ...+.|.+|+.++++++||||+++++++.+ +..|+|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 35677788999999999999998888889999998543 234678999999999999999999999876 67899999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++|+|.+++..... ..+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 259 ~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 9999999999974321 2478899999999999999999998 99999999999999999999999999998765322
Q ss_pred C-CcceeeeeceeeCCC
Q 046265 624 S-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~-~~~~~~gt~~Y~APE 639 (639)
. ......+++.|+|||
T Consensus 335 ~~~~~~~~~~~~y~aPE 351 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPE 351 (452)
T ss_dssp --------CCGGGSCHH
T ss_pred eecccCCcccccccCHh
Confidence 1 223345778999998
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-27 Score=239.05 Aligned_cols=167 Identities=22% Similarity=0.327 Sum_probs=136.5
Q ss_pred ccCCC-cceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEE
Q 046265 465 NNFDA-KYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 465 ~~f~~-~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 541 (639)
+.|.. .+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|++++.++ +||||+++++++.+++..|+|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 45655 36899999999999964 578999999997543 23456788999999885 799999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc---eEEcccccccc
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD---AHVSDFGISKF 618 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~---~kl~DfGla~~ 618 (639)
|||+++|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++. +||+|||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999997653 477899999999999999999999 9999999999999988765 99999999986
Q ss_pred CCCCCC-------CcceeeeeceeeCCC
Q 046265 619 LKPDSS-------NWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~-------~~~~~~gt~~Y~APE 639 (639)
...... .....+||+.|+|||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE 191 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPE 191 (316)
T ss_dssp ------------------CCSGGGCCHH
T ss_pred cccCCccccccccccccccCCcCccChH
Confidence 542211 122356999999998
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=242.89 Aligned_cols=173 Identities=22% Similarity=0.276 Sum_probs=142.7
Q ss_pred HHhccCCCc-ceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCce
Q 046265 462 RATNNFDAK-YCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 462 ~~~~~f~~~-~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~ 538 (639)
...+.|... +.||+|+||.||+|.. .+++.||||.+............+.+|+.++.+++ ||||+++++++...+..
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 334556555 7899999999999965 46899999999865444445677899999999985 69999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL---DYDAHVSDFGI 615 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~---~~~~kl~DfGl 615 (639)
|+||||+++|+|.+++..... ..+++..+..++.|++.||+|||.. +|+||||||+||+++. ++.+||+|||+
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred EEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 999999999999999865422 4588999999999999999999998 9999999999999987 78999999999
Q ss_pred cccCCCCCCCcceeeeeceeeCCC
Q 046265 616 SKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
++...... .....+||+.|+|||
T Consensus 181 a~~~~~~~-~~~~~~gt~~y~aPE 203 (327)
T 3lm5_A 181 SRKIGHAC-ELREIMGTPEYLAPE 203 (327)
T ss_dssp CEEC----------CCCGGGCCHH
T ss_pred ccccCCcc-ccccccCCcCccCCe
Confidence 98765332 234568999999998
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.5e-27 Score=240.19 Aligned_cols=169 Identities=24% Similarity=0.339 Sum_probs=144.0
Q ss_pred hccCCCcceeccCCCceEEEEEc-----CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc--CC
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-----PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH--PR 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~ 536 (639)
.++|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++.. .+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 35677889999999999999973 467899999997643 4456678999999999999999999999874 45
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
..|+||||+++|+|.+++..... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred eEEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 68999999999999999976432 478899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCC---CcceeeeeceeeCCC
Q 046265 617 KFLKPDSS---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~---~~~~~~gt~~Y~APE 639 (639)
+....... ......||+.|+|||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE 200 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPE 200 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHH
T ss_pred eecccCCccceeeccCCccccccCHH
Confidence 87654332 123356888999998
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.9e-27 Score=234.73 Aligned_cols=168 Identities=21% Similarity=0.335 Sum_probs=142.3
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCC----hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPD----MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
++|+..+.||+|+||.||+|... +++.||||.+...... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888899999999999999665 6899999998764322 123577899999999999999999999999999999
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC----ceEEccccc
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY----DAHVSDFGI 615 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~----~~kl~DfGl 615 (639)
+||||+++++|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999997543 478899999999999999999998 999999999999998877 899999999
Q ss_pred cccCCCCCCCcceeeeeceeeCCC
Q 046265 616 SKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+....... ......||+.|+|||
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~aPE 181 (283)
T 3bhy_A 159 AHKIEAGN-EFKNIFGTPEFVAPE 181 (283)
T ss_dssp CEECC---------CCCGGGCCHH
T ss_pred ceeccCCC-cccccCCCcCccCcc
Confidence 98765332 234467999999998
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=234.70 Aligned_cols=167 Identities=21% Similarity=0.355 Sum_probs=144.6
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
++|+..+.||+|+||.||+|...+++.||||.+..... ..+.+.+|++++++++||||+++++++..++..++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 56777889999999999999888889999999986432 246789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC-
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS- 623 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~- 623 (639)
+++++|.+++.... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 85 MEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp CTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 99999999997643 2578899999999999999999998 99999999999999999999999999998764321
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......|++.|+|||
T Consensus 160 ~~~~~~~~~~~y~aPE 175 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPE 175 (267)
T ss_dssp HSTTSTTCCGGGCCHH
T ss_pred cccccccccccccChh
Confidence 1122345788999998
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=8.7e-27 Score=233.48 Aligned_cols=169 Identities=27% Similarity=0.377 Sum_probs=145.8
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|+..+.||+|+||.||+|... +++.||||.+..... ....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 467888999999999999999654 789999999875332 234567899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++++|.+++.... .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||.+..+...
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999987543 478899999999999999999998 9999999999999999999999999999865322
Q ss_pred C--CCcceeeeeceeeCCC
Q 046265 623 S--SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~--~~~~~~~gt~~Y~APE 639 (639)
. ......+||+.|+|||
T Consensus 159 ~~~~~~~~~~~~~~y~aPE 177 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPE 177 (276)
T ss_dssp TEECCBCCCCSCGGGCCGG
T ss_pred cchhcccCCccccCccChH
Confidence 1 2234567999999998
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-27 Score=242.59 Aligned_cols=168 Identities=20% Similarity=0.337 Sum_probs=134.4
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcE----EEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEI----VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
++|+..+.||+|+||.||+|.. .+++. ||+|.+.... .....+.+.+|+.++++++||||++++++|..+. .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 5677889999999999999964 34443 6888886432 2334567899999999999999999999998754 78
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||+++|+|.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+|+.+
T Consensus 93 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 9999999999999997644 3588899999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCC--cceeeeeceeeCCC
Q 046265 620 KPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~--~~~~~gt~~Y~APE 639 (639)
...... .....||+.|+|||
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE 189 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALE 189 (327)
T ss_dssp TTTCC-------CCCGGGSCHH
T ss_pred cCCcccccccCCCccccccChH
Confidence 543322 23356788999998
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=236.48 Aligned_cols=165 Identities=22% Similarity=0.313 Sum_probs=140.2
Q ss_pred CCCcceeccCCCceEEEEEc-----CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC--Ccee
Q 046265 467 FDAKYCIGTAGQASVYKAEL-----PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP--RQSF 539 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~ 539 (639)
|+..+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|++++++++||||+++++++.+. ...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 47788999999999998854 267889999998643 344567789999999999999999999999874 5689
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||+++|+|.+++... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++..
T Consensus 112 lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 999999999999999754 378899999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCC---CcceeeeeceeeCCC
Q 046265 620 KPDSS---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~---~~~~~~gt~~Y~APE 639 (639)
..... ......||+.|+|||
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE 207 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPE 207 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHH
T ss_pred cccccccccccCCCCCceeeChH
Confidence 54332 123356888999998
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-27 Score=234.12 Aligned_cols=168 Identities=24% Similarity=0.390 Sum_probs=130.9
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCC--hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPD--MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.+|+..+.||+|+||.||+|... ++.||||.++..... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 56778899999999999999865 789999998754322 223467889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC--------CCceEEcccc
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL--------DYDAHVSDFG 614 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~--------~~~~kl~DfG 614 (639)
||+++++|.+++... .+++..+..++.|+++|++|||.....+|+||||||+||+++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999998643 4788999999999999999999983333999999999999986 6789999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+++...... .....||+.|+|||
T Consensus 162 ~~~~~~~~~--~~~~~~~~~y~aPE 184 (271)
T 3dtc_A 162 LAREWHRTT--KMSAAGAYAWMAPE 184 (271)
T ss_dssp C---------------CCGGGSCHH
T ss_pred ccccccccc--ccCCCCccceeCHH
Confidence 998765332 23457999999998
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=238.87 Aligned_cols=165 Identities=21% Similarity=0.341 Sum_probs=141.4
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CC-------cEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SW-------EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP 535 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 535 (639)
.++|...+.||+|+||.||+|... ++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++.++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 356778899999999999999644 23 469999986532 34457789999999999999999999999999
Q ss_pred CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc--------
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD-------- 607 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~-------- 607 (639)
+..++||||+++|+|.+++.... ..+++..+..++.|+++||+|||.. +|+||||||+||+++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999997643 2478899999999999999999999 9999999999999988877
Q ss_pred eEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 608 AHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 608 ~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+||+|||++..... .....||+.|+|||
T Consensus 160 ~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE 187 (289)
T 4fvq_A 160 IKLSDPGISITVLP----KDILQERIPWVPPE 187 (289)
T ss_dssp EEECCCCSCTTTSC----HHHHHHTTTTSCHH
T ss_pred eeeccCcccccccC----ccccCCcCcccCHH
Confidence 99999999876532 23456899999998
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=241.04 Aligned_cols=166 Identities=21% Similarity=0.252 Sum_probs=143.1
Q ss_pred HhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-----cCceeeeEEEEEcCC
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-----HRNVVKFYGFSFHPR 536 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----H~niv~l~~~~~~~~ 536 (639)
..++|+..+.||+|+||.||+|.. .+++.||||.+... ....+.+..|+.++++++ |||||++++++...+
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 357788899999999999999965 57899999998742 334556788999999886 999999999999999
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC------------
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL------------ 604 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~------------ 604 (639)
..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||.. +|+||||||+||+++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred eeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhc
Confidence 999999999 9999999976443 3478899999999999999999998 9999999999999975
Q ss_pred -------------CCceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 605 -------------DYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 605 -------------~~~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
++.+||+|||+|+..... ....+||+.|+|||
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE 229 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPE 229 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHH
T ss_pred ccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcH
Confidence 789999999999875432 23467999999998
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=239.85 Aligned_cols=167 Identities=25% Similarity=0.363 Sum_probs=137.1
Q ss_pred HhccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhc--cccCceeeeEEEEEcC----C
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTE--LRHRNVVKFYGFSFHP----R 536 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~----~ 536 (639)
..++|+..+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++.. ++||||+++++++... .
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 4578999999999999999999876 799999998642 23344555555554 4899999999999887 6
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeecCCCCCeeeCCCCceEEc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY-----FPPIVHRDISSKNVLLGLDYDAHVS 611 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----~~~iiHrdlk~~Nill~~~~~~kl~ 611 (639)
..|+||||+++|+|.++++.. .+++..+..++.|++.|++|||... .++|+||||||+||+++.++.+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred ceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 789999999999999999753 4788999999999999999999762 3489999999999999999999999
Q ss_pred cccccccCCCCCCC----cceeeeeceeeCCC
Q 046265 612 DFGISKFLKPDSSN----WSEFVGTFGYVAPI 639 (639)
Q Consensus 612 DfGla~~~~~~~~~----~~~~~gt~~Y~APE 639 (639)
|||+|+.+...... ....+||+.|+|||
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 216 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHH
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChh
Confidence 99999876543221 12457999999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-27 Score=237.89 Aligned_cols=174 Identities=19% Similarity=0.282 Sum_probs=134.8
Q ss_pred HhccCCCcceeccCCCceEEEEEcC----CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC--
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP----SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR-- 536 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-- 536 (639)
..++|...+.||+|+||.||+|... +++.||||.+..........+.+.+|+.++++++||||+++++++...+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3567788899999999999999643 3468999999866555555677899999999999999999999998765
Q ss_pred ---ceeEEecccCCCChhHHhhcCC---CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEE
Q 046265 537 ---QSFLLYEYLGRGSLAIILSNDA---AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV 610 (639)
Q Consensus 537 ---~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl 610 (639)
..++||||+++|+|.+++.... ....+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence 3599999999999999985322 234689999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 611 SDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 611 ~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
+|||+++....... ......+++.|+|||
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 219 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE 219 (313)
T ss_dssp CSCSCC----------------CCGGGSCHH
T ss_pred eecCcceecccccccCcccccCCCccccCch
Confidence 99999987643321 123356788999998
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-27 Score=244.52 Aligned_cols=177 Identities=21% Similarity=0.277 Sum_probs=141.1
Q ss_pred hHHHHHHHhccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCC---------hhhHHHHHHHHHHHhccccCcee
Q 046265 456 LYEEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPD---------MVVQQAFSNEIKALTELRHRNVV 526 (639)
Q Consensus 456 ~~~~~~~~~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~e~~~l~~l~H~niv 526 (639)
...++....++|...+.||+|+||.||+|...+++.||||++...... ....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456778889999999999999999999998888999999998653321 12236789999999999999999
Q ss_pred eeEEEEEcC-----CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCee
Q 046265 527 KFYGFSFHP-----RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVL 601 (639)
Q Consensus 527 ~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil 601 (639)
++++++... ...|+||||++ |++.+.+.... ..+++..+..++.|++.|++|||.. +|+||||||+||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 999998543 35799999997 68888876543 3578899999999999999999999 9999999999999
Q ss_pred eCCCCceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 602 LGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 602 l~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
++.++.+||+|||+++..... .......||+.|+|||
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE 203 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPE 203 (362)
T ss_dssp ECTTCCEEECCTTC----------------CGGGCCHH
T ss_pred EcCCCCEEEEecCcccccccc-cccceecccceecCcH
Confidence 999999999999999865433 2234568999999998
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=237.20 Aligned_cols=170 Identities=24% Similarity=0.343 Sum_probs=139.3
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.++|+..+.||+|+||.||+|.. .+++.||||.+..... .....+.+.+|+.++++++||||+++++++..++..|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 46788899999999999999965 4788999999875432 233457789999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++++|.+++.... .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999997643 478899999999999999999998 999999999999999999999999999987643
Q ss_pred CC-CCcceeeeeceeeCCC
Q 046265 622 DS-SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~-~~~~~~~gt~~Y~APE 639 (639)
.. .......||+.|+|||
T Consensus 187 ~~~~~~~~~~~~~~y~aPE 205 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPE 205 (309)
T ss_dssp ----------CCGGGCCGG
T ss_pred cccccccccCCCcCccCHH
Confidence 32 2233467999999998
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-27 Score=235.39 Aligned_cols=165 Identities=22% Similarity=0.429 Sum_probs=141.6
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc--------
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH-------- 534 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-------- 534 (639)
..+|+..+.||+|+||.||+|... +++.||||.+.... +.+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 456888899999999999999765 78999999997532 246789999999999999999998864
Q ss_pred --------CCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC
Q 046265 535 --------PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY 606 (639)
Q Consensus 535 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~ 606 (639)
....|+||||+++|+|.+++..... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 3457999999999999999975432 3578899999999999999999998 999999999999999999
Q ss_pred ceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 607 DAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 607 ~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
.+||+|||+++...... ......||+.|+|||
T Consensus 160 ~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE 191 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPE 191 (284)
T ss_dssp EEEECCCTTCEESSCCS-CCCCCCSCCTTSCHH
T ss_pred CEEECcchhheeccccc-cccccCCcccccChh
Confidence 99999999998775432 233457999999998
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=251.18 Aligned_cols=168 Identities=15% Similarity=0.180 Sum_probs=136.5
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCC-CChhhHHHHHHHH---HHHhccccCceeeeE-------EE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPH-PDMVVQQAFSNEI---KALTELRHRNVVKFY-------GF 531 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~---~~l~~l~H~niv~l~-------~~ 531 (639)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+ ..+++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45677789999999999999975 568999999997542 2334567789999 556666899999998 66
Q ss_pred EEcCCc-----------------eeEEecccCCCChhHHhhcCCCC----CCcCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 046265 532 SFHPRQ-----------------SFLLYEYLGRGSLAIILSNDAAI----DEFSWTVRMNVIKSVANTLSYMHHDYFPPI 590 (639)
Q Consensus 532 ~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i 590 (639)
+..++. .|+||||+ +|+|.+++...+.. ..++|..+..++.|+++||+|||.. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 665532 78999999 68999999754322 1345688889999999999999999 99
Q ss_pred EeecCCCCCeeeCCCCceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 591 VHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 591 iHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+||||||+||+++.++.+||+|||+|+.... .....+| +.|+|||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE 272 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPE 272 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChh
Confidence 9999999999999999999999999986432 3345678 9999998
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.94 E-value=8.2e-27 Score=236.83 Aligned_cols=169 Identities=23% Similarity=0.375 Sum_probs=138.1
Q ss_pred HhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc-------
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH------- 534 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------- 534 (639)
..++|+..+.||+|+||.||+|.. .+++.||||.+.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 356788899999999999999965 5789999999864 23345678899999999999999999999865
Q ss_pred ------CCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCce
Q 046265 535 ------PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDA 608 (639)
Q Consensus 535 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~ 608 (639)
.+..|+||||+++|+|.+++.... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~ 155 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNV 155 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCE
Confidence 346799999999999999997543 2467788999999999999999999 99999999999999999999
Q ss_pred EEccccccccCCCCC--------------CCcceeeeeceeeCCC
Q 046265 609 HVSDFGISKFLKPDS--------------SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 609 kl~DfGla~~~~~~~--------------~~~~~~~gt~~Y~APE 639 (639)
||+|||+++...... .......||+.|+|||
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 200 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE 200 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcc
Confidence 999999998764221 1223467999999998
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=9.4e-27 Score=243.70 Aligned_cols=166 Identities=19% Similarity=0.285 Sum_probs=132.6
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC------
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR------ 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 536 (639)
.++|+..+.||+|+||.||+|. ..+++.||||++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 3568888999999999999995 457899999999865545555677889999999999999999999998665
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
..|+||||+++ ++.+.+.. .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999974 78777753 377889999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCCcceeeeeceeeCCC
Q 046265 617 KFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+..... ......+||+.|+|||
T Consensus 175 ~~~~~~-~~~~~~~gt~~y~aPE 196 (371)
T 2xrw_A 175 RTAGTS-FMMTPYVVTRYYRAPE 196 (371)
T ss_dssp ----------------CTTCCHH
T ss_pred cccccc-cccCCceecCCccCHH
Confidence 876432 2234568999999998
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-27 Score=244.77 Aligned_cols=168 Identities=20% Similarity=0.291 Sum_probs=130.3
Q ss_pred cCCCcceeccCCCceEEEEEcC--CC--cEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc-CCceeE
Q 046265 466 NFDAKYCIGTAGQASVYKAELP--SW--EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH-PRQSFL 540 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~l 540 (639)
.|...+.||+|+||.||+|... ++ ..||||.+.... .....+.|.+|+.++++++|||||+++++|.. ++..|+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 3556689999999999999653 22 468999987533 33456779999999999999999999999765 457899
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||||+++|+|.++++.... .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 169 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999976442 467889999999999999999998 99999999999999999999999999998764
Q ss_pred CCCC----CcceeeeeceeeCCC
Q 046265 621 PDSS----NWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~----~~~~~~gt~~Y~APE 639 (639)
.... ......||+.|+|||
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE 266 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALE 266 (373)
T ss_dssp --------------CCGGGSCHH
T ss_pred ccccccccccCCCCCcccccChH
Confidence 3221 123356788999998
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.2e-27 Score=233.72 Aligned_cols=168 Identities=24% Similarity=0.388 Sum_probs=136.6
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|...+.||+|+||.||+|... +++.||||.+..... .....+.+.+|+.++++++||||+++++++..++..|+||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 56778899999999999999764 789999999864221 1123457889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++++|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999997653 377899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
. ......||+.|+|||
T Consensus 165 ~-~~~~~~~~~~y~aPE 180 (276)
T 2h6d_A 165 E-FLRTSCGSPNYAAPE 180 (276)
T ss_dssp -------------CCTG
T ss_pred c-ceecccCCccccCHH
Confidence 2 233467999999998
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=237.19 Aligned_cols=173 Identities=21% Similarity=0.321 Sum_probs=145.5
Q ss_pred HhccCCCcceeccCCCceEEEEEc------CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcC
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHP 535 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 535 (639)
..++|+..+.||+|+||.||+|.. .+++.||||.+.... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 356788899999999999999963 456889999997643 334456789999999999 699999999999876
Q ss_pred C-ceeEEecccCCCChhHHhhcCCC-------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCee
Q 046265 536 R-QSFLLYEYLGRGSLAIILSNDAA-------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVL 601 (639)
Q Consensus 536 ~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nil 601 (639)
+ ..++||||+++|+|.+++..... ...+++..+..++.|+++|++|||.. +|+||||||+||+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil 180 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 180 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEE
Confidence 5 58999999999999999976543 12278899999999999999999998 9999999999999
Q ss_pred eCCCCceEEccccccccCCCCCCC--cceeeeeceeeCCC
Q 046265 602 LGLDYDAHVSDFGISKFLKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 602 l~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~Y~APE 639 (639)
++.++.+||+|||+++........ .....||+.|+|||
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 220 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 220 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCch
Confidence 999999999999999876543221 23467899999998
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-27 Score=244.37 Aligned_cols=165 Identities=22% Similarity=0.351 Sum_probs=125.7
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC------C
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP------R 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~ 536 (639)
.++|+..+.||+|+||.||+|. ..+|+.||||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3678888999999999999995 56789999999976554455567788999999999999999999999754 5
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
..|+||||+ +++|.+++.. ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+|
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 7899988865 2478899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCCcceeeeeceeeCCC
Q 046265 617 KFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+..... ....+||+.|+|||
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE 199 (367)
T 2fst_X 180 RHTADE---MTGYVATRWYRAPE 199 (367)
T ss_dssp --------------CCCTTCCHH
T ss_pred cccccc---CCCcCcCcCccChH
Confidence 875432 34468999999998
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-25 Score=242.78 Aligned_cols=255 Identities=26% Similarity=0.304 Sum_probs=165.6
Q ss_pred CCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccC
Q 046265 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSM 109 (639)
Q Consensus 30 ~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~l 109 (639)
.++++|++++|.++ .+|..+. ++|++|+|++|+++ .+|. .+++|++|+|++|++++ +|. .+.
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~------- 101 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPP------- 101 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCT-------
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCC-------
Confidence 46999999999998 7788776 89999999999998 6776 57899999999999984 444 223
Q ss_pred CCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcC
Q 046265 110 PNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISN 189 (639)
Q Consensus 110 p~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 189 (639)
+| ++|+|++|++++ +|. .+++|+.|++++|++++ +|.. +++|++|++++|.+++. |. .
T Consensus 102 --------~L--~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l-~~---~ 159 (622)
T 3g06_A 102 --------GL--LELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-PA---L 159 (622)
T ss_dssp --------TC--CEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CC---C
T ss_pred --------CC--CEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCc-CC---c
Confidence 23 689999999984 565 57899999999999986 6654 48999999999999853 43 2
Q ss_pred CCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCC
Q 046265 190 LSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQN 269 (639)
Q Consensus 190 l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 269 (639)
+.+|+.|+++++.+...-..+++|+.|++++|.+.+ +|.. +++|+.|++++|.++.... .+++|+.|++++|
T Consensus 160 ~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l~~----~~~~L~~L~Ls~N 231 (622)
T 3g06_A 160 PSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPA----LPSGLKELIVSGN 231 (622)
T ss_dssp CTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSCCC----CCTTCCEEECCSS
T ss_pred cCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccccCC----CCCCCCEEEccCC
Confidence 345666666554433222334555566666655543 3322 2455555555555554221 2345555555544
Q ss_pred cccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeC
Q 046265 270 NFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDL 349 (639)
Q Consensus 270 ~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 349 (639)
.+. .+| ..+++|+.|++++|+++ .+|. .+++|+.|++++|+++ .+|..+..+++|+.|+|
T Consensus 232 ~L~------------~lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L 291 (622)
T 3g06_A 232 RLT------------SLP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291 (622)
T ss_dssp CCS------------CCC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred ccC------------cCC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence 442 133 22345555566555554 3333 3455555555555555 44555555555555555
Q ss_pred CCC
Q 046265 350 STN 352 (639)
Q Consensus 350 s~N 352 (639)
++|
T Consensus 292 ~~N 294 (622)
T 3g06_A 292 EGN 294 (622)
T ss_dssp CSC
T ss_pred cCC
Confidence 553
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-27 Score=241.58 Aligned_cols=168 Identities=24% Similarity=0.340 Sum_probs=135.8
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcE----EEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEI----VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
++|+..+.||+|+||.||+|.. .+++. ||+|.+..... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 4677788999999999999964 44443 88888764321 222345678999999999999999999986 46689
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||+++|+|.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 91 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 9999999999999997643 2477788999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCC--CcceeeeeceeeCCC
Q 046265 620 KPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~--~~~~~~gt~~Y~APE 639 (639)
..... ......||+.|+|||
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE 187 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALE 187 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHH
T ss_pred CcccccccccCCCCcccccChH
Confidence 54322 234467888999998
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-27 Score=244.80 Aligned_cols=168 Identities=24% Similarity=0.373 Sum_probs=143.7
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|+.++++++||||+++++++..++..|+||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 356888899999999999999654 78999999997643 3445677899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++.... .+++..+..++.+++.|++|||+.+ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 111 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred ECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999997653 4778999999999999999999842 7999999999999999999999999998765321
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
......||+.|+|||
T Consensus 186 --~~~~~~gt~~y~aPE 200 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPE 200 (360)
T ss_dssp --C----CCCCTTCCHH
T ss_pred --cccCCCCCCCeECHH
Confidence 223467999999998
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=233.48 Aligned_cols=167 Identities=18% Similarity=0.359 Sum_probs=142.2
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
++|+..+.||+|+||.||+|...+++.||||.+..... ..+.+.+|++++++++||||+++++++.. +..++||||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 56778899999999999999988888999999975432 35678999999999999999999999864 568999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++++|.+++..... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999999975321 2478899999999999999999998 999999999999999999999999999987653321
Q ss_pred -CcceeeeeceeeCCC
Q 046265 625 -NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 -~~~~~~gt~~Y~APE 639 (639)
......|++.|+|||
T Consensus 165 ~~~~~~~~~~~y~aPE 180 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPE 180 (279)
T ss_dssp ECCTTCCCCTTTSCHH
T ss_pred ccccCCCCccCccChh
Confidence 122345788999998
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.1e-27 Score=235.27 Aligned_cols=168 Identities=26% Similarity=0.455 Sum_probs=143.9
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
.++|+..+.||+|+||.||+|... +++.||||.+..... .....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 356888899999999999999654 678899999864221 112246788999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++|+|.+++.... .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999997653 478899999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
. ......||+.|+|||
T Consensus 167 ~--~~~~~~~~~~y~aPE 182 (284)
T 2vgo_A 167 L--RRRTMCGTLDYLPPE 182 (284)
T ss_dssp S--CBCCCCSCGGGCCHH
T ss_pred c--ccccccCCCCcCCHH
Confidence 2 223467999999998
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-27 Score=241.29 Aligned_cols=172 Identities=24% Similarity=0.313 Sum_probs=144.2
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CC-----cEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCC
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SW-----EIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPR 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 536 (639)
.++|+..+.||+|+||.||+|... ++ ..||||.+.... .....+.+.+|+.+++++ +||||+++++++..++
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 356778899999999999999653 22 479999997543 334567789999999999 8999999999999999
Q ss_pred ceeEEecccCCCChhHHhhcCCC-----------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAA-----------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD 605 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~ 605 (639)
..|+||||+++|+|.+++..... ...+++..+..++.|++.||+|||.. +|+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence 99999999999999999875321 23478899999999999999999998 99999999999999999
Q ss_pred CceEEccccccccCCCCCCC--cceeeeeceeeCCC
Q 046265 606 YDAHVSDFGISKFLKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 606 ~~~kl~DfGla~~~~~~~~~--~~~~~gt~~Y~APE 639 (639)
+.+||+|||+++........ .....||+.|+|||
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 236 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE 236 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHH
Confidence 99999999999865433221 23356888999998
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=236.84 Aligned_cols=167 Identities=28% Similarity=0.421 Sum_probs=140.8
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.+.|+..+.||+|+||.||+|... +|+.||||.+.... ..+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 467888899999999999999654 68999999997543 2356889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++.... ..+++..+..++.+++.|++|||.. +|+||||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999986432 3578899999999999999999998 9999999999999999999999999999876544
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
........||+.|+|||
T Consensus 179 ~~~~~~~~~~~~y~aPE 195 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPE 195 (314)
T ss_dssp BSCBCCCCSCGGGCCHH
T ss_pred ccccCccCCCCCccChh
Confidence 33344568999999998
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-28 Score=250.68 Aligned_cols=258 Identities=18% Similarity=0.167 Sum_probs=159.8
Q ss_pred CCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCC
Q 046265 32 LKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPN 111 (639)
Q Consensus 32 L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~ 111 (639)
++.++++.+.+...++..+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..| +..+++|
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L------- 82 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTL------- 82 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTC-------
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCC-------
Confidence 4455666666654444444556677777777777765555666777777777777776665433 4443322
Q ss_pred CCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCC
Q 046265 112 SLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLS 191 (639)
Q Consensus 112 ~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 191 (639)
++|++++|++++. | ..++|++|++++|++++..+. .+++
T Consensus 83 ----------~~L~Ls~n~l~~l-~----~~~~L~~L~l~~n~l~~~~~~---~~~~----------------------- 121 (317)
T 3o53_A 83 ----------RTLDLNNNYVQEL-L----VGPSIETLHAANNNISRVSCS---RGQG----------------------- 121 (317)
T ss_dssp ----------CEEECCSSEEEEE-E----ECTTCCEEECCSSCCSEEEEC---CCSS-----------------------
T ss_pred ----------CEEECcCCccccc-c----CCCCcCEEECCCCccCCcCcc---ccCC-----------------------
Confidence 3566666665532 2 125555555555555432221 1233
Q ss_pred CCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhh-hcCCCccEEeccCCc
Q 046265 192 NLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVF-GIYPNLTFLDLSQNN 270 (639)
Q Consensus 192 ~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~ 270 (639)
|+.|++++|++.+..|..+..+++|++|++++|.+++..+..+ ..+++|++|++++|.
T Consensus 122 ---------------------L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 180 (317)
T 3o53_A 122 ---------------------KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (317)
T ss_dssp ---------------------CEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred ---------------------CCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCc
Confidence 4444555555555445555566666666677676666555554 356777777766666
Q ss_pred ccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCC
Q 046265 271 FYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLS 350 (639)
Q Consensus 271 l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 350 (639)
+.+ +|. ...+++|+.|++++|++.+ +|..+..+++|+.|++++|+++ .+|..+..+++|+.|+++
T Consensus 181 l~~------------~~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~ 245 (317)
T 3o53_A 181 IYD------------VKG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLR 245 (317)
T ss_dssp CCE------------EEC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECT
T ss_pred Ccc------------ccc-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEcc
Confidence 531 222 2246778888888888874 4445788888888888888887 467778888888888888
Q ss_pred CCCCCcccccCChhhhccccCCeeecc
Q 046265 351 TNYNNEFRKEFPVELEKLVQLTELDLV 377 (639)
Q Consensus 351 ~N~~~~~~~~~p~~~~~l~~L~~l~l~ 377 (639)
+|++. .+.+|..+..++.|+.+++.
T Consensus 246 ~N~~~--~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 246 GNGFH--CGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp TCCCB--HHHHHHHHHTCHHHHHHHHH
T ss_pred CCCcc--CcCHHHHHhccccceEEECC
Confidence 85432 14567777888888888776
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=234.46 Aligned_cols=169 Identities=20% Similarity=0.297 Sum_probs=139.0
Q ss_pred ccCCCcceeccCCCceEEEEEcCC----CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc-CCcee
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS----WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH-PRQSF 539 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~ 539 (639)
..|+..+.||+|+||.||+|...+ ...||||.+.... .....+.+.+|+.++++++||||++++++|.. ++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 456778899999999999997542 2358999987533 34456778999999999999999999999754 46789
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||+++|+|.+++.... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 104 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999997643 3578899999999999999999998 9999999999999999999999999999876
Q ss_pred CCCC----CCcceeeeeceeeCCC
Q 046265 620 KPDS----SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~----~~~~~~~gt~~Y~APE 639 (639)
.... .......||+.|+|||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE 202 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALE 202 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHH
T ss_pred cccchhccccccCCCCCccccChH
Confidence 4322 1223456888999998
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-27 Score=243.55 Aligned_cols=169 Identities=22% Similarity=0.395 Sum_probs=144.6
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCCh---------------hhHHHHHHHHHHHhccccCceeee
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDM---------------VVQQAFSNEIKALTELRHRNVVKF 528 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~---------------~~~~~~~~e~~~l~~l~H~niv~l 528 (639)
.++|...+.||+|+||.||+|.. +++.||||.+....... ...+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35788889999999999999987 88999999987432111 011778999999999999999999
Q ss_pred EEEEEcCCceeEEecccCCCChhHH------hhcCCCCCCcCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCee
Q 046265 529 YGFSFHPRQSFLLYEYLGRGSLAII------LSNDAAIDEFSWTVRMNVIKSVANTLSYMHH-DYFPPIVHRDISSKNVL 601 (639)
Q Consensus 529 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~iiHrdlk~~Nil 601 (639)
++++.+.+..|+||||+++|+|.++ +.... ...+++..+..++.|++.|++|||. . +|+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999998 54321 2468899999999999999999998 7 9999999999999
Q ss_pred eCCCCceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 602 LGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 602 l~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
++.++.+||+|||.+...... ......||+.|+|||
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE 220 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPE 220 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGG
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCch
Confidence 999999999999999876432 234467999999998
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=232.77 Aligned_cols=169 Identities=24% Similarity=0.385 Sum_probs=145.9
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCC-------hhhHHHHHHHHHHHhccc-cCceeeeEEEEEc
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPD-------MVVQQAFSNEIKALTELR-HRNVVKFYGFSFH 534 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~ 534 (639)
.++|+..+.||+|+||.||+|.. .+++.||||.+...... ....+.+.+|+.++++++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 46788889999999999999965 46899999999754311 123466789999999996 9999999999999
Q ss_pred CCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 046265 535 PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614 (639)
Q Consensus 535 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfG 614 (639)
.+..++||||+++++|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence 999999999999999999997643 478899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
++....... ......||+.|+|||
T Consensus 170 ~~~~~~~~~-~~~~~~~~~~y~aPE 193 (298)
T 1phk_A 170 FSCQLDPGE-KLREVCGTPSYLAPE 193 (298)
T ss_dssp TCEECCTTC-CBCCCCSCGGGCCHH
T ss_pred chhhcCCCc-ccccccCCccccCHH
Confidence 998765432 334567999999998
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=234.82 Aligned_cols=166 Identities=24% Similarity=0.373 Sum_probs=141.7
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|...+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 45788889999999999999965 478999999998543 223456889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEccccccccC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL---GLDYDAHVSDFGISKFL 619 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill---~~~~~~kl~DfGla~~~ 619 (639)
||+++|+|.+++...+ .+++..+..++.|++.|++|||.. +|+||||||+||++ +.++.+||+|||+++..
T Consensus 86 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 86 QLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999999987543 477899999999999999999998 99999999999999 78899999999999765
Q ss_pred CCCCCCcceeeeeceeeCCC
Q 046265 620 KPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~~~~~~gt~~Y~APE 639 (639)
... .....+||+.|+|||
T Consensus 160 ~~~--~~~~~~~~~~y~aPE 177 (304)
T 2jam_A 160 QNG--IMSTACGTPGYVAPE 177 (304)
T ss_dssp CCB--TTHHHHSCCCBCCTT
T ss_pred CCC--ccccccCCCCccChH
Confidence 422 234467999999998
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=254.86 Aligned_cols=237 Identities=21% Similarity=0.195 Sum_probs=174.0
Q ss_pred CCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCccc
Q 046265 29 ISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGS 108 (639)
Q Consensus 29 l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~ 108 (639)
+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..| |+.+++|++|+|++|.+++..+. +
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~-----~------ 99 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG-----P------ 99 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC-----T------
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC-----C------
Confidence 3489999999999998888889999999999999999986554 88999999999999998854322 2
Q ss_pred CCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCc
Q 046265 109 MPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSIS 188 (639)
Q Consensus 109 lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 188 (639)
.|++|++++|.+++..+. .+++|++|+|++|.+++..|..++.+++|+.|++++|.+++..|..+.
T Consensus 100 -----------~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~ 165 (487)
T 3oja_A 100 -----------SIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165 (487)
T ss_dssp -----------TCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGG
T ss_pred -----------CcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHh
Confidence 236899999999866554 457899999999999888888888889999999999988877665543
Q ss_pred CCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccC
Q 046265 189 NLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQ 268 (639)
Q Consensus 189 ~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 268 (639)
..+++|+.|++++|.+.+. |. ...+++|+.|+|++|.+++.++. +..+++|+.|++++
T Consensus 166 -------------------~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~ 223 (487)
T 3oja_A 166 -------------------ASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRN 223 (487)
T ss_dssp -------------------GGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTT
T ss_pred -------------------hhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecC
Confidence 1334555666666666554 22 23477777777777777765444 66677777777666
Q ss_pred CcccccccCcCCccccccCccccCCCCCCEEeccCCccc-ccCCccccCCCCCCeeecc
Q 046265 269 NNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIV-GELPIELGNLKSLNYRALN 326 (639)
Q Consensus 269 N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~-~~~p~~~~~l~~L~~L~l~ 326 (639)
|.+. .+|..+..+++|+.|++++|.+. +.+|..+..++.|+.++++
T Consensus 224 N~l~------------~lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 224 NKLV------------LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp SCCC------------EECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred CcCc------------ccchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 6552 35666666777777777777776 5556666666666666554
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=238.52 Aligned_cols=169 Identities=24% Similarity=0.382 Sum_probs=136.0
Q ss_pred ccCCCcceeccCCCceEEEEEcCC-----CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS-----WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
.+|...+.||+|+||.||+|.... +..||||.+.... .......+.+|+.++++++||||+++++++...+..+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 345567899999999999996542 2459999997543 3445667899999999999999999999999999999
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||+++|+|.+++.... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999997543 3578899999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCC---cceeeeeceeeCCC
Q 046265 620 KPDSSN---WSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~---~~~~~gt~~Y~APE 639 (639)
...... .....+|+.|+|||
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE 220 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPE 220 (333)
T ss_dssp -------------CCCGGGSCHH
T ss_pred ccccccccccCCCCccccccCch
Confidence 533221 12245678999998
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=239.27 Aligned_cols=169 Identities=23% Similarity=0.360 Sum_probs=138.9
Q ss_pred hccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.+.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..++..|+||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 467788899999999999999665 58999999987543 233567889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++++|.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||++......
T Consensus 96 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp ECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999886532 2478899999999999999999998 9999999999999999999999999987643211
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
........||+.|+|||
T Consensus 171 ~~~~~~~~~~~~y~aPE 187 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPE 187 (302)
T ss_dssp HHC-----CCGGGCCHH
T ss_pred ccccccccCChhhcCCe
Confidence 11223457999999998
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.6e-26 Score=226.37 Aligned_cols=234 Identities=20% Similarity=0.223 Sum_probs=177.8
Q ss_pred ccceeeeE-EEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCC
Q 046265 2 SCLAFFFF-QVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSL 80 (639)
Q Consensus 2 ~~~~~~~~-~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L 80 (639)
+|.+.... .++-.+.+ ...+|..+. ++|++|+|++|.+++..+..|..+++|++|++++|++++..+..|.++++|
T Consensus 2 ~C~~~~~~~~~~c~~~~-l~~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 78 (276)
T 2z62_A 2 PCVEVVPNITYQCMELN-FYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78 (276)
T ss_dssp CSEEEETTTEEECTTSC-CSSCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTC
T ss_pred CceeccCCceEEecCCC-ccccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCC
Confidence 46554432 23344334 446787765 589999999999998777799999999999999999997777789999999
Q ss_pred CEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCC-C
Q 046265 81 KQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGS-I 159 (639)
Q Consensus 81 ~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~ 159 (639)
++|++++|++++..|..|.++++| ++|++++|++++..+..+..+++|++|++++|.+++. +
T Consensus 79 ~~L~L~~n~l~~~~~~~~~~l~~L-----------------~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l 141 (276)
T 2z62_A 79 STLILTGNPIQSLALGAFSGLSSL-----------------QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL 141 (276)
T ss_dssp CEEECTTCCCCEECTTTTTTCTTC-----------------CEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCC
T ss_pred CEEECCCCccCccChhhhcCCccc-----------------cEEECCCCCccccCchhcccCCCCCEEECcCCccceecC
Confidence 999999999998877888777743 5899999999877776899999999999999999863 6
Q ss_pred CccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCce
Q 046265 160 PPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNI 239 (639)
Q Consensus 160 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 239 (639)
|..+..+++|+.|++++|.+++..+..+..+.+|+.+.+ .|++++|.+.+..+..+. ..+|+.
T Consensus 142 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l----------------~L~ls~n~l~~~~~~~~~-~~~L~~ 204 (276)
T 2z62_A 142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL----------------SLDLSLNPMNFIQPGAFK-EIRLKE 204 (276)
T ss_dssp CGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCE----------------EEECCSSCCCEECTTSSC-SCCEEE
T ss_pred chhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccce----------------eeecCCCcccccCccccC-CCcccE
Confidence 889999999999999999998776666554444332111 677777777654444443 346777
Q ss_pred eccccccccCcchhhhhcCCCccEEeccCCccc
Q 046265 240 VHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFY 272 (639)
Q Consensus 240 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 272 (639)
|++++|.+++..+..|..+++|+.|++++|.+.
T Consensus 205 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 237 (276)
T 2z62_A 205 LALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237 (276)
T ss_dssp EECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred EECCCCceeecCHhHhcccccccEEEccCCccc
Confidence 777777777766666666777777776666553
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=231.37 Aligned_cols=167 Identities=25% Similarity=0.323 Sum_probs=140.0
Q ss_pred cCCCcc-eeccCCCceEEEEEcC---CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 466 NFDAKY-CIGTAGQASVYKAELP---SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 466 ~f~~~~-~ig~g~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
+|.... .||+|+||.||+|... +++.||||.+.... .....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 344444 8999999999999643 57889999998643 344567789999999999999999999999 45678999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++++|.+++.... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999997543 3578899999999999999999998 999999999999999999999999999987653
Q ss_pred CCC---CcceeeeeceeeCCC
Q 046265 622 DSS---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~---~~~~~~gt~~Y~APE 639 (639)
... ......||+.|+|||
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE 183 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPE 183 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHH
T ss_pred CcceeeccccccccccccCHH
Confidence 322 122345789999998
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.93 E-value=9.5e-27 Score=234.97 Aligned_cols=172 Identities=22% Similarity=0.302 Sum_probs=131.1
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|+..+.||+|+||.||+|.. .+++.||||++..........+.+.++...++.++||||+++++++.+++..|+||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788889999999999999965 67899999999865433344444555666688899999999999999999999999
Q ss_pred cccCCCChhHHhhcC-CCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 543 EYLGRGSLAIILSND-AAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 543 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
||++ |++.+++... .....+++..+..++.|++.|++|||... +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 5887776531 12245889999999999999999999852 799999999999999999999999999987654
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
.. ......||+.|+|||
T Consensus 163 ~~-~~~~~~~t~~y~aPE 179 (290)
T 3fme_A 163 DV-AKDIDAGCKPYMAPE 179 (290)
T ss_dssp --------CCCCCCSCHH
T ss_pred cc-cccccCCCccccChh
Confidence 32 223457999999998
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.8e-27 Score=259.66 Aligned_cols=162 Identities=23% Similarity=0.323 Sum_probs=134.5
Q ss_pred ceeccCCCceEEEEEc---CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCC
Q 046265 471 YCIGTAGQASVYKAEL---PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
+.||+|+||.||+|.. .+++.||||+++.........+.+.+|+.++++++|||||+++++|.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999954 346789999998654444556789999999999999999999999975 568899999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC---
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS--- 624 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~--- 624 (639)
|+|.+++.... .+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+|+.+.....
T Consensus 454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999997543 478899999999999999999998 999999999999999999999999999987654322
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......||+.|+|||
T Consensus 528 ~~~~~~~t~~y~APE 542 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPE 542 (635)
T ss_dssp -------CGGGSCHH
T ss_pred cccCCCCceeeeChh
Confidence 122345788999998
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.1e-27 Score=246.01 Aligned_cols=165 Identities=22% Similarity=0.276 Sum_probs=134.7
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc------e
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ------S 538 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------~ 538 (639)
.+|...++||+|+||.||+|+...+..||||++...... ..+|+++++.++|||||+++++|...+. .
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 457788999999999999998877777999998653311 2369999999999999999999965443 7
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG-LDYDAHVSDFGISK 617 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~-~~~~~kl~DfGla~ 617 (639)
++||||++++.+............+++..+..++.|+++||+|||.. +|+||||||+||+++ .++.+||+|||+|+
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 89999998765544443222234688899999999999999999998 999999999999999 78999999999998
Q ss_pred cCCCCCCCcceeeeeceeeCCC
Q 046265 618 FLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~~~~~~gt~~Y~APE 639 (639)
.+.... .....+||+.|+|||
T Consensus 191 ~~~~~~-~~~~~~~t~~y~aPE 211 (394)
T 4e7w_A 191 ILIAGE-PNVSYICSRYYRAPE 211 (394)
T ss_dssp ECCTTC-CCCSSCSCGGGCCHH
T ss_pred cccCCC-CCcccccCcCccCHH
Confidence 765432 233568999999998
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=233.07 Aligned_cols=168 Identities=23% Similarity=0.318 Sum_probs=138.0
Q ss_pred ccCCCcc-eeccCCCceEEEEEc---CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 465 NNFDAKY-CIGTAGQASVYKAEL---PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 465 ~~f~~~~-~ig~g~~g~vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
.+|...+ .||+|+||.||+|.. .+++.||||.+..........+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4566666 899999999999943 3468899999986554445567899999999999999999999999 5567899
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||||+++++|.+++.... .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 95 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 999999999999997643 478899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC---cceeeeeceeeCCC
Q 046265 621 PDSSN---WSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~---~~~~~gt~~Y~APE 639 (639)
..... .....|++.|+|||
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE 190 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPE 190 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHH
T ss_pred cCCCcccccccCCCCceeeChH
Confidence 43321 12245678999998
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-26 Score=232.06 Aligned_cols=166 Identities=21% Similarity=0.278 Sum_probs=141.9
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 541 (639)
.++|+..+.||+|+||.||+|. ..+++.||||.+..... .+.+.+|+.+++++ +|+|++++++++......++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 3568888999999999999996 46789999999875432 23477899999998 799999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc-----eEEcccccc
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD-----AHVSDFGIS 616 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~-----~kl~DfGla 616 (639)
|||+ +++|.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++. +||+|||++
T Consensus 85 ~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 9999 999999997643 2478899999999999999999998 9999999999999987776 999999999
Q ss_pred ccCCCCCC-------CcceeeeeceeeCCC
Q 046265 617 KFLKPDSS-------NWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~-------~~~~~~gt~~Y~APE 639 (639)
+....... ......||+.|+|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 188 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSIN 188 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred cccccccccccccccCccCCCCCcccCCch
Confidence 87654322 124567999999998
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.93 E-value=7.5e-27 Score=243.89 Aligned_cols=170 Identities=21% Similarity=0.300 Sum_probs=136.2
Q ss_pred hccCCCcceeccCCCceEEEEEcCC------CcEEEEEEccCCCCChh---------hHHHHHHHHHHHhccccCceeee
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPS------WEIVAVKKFHSPHPDMV---------VQQAFSNEIKALTELRHRNVVKF 528 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~------~~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~H~niv~l 528 (639)
..+|+..+.||+|+||.||+|.... ++.||||.+........ ....+.+|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578888999999999999997654 47799999875431111 11223456667788899999999
Q ss_pred EEEEEcC----CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-
Q 046265 529 YGFSFHP----RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG- 603 (639)
Q Consensus 529 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~- 603 (639)
++++... ...|+||||+ +++|.+++.... ..+++..+..++.|++.||+|||.. +|+||||||+||+++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 9999865 4589999999 999999997643 3589999999999999999999999 999999999999998
Q ss_pred -CCCceEEccccccccCCCCCC-------CcceeeeeceeeCCC
Q 046265 604 -LDYDAHVSDFGISKFLKPDSS-------NWSEFVGTFGYVAPI 639 (639)
Q Consensus 604 -~~~~~kl~DfGla~~~~~~~~-------~~~~~~gt~~Y~APE 639 (639)
.++.+||+|||+|+.+..... .....+||+.|||||
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 231 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSID 231 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHH
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHH
Confidence 889999999999987643211 123456999999998
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=237.95 Aligned_cols=170 Identities=25% Similarity=0.435 Sum_probs=138.8
Q ss_pred HhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEc------
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFH------ 534 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~------ 534 (639)
...+|+..+.||+|+||.||+|.. .+++.||||.+.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 456788889999999999999965 578999999987543 2345788999999998 79999999999986
Q ss_pred CCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 046265 535 PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614 (639)
Q Consensus 535 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfG 614 (639)
.+..|+||||+++|+|.+++..... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCc
Confidence 4678999999999999999976432 3578889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
++..............||+.|+|||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE 199 (326)
T 2x7f_A 175 VSAQLDRTVGRRNTFIGTPYWMAPE 199 (326)
T ss_dssp TTC-------------CCGGGCCHH
T ss_pred CceecCcCccccccccCCccccChh
Confidence 9987654333334568999999998
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=234.92 Aligned_cols=160 Identities=20% Similarity=0.347 Sum_probs=139.4
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEc--CCceeE
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFH--PRQSFL 540 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~--~~~~~l 540 (639)
++|+..+.||+|+||.||+|. ..+++.||||.+.... .+.+.+|+.++++++ ||||+++++++.. ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 678888999999999999995 5678999999987432 456889999999997 9999999999998 567899
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEccccccccC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY-DAHVSDFGISKFL 619 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~-~~kl~DfGla~~~ 619 (639)
||||+++++|.+++. .+++..+..++.|++.|++|||.. +|+||||||+||+++.++ .+||+|||+|+..
T Consensus 111 v~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 999999999999885 367788999999999999999998 999999999999999776 8999999999876
Q ss_pred CCCCCCcceeeeeceeeCCC
Q 046265 620 KPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~~~~~~gt~~Y~APE 639 (639)
.... ......||+.|+|||
T Consensus 182 ~~~~-~~~~~~~~~~y~aPE 200 (330)
T 3nsz_A 182 HPGQ-EYNVRVASRYFKGPE 200 (330)
T ss_dssp CTTC-CCCSCCSCGGGCCHH
T ss_pred CCCC-ccccccccccccChh
Confidence 5432 234467999999998
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=238.19 Aligned_cols=168 Identities=23% Similarity=0.305 Sum_probs=137.9
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC------ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP------DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 536 (639)
.++|...+.||+|+||.||+|.. .+++.||||.+..... .......+.+|+.++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46788899999999999999965 5678999999875431 1122345789999999999999999999987655
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc---eEEccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD---AHVSDF 613 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~---~kl~Df 613 (639)
.|+||||+++|+|.+++.... .+++..+..++.|+++|++|||.. +|+||||||+||+++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 899999999999999887543 478899999999999999999998 9999999999999987654 999999
Q ss_pred cccccCCCCCCCcceeeeeceeeCCC
Q 046265 614 GISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 614 Gla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|+++..... .......||+.|+|||
T Consensus 162 g~~~~~~~~-~~~~~~~gt~~y~aPE 186 (322)
T 2ycf_A 162 GHSKILGET-SLMRTLCGTPTYLAPE 186 (322)
T ss_dssp TTCEECCCC-HHHHHHHSCCTTCCHH
T ss_pred ccceecccc-cccccccCCcCccCch
Confidence 999876432 1223467999999998
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.9e-27 Score=237.08 Aligned_cols=172 Identities=27% Similarity=0.440 Sum_probs=127.5
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|+..+.||+|+||.||+|.. .+++.||||.+..... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 46788899999999999999965 4678999999875432 223456889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcC-----CCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 543 EYLGRGSLAIILSND-----AAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 543 e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
||+++|+|.+++... .....+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998631 1224588999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCC-----CcceeeeeceeeCCC
Q 046265 618 FLKPDSS-----NWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~-----~~~~~~gt~~Y~APE 639 (639)
....... ......||+.|+|||
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE 196 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPE 196 (303)
T ss_dssp HCC---------------CCCTTCCHH
T ss_pred eeccCCCccchhhhcccCCCccccCHH
Confidence 6643211 123467999999998
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-26 Score=236.08 Aligned_cols=165 Identities=26% Similarity=0.343 Sum_probs=141.3
Q ss_pred HHhccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhc--cccCceeeeEEEEEcCC---
Q 046265 462 RATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTE--LRHRNVVKFYGFSFHPR--- 536 (639)
Q Consensus 462 ~~~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~~--- 536 (639)
...++|+..+.||+|+||.||+|.. +++.||||.+... ....+.+|++++.. ++||||+++++++...+
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 3457899999999999999999987 4799999998642 34567788888877 78999999999998876
Q ss_pred -ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeecCCCCCeeeCCCCc
Q 046265 537 -QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH--------HDYFPPIVHRDISSKNVLLGLDYD 607 (639)
Q Consensus 537 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------~~~~~~iiHrdlk~~Nill~~~~~ 607 (639)
..|+||||+++|+|.+++... .+++..+..++.|++.|++||| .. +|+||||||+||+++.++.
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSC
T ss_pred ceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCC
Confidence 789999999999999999753 4788999999999999999999 55 8999999999999999999
Q ss_pred eEEccccccccCCCCCC----CcceeeeeceeeCCC
Q 046265 608 AHVSDFGISKFLKPDSS----NWSEFVGTFGYVAPI 639 (639)
Q Consensus 608 ~kl~DfGla~~~~~~~~----~~~~~~gt~~Y~APE 639 (639)
+||+|||+++....... ......||+.|+|||
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 221 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHH
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHh
Confidence 99999999987654322 123457999999998
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=256.42 Aligned_cols=161 Identities=24% Similarity=0.322 Sum_probs=133.1
Q ss_pred eeccCCCceEEEEEcC---CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCCC
Q 046265 472 CIGTAGQASVYKAELP---SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRG 548 (639)
Q Consensus 472 ~ig~g~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 548 (639)
.||+|+||.||+|..+ ++..||||.++... .....+.|.+|+.++++++|||||+++++|.. +..|+|||||++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 7999999999999653 45679999998643 23346779999999999999999999999976 5689999999999
Q ss_pred ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC---
Q 046265 549 SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN--- 625 (639)
Q Consensus 549 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~--- 625 (639)
+|.+++.... ..+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+|+.+......
T Consensus 421 ~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 421 PLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp BHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred cHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 9999997543 3588999999999999999999998 9999999999999999999999999999876533221
Q ss_pred cceeeeeceeeCCC
Q 046265 626 WSEFVGTFGYVAPI 639 (639)
Q Consensus 626 ~~~~~gt~~Y~APE 639 (639)
.....+++.|||||
T Consensus 496 ~~~~~~~~~y~APE 509 (613)
T 2ozo_A 496 RSAGKWPLKWYAPE 509 (613)
T ss_dssp ------CCTTSCHH
T ss_pred ccCCCCccceeCHh
Confidence 12234668999998
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=235.04 Aligned_cols=169 Identities=24% Similarity=0.379 Sum_probs=142.3
Q ss_pred hccCCCcceeccCCCceEEEEEc-----CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC--
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-----PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR-- 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-- 536 (639)
..+|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 34577788999999999999973 468899999997632 344567899999999999999999999987654
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
..++||||+++|+|.+++.... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||++
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence 7899999999999999997653 2478899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCC---cceeeeeceeeCCC
Q 046265 617 KFLKPDSSN---WSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~~---~~~~~gt~~Y~APE 639 (639)
+........ .....++..|+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE 218 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPE 218 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHH
T ss_pred hhccccccccccccCCCCceeEECch
Confidence 876543221 12345778899998
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=237.15 Aligned_cols=172 Identities=23% Similarity=0.346 Sum_probs=140.1
Q ss_pred hccCCCcceeccCCCceEEEEEc------CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 537 (639)
..+|+..+.||+|+||.||+|.. .+++.||||.+.... .......+.+|+.++++++||||+++++++...+.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 36788889999999999999974 356789999997543 33455678999999999999999999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCC----CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEE
Q 046265 538 SFLLYEYLGRGSLAIILSNDAA----IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL---DYDAHV 610 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~---~~~~kl 610 (639)
.|+||||+++|+|.+++..... ...+++..+..++.|++.|++|||.. +|+||||||+||+++. ...+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999976432 13588999999999999999999998 9999999999999984 446999
Q ss_pred ccccccccCCCCC--CCcceeeeeceeeCCC
Q 046265 611 SDFGISKFLKPDS--SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 611 ~DfGla~~~~~~~--~~~~~~~gt~~Y~APE 639 (639)
+|||+++...... .......||+.|+|||
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 215 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHh
Confidence 9999998653222 1123356889999998
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=231.58 Aligned_cols=167 Identities=21% Similarity=0.299 Sum_probs=139.1
Q ss_pred CCCcceeccCCCceEEEEEcC-CC---cEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCce-eEE
Q 046265 467 FDAKYCIGTAGQASVYKAELP-SW---EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS-FLL 541 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~-~lv 541 (639)
|...+.||+|+||.||+|... ++ ..||||.+.... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 445688999999999999643 22 379999987533 344567789999999999999999999999876655 999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+.+|+|.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999997643 3578899999999999999999999 999999999999999999999999999986543
Q ss_pred CC----CCcceeeeeceeeCCC
Q 046265 622 DS----SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~----~~~~~~~gt~~Y~APE 639 (639)
.. .......||+.|+|||
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE 198 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALE 198 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHH
T ss_pred CcccccccCcCCCCCccccChh
Confidence 21 1223456889999998
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=236.30 Aligned_cols=170 Identities=23% Similarity=0.346 Sum_probs=138.8
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcE--EEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeE
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEI--VAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~--vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 540 (639)
++|+..+.||+|+||.||+|+. .++.. ||||.+.... .....+.+.+|+++++++ +||||+++++++.+.+..|+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 5778889999999999999965 45554 5999987532 223445688999999999 89999999999999999999
Q ss_pred EecccCCCChhHHhhcCC-------------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 046265 541 LYEYLGRGSLAIILSNDA-------------AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD 607 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~ 607 (639)
||||+++|+|.+++.... ....+++..+..++.|+++|++|||.. +|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999997653 123588999999999999999999998 9999999999999999999
Q ss_pred eEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 608 AHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 608 ~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+||+|||+++...... ......+++.|+|||
T Consensus 181 ~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE 211 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV-KKTMGRLPVRWMAIE 211 (327)
T ss_dssp EEECCTTCEESSCEEC-CC----CCTTTCCHH
T ss_pred EEEcccCcCccccccc-cccCCCCCccccChh
Confidence 9999999998543221 123346788999998
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=7.1e-27 Score=256.07 Aligned_cols=168 Identities=20% Similarity=0.388 Sum_probs=142.2
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.++|+..+.||+|+||.||+|...++..||||+++.... ..+.|.+|++++++++|||||++++++.+ +..|+|||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 356777889999999999999988888899999985432 34678999999999999999999999876 67899999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++|+|.++++.... ..+++..+..++.|+++||+|||.. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 342 ~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hhcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 9999999999974321 2478899999999999999999998 99999999999999999999999999998764321
Q ss_pred -CCcceeeeeceeeCCC
Q 046265 624 -SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 -~~~~~~~gt~~Y~APE 639 (639)
.......++..|||||
T Consensus 418 ~~~~~~~~~~~~y~aPE 434 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPE 434 (535)
T ss_dssp HHTTCSTTSCGGGSCHH
T ss_pred eecccCCcCcccccCHH
Confidence 1112235678999998
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=241.05 Aligned_cols=164 Identities=24% Similarity=0.367 Sum_probs=138.3
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCce----
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS---- 538 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~---- 538 (639)
.++|...+.||+|+||.||+|. ..+|+.||||++..........+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3567788999999999999995 45789999999987655555567889999999999999999999999877654
Q ss_pred --eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 539 --FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 539 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
|+||||++ |+|.+.+.. .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 688877743 378899999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCcceeeeeceeeCCC
Q 046265 617 KFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+..... ....+||+.|+|||
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE 211 (371)
T 4exu_A 192 RHADAE---MTGYVVTRWYRAPE 211 (371)
T ss_dssp -----------CTTCCCTTSCHH
T ss_pred cccccC---cCCcccCccccCHH
Confidence 865432 23457899999998
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=229.65 Aligned_cols=169 Identities=19% Similarity=0.294 Sum_probs=139.0
Q ss_pred hccCCCcceeccCCCceEEEEEcCC----CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPS----WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
.++|...+.||+|+||.||+|.... +..||||.+.... .....+.+.+|+.++++++||||+++++++.+ +..|
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 4677888999999999999996432 3469999987643 33456778999999999999999999999865 4578
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||+++++|.+++.... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999997543 2478899999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCC-CcceeeeeceeeCCC
Q 046265 620 KPDSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~-~~~~~~gt~~Y~APE 639 (639)
..... ......||+.|+|||
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE 184 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPE 184 (281)
T ss_dssp ---------CCCCCGGGCCHH
T ss_pred ccccccccccCCCCcceeCch
Confidence 54322 223356788999998
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-26 Score=236.61 Aligned_cols=169 Identities=22% Similarity=0.262 Sum_probs=129.3
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEc--------
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFH-------- 534 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~-------- 534 (639)
.+|+..+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++.++. ||||+++++++..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 4677889999999999999964 57899999998643 2445567899999999996 9999999999952
Q ss_pred CCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeecCCCCCeeeCCCCceEEcc
Q 046265 535 PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP--IVHRDISSKNVLLGLDYDAHVSD 612 (639)
Q Consensus 535 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiHrdlk~~Nill~~~~~~kl~D 612 (639)
....++||||++ |+|.+++........+++..+..++.|++.|++|||.. + |+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence 334789999996 79988886533334589999999999999999999988 6 99999999999999999999999
Q ss_pred ccccccCCCCCCC------------cceeeeeceeeCCC
Q 046265 613 FGISKFLKPDSSN------------WSEFVGTFGYVAPI 639 (639)
Q Consensus 613 fGla~~~~~~~~~------------~~~~~gt~~Y~APE 639 (639)
||+++........ .....||+.|+|||
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE 220 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE 220 (337)
T ss_dssp CTTCBCCSSCC----------------------------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChh
Confidence 9999876532211 11356999999998
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=259.28 Aligned_cols=161 Identities=23% Similarity=0.360 Sum_probs=138.4
Q ss_pred ccCCCcceeccCCCceEEEEEcC--CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc-----
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP--SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ----- 537 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----- 537 (639)
++|+..+.||+|+||.||+|... +++.||||.+.... .......+.+|+.++++++|||||++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 67888999999999999999764 68999999987533 34456678999999999999999999999987665
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.|+||||+++++|.+++.. .++|..+..++.|+++||+|+|.. +|+||||||+||+++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999987654 488999999999999999999998 99999999999999875 89999999998
Q ss_pred cCCCCCCCcceeeeeceeeCCC
Q 046265 618 FLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~~~~~~gt~~Y~APE 639 (639)
..... ...+||++|||||
T Consensus 230 ~~~~~----~~~~gt~~y~aPE 247 (681)
T 2pzi_A 230 RINSF----GYLYGTPGFQAPE 247 (681)
T ss_dssp ETTCC----SCCCCCTTTSCTT
T ss_pred hcccC----CccCCCccccCHH
Confidence 76533 3467999999999
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=238.20 Aligned_cols=166 Identities=33% Similarity=0.445 Sum_probs=132.1
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHH--HhccccCceeeeEEEEEc-----CC
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKA--LTELRHRNVVKFYGFSFH-----PR 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~--l~~l~H~niv~l~~~~~~-----~~ 536 (639)
.++|+..+.||+|+||.||+|+. +++.||||++... ....+..|.++ +..++||||+++++++.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 35778889999999999999976 5789999998642 23334444444 556899999999986542 22
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCC------CCCeEeecCCCCCeeeCCCCceEE
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY------FPPIVHRDISSKNVLLGLDYDAHV 610 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~------~~~iiHrdlk~~Nill~~~~~~kl 610 (639)
..|+||||+++|+|.+++.... .+|..+..++.|+++||+|||..+ .++|+||||||+||+++.++.+||
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred eEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 5689999999999999997543 478899999999999999999863 338999999999999999999999
Q ss_pred ccccccccCCCCC--------CCcceeeeeceeeCCC
Q 046265 611 SDFGISKFLKPDS--------SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 611 ~DfGla~~~~~~~--------~~~~~~~gt~~Y~APE 639 (639)
+|||+|+.+.... ......+||+.|+|||
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 198 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE 198 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHH
T ss_pred eeccceeecccccccCccccccccccCCCccceeCch
Confidence 9999998764321 1122357999999998
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=238.81 Aligned_cols=167 Identities=25% Similarity=0.358 Sum_probs=141.9
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC-----Cc
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP-----RQ 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 537 (639)
..+|+..+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 45788889999999999999964 578899999997533 334457789999999999999999999999765 36
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.|+||||++ |+|.+++... .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 899999997 5899888653 478899999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCC---CcceeeeeceeeCCC
Q 046265 618 FLKPDSS---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~---~~~~~~gt~~Y~APE 639 (639)
....... .....+||+.|+|||
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE 201 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPE 201 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHH
T ss_pred ecCCCCCccccccccccccCCCCCH
Confidence 7653221 124468999999998
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=241.60 Aligned_cols=167 Identities=21% Similarity=0.295 Sum_probs=135.4
Q ss_pred HHhccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC-----
Q 046265 462 RATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP----- 535 (639)
Q Consensus 462 ~~~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~----- 535 (639)
...++|+..+.||+|+||.||+|. ..+++.||||++...... ..+|+.+++.++|||||++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345788899999999999999995 567899999998753211 24699999999999999999998543
Q ss_pred ---------------------------------CceeEEecccCCCChhHHhhcC-CCCCCcCHHHHHHHHHHHHHHHHH
Q 046265 536 ---------------------------------RQSFLLYEYLGRGSLAIILSND-AAIDEFSWTVRMNVIKSVANTLSY 581 (639)
Q Consensus 536 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~ 581 (639)
...++||||++ |+|.+.+... .....+++..+..++.|+++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 23789999998 5777776531 122358889999999999999999
Q ss_pred HHhCCCCCeEeecCCCCCeeeC-CCCceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 582 MHHDYFPPIVHRDISSKNVLLG-LDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 582 lH~~~~~~iiHrdlk~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
||.. +|+||||||+||+++ .++.+||+|||+|+.+.... .....+||+.|+|||
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE 211 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPE 211 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHH
Confidence 9998 999999999999998 68899999999998765433 234467899999998
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-26 Score=235.27 Aligned_cols=171 Identities=18% Similarity=0.243 Sum_probs=140.9
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc----CCce
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH----PRQS 538 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~ 538 (639)
.++|+..+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 35688889999999999999965 67899999998653 24456778999999999999999999999973 3478
Q ss_pred eEEecccCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
|+||||+++|+|.+++.... ....+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 99999999999999987521 124588999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCC---------cceeeeeceeeCCC
Q 046265 618 FLKPDSSN---------WSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~---------~~~~~gt~~Y~APE 639 (639)
........ .....||+.|+|||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 213 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPE 213 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGG
T ss_pred hcccccccccccccccccccccCCcccCCHh
Confidence 65321110 12346799999998
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=239.35 Aligned_cols=168 Identities=21% Similarity=0.272 Sum_probs=134.2
Q ss_pred ccCCCcceeccCCCceEEEEEcC----CCcEEEEEEccCCCCChh---------hHHHHHHHHHHHhccccCceeeeEEE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP----SWEIVAVKKFHSPHPDMV---------VQQAFSNEIKALTELRHRNVVKFYGF 531 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~----~~~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~H~niv~l~~~ 531 (639)
++|...+.||+|+||.||+|... ++..||||.......... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56778899999999999999765 568899999876432111 12346788899999999999999999
Q ss_pred EEc----CCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-
Q 046265 532 SFH----PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY- 606 (639)
Q Consensus 532 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~- 606 (639)
+.. ....|+||||+ +++|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSST
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCC
Confidence 987 67899999999 999999997654 578899999999999999999998 999999999999998877
Q ss_pred -ceEEccccccccCCCCC-------CCcceeeeeceeeCCC
Q 046265 607 -DAHVSDFGISKFLKPDS-------SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 607 -~~kl~DfGla~~~~~~~-------~~~~~~~gt~~Y~APE 639 (639)
.+||+|||+|+.+.... .......||+.|+|||
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 230 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLD 230 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHH
Confidence 99999999998764321 1124468999999998
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=245.26 Aligned_cols=164 Identities=25% Similarity=0.337 Sum_probs=131.9
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC------c
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR------Q 537 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~ 537 (639)
.+|+..++||+|+||.||+|.. .+++.||||++..... .+.+|++++++++|||||+++++|...+ .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 4577788999999999999976 4689999999875321 1346999999999999999999986421 3
Q ss_pred eeEEecccCCCChhHHhhc-CCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-CceEEccccc
Q 046265 538 SFLLYEYLGRGSLAIILSN-DAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD-YDAHVSDFGI 615 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~-~~~kl~DfGl 615 (639)
.++||||+++ ++.+.+.. ......+++..+..++.|+++||+|||.. +|+||||||+|||++.+ +.+||+|||+
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence 6789999986 55555432 11224688899999999999999999998 99999999999999965 5789999999
Q ss_pred cccCCCCCCCcceeeeeceeeCCC
Q 046265 616 SKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|+.+.... .....+||+.|+|||
T Consensus 204 a~~~~~~~-~~~~~~~t~~y~aPE 226 (420)
T 1j1b_A 204 AKQLVRGE-PNVSYICSRYYRAPE 226 (420)
T ss_dssp CEECCTTC-CCCSCCSCTTSCCHH
T ss_pred hhhcccCC-CceeeeeCCCcCCHH
Confidence 99765332 233468999999998
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-26 Score=237.02 Aligned_cols=163 Identities=23% Similarity=0.358 Sum_probs=137.4
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCc------
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQ------ 537 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------ 537 (639)
.+|...+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 5677889999999999999965 578999999998655455556778999999999999999999999987654
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.|+||||++ |+|.+++.. .+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 688877643 378899999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCCcceeeeeceeeCCC
Q 046265 618 FLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~~~~~~gt~~Y~APE 639 (639)
..... ....+||+.|+|||
T Consensus 175 ~~~~~---~~~~~~t~~y~aPE 193 (353)
T 3coi_A 175 HADAE---MTGYVVTRWYRAPE 193 (353)
T ss_dssp C-----------CCSBCCSCHH
T ss_pred CCCCC---ccccccCcCcCCHH
Confidence 65422 23467999999998
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=235.44 Aligned_cols=169 Identities=20% Similarity=0.335 Sum_probs=133.6
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcE----EEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEI----VAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
..+|+..+.||+|+||.||+|.. .+++. ||+|.+.... .....+.+.+|+.++++++||||++++++|..+. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 35677889999999999999964 44443 5788776433 2334567899999999999999999999998754 7
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
++|+||+++|+|.+++.... ..+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+++.
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred eEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 89999999999999997643 3578899999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCC--CcceeeeeceeeCCC
Q 046265 619 LKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~--~~~~~~gt~~Y~APE 639 (639)
...... ......||+.|+|||
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE 189 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALE 189 (327)
T ss_dssp -------------CCCGGGSCHH
T ss_pred ccCccccccccCCCccccccCHH
Confidence 643322 223346788999998
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=238.68 Aligned_cols=175 Identities=19% Similarity=0.209 Sum_probs=128.8
Q ss_pred HHHHHHhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC
Q 046265 458 EEVIRATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR 536 (639)
Q Consensus 458 ~~~~~~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 536 (639)
++.....++|+..+.||+|+||.||+|.. .+++.||||++..... ....+.+|+..++.++||||++++++|...+
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 34556678999999999999999999965 5689999999865321 2234567888888999999999999997644
Q ss_pred c-------eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeecCCCCCeeeCC-CC
Q 046265 537 Q-------SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH--HDYFPPIVHRDISSKNVLLGL-DY 606 (639)
Q Consensus 537 ~-------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~iiHrdlk~~Nill~~-~~ 606 (639)
. .++||||++++.+..+.........+++..+..++.|++.|++|+| .. +|+||||||+||+++. ++
T Consensus 93 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred cccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 3 7899999986533333222222345788899999999999999999 66 9999999999999996 89
Q ss_pred ceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 607 DAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 607 ~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
.+||+|||+++.+.... .....+||+.|+|||
T Consensus 170 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE 201 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPE 201 (360)
T ss_dssp EEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHH
T ss_pred cEEEeeCCCceecCCCC-CcccccCCcceeCHH
Confidence 99999999998765432 223467899999998
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-26 Score=229.67 Aligned_cols=170 Identities=24% Similarity=0.375 Sum_probs=145.6
Q ss_pred HhccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
..++|+..+.||+|+||.||+|... +++.||||.+..........+.+.+|+.++++++||||+++++++...+..|+|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3567888999999999999999654 789999999875443334467789999999999999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC---CceEEcccccccc
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD---YDAHVSDFGISKF 618 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~---~~~kl~DfGla~~ 618 (639)
|||+++++|.+.+.... .+++..+..++.|++.|++|||.. +|+||||||+||+++.+ +.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999999998886543 478899999999999999999998 99999999999999754 4799999999987
Q ss_pred CCCCCCCcceeeeeceeeCCC
Q 046265 619 LKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~~~~~~~gt~~Y~APE 639 (639)
..... ......||+.|+|||
T Consensus 174 ~~~~~-~~~~~~~~~~y~aPE 193 (287)
T 2wei_A 174 FQQNT-KMKDRIGTAYYIAPE 193 (287)
T ss_dssp BCCCS-SCSCHHHHHTTCCHH
T ss_pred ecCCC-ccccccCcccccChH
Confidence 65432 233457999999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9e-26 Score=240.58 Aligned_cols=165 Identities=22% Similarity=0.284 Sum_probs=140.0
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc------ccCceeeeEEEEEcCC
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL------RHRNVVKFYGFSFHPR 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~H~niv~l~~~~~~~~ 536 (639)
..+|+..+.||+|+||.||+|. ..+++.||||++... ....+.+.+|+++++.+ .|+||+++++++...+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 3568888999999999999995 456899999999752 33456677888888877 5679999999999999
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc--eEEcccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD--AHVSDFG 614 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~--~kl~DfG 614 (639)
..++||||++ ++|.+++..... ..+++..+..++.|++.||+|||.. +|+||||||+|||++.++. +||+|||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred eEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 9999999996 689988876432 3488999999999999999999999 9999999999999999887 9999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+|+..... ....+||+.|||||
T Consensus 248 ~a~~~~~~---~~~~~gt~~y~aPE 269 (429)
T 3kvw_A 248 SSCYEHQR---VYTYIQSRFYRAPE 269 (429)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHH
T ss_pred cceecCCc---ccccCCCCCccChH
Confidence 99765432 23468999999998
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-26 Score=235.61 Aligned_cols=167 Identities=25% Similarity=0.408 Sum_probs=140.0
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC-----Cc
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP-----RQ 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 537 (639)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... .......+.+|+.++++++||||+++++++..+ ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 46788889999999999999965 478999999996432 344456788999999999999999999998764 57
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.|+||||++ |+|.+++... .+++..+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 6899888753 478899999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCC----------CcceeeeeceeeCCC
Q 046265 618 FLKPDSS----------NWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~----------~~~~~~gt~~Y~APE 639 (639)
.+..... .....+||+.|+|||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 192 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHH
T ss_pred ccccccccccCccccccchhhccccccccCCe
Confidence 7643211 122357899999998
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-26 Score=231.84 Aligned_cols=171 Identities=20% Similarity=0.296 Sum_probs=139.7
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC--ChhhHHHHHHHHHHHhccccCceeeeEEEEE--cCCce
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP--DMVVQQAFSNEIKALTELRHRNVVKFYGFSF--HPRQS 538 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~ 538 (639)
.++|...+.||+|+||.||+|.. .+++.||||.+..... .....+.+.+|+.++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46789999999999999999975 5678999999875321 1234567899999999999999999999985 34578
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
|+||||+++| +.+++..... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999877 6666654322 4588899999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCC--CcceeeeeceeeCCC
Q 046265 619 LKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~--~~~~~~gt~~Y~APE 639 (639)
...... ......||+.|+|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE 181 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPE 181 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHH
T ss_pred cCccccccccccCCCCCCCcChh
Confidence 653221 223457999999998
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.1e-26 Score=231.37 Aligned_cols=168 Identities=23% Similarity=0.359 Sum_probs=140.2
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcccc--CceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH--RNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv 541 (639)
..+|+..+.||+|+||.||+|...+++.||||.+..........+.+.+|+.++.+++| |||+++++++..++..|+|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 45677889999999999999988889999999998655555566788999999999974 9999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|| +.+++|.+++.... .+++..+..++.|+++|++|||.. +|+||||||+||++++ +.+||+|||+++.+..
T Consensus 107 ~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp EC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred Ee-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 99 56889999997653 477889999999999999999998 9999999999999964 8999999999987654
Q ss_pred CCC--CcceeeeeceeeCCC
Q 046265 622 DSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~--~~~~~~gt~~Y~APE 639 (639)
... .....+||+.|+|||
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE 198 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPE 198 (313)
T ss_dssp -----------CCGGGCCHH
T ss_pred ccccccccCCCCCCCcCCHH
Confidence 322 123457999999998
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=241.71 Aligned_cols=166 Identities=10% Similarity=0.031 Sum_probs=122.1
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhcc--ccCceeeeE-------EEEE
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTEL--RHRNVVKFY-------GFSF 533 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l--~H~niv~l~-------~~~~ 533 (639)
.+|+..+.||+|+||.||+|.. .+++.||||++..... .....+.+.+|+.++..+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4577789999999999999964 5789999999987553 334456677885544444 699988755 4443
Q ss_pred cC-----------------CceeEEecccCCCChhHHhhcCCCCCCcCHHHH------HHHHHHHHHHHHHHHhCCCCCe
Q 046265 534 HP-----------------RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVR------MNVIKSVANTLSYMHHDYFPPI 590 (639)
Q Consensus 534 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~------~~i~~~i~~~l~~lH~~~~~~i 590 (639)
.+ ...|+||||++ |+|.+++..... .+++..+ ..++.|+++||+|||.. +|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK---GL 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CC
Confidence 33 23799999998 899999976422 1233445 67789999999999998 99
Q ss_pred EeecCCCCCeeeCCCCceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 591 VHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 591 iHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+||||||+|||++.++.+||+|||+|+..... .....||+.|+|||
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE 261 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPRE 261 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHH
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChh
Confidence 99999999999999999999999999876422 22356779999998
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=235.94 Aligned_cols=171 Identities=21% Similarity=0.331 Sum_probs=140.3
Q ss_pred HhccCCCcceeccCCCceEEEEEc--CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc---ccCceeeeEEEEE----
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL--PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL---RHRNVVKFYGFSF---- 533 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~---- 533 (639)
+.++|+..+.||+|+||.||+|.. .+++.||||++............+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457888899999999999999976 4678999999875432222233466787777766 8999999999997
Q ss_pred -cCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 046265 534 -HPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSD 612 (639)
Q Consensus 534 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~D 612 (639)
.....++||||++ |+|.+++..... ..+++..+..++.|++.|++|||.. +|+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 699999875432 3478899999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCCCCCcceeeeeceeeCCC
Q 046265 613 FGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 613 fGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
||+++..... .......||+.|+|||
T Consensus 164 fg~~~~~~~~-~~~~~~~~~~~y~aPE 189 (326)
T 1blx_A 164 FGLARIYSFQ-MALTSVVVTLWYRAPE 189 (326)
T ss_dssp CCSCCCCCGG-GGGCCCCCCCTTCCHH
T ss_pred CcccccccCC-CCccccccccceeCHH
Confidence 9999876432 2233467999999998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-26 Score=230.00 Aligned_cols=164 Identities=26% Similarity=0.368 Sum_probs=132.7
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC-CceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP-RQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~ 542 (639)
.++|+..+.||+|+||.||+|+.. ++.||||.+.... ..+.+.+|+.++++++||||+++++++.+. +..|+||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 356778899999999999999765 7899999987532 346788999999999999999999997655 4789999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+++|+|.+++..... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999999975421 2367888999999999999999998 9999999999999999999999999999865432
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
.....+++.|+|||
T Consensus 171 ---~~~~~~~~~y~aPE 184 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPE 184 (278)
T ss_dssp --------CCTTTSCHH
T ss_pred ---ccCCCccccccCHH
Confidence 22346789999998
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=243.55 Aligned_cols=167 Identities=22% Similarity=0.352 Sum_probs=124.0
Q ss_pred ccCCC-cceeccCCCceEEEEEcC---CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc--CCce
Q 046265 465 NNFDA-KYCIGTAGQASVYKAELP---SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH--PRQS 538 (639)
Q Consensus 465 ~~f~~-~~~ig~g~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~ 538 (639)
+.|.. .++||+|+||.||+|+.+ +++.||||++..... ...+.+|+.++++++|||||++++++.. ....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 44544 458999999999999765 568899999975432 2457899999999999999999999964 5688
Q ss_pred eEEecccCCCChhHHhhcCC------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee----CCCCce
Q 046265 539 FLLYEYLGRGSLAIILSNDA------AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL----GLDYDA 608 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill----~~~~~~ 608 (639)
|+||||++ |+|.+++.... ....+++..+..++.|++.||+|||.. +|+||||||+||++ +.++.+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcE
Confidence 99999996 57777775321 112488899999999999999999999 99999999999999 677899
Q ss_pred EEccccccccCCCCC---CCcceeeeeceeeCCC
Q 046265 609 HVSDFGISKFLKPDS---SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 609 kl~DfGla~~~~~~~---~~~~~~~gt~~Y~APE 639 (639)
||+|||+|+.+.... ......+||+.|+|||
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE 205 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCch
Confidence 999999998765322 2234578999999998
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=251.78 Aligned_cols=169 Identities=21% Similarity=0.319 Sum_probs=139.3
Q ss_pred hccCCCcceeccCCCceEEEEEcC----CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELP----SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
.++|+..+.||+|+||.||+|... .+..||||++.... .....+.+.+|+.++++++|||||++++++. ++..|
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 456778899999999999999754 24679999987543 3345577899999999999999999999985 46789
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||+++|+|.++++... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 9999999999999997543 2478899999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCC-CcceeeeeceeeCCC
Q 046265 620 KPDSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~-~~~~~~gt~~Y~APE 639 (639)
..... ......||+.|||||
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE 562 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPE 562 (656)
T ss_dssp CC----------CCGGGCCHH
T ss_pred CCCcceeccCCCCCcceeCHH
Confidence 54322 223356788999998
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.5e-26 Score=228.10 Aligned_cols=169 Identities=24% Similarity=0.348 Sum_probs=131.6
Q ss_pred ccCCCcceeccCCCceEEEEEcC--CCc--EEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP--SWE--IVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
++|+..+.||+|+||.||+|... +++ .||||.++.... .....+.+.+|+.++++++||||+++++++..+. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 56778899999999999999642 333 689999875432 2345677899999999999999999999998765 88
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+||||+++|+|.+++.... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+++..
T Consensus 97 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence 9999999999999997543 3478899999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCC---cceeeeeceeeCCC
Q 046265 620 KPDSSN---WSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~---~~~~~gt~~Y~APE 639 (639)
...... .....||+.|+|||
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE 194 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPE 194 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHH
T ss_pred cccccchhhhccCCCCceeeCch
Confidence 543321 22356788999998
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-26 Score=234.74 Aligned_cols=168 Identities=20% Similarity=0.295 Sum_probs=137.9
Q ss_pred hccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 464 TNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.++|+..+.||+|+||.||+|...+ .||||.+..........+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 3567788999999999999997654 49999997654333334557789999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC-
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD- 622 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~- 622 (639)
|+++++|.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++ ++.+||+|||+++.....
T Consensus 110 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred cccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 999999999997643 3477899999999999999999998 999999999999998 679999999998764321
Q ss_pred ----CCCcceeeeeceeeCCC
Q 046265 623 ----SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ----~~~~~~~~gt~~Y~APE 639 (639)
........||+.|+|||
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE 204 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPE 204 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHH
T ss_pred ccccccccccCCCcccccChH
Confidence 11223456999999998
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.2e-26 Score=241.84 Aligned_cols=164 Identities=26% Similarity=0.321 Sum_probs=127.0
Q ss_pred CCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEEeccc
Q 046265 467 FDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLYEYL 545 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~ 545 (639)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +|||||++++++.+++..|+|||||
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 3446789999999998887778999999998642 235578899999886 8999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCC----cCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC-------------Cce
Q 046265 546 GRGSLAIILSNDAAIDE----FSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD-------------YDA 608 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~-------------~~~ 608 (639)
+ |+|.+++........ ..+..+..++.|++.||+|||+. +|+||||||+||+++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 699999986543211 12334567999999999999998 99999999999999654 489
Q ss_pred EEccccccccCCCCCC----CcceeeeeceeeCCC
Q 046265 609 HVSDFGISKFLKPDSS----NWSEFVGTFGYVAPI 639 (639)
Q Consensus 609 kl~DfGla~~~~~~~~----~~~~~~gt~~Y~APE 639 (639)
||+|||+|+.+..... .....+||++|||||
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 202 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHH
Confidence 9999999998754322 123468999999998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=247.86 Aligned_cols=171 Identities=25% Similarity=0.342 Sum_probs=144.1
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc------CC
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH------PR 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~ 536 (639)
..+|+..+.||+|+||.||+|.. .+|+.||||.+.... .....+.+.+|++++++++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 36789999999999999999965 568999999987543 34456778999999999999999999999765 56
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc---eEEccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD---AHVSDF 613 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~---~kl~Df 613 (639)
..|+||||+++|+|.+++........+++..+..++.+++.|++|||.. +|+||||||+||+++.++. +||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 7899999999999999998765444578889999999999999999998 9999999999999987665 999999
Q ss_pred cccccCCCCCCCcceeeeeceeeCCC
Q 046265 614 GISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 614 Gla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|+++...... ......||+.|+|||
T Consensus 169 G~a~~~~~~~-~~~~~~gt~~Y~APE 193 (676)
T 3qa8_A 169 GYAKELDQGE-LCTEFVGTLQYLAPE 193 (676)
T ss_dssp CCCCBTTSCC-CCCCCCSCCTTCSSC
T ss_pred cccccccccc-ccccccCCcccCChH
Confidence 9998765432 234568999999998
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=228.58 Aligned_cols=165 Identities=24% Similarity=0.336 Sum_probs=131.7
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEE----------
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSF---------- 533 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~---------- 533 (639)
.+|+..+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 56778899999999999999655 5899999998753 2445677899999999999999999999884
Q ss_pred ----cCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCce
Q 046265 534 ----HPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG-LDYDA 608 (639)
Q Consensus 534 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~-~~~~~ 608 (639)
.....|+||||++ |+|.+++... .+++..+..++.|++.|++|||.. +|+||||||+||+++ .++.+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence 3357899999997 6999998642 477889999999999999999998 999999999999997 56799
Q ss_pred EEccccccccCCCCC---CCcceeeeeceeeCCC
Q 046265 609 HVSDFGISKFLKPDS---SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 609 kl~DfGla~~~~~~~---~~~~~~~gt~~Y~APE 639 (639)
||+|||+++...... .......||+.|+|||
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPR 194 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcH
Confidence 999999998764321 1223456799999998
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=224.99 Aligned_cols=167 Identities=18% Similarity=0.233 Sum_probs=135.8
Q ss_pred HhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEE-EcCCceeE
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFS-FHPRQSFL 540 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~l 540 (639)
..++|+..+.||+|+||.||+|.. .+++.||||.+..... .+.+.+|+.++++++|++++..+.++ ...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 457899999999999999999964 6789999998765332 23477899999999988877777666 56677899
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEccccccc
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL---GLDYDAHVSDFGISK 617 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill---~~~~~~kl~DfGla~ 617 (639)
||||+ +++|.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+||++ +.++.+||+|||+++
T Consensus 83 v~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 99999 999999997433 2488999999999999999999999 99999999999999 788999999999998
Q ss_pred cCCCCCC-------CcceeeeeceeeCCC
Q 046265 618 FLKPDSS-------NWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~-------~~~~~~gt~~Y~APE 639 (639)
....... ......||+.|+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 185 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASIN 185 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHH
T ss_pred eccCcccCccCCCCcccccCCCccccchH
Confidence 7654322 123568999999998
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-26 Score=238.70 Aligned_cols=163 Identities=18% Similarity=0.250 Sum_probs=136.6
Q ss_pred ccCCCcceeccCCCceEEEEEcCC---------CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceee--------
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS---------WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVK-------- 527 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~-------- 527 (639)
++|+..+.||+|+||.||+|.... ++.||||.+... +.+.+|+.++++++|||||+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 567788999999999999997653 788999998753 24788999999999999987
Q ss_pred -------eEEEEEc-CCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCC
Q 046265 528 -------FYGFSFH-PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKN 599 (639)
Q Consensus 528 -------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~N 599 (639)
+++++.. ++..|+||||+ +++|.+++.... ...+++..+..++.|++.||+|||.. +|+||||||+|
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 6777776 67889999999 999999998642 23588999999999999999999999 99999999999
Q ss_pred eeeCCCC--ceEEccccccccCCCCCC-------CcceeeeeceeeCCC
Q 046265 600 VLLGLDY--DAHVSDFGISKFLKPDSS-------NWSEFVGTFGYVAPI 639 (639)
Q Consensus 600 ill~~~~--~~kl~DfGla~~~~~~~~-------~~~~~~gt~~Y~APE 639 (639)
|+++.++ .+||+|||+++.+..... ......||+.|+|||
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 238 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMD 238 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHH
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHH
Confidence 9999988 899999999987643221 123358999999998
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-27 Score=265.14 Aligned_cols=380 Identities=13% Similarity=0.056 Sum_probs=224.8
Q ss_pred ccccCCCCCCEEECcCCCC---ccCCCCCCC------------CCCCCCEEEcccCcCCCCCCcccCCC--CCCCEEeee
Q 046265 24 PQIGNISNLKFLDMGNNQL---SGVIPQEID------------PLTHLKHLYINVNKLRGSVPREVGQL--SSLKQLVLY 86 (639)
Q Consensus 24 ~~~~~l~~L~~L~Ls~n~l---~~~~p~~~~------------~L~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~ 86 (639)
..+..+++|++|+|+++.. .+.+|..++ .+++|++|+|++|.+++..+..+..+ .+|++|+|+
T Consensus 67 ~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~ 146 (592)
T 3ogk_B 67 RLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLD 146 (592)
T ss_dssp HHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEE
T ss_pred HHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECc
Confidence 3345566666666665432 133443333 46666666666666654444444442 236666666
Q ss_pred ccc-Ccc-ccCccccCCCCCCcccCC-------------CCCcccCCCCccEEEccCCcCc----ccCCccccCCCCCCE
Q 046265 87 CNG-LSG-WLPSSFGNLNNLAIGSMP-------------NSLSNLTSLSLFHLDLSENQLS----GSIPHFLGHLSNLAV 147 (639)
Q Consensus 87 ~N~-l~~-~~p~~~~~l~~L~~~~lp-------------~~~~~l~~L~L~~L~L~~N~l~----~~~p~~~~~l~~L~~ 147 (639)
+|. ++. .++....++++|+...+. ....++++| ++|++++|.++ +.++..+.++++|++
T Consensus 147 ~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L--~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~ 224 (592)
T 3ogk_B 147 KCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL--EVLNFYMTEFAKISPKDLETIARNCRSLVS 224 (592)
T ss_dssp SCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCC--CEEECTTCCCSSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCc--cEEEeeccCCCccCHHHHHHHHhhCCCCcE
Confidence 554 110 111111233333311111 111223344 57777777775 334445566777777
Q ss_pred EeccCCCCCCCCCccccCCCcccEEEcccCcCC---ccCCccCcCCCCCCeEEccC---CccccccccccCCcEEEcCCc
Q 046265 148 LHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN---GVLPPSISNLSNLEGLYLYS---SLVSAEIGNLLQLIELEIDNK 221 (639)
Q Consensus 148 L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~---~~~p~~~~~l~~L~~L~l~~---~~~~~~~~~l~~L~~L~l~~n 221 (639)
|+|++|.+.+ +|..+..+++|+.|+++..... +..+..+..+++|+.++++. ..++..+..+++|++|++++|
T Consensus 225 L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~ 303 (592)
T 3ogk_B 225 VKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYA 303 (592)
T ss_dssp EECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTC
T ss_pred EeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcEEecCCC
Confidence 7777777764 5666777777777777653322 23445566777788877753 335566677888888888888
Q ss_pred ccCCCCC-ccccCCCCCceeccccccccCcchhhhhcCCCccEEeccC-----------Ccccc--------------cc
Q 046265 222 QLFGQIP-KSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQ-----------NNFYG--------------SL 275 (639)
Q Consensus 222 ~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-----------N~l~~--------------~l 275 (639)
.+.+... ..+..+++|+.|+++++...+.++..+..+++|++|++++ |.+++ .+
T Consensus 304 ~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L 383 (592)
T 3ogk_B 304 LLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYM 383 (592)
T ss_dssp CCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEE
T ss_pred cCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEE
Confidence 8654333 3357788888888884433444455556788888888883 45542 24
Q ss_pred cCcCCccccccCccccC-CCCCCEEecc----CCccccc-----CCccccCCCCCCeeeccCc--cCcccCCcCcc-CCC
Q 046265 276 NFSMNNITRSIPPKIGK-LYQLHKLDFS----LNHIVGE-----LPIELGNLKSLNYRALNGN--KVYGSLPRVLG-SIS 342 (639)
Q Consensus 276 ~ls~n~~~~~~p~~~~~-l~~L~~L~Ls----~N~~~~~-----~p~~~~~l~~L~~L~l~~N--~l~~~~p~~~~-~l~ 342 (639)
+++.|++++..+..+.. +++|+.|+++ .|++++. ++..+..+++|+.|+++++ .+++..+..++ .++
T Consensus 384 ~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~ 463 (592)
T 3ogk_B 384 AVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSP 463 (592)
T ss_dssp EEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCT
T ss_pred EeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCc
Confidence 55566666655555554 7778888885 5666542 3333566778888888643 35444443333 377
Q ss_pred CCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeeee
Q 046265 343 DLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELRG 417 (639)
Q Consensus 343 ~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~g 417 (639)
+|+.|++++|.+.. ..++..+..+++|+.|++++|.+++.. ....+..+++|+.|++++|++++
T Consensus 464 ~L~~L~L~~n~l~~--~~~~~~~~~~~~L~~L~l~~n~l~~~~---------~~~~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 464 NVRWMLLGYVGESD--EGLMEFSRGCPNLQKLEMRGCCFSERA---------IAAAVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp TCCEEEECSCCSSH--HHHHHHHTCCTTCCEEEEESCCCBHHH---------HHHHHHHCSSCCEEEEESCBCCT
T ss_pred cceEeeccCCCCCH--HHHHHHHhcCcccCeeeccCCCCcHHH---------HHHHHHhcCccCeeECcCCcCCH
Confidence 78888888754221 133445567788888888888764422 11344567888888888888653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=228.80 Aligned_cols=170 Identities=24% Similarity=0.303 Sum_probs=124.4
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHH-HHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIK-ALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||.||+|.. .+++.||||++..... ......+.+|+. +++.++||||+++++++..++..|+||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 5677788999999999999965 5789999999986543 233445556665 677789999999999999999999999
Q ss_pred cccCCCChhHHhhcC--CCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 543 EYLGRGSLAIILSND--AAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 543 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||+++ ++.+++... .....+++..+..++.+++.|++|||+.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99985 777776531 11245788999999999999999999852 79999999999999999999999999998765
Q ss_pred CCCCCcceeeeeceeeCCC
Q 046265 621 PDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~~~~~~~gt~~Y~APE 639 (639)
... ......||+.|+|||
T Consensus 178 ~~~-~~~~~~gt~~y~aPE 195 (327)
T 3aln_A 178 DSI-AKTRDAGCRPYMAPE 195 (327)
T ss_dssp -------------------
T ss_pred ccc-ccccCCCCccccCce
Confidence 332 223357999999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.8e-26 Score=232.50 Aligned_cols=170 Identities=19% Similarity=0.239 Sum_probs=136.0
Q ss_pred HHhccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCCh----hhHHHHHHHHHHHhcc----ccCceeeeEEEE
Q 046265 462 RATNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDM----VVQQAFSNEIKALTEL----RHRNVVKFYGFS 532 (639)
Q Consensus 462 ~~~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l----~H~niv~l~~~~ 532 (639)
...++|+..+.||+|+||.||+|.. .+++.||||.+....... .....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3457899999999999999999965 568899999997543211 1223456789999888 899999999999
Q ss_pred EcCCceeEEecc-cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEE
Q 046265 533 FHPRQSFLLYEY-LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG-LDYDAHV 610 (639)
Q Consensus 533 ~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~-~~~~~kl 610 (639)
...+..++|||| +++++|.+++.... .+++..+..++.|+++|++|||.. +|+||||||+||+++ .++.+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence 999999999999 78999999997643 478899999999999999999999 999999999999999 8899999
Q ss_pred ccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 611 SDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 611 ~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+|||+++..... ......||+.|+|||
T Consensus 182 ~dfg~~~~~~~~--~~~~~~~~~~y~aPE 208 (312)
T 2iwi_A 182 IDFGSGALLHDE--PYTDFDGTRVYSPPE 208 (312)
T ss_dssp CCCSSCEECCSS--CBCCCCSCTTTSCHH
T ss_pred EEcchhhhcccC--cccccCCcccccCce
Confidence 999999876532 234567999999998
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=7.2e-26 Score=232.02 Aligned_cols=169 Identities=20% Similarity=0.278 Sum_probs=142.7
Q ss_pred HhccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCCh----hhHHHHHHHHHHHhccc--cCceeeeEEEEEcC
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDM----VVQQAFSNEIKALTELR--HRNVVKFYGFSFHP 535 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~ 535 (639)
..++|+..+.||+|+||.||+|. ..+++.||||.+....... ...+.+.+|+.++++++ ||||+++++++..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 35678889999999999999995 5678999999987543211 12244678999999996 59999999999999
Q ss_pred CceeEEecccCC-CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEccc
Q 046265 536 RQSFLLYEYLGR-GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG-LDYDAHVSDF 613 (639)
Q Consensus 536 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~-~~~~~kl~Df 613 (639)
+..++||||+.+ ++|.+++.... .+++..+..++.|+++||+|||.. +|+||||||+||+++ .++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred CcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999976 89999987643 477899999999999999999998 999999999999999 7899999999
Q ss_pred cccccCCCCCCCcceeeeeceeeCCC
Q 046265 614 GISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 614 Gla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|+++..... ......||+.|+|||
T Consensus 195 g~~~~~~~~--~~~~~~gt~~y~aPE 218 (320)
T 3a99_A 195 GSGALLKDT--VYTDFDGTRVYSPPE 218 (320)
T ss_dssp TTCEECCSS--CBCCCCSCGGGSCHH
T ss_pred ccccccccc--cccCCCCCccCCChH
Confidence 999876532 233467999999998
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=238.76 Aligned_cols=164 Identities=23% Similarity=0.332 Sum_probs=129.6
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.+|...++||+|+||.||.+...+++.||||++..... ..+.+|+.+++++ +|||||++++++.+.+..|+|||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 45777889999999997766667789999999975332 1246799999998 79999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-----CCceEEcccccccc
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL-----DYDAHVSDFGISKF 618 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~-----~~~~kl~DfGla~~ 618 (639)
||+ |+|.+++..... ...+..+..++.|+++||+|||+. +|+||||||+||+++. ...+||+|||+|+.
T Consensus 99 ~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 996 699999976542 123344568999999999999998 9999999999999943 34688999999987
Q ss_pred CCCCC---CCcceeeeeceeeCCC
Q 046265 619 LKPDS---SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~---~~~~~~~gt~~Y~APE 639 (639)
..... ......+||++|||||
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE 196 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPE 196 (432)
T ss_dssp C------------CCSCTTSCCGG
T ss_pred ccCCCcceeeccccCCCcCccChh
Confidence 65332 2234568999999998
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=234.74 Aligned_cols=165 Identities=19% Similarity=0.289 Sum_probs=135.9
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc--------cCceeeeEEEEE--
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR--------HRNVVKFYGFSF-- 533 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------H~niv~l~~~~~-- 533 (639)
.+|+..+.||+|+||.||+|. ..+++.||||++... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 568888999999999999995 567889999999742 344567889999999986 788999999998
Q ss_pred --cCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-----
Q 046265 534 --HPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY----- 606 (639)
Q Consensus 534 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~----- 606 (639)
.....|+||||+ ++++.+.+.... ...+++..+..++.|++.||+|||..+ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhh
Confidence 456789999999 555555554322 135888999999999999999999854 799999999999998775
Q ss_pred --------------------------------------------ceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 607 --------------------------------------------DAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 607 --------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
.+||+|||+|+..... ....+||+.|||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE 263 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCCh
Confidence 7999999999876532 23457999999998
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-25 Score=227.61 Aligned_cols=165 Identities=20% Similarity=0.270 Sum_probs=140.9
Q ss_pred hccCCCcceeccCCCceEEEEEc--CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCc------eeeeEEEEEcC
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL--PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN------VVKFYGFSFHP 535 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~ 535 (639)
.++|+..+.||+|+||.||+|.. .+++.||||.+... ....+.+.+|+.+++.++|++ ++++++++...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 35778889999999999999964 46789999998742 344567889999999998775 99999999999
Q ss_pred CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-----------
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL----------- 604 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~----------- 604 (639)
+..++||||+ +++|.+++..... ..+++..+..++.|+++||+|||.. +|+||||||+||+++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 9999999999 8999999876542 3478899999999999999999998 9999999999999987
Q ss_pred --------CCceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 605 --------DYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 605 --------~~~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
++.+||+|||+++..... ....+||+.|+|||
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE 204 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPE 204 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHH
T ss_pred ccccccccCCCceEeeCcccccCccc---cccccCCccccChH
Confidence 668999999999875432 23467999999998
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.3e-25 Score=227.77 Aligned_cols=163 Identities=18% Similarity=0.261 Sum_probs=119.0
Q ss_pred hccCCC-cceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHH-HHHhccccCceeeeEEEEEc----CC
Q 046265 464 TNNFDA-KYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEI-KALTELRHRNVVKFYGFSFH----PR 536 (639)
Q Consensus 464 ~~~f~~-~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~-~~l~~l~H~niv~l~~~~~~----~~ 536 (639)
.++|.. .++||+|+||.||+|... +++.||||.+... .. ..+|+ ..++.++||||+++++++.. ..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 456666 457999999999999654 7899999998642 11 22333 33556789999999999976 34
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL---DYDAHVSDF 613 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~---~~~~kl~Df 613 (639)
..++||||+++|+|.+++..... ..+++..+..++.|++.|++|||.. +|+||||||+||+++. ++.+||+||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred eEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence 58999999999999999986543 3588999999999999999999999 9999999999999976 455999999
Q ss_pred cccccCCCCCCCcceeeeeceeeCCC
Q 046265 614 GISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 614 Gla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|+++..... .....+||+.|+|||
T Consensus 176 g~~~~~~~~--~~~~~~~t~~y~aPE 199 (336)
T 3fhr_A 176 GFAKETTQN--ALQTPCYTPYYVAPE 199 (336)
T ss_dssp TTCEEC--------------------
T ss_pred ccceecccc--ccccCCCCcCccChh
Confidence 999876532 234567999999998
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=226.96 Aligned_cols=170 Identities=18% Similarity=0.264 Sum_probs=124.8
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|+..+.||+|+||.||+|.. .+++.||||.+..........+.+.++..+++.++||||+++++++..++..|+||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 35677788999999999999966 47899999999865443333445555666788889999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+ ++.+..+..... ..+++..+..++.++++|++|||..+ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 104 e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 555555554322 34788999999999999999999832 8999999999999999999999999999876432
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
. ......||+.|+|||
T Consensus 179 ~-~~~~~~~~~~y~aPE 194 (318)
T 2dyl_A 179 K-AKDRSAGCAAYMAPE 194 (318)
T ss_dssp ---------CCTTCCHH
T ss_pred c-cccccCCCccccChh
Confidence 2 223467999999998
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-25 Score=223.26 Aligned_cols=166 Identities=18% Similarity=0.234 Sum_probs=138.6
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEE-EcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFS-FHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lv 541 (639)
.++|+..+.||+|+||.||+|+. .+++.||||.+..... .+.+.+|+.++++++|++++..+.++ ...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 46788889999999999999964 6789999999875432 23578999999999998877666665 556778999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEcccccccc
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL---GLDYDAHVSDFGISKF 618 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill---~~~~~~kl~DfGla~~ 618 (639)
|||+ +++|.+++.... ..+++..+..++.|++.|++|||.. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 84 ~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 9999 999999997433 2588899999999999999999999 99999999999999 4788999999999987
Q ss_pred CCCCCC-------CcceeeeeceeeCCC
Q 046265 619 LKPDSS-------NWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~-------~~~~~~gt~~Y~APE 639 (639)
...... ......||+.|+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE 185 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASIN 185 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHH
T ss_pred ccccccccccccccccccccccccCChh
Confidence 654322 124568999999998
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.4e-25 Score=235.30 Aligned_cols=166 Identities=20% Similarity=0.284 Sum_probs=138.1
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcccc-CceeeeEEEEEcCCceeEE
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH-RNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv 541 (639)
.++|+..+.||+|+||.||+|. ..+++.||||.+...... ..+.+|+.+++.++| ++|+.+..++...+..++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 3678889999999999999996 467899999987754322 247789999999987 5566666677778889999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee---CCCCceEEcccccccc
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL---GLDYDAHVSDFGISKF 618 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill---~~~~~~kl~DfGla~~ 618 (639)
|||+ +++|.+++.... ..+++..+..++.|++.||+|||.. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 me~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 9999 999999997433 3588999999999999999999998 99999999999999 5889999999999987
Q ss_pred CCCCCCC-------cceeeeeceeeCCC
Q 046265 619 LKPDSSN-------WSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~~-------~~~~~gt~~Y~APE 639 (639)
+...... ....+||+.|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 183 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVN 183 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred ccCCccccccccccccccCCCccccCHH
Confidence 6543221 22568999999998
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.7e-24 Score=212.09 Aligned_cols=127 Identities=20% Similarity=0.164 Sum_probs=81.1
Q ss_pred EEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCC
Q 046265 34 FLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSL 113 (639)
Q Consensus 34 ~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~ 113 (639)
..+.++..+. .+|..+. ++|++|++++|++++..+..|.++++|++|++++|++++..+..|.++++|
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L--------- 78 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL--------- 78 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTC---------
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCC---------
Confidence 4555666665 4565553 467777777777775555567777777777777777776555555555522
Q ss_pred cccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCC
Q 046265 114 SNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN 180 (639)
Q Consensus 114 ~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 180 (639)
++|+|++|++++..|..|.++++|++|++++|++.+..+..++.+++|++|++++|.++
T Consensus 79 --------~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 137 (276)
T 2z62_A 79 --------STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137 (276)
T ss_dssp --------CEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCC
T ss_pred --------CEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccc
Confidence 46777777776665666666777777777777666555545666666666666666554
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=227.93 Aligned_cols=167 Identities=20% Similarity=0.249 Sum_probs=138.1
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cC-----ceeeeEEEEEcCC
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HR-----NVVKFYGFSFHPR 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~-----niv~l~~~~~~~~ 536 (639)
.++|+..+.||+|+||.||+|.. .+++.||||++... ......+.+|+.++..++ |+ +|+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 46788889999999999999964 56789999999742 334556778888888875 44 4999999999999
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC--CCCceEEcccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG--LDYDAHVSDFG 614 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~--~~~~~kl~DfG 614 (639)
..|+||||++ |+|.+++..... ..+++..+..++.|++.|++|||.+ ..+|+||||||+||+++ .++.+||+|||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred ceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 9999999996 599999876432 3478999999999999999999952 12899999999999994 57889999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+|+..... ....+||+.|+|||
T Consensus 207 ~a~~~~~~---~~~~~~t~~y~aPE 228 (382)
T 2vx3_A 207 SSCQLGQR---IYQYIQSRFYRSPE 228 (382)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHH
T ss_pred Cceecccc---cccccCCccccChH
Confidence 99876432 23468999999998
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-25 Score=244.84 Aligned_cols=155 Identities=14% Similarity=0.204 Sum_probs=121.4
Q ss_pred CCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCCh------hhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEE
Q 046265 468 DAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDM------VVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 468 ~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 541 (639)
...+.||+|+||.||+|.. .++.+|+|+........ ...+.+.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999954 46788999876533221 1235589999999999999999777777778888999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
|||+++|+|.++++. +..++.|+++|++|||.. +|+||||||+|||++. .+||+|||+|+....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999875 446899999999999998 9999999999999998 999999999998754
Q ss_pred CCCC-------cceeeeeceeeCCC
Q 046265 622 DSSN-------WSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~-------~~~~~gt~~Y~APE 639 (639)
.... ....+||+.|||||
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APE 506 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDE 506 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHH
T ss_pred ccccccchhhhhhhhcCCCCcCCHH
Confidence 3221 13578999999998
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-23 Score=207.51 Aligned_cols=160 Identities=32% Similarity=0.353 Sum_probs=80.8
Q ss_pred cceee-eEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCC
Q 046265 3 CLAFF-FFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81 (639)
Q Consensus 3 ~~~~~-~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 81 (639)
|.|.. ...++++++++. .+|..+. +++++|+|++|.+++..+..|..+++|++|+|++|+++...+..|..+++|+
T Consensus 12 C~c~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~ 88 (270)
T 2o6q_A 12 CSCNNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE 88 (270)
T ss_dssp BEEETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCC
T ss_pred CEeCCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCC
Confidence 44432 234555555554 3444443 3555666666655544444555556666666655555533333345555555
Q ss_pred EEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCc
Q 046265 82 QLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP 161 (639)
Q Consensus 82 ~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 161 (639)
+|++++|++++..+..|..+++| ++|++++|++++..|..|..+++|++|+|++|.+++..+.
T Consensus 89 ~L~l~~n~l~~~~~~~~~~l~~L-----------------~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 151 (270)
T 2o6q_A 89 TLWVTDNKLQALPIGVFDQLVNL-----------------AELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKG 151 (270)
T ss_dssp EEECCSSCCCCCCTTTTTTCSSC-----------------CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred EEECCCCcCCcCCHhHcccccCC-----------------CEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHh
Confidence 55555555554443344433321 3555555555544444455555555555555555543333
Q ss_pred cccCCCcccEEEcccCcCCcc
Q 046265 162 ILGKVQSLLSLGFDLNLLNGV 182 (639)
Q Consensus 162 ~~~~l~~L~~L~l~~N~l~~~ 182 (639)
.|..+++|+.|++++|.+++.
T Consensus 152 ~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 152 VFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp TTTTCTTCCEEECCSSCCSCC
T ss_pred HccCCcccceeEecCCcCcEe
Confidence 445555555555555554433
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=223.92 Aligned_cols=165 Identities=17% Similarity=0.254 Sum_probs=137.7
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCC-cEEEEEEccCCCCChhhHHHHHHHHHHHhccccCc------eeeeEEEEEcC
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSW-EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN------VVKFYGFSFHP 535 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~ 535 (639)
.++|+..+.||+|+||.||+|.. .++ +.||||.++.. ....+.+.+|+.++++++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 35778889999999999999965 344 68999998742 344567889999999998877 99999999999
Q ss_pred CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee-------------
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL------------- 602 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill------------- 602 (639)
+..++||||+ ++++.+.+..... ..+++..+..++.|++.||+|||.. +|+||||||+||++
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred CeEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 9999999999 5666666654332 3578899999999999999999998 99999999999999
Q ss_pred ------CCCCceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 603 ------GLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 603 ------~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+.++.+||+|||+++..... ....+||+.|+|||
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE 209 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPE 209 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHH
T ss_pred cccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCe
Confidence 56789999999999875432 23467999999998
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=6.1e-23 Score=204.80 Aligned_cols=201 Identities=27% Similarity=0.331 Sum_probs=149.5
Q ss_pred CCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCC
Q 046265 31 NLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMP 110 (639)
Q Consensus 31 ~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp 110 (639)
+.+.+++++++++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|++++|+++...+..|.++++|
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L------ 87 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL------ 87 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTC------
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCC------
Confidence 5788999999988 5676665 678999999999886666688889999999999998886555555666533
Q ss_pred CCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCC
Q 046265 111 NSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNL 190 (639)
Q Consensus 111 ~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 190 (639)
++|++++|++++..+..|..+++|++|+|++|++++..|..|..+++|++|++++|.+++..+..|..+
T Consensus 88 -----------~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 156 (270)
T 2o6q_A 88 -----------ETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKL 156 (270)
T ss_dssp -----------CEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred -----------CEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCC
Confidence 588888888886666777888888888888888887777778888888888888888876554444433
Q ss_pred CCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCc
Q 046265 191 SNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN 270 (639)
Q Consensus 191 ~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 270 (639)
++|+.|++++|++.+..+..|..+++|+.|++++|.+++..+..|..+++|+.|++++|.
T Consensus 157 --------------------~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 216 (270)
T 2o6q_A 157 --------------------TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENP 216 (270)
T ss_dssp --------------------TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred --------------------cccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCC
Confidence 445555566666666555567777777777777777776666666667777777766665
Q ss_pred c
Q 046265 271 F 271 (639)
Q Consensus 271 l 271 (639)
+
T Consensus 217 ~ 217 (270)
T 2o6q_A 217 W 217 (270)
T ss_dssp B
T ss_pred e
Confidence 5
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=227.18 Aligned_cols=165 Identities=21% Similarity=0.289 Sum_probs=137.9
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-----------cCceeeeEEEE
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-----------HRNVVKFYGFS 532 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~ 532 (639)
.+|...+.||+|+||.||+|.. .+++.||||.+.. .....+.+.+|+.++++++ ||||+++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 5678889999999999999964 6789999999874 2344567889999998886 89999999999
Q ss_pred EcCC----ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-----
Q 046265 533 FHPR----QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG----- 603 (639)
Q Consensus 533 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~----- 603 (639)
...+ ..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||..+ +|+||||||+||+++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 8654 689999999 8999999876432 34788999999999999999999853 799999999999994
Q ss_pred -CCCceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 604 -LDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 604 -~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
..+.+||+|||+++..... ....+||+.|+|||
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE 205 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPE 205 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHH
T ss_pred cCcceEEEcccccccccCCC---CCCCCCCccccCcH
Confidence 4458999999999876532 23457999999998
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=211.09 Aligned_cols=145 Identities=13% Similarity=0.055 Sum_probs=126.6
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCC-hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPD-MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.+|+..+.||+|+||.||+|... +++.||||.+...... ....+.+.+|+..+++++||||+++++++..++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 46778899999999999999654 5899999999865432 344577899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
||+++++|.++++.. .....+.+++.|++.||+|||.. +|+||||||+||+++.++.+||+++|...
T Consensus 111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccccC
Confidence 999999999999643 23346788999999999999999 99999999999999999999999887653
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-23 Score=208.13 Aligned_cols=211 Identities=24% Similarity=0.294 Sum_probs=107.7
Q ss_pred ccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCC
Q 046265 26 IGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLA 105 (639)
Q Consensus 26 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 105 (639)
+..+++|+.|++++|.++. + ..+..+++|++|++++|.+++ + +.+..+++|++|++++|.+++..+..|.++++|
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L- 111 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNL- 111 (272)
T ss_dssp HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTC-
T ss_pred cccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCC-
Confidence 3445556666666665542 2 235555666666666665553 2 245555555555555555554444444444322
Q ss_pred cccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCc
Q 046265 106 IGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPP 185 (639)
Q Consensus 106 ~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 185 (639)
++|++++|++++..+..|..+++|++|+|++|++++..|..++.+++|+.|++++|.++
T Consensus 112 ----------------~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~----- 170 (272)
T 3rfs_A 112 ----------------KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ----- 170 (272)
T ss_dssp ----------------CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-----
T ss_pred ----------------CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcC-----
Confidence 35555555555444444555555555555555555444444445555555555555444
Q ss_pred cCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEe
Q 046265 186 SISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLD 265 (639)
Q Consensus 186 ~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 265 (639)
+..|..+..+++|+.|++++|.+++..+..+..+++|+.|+
T Consensus 171 ---------------------------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 211 (272)
T 3rfs_A 171 ---------------------------------------SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 211 (272)
T ss_dssp ---------------------------------------CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred ---------------------------------------ccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEE
Confidence 33333444455555555555555555554455555555555
Q ss_pred ccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCC
Q 046265 266 LSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKS 319 (639)
Q Consensus 266 Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~ 319 (639)
+++|.+. +.+++|+.|++..|.+.|.+|.+++.+..
T Consensus 212 l~~N~~~------------------~~~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 212 LHDNPWD------------------CTCPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp CCSSCBC------------------CCTTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred ccCCCcc------------------ccCcHHHHHHHHHHhCCCcccCcccccCC
Confidence 5444432 12234555556666666666655554433
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.4e-26 Score=254.03 Aligned_cols=356 Identities=14% Similarity=0.071 Sum_probs=229.0
Q ss_pred CCCCCCCCCCCCEEEcccCcC---CCCCCcccC------------CCCCCCEEeeecccCccccCccccC-----CCCCC
Q 046265 46 IPQEIDPLTHLKHLYINVNKL---RGSVPREVG------------QLSSLKQLVLYCNGLSGWLPSSFGN-----LNNLA 105 (639)
Q Consensus 46 ~p~~~~~L~~L~~L~L~~N~l---~~~~p~~~~------------~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~ 105 (639)
.+..+..+++|+.|+|+++.. .+.+|..++ .+++|++|+|++|.+++..+..++. |+.|.
T Consensus 65 ~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~ 144 (592)
T 3ogk_B 65 PDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLK 144 (592)
T ss_dssp HHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEE
T ss_pred hHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEE
Confidence 344557789999999987532 135555555 6899999999999988776665544 33333
Q ss_pred ccc--------CCCCCcccCCCCccEEEccCCcCccc----CCccccCCCCCCEEeccCCCCCC----CCCccccCCCcc
Q 046265 106 IGS--------MPNSLSNLTSLSLFHLDLSENQLSGS----IPHFLGHLSNLAVLHLGDNSLFG----SIPPILGKVQSL 169 (639)
Q Consensus 106 ~~~--------lp~~~~~l~~L~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L 169 (639)
+.. ++....++++| ++|+|++|.+++. ++..+..+++|++|++++|.+++ .++..+..+++|
T Consensus 145 L~~~~~~~~~~l~~~~~~~~~L--~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L 222 (592)
T 3ogk_B 145 LDKCSGFTTDGLLSIVTHCRKI--KTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSL 222 (592)
T ss_dssp EESCEEEEHHHHHHHHHHCTTC--SEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTC
T ss_pred CcCCCCcCHHHHHHHHhhCCCC--CEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCC
Confidence 211 11112245666 7999999988765 44456678999999999999873 334455678999
Q ss_pred cEEEcccCcCCccCCccCcCCCCCCeEEccCC-------ccccccccccCCcEEEcCCcccCCCCCccccCCCCCceecc
Q 046265 170 LSLGFDLNLLNGVLPPSISNLSNLEGLYLYSS-------LVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHL 242 (639)
Q Consensus 170 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~-------~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L 242 (639)
+.|++++|.+.+ +|..+..+++|+.|+++.. .....+..+++|+.|+++++. .+.+|..+..+++|++|++
T Consensus 223 ~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~L 300 (592)
T 3ogk_B 223 VSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDL 300 (592)
T ss_dssp CEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEE
T ss_pred cEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEec
Confidence 999999998886 5678888999999999631 223456778899999998864 3567888889999999999
Q ss_pred ccccccCcch-hhhhcCCCccEEeccCCcccc--------------cccCc-----------CCccccc-cCccccCCCC
Q 046265 243 EQNHLTGNIY-EVFGIYPNLTFLDLSQNNFYG--------------SLNFS-----------MNNITRS-IPPKIGKLYQ 295 (639)
Q Consensus 243 ~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~--------------~l~ls-----------~n~~~~~-~p~~~~~l~~ 295 (639)
++|.+++... ..+..+++|+.|+++ +.+.. .++++ .|.++.. ++.....+++
T Consensus 301 s~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~ 379 (592)
T 3ogk_B 301 LYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQE 379 (592)
T ss_dssp TTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTT
T ss_pred CCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCcc
Confidence 9999876544 446889999999998 43321 23444 2333322 1122233566
Q ss_pred CCEEeccCCcccccCCccccC-CCCCCeeecc----CccCccc-----CCcCccCCCCCCEEeCCCCCCCcccccCChhh
Q 046265 296 LHKLDFSLNHIVGELPIELGN-LKSLNYRALN----GNKVYGS-----LPRVLGSISDLEYLDLSTNYNNEFRKEFPVEL 365 (639)
Q Consensus 296 L~~L~Ls~N~~~~~~p~~~~~-l~~L~~L~l~----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~ 365 (639)
|+.|+++.|.+++..+..+.. +++|+.|+++ .|.+++. ++..+..+++|+.|+++++. +.+.+..+..+
T Consensus 380 L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~-~~l~~~~~~~~ 458 (592)
T 3ogk_B 380 LEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQ-GGLTDLGLSYI 458 (592)
T ss_dssp CSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCG-GGCCHHHHHHH
T ss_pred CeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCC-CCccHHHHHHH
Confidence 666666666665554444443 5666666664 4455432 22334456666666665422 12222222222
Q ss_pred h-ccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeee
Q 046265 366 E-KLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELR 416 (639)
Q Consensus 366 ~-~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~ 416 (639)
. .+++|+.|+++.|.+++.. .+..+..+++|+.||+++|.++
T Consensus 459 ~~~~~~L~~L~L~~n~l~~~~---------~~~~~~~~~~L~~L~l~~n~l~ 501 (592)
T 3ogk_B 459 GQYSPNVRWMLLGYVGESDEG---------LMEFSRGCPNLQKLEMRGCCFS 501 (592)
T ss_dssp HHSCTTCCEEEECSCCSSHHH---------HHHHHTCCTTCCEEEEESCCCB
T ss_pred HHhCccceEeeccCCCCCHHH---------HHHHHhcCcccCeeeccCCCCc
Confidence 2 2556666666666544321 1133455667777777777654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-22 Score=204.58 Aligned_cols=138 Identities=25% Similarity=0.237 Sum_probs=95.2
Q ss_pred cccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCC
Q 046265 25 QIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNL 104 (639)
Q Consensus 25 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 104 (639)
.+.++++++++++++|+++ .+|..+. ++++.|+|++|++++..|..|..+++|++|+|++|++++..+. +.++
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~-- 77 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLP-- 77 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCT--
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCC--
Confidence 3567778888888888887 5566554 5788888888888766677788888888888888877754322 2333
Q ss_pred CcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCC
Q 046265 105 AIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLP 184 (639)
Q Consensus 105 ~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 184 (639)
+| ++|++++|+++ .+|..+..+++|++|+|++|++++..|..|..+++|++|++++|++++..+
T Consensus 78 -------------~L--~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~ 141 (290)
T 1p9a_G 78 -------------VL--GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141 (290)
T ss_dssp -------------TC--CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCT
T ss_pred -------------cC--CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccCh
Confidence 22 57777777776 566667777777777777777776555666666777777776666664443
Q ss_pred c
Q 046265 185 P 185 (639)
Q Consensus 185 ~ 185 (639)
.
T Consensus 142 ~ 142 (290)
T 1p9a_G 142 G 142 (290)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.9e-23 Score=205.70 Aligned_cols=204 Identities=24% Similarity=0.319 Sum_probs=165.4
Q ss_pred eEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeec
Q 046265 8 FFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYC 87 (639)
Q Consensus 8 ~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 87 (639)
+..+++.+|.+.. + +.+..+++|++|+|++|.+++. +.+..+++|++|+|++|.+++..|..|+.+++|++|++++
T Consensus 43 L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 118 (272)
T 3rfs_A 43 IDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVE 118 (272)
T ss_dssp CCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred eeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCC
Confidence 4567788888763 3 4688999999999999999863 4799999999999999999977777789999999999999
Q ss_pred ccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCC
Q 046265 88 NGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQ 167 (639)
Q Consensus 88 N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 167 (639)
|++++..+..|+.+++| ++|++++|++++..+..+..+++|++|++++|++++..|..++.++
T Consensus 119 n~l~~~~~~~~~~l~~L-----------------~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 181 (272)
T 3rfs_A 119 NQLQSLPDGVFDKLTNL-----------------TYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLT 181 (272)
T ss_dssp SCCCCCCTTTTTTCTTC-----------------CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred CcCCccCHHHhccCCCC-----------------CEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCc
Confidence 99998777777777743 5999999999987777889999999999999999988778889999
Q ss_pred cccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccc
Q 046265 168 SLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHL 247 (639)
Q Consensus 168 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 247 (639)
+|+.|++++|.+++..|..+..+++|+.|++ ++|.+.+ .+++|+.|++..|.+
T Consensus 182 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l--------------------~~N~~~~-------~~~~l~~l~~~~n~~ 234 (272)
T 3rfs_A 182 QLKDLRLYQNQLKSVPDGVFDRLTSLQYIWL--------------------HDNPWDC-------TCPGIRYLSEWINKH 234 (272)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEEC--------------------CSSCBCC-------CTTTTHHHHHHHHHT
T ss_pred cCCEEECCCCcCCccCHHHHhCCcCCCEEEc--------------------cCCCccc-------cCcHHHHHHHHHHhC
Confidence 9999999999999887776776666665555 4454433 234566666666666
Q ss_pred cCcchhhhhcCC
Q 046265 248 TGNIYEVFGIYP 259 (639)
Q Consensus 248 ~~~~~~~~~~l~ 259 (639)
+|.+|..++.++
T Consensus 235 ~g~ip~~~~~~~ 246 (272)
T 3rfs_A 235 SGVVRNSAGSVA 246 (272)
T ss_dssp GGGBBCTTSCBC
T ss_pred CCcccCcccccC
Confidence 666666555443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=8e-23 Score=200.05 Aligned_cols=205 Identities=14% Similarity=0.162 Sum_probs=145.3
Q ss_pred cccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCc-CCCCCCcccCCCCCCCEEeeec-ccCccccCc
Q 046265 19 FAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNK-LRGSVPREVGQLSSLKQLVLYC-NGLSGWLPS 96 (639)
Q Consensus 19 ~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~ 96 (639)
.+.+|. +. ++|++|+|++|++++..+..|..+++|++|++++|+ ++...+..|.++++|++|++++ |++++..+.
T Consensus 23 l~~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~ 99 (239)
T 2xwt_C 23 IQRIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPD 99 (239)
T ss_dssp CSSCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTT
T ss_pred ccccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHH
Confidence 456777 54 389999999999987777788899999999999996 8755556788889999999988 888876667
Q ss_pred cccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCC---EEeccCC-CCCCCCCccccCCCccc-E
Q 046265 97 SFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLA---VLHLGDN-SLFGSIPPILGKVQSLL-S 171 (639)
Q Consensus 97 ~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~ 171 (639)
.|.++++| ++|++++|++++ +|. +..+++|+ +|++++| ++++..+..|..+++|+ .
T Consensus 100 ~f~~l~~L-----------------~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~ 160 (239)
T 2xwt_C 100 ALKELPLL-----------------KFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT 160 (239)
T ss_dssp SEECCTTC-----------------CEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEE
T ss_pred HhCCCCCC-----------------CEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeE
Confidence 77776633 478888888875 666 77778887 8888888 77766666677888888 8
Q ss_pred EEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcc-cCCCCCccccCC-CCCceeccccccccC
Q 046265 172 LGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQ-LFGQIPKSLRNF-TSLNIVHLEQNHLTG 249 (639)
Q Consensus 172 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~ 249 (639)
|++++|.++...+..+. . ++|+.|++++|+ +.+..+..|.++ ++|+.|++++|.+++
T Consensus 161 L~l~~n~l~~i~~~~~~--------------------~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~ 219 (239)
T 2xwt_C 161 LKLYNNGFTSVQGYAFN--------------------G-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA 219 (239)
T ss_dssp EECCSCCCCEECTTTTT--------------------T-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC
T ss_pred EEcCCCCCcccCHhhcC--------------------C-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc
Confidence 88888877632222221 1 345566666663 555445566666 677777777777665
Q ss_pred cchhhhhcCCCccEEeccCC
Q 046265 250 NIYEVFGIYPNLTFLDLSQN 269 (639)
Q Consensus 250 ~~~~~~~~l~~L~~L~Ls~N 269 (639)
.++. .+++|+.|+++++
T Consensus 220 l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 220 LPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CCCT---TCTTCSEEECTTC
T ss_pred CChh---HhccCceeeccCc
Confidence 4433 4456666665543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-22 Score=202.82 Aligned_cols=204 Identities=22% Similarity=0.208 Sum_probs=145.9
Q ss_pred CCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccC
Q 046265 49 EIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSE 128 (639)
Q Consensus 49 ~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~ 128 (639)
.+.++++++.+++++|.++ .+|..+. ++|+.|+|++|++++..|..|.++++| ++|+|++
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L-----------------~~L~L~~ 64 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRL-----------------TQLNLDR 64 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTC-----------------CEEECTT
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCC-----------------CEEECCC
Confidence 3677888999999999988 6777665 688889999998888777777777633 4888888
Q ss_pred CcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccc
Q 046265 129 NQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIG 208 (639)
Q Consensus 129 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~ 208 (639)
|++++. +.. ..+++|++|+|++|+++ .+|..+..+++|++|++++|++++..|..|..++
T Consensus 65 n~l~~~-~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~----------------- 124 (290)
T 1p9a_G 65 AELTKL-QVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG----------------- 124 (290)
T ss_dssp SCCCEE-ECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCT-----------------
T ss_pred CccCcc-cCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCC-----------------
Confidence 888754 333 67888888888888887 5777778888888888888888766555554443
Q ss_pred cccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCc
Q 046265 209 NLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPP 288 (639)
Q Consensus 209 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~ 288 (639)
+|+.|++++|++.+..+..|..+++|+.|++++|++++..+..|..+++|+.|++++|++ ..+|.
T Consensus 125 ---~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l------------~~ip~ 189 (290)
T 1p9a_G 125 ---ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL------------YTIPK 189 (290)
T ss_dssp ---TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCC------------CCCCT
T ss_pred ---CCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcC------------CccCh
Confidence 444555566666665556666777777777777777766666666677777777666655 24566
Q ss_pred cccCCCCCCEEeccCCccc
Q 046265 289 KIGKLYQLHKLDFSLNHIV 307 (639)
Q Consensus 289 ~~~~l~~L~~L~Ls~N~~~ 307 (639)
.+....+|+.+++++|.+.
T Consensus 190 ~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 190 GFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp TTTTTCCCSEEECCSCCBC
T ss_pred hhcccccCCeEEeCCCCcc
Confidence 6666666666666666654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-24 Score=225.11 Aligned_cols=265 Identities=16% Similarity=0.103 Sum_probs=139.9
Q ss_pred EeCCCcccccCCccccCCCCCCEEECcCCCCccCCC----CCCCCCC-CCCEEEcccCcCCCCCCcccCCC-----CCCC
Q 046265 12 VHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIP----QEIDPLT-HLKHLYINVNKLRGSVPREVGQL-----SSLK 81 (639)
Q Consensus 12 ~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p----~~~~~L~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~ 81 (639)
.++.|++.+.+|..+...++|++|||++|.+++..+ ..+..++ +|++|+|++|++++..+..+..+ ++|+
T Consensus 4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~ 83 (362)
T 3goz_A 4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83 (362)
T ss_dssp ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCcc
Confidence 466777777777766666667777777777775555 5566676 77777777777776556555554 6777
Q ss_pred EEeeecccCccccCccccCCCCCCcccCCCCCccc-CCCCccEEEccCCcCcccCCcccc----C-CCCCCEEeccCCCC
Q 046265 82 QLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNL-TSLSLFHLDLSENQLSGSIPHFLG----H-LSNLAVLHLGDNSL 155 (639)
Q Consensus 82 ~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l-~~L~L~~L~L~~N~l~~~~p~~~~----~-l~~L~~L~L~~N~l 155 (639)
+|+|++|++++..+..+... +..+ + +|++|+|++|++++..+..+. . .++|++|+|++|.+
T Consensus 84 ~L~Ls~n~l~~~~~~~l~~~-----------l~~~~~--~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l 150 (362)
T 3goz_A 84 SLNLSGNFLSYKSSDELVKT-----------LAAIPF--TITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDL 150 (362)
T ss_dssp EEECCSSCGGGSCHHHHHHH-----------HHTSCT--TCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCG
T ss_pred EEECcCCcCChHHHHHHHHH-----------HHhCCC--CccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcC
Confidence 77777777765555443321 0000 1 224667777766654443332 2 24666666666666
Q ss_pred CCCCC----ccccCCC-cccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccc-cCCcEEEcCCcccCCC---
Q 046265 156 FGSIP----PILGKVQ-SLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNL-LQLIELEIDNKQLFGQ--- 226 (639)
Q Consensus 156 ~~~~p----~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l-~~L~~L~l~~n~l~~~--- 226 (639)
+...+ ..+..++ +|++|++++|.+++..+..+. ..+... ++|+.|++++|.+...
T Consensus 151 ~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~----------------~~l~~~~~~L~~L~Ls~N~i~~~~~~ 214 (362)
T 3goz_A 151 GIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELA----------------KFLASIPASVTSLDLSANLLGLKSYA 214 (362)
T ss_dssp GGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHH----------------HHHHTSCTTCCEEECTTSCGGGSCHH
T ss_pred CHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHH----------------HHHHhCCCCCCEEECCCCCCChhHHH
Confidence 53222 2223333 566666666655543332221 112223 3566666666665442
Q ss_pred -CCccccC-CCCCceeccccccccCcchh----hhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEe
Q 046265 227 -IPKSLRN-FTSLNIVHLEQNHLTGNIYE----VFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLD 300 (639)
Q Consensus 227 -~p~~~~~-l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~ 300 (639)
++..+.. .++|+.|++++|.+++..+. .+..+++|+.|++++|.+.+. ....+ ..++..+..+++|+.||
T Consensus 215 ~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i---~~~~~-~~l~~~~~~l~~L~~Ld 290 (362)
T 3goz_A 215 ELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNM---SKEQC-KALGAAFPNIQKIILVD 290 (362)
T ss_dssp HHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTC---CHHHH-HHHHTTSTTCCEEEEEC
T ss_pred HHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCcccc---CHHHH-HHHHHHhccCCceEEEe
Confidence 2333333 23566666666666554332 233445555555555543210 00000 11223344455555555
Q ss_pred ccCCccccc
Q 046265 301 FSLNHIVGE 309 (639)
Q Consensus 301 Ls~N~~~~~ 309 (639)
+++|.+...
T Consensus 291 L~~N~l~~~ 299 (362)
T 3goz_A 291 KNGKEIHPS 299 (362)
T ss_dssp TTSCBCCGG
T ss_pred cCCCcCCCc
Confidence 555555443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=5e-22 Score=195.88 Aligned_cols=179 Identities=24% Similarity=0.275 Sum_probs=150.9
Q ss_pred ccce-eeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCC
Q 046265 2 SCLA-FFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSL 80 (639)
Q Consensus 2 ~~~~-~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L 80 (639)
+|.| -....++.+++++. .+|..+. +++++|+|++|.+++..|..|..+++|++|+|++|++++..|..|..+++|
T Consensus 9 gC~C~~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 85 (251)
T 3m19_A 9 GCTCNEGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85 (251)
T ss_dssp SSEEEGGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred ceEcCCCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcC
Confidence 4777 34456888888877 6777765 689999999999998888899999999999999999998788889999999
Q ss_pred CEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCC
Q 046265 81 KQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIP 160 (639)
Q Consensus 81 ~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 160 (639)
++|+|++|++++..+..|..+++| ++|+|++|++++..+..|..+++|++|+|++|++++..+
T Consensus 86 ~~L~L~~n~l~~~~~~~~~~l~~L-----------------~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 148 (251)
T 3m19_A 86 GTLGLANNQLASLPLGVFDHLTQL-----------------DKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPA 148 (251)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTC-----------------CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CEEECCCCcccccChhHhcccCCC-----------------CEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCH
Confidence 999999999997777777777643 589999999997777778999999999999999998777
Q ss_pred ccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccC
Q 046265 161 PILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYS 200 (639)
Q Consensus 161 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 200 (639)
..|+.+++|+.|++++|.+++..+..+..+++|+.|++++
T Consensus 149 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 188 (251)
T 3m19_A 149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFG 188 (251)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred HHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeC
Confidence 7899999999999999999987776776666555554443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7e-23 Score=207.64 Aligned_cols=146 Identities=18% Similarity=0.279 Sum_probs=125.0
Q ss_pred ccCCCc-ceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHH-hccccCceeeeEEEEEc----CCc
Q 046265 465 NNFDAK-YCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKAL-TELRHRNVVKFYGFSFH----PRQ 537 (639)
Q Consensus 465 ~~f~~~-~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~----~~~ 537 (639)
++|... +.||+|+||.||+|.. .+++.||||.+.. ...+.+|+.++ +..+||||+++++++.. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 445554 7899999999999954 6789999999863 23467888888 55689999999999986 567
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEcccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL---DYDAHVSDFG 614 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~---~~~~kl~DfG 614 (639)
.|+||||+++|+|.+++..... ..+++..+..++.|++.|++|||.. +|+||||||+||+++. ++.+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 8999999999999999986432 3578899999999999999999998 9999999999999997 7889999999
Q ss_pred ccccCCC
Q 046265 615 ISKFLKP 621 (639)
Q Consensus 615 la~~~~~ 621 (639)
+++....
T Consensus 166 ~a~~~~~ 172 (299)
T 3m2w_A 166 FAKETTG 172 (299)
T ss_dssp TCEECTT
T ss_pred ccccccc
Confidence 9987653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.1e-23 Score=219.95 Aligned_cols=168 Identities=15% Similarity=0.184 Sum_probs=124.1
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCC-CChhhHHHHHHHHHHHhcccc-Cceee-------------
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTELRH-RNVVK------------- 527 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H-~niv~------------- 527 (639)
+.+|...++||+|+||.||+|. ..+|+.||||++.... ......+.+.+|+.+++.++| +|...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3456677899999999999996 6678999999987432 222335678999999999977 22111
Q ss_pred --------eEEEEEc-----CCceeEEecccCCCChhHHhhc----CCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 046265 528 --------FYGFSFH-----PRQSFLLYEYLGRGSLAIILSN----DAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPI 590 (639)
Q Consensus 528 --------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i 590 (639)
+..++.. ....+++|+++ +++|.++++. ......++|..+..++.|+++||+|||+. +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 1111111 12356777755 6899988841 11223577889999999999999999998 99
Q ss_pred EeecCCCCCeeeCCCCceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 591 VHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 591 iHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+||||||+|||++.++.+||+|||+++..... ....+| +.|||||
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE 277 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPE 277 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCch
Confidence 99999999999999999999999999875432 344678 9999998
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-22 Score=205.13 Aligned_cols=229 Identities=18% Similarity=0.159 Sum_probs=165.7
Q ss_pred CCCCEEECcCCCCccCC-C--CCCCCCCCCCEEEcccCcCCCCCCccc--CCCCCCCEEeeecccCccccC----ccccC
Q 046265 30 SNLKFLDMGNNQLSGVI-P--QEIDPLTHLKHLYINVNKLRGSVPREV--GQLSSLKQLVLYCNGLSGWLP----SSFGN 100 (639)
Q Consensus 30 ~~L~~L~Ls~n~l~~~~-p--~~~~~L~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~ 100 (639)
..++.|.+.++.++... . ..+..+++|++|++++|.+++..|..+ ..+++|++|+|++|.+++..| ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 35788888888775210 0 012345679999999999998888888 889999999999999987554 22233
Q ss_pred CCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCC--C--CccccCCCcccEEEccc
Q 046265 101 LNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGS--I--PPILGKVQSLLSLGFDL 176 (639)
Q Consensus 101 l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~l~~ 176 (639)
++ +| ++|+|++|++++..|..+..+++|++|+|++|++.+. + +..++.+++|++|++++
T Consensus 144 ~~---------------~L--~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~ 206 (310)
T 4glp_A 144 KP---------------GL--KVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRN 206 (310)
T ss_dssp CS---------------CC--CEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCS
T ss_pred cc---------------CC--CEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCC
Confidence 33 33 6899999999888888899999999999999988652 2 23347889999999999
Q ss_pred CcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCC---CCCceeccccccccCcchh
Q 046265 177 NLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNF---TSLNIVHLEQNHLTGNIYE 253 (639)
Q Consensus 177 N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~~~ 253 (639)
|.++.. |... ...+..+++|++|++++|++.+..|..+..+ ++|++|++++|+++. +|.
T Consensus 207 N~l~~l-~~~~----------------~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~-lp~ 268 (310)
T 4glp_A 207 TGMETP-TGVC----------------AALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ-VPK 268 (310)
T ss_dssp SCCCCH-HHHH----------------HHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS-CCS
T ss_pred CCCCch-HHHH----------------HHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc-hhh
Confidence 988632 1100 0013456677778888888877777777666 688899999998885 444
Q ss_pred hhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccc
Q 046265 254 VFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVG 308 (639)
Q Consensus 254 ~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~ 308 (639)
.+ .++|+.|++++|+++ .+|. +..+++|+.|++++|.++.
T Consensus 269 ~~--~~~L~~L~Ls~N~l~------------~~~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 269 GL--PAKLRVLDLSSNRLN------------RAPQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CC--CSCCSCEECCSCCCC------------SCCC-TTSCCCCSCEECSSTTTSC
T ss_pred hh--cCCCCEEECCCCcCC------------CCch-hhhCCCccEEECcCCCCCC
Confidence 43 278888887777763 2233 4667888999999998863
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.6e-23 Score=204.79 Aligned_cols=146 Identities=18% Similarity=0.216 Sum_probs=115.4
Q ss_pred HHHHHHHhccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCCh----------------hhHHHHHHHHHHHhcc
Q 046265 457 YEEVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDM----------------VVQQAFSNEIKALTEL 520 (639)
Q Consensus 457 ~~~~~~~~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~e~~~l~~l 520 (639)
..........|+..+.||+|+||.||+|...+|+.||||.++...... .....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 344445555666779999999999999987889999999997532111 1356789999999999
Q ss_pred ccCceeeeEEEEEcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 046265 521 RHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNV 600 (639)
Q Consensus 521 ~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Ni 600 (639)
+| +++++++.. +..|+||||+++|+|.+ +.. .....++.|+++|++|+|.. +|+||||||+||
T Consensus 162 ~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NI 224 (282)
T 1zar_A 162 QG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV 224 (282)
T ss_dssp TT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred cC---CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHE
Confidence 84 555555433 56799999999999998 421 12346899999999999998 999999999999
Q ss_pred eeCCCCceEEccccccccCC
Q 046265 601 LLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 601 ll~~~~~~kl~DfGla~~~~ 620 (639)
+++ ++.+||+|||+|+...
T Consensus 225 Ll~-~~~vkl~DFG~a~~~~ 243 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVEVG 243 (282)
T ss_dssp EEE-TTEEEECCCTTCEETT
T ss_pred EEE-CCcEEEEECCCCeECC
Confidence 999 9999999999998653
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-21 Score=191.32 Aligned_cols=186 Identities=23% Similarity=0.249 Sum_probs=111.1
Q ss_pred CccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeeccc-CccccCccccCCCCCCcccCCCCCcccCCCC
Q 046265 42 LSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNG-LSGWLPSSFGNLNNLAIGSMPNSLSNLTSLS 120 (639)
Q Consensus 42 l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~ 120 (639)
++ .+|. +. ++|++|++++|++++..+..|.++++|++|++++|+ +++..+..|.++++|
T Consensus 23 l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L---------------- 82 (239)
T 2xwt_C 23 IQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKV---------------- 82 (239)
T ss_dssp CS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTC----------------
T ss_pred cc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCC----------------
Confidence 44 4565 43 377888888888876555577788888888888886 776555566666533
Q ss_pred ccEEEccC-CcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCccc---EEEcccC-cCCccCCccCcCCCCCCe
Q 046265 121 LFHLDLSE-NQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLL---SLGFDLN-LLNGVLPPSISNLSNLEG 195 (639)
Q Consensus 121 L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~l~~N-~l~~~~p~~~~~l~~L~~ 195 (639)
++|++++ |++++..+..|.++++|++|++++|++++ +|. +..+++|+ .|++++| .+++..+..|..
T Consensus 83 -~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~------ 153 (239)
T 2xwt_C 83 -THIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQG------ 153 (239)
T ss_dssp -CEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTT------
T ss_pred -cEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccc------
Confidence 4777777 77776555677777777777777777765 554 66666666 7777776 665444433332
Q ss_pred EEccCCccccccccccCCc-EEEcCCcccCCCCCccccCCCCCceecccccc-ccCcchhhhhcC-CCccEEeccCCcc
Q 046265 196 LYLYSSLVSAEIGNLLQLI-ELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNH-LTGNIYEVFGIY-PNLTFLDLSQNNF 271 (639)
Q Consensus 196 L~l~~~~~~~~~~~l~~L~-~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l-~~L~~L~Ls~N~l 271 (639)
+++|+ .|++++|++. .+|......++|+.|++++|+ +++..+..|..+ ++|+.|++++|++
T Consensus 154 --------------l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l 217 (239)
T 2xwt_C 154 --------------LCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV 217 (239)
T ss_dssp --------------TBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCC
T ss_pred --------------hhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcc
Confidence 33344 4444555554 233222222555555555553 554444445544 5555555444433
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-21 Score=201.80 Aligned_cols=90 Identities=18% Similarity=0.186 Sum_probs=40.5
Q ss_pred EEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCc-ccCCCCCCCE-Eeeec
Q 046265 10 QVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPR-EVGQLSSLKQ-LVLYC 87 (639)
Q Consensus 10 ~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~-L~L~~ 87 (639)
.|+-++++++ .+|..+ .+++++|+|++|+|+.+.+.+|.+|++|++|+|++|++.+.+|. .|.++++|++ +.+..
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 3444444443 344444 23455555555555533334455555555555555554433332 3444444433 33334
Q ss_pred ccCccccCccccCCC
Q 046265 88 NGLSGWLPSSFGNLN 102 (639)
Q Consensus 88 N~l~~~~p~~~~~l~ 102 (639)
|+++...|..|..++
T Consensus 90 N~l~~l~~~~f~~l~ 104 (350)
T 4ay9_X 90 NNLLYINPEAFQNLP 104 (350)
T ss_dssp TTCCEECTTSBCCCT
T ss_pred CcccccCchhhhhcc
Confidence 444444444444333
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-23 Score=220.82 Aligned_cols=247 Identities=18% Similarity=0.202 Sum_probs=175.1
Q ss_pred cCCccccCCCCCCEEECcCCCCccC----CCCCCCCCCCCCEEEcccC---cCCCCCCccc-------CCCCCCCEEeee
Q 046265 21 IIPPQIGNISNLKFLDMGNNQLSGV----IPQEIDPLTHLKHLYINVN---KLRGSVPREV-------GQLSSLKQLVLY 86 (639)
Q Consensus 21 ~~p~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~~L~~L~~L~L~~N---~l~~~~p~~~-------~~l~~L~~L~L~ 86 (639)
.++..+..+++|++|+|++|.++.. ++..+..+++|++|+|++| ++++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 5667778888899999999988765 3445778889999999885 4444556555 678888888888
Q ss_pred cccCcc----ccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCcccc----CC---------CCCCEEe
Q 046265 87 CNGLSG----WLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLG----HL---------SNLAVLH 149 (639)
Q Consensus 87 ~N~l~~----~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~ 149 (639)
+|.+++ .+|..+..+++| ++|+|++|.++...+..+. .+ ++|++|+
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L-----------------~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~ 165 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPL-----------------EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII 165 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTC-----------------CEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEE
T ss_pred CCcCCHHHHHHHHHHHHhCCCC-----------------CEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEE
Confidence 888876 355566555532 5888888888644443333 33 7888888
Q ss_pred ccCCCCC-CCCC---ccccCCCcccEEEcccCcCC--c---cCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCC
Q 046265 150 LGDNSLF-GSIP---PILGKVQSLLSLGFDLNLLN--G---VLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDN 220 (639)
Q Consensus 150 L~~N~l~-~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~ 220 (639)
|++|+++ +.+| ..+..+++|+.|++++|.++ | ..|. .+..+++|+.|++++
T Consensus 166 L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~--------------------~l~~~~~L~~L~Ls~ 225 (386)
T 2ca6_A 166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLE--------------------GLAYCQELKVLDLQD 225 (386)
T ss_dssp CCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHT--------------------TGGGCTTCCEEECCS
T ss_pred CCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHH--------------------HhhcCCCccEEECcC
Confidence 8888886 3444 35667778888888888776 2 1222 344556677777777
Q ss_pred cccC----CCCCccccCCCCCceeccccccccCc----chhhhhc--CCCccEEeccCCcccccccCcCCccccccCccc
Q 046265 221 KQLF----GQIPKSLRNFTSLNIVHLEQNHLTGN----IYEVFGI--YPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKI 290 (639)
Q Consensus 221 n~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~--l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~ 290 (639)
|.+. +.+|..+..+++|+.|+|++|.+++. ++..+.. +++|+.|+|++|.+.+. . ...+|..+
T Consensus 226 n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~------g-~~~l~~~l 298 (386)
T 2ca6_A 226 NTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELD------A-VRTLKTVI 298 (386)
T ss_dssp SCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHH------H-HHHHHHHH
T ss_pred CCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHH------H-HHHHHHHH
Confidence 7775 55777888889999999999998875 4556633 88999999777766320 0 00367766
Q ss_pred -cCCCCCCEEeccCCcccccCC
Q 046265 291 -GKLYQLHKLDFSLNHIVGELP 311 (639)
Q Consensus 291 -~~l~~L~~L~Ls~N~~~~~~p 311 (639)
.++++|+.|++++|.+++..|
T Consensus 299 ~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 299 DEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHCTTCCEEECTTSBSCTTSH
T ss_pred HhcCCCceEEEccCCcCCcchh
Confidence 557899999999999987654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-23 Score=219.88 Aligned_cols=237 Identities=20% Similarity=0.187 Sum_probs=177.0
Q ss_pred eeEEEEeCCCcccccCC----ccccCCC-CCCEEECcCCCCccCCCCCCCCC-----CCCCEEEcccCcCCCCCCcccC-
Q 046265 7 FFFQVVHESNTLFAIIP----PQIGNIS-NLKFLDMGNNQLSGVIPQEIDPL-----THLKHLYINVNKLRGSVPREVG- 75 (639)
Q Consensus 7 ~~~~~~~~~n~~~~~~p----~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~L-----~~L~~L~L~~N~l~~~~p~~~~- 75 (639)
.+..+++++|++.+..+ ..+..++ +|++|+|++|.+++..+..+..+ ++|++|+|++|++++..+..+.
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 36789999999998887 7788898 99999999999998777777775 9999999999999976666444
Q ss_pred ---CC-CCCCEEeeecccCccccCccccCC-CCCCcccCCCCCcccCCCCccEEEccCCcCcccC----CccccCCC-CC
Q 046265 76 ---QL-SSLKQLVLYCNGLSGWLPSSFGNL-NNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSI----PHFLGHLS-NL 145 (639)
Q Consensus 76 ---~l-~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~----p~~~~~l~-~L 145 (639)
.+ ++|++|+|++|++++..+..+... ..+ .+ +|++|+|++|+++... +..+..++ +|
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~-----------~~--~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 169 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL-----------PA--SITSLNLRGNDLGIKSSDELIQILAAIPANV 169 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTS-----------CT--TCCEEECTTSCGGGSCHHHHHHHHHTSCTTC
T ss_pred HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhC-----------CC--ceeEEEccCCcCCHHHHHHHHHHHhcCCccc
Confidence 44 899999999999987666555431 100 01 2369999999998533 44456665 99
Q ss_pred CEEeccCCCCCCCCCcccc----CC-CcccEEEcccCcCCccCCccCcCCCCCCeEEccCCcccccccc-ccCCcEEEcC
Q 046265 146 AVLHLGDNSLFGSIPPILG----KV-QSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGN-LLQLIELEID 219 (639)
Q Consensus 146 ~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~-l~~L~~L~l~ 219 (639)
++|+|++|++++..+..+. .. ++|+.|++++|.++...... ++..+.. .++|+.|+++
T Consensus 170 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~----------------l~~~l~~~~~~L~~L~Ls 233 (362)
T 3goz_A 170 NSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAE----------------LAYIFSSIPNHVVSLNLC 233 (362)
T ss_dssp CEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHH----------------HHHHHHHSCTTCCEEECC
T ss_pred cEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHH----------------HHHHHhcCCCCceEEECc
Confidence 9999999999877665444 44 69999999999987532111 1223333 3478888888
Q ss_pred CcccCCCCC----ccccCCCCCceeccccccccCcchh-------hhhcCCCccEEeccCCccc
Q 046265 220 NKQLFGQIP----KSLRNFTSLNIVHLEQNHLTGNIYE-------VFGIYPNLTFLDLSQNNFY 272 (639)
Q Consensus 220 ~n~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~~~-------~~~~l~~L~~L~Ls~N~l~ 272 (639)
+|.+.+..+ ..+..+++|+.|++++|.+.+..+. .+..+++|+.||+++|.+.
T Consensus 234 ~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~ 297 (362)
T 3goz_A 234 LNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297 (362)
T ss_dssp SSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCC
T ss_pred CCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCC
Confidence 888876544 3456789999999999996654433 4566778889998777663
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=4.7e-21 Score=188.89 Aligned_cols=181 Identities=23% Similarity=0.268 Sum_probs=136.1
Q ss_pred CCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccC
Q 046265 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSM 109 (639)
Q Consensus 30 ~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~l 109 (639)
...++++++++.++ .+|..+. ++|+.|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----- 85 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL----- 85 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTC-----
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcC-----
Confidence 35678999999987 6777665 588999999999987777788889999999999998887777777766633
Q ss_pred CCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcC
Q 046265 110 PNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISN 189 (639)
Q Consensus 110 p~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 189 (639)
++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|.+++..+..|..
T Consensus 86 ------------~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 153 (251)
T 3m19_A 86 ------------GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDK 153 (251)
T ss_dssp ------------CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred ------------CEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCc
Confidence 48888888888776777888888888888888888766666788888888888888887655544443
Q ss_pred CCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCc
Q 046265 190 LSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGN 250 (639)
Q Consensus 190 l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 250 (639)
+ ++|+.|++++|++.+..|..+..+++|+.|++++|.+++.
T Consensus 154 l--------------------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 154 L--------------------TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp C--------------------TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred C--------------------cCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 3 3444555566666665555666677777777777776654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.5e-21 Score=200.68 Aligned_cols=250 Identities=21% Similarity=0.178 Sum_probs=180.1
Q ss_pred cccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccC-ccccCCCC
Q 046265 25 QIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLP-SSFGNLNN 103 (639)
Q Consensus 25 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~ 103 (639)
.++.+.. ++++.++++++ .+|..+ .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+| ..|.++.+
T Consensus 5 ~~C~C~~-~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~ 80 (350)
T 4ay9_X 5 RICHCSN-RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80 (350)
T ss_dssp SSSEEET-TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTT
T ss_pred CccEeeC-CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchh
Confidence 3444432 67899999998 678777 3689999999999995445579999999999999999877665 46677765
Q ss_pred CCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEccc-CcCCcc
Q 046265 104 LAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDL-NLLNGV 182 (639)
Q Consensus 104 L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~ 182 (639)
+. ..++++.|+++...|..|..+++|++|++++|++.+..+..+....++..+++.+ |.+...
T Consensus 81 l~----------------~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l 144 (350)
T 4ay9_X 81 LH----------------EIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTI 144 (350)
T ss_dssp CC----------------EEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEE
T ss_pred hh----------------hhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccc
Confidence 43 4678888999988889999999999999999999987777777788889999865 567655
Q ss_pred CCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceecccc-ccccCcchhhhhcCCCc
Q 046265 183 LPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQ-NHLTGNIYEVFGIYPNL 261 (639)
Q Consensus 183 ~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L 261 (639)
.+..|..+. ..++.|++++|++.. +|......++|+.|++++ |.++...+++|..+++|
T Consensus 145 ~~~~f~~~~-------------------~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L 204 (350)
T 4ay9_X 145 ERNSFVGLS-------------------FESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGP 204 (350)
T ss_dssp CTTSSTTSB-------------------SSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECC
T ss_pred cccchhhcc-------------------hhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCccc
Confidence 555554432 245567777777754 444444556777777764 66776666677778888
Q ss_pred cEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCcc
Q 046265 262 TFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNK 329 (639)
Q Consensus 262 ~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~ 329 (639)
++|++++|+++ .+|.. .+.+|+.|.+.++.-...+| .+..+++|+.++++++.
T Consensus 205 ~~LdLs~N~l~------------~lp~~--~~~~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 205 VILDISRTRIH------------SLPSY--GLENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp SEEECTTSCCC------------CCCSS--SCTTCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCHH
T ss_pred chhhcCCCCcC------------ccChh--hhccchHhhhccCCCcCcCC-CchhCcChhhCcCCCCc
Confidence 88887776662 44542 23455555554444334666 36778888888887654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.86 E-value=6.5e-23 Score=211.51 Aligned_cols=255 Identities=16% Similarity=0.161 Sum_probs=162.9
Q ss_pred CCCEEECcCCCCccCCCCCCCCC--CCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccc-cCccccCCCCCCcc
Q 046265 31 NLKFLDMGNNQLSGVIPQEIDPL--THLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGW-LPSSFGNLNNLAIG 107 (639)
Q Consensus 31 ~L~~L~Ls~n~l~~~~p~~~~~L--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~~ 107 (639)
.++.|++++|.+. |..+..+ ++++.|++++|.+++..+. +..+++|++|++++|.+++. +|..+..+++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L--- 120 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL--- 120 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCC---
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCC---
Confidence 3667777777665 4455566 6777777777777754443 55677777777777776654 55555555422
Q ss_pred cCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCC-CCCC-CCCccccCCCcccEEEcccC-cCCcc-C
Q 046265 108 SMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDN-SLFG-SIPPILGKVQSLLSLGFDLN-LLNGV-L 183 (639)
Q Consensus 108 ~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~-~~p~~~~~l~~L~~L~l~~N-~l~~~-~ 183 (639)
++|+|++|.+++..|..++.+++|++|+|++| .+++ .+|..+..+++|++|++++| .+++. +
T Consensus 121 --------------~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~ 186 (336)
T 2ast_B 121 --------------QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHV 186 (336)
T ss_dssp --------------SEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHH
T ss_pred --------------CEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHH
Confidence 47777777777666777777777777777777 5554 24555666777777777777 66542 2
Q ss_pred CccCcCCCCCCeEEccCCcccccccccc-CCcEEEcCCc--ccC-CCCCccccCCCCCceecccccc-ccCcchhhhhcC
Q 046265 184 PPSISNLSNLEGLYLYSSLVSAEIGNLL-QLIELEIDNK--QLF-GQIPKSLRNFTSLNIVHLEQNH-LTGNIYEVFGIY 258 (639)
Q Consensus 184 p~~~~~l~~L~~L~l~~~~~~~~~~~l~-~L~~L~l~~n--~l~-~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l 258 (639)
+.. +..++ +|+.|++++| .+. +.+|..+..+++|+.|++++|. +++..+..+..+
T Consensus 187 ~~~--------------------~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l 246 (336)
T 2ast_B 187 QVA--------------------VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL 246 (336)
T ss_dssp HHH--------------------HHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGC
T ss_pred HHH--------------------HHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCC
Confidence 333 33444 5556666666 333 3455566677778888888777 666666677777
Q ss_pred CCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCC-CCCCeeeccCccCcccCCcC
Q 046265 259 PNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNL-KSLNYRALNGNKVYGSLPRV 337 (639)
Q Consensus 259 ~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p~~ 337 (639)
++|+.|++++|.- ++......+..+++|+.|++++| +.. ..+..+ ..+..|++++|++++..|..
T Consensus 247 ~~L~~L~l~~~~~----------~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~ 312 (336)
T 2ast_B 247 NYLQHLSLSRCYD----------IIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPT 312 (336)
T ss_dssp TTCCEEECTTCTT----------CCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred CCCCEeeCCCCCC----------CCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCc
Confidence 8888888776631 11111124566788888888887 332 223333 23666778888888888876
Q ss_pred ccC
Q 046265 338 LGS 340 (639)
Q Consensus 338 ~~~ 340 (639)
++.
T Consensus 313 ~~~ 315 (336)
T 2ast_B 313 IGN 315 (336)
T ss_dssp CSS
T ss_pred ccc
Confidence 654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.85 E-value=3.4e-23 Score=217.99 Aligned_cols=137 Identities=20% Similarity=0.227 Sum_probs=88.0
Q ss_pred cCCcEEEcCCcccC-CCCC---ccccCCCCCceeccccccccC-----cchhhhhcCCCccEEeccCCcccccccCcCCc
Q 046265 211 LQLIELEIDNKQLF-GQIP---KSLRNFTSLNIVHLEQNHLTG-----NIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNN 281 (639)
Q Consensus 211 ~~L~~L~l~~n~l~-~~~p---~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~ 281 (639)
++|+.|++++|++. +.+| ..+..+++|+.|++++|.++. ..+..+..+++|+.|+|++|.++..
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~------- 231 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL------- 231 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHH-------
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcH-------
Confidence 45555666666554 2333 345566677777777776662 2233566677777777666654210
Q ss_pred cccccCccccCCCCCCEEeccCCccccc----CCcccc--CCCCCCeeeccCccCcc----cCCcCc-cCCCCCCEEeCC
Q 046265 282 ITRSIPPKIGKLYQLHKLDFSLNHIVGE----LPIELG--NLKSLNYRALNGNKVYG----SLPRVL-GSISDLEYLDLS 350 (639)
Q Consensus 282 ~~~~~p~~~~~l~~L~~L~Ls~N~~~~~----~p~~~~--~l~~L~~L~l~~N~l~~----~~p~~~-~~l~~L~~L~Ls 350 (639)
-.+.+|..+..+++|+.|+|++|.+.+. +|..+. .+++|+.|+|++|.+++ .+|..+ .++++|+.|+++
T Consensus 232 g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~ 311 (386)
T 2ca6_A 232 GSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELN 311 (386)
T ss_dssp HHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECT
T ss_pred HHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEcc
Confidence 0034566677777788888888877654 455553 37888888888888876 477666 567889999998
Q ss_pred CCCC
Q 046265 351 TNYN 354 (639)
Q Consensus 351 ~N~~ 354 (639)
+|++
T Consensus 312 ~N~l 315 (386)
T 2ca6_A 312 GNRF 315 (386)
T ss_dssp TSBS
T ss_pred CCcC
Confidence 8543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.5e-24 Score=238.74 Aligned_cols=259 Identities=14% Similarity=0.101 Sum_probs=125.5
Q ss_pred CCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccC-------cCCccCCccCcCCCCCCeEE-cc---CCcccccccc
Q 046265 141 HLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLN-------LLNGVLPPSISNLSNLEGLY-LY---SSLVSAEIGN 209 (639)
Q Consensus 141 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N-------~l~~~~p~~~~~l~~L~~L~-l~---~~~~~~~~~~ 209 (639)
++++|++|+|++|...+.+|..+..+++|+.|+++.+ .+.+ ++..+.++++|+.+. +. ...++..+..
T Consensus 209 ~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~ 287 (594)
T 2p1m_B 209 RCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVPAYLPAVYSV 287 (594)
T ss_dssp HCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCGGGGGGGHHH
T ss_pred hCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccchhhHHHHHHh
Confidence 3466666666655222224555555566666664332 2222 223455666666662 22 1223333446
Q ss_pred ccCCcEEEcCCcccCCCC-CccccCCCCCceeccccccccC-cchhhhhcCCCccEEeccCCcccccccCcCCccccccC
Q 046265 210 LLQLIELEIDNKQLFGQI-PKSLRNFTSLNIVHLEQNHLTG-NIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIP 287 (639)
Q Consensus 210 l~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p 287 (639)
+++|+.|++++|.+.+.. +..+..+++|+.|++++| ++. ..+.....+++|+.|+++++.-.| ..+.+.++....
T Consensus 288 ~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g--~~~~~~l~~~~l 364 (594)
T 2p1m_B 288 CSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFV--MEPNVALTEQGL 364 (594)
T ss_dssp HTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTC--SSCSSCCCHHHH
T ss_pred hCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccc--cccCCCCCHHHH
Confidence 778888888888864432 223567888888888887 432 223334457888888874321100 011122222111
Q ss_pred ccc-cCCCCCCEEeccCCcccccCCcccc-CCCCCCeeecc--C----ccCcc-----cCCcCccCCCCCCEEeCCCCCC
Q 046265 288 PKI-GKLYQLHKLDFSLNHIVGELPIELG-NLKSLNYRALN--G----NKVYG-----SLPRVLGSISDLEYLDLSTNYN 354 (639)
Q Consensus 288 ~~~-~~l~~L~~L~Ls~N~~~~~~p~~~~-~l~~L~~L~l~--~----N~l~~-----~~p~~~~~l~~L~~L~Ls~N~~ 354 (639)
..+ ..+++|+.|+++.|.+++..+..+. .+++|+.|+++ + |.++. .++..+..+++|+.|++++
T Consensus 365 ~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~--- 441 (594)
T 2p1m_B 365 VSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG--- 441 (594)
T ss_dssp HHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS---
T ss_pred HHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC---
Confidence 112 1245566666655655544333333 35566666665 2 33331 1111234455666666644
Q ss_pred CcccccCChhhhc-cccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCeee
Q 046265 355 NEFRKEFPVELEK-LVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNELR 416 (639)
Q Consensus 355 ~~~~~~~p~~~~~-l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l~ 416 (639)
.+....+..+.. +++|+.|+++.|.+++.. .......+++|+.|++++|.++
T Consensus 442 -~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~---------~~~l~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 442 -LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLG---------MHHVLSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp -SCCHHHHHHHHHHCTTCCEEEEESCCSSHHH---------HHHHHHHCTTCCEEEEESCSCC
T ss_pred -cccHHHHHHHHHhchhccEeeccCCCCcHHH---------HHHHHhcCCCcCEEECcCCCCc
Confidence 112222222332 455666666555443211 0111234555666666666553
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.2e-21 Score=196.40 Aligned_cols=200 Identities=18% Similarity=0.161 Sum_probs=157.9
Q ss_pred CCCCCCEEECcCCCCccCCCCCC--CCCCCCCEEEcccCcCCCCCC----cccCCCCCCCEEeeecccCccccCccccCC
Q 046265 28 NISNLKFLDMGNNQLSGVIPQEI--DPLTHLKHLYINVNKLRGSVP----REVGQLSSLKQLVLYCNGLSGWLPSSFGNL 101 (639)
Q Consensus 28 ~l~~L~~L~Ls~n~l~~~~p~~~--~~L~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 101 (639)
.+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..| ..+..+++|++|+|++|++++..|..|+.+
T Consensus 89 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l 168 (310)
T 4glp_A 89 AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF 168 (310)
T ss_dssp HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence 35679999999999988888888 889999999999999887555 345678899999999999988777777777
Q ss_pred CCCCcccCCCCCcccCCCCccEEEccCCcCccc--C--CccccCCCCCCEEeccCCCCCCCCCc----cccCCCcccEEE
Q 046265 102 NNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGS--I--PHFLGHLSNLAVLHLGDNSLFGSIPP----ILGKVQSLLSLG 173 (639)
Q Consensus 102 ~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~ 173 (639)
++| ++|+|++|++.+. + +..+..+++|++|+|++|+++. +|. .++.+++|++|+
T Consensus 169 ~~L-----------------~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~ 230 (310)
T 4glp_A 169 PAL-----------------TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLD 230 (310)
T ss_dssp TTC-----------------CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEE
T ss_pred CCC-----------------CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEE
Confidence 643 5889999987642 2 2334678889999999998863 333 256778999999
Q ss_pred cccCcCCccCCccCcCC---CCCCeEEccCCccc---cccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccc
Q 046265 174 FDLNLLNGVLPPSISNL---SNLEGLYLYSSLVS---AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHL 247 (639)
Q Consensus 174 l~~N~l~~~~p~~~~~l---~~L~~L~l~~~~~~---~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 247 (639)
+++|.+++..|..+..+ ++|+.|+++.|.+. ..+. ++|+.|++++|++.+. |. +..+++|+.|++++|.+
T Consensus 231 Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l 306 (310)
T 4glp_A 231 LSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPF 306 (310)
T ss_dssp CTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTT
T ss_pred CCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCC
Confidence 99999988878777776 58999999876543 3332 6899999999999864 43 67889999999999998
Q ss_pred cC
Q 046265 248 TG 249 (639)
Q Consensus 248 ~~ 249 (639)
+.
T Consensus 307 ~~ 308 (310)
T 4glp_A 307 LV 308 (310)
T ss_dssp SC
T ss_pred CC
Confidence 74
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=9.6e-21 Score=192.53 Aligned_cols=194 Identities=24% Similarity=0.338 Sum_probs=149.3
Q ss_pred ccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCC
Q 046265 26 IGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLA 105 (639)
Q Consensus 26 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 105 (639)
+..+++|++|++++|.++. +| .+..+++|++|+|++|++++ ++. +..+++|++|+|++|++++. + .+..++
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~~-~-~~~~l~--- 107 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKNV-S-AIAGLQ--- 107 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSCC-G-GGTTCT---
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCCc-h-hhcCCC---
Confidence 4567889999999999974 55 68899999999999999984 555 89999999999999998853 2 455554
Q ss_pred cccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCc
Q 046265 106 IGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPP 185 (639)
Q Consensus 106 ~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 185 (639)
+| ++|++++|++++ +|. +..+++|++|++++|.+++..+ ++.+++|+.|++++|.+++..+
T Consensus 108 ------------~L--~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~- 168 (308)
T 1h6u_A 108 ------------SI--KTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP- 168 (308)
T ss_dssp ------------TC--CEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-
T ss_pred ------------CC--CEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh-
Confidence 33 589999999985 444 8889999999999999986433 8889999999999998875322
Q ss_pred cCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEe
Q 046265 186 SISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLD 265 (639)
Q Consensus 186 ~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 265 (639)
+.. +++|+.|++++|++.+..+ +..+++|+.|++++|++++..+ +..+++|+.|+
T Consensus 169 -l~~--------------------l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~ 223 (308)
T 1h6u_A 169 -LAN--------------------LSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223 (308)
T ss_dssp -GTT--------------------CTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEE
T ss_pred -hcC--------------------CCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEE
Confidence 444 4556666667777755433 6778888888888888887653 67788888888
Q ss_pred ccCCccc
Q 046265 266 LSQNNFY 272 (639)
Q Consensus 266 Ls~N~l~ 272 (639)
+++|.++
T Consensus 224 l~~N~i~ 230 (308)
T 1h6u_A 224 LTNQTIT 230 (308)
T ss_dssp EEEEEEE
T ss_pred ccCCeee
Confidence 7777764
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.7e-20 Score=177.84 Aligned_cols=186 Identities=24% Similarity=0.223 Sum_probs=110.3
Q ss_pred cceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCE
Q 046265 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQ 82 (639)
Q Consensus 3 ~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 82 (639)
|.|. ...++.+.+++. .+|..+ .++|++|++++|.+++..+..|..+++|++|++++|++++..+..|..+++|++
T Consensus 5 C~C~-~~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 80 (208)
T 2o6s_A 5 CSCS-GTTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTY 80 (208)
T ss_dssp CEEE-TTEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CEEC-CCEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCE
Confidence 5552 345555555554 345444 346777777777777655556677777777777777776544445666777777
Q ss_pred EeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCcc
Q 046265 83 LVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPI 162 (639)
Q Consensus 83 L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 162 (639)
|++++|++++..+..|.++++| ++|++++|++++..+..|..+++|++|+|++|++++..+..
T Consensus 81 L~Ls~n~l~~~~~~~~~~l~~L-----------------~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 143 (208)
T 2o6s_A 81 LNLSTNQLQSLPNGVFDKLTQL-----------------KELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGV 143 (208)
T ss_dssp EECCSSCCCCCCTTTTTTCTTC-----------------CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred EECCCCcCCccCHhHhcCccCC-----------------CEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHH
Confidence 7777776665444444444422 36666666666554555566666666666666666544444
Q ss_pred ccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCC
Q 046265 163 LGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTS 236 (639)
Q Consensus 163 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~ 236 (639)
+..+++|+.|++++|.+.+ .++.|+.|+++.|++.|.+|.++++++.
T Consensus 144 ~~~l~~L~~L~l~~N~~~~---------------------------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 144 FDRLTSLQYIWLHDNPWDC---------------------------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp TTTCTTCCEEECCSCCBCC---------------------------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred hccCCCccEEEecCCCeec---------------------------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 5556666666666554432 2233455555666666666666655543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.84 E-value=3.8e-22 Score=205.74 Aligned_cols=256 Identities=20% Similarity=0.215 Sum_probs=177.1
Q ss_pred CCCEEEcccCcCCCCCCcccCCC--CCCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCc
Q 046265 55 HLKHLYINVNKLRGSVPREVGQL--SSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLS 132 (639)
Q Consensus 55 ~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~ 132 (639)
.++.+++++|.+. |..+..+ ++++.|++++|.+++..+. +..++ +| ++|++++|.++
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~---------------~L--~~L~L~~~~l~ 106 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPF---------------RV--QHMDLSNSVIE 106 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCB---------------CC--CEEECTTCEEC
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCC---------------CC--CEEEccCCCcC
Confidence 4677888877765 4555655 6777777777777765444 22233 22 57777777776
Q ss_pred cc-CCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccC-cCCccCCccCcCCCCCCeEEccCCccccccccc
Q 046265 133 GS-IPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLN-LLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNL 210 (639)
Q Consensus 133 ~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l 210 (639)
+. +|..+..+++|++|+|++|.+++..|..++.+++|++|++++| .+++. .++..+..+
T Consensus 107 ~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~-------------------~l~~~~~~~ 167 (336)
T 2ast_B 107 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF-------------------ALQTLLSSC 167 (336)
T ss_dssp HHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHH-------------------HHHHHHHHC
T ss_pred HHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHH-------------------HHHHHHhcC
Confidence 54 6667777777777777777776666666777777777777777 45431 012234566
Q ss_pred cCCcEEEcCCc-ccCCC-CCccccCCC-CCceeccccc--ccc-CcchhhhhcCCCccEEeccCCcccccccCcCCcccc
Q 046265 211 LQLIELEIDNK-QLFGQ-IPKSLRNFT-SLNIVHLEQN--HLT-GNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITR 284 (639)
Q Consensus 211 ~~L~~L~l~~n-~l~~~-~p~~~~~l~-~L~~L~L~~N--~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~ 284 (639)
++|++|++++| .+.+. +|..+..++ +|++|++++| .++ +.++..+..+++|+.|++++|.+ +++
T Consensus 168 ~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~----------l~~ 237 (336)
T 2ast_B 168 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM----------LKN 237 (336)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTT----------CCG
T ss_pred CCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCc----------CCH
Confidence 77888888888 77654 577788899 9999999999 555 45677888999999999887762 234
Q ss_pred ccCccccCCCCCCEEeccCCc-ccccCCccccCCCCCCeeeccCccCcccCCcCccCC-CCCCEEeCCCCCCCcccccCC
Q 046265 285 SIPPKIGKLYQLHKLDFSLNH-IVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSI-SDLEYLDLSTNYNNEFRKEFP 362 (639)
Q Consensus 285 ~~p~~~~~l~~L~~L~Ls~N~-~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~~~~~~~~~p 362 (639)
..+..+..+++|+.|++++|. +.......+..+++|+.|++++| +.. ..+..+ ..+..|++++| .+.+..|
T Consensus 238 ~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n---~l~~~~~ 310 (336)
T 2ast_B 238 DCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCS---HFTTIAR 310 (336)
T ss_dssp GGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCC---CSCCTTC
T ss_pred HHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecc---cCccccC
Confidence 566788889999999999995 32222235888999999999998 432 233333 23667778884 5556666
Q ss_pred hhhhc
Q 046265 363 VELEK 367 (639)
Q Consensus 363 ~~~~~ 367 (639)
..+..
T Consensus 311 ~~~~~ 315 (336)
T 2ast_B 311 PTIGN 315 (336)
T ss_dssp SSCSS
T ss_pred Ccccc
Confidence 65543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.83 E-value=5.9e-23 Score=228.85 Aligned_cols=360 Identities=14% Similarity=0.095 Sum_probs=174.6
Q ss_pred cCCCCCCEEECcCCCCccCCCCCCC-CCCCCCEEEcccC-cCCCC-CCcccCCCCCCCEEeeecccCccccCcccc----
Q 046265 27 GNISNLKFLDMGNNQLSGVIPQEID-PLTHLKHLYINVN-KLRGS-VPREVGQLSSLKQLVLYCNGLSGWLPSSFG---- 99 (639)
Q Consensus 27 ~~l~~L~~L~Ls~n~l~~~~p~~~~-~L~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~---- 99 (639)
..+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~ 181 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD 181 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence 3567788888888877765555554 5778888888777 44422 333444677888888887776654433333
Q ss_pred CCCCCCcccCCC--------C----CcccCCCCccEEEccCC-cCcccCCccccCCCCCCEEeccCCC-------CCCCC
Q 046265 100 NLNNLAIGSMPN--------S----LSNLTSLSLFHLDLSEN-QLSGSIPHFLGHLSNLAVLHLGDNS-------LFGSI 159 (639)
Q Consensus 100 ~l~~L~~~~lp~--------~----~~~l~~L~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~-------l~~~~ 159 (639)
.+++|+...+.. . ..++++| ++|++++| .++ .+|..+..+++|+.|+++.+. +.+ +
T Consensus 182 ~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L--~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l 257 (594)
T 2p1m_B 182 TYTSLVSLNISCLASEVSFSALERLVTRCPNL--KSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSG-L 257 (594)
T ss_dssp TCCCCCEEECTTCCSCCCHHHHHHHHHHCTTC--CEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-H
T ss_pred cCCcCcEEEecccCCcCCHHHHHHHHHhCCCC--cEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHH-H
Confidence 333444211111 1 1223555 78999988 444 477888888999999866553 221 2
Q ss_pred CccccCCCcccEE-EcccCcCCccCCccCcCCCCCCeEEccCCcccc-----ccccccCCcEEEcCCcccCCCCCccccC
Q 046265 160 PPILGKVQSLLSL-GFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSA-----EIGNLLQLIELEIDNKQLFGQIPKSLRN 233 (639)
Q Consensus 160 p~~~~~l~~L~~L-~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 233 (639)
+..+.++++|+.| .+.... .+.+|..+..+++|+.|+++.+.+.. .+..+++|+.|++++|.-...++.....
T Consensus 258 ~~~l~~~~~L~~Ls~~~~~~-~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~~~~l~~l~~~ 336 (594)
T 2p1m_B 258 SVALSGCKELRCLSGFWDAV-PAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLAST 336 (594)
T ss_dssp HHHHHTCTTCCEEECCBTCC-GGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHH
T ss_pred HHHHhcCCCcccccCCcccc-hhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCccCHHHHHHHHHh
Confidence 2244555555555 222211 12233333345555566555443321 1334555666665555111111112223
Q ss_pred CCCCceeccc---------cccccCcchhhh-hcCCCccEEeccCCcccccccCcCCccccccCcccc-CCCCCCEEecc
Q 046265 234 FTSLNIVHLE---------QNHLTGNIYEVF-GIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIG-KLYQLHKLDFS 302 (639)
Q Consensus 234 l~~L~~L~L~---------~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~-~l~~L~~L~Ls 302 (639)
+++|+.|++. .+.+++.....+ ..+++|+.|+++.|.++ +..+..+. .+++|+.|+++
T Consensus 337 ~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~-----------~~~~~~l~~~~~~L~~L~L~ 405 (594)
T 2p1m_B 337 CKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMT-----------NAALITIARNRPNMTRFRLC 405 (594)
T ss_dssp CTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCC-----------HHHHHHHHHHCTTCCEEEEE
T ss_pred CCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcC-----------HHHHHHHHhhCCCcceeEee
Confidence 5555555552 233333222222 23555555554444332 22222222 24555555555
Q ss_pred --C----Cccccc-----CCccccCCCCCCeeeccCccCcccCCcCccC-CCCCCEEeCCCCCCCcccccCChhh-hccc
Q 046265 303 --L----NHIVGE-----LPIELGNLKSLNYRALNGNKVYGSLPRVLGS-ISDLEYLDLSTNYNNEFRKEFPVEL-EKLV 369 (639)
Q Consensus 303 --~----N~~~~~-----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~~~~~~~~~p~~~-~~l~ 369 (639)
+ |.+++. ++..+..+++|+.|++++ .++...+..++. +++|+.|++++|. +.+..+..+ ..++
T Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~---i~~~~~~~l~~~~~ 481 (594)
T 2p1m_B 406 IIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAG---DSDLGMHHVLSGCD 481 (594)
T ss_dssp ESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCC---SSHHHHHHHHHHCT
T ss_pred cccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCC---CcHHHHHHHHhcCC
Confidence 2 233211 111134455555555554 343333333332 5556666665532 221111222 3455
Q ss_pred cCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCCee
Q 046265 370 QLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYNEL 415 (639)
Q Consensus 370 ~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N~l 415 (639)
+|+.|++++|.+.+.. ....+..+++|+.|++++|++
T Consensus 482 ~L~~L~L~~n~~~~~~---------~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 482 SLRKLEIRDCPFGDKA---------LLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp TCCEEEEESCSCCHHH---------HHHTGGGGGGSSEEEEESSCC
T ss_pred CcCEEECcCCCCcHHH---------HHHHHHhCCCCCEEeeeCCCC
Confidence 5566666555442211 011233455566666666554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=4.8e-20 Score=187.36 Aligned_cols=215 Identities=21% Similarity=0.323 Sum_probs=168.1
Q ss_pred CCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCC
Q 046265 32 LKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPN 111 (639)
Q Consensus 32 L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~ 111 (639)
+..+.+..+.++... .+..+++|++|++++|.++ .+| .+..+++|++|++++|++++..+ +..+++|
T Consensus 21 ~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L------- 87 (308)
T 1h6u_A 21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKI------- 87 (308)
T ss_dssp HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSC-------
T ss_pred HHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCC-------
Confidence 334456666665432 3567889999999999998 466 68899999999999999986444 6555532
Q ss_pred CCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCC
Q 046265 112 SLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLS 191 (639)
Q Consensus 112 ~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 191 (639)
++|+|++|++++ +| .+..+++|++|+|++|++++ +|. +..+++|++|++++|.+++..+
T Consensus 88 ----------~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~------- 146 (308)
T 1h6u_A 88 ----------TELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP------- 146 (308)
T ss_dssp ----------CEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-------
T ss_pred ----------CEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc-------
Confidence 589999999985 44 68899999999999999986 443 8899999999999998875432
Q ss_pred CCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcc
Q 046265 192 NLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNF 271 (639)
Q Consensus 192 ~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 271 (639)
+..+++|+.|++++|++.+. |. +..+++|+.|++++|.+++..+ +..+++|++|++++|++
T Consensus 147 ---------------l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l 207 (308)
T 1h6u_A 147 ---------------LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQI 207 (308)
T ss_dssp ---------------GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCC
T ss_pred ---------------ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCcc
Confidence 33556677788888888664 33 8899999999999999998665 88899999999888877
Q ss_pred cccccCcCCccccccCccccCCCCCCEEeccCCcccccCCcc
Q 046265 272 YGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIE 313 (639)
Q Consensus 272 ~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~ 313 (639)
. .++ .+..+++|+.|++++|.+++ .|..
T Consensus 208 ~------------~~~-~l~~l~~L~~L~l~~N~i~~-~~~~ 235 (308)
T 1h6u_A 208 S------------DVS-PLANTSNLFIVTLTNQTITN-QPVF 235 (308)
T ss_dssp C------------BCG-GGTTCTTCCEEEEEEEEEEC-CCEE
T ss_pred C------------ccc-cccCCCCCCEEEccCCeeec-CCee
Confidence 3 233 37889999999999999974 4443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=6.1e-20 Score=200.38 Aligned_cols=118 Identities=32% Similarity=0.379 Sum_probs=76.5
Q ss_pred CCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCC
Q 046265 31 NLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMP 110 (639)
Q Consensus 31 ~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp 110 (639)
++++|+|++|++++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~---------- 120 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA---------- 120 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT----------
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc----------
Confidence 67777777777765 565553 66777777777776 566 345677777777777765 444 332
Q ss_pred CCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCc
Q 046265 111 NSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPP 185 (639)
Q Consensus 111 ~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 185 (639)
+|++|+|++|++++ +|. .+++|++|+|++|++++ +|. .+++|+.|++++|.+++ +|.
T Consensus 121 ---------~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~ 177 (571)
T 3cvr_A 121 ---------SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE 177 (571)
T ss_dssp ---------TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC
T ss_pred ---------CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch
Confidence 12467777777765 555 46777777777777765 554 45677777777777765 444
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.7e-19 Score=172.23 Aligned_cols=162 Identities=24% Similarity=0.260 Sum_probs=137.2
Q ss_pred eeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeee
Q 046265 7 FFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLY 86 (639)
Q Consensus 7 ~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 86 (639)
.+..+++++|++.+..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+++
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 35678899999997777788999999999999999997766778999999999999999996666668999999999999
Q ss_pred cccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCC
Q 046265 87 CNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKV 166 (639)
Q Consensus 87 ~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 166 (639)
+|++++..+..|..+++| ++|++++|++++..+..+..+++|++|++++|.+.+ .+
T Consensus 109 ~N~l~~~~~~~~~~l~~L-----------------~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~ 164 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQL-----------------KDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TC 164 (208)
T ss_dssp SSCCCCCCTTTTTTCTTC-----------------CEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CT
T ss_pred CCcCcccCHhHhccCCcC-----------------CEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CC
Confidence 999997766667766633 589999999997767778899999999999998765 34
Q ss_pred CcccEEEcccCcCCccCCccCcCCCC
Q 046265 167 QSLLSLGFDLNLLNGVLPPSISNLSN 192 (639)
Q Consensus 167 ~~L~~L~l~~N~l~~~~p~~~~~l~~ 192 (639)
++|+.|+++.|.++|.+|.+++.++.
T Consensus 165 ~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 165 PGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp TTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred CCHHHHHHHHHhCCceeeccCccccC
Confidence 57899999999999999988876653
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.9e-19 Score=173.37 Aligned_cols=157 Identities=22% Similarity=0.282 Sum_probs=109.5
Q ss_pred cceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCE
Q 046265 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQ 82 (639)
Q Consensus 3 ~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 82 (639)
|.|.. ..++.+++++. .+|..+. ++|++|+|++|.|++..|..|..+++|++|+|++|++++..|..|.++++|++
T Consensus 9 C~C~~-~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~ 84 (220)
T 2v9t_B 9 CTCSN-NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNS 84 (220)
T ss_dssp SEEET-TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCE
T ss_pred CEECC-CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCE
Confidence 66643 45666666655 4566554 57777888888777666667777777777777777777666777777777777
Q ss_pred EeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCcc
Q 046265 83 LVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPI 162 (639)
Q Consensus 83 L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 162 (639)
|+|++|+++...+..|..+++| ++|+|++|++++..|..|..+++|++|+|++|++++..+..
T Consensus 85 L~Ls~N~l~~l~~~~f~~l~~L-----------------~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 147 (220)
T 2v9t_B 85 LVLYGNKITELPKSLFEGLFSL-----------------QLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147 (220)
T ss_dssp EECCSSCCCCCCTTTTTTCTTC-----------------CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred EECCCCcCCccCHhHccCCCCC-----------------CEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHH
Confidence 7777777775554555555532 47777777777666777777777777777777777666666
Q ss_pred ccCCCcccEEEcccCcCC
Q 046265 163 LGKVQSLLSLGFDLNLLN 180 (639)
Q Consensus 163 ~~~l~~L~~L~l~~N~l~ 180 (639)
|..+++|+.|++++|.+.
T Consensus 148 ~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 148 FSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp TTTCTTCCEEECCSSCEE
T ss_pred HhCCCCCCEEEeCCCCcC
Confidence 777777777777777664
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.5e-19 Score=197.35 Aligned_cols=188 Identities=26% Similarity=0.279 Sum_probs=136.8
Q ss_pred CCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCccc
Q 046265 55 HLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGS 134 (639)
Q Consensus 55 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~ 134 (639)
+|+.|+|++|.+++ +|..+. ++|++|+|++|+|+ .+| ..++ + |++|+|++|++++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~---------------~--L~~L~Ls~N~l~~- 114 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPA---------------S--LEYLDACDNRLST- 114 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCT---------------T--CCEEECCSSCCSC-
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccC---------------C--CCEEEccCCCCCC-
Confidence 89999999999985 887774 78999999999998 555 2233 2 3689999999996
Q ss_pred CCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCc
Q 046265 135 IPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLI 214 (639)
Q Consensus 135 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~ 214 (639)
+|. +.. +|++|+|++|++++ +|. .+++|+.|++++|.+++ +|. . +++|+
T Consensus 115 ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~--------------------l~~L~ 163 (571)
T 3cvr_A 115 LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---L--------------------PTSLE 163 (571)
T ss_dssp CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---C--------------------CTTCC
T ss_pred cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---c--------------------CCCcC
Confidence 777 665 99999999999987 666 67899999999999886 443 2 23566
Q ss_pred EEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCc-------cEEeccCCcccccccCcCCccccccC
Q 046265 215 ELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNL-------TFLDLSQNNFYGSLNFSMNNITRSIP 287 (639)
Q Consensus 215 ~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-------~~L~Ls~N~l~~~l~ls~n~~~~~~p 287 (639)
.|++++|++.+ +|. +. ++|+.|+|++|.|+.. |. +.. +| +.|+|++|+| ..+|
T Consensus 164 ~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~l-p~-~~~--~L~~~~~~L~~L~Ls~N~l------------~~lp 223 (571)
T 3cvr_A 164 VLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESL-PA-VPV--RNHHSEETEIFFRCRENRI------------THIP 223 (571)
T ss_dssp EEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSC-CC-CC----------CCEEEECCSSCC------------CCCC
T ss_pred EEECCCCCCCC-cch-hh--CCCCEEECcCCCCCch-hh-HHH--hhhcccccceEEecCCCcc------------eecC
Confidence 67777777766 565 54 7788888888887743 33 332 45 6677665555 2466
Q ss_pred ccccCCCCCCEEeccCCcccccCCccccCCC
Q 046265 288 PKIGKLYQLHKLDFSLNHIVGELPIELGNLK 318 (639)
Q Consensus 288 ~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~ 318 (639)
..+..+++|+.|+|++|.+++.+|..+..++
T Consensus 224 ~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 224 ENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp GGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred HHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 6666677777777777777776666665543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.7e-19 Score=173.81 Aligned_cols=158 Identities=22% Similarity=0.222 Sum_probs=104.4
Q ss_pred cceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCC-CCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCC
Q 046265 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIP-QEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81 (639)
Q Consensus 3 ~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p-~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 81 (639)
|.|.. ..+++++|++. .+|..+. ..+++|+|++|.+++..| ..|..+++|++|+|++|+|++..|..|..+++|+
T Consensus 9 C~C~~-~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~ 84 (220)
T 2v70_A 9 CRCEG-TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVN 84 (220)
T ss_dssp CEEET-TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred CEECC-CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCC
Confidence 66643 35667766665 3565553 345677777777776544 3466777777777777777765555677777777
Q ss_pred EEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCc
Q 046265 82 QLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP 161 (639)
Q Consensus 82 ~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 161 (639)
+|+|++|++++..|..|.++++| ++|+|++|++++..|..|..+++|++|+|++|++++..|.
T Consensus 85 ~L~Ls~N~l~~~~~~~~~~l~~L-----------------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 147 (220)
T 2v70_A 85 EILLTSNRLENVQHKMFKGLESL-----------------KTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG 147 (220)
T ss_dssp EEECCSSCCCCCCGGGGTTCSSC-----------------CEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred EEECCCCccCccCHhHhcCCcCC-----------------CEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHH
Confidence 77777777776666556555532 4677777777766666677777777777777777766666
Q ss_pred cccCCCcccEEEcccCcCCc
Q 046265 162 ILGKVQSLLSLGFDLNLLNG 181 (639)
Q Consensus 162 ~~~~l~~L~~L~l~~N~l~~ 181 (639)
.|..+++|+.|++++|.+.+
T Consensus 148 ~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 148 AFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp TTTTCTTCCEEECCSCCEEC
T ss_pred HhcCCCCCCEEEecCcCCcC
Confidence 67777777777777776654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.4e-18 Score=168.47 Aligned_cols=158 Identities=25% Similarity=0.257 Sum_probs=117.6
Q ss_pred cceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCE
Q 046265 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQ 82 (639)
Q Consensus 3 ~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 82 (639)
|.|. -..|+.+++++. .+|..+. ++|++|+|++|.+++..|..|..+++|++|+|++|+++...+..|..+++|++
T Consensus 17 ~~Cs-~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~ 92 (229)
T 3e6j_A 17 CSCS-GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTV 92 (229)
T ss_dssp CEEE-TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CEEe-CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCE
Confidence 4443 334666666554 6666554 78888888888888777888888888888888888887544556788888888
Q ss_pred EeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCcc
Q 046265 83 LVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPI 162 (639)
Q Consensus 83 L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 162 (639)
|+|++|++++..+..|..+.+| ++|+|++|+++ .+|..+..+++|++|+|++|++++..+..
T Consensus 93 L~Ls~N~l~~l~~~~~~~l~~L-----------------~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~ 154 (229)
T 3e6j_A 93 LDLGTNQLTVLPSAVFDRLVHL-----------------KELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGA 154 (229)
T ss_dssp EECCSSCCCCCCTTTTTTCTTC-----------------CEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTT
T ss_pred EECCCCcCCccChhHhCcchhh-----------------CeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHH
Confidence 8888888886666666666533 47888888887 67777788888888888888888666667
Q ss_pred ccCCCcccEEEcccCcCCcc
Q 046265 163 LGKVQSLLSLGFDLNLLNGV 182 (639)
Q Consensus 163 ~~~l~~L~~L~l~~N~l~~~ 182 (639)
|..+++|+.|++++|.+.+.
T Consensus 155 ~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 155 FDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp TTTCTTCCEEECTTSCBCTT
T ss_pred HhCCCCCCEEEeeCCCccCC
Confidence 77888888888888877643
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.1e-19 Score=184.79 Aligned_cols=168 Identities=22% Similarity=0.222 Sum_probs=134.4
Q ss_pred cceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCC-CCCCCCEEEcccCcCCCCCCcccCCCCCCC
Q 046265 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEID-PLTHLKHLYINVNKLRGSVPREVGQLSSLK 81 (639)
Q Consensus 3 ~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~-~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 81 (639)
|.|.. ..++.+++++. .+|..+. +.+++|+|++|.|++..+..+. .+++|++|+|++|+|++..|..|.++++|+
T Consensus 16 C~C~~-~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~ 91 (361)
T 2xot_A 16 CLCAS-NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLR 91 (361)
T ss_dssp CEEET-TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred CEECC-CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCC
Confidence 77753 46778877776 4777665 4689999999999987777787 999999999999999977777899999999
Q ss_pred EEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCc
Q 046265 82 QLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP 161 (639)
Q Consensus 82 ~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 161 (639)
+|+|++|++++..+..|.++.+| ++|+|++|++++..|..|..+++|++|+|++|++++..+.
T Consensus 92 ~L~Ls~N~l~~~~~~~~~~l~~L-----------------~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~ 154 (361)
T 2xot_A 92 YLDLSSNHLHTLDEFLFSDLQAL-----------------EVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVE 154 (361)
T ss_dssp EEECCSSCCCEECTTTTTTCTTC-----------------CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGG
T ss_pred EEECCCCcCCcCCHHHhCCCcCC-----------------CEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHH
Confidence 99999999998777777777643 5899999999988888999999999999999999864444
Q ss_pred cc---cCCCcccEEEcccCcCCccCCccCcCCC
Q 046265 162 IL---GKVQSLLSLGFDLNLLNGVLPPSISNLS 191 (639)
Q Consensus 162 ~~---~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 191 (639)
.| ..+++|+.|+|++|.|++..+..+..++
T Consensus 155 ~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~ 187 (361)
T 2xot_A 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLP 187 (361)
T ss_dssp GTC----CTTCCEEECCSSCCCCCCHHHHHHSC
T ss_pred HhcCcccCCcCCEEECCCCCCCccCHHHhhhcc
Confidence 44 5789999999999999865544454443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.9e-18 Score=166.34 Aligned_cols=151 Identities=19% Similarity=0.241 Sum_probs=131.1
Q ss_pred CCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCC
Q 046265 32 LKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPN 111 (639)
Q Consensus 32 L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~ 111 (639)
-+.+++++++++ .+|..+. ++|+.|+|++|+|++..+..|..+++|++|+|++|++++..|..|.++++|
T Consensus 13 ~~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L------- 82 (220)
T 2v9t_B 13 NNIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL------- 82 (220)
T ss_dssp TTEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSC-------
T ss_pred CCEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCC-------
Confidence 368999999998 6787665 789999999999997777789999999999999999998888888887743
Q ss_pred CCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCC
Q 046265 112 SLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLS 191 (639)
Q Consensus 112 ~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 191 (639)
++|+|++|+++...+..|..+++|++|+|++|++++..|..|..+++|+.|++++|.+++..+..|..++
T Consensus 83 ----------~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 152 (220)
T 2v9t_B 83 ----------NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152 (220)
T ss_dssp ----------CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred ----------CEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCC
Confidence 5999999999966666789999999999999999998899999999999999999999988877787777
Q ss_pred CCCeEEccCCc
Q 046265 192 NLEGLYLYSSL 202 (639)
Q Consensus 192 ~L~~L~l~~~~ 202 (639)
+|+.|+++.|.
T Consensus 153 ~L~~L~L~~N~ 163 (220)
T 2v9t_B 153 AIQTMHLAQNP 163 (220)
T ss_dssp TCCEEECCSSC
T ss_pred CCCEEEeCCCC
Confidence 77766665544
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.6e-19 Score=176.89 Aligned_cols=139 Identities=19% Similarity=0.222 Sum_probs=106.7
Q ss_pred CCCcceeccCCCceEEEEEc-CCCcE--EEEEEccCCCCC----------------------hhhHHHHHHHHHHHhccc
Q 046265 467 FDAKYCIGTAGQASVYKAEL-PSWEI--VAVKKFHSPHPD----------------------MVVQQAFSNEIKALTELR 521 (639)
Q Consensus 467 f~~~~~ig~g~~g~vy~~~~-~~~~~--vavK~~~~~~~~----------------------~~~~~~~~~e~~~l~~l~ 521 (639)
|+....||+|+||.||+|.. .+|+. ||||.++..... ......+.+|+..+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45668999999999999977 78888 999987643211 012246789999999999
Q ss_pred cCce--eeeEEEEEcCCceeEEecccCC-C----ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHH-hCCCCCeEee
Q 046265 522 HRNV--VKFYGFSFHPRQSFLLYEYLGR-G----SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH-HDYFPPIVHR 593 (639)
Q Consensus 522 H~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~~~iiHr 593 (639)
|+++ +..+++ +..++||||+++ | .|.+.... .++..+..++.|++.|++||| .. +|+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 8864 344432 367899999942 4 66665432 122346678999999999999 77 99999
Q ss_pred cCCCCCeeeCCCCceEEccccccccCC
Q 046265 594 DISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 594 dlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||||+|||++. .++|+|||+|....
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCCHHHEEEcC--cEEEEECcccccCC
Confidence 99999999998 99999999998764
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.1e-18 Score=166.07 Aligned_cols=151 Identities=20% Similarity=0.210 Sum_probs=130.2
Q ss_pred CCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCC-cccCCCCCCCEEeeecccCccccCccccCCCCCCcccCC
Q 046265 32 LKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVP-REVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMP 110 (639)
Q Consensus 32 L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp 110 (639)
-+.+++++|.++ .+|..+. ..+++|+|++|++++..| ..|..+++|++|+|++|++++..+..|.++++|
T Consensus 13 ~~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L------ 83 (220)
T 2v70_A 13 GTTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV------ 83 (220)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTC------
T ss_pred CCEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCC------
Confidence 368999999998 5787664 356899999999997645 458999999999999999998888888887743
Q ss_pred CCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCC
Q 046265 111 NSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNL 190 (639)
Q Consensus 111 ~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 190 (639)
++|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|++++|.+++..|..|..+
T Consensus 84 -----------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 152 (220)
T 2v70_A 84 -----------NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTL 152 (220)
T ss_dssp -----------CEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTC
T ss_pred -----------CEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCC
Confidence 599999999998888889999999999999999999889999999999999999999999888888877
Q ss_pred CCCCeEEccCCc
Q 046265 191 SNLEGLYLYSSL 202 (639)
Q Consensus 191 ~~L~~L~l~~~~ 202 (639)
++|+.|+++.|.
T Consensus 153 ~~L~~L~L~~N~ 164 (220)
T 2v70_A 153 HSLSTLNLLANP 164 (220)
T ss_dssp TTCCEEECCSCC
T ss_pred CCCCEEEecCcC
Confidence 777666665443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.9e-18 Score=179.68 Aligned_cols=131 Identities=24% Similarity=0.236 Sum_probs=97.3
Q ss_pred CCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccC-CCCCCCEEeeecccCccccCccccCCCCCCcccCC
Q 046265 32 LKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVG-QLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMP 110 (639)
Q Consensus 32 L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp 110 (639)
-+.+++++++++ .+|..+. +.++.|+|++|+|++..+..|. ++++|++|+|++|+|++..|..|.++++|
T Consensus 20 ~~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L------ 90 (361)
T 2xot_A 20 SNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNL------ 90 (361)
T ss_dssp TTEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTC------
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCC------
Confidence 367888888887 4676554 3578888888888866666666 78888888888888887666667666633
Q ss_pred CCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCcc
Q 046265 111 NSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGV 182 (639)
Q Consensus 111 ~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 182 (639)
++|+|++|++++..+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|.+++.
T Consensus 91 -----------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l 151 (361)
T 2xot_A 91 -----------RYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRF 151 (361)
T ss_dssp -----------CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSC
T ss_pred -----------CEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCee
Confidence 4788888888766666777788888888888888776677777777777777777777643
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=9.8e-18 Score=162.51 Aligned_cols=149 Identities=27% Similarity=0.351 Sum_probs=126.9
Q ss_pred CCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCC
Q 046265 32 LKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPN 111 (639)
Q Consensus 32 L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~ 111 (639)
.+.++.+++.++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|+++...+..|..+++|
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L------- 90 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL------- 90 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-------
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCc-------
Confidence 578999999997 6777665 899999999999998889999999999999999999987666667777633
Q ss_pred CCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCC
Q 046265 112 SLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLS 191 (639)
Q Consensus 112 ~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 191 (639)
++|+|++|++++..+..|..+++|++|+|++|+++ .+|..+..+++|+.|++++|.+++..+..|..++
T Consensus 91 ----------~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 159 (229)
T 3e6j_A 91 ----------TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159 (229)
T ss_dssp ----------CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCT
T ss_pred ----------CEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCC
Confidence 59999999999777777899999999999999998 7899999999999999999999977666676666
Q ss_pred CCCeEEccCC
Q 046265 192 NLEGLYLYSS 201 (639)
Q Consensus 192 ~L~~L~l~~~ 201 (639)
+|+.|+++.|
T Consensus 160 ~L~~L~l~~N 169 (229)
T 3e6j_A 160 SLTHAYLFGN 169 (229)
T ss_dssp TCCEEECTTS
T ss_pred CCCEEEeeCC
Confidence 6655555443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.7e-18 Score=191.05 Aligned_cols=174 Identities=24% Similarity=0.397 Sum_probs=117.3
Q ss_pred ccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCC
Q 046265 26 IGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLA 105 (639)
Q Consensus 26 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 105 (639)
+..+++|+.|++++|.+.. +| .+..|++|+.|+|++|++++ +|+ +..+++|+.|+|++|++++ +| .+..++
T Consensus 39 ~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~-~~~-l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~--- 109 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IKP-LTNLKNLGWLFLDENKIKD-LS-SLKDLK--- 109 (605)
T ss_dssp HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCC-CGG-GGGCTTCCEEECCSSCCCC-CT-TSTTCT---
T ss_pred hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCC-Chh-hccCCCCCEEECcCCCCCC-Ch-hhccCC---
Confidence 4567788888888888873 34 57888888888888888875 333 7788888888888888774 22 344443
Q ss_pred cccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCc
Q 046265 106 IGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPP 185 (639)
Q Consensus 106 ~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 185 (639)
+| ++|+|++|++++ + +.+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.+++..|
T Consensus 110 ------------~L--~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~- 170 (605)
T 1m9s_A 110 ------------KL--KSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP- 170 (605)
T ss_dssp ------------TC--CEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-
T ss_pred ------------CC--CEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-
Confidence 33 578888888874 3 3477788888888888888754 567778888888888888776544
Q ss_pred cCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCc
Q 046265 186 SISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGN 250 (639)
Q Consensus 186 ~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 250 (639)
+..+++|+ .|+|++|++.+. | .+..+++|+.|+|++|.+.+.
T Consensus 171 -l~~l~~L~--------------------~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 171 -LAGLTKLQ--------------------NLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp -GTTCTTCC--------------------EEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEECC
T ss_pred -hccCCCCC--------------------EEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcCC
Confidence 44444444 444455555432 2 355566666666666666543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.1e-18 Score=172.40 Aligned_cols=175 Identities=24% Similarity=0.389 Sum_probs=133.1
Q ss_pred ccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCC
Q 046265 26 IGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLA 105 (639)
Q Consensus 26 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 105 (639)
+..+++|++|++++|.++.. | .+..+++|++|+|++|++++ +++ +..+++|++|++++|++++ +| .+..++
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~--- 112 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LS-SLKDLK--- 112 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCT---
T ss_pred hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-Ch-hhccCC---
Confidence 45678899999999998744 4 48889999999999999985 444 8899999999999998875 22 255544
Q ss_pred cccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCc
Q 046265 106 IGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPP 185 (639)
Q Consensus 106 ~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 185 (639)
+| ++|++++|++++ + +.+..+++|++|++++|++++. ..+..+++|+.|++++|.+++..|
T Consensus 113 ------------~L--~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~- 173 (291)
T 1h6t_A 113 ------------KL--KSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP- 173 (291)
T ss_dssp ------------TC--CEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-
T ss_pred ------------CC--CEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-
Confidence 33 589999999885 3 4678889999999999998864 568888999999999998876543
Q ss_pred cCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcc
Q 046265 186 SISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNI 251 (639)
Q Consensus 186 ~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 251 (639)
+.. +++|+.|++++|.+.+ +| .+..+++|+.|++++|.++...
T Consensus 174 -l~~--------------------l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~~ 216 (291)
T 1h6t_A 174 -LAG--------------------LTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNKP 216 (291)
T ss_dssp -GTT--------------------CTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECCC
T ss_pred -hcC--------------------CCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCCc
Confidence 444 4455566666777654 34 3778888899999988887643
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.75 E-value=6.4e-18 Score=186.48 Aligned_cols=192 Identities=23% Similarity=0.330 Sum_probs=152.7
Q ss_pred CCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCccc
Q 046265 29 ISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGS 108 (639)
Q Consensus 29 l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~ 108 (639)
+..+..++++.+.+....+ +..|++|+.|++++|.+. .+| .+..+++|+.|+|++|++++..| +..+++
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~----- 88 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKN----- 88 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTT-----
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCC-----
Confidence 3345667788887775443 578899999999999997 455 58899999999999999986554 555553
Q ss_pred CCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCc
Q 046265 109 MPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSIS 188 (639)
Q Consensus 109 lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 188 (639)
| ++|+|++|++++ +| .+..+++|+.|+|++|++.+ + +.+..+++|+.|+|++|.+++. ..
T Consensus 89 ----------L--~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~-- 148 (605)
T 1m9s_A 89 ----------L--GWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TV-- 148 (605)
T ss_dssp ----------C--CEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GG--
T ss_pred ----------C--CEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hh--
Confidence 3 589999999984 44 68889999999999999986 3 4588899999999999988754 22
Q ss_pred CCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccC
Q 046265 189 NLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQ 268 (639)
Q Consensus 189 ~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 268 (639)
+..+++|+.|+|++|++.+..| +..+++|+.|+|++|.+++. ..+..+++|+.|+|++
T Consensus 149 ------------------l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~ 206 (605)
T 1m9s_A 149 ------------------LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 206 (605)
T ss_dssp ------------------GGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCS
T ss_pred ------------------hcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccC
Confidence 3455677788888888877666 88999999999999999975 3588899999999999
Q ss_pred Ccccc
Q 046265 269 NNFYG 273 (639)
Q Consensus 269 N~l~~ 273 (639)
|.+.+
T Consensus 207 N~l~~ 211 (605)
T 1m9s_A 207 QECLN 211 (605)
T ss_dssp EEEEC
T ss_pred CcCcC
Confidence 88754
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=8.3e-18 Score=159.02 Aligned_cols=152 Identities=20% Similarity=0.289 Sum_probs=124.7
Q ss_pred cccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCC
Q 046265 25 QIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNL 104 (639)
Q Consensus 25 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 104 (639)
..+.+++|++|++++|.++ .+| .+..+++|++|++++|.++ .++.+..+++|++|++++|++++..|..++.+++|
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 3467789999999999998 566 6999999999999999776 44589999999999999999998788888777643
Q ss_pred CcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCC
Q 046265 105 AIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLP 184 (639)
Q Consensus 105 ~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 184 (639)
++|++++|++++..|..+..+++|++|+|++|.+.+.+| .+..+++|+.|++++|.+++. +
T Consensus 115 -----------------~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~-~ 175 (197)
T 4ezg_A 115 -----------------TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY-R 175 (197)
T ss_dssp -----------------CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCC-T
T ss_pred -----------------CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcCh-H
Confidence 589999999998888999999999999999998444566 689999999999999999853 2
Q ss_pred ccCcCCCCCCeEEccC
Q 046265 185 PSISNLSNLEGLYLYS 200 (639)
Q Consensus 185 ~~~~~l~~L~~L~l~~ 200 (639)
.+..+++|+.|+++.
T Consensus 176 -~l~~l~~L~~L~l~~ 190 (197)
T 4ezg_A 176 -GIEDFPKLNQLYAFS 190 (197)
T ss_dssp -TGGGCSSCCEEEECB
T ss_pred -HhccCCCCCEEEeeC
Confidence 455555555444443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=7e-21 Score=208.88 Aligned_cols=103 Identities=25% Similarity=0.369 Sum_probs=58.0
Q ss_pred CCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCccc
Q 046265 144 NLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQL 223 (639)
Q Consensus 144 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l 223 (639)
.|++|+|++|.+++ +|. ++.+++|+.|++++|.++ .+|..++.++ +|+.|++++|++
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~--------------------~L~~L~Ls~N~l 498 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALR--------------------CLEVLQASDNAL 498 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCT--------------------TCCEEECCSSCC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCC--------------------CCCEEECCCCCC
Confidence 36666666666664 454 666666666666666665 4454444333 333444445555
Q ss_pred CCCCCccccCCCCCceeccccccccCcc-hhhhhcCCCccEEeccCCcc
Q 046265 224 FGQIPKSLRNFTSLNIVHLEQNHLTGNI-YEVFGIYPNLTFLDLSQNNF 271 (639)
Q Consensus 224 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l 271 (639)
++ +| .++.+++|+.|+|++|.+++.. |..++.+++|+.|+|++|.+
T Consensus 499 ~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l 545 (567)
T 1dce_A 499 EN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545 (567)
T ss_dssp CC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred CC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcC
Confidence 44 34 4555566666666666665554 55555666666666555544
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.73 E-value=2.4e-17 Score=165.96 Aligned_cols=162 Identities=26% Similarity=0.419 Sum_probs=131.6
Q ss_pred eeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeee
Q 046265 7 FFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLY 86 (639)
Q Consensus 7 ~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 86 (639)
.+..+++++|.+... | .+..+++|++|+|++|.+++..| +..+++|++|++++|++++ +| .+..+++|++|+++
T Consensus 47 ~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~ 120 (291)
T 1h6t_A 47 SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLE 120 (291)
T ss_dssp TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECT
T ss_pred cccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECC
Confidence 356778999988755 4 58999999999999999996544 9999999999999999984 44 59999999999999
Q ss_pred cccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCC
Q 046265 87 CNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKV 166 (639)
Q Consensus 87 ~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 166 (639)
+|++++. +.+..++ +| ++|++++|++++. ..+..+++|++|+|++|++++..| +..+
T Consensus 121 ~n~i~~~--~~l~~l~---------------~L--~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l 177 (291)
T 1h6t_A 121 HNGISDI--NGLVHLP---------------QL--ESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGL 177 (291)
T ss_dssp TSCCCCC--GGGGGCT---------------TC--CEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred CCcCCCC--hhhcCCC---------------CC--CEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCC
Confidence 9999863 3455555 33 6999999999864 678999999999999999987544 8999
Q ss_pred CcccEEEcccCcCCccCCccCcCCCCCCeEEcc
Q 046265 167 QSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLY 199 (639)
Q Consensus 167 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 199 (639)
++|+.|++++|.+++. | .+..+++|+.|+++
T Consensus 178 ~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~ 208 (291)
T 1h6t_A 178 TKLQNLYLSKNHISDL-R-ALAGLKNLDVLELF 208 (291)
T ss_dssp TTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEE
T ss_pred CccCEEECCCCcCCCC-h-hhccCCCCCEEECc
Confidence 9999999999999853 3 35555555544443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=3.3e-17 Score=154.17 Aligned_cols=136 Identities=26% Similarity=0.299 Sum_probs=91.0
Q ss_pred cceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCC-CCCCCCCCCEEEcccCcCCCCCCcccCCCCCCC
Q 046265 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQ-EIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81 (639)
Q Consensus 3 ~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~-~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 81 (639)
|.|.. ..+++++|++ +.+|..+.. ++++|+|++|.+++..|. .|+.+++|++|+|++|+|++..|..|.++++|+
T Consensus 6 C~C~~-~~l~~s~~~l-~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 81 (192)
T 1w8a_A 6 CHCEG-TTVDCTGRGL-KEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQ 81 (192)
T ss_dssp SEEET-TEEECTTSCC-SSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCC
T ss_pred CEECC-CEEEcCCCCc-CcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCC
Confidence 66643 4566777766 356665543 677777777777755543 367777777777777777766677777777777
Q ss_pred EEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCC
Q 046265 82 QLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSI 159 (639)
Q Consensus 82 ~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 159 (639)
+|+|++|++++..|..|.++++| ++|+|++|++++..|..|..+++|++|+|++|.+.+..
T Consensus 82 ~L~Ls~N~l~~~~~~~~~~l~~L-----------------~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 82 ELQLGENKIKEISNKMFLGLHQL-----------------KTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp EEECCSCCCCEECSSSSTTCTTC-----------------CEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred EEECCCCcCCccCHHHhcCCCCC-----------------CEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 77777777776666666555532 46777777777666666667777777777777666543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=2.1e-20 Score=205.06 Aligned_cols=220 Identities=16% Similarity=0.121 Sum_probs=133.1
Q ss_pred cCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEE-c
Q 046265 140 GHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELE-I 218 (639)
Q Consensus 140 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~-l 218 (639)
..+++|+.|+|++|+++ .+|..++.+++|+.|++++|......|..+.. ++. .+..|..++.+++|+.|+ +
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~------~~~-~~~~~~~l~~l~~L~~L~~l 417 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRA------LDP-LLYEKETLQYFSTLKAVDPM 417 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHH------HCT-GGGHHHHHHHHHHHHHHCGG
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHh------ccc-ccCCHHHHHHHHhcccCcch
Confidence 45677777777777775 56777777777777777665411111100000 000 011233344444444444 3
Q ss_pred CCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCE
Q 046265 219 DNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHK 298 (639)
Q Consensus 219 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~ 298 (639)
+.|.+ .+|..+.+++|.++...+ ..|+.|++++|.++ .+|. ++.+++|+.
T Consensus 418 ~~n~~-----------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~------------~lp~-~~~l~~L~~ 467 (567)
T 1dce_A 418 RAAYL-----------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLT------------VLCH-LEQLLLVTH 467 (567)
T ss_dssp GHHHH-----------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCS------------SCCC-GGGGTTCCE
T ss_pred hhccc-----------chhhhhhhhcccccccCc------cCceEEEecCCCCC------------CCcC-ccccccCcE
Confidence 33322 234445555555554322 24777776666552 3565 777788888
Q ss_pred EeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccC-ChhhhccccCCeeecc
Q 046265 299 LDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEF-PVELEKLVQLTELDLV 377 (639)
Q Consensus 299 L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~-p~~~~~l~~L~~l~l~ 377 (639)
|+|++|+++ .+|..++.+++|+.|+|++|++++ +| .++.+++|+.|+|++|+ +.+.. |..+..+++|+.|+++
T Consensus 468 L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~---l~~~~~p~~l~~l~~L~~L~L~ 541 (567)
T 1dce_A 468 LDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR---LQQSAAIQPLVSCPRLVLLNLQ 541 (567)
T ss_dssp EECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC---CCSSSTTGGGGGCTTCCEEECT
T ss_pred eecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCC---CCCCCCcHHHhcCCCCCEEEec
Confidence 888888887 677788888888888888888875 56 67788888888888754 33333 7777888888888888
Q ss_pred CCcCceeecCcchhhhhhhhhhhhcccCcEEcc
Q 046265 378 ITFWEERYRPKSVIWKAWRSLISRMHGLSCIDI 410 (639)
Q Consensus 378 ~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldl 410 (639)
+|.+++.. |. ....+..+++|+.||+
T Consensus 542 ~N~l~~~~-~~------~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 542 GNSLCQEE-GI------QERLAEMLPSVSSILT 567 (567)
T ss_dssp TSGGGGSS-SC------TTHHHHHCTTCSEEEC
T ss_pred CCcCCCCc-cH------HHHHHHHCcccCccCC
Confidence 88777643 21 1133445777777764
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=4.3e-17 Score=154.11 Aligned_cols=150 Identities=18% Similarity=0.147 Sum_probs=128.5
Q ss_pred eeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeee
Q 046265 7 FFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLY 86 (639)
Q Consensus 7 ~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 86 (639)
.+..+++++|++. .+| .+..+++|++|++++|.++ .++.+..+++|++|++++|++++..|..++.+++|++|+++
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 3567889999988 666 7999999999999999775 34579999999999999999998789999999999999999
Q ss_pred cccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCc-CcccCCccccCCCCCCEEeccCCCCCCCCCccccC
Q 046265 87 CNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQ-LSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGK 165 (639)
Q Consensus 87 ~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 165 (639)
+|++++..|..++.+++| ++|++++|. ++ .+| .+..+++|++|++++|.+++ ++ .+..
T Consensus 121 ~n~i~~~~~~~l~~l~~L-----------------~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~ 179 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKV-----------------NSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIED 179 (197)
T ss_dssp SSBCBGGGHHHHTTCSSC-----------------CEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGG
T ss_pred CCccCcHhHHHHhhCCCC-----------------CEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-Hhcc
Confidence 999998888888877743 599999998 65 666 68899999999999999986 44 7899
Q ss_pred CCcccEEEcccCcCCc
Q 046265 166 VQSLLSLGFDLNLLNG 181 (639)
Q Consensus 166 l~~L~~L~l~~N~l~~ 181 (639)
+++|+.|++++|++.+
T Consensus 180 l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 180 FPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CSSCCEEEECBC----
T ss_pred CCCCCEEEeeCcccCC
Confidence 9999999999999864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=8.1e-17 Score=151.45 Aligned_cols=131 Identities=28% Similarity=0.353 Sum_probs=110.8
Q ss_pred CEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCc-ccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCC
Q 046265 33 KFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPR-EVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPN 111 (639)
Q Consensus 33 ~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~ 111 (639)
+++++++|+++ .+|..+.. +|++|++++|++++..+. .|+.+++|++|+|++|++++..|..|.++++|
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L------- 80 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI------- 80 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTC-------
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccC-------
Confidence 78999999996 67877654 899999999999865554 48899999999999999998888888877743
Q ss_pred CCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccC
Q 046265 112 SLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVL 183 (639)
Q Consensus 112 ~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 183 (639)
++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|++++|.+++..
T Consensus 81 ----------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 81 ----------QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp ----------CEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred ----------CEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 58999999999888888889999999999999999888888899999999999999887653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.70 E-value=3.4e-18 Score=193.44 Aligned_cols=215 Identities=20% Similarity=0.175 Sum_probs=112.2
Q ss_pred EEEEeCCCcccccCCccccCCCCCCE-----EECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEE
Q 046265 9 FQVVHESNTLFAIIPPQIGNISNLKF-----LDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQL 83 (639)
Q Consensus 9 ~~~~~~~n~~~~~~p~~~~~l~~L~~-----L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 83 (639)
..+.+..|.+.. +|..+.....|.. ++++.|.+. ..|..+..++.|+.|+|++|.+. .+|..+.++++|++|
T Consensus 176 ~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L 252 (727)
T 4b8c_D 176 PKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRL 252 (727)
T ss_dssp ------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCC
T ss_pred ceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEE
Confidence 445566666654 3444333333332 233344444 55778889999999999999988 788888899999999
Q ss_pred eeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccc
Q 046265 84 VLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPIL 163 (639)
Q Consensus 84 ~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 163 (639)
+|++|.|+ .+|..|+++++| ++|+|++|+|+ .+|..|++|++|++|+|++|.++ .+|..|
T Consensus 253 ~Ls~N~l~-~lp~~~~~l~~L-----------------~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~ 312 (727)
T 4b8c_D 253 YLNGNSLT-ELPAEIKNLSNL-----------------RVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEF 312 (727)
T ss_dssp BCTTSCCS-CCCGGGGGGTTC-----------------CEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSST
T ss_pred EeeCCcCc-ccChhhhCCCCC-----------------CEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhh
Confidence 99999988 777777776633 58999999998 77888999999999999999886 678889
Q ss_pred cCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccc
Q 046265 164 GKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLE 243 (639)
Q Consensus 164 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~ 243 (639)
+.+++|+.|+|++|.+++.+|..+..+.. .+..+++++|.+.+.+|..+ ..|+++
T Consensus 313 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~~-------------------~~~~l~l~~N~l~~~~p~~l------~~l~l~ 367 (727)
T 4b8c_D 313 GNLCNLQFLGVEGNPLEKQFLKILTEKSV-------------------TGLIFYLRDNRPEIPLPHER------RFIEIN 367 (727)
T ss_dssp TSCTTCCCEECTTSCCCSHHHHHHHHHHH-------------------HHHHHHHHHCCCCCCCCCC-------------
T ss_pred hcCCCccEEeCCCCccCCCChHHHhhcch-------------------hhhHHhhccCcccCcCcccc------ceeEee
Confidence 99999999999999998887766543210 11124566777777766543 344555
Q ss_pred cc--------cccCcchhhhhcCCCccEEeccCCcc
Q 046265 244 QN--------HLTGNIYEVFGIYPNLTFLDLSQNNF 271 (639)
Q Consensus 244 ~N--------~l~~~~~~~~~~l~~L~~L~Ls~N~l 271 (639)
.| .+.+..+..+..+..+....++.|.+
T Consensus 368 ~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil 403 (727)
T 4b8c_D 368 TDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTL 403 (727)
T ss_dssp ----------------------------------CC
T ss_pred cccccccccCCccccccchhhcccccceeeeecccc
Confidence 55 23333333333444445555555554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=9.1e-17 Score=159.08 Aligned_cols=159 Identities=20% Similarity=0.267 Sum_probs=123.5
Q ss_pred EeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCc
Q 046265 12 VHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLS 91 (639)
Q Consensus 12 ~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 91 (639)
+++.+.+.... .+..+++|++|++++|.++ .+| .+..+++|++|+|++|++++ +|+ +..+++|++|+|++|+++
T Consensus 25 ~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~ 98 (263)
T 1xeu_A 25 NLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLK 98 (263)
T ss_dssp HHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCS
T ss_pred HhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccC
Confidence 45666665433 5788899999999999998 456 78899999999999999985 554 899999999999999988
Q ss_pred cccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccE
Q 046265 92 GWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLS 171 (639)
Q Consensus 92 ~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 171 (639)
+. |.... . +|++|+|++|++++ ++ .+..+++|++|+|++|++++. | .+..+++|+.
T Consensus 99 ~l-~~~~~--~-----------------~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~ 154 (263)
T 1xeu_A 99 NL-NGIPS--A-----------------CLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEV 154 (263)
T ss_dssp CC-TTCCC--S-----------------SCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCE
T ss_pred Cc-Ccccc--C-----------------cccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCE
Confidence 53 32111 2 23689999999985 34 588999999999999999864 4 6888999999
Q ss_pred EEcccCcCCccCCccCcCCCCCCeEEccCCc
Q 046265 172 LGFDLNLLNGVLPPSISNLSNLEGLYLYSSL 202 (639)
Q Consensus 172 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~ 202 (639)
|++++|.+++. ..+..+++|+.|+++.+.
T Consensus 155 L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~ 183 (263)
T 1xeu_A 155 LDLHGNEITNT--GGLTRLKKVNWIDLTGQK 183 (263)
T ss_dssp EECTTSCCCBC--TTSTTCCCCCEEEEEEEE
T ss_pred EECCCCcCcch--HHhccCCCCCEEeCCCCc
Confidence 99999999876 556666666666665443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=6e-18 Score=167.62 Aligned_cols=171 Identities=19% Similarity=0.291 Sum_probs=122.1
Q ss_pred CCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcc
Q 046265 28 NISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIG 107 (639)
Q Consensus 28 ~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~ 107 (639)
.+.++..+++++|.++.. + .+..+++|++|++++|.++ .+| .+..+++|++|+|++|++++..| +.++++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L--- 87 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKL--- 87 (263)
T ss_dssp HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSC---
T ss_pred HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCC---
Confidence 455677788888888743 3 5788889999999999887 566 68888888888888888886444 5555532
Q ss_pred cCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccC
Q 046265 108 SMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSI 187 (639)
Q Consensus 108 ~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 187 (639)
++|+|++|++++ +|... . ++|++|+|++|++++ +| .+..+++|+.|++++|.+++. | .+
T Consensus 88 --------------~~L~L~~N~l~~-l~~~~-~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l 146 (263)
T 1xeu_A 88 --------------EELSVNRNRLKN-LNGIP-S-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-ML 146 (263)
T ss_dssp --------------CEEECCSSCCSC-CTTCC-C-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GG
T ss_pred --------------CEEECCCCccCC-cCccc-c-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HH
Confidence 588888888874 44433 2 788888888888875 33 577888888888888887653 2 23
Q ss_pred cCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCc
Q 046265 188 SNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGN 250 (639)
Q Consensus 188 ~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 250 (639)
..+++|+.|++++|++.+. ..+..+++|+.|++++|.+++.
T Consensus 147 --------------------~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 147 --------------------GFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp --------------------GGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred --------------------ccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 3445556666666766554 4566777777777777777754
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.69 E-value=1e-17 Score=189.56 Aligned_cols=129 Identities=22% Similarity=0.137 Sum_probs=40.8
Q ss_pred CCCCEEECcCCCCccCCCCCCCCCCCCCE-----EEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCC
Q 046265 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKH-----LYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNL 104 (639)
Q Consensus 30 ~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~-----L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 104 (639)
+.++.|+|.+|.+.. .|..+.....|.. ++++.|.+. ..|..+..+++|+.|+|++|.+. .+|..+.++++|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L 249 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFL 249 (727)
T ss_dssp ---------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSC
T ss_pred CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCC
Confidence 446667777776663 2333222222211 122222222 23444555555555555555544 333333333311
Q ss_pred CcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCC
Q 046265 105 AIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN 180 (639)
Q Consensus 105 ~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 180 (639)
++|+|++|.++ .+|..|++|++|++|+|++|+|+ .+|..|+.+++|++|+|++|.|+
T Consensus 250 -----------------~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 306 (727)
T 4b8c_D 250 -----------------TRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT 306 (727)
T ss_dssp -----------------SCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC
T ss_pred -----------------CEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC
Confidence 24455555554 44544555555555555555554 34444555555555555555443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.7e-16 Score=145.92 Aligned_cols=138 Identities=23% Similarity=0.153 Sum_probs=117.4
Q ss_pred CCCCCCEEECcCCCCc-cCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCc
Q 046265 28 NISNLKFLDMGNNQLS-GVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAI 106 (639)
Q Consensus 28 ~l~~L~~L~Ls~n~l~-~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 106 (639)
..++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|++++|++++.+|..+.++++|
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-- 97 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNL-- 97 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTC--
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCC--
Confidence 4578999999999998 78899999999999999999999854 789999999999999999998777777667643
Q ss_pred ccCCCCCcccCCCCccEEEccCCcCcccC-CccccCCCCCCEEeccCCCCCCCCC---ccccCCCcccEEEcccCcCCcc
Q 046265 107 GSMPNSLSNLTSLSLFHLDLSENQLSGSI-PHFLGHLSNLAVLHLGDNSLFGSIP---PILGKVQSLLSLGFDLNLLNGV 182 (639)
Q Consensus 107 ~~lp~~~~~l~~L~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~l~~N~l~~~ 182 (639)
++|++++|++++.. +..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+. .
T Consensus 98 ---------------~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~ 161 (168)
T 2ell_A 98 ---------------THLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-E 161 (168)
T ss_dssp ---------------CEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-B
T ss_pred ---------------CEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-h
Confidence 58999999998532 2788999999999999999987655 47899999999999999886 3
Q ss_pred CCc
Q 046265 183 LPP 185 (639)
Q Consensus 183 ~p~ 185 (639)
+|+
T Consensus 162 ~~~ 164 (168)
T 2ell_A 162 APD 164 (168)
T ss_dssp CCS
T ss_pred ccc
Confidence 443
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2e-17 Score=169.60 Aligned_cols=141 Identities=9% Similarity=0.039 Sum_probs=99.8
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCC------------hhhH--------HHHHHHHHHHhccccCc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPD------------MVVQ--------QAFSNEIKALTELRHRN 524 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~------------~~~~--------~~~~~e~~~l~~l~H~n 524 (639)
.-|+....||+|++|.||+|..++|+.||||.++..... .... ....+|...+.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 347788999999999999999899999999987642100 0001 11234566666665444
Q ss_pred eeeeEEEEEcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC
Q 046265 525 VVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL 604 (639)
Q Consensus 525 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~ 604 (639)
+.-..-+.. ...++||||++|+++.++... .....++.|++.++.|||.. +||||||||.|||+++
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 321111111 234799999999988765432 12345788999999999998 9999999999999987
Q ss_pred CC----------ceEEccccccccC
Q 046265 605 DY----------DAHVSDFGISKFL 619 (639)
Q Consensus 605 ~~----------~~kl~DfGla~~~ 619 (639)
++ .+.|+||+-+...
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCcccccccccceEEEEeCCcccC
Confidence 76 3899999977653
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=8.6e-16 Score=144.42 Aligned_cols=127 Identities=27% Similarity=0.362 Sum_probs=65.9
Q ss_pred CEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCC
Q 046265 33 KFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNS 112 (639)
Q Consensus 33 ~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~ 112 (639)
+++++++|+++ .+|..+. ++|++|+|++|+++ .+|..|.++++|++|+|++|++++..+..|.++++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L-------- 80 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL-------- 80 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTC--------
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCC--------
Confidence 34555555554 3444332 35555555555554 455555555555555555555554444444444422
Q ss_pred CcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCC
Q 046265 113 LSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN 180 (639)
Q Consensus 113 ~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 180 (639)
++|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|+.|++++|.+.
T Consensus 81 ---------~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 81 ---------LTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp ---------CEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ---------CEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 35555555555444455555555555555555555443344555555555555555543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.6e-16 Score=142.86 Aligned_cols=128 Identities=26% Similarity=0.206 Sum_probs=97.9
Q ss_pred CCCCCEEECcCCCCc-cCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcc
Q 046265 29 ISNLKFLDMGNNQLS-GVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIG 107 (639)
Q Consensus 29 l~~L~~L~Ls~n~l~-~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~ 107 (639)
.++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..++.+++|++|++++|++++.+|..+..+++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L--- 90 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNL--- 90 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTC---
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCC---
Confidence 467888899988887 67888888888888888888888854 678888888888888888887666666656533
Q ss_pred cCCCCCcccCCCCccEEEccCCcCccc-CCccccCCCCCCEEeccCCCCCCCCC---ccccCCCcccEEEcc
Q 046265 108 SMPNSLSNLTSLSLFHLDLSENQLSGS-IPHFLGHLSNLAVLHLGDNSLFGSIP---PILGKVQSLLSLGFD 175 (639)
Q Consensus 108 ~lp~~~~~l~~L~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~l~ 175 (639)
++|++++|++++. .+..+..+++|++|++++|.+++..+ ..+..+++|+.|+++
T Consensus 91 --------------~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 91 --------------THLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp --------------CEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred --------------CEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 4788888888753 34677788888888888888876554 467777777777765
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.65 E-value=5.9e-17 Score=166.22 Aligned_cols=82 Identities=12% Similarity=-0.010 Sum_probs=42.6
Q ss_pred cccCCCCCCEEeccCCcccccCCccccCCCCCC-eeeccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhc
Q 046265 289 KIGKLYQLHKLDFSLNHIVGELPIELGNLKSLN-YRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEK 367 (639)
Q Consensus 289 ~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~ 367 (639)
.|.++.+|+.+++++| +....+.+|.+|++|+ .+++.+ .++.+-+.+|.+|++|+.+++++|.+..+. +..|..
T Consensus 245 aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~---~~aF~~ 319 (329)
T 3sb4_A 245 TFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLG---DELFGN 319 (329)
T ss_dssp TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEEC---TTTTCT
T ss_pred hhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccc---hhhhcC
Confidence 4555555555555555 4444445555555565 555554 444444455555666666665554333332 334555
Q ss_pred cccCCeee
Q 046265 368 LVQLTELD 375 (639)
Q Consensus 368 l~~L~~l~ 375 (639)
+++|+.++
T Consensus 320 ~~~L~~ly 327 (329)
T 3sb4_A 320 GVPSKLIY 327 (329)
T ss_dssp TCCCCEEE
T ss_pred Ccchhhhc
Confidence 55555543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=9.7e-16 Score=144.06 Aligned_cols=134 Identities=25% Similarity=0.374 Sum_probs=116.7
Q ss_pred ccceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCC
Q 046265 2 SCLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81 (639)
Q Consensus 2 ~~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 81 (639)
.|.|.. ..++.++|++. .+|..+. ++|++|+|++|.++ .+|..|..+++|++|+|++|+|++..|..|.++++|+
T Consensus 7 ~C~C~~-~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~ 81 (193)
T 2wfh_A 7 ECTCLD-TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81 (193)
T ss_dssp TCEEET-TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred CCEeCC-CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCC
Confidence 377753 56788888876 6787664 68999999999998 7889999999999999999999987778899999999
Q ss_pred EEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCC
Q 046265 82 QLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFG 157 (639)
Q Consensus 82 ~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 157 (639)
+|+|++|++++..|..|..+++| ++|+|++|++++..+..|..+++|+.|+|++|.+..
T Consensus 82 ~L~Ls~N~l~~i~~~~f~~l~~L-----------------~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 82 TLILSYNRLRCIPPRTFDGLKSL-----------------RLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp EEECCSSCCCBCCTTTTTTCTTC-----------------CEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred EEECCCCccCEeCHHHhCCCCCC-----------------CEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 99999999998888888887743 599999999997666779999999999999999865
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.3e-15 Score=141.24 Aligned_cols=135 Identities=25% Similarity=0.277 Sum_probs=72.3
Q ss_pred cceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCE
Q 046265 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQ 82 (639)
Q Consensus 3 ~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 82 (639)
|.| ....++.+++++. .+|..+. ++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++
T Consensus 5 C~C-~~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 80 (177)
T 2o6r_A 5 CSC-SGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTI 80 (177)
T ss_dssp CEE-ETTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CEe-CCCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCE
Confidence 555 2345555555554 3443332 46666666666666554455566666666666666666444444556666666
Q ss_pred EeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCC
Q 046265 83 LVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGS 158 (639)
Q Consensus 83 L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 158 (639)
|++++|++++..+..|..+++| ++|++++|++++..+..+..+++|++|+|++|.+.+.
T Consensus 81 L~l~~N~l~~~~~~~~~~l~~L-----------------~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 81 LYLHENKLQSLPNGVFDKLTQL-----------------KELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp EECCSSCCCCCCTTTTTTCTTC-----------------CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred EECCCCCccccCHHHhhCCccc-----------------CEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 6666666654444444444422 3555555555543333345555555555555555543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.8e-15 Score=138.97 Aligned_cols=133 Identities=23% Similarity=0.258 Sum_probs=109.2
Q ss_pred CCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCC
Q 046265 32 LKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPN 111 (639)
Q Consensus 32 L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~ 111 (639)
.+.+++++|+++ .+|..+. ++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L------- 78 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKL------- 78 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTC-------
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCcc-------
Confidence 578999999997 5665543 689999999999986666678899999999999999987666667766633
Q ss_pred CCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCC
Q 046265 112 SLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLP 184 (639)
Q Consensus 112 ~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 184 (639)
++|++++|++++..+..+..+++|++|+|++|++++..+..+..+++|+.|++++|.+.+..|
T Consensus 79 ----------~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 79 ----------TILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp ----------CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ----------CEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 589999999997777778889999999999999987666667889999999999998876543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=8.9e-16 Score=140.98 Aligned_cols=137 Identities=23% Similarity=0.207 Sum_probs=117.2
Q ss_pred eeeEEEEeCCCccc-ccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEe
Q 046265 6 FFFFQVVHESNTLF-AIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLV 84 (639)
Q Consensus 6 ~~~~~~~~~~n~~~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 84 (639)
-.+..+++++|++. +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 34678899999998 78999999999999999999999865 7899999999999999999977888888899999999
Q ss_pred eecccCccccC-ccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCC---ccccCCCCCCEEeccCCCCCCCCC
Q 046265 85 LYCNGLSGWLP-SSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIP---HFLGHLSNLAVLHLGDNSLFGSIP 160 (639)
Q Consensus 85 L~~N~l~~~~p-~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p 160 (639)
+++|++++..+ ..+..+++ | ++|++++|.+++..+ ..+..+++|++|++++|.+. .+|
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~---------------L--~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~ 163 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLEC---------------L--KSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAP 163 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSC---------------C--CEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCC
T ss_pred ccCCccCcchhHHHHhcCCC---------------C--CEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcc
Confidence 99999986432 56666653 3 599999999996544 48999999999999999987 455
Q ss_pred cc
Q 046265 161 PI 162 (639)
Q Consensus 161 ~~ 162 (639)
+.
T Consensus 164 ~~ 165 (168)
T 2ell_A 164 DS 165 (168)
T ss_dssp SS
T ss_pred cc
Confidence 43
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.61 E-value=6.3e-16 Score=158.52 Aligned_cols=214 Identities=13% Similarity=0.042 Sum_probs=123.0
Q ss_pred cEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCc----CCccCCccCcCCCCCC-eE
Q 046265 122 FHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNL----LNGVLPPSISNLSNLE-GL 196 (639)
Q Consensus 122 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~----l~~~~p~~~~~l~~L~-~L 196 (639)
+.|+|.+ +++..-+.+|.++++|+.+++++|.+....+..|....++..+.+..+. ....-+..|.++.+|+ .+
T Consensus 104 ~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i 182 (329)
T 3sb4_A 104 EKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTI 182 (329)
T ss_dssp CC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEE
T ss_pred cEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeE
Confidence 3566665 5554445567777777777777776665555566666666655554421 1222233444455554 33
Q ss_pred EccC-Ccccccc----ccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcc
Q 046265 197 YLYS-SLVSAEI----GNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNF 271 (639)
Q Consensus 197 ~l~~-~~~~~~~----~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 271 (639)
.+.. +.++..+ ....++..+.+.++-...........+++|+.+++++|.++...+.+|..+++|+.+++.+| +
T Consensus 183 ~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i 261 (329)
T 3sb4_A 183 QVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-L 261 (329)
T ss_dssp EECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-C
T ss_pred EecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-c
Confidence 3321 1111111 12334445544433111100001113677778888877777777777777777888776654 2
Q ss_pred cccccCcCCccccccCccccCCCCCC-EEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeC
Q 046265 272 YGSLNFSMNNITRSIPPKIGKLYQLH-KLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDL 349 (639)
Q Consensus 272 ~~~l~ls~n~~~~~~p~~~~~l~~L~-~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 349 (639)
...-+..|.++.+|+ .+++.+ .+....+.+|.+|++|+.+++++|++...-+.+|.++++|+.++.
T Consensus 262 -----------~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 262 -----------KTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp -----------CEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred -----------ceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 223345567777787 777776 566555677777888888887777777666667777777777653
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=6.5e-16 Score=138.85 Aligned_cols=129 Identities=23% Similarity=0.265 Sum_probs=109.6
Q ss_pred CCCCCCEEEcccCcCC-CCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCc
Q 046265 52 PLTHLKHLYINVNKLR-GSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQ 130 (639)
Q Consensus 52 ~L~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~ 130 (639)
..++|+.|++++|.++ +.+|..+..+++|++|++++|++++. ..++.++ +| ++|++++|+
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~---------------~L--~~L~Ls~n~ 75 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLN---------------KL--KKLELSDNR 75 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCT---------------TC--CEEECCSSC
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCC---------------CC--CEEECCCCc
Confidence 3478999999999998 78999999999999999999999865 5555555 33 699999999
Q ss_pred CcccCCccccCCCCCCEEeccCCCCCCC-CCccccCCCcccEEEcccCcCCccCC---ccCcCCCCCCeEEcc
Q 046265 131 LSGSIPHFLGHLSNLAVLHLGDNSLFGS-IPPILGKVQSLLSLGFDLNLLNGVLP---PSISNLSNLEGLYLY 199 (639)
Q Consensus 131 l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~L~~L~l~ 199 (639)
+++.+|..+..+++|++|++++|.+++. .|..++.+++|++|++++|.+++..+ ..+..+++|+.|+++
T Consensus 76 i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 9987899888899999999999999863 34789999999999999999987765 467777888877664
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.55 E-value=7e-15 Score=136.09 Aligned_cols=134 Identities=21% Similarity=0.186 Sum_probs=103.1
Q ss_pred ccccCCCCCCEEECcCCCCccCCCCCCCCCC-CCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCC
Q 046265 24 PQIGNISNLKFLDMGNNQLSGVIPQEIDPLT-HLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLN 102 (639)
Q Consensus 24 ~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 102 (639)
+.+.++++|++|++++|.++. +|. +..+. +|++|++++|.+++. ..|..+++|++|++++|++++..|..|..++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 456778899999999999984 454 55554 899999999999854 5788889999999999988865545556666
Q ss_pred CCCcccCCCCCcccCCCCccEEEccCCcCcccCCc--cccCCCCCCEEeccCCCCCCCCCcc----ccCCCcccEEEccc
Q 046265 103 NLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPH--FLGHLSNLAVLHLGDNSLFGSIPPI----LGKVQSLLSLGFDL 176 (639)
Q Consensus 103 ~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~l~~ 176 (639)
+| ++|++++|+++ .+|. .+..+++|++|++++|.++ .+|.. +..+++|+.|+++.
T Consensus 89 ~L-----------------~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~ 149 (176)
T 1a9n_A 89 DL-----------------TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQK 149 (176)
T ss_dssp TC-----------------CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEE
T ss_pred CC-----------------CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCc
Confidence 33 58888888886 5665 7788888888888888887 45553 77888888888888
Q ss_pred CcCC
Q 046265 177 NLLN 180 (639)
Q Consensus 177 N~l~ 180 (639)
|.+.
T Consensus 150 n~~~ 153 (176)
T 1a9n_A 150 VKLK 153 (176)
T ss_dssp CCHH
T ss_pred CCHH
Confidence 7654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.48 E-value=7.2e-17 Score=152.67 Aligned_cols=138 Identities=21% Similarity=0.223 Sum_probs=103.8
Q ss_pred ccCCCCCCEEECcCCCCccCCCC------CCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCcccc
Q 046265 26 IGNISNLKFLDMGNNQLSGVIPQ------EIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFG 99 (639)
Q Consensus 26 ~~~l~~L~~L~Ls~n~l~~~~p~------~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 99 (639)
+.....++.++++.+.++|..|. .+..+++|++|+|++|++++ +| .+..+++|++|++++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 45566777788888888877776 78888888888888888875 67 7888888888888888887 4555554
Q ss_pred CCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCC-ccccCCCcccEEEcccCc
Q 046265 100 NLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIP-PILGKVQSLLSLGFDLNL 178 (639)
Q Consensus 100 ~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~ 178 (639)
.++ +| ++|++++|++++ +| .+..+++|++|++++|++++..+ ..+..+++|++|++++|.
T Consensus 91 ~~~---------------~L--~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~ 151 (198)
T 1ds9_A 91 VAD---------------TL--EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP 151 (198)
T ss_dssp HHH---------------HC--SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCH
T ss_pred cCC---------------cC--CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCc
Confidence 444 22 588888888875 45 57778888888888888875322 367788888888888888
Q ss_pred CCccCCc
Q 046265 179 LNGVLPP 185 (639)
Q Consensus 179 l~~~~p~ 185 (639)
+++..|.
T Consensus 152 l~~~~~~ 158 (198)
T 1ds9_A 152 LYNDYKE 158 (198)
T ss_dssp HHHHHHT
T ss_pred ccccccc
Confidence 8766554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=2.7e-13 Score=124.49 Aligned_cols=105 Identities=26% Similarity=0.312 Sum_probs=56.2
Q ss_pred CEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCC
Q 046265 33 KFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNS 112 (639)
Q Consensus 33 ~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~ 112 (639)
+.+++++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..|..+++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L-------- 80 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQL-------- 80 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTC--------
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCC--------
Confidence 45666666655 3454442 555566666666655445555555556555555555554444444444422
Q ss_pred CcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCC
Q 046265 113 LSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFG 157 (639)
Q Consensus 113 ~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 157 (639)
++|+|++|++++..+..|..+++|++|+|++|.+..
T Consensus 81 ---------~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 81 ---------TQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp ---------CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred ---------CEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 355555555554444445555555555555555543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.47 E-value=1.3e-16 Score=150.95 Aligned_cols=147 Identities=20% Similarity=0.299 Sum_probs=121.6
Q ss_pred EEEeCCCcccccCCc------cccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEE
Q 046265 10 QVVHESNTLFAIIPP------QIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQL 83 (639)
Q Consensus 10 ~~~~~~n~~~~~~p~------~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 83 (639)
.++++.+.+.+.+|. .+..+++|++|+|++|.+++ +| .+..+++|++|++++|.++ .+|..+..+++|++|
T Consensus 22 ~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L 98 (198)
T 1ds9_A 22 ATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEEL 98 (198)
T ss_dssp CTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEE
T ss_pred CcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEE
Confidence 345777788888887 89999999999999999986 67 8999999999999999998 788888888999999
Q ss_pred eeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCC-ccccCCCCCCEEeccCCCCCCCCCcc
Q 046265 84 VLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIP-HFLGHLSNLAVLHLGDNSLFGSIPPI 162 (639)
Q Consensus 84 ~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~ 162 (639)
++++|++++ +| .+..++ +| ++|++++|++++..+ ..+..+++|++|++++|.+.+.+|..
T Consensus 99 ~L~~N~l~~-l~-~~~~l~---------------~L--~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~ 159 (198)
T 1ds9_A 99 WISYNQIAS-LS-GIEKLV---------------NL--RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN 159 (198)
T ss_dssp EEEEEECCC-HH-HHHHHH---------------HS--SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTT
T ss_pred ECcCCcCCc-CC-ccccCC---------------CC--CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccc
Confidence 999999986 34 455554 33 699999999984332 47889999999999999998766653
Q ss_pred ----------ccCCCcccEEEcccCcCC
Q 046265 163 ----------LGKVQSLLSLGFDLNLLN 180 (639)
Q Consensus 163 ----------~~~l~~L~~L~l~~N~l~ 180 (639)
+..+++|+.|| +|.++
T Consensus 160 ~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 160 NATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp TTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred cchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 77888888876 55554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=2.9e-13 Score=124.33 Aligned_cols=112 Identities=27% Similarity=0.305 Sum_probs=96.4
Q ss_pred cceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCE
Q 046265 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQ 82 (639)
Q Consensus 3 ~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 82 (639)
|.|. ...+++++|++.. +|..+. ++|++|+|++|.|++..|..|..+++|++|+|++|+|++..|..|..+++|++
T Consensus 7 C~C~-~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~ 82 (170)
T 3g39_A 7 CSCS-GTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQ 82 (170)
T ss_dssp CEEE-TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCcC-CCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCE
Confidence 7663 4678999998875 787774 89999999999999988999999999999999999999766667899999999
Q ss_pred EeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccC
Q 046265 83 LVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSI 135 (639)
Q Consensus 83 L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~ 135 (639)
|+|++|++++..+..|..+++| ++|+|++|.++...
T Consensus 83 L~L~~N~l~~~~~~~~~~l~~L-----------------~~L~L~~N~~~c~c 118 (170)
T 3g39_A 83 LSLNDNQLKSIPRGAFDNLKSL-----------------THIWLLNNPWDCAC 118 (170)
T ss_dssp EECCSSCCCCCCTTTTTTCTTC-----------------CEEECCSSCBCTTB
T ss_pred EECCCCccCEeCHHHhcCCCCC-----------------CEEEeCCCCCCCCc
Confidence 9999999998777778777743 58999999998543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.46 E-value=5.7e-14 Score=129.94 Aligned_cols=131 Identities=18% Similarity=0.143 Sum_probs=102.7
Q ss_pred CCCCCCCCCCEEEcccCcCCCCCCcccCCCC-CCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEc
Q 046265 48 QEIDPLTHLKHLYINVNKLRGSVPREVGQLS-SLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDL 126 (639)
Q Consensus 48 ~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L 126 (639)
..+.++.+|+.|++++|+++ .+|. +..+. +|++|++++|++++. +.|..++ +| ++|++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~---------------~L--~~L~L 71 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLR---------------RL--KTLLV 71 (176)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCS---------------SC--CEEEC
T ss_pred HhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCC---------------CC--CEEEC
Confidence 34678899999999999998 5664 55555 999999999999864 4555555 33 69999
Q ss_pred cCCcCcccCCccccCCCCCCEEeccCCCCCCCCCc--cccCCCcccEEEcccCcCCccCCcc----CcCCCCCCeEEccC
Q 046265 127 SENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP--ILGKVQSLLSLGFDLNLLNGVLPPS----ISNLSNLEGLYLYS 200 (639)
Q Consensus 127 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~----~~~l~~L~~L~l~~ 200 (639)
++|++++..|..+..+++|++|+|++|++. .+|. .+..+++|+.|++++|.++. +|.. +..+++|+.|+++.
T Consensus 72 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~ 149 (176)
T 1a9n_A 72 NNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQK 149 (176)
T ss_dssp CSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEE
T ss_pred CCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCc
Confidence 999999665566689999999999999996 5666 78899999999999999974 4543 66666666666654
Q ss_pred C
Q 046265 201 S 201 (639)
Q Consensus 201 ~ 201 (639)
+
T Consensus 150 n 150 (176)
T 1a9n_A 150 V 150 (176)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.46 E-value=3.1e-12 Score=134.10 Aligned_cols=264 Identities=11% Similarity=0.084 Sum_probs=167.0
Q ss_pred CCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcc
Q 046265 28 NISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIG 107 (639)
Q Consensus 28 ~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~ 107 (639)
.+..++.+.+.++ ++.+-+.+|.+. +|+.+++..| ++..-..+|.+ .+|+.+.+.. .++.+-+.+|.++.+|
T Consensus 111 ~~~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L--- 182 (401)
T 4fdw_A 111 ILKGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNL--- 182 (401)
T ss_dssp ECSSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTC---
T ss_pred ecCCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccC---
Confidence 3466777777543 555556677764 6888887766 55444556666 4688887764 5555555666665533
Q ss_pred cCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccC
Q 046265 108 SMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSI 187 (639)
Q Consensus 108 ~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 187 (639)
+.+++++|+++......|. ..+|+.+.|.++ +...-+..|.++++|+.+++..| ++.+-..+|
T Consensus 183 --------------~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF 245 (401)
T 4fdw_A 183 --------------KKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAF 245 (401)
T ss_dssp --------------CEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTT
T ss_pred --------------CeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccc
Confidence 4777777777744444554 577888888744 55455567778888888888764 454555566
Q ss_pred cCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceecccccccc-----CcchhhhhcCCCcc
Q 046265 188 SNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLT-----GNIYEVFGIYPNLT 262 (639)
Q Consensus 188 ~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~ 262 (639)
.+ .+|+.+.+.+ .+...-+.+|.++++|+.+++.+|.+. ...+..|..+++|+
T Consensus 246 ~~-~~L~~i~lp~---------------------~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~ 303 (401)
T 4fdw_A 246 RE-SGITTVKLPN---------------------GVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLA 303 (401)
T ss_dssp TT-CCCSEEEEET---------------------TCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCC
T ss_pred cc-CCccEEEeCC---------------------CccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCC
Confidence 65 5666665522 121222345556666666666655543 34456677777777
Q ss_pred EEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCC
Q 046265 263 FLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSIS 342 (639)
Q Consensus 263 ~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 342 (639)
.+++.++ + +..-...|.++.+|+.+++..| +...-+.+|.++ +|+.+++++|.+....+..|.+++
T Consensus 304 ~l~l~~~-i-----------~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~ 369 (401)
T 4fdw_A 304 RFEIPES-I-----------RILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFP 369 (401)
T ss_dssp EECCCTT-C-----------CEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSC
T ss_pred eEEeCCc-e-----------EEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCC
Confidence 7776532 2 2223345667778888888554 555556778888 888888888887766666777774
Q ss_pred -CCCEEeCCCC
Q 046265 343 -DLEYLDLSTN 352 (639)
Q Consensus 343 -~L~~L~Ls~N 352 (639)
.++.|++..+
T Consensus 370 ~~l~~l~vp~~ 380 (401)
T 4fdw_A 370 DDITVIRVPAE 380 (401)
T ss_dssp TTCCEEEECGG
T ss_pred CCccEEEeCHH
Confidence 6788887653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.46 E-value=4.2e-12 Score=133.06 Aligned_cols=270 Identities=11% Similarity=0.052 Sum_probs=197.2
Q ss_pred CCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcC
Q 046265 52 PLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQL 131 (639)
Q Consensus 52 ~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l 131 (639)
.+..++.+.+.++ ++..-+.+|.+. +|+.+.+..| ++.+-..+|.+. +| +.+++.+ .+
T Consensus 111 ~~~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L-----------------~~i~lp~-~l 168 (401)
T 4fdw_A 111 ILKGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TV-----------------QEIVFPS-TL 168 (401)
T ss_dssp ECSSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CC-----------------CEEECCT-TC
T ss_pred ecCCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-Cc-----------------eEEEeCC-Cc
Confidence 4477888888764 554556678774 7999999766 666666666653 22 4777775 56
Q ss_pred cccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCcccccccccc
Q 046265 132 SGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLL 211 (639)
Q Consensus 132 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~ 211 (639)
+..-+..|.++++|+.+++..|+++...+..|. ..+|+.+.+..+ ++.+-..+|.++++|+.+.+..+
T Consensus 169 ~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~---------- 236 (401)
T 4fdw_A 169 EQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN---------- 236 (401)
T ss_dssp CEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT----------
T ss_pred cEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC----------
Confidence 656678899999999999999999865555666 589999999854 77677778888888887776432
Q ss_pred CCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCcccc
Q 046265 212 QLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIG 291 (639)
Q Consensus 212 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~ 291 (639)
+...-..+|.+ .+|+.+.+ .+.++.....+|..+++|+.+++.+|.+. .+.....-+..|.
T Consensus 237 -----------l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~------~~~~~~I~~~aF~ 297 (401)
T 4fdw_A 237 -----------VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN------DDPEAMIHPYCLE 297 (401)
T ss_dssp -----------CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC------CCTTCEECTTTTT
T ss_pred -----------ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc------CCcccEECHHHhh
Confidence 11222345655 68999999 46677777889999999999998887652 1222233456788
Q ss_pred CCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccc-c
Q 046265 292 KLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLV-Q 370 (639)
Q Consensus 292 ~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~-~ 370 (639)
++++|+.+++.+ .+...-..+|.+|++|+.+.+..| ++..-+.+|.++ +|+.+++++|....+. +..+..+. .
T Consensus 298 ~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~---~~~F~~~~~~ 371 (401)
T 4fdw_A 298 GCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVF---EKVWYGFPDD 371 (401)
T ss_dssp TCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCC---CSSCCCSCTT
T ss_pred CCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccc---cccccCCCCC
Confidence 999999999994 577666788999999999999654 766667889999 9999999997544433 34455553 6
Q ss_pred CCeeeccCCc
Q 046265 371 LTELDLVITF 380 (639)
Q Consensus 371 L~~l~l~~n~ 380 (639)
++.+.+-.+.
T Consensus 372 l~~l~vp~~~ 381 (401)
T 4fdw_A 372 ITVIRVPAES 381 (401)
T ss_dssp CCEEEECGGG
T ss_pred ccEEEeCHHH
Confidence 7778775543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=4.4e-13 Score=123.50 Aligned_cols=104 Identities=26% Similarity=0.365 Sum_probs=57.2
Q ss_pred CEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCC
Q 046265 33 KFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNS 112 (639)
Q Consensus 33 ~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~ 112 (639)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L-------- 83 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQL-------- 83 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC--------
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchh--------
Confidence 45666666664 4555443 566666666666665555556666666666666666554433334444422
Q ss_pred CcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCC
Q 046265 113 LSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLF 156 (639)
Q Consensus 113 ~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 156 (639)
++|+|++|++++..+..|..+++|++|+|++|.+.
T Consensus 84 ---------~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 84 ---------TQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp ---------CEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ---------hEEECCCCccceeCHHHhccccCCCEEEeCCCCcc
Confidence 35555555555433334555556666666666554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=4.7e-13 Score=123.33 Aligned_cols=111 Identities=31% Similarity=0.358 Sum_probs=94.0
Q ss_pred cceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCE
Q 046265 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQ 82 (639)
Q Consensus 3 ~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 82 (639)
|.|. ...+++++|++ +.+|..+. ++|++|+|++|.|++..|..|..+++|++|+|++|+|++..+..|.++++|++
T Consensus 10 C~C~-~~~l~~~~n~l-~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~ 85 (174)
T 2r9u_A 10 CSCD-QTLVNCQNIRL-ASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQ 85 (174)
T ss_dssp SEEC-SSEEECCSSCC-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CEEC-CcEEEeCCCCC-CccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhE
Confidence 6663 35678888888 47888775 89999999999999988999999999999999999999655556799999999
Q ss_pred EeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCccc
Q 046265 83 LVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGS 134 (639)
Q Consensus 83 L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~ 134 (639)
|+|++|+|++..+..|..+++| ++|+|++|.+...
T Consensus 86 L~L~~N~l~~l~~~~~~~l~~L-----------------~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 86 LDLNDNHLKSIPRGAFDNLKSL-----------------THIYLYNNPWDCE 120 (174)
T ss_dssp EECCSSCCCCCCTTTTTTCTTC-----------------SEEECCSSCBCTT
T ss_pred EECCCCccceeCHHHhccccCC-----------------CEEEeCCCCcccc
Confidence 9999999997666667777643 5899999999843
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.5e-11 Score=129.14 Aligned_cols=309 Identities=11% Similarity=0.014 Sum_probs=173.2
Q ss_pred ccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCC
Q 046265 24 PQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNN 103 (639)
Q Consensus 24 ~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 103 (639)
.+|.++++|+.+.|..+ ++.+-..+|.++++|+.+++..+ ++..-..+|.++++|+.+.+..+ +...-..+|.+...
T Consensus 65 ~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~ 141 (394)
T 4fs7_A 65 AAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDF 141 (394)
T ss_dssp TTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCC
T ss_pred HHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccc
Confidence 34555555555555432 44344445555555555555433 33222334555555555444322 22233333333321
Q ss_pred CCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccC
Q 046265 104 LAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVL 183 (639)
Q Consensus 104 L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 183 (639)
...... +.....-..+|.++++|+.+.+.++. .......|.++.+|+.+.+..| ++.+.
T Consensus 142 ------------------~~~~~~-~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~ 200 (394)
T 4fs7_A 142 ------------------KEITIP-EGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIR 200 (394)
T ss_dssp ------------------SEEECC-TTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEEC
T ss_pred ------------------cccccC-ccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeC
Confidence 122221 12222334567777788888876543 3233456777777887777665 44455
Q ss_pred CccCcCCCCCCeEEccCCc--cccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCc
Q 046265 184 PPSISNLSNLEGLYLYSSL--VSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNL 261 (639)
Q Consensus 184 p~~~~~l~~L~~L~l~~~~--~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 261 (639)
..+|.++..|+.+.+..+. +.........|+.+.+.... ...-...+.++..++.+.+..+... .....|..+..+
T Consensus 201 ~~~F~~~~~L~~i~~~~~~~~i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l 278 (394)
T 4fs7_A 201 DYCFAECILLENMEFPNSLYYLGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGL 278 (394)
T ss_dssp TTTTTTCTTCCBCCCCTTCCEECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTC
T ss_pred chhhccccccceeecCCCceEeehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce-eecccccccccc
Confidence 5667777777777664322 12222334566676665432 2222345667778888887766433 444567777777
Q ss_pred cEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCC
Q 046265 262 TFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSI 341 (639)
Q Consensus 262 ~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 341 (639)
+.+....+.+ ....+..+.+|+.+.+..+ +...-..+|.++++|+.+++..+ ++..-..+|.++
T Consensus 279 ~~~~~~~~~i--------------~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c 342 (394)
T 4fs7_A 279 KKVIYGSVIV--------------PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGC 342 (394)
T ss_dssp CEEEECSSEE--------------CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTC
T ss_pred ceeccCceee--------------ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCC
Confidence 7776543322 1234566777888777654 44444567788888888888643 554556677888
Q ss_pred CCCCEEeCCCCCCCcccccCChhhhccccCCeeeccC
Q 046265 342 SDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVI 378 (639)
Q Consensus 342 ~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~ 378 (639)
.+|+.+++..+ +..+. ...+..+.+|+.+++..
T Consensus 343 ~~L~~i~lp~~-l~~I~---~~aF~~C~~L~~i~lp~ 375 (394)
T 4fs7_A 343 TSLSNINFPLS-LRKIG---ANAFQGCINLKKVELPK 375 (394)
T ss_dssp TTCCEECCCTT-CCEEC---TTTBTTCTTCCEEEEEG
T ss_pred CCCCEEEECcc-ccEeh---HHHhhCCCCCCEEEECC
Confidence 88888888654 23332 35677788888887743
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.27 E-value=3e-10 Score=119.22 Aligned_cols=315 Identities=12% Similarity=0.030 Sum_probs=216.1
Q ss_pred CccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCc
Q 046265 42 LSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSL 121 (639)
Q Consensus 42 l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L 121 (639)
++.+-..+|.++++|+.+.|..+ ++..-..+|.++++|+.+++..+ ++.+-...|.++.+|+...+|..
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~--------- 127 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM--------- 127 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT---------
T ss_pred EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc---------
Confidence 45455678999999999999754 66445668999999999999755 66566677888877764444432
Q ss_pred cEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCC
Q 046265 122 FHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSS 201 (639)
Q Consensus 122 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~ 201 (639)
+...-..+|.+...+......... ..-...|.++++|+.+.+..+. ..+....|.++.+|+.+.+..+
T Consensus 128 ---------l~~i~~~aF~~~~~~~~~~~~~~~--~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~ 195 (394)
T 4fs7_A 128 ---------LKSIGVEAFKGCDFKEITIPEGVT--VIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN 195 (394)
T ss_dssp ---------CCEECTTTTTTCCCSEEECCTTCC--EECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT
T ss_pred ---------eeeecceeeecccccccccCcccc--ccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC
Confidence 222233445555444444333322 2234678999999999998664 4466678999999999988644
Q ss_pred c--c-ccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccCc
Q 046265 202 L--V-SAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFS 278 (639)
Q Consensus 202 ~--~-~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls 278 (639)
. + ...+.++..|+.+.+..+.. .+.......++|+.+.+..+ ++......|..+..++.+.+..+..
T Consensus 196 ~~~I~~~~F~~~~~L~~i~~~~~~~--~i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~------- 265 (394)
T 4fs7_A 196 LKIIRDYCFAECILLENMEFPNSLY--YLGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKL------- 265 (394)
T ss_dssp CCEECTTTTTTCTTCCBCCCCTTCC--EECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTC-------
T ss_pred ceEeCchhhccccccceeecCCCce--EeehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcc-------
Confidence 2 1 33567777888877766543 23334445678888887643 3434456788889999998765533
Q ss_pred CCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCccc
Q 046265 279 MNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFR 358 (639)
Q Consensus 279 ~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~ 358 (639)
......+..+..++.+....+.+. ...|..+.+|+.+.+..+ +...-..+|.++.+|+.++|..+ +..+
T Consensus 266 -----~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I- 334 (394)
T 4fs7_A 266 -----RIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEI- 334 (394)
T ss_dssp -----EECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEE-
T ss_pred -----eeeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEE-
Confidence 233455677788888888766542 356888999999999754 66555678999999999999753 2333
Q ss_pred ccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCC
Q 046265 359 KEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYN 413 (639)
Q Consensus 359 ~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N 413 (639)
-...+..+.+|+.+++..+ +. .+.. .++..+.+|+.+++..+
T Consensus 335 --~~~aF~~c~~L~~i~lp~~-l~-~I~~---------~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 335 --GKRSFRGCTSLSNINFPLS-LR-KIGA---------NAFQGCINLKKVELPKR 376 (394)
T ss_dssp --CTTTTTTCTTCCEECCCTT-CC-EECT---------TTBTTCTTCCEEEEEGG
T ss_pred --hHHhccCCCCCCEEEECcc-cc-EehH---------HHhhCCCCCCEEEECCC
Confidence 2467889999999998655 32 2212 56888999999998765
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.25 E-value=1.7e-11 Score=126.40 Aligned_cols=66 Identities=26% Similarity=0.272 Sum_probs=28.2
Q ss_pred ccCCCCCCEEECcC-CCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCc
Q 046265 26 IGNISNLKFLDMGN-NQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLS 91 (639)
Q Consensus 26 ~~~l~~L~~L~Ls~-n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 91 (639)
|..+++|++|+|++ |.|++..|..|+.|++|+.|+|++|+|++..|..|.+|++|++|+|++|+|+
T Consensus 27 l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 93 (347)
T 2ifg_A 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (347)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccc
Confidence 44444444444443 4444333334444444444444444444333334444444444444444443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=4.1e-11 Score=118.32 Aligned_cols=146 Identities=17% Similarity=0.062 Sum_probs=111.4
Q ss_pred HHhccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCceeE
Q 046265 462 RATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 462 ~~~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l 540 (639)
.....|......+.|+.+.||++... ++.+++|....... .....+.+|+++++.+. |..+.++++++...+..|+
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 34456777778888889999999755 57899999864211 11234788999998884 6788899999998889999
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY---------------------------------- 586 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---------------------------------- 586 (639)
||||++|.++.+..... .....++.+++++++.||...
T Consensus 88 v~e~i~G~~l~~~~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 88 LMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHCCTT--------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEecCCeehhhccCCc--------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 99999999998763211 123467888999999999810
Q ss_pred ----------------------CCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 587 ----------------------FPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 587 ----------------------~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
.+.++|+|++|.||++++...+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13589999999999998765667999987654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.23 E-value=2.6e-11 Score=124.97 Aligned_cols=103 Identities=27% Similarity=0.286 Sum_probs=60.7
Q ss_pred EEECcCC-CCccCCCCCCCCCCCCCEEEccc-CcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCC
Q 046265 34 FLDMGNN-QLSGVIPQEIDPLTHLKHLYINV-NKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPN 111 (639)
Q Consensus 34 ~L~Ls~n-~l~~~~p~~~~~L~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~ 111 (639)
.++++++ +++ .+|. |..+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|++..|..|.+|++|
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L------- 82 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL------- 82 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCC-------
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCC-------
Confidence 4566666 665 3555 66666666666664 66665555566666666666666666666555555555532
Q ss_pred CCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCC
Q 046265 112 SLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLF 156 (639)
Q Consensus 112 ~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 156 (639)
++|+|++|+|++..+..|..++ |+.|+|++|.+.
T Consensus 83 ----------~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 83 ----------SRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp ----------CEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred ----------CEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 3566666666644444444443 666666666554
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=1.1e-10 Score=115.04 Aligned_cols=130 Identities=15% Similarity=0.115 Sum_probs=96.7
Q ss_pred ccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCc--eeeeEEEEEcCCceeEEecccCCCChh
Q 046265 474 GTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN--VVKFYGFSFHPRQSFLLYEYLGRGSLA 551 (639)
Q Consensus 474 g~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~ 551 (639)
+.|..+.||++...+|+.++||...... ...+.+|+++++.+.+.+ +.+++++...++..|+||||++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 4556699999988888889999976431 234678999998886544 556888888888899999999998884
Q ss_pred HHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 046265 552 IILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY--------------------------------------------- 586 (639)
Q Consensus 552 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--------------------------------------------- 586 (639)
... .. ...++.++++.+..+|...
T Consensus 104 --~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 --SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp --TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred --cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 211 11 1246677777777777642
Q ss_pred ----------CCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 587 ----------FPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 587 ----------~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
.+.++|+|++|.||++++++.++|+|||.+...
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 113999999999999987766779999987653
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.01 E-value=4.2e-12 Score=131.72 Aligned_cols=165 Identities=19% Similarity=0.176 Sum_probs=108.1
Q ss_pred CCCCCEEECcCCCCccCCCCCCC-----CCCCCCEEEcccCcCCCCCCccc-CCCCCCCEEeeecccCccccCccccCCC
Q 046265 29 ISNLKFLDMGNNQLSGVIPQEID-----PLTHLKHLYINVNKLRGSVPREV-GQLSSLKQLVLYCNGLSGWLPSSFGNLN 102 (639)
Q Consensus 29 l~~L~~L~Ls~n~l~~~~p~~~~-----~L~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 102 (639)
++.|++|+|++|.++......+. ..++|+.|+|++|.++..-...+ ..+++|+.|+|++|+++......++..-
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 35788889988888754333332 23688889998888864322222 3456788899998888755444432110
Q ss_pred CCCcccCCCCCcccCCCCccEEEccCCcCcc----cCCccccCCCCCCEEeccCCCCCCC----CCccccCCCcccEEEc
Q 046265 103 NLAIGSMPNSLSNLTSLSLFHLDLSENQLSG----SIPHFLGHLSNLAVLHLGDNSLFGS----IPPILGKVQSLLSLGF 174 (639)
Q Consensus 103 ~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l 174 (639)
. ...+ .|++|+|++|.++. .++..+...++|++|+|++|.++.. ++..+...++|+.|+|
T Consensus 151 --~--------~~~~--~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~L 218 (372)
T 3un9_A 151 --L--------HDQC--QITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNV 218 (372)
T ss_dssp --H--------STTC--CCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEEC
T ss_pred --H--------hcCC--ccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEEC
Confidence 0 0011 23688888888864 2344557788899999998888632 2445666778899999
Q ss_pred ccCcCCcc----CCccCcCCCCCCeEEccCCcccc
Q 046265 175 DLNLLNGV----LPPSISNLSNLEGLYLYSSLVSA 205 (639)
Q Consensus 175 ~~N~l~~~----~p~~~~~l~~L~~L~l~~~~~~~ 205 (639)
++|.++.. ++..+...++|+.|+++.|.+..
T Consensus 219 s~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 219 AYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp CSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred CCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 99888743 33445566788999988776643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.7e-09 Score=111.90 Aligned_cols=142 Identities=16% Similarity=0.214 Sum_probs=104.7
Q ss_pred cceeccCCCceEEEEEcCCCcEEEEEEcc--CCCCChhhHHHHHHHHHHHhccc--cCceeeeEEEEEcC---CceeEEe
Q 046265 470 KYCIGTAGQASVYKAELPSWEIVAVKKFH--SPHPDMVVQQAFSNEIKALTELR--HRNVVKFYGFSFHP---RQSFLLY 542 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~---~~~~lv~ 542 (639)
.+.++.|.++.||+....+ ..+++|+.. .... ......+.+|+++++.+. +..+++++.++.+. +..|+||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4578999999999998765 578888876 3221 112345788999998886 45688999988776 4589999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY------------------------------------ 586 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~------------------------------------ 586 (639)
||++|..+.+.. ...++...+..++.+++++|+.||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998775311 123566778888999999999999731
Q ss_pred -------------------CCCeEeecCCCCCeeeCCCCc--eEEcccccccc
Q 046265 587 -------------------FPPIVHRDISSKNVLLGLDYD--AHVSDFGISKF 618 (639)
Q Consensus 587 -------------------~~~iiHrdlk~~Nill~~~~~--~kl~DfGla~~ 618 (639)
.+.++|+|+++.||+++.++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246899999999999997753 68999998764
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.99 E-value=5.7e-11 Score=123.21 Aligned_cols=136 Identities=17% Similarity=0.140 Sum_probs=62.2
Q ss_pred ccCCcEEEcCCcccCCCCCcccc-----CCCCCceeccccccccCcchhh-hhcCCCccEEeccCCcccccccCcCCccc
Q 046265 210 LLQLIELEIDNKQLFGQIPKSLR-----NFTSLNIVHLEQNHLTGNIYEV-FGIYPNLTFLDLSQNNFYGSLNFSMNNIT 283 (639)
Q Consensus 210 l~~L~~L~l~~n~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~ 283 (639)
++.|+.|++++|.+.......+. ..++|+.|+|++|.++...... ...+++|+.|+|++|.+...- .
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~-------~ 143 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEA-------C 143 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHH-------H
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHH-------H
Confidence 34566777777766443222222 1256666666666665432222 223445666665555542100 0
Q ss_pred cccCccc-cCCCCCCEEeccCCccccc----CCccccCCCCCCeeeccCccCccc----CCcCccCCCCCCEEeCCCC
Q 046265 284 RSIPPKI-GKLYQLHKLDFSLNHIVGE----LPIELGNLKSLNYRALNGNKVYGS----LPRVLGSISDLEYLDLSTN 352 (639)
Q Consensus 284 ~~~p~~~-~~l~~L~~L~Ls~N~~~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N 352 (639)
..+...+ ...++|+.|+|++|.+... ++..+..+++|+.|+|++|.+... ++..+...++|+.|+|++|
T Consensus 144 ~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N 221 (372)
T 3un9_A 144 KDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYN 221 (372)
T ss_dssp HHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSS
T ss_pred HHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCC
Confidence 0011111 1234566666666655421 222334455555555555555421 1233334445555555553
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.96 E-value=7e-08 Score=101.04 Aligned_cols=110 Identities=11% Similarity=0.117 Sum_probs=61.6
Q ss_pred hhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCc
Q 046265 252 YEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVY 331 (639)
Q Consensus 252 ~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~ 331 (639)
..+|..+..|+.+.+.++.. ..-...|.++..|+.+.+. +.+.......|.++++|+.+.+..+ ++
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~------------~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~ 323 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVV------------SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT 323 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCC------------EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC
T ss_pred cceeeecccccEEecccccc------------eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc
Confidence 44566666666666543321 1122345556667766665 3344344556667777777777543 44
Q ss_pred ccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCC
Q 046265 332 GSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVIT 379 (639)
Q Consensus 332 ~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n 379 (639)
.+-..+|.+|.+|+.+.+..+ ...+. ...|..+.+|+.+++..+
T Consensus 324 ~I~~~aF~~C~~L~~i~ip~s-v~~I~---~~aF~~C~~L~~i~~~~~ 367 (394)
T 4gt6_A 324 QILDDAFAGCEQLERIAIPSS-VTKIP---ESAFSNCTALNNIEYSGS 367 (394)
T ss_dssp EECTTTTTTCTTCCEEEECTT-CCBCC---GGGGTTCTTCCEEEESSC
T ss_pred EehHhHhhCCCCCCEEEECcc-cCEEh---HhHhhCCCCCCEEEECCc
Confidence 344556777777777777542 22221 345666777777766543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.88 E-value=1.2e-07 Score=99.21 Aligned_cols=323 Identities=14% Similarity=0.094 Sum_probs=174.0
Q ss_pred cCCccccCCC-CCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCc---CCCCCCcccCCCCCCCEEeeecccCccccCc
Q 046265 21 IIPPQIGNIS-NLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNK---LRGSVPREVGQLSSLKQLVLYCNGLSGWLPS 96 (639)
Q Consensus 21 ~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~---l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 96 (639)
+-..+|.+++ .|+.+.+..+ ++.+-..+|.++++|+.+.+..|. ++..-..+|..+.+|+.+.+..+ ++..-..
T Consensus 54 Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~ 131 (394)
T 4gt6_A 54 IGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSE 131 (394)
T ss_dssp ECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTT
T ss_pred cCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhh
Confidence 3445677664 5888888654 665667778888888888887764 54333456777788887777544 5555566
Q ss_pred cccCCCCCCcccCCCC--------CcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCc
Q 046265 97 SFGNLNNLAIGSMPNS--------LSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQS 168 (639)
Q Consensus 97 ~~~~l~~L~~~~lp~~--------~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 168 (639)
.|....+|+.-.+|.. +.++..| ..+.+.++ ++..-..+|.. .+|+.+.+..+-. ..-...|....+
T Consensus 132 aF~~c~~L~~i~lp~~~~~I~~~~F~~c~~L--~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~-~i~~~af~~c~~ 206 (394)
T 4gt6_A 132 AFHHCEELDTVTIPEGVTSVADGMFSYCYSL--HTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVT-RIGTNAFSECFA 206 (394)
T ss_dssp TTTTCTTCCEEECCTTCCEECTTTTTTCTTC--CEEECCTT-CCEECTTTTTT-CCCSEEEECTTCC-EECTTTTTTCTT
T ss_pred hhhhhcccccccccceeeeecccceeccccc--ccccccce-eeEeccccccc-cceeEEEECCccc-ccccchhhhccc
Confidence 7777777775555542 3444555 57777654 44333445543 6788888865432 234456777888
Q ss_pred ccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceecccccccc
Q 046265 169 LLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLT 248 (639)
Q Consensus 169 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 248 (639)
+.......+......-..+........... .......+..+.+.. .+...-..+|.++++|+.+.+.++..
T Consensus 207 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~- 277 (394)
T 4gt6_A 207 LSTITSDSESYPAIDNVLYEKSANGDYALI-------RYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVV- 277 (394)
T ss_dssp CCEEEECCSSSCBSSSCEEEECTTSCEEEE-------ECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCC-
T ss_pred cceecccccccccccceeeccccccccccc-------ccccccccceEEcCC-cceEcccceeeecccccEEecccccc-
Confidence 888776665443211111111110000000 011112222222221 11112234566666676666654432
Q ss_pred CcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCc
Q 046265 249 GNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGN 328 (639)
Q Consensus 249 ~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N 328 (639)
.....+|..++.|+.+.+..+ ++..-...|.++.+|+.+++..+ ++..-..+|.+|++|+.+.+..+
T Consensus 278 ~I~~~aF~~c~~L~~i~l~~~------------i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s 344 (394)
T 4gt6_A 278 SIGTGAFMNCPALQDIEFSSR------------ITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS 344 (394)
T ss_dssp EECTTTTTTCTTCCEEECCTT------------CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT
T ss_pred eecCcccccccccccccCCCc------------ccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc
Confidence 234456666777777765321 12222345666677777777654 44344566777777777777543
Q ss_pred cCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCC
Q 046265 329 KVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVIT 379 (639)
Q Consensus 329 ~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n 379 (639)
++..-..+|.+|++|+.+++.++. .. -..+..+..|+.+.+..+
T Consensus 345 -v~~I~~~aF~~C~~L~~i~~~~~~---~~---~~~~~~~~~L~~i~i~~~ 388 (394)
T 4gt6_A 345 -VTKIPESAFSNCTALNNIEYSGSR---SQ---WNAISTDSGLQNLPVAPG 388 (394)
T ss_dssp -CCBCCGGGGTTCTTCCEEEESSCH---HH---HHTCBCCCCC--------
T ss_pred -cCEEhHhHhhCCCCCCEEEECCce---ee---hhhhhccCCCCEEEeCCC
Confidence 543445567777777777777642 11 123445566666665544
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.61 E-value=4.7e-06 Score=86.48 Aligned_cols=286 Identities=9% Similarity=0.007 Sum_probs=154.3
Q ss_pred ccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCC
Q 046265 26 IGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLA 105 (639)
Q Consensus 26 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 105 (639)
+....+|+.+.+.. .++.+-..+|.++.+|+.++|..+ ++..-..+|.+. +|+.+.+..+ ++.+-..+|.+ .+|+
T Consensus 42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~ 116 (379)
T 4h09_A 42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLD 116 (379)
T ss_dssp GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCS
T ss_pred cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcc
Confidence 44566788888864 466555677888888888888654 553444566665 5777766543 44333344433 2343
Q ss_pred cccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCc----
Q 046265 106 IGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNG---- 181 (639)
Q Consensus 106 ~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~---- 181 (639)
.-.+|.++ +..-...|.+. +|+...+..+ ++..-...|.....++...+..+....
T Consensus 117 ~i~lp~~~------------------~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~ 176 (379)
T 4h09_A 117 DFEFPGAT------------------TEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAEN 176 (379)
T ss_dssp EEECCTTC------------------CEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEET
T ss_pred cccCCCcc------------------ccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeeccc
Confidence 22233221 11111122221 2333322211 111122233333334333333221110
Q ss_pred --------cCCccCcCCCCCCeEEccCCc---cccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCc
Q 046265 182 --------VLPPSISNLSNLEGLYLYSSL---VSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGN 250 (639)
Q Consensus 182 --------~~p~~~~~l~~L~~L~l~~~~---~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 250 (639)
.....+.....+..+.+.... ....+.....|..+.+..+ +......++.++..|+.+.+..+ ++..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I 254 (379)
T 4h09_A 177 YVLYNKNKTILESYPAAKTGTEFTIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSI 254 (379)
T ss_dssp TEEEETTSSEEEECCTTCCCSEEECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEE
T ss_pred ceecccccceeccccccccccccccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEe
Confidence 111122233334444332111 1223444556666666543 22233446677788888887655 5555
Q ss_pred chhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccC
Q 046265 251 IYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKV 330 (639)
Q Consensus 251 ~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l 330 (639)
...+|..+.+|+.+.+..+ +...-...|..+.+|+.+++.++.+...-...|.+|++|+.+.+..+ +
T Consensus 255 ~~~aF~~~~~l~~i~l~~~------------i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l 321 (379)
T 4h09_A 255 GSFLLQNCTALKTLNFYAK------------VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-L 321 (379)
T ss_dssp CTTTTTTCTTCCEEEECCC------------CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-C
T ss_pred Cccccceeehhcccccccc------------ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-c
Confidence 5667777888888876432 12222345677888888888887777666678888888888888644 5
Q ss_pred cccCCcCccCCCCCCEEeCCC
Q 046265 331 YGSLPRVLGSISDLEYLDLST 351 (639)
Q Consensus 331 ~~~~p~~~~~l~~L~~L~Ls~ 351 (639)
+.+-..+|.++++|+.+.+..
T Consensus 322 ~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 322 KTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp CEECTTTTTTCTTCCCCCCCT
T ss_pred cEEHHHHhhCCCCCCEEEECC
Confidence 545556788888888888865
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.58 E-value=1.9e-08 Score=103.28 Aligned_cols=58 Identities=16% Similarity=0.248 Sum_probs=28.9
Q ss_pred CCCEEECcCCCCcc-C-------CCCCCCCCCCCCEEEcccCcCC---------CCCCcccCCCCCCCEEeeecc
Q 046265 31 NLKFLDMGNNQLSG-V-------IPQEIDPLTHLKHLYINVNKLR---------GSVPREVGQLSSLKQLVLYCN 88 (639)
Q Consensus 31 ~L~~L~Ls~n~l~~-~-------~p~~~~~L~~L~~L~L~~N~l~---------~~~p~~~~~l~~L~~L~L~~N 88 (639)
.++.|.+....+.| . +..++..+++|+.|.+..+... +.++..+..+++|+.|+|++|
T Consensus 108 ~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~ 182 (362)
T 2ra8_A 108 SLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT 182 (362)
T ss_dssp GCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECC
T ss_pred hcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCC
Confidence 45666666554432 1 1223445666777766544221 113333445566666666655
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.50 E-value=7.3e-08 Score=98.98 Aligned_cols=111 Identities=19% Similarity=0.111 Sum_probs=62.4
Q ss_pred CCCCEEeccCCCCCC-CC-------CccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCc
Q 046265 143 SNLAVLHLGDNSLFG-SI-------PPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLI 214 (639)
Q Consensus 143 ~~L~~L~L~~N~l~~-~~-------p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~ 214 (639)
.+++.|.+....+.| .. ......+++|+.|.+..+..... .++.+ ....+...+..+++|+
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~---~is~~--------~~~~L~~ll~~~P~L~ 175 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQ---EISWI--------EQVDLSPVLDAMPLLN 175 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTC---CGGGC--------BCCBCHHHHHTCTTCC
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhc---ccccc--------cccCHHHHHhcCCCCc
Confidence 456778877665442 11 22244567777777755432100 00000 0112333455667888
Q ss_pred EEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhh--cCCCccEEecc
Q 046265 215 ELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFG--IYPNLTFLDLS 267 (639)
Q Consensus 215 ~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls 267 (639)
.|++++|.-. .+|. + .+++|+.|++..+.+.......+. .+|+|+.|+|+
T Consensus 176 ~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 176 NLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp EEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred EEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 8888776311 2333 3 378888999888887654444444 67888888875
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.49 E-value=1.1e-05 Score=83.60 Aligned_cols=288 Identities=10% Similarity=0.025 Sum_probs=185.2
Q ss_pred CCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEcc
Q 046265 48 QEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLS 127 (639)
Q Consensus 48 ~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~ 127 (639)
+++....+|+.+.+.. .++..-..+|.++.+|+.++|..+ ++.+-..+|.+. +|. .+.+.
T Consensus 40 ~~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~-----------------~i~~~ 99 (379)
T 4h09_A 40 PWYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQ-----------------SYTGM 99 (379)
T ss_dssp TTGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCC-----------------EEEEC
T ss_pred cccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCc-----------------eEECC
Confidence 3456677899998875 355444568999999999999654 665556666654 232 33443
Q ss_pred CCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCcc----
Q 046265 128 ENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLV---- 203 (639)
Q Consensus 128 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~---- 203 (639)
.+ ++..-..+|.. .+|+.+.+..+ +...-...|.+. +|+...+..+ ++..-...|....+++...+.....
T Consensus 100 ~~-l~~I~~~aF~~-~~L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~ 174 (379)
T 4h09_A 100 ER-VKKFGDYVFQG-TDLDDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVA 174 (379)
T ss_dssp TT-CCEECTTTTTT-CCCSEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEE
T ss_pred ce-eeEeccceecc-CCcccccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeec
Confidence 22 33233344544 47999998765 332223345443 5666665443 4445566778888888877653211
Q ss_pred ------------ccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcc
Q 046265 204 ------------SAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNF 271 (639)
Q Consensus 204 ------------~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 271 (639)
...+.....+..+.+.... .......+....+|+.+.+..+ +.......|..+..|+.+.+..+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-- 250 (379)
T 4h09_A 175 ENYVLYNKNKTILESYPAAKTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-- 250 (379)
T ss_dssp ETTEEEETTSSEEEECCTTCCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT--
T ss_pred ccceecccccceeccccccccccccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC--
Confidence 1122333445555444322 1223345667788888887654 44455667888899999887543
Q ss_pred cccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCC
Q 046265 272 YGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLST 351 (639)
Q Consensus 272 ~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 351 (639)
++..-...+..+.+|+.+.+..+ +.......|..+++|+.+.+.++.+...-+.+|.++.+|+.++|..
T Consensus 251 ----------v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~ 319 (379)
T 4h09_A 251 ----------VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPT 319 (379)
T ss_dssp ----------CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCT
T ss_pred ----------ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCc
Confidence 12223456677888999998654 5545566789999999999998888866678899999999999975
Q ss_pred CCCCcccccCChhhhccccCCeeeccCC
Q 046265 352 NYNNEFRKEFPVELEKLVQLTELDLVIT 379 (639)
Q Consensus 352 N~~~~~~~~~p~~~~~l~~L~~l~l~~n 379 (639)
+ +..+. ...+..+.+|+.+.+..+
T Consensus 320 ~-l~~I~---~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 320 A-LKTIQ---VYAFKNCKALSTISYPKS 343 (379)
T ss_dssp T-CCEEC---TTTTTTCTTCCCCCCCTT
T ss_pred c-ccEEH---HHHhhCCCCCCEEEECCc
Confidence 3 23332 457888999998887543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.41 E-value=5.3e-07 Score=90.66 Aligned_cols=137 Identities=18% Similarity=0.221 Sum_probs=94.2
Q ss_pred cceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCc--eeeeEEEEEcCC---ceeEEec
Q 046265 470 KYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRN--VVKFYGFSFHPR---QSFLLYE 543 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lv~e 543 (639)
.+.++.|....||++. ..+++|.-.. ......+.+|+++++.+. +.. +.+.+.+....+ ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 3468899999999864 4588888542 233567889999998873 332 445555544333 3589999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHD-------------------------------------- 585 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-------------------------------------- 585 (639)
|++|..+..... ..++..++..++.++++.++.+|..
T Consensus 97 ~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 97 KIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred ccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 999988864322 1234455566667777777777641
Q ss_pred -----------------CCCCeEeecCCCCCeeeCC--CCceEEccccccccC
Q 046265 586 -----------------YFPPIVHRDISSKNVLLGL--DYDAHVSDFGISKFL 619 (639)
Q Consensus 586 -----------------~~~~iiHrdlk~~Nill~~--~~~~kl~DfGla~~~ 619 (639)
..+.++|+|++|.||++++ ...+.|+||+.+...
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1136899999999999988 456889999987653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.30 E-value=2.4e-08 Score=97.41 Aligned_cols=49 Identities=33% Similarity=0.409 Sum_probs=23.4
Q ss_pred EEEccCCcCcccCCccccCCC--CCCEEeccCCCCCCCCCc-------cccCCCcccEEE
Q 046265 123 HLDLSENQLSGSIPHFLGHLS--NLAVLHLGDNSLFGSIPP-------ILGKVQSLLSLG 173 (639)
Q Consensus 123 ~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~-------~~~~l~~L~~L~ 173 (639)
.|+|++|++++. ..+..+. +|++|+|++|.+.+.+|. .+..+++|+.||
T Consensus 200 ~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 200 ILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp EEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred EEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 555555555432 1222222 555555555555554442 244555555543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=1.1e-05 Score=80.92 Aligned_cols=74 Identities=12% Similarity=0.021 Sum_probs=54.6
Q ss_pred ceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccC---ceeeeEEEEE-cCCceeEEecccC
Q 046265 471 YCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHR---NVVKFYGFSF-HPRQSFLLYEYLG 546 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~~~~~-~~~~~~lv~e~~~ 546 (639)
..++.|....||+. ++.++||.-. .......+.+|++++..+.+. .+.+.+.++. ..+..|+||||++
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eecCCCcceeEEEE----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 45778888899988 4668888743 123456788999999998642 3567777775 4566899999999
Q ss_pred CCChhH
Q 046265 547 RGSLAI 552 (639)
Q Consensus 547 ~g~L~~ 552 (639)
|..+..
T Consensus 97 G~~l~~ 102 (306)
T 3tdw_A 97 GQILGE 102 (306)
T ss_dssp SEECHH
T ss_pred CeECch
Confidence 988765
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.20 E-value=4.6e-07 Score=88.25 Aligned_cols=69 Identities=29% Similarity=0.379 Sum_probs=39.3
Q ss_pred hcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCC--CCCeeeccCccCccc
Q 046265 256 GIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLK--SLNYRALNGNKVYGS 333 (639)
Q Consensus 256 ~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~--~L~~L~l~~N~l~~~ 333 (639)
..+++|+.|+|++|++++. ..+|..+..+++|+.|+|++|+|.+. ..+..++ +|+.|+|++|.+.+.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l---------~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~ 235 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRL---------DDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDT 235 (267)
T ss_dssp HHCTTCCEEECTTSCCCCC---------GGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGG
T ss_pred hhCCCCCEEECCCCCCCCC---------ccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccc
Confidence 4566777777666665321 12445555666777777777776643 2233333 566666666666554
Q ss_pred CC
Q 046265 334 LP 335 (639)
Q Consensus 334 ~p 335 (639)
+|
T Consensus 236 ~~ 237 (267)
T 3rw6_A 236 FR 237 (267)
T ss_dssp CS
T ss_pred cC
Confidence 44
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.18 E-value=1.8e-07 Score=86.64 Aligned_cols=67 Identities=16% Similarity=0.133 Sum_probs=35.0
Q ss_pred cccCCCCCCEEECcCC-CCccC----CCCCCCCCCCCCEEEcccCcCCCC----CCcccCCCCCCCEEeeecccCc
Q 046265 25 QIGNISNLKFLDMGNN-QLSGV----IPQEIDPLTHLKHLYINVNKLRGS----VPREVGQLSSLKQLVLYCNGLS 91 (639)
Q Consensus 25 ~~~~l~~L~~L~Ls~n-~l~~~----~p~~~~~L~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 91 (639)
.+...+.|++|+|++| .+... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 3455666777777776 65421 223344455666666666665421 2223333445555555555554
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=1.5e-05 Score=78.43 Aligned_cols=134 Identities=16% Similarity=0.130 Sum_probs=89.3
Q ss_pred eccCCCc-eEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCceeEEecccCCCC
Q 046265 473 IGTAGQA-SVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQSFLLYEYLGRGS 549 (639)
Q Consensus 473 ig~g~~g-~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g~ 549 (639)
+..|..| .||+.... ++..++||.-.. .....+.+|+..++.+. +--+.++++++.+++..|+|||+++|.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 4445544 69988665 456788998653 23456788999888774 3347788999999999999999999987
Q ss_pred hhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 046265 550 LAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH--------------------------------------------- 584 (639)
Q Consensus 550 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--------------------------------------------- 584 (639)
+.+...... .....++.++++.+..||.
T Consensus 107 ~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 765432110 0111233333333333332
Q ss_pred ------C----CCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 585 ------D----YFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 585 ------~----~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
. ..+.++|+|+.+.||++++.+.+-|.||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1 112479999999999999877778999988764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.08 E-value=3.6e-07 Score=84.55 Aligned_cols=119 Identities=17% Similarity=0.202 Sum_probs=69.7
Q ss_pred CCCCCCCCCEEEcccC-cCCC----CCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccE
Q 046265 49 EIDPLTHLKHLYINVN-KLRG----SVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFH 123 (639)
Q Consensus 49 ~~~~L~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~ 123 (639)
.+...+.|++|+|++| .+.. .+...+...++|++|+|++|++...-...++. .+...++ |++
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~-----------~L~~n~~--L~~ 97 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAE-----------MLKVNNT--LKS 97 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHH-----------HHHHCSS--CCE
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHH-----------HHHhCCC--cCE
Confidence 3556778888888888 7753 23445666778888888888776422111111 0011112 257
Q ss_pred EEccCCcCccc----CCccccCCCCCCEEec--cCCCCCCC----CCccccCCCcccEEEcccCcCC
Q 046265 124 LDLSENQLSGS----IPHFLGHLSNLAVLHL--GDNSLFGS----IPPILGKVQSLLSLGFDLNLLN 180 (639)
Q Consensus 124 L~L~~N~l~~~----~p~~~~~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 180 (639)
|+|++|.++.. +...+...++|++|+| ++|.+... +...+...++|++|++++|.+.
T Consensus 98 L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 98 LNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp EECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred EECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 77887777632 3445566667777777 66776532 2223344466777777776653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=1.2e-05 Score=82.71 Aligned_cols=81 Identities=6% Similarity=0.014 Sum_probs=54.2
Q ss_pred cee-ccCCCceEEEEEcC-------CCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccc-c--CceeeeEEEEEcC---
Q 046265 471 YCI-GTAGQASVYKAELP-------SWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELR-H--RNVVKFYGFSFHP--- 535 (639)
Q Consensus 471 ~~i-g~g~~g~vy~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-H--~niv~l~~~~~~~--- 535 (639)
+.+ +.|....+|+.... +++.+++|.-..... .......+.+|+.+++.+. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999998654 256788887653210 0001134678888888774 3 3567888887665
Q ss_pred CceeEEecccCCCChh
Q 046265 536 RQSFLLYEYLGRGSLA 551 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~ 551 (639)
+..|+||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3578999999886654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=5.3e-05 Score=79.06 Aligned_cols=77 Identities=13% Similarity=-0.012 Sum_probs=49.0
Q ss_pred cceeccCCCceEEEEEcC-CCcEEEEEEccCCCC----C-hhhHHHHHHHHHHHhcccc--C-ceeeeEEEEEcCCceeE
Q 046265 470 KYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHP----D-MVVQQAFSNEIKALTELRH--R-NVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~----~-~~~~~~~~~e~~~l~~l~H--~-niv~l~~~~~~~~~~~l 540 (639)
.+.+|.|..+.||++... +++.|+||....... . ....+.+..|+++++.+.. | .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999764 467899998653211 0 0122345678888887642 3 34455544 3455689
Q ss_pred EecccCCC
Q 046265 541 LYEYLGRG 548 (639)
Q Consensus 541 v~e~~~~g 548 (639)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.83 E-value=7e-05 Score=76.23 Aligned_cols=141 Identities=21% Similarity=0.253 Sum_probs=78.6
Q ss_pred ceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcccc--CceeeeEE------EEEcCCceeEEe
Q 046265 471 YCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH--RNVVKFYG------FSFHPRQSFLLY 542 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~------~~~~~~~~~lv~ 542 (639)
..++.|..+.||+....+|+ +++|..... ...+..|+.++..+.. -.+++++. +....+..++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~-~vlk~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGA-VCLKRIHRP------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EECC----CEEEEEEETTEE-EEEEEECSC------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeccccccCcEEEEEeCCCC-EEEEecCCC------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 34556678999999876654 899988742 1223345555544431 12333332 112356789999
Q ss_pred cccCCCChh-----------H---Hhhc---CC--C------CCCcCHHHHH----------------------------
Q 046265 543 EYLGRGSLA-----------I---ILSN---DA--A------IDEFSWTVRM---------------------------- 569 (639)
Q Consensus 543 e~~~~g~L~-----------~---~l~~---~~--~------~~~~~~~~~~---------------------------- 569 (639)
||++|..+. . .++. .. . ...-.|....
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 0 0111 00 0 0012343211
Q ss_pred ---HHHHHHHHHHHHHHh----------CCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 570 ---NVIKSVANTLSYMHH----------DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 570 ---~i~~~i~~~l~~lH~----------~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
.+...+..++++++. ...+.++|+|+++.||+++.++.+.|+||+.+..
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 011123345666653 1234899999999999998888899999998754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00015 Score=72.57 Aligned_cols=138 Identities=20% Similarity=0.202 Sum_probs=91.7
Q ss_pred cceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc---cCceeeeEEEEEcCCceeEEecccC
Q 046265 470 KYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR---HRNVVKFYGFSFHPRQSFLLYEYLG 546 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~ 546 (639)
.+.++.|.+..+|+.... +..++||..... ....+.+|++.++.+. ...+++.++++...+..|+||||++
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 456899999999999864 567888886531 3566888999888874 2568889999888888999999999
Q ss_pred CCChhH--------H---hhcCCC-----CC--------------CcCHHHHH---HHHH----------------HHHH
Q 046265 547 RGSLAI--------I---LSNDAA-----ID--------------EFSWTVRM---NVIK----------------SVAN 577 (639)
Q Consensus 547 ~g~L~~--------~---l~~~~~-----~~--------------~~~~~~~~---~i~~----------------~i~~ 577 (639)
+..+.. . ++.... .+ .-+|.... ++.. .+.+
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 876421 1 121111 00 12565432 1111 1111
Q ss_pred -HHHHHHh-CCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 046265 578 -TLSYMHH-DYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614 (639)
Q Consensus 578 -~l~~lH~-~~~~~iiHrdlk~~Nill~~~~~~kl~DfG 614 (639)
..+.+.. ...|.+||+|+.+.|++++.++ +.|.|+.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1123321 2346899999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00033 Score=73.51 Aligned_cols=75 Identities=15% Similarity=0.092 Sum_probs=46.3
Q ss_pred cceeccCCCceEEEEEcCCCcEEEEEEccCCC----CC---hhhHHHHHHHHHHHhc-cccCceeeeEEEEEcCCceeEE
Q 046265 470 KYCIGTAGQASVYKAELPSWEIVAVKKFHSPH----PD---MVVQQAFSNEIKALTE-LRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~----~~---~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv 541 (639)
.+.+|.|..+.||++.. +++.++||...... .. ...+..++.|+..+.. .....+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 45689999999999964 45789999432110 00 1123344445443322 2234567777765 5677999
Q ss_pred eccc-CC
Q 046265 542 YEYL-GR 547 (639)
Q Consensus 542 ~e~~-~~ 547 (639)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00026 Score=70.17 Aligned_cols=76 Identities=20% Similarity=0.190 Sum_probs=54.1
Q ss_pred CcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-c--CceeeeEEEEEcCCceeEEeccc
Q 046265 469 AKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-H--RNVVKFYGFSFHPRQSFLLYEYL 545 (639)
Q Consensus 469 ~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H--~niv~l~~~~~~~~~~~lv~e~~ 545 (639)
....+|.|..+.||+.+..+|+.|.||+-.... ......|.+|++.|+.+. . --+++.+++ +..++||||+
T Consensus 19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l 92 (288)
T 3f7w_A 19 AVAERGHSHRWHLYRVELADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWV 92 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECC
T ss_pred EEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEee
Confidence 345789999999999999999999999876432 122345788998888773 2 234455554 2347999998
Q ss_pred CCCCh
Q 046265 546 GRGSL 550 (639)
Q Consensus 546 ~~g~L 550 (639)
+++..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0015 Score=66.02 Aligned_cols=32 Identities=31% Similarity=0.319 Sum_probs=27.2
Q ss_pred CCeEeecCCCCCeeeCCC----CceEEccccccccC
Q 046265 588 PPIVHRDISSKNVLLGLD----YDAHVSDFGISKFL 619 (639)
Q Consensus 588 ~~iiHrdlk~~Nill~~~----~~~kl~DfGla~~~ 619 (639)
+.++|+|+.+.||+++.+ +.+.|.||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 478999999999999874 67899999887653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0056 Score=61.57 Aligned_cols=141 Identities=13% Similarity=0.145 Sum_probs=79.6
Q ss_pred eeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCc--eeeeEEE-----EEcCCceeEEecc
Q 046265 472 CIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN--VVKFYGF-----SFHPRQSFLLYEY 544 (639)
Q Consensus 472 ~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~-----~~~~~~~~lv~e~ 544 (639)
.++ |....||+....+|+.+++|..+.... ....+..|..++..+.... +++++.. ....+..+.||||
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 466 778899999877787899999864321 2345667887777664222 3444443 1124456789999
Q ss_pred cCCCChh-----HH---------hhc----CC--CCCCcCHHHH----HHH---------------HHHHHHHHHHHHhC
Q 046265 545 LGRGSLA-----II---------LSN----DA--AIDEFSWTVR----MNV---------------IKSVANTLSYMHHD 585 (639)
Q Consensus 545 ~~~g~L~-----~~---------l~~----~~--~~~~~~~~~~----~~i---------------~~~i~~~l~~lH~~ 585 (639)
++|..+. .. ++. .. .....++... ..+ ...+.+.++.+...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 9875432 00 111 00 0111222211 000 01111222233221
Q ss_pred ----CCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 586 ----YFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 586 ----~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
..+.++|+|+++.||+++ + .+.++||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 223579999999999999 4 899999987654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0014 Score=65.81 Aligned_cols=158 Identities=12% Similarity=0.073 Sum_probs=85.0
Q ss_pred hHHHHHHHhccCCC-----cceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCc--eeee
Q 046265 456 LYEEVIRATNNFDA-----KYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN--VVKF 528 (639)
Q Consensus 456 ~~~~~~~~~~~f~~-----~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l 528 (639)
+.+++......|.. .+.++.|....+|+....+| .+++|...... ..+.+..|+.++..+.... +.++
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 44555555555543 23466677889999987665 57888876521 1223456777766654222 2333
Q ss_pred EEE------EEcCCceeEEecccCCCChhH----H----------hhcC--C-CC------CCcCHHHHHHH--------
Q 046265 529 YGF------SFHPRQSFLLYEYLGRGSLAI----I----------LSND--A-AI------DEFSWTVRMNV-------- 571 (639)
Q Consensus 529 ~~~------~~~~~~~~lv~e~~~~g~L~~----~----------l~~~--~-~~------~~~~~~~~~~i-------- 571 (639)
+.. ....+..+++|||++|..+.. . ++.. . .. ....|.....-
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 112356789999998865321 0 1110 0 00 01124331110
Q ss_pred ----HHHHHHHHHHHHhC----CCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 572 ----IKSVANTLSYMHHD----YFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 572 ----~~~i~~~l~~lH~~----~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
...+.+.++++... ..+.++|+|+.+.||+++.+..+.|+||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 01133445555432 123789999999999998876668999987643
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0003 Score=63.41 Aligned_cols=88 Identities=15% Similarity=0.140 Sum_probs=42.0
Q ss_pred CCCCEEEcccCcCCCCCCcccCCCCCCCEEeeeccc-CccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCC-cC
Q 046265 54 THLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNG-LSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSEN-QL 131 (639)
Q Consensus 54 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N-~l 131 (639)
.+|+.||++++.++..--..+..+++|++|+|+++. ++..--..++.+.+. .+ +|++|+|+++ ++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~-----------~~--~L~~L~Ls~C~~I 127 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENL-----------QK--SMLEMEIISCGNV 127 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHH-----------HH--HCCEEEEESCTTC
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccc-----------cC--CCCEEEcCCCCcC
Confidence 356666666666554333345566666666666663 442111111111000 00 1246666665 35
Q ss_pred cccCCccccCCCCCCEEeccCCC
Q 046265 132 SGSIPHFLGHLSNLAVLHLGDNS 154 (639)
Q Consensus 132 ~~~~p~~~~~l~~L~~L~L~~N~ 154 (639)
+..--..+.++++|++|+|+++.
T Consensus 128 TD~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 128 TDKGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp CHHHHHHGGGCTTCCEEEEESCT
T ss_pred CHHHHHHHhcCCCCCEEECCCCC
Confidence 43222334556666666666653
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0014 Score=56.24 Aligned_cols=61 Identities=21% Similarity=0.225 Sum_probs=32.0
Q ss_pred cceeeeEEEEeCCCccc-ccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcC
Q 046265 3 CLAFFFFQVVHESNTLF-AIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKL 66 (639)
Q Consensus 3 ~~~~~~~~~~~~~n~~~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l 66 (639)
|.|. -..|+-+++++. ..+|..+. ++|++|+|++|.|+...+..|..+++|+.|+|++|.+
T Consensus 6 C~C~-~~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 6 CSCA-GTLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp CEEE-TTEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CEEc-CCEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 5553 234555555553 35554432 2456666666666544444555555555555555544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.72 E-value=0.008 Score=59.70 Aligned_cols=71 Identities=14% Similarity=0.130 Sum_probs=43.0
Q ss_pred cceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCce-eeeEEEEEcCCceeEEeccc-CC
Q 046265 470 KYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNV-VKFYGFSFHPRQSFLLYEYL-GR 547 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~-~~ 547 (639)
.+.++.|....+|+. +.+++|......... ....+|+.+++.+....+ .+++++ ..+.-++|+||+ ++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~---~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY---INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C---CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce---eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 567888999999998 458888776421111 112457777766643233 355544 344457899999 65
Q ss_pred CCh
Q 046265 548 GSL 550 (639)
Q Consensus 548 g~L 550 (639)
.++
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 444
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0045 Score=64.89 Aligned_cols=72 Identities=21% Similarity=0.241 Sum_probs=47.9
Q ss_pred ceeccCCCceEEEEEcCC--------CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCce-eeeEEEEEcCCceeEE
Q 046265 471 YCIGTAGQASVYKAELPS--------WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNV-VKFYGFSFHPRQSFLL 541 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv 541 (639)
+.|+.|-...+|++..++ ++.+++|...... . .+.+.+|..+++.+...++ +++++.+.+ .+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 467788889999998653 4678899874321 1 1345578888887753334 566665432 389
Q ss_pred ecccCCCCh
Q 046265 542 YEYLGRGSL 550 (639)
Q Consensus 542 ~e~~~~g~L 550 (639)
|||++|..+
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999986443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.67 E-value=0.00036 Score=62.88 Aligned_cols=93 Identities=12% Similarity=0.139 Sum_probs=62.1
Q ss_pred cCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCc-CCCCCCcccCCC----CCCCEEeeeccc-Ccccc
Q 046265 21 IIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNK-LRGSVPREVGQL----SSLKQLVLYCNG-LSGWL 94 (639)
Q Consensus 21 ~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~ 94 (639)
.+|.....-.+|+.|||+++.++..-=..+..+++|++|+|+++. ++..--..+..+ ++|++|+|+++. ++..-
T Consensus 52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~G 131 (176)
T 3e4g_A 52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKG 131 (176)
T ss_dssp GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHH
T ss_pred cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHH
Confidence 456543334579999999999874333457889999999999995 664323345554 379999999874 76432
Q ss_pred CccccCCCCCCcccCCCCCcccCCCCccEEEccCCc
Q 046265 95 PSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQ 130 (639)
Q Consensus 95 p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~ 130 (639)
-..+..++ +| ++|+++++.
T Consensus 132 l~~L~~~~---------------~L--~~L~L~~c~ 150 (176)
T 3e4g_A 132 IIALHHFR---------------NL--KYLFLSDLP 150 (176)
T ss_dssp HHHGGGCT---------------TC--CEEEEESCT
T ss_pred HHHHhcCC---------------CC--CEEECCCCC
Confidence 23333343 33 689998874
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.45 E-value=0.005 Score=52.63 Aligned_cols=56 Identities=21% Similarity=0.260 Sum_probs=41.3
Q ss_pred EEEccCCcCc-ccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCC
Q 046265 123 HLDLSENQLS-GSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN 180 (639)
Q Consensus 123 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 180 (639)
.++.+++.++ ..+|..+. ++|++|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 6788888875 35665443 46888888888888665667788888888888888664
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.25 E-value=0.013 Score=60.06 Aligned_cols=141 Identities=16% Similarity=0.175 Sum_probs=79.8
Q ss_pred ceeccCCCceEEEEEcCC--------CcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCceeEE
Q 046265 471 YCIGTAGQASVYKAELPS--------WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv 541 (639)
+.+..|-...+|++..++ ++.|++|..... ........+|.++++.+. +.-..++++++.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 456677788999998753 467899885321 112344568998888774 3223566666543 399
Q ss_pred ecccCCCChhHH-----------------hhcCC-C-CCCc--CHHHHHHHHHHHHH-------------------HHHH
Q 046265 542 YEYLGRGSLAII-----------------LSNDA-A-IDEF--SWTVRMNVIKSVAN-------------------TLSY 581 (639)
Q Consensus 542 ~e~~~~g~L~~~-----------------l~~~~-~-~~~~--~~~~~~~i~~~i~~-------------------~l~~ 581 (639)
|||++|..+..- ++... . .... -|.+..++..++.. .++.
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999987654311 11110 0 1111 24444444433321 2233
Q ss_pred HH----hC-CCCCeEeecCCCCCeeeCCC----CceEEcccccccc
Q 046265 582 MH----HD-YFPPIVHRDISSKNVLLGLD----YDAHVSDFGISKF 618 (639)
Q Consensus 582 lH----~~-~~~~iiHrdlk~~Nill~~~----~~~kl~DfGla~~ 618 (639)
+. .. ....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 32 22 22368999999999999876 7899999987654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.20 E-value=0.018 Score=60.73 Aligned_cols=73 Identities=16% Similarity=0.110 Sum_probs=45.2
Q ss_pred ceeccCCCceEEEEEcCC-CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCce-eeeEEEEEcCCceeEEecccCCC
Q 046265 471 YCIGTAGQASVYKAELPS-WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNV-VKFYGFSFHPRQSFLLYEYLGRG 548 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~g 548 (639)
+.|+.|-...+|++...+ ++.+++|........... -.+|..++..+...++ .++++++. + ..||||++|.
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id---R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN---REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC---HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC---HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 467778888999998765 477888876432111111 1468888887754444 56676662 2 3599999875
Q ss_pred Ch
Q 046265 549 SL 550 (639)
Q Consensus 549 ~L 550 (639)
.+
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.01 E-value=0.011 Score=60.60 Aligned_cols=73 Identities=11% Similarity=0.038 Sum_probs=42.0
Q ss_pred ceeccCCCceEEEEEcCC---------CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCc-eeeeEEEEEcCCceeE
Q 046265 471 YCIGTAGQASVYKAELPS---------WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN-VVKFYGFSFHPRQSFL 540 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~l 540 (639)
..++.|....+|+....+ ++.+++|...... .. ......|.+++..+...+ +.++++.. . -++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DE--LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GG--TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cc--eecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 456777788999997654 2678888765321 11 111356777777765333 34666543 2 378
Q ss_pred EecccCCCCh
Q 046265 541 LYEYLGRGSL 550 (639)
Q Consensus 541 v~e~~~~g~L 550 (639)
||||++|..+
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.99 E-value=0.021 Score=57.66 Aligned_cols=31 Identities=26% Similarity=0.370 Sum_probs=27.0
Q ss_pred CCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 588 ~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
+.++|+|+.+.||+++.++.+.+.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3789999999999999888899999976654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.59 E-value=0.0022 Score=58.81 Aligned_cols=65 Identities=17% Similarity=0.194 Sum_probs=29.6
Q ss_pred cCCCCCCEEECcCC-CCcc----CCCCCCCCCCCCCEEEcccCcCCCC----CCcccCCCCCCCEEeeecccCc
Q 046265 27 GNISNLKFLDMGNN-QLSG----VIPQEIDPLTHLKHLYINVNKLRGS----VPREVGQLSSLKQLVLYCNGLS 91 (639)
Q Consensus 27 ~~l~~L~~L~Ls~n-~l~~----~~p~~~~~L~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 91 (639)
.+-+.|++|+|++| .|.. .+...+..=+.|+.|+|++|+|... +...+..-+.|++|+|+.|+|+
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 34455666666654 4431 1122233444555555555555421 2222223344555555555544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.25 E-value=0.014 Score=53.53 Aligned_cols=60 Identities=13% Similarity=0.056 Sum_probs=27.6
Q ss_pred CCCCCEEeccCCccccc----CCccccCCCCCCeeeccCccCccc----CCcCccCCCCCCEEeCCCC
Q 046265 293 LYQLHKLDFSLNHIVGE----LPIELGNLKSLNYRALNGNKVYGS----LPRVLGSISDLEYLDLSTN 352 (639)
Q Consensus 293 l~~L~~L~Ls~N~~~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N 352 (639)
-+.|+.|+|++|+|... +...+..-+.|+.|+|+.|.|... +-..+..-+.|+.|+|++|
T Consensus 69 N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 69 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred CCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCC
Confidence 34556666666655422 112222334555555555555321 1122233345666666543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.07 E-value=0.56 Score=48.60 Aligned_cols=73 Identities=10% Similarity=0.061 Sum_probs=45.1
Q ss_pred ceeccCCCceEEEEEcCC--------CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCc-eeeeEEEEEcCCceeEE
Q 046265 471 YCIGTAGQASVYKAELPS--------WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN-VVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv 541 (639)
+.+..|-...+|+....+ ++.|++|.......... +..+|.++++.+.-.+ ..++++.+ . -+.|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i---dR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY---DSKVELDVFRYLSNINIAPNIIADF--P--EGRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC---CHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc---CHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEE
Confidence 456667788899997663 57789988643211111 1246777777764222 34555433 2 2789
Q ss_pred ecccCCCCh
Q 046265 542 YEYLGRGSL 550 (639)
Q Consensus 542 ~e~~~~g~L 550 (639)
|||++|..+
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998654
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.76 E-value=0.067 Score=56.43 Aligned_cols=57 Identities=7% Similarity=-0.062 Sum_probs=14.7
Q ss_pred CceEEEEEcCC-CcEEEE------EEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc
Q 046265 478 QASVYKAELPS-WEIVAV------KKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH 534 (639)
Q Consensus 478 ~g~vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 534 (639)
||.||+|.+.. ...||| |+.+...........|.+|+.++...+|||+++.+++...
T Consensus 152 fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 152 YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 99999997764 357888 6665433233334568889999999999999999887653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.59 E-value=1.8 Score=44.45 Aligned_cols=29 Identities=28% Similarity=0.427 Sum_probs=24.1
Q ss_pred eEeecCCCCCeee------CCCCceEEcccccccc
Q 046265 590 IVHRDISSKNVLL------GLDYDAHVSDFGISKF 618 (639)
Q Consensus 590 iiHrdlk~~Nill------~~~~~~kl~DfGla~~ 618 (639)
++|+|+.+.||++ +++..++++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4457799999987654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.06 E-value=4.2 Score=37.35 Aligned_cols=90 Identities=7% Similarity=0.060 Sum_probs=63.5
Q ss_pred cccCceeeeEEEEEcCCceeEEecccCCC-ChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCC
Q 046265 520 LRHRNVVKFYGFSFHPRQSFLLYEYLGRG-SLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSK 598 (639)
Q Consensus 520 l~H~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~ 598 (639)
-.||+.+.. ..-.+.+.+.+.|+.-+.+ ++.. ++ ..+...+++++..++...++++.. +|--+.|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik------~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK------SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG------GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH------hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence 368888876 4555566666666643322 2222 22 345578888998888777666644 78889999
Q ss_pred CeeeCCCCceEEccccccccCCCC
Q 046265 599 NVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 599 Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
|+.++.++.+++.-.|+...+.+.
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~P~ 132 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVDPL 132 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBSCC
T ss_pred eEEEcCCCCEEEEEccCccCCCCC
Confidence 999999999999999987666543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 639 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-33 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-32 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-32 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-31 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-30 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-30 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-30 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-30 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-29 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-29 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-29 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-28 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-28 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-28 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-28 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-27 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-27 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-27 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-27 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-27 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-26 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-26 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-26 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-25 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-25 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-25 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-24 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-24 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-24 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-23 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-23 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-23 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-23 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-23 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-23 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-22 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-22 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-22 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-22 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-22 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-22 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-22 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-21 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-21 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-21 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-20 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-20 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-20 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-19 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-19 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-19 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-07 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-18 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-18 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-18 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-17 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-07 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 3e-33
Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 10/176 (5%)
Query: 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN 524
IG+ +VYK + VAVK + P QAF NE+ L + RH N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 525 VVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH 584
++ F G+S P Q ++ ++ SL L +F +++ + A + Y+H
Sbjct: 66 ILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHA 122
Query: 585 DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN--WSEFVGTFGYVAP 638
I+HRD+ S N+ L D + DFG++ S + + + G+ ++AP
Sbjct: 123 ---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 1e-32
Identities = 44/177 (24%), Positives = 76/177 (42%), Gaps = 9/177 (5%)
Query: 463 ATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR 521
++F+ +G V+K PS ++A K H + Q E++ L E
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ-IIRELQVLHECN 62
Query: 522 HRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSY 581
+V FYG + + + E++ GSL +L + V +V L+Y
Sbjct: 63 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTY 119
Query: 582 MHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+ + I+HRD+ N+L+ + + DFG+S L +N FVGT Y++P
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSP 172
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 6e-32
Identities = 44/179 (24%), Positives = 76/179 (42%), Gaps = 6/179 (3%)
Query: 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN 524
+++ Y IGT K +I+ K+ +Q +E+ L EL+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 525 VVKFYGFSFHPRQS--FLLYEYLGRGSLA-IILSNDAAIDEFSWTVRMNVIKSVANTLSY 581
+V++Y + +++ EY G LA +I + V+ + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 582 MH--HDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
H D ++HRD+ NV L + + DFG+++ L D+S FVGT Y++P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 1e-31
Identities = 32/175 (18%), Positives = 70/175 (40%), Gaps = 9/175 (5%)
Query: 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN 524
+G V+ VAVK + AF E + +L+H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQR 69
Query: 525 VVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH 584
+V+ Y +++ EY+ GSL L + I + + +++ +A ++++
Sbjct: 70 LVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEE 127
Query: 585 DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE-FVGTFGYVAP 638
+HRD+ + N+L+ ++DFG+++ ++ + E + AP
Sbjct: 128 ---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 6e-31
Identities = 45/186 (24%), Positives = 81/186 (43%), Gaps = 11/186 (5%)
Query: 457 YEEVIRATN---NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSN 512
YE V R N ++ +G VYKA+ + + A K + + + + +
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL--EDYMV 58
Query: 513 EIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVI 572
EI L H N+VK ++ ++L E+ G++ ++ + + V
Sbjct: 59 EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVC 116
Query: 573 KSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGT 632
K + L+Y+H I+HRD+ + N+L LD D ++DFG+S F+GT
Sbjct: 117 KQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT 173
Query: 633 FGYVAP 638
++AP
Sbjct: 174 PYWMAP 179
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 119 bits (299), Expect = 1e-30
Identities = 43/200 (21%), Positives = 82/200 (41%), Gaps = 24/200 (12%)
Query: 457 YEEVIRATNNFDAKY---------CIGTAGQASVYKAELPS----WEIVAVKKFHSPHPD 503
+E+ A F + IG V L VA+K S + +
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 504 MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEF 563
+ F +E + + H NV+ G ++ E++ GSL L + +F
Sbjct: 69 KQRRD-FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN--DGQF 125
Query: 564 SWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623
+ + +++ +A + Y+ VHRD++++N+L+ + VSDFG+S+FL+ D+
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 624 SNWSE-----FVGTFGYVAP 638
S+ + + AP
Sbjct: 183 SDPTYTSALGGKIPIRWTAP 202
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-30
Identities = 36/175 (20%), Positives = 74/175 (42%), Gaps = 9/175 (5%)
Query: 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN 524
+ IG+ V+ + + VA+K + ++ F E + + +L H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPK 61
Query: 525 VVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH 584
+V+ YG L++E++ G L+ L + F+ + + V M +
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVC---EGMAY 116
Query: 585 DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE-FVGTFGYVAP 638
++HRD++++N L+G + VSDFG+++F+ D S + +P
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 3e-30
Identities = 39/175 (22%), Positives = 66/175 (37%), Gaps = 9/175 (5%)
Query: 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN 524
+ +GT V + VA+K + + F E K + L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEK 60
Query: 525 VVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH 584
+V+ YG R F++ EY+ G L L F + + K V + Y+
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLES 118
Query: 585 DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE-FVGTFGYVAP 638
+HRD++++N L+ VSDFG+S+++ D S + P
Sbjct: 119 ---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 117 bits (295), Expect = 8e-30
Identities = 43/168 (25%), Positives = 74/168 (44%), Gaps = 12/168 (7%)
Query: 473 IGTAGQASVYKAE-LPSWEIVAVKKFH-SPHPDMVVQQAFSNEIKALTELRHRNVVKFYG 530
IG +VY A + + E+VA+KK S Q E++ L +LRH N +++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 531 FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPI 590
++L+ EY + ++ + V L+Y+H +
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HNM 136
Query: 591 VHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+HRD+ + N+LL + DFG + + P +S FVGT ++AP
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAP 180
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-29
Identities = 39/172 (22%), Positives = 67/172 (38%), Gaps = 12/172 (6%)
Query: 473 IGTAGQASVYKAELPSW-EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG +VYK VA + +Q F E + L L+H N+V+FY
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 532 SFHPRQS----FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF 587
+ L+ E + G+L L V + + + L ++H
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT- 132
Query: 588 PPIVHRDISSKNVLL-GLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
PPI+HRD+ N+ + G + D G++ + + +GT ++AP
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAP 182
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 5e-29
Identities = 35/175 (20%), Positives = 75/175 (42%), Gaps = 9/175 (5%)
Query: 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN 524
+ + +G V+ VA+K P + +AF E + + +LRH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEK 73
Query: 525 VVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH 584
+V+ Y +++ EY+ +GSL L + +++ +A+ ++Y+
Sbjct: 74 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVER 131
Query: 585 DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE-FVGTFGYVAP 638
VHRD+ + N+L+G + V+DFG+++ ++ + + + AP
Sbjct: 132 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 5e-29
Identities = 38/172 (22%), Positives = 69/172 (40%), Gaps = 13/172 (7%)
Query: 473 IGTAGQASVYKAELP---SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFY 529
+G+ +V K + VAVK + D ++ E + +L + +V+
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 530 GFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP 589
G L+ E G L L + + ++ V+ + Y+
Sbjct: 75 GI-CEAESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE---SN 127
Query: 590 IVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS---EFVGTFGYVAP 638
VHRD++++NVLL + A +SDFG+SK L+ D + + + AP
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-28
Identities = 48/176 (27%), Positives = 79/176 (44%), Gaps = 10/176 (5%)
Query: 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFH-SPHPDMVVQQAFSNEIKALTELRH 522
+F+ +G +VY A S I+A+K + V+ E++ + LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 523 RNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYM 582
N+++ YG+ + +L+ EY G++ L +F I +AN LSY
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYC 122
Query: 583 HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
H ++HRDI +N+LLG + ++DFG S SS + GT Y+ P
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPP 173
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 2e-28
Identities = 39/172 (22%), Positives = 68/172 (39%), Gaps = 13/172 (7%)
Query: 473 IGTAGQASVYKAEL---PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFY 529
+G SV + VA+K ++ E + + +L + +V+
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYIVRLI 75
Query: 530 GFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPP 589
G L+ E G G L L +E + ++ V+ + Y+
Sbjct: 76 GV-CQAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE---KN 129
Query: 590 IVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE---FVGTFGYVAP 638
VHRD++++NVLL + A +SDFG+SK L D S ++ + AP
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 5e-28
Identities = 43/167 (25%), Positives = 80/167 (47%), Gaps = 10/167 (5%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG +VY A ++ + + VA+++ + ++ NEI + E ++ N+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDS 85
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIV 591
+ +++ EYL GSL +++ V + L ++H + ++
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 592 HRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
HRDI S N+LLG+D ++DFG + P+ S S VGT ++AP
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 5e-28
Identities = 45/180 (25%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 472 CIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG V++ + E VAVK F S ++A EI LRH N++ F
Sbjct: 10 SIGKGRFGEVWRGKWRG-EEVAVKIFSSREERSWFREA---EIYQTVMLRHENILGFIAA 65
Query: 532 SFHPRQS----FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF 587
+ +L+ +Y GSL L+ + + + S A+ L+++H +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 588 -----PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS----EFVGTFGYVAP 638
P I HRD+ SKN+L+ + ++D G++ + VGT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-27
Identities = 46/177 (25%), Positives = 67/177 (37%), Gaps = 10/177 (5%)
Query: 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHR 523
++D +G V A + E VAVK + EI L H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICINKMLNHE 63
Query: 524 NVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH 583
NVVKFYG +L EY G L + D + + Y+H
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLH 120
Query: 584 HDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN--WSEFVGTFGYVAP 638
I HRDI +N+LL + +SDFG++ + ++ ++ GT YVAP
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-27
Identities = 45/175 (25%), Positives = 69/175 (39%), Gaps = 13/175 (7%)
Query: 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN 524
IG V + VAVK + QAF E +T+LRH N
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRG-NKVAVKCIKNDA----TAQAFLAEASVMTQLRHSN 61
Query: 525 VVKFYGFSFHPRQS-FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH 583
+V+ G + +++ EY+ +GSL L + + V + Y+
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE 120
Query: 584 HDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
VHRD++++NVL+ D A VSDFG++K SS + AP
Sbjct: 121 G---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAP 169
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (273), Expect = 4e-27
Identities = 38/176 (21%), Positives = 78/176 (44%), Gaps = 9/176 (5%)
Query: 465 NNFDAKYCIGTAGQASVYKAELPSW-EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHR 523
+ K+ +G VY+ + VAVK D + + F E + E++H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 73
Query: 524 NVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMH 583
N+V+ G +++ E++ G+L L + E S V + + +++ + Y+
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 584 HDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFV-GTFGYVAP 638
+HRD++++N L+G ++ V+DFG+S+ + D+ + AP
Sbjct: 133 K---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 5e-27
Identities = 40/203 (19%), Positives = 76/203 (37%), Gaps = 33/203 (16%)
Query: 465 NNFDAKYCIGTAGQASVYKAELPS------WEIVAVKKFHSPHPDMVVQQAFSNEIKALT 518
N + +G+ V A VAVK D ++A +E+K +T
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMT 95
Query: 519 EL-RHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSN--------------------D 557
+L H N+V G +L++EY G L L + +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 558 AAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
++ ++ + VA + ++ VHRD++++NVL+ + DFG+++
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 618 FLKPDSSN--WSEFVGTFGYVAP 638
+ DS+ ++AP
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAP 235
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 110 bits (275), Expect = 7e-27
Identities = 40/188 (21%), Positives = 82/188 (43%), Gaps = 14/188 (7%)
Query: 454 KILYEEVIRATNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSN 512
+I ++ V+ +++D +GT V++ E + A K +PH ++
Sbjct: 18 EIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRK 72
Query: 513 EIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVI 572
EI+ ++ LRH +V + + ++YE++ G L ++++ ++ S + +
Sbjct: 73 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYM 130
Query: 573 KSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSNWSEFV 630
+ V L +MH VH D+ +N++ + DFG++ L P S
Sbjct: 131 RQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TT 186
Query: 631 GTFGYVAP 638
GT + AP
Sbjct: 187 GTAEFAAP 194
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 109 bits (274), Expect = 1e-26
Identities = 37/169 (21%), Positives = 70/169 (41%), Gaps = 11/169 (6%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
+G+ V++ E + + K ++P+P + NEI + +L H ++ +
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLINLHDA 94
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIV 591
+ L+ E+L G L ++ + + S +N ++ L +MH IV
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHE---HSIV 149
Query: 592 HRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSNWSEFVGTFGYVAP 638
H DI +N++ + V DFG++ L PD T + AP
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK-VTTATAEFAAP 197
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (267), Expect = 3e-26
Identities = 42/203 (20%), Positives = 76/203 (37%), Gaps = 33/203 (16%)
Query: 465 NNFDAKYCIGTAGQASVYKAELPSW------EIVAVKKFHSPHPDMVVQQAFSNEIKALT 518
NN + IG V++A P +VAVK +Q F E +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMA 71
Query: 519 ELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSN---------------------D 557
E + N+VK G + LL+EY+ G L L +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 558 AAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617
S ++ + + VA ++Y+ VHRD++++N L+G + ++DFG+S+
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR 188
Query: 618 FLKPDSSNWSE--FVGTFGYVAP 638
+ ++ ++ P
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPP 211
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 106 bits (265), Expect = 3e-26
Identities = 37/166 (22%), Positives = 75/166 (45%), Gaps = 6/166 (3%)
Query: 473 IGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFS 532
IG VYKA+ E A+KK D + EI L EL+H N+VK Y
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 533 FHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVH 592
++ L++E+L + ++ + ++ + + L+ + + + ++H
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL------LQLLNGIAYCHDRRVLH 123
Query: 593 RDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
RD+ +N+L+ + + ++DFG+++ ++ + T Y AP
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-25
Identities = 44/181 (24%), Positives = 72/181 (39%), Gaps = 10/181 (5%)
Query: 462 RATNNFDAKYCIGTAGQASVYKA-ELPSWEIVAVKKFHSPH-PDMVVQQAFSNEIKALTE 519
+ +F +G ++V A EL + A+K H + E ++
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 520 LRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTL 579
L H VK Y + + Y G L + + DE A +
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE------TCTRFYTAEIV 118
Query: 580 SYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW--SEFVGTFGYVA 637
S + + + I+HRD+ +N+LL D ++DFG +K L P+S + FVGT YV+
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 638 P 638
P
Sbjct: 179 P 179
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 2e-25
Identities = 38/190 (20%), Positives = 72/190 (37%), Gaps = 28/190 (14%)
Query: 473 IGTAGQASVYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNV 525
+G V +A + VAVK P + ++A +E+K L+ L H N+
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 526 VKFYGFSFHPRQSFLLYEYLGRGSLAIILSN---------------DAAIDEFSWTVRMN 570
V G + ++ EY G L L + ++
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 571 VIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW--SE 628
VA ++++ +HRD++++N+LL + DFG+++ +K DS+
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 629 FVGTFGYVAP 638
++AP
Sbjct: 207 ARLPVKWMAP 216
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 9e-25
Identities = 39/191 (20%), Positives = 75/191 (39%), Gaps = 22/191 (11%)
Query: 465 NNFDAKYCIGTAGQASVYKAELPS---WEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL- 520
N+ + IG V KA + A+K+ + + F+ E++ L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLG 68
Query: 521 RHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDE-------------FSWTV 567
H N++ G H +L EY G+L L ++ S
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 568 RMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS 627
++ VA + Y+ +HRD++++N+L+G +Y A ++DFG+S+ +
Sbjct: 129 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 185
Query: 628 EFVGTFGYVAP 638
++A
Sbjct: 186 -GRLPVRWMAI 195
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 1e-24
Identities = 41/174 (23%), Positives = 75/174 (43%), Gaps = 14/174 (8%)
Query: 473 IGTAGQASVYKAELPS-----WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVK 527
IG VYK L + VA+K + + + F E + + H N+++
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNIIR 73
Query: 528 FYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF 587
G + ++ EY+ G+L L EFS + +++ +A + Y+ +
Sbjct: 74 LEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLAN--- 128
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW---SEFVGTFGYVAP 638
VHRD++++N+L+ + VSDFG+S+ L+ D S + AP
Sbjct: 129 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 102 bits (256), Expect = 1e-24
Identities = 46/180 (25%), Positives = 78/180 (43%), Gaps = 12/180 (6%)
Query: 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH 522
+ +D + +GT + V AE + ++VA+K + + NEI L +++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KKALEGKEGSMENEIAVLHKIKH 66
Query: 523 RNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYM 582
N+V +L+ + + G L + ++ +I V + + Y+
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYL 123
Query: 583 HHDYFPPIVHRDISSKNVLLGL---DYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639
H IVHRD+ +N+L D +SDFG+SK P S + GT GYVAP
Sbjct: 124 HDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAPE 179
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 9e-24
Identities = 37/171 (21%), Positives = 70/171 (40%), Gaps = 12/171 (7%)
Query: 472 CIGTAGQASVYKAELPSWE----IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVK 527
CIG V++ S E VA+K + D V ++ F E + + H ++VK
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVK 72
Query: 528 FYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF 587
G +++ E G L L + ++ L+Y+
Sbjct: 73 LIGV-ITENPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES--- 126
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS-NWSEFVGTFGYVA 637
VHRDI+++NVL+ + + DFG+S++++ + S+ ++A
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-23
Identities = 32/170 (18%), Positives = 64/170 (37%), Gaps = 11/170 (6%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
+G V++ E S + K D Q EI L RHRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHES 69
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIV 591
+ +++E++ + ++ A E + ++ + V L ++H I
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHS---HNIG 124
Query: 592 HRDISSKNVLLGLDYDAHV--SDFGISKFLKPDSSNWSEFVGTFGYVAPI 639
H DI +N++ + + +FG ++ LKP + F Y +
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.2 bits (246), Expect = 2e-23
Identities = 41/174 (23%), Positives = 75/174 (43%), Gaps = 6/174 (3%)
Query: 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN 524
NF IG VYKA + E+VA+KK V EI L EL H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 525 VVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH 584
+VK + +L++E+L + + ++ + + + + + L++ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 585 DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
++HRD+ +N+L+ + ++DFG+++ ++ V T Y AP
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 3e-23
Identities = 38/174 (21%), Positives = 63/174 (36%), Gaps = 14/174 (8%)
Query: 473 IGTAGQASVYKAELPS----WEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVK 527
+G V + E + VAVK F E+ A+ L HRN+++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 528 FYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF 587
YG ++ E GSL L F VA + Y+
Sbjct: 76 LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLES--- 129
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW---SEFVGTFGYVAP 638
+HRD++++N+LL + DFG+ + L + ++ F + AP
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 3e-23
Identities = 34/182 (18%), Positives = 63/182 (34%), Gaps = 17/182 (9%)
Query: 466 NFDAKYCIGTAGQASVYKAELP----SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR 521
+F+ IG VY L AVK + D+ F E + +
Sbjct: 30 HFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFS 86
Query: 522 HRNVVKFYGFSFHPRQS-FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLS 580
H NV+ G S ++ Y+ G L + N+ + + +
Sbjct: 87 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 142
Query: 581 YMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS----SNWSEFVGTFGYV 636
M VHRD++++N +L + V+DFG+++ + N + ++
Sbjct: 143 -MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 637 AP 638
A
Sbjct: 202 AL 203
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 4e-23
Identities = 43/170 (25%), Positives = 75/170 (44%), Gaps = 10/170 (5%)
Query: 473 IGTAGQASVYKAE-LPSWEIVAVKKFHSPH---PDMVVQQAFSNEIKALTELRHRNVVKF 528
+G A+VYKA + +IVA+KK H + + EIK L EL H N++
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 529 YGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFP 588
H L+++++ II N + ++ + TL + + +
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP------SHIKAYMLMTLQGLEYLHQH 119
Query: 589 PIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
I+HRD+ N+LL + ++DFG++K + ++ V T Y AP
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 169
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 6e-23
Identities = 37/177 (20%), Positives = 64/177 (36%), Gaps = 9/177 (5%)
Query: 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFH--SPHPDMVVQQAFSNEIKALTELR 521
+F +G V+ AE + + A+K D V+ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 522 HRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSY 581
H + + F + EYL G L + + +F + + L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQF 118
Query: 582 MHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+H IV+RD+ N+LL D ++DFG+ K + + F GT Y+AP
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 172
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 96.7 bits (240), Expect = 1e-22
Identities = 31/176 (17%), Positives = 68/176 (38%), Gaps = 11/176 (6%)
Query: 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFH-SPHPDMVVQQAFSNEIKALTELRH 522
+F +GT V+ + A+K + + ++E L+ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 523 RNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYM 582
+++ +G +Q F++ +Y+ G L +L + +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 583 HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+ + I++RD+ +N+LL + ++DFG +K++ GT Y+AP
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAP 170
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 3e-22
Identities = 33/189 (17%), Positives = 75/189 (39%), Gaps = 19/189 (10%)
Query: 465 NNFDAKYCIGTAGQASVYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALT 518
+G VY+ VA+K + M + F NE +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMK 78
Query: 519 ELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIIL-------SNDAAIDEFSWTVRMNV 571
E +VV+ G + + ++ E + RG L L +N+ + S + + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 572 IKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS--NWSEF 629
+A+ ++Y++ VHRD++++N ++ D+ + DFG+++ + +
Sbjct: 139 AGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 630 VGTFGYVAP 638
+ +++P
Sbjct: 196 LLPVRWMSP 204
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 4e-22
Identities = 32/187 (17%), Positives = 71/187 (37%), Gaps = 15/187 (8%)
Query: 459 EVIRATNNFDAKYCIGTAGQASVYKAELPS-----WEIVAVKKFHSPHPDMVVQQAFSNE 513
+++ T F +G+ +VYK VA+K+ ++ +E
Sbjct: 4 RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDE 61
Query: 514 IKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIK 573
+ + + +V + G L+ + + G L + D +N
Sbjct: 62 AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCV 118
Query: 574 SVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNW--SEFVG 631
+A ++Y+ +VHRD++++NVL+ ++DFG++K L + +
Sbjct: 119 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 632 TFGYVAP 638
++A
Sbjct: 176 PIKWMAL 182
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 94.4 bits (234), Expect = 4e-22
Identities = 38/184 (20%), Positives = 75/184 (40%), Gaps = 15/184 (8%)
Query: 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELR 521
++ ++ +G G + V+ A L VAVK + D F E + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 522 HRNVVKFYGFSFHPRQS----FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVAN 577
H +V Y + +++ EY+ +L I+ + + + VI
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQ 122
Query: 578 TLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSE---FVGTFG 634
L++ H I+HRD+ N+++ V DFGI++ + ++ ++ +GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 635 YVAP 638
Y++P
Sbjct: 180 YLSP 183
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 94.4 bits (234), Expect = 4e-22
Identities = 40/182 (21%), Positives = 76/182 (41%), Gaps = 16/182 (8%)
Query: 466 NFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMV-------VQQAFSNEIKAL 517
N++ K +G + V + P+ + AVK +++A E+ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 518 TELR-HRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVA 576
++ H N+++ FL+++ + +G L L+ S +++++
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALL 120
Query: 577 NTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYV 636
+ +H IVHRD+ +N+LL D + ++DFG S L P GT Y+
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTPSYL 176
Query: 637 AP 638
AP
Sbjct: 177 AP 178
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 96.0 bits (238), Expect = 5e-22
Identities = 36/178 (20%), Positives = 62/178 (34%), Gaps = 13/178 (7%)
Query: 465 NNFDAKYCIGTAGQASVYKAELPSW-EIVAVKKFHSPHPDMVVQQAFS----NEIKALTE 519
N+F IG G VY ++ A+K M + + + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 520 LRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTL 579
+V P + + + + G L LS FS + L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGL 120
Query: 580 SYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVA 637
+MH+ +V+RD+ N+LL +SD G++ + S GT GY+A
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMA 173
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 7e-22
Identities = 44/174 (25%), Positives = 67/174 (38%), Gaps = 16/174 (9%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG V A + + VA+KK SP Q EIK L RH N++
Sbjct: 16 IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 532 ----SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYF 587
+ + L +L L +L S + + L Y+H
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS--- 127
Query: 588 PPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN---WSEFVGTFGYVAP 638
++HRD+ N+LL D + DFG+++ PD + +E+V T Y AP
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.9 bits (232), Expect = 9e-22
Identities = 36/167 (21%), Positives = 72/167 (43%), Gaps = 7/167 (4%)
Query: 473 IGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG +V+KA+ + EIVA+K+ D V + EI L EL+H+N+V+ +
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 532 SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIV 591
++ L++E+ + V + L + + ++
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYF------DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 592 HRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
HRD+ +N+L+ + + +++FG+++ +S V T Y P
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 2e-21
Identities = 38/176 (21%), Positives = 61/176 (34%), Gaps = 8/176 (4%)
Query: 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFH-SPHPDMVVQQAFSNEIKALTELRH 522
N+FD +G V + A+K E + L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 523 RNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYM 582
+ + + EY G L LS + E A +S +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE------ERARFYGAEIVSAL 118
Query: 583 HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+ + +V+RDI +N++L D ++DFG+ K D + F GT Y+AP
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.5 bits (229), Expect = 2e-21
Identities = 37/186 (19%), Positives = 70/186 (37%), Gaps = 20/186 (10%)
Query: 466 NFDAKY----CIGTAGQASVYKA-ELPSWEIVAVKKFH----SPHPDMVVQQAFSNEIKA 516
N D Y +G+ A V K E + A K V ++ E+
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 517 LTELRHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVA 576
L E++H NV+ + + L+ E + G L L+ ++ E + +
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE------EEATEFLK 120
Query: 577 NTLSYMHHDYFPPIVHRDISSKNVLL----GLDYDAHVSDFGISKFLKPDSSNWSEFVGT 632
L+ +++ + I H D+ +N++L + DFG++ + + GT
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK-NIFGT 179
Query: 633 FGYVAP 638
+VAP
Sbjct: 180 PEFVAP 185
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.7 bits (229), Expect = 3e-21
Identities = 37/192 (19%), Positives = 78/192 (40%), Gaps = 19/192 (9%)
Query: 460 VIRATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALT 518
+ ++ IG V+KA + + VA+KK + EIK L
Sbjct: 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64
Query: 519 ELRHRNVVKFYGFSFHPRQS--------FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMN 570
L+H NVV +L++++ ++ + + +F+ +
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKR 121
Query: 571 VIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS----NW 626
V++ + L+ +++ + I+HRD+ + NVL+ D ++DFG+++ + +
Sbjct: 122 VMQML---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 627 SEFVGTFGYVAP 638
+ V T Y P
Sbjct: 179 TNRVVTLWYRPP 190
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 1e-20
Identities = 43/174 (24%), Positives = 74/174 (42%), Gaps = 18/174 (10%)
Query: 473 IGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG VY+A+L S E+VA+KK ++ + E++ + +L H N+V+ F
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 532 SFHPRQS------FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHD 585
+ + L+ +Y+ + A + + +L+Y+H
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS- 140
Query: 586 YFPPIVHRDISSKNVLLGLD-YDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
I HRDI +N+LL D + DFG +K L N S ++ + Y AP
Sbjct: 141 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YICSRYYRAP 191
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.0 bits (220), Expect = 3e-20
Identities = 36/175 (20%), Positives = 68/175 (38%), Gaps = 17/175 (9%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFH----SPHPDMVVQQAFSNEIKALTELR--HRNV 525
+G+ G SVY + VA+K S ++ E+ L ++ V
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 526 VKFYGFSFHPRQSFLLYEYL-GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH 584
++ + P L+ E L ++ A + + V + + H+
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCHN 128
Query: 585 DYFPPIVHRDISSKNVLLGLD-YDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
++HRDI +N+L+ L+ + + DFG LK + +++F GT Y P
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPP 178
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 89.5 bits (221), Expect = 3e-20
Identities = 30/190 (15%), Positives = 61/190 (32%), Gaps = 22/190 (11%)
Query: 461 IRATNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTE 519
+R N + IG+ +Y + + E VA+K E K
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKM 58
Query: 520 LRHRNVVKFYGFSFHPRQSFLLY-EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANT 578
++ + + ++ E LG + +FS + + + +
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMISR 115
Query: 579 LSYMHHDYFPPIVHRDISSKNVL---LGLDYDAHVSDFGISKFLKPDSSN-------WSE 628
+ Y+H +HRD+ N L ++ DFG++K + ++
Sbjct: 116 IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 629 FVGTFGYVAP 638
GT Y +
Sbjct: 173 LTGTARYASI 182
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 1e-19
Identities = 34/196 (17%), Positives = 66/196 (33%), Gaps = 25/196 (12%)
Query: 465 NNFDAKYCIGTAGQASVYKA------ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALT 518
+ +G V +A + + VAVK + S +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 519 ELRHRNVVKFYGFSFHPRQS-FLLYEYLGRGSLAIILSN-------------DAAIDEFS 564
H NVV G P ++ E+ G+L+ L + D D +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 565 WTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624
+ VA + ++ +HRD++++N+LL + DFG+++ + D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 625 NW--SEFVGTFGYVAP 638
+ ++AP
Sbjct: 190 YVRKGDARLPLKWMAP 205
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 2e-19
Identities = 34/198 (17%), Positives = 73/198 (36%), Gaps = 28/198 (14%)
Query: 465 NNFDAKYCIGTAGQASVYKAELPSW--------EIVAVKKFHSPHPDMVVQQAFSNEIKA 516
+ +G V AE VAVK S + + +E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEM 71
Query: 517 LTEL-RHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIIL-------------SNDAAIDE 562
+ + +H+N++ G +++ EY +G+L L + ++
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 563 FSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622
S ++ VA + Y+ +HRD++++NVL+ D ++DFG+++ +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 623 SSNWSEFV--GTFGYVAP 638
++AP
Sbjct: 189 DYYKKTTNGRLPVKWMAP 206
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 4e-19
Identities = 36/193 (18%), Positives = 73/193 (37%), Gaps = 22/193 (11%)
Query: 457 YEEVIRATNNFDAKY----CIGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFS 511
+EV + A Y +G+ +V A + + VA+KK + P + +
Sbjct: 6 RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY 65
Query: 512 NEIKALTELRHRNVVKFYGFSFHPRQS------FLLYEYLGRGSLAIILSNDAAIDEFSW 565
E++ L +RH NV+ +L+ ++G ++ +
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-----KLGE 120
Query: 566 TVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625
++ + L Y+H HRD+ N+ + D + + DFG+++ + +
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTG 177
Query: 626 WSEFVGTFGYVAP 638
+ V T Y AP
Sbjct: 178 Y---VVTRWYRAP 187
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.7 bits (211), Expect = 6e-19
Identities = 37/187 (19%), Positives = 71/187 (37%), Gaps = 16/187 (8%)
Query: 462 RATNNFDAKYCIGTAGQASVYKAE--LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTE 519
RA ++ IG V+KA VA+K+ + + + E+ L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 520 L---RHRNVVKFYGFSFHPRQS-----FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNV 571
L H NVV+ + R L++E++ + + ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDM 121
Query: 572 IKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVG 631
+ + L ++H +VHRD+ +N+L+ ++DFG+++ + S V
Sbjct: 122 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVV 177
Query: 632 TFGYVAP 638
T Y AP
Sbjct: 178 TLWYRAP 184
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 84.7 bits (208), Expect = 1e-18
Identities = 56/277 (20%), Positives = 107/277 (38%), Gaps = 22/277 (7%)
Query: 10 QVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGS 69
+VV S+ +P + + LD+ NN+++ + + L +L L + NK+
Sbjct: 13 RVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70
Query: 70 VPREVGQLSSLKQLVLYCNGLSG------WLPSSFGNLNNLAIGSMPNSLSNLTSLSLFH 123
P L L++L L N L N + + L + +
Sbjct: 71 SPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE 130
Query: 124 LDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVL 183
L + + SG + L+ + + D ++ +IP L SL L D N + V
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGLPP--SLTELHLDGNKITKVD 187
Query: 184 PPSISNLSNLEGL----YLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNI 239
S+ L+NL L S++ + + N L EL ++N +L ++P L + + +
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV 246
Query: 240 VHLEQNHLTGNIYEVF------GIYPNLTFLDLSQNN 270
V+L N+++ F + + + L N
Sbjct: 247 VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.0 bits (188), Expect = 5e-16
Identities = 58/283 (20%), Positives = 94/283 (33%), Gaps = 25/283 (8%)
Query: 100 NLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSI 159
++L + +P L LDL N+++ +L NL L L +N +
Sbjct: 16 QCSDLGLEKVPKDLPP----DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 160 PPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLL---QLIEL 216
P + L L N L + L L + V + N L ++EL
Sbjct: 72 PGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL 131
Query: 217 EIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLN 276
+ + G + + L+ + + ++T G+ P+LT L L
Sbjct: 132 GTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDG-------- 180
Query: 277 FSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPR 336
N IT+ + L L KL S N I L N L LN NK+ P
Sbjct: 181 ---NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PG 236
Query: 337 VLGSISDLEYLDLSTNYNNEFRKE---FPVELEKLVQLTELDL 376
L ++ + L N + P K + + L
Sbjct: 237 GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 279
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 49.7 bits (117), Expect = 5e-07
Identities = 29/171 (16%), Positives = 63/171 (36%), Gaps = 20/171 (11%)
Query: 6 FFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNK 65
++ I + L ++ + + ++ IPQ + L L+++ NK
Sbjct: 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNK 182
Query: 66 LRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSF--------GNLNNLAIGSMPNSLSNLT 117
+ + L++L +L L N +S S +LNN + +P L++
Sbjct: 183 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHK 242
Query: 118 SLSLFHLDLSENQLSG------SIPHFLGHLSNLAVLHLGDNSL-FGSIPP 161
+ + L N +S P + ++ + + L N + + I P
Sbjct: 243 YIQ--VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 291
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 2e-18
Identities = 38/181 (20%), Positives = 70/181 (38%), Gaps = 14/181 (7%)
Query: 465 NNFDAKYCIGTAGQASVYKAELPSW----EIVAVKKFHSPH--PDMVVQQAFSNEIKALT 518
NF+ +GT V+ S ++ A+K + E + L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 519 ELRHR-NVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVAN 577
+R +V + + L+ +Y+ G L LS E + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137
Query: 578 TLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWS-EFVGTFGYV 636
+ + H + I++RDI +N+LL + ++DFG+SK D + + +F GT Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 637 A 637
A
Sbjct: 198 A 198
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 84.5 bits (208), Expect = 3e-18
Identities = 36/176 (20%), Positives = 62/176 (35%), Gaps = 11/176 (6%)
Query: 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFH-SPHPDMVVQQAFSNEIKALTELRH 522
+ FD +GT V + S A+K + + NE + L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 523 RNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYM 582
+VK +++ EY+ G + L I FS + T Y+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYL 157
Query: 583 HHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
H +++RD+ +N+L+ V+DFG +K GT +AP
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWTLCGTPEALAP 207
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 82.5 bits (203), Expect = 6e-18
Identities = 33/180 (18%), Positives = 60/180 (33%), Gaps = 24/180 (13%)
Query: 473 IGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRN-VVKFYG 530
IG +++ L + + VA+K +E + L + Y
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 531 FSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPI 590
F + L+ + LG ++ +FS K + + +H +
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHE---KSL 122
Query: 591 VHRDISSKNVLLGLDYDAH-----VSDFGISKFLKPDSSN-------WSEFVGTFGYVAP 638
V+RDI N L+G + V DFG+ KF + + GT Y++
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.5 bits (203), Expect = 1e-17
Identities = 33/175 (18%), Positives = 62/175 (35%), Gaps = 21/175 (12%)
Query: 473 IGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYG 530
+G V + + E A+K E++ + ++V+
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVD 72
Query: 531 FSFHPRQS----FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY 586
+ ++ E L G L + D F+ ++KS+ + Y+H
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHS-- 129
Query: 587 FPPIVHRDISSKNVLL---GLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
I HRD+ +N+L + ++DFG +K +S + T YVAP
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAP 182
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 81.0 bits (199), Expect = 3e-17
Identities = 34/179 (18%), Positives = 69/179 (38%), Gaps = 20/179 (11%)
Query: 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-H 522
+++ +G + V++A + + E V VK V ++ EIK L LR
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGG 89
Query: 523 RNVVKFYGFSFHP--RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLS 580
N++ P R L++E++ + + + + L
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQL------YQTLTDYDIRFYMYEILKALD 143
Query: 581 YMHHDYFPPIVHRDISSKNVLLGLD-YDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
Y H I+HRD+ NV++ + + D+G+++F P ++ V + + P
Sbjct: 144 YCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGP 198
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.8 bits (193), Expect = 2e-16
Identities = 32/173 (18%), Positives = 65/173 (37%), Gaps = 17/173 (9%)
Query: 473 IGTAGQASVYKA-ELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
IG+ Q V A + VA+KK P + + E+ + + H+N++
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 532 SFHPRQS------FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHD 585
+ +L+ E + +I E ++ + + ++H
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA 138
Query: 586 YFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
+HRD+ N+++ D + DFG+++ S + +V T Y AP
Sbjct: 139 GI---IHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAP 187
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 74.7 bits (182), Expect = 6e-15
Identities = 69/349 (19%), Positives = 125/349 (35%), Gaps = 49/349 (14%)
Query: 26 IGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVL 85
+ ++NL ++ NNQL+ + P + LT L + +N N++ P + L
Sbjct: 62 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119
Query: 86 YC--------------------NGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLD 125
N +S S + +
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179
Query: 126 LSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPP 185
L + S L L+NL L +N + P + +L L + N L
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IG 235
Query: 186 SISNLSNLEGLYLYSSLVS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLE 243
++++L+NL L L ++ +S A + L +L EL++ Q+ P L T+L + L
Sbjct: 236 TLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELN 293
Query: 244 QNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSL 303
+N NLT+L L NN + L +L +L F+
Sbjct: 294 ENQ--LEDISPISNLKNLTYLTLYFNNISD-------------ISPVSSLTKLQRLFFAN 338
Query: 304 NHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTN 352
N + L NL ++N+ + N++ P L +++ + L L+
Sbjct: 339 NKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 70.4 bits (171), Expect = 2e-13
Identities = 49/221 (22%), Positives = 88/221 (39%), Gaps = 35/221 (15%)
Query: 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYIN 62
LA + ++ + ++NL+ L NNQ+S + P I +L L +N
Sbjct: 170 PLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLN 227
Query: 63 VNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLP-SSFGNLNNLAIGSMP-NSLSNLTSLS 120
N+L+ + L++L L L N +S P S L L +G+ +++S L L+
Sbjct: 228 GNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLT 285
Query: 121 -----------------------LFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFG 157
L +L L N +S P + L+ L L +N +
Sbjct: 286 ALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV-- 341
Query: 158 SIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYL 198
S L + ++ L N ++ + P ++NL+ + L L
Sbjct: 342 SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 380
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.7 bits (164), Expect = 1e-12
Identities = 43/156 (27%), Positives = 66/156 (42%), Gaps = 31/156 (19%)
Query: 23 PPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVP----------- 71
+ +++NL LD+ NNQ+S + P + LT L L + N++ P
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE 291
Query: 72 ---------REVGQLSSLKQLVLYCNGLSGWLP-SSFGNLNNLAIG----SMPNSLSNLT 117
+ L +L L LY N +S P SS L L S +SL+NLT
Sbjct: 292 LNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSDVSSLANLT 351
Query: 118 SLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDN 153
+++ L NQ+S P L +L+ + L L D
Sbjct: 352 NIN--WLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 62.3 bits (150), Expect = 5e-11
Identities = 67/379 (17%), Positives = 121/379 (31%), Gaps = 48/379 (12%)
Query: 28 NISNLKFLDMGNNQLSGVIPQ-EIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLY 86
++ +G ++ + Q ++D +T L+ + + + G V L++L Q+
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 87 CNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLA 146
N L+ P NL L M N+ + +L+ L + + L NL
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 147 VLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAE 206
L+ + S + L N + + P + + +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 207 IGNLLQLIELEIDNKQLFGQIPK--------------------SLRNFTSLNIVHLEQNH 246
+ L L L N Q+ P +L + T+L + L N
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQ 252
Query: 247 LTGNIYEVFGIYPNLTFLDLSQNNFYGSLNF---------SMNNITRSIPPKIGKLYQLH 297
++ LT L L N +N I L L
Sbjct: 253 ISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLT 310
Query: 298 KLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEF 357
L N+I P+ +L L NKV S L +++++ +L +N+
Sbjct: 311 YLTLYFNNISDISPV--SSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAG---HNQI 363
Query: 358 RKEFPVELEKLVQLTELDL 376
P L L ++T+L L
Sbjct: 364 SDLTP--LANLTRITQLGL 380
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 4e-07
Identities = 30/129 (23%), Positives = 50/129 (38%), Gaps = 23/129 (17%)
Query: 1 LSCLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLY 60
+S LA E N I N+ NL +L + N +S + P + LT L+ L+
Sbjct: 278 ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 335
Query: 61 INVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLS 120
NK+ + L+++ L N +S P L+NLT ++
Sbjct: 336 FANNKVSD--VSSLANLTNINWLSAGHNQISDLTP-----------------LANLTRIT 376
Query: 121 LFHLDLSEN 129
L L++
Sbjct: 377 --QLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 2e-05
Identities = 51/317 (16%), Positives = 104/317 (32%), Gaps = 26/317 (8%)
Query: 113 LSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSL 172
L +T+L L + + G + +L+NL ++ +N L P L + L+ +
Sbjct: 43 LDQVTTLQADRLGIKS--IDG-----VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI 93
Query: 173 GFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLR 232
+ N + + P + L+ + NL L LE+ + + S
Sbjct: 94 LMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGL 153
Query: 233 NFTSLNIVHLEQNH------LTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSI 286
+ LT L++ SL + N I+
Sbjct: 154 TSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDIT 213
Query: 287 PPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEY 346
P I L +L + N + L +L +L L N++ P L ++ L
Sbjct: 214 PLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 267
Query: 347 LDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSL-----ISR 401
L L N + + ++L E L + + + + ++ +S
Sbjct: 268 LKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSS 327
Query: 402 MHGLSCIDISYNELRGL 418
+ L + + N++ +
Sbjct: 328 LTKLQRLFFANNKVSDV 344
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.2 bits (181), Expect = 7e-15
Identities = 37/172 (21%), Positives = 65/172 (37%), Gaps = 16/172 (9%)
Query: 473 IGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGF 531
+G+ SV A + VAVKK P ++ + E++ L ++H NV+
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 532 -----SFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDY 586
S L +L L I+ + + +I + L Y+H
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 587 FPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSNWSEFVGTFGYVAP 638
HRD+ N+ + D + + DFG+++ + +V T Y AP
Sbjct: 142 II---HRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAP 187
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 69.8 bits (170), Expect = 2e-14
Identities = 27/174 (15%), Positives = 52/174 (29%), Gaps = 27/174 (15%)
Query: 473 IGTAGQASVYKAELPSWEIVAVKKFHS--------PHPDMVVQQAFSNEIKALTELRHRN 524
+G +++V+ + VK FS R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 525 VVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH 584
+ K G + Y + ++ + L + + V+ + ++ +H
Sbjct: 68 LQKLQGLAVPKV-----YAW-EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 585 DYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK---------FLKPDSSNWSEF 629
IVH D+S NVL+ + + DF S L+ D N +
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITY 171
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.7 bits (166), Expect = 2e-13
Identities = 59/319 (18%), Positives = 98/319 (30%), Gaps = 52/319 (16%)
Query: 11 VVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSV 70
+P I + + + + N++S V +L L+++ N L
Sbjct: 15 TTSCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 71 PREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQ 130
L+ L+QL L N + P + L L L L
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSV--------------DPATFHGLGRLH--TLHLDRCG 116
Query: 131 LSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNL 190
L P L+ L L+L DN+L + +L L N ++ V + L
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176
Query: 191 SNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGN 250
+L+ L L+ ++ P + R+ L ++L N+L+
Sbjct: 177 HSLDRLLLH--------------------QNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216
Query: 251 IYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGEL 310
E L +L L+ N + L K S + + L
Sbjct: 217 PTEALAPLRALQYLRLNDNPWVCD------------CRARPLWAWLQKFRGSSSEVPCSL 264
Query: 311 PIELGN--LKSLNYRALNG 327
P L LK L L G
Sbjct: 265 PQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.7 bits (135), Expect = 2e-09
Identities = 37/193 (19%), Positives = 65/193 (33%), Gaps = 8/193 (4%)
Query: 6 FFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNK 65
+ ++ L ++ P + L L + L + P L L++LY+ N
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA 140
Query: 66 LRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMP-NSLSNLTSLSLFHL 124
L+ L +L L L+ N +S +F L++L + N ++++ + L
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 125 ------DLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNL 178
L N LS L L L L L DN L +
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSE 259
Query: 179 LNGVLPPSISNLS 191
+ LP ++
Sbjct: 260 VPCSLPQRLAGRD 272
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 5e-06
Identities = 48/270 (17%), Positives = 79/270 (29%), Gaps = 21/270 (7%)
Query: 158 SIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELE 217
++P + + L N ++ V S NL L+L+S++++ + L
Sbjct: 25 AVPVGIPAASQRIFLHG--NRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 218 IDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNF 277
+S+ T + L HL + G L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ----- 137
Query: 278 SMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRV 337
N + L L L N I L SL+ L+ N+V P
Sbjct: 138 -DNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
Query: 338 LGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDL----------VITFWEERYRP 387
+ L L L N + E L L L L W +
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEAL---APLRALQYLRLNDNPWVCDCRARPLWAWLQKF 253
Query: 388 KSVIWKAWRSLISRMHGLSCIDISYNELRG 417
+ + SL R+ G ++ N+L+G
Sbjct: 254 RGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 66.3 bits (160), Expect = 2e-12
Identities = 60/271 (22%), Positives = 102/271 (37%), Gaps = 19/271 (7%)
Query: 75 GQLSSLKQLVLYCNGLSGW--LPSSFGNLNNLAIGSMPNSLSNLTSLS--------LFHL 124
Q + L L L +PSS NL L + + + + L +L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 125 DLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLP 184
++ +SG+IP FL + L L N+L G++PP + + +L+ + FD N ++G +P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 185 PSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQ 244
S + S L N L + S RN + L
Sbjct: 167 DSYGSFSKLFTSMTI-------SRNRLTGKIPPTFANLNLAFVDLS-RNMLEGDASVLFG 218
Query: 245 NHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLN 304
+ + + + L+ N I ++P + +L LH L+ S N
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 305 HIVGELPIELGNLKSLNYRALNGNKVYGSLP 335
++ GE+P + GNL+ + A NK P
Sbjct: 279 NLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 58.6 bits (140), Expect = 7e-10
Identities = 65/322 (20%), Positives = 119/322 (36%), Gaps = 44/322 (13%)
Query: 71 PREVGQLSSLKQLVLYCNGLSGWLPSS-FGNLNNLAIGSMPNSLSNLTSLSLFHLDLSEN 129
P++ L +K+ + LS WLP++ N L + ++ + + +LDLS
Sbjct: 5 PQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDT----QTYRVNNLDLSGL 60
Query: 130 QLSG--SIPHFLGHLSNLAVLHLGDN-SLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPS 186
L IP L +L L L++G +L G IPP + K+ L L ++G +P
Sbjct: 61 NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120
Query: 187 ISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNH 246
+S + L L L G +P S+ + +L + + N
Sbjct: 121 LSQIKTLVTLD--------------------FSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 247 LTGNIYEVFGIYPNLTFLDLSQNN------------FYGSLNFSMNNITRSIPPKIGKLY 294
++G I + +G + L N + N+ +
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSD 220
Query: 295 QLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYN 354
+ + + + ++G K+LN L N++YG+LP+ L + L L++S
Sbjct: 221 KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS---F 277
Query: 355 NEFRKEFPVELEKLVQLTELDL 376
N E P + L +
Sbjct: 278 NNLCGEIP-QGGNLQRFDVSAY 298
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 54.4 bits (129), Expect = 2e-08
Identities = 41/181 (22%), Positives = 66/181 (36%), Gaps = 9/181 (4%)
Query: 13 HESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINV-NKLRGSVP 71
N L +PP I ++ NL + N++SG IP + L N+L G +P
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191
Query: 72 REVGQLSSLKQLVLYCNGLSGWLPSSFGN-----LNNLAIGSMPNSLSNLTSLSLFHLDL 126
L+ + + ++ + S +L LDL
Sbjct: 192 PTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDL 251
Query: 127 SENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLN--LLNGVLP 184
N++ G++P L L L L++ N+L G IP G +Q + N L LP
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLP 310
Query: 185 P 185
Sbjct: 311 A 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 53.6 bits (127), Expect = 2e-08
Identities = 57/282 (20%), Positives = 98/282 (34%), Gaps = 25/282 (8%)
Query: 44 GVIPQEIDPLTHLKHLYINVNKLRG--SVPREVGQLSSLKQLVL-YCNGLSGWLPSSFGN 100
GV+ + +L ++ L +P + L L L + N L G +P +
Sbjct: 40 GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK 99
Query: 101 LNNLAIGS-------MPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDN 153
L L +L LD S N LSG++P + L NL + N
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159
Query: 154 SLFGSIPPILGKVQSLLSLGFDL-NLLNGVLPPSISNLSNLEGLYLYSSLVSAE--IGNL 210
+ G+IP G L + N L G +PP+ +NL+ + L +
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGS 219
Query: 211 LQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN 270
+ + K + +LN + L N + G + + L L++S NN
Sbjct: 220 DKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 271 FYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPI 312
G + P+ G L + ++ N + P+
Sbjct: 280 LCGEI------------PQGGNLQRFDVSAYANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 49.4 bits (116), Expect = 5e-07
Identities = 51/260 (19%), Positives = 90/260 (34%), Gaps = 26/260 (10%)
Query: 208 GNLLQLIELEIDNKQLFG--QIPKSLRNFTSLNIVHLEQNH-LTGNIYEVFGIYPNLTFL 264
++ L++ L IP SL N LN +++ + L G I L +L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 265 DLSQNNFYGS-------------LNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELP 311
++ N G+ L+FS N ++ ++PP I L L + F N I G +P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 312 IELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQL 371
G+ L + +L ++DLS N + ++
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 372 TELDLVITFWEERYRPKSVIWKAWRS----------LISRMHGLSCIDISYNELRGLIRN 421
+ F + + ++++ L +++S+N L G I
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 422 STGIHYNLVDALQGNKGLCG 441
+ V A NK LCG
Sbjct: 287 GGNLQRFDVSAYANNKCLCG 306
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 63.5 bits (153), Expect = 2e-11
Identities = 37/192 (19%), Positives = 69/192 (35%), Gaps = 26/192 (13%)
Query: 468 DAKY----CIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH 522
DA+Y +G ++V+ A+ + + VA+K D V +A +EIK L +
Sbjct: 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVND 68
Query: 523 RNVVK-------------FYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRM 569
+ K + P ++ + G + L
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 570 NVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL-DYDAHVSDFGISKFLKPDSS--NW 626
+ K + L YMH I+H DI +NVL+ + D ++ I+ ++
Sbjct: 129 QISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 627 SEFVGTFGYVAP 638
+ + T Y +P
Sbjct: 187 TNSIQTREYRSP 198
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 1e-08
Identities = 36/242 (14%), Positives = 80/242 (33%), Gaps = 9/242 (3%)
Query: 110 PNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSL-FGSIPPILGKVQS 168
P+ L S + + + + + + L ++ + ++ IL +
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTLHGILSQCSK 72
Query: 169 LLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELE----IDNKQLF 224
L +L + L+ + +++ SNL L L +E L ++ F
Sbjct: 73 LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 132
Query: 225 GQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITR 284
K ++ + + Q +L+G + + N +
Sbjct: 133 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRR--CPNLVHLDLSDSVMLKN 190
Query: 285 SIPPKIGKLYQLHKLDFS-LNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISD 343
+ +L L L S I+ E +ELG + +L + G G+L + ++
Sbjct: 191 DCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH 250
Query: 344 LE 345
L+
Sbjct: 251 LQ 252
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 2e-07
Identities = 41/206 (19%), Positives = 64/206 (31%), Gaps = 17/206 (8%)
Query: 100 NLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNS-LFGS 158
N + + ++P L L LSEN L L + L L+L
Sbjct: 16 NCDKRNLTALPPDLPK----DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ 71
Query: 159 IPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEI 218
+ L + +L L L + + +SL + L +L EL +
Sbjct: 72 VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131
Query: 219 DNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFS 278
+L P L L + L N+LT + NL L L +N+ Y
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY------ 185
Query: 279 MNNITRSIPPKIGKLYQLHKLDFSLN 304
+IP + L N
Sbjct: 186 ------TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 3e-07
Identities = 41/195 (21%), Positives = 67/195 (34%), Gaps = 11/195 (5%)
Query: 12 VHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVP 71
V+ +PP + + L + N L + P T L L N+++ +
Sbjct: 15 VNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQL--NLDRAELTKL 70
Query: 72 REVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSL------FHLD 125
+ G L L L L N L + N L++L +L L
Sbjct: 71 QVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130
Query: 126 LSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPP 185
L N+L P L L L L +N+L +L +++L +L N L +P
Sbjct: 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189
Query: 186 SISNLSNLEGLYLYS 200
L +L+
Sbjct: 190 GFFGSHLLPFAFLHG 204
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 35/205 (17%), Positives = 56/205 (27%), Gaps = 41/205 (20%)
Query: 206 EIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLD 265
E+ + +E+ D + L +P L I+HL +N L Y LT L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 266 LSQNNFYGSLNFSM----------------------------------NNITRSIPPKIG 291
L + N +T +
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 292 KLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLST 351
L +L +L N + P L L +L N + +L + +L+ L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 352 NYNNEFRKEFPVELEKLVQLTELDL 376
N P L L
Sbjct: 182 NSLY----TIPKGFFGSHLLPFAFL 202
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 4e-04
Identities = 17/82 (20%), Positives = 34/82 (41%), Gaps = 1/82 (1%)
Query: 7 FFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKL 66
++ + N L + P + L+ L + NN L+ + ++ L +L L + N L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 67 RGSVPREVGQLSSLKQLVLYCN 88
++P+ L L+ N
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 7e-07
Identities = 26/120 (21%), Positives = 43/120 (35%), Gaps = 10/120 (8%)
Query: 57 KHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNS---- 112
+ L++ L +V + QL + L L N L P + L L + ++
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALEN 57
Query: 113 -LSNLTSLSLFHLDLSENQL-SGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLL 170
L L L N+L + L L +L+L NSL I ++ +L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.8 bits (82), Expect = 0.003
Identities = 25/124 (20%), Positives = 50/124 (40%), Gaps = 9/124 (7%)
Query: 147 VLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAE 206
VLHL L ++ L ++ + L N L + PP+++ L LE L + +
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALENV 58
Query: 207 IGNLLQLIELEID---NKQLFGQIPKSLRNFTSLNIVHLEQNHLT---GNIYEVFGIYPN 260
G E+ N+ + L + L +++L+ N L G + + P+
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
Query: 261 LTFL 264
++ +
Sbjct: 119 VSSI 122
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.1 bits (115), Expect = 1e-06
Identities = 24/104 (23%), Positives = 40/104 (38%), Gaps = 20/104 (19%)
Query: 241 HLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLD 300
N + I + + P+L L++S N +P + L +L
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKL------------IELPALPPR---LERLI 310
Query: 301 FSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDL 344
S NH+ E+P NLK L+ + N + P + S+ DL
Sbjct: 311 ASFNHL-AEVPELPQNLKQLH---VEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 4e-06
Identities = 19/96 (19%), Positives = 30/96 (31%), Gaps = 12/96 (12%)
Query: 55 HLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNL-----AIGSM 109
L +N + SL++L + N L LP+ L L + +
Sbjct: 261 ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLIASFNHLAEV 319
Query: 110 PNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNL 145
P NL L + N L P + +L
Sbjct: 320 PELPQNLK-----QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 7e-06
Identities = 23/103 (22%), Positives = 39/103 (37%), Gaps = 9/103 (8%)
Query: 6 FFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNK 65
++ N I +L+ L++ NN+L +P L+ L + N
Sbjct: 260 SELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFNH 315
Query: 66 LRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGS 108
L VP +LKQL + N L P ++ +L + S
Sbjct: 316 L-AEVPEL---PQNLKQLHVEYNPLRE-FPDIPESVEDLRMNS 353
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 3e-05
Identities = 21/93 (22%), Positives = 32/93 (34%), Gaps = 10/93 (10%)
Query: 118 SLSLFHLDLSENQLSGS-IPHFLGHLSNLAVLHLGDNSL----FGSIPPILGKVQSLLSL 172
SL + LD+ +LS + L L V+ L D L I L +L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 173 GFDLNLLNGVLPPSI-----SNLSNLEGLYLYS 200
N L V + + ++ L L +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.001
Identities = 16/103 (15%), Positives = 33/103 (32%), Gaps = 14/103 (13%)
Query: 56 LKHLYINVNKLRGS-VPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLS 114
++ L I +L + + L + + L GL+ + ++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT-----------EARCKDISSALR 52
Query: 115 NLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFG 157
+L+ L+L N+L H + + SL
Sbjct: 53 VNPALA--ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.001
Identities = 20/95 (21%), Positives = 32/95 (33%), Gaps = 18/95 (18%)
Query: 78 SSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPH 137
S L+ L L ++++ + S+ +L SL LDLS N L +
Sbjct: 369 SVLRVLWLADC-----------DVSDSSCSSLAATLLANHSLR--ELDLSNNCLGDAGIL 415
Query: 138 FLG-----HLSNLAVLHLGDNSLFGSIPPILGKVQ 167
L L L L D + L ++
Sbjct: 416 QLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.001
Identities = 18/109 (16%), Positives = 35/109 (32%), Gaps = 9/109 (8%)
Query: 2 SCLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGV----IPQEIDPLTHLK 57
L E + + S L+ L + + +S + + L+
Sbjct: 341 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 400
Query: 58 HLYINVNKLRGSVPREVGQ-----LSSLKQLVLYCNGLSGWLPSSFGNL 101
L ++ N L + ++ + L+QLVLY S + L
Sbjct: 401 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 18/102 (17%), Positives = 32/102 (31%), Gaps = 14/102 (13%)
Query: 79 SLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHF 138
++ L + C L++ + L + L L+E + I
Sbjct: 3 DIQSLDIQCE-----------ELSDARWAELLPLLQQCQVVRLDDCGLTEARCK-DISSA 50
Query: 139 LGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN 180
L LA L+L N L + Q L + + L+
Sbjct: 51 LRVNPALAELNLRSNELGDVGVHCVL--QGLQTPSCKIQKLS 90
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.004
Identities = 25/108 (23%), Positives = 35/108 (32%), Gaps = 25/108 (23%)
Query: 120 SLFHLDLSENQLSG----SIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFD 175
L L L++ +S S+ L +L L L +N L + L +
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR------- 422
Query: 176 LNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQL 223
LE L LY S E+ + LQ LE D L
Sbjct: 423 ------------QPGCLLEQLVLYDIYWSEEMEDRLQ--ALEKDKPSL 456
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 5e-05
Identities = 14/78 (17%), Positives = 31/78 (39%), Gaps = 6/78 (7%)
Query: 100 NLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFL-----GHLSNLAVLHLGDNS 154
L+ ++ ++ S L ++ L L L N++ L + +L L L N
Sbjct: 254 LLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 313
Query: 155 LFGSIPPILGKVQSLLSL 172
F ++ +++ + S
Sbjct: 314 -FSEEDDVVDEIREVFST 330
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 6e-04
Identities = 24/154 (15%), Positives = 46/154 (29%), Gaps = 17/154 (11%)
Query: 125 DLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLP 184
+L Q+ + + + + L L P L + L ++ L
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLR 58
Query: 185 PSISNLSNLEGLYLYS------SLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLN 238
N+ L L L + +S+ + L L + +L + L
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 239 IVHLEQNHLTGNI-------YEVFGIYPNLTFLD 265
+ L+ N L+ + +P L LD
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 8e-04
Identities = 36/216 (16%), Positives = 74/216 (34%), Gaps = 9/216 (4%)
Query: 53 LTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMP-N 111
L + + + + +V + L + L + G++ LNNL + N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 112 SLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLS 171
+++L L + + ++ L S + L + +L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 172 LGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSL 231
L DLN + + P + + + NL +L L+ D+ ++ P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 232 RNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLS 267
+ +L VHL+ N ++ NL + L+
Sbjct: 192 ASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 16/83 (19%), Positives = 32/83 (38%), Gaps = 4/83 (4%)
Query: 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYIN 62
LA + N+S L L +N++S + P + L +L +++
Sbjct: 146 PLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLK 203
Query: 63 VNKLRGSVPREVGQLSSLKQLVL 85
N++ P + S+L + L
Sbjct: 204 NNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 37/216 (17%), Positives = 76/216 (35%), Gaps = 15/216 (6%)
Query: 142 LSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSS 201
L+N + G +++ ++ + + +L + + + L+NL GL L +
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 202 LVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNL 261
++ E++ + ++ S+ + L +T +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 262 TFLDLSQNNFYGSL-------NFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIEL 314
+LDL+Q L S+ N S + L +L L N I L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISPL 191
Query: 315 GNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLS 350
+L +L L N++ P L + S+L + L+
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.001
Identities = 23/138 (16%), Positives = 42/138 (30%), Gaps = 18/138 (13%)
Query: 24 PQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQL 83
Q N + LD+ ++ VI L + + N++R L LK L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 68
Query: 84 VLYCNGLSGWLPS-------------SFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQ 130
++ N + + +L L SL +LT L +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP--VTN 126
Query: 131 LSGSIPHFLGHLSNLAVL 148
+ + + + VL
Sbjct: 127 KKHYRLYVIYKVPQVRVL 144
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.002
Identities = 6/45 (13%), Positives = 14/45 (31%)
Query: 21 IIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNK 65
+ S LD+ ++ + ++ L L+ K
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.002
Identities = 8/52 (15%), Positives = 18/52 (34%), Gaps = 5/52 (9%)
Query: 111 NSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPI 162
+ + LD+S ++ + L +L L +L +P +
Sbjct: 195 DVFHGASGPV--ILDISRTRIHSLPSYGLENLKKLRARST--YNL-KKLPTL 241
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.004
Identities = 24/194 (12%), Positives = 54/194 (27%), Gaps = 27/194 (13%)
Query: 28 NISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYC 87
+ ++ ++ + Q L + + N + ++ + L ++ +L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 88 NGLSGWLPSSFGNLNNLAIGSMPNSLSN---------------------LTSLSLFHLDL 126
N L+ P + + L
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137
Query: 127 SENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPS 186
S + I + L S L + L +L N ++ + +
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL--RA 195
Query: 187 ISNLSNLEGLYLYS 200
++ L NL+ L L+S
Sbjct: 196 LAGLKNLDVLELFS 209
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 639 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.98 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.98 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.98 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.98 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.97 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.97 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.97 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.96 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.96 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.96 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.96 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.96 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.96 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.96 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.95 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.95 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.95 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.94 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.9 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.7 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.65 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.65 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.64 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.63 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.62 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.59 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.47 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.45 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.35 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.34 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.28 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.25 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.24 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.24 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.23 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.22 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.15 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.83 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.41 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.95 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.81 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.52 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.2 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.7 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.04 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.82 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-36 Score=299.79 Aligned_cols=169 Identities=27% Similarity=0.375 Sum_probs=145.2
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|+..+.||+|+||+||+|+. .+|+.||||.+..... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 35788889999999999999965 5789999999976432 223456899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
|||++|+|.+++.... .+++..+..++.|+++|++|||+. +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 83 Ey~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 9999999999997543 478899999999999999999998 9999999999999999999999999999976432
Q ss_pred C--CCcceeeeeceeeCCC
Q 046265 623 S--SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~--~~~~~~~gt~~Y~APE 639 (639)
. ......+||+.|||||
T Consensus 157 ~~~~~~~~~~GT~~Y~APE 175 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPE 175 (271)
T ss_dssp TEECCBCCCCSCGGGSCTH
T ss_pred CccccccceeeCcCccCHh
Confidence 2 2234578999999998
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-36 Score=300.04 Aligned_cols=175 Identities=24% Similarity=0.399 Sum_probs=137.5
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc--CCceeEE
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH--PRQSFLL 541 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv 541 (639)
++|+..+.||+|+||+||+|+ ..+|+.||||.+..........+.+.+|++++++++|||||++++++.+ ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 678889999999999999995 4678999999998766555567789999999999999999999999975 4568999
Q ss_pred ecccCCCChhHHhhcCC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 542 YEYLGRGSLAIILSNDA-AIDEFSWTVRMNVIKSVANTLSYMHHDY--FPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
||||++|+|.+++.... ....+++..+..++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986432 2245889999999999999999999862 12599999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeceeeCCC
Q 046265 619 LKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~~~~~~~gt~~Y~APE 639 (639)
+..........+||+.|||||
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE 184 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPE 184 (269)
T ss_dssp C-----------CCCSCCCHH
T ss_pred cccCCCccccCCCCcccCCHH
Confidence 765544455689999999998
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-36 Score=298.36 Aligned_cols=166 Identities=26% Similarity=0.435 Sum_probs=148.0
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
.+|+..+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 4688899999999999999964 6789999999875432 235678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
||++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 98 y~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 99999999988653 478899999999999999999998 99999999999999999999999999999876555
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
......+||+.|||||
T Consensus 171 ~~~~~~~gt~~Y~aPE 186 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPE 186 (293)
T ss_dssp CCBCCCCSCGGGCCHH
T ss_pred ccccccccCCCccChh
Confidence 5556678999999998
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-35 Score=294.16 Aligned_cols=167 Identities=27% Similarity=0.429 Sum_probs=141.4
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
++|+..+.||+|+||+||+|+.++ .||||+++.........+.|.+|+.++++++|||||++++++.+ +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 568888999999999999998654 59999998665555567789999999999999999999998765 568999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC-
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS- 623 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~- 623 (639)
|++|+|.+++..... .++|..+..++.|+++||+|||+. +||||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 85 CEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999975432 588999999999999999999998 99999999999999999999999999998764322
Q ss_pred -CCcceeeeeceeeCCC
Q 046265 624 -SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 -~~~~~~~gt~~Y~APE 639 (639)
......+||+.|||||
T Consensus 160 ~~~~~~~~gt~~y~APE 176 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPE 176 (276)
T ss_dssp ------CCCCGGGCCHH
T ss_pred cccccccccCcccCCHH
Confidence 2334578999999998
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-36 Score=293.13 Aligned_cols=167 Identities=28% Similarity=0.468 Sum_probs=146.2
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||+||+|+. .+++.||||.+..... +....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5688889999999999999965 5789999999864321 1233567889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
|||++|+|.+++.... .+++..+..++.|+++||+|||.. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999997654 478899999999999999999998 9999999999999999999999999999876533
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
.....+||+.|||||
T Consensus 160 --~~~~~~Gt~~Y~APE 174 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPE 174 (263)
T ss_dssp --CCEETTEEGGGCCHH
T ss_pred --cccccCCCCcccCHH
Confidence 234578999999998
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-35 Score=291.70 Aligned_cols=167 Identities=21% Similarity=0.370 Sum_probs=137.5
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
++|+..+.||+|+||.||+|++.+++.||||+++... ...+.|.+|+.++++++|||||+++|+|.+++..|+||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 4677788999999999999999888999999997533 2356799999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
|++|+|.+++.... ..++|..+..++.|+++|++|+|+. +|+||||||+||+++.++.+||+|||+|+.+.....
T Consensus 82 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp CTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred cCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999999987654 3578999999999999999999998 999999999999999999999999999987754332
Q ss_pred -CcceeeeeceeeCCC
Q 046265 625 -NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 -~~~~~~gt~~Y~APE 639 (639)
......||+.|||||
T Consensus 157 ~~~~~~~gt~~y~aPE 172 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPE 172 (263)
T ss_dssp --------CTTSCCHH
T ss_pred eeecceecCcccCChH
Confidence 223467999999998
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-35 Score=289.60 Aligned_cols=166 Identities=23% Similarity=0.343 Sum_probs=141.4
Q ss_pred CCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc----CCceeEEe
Q 046265 468 DAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH----PRQSFLLY 542 (639)
Q Consensus 468 ~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~ 542 (639)
+..+.||+|+||+||+|.. .+++.||||++..........+.|.+|++++++++|||||+++++|.+ ....|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 4556899999999999965 568899999998655455566789999999999999999999999875 34579999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC-CCCceEEccccccccCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG-LDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~-~~~~~kl~DfGla~~~~~ 621 (639)
|||++|+|.+++.... .+++..+..++.|+++|++|||+.. ++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999997653 4788999999999999999999871 2399999999999996 578999999999986543
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
......+||+.|||||
T Consensus 168 --~~~~~~~GT~~Y~aPE 183 (270)
T d1t4ha_ 168 --SFAKAVIGTPEFMAPE 183 (270)
T ss_dssp --TSBEESCSSCCCCCGG
T ss_pred --CccCCcccCccccCHH
Confidence 3345678999999998
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-35 Score=295.74 Aligned_cols=180 Identities=24% Similarity=0.398 Sum_probs=138.4
Q ss_pred cchHHHHHHHhccC---------CCcceeccCCCceEEEEEcC-CC---cEEEEEEccCCCCChhhHHHHHHHHHHHhcc
Q 046265 454 KILYEEVIRATNNF---------DAKYCIGTAGQASVYKAELP-SW---EIVAVKKFHSPHPDMVVQQAFSNEIKALTEL 520 (639)
Q Consensus 454 ~~~~~~~~~~~~~f---------~~~~~ig~g~~g~vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l 520 (639)
.++|++..+++.+| +..+.||+|+||+||+|+.+ ++ ..||||++.... .....+.|.+|+++++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l 84 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQF 84 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhC
Confidence 34555555555444 44578999999999999764 33 358999987543 334566799999999999
Q ss_pred ccCceeeeEEEEEcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCe
Q 046265 521 RHRNVVKFYGFSFHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNV 600 (639)
Q Consensus 521 ~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Ni 600 (639)
+|||||+++++|..++..|+|||||++|+|.+++.... ..++|..+..++.|+++||+|||+. +|+||||||+||
T Consensus 85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NI 159 (299)
T d1jpaa_ 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNI 159 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceE
Confidence 99999999999999999999999999999999887643 3589999999999999999999998 999999999999
Q ss_pred eeCCCCceEEccccccccCCCCCCC-----cceeeeeceeeCCC
Q 046265 601 LLGLDYDAHVSDFGISKFLKPDSSN-----WSEFVGTFGYVAPI 639 (639)
Q Consensus 601 ll~~~~~~kl~DfGla~~~~~~~~~-----~~~~~gt~~Y~APE 639 (639)
|++.++.+||+|||+|+.+...... .....||+.|||||
T Consensus 160 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE 203 (299)
T d1jpaa_ 160 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203 (299)
T ss_dssp EECTTCCEEECCC-----------------------CGGGSCHH
T ss_pred EECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHH
Confidence 9999999999999999976543221 12246899999998
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-36 Score=303.15 Aligned_cols=168 Identities=25% Similarity=0.389 Sum_probs=146.0
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.++|+..+.||+|+||+||+|+. .+|+.||||+++... .....+.+.+|+.++++++|||||+++++|.+++..|+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46788899999999999999964 678999999997643 3344677899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
|||++|+|.+++...+ .+++..+..++.|+++|++|||+.+ +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 84 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp ECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999997654 4788999999999999999999732 8999999999999999999999999999876432
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
...+.+||++|||||
T Consensus 159 --~~~~~~GT~~Y~APE 173 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPE 173 (322)
T ss_dssp --TC---CCSSCCCCHH
T ss_pred --ccccccCCccccCch
Confidence 234578999999998
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-36 Score=297.66 Aligned_cols=168 Identities=24% Similarity=0.366 Sum_probs=145.7
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
+.|+..+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4577788999999999999964 578999999997643 2334568899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
||++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+|+......
T Consensus 90 y~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 90 FCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred cCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 999999999876533 2478899999999999999999998 99999999999999999999999999998654322
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
......+||+.|||||
T Consensus 165 ~~~~~~~Gt~~y~APE 180 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPE 180 (288)
T ss_dssp HHHTCCCSCCTTCCHH
T ss_pred ccccccccccccCCHH
Confidence 2334578999999998
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-35 Score=292.95 Aligned_cols=168 Identities=22% Similarity=0.378 Sum_probs=146.1
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|+||+||+|..+ +++.||||+++... ...+.|.+|++++++++|||||+++++|.+++..|+|||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 46777889999999999999654 68899999987543 235678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
||++|++.+++..... ..++|..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+|+......
T Consensus 94 ~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 9999999999875432 4689999999999999999999998 99999999999999999999999999999875433
Q ss_pred CC-cceeeeeceeeCCC
Q 046265 624 SN-WSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~-~~~~~gt~~Y~APE 639 (639)
.. .....||+.|||||
T Consensus 170 ~~~~~~~~g~~~y~aPE 186 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPE 186 (287)
T ss_dssp SEEETTEEECGGGCCHH
T ss_pred ceeeccccccccccChH
Confidence 22 23356899999998
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-35 Score=293.43 Aligned_cols=169 Identities=25% Similarity=0.370 Sum_probs=144.1
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||+||+|+. .+++.||||.+..... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5688899999999999999965 5789999999864321 1223467899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
|||++|+|.+++...+ .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999987654 477899999999999999999999 9999999999999999999999999999987533
Q ss_pred C--CCcceeeeeceeeCCC
Q 046265 623 S--SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~--~~~~~~~gt~~Y~APE 639 (639)
. ......+||+.|||||
T Consensus 162 ~~~~~~~~~~GT~~Y~APE 180 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPE 180 (288)
T ss_dssp --------CCCCGGGCCHH
T ss_pred CcccccccccCCccccCce
Confidence 2 2334578999999998
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-35 Score=290.47 Aligned_cols=167 Identities=18% Similarity=0.367 Sum_probs=144.5
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
++|+..+.||+|+||.||+|.+++++.||||+++... ...+.|.+|+.++++++|||||++++++.+ +..|+||||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 5677788999999999999999988999999997533 235679999999999999999999998754 567999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++|+|.+++..... ..++|..+..++.|+++|++|||.. +|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 89 ~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 89 MENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 999999998765432 2489999999999999999999998 999999999999999999999999999998754322
Q ss_pred -CcceeeeeceeeCCC
Q 046265 625 -NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 -~~~~~~gt~~Y~APE 639 (639)
......||+.|||||
T Consensus 165 ~~~~~~~gt~~y~APE 180 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPE 180 (272)
T ss_dssp ECCTTCCCCTTTSCHH
T ss_pred ccccccCCcccccChH
Confidence 233467999999998
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-35 Score=296.99 Aligned_cols=169 Identities=23% Similarity=0.257 Sum_probs=149.1
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||+||+|+. .+|+.||||++.+... .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5788899999999999999964 6789999999875321 1223466889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
|||++|+|.+++...+. +++..+..++.|++.|++|||+. +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999987653 66788999999999999999999 9999999999999999999999999999987655
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
.......+||+.|||||
T Consensus 159 ~~~~~~~~GT~~Y~aPE 175 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPE 175 (337)
T ss_dssp TCCBCCCEECGGGCCGG
T ss_pred CcccccceeCHHHhhhh
Confidence 55556789999999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-35 Score=293.98 Aligned_cols=165 Identities=25% Similarity=0.386 Sum_probs=144.8
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
..|+..+.||+|+||+||+|. ..+++.||||++..... .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 347888999999999999995 56789999999986543 2334567899999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
|||++|++..++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999987766543 478899999999999999999998 999999999999999999999999999987643
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
....+||+.|||||
T Consensus 168 ---~~~~~GT~~Y~APE 181 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPE 181 (309)
T ss_dssp ---BCCCCSCGGGCCHH
T ss_pred ---CCccccCccccCHH
Confidence 23468999999998
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-34 Score=280.38 Aligned_cols=167 Identities=23% Similarity=0.350 Sum_probs=148.0
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
++|+..+.||+|+||.||+|+.++++.||||+++.... ..++|.+|+.++++++|||||+++|+|.+++..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 57889999999999999999999889999999986432 356799999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+++|++.+++.... ..++|..+.+++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+|+.+.....
T Consensus 81 ~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 81 MANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp CTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred cCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999999976543 3578899999999999999999998 999999999999999999999999999987654332
Q ss_pred -CcceeeeeceeeCCC
Q 046265 625 -NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 -~~~~~~gt~~Y~APE 639 (639)
......||+.|||||
T Consensus 156 ~~~~~~~~t~~y~aPE 171 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPE 171 (258)
T ss_dssp CCCCCSCCCGGGCCHH
T ss_pred eeecccCCCCCcCCcH
Confidence 233467999999998
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-34 Score=290.19 Aligned_cols=168 Identities=28% Similarity=0.382 Sum_probs=129.7
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
.+.|+..++||+|+||+||+|+. .+++.||||.+...... .....+.+|+.++++++|||||++++++.+++..|+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46688899999999999999965 57899999999764432 23456889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEEccccccccC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG---LDYDAHVSDFGISKFL 619 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~---~~~~~kl~DfGla~~~ 619 (639)
|||++|+|.+++...+ .+++..+..++.|++.|++|||.. +|+||||||+||++. +++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999997653 478899999999999999999998 999999999999994 5789999999999876
Q ss_pred CCCCCCcceeeeeceeeCCC
Q 046265 620 KPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~~~~~~gt~~Y~APE 639 (639)
... ....+.+||+.|||||
T Consensus 161 ~~~-~~~~~~~GT~~y~APE 179 (307)
T d1a06a_ 161 DPG-SVLSTACGTPGYVAPE 179 (307)
T ss_dssp -------------CTTSCHH
T ss_pred cCC-CeeeeeeeCccccCcH
Confidence 533 2334578999999998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.8e-34 Score=291.94 Aligned_cols=167 Identities=22% Similarity=0.372 Sum_probs=146.9
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5788899999999999999964 678999999997643 3456778999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC--CCCceEEccccccccCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG--LDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~--~~~~~kl~DfGla~~~~~ 621 (639)
||++|+|.+++.... ..+++..+..++.|++.||+|||.. +||||||||+|||++ .++.+||+|||+|+.+..
T Consensus 104 ~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 104 FMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred cCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999986543 2488899999999999999999998 999999999999995 457899999999998754
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
. ......+||+.|||||
T Consensus 179 ~-~~~~~~~gT~~Y~aPE 195 (350)
T d1koaa2 179 K-QSVKVTTGTAEFAAPE 195 (350)
T ss_dssp T-SCEEEECSCTTTCCHH
T ss_pred c-cccceecCcccccCHH
Confidence 3 3345678999999998
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-34 Score=283.64 Aligned_cols=162 Identities=23% Similarity=0.322 Sum_probs=135.7
Q ss_pred ceeccCCCceEEEEEcC---CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecccCC
Q 046265 471 YCIGTAGQASVYKAELP---SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYLGR 547 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 547 (639)
+.||+|+||+||+|.++ +++.||||+++....+....+.|.+|+.++++++|||||+++++|.. +..|+|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999654 34689999997655455556789999999999999999999999965 457899999999
Q ss_pred CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC--
Q 046265 548 GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN-- 625 (639)
Q Consensus 548 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-- 625 (639)
|+|.++++... .++|..+..++.|+++||+|||+. +|+||||||+|||++.++.+|++|||+|+.+......
T Consensus 92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999997654 488999999999999999999998 9999999999999999999999999999977543322
Q ss_pred -cceeeeeceeeCCC
Q 046265 626 -WSEFVGTFGYVAPI 639 (639)
Q Consensus 626 -~~~~~gt~~Y~APE 639 (639)
.....||+.|||||
T Consensus 166 ~~~~~~gt~~y~APE 180 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPE 180 (277)
T ss_dssp C----CCCGGGCCHH
T ss_pred cccccCCCceecCch
Confidence 22357999999998
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-34 Score=290.06 Aligned_cols=166 Identities=22% Similarity=0.348 Sum_probs=145.2
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||+||+|+. .+|+.||||+++.... .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5688899999999999999965 6789999999864321 1223467889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
|||+||++..++..... +++..+..++.|++.|++|||.. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999999876553 56688888999999999999998 9999999999999999999999999999987533
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
..+.+||+.|||||
T Consensus 158 ---~~~~~Gt~~Y~APE 171 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPE 171 (316)
T ss_dssp ---BCCCCSCTTTCCHH
T ss_pred ---cccccCcccccCHH
Confidence 34578999999998
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-33 Score=289.21 Aligned_cols=167 Identities=21% Similarity=0.306 Sum_probs=146.8
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
+.|+..+.||+|+||+||+|. ..+|+.||||++.... ......+.+|+.++++++|||||++++++.+++..|+|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 568888999999999999996 4679999999997643 3445678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC--CCCceEEccccccccCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG--LDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~--~~~~~kl~DfGla~~~~~ 621 (639)
||++|+|.+.+.... ..+++..+..++.|++.||+|||.. +|+||||||+|||++ .++.+||+|||+|+.+..
T Consensus 107 ~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 107 FLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred cCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999998876543 2478899999999999999999998 999999999999998 578999999999998764
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
. ......+||+.|||||
T Consensus 182 ~-~~~~~~~gt~~y~aPE 198 (352)
T d1koba_ 182 D-EIVKVTTATAEFAAPE 198 (352)
T ss_dssp T-SCEEEECSSGGGCCHH
T ss_pred C-CceeeccCcccccCHH
Confidence 3 3345678999999998
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-34 Score=283.44 Aligned_cols=169 Identities=24% Similarity=0.385 Sum_probs=137.8
Q ss_pred ccCCCcceeccCCCceEEEEEcCCC-----cEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSW-----EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
..|+..++||+|+||.||+|.+++. ..||||++.... .......|.+|++++++++|||||+++|+|.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4577789999999999999976532 369999997543 3344567999999999999999999999999999999
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+|||||.+|++.+.+.... ..++|..+..++.|++.|++|||.. +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 86 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999998876543 3589999999999999999999998 9999999999999999999999999999976
Q ss_pred CCCCC---CcceeeeeceeeCCC
Q 046265 620 KPDSS---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~---~~~~~~gt~~Y~APE 639 (639)
..... ......||+.|||||
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE 183 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPE 183 (283)
T ss_dssp -------------CCCGGGSCHH
T ss_pred cCCCccceEeccCCCCccccCHH
Confidence 54322 123357899999998
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-34 Score=281.52 Aligned_cols=168 Identities=24% Similarity=0.316 Sum_probs=141.3
Q ss_pred ccCCCcc-eeccCCCceEEEEEcC---CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 465 NNFDAKY-CIGTAGQASVYKAELP---SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 465 ~~f~~~~-~ig~g~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
++|...+ .||+|+||.||+|..+ ++..||||+++... .....+.|.+|++++++++|||||+++++|.. +..|+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 3455555 4999999999999654 34579999997543 34456789999999999999999999999875 56899
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
|||||++|+|.+++.... ..++|..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+|+.+.
T Consensus 86 vmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999999986543 3589999999999999999999998 99999999999999999999999999999875
Q ss_pred CCCC---CcceeeeeceeeCCC
Q 046265 621 PDSS---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~---~~~~~~gt~~Y~APE 639 (639)
.... .....+||+.|||||
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE 182 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPE 182 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHH
T ss_pred ccccccccccccccCccccChH
Confidence 4332 223457899999998
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-33 Score=282.69 Aligned_cols=169 Identities=21% Similarity=0.307 Sum_probs=147.3
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC----ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP----DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
.+.|+..+.||+|+||+||+|+. .+|+.||||++.+... .....+.+.+|+.++++++|||||+++++|.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36788899999999999999965 5789999999875432 123457899999999999999999999999999999
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC----ceEEcccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY----DAHVSDFG 614 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~----~~kl~DfG 614 (639)
|+|||||++|+|.+++...+ .+++..+..++.|++.|++|||+. +|+||||||+||+++.++ .+|++|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999997654 478899999999999999999999 999999999999998776 49999999
Q ss_pred ccccCCCCCCCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+|+..... .......||+.|||||
T Consensus 163 ~a~~~~~~-~~~~~~~~t~~y~APE 186 (293)
T d1jksa_ 163 LAHKIDFG-NEFKNIFGTPEFVAPE 186 (293)
T ss_dssp TCEECTTS-CBCSCCCCCGGGCCHH
T ss_pred hhhhcCCC-ccccccCCCCcccCHH
Confidence 99887543 2334568999999998
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-33 Score=287.74 Aligned_cols=171 Identities=23% Similarity=0.364 Sum_probs=142.1
Q ss_pred ccCCCcceeccCCCceEEEEEcCC-C-----cEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS-W-----EIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 537 (639)
++|+..++||+|+||+||+|+... + ..||||.+.... .......+.+|+.+++++ +|||||+++++|.+.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 567888999999999999996532 2 369999987543 233456789999999998 89999999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCC--------------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 046265 538 SFLLYEYLGRGSLAIILSNDAA--------------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISS 597 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~ 597 (639)
.|+|||||++|+|.++++.... ...++|..+..++.|+++|++|||+. +||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 9999999999999999976432 13488999999999999999999998 999999999
Q ss_pred CCeeeCCCCceEEccccccccCCCCCCC--cceeeeeceeeCCC
Q 046265 598 KNVLLGLDYDAHVSDFGISKFLKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 598 ~Nill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~Y~APE 639 (639)
+||+++.++.+||+|||+|+........ ....+||+.|||||
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 236 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 236 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChH
Confidence 9999999999999999999876543332 23467899999998
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-34 Score=281.48 Aligned_cols=167 Identities=20% Similarity=0.397 Sum_probs=138.5
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
++|+..+.||+|+||+||+|..++++.||||++.... ...+.|.+|+.++++++|||||+++++|. ++..|+||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence 5678889999999999999999888889999997543 23467999999999999999999999985 4668999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC-
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS- 623 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~- 623 (639)
+++|++..++..... ..++|..+..++.|++.|++|||.. +|+||||||+|||++.++.+||+|||+|+......
T Consensus 93 ~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 93 MSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred cCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 999999988865322 3489999999999999999999998 99999999999999999999999999998764332
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......||+.|||||
T Consensus 169 ~~~~~~~gt~~y~aPE 184 (285)
T d1fmka3 169 TARQGAKFPIKWTAPE 184 (285)
T ss_dssp -------CCGGGSCHH
T ss_pred eeeccccccccccChH
Confidence 2233467999999998
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.6e-33 Score=276.27 Aligned_cols=168 Identities=24% Similarity=0.391 Sum_probs=147.6
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCCh-------hhHHHHHHHHHHHhccc-cCceeeeEEEEEcC
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDM-------VVQQAFSNEIKALTELR-HRNVVKFYGFSFHP 535 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~ 535 (639)
++|+..+.||+|+||+||+|+. .+|+.||||++....... ...+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788899999999999999964 678999999997654221 23356889999999997 99999999999999
Q ss_pred CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccc
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGl 615 (639)
+..|+|||||++|+|.++++..+ .+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999997654 478899999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCcceeeeeceeeCCC
Q 046265 616 SKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|+.+.... .....+||+.|+|||
T Consensus 157 a~~~~~~~-~~~~~~gt~~y~~PE 179 (277)
T d1phka_ 157 SCQLDPGE-KLREVCGTPSYLAPE 179 (277)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHH
T ss_pred eeEccCCC-ceeeeeccCCCCCHH
Confidence 99875433 334578999999998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.9e-33 Score=281.18 Aligned_cols=170 Identities=24% Similarity=0.361 Sum_probs=143.0
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|+||+||+|. ..+|+.||||+++.........+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 578888999999999999995 5678999999997654333345678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+.++.+........ ..+++..+..++.|++.||+|||.. +||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 997654444333322 3588999999999999999999998 99999999999999999999999999999876555
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
......+||+.|+|||
T Consensus 157 ~~~~~~~gt~~y~apE 172 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPE 172 (298)
T ss_dssp BCTTCCBCCCTTCCHH
T ss_pred ccceeecccceeeehh
Confidence 5556678999999998
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.98 E-value=3e-33 Score=286.22 Aligned_cols=166 Identities=22% Similarity=0.231 Sum_probs=145.8
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||+||+|+. .+|+.||||++.+... .....+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5788889999999999999965 5789999999864321 1223456889999999999999999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPD 622 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~ 622 (639)
||+.+|++.+++...+ .+++..+..++.|++.||+|||.. +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999997654 477899999999999999999998 9999999999999999999999999999987533
Q ss_pred CCCcceeeeeceeeCCC
Q 046265 623 SSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 623 ~~~~~~~~gt~~Y~APE 639 (639)
....+||+.|||||
T Consensus 195 ---~~~~~Gt~~Y~APE 208 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPE 208 (350)
T ss_dssp ---BCCCEECGGGCCHH
T ss_pred ---cccccCccccCCHH
Confidence 23578999999998
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.98 E-value=2.6e-33 Score=288.27 Aligned_cols=167 Identities=22% Similarity=0.230 Sum_probs=140.9
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCC-hhhHHHHH---HHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPD-MVVQQAFS---NEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~---~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
++|+..++||+|+||.||+|+. .+|+.||||++...... ......+. +|+.+++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5788899999999999999965 57899999998642211 11122333 4467778889999999999999999999
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+|||||++|+|.+++.... .+++..+..++.|++.||+|||.. +||||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999997654 367789999999999999999998 9999999999999999999999999999977
Q ss_pred CCCCCCcceeeeeceeeCCC
Q 046265 620 KPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~~~~~~gt~~Y~APE 639 (639)
... .....+||+.|||||
T Consensus 158 ~~~--~~~~~~GT~~y~APE 175 (364)
T d1omwa3 158 SKK--KPHASVGTHGYMAPE 175 (364)
T ss_dssp SSS--CCCSCCSCGGGCCHH
T ss_pred CCC--cccccccccccchhH
Confidence 543 234568999999998
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4.9e-33 Score=281.24 Aligned_cols=169 Identities=22% Similarity=0.296 Sum_probs=144.6
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHh-ccccCceeeeEEEEEcCCceeEE
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALT-ELRHRNVVKFYGFSFHPRQSFLL 541 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~~lv 541 (639)
++|+..++||+|+||+||+|.. .+++.||||++++... .....+.+.+|+.++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5688899999999999999955 5789999999964221 1122345667777765 58999999999999999999999
Q ss_pred ecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCC
Q 046265 542 YEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKP 621 (639)
Q Consensus 542 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~ 621 (639)
||||++|+|.++++.... +++..+..++.|++.||+|||.. +|+||||||+|||++.++.+|++|||+|+....
T Consensus 82 mEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999986543 67788999999999999999999 999999999999999999999999999997765
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
........+||+.|||||
T Consensus 156 ~~~~~~~~~gt~~y~aPE 173 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPE 173 (320)
T ss_dssp TTCCBCCCCSCGGGCCHH
T ss_pred ccccccccCCCCCcCCHH
Confidence 555556678999999998
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.3e-32 Score=276.61 Aligned_cols=166 Identities=19% Similarity=0.251 Sum_probs=144.7
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|+||+||+|.. .+++.||||.++... .....+.+|++++++++|||||++++++.+++..|+|||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 5688889999999999999954 578999999997543 335568899999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCC--CceEEccccccccCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLD--YDAHVSDFGISKFLKP 621 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~--~~~kl~DfGla~~~~~ 621 (639)
||++|+|.+++...+. .+++..+..++.|++.|++|||.. +|+||||||+|||++.+ ..+||+|||+++....
T Consensus 82 ~~~gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 9999999999976532 478899999999999999999998 99999999999999854 5899999999987653
Q ss_pred CCCCcceeeeeceeeCCC
Q 046265 622 DSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 622 ~~~~~~~~~gt~~Y~APE 639 (639)
. ......+||+.|||||
T Consensus 157 ~-~~~~~~~~t~~y~ape 173 (321)
T d1tkia_ 157 G-DNFRLLFTAPEYYAPE 173 (321)
T ss_dssp T-CEEEEEESCGGGSCHH
T ss_pred C-Ccccccccccccccch
Confidence 3 3345578999999997
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6e-33 Score=279.17 Aligned_cols=164 Identities=27% Similarity=0.333 Sum_probs=137.8
Q ss_pred cceeccCCCceEEEEEc-CCCcEEEEEEccCCCCC---hhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEeccc
Q 046265 470 KYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPD---MVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEYL 545 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 545 (639)
.++||+|+||+||+|+. .+|+.||||+++..... ....+.+.+|+.++++++|||||++++++..++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 46899999999999975 56899999999754321 112356889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCCC
Q 046265 546 GRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSSN 625 (639)
Q Consensus 546 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 625 (639)
+++++..+..... .+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|||+|+........
T Consensus 83 ~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 9988877765443 356678889999999999999998 9999999999999999999999999999887655555
Q ss_pred cceeeeeceeeCCC
Q 046265 626 WSEFVGTFGYVAPI 639 (639)
Q Consensus 626 ~~~~~gt~~Y~APE 639 (639)
....+||+.|||||
T Consensus 157 ~~~~~gt~~y~aPE 170 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPE 170 (299)
T ss_dssp CCCSCCCCTTCCHH
T ss_pred ccceecChhhccHH
Confidence 55678999999998
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=8.9e-33 Score=277.83 Aligned_cols=173 Identities=24% Similarity=0.411 Sum_probs=146.7
Q ss_pred HhccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC
Q 046265 463 ATNNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR 536 (639)
Q Consensus 463 ~~~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 536 (639)
..++|+..+.||+|+||+||+|+.+ +++.||||++.... .....++|.+|++++++++||||++++++|.+.+
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 4578999999999999999999753 45789999997543 3445678999999999999999999999999999
Q ss_pred ceeEEecccCCCChhHHhhcCCC---------------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAA---------------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDI 595 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdl 595 (639)
..++||||+++|+|.+++..... ...++|..+..++.|++.|++|||.. +||||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEE
Confidence 99999999999999999864321 12478999999999999999999998 9999999
Q ss_pred CCCCeeeCCCCceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 596 SSKNVLLGLDYDAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 596 k~~Nill~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
||+|||+|.++.+||+|||+|+.+..... ......||+.|||||
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE 212 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 212 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHH
Confidence 99999999999999999999987644322 223467999999998
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=1.9e-32 Score=272.25 Aligned_cols=170 Identities=22% Similarity=0.386 Sum_probs=138.8
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC----c
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR----Q 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~ 537 (639)
.++|+..+.||+|+||+||+|+ ..+|+.||||.++.... +....+.|.+|++++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 3568888999999999999996 56789999999986543 3445567999999999999999999999998654 3
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.|+||||+++|+|.+++...+ .+++..+..++.|+++|++|||+. +|+||||||+||+++.++..+++|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 789999999999999887654 478899999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCC---CCcceeeeeceeeCCC
Q 046265 618 FLKPDS---SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~---~~~~~~~gt~~Y~APE 639 (639)
...... ......+||+.|||||
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE 184 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPE 184 (277)
T ss_dssp ECC----------------TTCCHH
T ss_pred hhccccccccccccccCcccccCHH
Confidence 654322 2234578999999998
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=9.9e-32 Score=272.41 Aligned_cols=248 Identities=31% Similarity=0.498 Sum_probs=148.4
Q ss_pred CCCEEECcCCCCcc--CCCCCCCCCCCCCEEEccc-CcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcc
Q 046265 31 NLKFLDMGNNQLSG--VIPQEIDPLTHLKHLYINV-NKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIG 107 (639)
Q Consensus 31 ~L~~L~Ls~n~l~~--~~p~~~~~L~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~ 107 (639)
+++.|||++|.++| .+|+++++|++|++|+|++ |+++|.+|++|++|++|++|+|++|++.+..|..+..+.+|
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L--- 127 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL--- 127 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTC---
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhh---
Confidence 46667777776665 3566677777777777764 66666677677777777777777777666666656555522
Q ss_pred cCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcc-cEEEcccCcCCccCCcc
Q 046265 108 SMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSL-LSLGFDLNLLNGVLPPS 186 (639)
Q Consensus 108 ~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~l~~N~l~~~~p~~ 186 (639)
++++++.|++.+.+|..+.++++|+++++++|.+.|.+|..+..+..+ +.++++.|++++..|..
T Consensus 128 --------------~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~ 193 (313)
T d1ogqa_ 128 --------------VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193 (313)
T ss_dssp --------------CEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGG
T ss_pred --------------cccccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccc
Confidence 366666666666666666666666667766666666666666665554 56666666666655544
Q ss_pred CcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEec
Q 046265 187 ISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDL 266 (639)
Q Consensus 187 ~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 266 (639)
+..+. ...+++..+...+.+|..+..+++++.+++++|.+++.++ .++.+++|+.|++
T Consensus 194 ~~~l~---------------------~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~L 251 (313)
T d1ogqa_ 194 FANLN---------------------LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDL 251 (313)
T ss_dssp GGGCC---------------------CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEEC
T ss_pred ccccc---------------------cccccccccccccccccccccccccccccccccccccccc-ccccccccccccC
Confidence 43221 2234455555555566656666666666666666655443 3445555555554
Q ss_pred cCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCcc
Q 046265 267 SQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNK 329 (639)
Q Consensus 267 s~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~ 329 (639)
++|++ +|.+|++++.+++|++|+|++|+++|.+|. ++++++|+.+++++|+
T Consensus 252 s~N~l-----------~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 252 RNNRI-----------YGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp CSSCC-----------EECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred ccCee-----------cccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 43333 345555555555555555555555555552 3455555555555554
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.3e-32 Score=273.43 Aligned_cols=167 Identities=27% Similarity=0.306 Sum_probs=135.4
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC----ceeE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR----QSFL 540 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~l 540 (639)
.+|...+.||+|+||.||+|++ +|+.||||+++.. ......++.|+..+.+++|||||+++++|.+.+ ..|+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 3456678999999999999986 5789999998642 222223344566667789999999999998654 5789
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeecCCCCCeeeCCCCceEEccccc
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHD-----YFPPIVHRDISSKNVLLGLDYDAHVSDFGI 615 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----~~~~iiHrdlk~~Nill~~~~~~kl~DfGl 615 (639)
|||||++|+|.++++.. .++|..+..++.+++.|++|+|+. +.++|+||||||+|||++.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 99999999999999753 488999999999999999999974 235999999999999999999999999999
Q ss_pred cccCCCCCC----CcceeeeeceeeCCC
Q 046265 616 SKFLKPDSS----NWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~----~~~~~~gt~~Y~APE 639 (639)
++....... .....+||+.|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE 182 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPE 182 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHH
T ss_pred cccccCCCcceeccccceecccCcCChh
Confidence 987643322 233468999999998
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=1.8e-32 Score=273.90 Aligned_cols=169 Identities=23% Similarity=0.369 Sum_probs=144.1
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEecc
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYEY 544 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 544 (639)
++|+..+.||+|+||+||+|+.++|+.||||++..........+.+.+|+.++++++|||||++++++..++..|+||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 47888899999999999999988999999999976544444457789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
+.++.+..+.+..+ .+++..+..++.|++.||+|||+. +||||||||+|||++.++.+|++|||.|........
T Consensus 82 ~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 98888777765443 478899999999999999999998 999999999999999999999999999988765444
Q ss_pred CcceeeeeceeeCCC
Q 046265 625 NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ~~~~~~gt~~Y~APE 639 (639)
......|++.|+|||
T Consensus 156 ~~~~~~~~~~y~~pE 170 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPD 170 (286)
T ss_dssp ------CCCTTCCHH
T ss_pred ccceecccchhhhHH
Confidence 445567999999997
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.2e-32 Score=275.44 Aligned_cols=164 Identities=19% Similarity=0.266 Sum_probs=138.2
Q ss_pred hccCCCc-ceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEc----CC
Q 046265 464 TNNFDAK-YCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFH----PR 536 (639)
Q Consensus 464 ~~~f~~~-~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~----~~ 536 (639)
.++|... ++||+|+||+||+|. ..+++.||||+++. ...+.+|+.++.++ +|||||+++++|.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 3567665 469999999999995 46789999999864 23467899987665 89999999999875 35
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC---CCceEEccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL---DYDAHVSDF 613 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~---~~~~kl~Df 613 (639)
..|+|||||+||+|.+++...+. ..+++..+..++.|++.|++|||.. +|+||||||+|||++. .+.+||+||
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence 68999999999999999986432 3588999999999999999999998 9999999999999975 567999999
Q ss_pred cccccCCCCCCCcceeeeeceeeCCC
Q 046265 614 GISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 614 Gla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|+|+...... .....+||+.|||||
T Consensus 159 G~a~~~~~~~-~~~~~~gt~~y~aPE 183 (335)
T d2ozaa1 159 GFAKETTSHN-SLTTPCYTPYYVAPE 183 (335)
T ss_dssp TTCEECCCCC-CCCCCSCCCSSCCCC
T ss_pred ceeeeccCCC-ccccccCCcccCCcH
Confidence 9999776433 334578999999999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5e-32 Score=268.45 Aligned_cols=168 Identities=21% Similarity=0.326 Sum_probs=131.7
Q ss_pred ccCCCcceeccCCCceEEEEEcCC----CcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS----WEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 540 (639)
++|+..+.||+|+||.||+|.... +..||||.++... .....+.|.+|+.++++++|||||++++++. ++..|+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 567888999999999999997542 3569999986543 3445678999999999999999999999986 467899
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLK 620 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~ 620 (639)
||||+++|++.+++.... ..+++..+..++.|+++|++|||.. +|+||||||+||+++.++.+||+|||+|+.+.
T Consensus 85 v~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence 999999999999876543 2578899999999999999999998 99999999999999999999999999998765
Q ss_pred CCCC-CcceeeeeceeeCCC
Q 046265 621 PDSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 621 ~~~~-~~~~~~gt~~Y~APE 639 (639)
.... ......||+.|||||
T Consensus 160 ~~~~~~~~~~~gt~~y~apE 179 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPE 179 (273)
T ss_dssp -----------CCGGGCCHH
T ss_pred CCcceeccceecCcccchhh
Confidence 4322 234467899999998
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.8e-32 Score=267.55 Aligned_cols=163 Identities=26% Similarity=0.371 Sum_probs=132.9
Q ss_pred ccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc-CCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH-PRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e 543 (639)
++|+..+.||+|+||.||+|+.+ |+.||||+++... ..+.|.+|++++++++|||||+++|+|.+ .+..|+|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 45677889999999999999885 6789999997532 34678999999999999999999999965 456899999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+++|+|.+++..... ..++|..++.++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC-
Confidence 9999999999975432 2478999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.....+|+.|||||
T Consensus 157 --~~~~~~~~~y~aPE 170 (262)
T d1byga_ 157 --QDTGKLPVKWTAPE 170 (262)
T ss_dssp -------CCTTTSCHH
T ss_pred --CccccccccCCChH
Confidence 23457899999998
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8e-32 Score=270.87 Aligned_cols=171 Identities=21% Similarity=0.320 Sum_probs=134.2
Q ss_pred ccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCC-
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPR- 536 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~- 536 (639)
++|+..+.||+|+||+||+|+.. +++.||||+++... .....+.+.+|+..+.++ +|||||.+++++.+++
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 56888899999999999999643 35789999997543 234456678888888877 6899999999987654
Q ss_pred ceeEEecccCCCChhHHhhcCCC-------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAA-------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG 603 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~ 603 (639)
..++|||||++|+|.++++.... ...++|..+..++.|+++|++|||+. +||||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 68999999999999999975432 23488999999999999999999998 999999999999999
Q ss_pred CCCceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 604 LDYDAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 604 ~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
.++.+||+|||+|+....... .....+||+.|||||
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 206 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 206 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchh
Confidence 999999999999987654322 234578999999998
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.8e-32 Score=272.84 Aligned_cols=168 Identities=20% Similarity=0.336 Sum_probs=136.6
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCc----EEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWE----IVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
.+|+..++||+|+||+||+|.. .+|+ .||||+++... .....+.|.+|+.++++++|||||+++++|.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 4588889999999999999965 3444 58999887533 233467799999999999999999999999874 567
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
++|||+.+|+|.+.+.... ..++|..+..++.|+++||+|||.. +|+||||||+||+++.++.+||+|||+|+.+
T Consensus 87 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 8899999999998887543 3588999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCCCC--cceeeeeceeeCCC
Q 046265 620 KPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~--~~~~~gt~~Y~APE 639 (639)
...... .....||+.|||||
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE 183 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALE 183 (317)
T ss_dssp TTTCC--------CCTTTSCHH
T ss_pred ccccccccccccccCccccChH
Confidence 543332 23457899999998
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.7e-32 Score=271.85 Aligned_cols=170 Identities=23% Similarity=0.341 Sum_probs=140.2
Q ss_pred ccCCCcceeccCCCceEEEEEcC-CCc--EEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCceeE
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP-SWE--IVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 540 (639)
++|+..++||+|+||.||+|.++ ++. .||||++..... ....+.|.+|+++++++ +|||||+++++|.+.+..|+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 57788899999999999999664 443 478888864332 23456789999999998 79999999999999999999
Q ss_pred EecccCCCChhHHhhcCC-------------CCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCc
Q 046265 541 LYEYLGRGSLAIILSNDA-------------AIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYD 607 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~ 607 (639)
||||+++|+|.++++... ....++|..+..++.|+++|++|+|+. +|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence 999999999999997542 234689999999999999999999998 9999999999999999999
Q ss_pred eEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 608 AHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 608 ~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+||+|||+|+....... ....+||+.|+|||
T Consensus 166 ~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE 196 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK-KTMGRLPVRWMAIE 196 (309)
T ss_dssp EEECCTTCEESSCEECC-C----CCTTTCCHH
T ss_pred eEEcccccccccccccc-ccceecCCcccchH
Confidence 99999999987543322 23467999999998
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=4.7e-31 Score=267.37 Aligned_cols=261 Identities=28% Similarity=0.462 Sum_probs=220.2
Q ss_pred CccCCCCCCCCCCCCCEEEcccCcCCC--CCCcccCCCCCCCEEeeec-ccCccccCccccCCCCCCcccCCCCCcccCC
Q 046265 42 LSGVIPQEIDPLTHLKHLYINVNKLRG--SVPREVGQLSSLKQLVLYC-NGLSGWLPSSFGNLNNLAIGSMPNSLSNLTS 118 (639)
Q Consensus 42 l~~~~p~~~~~L~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~ 118 (639)
..|+....-+.-.+++.|||++|.++| .+|+++++|++|++|+|++ |+++|.+|++|+++++|
T Consensus 38 w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L-------------- 103 (313)
T d1ogqa_ 38 WLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL-------------- 103 (313)
T ss_dssp STTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTC--------------
T ss_pred CCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccccccccccccccccccccccccc--------------
Confidence 334433333344579999999999988 5899999999999999986 88999999988888744
Q ss_pred CCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEc
Q 046265 119 LSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYL 198 (639)
Q Consensus 119 L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 198 (639)
++|+|++|++.+..|..+..+.+|++++++.|++.+.+|..++.++.|+.+++++|.+.+.+|..+..+.++
T Consensus 104 ---~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l----- 175 (313)
T d1ogqa_ 104 ---HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL----- 175 (313)
T ss_dssp ---SEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT-----
T ss_pred ---chhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccccccccccccccccc-----
Confidence 589999999999999999999999999999999999999999999999999999999999998877665543
Q ss_pred cCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccCc
Q 046265 199 YSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFS 278 (639)
Q Consensus 199 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls 278 (639)
++.+++++|++++..|..+..+..+ .++++++...+.+|..+..+++++.+++++|.+.
T Consensus 176 --------------~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~------ 234 (313)
T d1ogqa_ 176 --------------FTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA------ 234 (313)
T ss_dssp --------------CCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEEC------
T ss_pred --------------ccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccc------
Confidence 3566778888888888888777554 6899999999988888888899999997777663
Q ss_pred CCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCC
Q 046265 279 MNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTN 352 (639)
Q Consensus 279 ~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 352 (639)
+.+ +.++.+++|+.|+|++|+++|.+|.+++++++|++|+|++|+++|.+|. ++.+++|+.+++++|
T Consensus 235 -----~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N 301 (313)
T d1ogqa_ 235 -----FDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANN 301 (313)
T ss_dssp -----CBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSS
T ss_pred -----ccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCC
Confidence 333 4577788999999999999999999999999999999999999988885 578888998999886
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-31 Score=268.89 Aligned_cols=171 Identities=19% Similarity=0.345 Sum_probs=145.5
Q ss_pred ccCCCcceeccCCCceEEEEEcC------CCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCce
Q 046265 465 NNFDAKYCIGTAGQASVYKAELP------SWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQS 538 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 538 (639)
++|+..+.||+|+||.||+|.+. +++.||||+++... .......|.+|+.++++++|||||+++++|..++..
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 56677889999999999999653 35789999997543 344556789999999999999999999999999999
Q ss_pred eEEecccCCCChhHHhhcC-------CCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEc
Q 046265 539 FLLYEYLGRGSLAIILSND-------AAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVS 611 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~ 611 (639)
++|||||++|+|.+++... .....++|..+..++.|+++||.|||.. +|+||||||+|||++.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 9999999999999988642 2223578999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 612 DFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 612 DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
|||+|+.+..... ......||+.|||||
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe 205 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPE 205 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred ecccceeccCCcceeeccceecccccCCHH
Confidence 9999987643322 223457999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.3e-31 Score=268.65 Aligned_cols=171 Identities=22% Similarity=0.315 Sum_probs=146.5
Q ss_pred ccCCCcceeccCCCceEEEEEc------CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcCCc
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL------PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 537 (639)
++|+..+.||+|+||.||+|++ .+++.||||+++... .......|.+|+.+++++ +|||||+++++|.+++.
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 5677788999999999999964 345789999998644 344566789999999999 69999999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCC---------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 046265 538 SFLLYEYLGRGSLAIILSNDAA---------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL 602 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill 602 (639)
.|+|||||++|+|.++++.... ...+++..+..++.|+++|++|||.+ +||||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 9999999999999999975431 22588999999999999999999999 99999999999999
Q ss_pred CCCCceEEccccccccCCCCCCC--cceeeeeceeeCCC
Q 046265 603 GLDYDAHVSDFGISKFLKPDSSN--WSEFVGTFGYVAPI 639 (639)
Q Consensus 603 ~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~Y~APE 639 (639)
+.++.+|++|||+++........ ....+||+.|||||
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE 217 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE 217 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHH
Confidence 99999999999999987543322 23468999999998
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.3e-31 Score=265.98 Aligned_cols=164 Identities=20% Similarity=0.308 Sum_probs=138.7
Q ss_pred cceeccCCCceEEEEEcCCC----cEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEc-CCceeEEecc
Q 046265 470 KYCIGTAGQASVYKAELPSW----EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFH-PRQSFLLYEY 544 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~ 544 (639)
.++||+|+||+||+|.+... ..||||+++... .....++|.+|++++++++|||||+++|+|.+ ++..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 46899999999999976432 358999997532 44556789999999999999999999999876 4578999999
Q ss_pred cCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCCC
Q 046265 545 LGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDSS 624 (639)
Q Consensus 545 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 624 (639)
|++|++.+++..... ..++..+.+++.|+++|+.|+|.. +|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 111 ~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred eecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999999876543 467888999999999999999998 999999999999999999999999999997654322
Q ss_pred ----CcceeeeeceeeCCC
Q 046265 625 ----NWSEFVGTFGYVAPI 639 (639)
Q Consensus 625 ----~~~~~~gt~~Y~APE 639 (639)
......||+.|+|||
T Consensus 186 ~~~~~~~~~~gt~~y~aPE 204 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALE 204 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHH
T ss_pred ccceecccccccccccChH
Confidence 223457999999998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-31 Score=264.37 Aligned_cols=169 Identities=24% Similarity=0.343 Sum_probs=131.7
Q ss_pred ccCCCcceeccCCCceEEEEEc--CCC--cEEEEEEccCCCC-ChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCcee
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL--PSW--EIVAVKKFHSPHP-DMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSF 539 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~--~~~--~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 539 (639)
++|+..+.||+|+||.||+|+. .++ ..||||++..... .....+.|.+|+.++++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 4678888999999999999964 333 3689999876432 23345679999999999999999999999976 4678
Q ss_pred EEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccC
Q 046265 540 LLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFL 619 (639)
Q Consensus 540 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~ 619 (639)
+|||||++|++.+.+.... ..++|..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence 9999999999998876543 3588999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCCCC---cceeeeeceeeCCC
Q 046265 620 KPDSSN---WSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~---~~~~~gt~~Y~APE 639 (639)
...... .....|++.|||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE 184 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPE 184 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHH
T ss_pred ccCCCcceecCccccCcccCCHH
Confidence 544321 23356888999998
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.1e-32 Score=268.11 Aligned_cols=167 Identities=20% Similarity=0.301 Sum_probs=140.1
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCCh----hhHHHHHHHHHHHhccc--cCceeeeEEEEEcCCc
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDM----VVQQAFSNEIKALTELR--HRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~ 537 (639)
++|+..+.||+|+||+||+|+ ..+++.||||++....... .....+.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 468888999999999999996 4678999999987532111 11233678999999986 8999999999999999
Q ss_pred eeEEecccCC-CChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-CCceEEccccc
Q 046265 538 SFLLYEYLGR-GSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL-DYDAHVSDFGI 615 (639)
Q Consensus 538 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~-~~~~kl~DfGl 615 (639)
.|+||||+.+ +++.+++.... .+++..+..++.|+++|++|||.. +|+||||||+||+++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 67888876543 478899999999999999999998 9999999999999985 47999999999
Q ss_pred cccCCCCCCCcceeeeeceeeCCC
Q 046265 616 SKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 616 a~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|+.... ....+.+||+.|||||
T Consensus 158 a~~~~~--~~~~~~~GT~~y~aPE 179 (273)
T d1xwsa_ 158 GALLKD--TVYTDFDGTRVYSPPE 179 (273)
T ss_dssp CEECCS--SCBCCCCSCGGGSCHH
T ss_pred ceeccc--ccccccccCCCcCCHH
Confidence 987543 2345678999999998
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.6e-31 Score=264.79 Aligned_cols=171 Identities=20% Similarity=0.285 Sum_probs=140.5
Q ss_pred ccCCCcceeccCCCceEEEEEcCC--------CcEEEEEEccCCCCChhhHHHHHHHHHHHhcc-ccCceeeeEEEEEcC
Q 046265 465 NNFDAKYCIGTAGQASVYKAELPS--------WEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL-RHRNVVKFYGFSFHP 535 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 535 (639)
++|...+.||+|+||.||+|+..+ +..||||+++... .......+.+|+..+.++ +|||||+++++|.++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 567778899999999999996432 3479999997644 334456788999999888 899999999999999
Q ss_pred CceeEEecccCCCChhHHhhcCCC-------------CCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeee
Q 046265 536 RQSFLLYEYLGRGSLAIILSNDAA-------------IDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLL 602 (639)
Q Consensus 536 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill 602 (639)
+..|+|||||++|++.+++..... ...+++..++.++.|++.|++|||.. +||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 999999999999999999976542 23589999999999999999999999 99999999999999
Q ss_pred CCCCceEEccccccccCCCCCC--CcceeeeeceeeCCC
Q 046265 603 GLDYDAHVSDFGISKFLKPDSS--NWSEFVGTFGYVAPI 639 (639)
Q Consensus 603 ~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~Y~APE 639 (639)
+.++.+||+|||+++....... .....+||+.|||||
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 207 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 207 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhh
Confidence 9999999999999997654322 233468999999998
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.8e-30 Score=257.93 Aligned_cols=169 Identities=22% Similarity=0.346 Sum_probs=149.0
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCCceeEEec
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPRQSFLLYE 543 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 543 (639)
++|+..+.||+|+||+||+|+ ..+++.||||+++...........+.+|+.+++.++|||||+++++|.+.+..++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 468888999999999999996 4678999999997665555567788999999999999999999999999999999999
Q ss_pred ccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccccCCCCC
Q 046265 544 YLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKFLKPDS 623 (639)
Q Consensus 544 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~~~~~~ 623 (639)
|+.++++..+++..+ .+++..+..++.|+++||+|||.. +|+||||||+|||++.++.+|++|||.|+......
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999998887654 467789999999999999999998 99999999999999999999999999999876554
Q ss_pred CCcceeeeeceeeCCC
Q 046265 624 SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 624 ~~~~~~~gt~~Y~APE 639 (639)
.......+++.|+|||
T Consensus 156 ~~~~~~~~~~~~~~pe 171 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPD 171 (292)
T ss_dssp SCCCSCCSCGGGCCHH
T ss_pred ccceeeccccchhhhh
Confidence 4445567888899987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.7e-30 Score=265.24 Aligned_cols=165 Identities=20% Similarity=0.331 Sum_probs=137.5
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC------
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR------ 536 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 536 (639)
.++|+..+.||+|+||+||+|. ..+|+.||||+++.........+.+.+|+.++++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4578888999999999999996 567999999999865555555677899999999999999999999998665
Q ss_pred ceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccc
Q 046265 537 QSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGIS 616 (639)
Q Consensus 537 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla 616 (639)
..|+||||+ ++++..+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence 469999999 66787777543 478899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCCcceeeeeceeeCCC
Q 046265 617 KFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 617 ~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
+..... ....+||+.|||||
T Consensus 169 ~~~~~~---~~~~~~t~~y~aPE 188 (346)
T d1cm8a_ 169 RQADSE---MTGYVVTRWYRAPE 188 (346)
T ss_dssp EECCSS---CCSSCSCGGGCCTH
T ss_pred eccCCc---cccccccccccCHH
Confidence 876533 34568999999998
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.4e-30 Score=267.51 Aligned_cols=164 Identities=25% Similarity=0.326 Sum_probs=134.5
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC------ce
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR------QS 538 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~ 538 (639)
+|+..++||+|+||+||+|+. .+|+.||||++...... ..+|++++++++|||||+++++|.... ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 567788999999999999965 57899999999754321 247999999999999999999986432 47
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY-DAHVSDFGISK 617 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~-~~kl~DfGla~ 617 (639)
|+|||||++|.+..+.........+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+|+
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 89999998775555443333334689999999999999999999998 999999999999999775 89999999998
Q ss_pred cCCCCCCCcceeeeeceeeCCC
Q 046265 618 FLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~~~~~~gt~~Y~APE 639 (639)
.+... ....+.+||+.|+|||
T Consensus 172 ~~~~~-~~~~~~~gt~~y~aPE 192 (350)
T d1q5ka_ 172 QLVRG-EPNVSYICSRYYRAPE 192 (350)
T ss_dssp ECCTT-SCCCSCCSCTTSCCHH
T ss_pred hccCC-cccccccccccccChH
Confidence 77543 2334578999999998
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1e-30 Score=263.65 Aligned_cols=170 Identities=19% Similarity=0.302 Sum_probs=136.8
Q ss_pred hccCCCcceeccCCCceEEEEEc-CC-CcEEEEEEccCCCCChhhHHHHHHHHHHHhcc---ccCceeeeEEEEEc----
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PS-WEIVAVKKFHSPHPDMVVQQAFSNEIKALTEL---RHRNVVKFYGFSFH---- 534 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~---- 534 (639)
.++|+..+.||+|+||+||+|+. ++ ++.||||+++...........+.+|+.+++.+ +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46888999999999999999965 44 57799999875433222233456788777665 79999999999863
Q ss_pred -CCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccc
Q 046265 535 -PRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDF 613 (639)
Q Consensus 535 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~Df 613 (639)
....+++|||+++|.+........ ..+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence 246799999999887765544332 3578889999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCCCcceeeeeceeeCCC
Q 046265 614 GISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 614 Gla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
|+++..... ......+||+.|||||
T Consensus 161 g~~~~~~~~-~~~~~~~gT~~Y~APE 185 (305)
T d1blxa_ 161 GLARIYSFQ-MALTSVVVTLWYRAPE 185 (305)
T ss_dssp CSCCCCCGG-GGGCCCCCCCTTCCHH
T ss_pred hhhhhhccc-ccCCCcccChhhcCcc
Confidence 999865432 2334578999999998
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.4e-30 Score=262.55 Aligned_cols=168 Identities=26% Similarity=0.336 Sum_probs=138.6
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcCC----ce
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHPR----QS 538 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~ 538 (639)
+.+|+..+.||+|+||+||+|. ..+|+.||||++.... .....+.+.+|++++++++|||||++++++..+. ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 3568888999999999999995 5789999999997543 3445567899999999999999999999997654 23
Q ss_pred eEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 539 FLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 539 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
+++++|+.+|+|.+++..+ .+++..+..++.|++.||+|||.. +||||||||+|||++.++.+||+|||+|+.
T Consensus 86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 4555667799999999753 478899999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCC---CcceeeeeceeeCCC
Q 046265 619 LKPDSS---NWSEFVGTFGYVAPI 639 (639)
Q Consensus 619 ~~~~~~---~~~~~~gt~~Y~APE 639 (639)
...... .....+||+.|+|||
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE 182 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPE 182 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGG
T ss_pred ccCCCccceeeccccccceechHH
Confidence 643221 234568999999998
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.96 E-value=8.9e-30 Score=259.43 Aligned_cols=160 Identities=21% Similarity=0.350 Sum_probs=137.6
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcC--CceeE
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHP--RQSFL 540 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~l 540 (639)
++|+..+.||+|+||+||+|+. .+++.||||+++... .+.+.+|++++++++ ||||+++++++... ...++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 5788899999999999999965 678999999987532 456889999999995 99999999999854 46899
Q ss_pred EecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-ceEEccccccccC
Q 046265 541 LYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY-DAHVSDFGISKFL 619 (639)
Q Consensus 541 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~-~~kl~DfGla~~~ 619 (639)
|||||++|+|..+.+ .+++..+..++.|++.||+|||.+ +|+||||||+|||++.++ .+|++|||+|+..
T Consensus 110 v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 110 VFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence 999999999986642 477889999999999999999999 999999999999998665 6999999999877
Q ss_pred CCCCCCcceeeeeceeeCCC
Q 046265 620 KPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~~~~~~~gt~~Y~APE 639 (639)
... ......+||+.|+|||
T Consensus 181 ~~~-~~~~~~~~t~~y~aPE 199 (328)
T d3bqca1 181 HPG-QEYNVRVASRYFKGPE 199 (328)
T ss_dssp CTT-CCCCSCCSCGGGCCHH
T ss_pred cCC-CcccccccCccccCcc
Confidence 543 2345578999999998
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.7e-30 Score=259.75 Aligned_cols=170 Identities=24% Similarity=0.342 Sum_probs=138.6
Q ss_pred hccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC-------
Q 046265 464 TNNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP------- 535 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------- 535 (639)
.++|+..+.||+|+||+||+|.. ++|+.||||++............+.+|+.++++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36788889999999999999964 6889999999976554444567788999999999999999999998653
Q ss_pred -CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcccc
Q 046265 536 -RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFG 614 (639)
Q Consensus 536 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfG 614 (639)
+..|+||||++++.+....... ..++...+..++.|+++|++|||.. +|+||||||+|||++.++.+|++|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 4579999999888777655433 2467788899999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCC----CCcceeeeeceeeCCC
Q 046265 615 ISKFLKPDS----SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 615 la~~~~~~~----~~~~~~~gt~~Y~APE 639 (639)
+|+...... ......+||+.|+|||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE 191 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPE 191 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHH
T ss_pred eeeecccccccccccccceecCHHHhhHH
Confidence 998764322 1223468999999998
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.96 E-value=5.3e-29 Score=248.92 Aligned_cols=165 Identities=21% Similarity=0.272 Sum_probs=138.3
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcccc-CceeeeEEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH-RNVVKFYGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||+||+|+ ..+++.||||.+..... ...+.+|++.++.++| +|++.+++++.++...|+||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 468888999999999999996 45789999998865432 2236778899988875 89999999999999999999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCC-----CCceEEccccccc
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGL-----DYDAHVSDFGISK 617 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~-----~~~~kl~DfGla~ 617 (639)
||+ +|+|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+||+|||+|+
T Consensus 81 e~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 999 6899988875442 478899999999999999999998 9999999999999974 5789999999998
Q ss_pred cCCCCC-------CCcceeeeeceeeCCC
Q 046265 618 FLKPDS-------SNWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~-------~~~~~~~gt~~Y~APE 639 (639)
.+.... ......+||+.|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE 183 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSIN 183 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred EcccCccccceeecccCceEEchhhcCHH
Confidence 764321 1233568999999998
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.7e-29 Score=257.14 Aligned_cols=166 Identities=22% Similarity=0.320 Sum_probs=139.8
Q ss_pred hccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC-----Cc
Q 046265 464 TNNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP-----RQ 537 (639)
Q Consensus 464 ~~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 537 (639)
.++|+..+.||+|+||+||+|+ ..+|+.||||++..........+.+.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4578888999999999999996 56899999999987665555667789999999999999999999998743 34
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.+++|||+.+|+|.+++..+ .+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+|++|||+|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhc
Confidence 56778888899999999653 478899999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCCCcceeeeeceeeCCC
Q 046265 618 FLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~~~~~~gt~~Y~APE 639 (639)
.... ...+..||+.|+|||
T Consensus 170 ~~~~---~~~~~~g~~~y~apE 188 (348)
T d2gfsa1 170 HTDD---EMTGYVATRWYRAPE 188 (348)
T ss_dssp CCTG---GGSSSCHHHHTSCHH
T ss_pred ccCc---ccccccccccccCch
Confidence 6542 234568999999998
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.1e-29 Score=256.97 Aligned_cols=169 Identities=23% Similarity=0.309 Sum_probs=143.4
Q ss_pred ccCCCcceeccCCCceEEEEEc----CCCcEEEEEEccCCCC--ChhhHHHHHHHHHHHhcccc-CceeeeEEEEEcCCc
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL----PSWEIVAVKKFHSPHP--DMVVQQAFSNEIKALTELRH-RNVVKFYGFSFHPRQ 537 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~ 537 (639)
++|+..+.||+|+||+||+|+. .+|+.||||.+..... +....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6688899999999999999964 3578999999875321 12234567889999999987 899999999999999
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.++||||+.+|+|.+++...+. ++...+..++.|++.|++|+|.. +|+||||||+||+++.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999986654 45578888999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCC-CcceeeeeceeeCCC
Q 046265 618 FLKPDSS-NWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~-~~~~~~gt~~Y~APE 639 (639)
.+..... ......|++.|+|||
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe 200 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPD 200 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHH
T ss_pred hhcccccccccccccccccchhH
Confidence 7654322 234568999999997
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=7.9e-29 Score=254.84 Aligned_cols=165 Identities=19% Similarity=0.272 Sum_probs=130.0
Q ss_pred ccCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeeeEEEEEcC------Cc
Q 046265 465 NNFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKFYGFSFHP------RQ 537 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~ 537 (639)
++|+..+.||+|+||+||+|.. .+|+.||||+++...........+.+|+.++++++|||||+++++|... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5688889999999999999964 5789999999987655555566789999999999999999999999643 57
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
.|+|||||.++.+... . ..+++..+..++.|++.|++|||+. +|+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~-~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI-Q-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHH-T-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhh-h-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence 8999999976655543 2 2478899999999999999999999 99999999999999999999999999988
Q ss_pred cCCCCCCCcceeeeeceeeCCC
Q 046265 618 FLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 618 ~~~~~~~~~~~~~gt~~Y~APE 639 (639)
..... ......+||+.|+|||
T Consensus 168 ~~~~~-~~~~~~~~t~~y~aPE 188 (355)
T d2b1pa1 168 TAGTS-FMMTPYVVTRYYRAPE 188 (355)
T ss_dssp --------------CCTTCCHH
T ss_pred ccccc-cccccccccccccChh
Confidence 76533 2334568999999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=5.4e-28 Score=242.76 Aligned_cols=165 Identities=19% Similarity=0.266 Sum_probs=131.2
Q ss_pred ccCCCcceeccCCCceEEEEE-cCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCceeee-EEEEEcCCceeEEe
Q 046265 465 NNFDAKYCIGTAGQASVYKAE-LPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVVKF-YGFSFHPRQSFLLY 542 (639)
Q Consensus 465 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l-~~~~~~~~~~~lv~ 542 (639)
++|+..+.||+|+||+||+|. ..+++.||||.+..... .+.+.+|++++++++|+|+|.. .+++.+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 468888999999999999995 46789999998875432 2347789999999987765555 55556778889999
Q ss_pred cccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeC---CCCceEEccccccccC
Q 046265 543 EYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLG---LDYDAHVSDFGISKFL 619 (639)
Q Consensus 543 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~---~~~~~kl~DfGla~~~ 619 (639)
||++ |++...+.... ..+++..+..++.|++.|++|||.. +|+||||||+||+++ .+..+|++|||+|+.+
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 83 ELLG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp ECCC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEcC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 9995 55555554322 3578899999999999999999998 999999999999985 4557999999999976
Q ss_pred CCCCC-------CcceeeeeceeeCCC
Q 046265 620 KPDSS-------NWSEFVGTFGYVAPI 639 (639)
Q Consensus 620 ~~~~~-------~~~~~~gt~~Y~APE 639 (639)
..... .....+||+.|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE 183 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASIN 183 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHH
T ss_pred cccccccceeccccCCcCCCccccCHH
Confidence 54321 123468999999998
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=2.5e-25 Score=223.99 Aligned_cols=248 Identities=21% Similarity=0.290 Sum_probs=173.5
Q ss_pred ccceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCC
Q 046265 2 SCLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81 (639)
Q Consensus 2 ~~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 81 (639)
.|-| ....++=+++++. .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.++...|..|.++++|+
T Consensus 7 ~c~c-~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~ 82 (305)
T d1xkua_ 7 RCQC-HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82 (305)
T ss_dssp TCEE-ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCC
T ss_pred CCEe-cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccC
Confidence 3666 2333443444444 6787774 6899999999999866566889999999999999999876788899999999
Q ss_pred EEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCC--CCC
Q 046265 82 QLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLF--GSI 159 (639)
Q Consensus 82 ~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~ 159 (639)
+|++++|+++. +|..+.. .+..|++++|.+.+..+..+.....++.++...|... ...
T Consensus 83 ~L~l~~n~l~~-l~~~~~~-------------------~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~ 142 (305)
T d1xkua_ 83 RLYLSKNQLKE-LPEKMPK-------------------TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142 (305)
T ss_dssp EEECCSSCCSB-CCSSCCT-------------------TCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBC
T ss_pred EecccCCccCc-Cccchhh-------------------hhhhhhccccchhhhhhhhhhccccccccccccccccccCCC
Confidence 99999998884 3433221 1247888888888666666777777888888777543 233
Q ss_pred CccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCce
Q 046265 160 PPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNI 239 (639)
Q Consensus 160 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 239 (639)
+..+..+++|+.+++++|.++. +|.. ..++|+.|++++|...+..+..+..++.++.
T Consensus 143 ~~~~~~l~~L~~l~l~~n~l~~-l~~~----------------------~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~ 199 (305)
T d1xkua_ 143 NGAFQGMKKLSYIRIADTNITT-IPQG----------------------LPPSLTELHLDGNKITKVDAASLKGLNNLAK 199 (305)
T ss_dssp TTGGGGCTTCCEEECCSSCCCS-CCSS----------------------CCTTCSEEECTTSCCCEECTGGGTTCTTCCE
T ss_pred ccccccccccCccccccCCccc-cCcc----------------------cCCccCEEECCCCcCCCCChhHhhccccccc
Confidence 4566777777888877777652 2221 1235666667777776777777777777777
Q ss_pred eccccccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccc
Q 046265 240 VHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVG 308 (639)
Q Consensus 240 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~ 308 (639)
|++++|.+++..+..+..+++|++|+|++|++ ..+|+++..+++|+.|++++|+|+.
T Consensus 200 L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L------------~~lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKL------------VKVPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp EECCSSCCCEECTTTGGGSTTCCEEECCSSCC------------SSCCTTTTTCSSCCEEECCSSCCCC
T ss_pred cccccccccccccccccccccceeeecccccc------------cccccccccccCCCEEECCCCccCc
Confidence 77777777777677777777777777666655 2456666777777777777777663
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.94 E-value=8.1e-25 Score=227.44 Aligned_cols=165 Identities=22% Similarity=0.304 Sum_probs=79.2
Q ss_pred cCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccc
Q 046265 211 LQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKI 290 (639)
Q Consensus 211 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~ 290 (639)
++|+.|++++|++.. + +.+..+++|+.|++++|.+++..+ ++.+++|+.|++++|.+.+ ++ .+
T Consensus 219 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~------------~~-~~ 281 (384)
T d2omza2 219 TNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN------------IS-PL 281 (384)
T ss_dssp TTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC------------CG-GG
T ss_pred CCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCC------------CC-cc
Confidence 344455555555433 1 234455555555555555554332 4445555555554444321 11 13
Q ss_pred cCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCcccccCChhhhcccc
Q 046265 291 GKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQ 370 (639)
Q Consensus 291 ~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~ 370 (639)
..+..++.++++.|.+.+. ..+..+++++.|++++|++++..| +..+++|+.|++++|++.. +| .+..+++
T Consensus 282 ~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~----l~-~l~~l~~ 352 (384)
T d2omza2 282 AGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD----VS-SLANLTN 352 (384)
T ss_dssp TTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC----CG-GGGGCTT
T ss_pred ccccccccccccccccccc--cccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC----Ch-hHcCCCC
Confidence 3444555555555555431 234455555555555555553321 4455555555555543322 12 3455555
Q ss_pred CCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCCC
Q 046265 371 LTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISYN 413 (639)
Q Consensus 371 L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~N 413 (639)
|+.|++++|.+++.. | +.++++|+.|++++|
T Consensus 353 L~~L~l~~N~l~~l~-~-----------l~~l~~L~~L~L~~N 383 (384)
T d2omza2 353 INWLSAGHNQISDLT-P-----------LANLTRITQLGLNDQ 383 (384)
T ss_dssp CCEEECCSSCCCBCG-G-----------GTTCTTCSEEECCCE
T ss_pred CCEEECCCCcCCCCh-h-----------hccCCCCCEeeCCCC
Confidence 555555555554321 1 445555666666555
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.93 E-value=1.8e-24 Score=224.80 Aligned_cols=336 Identities=23% Similarity=0.306 Sum_probs=176.1
Q ss_pred CCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCcccc
Q 046265 15 SNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWL 94 (639)
Q Consensus 15 ~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 94 (639)
.+++.+.++ ...+.+|++|++++|+|+. + +.+..|++|++|+|++|+|++ +| .++++++|++|++++|++++..
T Consensus 31 ~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i~ 104 (384)
T d2omza2 31 KTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADIT 104 (384)
T ss_dssp CSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCCG
T ss_pred CCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCC-Cc-cccCCccccccccccccccccc
Confidence 344444333 2355678888888888874 3 357778888888888888874 44 3788888888888888877533
Q ss_pred CccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEc
Q 046265 95 PSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGF 174 (639)
Q Consensus 95 p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 174 (639)
| ++++++| +.|++++|.+++..+ ......+..+....|.+....+..............
T Consensus 105 ~--l~~l~~L-----------------~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 163 (384)
T d2omza2 105 P--LANLTNL-----------------TGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGN 163 (384)
T ss_dssp G--GTTCTTC-----------------CEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEE
T ss_pred c--ccccccc-----------------ccccccccccccccc--cccccccccccccccccccccccccccccccccccc
Confidence 2 4444433 466666666653322 223345555555555543322221111111111111
Q ss_pred ccCcCCccCCccCcCCCCCCeEEccCCc--cccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcch
Q 046265 175 DLNLLNGVLPPSISNLSNLEGLYLYSSL--VSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIY 252 (639)
Q Consensus 175 ~~N~l~~~~p~~~~~l~~L~~L~l~~~~--~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 252 (639)
....+ ..+.............+. .......++++..+++++|.+.+..| +..+++|+.|++++|.++..
T Consensus 164 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~-- 234 (384)
T d2omza2 164 QVTDL-----KPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI-- 234 (384)
T ss_dssp SCCCC-----GGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--
T ss_pred ccchh-----hhhccccccccccccccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--
Confidence 11111 122222222222222211 12234455566666666666655433 23455666666666666542
Q ss_pred hhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcc
Q 046265 253 EVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYG 332 (639)
Q Consensus 253 ~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~ 332 (639)
..+..+++|+.|++++|.+. + ++ .++.+++|+.|++++|++.+.. .+..++.++.+.++.|.+.+
T Consensus 235 ~~l~~l~~L~~L~l~~n~l~-----------~-~~-~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~ 299 (384)
T d2omza2 235 GTLASLTNLTDLDLANNQIS-----------N-LA-PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED 299 (384)
T ss_dssp GGGGGCTTCSEEECCSSCCC-----------C-CG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC
T ss_pred chhhcccccchhccccCccC-----------C-CC-cccccccCCEeeccCcccCCCC--cccccccccccccccccccc
Confidence 23455566666665555442 1 11 2445556666666666665332 24555666666666666653
Q ss_pred cCCcCccCCCCCCEEeCCCCCCCcccccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhhhcccCcEEccCC
Q 046265 333 SLPRVLGSISDLEYLDLSTNYNNEFRKEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLISRMHGLSCIDISY 412 (639)
Q Consensus 333 ~~p~~~~~l~~L~~L~Ls~N~~~~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~l~~L~~ldls~ 412 (639)
+..+..+++++.|++++|++..+ + .+..+++|+.|++++|.+++ + ..++.+++|+.||+++
T Consensus 300 --~~~~~~~~~l~~L~ls~n~l~~l----~-~l~~l~~L~~L~L~~n~l~~-l-----------~~l~~l~~L~~L~l~~ 360 (384)
T d2omza2 300 --ISPISNLKNLTYLTLYFNNISDI----S-PVSSLTKLQRLFFANNKVSD-V-----------SSLANLTNINWLSAGH 360 (384)
T ss_dssp --CGGGGGCTTCSEEECCSSCCSCC----G-GGGGCTTCCEEECCSSCCCC-C-----------GGGGGCTTCCEEECCS
T ss_pred --ccccchhcccCeEECCCCCCCCC----c-ccccCCCCCEEECCCCCCCC-C-----------hhHcCCCCCCEEECCC
Confidence 22355566666666666443322 1 24556666666666665543 1 2245566666666666
Q ss_pred Ceeeeeec
Q 046265 413 NELRGLIR 420 (639)
Q Consensus 413 N~l~g~~p 420 (639)
|++++..|
T Consensus 361 N~l~~l~~ 368 (384)
T d2omza2 361 NQISDLTP 368 (384)
T ss_dssp SCCCBCGG
T ss_pred CcCCCChh
Confidence 66665543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.6e-24 Score=215.61 Aligned_cols=276 Identities=21% Similarity=0.239 Sum_probs=207.3
Q ss_pred ccceee--eEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCC
Q 046265 2 SCLAFF--FFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSS 79 (639)
Q Consensus 2 ~~~~~~--~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~ 79 (639)
.|.|-. -+.|+.++.++. .+|..+. +++++|+|++|+|++..+.+|.++++|++|++++|++....+..+..+..
T Consensus 5 ~C~C~~~~~~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~ 81 (284)
T d1ozna_ 5 ACVCYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81 (284)
T ss_dssp TCEEECSSSCEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred CCEEcCCCCeEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccc
Confidence 466742 234555555544 7787775 57899999999999777778999999999999999999878888888999
Q ss_pred CCEEeee-cccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCC
Q 046265 80 LKQLVLY-CNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGS 158 (639)
Q Consensus 80 L~~L~L~-~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 158 (639)
++.++.. .|.++...|..|.++++| ++|++++|.+....+..+...++|+.+++++|++++.
T Consensus 82 ~~~l~~~~~~~~~~l~~~~~~~l~~L-----------------~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i 144 (284)
T d1ozna_ 82 LEQLDLSDNAQLRSVDPATFHGLGRL-----------------HTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQAL 144 (284)
T ss_dssp CCEEECCSCTTCCCCCTTTTTTCTTC-----------------CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred ccccccccccccccccchhhcccccC-----------------CEEecCCcccccccccccchhcccchhhhcccccccc
Confidence 9998764 666776667777766643 5899999998877777888889999999999999877
Q ss_pred CCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCc
Q 046265 159 IPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLN 238 (639)
Q Consensus 159 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 238 (639)
.+..|..+++|+.|++++|.+++..+.+|.+++ +|+.+++++|++.+..|.+|.++++|+
T Consensus 145 ~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~--------------------~L~~l~l~~N~l~~i~~~~f~~l~~L~ 204 (284)
T d1ozna_ 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH--------------------SLDRLLLHQNRVAHVHPHAFRDLGRLM 204 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT--------------------TCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred ChhHhccccchhhcccccCcccccchhhhcccc--------------------ccchhhhhhccccccChhHhhhhhhcc
Confidence 777888899999999999999877776666555 455667778888888889999999999
Q ss_pred eeccccccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCC
Q 046265 239 IVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLK 318 (639)
Q Consensus 239 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~ 318 (639)
+|++++|.+.+..+..|+.+++|++|++++|.+.....+ . ++ ...++.+....+++....|..+.+
T Consensus 205 ~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-----~-----~l--~~~l~~~~~~~~~~~C~~p~~l~g-- 270 (284)
T d1ozna_ 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-----R-----PL--WAWLQKFRGSSSEVPCSLPQRLAG-- 270 (284)
T ss_dssp EEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-----H-----HH--HHHHHHCCSEECCCBEEESGGGTT--
T ss_pred cccccccccccccccccccccccCEEEecCCCCCCCccc-----h-----HH--HHHHHhCcCCCCceEeCCchHHcC--
Confidence 999999999999999999999999999888877532110 0 00 112334445555665555655543
Q ss_pred CCCeeeccCccCcc
Q 046265 319 SLNYRALNGNKVYG 332 (639)
Q Consensus 319 ~L~~L~l~~N~l~~ 332 (639)
....+++.+.++|
T Consensus 271 -~~l~~l~~~~l~g 283 (284)
T d1ozna_ 271 -RDLKRLAANDLQG 283 (284)
T ss_dssp -CBGGGSCGGGSCC
T ss_pred -CccccCCHHHCCC
Confidence 3444455555543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=1.1e-23 Score=211.81 Aligned_cols=268 Identities=21% Similarity=0.266 Sum_probs=168.9
Q ss_pred CCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCC
Q 046265 31 NLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMP 110 (639)
Q Consensus 31 ~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp 110 (639)
..+.+|-++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L------ 81 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL------ 81 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTC------
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCcc------
Confidence 4677888888887 5676664 578888888888874444568888888888888888887667777766633
Q ss_pred CCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCC
Q 046265 111 NSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNL 190 (639)
Q Consensus 111 ~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 190 (639)
++|++++|+++ .+|..+ ...|+.|++.+|.+.+..+..+.....+..++...|......
T Consensus 82 -----------~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~------- 140 (305)
T d1xkua_ 82 -----------ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG------- 140 (305)
T ss_dssp -----------CEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG-------
T ss_pred -----------CEecccCCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccC-------
Confidence 47888888887 455543 356777888888777655555566666666666665432110
Q ss_pred CCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCc
Q 046265 191 SNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNN 270 (639)
Q Consensus 191 ~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 270 (639)
..+..+..+++|+.+++++|.+.. +|..+ +++|+.|++++|..++..+..|..++.++.|++++|.
T Consensus 141 -----------~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~ 206 (305)
T d1xkua_ 141 -----------IENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206 (305)
T ss_dssp -----------BCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSC
T ss_pred -----------CCccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccc
Confidence 011223445556666666666543 34332 4667777777777776666666666777777655544
Q ss_pred ccccccCcCCccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCc------cCCCCC
Q 046265 271 FYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVL------GSISDL 344 (639)
Q Consensus 271 l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~------~~l~~L 344 (639)
+ ++..+..+..+++|++|+|++|+++ .+|.++..+++|+.|++++|+|+..-+..| ..+.+|
T Consensus 207 l-----------~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L 274 (305)
T d1xkua_ 207 I-----------SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY 274 (305)
T ss_dssp C-----------CEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCC
T ss_pred c-----------cccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCC
Confidence 4 3344555666666777777777665 445666666677777777666653222222 234556
Q ss_pred CEEeCCCCCC
Q 046265 345 EYLDLSTNYN 354 (639)
Q Consensus 345 ~~L~Ls~N~~ 354 (639)
+.|+|++|++
T Consensus 275 ~~L~L~~N~~ 284 (305)
T d1xkua_ 275 SGVSLFSNPV 284 (305)
T ss_dssp SEEECCSSSS
T ss_pred CEEECCCCcC
Confidence 6666666543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=3.8e-23 Score=205.48 Aligned_cols=225 Identities=22% Similarity=0.213 Sum_probs=165.5
Q ss_pred CEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCC
Q 046265 33 KFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNS 112 (639)
Q Consensus 33 ~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~ 112 (639)
...+.++++++ .+|..+. +.+++|+|++|+|+...+.+|.++++|++|++++|++.+..+..+..+..+
T Consensus 14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~-------- 82 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL-------- 82 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC--------
T ss_pred eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccc--------
Confidence 45678888887 6676654 578899999999986555678999999999999999987777777666532
Q ss_pred CcccCCCCccEEEc-cCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCC
Q 046265 113 LSNLTSLSLFHLDL-SENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLS 191 (639)
Q Consensus 113 ~~~l~~L~L~~L~L-~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 191 (639)
..++. ..|.++...|..|.++++|++|++++|.+....+..+....+|+.+++++|+++++.+..|..+
T Consensus 83 ---------~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~- 152 (284)
T d1ozna_ 83 ---------EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL- 152 (284)
T ss_dssp ---------CEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC-
T ss_pred ---------cccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccc-
Confidence 35554 4566776667788888999999999988877667777888888888888888876655554433
Q ss_pred CCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcc
Q 046265 192 NLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNF 271 (639)
Q Consensus 192 ~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 271 (639)
++|+.|++++|++.+..|.+|.++++|+++++++|++++..|..|..+++|++|++++|++
T Consensus 153 -------------------~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i 213 (284)
T d1ozna_ 153 -------------------GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213 (284)
T ss_dssp -------------------TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred -------------------cchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccc
Confidence 3455666667777666667777788888888888888777777777777777777665554
Q ss_pred cccccCcCCccccccCccccCCCCCCEEeccCCcccc
Q 046265 272 YGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVG 308 (639)
Q Consensus 272 ~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~ 308 (639)
.+..|..++.+++|+.|++++|.+..
T Consensus 214 -----------~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 214 -----------SALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp -----------SCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred -----------ccccccccccccccCEEEecCCCCCC
Confidence 33445566677777777777777653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.89 E-value=9e-24 Score=217.87 Aligned_cols=166 Identities=20% Similarity=0.248 Sum_probs=129.3
Q ss_pred cCCCcceeccCCCceEEEEEc-CCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-----------cCceeeeEEEEE
Q 046265 466 NFDAKYCIGTAGQASVYKAEL-PSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-----------HRNVVKFYGFSF 533 (639)
Q Consensus 466 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~~ 533 (639)
+|+..+.||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.++++++ |+|||++++++.
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 478889999999999999964 67999999999753 234456788998887775 578999998886
Q ss_pred cC--CceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCC-----
Q 046265 534 HP--RQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDY----- 606 (639)
Q Consensus 534 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~----- 606 (639)
.. ...+++|+++..+..............+++..+..++.|++.|++|||+.. +|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCccccc
Confidence 43 456677777665554333333333356788899999999999999999832 899999999999998654
Q ss_pred -ceEEccccccccCCCCCCCcceeeeeceeeCCC
Q 046265 607 -DAHVSDFGISKFLKPDSSNWSEFVGTFGYVAPI 639 (639)
Q Consensus 607 -~~kl~DfGla~~~~~~~~~~~~~~gt~~Y~APE 639 (639)
.+|++|||.|...... ....+||+.|||||
T Consensus 169 ~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE 199 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH---YTNSIQTREYRSPE 199 (362)
T ss_dssp EEEEECCCTTCEETTBC---CCSCCSCGGGCCHH
T ss_pred ceeeEeecccccccccc---cccccccccccChh
Confidence 3899999999865432 23468999999998
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=6.4e-22 Score=194.43 Aligned_cols=196 Identities=26% Similarity=0.281 Sum_probs=99.8
Q ss_pred EEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecc
Q 046265 9 FQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCN 88 (639)
Q Consensus 9 ~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 88 (639)
++|+-++++++ .+|+.+. +++++|+|++|.|++..+.+|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|
T Consensus 13 ~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N 87 (266)
T d1p9ag_ 13 LEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHN 87 (266)
T ss_dssp CEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSS
T ss_pred eEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccccccc
Confidence 34555555555 3455543 35666666666665544455666666666666666665 333 2455556666666666
Q ss_pred cCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCc
Q 046265 89 GLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQS 168 (639)
Q Consensus 89 ~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 168 (639)
++++ .+..+..+++ | ++|++++|.+.+..+..+..+.++++|++++|.++...+..+..+++
T Consensus 88 ~l~~-~~~~~~~l~~---------------L--~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~ 149 (266)
T d1p9ag_ 88 QLQS-LPLLGQTLPA---------------L--TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK 149 (266)
T ss_dssp CCSS-CCCCTTTCTT---------------C--CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTT
T ss_pred cccc-cccccccccc---------------c--ccccccccccceeeccccccccccccccccccccceecccccccccc
Confidence 5552 2333333331 1 35555555555444455555555555555555555444444555555
Q ss_pred ccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceecccccccc
Q 046265 169 LLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLT 248 (639)
Q Consensus 169 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 248 (639)
|+.+++++|++++..+..|..+ ++|+.|++++|+++ .+|..+..+++|+.|+|++|.+.
T Consensus 150 l~~l~l~~N~l~~~~~~~~~~l--------------------~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 150 LEKLSLANNNLTELPAGLLNGL--------------------ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CCEEECTTSCCSCCCTTTTTTC--------------------TTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred chhcccccccccccCccccccc--------------------cccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 5555555555554443333322 23334444444443 34444444555555555555443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.8e-21 Score=191.20 Aligned_cols=200 Identities=25% Similarity=0.208 Sum_probs=113.8
Q ss_pred cCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCc
Q 046265 27 GNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAI 106 (639)
Q Consensus 27 ~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 106 (639)
...+.+...|.++++++ .+|+.+. ++|++|+|++|+|++..+.+|.++++|++|+|++|+|+.. | .++.++
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~---- 77 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLP---- 77 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCT----
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccc----
Confidence 34556667788888887 4676654 4677888888888754456677788888888887777632 2 123333
Q ss_pred ccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCcc
Q 046265 107 GSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPS 186 (639)
Q Consensus 107 ~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 186 (639)
+| ++|+|++|+++ ..+..+.++++|++|++++|.+.+..+..+..+.+++.|++++|.++...+..
T Consensus 78 -----------~L--~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~ 143 (266)
T d1p9ag_ 78 -----------VL--GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGL 143 (266)
T ss_dssp -----------TC--CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTT
T ss_pred -----------cc--ccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceecccc
Confidence 22 46777777776 34556666777777777777666555555566666666666666655443332
Q ss_pred CcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEec
Q 046265 187 ISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDL 266 (639)
Q Consensus 187 ~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 266 (639)
+.. ++.++.+++++|++++..+..|..+++|++|+|++|+|+. +|+.+..+++|+.|+|
T Consensus 144 ~~~--------------------l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~-lp~~~~~~~~L~~L~L 202 (266)
T d1p9ag_ 144 LTP--------------------TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFL 202 (266)
T ss_dssp TTT--------------------CTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCCCSEEEC
T ss_pred ccc--------------------cccchhcccccccccccCccccccccccceeecccCCCcc-cChhHCCCCCCCEEEe
Confidence 222 2233334444444444444444444555555555554442 2333333444444444
Q ss_pred cCCc
Q 046265 267 SQNN 270 (639)
Q Consensus 267 s~N~ 270 (639)
++|.
T Consensus 203 ~~Np 206 (266)
T d1p9ag_ 203 HGNP 206 (266)
T ss_dssp CSCC
T ss_pred cCCC
Confidence 4443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=6.3e-22 Score=184.11 Aligned_cols=134 Identities=22% Similarity=0.280 Sum_probs=105.3
Q ss_pred CcceeccCCCceEEEEEcCCCcEEEEEEccCCCCC----------------hhhHHHHHHHHHHHhccccCceeeeEEEE
Q 046265 469 AKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPD----------------MVVQQAFSNEIKALTELRHRNVVKFYGFS 532 (639)
Q Consensus 469 ~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~H~niv~l~~~~ 532 (639)
..+.||+|+||.||+|...+|+.||||.++..... ........+|+..+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 46799999999999998888999999987632110 11223456788899999999999887663
Q ss_pred EcCCceeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCeeeCCCCceEEcc
Q 046265 533 FHPRQSFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHHDYFPPIVHRDISSKNVLLGLDYDAHVSD 612 (639)
Q Consensus 533 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiHrdlk~~Nill~~~~~~kl~D 612 (639)
..++||||++++...++ ++.....++.|+++|++|||.. +|+||||||+|||++++ .++++|
T Consensus 84 ----~~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 ----GNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ----TTEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred ----CCEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 23799999988665432 2233557899999999999998 99999999999999865 589999
Q ss_pred ccccccCC
Q 046265 613 FGISKFLK 620 (639)
Q Consensus 613 fGla~~~~ 620 (639)
||.|+...
T Consensus 146 FG~a~~~~ 153 (191)
T d1zara2 146 FPQSVEVG 153 (191)
T ss_dssp CTTCEETT
T ss_pred CCCcccCC
Confidence 99998764
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=3.1e-18 Score=174.65 Aligned_cols=134 Identities=31% Similarity=0.408 Sum_probs=70.6
Q ss_pred CCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCC
Q 046265 31 NLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMP 110 (639)
Q Consensus 31 ~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp 110 (639)
++++|||++|+++ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++. ++. +|
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~------------lp 97 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSD------------LP 97 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCS------------CC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhh------------hc
Confidence 4666777777665 45542 356666677777666 556543 356666666666552 221 11
Q ss_pred CCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCC
Q 046265 111 NSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNL 190 (639)
Q Consensus 111 ~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 190 (639)
. . |++|++++|.++ .+|. ++.+++|++|++++|.+... |.. ...+..+.+..+... .+..+..+
T Consensus 98 ~------~--L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~--~~~~l~~l 161 (353)
T d1jl5a_ 98 P------L--LEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLE--ELPELQNL 161 (353)
T ss_dssp T------T--CCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS--SCCCCTTC
T ss_pred c------c--cccccccccccc-cccc-hhhhccceeecccccccccc-ccc---cccccchhhcccccc--cccccccc
Confidence 1 1 246666666665 4443 45666666666666666532 222 233444444443332 12334455
Q ss_pred CCCCeEEccCC
Q 046265 191 SNLEGLYLYSS 201 (639)
Q Consensus 191 ~~L~~L~l~~~ 201 (639)
+.++.+++..+
T Consensus 162 ~~l~~L~l~~n 172 (353)
T d1jl5a_ 162 PFLTAIYADNN 172 (353)
T ss_dssp TTCCEEECCSS
T ss_pred ccceecccccc
Confidence 55555555443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.77 E-value=2.8e-17 Score=167.47 Aligned_cols=295 Identities=27% Similarity=0.300 Sum_probs=201.6
Q ss_pred cceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCE
Q 046265 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQ 82 (639)
Q Consensus 3 ~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 82 (639)
|..-....+++++++++ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.. . +.|++
T Consensus 35 c~~~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l-p--~~L~~ 102 (353)
T d1jl5a_ 35 CLDRQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL-P--PLLEY 102 (353)
T ss_dssp HHHHTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC-C--TTCCE
T ss_pred HHHcCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh-c--ccccc
Confidence 43344668899999986 57864 468999999999998 678664 57899999999998 45532 1 46999
Q ss_pred EeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCcc
Q 046265 83 LVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPI 162 (639)
Q Consensus 83 L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 162 (639)
|++++|.++. +|. ++.+++ | ++|++++|.++. .|.. ...+..+.+..+... .+..
T Consensus 103 L~L~~n~l~~-lp~-~~~l~~---------------L--~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~ 157 (353)
T d1jl5a_ 103 LGVSNNQLEK-LPE-LQNSSF---------------L--KIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPE 157 (353)
T ss_dssp EECCSSCCSS-CCC-CTTCTT---------------C--CEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--SCCC
T ss_pred cccccccccc-ccc-hhhhcc---------------c--eeeccccccccc-cccc---cccccchhhcccccc--cccc
Confidence 9999999984 443 445553 3 589999988873 3433 456777887766554 3456
Q ss_pred ccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCcc--ccccccccCCcEEEcCCcccCCCCCccccCCCCCcee
Q 046265 163 LGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLV--SAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIV 240 (639)
Q Consensus 163 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~--~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L 240 (639)
+..++.++.++++.|.+.... .. ....+.+......+ ...+..++.|+.+++++|.... +|.. ..++..+
T Consensus 158 l~~l~~l~~L~l~~n~~~~~~-~~---~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~~---~~~l~~~ 229 (353)
T d1jl5a_ 158 LQNLPFLTAIYADNNSLKKLP-DL---PLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPDL---PPSLEAL 229 (353)
T ss_dssp CTTCTTCCEEECCSSCCSSCC-CC---CTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEE
T ss_pred ccccccceecccccccccccc-cc---cccccccccccccccccccccccccccccccccccccc-cccc---ccccccc
Confidence 778888999999998876432 21 22334455543322 1235667888999998887643 4433 4556677
Q ss_pred ccccccccCcchhhhhcCCCccEEeccCCccccc---------ccCcCCccccccCccccCCCCCCEEeccCCcccccCC
Q 046265 241 HLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGS---------LNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELP 311 (639)
Q Consensus 241 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---------l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p 311 (639)
.+..+.+.... ...+.+...++..+.+.+- .++..+.+. .....+++|++|++++|++. .+|
T Consensus 230 ~~~~~~~~~~~----~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~----~~~~~~~~L~~L~Ls~N~l~-~lp 300 (353)
T d1jl5a_ 230 NVRDNYLTDLP----ELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR----SLCDLPPSLEELNVSNNKLI-ELP 300 (353)
T ss_dssp ECCSSCCSCCC----CCCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCS----EECCCCTTCCEEECCSSCCS-CCC
T ss_pred ccccccccccc----cccccccccccccccccccccccchhcccccccCccc----cccccCCCCCEEECCCCccC-ccc
Confidence 77777776432 2235566777777666542 123333332 22234678999999999997 566
Q ss_pred ccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCCCCCCCccc
Q 046265 312 IELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLSTNYNNEFR 358 (639)
Q Consensus 312 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~ 358 (639)
.. +++|+.|++++|+++ .+|.. +++|+.|++++|++..++
T Consensus 301 ~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~lp 340 (353)
T d1jl5a_ 301 AL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLREFP 340 (353)
T ss_dssp CC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSSCC
T ss_pred cc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCCCC
Confidence 54 568899999999998 67753 568999999998766553
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=4.6e-18 Score=164.05 Aligned_cols=157 Identities=15% Similarity=0.111 Sum_probs=84.1
Q ss_pred cceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCC-CcccCCCCCCC
Q 046265 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSV-PREVGQLSSLK 81 (639)
Q Consensus 3 ~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~-p~~~~~l~~L~ 81 (639)
|.|+. ..++-++.++. .+|..+. +++++|+|++|.|+...+.+|.++++|++|++++|.+...+ +..|..+++++
T Consensus 6 C~C~~-~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~ 81 (242)
T d1xwdc1 6 CHCSN-RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLH 81 (242)
T ss_dssp EEECS-SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCC
T ss_pred CCCcC-CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccc
Confidence 66664 34555555554 6666553 46777777777777555556777777777777777765433 33566677777
Q ss_pred EEeeec-ccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCc-cccCCCCCCEEeccCCCCCCCC
Q 046265 82 QLVLYC-NGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPH-FLGHLSNLAVLHLGDNSLFGSI 159 (639)
Q Consensus 82 ~L~L~~-N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~ 159 (639)
+|.+.. |++....+..|.++++| ++|++++|++....+. .+..+..+..+..+++.+....
T Consensus 82 ~l~~~~~n~l~~~~~~~~~~l~~L-----------------~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~ 144 (242)
T d1xwdc1 82 EIRIEKANNLLYINPEAFQNLPNL-----------------QYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 144 (242)
T ss_dssp EEEEECCTTCCEECTTSEECCTTC-----------------CEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEEC
T ss_pred cccccccccccccccccccccccc-----------------cccccchhhhccccccccccccccccccccccccccccc
Confidence 776543 45555555555554422 3566666655422111 1223333444444444444333
Q ss_pred CccccCCC-cccEEEcccCcCC
Q 046265 160 PPILGKVQ-SLLSLGFDLNLLN 180 (639)
Q Consensus 160 p~~~~~l~-~L~~L~l~~N~l~ 180 (639)
+..|..+. .++.|++++|.++
T Consensus 145 ~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 145 RNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp TTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccccccccceeeeccccccc
Confidence 33333332 4444555555444
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=4.4e-18 Score=157.84 Aligned_cols=164 Identities=23% Similarity=0.222 Sum_probs=132.9
Q ss_pred ccceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCCCCccCC-CCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCC
Q 046265 2 SCLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVI-PQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSL 80 (639)
Q Consensus 2 ~~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L 80 (639)
.|.|.. ..|+.+++++. .+|..+. +++++|+|++|.|++.+ +..|..+++|+.|+|++|.++...+..|..+++|
T Consensus 5 ~C~C~~-~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L 80 (192)
T d1w8aa_ 5 MCHCEG-TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80 (192)
T ss_dssp TSEEET-TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTC
T ss_pred CCEEcC-CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccccccc
Confidence 377754 47888888887 6788774 68999999999998644 5667999999999999999998888999999999
Q ss_pred CEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCC
Q 046265 81 KQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIP 160 (639)
Q Consensus 81 ~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 160 (639)
++|+|++|++++..|..|.++++| ++|+|++|+|++..|.+|..+++|++|+|++|.+....+
T Consensus 81 ~~L~Ls~N~l~~l~~~~F~~l~~L-----------------~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 81 QELQLGENKIKEISNKMFLGLHQL-----------------KTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CEEECCSCCCCEECSSSSTTCTTC-----------------CEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred ceeeeccccccccCHHHHhCCCcc-----------------cccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 999999999998888888888744 589999999998888899999999999999999876443
Q ss_pred ccccCCCcccEEEcccCcCCccCCccC
Q 046265 161 PILGKVQSLLSLGFDLNLLNGVLPPSI 187 (639)
Q Consensus 161 ~~~~~l~~L~~L~l~~N~l~~~~p~~~ 187 (639)
..+ -...++.+.+..|.+....|..+
T Consensus 144 ~~~-~~~~l~~~~l~~~~~~c~~p~~l 169 (192)
T d1w8aa_ 144 LAW-FAEWLRKKSLNGGAARCGAPSKV 169 (192)
T ss_dssp GHH-HHHHHHHHCCSGGGCBBCSSTTT
T ss_pred hHH-HhhhhhhhcccCCCeEeCCChhh
Confidence 221 12345666677777776666443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=1.6e-17 Score=154.07 Aligned_cols=130 Identities=28% Similarity=0.352 Sum_probs=101.1
Q ss_pred CCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCC-CcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCC
Q 046265 32 LKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSV-PREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMP 110 (639)
Q Consensus 32 L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp 110 (639)
.++++.++++++ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..|..+++|
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L------ 80 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI------ 80 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTC------
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccccccc------
Confidence 457888888887 6677664 67888888888887544 5567888888888888888887777777776633
Q ss_pred CCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCc
Q 046265 111 NSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNG 181 (639)
Q Consensus 111 ~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 181 (639)
++|+|++|+++...|.+|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+..
T Consensus 81 -----------~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 81 -----------QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp -----------CEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred -----------ceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence 478888888887777778888888888888888887777778888888888888887653
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=1.7e-16 Score=152.87 Aligned_cols=129 Identities=17% Similarity=0.188 Sum_probs=83.9
Q ss_pred CEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccC-ccccCCCCCCcccCCC
Q 046265 33 KFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLP-SSFGNLNNLAIGSMPN 111 (639)
Q Consensus 33 ~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~~~lp~ 111 (639)
+.++.++++++ .+|+.+. +++++|||++|+|+...+..|.++++|++|++++|.+...+| ..|.++.++
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l------- 80 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL------- 80 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTC-------
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccc-------
Confidence 67888888887 6776653 578888888888875444568888888888888888765443 355555533
Q ss_pred CCcccCCCCccEEEcc-CCcCcccCCccccCCCCCCEEeccCCCCCCCCCc-cccCCCcccEEEcccCcCCc
Q 046265 112 SLSNLTSLSLFHLDLS-ENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPP-ILGKVQSLLSLGFDLNLLNG 181 (639)
Q Consensus 112 ~~~~l~~L~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~ 181 (639)
+++++. .|++....+..|.++++|++|++++|.+....+. .+..++.+..+..+++.+..
T Consensus 81 ----------~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~ 142 (242)
T d1xwdc1 81 ----------HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT 142 (242)
T ss_dssp ----------CEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCE
T ss_pred ----------ccccccccccccccccccccccccccccccchhhhccccccccccccccccccccccccccc
Confidence 355543 4566666677777888888888888877643221 23334444444445554443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=1.1e-16 Score=152.57 Aligned_cols=201 Identities=18% Similarity=0.292 Sum_probs=95.9
Q ss_pred EEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCc
Q 046265 123 HLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSL 202 (639)
Q Consensus 123 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~ 202 (639)
.++++.+++++.+ .+..+.+|+.|++.+|.++. ++ .+..+++|++|++++|.+++..| +..+++++.++++.+.
T Consensus 23 ~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~ 96 (227)
T d1h6ua2 23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (227)
T ss_dssp HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccc
Confidence 3455566665433 33456777777777777763 43 46777777777777777765432 4555555555554332
Q ss_pred cc--cccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccCcCC
Q 046265 203 VS--AEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMN 280 (639)
Q Consensus 203 ~~--~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n 280 (639)
+. ..+..+++|+.++++++...+. ..+...+.+..+.++++.+.... .+..+++|+.|++++|.+.
T Consensus 97 ~~~i~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~-------- 164 (227)
T d1h6ua2 97 LKNVSAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVS-------- 164 (227)
T ss_dssp CSCCGGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCC--------
T ss_pred cccccccccccccccccccccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccccccc--------
Confidence 21 1233344444444444443322 11333444444444444444322 1334444454444444331
Q ss_pred ccccccCccccCCCCCCEEeccCCcccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCCEEeCC
Q 046265 281 NITRSIPPKIGKLYQLHKLDFSLNHIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLEYLDLS 350 (639)
Q Consensus 281 ~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 350 (639)
. ...++.+++|+.|++++|++++ +| .+..+++|+.|++++|+++. +|. ++++++|+.|+++
T Consensus 165 ---~--~~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~-i~~-l~~l~~L~~L~ls 225 (227)
T d1h6ua2 165 ---D--LTPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISD-VSP-LANTSNLFIVTLT 225 (227)
T ss_dssp ---C--CGGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCB-CGG-GTTCTTCCEEEEE
T ss_pred ---c--chhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCC-Ccc-cccCCCCCEEEee
Confidence 0 1113344444555555544442 21 24444444444444444442 221 3444444444443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=8.3e-17 Score=153.45 Aligned_cols=202 Identities=21% Similarity=0.312 Sum_probs=92.5
Q ss_pred EECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCc
Q 046265 35 LDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLS 114 (639)
Q Consensus 35 L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~ 114 (639)
++++.+++++.. .+..|.+|+.|++.+|.|+ .++ .+..+++|++|++++|++++..| +..+.
T Consensus 24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~------------ 85 (227)
T d1h6ua2 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLT------------ 85 (227)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCC------------
T ss_pred HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--ccccc------------
Confidence 344444444322 2344455555555555554 232 34555555555555555543221 22222
Q ss_pred ccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcCCCCCC
Q 046265 115 NLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLE 194 (639)
Q Consensus 115 ~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 194 (639)
.+ +++++++|.++ .++ .+.++++|+++++++|...+. ..+.....+..+.++.+.+.... .+
T Consensus 86 ---~l--~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~------- 147 (227)
T d1h6ua2 86 ---KI--TELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PL------- 147 (227)
T ss_dssp ---SC--CEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GG-------
T ss_pred ---cc--ccccccccccc-ccc-ccccccccccccccccccccc--chhccccchhhhhchhhhhchhh--hh-------
Confidence 11 34555555444 222 244555555555555554432 22334445555555554443221 12
Q ss_pred eEEccCCccccccccccCCcEEEcCCcccCCCCCccccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCccccc
Q 046265 195 GLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGS 274 (639)
Q Consensus 195 ~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 274 (639)
...++|+.|++++|.+... ..+.++++|+.|++++|++++.. .++.+++|++|++++|+++
T Consensus 148 -------------~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt-- 208 (227)
T d1h6ua2 148 -------------AGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQIS-- 208 (227)
T ss_dssp -------------GGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCC--
T ss_pred -------------ccccccccccccccccccc--hhhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCC--
Confidence 2233344444444444321 12455556666666666555432 2555566666665555442
Q ss_pred ccCcCCccccccCccccCCCCCCEEecc
Q 046265 275 LNFSMNNITRSIPPKIGKLYQLHKLDFS 302 (639)
Q Consensus 275 l~ls~n~~~~~~p~~~~~l~~L~~L~Ls 302 (639)
.+| .+..+++|+.|+++
T Consensus 209 ----------~i~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 209 ----------DVS-PLANTSNLFIVTLT 225 (227)
T ss_dssp ----------BCG-GGTTCTTCCEEEEE
T ss_pred ----------CCc-ccccCCCCCEEEee
Confidence 222 24556666666664
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.65 E-value=4.6e-16 Score=146.15 Aligned_cols=118 Identities=25% Similarity=0.344 Sum_probs=54.5
Q ss_pred ECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCcc
Q 046265 36 DMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSN 115 (639)
Q Consensus 36 ~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~ 115 (639)
+++.+.+++.++. ..|.+|+.|++++|.++. ++ .+..+++|++|++++|++++..| ++.++
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~~--~~~l~------------- 90 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLK------------- 90 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCT-------------
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCccc--cccCc-------------
Confidence 4444444433321 234455555555555542 22 24555555555555555553211 22222
Q ss_pred cCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCC
Q 046265 116 LTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLN 180 (639)
Q Consensus 116 l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 180 (639)
+| ++|++++|+++ .+| .+..+++|+.|++++|.+.. + ..+..++.|+.++++.|.++
T Consensus 91 --~L--~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~ 147 (210)
T d1h6ta2 91 --NL--GWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKIT 147 (210)
T ss_dssp --TC--CEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCC
T ss_pred --cc--ccccccccccc-ccc-cccccccccccccccccccc-c-cccccccccccccccccccc
Confidence 11 35555555554 233 24555555555555555432 1 23444555555555555443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.65 E-value=7.9e-16 Score=144.52 Aligned_cols=176 Identities=26% Similarity=0.396 Sum_probs=119.4
Q ss_pred CCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccc
Q 046265 14 ESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGW 93 (639)
Q Consensus 14 ~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 93 (639)
..+.+.+.++. ..+..|++|++++|.++.. + .+..+++|++|+|++|++++ ++ .++.+++|++|++++|++++
T Consensus 32 ~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~- 104 (210)
T d1h6ta2 32 KKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD- 104 (210)
T ss_dssp TCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-
T ss_pred CcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-
Confidence 34444444432 3466788888888888743 3 37788888999998888884 44 36788888999988888874
Q ss_pred cCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEE
Q 046265 94 LPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLG 173 (639)
Q Consensus 94 ~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 173 (639)
+| .+.++++| +.|++++|.+. .+ ..+.++++|+.+++++|.++. +..+..+++|+.++
T Consensus 105 l~-~l~~l~~L-----------------~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~ 162 (210)
T d1h6ta2 105 LS-SLKDLKKL-----------------KSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLS 162 (210)
T ss_dssp GG-GGTTCTTC-----------------CEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEE
T ss_pred cc-cccccccc-----------------ccccccccccc-cc-ccccccccccccccccccccc--cccccccccccccc
Confidence 33 35555533 47777777765 33 346677777777777777753 33466777777777
Q ss_pred cccCcCCccCCccCcCCCCCCeEEccCCccc--cccccccCCcEEEcCC
Q 046265 174 FDLNLLNGVLPPSISNLSNLEGLYLYSSLVS--AEIGNLLQLIELEIDN 220 (639)
Q Consensus 174 l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~--~~~~~l~~L~~L~l~~ 220 (639)
+++|++++. + .+.++++|+.|+++.+.+. ..+..+++|+.|++++
T Consensus 163 l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~l~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 163 LEDNQISDI-V-PLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFS 209 (210)
T ss_dssp CCSSCCCCC-G-GGTTCTTCCEEECCSSCCCBCGGGTTCTTCSEEEEEE
T ss_pred ccccccccc-c-cccCCCCCCEEECCCCCCCCChhhcCCCCCCEEEccC
Confidence 777777653 2 2667777777777765543 2466777777777753
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.64 E-value=1.2e-15 Score=141.92 Aligned_cols=173 Identities=24% Similarity=0.349 Sum_probs=126.4
Q ss_pred eCCCcccccCCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCcc
Q 046265 13 HESNTLFAIIPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSG 92 (639)
Q Consensus 13 ~~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 92 (639)
+..+.+.+.++ ...+.++++|++++|+++. ++ .+..+++|++|++++|++++ +++ ++++++|++|++++|.+..
T Consensus 25 l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~~ 98 (199)
T d2omxa2 25 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD 98 (199)
T ss_dssp TTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC
T ss_pred hCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccC-ccc-ccCCccccccccccccccc
Confidence 44455554433 3457789999999999874 43 48889999999999999985 443 8899999999999998774
Q ss_pred ccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEE
Q 046265 93 WLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSL 172 (639)
Q Consensus 93 ~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 172 (639)
. + .+.++++ | ++|++++|.+... ..+..+++|+.|++++|++.. + +.+..+++|+.|
T Consensus 99 ~-~-~l~~l~~---------------L--~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L 155 (199)
T d2omxa2 99 I-T-PLANLTN---------------L--TGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQL 155 (199)
T ss_dssp C-G-GGTTCTT---------------C--SEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEE
T ss_pred c-c-ccccccc---------------c--ccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-cccccccccccc
Confidence 2 2 2555543 2 5788888877632 346788888888888888863 3 357788888888
Q ss_pred EcccCcCCccCCccCcCCCCCCeEEccCCcccc--ccccccCCcEE
Q 046265 173 GFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSA--EIGNLLQLIEL 216 (639)
Q Consensus 173 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~--~~~~l~~L~~L 216 (639)
++++|++++.. .++++++|+.|+++++.+.. .+..+++|+.|
T Consensus 156 ~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~i~~l~~L~~L~~L 199 (199)
T d2omxa2 156 NFSSNQVTDLK--PLANLTTLERLDISSNKVSDISVLAKLTNLESL 199 (199)
T ss_dssp ECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEE
T ss_pred ccccccccCCc--cccCCCCCCEEECCCCCCCCCccccCCCCCCcC
Confidence 88888887642 47788888888888776543 45667777654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.63 E-value=1.8e-15 Score=140.81 Aligned_cols=180 Identities=24% Similarity=0.343 Sum_probs=136.5
Q ss_pred CCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccC
Q 046265 30 SNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSM 109 (639)
Q Consensus 30 ~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~l 109 (639)
.+...+.++.+.+++.++ ...+.++++|++++|.++ .++ .+..+++|++|++++|++++..| ++++++|
T Consensus 18 ~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L----- 86 (199)
T d2omxa2 18 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKL----- 86 (199)
T ss_dssp HHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTC-----
T ss_pred HHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc--ccCCccc-----
Confidence 344455677787775443 356788999999999987 454 47889999999999999886433 5555532
Q ss_pred CCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccCcCCccCCccCcC
Q 046265 110 PNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLNLLNGVLPPSISN 189 (639)
Q Consensus 110 p~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 189 (639)
++|++++|.+. .++ .+.++++|+.|++++|.+... +.+..+++|+.|++++|.+.. + +.+..
T Consensus 87 ------------~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~ 148 (199)
T d2omxa2 87 ------------VDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSG 148 (199)
T ss_dssp ------------CEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTT
T ss_pred ------------ccccccccccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccc
Confidence 58999999887 444 478899999999998888653 347788999999999998874 3 35788
Q ss_pred CCCCCeEEccCCcccc--ccccccCCcEEEcCCcccCCCCCccccCCCCCcee
Q 046265 190 LSNLEGLYLYSSLVSA--EIGNLLQLIELEIDNKQLFGQIPKSLRNFTSLNIV 240 (639)
Q Consensus 190 l~~L~~L~l~~~~~~~--~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L 240 (639)
+++|+.|++..+.+.. .++.+++|+.|++++|+++. +| .+.++++|+.|
T Consensus 149 ~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 149 LTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp CTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cccccccccccccccCCccccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 8999999998765532 47788999999999998865 44 47788888765
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=1e-17 Score=177.12 Aligned_cols=195 Identities=17% Similarity=0.054 Sum_probs=96.7
Q ss_pred cccCCcEEEcCCcccCCC-----CCccccCCCCCceeccccccccCcc----hhhhhcCCCccEEeccCCcccccccCcC
Q 046265 209 NLLQLIELEIDNKQLFGQ-----IPKSLRNFTSLNIVHLEQNHLTGNI----YEVFGIYPNLTFLDLSQNNFYGSLNFSM 279 (639)
Q Consensus 209 ~l~~L~~L~l~~n~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~l~ls~ 279 (639)
....++.+++++|.+... .+........++.+++++|.+.... ...+...+.++.+++++|.+...
T Consensus 224 ~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~----- 298 (460)
T d1z7xw1 224 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE----- 298 (460)
T ss_dssp HCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHH-----
T ss_pred ccccccccchhhccccccccchhhccccccccccccccccccccccccccccccccccccccccccccccccccc-----
Confidence 345566666666543211 1122233455666666666554322 22234455666666555554210
Q ss_pred CccccccCccc-cCCCCCCEEeccCCcccccCCc----cccCCCCCCeeeccCccCccc----CCcCcc-CCCCCCEEeC
Q 046265 280 NNITRSIPPKI-GKLYQLHKLDFSLNHIVGELPI----ELGNLKSLNYRALNGNKVYGS----LPRVLG-SISDLEYLDL 349 (639)
Q Consensus 280 n~~~~~~p~~~-~~l~~L~~L~Ls~N~~~~~~p~----~~~~l~~L~~L~l~~N~l~~~----~p~~~~-~l~~L~~L~L 349 (639)
.+ ..+...+ .....|+.+++++|.+...... .+...++|+.|+|++|.+... ++..+. ..+.|+.|+|
T Consensus 299 -~~-~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~L 376 (460)
T d1z7xw1 299 -GA-RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWL 376 (460)
T ss_dssp -HH-HHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred -cc-chhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEEC
Confidence 00 0011111 1234677777777776543222 233455677777777777532 233332 3456777777
Q ss_pred CCCCCCccc-ccCChhhhccccCCeeeccCCcCceeecCcchhhhhhhhhhh-hcccCcEEccCCCeee
Q 046265 350 STNYNNEFR-KEFPVELEKLVQLTELDLVITFWEERYRPKSVIWKAWRSLIS-RMHGLSCIDISYNELR 416 (639)
Q Consensus 350 s~N~~~~~~-~~~p~~~~~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~-~l~~L~~ldls~N~l~ 416 (639)
++|.+.... ..++..+..+++|++|++++|.+.... +..+...+. .-..|+.++++.|.+.
T Consensus 377 s~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g------~~~l~~~l~~~~~~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 377 ADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG------ILQLVESVRQPGCLLEQLVLYDIYWS 439 (460)
T ss_dssp TTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHH------HHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred CCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHH------HHHHHHHHHhCCCccCEEECCCCCCC
Confidence 775443211 123444556677777777777665422 111112222 2235777777777654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=2.6e-17 Score=173.84 Aligned_cols=372 Identities=19% Similarity=0.147 Sum_probs=217.9
Q ss_pred eeEEEEeCCCcccccC-CccccCCCCCCEEECcCCCCcc----CCCCCCCCCCCCCEEEcccCcCCC----CCCcccC-C
Q 046265 7 FFFQVVHESNTLFAII-PPQIGNISNLKFLDMGNNQLSG----VIPQEIDPLTHLKHLYINVNKLRG----SVPREVG-Q 76 (639)
Q Consensus 7 ~~~~~~~~~n~~~~~~-p~~~~~l~~L~~L~Ls~n~l~~----~~p~~~~~L~~L~~L~L~~N~l~~----~~p~~~~-~ 76 (639)
.+..+|+++|+++... ..-+..++++++|+|++|+++. .++..+..+++|++|||++|.|+. .+...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 4567888888887642 3345667888899999998762 234456788889999999888852 1222332 2
Q ss_pred CCCCCEEeeecccCccc----cCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCcc--------------
Q 046265 77 LSSLKQLVLYCNGLSGW----LPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHF-------------- 138 (639)
Q Consensus 77 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~-------------- 138 (639)
..+|++|+|++|+++.. ++..+..+++ | ++|++++|.++..-...
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~---------------L--~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~ 145 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPT---------------L--QELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 145 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTT---------------C--CEEECCSSBCHHHHHHHHHHHHTSTTCCCCE
T ss_pred CCCCCEEECCCCCccccccccccchhhcccc---------------c--cccccccccchhhhhhhhhhccccccccccc
Confidence 34789999998888743 2333444442 2 47777777664211111
Q ss_pred -------------------ccCCCCCCEEeccCCCCCCC----CCccc-cCCCcccEEEcccCcCCcc----CCccCcCC
Q 046265 139 -------------------LGHLSNLAVLHLGDNSLFGS----IPPIL-GKVQSLLSLGFDLNLLNGV----LPPSISNL 190 (639)
Q Consensus 139 -------------------~~~l~~L~~L~L~~N~l~~~----~p~~~-~~l~~L~~L~l~~N~l~~~----~p~~~~~l 190 (639)
+.....++.++++++..... ....+ ........+++..+.+... ....+...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~ 225 (460)
T d1z7xw1 146 LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASK 225 (460)
T ss_dssp EECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHC
T ss_pred ccccccccchhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhccccccccc
Confidence 11223444555544433210 00000 1112334455555544311 11123345
Q ss_pred CCCCeEEccCCcccc---------ccccccCCcEEEcCCcccCCC----CCccccCCCCCceeccccccccCcchhhh--
Q 046265 191 SNLEGLYLYSSLVSA---------EIGNLLQLIELEIDNKQLFGQ----IPKSLRNFTSLNIVHLEQNHLTGNIYEVF-- 255 (639)
Q Consensus 191 ~~L~~L~l~~~~~~~---------~~~~l~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-- 255 (639)
..++.+++..+.+.. .......++.+++++|.+... ....+...+.++.+++++|.++......+
T Consensus 226 ~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~ 305 (460)
T d1z7xw1 226 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 305 (460)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred ccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhc
Confidence 677788877554321 233456899999999887543 22345567889999999998875333222
Q ss_pred ---hcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCccccc----CCcccc-CCCCCCeeeccC
Q 046265 256 ---GIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGE----LPIELG-NLKSLNYRALNG 327 (639)
Q Consensus 256 ---~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~----~p~~~~-~l~~L~~L~l~~ 327 (639)
.....|+.+++++|.+... .. ..+...+....+|+.|+|++|++... ++..+. ..+.|+.|+|++
T Consensus 306 ~l~~~~~~L~~l~l~~~~l~~~------~~-~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~ 378 (460)
T d1z7xw1 306 TLLEPGCQLESLWVKSCSFTAA------CC-SHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD 378 (460)
T ss_dssp HHTSTTCCCCEEECTTSCCBGG------GH-HHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred cccccccccccccccccchhhh------hh-hhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCC
Confidence 2346789999888776321 00 11222334556899999999998643 333333 467799999999
Q ss_pred ccCccc----CCcCccCCCCCCEEeCCCCCCCccc-ccCChhhh-ccccCCeeeccCCcCceeecCcchhhhhhhhhhhh
Q 046265 328 NKVYGS----LPRVLGSISDLEYLDLSTNYNNEFR-KEFPVELE-KLVQLTELDLVITFWEERYRPKSVIWKAWRSLISR 401 (639)
Q Consensus 328 N~l~~~----~p~~~~~l~~L~~L~Ls~N~~~~~~-~~~p~~~~-~l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~ 401 (639)
|.++.. ++..+..+++|++|||++|++..-. ..+...+. ....|+.+++..+.+..+. . +........
T Consensus 379 n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~-~-----~~l~~l~~~ 452 (460)
T d1z7xw1 379 CDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEM-E-----DRLQALEKD 452 (460)
T ss_dssp SCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHH-H-----HHHHHHHHH
T ss_pred CCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHH-H-----HHHHHHHHh
Confidence 999742 4455667899999999997654211 01111222 2346999999998877543 1 222334445
Q ss_pred cccCcEE
Q 046265 402 MHGLSCI 408 (639)
Q Consensus 402 l~~L~~l 408 (639)
.++|+++
T Consensus 453 ~~~l~~~ 459 (460)
T d1z7xw1 453 KPSLRVI 459 (460)
T ss_dssp CTTSEEE
T ss_pred CCCCEEe
Confidence 6666654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=6.1e-15 Score=131.82 Aligned_cols=127 Identities=22% Similarity=0.207 Sum_probs=90.7
Q ss_pred cccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCC
Q 046265 25 QIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNL 104 (639)
Q Consensus 25 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 104 (639)
.+.+..++++|||++|+|+ .+|..+..+++|++|||++|+|+ .++ .|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 4667778888999999887 45666678888888888888887 454 47888888888888888886555445555532
Q ss_pred CcccCCCCCcccCCCCccEEEccCCcCcccCC--ccccCCCCCCEEeccCCCCCCCCCc----cccCCCcccEEE
Q 046265 105 AIGSMPNSLSNLTSLSLFHLDLSENQLSGSIP--HFLGHLSNLAVLHLGDNSLFGSIPP----ILGKVQSLLSLG 173 (639)
Q Consensus 105 ~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~ 173 (639)
++|++++|+++ .++ ..+..+++|++|++++|.++. .|. .+..+++|++||
T Consensus 90 -----------------~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 -----------------TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp -----------------CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred -----------------ccceecccccc-ccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence 47888888876 333 356777888888888887753 332 355666666654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=2.8e-14 Score=121.14 Aligned_cols=102 Identities=29% Similarity=0.402 Sum_probs=65.0
Q ss_pred CEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCC
Q 046265 33 KFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNS 112 (639)
Q Consensus 33 ~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~ 112 (639)
|+|||++|+++ .+| .+..+++|++|++++|+|+ .+|+.|+.+++|++|++++|+|+. +| .+..+++
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~--------- 66 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPR--------- 66 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSS---------
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccc---------
Confidence 46777777776 344 3677777777777777776 566677777777777777777763 22 2444432
Q ss_pred CcccCCCCccEEEccCCcCcccC-CccccCCCCCCEEeccCCCCC
Q 046265 113 LSNLTSLSLFHLDLSENQLSGSI-PHFLGHLSNLAVLHLGDNSLF 156 (639)
Q Consensus 113 ~~~l~~L~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~ 156 (639)
| ++|++++|+++... ...+..+++|++|++++|.++
T Consensus 67 ------L--~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 67 ------L--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp ------C--CEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ------c--CeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 2 46677777665322 134666677777777777665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.47 E-value=7.8e-14 Score=118.36 Aligned_cols=103 Identities=27% Similarity=0.252 Sum_probs=87.1
Q ss_pred CEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCC
Q 046265 57 KHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIP 136 (639)
Q Consensus 57 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p 136 (639)
|+|||++|+++ .+| .+.++++|++|++++|+++ .+|+.|+.+++| ++|++++|+++ .+|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L-----------------~~L~l~~N~i~-~l~ 59 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCL-----------------EVLQASDNALE-NVD 59 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTC-----------------CEEECCSSCCC-CCG
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcc-----------------ccccccccccc-ccC
Confidence 68999999998 566 4899999999999999998 567777777743 58999999998 455
Q ss_pred ccccCCCCCCEEeccCCCCCCCCC-ccccCCCcccEEEcccCcCCc
Q 046265 137 HFLGHLSNLAVLHLGDNSLFGSIP-PILGKVQSLLSLGFDLNLLNG 181 (639)
Q Consensus 137 ~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~ 181 (639)
.++.+++|++|++++|+++...+ ..++.+++|+.|++++|.++.
T Consensus 60 -~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 60 -GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp -GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred -ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 48899999999999999985432 568899999999999999874
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=3.1e-14 Score=127.14 Aligned_cols=128 Identities=18% Similarity=0.116 Sum_probs=99.7
Q ss_pred CCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccC
Q 046265 49 EIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSE 128 (639)
Q Consensus 49 ~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~ 128 (639)
.+.+..+|++|||++|+|+ .+|..+..+++|+.|+|++|+|+.. + .|..++ +| ++|++++
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~-~~~~l~---------------~L--~~L~ls~ 72 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-D-GFPLLR---------------RL--KTLLVNN 72 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-C-CCCCCS---------------SC--CEEECCS
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-C-CcccCc---------------ch--hhhhccc
Confidence 4678889999999999998 5787778899999999999999843 2 355444 33 6999999
Q ss_pred CcCcccCCccccCCCCCCEEeccCCCCCCCCC--ccccCCCcccEEEcccCcCCccC---CccCcCCCCCCeEE
Q 046265 129 NQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIP--PILGKVQSLLSLGFDLNLLNGVL---PPSISNLSNLEGLY 197 (639)
Q Consensus 129 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~---p~~~~~l~~L~~L~ 197 (639)
|+++...+..+..+++|++|++++|++.. ++ ..+..+++|++|++++|.++... +..+..+++|+.||
T Consensus 73 N~i~~l~~~~~~~l~~L~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 73 NRICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp SCCCEECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ccccCCCccccccccccccceeccccccc-cccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 99986656667789999999999999974 33 46788999999999999886432 12355566666665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=7.7e-14 Score=137.19 Aligned_cols=95 Identities=19% Similarity=0.192 Sum_probs=42.9
Q ss_pred CCCCCceeccccc-cccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccCC
Q 046265 233 NFTSLNIVHLEQN-HLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGELP 311 (639)
Q Consensus 233 ~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~p 311 (639)
++++|+.|++++| .+++.....+..+++|++|+++++. .++......++.+++|+.|+++++--.+.++
T Consensus 173 ~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~----------~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~ 242 (284)
T d2astb2 173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY----------DIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242 (284)
T ss_dssp HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT----------TCCGGGGGGGGGCTTCCEEECTTSSCTTCHH
T ss_pred ccccccccccccccCCCchhhhhhcccCcCCEEECCCCC----------CCChHHHHHHhcCCCCCEEeeeCCCCHHHHH
Confidence 4455555555553 3444444445555666666655432 1112222334555666666666551111111
Q ss_pred ccccCCCCCCeeeccCccCcccCCcCccC
Q 046265 312 IELGNLKSLNYRALNGNKVYGSLPRVLGS 340 (639)
Q Consensus 312 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 340 (639)
.-...+++| .+..++++...++.++.
T Consensus 243 ~l~~~lp~L---~i~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 243 LLKEALPHL---QINCSHFTTIARPTIGN 268 (284)
T ss_dssp HHHHHSTTS---EESCCCSCCTTCSSCSS
T ss_pred HHHHhCccc---cccCccCCCCCCCccCc
Confidence 112233333 33455555544444443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=1.6e-13 Score=134.92 Aligned_cols=195 Identities=22% Similarity=0.250 Sum_probs=102.6
Q ss_pred cEEEccCCcCccc-CCccccCCCCCCEEeccCCCCCCCCCccccCCCcccEEEcccC-cCCccCCccCcCCCCCCeEEcc
Q 046265 122 FHLDLSENQLSGS-IPHFLGHLSNLAVLHLGDNSLFGSIPPILGKVQSLLSLGFDLN-LLNGVLPPSISNLSNLEGLYLY 199 (639)
Q Consensus 122 ~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~ 199 (639)
++||++++.++.. ++..+.++++|++|+|++|.++...+..+..+++|++|+++++ .++.. .
T Consensus 49 ~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~---~------------- 112 (284)
T d2astb2 49 QHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF---A------------- 112 (284)
T ss_dssp CEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHH---H-------------
T ss_pred CEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccccccccc---c-------------
Confidence 4555555544322 2333445555555555555554444444555555555555542 23210 0
Q ss_pred CCccccccccccCCcEEEcCCcc-cCC-CCCcccc-CCCCCceeccccc--cccCc-chhhhhcCCCccEEeccCCcccc
Q 046265 200 SSLVSAEIGNLLQLIELEIDNKQ-LFG-QIPKSLR-NFTSLNIVHLEQN--HLTGN-IYEVFGIYPNLTFLDLSQNNFYG 273 (639)
Q Consensus 200 ~~~~~~~~~~l~~L~~L~l~~n~-l~~-~~p~~~~-~l~~L~~L~L~~N--~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~ 273 (639)
+......+++|++|+++++. ++. .++..+. ..++|+.|++++. .++.. +......+++|++|++++|..
T Consensus 113 ---l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~-- 187 (284)
T d2astb2 113 ---LQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM-- 187 (284)
T ss_dssp ---HHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTT--
T ss_pred ---cchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccC--
Confidence 00011233445555555432 111 0111122 2356777777653 23322 333446688999999876532
Q ss_pred cccCcCCccccccCccccCCCCCCEEeccCC-cccccCCccccCCCCCCeeeccCccCcccCCcCccCCCCCC
Q 046265 274 SLNFSMNNITRSIPPKIGKLYQLHKLDFSLN-HIVGELPIELGNLKSLNYRALNGNKVYGSLPRVLGSISDLE 345 (639)
Q Consensus 274 ~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N-~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 345 (639)
++......+..+++|++|++++| .+++.....++.+++|+.|+++++--.+.++.....+++|+
T Consensus 188 --------itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~L~ 252 (284)
T d2astb2 188 --------LKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 252 (284)
T ss_dssp --------CCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTTSE
T ss_pred --------CCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCcccc
Confidence 23445566778889999999985 56666566778889999999987722222222223455654
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.28 E-value=3.7e-13 Score=136.31 Aligned_cols=253 Identities=16% Similarity=0.107 Sum_probs=145.7
Q ss_pred cCCccccCCCCCCEEECcCCCCcc----CCCCCCCCCCCCCEEEcccCcCCCC----------CCcccCCCCCCCEEeee
Q 046265 21 IIPPQIGNISNLKFLDMGNNQLSG----VIPQEIDPLTHLKHLYINVNKLRGS----------VPREVGQLSSLKQLVLY 86 (639)
Q Consensus 21 ~~p~~~~~l~~L~~L~Ls~n~l~~----~~p~~~~~L~~L~~L~L~~N~l~~~----------~p~~~~~l~~L~~L~L~ 86 (639)
.+...+...+.++.|+|++|.+.. .+...+...++|+.|+++++..... +...+...++|+.|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 344566778889999999998753 2334577888999999988765421 12234567888888888
Q ss_pred cccCccccCccccCCCCCCcccCCCCCcccCCCCccEEEccCCcCcccCCcc-------------ccCCCCCCEEeccCC
Q 046265 87 CNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHF-------------LGHLSNLAVLHLGDN 153 (639)
Q Consensus 87 ~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~-------------~~~l~~L~~L~L~~N 153 (639)
+|.++..-...+. ..+...++| ++|++++|.++..-... ....+.|+.+++++|
T Consensus 102 ~n~i~~~~~~~l~-----------~~l~~~~~L--~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n 168 (344)
T d2ca6a1 102 DNAFGPTAQEPLI-----------DFLSKHTPL--EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 168 (344)
T ss_dssp SCCCCTTTHHHHH-----------HHHHHCTTC--CEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred ccccccccccchh-----------hhhcccccc--hheecccccccccccccccccccccccccccccCcccceeecccc
Confidence 8877643111111 111112233 57888888764211111 134567888888887
Q ss_pred CCCCC----CCccccCCCcccEEEcccCcCCccCCccCcCCCCCCeEEccCCccccccccccCCcEEEcCCcccCCC---
Q 046265 154 SLFGS----IPPILGKVQSLLSLGFDLNLLNGVLPPSISNLSNLEGLYLYSSLVSAEIGNLLQLIELEIDNKQLFGQ--- 226 (639)
Q Consensus 154 ~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--- 226 (639)
++... +...+...+.|+.|++++|.++..-... .+...+...++|+.|++++|.+...
T Consensus 169 ~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~---------------~l~~~l~~~~~L~~L~Ls~N~i~~~g~~ 233 (344)
T d2ca6a1 169 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEH---------------LLLEGLAYCQELKVLDLQDNTFTHLGSS 233 (344)
T ss_dssp CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHH---------------HHHTTGGGCTTCCEEECCSSCCHHHHHH
T ss_pred cccccccccccchhhhhhhhccccccccccccccccc---------------chhhhhcchhhhcccccccccccccccc
Confidence 76521 1222445567777777777765310000 0011233455666666666665322
Q ss_pred -CCccccCCCCCceeccccccccCcchh----hhhc--CCCccEEeccCCcccccccCcCCccccccCcccc-CCCCCCE
Q 046265 227 -IPKSLRNFTSLNIVHLEQNHLTGNIYE----VFGI--YPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIG-KLYQLHK 298 (639)
Q Consensus 227 -~p~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~--l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~-~l~~L~~ 298 (639)
+...+..+++|++|++++|.+++.... .+.. .+.|+.|++++|.+... .+ ..+...+. ++++|+.
T Consensus 234 ~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~------~~-~~l~~~l~~~~~~L~~ 306 (344)
T d2ca6a1 234 ALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELD------AV-RTLKTVIDEKMPDLLF 306 (344)
T ss_dssp HHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHH------HH-HHHHHHHHHHCTTCCE
T ss_pred cccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChH------HH-HHHHHHHHccCCCCCE
Confidence 234556677888888888887754322 2322 35688888777765320 00 01222232 4567888
Q ss_pred EeccCCcccc
Q 046265 299 LDFSLNHIVG 308 (639)
Q Consensus 299 L~Ls~N~~~~ 308 (639)
|++++|.+..
T Consensus 307 L~l~~N~~~~ 316 (344)
T d2ca6a1 307 LELNGNRFSE 316 (344)
T ss_dssp EECTTSBSCT
T ss_pred EECCCCcCCC
Confidence 8898888863
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=2.9e-12 Score=113.28 Aligned_cols=88 Identities=20% Similarity=0.170 Sum_probs=42.6
Q ss_pred cceeeeEEEEeCCCcccccCCccccCCCCCCEEECcCC-CCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCC
Q 046265 3 CLAFFFFQVVHESNTLFAIIPPQIGNISNLKFLDMGNN-QLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLK 81 (639)
Q Consensus 3 ~~~~~~~~~~~~~n~~~~~~p~~~~~l~~L~~L~Ls~n-~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 81 (639)
|+|.....++.+.+++. .+|..+..+++|++|++++| .++.+.+.+|.++++|+.|+|++|+|+...|.+|..+++|+
T Consensus 5 C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~ 83 (156)
T d2ifga3 5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83 (156)
T ss_dssp SCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred CCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccc
Confidence 44444444444444443 23444555555555555433 24444344455555555555555555543344455555555
Q ss_pred EEeeecccCc
Q 046265 82 QLVLYCNGLS 91 (639)
Q Consensus 82 ~L~L~~N~l~ 91 (639)
+|+|++|+++
T Consensus 84 ~L~Ls~N~l~ 93 (156)
T d2ifga3 84 RLNLSFNALE 93 (156)
T ss_dssp EEECCSSCCS
T ss_pred ceeccCCCCc
Confidence 5555555554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=7.7e-12 Score=110.49 Aligned_cols=111 Identities=23% Similarity=0.163 Sum_probs=79.2
Q ss_pred cCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccC-cCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCC
Q 046265 27 GNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVN-KLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLA 105 (639)
Q Consensus 27 ~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 105 (639)
......+.++.+++++. ..|..+..+++|+.|++++| .++..-+.+|.++++|+.|+|++|+|+.+.|.+|..+++|
T Consensus 5 C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L- 82 (156)
T d2ifga3 5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL- 82 (156)
T ss_dssp SCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCC-
T ss_pred CCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccc-
Confidence 34455667888888876 56777888888888888655 4775555678888888888888888887777777777633
Q ss_pred cccCCCCCcccCCCCccEEEccCCcCcccCCccccCCCCCCEEeccCCCCC
Q 046265 106 IGSMPNSLSNLTSLSLFHLDLSENQLSGSIPHFLGHLSNLAVLHLGDNSLF 156 (639)
Q Consensus 106 ~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 156 (639)
++|+|++|+++...+..|. ..+|+.|+|++|.+.
T Consensus 83 ----------------~~L~Ls~N~l~~l~~~~~~-~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 83 ----------------SRLNLSFNALESLSWKTVQ-GLSLQELVLSGNPLH 116 (156)
T ss_dssp ----------------CEEECCSSCCSCCCSTTTC-SCCCCEEECCSSCCC
T ss_pred ----------------cceeccCCCCcccChhhhc-cccccccccCCCccc
Confidence 4788888888744344443 346888888888774
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.25 E-value=1.9e-14 Score=133.29 Aligned_cols=131 Identities=22% Similarity=0.223 Sum_probs=73.2
Q ss_pred CCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCCCCCCcccCCCCCcccCCCCccEEE
Q 046265 46 IPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNLNNLAIGSMPNSLSNLTSLSLFHLD 125 (639)
Q Consensus 46 ~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~~lp~~~~~l~~L~L~~L~ 125 (639)
+|.++..|++|++|+|++|+|+ .++ .+..+++|++|+|++|+++ .+|..+..+. . |++|+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~---------------~--L~~L~ 99 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVAD---------------T--LEELW 99 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHH---------------H--CCEEE
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccc---------------c--ccccc
Confidence 3445666666666666666665 343 3666666666666666665 2332222211 1 24666
Q ss_pred ccCCcCcccCCccccCCCCCCEEeccCCCCCCCCC-ccccCCCcccEEEcccCcCCccCCcc----------CcCCCCCC
Q 046265 126 LSENQLSGSIPHFLGHLSNLAVLHLGDNSLFGSIP-PILGKVQSLLSLGFDLNLLNGVLPPS----------ISNLSNLE 194 (639)
Q Consensus 126 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~----------~~~l~~L~ 194 (639)
+++|+++. ++ .+..+++|++|++++|+++.... ..+..+++|+.|++++|.+....+.. +..+++|+
T Consensus 100 l~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~ 177 (198)
T d1m9la_ 100 ISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK 177 (198)
T ss_dssp CSEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCC
T ss_pred cccccccc-cc-cccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcC
Confidence 66666653 22 35566667777777666653211 34566667777777776665433322 34567777
Q ss_pred eEEc
Q 046265 195 GLYL 198 (639)
Q Consensus 195 ~L~l 198 (639)
.||-
T Consensus 178 ~LD~ 181 (198)
T d1m9la_ 178 KLDG 181 (198)
T ss_dssp EESS
T ss_pred EeCC
Confidence 7763
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.24 E-value=2.9e-14 Score=131.94 Aligned_cols=129 Identities=19% Similarity=0.294 Sum_probs=76.0
Q ss_pred CCccccCCCCCCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCccccCccccCC
Q 046265 22 IPPQIGNISNLKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSGWLPSSFGNL 101 (639)
Q Consensus 22 ~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 101 (639)
+|.++..+++|++|+|++|.|+ .++ .+..+++|++|+|++|+|+ .+|..+..+++|++|++++|+++.. + .+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l-~-~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-S-GIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH-H-HHHHH
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc-c-ccccc
Confidence 3455666777777777777776 333 3666777777777777766 4555444455677777777766632 1 23333
Q ss_pred CCCCcccCCCCCcccCCCCccEEEccCCcCcccCC--ccccCCCCCCEEeccCCCCCCCCCcc----------ccCCCcc
Q 046265 102 NNLAIGSMPNSLSNLTSLSLFHLDLSENQLSGSIP--HFLGHLSNLAVLHLGDNSLFGSIPPI----------LGKVQSL 169 (639)
Q Consensus 102 ~~L~~~~lp~~~~~l~~L~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~----------~~~l~~L 169 (639)
+ +| ++|++++|+++. ++ ..+..+++|++|+|++|.+....+.. +..+++|
T Consensus 115 ~---------------~L--~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L 176 (198)
T d1m9la_ 115 V---------------NL--RVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL 176 (198)
T ss_dssp H---------------HS--SEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSC
T ss_pred c---------------cc--cccccccchhcc-ccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCc
Confidence 3 22 467777777653 23 34666777777777777664332221 3456666
Q ss_pred cEEE
Q 046265 170 LSLG 173 (639)
Q Consensus 170 ~~L~ 173 (639)
+.||
T Consensus 177 ~~LD 180 (198)
T d1m9la_ 177 KKLD 180 (198)
T ss_dssp CEES
T ss_pred CEeC
Confidence 6654
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.24 E-value=1.9e-12 Score=130.89 Aligned_cols=257 Identities=17% Similarity=0.130 Sum_probs=156.3
Q ss_pred cCCccccCCCCCCEEeccCCCCCCC----CCccccCCCcccEEEcccCcCCccC---CccCcCCCCCCeEEccCCccccc
Q 046265 134 SIPHFLGHLSNLAVLHLGDNSLFGS----IPPILGKVQSLLSLGFDLNLLNGVL---PPSISNLSNLEGLYLYSSLVSAE 206 (639)
Q Consensus 134 ~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~---p~~~~~l~~L~~L~l~~~~~~~~ 206 (639)
.+...+....+|+.|+|++|.+... +-..+...++|+.++++++...... |..+. .+...
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~-------------~l~~~ 88 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR-------------LLLQA 88 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH-------------HHHHH
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHH-------------HHHHH
Confidence 3445567778899999999887432 2234566778888888776543211 11100 01123
Q ss_pred cccccCCcEEEcCCcccCCC----CCccccCCCCCceeccccccccCcchh-------------hhhcCCCccEEeccCC
Q 046265 207 IGNLLQLIELEIDNKQLFGQ----IPKSLRNFTSLNIVHLEQNHLTGNIYE-------------VFGIYPNLTFLDLSQN 269 (639)
Q Consensus 207 ~~~l~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~-------------~~~~l~~L~~L~Ls~N 269 (639)
+...++|+.|++++|.+... +...+...++|+.|++++|.+...... .....+.|+.+++++|
T Consensus 89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n 168 (344)
T d2ca6a1 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 168 (344)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred HhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccc
Confidence 34556777778877776543 223445667888888888876532111 1234577888887777
Q ss_pred cccccccCcCCccccccCccccCCCCCCEEeccCCccccc-----CCccccCCCCCCeeeccCccCccc----CCcCccC
Q 046265 270 NFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGE-----LPIELGNLKSLNYRALNGNKVYGS----LPRVLGS 340 (639)
Q Consensus 270 ~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~-----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~ 340 (639)
++... . ...+...+...+.|+.|++++|++... +...+..+++|+.|++++|.++.. +...+..
T Consensus 169 ~i~~~------~-~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~ 241 (344)
T d2ca6a1 169 RLENG------S-MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241 (344)
T ss_dssp CCTGG------G-HHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred ccccc------c-cccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccc
Confidence 65310 0 012333455567889999999887632 234466788899999999887532 3455677
Q ss_pred CCCCCEEeCCCCCCCccc-ccCChhhhc--cccCCeeeccCCcCceeecCcchhhhhhhhhh-hhcccCcEEccCCCeee
Q 046265 341 ISDLEYLDLSTNYNNEFR-KEFPVELEK--LVQLTELDLVITFWEERYRPKSVIWKAWRSLI-SRMHGLSCIDISYNELR 416 (639)
Q Consensus 341 l~~L~~L~Ls~N~~~~~~-~~~p~~~~~--l~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~-~~l~~L~~ldls~N~l~ 416 (639)
+++|+.|+|++|.+.... ..+-..+.. ...|+.|+++.|.+.... .+.....+ ...+.|+.+|+++|++.
T Consensus 242 ~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~------~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDA------VRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHH------HHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred cccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHH------HHHHHHHHHccCCCCCEEECCCCcCC
Confidence 888999999986543211 011112222 356889999998765422 12222334 35778999999999875
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.23 E-value=2.2e-08 Score=88.36 Aligned_cols=56 Identities=14% Similarity=0.008 Sum_probs=26.6
Q ss_pred CCEEECcCCCCccCCCCCCCCCCCCCEEEcccCcCCCCCCcccCCCCCCCEEeeecccCcc
Q 046265 32 LKFLDMGNNQLSGVIPQEIDPLTHLKHLYINVNKLRGSVPREVGQLSSLKQLVLYCNGLSG 92 (639)
Q Consensus 32 L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 92 (639)
.+.||+++.... +.+..+..+..++...+... .++..+..+++|++|+|++|+|+.
T Consensus 24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~ 79 (162)
T d1koha1 24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYR 79 (162)
T ss_dssp SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCC
T ss_pred hCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccC
Confidence 445566554321 22344444444444444332 233333455666666666666653
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.22 E-value=1.8e-07 Score=82.32 Aligned_cols=108 Identities=19% Similarity=0.196 Sum_probs=62.2
Q ss_pred ccCCCCCceeccccccccCcchhhhhcCCCccEEeccCCcccccccCcCCccccccCccccCCCCCCEEeccCCcccccC
Q 046265 231 LRNFTSLNIVHLEQNHLTGNIYEVFGIYPNLTFLDLSQNNFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGEL 310 (639)
Q Consensus 231 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~ 310 (639)
+..+..+..+...++... .++..+..+++|++|+|++|+++. + ..++..+..+++|+.|+|++|.|....
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~--------l-~~~~~~~~~l~~L~~L~Ls~N~i~~l~ 107 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYR--------L-DDMSSIVQKAPNLKILNLSGNELKSER 107 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCC--------C-SGGGTHHHHSTTCCCCCCTTSCCCCGG
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccC--------C-chhHHHHhhCCcccccccccCccccch
Confidence 334444445555554433 344555667888888877776632 0 112344556777888888888876543
Q ss_pred CccccCCCCCCeeeccCccCcccCCc-------CccCCCCCCEEe
Q 046265 311 PIELGNLKSLNYRALNGNKVYGSLPR-------VLGSISDLEYLD 348 (639)
Q Consensus 311 p~~~~~l~~L~~L~l~~N~l~~~~p~-------~~~~l~~L~~L~ 348 (639)
+..+.....|+.+++++|.+...... .+..+++|+.||
T Consensus 108 ~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 108 ELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp GHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred hhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 33344445677777777777644332 134456666664
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.15 E-value=1.1e-05 Score=76.66 Aligned_cols=149 Identities=18% Similarity=0.098 Sum_probs=89.7
Q ss_pred HHHHHhccCCCcceeccCCCceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccc-cCceeeeEEEEEcCCc
Q 046265 459 EVIRATNNFDAKYCIGTAGQASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELR-HRNVVKFYGFSFHPRQ 537 (639)
Q Consensus 459 ~~~~~~~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~ 537 (639)
++.+.-..|...+..+.++.+.||+.... ++.++||+....... ....+.+|+..+..+. +--+.+++.++..++.
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 33333445544343333445689998754 456778876542211 1223567777766553 4346778888888889
Q ss_pred eeEEecccCCCChhHHhhcCCCCCCcCHHHHHHHHHHHHHHHHHHHh---------------------------------
Q 046265 538 SFLLYEYLGRGSLAIILSNDAAIDEFSWTVRMNVIKSVANTLSYMHH--------------------------------- 584 (639)
Q Consensus 538 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--------------------------------- 584 (639)
.|+||++++|..+.+...... . ...++.++++.++.||.
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~~-----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDEQ-----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTCS-----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred eEEEEEecccccccccccccc-----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 999999999987755432110 0 11122333333333332
Q ss_pred --------------------CC---CCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 585 --------------------DY---FPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 585 --------------------~~---~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
.. .+.++|+|+.|.||++++++.+-|.||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 10 12378999999999999776677999987654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.83 E-value=3.4e-05 Score=72.59 Aligned_cols=141 Identities=13% Similarity=0.066 Sum_probs=84.2
Q ss_pred eccCC-CceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhcccc--CceeeeEEEEEcCCceeEEecccCCCC
Q 046265 473 IGTAG-QASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRH--RNVVKFYGFSFHPRQSFLLYEYLGRGS 549 (639)
Q Consensus 473 ig~g~-~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~g~ 549 (639)
+..|. -+.||+....++..+++|.-..... ..+.+|+..++.+.. --+.+++++..+++..|+||||++|.+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 34443 4679999988888889998654331 235667777766542 336678888888889999999998766
Q ss_pred hhHH--------------h---hcCC---CCCCcCHHHHHHHHH--------------------HHHHHHHHHHhCC---
Q 046265 550 LAII--------------L---SNDA---AIDEFSWTVRMNVIK--------------------SVANTLSYMHHDY--- 586 (639)
Q Consensus 550 L~~~--------------l---~~~~---~~~~~~~~~~~~i~~--------------------~i~~~l~~lH~~~--- 586 (639)
+.+. + +... ......+.....-.. .....+..+....
T Consensus 93 ~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 172 (255)
T d1nd4a_ 93 LLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDG 172 (255)
T ss_dssp TTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSS
T ss_pred cccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCcc
Confidence 5321 0 1000 000001111110000 0112223333221
Q ss_pred -CCCeEeecCCCCCeeeCCCCceEEcccccccc
Q 046265 587 -FPPIVHRDISSKNVLLGLDYDAHVSDFGISKF 618 (639)
Q Consensus 587 -~~~iiHrdlk~~Nill~~~~~~kl~DfGla~~ 618 (639)
.+.++|+|+.|.||+++.+..+-|+||+.+..
T Consensus 173 ~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 173 EDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 12479999999999999876678999987754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.41 E-value=0.00033 Score=70.27 Aligned_cols=78 Identities=14% Similarity=-0.006 Sum_probs=46.9
Q ss_pred cceeccCCCceEEEEEcCC-CcEEEEEEccCC----CC-ChhhHHHHHHHHHHHhccc-c--CceeeeEEEEEcCCceeE
Q 046265 470 KYCIGTAGQASVYKAELPS-WEIVAVKKFHSP----HP-DMVVQQAFSNEIKALTELR-H--RNVVKFYGFSFHPRQSFL 540 (639)
Q Consensus 470 ~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~----~~-~~~~~~~~~~e~~~l~~l~-H--~niv~l~~~~~~~~~~~l 540 (639)
.+.||.|....||+...++ ++.|+||.-... .. ......+...|++.++.+. + ..+++++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3468999999999997765 578899964321 10 0111223445777776552 2 345566554 4456689
Q ss_pred EecccCCCC
Q 046265 541 LYEYLGRGS 549 (639)
Q Consensus 541 v~e~~~~g~ 549 (639)
||||+++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.95 E-value=9.7e-05 Score=64.51 Aligned_cols=64 Identities=17% Similarity=0.196 Sum_probs=32.9
Q ss_pred CCCCCCEEECcCC-CCccC----CCCCCCCCCCCCEEEcccCcCCCC----CCcccCCCCCCCEEeeecccCc
Q 046265 28 NISNLKFLDMGNN-QLSGV----IPQEIDPLTHLKHLYINVNKLRGS----VPREVGQLSSLKQLVLYCNGLS 91 (639)
Q Consensus 28 ~l~~L~~L~Ls~n-~l~~~----~p~~~~~L~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 91 (639)
+.+.|++|+|+++ .++.. +-..+...+.|++|+|++|.++.. +...+...+.|++|+|++|.++
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 4566777777753 34311 112344555666666666666421 2222334455666666666554
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.81 E-value=0.00038 Score=60.55 Aligned_cols=94 Identities=13% Similarity=0.054 Sum_probs=49.6
Q ss_pred hhhcCCCccEEeccCC-cccccccCcCCccccccCccccCCCCCCEEeccCCccccc----CCccccCCCCCCeeeccCc
Q 046265 254 VFGIYPNLTFLDLSQN-NFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGE----LPIELGNLKSLNYRALNGN 328 (639)
Q Consensus 254 ~~~~l~~L~~L~Ls~N-~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~----~p~~~~~l~~L~~L~l~~N 328 (639)
.....+.|+.|+|+++ .+... .+ ..+-..+...+.|+.|+|++|.+... +...+...+.|+.|++++|
T Consensus 10 l~~n~~~L~~L~L~~~~~i~~~------~~-~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n 82 (167)
T d1pgva_ 10 LREDDTDLKEVNINNMKRVSKE------RI-RSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESN 82 (167)
T ss_dssp HHTTCSSCCEEECTTCCSSCHH------HH-HHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSS
T ss_pred HHhCCCCCcEEEeCCCCCCCHH------HH-HHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehh
Confidence 3445678888887753 23110 00 01222344556778888888877532 1223344566777777777
Q ss_pred cCccc----CCcCccCCCCCCEEeCCCCCC
Q 046265 329 KVYGS----LPRVLGSISDLEYLDLSTNYN 354 (639)
Q Consensus 329 ~l~~~----~p~~~~~l~~L~~L~Ls~N~~ 354 (639)
.+... +-..+...++|+.|++++|..
T Consensus 83 ~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 83 FLTPELLARLLRSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp BCCHHHHHHHHHHTTTTCCCSEEECCCCSS
T ss_pred hcchHHHHHHHHHHHhCCcCCEEECCCCcC
Confidence 66522 112334455566666665543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.52 E-value=0.0038 Score=60.45 Aligned_cols=68 Identities=15% Similarity=0.109 Sum_probs=44.2
Q ss_pred ceEEEEEcCCCcEEEEEEccCCCCChhhHHHHHHHHHHHhccccCcee--eeE-----EEEEcCCceeEEecccCCCC
Q 046265 479 ASVYKAELPSWEIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNVV--KFY-----GFSFHPRQSFLLYEYLGRGS 549 (639)
Q Consensus 479 g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv--~l~-----~~~~~~~~~~lv~e~~~~g~ 549 (639)
-.||+++.++|+.|++|..+.... ..+++..|...+..+....+. ... ......+..+.+++|++|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 479999999999999999875432 234567788877776533221 111 11223456788999987643
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.20 E-value=0.00016 Score=62.96 Aligned_cols=66 Identities=17% Similarity=0.148 Sum_probs=38.3
Q ss_pred ccCCCCCCEEECcC-CCCccC----CCCCCCCCCCCCEEEcccCcCCCC----CCcccCCCCCCCEEeeecccCc
Q 046265 26 IGNISNLKFLDMGN-NQLSGV----IPQEIDPLTHLKHLYINVNKLRGS----VPREVGQLSSLKQLVLYCNGLS 91 (639)
Q Consensus 26 ~~~l~~L~~L~Ls~-n~l~~~----~p~~~~~L~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 91 (639)
..+.+.|++|+|++ +.++.. +-..+...++|+.|+|++|.++.. +-..+...++++.+++++|.++
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 34567788888876 345411 222345667777777777776532 2223445566677777666654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.70 E-value=0.02 Score=56.78 Aligned_cols=72 Identities=21% Similarity=0.255 Sum_probs=45.6
Q ss_pred ceeccCCCceEEEEEcCCC--------cEEEEEEccCCCCChhhHHHHHHHHHHHhccccCce-eeeEEEEEcCCceeEE
Q 046265 471 YCIGTAGQASVYKAELPSW--------EIVAVKKFHSPHPDMVVQQAFSNEIKALTELRHRNV-VKFYGFSFHPRQSFLL 541 (639)
Q Consensus 471 ~~ig~g~~g~vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv 541 (639)
+.++.|-.-.+|++..+.+ +.|.++...... . .....+|..+++.+.-.++ .++++++.. ++|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-h---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 4677788889999976532 456666654221 1 2234578888887743344 467776643 689
Q ss_pred ecccCCCCh
Q 046265 542 YEYLGRGSL 550 (639)
Q Consensus 542 ~e~~~~g~L 550 (639)
|||++|..+
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.04 E-value=0.032 Score=53.20 Aligned_cols=29 Identities=24% Similarity=0.260 Sum_probs=26.3
Q ss_pred CeEeecCCCCCeeeCCCCceEEccccccc
Q 046265 589 PIVHRDISSKNVLLGLDYDAHVSDFGISK 617 (639)
Q Consensus 589 ~iiHrdlk~~Nill~~~~~~kl~DfGla~ 617 (639)
++||+|+.+.||+++.+...-|.||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 79999999999999988877899998764
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.82 E-value=0.01 Score=50.92 Aligned_cols=71 Identities=11% Similarity=0.061 Sum_probs=33.9
Q ss_pred hhhhcCCCccEEeccCC-cccccccCcCCccccccCccccCCCCCCEEeccCCcccccC----CccccCCCCCCeeeccC
Q 046265 253 EVFGIYPNLTFLDLSQN-NFYGSLNFSMNNITRSIPPKIGKLYQLHKLDFSLNHIVGEL----PIELGNLKSLNYRALNG 327 (639)
Q Consensus 253 ~~~~~l~~L~~L~Ls~N-~l~~~l~ls~n~~~~~~p~~~~~l~~L~~L~Ls~N~~~~~~----p~~~~~l~~L~~L~l~~ 327 (639)
......+.|++|+++++ .++.. . ...+-..+...++|+.|++++|.+.... ...+...+.++.+++++
T Consensus 11 ~~~~~~~~L~~L~L~~~~~i~~~------~-~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~ 83 (166)
T d1io0a_ 11 RIQNNDPDLEEVNLNNIMNIPVP------T-LKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVES 83 (166)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHH------H-HHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCS
T ss_pred HHHhcCCCCcEEEcCCCCCCCHH------H-HHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcc
Confidence 34455677777777652 33110 0 0012223345566777777777664321 12233344455555554
Q ss_pred ccC
Q 046265 328 NKV 330 (639)
Q Consensus 328 N~l 330 (639)
|.+
T Consensus 84 ~~~ 86 (166)
T d1io0a_ 84 NFI 86 (166)
T ss_dssp SCC
T ss_pred ccc
Confidence 444
|